rp_entity_id,category,relevance,ess,rpna_date_utc
00326D,conference-call,100,50,1/2/2018
9397,earnings,100,50,1/2/2018
02FC1A,conference-participant,100,50,1/2/2018
04CCCD,dividend,100,50,1/2/2018
51332,executive-appointment,100,54,1/2/2018
078D52,dividend,100,50,1/2/2018
081AB9,conference-call,100,50,1/2/2018
0A9D0A,conference-participant,100,50,1/2/2018
0C136E,acquisition-completed-acquiree,100,76,1/2/2018
0E439E,earnings,100,50,1/2/2018
105D00,acquisition-completed-acquirer,100,49,1/2/2018
1096C6,acquisition-completed-acquirer,100,49,1/2/2018
10C19B,dividend-up,100,81,1/2/2018
1201B5,conference-participant,100,50,1/2/2018
12E454,earnings,100,50,1/2/2018
157D9F,acquisition-completed-acquiree,100,76,1/2/2018
157D9F,asset-sale,100,62,1/2/2018
1A2D9F,earnings,100,50,1/2/2018
1E1125,legal-issues-defendant,100,22,1/2/2018
1F716B,conference-participant,100,50,1/2/2018
1F9D90,conference-participant,100,50,1/2/2018
1F9D90,earnings,100,50,1/2/2018
2082EA,executive-appointment,100,54,1/2/2018
21022F,conference-participant,100,50,1/2/2018
221AD7,earnings,100,50,1/2/2018
221AD7,earnings,100,50,1/2/2018
22C58E,earnings,100,50,1/2/2018
24C48B,acquisition-completed-acquirer,100,49,1/2/2018
250BEE,conference-call,100,50,1/2/2018
2571FA,acquisition-completed-acquirer,100,49,1/2/2018
27A791,conference-participant,100,50,1/2/2018
2920D5,conference-participant,100,50,1/2/2018
2C19A4,dividend,100,50,1/2/2018
2E2E6E,acquisition-completed-acquirer,100,49,1/2/2018
31803E,conference-participant,100,50,1/2/2018
31F25C,conference-call,100,50,1/2/2018
32F943,conference-participant,100,50,1/2/2018
34B411,earnings,100,50,1/2/2018
367E1C,conference-participant,100,50,1/2/2018
37020C,dividend,100,50,1/2/2018
3AF7FD,conference-call,100,50,1/2/2018
3C11C4,acquisition-completed-acquirer,100,49,1/2/2018
41B53E,dividend,100,50,1/2/2018
422CE3,hirings,100,65,1/2/2018
451D61,conference-participant,100,50,1/2/2018
467F2C,conference-participant,100,50,1/2/2018
46A16E,conference-participant,100,50,1/2/2018
46CF27,earnings,100,50,1/2/2018
4A2457,award,100,58,1/2/2018
4F9926,executive-appointment,100,54,1/2/2018
4F9926,executive-appointment,100,54,1/2/2018
4F9926,executive-appointment,100,54,1/2/2018
50070E,conference-organizer,100,57,1/2/2018
524CE4,executive-appointment,100,54,1/2/2018
52FB2F,executive-appointment,100,54,1/2/2018
53F491,earnings,100,50,1/2/2018
546A9C,conference-call,100,50,1/2/2018
56277A,conference-participant,100,50,1/2/2018
56EFC7,facility-open,100,65,1/2/2018
57B174,acquisition-completed-acquirer,100,49,1/2/2018
586BD7,conference-participant,100,50,1/2/2018
58CA9A,dividend,100,50,1/2/2018
58EA22,ipo-completed,100,76,1/2/2018
59C539,conference-call,100,50,1/2/2018
5B226B,unit-acquisition-completed-acquirer,100,49,1/2/2018
5C7601,executive-appointment,100,54,1/2/2018
5EAA43,business-contract,100,69,1/2/2018
6137BF,conference-participant,100,50,1/2/2018
6.18E+08,conference-participant,100,50,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
619882,conference-organizer,100,57,1/2/2018
6284B5,conference-participant,100,50,1/2/2018
63F892,earnings,100,50,1/2/2018
665618,dividend,100,50,1/2/2018
6925EB,conference-participant,100,50,1/2/2018
6B6375,clinical-trials-start,100,64,1/2/2018
6DD6BA,executive-appointment,100,54,1/2/2018
6E1E61,earnings,100,50,1/2/2018
6F22E7,conference-participant,100,50,1/2/2018
726DDF,unit-acquisition-acquiree,100,76,1/2/2018
747219,conference-participant,100,50,1/2/2018
7520CC,acquisition-completed-acquirer,100,49,1/2/2018
763724,dividend,100,50,1/2/2018
763DBE,conference-participant,100,50,1/2/2018
765913,earnings,100,50,1/2/2018
789ADD,earnings,100,50,1/2/2018
7C4F43,business-contract,100,69,1/2/2018
805CD8,conference-participant,100,50,1/2/2018
8.10E+32,conference-call,100,50,1/2/2018
810FAD,conference-organizer,100,57,1/2/2018
81EAD4,conference-participant,100,50,1/2/2018
82F088,unit-acquisition-acquirer,100,49,1/2/2018
85AD00,acquisition-completed-acquirer,100,49,1/2/2018
8665BA,conference-participant,100,50,1/2/2018
868808,acquisition-completed-acquirer,100,49,1/2/2018
8B2C4A,conference-call,100,50,1/2/2018
8DAAB9,acquisition-completed-acquirer,100,49,1/2/2018
8DCBBB,conference-call,100,50,1/2/2018
8E4250,unit-acquisition-acquirer,100,49,1/2/2018
8E4F9A,campaign-ad-release,100,59,1/2/2018
92D3A0,conference-call,100,50,1/2/2018
9.31E+77,conference-participant,100,50,1/2/2018
94983E,conference-participant,100,50,1/2/2018
9A2760,conference-participant,100,50,1/2/2018
9A602D,unit-acquisition-acquirer,100,49,1/2/2018
9B4066,facility-sale,100,52,1/2/2018
9F18FA,executive-appointment,100,54,1/2/2018
9F18FA,executive-appointment,100,54,1/2/2018
9F37C5,dividend,100,50,1/2/2018
9F71E5,acquisition-completed-acquirer,100,49,1/2/2018
A26C26,conference-participant,100,50,1/2/2018
A52533,conference-participant,100,50,1/2/2018
A5628C,executive-appointment,100,54,1/2/2018
A5A4F5,acquisition-acquirer,100,49,1/2/2018
A5B913,earnings,100,50,1/2/2018
A65325,conference-call,100,50,1/2/2018
A6828A,dividend,100,50,1/2/2018
A6828A,legal-issues-defendant,100,22,1/2/2018
AE7D16,business-contract,100,69,1/2/2018
AED6CF,asset-sale,100,62,1/2/2018
AFF43F,earnings,100,50,1/2/2018
B1B10C,acquisition-acquirer,100,49,1/2/2018
B290A2,conference-participant,100,50,1/2/2018
B33E77,business-contract,100,69,1/2/2018
B7EB38,conference-participant,100,50,1/2/2018
B83D67,conference-participant,100,50,1/2/2018
BB88B6,earnings,100,50,1/2/2018
BDEC1E,conference-participant,100,50,1/2/2018
C06EB6,earnings,100,50,1/2/2018
C07E05,conference-participant,100,50,1/2/2018
C22BE8,patent-infringement-defendant,100,26,1/2/2018
C45C1F,conference-participant,100,50,1/2/2018
C4FBDC,executive-appointment,100,54,1/2/2018
C598D7,conference-call,100,50,1/2/2018
C7AE14,dividend,100,50,1/2/2018
C81E00,conference-participant,100,50,1/2/2018
C951A2,conference-participant,100,50,1/2/2018
CC339B,product-release,100,64,1/2/2018
CC339B,product-release,100,64,1/2/2018
CE4FD9,acquisition-acquirer,100,49,1/2/2018
CF3FF9,conference-participant,100,50,1/2/2018
D08D2C,conference-call,100,50,1/2/2018
D7918D,ipo,100,71,1/2/2018
DC486E,earnings,100,50,1/2/2018
DD0099,merger-completed,100,66,1/2/2018
DF1F7A,conference-call,100,50,1/2/2018
DF532D,conference-call,100,50,1/2/2018
E124EB,conference-participant,100,50,1/2/2018
E13782,note-sale,100,52,1/2/2018
E30A8F,business-contract,100,69,1/2/2018
E67C2C,conference-participant,100,50,1/2/2018
E8B21D,executive-appointment,100,54,1/2/2018
EB7FBF,unit-acquisition-acquirer,100,49,1/2/2018
EB7FBF,dividend,100,50,1/2/2018
ED2A5E,conference-participant,100,50,1/2/2018
EF1AD9,conference-call,100,50,1/2/2018
EF5BED,conference-call,100,50,1/2/2018
F1CD47,executive-appointment,100,54,1/2/2018
F30508,conference-participant,100,50,1/2/2018
F5349B,executive-appointment,100,54,1/2/2018
FACF19,conference-participant,100,50,1/2/2018
FDC7E6,buybacks,100,74,1/2/2018
FDC7E6,conference-call,100,50,1/2/2018
FE7A63,earnings,100,50,1/2/2018
04EB2F,conference-participant,100,50,1/3/2018
05D148,patient-enrollment-start,100,58,1/3/2018
099A02,executive-appointment,100,54,1/3/2018
0B57D7,conference-call,100,50,1/3/2018
0B7375,conference-participant,100,50,1/3/2018
0CE204,product-release,100,64,1/3/2018
0E499E,conference-participant,100,50,1/3/2018
0F04E5,conference-participant,100,50,1/3/2018
1216D1,executive-appointment,100,54,1/3/2018
1220D2,conference-participant,100,50,1/3/2018
16F4D8,conference-participant,100,50,1/3/2018
16FC89,buybacks,100,74,1/3/2018
17EDA5,legal-issues-defendant,100,22,1/3/2018
18D9FA,regulatory-product-approval-granted,100,81,1/3/2018
19CAC7,conference-call,100,50,1/3/2018
1AD9CC,revenues,100,50,1/3/2018
1B5FEA,executive-appointment,100,54,1/3/2018
1DE526,conference-call,100,50,1/3/2018
1E1125,conference-organizer,100,57,1/3/2018
1E1125,legal-issues-defendant,100,22,1/3/2018
1EA923,conference-participant,100,50,1/3/2018
1EBF8D,conference-call,100,50,1/3/2018
1EBF8D,conference-participant,100,50,1/3/2018
202E5A,regulatory-product-application,100,69,1/3/2018
202E5A,conference-participant,100,50,1/3/2018
267718,partnership,100,61,1/3/2018
267718,partnership,100,61,1/3/2018
28DCA8,executive-appointment,100,54,1/3/2018
2A1009,conference-participant,100,50,1/3/2018
2AA6A8,conference-participant,100,50,1/3/2018
2B0AF4,conference-call,100,50,1/3/2018
2C35B5,executive-appointment,100,54,1/3/2018
31553A,earnings,100,50,1/3/2018
326EDD,conference-call,100,50,1/3/2018
338544,conference-call,100,50,1/3/2018
34B411,investment-investor,100,55,1/3/2018
3.88E+02,dividend-up,100,81,1/3/2018
38C46F,dividend,100,50,1/3/2018
3C7F5F,earnings,100,50,1/3/2018
408089,earnings,100,50,1/3/2018
41C528,acquisition-completed-acquirer,100,49,1/3/2018
434F38,earnings,100,50,1/3/2018
458D2C,earnings-guidance,100,50,1/3/2018
4A2457,business-contract,100,69,1/3/2018
4A5C8D,acquisition-completed-acquirer,100,49,1/3/2018
4C7DB5,earnings,100,50,1/3/2018
4C92B9,acquisition-acquirer,100,49,1/3/2018
4D8313,conference-call,100,50,1/3/2018
4E4E75,conference-participant,100,50,1/3/2018
4E6F5A,conference-participant,100,50,1/3/2018
50070E,conference-organizer,100,57,1/3/2018
510EA6,revenue-up,100,69,1/3/2018
510EA6,revenue-up,100,69,1/3/2018
54DF47,unit-acquisition-acquirer,100,49,1/3/2018
56277A,regulatory-product-approval-granted,100,81,1/3/2018
56B7C1,dividend,100,50,1/3/2018
56EA2B,conference-participant,100,50,1/3/2018
56EA2B,public-offering,100,43,1/3/2018
57CAAB,conference-participant,100,50,1/3/2018
57DDB9,partnership,100,61,1/3/2018
59B229,earnings,100,50,1/3/2018
5B35C7,buyback-suspended,100,24,1/3/2018
5B6C11,executive-appointment,100,54,1/3/2018
5C7601,executive-appointment,100,54,1/3/2018
5D43A7,conference-call,100,50,1/3/2018
5DA8B3,acquisition-completed-acquirer,100,49,1/3/2018
5F9CE3,conference-participant,100,50,1/3/2018
5FE4B6,conference-participant,100,50,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
619882,conference-organizer,100,57,1/3/2018
62B1C6,dividend,100,50,1/3/2018
62B1C6,dividend,100,50,1/3/2018
66A667,legal-issues-defendant,100,22,1/3/2018
66A667,legal-issues-defendant,100,22,1/3/2018
68BA15,conference-call,100,50,1/3/2018
6B0784,conference-participant,100,50,1/3/2018
709AED,conference-participant,100,50,1/3/2018
717DB4,conference-participant,100,50,1/3/2018
731675,public-offering,100,43,1/3/2018
7.40E+289,dividend-up,100,70,1/3/2018
767F86,partnership,100,61,1/3/2018
7A975D,earnings,100,50,1/3/2018
7A975D,earnings,100,50,1/3/2018
7AB859,conference-call,100,50,1/3/2018
7AB859,fundraising,100,64,1/3/2018
7D85A9,acquisition-completed-acquirer,100,49,1/3/2018
81EAD4,partnership,100,61,1/3/2018
830BDB,conference-participant,100,50,1/3/2018
863350,partnership,100,61,1/3/2018
877C0C,legal-issues-defendant,100,22,1/3/2018
877C0C,conference-participant,100,50,1/3/2018
88193E,conference-participant,100,50,1/3/2018
8A8E41,partnership,100,61,1/3/2018
8D5145,earnings,100,50,1/3/2018
9087B9,note-sale,100,52,1/3/2018
93965C,conference-participant,100,50,1/3/2018
94637C,conference-participant,100,50,1/3/2018
958938,partnership,100,61,1/3/2018
958938,partnership,100,61,1/3/2018
96A6CD,conference-participant,100,50,1/3/2018
977A1E,merger,100,66,1/3/2018
977A1E,merger,100,66,1/3/2018
9.82E+06,conference-participant,100,50,1/3/2018
98CEBB,merger-regulatory-approval,100,81,1/3/2018
9CA4C6,conference-call,100,50,1/3/2018
9CE4C7,earnings,100,50,1/3/2018
9E298A,conference-call,100,50,1/3/2018
9FA83B,conference-participant,100,50,1/3/2018
A5195E,conference-participant,100,50,1/3/2018
A5628C,executive-appointment,100,54,1/3/2018
A5A4F5,acquisition-acquirer,100,49,1/3/2018
A5DD24,conference-participant,100,50,1/3/2018
A6213D,conference-participant,100,50,1/3/2018
A63387,business-contract,100,69,1/3/2018
A6828A,partnership,100,61,1/3/2018
A6828A,partnership,100,61,1/3/2018
A70BF5,earnings,100,50,1/3/2018
A8B137,conference-call,100,50,1/3/2018
AB4A7E,conference-participant,100,50,1/3/2018
ABBAD1,earnings,100,50,1/3/2018
AD9F1D,facility-open,100,65,1/3/2018
AE79CD,clinical-trials-start,100,64,1/3/2018
AEF2C3,conference-participant,100,50,1/3/2018
B04426,conference-participant,100,50,1/3/2018
B05118,conference-participant,100,50,1/3/2018
B08954,conference-call,100,50,1/3/2018
B2206F,conference-participant,100,50,1/3/2018
B2DAF6,conference-participant,100,50,1/3/2018
B66928,executive-appointment,100,54,1/3/2018
B9764A,conference-participant,100,50,1/3/2018
BA218A,conference-call,100,50,1/3/2018
C3EE99,earnings,100,50,1/3/2018
C584BE,executive-appointment,100,54,1/3/2018
C584BE,executive-appointment,100,54,1/3/2018
C659EB,conference-call,100,50,1/3/2018
C98CDB,conference-participant,100,50,1/3/2018
C9E107,earnings,100,50,1/3/2018
C9F39B,conference-call,100,50,1/3/2018
CAB222,conference-participant,100,50,1/3/2018
CAC8D0,earnings,100,50,1/3/2018
CAC8D0,earnings,100,50,1/3/2018
CAD7D9,earnings,100,50,1/3/2018
CBFFDD,executive-appointment,100,54,1/3/2018
CBFFDD,executive-appointment,100,54,1/3/2018
CC8F6E,partnership,100,61,1/3/2018
CF6A5A,earnings,100,50,1/3/2018
D4AC65,partnership,100,61,1/3/2018
D8760C,earnings-guidance,100,50,1/3/2018
DF6FDD,product-release,100,64,1/3/2018
E87676,acquisition-acquirer,100,49,1/3/2018
E8E899,partnership,100,61,1/3/2018
EB43F4,government-contract,100,69,1/3/2018
EB43F4,settlement,100,56,1/3/2018
EB7FBF,earnings-per-share-positive,100,69,1/3/2018
EC70EC,stake-acquirer,100,48,1/3/2018
EC70EC,acquisition-acquirer,100,49,1/3/2018
ED5171,earnings,100,50,1/3/2018
EF5BED,executive-appointment,100,54,1/3/2018
F0B335,conference-participant,100,50,1/3/2018
F1EB39,joint-venture,100,62,1/3/2018
F47871,conference-participant,100,50,1/3/2018
F4E992,conference-call,100,50,1/3/2018
F50BAB,conference-call,100,50,1/3/2018
F5D059,dividend,100,50,1/3/2018
F5D410,conference-call,100,50,1/3/2018
F6DE54,executive-appointment,100,54,1/3/2018
F88A04,name-change,100,49,1/3/2018
F8BA6C,conference-participant,100,50,1/3/2018
FC1A6E,conference-participant,100,50,1/3/2018
FD9526,conference-call,100,50,1/3/2018
FDD3FC,conference-participant,100,50,1/3/2018
FE7A63,dividend,100,50,1/3/2018
FEE4B0,earnings,100,50,1/3/2018
00067A,conference-participant,100,50,1/4/2018
001F1B,earnings,100,50,1/4/2018
001F1B,earnings,100,50,1/4/2018
00326D,earnings,100,50,1/4/2018
003B70,executive-appointment,100,54,1/4/2018
00E601,executive-appointment,100,54,1/4/2018
01D03F,partnership,100,61,1/4/2018
0358AF,earnings,100,50,1/4/2018
03CF95,legal-issues-defendant,100,22,1/4/2018
03FAA6,earnings,100,50,1/4/2018
43862,clinical-trials-start,100,64,1/4/2018
061A3B,earnings,100,50,1/4/2018
09F623,public-offering,100,43,1/4/2018
0A59F8,debt-extension-recipient,100,73,1/4/2018
0DE3D5,executive-appointment,100,54,1/4/2018
0E499E,revenues,100,50,1/4/2018
0F0693,clinical-trials-positive,100,87,1/4/2018
0FC848,partnership,100,61,1/4/2018
105D00,conference-call,100,50,1/4/2018
11A49E,conference-participant,100,50,1/4/2018
17EDA5,fraud-defendant,100,20,1/4/2018
184988,conference-participant,100,50,1/4/2018
1E83DE,partnership,100,61,1/4/2018
1EC3E8,executive-appointment,100,54,1/4/2018
1FC422,conference-participant,100,50,1/4/2018
206852,conference-call,100,50,1/4/2018
228D42,partnership,100,61,1/4/2018
251988,product-release,100,64,1/4/2018
251988,product-release,100,64,1/4/2018
2667B6,earnings,100,50,1/4/2018
27BFA1,conference-call,100,50,1/4/2018
2A1009,clinical-trials-start,100,64,1/4/2018
2B5483,product-release,100,64,1/4/2018
2B8179,patent-awarded,100,72,1/4/2018
2BDC1C,executive-appointment,100,54,1/4/2018
2BDC1C,executive-appointment,100,54,1/4/2018
2C35B5,patient-enrollment-complete,100,64,1/4/2018
2CC71C,conference-participant,100,50,1/4/2018
2D643C,conference-call,100,50,1/4/2018
2F7474,conference-call,100,50,1/4/2018
3587B4,conference-participant,100,50,1/4/2018
3.73E+87,executive-resignation,100,44,1/4/2018
3.73E+87,executive-appointment,100,54,1/4/2018
37727A,executive-appointment,100,54,1/4/2018
39D9DA,earnings,100,50,1/4/2018
3A3447,facility-open,100,65,1/4/2018
3D9999,earnings,100,50,1/4/2018
3DD5E2,partnership,100,61,1/4/2018
3F4497,conference-call,100,50,1/4/2018
41A93D,conference-participant,100,50,1/4/2018
43A060,partnership,100,61,1/4/2018
46017C,conference-participant,100,50,1/4/2018
4.60E+06,revenue-up,100,75,1/4/2018
499C75,acquisition-acquirer,100,49,1/4/2018
4A2457,business-contract,100,69,1/4/2018
4A2457,government-contract,100,69,1/4/2018
4A5C8D,conference-call,100,50,1/4/2018
4A6F00,partnership,100,61,1/4/2018
4AC91D,product-recall,100,29,1/4/2018
52BF94,conference-call,100,50,1/4/2018
5.43E+08,partnership,100,61,1/4/2018
5.43E+08,conference-participant,100,50,1/4/2018
546A27,conference-participant,100,50,1/4/2018
5.47E+28,executive-appointment,100,54,1/4/2018
54DF47,acquisition-acquirer,100,49,1/4/2018
567F3D,conference-call,100,50,1/4/2018
56EA2B,public-offering,100,43,1/4/2018
58B46F,earnings-estimate,100,50,1/4/2018
58B46F,earnings,100,50,1/4/2018
58CA9A,conference-organizer,100,57,1/4/2018
5B226B,acquisition-acquirer,100,49,1/4/2018
5B226B,acquisition-acquirer,100,49,1/4/2018
5B3FA2,conference-participant,100,50,1/4/2018
5CC29D,earnings,100,50,1/4/2018
5F2FF7,earnings,100,50,1/4/2018
5F3D91,conference-participant,100,50,1/4/2018
60EA12,earnings,100,50,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
619882,conference-organizer,100,57,1/4/2018
61B81B,executive-appointment,100,54,1/4/2018
627186,earnings,100,50,1/4/2018
66A667,legal-issues-defendant,100,22,1/4/2018
68E3E0,conference-participant,100,50,1/4/2018
69CE71,earnings-guidance-meet-expectations,100,59,1/4/2018
69CE71,earnings-guidance-meet-expectations,100,59,1/4/2018
69CE71,earnings-guidance,100,50,1/4/2018
69CE71,earnings-guidance,100,50,1/4/2018
69CE71,earnings-guidance,100,50,1/4/2018
6B6375,conference-participant,100,50,1/4/2018
6-Dec-05,partnership,100,61,1/4/2018
6E8864,conference-participant,100,50,1/4/2018
713810,partnership,100,61,1/4/2018
72CB93,executive-appointment,100,54,1/4/2018
731675,public-offering,100,43,1/4/2018
7.44E+09,conference-call,100,50,1/4/2018
7448A3,conference-participant,100,50,1/4/2018
76F067,conference-participant,100,50,1/4/2018
7740DE,same-store-sales-down,100,41,1/4/2018
775439,earnings,100,50,1/4/2018
7771D7,earnings,100,50,1/4/2018
790C34,product-release,100,64,1/4/2018
7B0BA6,earnings,100,50,1/4/2018
7B9212,revenues,100,50,1/4/2018
7BEA98,executive-appointment,100,54,1/4/2018
7BEA98,executive-appointment,100,54,1/4/2018
7C4F43,conference-participant,100,50,1/4/2018
7CD98F,earnings-guidance,100,50,1/4/2018
7F3665,conference-participant,100,50,1/4/2018
81222C,campaign-ad-release,100,59,1/4/2018
8303CD,conference-participant,100,50,1/4/2018
85AD00,conference-call,100,50,1/4/2018
8BAA15,conference-participant,100,50,1/4/2018
8E4250,conference-call,100,50,1/4/2018
8E4F9A,conference-participant,100,50,1/4/2018
8EF425,conference-call,100,50,1/4/2018
90D6A5,earnings-guidance,100,50,1/4/2018
9196A2,conference-call,100,50,1/4/2018
922F0C,earnings,100,50,1/4/2018
92B047,conference-call,100,50,1/4/2018
9.36E+10,business-contract,100,69,1/4/2018
93965C,product-release,100,64,1/4/2018
93D207,earnings,100,50,1/4/2018
94C0B5,conference-call,100,50,1/4/2018
958938,conference-participant,100,50,1/4/2018
977A1E,acquisition-acquirer,100,49,1/4/2018
9810C0,earnings-guidance,100,50,1/4/2018
986AF6,conference-call,100,50,1/4/2018
9D3360,earnings,100,50,1/4/2018
A1E3B3,conference-participant,100,50,1/4/2018
B303A6,executive-appointment,100,54,1/4/2018
B4703C,conference-call,100,50,1/4/2018
B54A74,conference-participant,100,50,1/4/2018
B5766D,investment-investor,100,55,1/4/2018
B8EF97,revenues,100,50,1/4/2018
BB5271,executive-appointment,100,54,1/4/2018
BB58FF,fundraising,100,64,1/4/2018
BE5935,conference-participant,100,50,1/4/2018
BE7BA4,unit-acquisition-acquirer,100,49,1/4/2018
BEB756,conference-call,100,50,1/4/2018
C3BAE7,conference-participant,100,50,1/4/2018
C45CE7,conference-participant,100,50,1/4/2018
C564E4,conference-participant,100,50,1/4/2018
C5C137,same-store-sales,100,50,1/4/2018
C5C137,same-store-sales,100,50,1/4/2018
C83B88,executive-appointment,100,54,1/4/2018
CB9E13,executive-appointment,100,54,1/4/2018
CD2DA4,dividend,100,50,1/4/2018
CEDFD5,earnings,100,50,1/4/2018
D21D8A,conference-call,100,50,1/4/2018
D2B9E5,facility-open,100,65,1/4/2018
D437C3,earnings,100,50,1/4/2018
D4AC65,acquisition-acquirer,100,49,1/4/2018
D54E62,conference-call,100,50,1/4/2018
D56D6D,acquisition-acquirer,100,49,1/4/2018
D6EAA3,executive-appointment,100,54,1/4/2018
DA9443,clinical-trials-start,100,64,1/4/2018
DB7FA7,conference-call,100,50,1/4/2018
DF18E6,earnings-guidance,100,50,1/4/2018
DF6FDD,product-release,100,64,1/4/2018
E124EB,regulatory-product-approval-granted,100,81,1/4/2018
E28D9C,conference-participant,100,50,1/4/2018
E30A8F,earnings,100,50,1/4/2018
E68E62,merger-completed,100,66,1/4/2018
E6D89E,partnership,100,61,1/4/2018
E8E899,conference-participant,100,50,1/4/2018
E9E6FD,conference-call,100,50,1/4/2018
ED9576,conference-call,100,50,1/4/2018
F5D059,earnings-up,100,68,1/4/2018
F5D059,earnings,100,50,1/4/2018
F5D059,earnings,100,50,1/4/2018
F5D059,earnings,100,50,1/4/2018
F80389,earnings-guidance,100,50,1/4/2018
F85CC0,earnings,100,50,1/4/2018
FACF19,earnings,100,50,1/4/2018
FACF19,executive-appointment,100,54,1/4/2018
FC1B7B,conference-call,100,50,1/4/2018
FC4550,dividend,100,50,1/4/2018
FC80E6,acquisition-completed-acquirer,100,49,1/4/2018
FD0CA4,conference-call,100,50,1/4/2018
FD2565,conference-participant,100,50,1/4/2018
FDD3FC,clinical-trials-start,100,64,1/4/2018
FEC475,conference-call,100,50,1/4/2018
FF4BA4,earnings,100,50,1/4/2018
001F1B,revenues,100,50,1/5/2018
9397,legal-issues-defendant,100,22,1/5/2018
00E601,earnings,100,50,1/5/2018
31025,earnings,100,50,1/5/2018
048B70,conference-call,100,50,1/5/2018
054B55,legal-issues-defendant,100,22,1/5/2018
09F623,public-offering,100,43,1/5/2018
0BF528,conference-participant,100,50,1/5/2018
0C2A0D,conference-participant,100,50,1/5/2018
17EDA5,legal-issues-defendant,100,22,1/5/2018
184988,executive-appointment,100,54,1/5/2018
1BC12C,conference-call,100,50,1/5/2018
1D1B07,earnings,100,50,1/5/2018
1D1B07,earnings,100,50,1/5/2018
1D1B07,earnings,100,50,1/5/2018
1D5C51,conference-participant,100,50,1/5/2018
20BEEA,conference-call,100,50,1/5/2018
21022F,executive-appointment,100,54,1/5/2018
29A4CC,conference-call,100,50,1/5/2018
2A9C0A,conference-call,100,50,1/5/2018
2BF36E,conference-participant,100,50,1/5/2018
2EC172,award,100,58,1/5/2018
30DFD3,executive-appointment,100,54,1/5/2018
3.14E+47,earnings,100,50,1/5/2018
3390DE,conference-call,100,50,1/5/2018
3A3447,facility-open,100,65,1/5/2018
42DC93,earnings,100,50,1/5/2018
43A74A,conference-participant,100,50,1/5/2018
442587,business-contract,100,69,1/5/2018
499C75,earnings-guidance,100,50,1/5/2018
4B3555,earnings,100,50,1/5/2018
4EC4C1,earnings,100,50,1/5/2018
4EC4C1,earnings,100,50,1/5/2018
4EC4C1,earnings,100,50,1/5/2018
4EC4C1,earnings,100,50,1/5/2018
52015A,dividend,100,50,1/5/2018
550D01,conference-call,100,50,1/5/2018
5675EB,earnings,100,50,1/5/2018
57DDB9,conference-participant,100,50,1/5/2018
5EC388,executive-appointment,100,54,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
619882,conference-organizer,100,57,1/5/2018
6474BA,earnings,100,50,1/5/2018
66A667,dividend,100,50,1/5/2018
68B03F,executive-appointment,100,54,1/5/2018
701531,partnership,100,61,1/5/2018
70FCEF,executive-appointment,100,54,1/5/2018
76959C,executive-appointment,100,54,1/5/2018
7AF5B8,partnership,100,61,1/5/2018
7D7716,earnings,100,50,1/5/2018
8.10E+32,dividend,100,50,1/5/2018
84A6B9,earnings,100,50,1/5/2018
859281,earnings,100,50,1/5/2018
862941,conference-participant,100,50,1/5/2018
8665BA,conference-call,100,50,1/5/2018
86A1B9,earnings,100,50,1/5/2018
88923D,partnership,100,61,1/5/2018
88923D,partnership,100,61,1/5/2018
88923D,partnership,100,61,1/5/2018
8A8E41,acquisition-acquirer,100,49,1/5/2018
8B6E7E,acquisition-acquirer,100,49,1/5/2018
93AD2E,conference-call,100,50,1/5/2018
9592FB,revenue-guidance,100,50,1/5/2018
95A92E,earnings-guidance,100,50,1/5/2018
98CEBB,acquisition-completed-acquirer,100,49,1/5/2018
9D6A24,conference-call,100,50,1/5/2018
A41450,dividend,100,50,1/5/2018
AFF7B4,conference-call,100,50,1/5/2018
B1A85D,acquisition-completed-acquirer,100,49,1/5/2018
B446B8,earnings,100,50,1/5/2018
B762D3,earnings,100,50,1/5/2018
B762D3,earnings,100,50,1/5/2018
B80AD1,product-release,100,64,1/5/2018
B8F71F,executive-appointment,100,54,1/5/2018
BBAE2A,conference-call,100,50,1/5/2018
BCC55F,conference-participant,100,50,1/5/2018
BD15E8,conference-call,100,50,1/5/2018
BDE867,executive-appointment,100,54,1/5/2018
C07E05,executive-appointment,100,54,1/5/2018
C27E19,earnings,100,50,1/5/2018
C41C25,earnings,100,50,1/5/2018
C74887,clinical-trials,100,56,1/5/2018
CAC8D0,conference-participant,100,50,1/5/2018
CBB77B,name-change,100,49,1/5/2018
CC339B,earnings,100,50,1/5/2018
CC6FF5,earnings,100,50,1/5/2018
CD06A2,earnings,100,50,1/5/2018
CE4FD9,conference-participant,100,50,1/5/2018
D06755,earnings,100,50,1/5/2018
D0909F,resource-discovery,100,88,1/5/2018
D1173F,conference-call,100,50,1/5/2018
D2C0B6,joint-venture,100,62,1/5/2018
D3FA2C,executive-appointment,100,54,1/5/2018
D88EF3,executive-appointment,100,54,1/5/2018
D8C09D,earnings-guidance,100,50,1/5/2018
DB5CA5,dividend,100,50,1/5/2018
DC5299,conference-call,100,50,1/5/2018
DC6EF3,investment-investor,100,55,1/5/2018
E12A6E,earnings,100,50,1/5/2018
E20392,conference-participant,100,50,1/5/2018
E30B34,conference-participant,100,50,1/5/2018
E70531,resource-discovery,100,88,1/5/2018
EDF5CA,conference-call,100,50,1/5/2018
EFA7B2,executive-appointment,100,54,1/5/2018
F30508,conference-call,100,50,1/5/2018
F82D37,conference-call,100,50,1/5/2018
FAEABE,executive-appointment,100,54,1/5/2018
FEE4B0,award,100,58,1/5/2018
FF6644,conference-call,100,50,1/5/2018
619882,conference-organizer,100,57,1/6/2018
CA1620,legal-issues-defendant,100,22,1/6/2018
D8442A,legal-issues-defendant,100,22,1/6/2018
DC2F77,earnings,100,50,1/6/2018
367E1C,executive-resignation,100,44,1/7/2018
45BC35,revenues,100,50,1/7/2018
91E5EE,revenue-guidance,100,50,1/7/2018
C564E4,clinical-trials-positive,100,87,1/7/2018
00326E,conference-call,100,50,1/8/2018
02870F,executive-resignation,100,44,1/8/2018
03FAA6,unit-acquisition-acquirer,100,49,1/8/2018
07CA6A,conference-call,100,50,1/8/2018
0A9D0A,executive-appointment,100,54,1/8/2018
0B4D10,public-offering,100,43,1/8/2018
0B7375,executive-appointment,100,54,1/8/2018
0C136E,executive-appointment,100,54,1/8/2018
0C355F,earnings-guidance-up,100,83,1/8/2018
0E499E,partnership,100,61,1/8/2018
0F0440,revenues,100,50,1/8/2018
1151F4,conference-call,100,50,1/8/2018
1272B3,conference-participant,100,50,1/8/2018
12DE76,conference-participant,100,50,1/8/2018
135B09,conference-call,100,50,1/8/2018
1490F3,conference-call,100,50,1/8/2018
17EDA5,legal-issues-defendant,100,22,1/8/2018
188394,conference-call,100,50,1/8/2018
1921DD,partnership,100,61,1/8/2018
1B4F31,executive-appointment,100,54,1/8/2018
1B4F31,executive-appointment,100,54,1/8/2018
1B4F31,executive-appointment,100,54,1/8/2018
1D3A00,earnings-guidance,100,50,1/8/2018
1D9E55,conference-organizer,100,57,1/8/2018
21022F,revenues,100,50,1/8/2018
228D42,partnership,100,61,1/8/2018
228D42,stock-gain,100,63,1/8/2018
275300,conference-call,100,50,1/8/2018
279916,business-contract,100,69,1/8/2018
284289,facility-open,100,65,1/8/2018
2A1009,earnings,100,50,1/8/2018
2C35B5,executive-appointment,100,54,1/8/2018
2CB4C9,facility-open,100,65,1/8/2018
2D2D43,earnings,100,50,1/8/2018
2D76CE,earnings,100,50,1/8/2018
2D76CE,earnings,100,50,1/8/2018
2E89AE,regulatory-product-approval-granted,100,81,1/8/2018
2EC172,facility-open,100,65,1/8/2018
32F943,revenues,100,50,1/8/2018
33FD66,earnings,100,50,1/8/2018
342218,conference-call,100,50,1/8/2018
36C09B,conference-participant,100,50,1/8/2018
36C09B,business-contract,100,69,1/8/2018
37727A,earnings,100,50,1/8/2018
39BFF6,conference-call,100,50,1/8/2018
3A113F,earnings,100,50,1/8/2018
3A3447,executive-appointment,100,54,1/8/2018
3F4497,business-contract,100,69,1/8/2018
41785E,earnings,100,50,1/8/2018
422CE3,executive-resignation,100,44,1/8/2018
425BDC,product-release,100,64,1/8/2018
42AABD,business-contract,100,69,1/8/2018
467F2C,earnings,100,50,1/8/2018
4A2457,award,100,58,1/8/2018
4BEB48,product-release,100,64,1/8/2018
4C31F3,executive-appointment,100,54,1/8/2018
4D8124,legal-issues-defendant,100,22,1/8/2018
4E7C1F,business-contract,100,69,1/8/2018
50070E,conference-participant,100,50,1/8/2018
51B442,earnings,100,50,1/8/2018
54512F,executive-appointment,100,54,1/8/2018
550D01,partnership,100,61,1/8/2018
55ACCB,earnings,100,50,1/8/2018
55D0F3,legal-issues-defendant,100,22,1/8/2018
56EA2B,public-offering,100,43,1/8/2018
5A423F,partnership,100,61,1/8/2018
5AF08A,note-sale,100,52,1/8/2018
5B6C11,earnings,100,50,1/8/2018
5C2A47,partnership,100,61,1/8/2018
5D41E4,conference-participant,100,50,1/8/2018
5D41E4,conference-participant,100,50,1/8/2018
5EC388,earnings,100,50,1/8/2018
5FF95F,earnings,100,50,1/8/2018
610D47,conference-call,100,50,1/8/2018
6166D1,partnership,100,61,1/8/2018
619882,conference-organizer,100,57,1/8/2018
619882,conference-organizer,100,57,1/8/2018
619882,conference-organizer,100,57,1/8/2018
619882,conference-organizer,100,57,1/8/2018
619882,conference-organizer,100,57,1/8/2018
619882,conference-organizer,100,57,1/8/2018
619882,conference-organizer,100,57,1/8/2018
67303E,public-offering,100,43,1/8/2018
67529E,conference-call,100,50,1/8/2018
694749,executive-appointment,100,54,1/8/2018
6D2BF6,revenues,100,50,1/8/2018
6E705B,product-release,100,64,1/8/2018
6F5DD2,patent-awarded,100,72,1/8/2018
724F84,executive-appointment,100,54,1/8/2018
72609A,earnings,100,50,1/8/2018
7262F2,earnings-guidance-meet-expectations,100,59,1/8/2018
73C9E2,conference-call,100,50,1/8/2018
747219,earnings,100,50,1/8/2018
76CEFB,executive-resignation,100,44,1/8/2018
771985,earnings,100,50,1/8/2018
7A5D58,executive-appointment,100,54,1/8/2018
7B492C,conference-call,100,50,1/8/2018
7D5384,headquarters-change,100,50,1/8/2018
81222C,market-entry,100,57,1/8/2018
8.22E+27,conference-call,100,50,1/8/2018
82FD6D,executive-appointment,100,54,1/8/2018
88923D,earnings,100,50,1/8/2018
895D56,conference-participant,100,50,1/8/2018
89F693,executive-appointment,100,54,1/8/2018
89F693,executive-appointment,100,54,1/8/2018
89F693,executive-appointment,100,54,1/8/2018
8B6E7E,executive-appointment,100,54,1/8/2018
8E9CD8,earnings-guidance,100,50,1/8/2018
8E9CD8,earnings-guidance,100,50,1/8/2018
9.36E+10,business-contract,100,69,1/8/2018
93633B,conference-call,100,50,1/8/2018
93965C,partnership,100,61,1/8/2018
96F126,executive-appointment,100,54,1/8/2018
9.74E+08,earnings,100,50,1/8/2018
97693A,earnings-guidance,100,50,1/8/2018
97693A,earnings-guidance,100,50,1/8/2018
9978F1,business-contract,100,69,1/8/2018
9A2760,acquisition-acquirer,100,49,1/8/2018
9B730A,partnership,100,61,1/8/2018
9B730A,partnership,100,61,1/8/2018
9BBFA5,earnings-guidance-up,100,83,1/8/2018
9C5BA5,acquisition-completed-acquirer,100,49,1/8/2018
9D6A24,acquisition-completed-acquirer,100,49,1/8/2018
9E575E,clinical-trials,100,56,1/8/2018
A02FB1,conference-call,100,50,1/8/2018
A26C26,earnings,100,50,1/8/2018
A4B899,executive-appointment,100,54,1/8/2018
A52533,executive-appointment,100,54,1/8/2018
A7102F,stake-acquirer,100,48,1/8/2018
ADF092,earnings,100,50,1/8/2018
AED61E,conference-participant,100,50,1/8/2018
B09B1F,executive-appointment,100,54,1/8/2018
B13B68,conference-participant,100,50,1/8/2018
B1FC3B,business-contract,100,69,1/8/2018
B4B281,revenues,100,50,1/8/2018
B5766D,conference-call,100,50,1/8/2018
B85DCE,acquisition-completed-acquiree,100,76,1/8/2018
B9764A,partnership,100,61,1/8/2018
BA218A,legal-issues-defendant,100,22,1/8/2018
BBF349,partnership,100,61,1/8/2018
BDD12C,partnership,100,61,1/8/2018
BDF85E,earnings-guidance-up,100,83,1/8/2018
C32A39,earnings-guidance,100,50,1/8/2018
C4F9C6,clinical-trials,100,56,1/8/2018
C5D2AE,earnings,100,50,1/8/2018
C659EB,executive-appointment,100,54,1/8/2018
C7FC95,partnership,100,61,1/8/2018
C81E00,executive-appointment,100,54,1/8/2018
C951A2,revenue-up,100,58,1/8/2018
C951A2,earnings,100,50,1/8/2018
CA1620,legal-issues-defendant,100,22,1/8/2018
CB89EA,executive-appointment,100,54,1/8/2018
CC339B,stake-acquirer,100,48,1/8/2018
CFF15D,partnership,100,61,1/8/2018
CFF15D,product-release,100,64,1/8/2018
CFF15D,product-release,100,64,1/8/2018
CFF15D,business-contract,100,69,1/8/2018
CFF15D,product-release,100,64,1/8/2018
D1CFC8,partnership,100,61,1/8/2018
D501DC,dividend,100,50,1/8/2018
D5938F,regulatory-product-approval-granted,100,81,1/8/2018
D65A13,revenue-up,100,75,1/8/2018
D65A13,revenue-up,100,75,1/8/2018
D65A13,revenue-up,100,75,1/8/2018
D9E036,conference-participant,100,50,1/8/2018
DB5CA5,executive-appointment,100,54,1/8/2018
DB7014,earnings,100,50,1/8/2018
DF11D9,conference-call,100,50,1/8/2018
E09E2B,partnership,100,61,1/8/2018
E09E2B,product-release,100,64,1/8/2018
E0D3BA,earnings,100,50,1/8/2018
E11C41,executive-appointment,100,54,1/8/2018
E20BFE,revenues,100,50,1/8/2018
E30B34,executive-appointment,100,54,1/8/2018
E35610,executive-appointment,100,54,1/8/2018
E829E8,partnership,100,61,1/8/2018
E8A49A,earnings,100,50,1/8/2018
E8B315,earnings,100,50,1/8/2018
ECA300,same-store-sales,100,50,1/8/2018
ECA300,same-store-sales,100,50,1/8/2018
ED2A5E,revenue-guidance,100,50,1/8/2018
ED2A5E,revenue-guidance,100,50,1/8/2018
EE74E1,earnings,100,50,1/8/2018
EFD406,conference-participant,100,50,1/8/2018
F00285,executive-appointment,100,54,1/8/2018
F02170,product-release,100,64,1/8/2018
F0B877,executive-appointment,100,54,1/8/2018
F11638,campaign-ad-release,100,59,1/8/2018
F30508,partnership,100,61,1/8/2018
F46EC9,earnings,100,50,1/8/2018
F51DB0,earnings,100,50,1/8/2018
F5349B,executive-appointment,100,54,1/8/2018
F6A945,conference-call,100,50,1/8/2018
F6E1B5,partnership,100,61,1/8/2018
F7935D,regulatory-product-approval-granted,100,81,1/8/2018
F85CC0,executive-appointment,100,54,1/8/2018
FC1B7B,conference-call,100,50,1/8/2018
FCA54E,merger,100,66,1/8/2018
FDF799,earnings,100,50,1/8/2018
FF5413,revenue-volume,100,50,1/8/2018
00067A,partnership,100,61,1/9/2018
00326E,product-release,100,64,1/9/2018
0157B1,product-release,100,64,1/9/2018
01D03F,partnership,100,61,1/9/2018
03B8CF,product-release,100,64,1/9/2018
03FAA6,partnership,100,61,1/9/2018
51332,conference-call,100,50,1/9/2018
09DE1F,note-sale,100,52,1/9/2018
1220D2,regulatory-product-approval-granted,100,81,1/9/2018
12DE76,product-release,100,64,1/9/2018
12DE76,product-release,100,64,1/9/2018
12DE76,product-release,100,64,1/9/2018
12DE76,product-release,100,64,1/9/2018
147C38,partnership,100,61,1/9/2018
147C38,partnership,100,61,1/9/2018
15901B,executive-appointment,100,54,1/9/2018
16B183,earnings-guidance-up,100,83,1/9/2018
17EDA5,partnership,100,61,1/9/2018
17EDA5,partnership,100,61,1/9/2018
19BF16,partnership,100,61,1/9/2018
19C105,award,100,58,1/9/2018
1B9535,partnership,100,61,1/9/2018
1BC12C,trading-delisting,100,36,1/9/2018
1CDD1C,earnings-guidance,100,50,1/9/2018
1FAF22,conference-call,100,50,1/9/2018
22C58E,partnership,100,61,1/9/2018
275300,note-sale,100,52,1/9/2018
275300,note-sale,100,52,1/9/2018
279916,executive-appointment,100,54,1/9/2018
27A791,revenues,100,50,1/9/2018
2BBE62,earnings,100,50,1/9/2018
2E61CC,dividend,100,50,1/9/2018
384CD3,business-contract,100,69,1/9/2018
3DE4D1,conference-call,100,50,1/9/2018
3E15F6,conference-call,100,50,1/9/2018
407878,earnings,100,50,1/9/2018
4.00E+163,executive-appointment,100,54,1/9/2018
44DDBD,executive-appointment,100,54,1/9/2018
4A6F00,product-release,100,64,1/9/2018
4B3DC9,conference-call,100,50,1/9/2018
4F9926,revenue-volume,100,50,1/9/2018
4F9926,product-release,100,64,1/9/2018
4F9926,product-release,100,64,1/9/2018
4F9926,product-release,100,64,1/9/2018
4F9926,product-release,100,64,1/9/2018
4F9926,product-release,100,64,1/9/2018
51D876,conference-call,100,50,1/9/2018
546A9C,earnings,100,50,1/9/2018
55ACCB,legal-issues-defendant,100,22,1/9/2018
55ACCB,legal-issues-defendant,100,22,1/9/2018
57356F,conference-call,100,50,1/9/2018
589846,executive-appointment,100,54,1/9/2018
5AF08A,note-sale,100,52,1/9/2018
5BE42C,conference-call,100,50,1/9/2018
5F1B7B,earnings,100,50,1/9/2018
619882,conference-organizer,100,57,1/9/2018
61BCA7,earnings,100,50,1/9/2018
64E615,conference-participant,100,50,1/9/2018
66A667,legal-issues-defendant,100,22,1/9/2018
66A667,earnings,100,50,1/9/2018
68AB62,conference-call,100,50,1/9/2018
69345C,earnings,100,50,1/9/2018
6B494E,dividend,100,50,1/9/2018
6D3B7B,donation,100,54,1/9/2018
71E2EF,facility-open,100,65,1/9/2018
732449,executive-appointment,100,54,1/9/2018
76F067,business-contract,100,69,1/9/2018
76F067,business-contract,100,69,1/9/2018
790C34,partnership,100,61,1/9/2018
791EC1,unit-acquisition-acquirer,100,49,1/9/2018
79340A,earnings,100,50,1/9/2018
7A975D,dividend,100,50,1/9/2018
7ACD98,name-change,100,49,1/9/2018
7D5FD6,partnership,100,61,1/9/2018
7D5FD6,partnership,100,61,1/9/2018
7E2DE6,earnings,100,50,1/9/2018
7F3669,conference-participant,100,50,1/9/2018
8665BA,business-contract,100,69,1/9/2018
8AB37F,partnership,100,61,1/9/2018
8C311A,earnings,100,50,1/9/2018
8D5145,acquisition-regulatory-approval-acquirer,100,54,1/9/2018
8E0E32,dividend,100,50,1/9/2018
8E93A4,earnings,100,50,1/9/2018
92D757,executive-appointment,100,54,1/9/2018
945DE6,executive-appointment,100,54,1/9/2018
949625,conference-call,100,50,1/9/2018
9.62E+76,earnings,100,50,1/9/2018
96BFF4,partnership,100,61,1/9/2018
9.86E+03,conference-participant,100,50,1/9/2018
9BB35A,conference-call,100,50,1/9/2018
9C5174,partnership,100,61,1/9/2018
9C5174,partnership,100,61,1/9/2018
9E5C2C,public-offering,100,43,1/9/2018
9EBAFA,dividend,100,50,1/9/2018
A5A4F5,acquisition-acquirer,100,49,1/9/2018
A6213D,partnership,100,61,1/9/2018
A6213D,partnership,100,61,1/9/2018
A63820,earnings,100,50,1/9/2018
A75D43,conference-call,100,50,1/9/2018
A87CD6,earnings,100,50,1/9/2018
A8B137,executive-appointment,100,54,1/9/2018
AA09AD,executive-appointment,100,54,1/9/2018
AF210D,joint-venture,100,62,1/9/2018
AFDF2E,revenue-guidance,100,50,1/9/2018
AFDF2E,legal-issues-defendant,100,22,1/9/2018
AFDF2E,legal-issues-defendant,100,22,1/9/2018
B1B10C,conference-call,100,50,1/9/2018
B1FC3B,business-contract,100,69,1/9/2018
B2256A,conference-call,100,50,1/9/2018
B2E6B5,conference-call,100,50,1/9/2018
B33E77,partnership,100,61,1/9/2018
B37FB4,earnings,100,50,1/9/2018
B4F5F4,unit-acquisition-acquiree,100,76,1/9/2018
B4F5F4,unit-acquisition-acquiree,100,76,1/9/2018
B6082A,conference-call,100,50,1/9/2018
B6843B,facility-open,100,65,1/9/2018
B7FA9B,acquisition-acquirer,100,49,1/9/2018
B96637,conference-participant,100,50,1/9/2018
BD9668,note-sale,100,52,1/9/2018
C0200F,earnings,100,50,1/9/2018
C2609A,product-release,100,64,1/9/2018
C3BAE7,earnings,100,50,1/9/2018
C3DE7D,award,100,58,1/9/2018
C81E00,revenues,100,50,1/9/2018
C97B2D,revenues,100,50,1/9/2018
CE96E7,product-release,100,64,1/9/2018
CFF15D,facility-open,100,65,1/9/2018
CFF15D,partnership,100,61,1/9/2018
CFF15D,partnership,100,61,1/9/2018
D4AC65,partnership,100,61,1/9/2018
D7AC6E,earnings,100,50,1/9/2018
D7AC6E,earnings,100,50,1/9/2018
D8442A,product-release,100,64,1/9/2018
D854F3,earnings,100,50,1/9/2018
D8DA3D,conference-call,100,50,1/9/2018
DA48E4,unit-acquisition-acquirer,100,49,1/9/2018
DB5CA5,earnings,100,50,1/9/2018
DC0998,product-release,100,64,1/9/2018
DC0998,product-release,100,64,1/9/2018
E09E2B,partnership,100,61,1/9/2018
E30B34,executive-appointment,100,54,1/9/2018
E3E68E,conference-call,100,50,1/9/2018
E68733,patient-enrollment-start,100,58,1/9/2018
E6D89E,business-contract,100,69,1/9/2018
E6E012,product-release,100,64,1/9/2018
E6E012,product-release,100,64,1/9/2018
E866D2,revenue-volume,100,50,1/9/2018
E959F3,earnings,100,50,1/9/2018
EAA0A7,conference-participant,100,50,1/9/2018
EB5E78,conference-call,100,50,1/9/2018
ED79D9,executive-appointment,100,54,1/9/2018
ED79D9,acquisition-acquirer,100,49,1/9/2018
EF77A3,dividend-up,100,81,1/9/2018
EFD406,conference-participant,100,50,1/9/2018
F02170,executive-appointment,100,54,1/9/2018
F1EB39,product-release,100,64,1/9/2018
F32F88,conference-call,100,50,1/9/2018
F3EDB4,executive-resignation,100,44,1/9/2018
F3EDB4,dividend,100,50,1/9/2018
F4E992,earnings,100,50,1/9/2018
F6DCE4,earnings-guidance-up,100,83,1/9/2018
F793FA,merger-completed,100,66,1/9/2018
F7ADEB,conference-participant,100,50,1/9/2018
FC4550,conference-call,100,50,1/9/2018
FF4BA4,executive-resignation,100,44,1/9/2018
01478A,conference-call,100,50,1/10/2018
07EC43,earnings-guidance,100,50,1/10/2018
0F04E5,business-contract,100,69,1/10/2018
0FC848,product-release,100,64,1/10/2018
1096C6,business-contract,100,69,1/10/2018
1096C6,business-contract,100,69,1/10/2018
1096C6,business-contract,100,69,1/10/2018
11074E,conference-call,100,50,1/10/2018
119CB6,conference-call,100,50,1/10/2018
1.79E+10,conference-call,100,50,1/10/2018
17EDA5,legal-issues-defendant,100,22,1/10/2018
19BF16,earnings,100,50,1/10/2018
1A5D5D,partnership,100,61,1/10/2018
239106,unit-acquisition-acquirer,100,49,1/10/2018
2.45E+15,earnings,100,50,1/10/2018
272704,earnings,100,50,1/10/2018
28AF37,executive-appointment,100,54,1/10/2018
2DB344,earnings,100,50,1/10/2018
2F1299,note-sale,100,52,1/10/2018
309922,conference-call,100,50,1/10/2018
31666F,dividend,100,50,1/10/2018
343996,executive-appointment,100,54,1/10/2018
3CBA2A,conference-call,100,50,1/10/2018
416C55,earnings,100,50,1/10/2018
442587,partnership,100,61,1/10/2018
4.91E+58,conference-call,100,50,1/10/2018
4B5054,conference-call,100,50,1/10/2018
50070E,partnership,100,61,1/10/2018
525A1C,earnings,100,50,1/10/2018
55438C,product-release,100,64,1/10/2018
55438C,donation,100,54,1/10/2018
55ACCB,legal-issues-defendant,100,22,1/10/2018
55ACCB,legal-issues-defendant,100,22,1/10/2018
57356F,note-sale,100,52,1/10/2018
57CAAB,regulatory-product-approval-granted,100,81,1/10/2018
57DDB9,product-release,100,64,1/10/2018
589846,conference-participant,100,50,1/10/2018
59872F,executive-appointment,100,54,1/10/2018
5C2A47,conference-call,100,50,1/10/2018
5D63F1,partnership,100,61,1/10/2018
5EAA43,conference-call,100,50,1/10/2018
601785,earnings,100,50,1/10/2018
60DD84,conference-call,100,50,1/10/2018
616E3B,conference-call,100,50,1/10/2018
619882,conference-organizer,100,57,1/10/2018
6284B5,acquisition-completed-acquirer,100,49,1/10/2018
62EFEE,earnings,100,50,1/10/2018
6.52E+64,earnings-guidance,100,50,1/10/2018
6.52E+64,award,100,58,1/10/2018
66749D,earnings,100,50,1/10/2018
69345C,partnership,100,61,1/10/2018
69E8E1,conference-call,100,50,1/10/2018
69E8E1,conference-call,100,50,1/10/2018
69E8E1,conference-call,100,50,1/10/2018
69FDFC,executive-appointment,100,54,1/10/2018
69FDFC,executive-appointment,100,54,1/10/2018
6A3C35,acquisition-acquiree,100,76,1/10/2018
6D6B40,earnings,100,50,1/10/2018
72CB93,partnership,100,61,1/10/2018
72FCA3,earnings,100,50,1/10/2018
7.40E+289,earnings,100,50,1/10/2018
7.40E+289,earnings,100,50,1/10/2018
7.40E+289,earnings,100,50,1/10/2018
7823A3,earnings,100,50,1/10/2018
787D14,product-release,100,64,1/10/2018
7E1D5D,acquisition-acquirer,100,49,1/10/2018
7E62B5,earnings-guidance,100,50,1/10/2018
838ADD,unit-acquisition-acquirer,100,49,1/10/2018
86478F,earnings,100,50,1/10/2018
8FE7A5,conference-participant,100,50,1/10/2018
901327,earnings,100,50,1/10/2018
91C82E,earnings-per-share-positive,100,69,1/10/2018
91C82E,earnings-per-share-positive,100,69,1/10/2018
91C82E,earnings-per-share-positive,100,69,1/10/2018
91C82E,earnings-per-share-positive,100,69,1/10/2018
91C82E,earnings-per-share-positive,100,69,1/10/2018
93D207,partnership,100,61,1/10/2018
9.74E+08,executive-appointment,100,54,1/10/2018
980C14,dividend,100,50,1/10/2018
994468,conference-participant,100,50,1/10/2018
9E98F2,conference-participant,100,50,1/10/2018
9EBAFA,public-offering,100,43,1/10/2018
A01664,earnings,100,50,1/10/2018
A29DBD,conference-call,100,50,1/10/2018
A48593,conference-call,100,50,1/10/2018
A5A4F5,acquisition-acquirer,100,49,1/10/2018
A666C8,conference-participant,100,50,1/10/2018
A99576,conference-call,100,50,1/10/2018
AA09AD,product-release,100,64,1/10/2018
AFD1CA,conference-participant,100,50,1/10/2018
AFDF2E,legal-issues-defendant,100,22,1/10/2018
B1FC3B,business-contract,100,69,1/10/2018
B2DAF6,earnings,100,50,1/10/2018
B37FB4,earnings,100,50,1/10/2018
B54A74,earnings,100,50,1/10/2018
B54A74,conference-participant,100,50,1/10/2018
B5BA39,executive-appointment,100,54,1/10/2018
B7202A,business-contract,100,69,1/10/2018
B840EF,product-release,100,64,1/10/2018
B840EF,product-release,100,64,1/10/2018
BAAA60,conference-call,100,50,1/10/2018
BB127B,business-contract,100,69,1/10/2018
BB5142,earnings,100,50,1/10/2018
BBBB41,conference-call,100,50,1/10/2018
BD682F,dividend,100,50,1/10/2018
C0F70B,earnings,100,50,1/10/2018
C1114B,unit-acquisition-acquiree,100,76,1/10/2018
C230FE,earnings,100,50,1/10/2018
C4C77F,dividend,100,50,1/10/2018
C6C702,conference-call,100,50,1/10/2018
C7AE14,conference-call,100,50,1/10/2018
C83B88,product-release,100,64,1/10/2018
CE96E7,conference-call,100,50,1/10/2018
CEC08B,product-release,100,64,1/10/2018
CF6A5A,executive-appointment,100,54,1/10/2018
D17F7E,earnings,100,50,1/10/2018
D1C0B9,earnings,100,50,1/10/2018
D58A11,earnings,100,50,1/10/2018
D7A953,earnings,100,50,1/10/2018
D82EF3,conference-call,100,50,1/10/2018
DAFED3,conference-participant,100,50,1/10/2018
DC0998,partnership,100,61,1/10/2018
DDCB34,conference-participant,100,50,1/10/2018
DF46C5,acquisition-completed-acquirer,100,49,1/10/2018
DF6FDD,earnings-guidance,100,50,1/10/2018
E8B21D,acquisition-acquiree,100,76,1/10/2018
E8B21D,acquisition-acquiree,100,76,1/10/2018
E9E6FD,market-entry,100,57,1/10/2018
EC99D0,partnership,100,61,1/10/2018
EF25A5,award,100,58,1/10/2018
F02170,product-release,100,64,1/10/2018
F1529C,executive-resignation,100,44,1/10/2018
F179ED,earnings,100,50,1/10/2018
F5349B,business-contract,100,69,1/10/2018
FA044A,conference-call,100,50,1/10/2018
FDF28E,earnings,100,50,1/10/2018
13528,campaign-ad-release,100,59,1/11/2018
48590,earnings,100,50,1/11/2018
71860,earnings,100,50,1/11/2018
07CA6A,executive-appointment,100,54,1/11/2018
0BB9E5,acquisition-completed-acquirer,100,49,1/11/2018
0FC848,executive-appointment,100,54,1/11/2018
1096C6,business-contract,100,69,1/11/2018
13C3E0,earnings,100,50,1/11/2018
14ED2B,partnership,100,61,1/11/2018
157D9F,conference-call,100,50,1/11/2018
17EDA5,legal-issues-defendant,100,22,1/11/2018
17EDA5,legal-issues-defendant,100,22,1/11/2018
17EDA5,legal-issues-defendant,100,22,1/11/2018
17EDA5,legal-issues-defendant,100,22,1/11/2018
182B8C,conference-call,100,50,1/11/2018
1921DD,fundraising,100,64,1/11/2018
1D5C51,product-release,100,64,1/11/2018
1F08A6,asset-sale,100,62,1/11/2018
1F716B,executive-resignation,100,44,1/11/2018
1FE3CB,conference-call,100,50,1/11/2018
21153F,partnership,100,61,1/11/2018
228D42,product-release,100,64,1/11/2018
24CB56,dividend,100,50,1/11/2018
26CC63,board-meeting,100,51,1/11/2018
28DCA8,earnings-guidance,100,50,1/11/2018
2EC172,partnership,100,61,1/11/2018
2F94A5,executive-appointment,100,54,1/11/2018
30CBF9,executive-appointment,100,54,1/11/2018
31AA84,conference-participant,100,50,1/11/2018
32CB22,conference-call,100,50,1/11/2018
32F24A,conference-call,100,50,1/11/2018
370C50,conference-call,100,50,1/11/2018
384CD3,earnings,100,50,1/11/2018
39692D,partnership,100,61,1/11/2018
3B20AB,dividend,100,50,1/11/2018
3DB18B,product-release,100,64,1/11/2018
435ACE,conference-call,100,50,1/11/2018
43A74A,asset-sale,100,62,1/11/2018
442769,conference-participant,100,50,1/11/2018
447FC6,conference-call,100,50,1/11/2018
4591D3,executive-appointment,100,54,1/11/2018
4591D3,conference-call,100,50,1/11/2018
45ABCC,product-release,100,64,1/11/2018
45BC35,note-sale,100,52,1/11/2018
50D1EC,conference-participant,100,50,1/11/2018
5340D0,earnings,100,50,1/11/2018
546A9C,award,100,58,1/11/2018
55ACCB,legal-issues-defendant,100,22,1/11/2018
583A75,conference-call,100,50,1/11/2018
5D0337,executive-appointment,100,54,1/11/2018
5D0337,earnings,100,50,1/11/2018
5E6959,conference-call,100,50,1/11/2018
619882,partnership,100,61,1/11/2018
619882,conference-organizer,100,57,1/11/2018
66667F,partnership,100,61,1/11/2018
66E04A,earnings,100,50,1/11/2018
68E6E9,earnings,100,50,1/11/2018
6C4D2F,conference-call,100,50,1/11/2018
6F92A9,product-release,100,64,1/11/2018
71E2EF,note-sale,100,52,1/11/2018
728737,dividend,100,50,1/11/2018
72CB93,conference-call,100,50,1/11/2018
731675,public-offering,100,43,1/11/2018
73C521,executive-appointment,100,54,1/11/2018
767F86,earnings,100,50,1/11/2018
76CEFB,earnings,100,50,1/11/2018
773A17,earnings,100,50,1/11/2018
7A51FE,conference-call,100,50,1/11/2018
7AC86E,award,100,58,1/11/2018
7ACD98,name-change,100,49,1/11/2018
7ACD98,name-change,100,49,1/11/2018
7B9AFA,conference-participant,100,50,1/11/2018
7D5384,conference-call,100,50,1/11/2018
82C202,business-contract,100,69,1/11/2018
82E58A,earnings-guidance,100,50,1/11/2018
8377DB,product-release,100,64,1/11/2018
837C04,conference-call,100,50,1/11/2018
8802B4,conference-call,100,50,1/11/2018
8D0EEA,conference-participant,100,50,1/11/2018
8E0E32,earnings,100,50,1/11/2018
911AB8,earnings,100,50,1/11/2018
91C82E,dividend,100,50,1/11/2018
96F126,product-release,100,64,1/11/2018
977A1E,award,100,58,1/11/2018
98CEBB,earnings,100,50,1/11/2018
9B5968,executive-appointment,100,54,1/11/2018
9B5968,executive-appointment,100,54,1/11/2018
9B5968,executive-appointment,100,54,1/11/2018
9CA432,conference-call,100,50,1/11/2018
9D56F2,conference-call,100,50,1/11/2018
9EED50,conference-call,100,50,1/11/2018
9F048E,conference-participant,100,50,1/11/2018
9FF5F1,earnings,100,50,1/11/2018
A4A612,earnings,100,50,1/11/2018
A5A4F5,acquisition-acquirer,100,49,1/11/2018
A868C9,partnership,100,61,1/11/2018
AA09AD,executive-appointment,100,54,1/11/2018
AE7D16,partnership,100,61,1/11/2018
AFDF2E,legal-issues-defendant,100,22,1/11/2018
AFDF2E,legal-issues-defendant,100,22,1/11/2018
B0FE08,conference-call,100,50,1/11/2018
B1DF3C,earnings,100,50,1/11/2018
B1FC3B,business-contract,100,69,1/11/2018
B2DAF6,executive-appointment,100,54,1/11/2018
B5734D,earnings,100,50,1/11/2018
B5DE80,earnings,100,50,1/11/2018
B604DF,earnings-guidance,100,50,1/11/2018
B6843B,facility-open,100,65,1/11/2018
BB5142,government-contract,100,69,1/11/2018
BB5271,conference-call,100,50,1/11/2018
BDD12C,earnings,100,50,1/11/2018
BFAEB4,facility-close,100,47,1/11/2018
C0F70B,conference-participant,100,50,1/11/2018
C32A39,executive-appointment,100,54,1/11/2018
C4706C,dividend,100,50,1/11/2018
C83B88,legal-issues-defendant,100,22,1/11/2018
C951A2,executive-appointment,100,54,1/11/2018
C97B2D,regulatory-product-approval-granted,100,81,1/11/2018
CDE51C,earnings,100,50,1/11/2018
CE5664,earnings,100,50,1/11/2018
D08D2C,dividend,100,50,1/11/2018
D0909F,earnings-guidance,100,50,1/11/2018
D17C1B,revenue-volume,100,50,1/11/2018
D17C1B,conference-call,100,50,1/11/2018
D437C3,partnership,100,61,1/11/2018
D5938F,orphan-drug-designation,100,76,1/11/2018
D9FC89,earnings,100,50,1/11/2018
DB23C8,conference-participant,100,50,1/11/2018
E0207A,acquisition-acquirer,100,49,1/11/2018
E0207A,acquisition-acquirer,100,49,1/11/2018
E0207A,acquisition-acquirer,100,49,1/11/2018
E074A0,earnings,100,50,1/11/2018
E2CB7B,conference-participant,100,50,1/11/2018
E6A53A,earnings,100,50,1/11/2018
E829E8,earnings,100,50,1/11/2018
EB6965,dividend,100,50,1/11/2018
ED9C04,patent-infringement-plaintiff,100,47,1/11/2018
EEA6B3,conference-call,100,50,1/11/2018
F11638,board-meeting,100,51,1/11/2018
F6DCE4,dividend,100,50,1/11/2018
F6FA6A,conference-call,100,50,1/11/2018
F721A7,conference-call,100,50,1/11/2018
F721A7,conference-call,100,50,1/11/2018
FE89E0,conference-call,100,50,1/11/2018
FF4343,earnings,100,50,1/11/2018
07C69F,conference-call,100,50,1/12/2018
0ED415,conference-call,100,50,1/12/2018
14BA06,earnings,100,50,1/12/2018
1748B3,conference-call,100,50,1/12/2018
1E9A6D,earnings,100,50,1/12/2018
250BEE,dividend,100,50,1/12/2018
26F31D,earnings,100,50,1/12/2018
26F31D,executive-appointment,100,54,1/12/2018
2.89E+11,dividend,100,50,1/12/2018
2CB4C9,earnings,100,50,1/12/2018
2DA92D,conference-call,100,50,1/12/2018
2E1322,earnings,100,50,1/12/2018
2E902B,conference-call,100,50,1/12/2018
2EBA55,dividend,100,50,1/12/2018
2F5256,executive-appointment,100,54,1/12/2018
35F4B5,earnings,100,50,1/12/2018
3BCF24,earnings,100,50,1/12/2018
3DDE54,earnings,100,50,1/12/2018
458D2C,revenue-volume,100,50,1/12/2018
4AE584,fundraising,100,64,1/12/2018
4B49CF,conference-call,100,50,1/12/2018
50070E,executive-resignation,100,44,1/12/2018
5225A4,conference-call,100,50,1/12/2018
5546DA,conference-call,100,50,1/12/2018
55ACCB,legal-issues-defendant,100,22,1/12/2018
55ACCB,legal-issues-defendant,100,22,1/12/2018
55C289,conference-call,100,50,1/12/2018
5B6C11,dividend,100,50,1/12/2018
619882,earnings,100,50,1/12/2018
619882,dividend,100,50,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
61B81B,earnings-up,100,68,1/12/2018
629F0F,dividend,100,50,1/12/2018
665618,conference-call,100,50,1/12/2018
665D7D,conference-call,100,50,1/12/2018
69345C,legal-issues-defendant,100,22,1/12/2018
6CDFC6,conference-call,100,50,1/12/2018
6D0CAB,dividend,100,50,1/12/2018
731675,public-offering,100,43,1/12/2018
773A17,executive-appointment,100,54,1/12/2018
88350F,conference-call,100,50,1/12/2018
92D757,acquisition-acquirer,100,49,1/12/2018
93633B,earnings,100,50,1/12/2018
93F143,earnings,100,50,1/12/2018
972356,executive-appointment,100,54,1/12/2018
9D30A8,conference-participant,100,50,1/12/2018
A3800A,legal-issues-defendant,100,22,1/12/2018
A4F67C,earnings,100,50,1/12/2018
A5A4F5,acquisition-acquirer,100,49,1/12/2018
AA5C8E,earnings,100,50,1/12/2018
AADE0B,conference-call,100,50,1/12/2018
AD3C93,award,100,58,1/12/2018
AD3C93,legal-issues-defendant,100,22,1/12/2018
AFDF2E,legal-issues-defendant,100,22,1/12/2018
AFDF2E,legal-issues-defendant,100,22,1/12/2018
AFDF2E,legal-issues-defendant,100,22,1/12/2018
CA1620,legal-issues-defendant,100,22,1/12/2018
CF6A5A,earnings,100,50,1/12/2018
CFF15D,dividend,100,50,1/12/2018
D13F1C,executive-appointment,100,54,1/12/2018
D42DBA,revenues,100,50,1/12/2018
D42DBA,revenues,100,50,1/12/2018
D57D99,conference-participant,100,50,1/12/2018
D5AF19,earnings-per-share-positive,100,69,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D5AF19,earnings,100,50,1/12/2018
D6853F,conference-call,100,50,1/12/2018
D697DE,conference-participant,100,50,1/12/2018
D7918D,ipo-pricing,100,50,1/12/2018
D88EF3,conference-call,100,50,1/12/2018
DCD97F,business-contract,100,69,1/12/2018
DCD97F,business-contract,100,69,1/12/2018
DCD97F,conference-call,100,50,1/12/2018
E30A8F,acquisition-acquirer,100,49,1/12/2018
E4158B,earnings,100,50,1/12/2018
E592F0,earnings,100,50,1/12/2018
E8846E,earnings-positive,100,69,1/12/2018
EBC84C,earnings,100,50,1/12/2018
F0027C,fast-track-designation,100,81,1/12/2018
F793FA,facility-open,100,65,1/12/2018
FA36A4,ipo-pricing,100,50,1/12/2018
FF4343,earnings,100,50,1/12/2018
FF5413,earnings,100,50,1/12/2018
AFDF2E,legal-issues-defendant,100,22,1/13/2018
31025,product-release,100,64,1/14/2018
93D207,product-release,100,64,1/14/2018
A6213D,partnership,100,61,1/14/2018
AFDF2E,legal-issues-defendant,100,22,1/14/2018
00067A,earnings,100,50,1/15/2018
0157B1,product-release,100,64,1/15/2018
0157B1,product-release,100,64,1/15/2018
06C826,executive-appointment,100,54,1/15/2018
06C826,executive-appointment,100,54,1/15/2018
10943B,conference-call,100,50,1/15/2018
15789A,conference-participant,100,50,1/15/2018
1E1125,legal-issues-defendant,100,22,1/15/2018
228D42,partnership,100,61,1/15/2018
228D42,partnership,100,61,1/15/2018
4C6C63,product-release,100,64,1/15/2018
4F9926,executive-appointment,100,54,1/15/2018
4F9926,executive-appointment,100,54,1/15/2018
4F9926,executive-appointment,100,54,1/15/2018
5876DC,acquisition-acquirer,100,49,1/15/2018
58B46F,conference-call,100,50,1/15/2018
6B0E45,conference-call,100,50,1/15/2018
78F9ED,conference-call,100,50,1/15/2018
7A975D,product-release,100,64,1/15/2018
7AB859,fundraising,100,64,1/15/2018
7B1156,headquarters-change,100,50,1/15/2018
7F3A5F,shareholder-rights-plan,100,43,1/15/2018
838ADD,dividend,100,50,1/15/2018
8FF57A,joint-venture,100,62,1/15/2018
911AB8,business-contract,100,69,1/15/2018
9A602D,conference-call,100,50,1/15/2018
A3800A,legal-issues-defendant,100,22,1/15/2018
A52533,facility-open,100,65,1/15/2018
AA847A,conference-call,100,50,1/15/2018
AADE0B,acquisition-acquirer,100,49,1/15/2018
B2206F,earnings,100,50,1/15/2018
C99CC8,conference-call,100,50,1/15/2018
E6EDED,conference-call,100,50,1/15/2018
EA62FC,conference-call,100,50,1/15/2018
F02D0A,earnings,100,50,1/15/2018
F93C8A,dividend,100,50,1/15/2018
9397,legal-issues-defendant,100,22,1/16/2018
03596A,earnings,100,50,1/16/2018
03596A,business-contract,100,69,1/16/2018
03FB17,earnings,100,50,1/16/2018
03FB17,dividend,100,50,1/16/2018
07CA6A,patent-awarded,100,72,1/16/2018
0A0D9E,conference-call,100,50,1/16/2018
0A6824,acquisition-acquirer,100,49,1/16/2018
0EF1AF,business-contract,100,69,1/16/2018
0F04E5,buybacks,100,74,1/16/2018
143C52,executive-appointment,100,54,1/16/2018
15B10D,conference-participant,100,50,1/16/2018
16FC89,earnings,100,50,1/16/2018
17EDA5,legal-issues-defendant,100,22,1/16/2018
17EDA5,legal-issues-defendant,100,22,1/16/2018
1A6A94,dividend,100,50,1/16/2018
1BDB2A,conference-call,100,50,1/16/2018
1EA923,earnings-guidance,100,50,1/16/2018
1F08A6,conference-call,100,50,1/16/2018
1F9D90,partnership,100,61,1/16/2018
205AD5,earnings,100,50,1/16/2018
205AD5,earnings,100,50,1/16/2018
205AD5,earnings,100,50,1/16/2018
205AD5,earnings,100,50,1/16/2018
205AD5,earnings,100,50,1/16/2018
2082EA,executive-appointment,100,54,1/16/2018
21245F,conference-call,100,50,1/16/2018
21245F,executive-appointment,100,54,1/16/2018
219B21,product-release,100,64,1/16/2018
228D42,partnership,100,61,1/16/2018
25102A,product-release,100,64,1/16/2018
25102A,product-release,100,64,1/16/2018
25102A,product-release,100,64,1/16/2018
267718,partnership,100,61,1/16/2018
29B702,earnings,100,50,1/16/2018
2.90E+62,fundraising,100,64,1/16/2018
2B7A40,earnings,100,50,1/16/2018
2B9DBB,earnings,100,50,1/16/2018
2CBB58,conference-call,100,50,1/16/2018
2F1299,conference-call,100,50,1/16/2018
2FEA66,dividend,100,50,1/16/2018
31DB20,dividend,100,50,1/16/2018
328250,conference-call,100,50,1/16/2018
34B411,acquisition-completed-acquirer,100,49,1/16/2018
34B97A,executive-appointment,100,54,1/16/2018
36529A,patent-awarded,100,72,1/16/2018
3696BF,conference-call,100,50,1/16/2018
370C50,product-price-raise,100,57,1/16/2018
387541,dividend-up,100,60,1/16/2018
39FB23,partnership,100,61,1/16/2018
3B37F7,stake-acquirer,100,48,1/16/2018
3C6CCC,executive-appointment,100,54,1/16/2018
3DD5E2,executive-appointment,100,54,1/16/2018
4.03E+05,product-release,100,64,1/16/2018
43A060,business-contract,100,69,1/16/2018
44209A,earnings,100,50,1/16/2018
44209A,executive-appointment,100,54,1/16/2018
44A4FC,earnings,100,50,1/16/2018
44ED36,dividend,100,50,1/16/2018
45ABCC,market-entry,100,57,1/16/2018
45ABCC,product-release,100,64,1/16/2018
4.60E+06,conference-participant,100,50,1/16/2018
485445,earnings,100,50,1/16/2018
49A344,earnings,100,50,1/16/2018
4A5C8D,donation,100,54,1/16/2018
4B49CF,product-price-raise,100,57,1/16/2018
4BEB48,earnings,100,50,1/16/2018
4C6C63,earnings,100,50,1/16/2018
4EE167,executive-appointment,100,54,1/16/2018
4EE167,acquisition-acquirer,100,49,1/16/2018
51527B,conference-call,100,50,1/16/2018
51B442,public-offering,100,43,1/16/2018
532D47,earnings,100,50,1/16/2018
545272,conference-call,100,50,1/16/2018
546A27,public-offering,100,43,1/16/2018
55438C,product-release,100,64,1/16/2018
55ACCB,legal-issues-defendant,100,22,1/16/2018
55ACCB,legal-issues-defendant,100,22,1/16/2018
56B7C1,earnings,100,50,1/16/2018
56EFC7,partnership,100,61,1/16/2018
586FFD,conference-call,100,50,1/16/2018
589F5A,dividend,100,50,1/16/2018
58B46F,conference-call,100,50,1/16/2018
58CA9A,earnings,100,50,1/16/2018
59872F,note-sale,100,52,1/16/2018
5AF08A,earnings,100,50,1/16/2018
5D16CF,note-sale,100,52,1/16/2018
5EAA43,executive-appointment,100,54,1/16/2018
5FDBD0,public-offering,100,43,1/16/2018
605F40,conference-call,100,50,1/16/2018
6166D1,executive-appointment,100,54,1/16/2018
619882,stake-acquiree,100,62,1/16/2018
619882,stake-acquiree,100,62,1/16/2018
619882,stake-acquiree,100,62,1/16/2018
66ECFD,dividend,100,50,1/16/2018
6844D2,partnership,100,61,1/16/2018
69345C,legal-issues-defendant,100,22,1/16/2018
69345C,legal-issues-defendant,100,22,1/16/2018
693ECD,conference-participant,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6C4D2F,earnings,100,50,1/16/2018
6D0CAB,operating-earnings,100,50,1/16/2018
6E705B,executive-appointment,100,54,1/16/2018
6EA292,public-offering,100,43,1/16/2018
6F0A63,earnings-guidance,100,50,1/16/2018
6F22E7,executive-appointment,100,54,1/16/2018
70FCEF,executive-appointment,100,54,1/16/2018
713810,partnership,100,61,1/16/2018
722D55,earnings,100,50,1/16/2018
7273FF,ownership-decrease-owner,100,46,1/16/2018
7823A3,partnership,100,61,1/16/2018
7AB859,fundraising,100,64,1/16/2018
7B1E50,dividend,100,50,1/16/2018
7DA412,facility-open,100,65,1/16/2018
7F3A5F,earnings,100,50,1/16/2018
7F9984,earnings,100,50,1/16/2018
7FD8B9,business-contract,100,69,1/16/2018
805CD8,clinical-trials,100,56,1/16/2018
855DF7,dividend,100,50,1/16/2018
85CDC9,clinical-trials,100,56,1/16/2018
85CDC9,clinical-trials,100,56,1/16/2018
85CDC9,clinical-trials,100,56,1/16/2018
85CDC9,clinical-trials,100,56,1/16/2018
85CDC9,clinical-trials,100,56,1/16/2018
85CDC9,clinical-trials,100,56,1/16/2018
86A1B9,business-contract,100,69,1/16/2018
877734,executive-appointment,100,54,1/16/2018
877C0C,earnings,100,50,1/16/2018
8802B4,earnings-guidance,100,50,1/16/2018
8802B4,earnings-guidance,100,50,1/16/2018
8802B4,dividend-up,100,81,1/16/2018
8AB37F,conference-participant,100,50,1/16/2018
8B6E7E,conference-call,100,50,1/16/2018
8CF6DD,earnings,100,50,1/16/2018
8D4486,joint-venture,100,62,1/16/2018
8D4486,joint-venture,100,62,1/16/2018
8D4486,joint-venture,100,62,1/16/2018
8D4486,joint-venture,100,62,1/16/2018
8DDA23,dividend-up,100,81,1/16/2018
8E82A6,earnings,100,50,1/16/2018
900356,earnings-guidance,100,50,1/16/2018
92B047,note-sale,100,52,1/16/2018
92D3A0,dividend,100,50,1/16/2018
92D757,executive-appointment,100,54,1/16/2018
92D9C9,public-offering,100,43,1/16/2018
934CC3,partnership,100,61,1/16/2018
9.36E+10,business-contract,100,69,1/16/2018
9.36E+10,business-contract,100,69,1/16/2018
9368BE,conference-call,100,50,1/16/2018
93965C,earnings,100,50,1/16/2018
967D92,conference-call,100,50,1/16/2018
97AF94,dividend,100,50,1/16/2018
9B5968,unit-acquisition-acquirer,100,49,1/16/2018
9B5968,partnership,100,61,1/16/2018
9CA4C6,dividend-up,100,81,1/16/2018
9D65C1,executive-appointment,100,54,1/16/2018
9D65C1,earnings,100,50,1/16/2018
9E0811,conference-call,100,50,1/16/2018
9E3224,merger,100,66,1/16/2018
9F048E,earnings,100,50,1/16/2018
9F5997,conference-call,100,50,1/16/2018
A4386C,earnings,100,50,1/16/2018
A5A4F5,acquisition-acquirer,100,49,1/16/2018
A666C8,dividend,100,50,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
A746F6,earnings-per-share-positive,100,69,1/16/2018
AD3008,business-contract,100,69,1/16/2018
AD9F1D,earnings,100,50,1/16/2018
AFDF2E,legal-issues-defendant,100,22,1/16/2018
AFF7B4,dividend,100,50,1/16/2018
B0B969,conference-call,100,50,1/16/2018
B13B68,executive-appointment,100,54,1/16/2018
B1FC3B,business-contract,100,69,1/16/2018
B77F14,business-contract,100,69,1/16/2018
B96DF5,earnings,100,50,1/16/2018
BB58FF,executive-appointment,100,54,1/16/2018
BEB756,acquisition-completed-acquirer,100,49,1/16/2018
BFCACF,conference-call,100,50,1/16/2018
C0030A,earnings,100,50,1/16/2018
C4706C,executive-appointment,100,54,1/16/2018
C4A432,earnings,100,50,1/16/2018
C4A432,award,100,58,1/16/2018
C5C0E9,earnings,100,50,1/16/2018
C66A8C,product-release,100,64,1/16/2018
C72B8F,partnership,100,61,1/16/2018
C7859D,earnings-up,100,68,1/16/2018
C7859D,earnings-up,100,68,1/16/2018
C7859D,earnings-up,100,68,1/16/2018
C7859D,earnings-up,100,68,1/16/2018
C7859D,earnings-up,100,68,1/16/2018
C7859D,earnings-up,100,68,1/16/2018
C8257F,facility-open,100,65,1/16/2018
C8FAC7,partnership,100,61,1/16/2018
C951A2,note-sale,100,52,1/16/2018
C9D866,conference-call,100,50,1/16/2018
CA1620,trading-delisting,100,36,1/16/2018
CBCC6A,product-release,100,64,1/16/2018
CDAF5B,conference-call,100,50,1/16/2018
CE96E7,product-release,100,64,1/16/2018
CEC5B9,conference-call,100,50,1/16/2018
CFD4B6,partnership,100,61,1/16/2018
CFF15D,acquisition-interest-acquirer,100,46,1/16/2018
CFF97C,conference-call,100,50,1/16/2018
D6853F,business-contract,100,69,1/16/2018
D6EAA3,partnership,100,61,1/16/2018
DD682D,earnings,100,50,1/16/2018
DF532D,earnings,100,50,1/16/2018
DF532D,earnings,100,50,1/16/2018
E16133,business-contract,100,69,1/16/2018
E1BD05,earnings,100,50,1/16/2018
E26FC3,earnings,100,50,1/16/2018
E68733,regulatory-product-approval-granted,100,81,1/16/2018
E6D89E,earnings,100,50,1/16/2018
E6E012,earnings,100,50,1/16/2018
E8846E,acquisition-completed-acquiree,100,76,1/16/2018
EB36DE,executive-appointment,100,54,1/16/2018
EB6965,conference-call,100,50,1/16/2018
EBD89A,business-contract,100,69,1/16/2018
ECDEB2,executive-salary,100,52,1/16/2018
ED9C04,earnings,100,50,1/16/2018
EE967B,earnings,100,50,1/16/2018
EF5914,public-offering,100,43,1/16/2018
F02D0A,executive-appointment,100,54,1/16/2018
F2E253,executive-resignation,100,44,1/16/2018
F3FCC3,conference-call,100,50,1/16/2018
F4E992,dividend,100,50,1/16/2018
F793FA,merger,100,66,1/16/2018
F88A04,earnings,100,50,1/16/2018
F9CAF8,earnings-guidance,100,50,1/16/2018
FB728F,dividend,100,50,1/16/2018
003B70,dividend-up,100,81,1/17/2018
03D5F9,earnings,100,50,1/17/2018
04EB2F,earnings,100,50,1/17/2018
09F623,dividend-up,100,81,1/17/2018
0C2A0D,earnings,100,50,1/17/2018
0CADBC,dividend,100,50,1/17/2018
1490F3,executive-appointment,100,54,1/17/2018
1.79E+10,revenue-guidance-up,100,83,1/17/2018
190B91,earnings,100,50,1/17/2018
1921DD,business-contract,100,69,1/17/2018
1921DD,legal-issues-defendant,100,22,1/17/2018
1A2D9F,earnings,100,50,1/17/2018
1A9DE1,earnings-up,100,68,1/17/2018
1A9DE1,earnings-up,100,68,1/17/2018
1A9DE1,earnings-up,100,68,1/17/2018
1F19C8,conference-call,100,50,1/17/2018
1F716B,conference-call,100,50,1/17/2018
1FAF22,conference-participant,100,50,1/17/2018
205AD5,partnership,100,61,1/17/2018
205AD5,partnership,100,61,1/17/2018
205AD5,partnership,100,61,1/17/2018
21DED4,conference-call,100,50,1/17/2018
238302,conference-call,100,50,1/17/2018
25DD05,earnings,100,50,1/17/2018
27B191,conference-call,100,50,1/17/2018
284289,conference-call,100,50,1/17/2018
28AF37,earnings,100,50,1/17/2018
2950FF,earnings,100,50,1/17/2018
2BF36E,executive-appointment,100,54,1/17/2018
30DFD3,conference-call,100,50,1/17/2018
315EB0,conference-call,100,50,1/17/2018
31A7CC,earnings-up,100,68,1/17/2018
34B97A,conference-call,100,50,1/17/2018
3.50E+27,earnings,100,50,1/17/2018
366A08,dividend,100,50,1/17/2018
37020C,earnings-guidance,100,50,1/17/2018
3A3447,earnings,100,50,1/17/2018
3DCECC,conference-call,100,50,1/17/2018
4.03E+05,acquisition-completed-acquirer,100,49,1/17/2018
42AABD,conference-call,100,50,1/17/2018
442587,business-contract,100,69,1/17/2018
451D61,public-offering,100,43,1/17/2018
49A344,executive-appointment,100,54,1/17/2018
4A2457,business-contract,100,69,1/17/2018
4A3438,executive-appointment,100,54,1/17/2018
4AE584,executive-appointment,100,54,1/17/2018
4B3676,earnings,100,50,1/17/2018
4B7006,partnership,100,61,1/17/2018
504FE2,conference-call,100,50,1/17/2018
546A27,public-offering,100,43,1/17/2018
5487B1,executive-appointment,100,54,1/17/2018
553949,conference-call,100,50,1/17/2018
55438C,product-release,100,64,1/17/2018
55ACCB,legal-issues-defendant,100,22,1/17/2018
55ACCB,legal-issues-defendant,100,22,1/17/2018
57DDB9,partnership,100,61,1/17/2018
6166D1,earnings,100,50,1/17/2018
619882,partnership,100,61,1/17/2018
622DBE,conference-call,100,50,1/17/2018
636BBF,award,100,58,1/17/2018
6.52E+64,product-release,100,64,1/17/2018
657097,public-offering,100,43,1/17/2018
69CE71,product-release,100,64,1/17/2018
6-Dec-05,partnership,100,61,1/17/2018
70FCEF,executive-appointment,100,54,1/17/2018
713810,product-release,100,64,1/17/2018
713810,executive-appointment,100,54,1/17/2018
71E2EF,fundraising,100,64,1/17/2018
7448A3,dividend,100,50,1/17/2018
762B8D,dividend,100,50,1/17/2018
789A7D,earnings,100,50,1/17/2018
790C34,earnings,100,50,1/17/2018
7A10FF,earnings,100,50,1/17/2018
7AC86E,award,100,58,1/17/2018
81222C,earnings,100,50,1/17/2018
8275FE,dividend,100,50,1/17/2018
8275FE,earnings,100,50,1/17/2018
8275FE,earnings,100,50,1/17/2018
8275FE,earnings,100,50,1/17/2018
850779,earnings-per-share-positive,100,69,1/17/2018
850779,earnings-per-share-positive,100,69,1/17/2018
850779,earnings-per-share-positive,100,69,1/17/2018
850779,earnings-per-share-positive,100,69,1/17/2018
860AB6,dividend-up,100,81,1/17/2018
860AB6,dividend,100,50,1/17/2018
8DBBE6,conference-call,100,50,1/17/2018
8DCF18,legal-issues-defendant,100,22,1/17/2018
8E8E6E,product-release,100,64,1/17/2018
8E9CD8,earnings,100,50,1/17/2018
8E9CD8,earnings,100,50,1/17/2018
8FE7A5,earnings,100,50,1/17/2018
92D3A0,earnings,100,50,1/17/2018
92D6A5,dividend,100,50,1/17/2018
92D9C9,public-offering,100,43,1/17/2018
95C392,earnings,100,50,1/17/2018
98CEBB,public-offering,100,43,1/17/2018
990AD0,earnings,100,50,1/17/2018
9A2760,acquisition-completed-acquirer,100,49,1/17/2018
9B5968,dividend,100,50,1/17/2018
9B5968,dividend,100,50,1/17/2018
9CE4C7,earnings,100,50,1/17/2018
9CF9B1,earnings,100,50,1/17/2018
9D6A24,executive-appointment,100,54,1/17/2018
9E98F2,earnings,100,50,1/17/2018
9E98F2,earnings,100,50,1/17/2018
9E98F2,earnings,100,50,1/17/2018
A16DEA,earnings,100,50,1/17/2018
A21649,conference-call,100,50,1/17/2018
A247F5,partnership,100,61,1/17/2018
A2CAF7,earnings,100,50,1/17/2018
A3800A,legal-issues-defendant,100,22,1/17/2018
A3800A,legal-issues-defendant,100,22,1/17/2018
A5A4F5,acquisition-acquirer,100,49,1/17/2018
A60354,acquisition-acquirer,100,49,1/17/2018
A80FE0,partnership,100,61,1/17/2018
A80FE0,conference-call,100,50,1/17/2018
A8B137,executive-appointment,100,54,1/17/2018
A8E2FE,acquisition-acquirer,100,49,1/17/2018
AA5C8E,dividend,100,50,1/17/2018
AA5C8E,dividend,100,50,1/17/2018
AA5C8E,dividend,100,50,1/17/2018
AA5C8E,dividend,100,50,1/17/2018
AA5C8E,dividend,100,50,1/17/2018
AA5C8E,dividend,100,50,1/17/2018
AA5C8E,dividend,100,50,1/17/2018
AABEA0,dividend,100,50,1/17/2018
AEFC90,public-offering,100,43,1/17/2018
AFDF2E,legal-issues-defendant,100,22,1/17/2018
B1FC3B,business-contract,100,69,1/17/2018
B5BA39,debt-renegotiation,100,59,1/17/2018
B83BCE,earnings,100,50,1/17/2018
B83BCE,conference-participant,100,50,1/17/2018
B8F5C8,conference-call,100,50,1/17/2018
B9CD50,earnings,100,50,1/17/2018
BAD9EA,patient-enrollment-complete,100,64,1/17/2018
BAD9EA,patient-enrollment-complete,100,64,1/17/2018
BB5271,executive-appointment,100,54,1/17/2018
BBF349,earnings,100,50,1/17/2018
BC4876,dividend-up,100,81,1/17/2018
BC5680,earnings,100,50,1/17/2018
C037A8,conference-call,100,50,1/17/2018
C16A8F,conference-call,100,50,1/17/2018
C32A39,dividend,100,50,1/17/2018
C3BAE7,acquisition-completed-acquirer,100,49,1/17/2018
C7863D,conference-call,100,50,1/17/2018
C81E00,partnership,100,61,1/17/2018
C8A248,partnership,100,61,1/17/2018
C951A2,note-sale,100,52,1/17/2018
CC0C78,public-offering,100,43,1/17/2018
CD4DA8,earnings,100,50,1/17/2018
D06755,acquisition-completed-acquirer,100,49,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D0C79E,acquisition-interest-acquirer,100,46,1/17/2018
D139BC,conference-call,100,50,1/17/2018
D33D8C,earnings-positive,100,69,1/17/2018
D33D8C,earnings-positive,100,69,1/17/2018
D33D8C,earnings-positive,100,69,1/17/2018
D33D8C,earnings-positive,100,69,1/17/2018
D33D8C,earnings-positive,100,69,1/17/2018
D33D8C,earnings-positive,100,69,1/17/2018
D33D8C,earnings-positive,100,69,1/17/2018
D437C3,earnings,100,50,1/17/2018
D63B0F,acquisition-acquirer,100,49,1/17/2018
D93A25,earnings,100,50,1/17/2018
DA0CB8,dividend,100,50,1/17/2018
DB5CA5,donation,100,54,1/17/2018
DC0998,conference-call,100,50,1/17/2018
DD1BA1,earnings,100,50,1/17/2018
E1E36F,earnings,100,50,1/17/2018
E38906,merger-completed,100,66,1/17/2018
E6EDED,conference-call,100,50,1/17/2018
E74B55,partnership,100,61,1/17/2018
E8846E,executive-resignation,100,44,1/17/2018
E8A49A,executive-appointment,100,54,1/17/2018
EBD89A,business-contract,100,69,1/17/2018
EC70EC,conference-call,100,50,1/17/2018
ECA300,executive-appointment,100,54,1/17/2018
ECDEB2,conference-call,100,50,1/17/2018
EE6F1C,earnings,100,50,1/17/2018
F02170,facility-open,100,65,1/17/2018
F1CD47,earnings,100,50,1/17/2018
F4E882,conference-call,100,50,1/17/2018
F72E4B,joint-venture,100,62,1/17/2018
F72E4B,joint-venture,100,62,1/17/2018
F7902B,earnings,100,50,1/17/2018
F8084B,conference-call,100,50,1/17/2018
FAEABE,earnings,100,50,1/17/2018
FD4E8D,earnings,100,50,1/17/2018
00698D,dividend,100,50,1/18/2018
0142B5,conference-call,100,50,1/18/2018
0157B1,facility-open,100,65,1/18/2018
0157B1,conference-call,100,50,1/18/2018
02870F,market-entry,100,57,1/18/2018
06EF42,conference-call,100,50,1/18/2018
07CA6A,award,100,58,1/18/2018
95294,earnings,100,50,1/18/2018
95294,executive-appointment,100,54,1/18/2018
099A02,dividend-guidance,100,50,1/18/2018
099A92,conference-call,100,50,1/18/2018
0A59F8,debt-extension-recipient,100,73,1/18/2018
0A7650,earnings-positive,100,69,1/18/2018
0A7650,earnings-positive,100,69,1/18/2018
0A7650,earnings-positive,100,69,1/18/2018
0A77DB,executive-appointment,100,54,1/18/2018
0BB9E5,earnings,100,50,1/18/2018
0D03C8,business-contract,100,69,1/18/2018
0FDE97,conference-call,100,50,1/18/2018
105D00,earnings-positive,100,69,1/18/2018
105D00,earnings-positive,100,69,1/18/2018
105D00,earnings-positive,100,69,1/18/2018
105D00,earnings-positive,100,69,1/18/2018
105D00,earnings-positive,100,69,1/18/2018
105D00,earnings-positive,100,69,1/18/2018
105D00,earnings-positive,100,69,1/18/2018
11074E,reorganization-unit,100,53,1/18/2018
13C3E0,product-release,100,64,1/18/2018
156A99,executive-appointment,100,54,1/18/2018
18D9FA,conference-call,100,50,1/18/2018
1921DD,business-contract,100,69,1/18/2018
1921DD,business-contract,100,69,1/18/2018
1921DD,business-contract,100,69,1/18/2018
1921DD,partnership,100,61,1/18/2018
1921DD,partnership,100,61,1/18/2018
1921DD,legal-issues-defendant,100,22,1/18/2018
1921DD,legal-issues-defendant,100,22,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1A3E1B,earnings,100,50,1/18/2018
1B637E,dividend,100,50,1/18/2018
1E5786,earnings,100,50,1/18/2018
1E5786,earnings,100,50,1/18/2018
1E5786,earnings,100,50,1/18/2018
1E5786,earnings,100,50,1/18/2018
1E5786,earnings,100,50,1/18/2018
1E5786,earnings,100,50,1/18/2018
1E5786,earnings,100,50,1/18/2018
1F3CFB,earnings,100,50,1/18/2018
219B21,earnings,100,50,1/18/2018
228D42,partnership,100,61,1/18/2018
228D42,partnership,100,61,1/18/2018
24CB56,earnings-positive,100,69,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
24CB56,earnings,100,50,1/18/2018
251988,partnership,100,61,1/18/2018
279916,partnership,100,61,1/18/2018
2A17B1,conference-call,100,50,1/18/2018
2EC172,conference-call,100,50,1/18/2018
3159AA,conference-call,100,50,1/18/2018
31666F,earnings,100,50,1/18/2018
31666F,earnings,100,50,1/18/2018
326EDD,dividend,100,50,1/18/2018
343996,dividend-up,100,81,1/18/2018
39BFF6,dividend,100,50,1/18/2018
39FB23,earnings,100,50,1/18/2018
39FB23,dividend,100,50,1/18/2018
3BE00F,earnings,100,50,1/18/2018
3C8A04,earnings,100,50,1/18/2018
3DC887,earnings,100,50,1/18/2018
3ED92D,conference-call,100,50,1/18/2018
3FBC9B,earnings,100,50,1/18/2018
423279,earnings,100,50,1/18/2018
449A26,earnings-positive,100,69,1/18/2018
449A26,dividend,100,50,1/18/2018
46A16E,conference-call,100,50,1/18/2018
487B7A,earnings-up,100,68,1/18/2018
487B7A,earnings-up,100,68,1/18/2018
487B7A,earnings-up,100,68,1/18/2018
487B7A,earnings-up,100,68,1/18/2018
487B7A,earnings-up,100,68,1/18/2018
487B7A,earnings-up,100,68,1/18/2018
4885C8,earnings,100,50,1/18/2018
48F795,earnings,100,50,1/18/2018
4A6F00,business-contract,100,69,1/18/2018
4B49CF,dividend,100,50,1/18/2018
4B6EF9,dividend,100,50,1/18/2018
4C37C5,executive-appointment,100,54,1/18/2018
4C37C5,revenue-up,100,60,1/18/2018
4C37C5,revenue-up,100,69,1/18/2018
4C37C5,revenue-up,100,69,1/18/2018
4C37C5,revenue-up,100,69,1/18/2018
4DD09F,conference-participant,100,50,1/18/2018
4FCC78,public-offering,100,43,1/18/2018
504FE2,executive-appointment,100,54,1/18/2018
51D876,executive-appointment,100,54,1/18/2018
5225A4,earnings,100,50,1/18/2018
53E575,conference-call,100,50,1/18/2018
56277A,conference-call,100,50,1/18/2018
56EA2B,award,100,58,1/18/2018
5876DC,dividend,100,50,1/18/2018
58CA9A,dividend,100,50,1/18/2018
5A9A82,executive-appointment,100,54,1/18/2018
5B97B2,earnings-up,100,68,1/18/2018
5B97B2,earnings,100,50,1/18/2018
5B97B2,earnings,100,50,1/18/2018
5B97B2,earnings,100,50,1/18/2018
5B97B2,earnings,100,50,1/18/2018
5B97B2,earnings,100,50,1/18/2018
5BE42C,dividend-up,100,81,1/18/2018
5D16CF,note-sale,100,52,1/18/2018
6137BF,conference-call,100,50,1/18/2018
622037,earnings,100,50,1/18/2018
6284B5,conference-call,100,50,1/18/2018
657097,public-offering,100,43,1/18/2018
68586A,facility-open,100,65,1/18/2018
68BA15,dividend,100,50,1/18/2018
6D3B7B,earnings,100,50,1/18/2018
6E705B,campaign-ad-release,100,59,1/18/2018
71E2EF,unit-acquisition-acquiree,100,76,1/18/2018
72DF04,revenues,100,50,1/18/2018
73A71F,earnings,100,50,1/18/2018
752A70,earnings,100,50,1/18/2018
762B8D,earnings,100,50,1/18/2018
7999F3,earnings,100,50,1/18/2018
7B6C88,earnings,100,50,1/18/2018
7BAAE7,earnings,100,50,1/18/2018
80D744,conference-call,100,50,1/18/2018
859281,dividend,100,50,1/18/2018
85CDC9,facility-open,100,65,1/18/2018
85DA04,conference-call,100,50,1/18/2018
85DE00,conference-call,100,50,1/18/2018
860AB6,earnings,100,50,1/18/2018
8BFAA4,executive-appointment,100,54,1/18/2018
8BFAA4,dividend,100,50,1/18/2018
8D4486,earnings,100,50,1/18/2018
8DAAB9,dividend,100,50,1/18/2018
8DE74B,executive-appointment,100,54,1/18/2018
8E82A6,executive-resignation,100,44,1/18/2018
8E8E6E,earnings,100,50,1/18/2018
92B047,note-sale,100,52,1/18/2018
931AE7,clinical-trials,100,56,1/18/2018
934029,conference-call,100,50,1/18/2018
97AAF6,dividend,100,50,1/18/2018
99028D,conference-call,100,50,1/18/2018
9B71A7,product-recall,100,29,1/18/2018
9C8BC3,executive-appointment,100,54,1/18/2018
9E5C2C,product-release,100,64,1/18/2018
9E5C2C,conference-call,100,50,1/18/2018
9F03CF,conference-call,100,50,1/18/2018
A1EAC8,conference-call,100,50,1/18/2018
A247F5,earnings,100,50,1/18/2018
A403CF,earnings,100,50,1/18/2018
A43906,conference-call,100,50,1/18/2018
A5A4F5,acquisition-acquirer,100,49,1/18/2018
A8CBDA,dividend,100,50,1/18/2018
A9ED24,dividend-up,100,81,1/18/2018
AD9F1D,executive-appointment,100,54,1/18/2018
AEFC90,public-offering,100,43,1/18/2018
B7EB38,earnings,100,50,1/18/2018
BD8517,earnings,100,50,1/18/2018
C0BA36,conference-call,100,50,1/18/2018
C1114B,conference-call,100,50,1/18/2018
C188F8,executive-appointment,100,54,1/18/2018
C2609A,note-sale,100,52,1/18/2018
C41C25,earnings,100,50,1/18/2018
C54140,earnings,100,50,1/18/2018
C5F463,earnings-up,100,68,1/18/2018
C72B8F,conference-call,100,50,1/18/2018
C9881C,award,100,58,1/18/2018
C9B932,earnings,100,50,1/18/2018
CB7AB2,earnings,100,50,1/18/2018
CC0C78,public-offering,100,43,1/18/2018
CFE5BE,dividend-up,100,70,1/18/2018
D1AE3B,earnings,100,50,1/18/2018
D1AE3B,dividend,100,50,1/18/2018
D29B44,executive-appointment,100,54,1/18/2018
D64C6D,executive-appointment,100,54,1/18/2018
D75910,note-sale,100,52,1/18/2018
D78CCD,hirings,100,65,1/18/2018
D8C09D,note-sale,100,52,1/18/2018
D8C09D,note-sale,100,52,1/18/2018
DBB28E,product-release,100,64,1/18/2018
DD3BB1,executive-appointment,100,54,1/18/2018
E114F4,conference-call,100,50,1/18/2018
E35610,earnings-guidance,100,50,1/18/2018
E829E8,unit-acquisition-acquirer,100,49,1/18/2018
E8846E,executive-appointment,100,54,1/18/2018
E8B315,earnings-positive,100,69,1/18/2018
E8E899,partnership,100,61,1/18/2018
E90C84,conference-call,100,50,1/18/2018
EAEBF3,dividend,100,50,1/18/2018
EB2F14,earnings,100,50,1/18/2018
ECDEB2,earnings-up,100,68,1/18/2018
ED79D9,executive-appointment,100,54,1/18/2018
EE6F1C,executive-appointment,100,54,1/18/2018
EF1AD9,product-release,100,64,1/18/2018
EF5BED,earnings-positive,100,69,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
EF5BED,earnings,100,50,1/18/2018
F0B877,conference-call,100,50,1/18/2018
F2E253,facility-open,100,65,1/18/2018
F4F46F,partnership,100,61,1/18/2018
F57F6F,facility-open,100,65,1/18/2018
FA918D,earnings-guidance,100,50,1/18/2018
FACF19,dividend,100,50,1/18/2018
FD0CA4,earnings,100,50,1/18/2018
FD4BBE,earnings,100,50,1/18/2018
003B70,dividend,100,50,1/19/2018
083F72,dividend,100,50,1/19/2018
099A02,earnings,100,50,1/19/2018
099A02,earnings,100,50,1/19/2018
0BC17A,earnings,100,50,1/19/2018
0D26E0,dividend,100,50,1/19/2018
147C38,dividend,100,50,1/19/2018
159AE4,dividend,100,50,1/19/2018
159AE4,dividend,100,50,1/19/2018
19C105,earnings,100,50,1/19/2018
1A6A94,dividend,100,50,1/19/2018
1A9DE1,earnings,100,50,1/19/2018
1DA44F,award,100,58,1/19/2018
1E9A6D,partnership,100,61,1/19/2018
20BEEA,award,100,58,1/19/2018
24C48B,award,100,58,1/19/2018
28AF37,award,100,58,1/19/2018
2B5483,conference-call,100,50,1/19/2018
2EC172,executive-appointment,100,54,1/19/2018
2F98A5,dividend,100,50,1/19/2018
33E8C7,earnings,100,50,1/19/2018
342218,earnings,100,50,1/19/2018
355B19,dividend,100,50,1/19/2018
387375,conference-call,100,50,1/19/2018
3D9999,earnings-positive,100,69,1/19/2018
4135F7,merger-regulatory-approval,100,81,1/19/2018
4135F7,merger-regulatory-approval,100,81,1/19/2018
420168,earnings,100,50,1/19/2018
422A82,stake-acquirer,100,48,1/19/2018
4885C8,earnings,100,50,1/19/2018
4A6F00,partnership,100,61,1/19/2018
4A6F00,partnership,100,61,1/19/2018
4BBA23,earnings-guidance,100,50,1/19/2018
546A27,public-offering,100,43,1/19/2018
562853,earnings,100,50,1/19/2018
57356F,note-sale,100,52,1/19/2018
5C7601,acquisition-acquirer,100,49,1/19/2018
5C7601,business-contract,100,69,1/19/2018
5F2FF7,product-release,100,64,1/19/2018
5F3D91,clinical-trials,100,56,1/19/2018
5F9CE3,earnings,100,50,1/19/2018
5F9CE3,award,100,58,1/19/2018
647143,dividend,100,50,1/19/2018
66CB62,dividend,100,50,1/19/2018
66E04A,facility-open,100,65,1/19/2018
6D4636,earnings,100,50,1/19/2018
6F3FA8,conference-call,100,50,1/19/2018
6F6559,dividend,100,50,1/19/2018
73C521,earnings-positive,100,69,1/19/2018
73C521,earnings-positive,100,69,1/19/2018
73C521,earnings-positive,100,69,1/19/2018
73C521,earnings-positive,100,69,1/19/2018
73C521,earnings-positive,100,69,1/19/2018
73C521,earnings-positive,100,69,1/19/2018
73C521,earnings-positive,100,69,1/19/2018
7DC1C4,earnings,100,50,1/19/2018
7E3F8F,award,100,58,1/19/2018
855DF7,dividend,100,50,1/19/2018
8D4486,earnings,100,50,1/19/2018
911ACB,earnings,100,50,1/19/2018
92D757,note-sale,100,52,1/19/2018
943239,legal-issues-defendant,100,22,1/19/2018
943239,legal-issues-defendant,100,22,1/19/2018
943239,legal-issues-defendant,100,22,1/19/2018
943239,legal-issues-defendant,100,22,1/19/2018
95DC1F,dividend,100,50,1/19/2018
980C14,conference-call,100,50,1/19/2018
9CE4C7,award,100,58,1/19/2018
9D6A24,award,100,58,1/19/2018
9F6B1A,award,100,58,1/19/2018
9FD2D9,earnings-guidance,100,50,1/19/2018
A5A4F5,acquisition-acquirer,100,49,1/19/2018
A63387,executive-appointment,100,54,1/19/2018
A806FA,earnings-guidance,100,50,1/19/2018
AD3C93,award,100,58,1/19/2018
AFDF2E,dividend,100,50,1/19/2018
B4703C,dividend-up,100,81,1/19/2018
B642E8,award,100,58,1/19/2018
B934BF,conference-call,100,50,1/19/2018
BFE02C,earnings-positive,100,69,1/19/2018
C2609A,award,100,58,1/19/2018
C598D7,dividend,100,50,1/19/2018
C97B2D,conference-call,100,50,1/19/2018
CBBFBF,earnings,100,50,1/19/2018
CBBFBF,earnings,100,50,1/19/2018
CD051C,earnings,100,50,1/19/2018
CD051C,earnings,100,50,1/19/2018
CD051C,earnings,100,50,1/19/2018
CD051C,earnings,100,50,1/19/2018
CD051C,earnings,100,50,1/19/2018
CFF15D,acquisition-interest-acquiree,100,82,1/19/2018
D1C26F,conference-participant,100,50,1/19/2018
D650A7,unit-acquisition-acquirer,100,49,1/19/2018
DB5CA5,award,100,58,1/19/2018
DD682D,dividend,100,50,1/19/2018
E30B34,earnings-guidance,100,50,1/19/2018
E3E68E,award,100,58,1/19/2018
E41190,executive-resignation,100,44,1/19/2018
E49AA3,earnings,100,50,1/19/2018
E8D221,dividend,100,50,1/19/2018
EB2F14,buybacks,100,74,1/19/2018
EF5914,public-offering,100,43,1/19/2018
F72E4B,joint-venture,100,62,1/19/2018
F7FCA4,dividend,100,50,1/19/2018
F82D37,earnings-up,100,68,1/19/2018
F85CC0,award,100,58,1/19/2018
FACF19,executive-appointment,100,54,1/19/2018
FB728F,dividend,100,50,1/19/2018
FD39EB,dividend,100,50,1/19/2018
85CDC9,clinical-trials,100,56,1/20/2018
61BCA7,executive-appointment,100,54,1/21/2018
69345C,legal-issues-defendant,100,22,1/21/2018
A3800A,legal-issues-defendant,100,22,1/21/2018
034B61,executive-appointment,100,54,1/22/2018
0624BE,earnings-guidance,100,50,1/22/2018
0624BE,executive-resignation,100,44,1/22/2018
08A40F,earnings,100,50,1/22/2018
08A40F,earnings,100,50,1/22/2018
08A40F,earnings,100,50,1/22/2018
08A40F,earnings,100,50,1/22/2018
08A40F,earnings,100,50,1/22/2018
08A40F,earnings,100,50,1/22/2018
08A40F,earnings,100,50,1/22/2018
09F623,earnings-guidance,100,50,1/22/2018
09F623,earnings-guidance,100,50,1/22/2018
09F623,earnings-guidance,100,50,1/22/2018
0BC29E,acquisition-acquirer,100,49,1/22/2018
0BC29E,acquisition-acquirer,100,49,1/22/2018
0BF198,public-offering,100,43,1/22/2018
0BF198,public-offering,100,43,1/22/2018
0C466B,unit-acquisition-acquiree,100,76,1/22/2018
0CC01F,earnings,100,50,1/22/2018
0F65C9,dividend,100,50,1/22/2018
102F04,executive-resignation,100,44,1/22/2018
16F4D8,executive-appointment,100,54,1/22/2018
16FC89,dividend,100,50,1/22/2018
1748B3,earnings,100,50,1/22/2018
1748B3,earnings,100,50,1/22/2018
1748B3,earnings,100,50,1/22/2018
1748B3,earnings,100,50,1/22/2018
1748B3,earnings,100,50,1/22/2018
1748B3,earnings,100,50,1/22/2018
1D943E,earnings,100,50,1/22/2018
1E9A6D,dividend,100,50,1/22/2018
1FAF22,regulatory-product-approval-granted,100,81,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
206852,earnings,100,50,1/22/2018
20BEEA,earnings,100,50,1/22/2018
214051,earnings,100,50,1/22/2018
221445,dividend,100,50,1/22/2018
238302,dividend,100,50,1/22/2018
239106,conference-call,100,50,1/22/2018
25102A,executive-appointment,100,54,1/22/2018
251988,product-release,100,64,1/22/2018
251988,product-release,100,64,1/22/2018
272704,earnings-up,100,68,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
272704,earnings,100,50,1/22/2018
2.90E+62,business-contract,100,69,1/22/2018
2B49F4,earnings,100,50,1/22/2018
2B49F4,earnings,100,50,1/22/2018
2B49F4,earnings,100,50,1/22/2018
2B49F4,earnings,100,50,1/22/2018
2B49F4,earnings,100,50,1/22/2018
2CA60F,partnership,100,61,1/22/2018
2D643C,executive-appointment,100,54,1/22/2018
2F1299,unit-acquisition-completed-acquirer,100,49,1/22/2018
30E01D,earnings,100,50,1/22/2018
3.14E+47,earnings,100,50,1/22/2018
343996,dividend,100,50,1/22/2018
3A4BDB,earnings,100,50,1/22/2018
3A4BDB,earnings,100,50,1/22/2018
3A4BDB,earnings,100,50,1/22/2018
3A4BDB,earnings,100,50,1/22/2018
3A4BDB,earnings,100,50,1/22/2018
434F38,earnings,100,50,1/22/2018
4595EF,conference-call,100,50,1/22/2018
47FCF2,earnings,100,50,1/22/2018
49914B,earnings,100,50,1/22/2018
4D371E,earnings,100,50,1/22/2018
4FB770,conference-call,100,50,1/22/2018
4FCC78,public-offering,100,43,1/22/2018
5088A5,earnings,100,50,1/22/2018
51D876,award,100,58,1/22/2018
545272,dividend,100,50,1/22/2018
55438C,executive-resignation,100,44,1/22/2018
55438C,partnership,100,61,1/22/2018
5704AC,earnings,100,50,1/22/2018
57DDB9,public-offering,100,43,1/22/2018
5876DC,earnings,100,50,1/22/2018
5B3415,conference-call,100,50,1/22/2018
5D63F1,earnings,100,50,1/22/2018
5EAA43,partnership,100,61,1/22/2018
5EC388,earnings,100,50,1/22/2018
647143,earnings,100,50,1/22/2018
647143,earnings,100,50,1/22/2018
647143,earnings,100,50,1/22/2018
647143,earnings,100,50,1/22/2018
64854A,regulatory-product-approval-granted,100,81,1/22/2018
65D0AA,conference-participant,100,50,1/22/2018
66ECFD,acquisition-acquirer,100,49,1/22/2018
6810DE,clinical-trials,100,56,1/22/2018
68BA15,acquisition-acquirer,100,49,1/22/2018
6B236C,legal-issues-defendant,100,22,1/22/2018
6B5379,earnings,100,50,1/22/2018
719477,executive-resignation,100,44,1/22/2018
732449,partnership,100,61,1/22/2018
732449,executive-appointment,100,54,1/22/2018
73BCBA,conference-call,100,50,1/22/2018
75F665,earnings,100,50,1/22/2018
7AB859,acquisition-completed-acquirer,100,49,1/22/2018
7B0BA6,award,100,58,1/22/2018
7B6EB1,earnings,100,50,1/22/2018
7C4F43,patent-awarded,100,72,1/22/2018
7C62A3,conference-call,100,50,1/22/2018
7DD8CC,dividend,100,50,1/22/2018
7F3669,earnings,100,50,1/22/2018
82C202,business-contract,100,69,1/22/2018
838ADD,earnings,100,50,1/22/2018
845655,conference-call,100,50,1/22/2018
859281,earnings,100,50,1/22/2018
859281,earnings,100,50,1/22/2018
859281,earnings,100,50,1/22/2018
859281,earnings,100,50,1/22/2018
859281,earnings,100,50,1/22/2018
859281,earnings,100,50,1/22/2018
85AD00,earnings,100,50,1/22/2018
8665BA,business-contract,100,69,1/22/2018
89FBB1,dividend,100,50,1/22/2018
8A8E41,earnings,100,50,1/22/2018
8A8E41,partnership,100,61,1/22/2018
8BE916,conference-call,100,50,1/22/2018
8DCF18,conference-call,100,50,1/22/2018
9196A2,executive-appointment,100,54,1/22/2018
9.36E+10,business-contract,100,69,1/22/2018
93633B,earnings,100,50,1/22/2018
93633B,earnings,100,50,1/22/2018
93633B,earnings,100,50,1/22/2018
93633B,earnings,100,50,1/22/2018
93965C,sponsorship,100,57,1/22/2018
943239,legal-issues-defendant,100,22,1/22/2018
96F126,earnings,100,50,1/22/2018
979451,earnings,100,50,1/22/2018
98CAED,earnings,100,50,1/22/2018
9981C6,earnings,100,50,1/22/2018
99ACAD,earnings,100,50,1/22/2018
9C8664,earnings,100,50,1/22/2018
9C8664,earnings,100,50,1/22/2018
9C8664,earnings,100,50,1/22/2018
9C8664,earnings,100,50,1/22/2018
9D2790,earnings,100,50,1/22/2018
9D5FA4,regulatory-product-approval-granted,100,81,1/22/2018
9E91C6,earnings,100,50,1/22/2018
9F71E5,business-contract,100,69,1/22/2018
A28C54,executive-appointment,100,54,1/22/2018
A350C1,conference-call,100,50,1/22/2018
A3800A,legal-issues-defendant,100,22,1/22/2018
A3800A,legal-issues-defendant,100,22,1/22/2018
A3BFAA,dividend,100,50,1/22/2018
A3F598,conference-call,100,50,1/22/2018
A4D173,conference-call,100,50,1/22/2018
A4D173,conference-call,100,50,1/22/2018
A5195E,merger,100,66,1/22/2018
A5A4F5,acquisition-acquirer,100,49,1/22/2018
A7CCF0,conference-call,100,50,1/22/2018
AAC8B6,dividend,100,50,1/22/2018
AED6CF,asset-sale,100,62,1/22/2018
AEFC90,public-offering,100,43,1/22/2018
AFEC35,earnings,100,50,1/22/2018
B08954,earnings,100,50,1/22/2018
B0B969,executive-appointment,100,54,1/22/2018
B2F431,earnings,100,50,1/22/2018
B72BE9,conference-call,100,50,1/22/2018
B9764A,conference-call,100,50,1/22/2018
BDD12C,award,100,58,1/22/2018
C15F8F,buybacks,100,74,1/22/2018
C356AC,earnings,100,50,1/22/2018
C564E4,public-offering,100,43,1/22/2018
C598D7,revenue-up,100,59,1/22/2018
C598D7,revenues,100,50,1/22/2018
C598D7,revenues,100,50,1/22/2018
C62AA4,acquisition-acquirer,100,49,1/22/2018
C9881C,executive-resignation,100,44,1/22/2018
CAC8D0,asset-sale,100,62,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFE5BE,earnings,100,50,1/22/2018
CFF15D,earnings-guidance,100,50,1/22/2018
D0DFE5,earnings-up,100,87,1/22/2018
D1CFC8,award,100,58,1/22/2018
D20C8F,partnership,100,61,1/22/2018
D63B0F,conference-participant,100,50,1/22/2018
D6489C,partnership,100,61,1/22/2018
D64C6D,partnership,100,61,1/22/2018
D6853F,award,100,58,1/22/2018
D75910,award,100,58,1/22/2018
D8442A,partnership,100,61,1/22/2018
D9B1C9,award,100,58,1/22/2018
DAC66A,earnings,100,50,1/22/2018
DD7A96,conference-call,100,50,1/22/2018
DF01B1,conference-call,100,50,1/22/2018
E0207A,earnings,100,50,1/22/2018
E4158B,earnings,100,50,1/22/2018
E5752F,earnings,100,50,1/22/2018
E87676,dividend,100,50,1/22/2018
EA62FC,dividend,100,50,1/22/2018
EBD89A,conference-call,100,50,1/22/2018
ECD263,earnings,100,50,1/22/2018
ECD263,executive-appointment,100,54,1/22/2018
ED79D9,conference-call,100,50,1/22/2018
EF5BED,product-release,100,64,1/22/2018
EF5BED,product-release,100,64,1/22/2018
EFD406,executive-appointment,100,54,1/22/2018
F04E05,dividend-up,100,72,1/22/2018
F30508,business-contract,100,69,1/22/2018
F50BAB,dividend,100,50,1/22/2018
F5C78B,earnings,100,50,1/22/2018
F5D410,government-contract,100,69,1/22/2018
F5D410,business-contract,100,69,1/22/2018
F6E1B5,patent-filing-rejected,100,43,1/22/2018
F7935D,clinical-trials,100,56,1/22/2018
F7935D,public-offering,100,43,1/22/2018
F80FF9,conference-call,100,50,1/22/2018
F85CC0,executive-appointment,100,54,1/22/2018
F95726,earnings,100,50,1/22/2018
FAE021,partnership,100,61,1/22/2018
FAE021,partnership,100,61,1/22/2018
FAE021,earnings,100,50,1/22/2018
FD9A97,earnings,100,50,1/22/2018
0157B1,partnership,100,61,1/23/2018
0157B1,partnership,100,61,1/23/2018
0157B1,unit-acquisition-acquiree,100,76,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
55018,earnings-negative,100,33,1/23/2018
0A0D9E,unit-acquisition-acquirer,100,49,1/23/2018
0A7650,earnings,100,50,1/23/2018
0B13E8,executive-appointment,100,54,1/23/2018
0CE204,partnership,100,61,1/23/2018
0CE204,conference-call,100,50,1/23/2018
1065BC,partnership-terminated,100,36,1/23/2018
17EDA5,legal-issues-defendant,100,22,1/23/2018
1A3E1B,dividend,100,50,1/23/2018
1D9E55,earnings,100,50,1/23/2018
1E1125,conference-organizer,100,57,1/23/2018
1EBF8D,dividend,100,50,1/23/2018
1F9D90,earnings,100,50,1/23/2018
202E5A,public-offering,100,43,1/23/2018
2082EA,public-offering,100,43,1/23/2018
20BEEA,conference-call,100,50,1/23/2018
21268E,conference-participant,100,50,1/23/2018
21D903,patient-enrollment-start,100,58,1/23/2018
2262BD,earnings,100,50,1/23/2018
2491BC,executive-resignation,100,44,1/23/2018
29A4CC,earnings,100,50,1/23/2018
29A4CC,earnings,100,50,1/23/2018
29A4CC,earnings,100,50,1/23/2018
29A4CC,earnings,100,50,1/23/2018
29A4CC,earnings,100,50,1/23/2018
29A4CC,earnings,100,50,1/23/2018
29A4CC,earnings,100,50,1/23/2018
2AE625,conference-call,100,50,1/23/2018
2D643C,dividend-up,100,68,1/23/2018
2D643C,executive-appointment,100,54,1/23/2018
2E2E6E,earnings,100,50,1/23/2018
2E2E6E,earnings,100,50,1/23/2018
2E2E6E,earnings,100,50,1/23/2018
2E2E6E,earnings,100,50,1/23/2018
2E2E6E,earnings,100,50,1/23/2018
2E61CC,earnings,100,50,1/23/2018
2E61CC,earnings,100,50,1/23/2018
2E61CC,earnings,100,50,1/23/2018
2E61CC,earnings,100,50,1/23/2018
2E61CC,earnings,100,50,1/23/2018
2E61CC,earnings,100,50,1/23/2018
315416,business-contract,100,69,1/23/2018
31643A,product-release,100,64,1/23/2018
332F87,earnings-per-share-up,100,62,1/23/2018
332F87,earnings-per-share-up,100,68,1/23/2018
332F87,earnings-per-share-up,100,68,1/23/2018
332F87,earnings-per-share-up,100,68,1/23/2018
3.30E+34,earnings-up,100,68,1/23/2018
3.30E+34,earnings-up,100,68,1/23/2018
3.30E+34,earnings-up,100,68,1/23/2018
3696BF,executive-appointment,100,54,1/23/2018
370C50,facility-open,100,65,1/23/2018
373B06,earnings,100,50,1/23/2018
39BFF6,earnings,100,50,1/23/2018
39BFF6,earnings,100,50,1/23/2018
39BFF6,earnings,100,50,1/23/2018
3C11C4,earnings,100,50,1/23/2018
3C3B6B,earnings,100,50,1/23/2018
3CCC90,dividend,100,50,1/23/2018
3D9999,dividend,100,50,1/23/2018
3DE4D1,earnings,100,50,1/23/2018
3DE4D1,earnings,100,50,1/23/2018
3DE4D1,earnings,100,50,1/23/2018
3DE4D1,earnings,100,50,1/23/2018
3FACA7,conference-participant,100,50,1/23/2018
415188,business-contract,100,69,1/23/2018
41785E,earnings,100,50,1/23/2018
41EC04,conference-call,100,50,1/23/2018
43A060,business-contract,100,69,1/23/2018
451D61,public-offering,100,43,1/23/2018
453282,acquisition-regulatory-approval-acquirer,100,54,1/23/2018
467F2C,conference-call,100,50,1/23/2018
46A16E,buybacks,100,74,1/23/2018
4.60E+06,partnership,100,61,1/23/2018
479930,earnings,100,50,1/23/2018
490D4B,conference-call,100,50,1/23/2018
49914B,earnings,100,50,1/23/2018
49BBBC,product-release,100,64,1/23/2018
4B3555,earnings,100,50,1/23/2018
4B3555,earnings,100,50,1/23/2018
4B3555,earnings,100,50,1/23/2018
4B3555,earnings,100,50,1/23/2018
4B3555,earnings,100,50,1/23/2018
4B3555,earnings,100,50,1/23/2018
4B3555,earnings,100,50,1/23/2018
4B3DC9,earnings-positive,100,69,1/23/2018
4C37C5,dividend,100,50,1/23/2018
4C6C63,dividend,100,50,1/23/2018
4DD09F,acquisition-acquirer,100,49,1/23/2018
4F9926,partnership,100,61,1/23/2018
50070E,conference-call,100,50,1/23/2018
53A226,earnings,100,50,1/23/2018
5480A7,earnings,100,50,1/23/2018
5487B1,earnings,100,50,1/23/2018
5675EB,dividend,100,50,1/23/2018
567F3D,dividend,100,50,1/23/2018
57634F,earnings,100,50,1/23/2018
5876DC,public-offering,100,43,1/23/2018
589803,earnings,100,50,1/23/2018
59C539,dividend,100,50,1/23/2018
5D87DF,earnings,100,50,1/23/2018
641F17,dividend-up,100,64,1/23/2018
647143,acquisition-acquirer,100,49,1/23/2018
67B923,conference-call,100,50,1/23/2018
68B03F,dividend,100,50,1/23/2018
6B236C,conference-call,100,50,1/23/2018
6D4636,conference-call,100,50,1/23/2018
6EA292,public-offering,100,43,1/23/2018
6F6559,merger-rumor,100,73,1/23/2018
713810,workforce-salary-increase,100,44,1/23/2018
713810,workforce-salary-increase,100,44,1/23/2018
713810,workforce-salary-increase,100,44,1/23/2018
713810,workforce-salary-increase,100,44,1/23/2018
713810,partnership,100,61,1/23/2018
746373,conference-call,100,50,1/23/2018
75F665,earnings,100,50,1/23/2018
75F665,dividend-up,100,81,1/23/2018
7AB859,product-release,100,64,1/23/2018
7F3669,product-release,100,64,1/23/2018
7F9E16,executive-appointment,100,54,1/23/2018
82E58A,dividend,100,50,1/23/2018
83598E,earnings,100,50,1/23/2018
8377DB,earnings,100,50,1/23/2018
86BAC7,dividend,100,50,1/23/2018
8C5519,earnings,100,50,1/23/2018
8CF6DD,dividend,100,50,1/23/2018
8D9993,conference-call,100,50,1/23/2018
907ED2,earnings,100,50,1/23/2018
907ED2,earnings,100,50,1/23/2018
907ED2,earnings,100,50,1/23/2018
907ED2,earnings,100,50,1/23/2018
907ED2,earnings,100,50,1/23/2018
907ED2,earnings,100,50,1/23/2018
907ED2,earnings,100,50,1/23/2018
91E5EE,business-contract,100,69,1/23/2018
91E5EE,business-contract,100,69,1/23/2018
91E5EE,business-contract,100,69,1/23/2018
92D6A5,executive-appointment,100,54,1/23/2018
940C3D,dividend,100,50,1/23/2018
943239,legal-issues-defendant,100,22,1/23/2018
943239,legal-issues-defendant,100,22,1/23/2018
943239,legal-issues-defendant,100,22,1/23/2018
94C0B5,dividend,100,50,1/23/2018
95C575,earnings-positive,100,69,1/23/2018
95DC1F,partnership,100,61,1/23/2018
965360,earnings,100,50,1/23/2018
965360,public-offering,100,43,1/23/2018
968B00,earnings,100,50,1/23/2018
97AAF6,earnings,100,50,1/23/2018
9B5968,executive-appointment,100,54,1/23/2018
9D4EC7,conference-call,100,50,1/23/2018
A247F5,partnership,100,61,1/23/2018
A3800A,legal-issues-defendant,100,22,1/23/2018
A3800A,legal-issues-defendant,100,22,1/23/2018
A398F8,unit-acquisition-acquirer,100,49,1/23/2018
A4BCDE,executive-appointment,100,54,1/23/2018
A5A4F5,acquisition-acquirer,100,49,1/23/2018
A65325,earnings,100,50,1/23/2018
A6828A,earnings,100,50,1/23/2018
AFF7B4,acquisition-acquirer,100,49,1/23/2018
AFF7B4,acquisition-acquirer,100,49,1/23/2018
AFF7B4,acquisition-acquirer,100,49,1/23/2018
B05000,executive-appointment,100,54,1/23/2018
B1A85D,acquisition-completed-acquirer,100,49,1/23/2018
B1DF3C,public-offering,100,43,1/23/2018
B1DF3C,public-offering,100,43,1/23/2018
B1FC3B,award,100,58,1/23/2018
B2DAF6,revenue-up,100,65,1/23/2018
B2DAF6,revenues,100,50,1/23/2018
B2DAF6,revenues,100,50,1/23/2018
B5766D,earnings,100,50,1/23/2018
B5766D,earnings,100,50,1/23/2018
B5766D,earnings,100,50,1/23/2018
B5766D,earnings,100,50,1/23/2018
B5766D,earnings,100,50,1/23/2018
B5766D,earnings,100,50,1/23/2018
B5DE80,unit-acquisition-acquirer,100,49,1/23/2018
BCC55F,conference-call,100,50,1/23/2018
BD9668,earnings,100,50,1/23/2018
BFCACF,earnings,100,50,1/23/2018
C0BA36,conference-call,100,50,1/23/2018
C32A39,earnings,100,50,1/23/2018
C41C25,dividend-up,100,62,1/23/2018
C4A241,conference-call,100,50,1/23/2018
C8923A,clinical-trials-positive,100,87,1/23/2018
C9E107,earnings,100,50,1/23/2018
C9E107,dividend,100,50,1/23/2018
C9F39B,earnings,100,50,1/23/2018
C9F39B,earnings,100,50,1/23/2018
C9F39B,earnings,100,50,1/23/2018
C9F39B,earnings,100,50,1/23/2018
C9F39B,earnings,100,50,1/23/2018
C9F39B,earnings,100,50,1/23/2018
C9F39B,earnings,100,50,1/23/2018
CBA33B,dividend-up,100,71,1/23/2018
CD06A2,dividend-up,100,74,1/23/2018
CFE5BE,earnings,100,50,1/23/2018
D1173F,earnings,100,50,1/23/2018
D1AE3B,merger-rumor,100,73,1/23/2018
D3FA2C,conference-call,100,50,1/23/2018
D77F7E,earnings,100,50,1/23/2018
D854DD,conference-call,100,50,1/23/2018
D9B1C9,dividend,100,50,1/23/2018
DA91AE,executive-appointment,100,54,1/23/2018
DB7FA7,earnings-positive,100,69,1/23/2018
DB7FA7,earnings-up,100,68,1/23/2018
DB7FA7,earnings-up,100,68,1/23/2018
DB7FA7,earnings-up,100,68,1/23/2018
DB7FA7,earnings-up,100,68,1/23/2018
DB7FA7,earnings-up,100,68,1/23/2018
DB7FA7,earnings-up,100,68,1/23/2018
DB7FA7,earnings-up,100,68,1/23/2018
DB7FA7,dividend-up,100,55,1/23/2018
DC0D18,earnings,100,50,1/23/2018
DDC415,earnings,100,50,1/23/2018
DDCB34,conference-call,100,50,1/23/2018
DF42A0,conference-call,100,50,1/23/2018
E10D31,conference-call,100,50,1/23/2018
E1BD05,partnership,100,61,1/23/2018
E2F66E,business-contract,100,69,1/23/2018
E50F1C,earnings,100,50,1/23/2018
E68E62,public-offering,100,43,1/23/2018
E8846E,dividend,100,50,1/23/2018
E9E6FD,earnings,100,50,1/23/2018
E9FF33,earnings,100,50,1/23/2018
EB36DE,conference-call,100,50,1/23/2018
EC70EC,dividend-up,100,81,1/23/2018
ED5171,executive-appointment,100,54,1/23/2018
EDF5CA,earnings,100,50,1/23/2018
EDF5CA,earnings,100,50,1/23/2018
EDF5CA,earnings,100,50,1/23/2018
EDF5CA,earnings,100,50,1/23/2018
EDF5CA,earnings,100,50,1/23/2018
EDF5CA,earnings,100,50,1/23/2018
EDF5CA,earnings,100,50,1/23/2018
EEA734,regulatory-product-approval-granted,100,81,1/23/2018
EF5914,public-offering,100,43,1/23/2018
F0A9DE,earnings,100,50,1/23/2018
F4F46F,conference-call,100,50,1/23/2018
F57F6F,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6A945,earnings,100,50,1/23/2018
F6E1B5,executive-appointment,100,54,1/23/2018
F6E248,earnings,100,50,1/23/2018
F92DBC,unit-acquisition-acquiree,100,76,1/23/2018
FC4550,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FE7A63,earnings,100,50,1/23/2018
FEC475,acquisition-acquiree,100,76,1/23/2018
FEC475,acquisition-acquiree,100,76,1/23/2018
FEC475,acquisition-acquiree,100,76,1/23/2018
00FC70,conference-call,100,50,1/24/2018
0142B5,dividend,100,50,1/24/2018
018C11,conference-call,100,50,1/24/2018
20751,public-offering,100,43,1/24/2018
43862,executive-appointment,100,54,1/24/2018
0624BE,partnership,100,61,1/24/2018
75172,conference-call,100,50,1/24/2018
081AB9,dividend-up,100,78,1/24/2018
081AB9,earnings,100,50,1/24/2018
099C88,business-contract,100,69,1/24/2018
0AB700,earnings,100,50,1/24/2018
0AB700,earnings,100,50,1/24/2018
0B57D7,executive-appointment,100,54,1/24/2018
0B57D7,earnings,100,50,1/24/2018
0B9E6F,earnings-up,100,68,1/24/2018
0B9E6F,earnings,100,50,1/24/2018
0BF198,public-offering,100,43,1/24/2018
0BF198,public-offering,100,43,1/24/2018
0CE204,earnings,100,50,1/24/2018
0DE3D5,conference-call,100,50,1/24/2018
0E6027,earnings-negative,100,33,1/24/2018
11074E,executive-appointment,100,54,1/24/2018
1216D1,earnings,100,50,1/24/2018
1216D1,earnings-up,100,68,1/24/2018
1216D1,earnings-up,100,68,1/24/2018
1216D1,earnings-up,100,68,1/24/2018
1216D1,earnings-up,100,68,1/24/2018
1216D1,earnings-up,100,68,1/24/2018
1216D1,earnings-up,100,68,1/24/2018
12E454,partnership,100,61,1/24/2018
13D576,auditor-appointment,100,50,1/24/2018
147C38,earnings,100,50,1/24/2018
149301,earnings,100,50,1/24/2018
165B3A,earnings-positive,100,69,1/24/2018
165B3A,earnings-positive,100,69,1/24/2018
165B3A,earnings-positive,100,69,1/24/2018
165B3A,earnings-positive,100,69,1/24/2018
16B882,conference-participant,100,50,1/24/2018
188394,board-meeting,100,51,1/24/2018
1BDB2A,partnership,100,61,1/24/2018
1DA44F,conference-call,100,50,1/24/2018
1E5786,dividend-up,100,71,1/24/2018
1E8A99,earnings,100,50,1/24/2018
1E9A6D,executive-appointment,100,54,1/24/2018
1EBF8D,executive-appointment,100,54,1/24/2018
1FA8F7,earnings,100,50,1/24/2018
2082EA,public-offering,100,43,1/24/2018
20D00A,earnings,100,50,1/24/2018
2.45E+15,earnings,100,50,1/24/2018
25102A,exchange-noncompliance-authority,100,50,1/24/2018
2571FA,earnings,100,50,1/24/2018
2667B6,earnings-above-expectations,100,88,1/24/2018
2667B6,earnings,100,50,1/24/2018
2667B6,earnings,100,50,1/24/2018
2667B6,earnings,100,50,1/24/2018
2667B6,earnings,100,50,1/24/2018
275300,earnings,100,50,1/24/2018
27BFA1,earnings,100,50,1/24/2018
29CEBF,earnings-guidance,100,50,1/24/2018
29CEBF,earnings-guidance,100,50,1/24/2018
2ABF77,conference-call,100,50,1/24/2018
2B7A40,facility-open,100,65,1/24/2018
2D643C,earnings,100,50,1/24/2018
2EB04E,partnership,100,61,1/24/2018
32CB22,earnings,100,50,1/24/2018
343996,conference-call,100,50,1/24/2018
3461CF,dividend,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
34B411,earnings,100,50,1/24/2018
353DBB,earnings,100,50,1/24/2018
3696BF,earnings-positive,100,69,1/24/2018
3696BF,earnings,100,50,1/24/2018
3696BF,earnings,100,50,1/24/2018
3696BF,earnings,100,50,1/24/2018
3696BF,earnings,100,50,1/24/2018
3696BF,earnings,100,50,1/24/2018
3696BF,earnings,100,50,1/24/2018
370C50,product-price-raise,100,57,1/24/2018
3.73E+87,revenue-up,100,69,1/24/2018
3.73E+87,revenue-up,100,69,1/24/2018
3798B9,earnings,100,50,1/24/2018
3CCC90,earnings,100,50,1/24/2018
416C55,earnings,100,50,1/24/2018
41B0E2,earnings,100,50,1/24/2018
435ACE,executive-appointment,100,54,1/24/2018
435ACE,dividend-up,100,72,1/24/2018
4455C4,note-sale,100,52,1/24/2018
447FC6,executive-appointment,100,54,1/24/2018
45444E,acquisition-acquirer,100,49,1/24/2018
45444E,acquisition-acquirer,100,49,1/24/2018
4649D5,earnings,100,50,1/24/2018
4A6F00,donation,100,54,1/24/2018
4AE584,asset-up,100,72,1/24/2018
4B3555,executive-appointment,100,54,1/24/2018
4B49CF,earnings,100,50,1/24/2018
4B49CF,earnings,100,50,1/24/2018
4E4E75,conference-call,100,50,1/24/2018
4E7C1F,earnings,100,50,1/24/2018
4E7C1F,earnings,100,50,1/24/2018
4E7C1F,earnings,100,50,1/24/2018
4E7C1F,facility-open,100,65,1/24/2018
4F9487,earnings,100,50,1/24/2018
51B442,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
520632,earnings,100,50,1/24/2018
5340D0,conference-call,100,50,1/24/2018
55C289,earnings,100,50,1/24/2018
587EDF,earnings,100,50,1/24/2018
5A64D5,dividend,100,50,1/24/2018
5F6D73,earnings,100,50,1/24/2018
5F6D73,earnings,100,50,1/24/2018
5F6D73,earnings,100,50,1/24/2018
5F6D73,earnings,100,50,1/24/2018
5F6D73,earnings,100,50,1/24/2018
5F6D73,earnings,100,50,1/24/2018
5FE4B6,earnings,100,50,1/24/2018
6.18E+08,earnings,100,50,1/24/2018
62B20A,conference-call,100,50,1/24/2018
65CF8E,earnings,100,50,1/24/2018
67529E,earnings,100,50,1/24/2018
6ACFBF,earnings,100,50,1/24/2018
6BF593,earnings,100,50,1/24/2018
6C987C,earnings-positive,100,69,1/24/2018
6C987C,earnings,100,50,1/24/2018
6C987C,earnings,100,50,1/24/2018
6C987C,earnings,100,50,1/24/2018
6C987C,earnings,100,50,1/24/2018
6C987C,earnings,100,50,1/24/2018
6C987C,earnings,100,50,1/24/2018
6CC55E,earnings,100,50,1/24/2018
6CF43C,earnings,100,50,1/24/2018
6D4636,executive-appointment,100,54,1/24/2018
6EB9DA,earnings,100,50,1/24/2018
6EB9DA,earnings,100,50,1/24/2018
6EB9DA,earnings,100,50,1/24/2018
6EB9DA,earnings,100,50,1/24/2018
71E2EF,conference-call,100,50,1/24/2018
731675,earnings,100,50,1/24/2018
76D79A,dividend,100,50,1/24/2018
76E80F,hirings,100,65,1/24/2018
791EC1,conference-call,100,50,1/24/2018
7A5097,partnership,100,61,1/24/2018
7A5097,conference-call,100,50,1/24/2018
7AB859,private-placement,100,56,1/24/2018
7B6C88,earnings,100,50,1/24/2018
7DA412,earnings,100,50,1/24/2018
8.22E+27,executive-appointment,100,54,1/24/2018
82FD6D,conference-call,100,50,1/24/2018
830BDB,conference-call,100,50,1/24/2018
850779,dividend,100,50,1/24/2018
883D82,earnings,100,50,1/24/2018
8A8E41,partnership,100,61,1/24/2018
8C1238,conference-call,100,50,1/24/2018
8CF6DD,executive-appointment,100,54,1/24/2018
8E4250,acquisition-completed-acquirer,100,49,1/24/2018
8E8E6E,award,100,58,1/24/2018
8FF2EF,earnings,100,50,1/24/2018
901327,product-release,100,64,1/24/2018
91E5EE,dividend,100,50,1/24/2018
93F143,earnings,100,50,1/24/2018
942165,dividend,100,50,1/24/2018
943239,earnings,100,50,1/24/2018
94563D,business-contract,100,69,1/24/2018
9.62E+76,earnings,100,50,1/24/2018
965360,public-offering,100,43,1/24/2018
96F126,executive-appointment,100,54,1/24/2018
96F126,dividend,100,50,1/24/2018
9.92E+94,earnings,100,50,1/24/2018
9A02C4,earnings,100,50,1/24/2018
9A02C4,dividend,100,50,1/24/2018
9D30A8,earnings,100,50,1/24/2018
9D5D35,earnings,100,50,1/24/2018
A48593,partnership,100,61,1/24/2018
A5628C,executive-appointment,100,54,1/24/2018
A5A4F5,acquisition-acquirer,100,49,1/24/2018
A6213D,earnings,100,50,1/24/2018
A868C9,conference-call,100,50,1/24/2018
A8CBDA,earnings-positive,100,69,1/24/2018
A99576,earnings,100,50,1/24/2018
A9ED24,conference-call,100,50,1/24/2018
AA98ED,conference-call,100,50,1/24/2018
AABEA0,earnings-up,100,74,1/24/2018
AADE0B,dividend-up,100,81,1/24/2018
AAEE21,conference-call,100,50,1/24/2018
AD3C93,earnings,100,50,1/24/2018
B1FC3B,business-contract,100,69,1/24/2018
B5DE80,acquisition-acquirer,100,49,1/24/2018
B604DF,earnings,100,50,1/24/2018
B604DF,dividend,100,50,1/24/2018
B604DF,dividend,100,50,1/24/2018
B604DF,earnings,100,50,1/24/2018
B7BDA3,earnings,100,50,1/24/2018
BD15E8,executive-appointment,100,54,1/24/2018
BDD12C,earnings,100,50,1/24/2018
C15DB3,earnings,100,50,1/24/2018
C38440,partnership,100,61,1/24/2018
C50B26,facility-upgrade,100,65,1/24/2018
C564E4,public-offering,100,43,1/24/2018
C66B44,conference-call,100,50,1/24/2018
C83B88,earnings,100,50,1/24/2018
C83B88,dividend-up,100,81,1/24/2018
C9B932,earnings,100,50,1/24/2018
CA3CB9,conference-call,100,50,1/24/2018
CA99D7,conference-call,100,50,1/24/2018
CBA33B,earnings,100,50,1/24/2018
CE1002,earnings,100,50,1/24/2018
CE1002,earnings,100,50,1/24/2018
CE1002,earnings,100,50,1/24/2018
CE1002,earnings,100,50,1/24/2018
CE2791,note-sale,100,52,1/24/2018
CF9054,earnings,100,50,1/24/2018
CFF15D,appeal-plaintiff,100,22,1/24/2018
D04D9F,earnings,100,50,1/24/2018
D15833,dividend,100,50,1/24/2018
D1C26F,executive-appointment,100,54,1/24/2018
D21D8A,earnings,100,50,1/24/2018
D21D8A,earnings,100,50,1/24/2018
D21D8A,earnings,100,50,1/24/2018
D21D8A,earnings,100,50,1/24/2018
D21D8A,earnings,100,50,1/24/2018
D21D8A,earnings,100,50,1/24/2018
D21D8A,earnings,100,50,1/24/2018
D58A11,earnings,100,50,1/24/2018
D58A11,earnings,100,50,1/24/2018
D58A11,earnings,100,50,1/24/2018
D64C6D,partnership,100,61,1/24/2018
D7A953,earnings,100,50,1/24/2018
D8442A,revenue-volume,100,50,1/24/2018
DA48E4,business-contract,100,69,1/24/2018
DBB28E,executive-appointment,100,54,1/24/2018
DC2F77,dividend-up,100,70,1/24/2018
DCD97F,earnings,100,50,1/24/2018
DD1BA1,partnership,100,61,1/24/2018
DE4924,conference-call,100,50,1/24/2018
E0207A,executive-appointment,100,54,1/24/2018
E074A0,executive-appointment,100,54,1/24/2018
E07573,dividend,100,50,1/24/2018
E0F4E5,executive-appointment,100,54,1/24/2018
E124EB,patent-awarded,100,72,1/24/2018
E15736,public-offering,100,43,1/24/2018
E3E68E,executive-appointment,100,54,1/24/2018
E68E62,public-offering,100,43,1/24/2018
E8A49A,earnings,100,50,1/24/2018
ECDEB2,board-meeting,100,51,1/24/2018
F24FF0,conference-call,100,50,1/24/2018
F48947,conference-participant,100,50,1/24/2018
F82D37,dividend,100,50,1/24/2018
FAEABE,dividend-up,100,63,1/24/2018
FB7724,earnings,100,50,1/24/2018
FD4588,earnings,100,50,1/24/2018
FDC7E6,earnings,100,50,1/24/2018
FDC7E6,dividend-up,100,78,1/24/2018
FEE4B0,dividend,100,50,1/24/2018
FF4343,earnings-positive,100,69,1/24/2018
20751,public-offering,100,43,1/25/2018
03B8CF,dividend-up,100,66,1/25/2018
03B8CF,earnings,100,50,1/25/2018
03B8CF,earnings,100,50,1/25/2018
03B8CF,earnings,100,50,1/25/2018
03B8CF,earnings,100,50,1/25/2018
03B8CF,earnings,100,50,1/25/2018
51332,dividend,100,50,1/25/2018
0560D8,dividend,100,50,1/25/2018
061A3B,earnings,100,50,1/25/2018
06A456,unit-acquisition-acquirer,100,49,1/25/2018
07C907,earnings,100,50,1/25/2018
083F72,conference-call,100,50,1/25/2018
09DE1F,partnership,100,61,1/25/2018
09F623,conference-call,100,50,1/25/2018
0A77DB,partnership,100,61,1/25/2018
0DC050,earnings,100,50,1/25/2018
0ED415,earnings,100,50,1/25/2018
102F04,executive-appointment,100,54,1/25/2018
108A2B,conference-call,100,50,1/25/2018
129DC8,conference-call,100,50,1/25/2018
139303,conference-call,100,50,1/25/2018
156A99,earnings,100,50,1/25/2018
15B10D,product-release,100,64,1/25/2018
182B8C,earnings,100,50,1/25/2018
18EC17,earnings,100,50,1/25/2018
1B9535,conference-call,100,50,1/25/2018
1DB6A6,earnings,100,50,1/25/2018
1DB6A6,earnings,100,50,1/25/2018
1DB6A6,earnings,100,50,1/25/2018
1DB6A6,earnings,100,50,1/25/2018
1DB6A6,earnings,100,50,1/25/2018
1DB6A6,earnings,100,50,1/25/2018
1DE526,earnings,100,50,1/25/2018
1EC3E8,executive-appointment,100,54,1/25/2018
1FAF22,conference-participant,100,50,1/25/2018
202E5A,public-offering,100,43,1/25/2018
2031CE,earnings,100,50,1/25/2018
20DC4E,earnings,100,50,1/25/2018
2158DF,earnings,100,50,1/25/2018
22C58E,earnings,100,50,1/25/2018
24C48B,product-release,100,64,1/25/2018
24C48B,product-release,100,64,1/25/2018
24C48B,conference-call,100,50,1/25/2018
24CB56,executive-appointment,100,54,1/25/2018
25529C,earnings,100,50,1/25/2018
26CC63,dividend,100,50,1/25/2018
272472,earnings,100,50,1/25/2018
272704,dividend,100,50,1/25/2018
29B702,earnings,100,50,1/25/2018
2.90E+62,award,100,58,1/25/2018
2A17B1,executive-resignation,100,44,1/25/2018
2AA6A8,partnership,100,61,1/25/2018
2B9DBB,earnings,100,50,1/25/2018
2D981A,ipo-pricing,100,50,1/25/2018
2DA92D,earnings,100,50,1/25/2018
2EB88B,conference-call,100,50,1/25/2018
2F7474,earnings,100,50,1/25/2018
306623,conference-call,100,50,1/25/2018
315EB0,executive-resignation,100,44,1/25/2018
31F25C,earnings,100,50,1/25/2018
328250,earnings,100,50,1/25/2018
33AD83,partnership,100,61,1/25/2018
341759,ipo-pricing,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
370C50,earnings,100,50,1/25/2018
3A3447,product-release,100,64,1/25/2018
3B20AB,product-release,100,64,1/25/2018
3C75D6,executive-appointment,100,54,1/25/2018
3CBA2A,earnings-up,100,68,1/25/2018
3CBA2A,earnings-up,100,68,1/25/2018
3CBA2A,earnings-up,100,68,1/25/2018
3CBA2A,earnings-up,100,68,1/25/2018
3CBA2A,earnings-up,100,68,1/25/2018
3CBA2A,conference-call,100,50,1/25/2018
408089,earnings,100,50,1/25/2018
4.00E+163,award,100,58,1/25/2018
442769,conference-call,100,50,1/25/2018
447FC6,earnings,100,50,1/25/2018
447FC6,earnings,100,50,1/25/2018
449217,earnings,100,50,1/25/2018
449217,earnings,100,50,1/25/2018
449217,earnings,100,50,1/25/2018
449217,earnings,100,50,1/25/2018
449217,earnings,100,50,1/25/2018
453282,earnings-per-share-positive,100,69,1/25/2018
453282,earnings,100,50,1/25/2018
4591D3,revenues,100,50,1/25/2018
46CF27,earnings,100,50,1/25/2018
49914B,executive-appointment,100,54,1/25/2018
4BBA23,operating-earnings,100,50,1/25/2018
4BD6DB,earnings,100,50,1/25/2018
4C7DB5,earnings,100,50,1/25/2018
4D72C8,conference-call,100,50,1/25/2018
4EE167,product-release,100,64,1/25/2018
4EEE7E,earnings,100,50,1/25/2018
4FCC78,dividend,100,50,1/25/2018
50070E,conference-call,100,50,1/25/2018
507AE7,earnings,100,50,1/25/2018
51888A,dividend,100,50,1/25/2018
519FE0,earnings,100,50,1/25/2018
53E575,earnings,100,50,1/25/2018
548AC0,conference-call,100,50,1/25/2018
5546DA,earnings,100,50,1/25/2018
586FFD,revenues,100,50,1/25/2018
586FFD,revenues,100,50,1/25/2018
59C539,earnings,100,50,1/25/2018
5A64D5,conference-call,100,50,1/25/2018
5B7739,executive-appointment,100,54,1/25/2018
5D41E4,executive-appointment,100,54,1/25/2018
5D41E4,executive-appointment,100,54,1/25/2018
5EAA43,business-contract,100,69,1/25/2018
5F6D73,dividend-up,100,81,1/25/2018
5FDBD0,conference-call,100,50,1/25/2018
622037,dividend,100,50,1/25/2018
636931,earnings,100,50,1/25/2018
6474BA,earnings,100,50,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings-up,100,68,1/25/2018
6474BA,earnings,100,50,1/25/2018
6474BA,earnings,100,50,1/25/2018
6474BA,earnings,100,50,1/25/2018
65CF8E,dividend,100,50,1/25/2018
66A667,legal-issues-defendant,100,22,1/25/2018
69FDFC,revenue-guidance,100,50,1/25/2018
69FDFC,revenue-guidance,100,50,1/25/2018
6ABCB8,earnings,100,50,1/25/2018
6B5379,dividend,100,50,1/25/2018
6BC6F9,earnings,100,50,1/25/2018
6CDFC6,earnings,100,50,1/25/2018
72FCA3,dividend,100,50,1/25/2018
73C9E2,earnings,100,50,1/25/2018
7520CC,earnings,100,50,1/25/2018
75768D,executive-appointment,100,54,1/25/2018
762A3E,dividend,100,50,1/25/2018
767F86,earnings,100,50,1/25/2018
76CEFB,earnings,100,50,1/25/2018
76D79A,earnings-guidance,100,50,1/25/2018
773A17,revenues,100,50,1/25/2018
7.83E+79,earnings,100,50,1/25/2018
7.83E+79,earnings,100,50,1/25/2018
7.83E+79,earnings,100,50,1/25/2018
7.83E+79,earnings,100,50,1/25/2018
7.83E+79,earnings,100,50,1/25/2018
78A1BB,earnings,100,50,1/25/2018
78A1BB,earnings,100,50,1/25/2018
78A1BB,earnings,100,50,1/25/2018
78A1BB,earnings,100,50,1/25/2018
78A1BB,earnings,100,50,1/25/2018
791D59,earnings,100,50,1/25/2018
7A2A49,conference-call,100,50,1/25/2018
7B1156,earnings-guidance,100,50,1/25/2018
7B4B91,conference-call,100,50,1/25/2018
7C75FD,dividend,100,50,1/25/2018
7D5384,earnings,100,50,1/25/2018
7D5384,earnings,100,50,1/25/2018
7D5384,earnings,100,50,1/25/2018
7D5384,earnings,100,50,1/25/2018
7D5384,earnings,100,50,1/25/2018
7DC1C4,earnings,100,50,1/25/2018
7F3669,business-contract,100,69,1/25/2018
80D744,dividend,100,50,1/25/2018
8.22E+27,earnings,100,50,1/25/2018
83598E,dividend,100,50,1/25/2018
837C04,earnings,100,50,1/25/2018
837C04,dividend,100,50,1/25/2018
858942,partnership,100,61,1/25/2018
858942,earnings,100,50,1/25/2018
86478F,earnings,100,50,1/25/2018
8.73E+09,revenue-up,100,69,1/25/2018
8.73E+09,revenue-up,100,69,1/25/2018
8817D5,earnings-up,100,68,1/25/2018
8D4AE6,acquisition-completed-acquirer,100,49,1/25/2018
8D5145,earnings,100,50,1/25/2018
8DAAB9,earnings,100,50,1/25/2018
8DBE73,conference-call,100,50,1/25/2018
8DDA23,earnings,100,50,1/25/2018
8DE56F,earnings,100,50,1/25/2018
8DE56F,earnings,100,50,1/25/2018
8DE56F,earnings,100,50,1/25/2018
8F3231,earnings,100,50,1/25/2018
8FCA78,earnings-guidance-up,100,83,1/25/2018
902255,earnings,100,50,1/25/2018
915E7B,earnings-guidance,100,50,1/25/2018
922F0C,earnings-up,100,68,1/25/2018
92D6A5,earnings,100,50,1/25/2018
93C130,dividend,100,50,1/25/2018
943239,legal-issues-defendant,100,22,1/25/2018
94563D,earnings,100,50,1/25/2018
968103,earnings,100,50,1/25/2018
989E2F,earnings,100,50,1/25/2018
989E2F,earnings,100,50,1/25/2018
989E2F,earnings,100,50,1/25/2018
9C25FF,legal-issues-defendant,100,22,1/25/2018
9D56F2,earnings-up,100,68,1/25/2018
9D56F2,earnings-up,100,68,1/25/2018
9D56F2,earnings-up,100,68,1/25/2018
9D56F2,earnings-up,100,68,1/25/2018
9D56F2,earnings-up,100,68,1/25/2018
9DDE1B,dividend,100,50,1/25/2018
9E298A,dividend,100,50,1/25/2018
9E298A,earnings,100,50,1/25/2018
9E298A,earnings,100,50,1/25/2018
9EA947,conference-call,100,50,1/25/2018
9EED50,earnings,100,50,1/25/2018
9FF5F1,product-release,100,64,1/25/2018
A1A317,earnings,100,50,1/25/2018
A247F5,partnership,100,61,1/25/2018
A247F5,earnings-per-share-positive,100,69,1/25/2018
A247F5,earnings-per-share-positive,100,69,1/25/2018
A247F5,earnings-per-share-positive,100,69,1/25/2018
A5151E,earnings,100,50,1/25/2018
A5A4F5,acquisition-acquirer,100,49,1/25/2018
A60354,conference-call,100,50,1/25/2018
A6213D,conference-call,100,50,1/25/2018
A75D43,earnings,100,50,1/25/2018
A87CD6,conference-participant,100,50,1/25/2018
AA3AB8,dividend,100,50,1/25/2018
AADE0B,earnings,100,50,1/25/2018
AB7F05,earnings,100,50,1/25/2018
AE7D16,executive-appointment,100,54,1/25/2018
AEEB76,partnership,100,61,1/25/2018
B08954,earnings,100,50,1/25/2018
B0FE08,dividend,100,50,1/25/2018
B13B68,earnings-guidance,100,50,1/25/2018
B1FC3B,conference-participant,100,50,1/25/2018
B2206F,earnings,100,50,1/25/2018
B6CD92,earnings,100,50,1/25/2018
B6CD92,earnings,100,50,1/25/2018
B6CD92,earnings,100,50,1/25/2018
B6CD92,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BC3AD2,earnings,100,50,1/25/2018
BD8517,earnings,100,50,1/25/2018
BEB756,earnings,100,50,1/25/2018
BFEA04,conference-call,100,50,1/25/2018
C062D4,earnings,100,50,1/25/2018
C062D4,earnings,100,50,1/25/2018
C062D4,earnings,100,50,1/25/2018
C062D4,earnings,100,50,1/25/2018
C062D4,earnings,100,50,1/25/2018
C062D4,earnings,100,50,1/25/2018
C062D4,earnings,100,50,1/25/2018
C29715,earnings,100,50,1/25/2018
C4706C,conference-call,100,50,1/25/2018
C62AA4,conference-call,100,50,1/25/2018
C72B8F,earnings,100,50,1/25/2018
C93C44,patent-awarded,100,72,1/25/2018
C98CDB,earnings,100,50,1/25/2018
C99CC8,partnership,100,61,1/25/2018
CC8F6E,earnings,100,50,1/25/2018
CDAB24,earnings,100,50,1/25/2018
CDEDFE,dividend,100,50,1/25/2018
CE2791,conference-call,100,50,1/25/2018
CE96E7,earnings,100,50,1/25/2018
CE96E7,earnings,100,50,1/25/2018
CE96E7,earnings,100,50,1/25/2018
CEDFD5,revenue-up,100,69,1/25/2018
CEDFD5,revenue-up,100,69,1/25/2018
CEDFD5,revenue-up,100,69,1/25/2018
CEDFD5,revenue-up,100,69,1/25/2018
CEDFD5,revenue-up,100,69,1/25/2018
CEDFD5,revenue-up,100,69,1/25/2018
CF6A5A,earnings,100,50,1/25/2018
CFF15D,business-contract,100,69,1/25/2018
CFF97C,credit-rating-upgrade-rater,20,50,1/25/2018
CFF97C,credit-rating-upgrade-rater,20,50,1/25/2018
D17C1B,earnings,100,50,1/25/2018
D17C1B,earnings,100,50,1/25/2018
D17C1B,earnings,100,50,1/25/2018
D3F64D,earnings-guidance,100,50,1/25/2018
D4463B,earnings,100,50,1/25/2018
D48275,earnings,100,50,1/25/2018
D8760C,dividend,100,50,1/25/2018
D8F347,earnings,100,50,1/25/2018
D9164D,conference-participant,100,50,1/25/2018
D9B1C9,earnings,100,50,1/25/2018
D9B1C9,earnings,100,50,1/25/2018
D9B1C9,earnings,100,50,1/25/2018
DA48E4,dividend,100,50,1/25/2018
DA48E4,business-contract,100,69,1/25/2018
DA90E1,earnings,100,50,1/25/2018
DB23C8,partnership,100,61,1/25/2018
DBCA3F,earnings,100,50,1/25/2018
DD0099,earnings,100,50,1/25/2018
DD3BB1,earnings,100,50,1/25/2018
DF18E6,partnership,100,61,1/25/2018
DF204B,executive-appointment,100,54,1/25/2018
DF6FDD,earnings,100,50,1/25/2018
DF6FDD,earnings,100,50,1/25/2018
DF6FDD,earnings,100,50,1/25/2018
DF6FDD,earnings,100,50,1/25/2018
DF6FDD,earnings,100,50,1/25/2018
DF6FDD,earnings,100,50,1/25/2018
E00373,earnings,100,50,1/25/2018
E0339F,partnership,100,61,1/25/2018
E0339F,partnership,100,61,1/25/2018
E09E2B,conference-call,100,50,1/25/2018
E10D31,legal-issues-defendant,100,22,1/25/2018
E10D31,legal-issues-defendant,100,22,1/25/2018
E1BD05,revenue-up,100,74,1/25/2018
E1BD05,revenue-up,100,74,1/25/2018
E393B0,earnings,100,50,1/25/2018
E393B0,earnings,100,50,1/25/2018
E393B0,earnings,100,50,1/25/2018
E393B0,earnings,100,50,1/25/2018
E4CE73,award,100,58,1/25/2018
E4CE73,award,100,58,1/25/2018
E6A53A,dividend,100,50,1/25/2018
E866D2,earnings,100,50,1/25/2018
E866D2,earnings,100,50,1/25/2018
E866D2,earnings,100,50,1/25/2018
E866D2,earnings,100,50,1/25/2018
E866D2,earnings,100,50,1/25/2018
E866D2,earnings,100,50,1/25/2018
E866D2,earnings,100,50,1/25/2018
E94704,conference-call,100,50,1/25/2018
EA4E68,earnings,100,50,1/25/2018
EA4E68,earnings,100,50,1/25/2018
EA4E68,earnings,100,50,1/25/2018
EB5E78,partnership,100,61,1/25/2018
ED8676,earnings,100,50,1/25/2018
ED8676,dividend-up,100,60,1/25/2018
EDF5CA,dividend-up,100,64,1/25/2018
EF1AD9,dividend,100,50,1/25/2018
EF1AD9,earnings,100,50,1/25/2018
EF1AD9,earnings,100,50,1/25/2018
EF1AD9,earnings,100,50,1/25/2018
F0B2B5,executive-appointment,100,54,1/25/2018
F4E882,partnership,100,61,1/25/2018
F4E882,partnership,100,61,1/25/2018
F88A04,earnings,100,50,1/25/2018
F93C8A,conference-call,100,50,1/25/2018
FAB97A,earnings,100,50,1/25/2018
FADF1A,conference-call,100,50,1/25/2018
FC1B7B,earnings,100,50,1/25/2018
FC1B7B,dividend-up,100,60,1/25/2018
003B70,earnings,100,50,1/26/2018
43862,conference-call,100,50,1/26/2018
0BF198,public-offering,100,43,1/26/2018
0BF198,public-offering,100,43,1/26/2018
0F91FC,conference-call,100,50,1/26/2018
108FDA,earnings,100,50,1/26/2018
16C544,dividend,100,50,1/26/2018
19C105,earnings,100,50,1/26/2018
19C105,earnings,100,50,1/26/2018
1BC12C,trading-delisting,100,36,1/26/2018
25DD05,dividend,100,50,1/26/2018
26D8ED,conference-call,100,50,1/26/2018
26E3BA,unit-acquisition-acquirer,100,49,1/26/2018
272472,dividend-up,100,58,1/26/2018
282C18,earnings,100,50,1/26/2018
28DCF3,earnings-up,100,60,1/26/2018
2BDC1C,clinical-trials,100,56,1/26/2018
2BDC1C,clinical-trials,100,56,1/26/2018
2F7A7E,conference-call,100,50,1/26/2018
2F98A5,conference-call,100,50,1/26/2018
31A7CC,dividend,100,50,1/26/2018
338544,earnings,100,50,1/26/2018
34B97A,conference-participant,100,50,1/26/2018
3A94DF,earnings,100,50,1/26/2018
3E39A5,dividend,100,50,1/26/2018
3F6A9C,conference-call,100,50,1/26/2018
423279,dividend,100,50,1/26/2018
460C93,earnings,100,50,1/26/2018
494EB9,earnings,100,50,1/26/2018
4A2457,demand-guidance-increase,100,83,1/26/2018
4D203E,earnings,100,50,1/26/2018
4D371E,dividend,100,50,1/26/2018
4DD09F,conference-participant,100,50,1/26/2018
50070E,conference-organizer,100,57,1/26/2018
51888A,facility-open,100,65,1/26/2018
51E682,dividend-up,100,81,1/26/2018
5BFE94,dividend,100,50,1/26/2018
5BFE94,conference-call,100,50,1/26/2018
665D7D,earnings,100,50,1/26/2018
665D7D,earnings,100,50,1/26/2018
665D7D,earnings,100,50,1/26/2018
665D7D,earnings,100,50,1/26/2018
6B236C,dividend,100,50,1/26/2018
6E7060,dividend,100,50,1/26/2018
6ED519,dividend-up,100,81,1/26/2018
713810,partnership,100,61,1/26/2018
72EF75,dividend,100,50,1/26/2018
72F0FC,dividend-up,100,81,1/26/2018
72F0FC,earnings,100,50,1/26/2018
7.44E+09,conference-call,100,50,1/26/2018
762A3E,executive-appointment,100,54,1/26/2018
762A3E,conference-organizer,100,57,1/26/2018
767F86,executive-resignation,100,44,1/26/2018
76E80F,buybacks,100,74,1/26/2018
7712CB,conference-call,100,50,1/26/2018
771985,conference-participant,100,50,1/26/2018
787D14,conference-participant,100,50,1/26/2018
87B81A,earnings,100,50,1/26/2018
8A8E41,executive-appointment,100,54,1/26/2018
8B2C4A,business-contract,100,69,1/26/2018
8B2C4A,merger,100,66,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8B2C4A,earnings,100,50,1/26/2018
8E0E32,conference-participant,100,50,1/26/2018
92D757,earnings,100,50,1/26/2018
957A07,earnings,100,50,1/26/2018
965360,public-offering,100,43,1/26/2018
977A1E,dividend,100,50,1/26/2018
990AD0,credit-extension-provider,100,57,1/26/2018
990AD0,conference-organizer,100,57,1/26/2018
9934AD,conference-call,100,50,1/26/2018
9C8BC3,conference-call,100,50,1/26/2018
9E98F2,conference-participant,100,50,1/26/2018
A23747,earnings,100,50,1/26/2018
A2CA3F,dividend,100,50,1/26/2018
A2CA3F,conference-call,100,50,1/26/2018
A5A4F5,acquisition-acquirer,100,49,1/26/2018
A60354,acquisition-completed-acquirer,100,49,1/26/2018
A7F0A5,dividend,100,50,1/26/2018
A806FA,dividend,100,50,1/26/2018
AADE0B,acquisition-acquirer,100,49,1/26/2018
AF210D,earnings,100,50,1/26/2018
AFF43F,dividend,100,50,1/26/2018
B0B969,earnings,100,50,1/26/2018
B1B10C,earnings,100,50,1/26/2018
B1DF3C,public-offering,100,43,1/26/2018
B4C673,dividend-up,100,70,1/26/2018
B619CB,earnings-positive,100,69,1/26/2018
BB0587,conference-call,100,50,1/26/2018
BB58FF,conference-call,100,50,1/26/2018
BBBB41,dividend-up,100,81,1/26/2018
C0030A,product-release,100,64,1/26/2018
C062D4,dividend,100,50,1/26/2018
C16A8F,dividend,100,50,1/26/2018
C356AC,conference-call,100,50,1/26/2018
C83B88,executive-appointment,100,54,1/26/2018
CC176E,earnings,100,50,1/26/2018
CC339B,earnings,100,50,1/26/2018
CE69E9,legal-issues-defendant,100,22,1/26/2018
D518D8,earnings,100,50,1/26/2018
D64EDF,earnings,100,50,1/26/2018
D7F569,dividend,100,50,1/26/2018
D854F3,executive-resignation,100,44,1/26/2018
DAFED3,earnings-up,100,68,1/26/2018
DAFED3,earnings,100,50,1/26/2018
DAFED3,earnings,100,50,1/26/2018
DAFED3,earnings,100,50,1/26/2018
DBEF02,earnings,100,50,1/26/2018
DBEF02,earnings,100,50,1/26/2018
DBEF02,earnings,100,50,1/26/2018
DBEF02,earnings,100,50,1/26/2018
DE5611,dividend,100,50,1/26/2018
E114F4,executive-appointment,100,54,1/26/2018
E11C41,conference-call,100,50,1/26/2018
E5752F,executive-appointment,100,54,1/26/2018
E6A53A,product-price-raise,100,57,1/26/2018
E6E012,dividend,100,50,1/26/2018
E99180,revenue-up,100,69,1/26/2018
EB6965,earnings,100,50,1/26/2018
EB6965,earnings,100,50,1/26/2018
EB6965,earnings,100,50,1/26/2018
EB6965,earnings,100,50,1/26/2018
EB6965,earnings,100,50,1/26/2018
EB6965,earnings,100,50,1/26/2018
EB6965,earnings,100,50,1/26/2018
ED3CA8,earnings,100,50,1/26/2018
EF45B6,earnings,100,50,1/26/2018
F30508,conference-participant,100,50,1/26/2018
F3FCC3,dividend,100,50,1/26/2018
F40EE2,facility-open,100,65,1/26/2018
F793FA,earnings,100,50,1/26/2018
FA35C6,earnings,100,50,1/26/2018
FD0CA4,dividend-up,100,81,1/26/2018
FF6644,earnings,100,50,1/26/2018
FF6644,earnings,100,50,1/26/2018
FF6644,earnings,100,50,1/26/2018
FF6644,earnings,100,50,1/26/2018
FF6644,earnings,100,50,1/26/2018
0C4131,conference-call,100,50,1/27/2018
58CA9A,executive-appointment,100,54,1/27/2018
96F126,business-contract,100,69,1/27/2018
77B8E9,clinical-trials,100,56,1/28/2018
00D6B5,earnings,100,50,1/29/2018
01478A,earnings,100,50,1/29/2018
20751,public-offering,100,43,1/29/2018
03B8CF,partnership,100,61,1/29/2018
03F5A4,earnings-positive,100,69,1/29/2018
040DBB,earnings,100,50,1/29/2018
040DBB,earnings,100,50,1/29/2018
040DBB,public-offering,100,43,1/29/2018
58828,operating-earnings,100,50,1/29/2018
0968A5,note-sale,100,52,1/29/2018
0A6824,executive-appointment,100,54,1/29/2018
0A6824,dividend,100,50,1/29/2018
0ED415,executive-resignation,100,44,1/29/2018
0F2BC9,business-contract,100,69,1/29/2018
10673F,earnings,100,50,1/29/2018
10673F,earnings,100,50,1/29/2018
126F95,earnings,100,50,1/29/2018
126F95,earnings,100,50,1/29/2018
126F95,earnings,100,50,1/29/2018
126F95,earnings,100,50,1/29/2018
12F98C,partnership,100,61,1/29/2018
16AAE0,earnings,100,50,1/29/2018
196D18,sponsorship,100,57,1/29/2018
196D18,sponsorship,100,57,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1A9DE1,earnings,100,50,1/29/2018
1D1B07,note-sale,100,52,1/29/2018
1D1B07,note-sale,100,52,1/29/2018
1DEBBE,facility-open,100,65,1/29/2018
1E68B3,earnings,100,50,1/29/2018
1F19C8,credit-extension-provider,100,57,1/29/2018
202E5A,public-offering,100,43,1/29/2018
20DC4E,dividend-up,100,81,1/29/2018
228D42,partnership,100,61,1/29/2018
228D42,partnership,100,61,1/29/2018
25102A,acquisition-acquiree,100,76,1/29/2018
25102A,acquisition-acquiree,100,76,1/29/2018
25102A,acquisition-acquiree,100,76,1/29/2018
25102A,acquisition-acquiree,100,76,1/29/2018
25AB8E,conference-call,100,50,1/29/2018
2CA60F,earnings,100,50,1/29/2018
2D2D43,dividend-up,100,81,1/29/2018
2D2D43,board-meeting,100,51,1/29/2018
2D981A,ipo-completed,100,76,1/29/2018
3461CF,credit-rating-downgrade-rater,20,50,1/29/2018
3461CF,executive-resignation,100,44,1/29/2018
3461CF,partnership,100,61,1/29/2018
372037,product-release,100,64,1/29/2018
3.88E+02,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
38FB49,earnings,100,50,1/29/2018
3BC360,ipo,100,71,1/29/2018
4.03E+05,business-contract,100,69,1/29/2018
45444E,conference-call,100,50,1/29/2018
49F4D0,index-listing,100,76,1/29/2018
4AC91D,dividend,100,50,1/29/2018
4D8313,earnings,100,50,1/29/2018
4D8313,earnings,100,50,1/29/2018
4D8313,earnings,100,50,1/29/2018
4D8313,earnings,100,50,1/29/2018
513A86,earnings,100,50,1/29/2018
513A86,executive-appointment,100,54,1/29/2018
51D876,business-contract,100,69,1/29/2018
51D876,business-contract,100,69,1/29/2018
54F271,earnings,100,50,1/29/2018
55438C,product-release,100,64,1/29/2018
56AFF4,dividend,100,50,1/29/2018
56EA2B,earnings,100,50,1/29/2018
583A75,earnings,100,50,1/29/2018
58CA9A,partnership,100,61,1/29/2018
5BE42C,earnings,100,50,1/29/2018
5EAA43,business-contract,100,69,1/29/2018
619882,executive-appointment,100,54,1/29/2018
622DBE,executive-appointment,100,54,1/29/2018
64E615,conference-call,100,50,1/29/2018
66667F,conference-participant,100,50,1/29/2018
69CE71,conference-call,100,50,1/29/2018
6A3C35,earnings-guidance,100,50,1/29/2018
6A961B,earnings,100,50,1/29/2018
6B494E,conference-call,100,50,1/29/2018
6D4636,earnings,100,50,1/29/2018
6D4636,earnings,100,50,1/29/2018
6.00E+19,settlement,100,56,1/29/2018
6.00E+19,earnings,100,50,1/29/2018
6EB9DA,award,100,58,1/29/2018
70FCEF,executive-appointment,100,54,1/29/2018
724F84,earnings,100,50,1/29/2018
729368,public-offering,100,43,1/29/2018
72C2CE,conference-call,100,50,1/29/2018
735388,earnings,100,50,1/29/2018
76F067,earnings,100,50,1/29/2018
773A17,partnership,100,61,1/29/2018
773A17,partnership,100,61,1/29/2018
782B46,earnings,100,50,1/29/2018
790C34,partnership,100,61,1/29/2018
791EC1,unit-acquisition-acquirer,100,49,1/29/2018
7DD584,earnings,100,50,1/29/2018
7F3669,earnings,100,50,1/29/2018
8.10E+32,executive-appointment,100,54,1/29/2018
8.10E+32,conference-call,100,50,1/29/2018
860AB6,conference-call,100,50,1/29/2018
8A8E41,executive-appointment,100,54,1/29/2018
8C1238,earnings,100,50,1/29/2018
8C1238,earnings,100,50,1/29/2018
8C1238,earnings,100,50,1/29/2018
8C1238,earnings,100,50,1/29/2018
8C1238,earnings,100,50,1/29/2018
8D9993,dividend,100,50,1/29/2018
8E93A4,earnings,100,50,1/29/2018
92D230,executive-appointment,100,54,1/29/2018
92D230,executive-appointment,100,54,1/29/2018
92D230,executive-appointment,100,54,1/29/2018
92D757,dividend-up,100,81,1/29/2018
945DE6,dividend,100,50,1/29/2018
950CDB,executive-death,100,31,1/29/2018
965360,acquisition-acquirer,100,49,1/29/2018
96F126,earnings,100,50,1/29/2018
971F7B,earnings,100,50,1/29/2018
977A1E,earnings,100,50,1/29/2018
986AF6,conference-call,100,50,1/29/2018
99DC8D,conference-call,100,50,1/29/2018
9C5174,earnings,100,50,1/29/2018
9D6A24,conference-call,100,50,1/29/2018
9D6A24,earnings,100,50,1/29/2018
9D6A24,earnings,100,50,1/29/2018
9D6A24,acquisition-acquirer,100,49,1/29/2018
9D6A24,acquisition-acquirer,100,49,1/29/2018
9E91C6,legal-issues-defendant,100,22,1/29/2018
9F18FA,earnings,100,50,1/29/2018
9F18FA,earnings,100,50,1/29/2018
9F37C5,dividend,100,50,1/29/2018
A02FB1,earnings,100,50,1/29/2018
A15C71,earnings,100,50,1/29/2018
A2CA3F,earnings,100,50,1/29/2018
A495F7,partnership,100,61,1/29/2018
A4CD53,executive-appointment,100,54,1/29/2018
A5628C,earnings,100,50,1/29/2018
A5A4F5,acquisition-acquirer,100,49,1/29/2018
A63387,conference-call,100,50,1/29/2018
A74F6F,conference-call,100,50,1/29/2018
AD1ACF,investment-investor,100,55,1/29/2018
AD3C93,partnership,100,61,1/29/2018
B48FC9,earnings,100,50,1/29/2018
B72BE9,revenues,100,50,1/29/2018
B72BE9,revenues,100,50,1/29/2018
B72BE9,revenues,100,50,1/29/2018
BC3AD2,merger-completed,100,66,1/29/2018
BE14CF,conference-call,100,50,1/29/2018
C2F597,earnings,100,50,1/29/2018
C564E4,executive-appointment,100,54,1/29/2018
C65004,earnings,100,50,1/29/2018
C66B44,index-listing,100,76,1/29/2018
C97B2D,conference-participant,100,50,1/29/2018
C99CC8,executive-appointment,100,54,1/29/2018
CA1620,product-release,100,64,1/29/2018
CB88B3,earnings,100,50,1/29/2018
CE4FD9,conference-call,100,50,1/29/2018
CE96E7,dividend,100,50,1/29/2018
CE96E7,note-sale,100,52,1/29/2018
CF3FF9,public-offering,100,43,1/29/2018
CFF15D,product-release,100,64,1/29/2018
D20C8F,executive-appointment,100,54,1/29/2018
D29B44,earnings,100,50,1/29/2018
D501DC,earnings,100,50,1/29/2018
D63B0F,conference-call,100,50,1/29/2018
DF46C5,dividend,100,50,1/29/2018
DF46C5,earnings,100,50,1/29/2018
DF46C5,earnings,100,50,1/29/2018
DF46C5,earnings,100,50,1/29/2018
DF46C5,earnings,100,50,1/29/2018
E114F4,executive-appointment,100,54,1/29/2018
E6A53A,earnings,100,50,1/29/2018
E6BC2C,partnership,100,61,1/29/2018
E70531,earnings,100,50,1/29/2018
E71AE6,business-contract,100,69,1/29/2018
E71AE6,business-contract,100,69,1/29/2018
E71AE6,business-contract,100,69,1/29/2018
E8846E,executive-appointment,100,54,1/29/2018
E8B21D,earnings-up,100,68,1/29/2018
E8B21D,earnings,100,50,1/29/2018
E8B21D,earnings,100,50,1/29/2018
E8B21D,earnings,100,50,1/29/2018
E8B21D,earnings,100,50,1/29/2018
E8B21D,earnings,100,50,1/29/2018
E8B21D,earnings,100,50,1/29/2018
EAEBF3,product-release,100,64,1/29/2018
EBC84C,award,100,58,1/29/2018
ED2EFD,dividend,100,50,1/29/2018
ED79D9,partnership,100,61,1/29/2018
EEEA9F,earnings,100,50,1/29/2018
EF5BED,partnership,100,61,1/29/2018
EF5BED,partnership,100,61,1/29/2018
F24FF0,earnings,100,50,1/29/2018
F5A214,earnings,100,50,1/29/2018
F92DBC,partnership,100,61,1/29/2018
F92DBC,partnership,100,61,1/29/2018
FACF19,patent-awarded,100,72,1/29/2018
FAE021,earnings,100,50,1/29/2018
FC1B7B,conference-participant,100,50,1/29/2018
0157B1,partnership,100,61,1/30/2018
03FB17,earnings,100,50,1/30/2018
98977,earnings,100,50,1/30/2018
0C2A0D,earnings,100,50,1/30/2018
0E439E,earnings,100,50,1/30/2018
0E439E,earnings,100,50,1/30/2018
0E439E,earnings,100,50,1/30/2018
0E439E,earnings,100,50,1/30/2018
0E439E,earnings,100,50,1/30/2018
102727,earnings,100,50,1/30/2018
1220D2,earnings,100,50,1/30/2018
168A5D,partnership,100,61,1/30/2018
16F4D8,note-sale,100,52,1/30/2018
1.79E+10,conference-call,100,50,1/30/2018
1CD09C,business-contract,100,69,1/30/2018
1D1B07,note-sale,100,52,1/30/2018
1D943E,earnings,100,50,1/30/2018
1DA44F,dividend-up,100,81,1/30/2018
1E9A6D,earnings,100,50,1/30/2018
200D8B,award,100,58,1/30/2018
221AD7,earnings,100,50,1/30/2018
221AD7,earnings,100,50,1/30/2018
228D42,partnership,100,61,1/30/2018
23207A,conference-call,100,50,1/30/2018
23207A,conference-call,100,50,1/30/2018
267718,earnings,100,50,1/30/2018
2A9C0A,earnings-up,100,87,1/30/2018
2DB344,earnings,100,50,1/30/2018
2F24A5,earnings,100,50,1/30/2018
2F94A5,earnings,100,50,1/30/2018
31553A,product-release,100,64,1/30/2018
341759,ipo-completed,100,76,1/30/2018
3461CF,credit-rating-upgrade-rater,20,50,1/30/2018
3461CF,credit-rating-upgrade-rater,20,50,1/30/2018
3461CF,credit-rating-upgrade-rater,20,50,1/30/2018
34B97A,earnings,100,50,1/30/2018
34B97A,earnings,100,50,1/30/2018
34B97A,earnings,100,50,1/30/2018
34B97A,earnings,100,50,1/30/2018
34B97A,earnings,100,50,1/30/2018
3.50E+27,earnings,100,50,1/30/2018
3B20AB,earnings,100,50,1/30/2018
3BCF24,earnings,100,50,1/30/2018
3CBA2A,legal-issues-defendant,100,22,1/30/2018
415188,conference-call,100,50,1/30/2018
41D61C,earnings,100,50,1/30/2018
420168,earnings,100,50,1/30/2018
422A82,earnings,100,50,1/30/2018
422A82,earnings,100,50,1/30/2018
422A82,earnings,100,50,1/30/2018
44209A,earnings,100,50,1/30/2018
4455C4,credit-extension-recipient,100,69,1/30/2018
458D2C,donation,100,54,1/30/2018
4885C8,dividend-up,100,81,1/30/2018
494EB9,earnings,100,50,1/30/2018
49A344,government-contract,100,69,1/30/2018
4A6F00,partnership,100,61,1/30/2018
4C37C5,product-release,100,64,1/30/2018
4E7C1F,acquisition-acquirer,100,49,1/30/2018
504FE2,conference-participant,100,50,1/30/2018
525A1C,earnings,100,50,1/30/2018
525A1C,earnings,100,50,1/30/2018
525A1C,earnings,100,50,1/30/2018
525A1C,earnings,100,50,1/30/2018
525A1C,earnings,100,50,1/30/2018
53A226,earnings,100,50,1/30/2018
54A646,earnings,100,50,1/30/2018
54A646,earnings,100,50,1/30/2018
54A646,earnings,100,50,1/30/2018
54A646,earnings,100,50,1/30/2018
553949,earnings,100,50,1/30/2018
56277A,earnings,100,50,1/30/2018
57634F,earnings,100,50,1/30/2018
589F5A,earnings,100,50,1/30/2018
59A832,conference-call,100,50,1/30/2018
5A64D5,product-price-raise,100,57,1/30/2018
5B3FA2,partnership,100,61,1/30/2018
5B6C11,earnings,100,50,1/30/2018
5D16CF,buybacks,100,74,1/30/2018
5F9CE3,award,100,58,1/30/2018
619882,partnership,100,61,1/30/2018
636639,earnings,100,50,1/30/2018
64854A,conference-call,100,50,1/30/2018
6634D9,earnings,100,50,1/30/2018
69345C,earnings,100,50,1/30/2018
69494C,conference-call,100,50,1/30/2018
6B0784,conference-call,100,50,1/30/2018
6CD55A,earnings,100,50,1/30/2018
6.00E+19,business-contract,100,69,1/30/2018
6ED519,conference-call,100,50,1/30/2018
7032D0,earnings,100,50,1/30/2018
7255D2,conference-call,100,50,1/30/2018
732449,earnings,100,50,1/30/2018
742AAB,conference-call,100,50,1/30/2018
762A3E,conference-organizer,100,57,1/30/2018
765913,earnings,100,50,1/30/2018
782B46,dividend,100,50,1/30/2018
79340A,earnings,100,50,1/30/2018
7A3633,earnings,100,50,1/30/2018
7B4B91,earnings,100,50,1/30/2018
7C4F43,public-offering,100,43,1/30/2018
7D5FD6,buybacks,100,74,1/30/2018
7D5FD6,earnings,100,50,1/30/2018
7DD8CC,conference-call,100,50,1/30/2018
7F2922,earnings,100,50,1/30/2018
804708,conference-call,100,50,1/30/2018
8.10E+32,legal-issues-defendant,100,22,1/30/2018
8.10E+32,legal-issues-defendant,100,22,1/30/2018
81F4BE,earnings,100,50,1/30/2018
81F4BE,earnings,100,50,1/30/2018
824CCA,conference-call,100,50,1/30/2018
83598E,earnings,100,50,1/30/2018
86AA9C,conference-call,100,50,1/30/2018
8D4486,partnership,100,61,1/30/2018
8D4486,dividend,100,50,1/30/2018
8D4486,dividend,100,50,1/30/2018
902670,dividend,100,50,1/30/2018
9.54E+32,earnings,100,50,1/30/2018
95DC1F,executive-appointment,100,54,1/30/2018
9.86E+03,earnings,100,50,1/30/2018
986AF6,earnings,100,50,1/30/2018
986AF6,earnings,100,50,1/30/2018
986AF6,earnings,100,50,1/30/2018
990AD0,conference-organizer,100,57,1/30/2018
997348,earnings,100,50,1/30/2018
997348,earnings,100,50,1/30/2018
9B5968,partnership,100,61,1/30/2018
9BB35A,operating-earnings-positive,100,69,1/30/2018
9BB35A,earnings-per-share,100,50,1/30/2018
9BB35A,earnings-per-share,100,50,1/30/2018
9BB35A,earnings-per-share,100,50,1/30/2018
9BB35A,dividend,100,50,1/30/2018
9E91C6,legal-issues-defendant,100,22,1/30/2018
9EBAFA,conference-call,100,50,1/30/2018
9F5CBB,dividend,100,50,1/30/2018
A4D173,earnings,100,50,1/30/2018
A4D173,earnings,100,50,1/30/2018
A5A4F5,acquisition-acquirer,100,49,1/30/2018
A5E715,earnings,100,50,1/30/2018
A666C8,earnings,100,50,1/30/2018
A75D43,product-release,100,64,1/30/2018
A8B137,earnings,100,50,1/30/2018
AD3C93,partnership,100,61,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AE4EEB,earnings,100,50,1/30/2018
AFF43F,earnings,100,50,1/30/2018
B303A6,dividend,100,50,1/30/2018
B4528F,earnings,100,50,1/30/2018
B4703C,revenue-up,100,69,1/30/2018
B4703C,revenue-up,100,69,1/30/2018
B4703C,revenue-up,100,69,1/30/2018
B5766D,dividend,100,50,1/30/2018
B6082A,earnings,100,50,1/30/2018
B66928,facility-upgrade,100,65,1/30/2018
B8EF97,dividend,100,50,1/30/2018
B8F71F,earnings,100,50,1/30/2018
BBAE2A,dividend-up,100,67,1/30/2018
BC3AD2,earnings,100,50,1/30/2018
BC3AD2,earnings,100,50,1/30/2018
BD682F,earnings,100,50,1/30/2018
BDEF34,earnings,100,50,1/30/2018
BE86A1,earnings-up,100,64,1/30/2018
C407A0,earnings,100,50,1/30/2018
C4A912,conference-call,100,50,1/30/2018
C4F567,revenue-up,100,69,1/30/2018
C4F567,earnings,100,50,1/30/2018
C4F567,earnings,100,50,1/30/2018
C4F567,earnings,100,50,1/30/2018
C659EB,earnings,100,50,1/30/2018
C659EB,earnings,100,50,1/30/2018
C659EB,earnings,100,50,1/30/2018
C659EB,earnings,100,50,1/30/2018
C7AE14,conference-participant,100,50,1/30/2018
C81E00,earnings,100,50,1/30/2018
C81E00,earnings,100,50,1/30/2018
C81E00,earnings,100,50,1/30/2018
C81E00,earnings,100,50,1/30/2018
C8923A,public-offering,100,43,1/30/2018
CE4FD9,executive-appointment,100,54,1/30/2018
CF3FF9,public-offering,100,43,1/30/2018
D437C3,partnership,100,61,1/30/2018
D54E62,resource-discovery,100,88,1/30/2018
D8442A,legal-issues-defendant,100,22,1/30/2018
D8DBA3,operating-earnings,100,50,1/30/2018
D90F43,partnership,100,61,1/30/2018
DA199F,stake-acquirer,100,48,1/30/2018
DA48E4,award,100,58,1/30/2018
DB06B0,earnings,100,50,1/30/2018
DB06B0,earnings,100,50,1/30/2018
DB06B0,earnings,100,50,1/30/2018
DB06B0,earnings,100,50,1/30/2018
DB06B0,earnings,100,50,1/30/2018
DC486E,earnings,100,50,1/30/2018
DEF058,earnings,100,50,1/30/2018
E114F4,earnings,100,50,1/30/2018
E114F4,earnings,100,50,1/30/2018
E114F4,earnings,100,50,1/30/2018
E114F4,earnings,100,50,1/30/2018
E124EB,earnings,100,50,1/30/2018
E16133,partnership,100,61,1/30/2018
E21871,note-sale,100,52,1/30/2018
E67C2C,earnings,100,50,1/30/2018
E68733,acquisition-completed-acquirer,100,49,1/30/2018
E68733,partnership,100,61,1/30/2018
E6D89E,earnings,100,50,1/30/2018
E6D89E,earnings,100,50,1/30/2018
E6D89E,earnings,100,50,1/30/2018
E6D89E,earnings,100,50,1/30/2018
E6D89E,earnings,100,50,1/30/2018
E6E012,earnings,100,50,1/30/2018
E70531,supply-guidance-increase,100,74,1/30/2018
E71AE6,award,100,58,1/30/2018
E71AE6,award,100,58,1/30/2018
E96E0B,conference-call,100,50,1/30/2018
EC1AF3,conference-call,100,50,1/30/2018
EC70EC,earnings,100,50,1/30/2018
EC70EC,earnings,100,50,1/30/2018
EC70EC,earnings,100,50,1/30/2018
EC70EC,earnings,100,50,1/30/2018
EC99D0,dividend-up,100,81,1/30/2018
EC99D0,earnings,100,50,1/30/2018
ECDEB2,earnings,100,50,1/30/2018
ED79D9,award,100,58,1/30/2018
ED9576,earnings,100,50,1/30/2018
EE1E44,earnings,100,50,1/30/2018
EE1E44,earnings,100,50,1/30/2018
EE1E44,earnings,100,50,1/30/2018
EE1E44,earnings,100,50,1/30/2018
EE1E44,earnings,100,50,1/30/2018
EE1E44,earnings,100,50,1/30/2018
EE6F1C,earnings-positive,100,69,1/30/2018
EE6F1C,earnings,100,50,1/30/2018
EE6F1C,earnings,100,50,1/30/2018
EE6F1C,earnings,100,50,1/30/2018
EE6F1C,earnings,100,50,1/30/2018
F04E05,earnings,100,50,1/30/2018
F3FCC3,revenue-up,100,57,1/30/2018
F3FCC3,earnings,100,50,1/30/2018
F3FCC3,earnings,100,50,1/30/2018
F3FCC3,earnings,100,50,1/30/2018
F3FCC3,earnings,100,50,1/30/2018
F40EE2,earnings,100,50,1/30/2018
F4E882,joint-venture,100,62,1/30/2018
F5349B,executive-appointment,100,54,1/30/2018
F8DE55,dividend-up,100,81,1/30/2018
FAE021,executive-resignation,100,44,1/30/2018
FCA54E,business-contract,100,69,1/30/2018
00326E,earnings,100,50,1/31/2018
03CF95,earnings,100,50,1/31/2018
03D5F9,executive-appointment,100,54,1/31/2018
03D5F9,executive-appointment,100,54,1/31/2018
03FAA6,executive-appointment,100,54,1/31/2018
04996E,earnings,100,50,1/31/2018
71860,earnings,100,50,1/31/2018
0968A5,note-sale,100,52,1/31/2018
0986B5,earnings,100,50,1/31/2018
0A6824,earnings,100,50,1/31/2018
0B4D10,earnings,100,50,1/31/2018
0E2992,earnings,100,50,1/31/2018
106394,public-offering,100,43,1/31/2018
12DE76,conference-call,100,50,1/31/2018
12E454,patent-infringement-defendant,100,26,1/31/2018
12E454,earnings,100,50,1/31/2018
1348C9,asset-sale,100,62,1/31/2018
159AE4,dividend,100,50,1/31/2018
18D9FA,executive-appointment,100,54,1/31/2018
197019,dividend-up,100,81,1/31/2018
1A3E1B,unit-acquisition-acquiree,100,76,1/31/2018
1B4F31,earnings,100,50,1/31/2018
1BDB2A,earnings,100,50,1/31/2018
1CD708,executive-appointment,100,54,1/31/2018
1DDEDA,conference-call,100,50,1/31/2018
1E1125,conference-organizer,100,57,1/31/2018
1E9A6D,hirings,100,65,1/31/2018
225CA2,business-contract,100,69,1/31/2018
225CA2,business-contract,100,69,1/31/2018
225CA2,business-contract,100,69,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
225CA2,earnings-up,100,68,1/31/2018
232053,executive-appointment,100,54,1/31/2018
24CB56,executive-appointment,100,54,1/31/2018
25102A,earnings,100,50,1/31/2018
25102A,dividend,100,50,1/31/2018
25102A,earnings,100,50,1/31/2018
25102A,dividend,100,50,1/31/2018
25102A,earnings,100,50,1/31/2018
251988,earnings,100,50,1/31/2018
251988,earnings,100,50,1/31/2018
251988,earnings,100,50,1/31/2018
251988,earnings,100,50,1/31/2018
251988,earnings,100,50,1/31/2018
251988,earnings,100,50,1/31/2018
264EB3,board-meeting,100,51,1/31/2018
264EB3,earnings,100,50,1/31/2018
264EB3,earnings,100,50,1/31/2018
270305,earnings,100,50,1/31/2018
270305,earnings,100,50,1/31/2018
270305,earnings,100,50,1/31/2018
270305,dividend,100,50,1/31/2018
28DCF3,earnings,100,50,1/31/2018
2B0AF4,earnings,100,50,1/31/2018
2B8179,conference-participant,100,50,1/31/2018
2CC71C,executive-appointment,100,54,1/31/2018
2F1299,dividend,100,50,1/31/2018
2F6782,conference-call,100,50,1/31/2018
2FEA66,operating-earnings,100,50,1/31/2018
30A565,legal-issues-defendant,100,22,1/31/2018
326EDD,unit-acquisition-acquirer,100,49,1/31/2018
326EDD,earnings,100,50,1/31/2018
343996,earnings-up,100,68,1/31/2018
343996,earnings-up,100,68,1/31/2018
37020C,earnings,100,50,1/31/2018
37020C,earnings,100,50,1/31/2018
37020C,earnings,100,50,1/31/2018
37020C,earnings,100,50,1/31/2018
37020C,earnings,100,50,1/31/2018
37020C,earnings,100,50,1/31/2018
3A3447,dividend,100,50,1/31/2018
42AABD,conference-participant,100,50,1/31/2018
43A74A,earnings,100,50,1/31/2018
44740A,acquisition-completed-acquirer,100,49,1/31/2018
451D61,conference-call,100,50,1/31/2018
47752F,earnings,100,50,1/31/2018
485445,executive-appointment,100,54,1/31/2018
494EB9,dividend,100,50,1/31/2018
4AE584,unit-acquisition-acquirer,100,49,1/31/2018
4C6C63,earnings,100,50,1/31/2018
4E2D94,executive-resignation,100,44,1/31/2018
4E2D94,earnings,100,50,1/31/2018
4E2D94,dividend,100,50,1/31/2018
50070E,conference-organizer,100,57,1/31/2018
50070E,conference-organizer,100,57,1/31/2018
51B442,earnings,100,50,1/31/2018
532D47,acquisition-acquirer,100,49,1/31/2018
5403F8,earnings,100,50,1/31/2018
54A646,dividend,100,50,1/31/2018
55438C,earnings-up,100,68,1/31/2018
55438C,earnings-up,100,68,1/31/2018
55438C,earnings-up,100,68,1/31/2018
55438C,earnings-up,100,68,1/31/2018
55438C,earnings-up,100,68,1/31/2018
55438C,earnings-up,100,68,1/31/2018
55438C,product-release,100,64,1/31/2018
55ACCB,product-release,100,64,1/31/2018
56765E,earnings,100,50,1/31/2018
57B174,conference-call,100,50,1/31/2018
57CAAB,earnings,100,50,1/31/2018
57CAAB,earnings,100,50,1/31/2018
57CAAB,earnings,100,50,1/31/2018
57CAAB,earnings,100,50,1/31/2018
57CAAB,earnings,100,50,1/31/2018
57EF50,dividend,100,50,1/31/2018
57F3DA,earnings,100,50,1/31/2018
587EDF,earnings,100,50,1/31/2018
58CA9A,unit-acquisition-acquiree,100,76,1/31/2018
5B6C11,executive-appointment,100,54,1/31/2018
5C7601,earnings,100,50,1/31/2018
5D1329,conference-participant,100,50,1/31/2018
601785,executive-appointment,100,54,1/31/2018
60DD84,revenues,100,50,1/31/2018
60DD84,revenues,100,50,1/31/2018
60DD84,revenues,100,50,1/31/2018
619882,unit-acquisition-acquirer,100,49,1/31/2018
62EFEE,earnings,100,50,1/31/2018
63E8D5,earnings,100,50,1/31/2018
662682,earnings,100,50,1/31/2018
662682,dividend,100,50,1/31/2018
66ECFD,earnings,100,50,1/31/2018
66ECFD,earnings,100,50,1/31/2018
66ECFD,earnings,100,50,1/31/2018
66ECFD,earnings,100,50,1/31/2018
66ECFD,earnings,100,50,1/31/2018
66ECFD,earnings,100,50,1/31/2018
673C9A,conference-call,100,50,1/31/2018
6CC55E,conference-call,100,50,1/31/2018
6D156D,earnings,100,50,1/31/2018
6D4636,conference-participant,100,50,1/31/2018
6EB9DA,dividend,100,50,1/31/2018
71E2EF,unit-acquisition-acquiree,100,76,1/31/2018
722DE3,earnings-up,100,68,1/31/2018
722DE3,earnings,100,50,1/31/2018
726EEA,earnings,100,50,1/31/2018
728737,earnings,100,50,1/31/2018
729368,public-offering,100,43,1/31/2018
73A213,earnings,100,50,1/31/2018
791D59,conference-participant,100,50,1/31/2018
7A10FF,earnings,100,50,1/31/2018
7AB859,earnings,100,50,1/31/2018
7C62A3,earnings,100,50,1/31/2018
7D35D8,earnings-guidance,100,50,1/31/2018
7D7716,earnings,100,50,1/31/2018
7D97DE,conference-call,100,50,1/31/2018
7E3F8F,earnings,100,50,1/31/2018
7E62B5,earnings,100,50,1/31/2018
8.10E+32,legal-issues-defendant,100,22,1/31/2018
8.10E+32,legal-issues-defendant,100,22,1/31/2018
863350,facility-open,100,65,1/31/2018
8665BA,earnings,100,50,1/31/2018
8665BA,dividend-up,100,81,1/31/2018
86A1B9,workforce-salary-increase,100,44,1/31/2018
87486A,executive-appointment,100,54,1/31/2018
881190,conference-call,100,50,1/31/2018
89F693,earnings,100,50,1/31/2018
8A8E41,partnership,100,61,1/31/2018
8B9B3B,patient-enrollment-complete,100,64,1/31/2018
8BAA15,executive-resignation,100,44,1/31/2018
8D4486,business-contract,100,69,1/31/2018
8D4486,business-contract,100,69,1/31/2018
8DCBBB,earnings,100,50,1/31/2018
8DE74B,conference-call,100,50,1/31/2018
8E93A4,dividend,100,50,1/31/2018
8EF425,earnings,100,50,1/31/2018
8EF425,earnings,100,50,1/31/2018
8EF425,earnings,100,50,1/31/2018
8EF425,earnings,100,50,1/31/2018
8EF425,earnings,100,50,1/31/2018
8EF425,earnings,100,50,1/31/2018
8F3231,acquisition-completed-acquirer,100,49,1/31/2018
8FE7A5,earnings,100,50,1/31/2018
900356,earnings,100,50,1/31/2018
92D757,acquisition-completed-acquirer,100,49,1/31/2018
934029,acquisition-acquirer,100,49,1/31/2018
934029,acquisition-acquirer,100,49,1/31/2018
934029,public-offering,100,43,1/31/2018
95DE39,earnings,100,50,1/31/2018
965360,earnings,100,50,1/31/2018
968966,earnings,100,50,1/31/2018
96F126,business-contract,100,69,1/31/2018
972356,earnings,100,50,1/31/2018
9.92E+94,earnings,100,50,1/31/2018
9.92E+94,earnings,100,50,1/31/2018
9.92E+94,earnings,100,50,1/31/2018
99ACAD,business-contract,100,69,1/31/2018
9B0C9C,earnings,100,50,1/31/2018
9CA432,conference-call,100,50,1/31/2018
9EBAFA,conference-call,100,50,1/31/2018
A3800A,earnings,100,50,1/31/2018
A3AAA5,dividend,100,50,1/31/2018
A4CD53,executive-appointment,100,54,1/31/2018
A4CD53,executive-appointment,100,54,1/31/2018
A6213D,product-release,100,64,1/31/2018
A6828A,conference-participant,100,50,1/31/2018
A6ABE9,earnings,100,50,1/31/2018
A6ABE9,partnership,100,61,1/31/2018
A70BF5,earnings,100,50,1/31/2018
A70BF5,earnings,100,50,1/31/2018
A70BF5,earnings,100,50,1/31/2018
A70BF5,earnings,100,50,1/31/2018
A70BF5,earnings,100,50,1/31/2018
A70BF5,earnings,100,50,1/31/2018
AB7F05,partnership,100,61,1/31/2018
ABBAD1,earnings,100,50,1/31/2018
AC775C,conference-call,100,50,1/31/2018
AD3C93,earnings,100,50,1/31/2018
AFF7B4,earnings,100,50,1/31/2018
AFF7B4,earnings,100,50,1/31/2018
AFF7B4,earnings,100,50,1/31/2018
AFF7B4,earnings,100,50,1/31/2018
B08C51,legal-issues-dismissed-defendant,100,79,1/31/2018
B0FE08,earnings-up,100,68,1/31/2018
B0FE08,earnings-up,100,68,1/31/2018
B0FE08,earnings-up,100,68,1/31/2018
B48D6A,conference-participant,100,50,1/31/2018
B48FC9,conference-participant,100,50,1/31/2018
BAD9EA,clinical-trials-start,100,64,1/31/2018
BB88B6,earnings,100,50,1/31/2018
BB88B6,earnings,100,50,1/31/2018
BB88B6,earnings,100,50,1/31/2018
BB88B6,earnings,100,50,1/31/2018
BB88B6,earnings,100,50,1/31/2018
BB88B6,earnings,100,50,1/31/2018
BB88B6,earnings,100,50,1/31/2018
C188F8,conference-call,100,50,1/31/2018
C32A39,acquisition-completed-acquiree,100,76,1/31/2018
C50B26,conference-call,100,50,1/31/2018
C5E100,business-contract,100,69,1/31/2018
C7AE14,earnings,100,50,1/31/2018
C8923A,public-offering,100,43,1/31/2018
C941DC,conference-participant,100,50,1/31/2018
CC0C78,conference-participant,100,50,1/31/2018
CC6FF5,earnings,100,50,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CD4DA8,earnings-up,100,68,1/31/2018
CE4FD9,dividend,100,50,1/31/2018
CE96E7,note-sale,100,52,1/31/2018
CFF15D,partnership,100,61,1/31/2018
CFF15D,earnings,100,50,1/31/2018
CFF15D,earnings,100,50,1/31/2018
D06755,earnings,100,50,1/31/2018
D2C0B6,earnings,100,50,1/31/2018
D3DE34,earnings,100,50,1/31/2018
D3FA2C,dividend,100,50,1/31/2018
D54E62,dividend-up,100,81,1/31/2018
D5A350,earnings,100,50,1/31/2018
D854DD,earnings,100,50,1/31/2018
DD9E41,earnings,100,50,1/31/2018
DE4924,dividend,100,50,1/31/2018
DE4924,earnings,100,50,1/31/2018
DF11D9,earnings,100,50,1/31/2018
DF11D9,earnings,100,50,1/31/2018
DF11D9,earnings,100,50,1/31/2018
DF11D9,earnings,100,50,1/31/2018
DF11D9,earnings,100,50,1/31/2018
DF11D9,earnings,100,50,1/31/2018
E0339F,earnings,100,50,1/31/2018
E0339F,earnings,100,50,1/31/2018
E0339F,earnings,100,50,1/31/2018
E0339F,earnings,100,50,1/31/2018
E074A0,earnings,100,50,1/31/2018
E114F4,executive-appointment,100,54,1/31/2018
E15736,conference-call,100,50,1/31/2018
E15736,conference-call,100,50,1/31/2018
E21871,executive-appointment,100,54,1/31/2018
E259C7,dividend,100,50,1/31/2018
E68733,executive-appointment,100,54,1/31/2018
E6E012,note-sale,100,52,1/31/2018
E6EDED,earnings,100,50,1/31/2018
E70531,dividend,100,50,1/31/2018
E829E8,unit-acquisition-acquirer,100,49,1/31/2018
E866D2,dividend,100,50,1/31/2018
ED3CA8,public-offering,100,43,1/31/2018
EE74E1,earnings-per-share,100,50,1/31/2018
EE74E1,earnings-per-share,100,50,1/31/2018
EE74E1,earnings-per-share,100,50,1/31/2018
EFD406,conference-call,100,50,1/31/2018
F0B2B5,conference-call,100,50,1/31/2018
F11638,earnings,100,50,1/31/2018
F1CD47,earnings,100,50,1/31/2018
F2E253,dividend,100,50,1/31/2018
F30508,earnings,100,50,1/31/2018
F30508,earnings,100,50,1/31/2018
F30508,earnings,100,50,1/31/2018
F30508,earnings,100,50,1/31/2018
F30508,earnings,100,50,1/31/2018
F30508,earnings,100,50,1/31/2018
F4F46F,conference-participant,100,50,1/31/2018
F50BAB,earnings,100,50,1/31/2018
F5A214,acquisition-completed-acquirer,100,49,1/31/2018
F7902B,earnings,100,50,1/31/2018
F7902B,earnings,100,50,1/31/2018
F9CAF8,earnings-per-share-up,100,87,1/31/2018
F9CAF8,earnings-per-share-up,100,68,1/31/2018
F9CAF8,earnings-per-share-up,100,68,1/31/2018
FC1F9D,earnings,100,50,1/31/2018
FD39EB,earnings,100,50,1/31/2018
FD4E8D,revenues,100,50,1/31/2018
FD4E8D,revenues,100,50,1/31/2018
FD4E8D,revenues,100,50,1/31/2018
FD9A97,dividend,100,50,1/31/2018
FF6644,product-release,100,64,1/31/2018
9397,earnings,100,50,2/1/2018
00E601,earnings,100,50,2/1/2018
0142B5,earnings-per-share-positive,100,69,2/1/2018
0157B1,revenue-up,100,76,2/1/2018
0157B1,revenue-up,100,76,2/1/2018
0157B1,revenue-up,100,76,2/1/2018
0157B1,revenue-up,100,76,2/1/2018
0157B1,revenue-up,100,76,2/1/2018
0157B1,revenue-up,100,76,2/1/2018
048B70,earnings,100,50,2/1/2018
048B70,earnings,100,50,2/1/2018
048B70,earnings,100,50,2/1/2018
048B70,earnings,100,50,2/1/2018
55018,dividend,100,50,2/1/2018
0560D8,earnings,100,50,2/1/2018
06A456,executive-appointment,100,54,2/1/2018
07CA6A,earnings,100,50,2/1/2018
0BC17A,dividend-up,100,71,2/1/2018
0BC17A,earnings,100,50,2/1/2018
0BC853,earnings,100,50,2/1/2018
0C6861,conference-call,100,50,2/1/2018
0C8D82,conference-call,100,50,2/1/2018
0F65C9,conference-call,100,50,2/1/2018
0F91FC,executive-appointment,100,54,2/1/2018
105D00,dividend,100,50,2/1/2018
1065BC,earnings,100,50,2/1/2018
11074E,campaign-ad-release,100,59,2/1/2018
1201B5,earnings,100,50,2/1/2018
1216D1,earnings,100,50,2/1/2018
12E454,patent-infringement-defendant,100,26,2/1/2018
139303,earnings,100,50,2/1/2018
16F4D8,conference-call,100,50,2/1/2018
16F4D8,note-sale,100,52,2/1/2018
1921DD,business-contract,100,69,2/1/2018
1921DD,executive-appointment,100,54,2/1/2018
1BC12C,revenue-up,100,69,2/1/2018
1DB6A6,dividend,100,50,2/1/2018
1EA923,earnings,100,50,2/1/2018
1EA923,earnings,100,50,2/1/2018
1EA923,earnings,100,50,2/1/2018
1FAF22,earnings,100,50,2/1/2018
2082EA,executive-appointment,100,54,2/1/2018
21022F,earnings,100,50,2/1/2018
214051,earnings-up,100,68,2/1/2018
214051,earnings-up,100,68,2/1/2018
219B21,earnings,100,50,2/1/2018
228D42,partnership,100,61,2/1/2018
22C58E,conference-participant,100,50,2/1/2018
24CB56,conference-participant,100,50,2/1/2018
24FA23,public-offering,100,43,2/1/2018
250BEE,dividend-up,100,56,2/1/2018
250BEE,earnings,100,50,2/1/2018
250BEE,earnings,100,50,2/1/2018
250BEE,earnings,100,50,2/1/2018
250BEE,earnings,100,50,2/1/2018
250BEE,earnings,100,50,2/1/2018
28DCA8,earnings,100,50,2/1/2018
2A17B1,earnings,100,50,2/1/2018
2A17B1,earnings,100,50,2/1/2018
2A17B1,earnings,100,50,2/1/2018
2A17B1,earnings,100,50,2/1/2018
2A17B1,earnings,100,50,2/1/2018
2B5483,earnings,100,50,2/1/2018
2BA977,earnings,100,50,2/1/2018
2BA977,executive-appointment,100,54,2/1/2018
2C7505,regulatory-product-approval-granted,100,81,2/1/2018
2D2D43,earnings,100,50,2/1/2018
2E0496,earnings,100,50,2/1/2018
2E0496,earnings,100,50,2/1/2018
2F7474,acquisition-completed-acquirer,100,49,2/1/2018
30A565,legal-issues-defendant,100,22,2/1/2018
3159AA,earnings,100,50,2/1/2018
3224CC,earnings,100,50,2/1/2018
33E8C7,earnings,100,50,2/1/2018
34E9F9,conference-call,100,50,2/1/2018
35F4B5,earnings-up,100,68,2/1/2018
35F4B5,dividend-up,100,81,2/1/2018
35F4B5,acquisition-completed-acquirer,100,49,2/1/2018
366A08,conference-call,100,50,2/1/2018
366C3B,business-contract,100,69,2/1/2018
370C50,acquisition-completed-acquirer,100,49,2/1/2018
373B06,dividend,100,50,2/1/2018
387541,conference-call,100,50,2/1/2018
3A113F,conference-call,100,50,2/1/2018
3A3447,facility-open,100,65,2/1/2018
3C7F5F,dividend,100,50,2/1/2018
3CBA2A,product-release,100,64,2/1/2018
3ED92D,earnings,100,50,2/1/2018
3ED92D,earnings,100,50,2/1/2018
3ED92D,earnings,100,50,2/1/2018
3ED92D,earnings,100,50,2/1/2018
3ED92D,earnings,100,50,2/1/2018
3ED92D,earnings,100,50,2/1/2018
3ED92D,earnings,100,50,2/1/2018
3ED92D,earnings,100,50,2/1/2018
4017AD,earnings,100,50,2/1/2018
414FFF,campaign-ad-release,100,59,2/1/2018
423279,executive-appointment,100,54,2/1/2018
435ACE,earnings,100,50,2/1/2018
453282,acquisition-completed-acquirer,100,49,2/1/2018
4595EF,earnings,100,50,2/1/2018
45ABCC,product-release,100,64,2/1/2018
45BC35,conference-participant,100,50,2/1/2018
46017C,conference-call,100,50,2/1/2018
47752F,dividend,100,50,2/1/2018
4885C8,earnings,100,50,2/1/2018
4A5C8D,earnings,100,50,2/1/2018
4A5C8D,earnings,100,50,2/1/2018
4D7BD8,earnings-up,100,68,2/1/2018
4D7BD8,earnings,100,50,2/1/2018
4D7BD8,earnings,100,50,2/1/2018
4D7BD8,earnings,100,50,2/1/2018
4D7BD8,earnings,100,50,2/1/2018
4D7BD8,earnings,100,50,2/1/2018
4D7BD8,earnings,100,50,2/1/2018
4D7BD8,earnings,100,50,2/1/2018
4FCC78,conference-call,100,50,2/1/2018
50070E,conference-organizer,100,57,2/1/2018
507AE7,dividend,100,50,2/1/2018
510EA6,product-release,100,64,2/1/2018
514067,conference-participant,100,50,2/1/2018
52015A,conference-call,100,50,2/1/2018
524CE4,conference-call,100,50,2/1/2018
5.47E+28,executive-appointment,100,54,2/1/2018
548AC0,earnings,100,50,2/1/2018
553949,conference-organizer,100,57,2/1/2018
55ACCB,legal-issues-defendant,100,22,2/1/2018
55ACCB,earnings,100,50,2/1/2018
55C9B5,partnership,100,61,2/1/2018
562853,dividend,100,50,2/1/2018
56632F,conference-call,100,50,2/1/2018
56FB7C,dividend-up,100,81,2/1/2018
583A75,dividend,100,50,2/1/2018
5A64D5,earnings,100,50,2/1/2018
5D16CF,conference-call,100,50,2/1/2018
5D63F1,unit-acquisition-completed-acquirer,100,49,2/1/2018
5DD486,earnings,100,50,2/1/2018
5EAA43,earnings,100,50,2/1/2018
5EF130,conference-call,100,50,2/1/2018
5F1B7B,conference-participant,100,50,2/1/2018
5F3D91,executive-appointment,100,54,2/1/2018
5F9CE3,earnings,100,50,2/1/2018
5F9CE3,acquisition-completed-acquirer,100,49,2/1/2018
6137BF,earnings,100,50,2/1/2018
6166D1,partnership,100,61,2/1/2018
619882,product-release,100,64,2/1/2018
641F17,earnings,100,50,2/1/2018
68B03F,executive-appointment,100,54,2/1/2018
68B03F,executive-appointment,100,54,2/1/2018
68B03F,executive-appointment,100,54,2/1/2018
69494C,earnings,100,50,2/1/2018
6A01DF,earnings,100,50,2/1/2018
6B5379,earnings,100,50,2/1/2018
6B5379,earnings,100,50,2/1/2018
6B5379,earnings,100,50,2/1/2018
6D3B7B,dividend,100,50,2/1/2018
701531,conference-participant,100,50,2/1/2018
713810,market-share-loss,100,20,2/1/2018
7448A3,conference-participant,100,50,2/1/2018
762A3E,executive-appointment,100,54,2/1/2018
76F067,earnings,100,50,2/1/2018
79167B,conference-call,100,50,2/1/2018
791EC1,dividend,100,50,2/1/2018
7B0BA6,dividend-up,100,60,2/1/2018
7B492C,executive-appointment,100,54,2/1/2018
80C400,dividend-up,100,81,2/1/2018
80D744,unit-acquisition-completed-acquirer,100,49,2/1/2018
8.10E+32,legal-issues-defendant,100,22,2/1/2018
84920B,earnings,100,50,2/1/2018
86478F,acquisition-completed-acquirer,100,49,2/1/2018
8665BA,award,100,58,2/1/2018
86A1B9,earnings-positive,100,69,2/1/2018
86A1B9,earnings-positive,100,69,2/1/2018
86A1B9,earnings-positive,100,69,2/1/2018
86A1B9,earnings-positive,100,69,2/1/2018
86A1B9,earnings-positive,100,69,2/1/2018
86BAC7,earnings,100,50,2/1/2018
86BAC7,earnings,100,50,2/1/2018
89F693,conference-participant,100,50,2/1/2018
8AC740,conference-call,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B1F37,earnings,100,50,2/1/2018
8B3B0E,conference-call,100,50,2/1/2018
8BE916,earnings-up,100,68,2/1/2018
8BE916,earnings-up,100,68,2/1/2018
8BE916,earnings-up,100,68,2/1/2018
8BE916,earnings-up,100,68,2/1/2018
8BE916,earnings-up,100,68,2/1/2018
8BE916,earnings-up,100,68,2/1/2018
8D4AE6,earnings,100,50,2/1/2018
8DE56F,earnings,100,50,2/1/2018
8DE56F,earnings,100,50,2/1/2018
8DE56F,earnings,100,50,2/1/2018
8DE74B,executive-appointment,100,54,2/1/2018
8E0E32,earnings,100,50,2/1/2018
8F6995,conference-call,100,50,2/1/2018
901327,earnings,100,50,2/1/2018
901327,earnings,100,50,2/1/2018
901327,earnings,100,50,2/1/2018
901327,earnings,100,50,2/1/2018
901327,earnings,100,50,2/1/2018
902255,dividend,100,50,2/1/2018
907ED2,executive-appointment,100,54,2/1/2018
934029,public-offering,100,43,2/1/2018
93965C,earnings,100,50,2/1/2018
93D207,earnings,100,50,2/1/2018
94563D,earnings,100,50,2/1/2018
94563D,earnings,100,50,2/1/2018
94563D,earnings,100,50,2/1/2018
94563D,earnings,100,50,2/1/2018
94563D,earnings,100,50,2/1/2018
979451,earnings,100,50,2/1/2018
98CAED,credit-extension-recipient,100,69,2/1/2018
98D33E,dividend,100,50,2/1/2018
990AD0,unit-acquisition-completed-acquiree,100,67,2/1/2018
990AD0,conference-organizer,100,57,2/1/2018
990AD0,conference-organizer,100,57,2/1/2018
9.97E+09,earnings,100,50,2/1/2018
9A602D,award,100,58,2/1/2018
9B4066,unit-acquisition-acquirer,100,49,2/1/2018
9B5968,earnings,100,50,2/1/2018
9B5968,earnings,100,50,2/1/2018
9CF9B1,earnings,100,50,2/1/2018
9D30A8,earnings,100,50,2/1/2018
9D65C1,revenues,100,50,2/1/2018
9E298A,acquisition-acquirer,100,49,2/1/2018
9F03CF,earnings,100,50,2/1/2018
9F03CF,dividend,100,50,2/1/2018
A01664,earnings-guidance-meet-expectations,100,59,2/1/2018
A29DBD,conference-participant,100,50,2/1/2018
A398B9,earnings,100,50,2/1/2018
A429A5,earnings,100,50,2/1/2018
A429A5,earnings,100,50,2/1/2018
A429A5,earnings,100,50,2/1/2018
A429A5,earnings,100,50,2/1/2018
A429A5,earnings,100,50,2/1/2018
A429A5,earnings,100,50,2/1/2018
A4386C,dividend,100,50,2/1/2018
A52533,facility-open,100,65,2/1/2018
A58224,conference-call,100,50,2/1/2018
A5A4F5,acquisition-acquirer,100,49,2/1/2018
A6213D,revenue-up,100,69,2/1/2018
AA09AD,partnership,100,61,2/1/2018
AA09AD,dividend,100,50,2/1/2018
AC7AAE,partnership,100,61,2/1/2018
AF210D,business-contract,100,69,2/1/2018
AFDF2E,acquisition-acquirer,100,49,2/1/2018
AFDF2E,legal-issues-defendant,100,22,2/1/2018
B0998E,earnings,100,50,2/1/2018
B2D799,settlement,100,56,2/1/2018
B381D8,earnings,100,50,2/1/2018
B73395,acquisition-completed-acquiree,100,76,2/1/2018
B73395,stake-acquirer,100,48,2/1/2018
B7BBFF,conference-call,100,50,2/1/2018
B7EB38,earnings,100,50,2/1/2018
B803B1,conference-call,100,50,2/1/2018
B840EF,conference-call,100,50,2/1/2018
B85DCE,executive-appointment,100,54,2/1/2018
B8F71F,conference-participant,100,50,2/1/2018
BB07E4,dividend,100,50,2/1/2018
BB58FF,earnings,100,50,2/1/2018
BC948D,conference-call,100,50,2/1/2018
BCC13E,conference-participant,100,50,2/1/2018
BD8517,award,100,58,2/1/2018
BD9668,merger-completed,100,66,2/1/2018
BDE867,executive-appointment,100,54,2/1/2018
BF79F5,conference-call,100,50,2/1/2018
C0BA36,earnings,100,50,2/1/2018
C188F8,business-contract,100,69,2/1/2018
C2609A,dividend,100,50,2/1/2018
C38440,partnership,100,61,2/1/2018
C4FBDC,conference-call,100,50,2/1/2018
C66B44,executive-appointment,100,54,2/1/2018
C8A248,earnings,100,50,2/1/2018
C97B2D,earnings,100,50,2/1/2018
C9881C,executive-appointment,100,54,2/1/2018
C9C62A,earnings,100,50,2/1/2018
CB22CD,conference-call,100,50,2/1/2018
CBCC6A,earnings,100,50,2/1/2018
CBCC6A,earnings,100,50,2/1/2018
CC6FF5,product-release,100,64,2/1/2018
CEC5B9,earnings,100,50,2/1/2018
CEC5B9,earnings,100,50,2/1/2018
CF3FF9,public-offering,100,43,2/1/2018
CF6A5A,executive-appointment,100,54,2/1/2018
D20C8F,earnings,100,50,2/1/2018
D296C6,earnings,100,50,2/1/2018
D4070C,earnings,100,50,2/1/2018
D437C3,executive-resignation,100,44,2/1/2018
D54E62,executive-appointment,100,54,2/1/2018
D56D6D,earnings,100,50,2/1/2018
D65A13,revenue-up,100,75,2/1/2018
D65A13,revenue-up,100,69,2/1/2018
D65A13,revenue-up,100,75,2/1/2018
D65A13,revenue-up,100,75,2/1/2018
D65A13,revenue-up,100,69,2/1/2018
D6853F,dividend,100,50,2/1/2018
D69D42,earnings,100,50,2/1/2018
D8442A,earnings,100,50,2/1/2018
D8442A,earnings,100,50,2/1/2018
D8442A,earnings,100,50,2/1/2018
DB396B,conference-call,100,50,2/1/2018
DBB28E,partnership,100,61,2/1/2018
DC2F77,earnings,100,50,2/1/2018
DC5299,operating-earnings,100,50,2/1/2018
DF46C5,note-sale,100,52,2/1/2018
E05DC8,earnings,100,50,2/1/2018
E0D3BA,earnings,100,50,2/1/2018
E10D31,legal-issues-defendant,100,22,2/1/2018
E1C16B,conference-participant,100,50,2/1/2018
E49AA3,earnings,100,50,2/1/2018
E49AA3,acquisition-acquirer,100,49,2/1/2018
E49AA3,acquisition-acquirer,100,49,2/1/2018
E49AA3,acquisition-acquirer,100,49,2/1/2018
E49AA3,acquisition-acquirer,100,49,2/1/2018
E592F0,acquisition-acquirer,100,49,2/1/2018
E592F0,earnings,100,50,2/1/2018
E592F0,earnings,100,50,2/1/2018
E68C3D,earnings,100,50,2/1/2018
E70531,executive-appointment,100,54,2/1/2018
E82A2D,dividend,100,50,2/1/2018
E866D2,executive-appointment,100,54,2/1/2018
E8846E,asset-sale,100,62,2/1/2018
E90C84,conference-call,100,50,2/1/2018
EBD89A,earnings,100,50,2/1/2018
EC99D0,business-contract,100,69,2/1/2018
EC99D0,business-contract,100,69,2/1/2018
EC99D0,business-contract,100,69,2/1/2018
ED7F13,earnings,100,50,2/1/2018
ED9576,dividend,100,50,2/1/2018
EE74E1,partnership,100,61,2/1/2018
EF25A5,earnings,100,50,2/1/2018
EF7163,conference-call,100,50,2/1/2018
F46EC9,revenue-up,100,57,2/1/2018
F4E882,earnings,100,50,2/1/2018
F4E882,earnings,100,50,2/1/2018
F4E882,earnings,100,50,2/1/2018
F4E882,earnings,100,50,2/1/2018
F4E882,earnings,100,50,2/1/2018
F4E882,earnings,100,50,2/1/2018
F5349B,business-contract,100,69,2/1/2018
F58C23,conference-organizer,100,57,2/1/2018
F5D499,ipo-completed,100,76,2/1/2018
F6E248,executive-appointment,100,54,2/1/2018
F80FF9,earnings,100,50,2/1/2018
F85CC0,earnings-positive,100,69,2/1/2018
F9CAF8,dividend,100,50,2/1/2018
FA918D,earnings,100,50,2/1/2018
FD4BBE,earnings,100,50,2/1/2018
FD554E,conference-call,100,50,2/1/2018
FD9A97,earnings,100,50,2/1/2018
FE89E0,earnings,100,50,2/1/2018
FF5413,earnings-positive,100,69,2/1/2018
FF5413,earnings-positive,100,69,2/1/2018
FF6644,conference-participant,100,50,2/1/2018
FFE543,earnings,100,50,2/1/2018
13528,conference-participant,100,50,2/2/2018
02870F,conference-call,100,50,2/2/2018
040DBB,public-offering,100,43,2/2/2018
71860,buybacks,100,74,2/2/2018
0BD4E8,conference-call,100,50,2/2/2018
0EC508,earnings,100,50,2/2/2018
0FABBD,conference-call,100,50,2/2/2018
0FDE97,earnings,100,50,2/2/2018
0FDE97,earnings,100,50,2/2/2018
0FDE97,earnings,100,50,2/2/2018
0FDE97,earnings,100,50,2/2/2018
0FDE97,earnings,100,50,2/2/2018
0FDE97,earnings,100,50,2/2/2018
108BD2,earnings,100,50,2/2/2018
12DE76,acquisition-completed-acquirer,100,49,2/2/2018
12DE76,acquisition-completed-acquirer,100,49,2/2/2018
12DE76,acquisition-completed-acquirer,100,49,2/2/2018
14ED2B,dividend,100,50,2/2/2018
14ED2B,revenue-up,100,67,2/2/2018
17EDA5,legal-issues-defendant,100,22,2/2/2018
184866,earnings,100,50,2/2/2018
1E1125,legal-issues-defendant,100,22,2/2/2018
1EBF8D,earnings,100,50,2/2/2018
270305,earnings,100,50,2/2/2018
2EBA55,conference-call,100,50,2/2/2018
35AE32,earnings,100,50,2/2/2018
36C09B,clinical-trials,100,56,2/2/2018
38C46F,dividend,100,50,2/2/2018
3FACA7,earnings-positive,100,69,2/2/2018
3FACA7,earnings,100,50,2/2/2018
3FACA7,earnings,100,50,2/2/2018
3FACA7,earnings,100,50,2/2/2018
40F7DE,conference-call,100,50,2/2/2018
47752F,executive-appointment,100,54,2/2/2018
490D4B,executive-appointment,100,54,2/2/2018
4E2D94,executive-appointment,100,54,2/2/2018
50070E,conference-organizer,100,57,2/2/2018
54F271,legal-issues-defendant,100,22,2/2/2018
55ACCB,legal-verdict-disfavored,100,22,2/2/2018
57F3DA,acquisition-acquirer,100,49,2/2/2018
5E6959,earnings-up,100,68,2/2/2018
5E6959,executive-appointment,100,54,2/2/2018
633054,partnership,100,61,2/2/2018
64E346,executive-appointment,100,54,2/2/2018
66A667,legal-issues-defendant,100,22,2/2/2018
67303E,conference-participant,100,50,2/2/2018
6A6BDC,earnings,100,50,2/2/2018
6B236C,dividend,100,50,2/2/2018
6D1ADF,conference-call,100,50,2/2/2018
6-Dec-05,executive-appointment,100,54,2/2/2018
7032D0,earnings,100,50,2/2/2018
719477,earnings,100,50,2/2/2018
719477,earnings,100,50,2/2/2018
719477,earnings,100,50,2/2/2018
72EF75,earnings,100,50,2/2/2018
741937,conference-call,100,50,2/2/2018
7.44E+09,earnings,100,50,2/2/2018
743C70,earnings,100,50,2/2/2018
743C70,earnings,100,50,2/2/2018
76BD96,dividend,100,50,2/2/2018
78F9ED,executive-appointment,100,54,2/2/2018
790C34,earnings,100,50,2/2/2018
7AC86E,earnings-guidance,100,50,2/2/2018
7AC86E,dividend,100,50,2/2/2018
7B492C,award,100,58,2/2/2018
835C86,earnings,100,50,2/2/2018
8.73E+09,acquisition-completed-acquirer,100,49,2/2/2018
8FCA78,executive-death,100,31,2/2/2018
8FCA78,executive-death,100,31,2/2/2018
8FCA78,executive-death,100,31,2/2/2018
9087B9,earnings,100,50,2/2/2018
990AD0,conference-organizer,100,57,2/2/2018
9981C6,earnings,100,50,2/2/2018
9D6A24,dividend,100,50,2/2/2018
9E91C6,regulatory-investigation,100,22,2/2/2018
9F62D1,earnings,100,50,2/2/2018
A41450,earnings,100,50,2/2/2018
A52B6B,earnings,100,50,2/2/2018
A5A4F5,acquisition-acquirer,100,49,2/2/2018
A8B137,dividend-up,100,81,2/2/2018
A8FDE8,executive-appointment,100,54,2/2/2018
AFDF2E,legal-issues-defendant,100,22,2/2/2018
AFF7B4,conference-participant,100,50,2/2/2018
B560AF,partnership,100,61,2/2/2018
B560AF,partnership,100,61,2/2/2018
C0200F,earnings,100,50,2/2/2018
C230FE,earnings,100,50,2/2/2018
C230FE,earnings,100,50,2/2/2018
C7859D,board-meeting,100,51,2/2/2018
C8923A,public-offering,100,43,2/2/2018
CBBFBF,earnings-up,100,68,2/2/2018
CBBFBF,earnings-up,100,68,2/2/2018
CBBFBF,earnings-up,100,68,2/2/2018
CBBFBF,earnings-up,100,68,2/2/2018
CBBFBF,earnings-up,100,68,2/2/2018
CBBFBF,earnings,100,50,2/2/2018
CBBFBF,earnings,100,50,2/2/2018
CBBFBF,earnings,100,50,2/2/2018
CD4DA8,executive-appointment,100,54,2/2/2018
CEC5B9,earnings,100,50,2/2/2018
D29F43,conference-call,100,50,2/2/2018
D4AC65,acquisition-acquirer,100,49,2/2/2018
D4AC65,acquisition-acquirer,100,49,2/2/2018
D54E62,earnings-positive,100,69,2/2/2018
D54E62,earnings-positive,100,69,2/2/2018
D54E62,earnings-positive,100,69,2/2/2018
D54E62,earnings-positive,100,69,2/2/2018
D88EF3,earnings,100,50,2/2/2018
D8ECA1,stake-acquirer,100,48,2/2/2018
D9E036,business-contract,100,69,2/2/2018
DB9F70,conference-participant,100,50,2/2/2018
DF6FDD,conference-participant,100,50,2/2/2018
E20392,executive-appointment,100,54,2/2/2018
E2CFD2,conference-call,100,50,2/2/2018
E70531,earnings,100,50,2/2/2018
E70531,earnings,100,50,2/2/2018
E70531,earnings,100,50,2/2/2018
E70531,earnings,100,50,2/2/2018
E70531,executive-resignation,100,44,2/2/2018
E959F3,dividend,100,50,2/2/2018
FCA54E,business-contract,100,69,2/2/2018
FF4BA4,earnings,100,50,2/2/2018
19C105,conference-participant,100,50,2/3/2018
762A3E,conference-organizer,100,57,2/3/2018
9D5D35,award,100,58,2/3/2018
D33270,partnership,100,61,2/4/2018
0157B1,product-price-cut,100,49,2/5/2018
58828,revenue-up,100,54,2/5/2018
58828,revenue-up,100,69,2/5/2018
58828,revenue-up,100,69,2/5/2018
61366,business-contract,100,69,2/5/2018
71860,executive-appointment,100,54,2/5/2018
078D52,earnings,100,50,2/5/2018
078D52,earnings,100,50,2/5/2018
0FABBD,executive-appointment,100,54,2/5/2018
106394,ipo-completed,100,76,2/5/2018
11074E,conference-participant,100,50,2/5/2018
11A49E,conference-participant,100,50,2/5/2018
125212,earnings,100,50,2/5/2018
125212,earnings,100,50,2/5/2018
182BE7,conference-call,100,50,2/5/2018
1921DD,business-contract,100,69,2/5/2018
1921DD,product-release,100,64,2/5/2018
1921DD,business-contract,100,69,2/5/2018
19CAC7,revenue-up,100,69,2/5/2018
19CAC7,revenue-up,100,69,2/5/2018
1BC12C,dividend,100,50,2/5/2018
1E1125,conference-organizer,100,57,2/5/2018
1E1125,conference-organizer,100,57,2/5/2018
1E9A6D,partnership,100,61,2/5/2018
1FCC00,executive-appointment,100,54,2/5/2018
2667B6,dividend,100,50,2/5/2018
26CC63,facility-open,100,65,2/5/2018
28B730,earnings,100,50,2/5/2018
2920D5,conference-participant,100,50,2/5/2018
2C19A4,executive-appointment,100,54,2/5/2018
2D485F,dividend,100,50,2/5/2018
2F9304,earnings,100,50,2/5/2018
32F24A,earnings,100,50,2/5/2018
32F943,conference-participant,100,50,2/5/2018
34E9F9,dividend,100,50,2/5/2018
36E479,earnings,100,50,2/5/2018
3AF7FD,dividend,100,50,2/5/2018
3BA1BF,conference-participant,100,50,2/5/2018
3BB616,conference-call,100,50,2/5/2018
41785E,dividend,100,50,2/5/2018
42AABD,business-contract,100,69,2/5/2018
44A4FC,earnings,100,50,2/5/2018
44ED36,conference-call,100,50,2/5/2018
47752F,acquisition-completed-acquirer,100,49,2/5/2018
47FCF2,business-contract,100,69,2/5/2018
49BBBC,executive-appointment,100,54,2/5/2018
49BBBC,earnings-guidance,100,50,2/5/2018
4AC91D,partnership,100,61,2/5/2018
4AC91D,revenue-up,100,69,2/5/2018
4F9487,conference-participant,100,50,2/5/2018
50070E,conference-organizer,100,57,2/5/2018
504FE2,partnership,100,61,2/5/2018
553949,conference-organizer,100,57,2/5/2018
55438C,product-release,100,64,2/5/2018
55C9B5,dividend,100,50,2/5/2018
5A0FF1,earnings,100,50,2/5/2018
5B7739,conference-call,100,50,2/5/2018
5C2A47,conference-call,100,50,2/5/2018
61E975,conference-call,100,50,2/5/2018
636BBF,executive-appointment,100,54,2/5/2018
63F892,earnings,100,50,2/5/2018
63F892,executive-appointment,100,54,2/5/2018
665D7D,partnership,100,61,2/5/2018
68B03F,earnings,100,50,2/5/2018
68E3E0,conference-call,100,50,2/5/2018
693ECD,executive-appointment,100,54,2/5/2018
694749,award,100,58,2/5/2018
69C99E,conference-participant,100,50,2/5/2018
6D0CAB,executive-appointment,100,54,2/5/2018
6D6B40,earnings,100,50,2/5/2018
6F5DD2,conference-participant,100,50,2/5/2018
73A213,earnings,100,50,2/5/2018
73A213,earnings,100,50,2/5/2018
762A3E,conference-organizer,100,57,2/5/2018
771985,executive-appointment,100,54,2/5/2018
789ADD,earnings,100,50,2/5/2018
789ADD,earnings,100,50,2/5/2018
789ADD,earnings,100,50,2/5/2018
789ADD,earnings,100,50,2/5/2018
793C11,executive-appointment,100,54,2/5/2018
797C20,conference-call,100,50,2/5/2018
797C20,dividend-up,100,81,2/5/2018
7BAAE7,dividend-up,100,81,2/5/2018
7BAAE7,dividend,100,50,2/5/2018
8.10E+32,sponsorship,100,57,2/5/2018
8.10E+32,conference-call,100,50,2/5/2018
8.10E+205,earnings-guidance,100,50,2/5/2018
824CCA,conference-call,100,50,2/5/2018
82C202,earnings,100,50,2/5/2018
82E58A,executive-appointment,100,54,2/5/2018
85DE00,conference-participant,100,50,2/5/2018
8D4486,partnership,100,61,2/5/2018
8D4486,award,100,58,2/5/2018
8F6995,earnings,100,50,2/5/2018
94563D,award,100,58,2/5/2018
94637C,earnings,100,50,2/5/2018
968966,dividend,100,50,2/5/2018
97693A,executive-resignation,100,44,2/5/2018
990AD0,conference-organizer,100,57,2/5/2018
9B5968,executive-appointment,100,54,2/5/2018
9D2790,earnings,100,50,2/5/2018
9D2790,earnings,100,50,2/5/2018
9D2790,earnings,100,50,2/5/2018
9D2790,earnings,100,50,2/5/2018
9D2790,earnings,100,50,2/5/2018
9D2790,earnings,100,50,2/5/2018
9D30A8,conference-participant,100,50,2/5/2018
9D4EC7,earnings,100,50,2/5/2018
A37D68,spin-off,100,58,2/5/2018
A4386C,executive-resignation,100,44,2/5/2018
A47F2E,earnings,100,50,2/5/2018
A4BCDE,business-contract,100,69,2/5/2018
A5A4F5,acquisition-acquirer,100,49,2/5/2018
A70BF5,conference-participant,100,50,2/5/2018
A753BB,earnings,100,50,2/5/2018
A806FA,earnings,100,50,2/5/2018
A806FA,earnings,100,50,2/5/2018
A806FA,earnings,100,50,2/5/2018
ABBAD1,acquisition-acquirer,100,49,2/5/2018
AFD7DD,conference-call,100,50,2/5/2018
B4C673,conference-call,100,50,2/5/2018
B7EB38,product-release,100,64,2/5/2018
B7EB38,product-release,100,64,2/5/2018
B9764A,earnings,100,50,2/5/2018
BAD655,investment-investor,100,55,2/5/2018
BCC13E,conference-participant,100,50,2/5/2018
C0200F,executive-appointment,100,54,2/5/2018
C4FBDC,business-contract,100,69,2/5/2018
C659EB,conference-participant,100,50,2/5/2018
C99CC8,partnership,100,61,2/5/2018
CB7AB2,award,100,58,2/5/2018
CC0C78,regulatory-product-application,100,69,2/5/2018
CC35BE,earnings,100,50,2/5/2018
CEDFD5,conference-participant,100,50,2/5/2018
D11C1C,market-entry,100,57,2/5/2018
D1AE3B,business-contract,100,69,2/5/2018
D1CFC8,earnings-guidance-up,100,83,2/5/2018
D4AC65,product-release,100,64,2/5/2018
D598E7,earnings,100,50,2/5/2018
D77F7E,executive-appointment,100,54,2/5/2018
D78CCD,conference-call,100,50,2/5/2018
DA91AE,earnings,100,50,2/5/2018
DC486E,dividend-up,100,81,2/5/2018
DCD97F,product-release,100,64,2/5/2018
E09E2B,partnership,100,61,2/5/2018
E09E2B,partnership,100,61,2/5/2018
E6E012,acquisition-completed-acquirer,100,49,2/5/2018
E7BF32,executive-appointment,100,54,2/5/2018
E7BF32,executive-appointment,100,54,2/5/2018
E7BF32,executive-appointment,100,54,2/5/2018
E802CE,earnings,100,50,2/5/2018
E82A2D,conference-call,100,50,2/5/2018
E8846E,legal-issues-defendant,100,22,2/5/2018
E8A49A,executive-appointment,100,54,2/5/2018
EA62FC,earnings,100,50,2/5/2018
EB5E78,buybacks,100,74,2/5/2018
EB5E78,earnings-above-expectations,100,88,2/5/2018
EB5E78,earnings-above-expectations,100,88,2/5/2018
EB5E78,earnings-above-expectations,100,88,2/5/2018
EB5E78,earnings-above-expectations,100,88,2/5/2018
EE967B,earnings,100,50,2/5/2018
EE967B,executive-appointment,100,54,2/5/2018
EEBCEF,dividend-up,100,56,2/5/2018
F179ED,conference-participant,100,50,2/5/2018
F1CD47,conference-participant,100,50,2/5/2018
F39E1E,legal-issues-defendant,100,22,2/5/2018
F4CDA3,conference-call,100,50,2/5/2018
F50BAB,executive-appointment,100,54,2/5/2018
F5349B,earnings,100,50,2/5/2018
F5D410,executive-appointment,100,54,2/5/2018
F721A7,conference-call,100,50,2/5/2018
F721A7,conference-call,100,50,2/5/2018
F748C7,executive-appointment,100,54,2/5/2018
F769E9,conference-call,100,50,2/5/2018
F90EE5,executive-appointment,100,54,2/5/2018
FA40E2,unit-acquisition-acquirer,100,49,2/5/2018
FC4550,dividend,100,50,2/5/2018
00E601,board-meeting,100,51,2/6/2018
13528,dividend,100,50,2/6/2018
03596A,earnings,100,50,2/6/2018
03B431,earnings,100,50,2/6/2018
03B431,earnings,100,50,2/6/2018
040DBB,public-offering,100,43,2/6/2018
0560D8,conference-participant,100,50,2/6/2018
07EC43,conference-participant,100,50,2/6/2018
0919B1,earnings,100,50,2/6/2018
099C88,dividend,100,50,2/6/2018
0BC29E,executive-appointment,100,54,2/6/2018
0BC29E,conference-participant,100,50,2/6/2018
0BD4E8,dividend,100,50,2/6/2018
0E5223,conference-call,100,50,2/6/2018
0F0440,donation,100,54,2/6/2018
12DE76,product-release,100,64,2/6/2018
12DE76,product-release,100,64,2/6/2018
131443,earnings,100,50,2/6/2018
135B09,earnings,100,50,2/6/2018
135B09,earnings,100,50,2/6/2018
135B09,earnings,100,50,2/6/2018
135B09,earnings,100,50,2/6/2018
135B09,earnings,100,50,2/6/2018
168A5D,executive-appointment,100,54,2/6/2018
1BC12C,earnings-per-share-positive,100,69,2/6/2018
1DDEDA,earnings,100,50,2/6/2018
1E1125,conference-organizer,100,57,2/6/2018
1E1125,legal-issues-defendant,100,22,2/6/2018
1E1125,conference-organizer,100,57,2/6/2018
1FA886,business-contract,100,69,2/6/2018
1FAF22,conference-participant,100,50,2/6/2018
2262BD,earnings,100,50,2/6/2018
228D42,partnership,100,61,2/6/2018
24C48B,dividend,100,50,2/6/2018
24FA23,public-offering,100,43,2/6/2018
2667B6,product-release,100,64,2/6/2018
2667B6,business-contract,100,69,2/6/2018
26D8ED,earnings,100,50,2/6/2018
26F31D,earnings,100,50,2/6/2018
26F31D,earnings,100,50,2/6/2018
28AF37,revenues,100,50,2/6/2018
28AF37,revenues,100,50,2/6/2018
28AF37,revenues,100,50,2/6/2018
28AF37,revenues,100,50,2/6/2018
28DCA8,conference-participant,100,50,2/6/2018
2920D5,dividend-up,100,81,2/6/2018
2920D5,earnings,100,50,2/6/2018
2B7A40,earnings-per-share-positive,100,69,2/6/2018
2B7A40,earnings-positive,100,69,2/6/2018
2B7A40,earnings-positive,100,69,2/6/2018
2B7A40,earnings-positive,100,69,2/6/2018
2B9DBB,conference-call,100,50,2/6/2018
2C19A4,conference-call,100,50,2/6/2018
2E902B,earnings,100,50,2/6/2018
2F1299,earnings,100,50,2/6/2018
2F1299,earnings,100,50,2/6/2018
2F1299,earnings,100,50,2/6/2018
2F1299,earnings,100,50,2/6/2018
2F1299,earnings,100,50,2/6/2018
2F5256,earnings,100,50,2/6/2018
2FF046,earnings,100,50,2/6/2018
2FF046,earnings,100,50,2/6/2018
2FF046,earnings,100,50,2/6/2018
367E1C,conference-call,100,50,2/6/2018
371B0A,conference-call,100,50,2/6/2018
373B06,earnings,100,50,2/6/2018
37727A,earnings,100,50,2/6/2018
3AF7FD,conference-participant,100,50,2/6/2018
3B50FE,conference-call,100,50,2/6/2018
3BE00F,earnings,100,50,2/6/2018
3BE00F,earnings,100,50,2/6/2018
3BE00F,earnings,100,50,2/6/2018
3BE00F,earnings,100,50,2/6/2018
3C6CCC,business-contract,100,69,2/6/2018
3F4668,earnings,100,50,2/6/2018
4.03E+05,earnings,100,50,2/6/2018
4.03E+05,earnings,100,50,2/6/2018
4.03E+05,earnings,100,50,2/6/2018
4.03E+05,dividend,100,50,2/6/2018
4.00E+163,earnings,100,50,2/6/2018
41A93D,earnings,100,50,2/6/2018
44209A,legal-issues-defendant,100,22,2/6/2018
44209A,legal-issues-defendant,100,22,2/6/2018
442587,earnings,100,50,2/6/2018
442587,earnings,100,50,2/6/2018
4455C4,conference-call,100,50,2/6/2018
453282,dividend-up,100,81,2/6/2018
479930,earnings,100,50,2/6/2018
492117,earnings,100,50,2/6/2018
4E5784,earnings,100,50,2/6/2018
4EE14A,legal-issues-defendant,100,22,2/6/2018
50070E,conference-organizer,100,57,2/6/2018
50070E,conference-organizer,100,57,2/6/2018
51F541,conference-call,100,50,2/6/2018
545272,earnings,100,50,2/6/2018
54A713,earnings,100,50,2/6/2018
54F1D2,earnings,100,50,2/6/2018
553949,conference-organizer,100,57,2/6/2018
553949,conference-organizer,100,57,2/6/2018
562853,earnings,100,50,2/6/2018
57A854,settlement,100,56,2/6/2018
57DDB9,conference-call,100,50,2/6/2018
583A75,revenue-volume,100,50,2/6/2018
5968F9,conference-call,100,50,2/6/2018
59C539,executive-resignation,100,44,2/6/2018
5C2A47,earnings,100,50,2/6/2018
5C8D61,earnings,100,50,2/6/2018
5D02B7,earnings,100,50,2/6/2018
5D63F1,executive-appointment,100,54,2/6/2018
5DD48B,earnings,100,50,2/6/2018
5F1B7B,earnings,100,50,2/6/2018
5FE4B6,earnings,100,50,2/6/2018
601785,dividend,100,50,2/6/2018
60FE03,conference-participant,100,50,2/6/2018
622DBE,earnings,100,50,2/6/2018
62B20A,earnings,100,50,2/6/2018
639BD6,revenues,100,50,2/6/2018
639BD6,revenues,100,50,2/6/2018
639BD6,revenues,100,50,2/6/2018
639BD6,revenues,100,50,2/6/2018
67B923,earnings,100,50,2/6/2018
693ECD,conference-participant,100,50,2/6/2018
6BDA0C,dividend,100,50,2/6/2018
6CB7F9,conference-call,100,50,2/6/2018
6CC55E,conference-participant,100,50,2/6/2018
6D0CAB,earnings,100,50,2/6/2018
6F39FC,conference-call,100,50,2/6/2018
717DB4,earnings,100,50,2/6/2018
722D55,earnings,100,50,2/6/2018
72CB93,earnings,100,50,2/6/2018
732449,dividend,100,50,2/6/2018
73F70F,conference-call,100,50,2/6/2018
762A3E,conference-organizer,100,57,2/6/2018
762B8D,earnings,100,50,2/6/2018
790C34,executive-appointment,100,54,2/6/2018
79167B,executive-appointment,100,54,2/6/2018
7AB859,executive-appointment,100,54,2/6/2018
7B0BA6,earnings,100,50,2/6/2018
7B492C,earnings,100,50,2/6/2018
7BC92D,private-placement,100,56,2/6/2018
7D85A9,earnings,100,50,2/6/2018
7E2DE6,public-offering,100,43,2/6/2018
7F3665,earnings,100,50,2/6/2018
7F9984,facility-open,100,65,2/6/2018
7F9984,earnings,100,50,2/6/2018
8.10E+32,legal-issues-defendant,100,22,2/6/2018
8.10E+32,legal-issues-defendant,100,22,2/6/2018
82FD6D,earnings,100,50,2/6/2018
8303CD,conference-call,100,50,2/6/2018
85CDC9,conference-participant,100,50,2/6/2018
85DE00,earnings,100,50,2/6/2018
85DE00,dividend,100,50,2/6/2018
8B6E7E,earnings-up,100,68,2/6/2018
8B6E7E,earnings,100,50,2/6/2018
8B6E7E,earnings,100,50,2/6/2018
8B6E7E,earnings,100,50,2/6/2018
8D4AE6,dividend,100,50,2/6/2018
8D5145,dividend-up,100,60,2/6/2018
8D9993,earnings,100,50,2/6/2018
8DE56F,award,100,58,2/6/2018
8DE56F,award,100,58,2/6/2018
8DE56F,award,100,58,2/6/2018
8F6995,dividend,100,50,2/6/2018
8F8F2F,conference-call,100,50,2/6/2018
8FF2EF,hirings,100,65,2/6/2018
91E5EE,conference-participant,100,50,2/6/2018
92B625,executive-appointment,100,54,2/6/2018
934029,earnings,100,50,2/6/2018
9470CC,earnings,100,50,2/6/2018
9.74E+08,earnings,100,50,2/6/2018
97693A,legal-issues-defendant,100,22,2/6/2018
990AD0,conference-organizer,100,57,2/6/2018
990AD0,conference-organizer,100,57,2/6/2018
990AD0,conference-organizer,100,57,2/6/2018
990AD0,conference-organizer,100,57,2/6/2018
99DC8D,dividend,100,50,2/6/2018
99DC8D,earnings,100,50,2/6/2018
9B5968,executive-appointment,100,54,2/6/2018
9D5FA4,earnings,100,50,2/6/2018
9E0811,earnings,100,50,2/6/2018
9F18FA,earnings,100,50,2/6/2018
9F18FA,earnings,100,50,2/6/2018
9F6B1A,earnings-up,100,68,2/6/2018
9FD2D9,earnings,100,50,2/6/2018
9FD2D9,earnings,100,50,2/6/2018
9FD2D9,earnings,100,50,2/6/2018
A1E3B3,earnings,100,50,2/6/2018
A2A9BA,business-contract,100,69,2/6/2018
A350C1,executive-appointment,100,54,2/6/2018
A4B899,earnings,100,50,2/6/2018
A52B6B,product-release,100,64,2/6/2018
A5A4F5,acquisition-acquirer,100,49,2/6/2018
A63387,earnings,100,50,2/6/2018
A63387,earnings,100,50,2/6/2018
A63387,earnings,100,50,2/6/2018
A63820,earnings-per-share-up,100,92,2/6/2018
A63820,earnings-per-share-up,100,68,2/6/2018
A63820,earnings-per-share-up,100,68,2/6/2018
A7102F,conference-call,100,50,2/6/2018
AADE0B,unit-acquisition-acquirer,100,49,2/6/2018
ACD9A4,earnings,100,50,2/6/2018
ACDF88,conference-call,100,50,2/6/2018
ACDF88,conference-call,100,50,2/6/2018
AD3008,earnings,100,50,2/6/2018
ADF092,acquisition-regulatory-approval-acquirer,100,54,2/6/2018
AE79CD,executive-appointment,100,54,2/6/2018
AED61E,revenues,100,50,2/6/2018
B13B68,partnership,100,61,2/6/2018
B2D492,earnings,100,50,2/6/2018
B2E6B5,dividend,100,50,2/6/2018
B2E6B5,earnings,100,50,2/6/2018
B2E6B5,earnings,100,50,2/6/2018
B2E6B5,earnings,100,50,2/6/2018
B3CB74,conference-organizer,100,57,2/6/2018
B3CB74,conference-organizer,100,57,2/6/2018
B4528F,earnings,100,50,2/6/2018
B4528F,earnings,100,50,2/6/2018
B54A74,earnings,100,50,2/6/2018
B66928,dividend,100,50,2/6/2018
B7FA9B,conference-call,100,50,2/6/2018
B9CD50,executive-appointment,100,54,2/6/2018
BAAA60,earnings,100,50,2/6/2018
BB0787,earnings,100,50,2/6/2018
BB5142,revenue-up,100,69,2/6/2018
BB5271,earnings,100,50,2/6/2018
BBBB41,earnings,100,50,2/6/2018
BBBB41,earnings,100,50,2/6/2018
BBBB41,earnings,100,50,2/6/2018
BBBB41,earnings,100,50,2/6/2018
BBBB41,earnings,100,50,2/6/2018
BBBB41,earnings,100,50,2/6/2018
BC3AD2,executive-resignation,100,44,2/6/2018
C15F8F,earnings,100,50,2/6/2018
C16A8F,earnings,100,50,2/6/2018
C16A8F,earnings,100,50,2/6/2018
C16A8F,earnings,100,50,2/6/2018
C16A8F,earnings,100,50,2/6/2018
C2609A,conference-participant,100,50,2/6/2018
C3BAE7,earnings,100,50,2/6/2018
C4A432,executive-resignation,100,44,2/6/2018
C5C0E9,earnings,100,50,2/6/2018
C5D2AE,earnings,100,50,2/6/2018
C5D2AE,acquisition-acquirer,100,49,2/6/2018
C65004,revenues,100,50,2/6/2018
C65004,revenues,100,50,2/6/2018
C66B44,earnings,100,50,2/6/2018
C7FC95,product-release,100,64,2/6/2018
C7FC95,product-release,100,64,2/6/2018
C83B88,business-contract,100,69,2/6/2018
C93C44,conference-participant,100,50,2/6/2018
C9C62A,earnings,100,50,2/6/2018
C9E04B,conference-call,100,50,2/6/2018
CB9E13,conference-call,100,50,2/6/2018
CC8F6E,earnings,100,50,2/6/2018
CDFCC9,dividend,100,50,2/6/2018
CDFCC9,revenues,100,50,2/6/2018
CDFCC9,revenues,100,50,2/6/2018
CDFCC9,revenues,100,50,2/6/2018
CDFCC9,revenues,100,50,2/6/2018
CDFCC9,revenues,100,50,2/6/2018
CE5664,earnings,100,50,2/6/2018
CE5664,earnings,100,50,2/6/2018
CE5664,earnings,100,50,2/6/2018
CE5C6E,conference-participant,100,50,2/6/2018
CED4D0,earnings,100,50,2/6/2018
CF351E,earnings,100,50,2/6/2018
CFF97C,dividend-up,100,71,2/6/2018
CFF97C,earnings,100,50,2/6/2018
D0909F,conference-participant,100,50,2/6/2018
D296C6,earnings,100,50,2/6/2018
D42DBA,executive-appointment,100,54,2/6/2018
D4463B,dividend,100,50,2/6/2018
D4AC65,executive-appointment,100,54,2/6/2018
D56D6D,dividend,100,50,2/6/2018
D57D99,earnings,100,50,2/6/2018
D5B13D,conference-participant,100,50,2/6/2018
D6534D,conference-call,100,50,2/6/2018
D9164D,conference-call,100,50,2/6/2018
DC2B00,conference-call,100,50,2/6/2018
DF204B,executive-appointment,100,54,2/6/2018
DF42A0,dividend,100,50,2/6/2018
DF42A0,earnings,100,50,2/6/2018
DF42A0,earnings,100,50,2/6/2018
DF42A0,earnings,100,50,2/6/2018
DF42A0,earnings,100,50,2/6/2018
DF42A0,earnings,100,50,2/6/2018
DF6FDD,dividend-up,100,55,2/6/2018
DF8855,campaign-ad-release,100,59,2/6/2018
E15736,earnings,100,50,2/6/2018
E69BA5,dividend,100,50,2/6/2018
E71AE6,conference-participant,100,50,2/6/2018
E71AE6,conference-participant,100,50,2/6/2018
E87676,conference-call,100,50,2/6/2018
E90C84,conference-participant,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
E9C7C0,earnings,100,50,2/6/2018
EAEBF3,joint-venture,100,62,2/6/2018
EB36DE,earnings,100,50,2/6/2018
ECDEB2,earnings,100,50,2/6/2018
ECDEB2,earnings,100,50,2/6/2018
ED0D7C,conference-call,100,50,2/6/2018
F0B2B5,earnings,100,50,2/6/2018
F0B2B5,earnings,100,50,2/6/2018
F0B2B5,earnings,100,50,2/6/2018
F0B2B5,earnings,100,50,2/6/2018
F0B2B5,earnings,100,50,2/6/2018
F0B2B5,earnings,100,50,2/6/2018
F1EB39,conference-participant,100,50,2/6/2018
F30508,legal-issues-defendant,100,22,2/6/2018
F39E1E,legal-issues-defendant,100,22,2/6/2018
F39E1E,earnings,100,50,2/6/2018
F46EC9,acquisition-acquirer,100,49,2/6/2018
F4F46F,earnings,100,50,2/6/2018
F57F6F,business-contract,100,69,2/6/2018
F57F6F,earnings,100,50,2/6/2018
F57F6F,earnings,100,50,2/6/2018
F57F6F,earnings,100,50,2/6/2018
F57F6F,earnings,100,50,2/6/2018
F5D410,earnings-guidance-up,100,83,2/6/2018
F5D410,earnings,100,50,2/6/2018
F5D410,earnings,100,50,2/6/2018
F5D410,earnings,100,50,2/6/2018
F5D410,earnings,100,50,2/6/2018
F5D410,earnings,100,50,2/6/2018
F6E248,earnings,100,50,2/6/2018
F6E248,dividend-up,100,60,2/6/2018
F72E4B,conference-participant,100,50,2/6/2018
F8084B,earnings,100,50,2/6/2018
F8DE55,earnings,100,50,2/6/2018
FD4E8D,conference-participant,100,50,2/6/2018
00067A,earnings,100,50,2/7/2018
001F1B,revenues,100,50,2/7/2018
00E601,executive-appointment,100,54,2/7/2018
04EB2F,earnings,100,50,2/7/2018
75172,earnings,100,50,2/7/2018
75172,facility-upgrade,100,65,2/7/2018
07EC43,earnings,100,50,2/7/2018
07EC43,investment-investor,100,55,2/7/2018
0A77DB,executive-appointment,100,54,2/7/2018
0BF198,conference-participant,100,50,2/7/2018
0CBC4D,revenues,100,50,2/7/2018
0CE204,executive-appointment,100,54,2/7/2018
0DC050,earnings,100,50,2/7/2018
0F04E5,earnings,100,50,2/7/2018
0F91FC,earnings,100,50,2/7/2018
10943B,earnings,100,50,2/7/2018
11074E,earnings,100,50,2/7/2018
11074E,executive-appointment,100,54,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
1151F4,earnings,100,50,2/7/2018
12A3A3,dividend,100,50,2/7/2018
138DDE,earnings,100,50,2/7/2018
17EDA5,legal-issues-defendant,100,22,2/7/2018
17EDA5,executive-appointment,100,54,2/7/2018
1880C5,conference-participant,100,50,2/7/2018
190B91,ownership-decrease-owner,100,46,2/7/2018
190B91,earnings,100,50,2/7/2018
1921DD,business-contract,100,69,2/7/2018
1AD9CC,revenues,100,50,2/7/2018
1C2593,executive-appointment,100,54,2/7/2018
1CD09C,conference-participant,100,50,2/7/2018
1E1125,conference-organizer,100,57,2/7/2018
1E1125,conference-organizer,100,57,2/7/2018
1E4FB9,conference-participant,100,50,2/7/2018
1F19C8,earnings-up,100,92,2/7/2018
1F19C8,earnings-up,100,92,2/7/2018
1F19C8,earnings-up,100,92,2/7/2018
1F19C8,earnings-up,100,92,2/7/2018
1F19C8,earnings-up,100,92,2/7/2018
1F19C8,earnings-up,100,92,2/7/2018
200D8B,earnings,100,50,2/7/2018
227F04,earnings,100,50,2/7/2018
238302,earnings,100,50,2/7/2018
24C48B,executive-salary-increase,100,44,2/7/2018
24FA23,conference-participant,100,50,2/7/2018
250BEE,partnership,100,61,2/7/2018
250BEE,partnership,100,61,2/7/2018
250BEE,partnership,100,61,2/7/2018
25102A,headquarters-change,100,50,2/7/2018
25102A,headquarters-change,100,50,2/7/2018
251988,ipo-unit-considered,100,60,2/7/2018
251988,executive-appointment,100,54,2/7/2018
263216,earnings,100,50,2/7/2018
263216,earnings,100,50,2/7/2018
263216,earnings,100,50,2/7/2018
263216,earnings,100,50,2/7/2018
263216,earnings,100,50,2/7/2018
263216,earnings,100,50,2/7/2018
263216,earnings,100,50,2/7/2018
27B191,earnings,100,50,2/7/2018
27B191,earnings,100,50,2/7/2018
27B191,earnings,100,50,2/7/2018
27B191,dividend,100,50,2/7/2018
28B730,acquisition-acquirer,100,49,2/7/2018
2950FF,earnings,100,50,2/7/2018
2ABF77,earnings,100,50,2/7/2018
2ABF77,earnings,100,50,2/7/2018
2B9DBB,executive-appointment,100,54,2/7/2018
2BAE5F,dividend-up,100,56,2/7/2018
2BBE62,acquisition-completed-acquirer,100,49,2/7/2018
2BDC1C,regulatory-product-application,100,69,2/7/2018
2BDC1C,regulatory-product-application,100,69,2/7/2018
2E36AD,regulatory-product-approval-granted,100,81,2/7/2018
301493,conference-call,100,50,2/7/2018
306623,earnings,100,50,2/7/2018
306623,dividend,100,50,2/7/2018
30DFD3,earnings,100,50,2/7/2018
31553A,earnings,100,50,2/7/2018
31553A,earnings,100,50,2/7/2018
31553A,earnings,100,50,2/7/2018
31553A,earnings,100,50,2/7/2018
31643A,earnings,100,50,2/7/2018
31803E,public-offering,100,43,2/7/2018
31AA84,executive-appointment,100,54,2/7/2018
31DB20,earnings,100,50,2/7/2018
31F25C,public-offering,100,43,2/7/2018
3587B4,dividend,100,50,2/7/2018
36E479,earnings,100,50,2/7/2018
371C01,conference-call,100,50,2/7/2018
384CD3,dividend,100,50,2/7/2018
3A3447,earnings,100,50,2/7/2018
3A3447,earnings,100,50,2/7/2018
3A3447,earnings,100,50,2/7/2018
3A3447,earnings,100,50,2/7/2018
3A3447,earnings,100,50,2/7/2018
3A3447,earnings,100,50,2/7/2018
3B318A,conference-participant,100,50,2/7/2018
3F1C69,conference-participant,100,50,2/7/2018
3FACA7,dividend,100,50,2/7/2018
416C55,dividend,100,50,2/7/2018
423279,conference-participant,100,50,2/7/2018
425BDC,conference-call,100,50,2/7/2018
42AABD,earnings,100,50,2/7/2018
458D2C,facility-open,100,65,2/7/2018
4.91E+58,earnings,100,50,2/7/2018
4.91E+58,earnings,100,50,2/7/2018
4.91E+58,earnings,100,50,2/7/2018
4.91E+58,earnings,100,50,2/7/2018
4.91E+58,earnings,100,50,2/7/2018
4.91E+58,earnings,100,50,2/7/2018
4.91E+58,earnings,100,50,2/7/2018
4A5C8D,acquisition-interest-acquirer,100,46,2/7/2018
4A5C8D,acquisition-interest-acquirer,100,46,2/7/2018
4BDCA7,conference-participant,100,50,2/7/2018
50070E,conference-organizer,100,57,2/7/2018
50070E,conference-organizer,100,57,2/7/2018
50070E,conference-organizer,100,57,2/7/2018
50070E,conference-organizer,100,57,2/7/2018
51888A,revenues,100,50,2/7/2018
51E682,earnings,100,50,2/7/2018
53F491,board-meeting,100,51,2/7/2018
54F271,revenue-up,100,69,2/7/2018
553949,conference-organizer,100,57,2/7/2018
56632F,buybacks,100,74,2/7/2018
58EA22,conference-participant,100,50,2/7/2018
59B229,conference-organizer,100,57,2/7/2018
5A423F,earnings,100,50,2/7/2018
5A53BF,conference-participant,100,50,2/7/2018
5B15E1,earnings,100,50,2/7/2018
5DD486,dividend-up,100,56,2/7/2018
5EAA43,business-contract,100,69,2/7/2018
5EAA43,dividend,100,50,2/7/2018
5F3D91,conference-participant,100,50,2/7/2018
5F60CE,earnings,100,50,2/7/2018
605F40,earnings,100,50,2/7/2018
6.18E+08,earnings,100,50,2/7/2018
6.18E+08,earnings,100,50,2/7/2018
6.18E+08,earnings,100,50,2/7/2018
61E975,dividend,100,50,2/7/2018
633043,earnings,100,50,2/7/2018
641F17,executive-resignation,100,44,2/7/2018
66749D,earnings,100,50,2/7/2018
66749D,earnings,100,50,2/7/2018
66749D,earnings,100,50,2/7/2018
66749D,earnings,100,50,2/7/2018
66749D,earnings,100,50,2/7/2018
68BA15,earnings,100,50,2/7/2018
68E3E0,dividend,100,50,2/7/2018
69345C,legal-issues-defendant,100,22,2/7/2018
69494C,product-price-raise,100,57,2/7/2018
6A961B,dividend-up,100,74,2/7/2018
6BD606,dividend,100,50,2/7/2018
6CF43C,earnings,100,50,2/7/2018
6D156D,conference-participant,100,50,2/7/2018
6DDA15,earnings,100,50,2/7/2018
6E1E61,earnings,100,50,2/7/2018
6E7060,partnership,100,61,2/7/2018
6F39FC,dividend,100,50,2/7/2018
6F3FA8,earnings,100,50,2/7/2018
6F3FA8,earnings,100,50,2/7/2018
6F3FA8,earnings,100,50,2/7/2018
6F3FA8,earnings,100,50,2/7/2018
6F3FA8,earnings,100,50,2/7/2018
71E2EF,headquarters-change,100,50,2/7/2018
7273FF,earnings,100,50,2/7/2018
747219,dividend,100,50,2/7/2018
752A70,earnings,100,50,2/7/2018
769F40,stake-acquirer,100,48,2/7/2018
7710F3,executive-appointment,100,54,2/7/2018
771985,earnings,100,50,2/7/2018
77B8E9,public-offering,100,43,2/7/2018
7823A3,conference-participant,100,50,2/7/2018
7A10FF,conference-participant,100,50,2/7/2018
7A2A49,earnings,100,50,2/7/2018
7B6EB1,acquisition-acquirer,100,49,2/7/2018
7C4F43,public-offering,100,43,2/7/2018
7C75FD,earnings,100,50,2/7/2018
7D35D8,revenue-up,100,69,2/7/2018
7D35D8,earnings,100,50,2/7/2018
7D35D8,earnings,100,50,2/7/2018
7D85A9,dividend,100,50,2/7/2018
7E1D5D,partnership,100,61,2/7/2018
7E1D5D,earnings,100,50,2/7/2018
810FAD,dividend-up,100,56,2/7/2018
810FAD,earnings-up,100,68,2/7/2018
838ADD,earnings,100,50,2/7/2018
83B1C8,earnings,100,50,2/7/2018
85CDC9,clinical-trials,100,56,2/7/2018
85CDC9,clinical-trials,100,56,2/7/2018
85CDC9,clinical-trials,100,56,2/7/2018
8665BA,award,100,58,2/7/2018
8.79E+06,earnings,100,50,2/7/2018
87B81A,revenue-up,100,69,2/7/2018
87B81A,earnings,100,50,2/7/2018
87B81A,earnings,100,50,2/7/2018
87B81A,earnings,100,50,2/7/2018
87B81A,earnings,100,50,2/7/2018
87B81A,dividend,100,50,2/7/2018
88193E,conference-call,100,50,2/7/2018
8C6C1B,facility-open,100,65,2/7/2018
92B047,earnings,100,50,2/7/2018
943239,earnings,100,50,2/7/2018
949625,dividend,100,50,2/7/2018
966ACE,conference-participant,100,50,2/7/2018
9B4066,dividend,100,50,2/7/2018
9B5968,partnership,100,61,2/7/2018
9C5BA5,conference-participant,100,50,2/7/2018
9D5D35,earnings,100,50,2/7/2018
9E91C6,executive-resignation,100,44,2/7/2018
9F71E5,dividend-up,100,70,2/7/2018
9FA83B,earnings,100,50,2/7/2018
A01664,earnings,100,50,2/7/2018
A28675,executive-appointment,100,54,2/7/2018
A28C54,earnings,100,50,2/7/2018
A28C54,earnings,100,50,2/7/2018
A28C54,earnings,100,50,2/7/2018
A28C54,earnings,100,50,2/7/2018
A28C54,earnings,100,50,2/7/2018
A28C54,earnings,100,50,2/7/2018
A28C54,earnings,100,50,2/7/2018
A29A46,conference-call,100,50,2/7/2018
A29DBD,earnings,100,50,2/7/2018
A4A612,earnings,100,50,2/7/2018
A4A612,earnings,100,50,2/7/2018
A4A612,earnings,100,50,2/7/2018
A4A612,earnings,100,50,2/7/2018
A4A612,earnings,100,50,2/7/2018
A5A4F5,acquisition-acquirer,100,49,2/7/2018
A63387,business-contract,100,69,2/7/2018
A6828A,partnership,100,61,2/7/2018
A6828A,partnership,100,61,2/7/2018
A6828A,conference-participant,100,50,2/7/2018
A6828A,legal-issues-defendant,100,22,2/7/2018
A746F6,award,100,58,2/7/2018
A868C9,revenues,100,50,2/7/2018
A868C9,revenues,100,50,2/7/2018
AA98ED,earnings,100,50,2/7/2018
AA98ED,earnings,100,50,2/7/2018
AA98ED,earnings,100,50,2/7/2018
AA98ED,earnings,100,50,2/7/2018
AA98ED,earnings,100,50,2/7/2018
ABBAD1,conference-participant,100,50,2/7/2018
AE4125,conference-call,100,50,2/7/2018
B08C51,executive-resignation,100,44,2/7/2018
B303A6,earnings,100,50,2/7/2018
B66928,unit-acquisition-acquiree,100,76,2/7/2018
B96637,conference-call,100,50,2/7/2018
BAD9EA,public-offering,100,43,2/7/2018
BB02FB,conference-call,100,50,2/7/2018
BB127B,conference-call,100,50,2/7/2018
BBF349,earnings,100,50,2/7/2018
BBF349,earnings,100,50,2/7/2018
BBF349,earnings,100,50,2/7/2018
BDEC1E,conference-participant,100,50,2/7/2018
C06EB6,conference-call,100,50,2/7/2018
C188F8,earnings,100,50,2/7/2018
C2F597,earnings,100,50,2/7/2018
C38440,earnings,100,50,2/7/2018
C3EE99,conference-call,100,50,2/7/2018
C425AE,earnings,100,50,2/7/2018
C50B26,earnings,100,50,2/7/2018
C5D2AE,conference-participant,100,50,2/7/2018
C5F463,facility-close,100,47,2/7/2018
C7FC95,product-release,100,64,2/7/2018
C7FC95,product-release,100,64,2/7/2018
C8257F,executive-appointment,100,54,2/7/2018
C8257F,executive-appointment,100,54,2/7/2018
CA3CB9,unit-acquisition-acquirer,100,49,2/7/2018
CA3CB9,acquisition-completed-acquirer,100,49,2/7/2018
CA3CB9,earnings,100,50,2/7/2018
CA99D7,earnings,100,50,2/7/2018
CC6FF5,partnership,100,61,2/7/2018
CDAB24,earnings,100,50,2/7/2018
CEDFD5,clinical-trials,100,56,2/7/2018
D04D9F,earnings,100,50,2/7/2018
D04D9F,earnings,100,50,2/7/2018
D04D9F,earnings,100,50,2/7/2018
D04D9F,earnings,100,50,2/7/2018
D17F7E,earnings,100,50,2/7/2018
D17F7E,earnings,100,50,2/7/2018
D17F7E,earnings,100,50,2/7/2018
D17F7E,earnings,100,50,2/7/2018
D17F7E,earnings,100,50,2/7/2018
D17F7E,earnings,100,50,2/7/2018
D17F7E,earnings,100,50,2/7/2018
D2E553,earnings,100,50,2/7/2018
D57D99,facility-open,100,65,2/7/2018
D76AEF,conference-call,100,50,2/7/2018
DD3BB1,earnings,100,50,2/7/2018
DE4924,unit-acquisition-acquiree,100,76,2/7/2018
DE4924,acquisition-completed-acquiree,100,76,2/7/2018
DF18E6,public-offering,100,43,2/7/2018
E00373,earnings,100,50,2/7/2018
E19A99,earnings,100,50,2/7/2018
E1C16B,dividend-up,100,71,2/7/2018
E1E36F,earnings,100,50,2/7/2018
E1E36F,earnings,100,50,2/7/2018
E1E36F,earnings,100,50,2/7/2018
E1E36F,earnings,100,50,2/7/2018
E1E36F,earnings,100,50,2/7/2018
E1E36F,earnings,100,50,2/7/2018
E1E36F,earnings,100,50,2/7/2018
E20392,earnings,100,50,2/7/2018
E259C7,earnings,100,50,2/7/2018
E3E68E,earnings,100,50,2/7/2018
E4CE73,executive-appointment,100,54,2/7/2018
E68E62,conference-participant,100,50,2/7/2018
E70531,stake-acquirer,100,48,2/7/2018
E74B55,conference-call,100,50,2/7/2018
E866D2,revenue-volume,100,50,2/7/2018
E90C84,earnings,100,50,2/7/2018
EAA0A7,executive-appointment,100,54,2/7/2018
EAA0A7,executive-appointment,100,54,2/7/2018
EB5E78,conference-participant,100,50,2/7/2018
EBD89A,legal-issues-defendant,100,22,2/7/2018
EC70EC,unit-acquisition-acquiree,100,76,2/7/2018
ED0402,earnings,100,50,2/7/2018
EEA734,conference-participant,100,50,2/7/2018
F1529C,conference-call,100,50,2/7/2018
F1529C,conference-call,100,50,2/7/2018
F18844,product-release,100,64,2/7/2018
F39E1E,dividend,100,50,2/7/2018
F3EDB4,joint-venture,100,62,2/7/2018
F40EE2,dividend,100,50,2/7/2018
F51DB0,conference-call,100,50,2/7/2018
F6A987,earnings-up,100,68,2/7/2018
F6FA6A,dividend,100,50,2/7/2018
FA35C6,executive-resignation,100,44,2/7/2018
FA35C6,earnings,100,50,2/7/2018
FA35C6,earnings,100,50,2/7/2018
FA35C6,earnings,100,50,2/7/2018
FC1A6E,earnings,100,50,2/7/2018
FD39EB,asset-sale,100,62,2/7/2018
FD39EB,asset-sale,100,62,2/7/2018
FEC475,earnings,100,50,2/7/2018
FEC475,earnings,100,50,2/7/2018
FEC475,earnings,100,50,2/7/2018
FEC475,earnings,100,50,2/7/2018
FEC475,earnings,100,50,2/7/2018
FEC475,earnings,100,50,2/7/2018
FEE4B0,operating-earnings-positive,100,69,2/7/2018
FEE4B0,operating-earnings-positive,100,69,2/7/2018
FEE4B0,operating-earnings-positive,100,69,2/7/2018
FEE4B0,operating-earnings-positive,100,69,2/7/2018
FEE4B0,operating-earnings-positive,100,69,2/7/2018
FEE4B0,operating-earnings-positive,100,69,2/7/2018
FF227B,conference-participant,100,50,2/7/2018
00698D,conference-call,100,50,2/8/2018
0157B1,product-release,100,64,2/8/2018
48590,earnings,100,50,2/8/2018
61366,earnings,100,50,2/8/2018
061A3B,product-price-raise,100,57,2/8/2018
070B45,earnings,100,50,2/8/2018
71860,conference-participant,100,50,2/8/2018
083F72,earnings,100,50,2/8/2018
09DE1F,debt-extension-recipient,100,73,2/8/2018
0A0D9E,conference-participant,100,50,2/8/2018
0A9D0A,earnings,100,50,2/8/2018
0B57D7,dividend,100,50,2/8/2018
0BC29E,earnings,100,50,2/8/2018
0BC29E,earnings,100,50,2/8/2018
0BC29E,earnings,100,50,2/8/2018
0BC29E,earnings,100,50,2/8/2018
0BC29E,earnings,100,50,2/8/2018
0BC29E,earnings,100,50,2/8/2018
0BF528,conference-participant,100,50,2/8/2018
0CCCB7,conference-call,100,50,2/8/2018
0EC508,earnings,100,50,2/8/2018
0EC508,earnings,100,50,2/8/2018
0EC508,earnings,100,50,2/8/2018
0F0693,conference-participant,100,50,2/8/2018
0FDE97,partnership,100,61,2/8/2018
1080C0,conference-participant,100,50,2/8/2018
1096C6,earnings,100,50,2/8/2018
119CB6,revenue-up,100,69,2/8/2018
119CB6,revenues,100,50,2/8/2018
119CB6,revenues,100,50,2/8/2018
1201B5,conference-call,100,50,2/8/2018
12A3A3,partnership,100,61,2/8/2018
152B9E,earnings-guidance,100,50,2/8/2018
157D9F,earnings,100,50,2/8/2018
16B183,executive-appointment,100,54,2/8/2018
1782D5,conference-call,100,50,2/8/2018
1.79E+10,dividend,100,50,2/8/2018
1834C0,earnings-guidance,100,50,2/8/2018
184988,conference-participant,100,50,2/8/2018
1DA44F,earnings-up,100,68,2/8/2018
1DA44F,earnings,100,50,2/8/2018
1DA44F,earnings,100,50,2/8/2018
1DA44F,earnings,100,50,2/8/2018
1DA44F,earnings,100,50,2/8/2018
1FC422,conference-participant,100,50,2/8/2018
1FE7F0,earnings,100,50,2/8/2018
202E5A,conference-participant,100,50,2/8/2018
2082EA,executive-appointment,100,54,2/8/2018
2093B1,earnings,100,50,2/8/2018
21245F,legal-issues-defendant,100,22,2/8/2018
21245F,legal-issues-defendant,100,22,2/8/2018
21245F,stock-loss,100,40,2/8/2018
221445,conference-call,100,50,2/8/2018
23207A,earnings,100,50,2/8/2018
239106,earnings-per-share-positive,100,69,2/8/2018
239106,earnings-per-share-positive,100,69,2/8/2018
239106,earnings-per-share-positive,100,69,2/8/2018
2491BC,earnings,100,50,2/8/2018
24C48B,earnings,100,50,2/8/2018
2667B6,product-release,100,64,2/8/2018
27C10F,debt-reduction,100,74,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
284289,earnings,100,50,2/8/2018
2.90E+62,earnings,100,50,2/8/2018
2.90E+62,dividend-up,100,64,2/8/2018
2.90E+62,executive-appointment,100,54,2/8/2018
2A1009,earnings,100,50,2/8/2018
2C7505,earnings,100,50,2/8/2018
2EB88B,revenues,100,50,2/8/2018
2EC172,earnings,100,50,2/8/2018
30A565,legal-issues-defendant,100,22,2/8/2018
30A565,legal-issues-defendant,100,22,2/8/2018
32F943,earnings,100,50,2/8/2018
3390DE,earnings,100,50,2/8/2018
339F20,earnings,100,50,2/8/2018
3587B4,earnings,100,50,2/8/2018
3587B4,earnings,100,50,2/8/2018
3587B4,earnings,100,50,2/8/2018
3587B4,earnings,100,50,2/8/2018
3587B4,earnings,100,50,2/8/2018
367E1C,conference-participant,100,50,2/8/2018
36E479,conference-participant,100,50,2/8/2018
370C50,dividend,100,50,2/8/2018
3A3948,earnings,100,50,2/8/2018
3BC360,ipo-pricing,100,50,2/8/2018
3C11C4,earnings,100,50,2/8/2018
3E70FC,earnings,100,50,2/8/2018
3EE65E,earnings,100,50,2/8/2018
3F4497,earnings,100,50,2/8/2018
3F6A9C,earnings,100,50,2/8/2018
3F6A9C,earnings,100,50,2/8/2018
3F6A9C,earnings,100,50,2/8/2018
3F6A9C,earnings,100,50,2/8/2018
3F6A9C,earnings,100,50,2/8/2018
3F6A9C,earnings,100,50,2/8/2018
415188,business-contract,100,69,2/8/2018
435ACE,executive-appointment,100,54,2/8/2018
45ABCC,earnings,100,50,2/8/2018
45BC35,earnings-guidance,100,50,2/8/2018
4806CE,earnings-guidance,100,50,2/8/2018
49F4D0,earnings,100,50,2/8/2018
4AC91D,earnings,100,50,2/8/2018
4B6EF9,earnings,100,50,2/8/2018
4C1FA1,conference-call,100,50,2/8/2018
4E6F5A,conference-participant,100,50,2/8/2018
4EEE7E,earnings,100,50,2/8/2018
50070E,conference-organizer,100,57,2/8/2018
50070E,conference-organizer,100,57,2/8/2018
50070E,conference-organizer,100,57,2/8/2018
50070E,conference-organizer,100,57,2/8/2018
50070E,conference-organizer,100,57,2/8/2018
51D876,earnings,100,50,2/8/2018
51D876,earnings,100,50,2/8/2018
51D876,earnings,100,50,2/8/2018
51D876,earnings,100,50,2/8/2018
51D876,earnings,100,50,2/8/2018
51D876,earnings,100,50,2/8/2018
51D876,earnings,100,50,2/8/2018
55438C,business-contract,100,69,2/8/2018
55C9B5,partnership,100,61,2/8/2018
567F3D,earnings,100,50,2/8/2018
567F3D,earnings,100,50,2/8/2018
567F3D,earnings,100,50,2/8/2018
567F3D,earnings,100,50,2/8/2018
57356F,earnings,100,50,2/8/2018
57356F,earnings,100,50,2/8/2018
57356F,earnings,100,50,2/8/2018
57DDB9,earnings,100,50,2/8/2018
57DDB9,earnings,100,50,2/8/2018
57DDB9,earnings,100,50,2/8/2018
57DDB9,earnings,100,50,2/8/2018
57DDB9,earnings,100,50,2/8/2018
57DDB9,earnings,100,50,2/8/2018
589803,earnings,100,50,2/8/2018
59872F,award,100,58,2/8/2018
5BFE94,earnings,100,50,2/8/2018
5D0337,earnings,100,50,2/8/2018
5DD486,executive-appointment,100,54,2/8/2018
5DE5A5,conference-organizer,100,57,2/8/2018
5EAA43,business-contract,100,69,2/8/2018
5EF130,earnings,100,50,2/8/2018
5EF130,earnings,100,50,2/8/2018
5EF130,earnings,100,50,2/8/2018
5FE4B6,dividend,100,50,2/8/2018
629F0F,earnings,100,50,2/8/2018
64854A,earnings,100,50,2/8/2018
64E615,executive-appointment,100,54,2/8/2018
665618,dividend-up,100,66,2/8/2018
69345C,legal-issues-defendant,100,22,2/8/2018
69CE71,earnings,100,50,2/8/2018
69CE71,earnings,100,50,2/8/2018
69CE71,earnings,100,50,2/8/2018
69CE71,earnings,100,50,2/8/2018
69CE71,earnings,100,50,2/8/2018
69CE71,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
69E8E1,earnings,100,50,2/8/2018
6ABCB8,earnings,100,50,2/8/2018
6B0784,earnings,100,50,2/8/2018
6BC6F9,earnings,100,50,2/8/2018
6E705B,business-contract,100,69,2/8/2018
6F0A63,earnings,100,50,2/8/2018
6F3936,legal-issues-defendant,100,22,2/8/2018
6F92A9,earnings,100,50,2/8/2018
705636,dividend,100,50,2/8/2018
7255D2,conference-call,100,50,2/8/2018
72C2CE,earnings,100,50,2/8/2018
73C521,dividend,100,50,2/8/2018
73C521,executive-resignation,100,44,2/8/2018
742AAB,earnings,100,50,2/8/2018
762A3E,conference-call,100,50,2/8/2018
766047,earnings,100,50,2/8/2018
76B926,conference-call,100,50,2/8/2018
76F067,conference-participant,100,50,2/8/2018
7740DE,same-store-sales-down,100,44,2/8/2018
77B8E9,public-offering,100,43,2/8/2018
791D59,revenues,100,50,2/8/2018
791D59,revenues,100,50,2/8/2018
791D59,revenues,100,50,2/8/2018
791D59,revenues,100,50,2/8/2018
791D59,revenues,100,50,2/8/2018
791D59,revenues,100,50,2/8/2018
791D59,revenues,100,50,2/8/2018
793C11,earnings-above-expectations,100,88,2/8/2018
793C11,earnings-above-expectations,100,88,2/8/2018
7A10FF,dividend,100,50,2/8/2018
7AF5B8,partnership,100,61,2/8/2018
7B1156,earnings,100,50,2/8/2018
7B9212,revenues,100,50,2/8/2018
7C4F43,conference-participant,100,50,2/8/2018
7CD98F,earnings,100,50,2/8/2018
7D5FD6,dividend,100,50,2/8/2018
7F0372,earnings,100,50,2/8/2018
80D744,earnings,100,50,2/8/2018
8.10E+32,legal-issues-defendant,100,22,2/8/2018
8.10E+205,earnings,100,50,2/8/2018
82E58A,earnings,100,50,2/8/2018
85CDC9,earnings,100,50,2/8/2018
862941,conference-participant,100,50,2/8/2018
881190,earnings,100,50,2/8/2018
881190,earnings,100,50,2/8/2018
881190,earnings,100,50,2/8/2018
881190,earnings,100,50,2/8/2018
88193E,executive-appointment,100,54,2/8/2018
883D82,earnings,100,50,2/8/2018
89B2E7,earnings,100,50,2/8/2018
8AC740,earnings,100,50,2/8/2018
8B9B3B,conference-participant,100,50,2/8/2018
8BFAA4,conference-call,100,50,2/8/2018
8C311A,product-release,100,64,2/8/2018
8C6C1B,facility-open,100,65,2/8/2018
8D4AE6,earnings,100,50,2/8/2018
8D4AE6,earnings,100,50,2/8/2018
8DE74B,dividend,100,50,2/8/2018
8E4F9A,conference-participant,100,50,2/8/2018
8EEA28,dividend,100,50,2/8/2018
9196A2,conference-organizer,100,57,2/8/2018
943239,legal-issues-defendant,100,22,2/8/2018
94637C,conference-participant,100,50,2/8/2018
94756D,earnings,100,50,2/8/2018
94983E,earnings,100,50,2/8/2018
9548BB,revenue-up,100,69,2/8/2018
9548BB,earnings,100,50,2/8/2018
9548BB,earnings,100,50,2/8/2018
9548BB,earnings,100,50,2/8/2018
9548BB,earnings,100,50,2/8/2018
9.62E+76,dividend,100,50,2/8/2018
9673BD,earnings-guidance,100,50,2/8/2018
9673BD,earnings-guidance,100,50,2/8/2018
9673BD,earnings-guidance,100,50,2/8/2018
9673BD,dividend-up,100,74,2/8/2018
96F126,award,100,58,2/8/2018
96F126,business-contract,100,69,2/8/2018
9810C0,earnings,100,50,2/8/2018
990AD0,conference-organizer,100,57,2/8/2018
990AD0,conference-organizer,100,57,2/8/2018
9.97E+09,earnings,100,50,2/8/2018
9978F1,conference-participant,100,50,2/8/2018
9AF3DC,earnings,100,50,2/8/2018
9E3224,earnings,100,50,2/8/2018
9EA947,dividend,100,50,2/8/2018
9F048E,earnings,100,50,2/8/2018
A0F146,conference-call,100,50,2/8/2018
A16DEA,conference-participant,100,50,2/8/2018
A16DEA,partnership,100,61,2/8/2018
A1EAC8,dividend,100,50,2/8/2018
A3800A,legal-issues-defendant,100,22,2/8/2018
A403CF,earnings,100,50,2/8/2018
A403CF,dividend,100,50,2/8/2018
A495F7,earnings,100,50,2/8/2018
A4BCDE,conference-participant,100,50,2/8/2018
A5A4F5,acquisition-acquirer,100,49,2/8/2018
A5B913,earnings,100,50,2/8/2018
A60354,earnings,100,50,2/8/2018
A666C8,earnings,100,50,2/8/2018
A6828A,legal-issues-defendant,100,22,2/8/2018
A6828A,conference-participant,100,50,2/8/2018
A7CCF0,earnings,100,50,2/8/2018
A7F0A5,conference-call,100,50,2/8/2018
AA847A,earnings,100,50,2/8/2018
AB4A7E,earnings,100,50,2/8/2018
AD3C93,conference-participant,100,50,2/8/2018
ADD9DC,earnings,100,50,2/8/2018
AECCA9,conference-call,100,50,2/8/2018
B01111,facility-open,100,65,2/8/2018
B05118,earnings,100,50,2/8/2018
B37FB4,partnership,100,61,2/8/2018
B4C673,earnings-up,100,68,2/8/2018
B5BA39,credit-extension-recipient,100,69,2/8/2018
B5DE80,earnings,100,50,2/8/2018
B7BBFF,earnings,100,50,2/8/2018
B8EF97,revenues,100,50,2/8/2018
B8F5C8,revenue-up,100,69,2/8/2018
B8F5C8,revenue-up,100,69,2/8/2018
B8F5C8,revenue-up,100,69,2/8/2018
B8F5C8,revenue-up,100,69,2/8/2018
BB127B,investment-investor,100,55,2/8/2018
BB127B,investment-investor,100,55,2/8/2018
BB127B,investment-investor,100,55,2/8/2018
BC5680,earnings-up,100,68,2/8/2018
BC5680,earnings-up,100,68,2/8/2018
BC5680,earnings-up,100,68,2/8/2018
BD682F,earnings,100,50,2/8/2018
BE5935,conference-call,100,50,2/8/2018
BFEA04,earnings,100,50,2/8/2018
C0030A,unit-acquisition-acquirer,100,49,2/8/2018
C01737,business-contract,100,69,2/8/2018
C037A8,earnings,100,50,2/8/2018
C16A8F,unit-acquisition-acquiree,100,76,2/8/2018
C3DE7D,earnings,100,50,2/8/2018
C4706C,earnings-guidance-up,100,83,2/8/2018
C4706C,earnings,100,50,2/8/2018
C4706C,earnings,100,50,2/8/2018
C564E4,conference-participant,100,50,2/8/2018
C659EB,dividend,100,50,2/8/2018
C951A2,earnings,100,50,2/8/2018
C951A2,earnings,100,50,2/8/2018
C951A2,earnings,100,50,2/8/2018
C951A2,earnings,100,50,2/8/2018
C951A2,earnings,100,50,2/8/2018
C99CC8,earnings,100,50,2/8/2018
C99CC8,earnings,100,50,2/8/2018
C99CC8,earnings,100,50,2/8/2018
C99CC8,earnings,100,50,2/8/2018
CA1620,earnings,100,50,2/8/2018
CA1620,earnings,100,50,2/8/2018
CA1620,legal-issues-defendant,100,22,2/8/2018
CA212F,dividend,100,50,2/8/2018
CAC8D0,asset-sale,100,62,2/8/2018
CCB623,earnings,100,50,2/8/2018
CCB623,public-offering,100,43,2/8/2018
CDC817,ipo-pricing,100,50,2/8/2018
CDE118,earnings,100,50,2/8/2018
CE4FD9,unit-acquisition-acquirer,100,49,2/8/2018
CE69E9,legal-issues-defendant,100,22,2/8/2018
D29B44,earnings,100,50,2/8/2018
D3CEDF,earnings-guidance,100,50,2/8/2018
D3F64D,earnings,100,50,2/8/2018
D4AC65,earnings,100,50,2/8/2018
D56E4C,conference-call,100,50,2/8/2018
D57D99,business-contract,100,69,2/8/2018
D5938F,earnings,100,50,2/8/2018
D5A350,dividend-up,100,81,2/8/2018
D650A7,award,100,58,2/8/2018
D8DA3D,earnings,100,50,2/8/2018
D8F347,dividend-up,100,60,2/8/2018
D96202,earnings,100,50,2/8/2018
DBB28E,conference-call,100,50,2/8/2018
DC437D,earnings,100,50,2/8/2018
DC437D,dividend,100,50,2/8/2018
DD1BA1,earnings,100,50,2/8/2018
DD1BA1,earnings,100,50,2/8/2018
DD1BA1,earnings,100,50,2/8/2018
DD1BA1,earnings,100,50,2/8/2018
DD1BA1,earnings,100,50,2/8/2018
DD1BA1,earnings,100,50,2/8/2018
DD1BA1,earnings,100,50,2/8/2018
DD682D,earnings,100,50,2/8/2018
DF204B,conference-call,100,50,2/8/2018
DF42A0,executive-resignation,100,44,2/8/2018
E09997,dividend,100,50,2/8/2018
E09E2B,partnership,100,61,2/8/2018
E09E2B,earnings,100,50,2/8/2018
E09E2B,earnings,100,50,2/8/2018
E09E2B,earnings,100,50,2/8/2018
E124EB,earnings,100,50,2/8/2018
E124EB,earnings,100,50,2/8/2018
E20392,conference-participant,100,50,2/8/2018
E20BFE,same-store-sales-up,100,54,2/8/2018
E30A8F,revenue-up,100,69,2/8/2018
E30A8F,revenue-up,100,69,2/8/2018
E30A8F,revenue-up,100,69,2/8/2018
E30A8F,revenue-up,100,69,2/8/2018
E30A8F,revenue-up,100,69,2/8/2018
E4CE73,conference-call,100,50,2/8/2018
E5752F,earnings,100,50,2/8/2018
E5752F,earnings,100,50,2/8/2018
E5752F,earnings,100,50,2/8/2018
E5752F,earnings,100,50,2/8/2018
E8846E,merger,100,66,2/8/2018
E94704,earnings,100,50,2/8/2018
EAA0A7,award,100,58,2/8/2018
EBD89A,legal-issues-defendant,100,22,2/8/2018
F18844,dividend,100,50,2/8/2018
F18844,earnings,100,50,2/8/2018
F32F88,dividend,100,50,2/8/2018
F48947,earnings,100,50,2/8/2018
F4CDA3,earnings,100,50,2/8/2018
F4E882,executive-appointment,100,54,2/8/2018
F6DA75,earnings,100,50,2/8/2018
F6DE54,product-price-raise,100,57,2/8/2018
F6E248,conference-participant,100,50,2/8/2018
F769E9,earnings,100,50,2/8/2018
F7ADEB,business-contract,100,69,2/8/2018
FAB97A,earnings,100,50,2/8/2018
FAE021,executive-appointment,100,54,2/8/2018
FC1F9D,dividend,100,50,2/8/2018
FC80E6,conference-call,100,50,2/8/2018
FD554E,executive-appointment,100,54,2/8/2018
FD6926,conference-call,100,50,2/8/2018
FD9526,dividend,100,50,2/8/2018
FF5413,dividend-up,100,81,2/8/2018
FF6644,dividend,100,50,2/8/2018
FFE543,revenue-up,100,69,2/8/2018
FFE543,revenue-up,100,69,2/8/2018
FFE543,revenue-up,100,69,2/8/2018
02870F,investment-investor,100,55,2/9/2018
71860,conference-participant,100,50,2/9/2018
09062E,conference-call,100,50,2/9/2018
099C88,conference-call,100,50,2/9/2018
10943B,conference-participant,100,50,2/9/2018
12731D,conference-call,100,50,2/9/2018
16AAE0,earnings,100,50,2/9/2018
1921DD,dividend,100,50,2/9/2018
1921DD,dividend,100,50,2/9/2018
1921DD,dividend,100,50,2/9/2018
1921DD,dividend,100,50,2/9/2018
19CAC7,dividend,100,50,2/9/2018
1D5C51,conference-call,100,50,2/9/2018
1E1125,conference-organizer,100,57,2/9/2018
1E1125,conference-organizer,100,57,2/9/2018
1F08A6,dividend,100,50,2/9/2018
1F43A1,earnings,100,50,2/9/2018
200D8B,award,100,58,2/9/2018
21268E,conference-call,100,50,2/9/2018
251988,acquisition-completed-acquirer,100,49,2/9/2018
253B2F,conference-call,100,50,2/9/2018
26E3BA,conference-participant,100,50,2/9/2018
2CB4C9,product-release,100,64,2/9/2018
2CB4C9,product-release,100,64,2/9/2018
2CB4C9,product-release,100,64,2/9/2018
30A565,legal-issues-defendant,100,22,2/9/2018
30A565,fraud-defendant,100,20,2/9/2018
30A565,legal-issues-defendant,100,22,2/9/2018
31803E,public-offering,100,43,2/9/2018
3461CF,earnings,100,50,2/9/2018
34A959,earnings,100,50,2/9/2018
353DBB,conference-participant,100,50,2/9/2018
385DD4,dividend,100,50,2/9/2018
40F7DE,earnings,100,50,2/9/2018
41B53E,conference-call,100,50,2/9/2018
458D2C,revenue-volume,100,50,2/9/2018
4A6F00,partnership,100,61,2/9/2018
4A6F00,partnership,100,61,2/9/2018
4C3FE9,conference-participant,100,50,2/9/2018
4D8124,executive-resignation,100,44,2/9/2018
50070E,conference-organizer,100,57,2/9/2018
5065B1,earnings,100,50,2/9/2018
553949,conference-organizer,100,57,2/9/2018
553949,conference-organizer,100,57,2/9/2018
553949,conference-organizer,100,57,2/9/2018
56632F,dividend-up,100,81,2/9/2018
57B174,dividend-up,100,81,2/9/2018
5BC2F4,executive-appointment,100,54,2/9/2018
5C8D61,executive-appointment,100,54,2/9/2018
5DD486,conference-participant,100,50,2/9/2018
5F2FF7,dividend,100,50,2/9/2018
636639,dividend,100,50,2/9/2018
636931,public-offering,100,43,2/9/2018
6.52E+64,earnings,100,50,2/9/2018
66749D,dividend,100,50,2/9/2018
6DC1D7,conference-call,100,50,2/9/2018
705636,earnings-per-share-positive,100,69,2/9/2018
726DDF,conference-call,100,50,2/9/2018
72FCA3,facility-open,100,65,2/9/2018
76BD96,conference-call,100,50,2/9/2018
789A7D,dividend,100,50,2/9/2018
78F9ED,executive-appointment,100,54,2/9/2018
7999F3,earnings,100,50,2/9/2018
7B9AFA,earnings,100,50,2/9/2018
82F088,earnings,100,50,2/9/2018
8C6C1B,facility-open,100,65,2/9/2018
9043FE,earnings,100,50,2/9/2018
9043FE,earnings,100,50,2/9/2018
922F0C,dividend,100,50,2/9/2018
93D207,acquisition-acquirer,100,49,2/9/2018
94983E,conference-participant,100,50,2/9/2018
95F59E,earnings,100,50,2/9/2018
966DBE,earnings,100,50,2/9/2018
972356,partnership,100,61,2/9/2018
97644E,earnings,100,50,2/9/2018
980C14,dividend,100,50,2/9/2018
99028D,earnings,100,50,2/9/2018
9D56F2,conference-participant,100,50,2/9/2018
9F5CBB,conference-call,100,50,2/9/2018
A5A4F5,acquisition-acquirer,100,49,2/9/2018
A631A3,award,100,58,2/9/2018
A6828A,legal-issues-defendant,100,22,2/9/2018
A6828A,legal-issues-defendant,100,22,2/9/2018
AD9F1D,executive-appointment,100,54,2/9/2018
AEFC90,earnings,100,50,2/9/2018
AFEC35,facility-open,100,65,2/9/2018
BD9668,dividend-up,100,81,2/9/2018
C07E05,earnings,100,50,2/9/2018
C3CF29,earnings,100,50,2/9/2018
C8257F,conference-call,100,50,2/9/2018
C8A059,earnings,100,50,2/9/2018
C99CC8,earnings,100,50,2/9/2018
C99CC8,earnings,100,50,2/9/2018
CAB222,conference-participant,100,50,2/9/2018
CB89EA,earnings,100,50,2/9/2018
CBFFDD,conference-call,100,50,2/9/2018
CBFFDD,conference-call,100,50,2/9/2018
CCB623,public-offering,100,43,2/9/2018
CE2791,conference-call,100,50,2/9/2018
D78BF1,award,100,58,2/9/2018
D7F569,earnings,100,50,2/9/2018
DA0A9E,dividend,100,50,2/9/2018
E05026,business-contract,100,69,2/9/2018
E13782,conference-participant,100,50,2/9/2018
EAA0A7,conference-participant,100,50,2/9/2018
EF45B6,acquisition-completed-acquirer,100,49,2/9/2018
EF5BED,executive-appointment,100,54,2/9/2018
F1529C,earnings,100,50,2/9/2018
F39E1E,legal-issues-defendant,100,22,2/9/2018
F58C23,earnings,100,50,2/9/2018
F58C23,earnings,100,50,2/9/2018
F6FA6A,earnings,100,50,2/9/2018
F721A7,earnings,100,50,2/9/2018
FD0CA4,conference-participant,100,50,2/9/2018
FF4BA4,dividend,100,50,2/9/2018
FF5413,revenue-volume,100,50,2/9/2018
713810,executive-appointment,100,54,2/10/2018
99028D,earnings,100,50,2/10/2018
CB89EA,earnings,100,50,2/10/2018
02870F,earnings-up,100,68,2/12/2018
02FC1A,conference-participant,100,50,2/12/2018
04996E,earnings,100,50,2/12/2018
0968A5,note-sale,100,52,2/12/2018
0BD4E8,award,100,58,2/12/2018
0C355F,conference-call,100,50,2/12/2018
108FDA,executive-appointment,100,54,2/12/2018
168A5D,facility-open,100,65,2/12/2018
16B183,dividend,100,50,2/12/2018
184866,executive-appointment,100,54,2/12/2018
188394,earnings,100,50,2/12/2018
1A3E1B,award,100,58,2/12/2018
1A6A94,conference-call,100,50,2/12/2018
1AE482,earnings,100,50,2/12/2018
1C599A,earnings,100,50,2/12/2018
1D3A00,conference-call,100,50,2/12/2018
1E1125,conference-organizer,100,57,2/12/2018
1E1125,conference-organizer,100,57,2/12/2018
1E1125,conference-organizer,100,57,2/12/2018
1F3CFB,earnings,100,50,2/12/2018
1F3CFB,earnings,100,50,2/12/2018
1F716B,earnings,100,50,2/12/2018
1FC422,earnings,100,50,2/12/2018
2082EA,executive-appointment,100,54,2/12/2018
21245F,legal-issues-defendant,100,22,2/12/2018
21D903,earnings,100,50,2/12/2018
249674,conference-call,100,50,2/12/2018
24A89A,orphan-drug-designation,100,76,2/12/2018
25A6CC,earnings,100,50,2/12/2018
26008A,conference-call,100,50,2/12/2018
2667B6,conference-participant,100,50,2/12/2018
27A791,conference-call,100,50,2/12/2018
295F9F,conference-call,100,50,2/12/2018
297DA8,conference-call,100,50,2/12/2018
29A4CC,merger-regulatory-approval,100,81,2/12/2018
2ABF77,conference-participant,100,50,2/12/2018
2CB4C9,award,100,58,2/12/2018
30AB63,earnings,100,50,2/12/2018
31803E,conference-participant,100,50,2/12/2018
33AD83,award,100,58,2/12/2018
3461CF,award,100,58,2/12/2018
34B97A,award,100,58,2/12/2018
3B318A,conference-call,100,50,2/12/2018
3BE00F,conference-participant,100,50,2/12/2018
3DED49,conference-call,100,50,2/12/2018
4.03E+05,partnership,100,61,2/12/2018
416C55,award,100,58,2/12/2018
41A93D,executive-appointment,100,54,2/12/2018
43E8F5,conference-call,100,50,2/12/2018
449447,conference-participant,100,50,2/12/2018
485445,conference-participant,100,50,2/12/2018
490D4B,earnings,100,50,2/12/2018
4E6F5A,executive-resignation,100,44,2/12/2018
4F9926,partnership,100,61,2/12/2018
51D876,award,100,58,2/12/2018
524CE4,executive-appointment,100,54,2/12/2018
52FB2F,facility-open,100,65,2/12/2018
5704AC,credit-extension-recipient,100,69,2/12/2018
57356F,conference-participant,100,50,2/12/2018
57DDB9,award,100,58,2/12/2018
583A75,settlement,100,56,2/12/2018
589803,executive-appointment,100,54,2/12/2018
59872F,conference-call,100,50,2/12/2018
5B3415,earnings,100,50,2/12/2018
5C8D61,earnings,100,50,2/12/2018
5C8D61,earnings,100,50,2/12/2018
5C8D61,earnings,100,50,2/12/2018
5CCDAD,executive-appointment,100,54,2/12/2018
619882,conference-organizer,100,57,2/12/2018
619882,conference-organizer,100,57,2/12/2018
61A586,earnings,100,50,2/12/2018
61BCA7,earnings,100,50,2/12/2018
64FF65,conference-call,100,50,2/12/2018
66749D,award,100,58,2/12/2018
66A667,acquisition-acquirer,100,49,2/12/2018
6A01DF,public-offering,100,43,2/12/2018
6-Dec-05,executive-appointment,100,54,2/12/2018
6E8864,earnings,100,50,2/12/2018
6ED519,award,100,58,2/12/2018
6F5DD2,earnings,100,50,2/12/2018
713810,conference-call,100,50,2/12/2018
741937,dividend,100,50,2/12/2018
7448A3,earnings,100,50,2/12/2018
763DBE,conference-participant,100,50,2/12/2018
766047,award,100,58,2/12/2018
77B8E9,public-offering,100,43,2/12/2018
790C34,award,100,58,2/12/2018
797C20,operating-earnings-positive,100,69,2/12/2018
7A51FE,earnings,100,50,2/12/2018
7CD98F,executive-appointment,100,54,2/12/2018
83066C,conference-call,100,50,2/12/2018
834152,clinical-trials-positive,100,87,2/12/2018
85DA04,earnings,100,50,2/12/2018
860AB6,earnings,100,50,2/12/2018
8C6C1B,facility-open,100,65,2/12/2018
8D9993,executive-appointment,100,54,2/12/2018
8DBBE6,credit-extension-recipient,100,69,2/12/2018
8E0E32,award,100,58,2/12/2018
8E82A6,conference-participant,100,50,2/12/2018
900356,executive-appointment,100,54,2/12/2018
915E7B,earnings,100,50,2/12/2018
91E5EE,earnings,100,50,2/12/2018
92D9C9,conference-call,100,50,2/12/2018
9.31E+77,conference-call,100,50,2/12/2018
9.36E+10,business-contract,100,69,2/12/2018
945DE6,business-contract,100,69,2/12/2018
94637C,legal-issues-defendant,100,22,2/12/2018
949625,executive-resignation,100,44,2/12/2018
958938,executive-appointment,100,54,2/12/2018
968B00,earnings-positive,100,69,2/12/2018
968B00,earnings,100,50,2/12/2018
968B00,earnings,100,50,2/12/2018
96F126,product-release,100,64,2/12/2018
9CDA4F,earnings,100,50,2/12/2018
A072C4,conference-participant,100,50,2/12/2018
A4BCDE,award,100,58,2/12/2018
A5A4F5,acquisition-acquirer,100,49,2/12/2018
A631A3,partnership,100,61,2/12/2018
A7102F,award,100,58,2/12/2018
A790A5,conference-call,100,50,2/12/2018
AA3AB8,earnings,100,50,2/12/2018
AADE0B,award,100,58,2/12/2018
AADE0B,award,100,58,2/12/2018
AADE0B,award,100,58,2/12/2018
AD1ACF,dividend,100,50,2/12/2018
AD23DE,executive-appointment,100,54,2/12/2018
AD3C93,legal-issues-defendant,100,22,2/12/2018
AD3C93,legal-issues-defendant,100,22,2/12/2018
AD9F1D,dividend-up,100,81,2/12/2018
ADF1B0,unit-acquisition-acquiree,100,76,2/12/2018
ADF1B0,unit-acquisition-acquiree,100,76,2/12/2018
ADF1B0,business-contract,100,69,2/12/2018
AFD1CA,earnings,100,50,2/12/2018
B05000,market-entry,100,57,2/12/2018
B076A1,conference-call,100,50,2/12/2018
B0D41A,conference-participant,100,50,2/12/2018
B1DF3C,earnings,100,50,2/12/2018
B54A74,product-release,100,64,2/12/2018
B5BA39,award,100,58,2/12/2018
B72BE9,dividend,100,50,2/12/2018
BB58FF,award,100,58,2/12/2018
BB88B6,conference-participant,100,50,2/12/2018
BC4876,earnings,100,50,2/12/2018
BDE867,operating-earnings,100,50,2/12/2018
C0200F,award,100,58,2/12/2018
C0F70B,earnings,100,50,2/12/2018
C2609A,award,100,58,2/12/2018
C7859D,award,100,58,2/12/2018
C941DC,conference-call,100,50,2/12/2018
CCBBAD,earnings,100,50,2/12/2018
CDE51C,executive-appointment,100,54,2/12/2018
CDE51C,earnings,100,50,2/12/2018
D03C7A,dividend,100,50,2/12/2018
D25249,conference-call,100,50,2/12/2018
D29B44,conference-participant,100,50,2/12/2018
D4070C,award,100,58,2/12/2018
D437C3,business-contract,100,69,2/12/2018
D60BB2,dividend-up,100,81,2/12/2018
D75910,conference-call,100,50,2/12/2018
DA91AE,dividend,100,50,2/12/2018
DA9443,public-offering,100,43,2/12/2018
DB2E4E,conference-participant,100,50,2/12/2018
DB7014,executive-appointment,100,54,2/12/2018
DB9829,executive-appointment,100,54,2/12/2018
DCD97F,acquisition-acquirer,100,49,2/12/2018
DCD97F,acquisition-acquirer,100,49,2/12/2018
DD9E41,executive-appointment,100,54,2/12/2018
DF18E6,public-offering,100,43,2/12/2018
E26FC3,dividend-up,100,81,2/12/2018
E2F130,executive-appointment,100,54,2/12/2018
E959F3,award,100,58,2/12/2018
EB61C4,award,100,58,2/12/2018
EC4E82,acquisition-completed-acquirer,100,49,2/12/2018
ECF4F8,conference-call,100,50,2/12/2018
F0027C,clinical-trials-start,100,64,2/12/2018
F05B1B,acquisition-acquirer,100,49,2/12/2018
F05B1B,acquisition-acquirer,100,49,2/12/2018
F3016C,earnings,100,50,2/12/2018
F39E1E,legal-issues-defendant,100,22,2/12/2018
F44EA2,earnings,100,50,2/12/2018
F6E1B5,earnings,100,50,2/12/2018
F83279,executive-appointment,100,54,2/12/2018
F85CC0,award,100,58,2/12/2018
FC1B7B,acquisition-regulatory-approval-acquirer,100,54,2/12/2018
FD4BBE,conference-participant,100,50,2/12/2018
FEC475,award,100,58,2/12/2018
13528,earnings,100,50,2/13/2018
040DBB,conference-call,100,50,2/13/2018
0BF528,partnership,100,61,2/13/2018
0C136E,executive-appointment,100,54,2/13/2018
0C2A0D,earnings,100,50,2/13/2018
0CE204,earnings,100,50,2/13/2018
0F65C9,earnings,100,50,2/13/2018
0F65C9,dividend,100,50,2/13/2018
0FC848,spin-off,100,58,2/13/2018
0FC848,insider-buy,100,61,2/13/2018
126F95,dividend,100,50,2/13/2018
1272B3,earnings,100,50,2/13/2018
131443,dividend,100,50,2/13/2018
13C3E0,product-release,100,64,2/13/2018
149301,dividend,100,50,2/13/2018
168A5D,business-contract,100,69,2/13/2018
196D18,public-offering,100,43,2/13/2018
196D18,public-offering,100,43,2/13/2018
1BDB2A,dividend,100,50,2/13/2018
1CDD1C,earnings,100,50,2/13/2018
1E04A5,earnings,100,50,2/13/2018
1E1125,conference-organizer,100,57,2/13/2018
1E4FB9,earnings,100,50,2/13/2018
1E9A6D,partnership,100,61,2/13/2018
1E9A6D,partnership,100,61,2/13/2018
1F9258,regulatory-product-approval-granted,100,81,2/13/2018
1FAF22,conference-participant,100,50,2/13/2018
202E5A,earnings,100,50,2/13/2018
20D00A,earnings,100,50,2/13/2018
21245F,legal-issues-defendant,100,22,2/13/2018
21245F,legal-issues-defendant,100,22,2/13/2018
21245F,legal-issues-defendant,100,22,2/13/2018
225CA2,business-contract,100,69,2/13/2018
225CA2,business-contract,100,69,2/13/2018
228D42,award,100,58,2/13/2018
2F6782,dividend-up,100,81,2/13/2018
2F6782,earnings,100,50,2/13/2018
2F94A5,dividend,100,50,2/13/2018
2F960F,conference-call,100,50,2/13/2018
30DFD3,conference-participant,100,50,2/13/2018
31803E,earnings,100,50,2/13/2018
35557B,merger,100,66,2/13/2018
35557B,merger,100,66,2/13/2018
367E1C,earnings,100,50,2/13/2018
3C3B6B,earnings,100,50,2/13/2018
3C8A04,dividend,100,50,2/13/2018
3E15F6,dividend,100,50,2/13/2018
3F6A9C,acquisition-completed-acquirer,100,49,2/13/2018
3FACA7,business-contract,100,69,2/13/2018
41EC04,earnings,100,50,2/13/2018
427F32,board-meeting,100,51,2/13/2018
429BFB,conference-call,100,50,2/13/2018
42AABD,public-offering,100,43,2/13/2018
448BF3,earnings,100,50,2/13/2018
44DDBD,conference-call,100,50,2/13/2018
44ED36,earnings,100,50,2/13/2018
4591D3,executive-appointment,100,54,2/13/2018
467F2C,earnings,100,50,2/13/2018
46A16E,conference-participant,100,50,2/13/2018
4.60E+06,business-contract,100,69,2/13/2018
4A6F00,partnership,100,61,2/13/2018
4C5CC9,conference-call,100,50,2/13/2018
4E4E75,legal-issues-defendant,100,22,2/13/2018
4E4E75,legal-issues-defendant,100,22,2/13/2018
4E5784,conference-participant,100,50,2/13/2018
4F9926,partnership,100,61,2/13/2018
50D1EC,partnership,100,61,2/13/2018
513A86,earnings,100,50,2/13/2018
51F541,earnings,100,50,2/13/2018
56632F,earnings,100,50,2/13/2018
59A832,earnings,100,50,2/13/2018
5CCDAD,earnings,100,50,2/13/2018
5DD486,executive-appointment,100,54,2/13/2018
5DD486,executive-appointment,100,54,2/13/2018
605F40,award,100,58,2/13/2018
619882,conference-organizer,100,57,2/13/2018
636931,public-offering,100,43,2/13/2018
66A667,legal-issues-defendant,100,22,2/13/2018
673C9A,earnings,100,50,2/13/2018
6A01DF,public-offering,100,43,2/13/2018
6B0E45,dividend,100,50,2/13/2018
6F39FC,earnings,100,50,2/13/2018
701531,earnings,100,50,2/13/2018
70FCEF,executive-appointment,100,54,2/13/2018
722DE3,business-contract,100,69,2/13/2018
72609A,conference-call,100,50,2/13/2018
7262F2,earnings,100,50,2/13/2018
728737,dividend,100,50,2/13/2018
72FCA3,award,100,58,2/13/2018
73A71F,business-contract,100,69,2/13/2018
7734AC,dividend,100,50,2/13/2018
7999F3,note-sale,100,52,2/13/2018
7999F3,note-sale,100,52,2/13/2018
7999F3,note-sale,100,52,2/13/2018
7A10FF,executive-appointment,100,54,2/13/2018
7C790D,conference-call,100,50,2/13/2018
7F9984,buybacks,100,74,2/13/2018
7F9BE2,dividend,100,50,2/13/2018
8.10E+32,legal-issues-defendant,100,22,2/13/2018
8.10E+32,legal-issues-defendant,100,22,2/13/2018
8.10E+32,earnings,100,50,2/13/2018
8303CD,earnings,100,50,2/13/2018
834152,conference-call,100,50,2/13/2018
838ADD,conference-participant,100,50,2/13/2018
83A065,conference-call,100,50,2/13/2018
8.79E+06,earnings,100,50,2/13/2018
8B6E7E,executive-appointment,100,54,2/13/2018
8C311A,earnings,100,50,2/13/2018
8C6C1B,facility-open,100,65,2/13/2018
8DE56F,executive-appointment,100,54,2/13/2018
8DE56F,executive-appointment,100,54,2/13/2018
8E3F58,earnings,100,50,2/13/2018
8EEA28,earnings,100,50,2/13/2018
9196A2,conference-organizer,100,57,2/13/2018
9196A2,conference-organizer,100,57,2/13/2018
9196A2,conference-organizer,100,57,2/13/2018
925759,conference-call,100,50,2/13/2018
92D757,partnership,100,61,2/13/2018
92D9C9,earnings,100,50,2/13/2018
943239,legal-issues-defendant,100,22,2/13/2018
9592FB,conference-participant,100,50,2/13/2018
95C575,dividend,100,50,2/13/2018
9.65E+09,earnings,100,50,2/13/2018
968B00,dividend,100,50,2/13/2018
972356,executive-appointment,100,54,2/13/2018
97AAF6,award,100,58,2/13/2018
97AF94,earnings,100,50,2/13/2018
990AD0,conference-organizer,100,57,2/13/2018
9C25FF,earnings-guidance,100,50,2/13/2018
9C8664,unit-acquisition-regulatory-approval-acquirer,100,53,2/13/2018
9CA432,conference-participant,100,50,2/13/2018
9CA432,conference-participant,100,50,2/13/2018
9F62D1,dividend,100,50,2/13/2018
9FF5F1,earnings,100,50,2/13/2018
A0F146,executive-appointment,100,54,2/13/2018
A16DEA,earnings,100,50,2/13/2018
A1EAC8,conference-call,100,50,2/13/2018
A29DBD,conference-participant,100,50,2/13/2018
A41450,earnings,100,50,2/13/2018
A4386C,earnings,100,50,2/13/2018
A4386C,earnings,100,50,2/13/2018
A4386C,earnings,100,50,2/13/2018
A4386C,earnings,100,50,2/13/2018
A4386C,earnings,100,50,2/13/2018
A4D173,buybacks,100,74,2/13/2018
A4D173,buybacks,100,74,2/13/2018
A4F67C,earnings,100,50,2/13/2018
A5A4F5,acquisition-acquirer,100,49,2/13/2018
A63820,executive-appointment,100,54,2/13/2018
A7102F,legal-issues-plaintiff,100,44,2/13/2018
A7102F,legal-issues-defendant,100,22,2/13/2018
A7102F,legal-issues-defendant,100,22,2/13/2018
A868C9,product-release,100,64,2/13/2018
AA09AD,earnings,100,50,2/13/2018
AD3C93,stock-splits,100,49,2/13/2018
AEF2C3,conference-call,100,50,2/13/2018
B13B68,earnings,100,50,2/13/2018
B13B68,executive-appointment,100,54,2/13/2018
B1FC3B,product-release,100,64,2/13/2018
B2206F,conference-participant,100,50,2/13/2018
B37FB4,earnings,100,50,2/13/2018
B37FB4,earnings,100,50,2/13/2018
B37FB4,earnings,100,50,2/13/2018
B37FB4,earnings,100,50,2/13/2018
B37FB4,earnings,100,50,2/13/2018
B37FB4,earnings,100,50,2/13/2018
B37FB4,earnings,100,50,2/13/2018
B3CB74,conference-organizer,100,57,2/13/2018
B3CB74,conference-organizer,100,57,2/13/2018
B560AF,executive-appointment,100,54,2/13/2018
B83BCE,earnings,100,50,2/13/2018
B9CD50,executive-appointment,100,54,2/13/2018
BB0587,earnings,100,50,2/13/2018
BB0587,earnings,100,50,2/13/2018
BB0587,earnings,100,50,2/13/2018
BB0587,earnings,100,50,2/13/2018
BB0587,earnings,100,50,2/13/2018
BB0587,earnings,100,50,2/13/2018
BB0587,earnings,100,50,2/13/2018
BC5680,partnership,100,61,2/13/2018
BD15E8,executive-appointment,100,54,2/13/2018
BD8517,award,100,58,2/13/2018
BE7BA4,conference-call,100,50,2/13/2018
BFE02C,executive-appointment,100,54,2/13/2018
C03C8B,dividend,100,50,2/13/2018
C2609A,earnings,100,50,2/13/2018
C4A241,earnings-up,100,68,2/13/2018
C4A241,earnings,100,50,2/13/2018
C4A241,earnings,100,50,2/13/2018
C4A241,earnings,100,50,2/13/2018
C4A912,earnings,100,50,2/13/2018
C8257F,executive-appointment,100,54,2/13/2018
C9E04B,earnings,100,50,2/13/2018
CA212F,earnings,100,50,2/13/2018
CB6A9C,conference-call,100,50,2/13/2018
CE96E7,note-sale,100,52,2/13/2018
D08D2C,earnings,100,50,2/13/2018
D139BC,earnings,100,50,2/13/2018
D139BC,earnings,100,50,2/13/2018
D17C1B,revenue-volume,100,50,2/13/2018
D1C26F,executive-appointment,100,54,2/13/2018
D3FA2C,executive-appointment,100,54,2/13/2018
D6534D,earnings-up,100,68,2/13/2018
D6534D,earnings,100,50,2/13/2018
D6534D,earnings,100,50,2/13/2018
D6534D,earnings,100,50,2/13/2018
D6534D,earnings,100,50,2/13/2018
D6534D,earnings,100,50,2/13/2018
D77F7E,business-contract,100,69,2/13/2018
D96202,award,100,58,2/13/2018
DA0CB8,earnings,100,50,2/13/2018
DA9443,public-offering,100,43,2/13/2018
DC2B00,executive-appointment,100,54,2/13/2018
DDB002,conference-call,100,50,2/13/2018
DDC415,earnings,100,50,2/13/2018
DF6FDD,award,100,58,2/13/2018
E06265,dividend,100,50,2/13/2018
E074A0,dividend,100,50,2/13/2018
E15736,earnings,100,50,2/13/2018
E2F66E,earnings-guidance,100,50,2/13/2018
E68733,earnings,100,50,2/13/2018
E6BC2C,business-contract,100,69,2/13/2018
ED0D7C,dividend,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
EFD406,earnings,100,50,2/13/2018
F179ED,earnings,100,50,2/13/2018
F30508,clinical-trials,100,56,2/13/2018
F4D241,conference-participant,100,50,2/13/2018
F7935D,product-release,100,64,2/13/2018
F7ADEB,conference-participant,100,50,2/13/2018
F8BA6C,conference-participant,100,50,2/13/2018
F90EE5,earnings,100,50,2/13/2018
FA044A,earnings,100,50,2/13/2018
FA044A,earnings,100,50,2/13/2018
FA044A,earnings,100,50,2/13/2018
FB728F,conference-call,100,50,2/13/2018
FDE409,executive-appointment,100,54,2/13/2018
FEC475,partnership,100,61,2/13/2018
FEC475,partnership,100,61,2/13/2018
FFAB4A,earnings,100,50,2/13/2018
00E601,dividend,100,50,2/14/2018
0157B1,partnership,100,61,2/14/2018
036C6F,earnings,100,50,2/14/2018
053EFF,dividend,100,50,2/14/2018
07C69F,earnings,100,50,2/14/2018
84625,dividend,100,50,2/14/2018
98977,earnings,100,50,2/14/2018
0B4D10,earnings,100,50,2/14/2018
0BD4E8,acquisition-acquirer,100,49,2/14/2018
0BD4E8,acquisition-acquirer,100,49,2/14/2018
0BD4E8,acquisition-acquirer,100,49,2/14/2018
0CE7F6,earnings,100,50,2/14/2018
0E64D4,earnings,100,50,2/14/2018
0E64D4,earnings,100,50,2/14/2018
0E64D4,earnings,100,50,2/14/2018
0E64D4,earnings,100,50,2/14/2018
0F2BC9,conference-call,100,50,2/14/2018
1065BC,dividend,100,50,2/14/2018
108BD2,merger-regulatory-approval,100,81,2/14/2018
12731D,conference-call,100,50,2/14/2018
12DE76,earnings,100,50,2/14/2018
12DE76,earnings,100,50,2/14/2018
12DE76,earnings,100,50,2/14/2018
12DE76,earnings,100,50,2/14/2018
12DE76,earnings,100,50,2/14/2018
12DE76,earnings,100,50,2/14/2018
149301,earnings,100,50,2/14/2018
184866,conference-participant,100,50,2/14/2018
196D18,public-offering,100,43,2/14/2018
196D18,public-offering,100,43,2/14/2018
1A5957,earnings,100,50,2/14/2018
1AB808,earnings,100,50,2/14/2018
1AF7E2,earnings,100,50,2/14/2018
1BDB2A,conference-participant,100,50,2/14/2018
1D1B07,executive-appointment,100,54,2/14/2018
1D1B07,executive-appointment,100,54,2/14/2018
1E1125,earnings,100,50,2/14/2018
1E1125,conference-organizer,100,57,2/14/2018
1E4FB9,executive-appointment,100,54,2/14/2018
1E7785,conference-participant,100,50,2/14/2018
1FA886,executive-appointment,100,54,2/14/2018
21245F,legal-issues-defendant,100,22,2/14/2018
21245F,legal-issues-defendant,100,22,2/14/2018
227F04,conference-participant,100,50,2/14/2018
241AF7,conference-call,100,50,2/14/2018
25AB8E,earnings,100,50,2/14/2018
25DD05,earnings,100,50,2/14/2018
275300,conference-participant,100,50,2/14/2018
2.89E+11,dividend,100,50,2/14/2018
2A6DBE,merger-completed,100,66,2/14/2018
2B49F4,conference-participant,100,50,2/14/2018
2BF36E,dividend,100,50,2/14/2018
2EBA55,earnings,100,50,2/14/2018
2EBA55,buybacks,100,74,2/14/2018
2F94A5,executive-resignation,100,44,2/14/2018
315EB0,earnings,100,50,2/14/2018
315EB0,acquisition-acquirer,100,49,2/14/2018
315EB0,dividend,100,50,2/14/2018
31F25C,executive-appointment,100,54,2/14/2018
326EDD,dividend,100,50,2/14/2018
32CB22,conference-participant,100,50,2/14/2018
34E9F9,earnings,100,50,2/14/2018
36A1CB,conference-call,100,50,2/14/2018
385DD4,earnings-up,100,68,2/14/2018
3DCECC,earnings,100,50,2/14/2018
3E70FC,executive-appointment,100,54,2/14/2018
401072,earnings,100,50,2/14/2018
408089,dividend,100,50,2/14/2018
40B903,earnings,100,50,2/14/2018
415188,business-contract,100,69,2/14/2018
416C55,conference-participant,100,50,2/14/2018
41EC04,business-contract,100,69,2/14/2018
42AABD,public-offering,100,43,2/14/2018
4455C4,earnings,100,50,2/14/2018
4455C4,earnings,100,50,2/14/2018
4455C4,earnings,100,50,2/14/2018
4455C4,earnings,100,50,2/14/2018
44DDBD,executive-appointment,100,54,2/14/2018
44DDBD,earnings,100,50,2/14/2018
451D61,earnings,100,50,2/14/2018
46CF27,index-listing,100,76,2/14/2018
47FCF2,earnings,100,50,2/14/2018
485445,earnings,100,50,2/14/2018
4A3438,conference-call,100,50,2/14/2018
4A6F00,executive-appointment,100,54,2/14/2018
4AE584,unit-acquisition-acquirer,100,49,2/14/2018
4B5054,dividend,100,50,2/14/2018
4C350A,earnings,100,50,2/14/2018
4C92B9,conference-call,100,50,2/14/2018
4D371E,award,100,58,2/14/2018
4E4E75,legal-issues-defendant,100,22,2/14/2018
507AE7,dividend-up,100,72,2/14/2018
514067,earnings,100,50,2/14/2018
51D876,executive-appointment,100,54,2/14/2018
51F541,conference-call,100,50,2/14/2018
532D47,earnings,100,50,2/14/2018
5.43E+08,conference-call,100,50,2/14/2018
548AC0,partnership,100,61,2/14/2018
54DF47,earnings-guidance,100,50,2/14/2018
56EA2B,conference-participant,100,50,2/14/2018
58CA9A,conference-organizer,100,57,2/14/2018
58CA9A,conference-organizer,100,57,2/14/2018
594402,earnings,100,50,2/14/2018
5A9F54,earnings-up,100,68,2/14/2018
5A9F54,earnings,100,50,2/14/2018
5A9F54,earnings,100,50,2/14/2018
5A9F54,earnings,100,50,2/14/2018
5A9F54,earnings,100,50,2/14/2018
5B226B,unit-acquisition-completed-acquirer,100,49,2/14/2018
5B6C11,dividend,100,50,2/14/2018
5D02B7,conference-call,100,50,2/14/2018
61E975,earnings-positive,100,69,2/14/2018
62CDDE,conference-call,100,50,2/14/2018
639BD6,conference-participant,100,50,2/14/2018
6.52E+64,legal-issues-defendant,100,22,2/14/2018
67303E,executive-appointment,100,54,2/14/2018
68E6E9,dividend,100,50,2/14/2018
69345C,legal-issues-defendant,100,22,2/14/2018
6B0E45,earnings,100,50,2/14/2018
6B494E,earnings,100,50,2/14/2018
6CB7F9,earnings,100,50,2/14/2018
6D156D,earnings,100,50,2/14/2018
6F22E7,conference-call,100,50,2/14/2018
719477,dividend-up,100,64,2/14/2018
722D55,conference-participant,100,50,2/14/2018
73A71F,earnings,100,50,2/14/2018
73A71F,executive-appointment,100,54,2/14/2018
76BECC,conference-call,100,50,2/14/2018
78F776,business-contract-terminated,100,31,2/14/2018
78F9ED,earnings,100,50,2/14/2018
790D0D,earnings,100,50,2/14/2018
7C75FD,earnings,100,50,2/14/2018
7C75FD,earnings,100,50,2/14/2018
7C75FD,earnings,100,50,2/14/2018
7C75FD,earnings,100,50,2/14/2018
7C75FD,earnings,100,50,2/14/2018
7C75FD,earnings,100,50,2/14/2018
7C790D,conference-participant,100,50,2/14/2018
7CBC40,earnings,100,50,2/14/2018
7E3F8F,earnings,100,50,2/14/2018
7F3669,business-contract,100,69,2/14/2018
7F9BE2,earnings,100,50,2/14/2018
7FDE1C,conference-call,100,50,2/14/2018
81222C,earnings,100,50,2/14/2018
824CCA,buybacks,100,74,2/14/2018
82B57E,earnings,100,50,2/14/2018
83B1C8,earnings,100,50,2/14/2018
83B1C8,earnings,100,50,2/14/2018
83B1C8,earnings,100,50,2/14/2018
85CDC9,conference-participant,100,50,2/14/2018
862941,earnings,100,50,2/14/2018
862941,conference-participant,100,50,2/14/2018
881190,dividend,100,50,2/14/2018
88611B,earnings,100,50,2/14/2018
8AB37F,conference-call,100,50,2/14/2018
8C6C1B,facility-open,100,65,2/14/2018
8FF2EF,earnings,100,50,2/14/2018
9004C4,conference-call,100,50,2/14/2018
902255,earnings,100,50,2/14/2018
90D6A5,earnings,100,50,2/14/2018
9196A2,conference-organizer,100,57,2/14/2018
9196A2,conference-organizer,100,57,2/14/2018
9196A2,conference-organizer,100,57,2/14/2018
9196A2,conference-organizer,100,57,2/14/2018
934CC3,earnings,100,50,2/14/2018
96F126,facility-open,100,65,2/14/2018
9810C0,facility-upgrade,100,65,2/14/2018
990AD0,conference-organizer,100,57,2/14/2018
990AD0,conference-organizer,100,57,2/14/2018
9A602D,award,100,58,2/14/2018
9AF3DC,award,100,58,2/14/2018
9E575E,conference-participant,100,50,2/14/2018
9EA947,earnings,100,50,2/14/2018
9F37C5,earnings,100,50,2/14/2018
A0F146,unit-acquisition-acquirer,100,49,2/14/2018
A398F8,earnings,100,50,2/14/2018
A5A4F5,acquisition-acquirer,100,49,2/14/2018
A7102F,legal-issues-defendant,100,22,2/14/2018
A87CD6,earnings,100,50,2/14/2018
A87CD6,dividend,100,50,2/14/2018
A8AC4C,conference-call,100,50,2/14/2018
AAEE21,earnings,100,50,2/14/2018
ADF1B0,conference-call,100,50,2/14/2018
B1B10C,dividend,100,50,2/14/2018
B2206F,partnership,100,61,2/14/2018
B4B281,conference-call,100,50,2/14/2018
B5BA39,earnings,100,50,2/14/2018
B5DE80,executive-resignation,100,44,2/14/2018
B66928,earnings,100,50,2/14/2018
B9CD50,acquisition-interest-acquirer,100,46,2/14/2018
B9CD50,acquisition-interest-acquirer,100,46,2/14/2018
BB58FF,conference-participant,100,50,2/14/2018
BCE9DA,earnings,100,50,2/14/2018
BCE9DA,earnings,100,50,2/14/2018
BCE9DA,earnings,100,50,2/14/2018
BD682F,dividend,100,50,2/14/2018
BDF2BD,conference-call,100,50,2/14/2018
C0200F,executive-appointment,100,54,2/14/2018
C06EB6,earnings,100,50,2/14/2018
C15F8F,public-offering,100,43,2/14/2018
C29715,buybacks,100,74,2/14/2018
C3BCD5,dividend,100,50,2/14/2018
C45C1F,earnings,100,50,2/14/2018
C4A432,executive-appointment,100,54,2/14/2018
C4F9C6,conference-participant,100,50,2/14/2018
C564E4,conference-call,100,50,2/14/2018
C624A1,earnings,100,50,2/14/2018
C624A1,earnings,100,50,2/14/2018
C62AA4,earnings,100,50,2/14/2018
C83B88,conference-participant,100,50,2/14/2018
CB9E13,earnings,100,50,2/14/2018
CBB77B,public-offering,100,43,2/14/2018
CDAF5B,dividend,100,50,2/14/2018
CE1002,conference-participant,100,50,2/14/2018
CF9054,earnings,100,50,2/14/2018
D06996,conference-call,100,50,2/14/2018
D0DE27,earnings,100,50,2/14/2018
D2B9E5,earnings,100,50,2/14/2018
D2B9E5,earnings,100,50,2/14/2018
D2B9E5,earnings,100,50,2/14/2018
D2B9E5,earnings,100,50,2/14/2018
D2C0B6,earnings,100,50,2/14/2018
D78CCD,award,100,58,2/14/2018
D8442A,business-contract,100,69,2/14/2018
D8DA3D,dividend,100,50,2/14/2018
DA48E4,conference-participant,100,50,2/14/2018
DAFED3,buybacks,100,74,2/14/2018
DD9E41,product-release,100,64,2/14/2018
DDEA6A,regulatory-product-approval-granted,100,81,2/14/2018
E124EB,conference-participant,100,50,2/14/2018
E21871,earnings,100,50,2/14/2018
E21871,earnings,100,50,2/14/2018
E21871,earnings,100,50,2/14/2018
E21871,earnings,100,50,2/14/2018
E21871,earnings,100,50,2/14/2018
E21871,earnings,100,50,2/14/2018
E30B34,earnings,100,50,2/14/2018
E71AE6,conference-participant,100,50,2/14/2018
E71AE6,conference-participant,100,50,2/14/2018
E829E8,dividend,100,50,2/14/2018
E8846E,executive-appointment,100,54,2/14/2018
E8846E,executive-appointment,100,54,2/14/2018
E8846E,legal-issues-defendant,100,22,2/14/2018
E8846E,legal-issues-defendant,100,22,2/14/2018
E8846E,legal-issues-defendant,100,22,2/14/2018
E8C557,conference-participant,100,50,2/14/2018
EA62FC,conference-participant,100,50,2/14/2018
EB61C4,earnings,100,50,2/14/2018
EBC84C,facility-open,100,65,2/14/2018
EBC84C,earnings,100,50,2/14/2018
EBC84C,earnings,100,50,2/14/2018
EBC84C,earnings,100,50,2/14/2018
EBC84C,earnings,100,50,2/14/2018
EBC84C,earnings,100,50,2/14/2018
EBC84C,earnings,100,50,2/14/2018
EBC84C,earnings,100,50,2/14/2018
EC4E82,earnings-up,100,68,2/14/2018
EC4E82,earnings-up,100,68,2/14/2018
ED2A5E,conference-call,100,50,2/14/2018
ED79D9,earnings,100,50,2/14/2018
ED9C04,market-entry,100,57,2/14/2018
EEEA9F,conference-participant,100,50,2/14/2018
EEEA9F,conference-participant,100,50,2/14/2018
F1C04C,conference-call,100,50,2/14/2018
F209B4,earnings,100,50,2/14/2018
F39E1E,legal-issues-defendant,100,22,2/14/2018
F4D241,public-offering,100,43,2/14/2018
F702CA,dividend,100,50,2/14/2018
FD2565,conference-participant,100,50,2/14/2018
FF4343,dividend,100,50,2/14/2018
00D6B5,conference-call,100,50,2/15/2018
036C6F,dividend,100,50,2/15/2018
03FAA6,unit-acquisition-acquiree,100,76,2/15/2018
03FAA6,earnings,100,50,2/15/2018
03FAA6,unit-acquisition-acquiree,100,76,2/15/2018
0490C6,conference-participant,100,50,2/15/2018
053EFF,trading-halt,100,43,2/15/2018
053EFF,trading-resumed,100,58,2/15/2018
0624BE,partnership,100,61,2/15/2018
75172,conference-participant,100,50,2/15/2018
07CA6A,dividend,100,50,2/15/2018
099C88,business-contract,100,69,2/15/2018
0A59F8,debt-extension-recipient,100,73,2/15/2018
0A9D0A,dividend,100,50,2/15/2018
0B4D10,dividend,100,50,2/15/2018
0BF198,conference-call,100,50,2/15/2018
0BF528,conference-call,100,50,2/15/2018
0C28D1,earnings,100,50,2/15/2018
0C28D1,earnings,100,50,2/15/2018
0C28D1,earnings,100,50,2/15/2018
0C28D1,earnings,100,50,2/15/2018
0C28D1,earnings,100,50,2/15/2018
0C28D1,earnings,100,50,2/15/2018
0D26E0,earnings-up,100,72,2/15/2018
0D26E0,earnings-up,100,72,2/15/2018
0D26E0,earnings-up,100,72,2/15/2018
0D26E0,earnings-up,100,72,2/15/2018
1096C6,conference-participant,100,50,2/15/2018
126F95,headquarters-change,100,50,2/15/2018
1348C9,dividend,100,50,2/15/2018
135B09,dividend,100,50,2/15/2018
1490F3,earnings,100,50,2/15/2018
159AE4,earnings,100,50,2/15/2018
184866,earnings,100,50,2/15/2018
1CD09C,conference-call,100,50,2/15/2018
1D1B07,conference-participant,100,50,2/15/2018
1D1B07,conference-participant,100,50,2/15/2018
1D9E55,earnings,100,50,2/15/2018
1D9E55,earnings,100,50,2/15/2018
1D9E55,earnings,100,50,2/15/2018
1D9E55,earnings,100,50,2/15/2018
1D9E55,earnings,100,50,2/15/2018
1D9E55,earnings,100,50,2/15/2018
1DEBBE,earnings,100,50,2/15/2018
1F08A6,earnings,100,50,2/15/2018
205AD5,executive-appointment,100,54,2/15/2018
21153F,executive-resignation,100,44,2/15/2018
21153F,executive-resignation,100,44,2/15/2018
21245F,legal-issues-defendant,100,22,2/15/2018
225CA2,legal-issues-defendant,100,22,2/15/2018
23207A,partnership,100,61,2/15/2018
25A6CC,acquisition-acquirer,100,49,2/15/2018
284289,dividend-up,100,81,2/15/2018
2B9DBB,dividend,100,50,2/15/2018
2C19A4,earnings,100,50,2/15/2018
2D643C,conference-participant,100,50,2/15/2018
2E1322,earnings,100,50,2/15/2018
2EC172,partnership,100,61,2/15/2018
2EC172,partnership,100,61,2/15/2018
2F94A5,partnership,100,61,2/15/2018
2FEA66,board-meeting,100,51,2/15/2018
30A565,legal-issues-defendant,100,22,2/15/2018
30A565,legal-issues-defendant,100,22,2/15/2018
3159AA,facility-open,100,65,2/15/2018
31666F,buybacks,100,74,2/15/2018
319BE2,conference-call,100,50,2/15/2018
353DBB,dividend,100,50,2/15/2018
35AE32,executive-appointment,100,54,2/15/2018
35AE32,earnings,100,50,2/15/2018
366A08,earnings,100,50,2/15/2018
372037,conference-call,100,50,2/15/2018
383ADA,dividend-up,100,81,2/15/2018
389CFB,conference-call,100,50,2/15/2018
3C7F5F,earnings,100,50,2/15/2018
3DC887,earnings,100,50,2/15/2018
3DCECC,partnership,100,61,2/15/2018
3DDE54,earnings,100,50,2/15/2018
3DDE54,earnings,100,50,2/15/2018
3DDE54,earnings,100,50,2/15/2018
3DDE54,earnings,100,50,2/15/2018
3DDE54,earnings,100,50,2/15/2018
3DDE54,earnings,100,50,2/15/2018
3E15F6,earnings,100,50,2/15/2018
3E15F6,earnings,100,50,2/15/2018
3E15F6,earnings,100,50,2/15/2018
3E15F6,earnings,100,50,2/15/2018
3E39A5,executive-appointment,100,54,2/15/2018
4017AD,earnings,100,50,2/15/2018
44A4FC,conference-participant,100,50,2/15/2018
4.91E+58,award,100,58,2/15/2018
494EB9,board-meeting,100,51,2/15/2018
49BBBC,earnings,100,50,2/15/2018
4A6F00,partnership,100,61,2/15/2018
4AC91D,product-release,100,64,2/15/2018
4DD09F,earnings,100,50,2/15/2018
4EE167,earnings,100,50,2/15/2018
4FB770,dividend,100,50,2/15/2018
52BF94,earnings,100,50,2/15/2018
556F08,earnings,100,50,2/15/2018
56765E,dividend-up,100,53,2/15/2018
567F3D,conference-participant,100,50,2/15/2018
56EFC7,earnings,100,50,2/15/2018
57F3DA,earnings,100,50,2/15/2018
58C2D4,earnings,100,50,2/15/2018
58CA9A,conference-organizer,100,57,2/15/2018
5B226B,dividend,100,50,2/15/2018
5B3FA2,earnings-guidance-up,100,83,2/15/2018
5BC2F4,dividend,100,50,2/15/2018
5BC2F4,dividend,100,50,2/15/2018
5D16CF,earnings,100,50,2/15/2018
5DE5A5,earnings-up,100,68,2/15/2018
5DE5A5,earnings-up,100,68,2/15/2018
5DE5A5,earnings-up,100,68,2/15/2018
60EA12,earnings,100,50,2/15/2018
60EA12,dividend-up,100,81,2/15/2018
616E3B,earnings,100,50,2/15/2018
619882,dividend,100,50,2/15/2018
627186,conference-participant,100,50,2/15/2018
6284B5,dividend,100,50,2/15/2018
64E615,earnings-up,100,68,2/15/2018
64E615,earnings-up,100,68,2/15/2018
64E615,earnings-up,100,68,2/15/2018
64E615,earnings-up,100,68,2/15/2018
665618,conference-participant,100,50,2/15/2018
665D7D,dividend-up,100,81,2/15/2018
6ACFBF,executive-appointment,100,54,2/15/2018
6CC55E,earnings,100,50,2/15/2018
6F0096,conference-call,100,50,2/15/2018
6F39FC,board-meeting,100,51,2/15/2018
7032D0,dividend,100,50,2/15/2018
709AED,dividend,100,50,2/15/2018
709AED,buybacks,100,74,2/15/2018
709AED,revenue-up,100,69,2/15/2018
709AED,revenue-up,100,69,2/15/2018
709AED,revenue-up,100,69,2/15/2018
709AED,revenue-up,100,69,2/15/2018
709AED,revenue-up,100,69,2/15/2018
717DB4,earnings,100,50,2/15/2018
73A71F,executive-appointment,100,54,2/15/2018
73BCBA,product-release,100,64,2/15/2018
73F70F,dividend,100,50,2/15/2018
762A3E,earnings,100,50,2/15/2018
76B926,dividend,100,50,2/15/2018
7AB859,private-placement,100,56,2/15/2018
7AB859,acquisition-completed-acquirer,100,49,2/15/2018
7ACD98,product-release,100,64,2/15/2018
7B8CB5,dividend,100,50,2/15/2018
80C400,conference-call,100,50,2/15/2018
845533,earnings,100,50,2/15/2018
855DF7,conference-call,100,50,2/15/2018
86AA9C,earnings,100,50,2/15/2018
896771,earnings,100,50,2/15/2018
8AB37F,conference-participant,100,50,2/15/2018
8AC740,board-meeting,100,51,2/15/2018
8C6C1B,facility-open,100,65,2/15/2018
8DBBE6,earnings,100,50,2/15/2018
8DBE73,revenues,100,50,2/15/2018
8DE74B,earnings,100,50,2/15/2018
8E4250,earnings,100,50,2/15/2018
8E9CD8,earnings-up,100,68,2/15/2018
8E9CD8,earnings,100,50,2/15/2018
8E9CD8,earnings,100,50,2/15/2018
8E9CD8,earnings,100,50,2/15/2018
8E9CD8,earnings,100,50,2/15/2018
93AD2E,earnings,100,50,2/15/2018
93AD2E,facility-close,100,47,2/15/2018
954A47,earnings-positive,100,69,2/15/2018
95C392,earnings,100,50,2/15/2018
95C392,executive-appointment,100,54,2/15/2018
95C392,partnership,100,61,2/15/2018
95C392,partnership,100,61,2/15/2018
9.65E+07,conference-call,100,50,2/15/2018
968103,earnings,100,50,2/15/2018
971F7B,earnings,100,50,2/15/2018
97AAF6,earnings,100,50,2/15/2018
97AAF6,earnings,100,50,2/15/2018
97AAF6,earnings,100,50,2/15/2018
97AAF6,earnings,100,50,2/15/2018
97AAF6,earnings,100,50,2/15/2018
990AD0,conference-organizer,100,57,2/15/2018
9.97E+09,dividend-up,100,54,2/15/2018
9D65C1,earnings,100,50,2/15/2018
9E91C6,legal-issues-defendant,100,22,2/15/2018
9F5997,executive-appointment,100,54,2/15/2018
A072C4,executive-appointment,100,54,2/15/2018
A1EAC8,earnings,100,50,2/15/2018
A21649,earnings,100,50,2/15/2018
A350C1,conference-participant,100,50,2/15/2018
A52B6B,conference-participant,100,50,2/15/2018
A5A4F5,acquisition-acquirer,100,49,2/15/2018
A631A3,earnings,100,50,2/15/2018
A9ED24,dividend,100,50,2/15/2018
AB7F05,earnings-up,100,68,2/15/2018
ABBAD1,acquisition-completed-acquirer,100,49,2/15/2018
AD375D,earnings,100,50,2/15/2018
ADFB3A,conference-participant,100,50,2/15/2018
AEFC90,orphan-drug-designation,100,76,2/15/2018
B01111,dividend-up,100,74,2/15/2018
B076A1,earnings,100,50,2/15/2018
B0998E,earnings,100,50,2/15/2018
B09B1F,conference-call,100,50,2/15/2018
B2DAF6,conference-participant,100,50,2/15/2018
B381D8,earnings,100,50,2/15/2018
B7EB38,conference-participant,100,50,2/15/2018
B98EFA,partnership,100,61,2/15/2018
BB0787,dividend,100,50,2/15/2018
BBBB41,conference-participant,100,50,2/15/2018
BCC55F,executive-appointment,100,54,2/15/2018
BDE867,dividend,100,50,2/15/2018
BDEC1E,conference-participant,100,50,2/15/2018
BE5935,earnings,100,50,2/15/2018
BF79F5,earnings,100,50,2/15/2018
C03C8B,earnings,100,50,2/15/2018
C1114B,dividend,100,50,2/15/2018
C3BCD5,conference-participant,100,50,2/15/2018
C8257F,earnings,100,50,2/15/2018
C8257F,dividend,100,50,2/15/2018
C8A248,partnership,100,61,2/15/2018
C8A248,dividend,100,50,2/15/2018
C8A248,dividend,100,50,2/15/2018
C98CDB,earnings,100,50,2/15/2018
CA14CC,dividend,100,50,2/15/2018
CBB77B,public-offering,100,43,2/15/2018
CC0C78,earnings,100,50,2/15/2018
CC3EC4,conference-call,100,50,2/15/2018
CDAF5B,earnings,100,50,2/15/2018
CE5664,dividend,100,50,2/15/2018
CF6A5A,earnings,100,50,2/15/2018
CFD4B6,conference-call,100,50,2/15/2018
D296C6,dividend,100,50,2/15/2018
D2E553,partnership,100,61,2/15/2018
D4070C,dividend,100,50,2/15/2018
D45285,conference-call,100,50,2/15/2018
D518D8,buybacks,100,74,2/15/2018
D518D8,earnings,100,50,2/15/2018
D64C6D,dividend,100,50,2/15/2018
D6EAA3,acquisition-completed-acquirer,100,49,2/15/2018
D77F7E,partnership,100,61,2/15/2018
D854DD,dividend,100,50,2/15/2018
D8DA3D,product-price-raise,100,57,2/15/2018
D9164D,dividend,100,50,2/15/2018
D9164D,earnings,100,50,2/15/2018
DA48E4,acquisition-acquirer,100,49,2/15/2018
DA9443,public-offering,100,43,2/15/2018
DB9829,earnings,100,50,2/15/2018
DC0D18,earnings,100,50,2/15/2018
DDCB34,dividend,100,50,2/15/2018
DDCB34,earnings,100,50,2/15/2018
DDEA6A,regulatory-product-approval-granted,100,81,2/15/2018
E0207A,earnings,100,50,2/15/2018
E0207A,earnings,100,50,2/15/2018
E0207A,dividend,100,50,2/15/2018
E05DC8,earnings,100,50,2/15/2018
E0647D,earnings,100,50,2/15/2018
E0647D,earnings,100,50,2/15/2018
E124EB,award,100,58,2/15/2018
E12A6E,earnings,100,50,2/15/2018
E13782,conference-participant,100,50,2/15/2018
E1E36F,conference-participant,100,50,2/15/2018
E28D9C,conference-call,100,50,2/15/2018
E38906,patient-enrollment-complete,100,64,2/15/2018
E3E68E,market-entry,100,57,2/15/2018
E49AA3,dividend,100,50,2/15/2018
E592F0,buybacks,100,74,2/15/2018
E5D914,conference-call,100,50,2/15/2018
E67C2C,earnings,100,50,2/15/2018
E94704,dividend,100,50,2/15/2018
E9C7C0,acquisition-acquirer,100,49,2/15/2018
EAEBF3,earnings,100,50,2/15/2018
EBC84C,conference-participant,100,50,2/15/2018
ED2A5E,conference-participant,100,50,2/15/2018
ED9C04,earnings,100,50,2/15/2018
ED9C04,earnings,100,50,2/15/2018
ED9C04,earnings,100,50,2/15/2018
ED9C04,earnings,100,50,2/15/2018
ED9C04,earnings,100,50,2/15/2018
EE04F0,conference-call,100,50,2/15/2018
EE967B,earnings,100,50,2/15/2018
EEA6B3,dividend-up,100,81,2/15/2018
EEEA9F,earnings,100,50,2/15/2018
EEEA9F,earnings,100,50,2/15/2018
EEEA9F,earnings,100,50,2/15/2018
EEEA9F,earnings,100,50,2/15/2018
EF5BED,executive-appointment,100,54,2/15/2018
F02D0A,earnings-per-share-positive,100,69,2/15/2018
F02D0A,earnings-positive,100,69,2/15/2018
F1529C,dividend,100,50,2/15/2018
F1CD47,conference-participant,100,50,2/15/2018
F209B4,legal-issues-defendant,100,22,2/15/2018
F209B4,legal-issues-defendant,100,22,2/15/2018
F4F46F,acquisition-acquiree,100,76,2/15/2018
F702CA,earnings,100,50,2/15/2018
F73DD1,earnings,100,50,2/15/2018
F93C8A,dividend,100,50,2/15/2018
FACCF6,earnings,100,50,2/15/2018
FD9526,earnings,100,50,2/15/2018
FDF28E,earnings,100,50,2/15/2018
FEE4B0,conference-participant,100,50,2/15/2018
FF4BA4,conference-participant,100,50,2/15/2018
0624BE,earnings,100,50,2/16/2018
0BD4E8,earnings,100,50,2/16/2018
0C2A0D,dividend-up,100,84,2/16/2018
0E499E,conference-participant,100,50,2/16/2018
1348C9,asset-sale,100,62,2/16/2018
15B10D,business-contract,100,69,2/16/2018
16C544,earnings,100,50,2/16/2018
17EDA5,executive-resignation,100,44,2/16/2018
188394,dividend,100,50,2/16/2018
196D18,public-offering,100,43,2/16/2018
196D18,public-offering,100,43,2/16/2018
1CD708,executive-appointment,100,54,2/16/2018
225CA2,award,100,58,2/16/2018
2AA6A8,executive-appointment,100,54,2/16/2018
2CB4C9,dividend,100,50,2/16/2018
2CB4C9,dividend,100,50,2/16/2018
2DB344,dividend,100,50,2/16/2018
2F98A5,earnings,100,50,2/16/2018
339F20,earnings,100,50,2/16/2018
37B120,conference-participant,100,50,2/16/2018
3BA1BF,executive-appointment,100,54,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
431B74,earnings-negative,100,33,2/16/2018
46017C,conference-participant,100,50,2/16/2018
49CC59,board-meeting,100,51,2/16/2018
49F4D0,dividend,100,50,2/16/2018
4A6F00,investment-investor,100,55,2/16/2018
4B5054,earnings,100,50,2/16/2018
4D8313,dividend,100,50,2/16/2018
4DAF5F,buybacks,100,74,2/16/2018
4DAF5F,buybacks,100,74,2/16/2018
504FE2,dividend,100,50,2/16/2018
520632,dividend,100,50,2/16/2018
53A226,dividend,100,50,2/16/2018
57B174,earnings,100,50,2/16/2018
57B174,earnings,100,50,2/16/2018
57B174,earnings,100,50,2/16/2018
57B174,earnings,100,50,2/16/2018
57B174,earnings,100,50,2/16/2018
586BD7,conference-call,100,50,2/16/2018
594402,settlement,100,56,2/16/2018
5D41E4,conference-call,100,50,2/16/2018
5D41E4,conference-call,100,50,2/16/2018
6284B5,earnings,100,50,2/16/2018
6844D2,dividend,100,50,2/16/2018
69345C,legal-issues-defendant,100,22,2/16/2018
6BD606,earnings,100,50,2/16/2018
6BDA0C,conference-call,100,50,2/16/2018
6E7060,conference-call,100,50,2/16/2018
726EEA,earnings,100,50,2/16/2018
726EEA,dividend-up,100,81,2/16/2018
7410C3,earnings,100,50,2/16/2018
767F86,executive-resignation,100,44,2/16/2018
789A7D,earnings,100,50,2/16/2018
789A7D,earnings,100,50,2/16/2018
789A7D,earnings,100,50,2/16/2018
789A7D,earnings,100,50,2/16/2018
7AC86E,earnings,100,50,2/16/2018
7AC86E,earnings,100,50,2/16/2018
7AC86E,earnings,100,50,2/16/2018
7F3A5F,executive-appointment,100,54,2/16/2018
8.10E+32,dividend,100,50,2/16/2018
8.10E+32,legal-issues-defendant,100,22,2/16/2018
81EAD4,conference-call,100,50,2/16/2018
8.73E+09,facility-close,100,47,2/16/2018
88923D,earnings,100,50,2/16/2018
88923D,earnings,100,50,2/16/2018
88923D,earnings,100,50,2/16/2018
89E771,earnings,100,50,2/16/2018
8C6C1B,facility-open,100,65,2/16/2018
8FF57A,business-contract,100,69,2/16/2018
9196A2,conference-organizer,100,57,2/16/2018
9AF3DC,dividend,100,50,2/16/2018
9D30A8,business-contract,100,69,2/16/2018
9F5997,partnership,100,61,2/16/2018
A1EAC8,business-contract,100,69,2/16/2018
A23747,revenue-up,100,77,2/16/2018
A23747,revenue-up,100,77,2/16/2018
A23747,revenue-up,100,77,2/16/2018
A398B9,conference-participant,100,50,2/16/2018
A4B899,dividend,100,50,2/16/2018
A5A4F5,acquisition-acquirer,100,49,2/16/2018
A60354,unit-acquisition-acquirer,100,49,2/16/2018
A790A5,investment-investor,100,55,2/16/2018
AA98ED,partnership,100,61,2/16/2018
AA98ED,partnership,100,61,2/16/2018
AAC8B6,conference-call,100,50,2/16/2018
AC1952,ipo-considered,100,60,2/16/2018
ACF77B,executive-appointment,100,54,2/16/2018
AD9F1D,earnings,100,50,2/16/2018
AF210D,earnings,100,50,2/16/2018
B3CB74,conference-organizer,100,57,2/16/2018
B642E8,earnings,100,50,2/16/2018
BC3AD2,executive-appointment,100,54,2/16/2018
C356AC,dividend,100,50,2/16/2018
C356AC,earnings,100,50,2/16/2018
C3BCD5,earnings,100,50,2/16/2018
C8257F,executive-appointment,100,54,2/16/2018
C9A96E,dividend,100,50,2/16/2018
CA99D7,dividend,100,50,2/16/2018
CE5C6E,executive-appointment,100,54,2/16/2018
CE69E9,legal-issues-defendant,100,22,2/16/2018
D25249,dividend,100,50,2/16/2018
D57D99,dividend,100,50,2/16/2018
D63B0F,earnings,100,50,2/16/2018
D63B0F,earnings,100,50,2/16/2018
D63B0F,earnings,100,50,2/16/2018
D63B0F,dividend-up,100,81,2/16/2018
DA0A9E,earnings,100,50,2/16/2018
DB23C8,earnings,100,50,2/16/2018
DCD97F,market-entry,100,57,2/16/2018
E38906,conference-participant,100,50,2/16/2018
E41190,conference-call,100,50,2/16/2018
E8846E,dividend,100,50,2/16/2018
EBC84C,dividend,100,50,2/16/2018
ECD263,partnership,100,61,2/16/2018
ECF709,earnings,100,50,2/16/2018
F209B4,legal-issues-defendant,100,22,2/16/2018
F4D241,public-offering,100,43,2/16/2018
F4F46F,conference-participant,100,50,2/16/2018
F6E1B5,executive-resignation,100,44,2/16/2018
F7935D,conference-participant,100,50,2/16/2018
FC80E6,dividend,100,50,2/16/2018
96F126,business-contract,100,69,2/17/2018
F4E882,award,100,58,2/17/2018
F4E882,partnership,100,61,2/17/2018
040DBB,acquisition-acquirer,100,49,2/19/2018
054B55,executive-appointment,100,54,2/19/2018
07EC43,conference-participant,100,50,2/19/2018
17EDA5,legal-issues-defendant,100,22,2/19/2018
196D18,conference-participant,100,50,2/19/2018
196D18,conference-participant,100,50,2/19/2018
21245F,legal-issues-defendant,100,22,2/19/2018
301493,legal-issues-defendant,100,22,2/19/2018
301493,legal-issues-defendant,100,22,2/19/2018
315416,acquisition-completed-acquirer,100,49,2/19/2018
370C50,executive-appointment,100,54,2/19/2018
39FB23,executive-appointment,100,54,2/19/2018
44209A,legal-issues-defendant,100,22,2/19/2018
4C5CC9,dividend,100,50,2/19/2018
4DAF5F,buybacks,100,74,2/19/2018
4DAF5F,buybacks,100,74,2/19/2018
55ACCB,legal-issues-defendant,100,22,2/19/2018
616E3B,dividend,100,50,2/19/2018
6DD6BA,earnings,100,50,2/19/2018
6DD6BA,earnings,100,50,2/19/2018
6DD6BA,earnings,100,50,2/19/2018
6F6559,award,100,58,2/19/2018
73529F,conference-call,100,50,2/19/2018
73F7F9,conference-call,100,50,2/19/2018
767F86,executive-appointment,100,54,2/19/2018
767F86,conference-participant,100,50,2/19/2018
810FAD,product-release,100,64,2/19/2018
817ED9,earnings,100,50,2/19/2018
8C6C1B,facility-open,100,65,2/19/2018
905356,earnings-per-share-positive,100,69,2/19/2018
905356,earnings,100,50,2/19/2018
905356,earnings,100,50,2/19/2018
9196A2,conference-organizer,100,57,2/19/2018
9C5BA5,earnings,100,50,2/19/2018
9D2790,unit-acquisition-acquirer,100,49,2/19/2018
A52533,facility-open,100,65,2/19/2018
A5A4F5,acquisition-acquirer,100,49,2/19/2018
A63387,dividend,100,50,2/19/2018
BBC05B,operating-earnings,100,50,2/19/2018
BD44C9,conference-organizer,100,57,2/19/2018
C66B44,partnership,100,61,2/19/2018
DBFB51,product-release,100,64,2/19/2018
F39E1E,legal-issues-defendant,100,22,2/19/2018
018C11,conference-participant,100,50,2/20/2018
03B8CF,settlement,100,56,2/20/2018
0560D8,earnings,100,50,2/20/2018
68396,earnings,100,50,2/20/2018
84625,earnings,100,50,2/20/2018
099A92,earnings,100,50,2/20/2018
0A9D0A,executive-appointment,100,54,2/20/2018
0C136E,earnings,100,50,2/20/2018
0C2A0D,executive-appointment,100,54,2/20/2018
0CC01F,dividend-up,100,91,2/20/2018
0F0440,donation,100,54,2/20/2018
12731D,conference-call,100,50,2/20/2018
129DC8,earnings,100,50,2/20/2018
1348C9,earnings,100,50,2/20/2018
1348C9,earnings,100,50,2/20/2018
1348C9,earnings,100,50,2/20/2018
1348C9,earnings,100,50,2/20/2018
138DDE,earnings,100,50,2/20/2018
14BA06,earnings,100,50,2/20/2018
14BA06,earnings-guidance,100,50,2/20/2018
14BA06,earnings-guidance,100,50,2/20/2018
14BA06,earnings-guidance,100,50,2/20/2018
14BA06,earnings-guidance,100,50,2/20/2018
14BA06,earnings-guidance,100,50,2/20/2018
14BA06,earnings-guidance,100,50,2/20/2018
165B86,conference-call,100,50,2/20/2018
16F4D8,debt-extension-recipient,100,73,2/20/2018
197612,dividend,100,50,2/20/2018
1B637E,dividend,100,50,2/20/2018
1BC12C,legal-issues-defendant,100,22,2/20/2018
1BC12C,legal-issues-defendant,100,22,2/20/2018
1E7785,conference-participant,100,50,2/20/2018
1EA923,conference-participant,100,50,2/20/2018
1FAF22,dividend,100,50,2/20/2018
2082EA,executive-appointment,100,54,2/20/2018
20BEEA,dividend-up,100,81,2/20/2018
20D00A,executive-appointment,100,54,2/20/2018
221445,earnings,100,50,2/20/2018
24C48B,conference-participant,100,50,2/20/2018
24CB56,earnings,100,50,2/20/2018
26FA41,revenues,100,50,2/20/2018
275300,conference-participant,100,50,2/20/2018
27C10F,earnings,100,50,2/20/2018
28B730,earnings,100,50,2/20/2018
2A17B1,dividend-up,100,65,2/20/2018
2B9DBB,executive-resignation,100,44,2/20/2018
2E0496,earnings,100,50,2/20/2018
2E1322,conference-participant,100,50,2/20/2018
2E902B,conference-participant,100,50,2/20/2018
301493,legal-issues-defendant,100,22,2/20/2018
30A565,legal-issues-defendant,100,22,2/20/2018
31AA84,earnings,100,50,2/20/2018
31DB20,earnings,100,50,2/20/2018
31DB20,earnings,100,50,2/20/2018
31DB20,earnings,100,50,2/20/2018
31DB20,earnings,100,50,2/20/2018
3224CC,earnings,100,50,2/20/2018
34B97A,patent-awarded,100,72,2/20/2018
384CD3,acquisition-acquirer,100,49,2/20/2018
3B50FE,earnings,100,50,2/20/2018
3B50FE,earnings,100,50,2/20/2018
3B50FE,earnings,100,50,2/20/2018
3BB616,earnings,100,50,2/20/2018
3D7971,dividend,100,50,2/20/2018
3DB18B,earnings,100,50,2/20/2018
3DCECC,note-sale,100,52,2/20/2018
3F868D,earnings-guidance,100,50,2/20/2018
425BDC,earnings,100,50,2/20/2018
427F32,conference-call,100,50,2/20/2018
4290EF,earnings,100,50,2/20/2018
44A4FC,executive-appointment,100,54,2/20/2018
468DD4,earnings,100,50,2/20/2018
4.91E+58,asset-sale,100,62,2/20/2018
49CC59,conference-call,100,50,2/20/2018
4A2457,government-contract,100,69,2/20/2018
4BDCA7,conference-call,100,50,2/20/2018
4DAF5F,buybacks,100,74,2/20/2018
4DAF5F,buybacks,100,74,2/20/2018
4DD09F,government-contract,100,69,2/20/2018
4FB770,earnings,100,50,2/20/2018
5088A5,earnings,100,50,2/20/2018
514067,conference-participant,100,50,2/20/2018
52FB2F,earnings,100,50,2/20/2018
53EF9E,earnings,100,50,2/20/2018
53EF9E,earnings,100,50,2/20/2018
55438C,partnership,100,61,2/20/2018
55438C,partnership,100,61,2/20/2018
57B174,note-sale,100,52,2/20/2018
583223,earnings,100,50,2/20/2018
58CA9A,conference-organizer,100,57,2/20/2018
58CA9A,conference-participant,100,50,2/20/2018
5968F9,earnings,100,50,2/20/2018
59A832,dividend,100,50,2/20/2018
59B229,acquisition-completed-acquirer,100,49,2/20/2018
59B229,acquisition-completed-acquirer,100,49,2/20/2018
5A423F,executive-appointment,100,54,2/20/2018
5AF08A,earnings,100,50,2/20/2018
5D16CF,acquisition-completed-acquirer,100,49,2/20/2018
5D63F1,earnings,100,50,2/20/2018
5D63F1,facility-open,100,65,2/20/2018
5E7E82,fundraising,100,64,2/20/2018
5F60CE,earnings,100,50,2/20/2018
6.18E+08,product-release,100,64,2/20/2018
619882,conference-organizer,100,57,2/20/2018
665D7D,partnership,100,61,2/20/2018
665D7D,partnership,100,61,2/20/2018
66A667,legal-issues-defendant,100,22,2/20/2018
69345C,conference-participant,100,50,2/20/2018
6B494E,unit-acquisition-acquiree,100,76,2/20/2018
6CC55E,conference-participant,100,50,2/20/2018
6E8349,earnings,100,50,2/20/2018
6ED519,earnings,100,50,2/20/2018
6ED519,earnings,100,50,2/20/2018
6F3936,executive-resignation,100,44,2/20/2018
70CA28,executive-appointment,100,54,2/20/2018
713810,revenue-volume-up,100,78,2/20/2018
713810,dividend-up,100,81,2/20/2018
72CB93,conference-participant,100,50,2/20/2018
72FCA3,executive-appointment,100,54,2/20/2018
752A70,earnings,100,50,2/20/2018
75F665,dividend,100,50,2/20/2018
75F982,executive-appointment,100,54,2/20/2018
767F86,conference-participant,100,50,2/20/2018
771985,business-contract,100,69,2/20/2018
773A17,partnership,100,61,2/20/2018
7823A3,conference-participant,100,50,2/20/2018
79340A,merger-completed,100,66,2/20/2018
7AB859,executive-appointment,100,54,2/20/2018
7ACD98,earnings-guidance,100,50,2/20/2018
7B0BA6,award,100,58,2/20/2018
7B1E50,executive-appointment,100,54,2/20/2018
7B1E50,executive-appointment,100,54,2/20/2018
7B1E50,executive-appointment,100,54,2/20/2018
7B1E50,earnings,100,50,2/20/2018
7B1E50,earnings,100,50,2/20/2018
7B1E50,earnings,100,50,2/20/2018
7C4168,conference-participant,100,50,2/20/2018
7F2922,conference-participant,100,50,2/20/2018
7F9984,executive-appointment,100,54,2/20/2018
80C400,earnings,100,50,2/20/2018
8.10E+32,legal-issues-defendant,100,22,2/20/2018
8.10E+32,legal-issues-defendant,100,22,2/20/2018
8.10E+32,executive-appointment,100,54,2/20/2018
817ED9,executive-resignation,100,44,2/20/2018
8377DB,conference-call,100,50,2/20/2018
8377DB,conference-participant,100,50,2/20/2018
83A065,earnings,100,50,2/20/2018
883D82,legal-issues-defendant,100,22,2/20/2018
883D82,legal-issues-defendant,100,22,2/20/2018
89E771,earnings,100,50,2/20/2018
8C6C1B,conference-call,100,50,2/20/2018
8C6C1B,facility-open,100,65,2/20/2018
8DCF18,earnings,100,50,2/20/2018
8E8E6E,earnings,100,50,2/20/2018
8E8E6E,partnership,100,61,2/20/2018
8FCA78,executive-appointment,100,54,2/20/2018
8FE7A5,executive-appointment,100,54,2/20/2018
9087B9,dividend,100,50,2/20/2018
911AB8,dividend-up,100,81,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
9196A2,conference-organizer,100,57,2/20/2018
945DE6,earnings,100,50,2/20/2018
945DE6,earnings,100,50,2/20/2018
945DE6,earnings,100,50,2/20/2018
94983E,dividend,100,50,2/20/2018
94C0B5,earnings,100,50,2/20/2018
958938,conference-call,100,50,2/20/2018
9592FB,conference-participant,100,50,2/20/2018
965360,conference-participant,100,50,2/20/2018
9.86E+03,earnings,100,50,2/20/2018
986AF6,dividend,100,50,2/20/2018
990AD0,executive-appointment,100,54,2/20/2018
9A602D,earnings-per-share-positive,100,69,2/20/2018
9A602D,earnings-per-share-positive,100,69,2/20/2018
9A602D,earnings-per-share-positive,100,69,2/20/2018
9A602D,earnings-per-share-positive,100,69,2/20/2018
9A602D,earnings-per-share-positive,100,69,2/20/2018
9A602D,earnings-per-share-positive,100,69,2/20/2018
9A602D,earnings-per-share-positive,100,69,2/20/2018
9D65C1,conference-participant,100,50,2/20/2018
9E91C6,award,100,58,2/20/2018
9EBAFA,earnings,100,50,2/20/2018
A15C71,earnings,100,50,2/20/2018
A21649,dividend,100,50,2/20/2018
A26C26,earnings,100,50,2/20/2018
A350C1,earnings,100,50,2/20/2018
A350C1,dividend,100,50,2/20/2018
A48593,conference-participant,100,50,2/20/2018
A48593,earnings,100,50,2/20/2018
A4B899,earnings-up,100,68,2/20/2018
A5195E,earnings,100,50,2/20/2018
A5A4F5,acquisition-acquirer,100,49,2/20/2018
A63387,executive-appointment,100,54,2/20/2018
A6828A,legal-issues-defendant,100,22,2/20/2018
A6828A,conference-participant,100,50,2/20/2018
A7102F,earnings,100,50,2/20/2018
A7102F,earnings,100,50,2/20/2018
A7102F,earnings,100,50,2/20/2018
A7102F,earnings,100,50,2/20/2018
A790A5,earnings,100,50,2/20/2018
A790A5,earnings,100,50,2/20/2018
A7CCF0,partnership,100,61,2/20/2018
A94637,conference-call,100,50,2/20/2018
A94718,legal-issues-defendant,100,22,2/20/2018
AA1EAA,earnings,100,50,2/20/2018
AC3584,earnings,100,50,2/20/2018
ACDF88,earnings,100,50,2/20/2018
ACDF88,earnings,100,50,2/20/2018
AD3008,earnings,100,50,2/20/2018
ADF1B0,earnings,100,50,2/20/2018
AEBB80,earnings,100,50,2/20/2018
AED61E,conference-participant,100,50,2/20/2018
AFDF2E,legal-issues-defendant,100,22,2/20/2018
AFDF2E,legal-issues-defendant,100,22,2/20/2018
AFEC35,earnings,100,50,2/20/2018
B05118,name-change,100,49,2/20/2018
B106FA,earnings,100,50,2/20/2018
B1A85D,earnings,100,50,2/20/2018
B1FC3B,business-contract,100,69,2/20/2018
B3A166,dividend,100,50,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B3CB74,conference-organizer,100,57,2/20/2018
B53C12,conference-call,100,50,2/20/2018
B5734D,executive-appointment,100,54,2/20/2018
B96637,operating-earnings,100,50,2/20/2018
B9764A,conference-participant,100,50,2/20/2018
BDD12C,dividend,100,50,2/20/2018
BDD12C,award,100,58,2/20/2018
C0F70B,conference-participant,100,50,2/20/2018
C15DB3,earnings,100,50,2/20/2018
C15DB3,revenues,100,50,2/20/2018
C2609A,product-release,100,64,2/20/2018
C45CE7,dividend,100,50,2/20/2018
C45CE7,earnings,100,50,2/20/2018
C4C77F,conference-call,100,50,2/20/2018
C4FBDC,earnings,100,50,2/20/2018
C564E4,earnings,100,50,2/20/2018
C72B8F,conference-participant,100,50,2/20/2018
C72B8F,conference-participant,100,50,2/20/2018
C83B88,conference-participant,100,50,2/20/2018
CAC8D0,merger,100,66,2/20/2018
CAC8D0,merger,100,66,2/20/2018
CAC8D0,merger,100,66,2/20/2018
CAC8D0,merger,100,66,2/20/2018
CBB77B,public-offering,100,43,2/20/2018
CD2A4D,conference-participant,100,50,2/20/2018
CDFCC9,conference-participant,100,50,2/20/2018
CF351E,earnings-guidance,100,50,2/20/2018
CFF15D,business-contract,100,69,2/20/2018
D11C1C,conference-call,100,50,2/20/2018
D17C1B,executive-appointment,100,54,2/20/2018
D3CEDF,earnings,100,50,2/20/2018
D3FD6D,conference-call,100,50,2/20/2018
D57D99,earnings,100,50,2/20/2018
D6853F,earnings,100,50,2/20/2018
D9E036,business-contract,100,69,2/20/2018
DA48E4,product-release,100,64,2/20/2018
DB5CA5,earnings,100,50,2/20/2018
DDB002,earnings,100,50,2/20/2018
DE20DF,dividend,100,50,2/20/2018
DF1F7A,earnings,100,50,2/20/2018
E0207A,executive-appointment,100,54,2/20/2018
E124EB,dividend,100,50,2/20/2018
E1E093,patent-awarded,100,72,2/20/2018
E3E68E,product-release,100,64,2/20/2018
E4158B,dividend,100,50,2/20/2018
E68733,earnings,100,50,2/20/2018
E69BA5,earnings,100,50,2/20/2018
E829E8,executive-appointment,100,54,2/20/2018
E866D2,partnership,100,61,2/20/2018
EAA0A7,earnings,100,50,2/20/2018
EC1AF3,earnings,100,50,2/20/2018
ED2A5E,earnings,100,50,2/20/2018
EEA734,partnership,100,61,2/20/2018
EEA734,partnership,100,61,2/20/2018
EEBCEF,board-meeting,100,51,2/20/2018
EF1AD9,conference-participant,100,50,2/20/2018
F0B877,earnings,100,50,2/20/2018
F1EB39,earnings-guidance,100,50,2/20/2018
F3D2EB,dividend,100,50,2/20/2018
F5C8AB,earnings-per-share-positive,100,69,2/20/2018
F5C8AB,earnings-per-share,100,50,2/20/2018
F5C8AB,earnings-per-share,100,50,2/20/2018
F6DE54,dividend,100,50,2/20/2018
F73DD1,dividend,100,50,2/20/2018
F7935D,clinical-trials,100,56,2/20/2018
FA40E2,business-contract,100,69,2/20/2018
FA40E2,business-contract,100,69,2/20/2018
FD2565,fundraising,100,64,2/20/2018
FD6926,conference-participant,100,50,2/20/2018
FDE409,earnings,100,50,2/20/2018
FEE4B0,product-release,100,64,2/20/2018
FF6644,executive-appointment,100,54,2/20/2018
002A99,earnings,100,50,2/21/2018
00698D,earnings,100,50,2/21/2018
0157B1,partnership,100,61,2/21/2018
018C11,earnings,100,50,2/21/2018
034B61,name-change,100,49,2/21/2018
034B61,name-change,100,49,2/21/2018
03FAA6,conference-participant,100,50,2/21/2018
09DE1F,acquisition-interest-acquirer,100,46,2/21/2018
09DE1F,acquisition-interest-acquirer,100,46,2/21/2018
09F623,investment-investor,100,55,2/21/2018
09F623,investment-investor,100,55,2/21/2018
0BF528,note-sale,100,52,2/21/2018
0DC050,executive-appointment,100,54,2/21/2018
10673F,dividend-up,100,81,2/21/2018
1151F4,dividend-up,100,56,2/21/2018
1151F4,executive-appointment,100,54,2/21/2018
12731D,earnings,100,50,2/21/2018
138DDE,board-meeting,100,51,2/21/2018
139303,conference-organizer,100,57,2/21/2018
13D576,earnings,100,50,2/21/2018
143C52,conference-call,100,50,2/21/2018
147C38,earnings,100,50,2/21/2018
152B9E,earnings,100,50,2/21/2018
159739,earnings,100,50,2/21/2018
16FC89,earnings,100,50,2/21/2018
182B8C,unit-acquisition-acquirer,100,49,2/21/2018
197019,earnings,100,50,2/21/2018
1A5957,earnings,100,50,2/21/2018
1A5D5D,earnings,100,50,2/21/2018
1C599A,earnings,100,50,2/21/2018
1CD708,earnings,100,50,2/21/2018
1D3A00,dividend,100,50,2/21/2018
1D5C51,earnings,100,50,2/21/2018
1E7785,earnings,100,50,2/21/2018
1E7785,earnings,100,50,2/21/2018
1E7785,earnings,100,50,2/21/2018
1E7785,earnings,100,50,2/21/2018
1E7785,earnings,100,50,2/21/2018
1E7785,earnings,100,50,2/21/2018
1E83DE,earnings,100,50,2/21/2018
1EBF8D,business-contract,100,69,2/21/2018
2031CE,dividend-up,100,60,2/21/2018
2082EA,earnings,100,50,2/21/2018
2096DE,earnings,100,50,2/21/2018
21245F,legal-issues-defendant,100,22,2/21/2018
2158DF,buybacks,100,74,2/21/2018
2158DF,earnings,100,50,2/21/2018
2158DF,earnings,100,50,2/21/2018
2158DF,earnings,100,50,2/21/2018
2158DF,earnings,100,50,2/21/2018
2158DF,earnings,100,50,2/21/2018
228D42,partnership,100,61,2/21/2018
228D42,partnership,100,61,2/21/2018
232053,earnings,100,50,2/21/2018
24CB56,conference-organizer,100,57,2/21/2018
25102A,trading-delisting,100,36,2/21/2018
25AB8E,business-contract,100,69,2/21/2018
25DD05,board-meeting,100,51,2/21/2018
270B78,earnings,100,50,2/21/2018
275300,dividend,100,50,2/21/2018
279916,earnings,100,50,2/21/2018
2A17B1,executive-appointment,100,54,2/21/2018
2B0AF4,executive-appointment,100,54,2/21/2018
2EC172,conference-participant,100,50,2/21/2018
2FDEE3,earnings,100,50,2/21/2018
30A565,legal-issues-defendant,100,22,2/21/2018
30DFD3,conference-participant,100,50,2/21/2018
31AA84,partnership,100,61,2/21/2018
3798B9,earnings,100,50,2/21/2018
384CD3,earnings,100,50,2/21/2018
387541,earnings,100,50,2/21/2018
3A113F,conference-participant,100,50,2/21/2018
3B8484,earnings,100,50,2/21/2018
3DD5E2,earnings,100,50,2/21/2018
401072,earnings,100,50,2/21/2018
422CE3,dividend,100,50,2/21/2018
425BDC,legal-issues-defendant,100,22,2/21/2018
429BFB,conference-participant,100,50,2/21/2018
442769,earnings,100,50,2/21/2018
442769,earnings,100,50,2/21/2018
442769,earnings,100,50,2/21/2018
442769,earnings,100,50,2/21/2018
4455C4,public-offering,100,43,2/21/2018
45444E,conference-call,100,50,2/21/2018
47752F,earnings,100,50,2/21/2018
479930,conference-participant,100,50,2/21/2018
48F795,earnings,100,50,2/21/2018
49A344,earnings,100,50,2/21/2018
49A344,earnings,100,50,2/21/2018
49A344,earnings,100,50,2/21/2018
4A6F00,partnership,100,61,2/21/2018
4D203E,dividend,100,50,2/21/2018
4D8124,dividend-up,100,61,2/21/2018
4DAF5F,buybacks,100,74,2/21/2018
4DAF5F,buybacks,100,74,2/21/2018
50D1EC,earnings,100,50,2/21/2018
5487B1,earnings,100,50,2/21/2018
5487B1,earnings,100,50,2/21/2018
5487B1,earnings,100,50,2/21/2018
5487B1,earnings,100,50,2/21/2018
5487B1,earnings,100,50,2/21/2018
56B7C1,earnings,100,50,2/21/2018
57CAAB,clinical-trials-start,100,64,2/21/2018
594402,earnings,100,50,2/21/2018
59F0B0,earnings-up,100,68,2/21/2018
59F0B0,earnings,100,50,2/21/2018
59F0B0,earnings,100,50,2/21/2018
59F0B0,earnings,100,50,2/21/2018
5CCDAD,partnership,100,61,2/21/2018
5CEE02,earnings,100,50,2/21/2018
5CEE02,earnings,100,50,2/21/2018
5CEE02,earnings,100,50,2/21/2018
5D63F1,facility-open,100,65,2/21/2018
5D87DF,dividend,100,50,2/21/2018
5F60CE,earnings-positive,100,69,2/21/2018
665D7D,clinical-trials-positive,100,87,2/21/2018
67303E,earnings,100,50,2/21/2018
676FFD,earnings,100,50,2/21/2018
68E6E9,earnings,100,50,2/21/2018
6A3C35,earnings,100,50,2/21/2018
6A3C35,earnings,100,50,2/21/2018
6A3C35,earnings,100,50,2/21/2018
6A3C35,earnings,100,50,2/21/2018
6A3C35,earnings,100,50,2/21/2018
6A3C35,earnings,100,50,2/21/2018
6B236C,earnings,100,50,2/21/2018
6BF593,earnings,100,50,2/21/2018
6BF593,earnings,100,50,2/21/2018
6D1ADF,earnings,100,50,2/21/2018
6F0096,earnings,100,50,2/21/2018
6F22E7,earnings,100,50,2/21/2018
704B78,earnings,100,50,2/21/2018
713810,partnership,100,61,2/21/2018
71E2EF,unit-acquisition-acquiree,100,76,2/21/2018
71E2EF,earnings,100,50,2/21/2018
7273FF,earnings,100,50,2/21/2018
729368,earnings,100,50,2/21/2018
76E80F,conference-call,100,50,2/21/2018
78A1BB,dividend,100,50,2/21/2018
7B6EB1,earnings,100,50,2/21/2018
7B9AFA,revenues,100,50,2/21/2018
7B9AFA,revenues,100,50,2/21/2018
7DA412,earnings,100,50,2/21/2018
7E1D5D,earnings,100,50,2/21/2018
7E1D5D,earnings,100,50,2/21/2018
7E1D5D,earnings,100,50,2/21/2018
7F2922,earnings,100,50,2/21/2018
7F3A5F,earnings,100,50,2/21/2018
7F9E16,conference-call,100,50,2/21/2018
7FDE1C,earnings,100,50,2/21/2018
805CD8,earnings,100,50,2/21/2018
80C400,product-release,100,64,2/21/2018
818A2F,dividend-up,100,81,2/21/2018
82C202,earnings,100,50,2/21/2018
859D62,earnings,100,50,2/21/2018
85AD00,dividend,100,50,2/21/2018
86A1B9,conference-participant,100,50,2/21/2018
8802B4,earnings,100,50,2/21/2018
883D82,legal-issues-defendant,100,22,2/21/2018
8BE916,dividend,100,50,2/21/2018
8C311A,unit-acquisition-acquiree,100,76,2/21/2018
8C311A,conference-participant,100,50,2/21/2018
8C6C1B,facility-open,100,65,2/21/2018
8DBE73,note-sale,100,52,2/21/2018
8EDACA,conference-call,100,50,2/21/2018
8FF2EF,conference-call,100,50,2/21/2018
9196A2,conference-organizer,100,57,2/21/2018
9196A2,conference-organizer,100,57,2/21/2018
9196A2,conference-organizer,100,57,2/21/2018
9196A2,conference-organizer,100,57,2/21/2018
9196A2,conference-organizer,100,57,2/21/2018
9196A2,conference-organizer,100,57,2/21/2018
94637C,legal-issues-defendant,100,22,2/21/2018
94983E,executive-resignation,100,44,2/21/2018
94C0B5,executive-appointment,100,54,2/21/2018
957A07,conference-participant,100,50,2/21/2018
9673BD,earnings,100,50,2/21/2018
968103,earnings,100,50,2/21/2018
990AD0,earnings,100,50,2/21/2018
990AD0,conference-organizer,100,57,2/21/2018
990AD0,conference-organizer,100,57,2/21/2018
9.92E+94,executive-appointment,100,54,2/21/2018
9C5174,revenue-up,100,72,2/21/2018
9C5174,revenues,100,50,2/21/2018
9D4EC7,dividend,100,50,2/21/2018
9E91C6,legal-issues-defendant,100,22,2/21/2018
9E91C6,legal-issues-defendant,100,22,2/21/2018
9E91C6,legal-issues-defendant,100,22,2/21/2018
A38F30,earnings,100,50,2/21/2018
A3AAA5,earnings,100,50,2/21/2018
A3F598,earnings,100,50,2/21/2018
A3F598,earnings,100,50,2/21/2018
A3F598,earnings,100,50,2/21/2018
A3F598,earnings,100,50,2/21/2018
A47A7D,earnings,100,50,2/21/2018
A48593,conference-participant,100,50,2/21/2018
A5A4F5,acquisition-acquirer,100,49,2/21/2018
A868C9,conference-participant,100,50,2/21/2018
AA09AD,executive-appointment,100,54,2/21/2018
AA09AD,executive-appointment,100,54,2/21/2018
AA09AD,executive-appointment,100,54,2/21/2018
AAEE21,public-offering,100,43,2/21/2018
AC775C,earnings,100,50,2/21/2018
ACDF88,conference-participant,100,50,2/21/2018
AFD7DD,earnings,100,50,2/21/2018
AFD7DD,earnings,100,50,2/21/2018
AFEC35,executive-appointment,100,54,2/21/2018
B3CB74,conference-organizer,100,57,2/21/2018
B3CB74,conference-organizer,100,57,2/21/2018
B3CB74,conference-organizer,100,57,2/21/2018
B3CB74,conference-organizer,100,57,2/21/2018
B446B8,earnings,100,50,2/21/2018
B446B8,earnings,100,50,2/21/2018
B446B8,earnings,100,50,2/21/2018
B614F8,product-release,100,64,2/21/2018
B7BDA3,earnings,100,50,2/21/2018
B9CD50,earnings,100,50,2/21/2018
BCC55F,earnings,100,50,2/21/2018
BCC55F,earnings,100,50,2/21/2018
BCC55F,earnings,100,50,2/21/2018
BCC55F,earnings,100,50,2/21/2018
BCC55F,earnings,100,50,2/21/2018
BDA775,dividend,100,50,2/21/2018
BE14CF,conference-participant,100,50,2/21/2018
C03C8B,conference-participant,100,50,2/21/2018
C05839,earnings,100,50,2/21/2018
C27E19,earnings,100,50,2/21/2018
C2E426,earnings,100,50,2/21/2018
C32A39,dividend,100,50,2/21/2018
C38440,earnings,100,50,2/21/2018
C3CF29,executive-appointment,100,54,2/21/2018
C3CF29,earnings,100,50,2/21/2018
C3CF29,earnings,100,50,2/21/2018
C3CF29,earnings,100,50,2/21/2018
C45C1F,earnings,100,50,2/21/2018
C7FC95,earnings,100,50,2/21/2018
C7FC95,earnings,100,50,2/21/2018
C7FC95,earnings,100,50,2/21/2018
C7FC95,earnings,100,50,2/21/2018
C7FC95,earnings,100,50,2/21/2018
C7FC95,earnings,100,50,2/21/2018
C8257F,executive-appointment,100,54,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C85A72,revenues,100,50,2/21/2018
C9881C,award,100,58,2/21/2018
C9A96E,earnings,100,50,2/21/2018
C9D866,earnings,100,50,2/21/2018
CAB222,conference-call,100,50,2/21/2018
CB22CD,dividend-up,100,70,2/21/2018
CB88B3,earnings,100,50,2/21/2018
CC35BE,earnings,100,50,2/21/2018
CCBBAD,dividend,100,50,2/21/2018
CE4E6D,conference-call,100,50,2/21/2018
CFF15D,product-release,100,64,2/21/2018
CFF15D,partnership,100,61,2/21/2018
CFF15D,acquisition-interest-acquiree,100,82,2/21/2018
CFF15D,acquisition-interest-acquiree,100,82,2/21/2018
D09938,earnings,100,50,2/21/2018
D1173F,executive-appointment,100,54,2/21/2018
D1AE3B,dividend,100,50,2/21/2018
D20C8F,earnings,100,50,2/21/2018
D29F43,earnings,100,50,2/21/2018
D42DBA,dividend,100,50,2/21/2018
D64C6D,executive-appointment,100,54,2/21/2018
D76AEF,earnings,100,50,2/21/2018
D8DBA3,dividend,100,50,2/21/2018
DB23C8,conference-participant,100,50,2/21/2018
DB396B,earnings,100,50,2/21/2018
DB396B,dividend,100,50,2/21/2018
DD7A96,earnings,100,50,2/21/2018
DF01B1,earnings,100,50,2/21/2018
E07573,earnings-guidance,100,50,2/21/2018
E21871,dividend,100,50,2/21/2018
E30B34,facility-open,100,65,2/21/2018
E38906,fast-track-designation,100,81,2/21/2018
E5D914,earnings,100,50,2/21/2018
E6C8DC,ipo-completed,100,76,2/21/2018
E829E8,unit-acquisition-acquirer,100,49,2/21/2018
E8846E,conference-participant,100,50,2/21/2018
E9C7C0,conference-participant,100,50,2/21/2018
EAEBF3,capex-up,100,65,2/21/2018
EB2F14,dividend,100,50,2/21/2018
EB61C4,dividend,100,50,2/21/2018
ECD263,executive-appointment,100,54,2/21/2018
ED0D7C,earnings,100,50,2/21/2018
ED0D7C,earnings,100,50,2/21/2018
ED0D7C,earnings,100,50,2/21/2018
EEBCEF,earnings,100,50,2/21/2018
EF45B6,dividend,100,50,2/21/2018
F0027C,earnings,100,50,2/21/2018
F0B2B5,executive-appointment,100,54,2/21/2018
F0B877,product-release,100,64,2/21/2018
F15E41,earnings,100,50,2/21/2018
F15E41,earnings,100,50,2/21/2018
F2E253,facility-open,100,65,2/21/2018
F2E253,conference-call,100,50,2/21/2018
F30508,conference-participant,100,50,2/21/2018
F39E1E,earnings,100,50,2/21/2018
F39E1E,legal-issues-defendant,100,22,2/21/2018
F4D241,earnings,100,50,2/21/2018
F4D241,public-offering,100,43,2/21/2018
F6DE54,earnings,100,50,2/21/2018
F73DD1,earnings,100,50,2/21/2018
F83279,dividend,100,50,2/21/2018
F8BA6C,executive-appointment,100,54,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F8C5D7,earnings,100,50,2/21/2018
F90EE5,dividend,100,50,2/21/2018
FA35C6,executive-appointment,100,54,2/21/2018
FC1A6E,revenues,100,50,2/21/2018
FC1A6E,revenues,100,50,2/21/2018
FC1A6E,revenues,100,50,2/21/2018
FC1A6E,revenues,100,50,2/21/2018
FEE4B0,conference-participant,100,50,2/21/2018
FF4BA4,conference-participant,100,50,2/21/2018
00FC70,earnings,100,50,2/22/2018
0157B1,market-share-loss,100,20,2/22/2018
02870F,dividend-up,100,74,2/22/2018
61366,earnings,100,50,2/22/2018
06A456,conference-call,100,50,2/22/2018
070B45,earnings,100,50,2/22/2018
09DE1F,acquisition-interest-acquirer,100,46,2/22/2018
0A0D9E,earnings,100,50,2/22/2018
0A0D9E,earnings,100,50,2/22/2018
0A0D9E,earnings,100,50,2/22/2018
0A0D9E,earnings,100,50,2/22/2018
0A7650,dividend-up,100,67,2/22/2018
0BA8CE,earnings,100,50,2/22/2018
0C466B,earnings-up,100,68,2/22/2018
0C466B,earnings,100,50,2/22/2018
0C8D82,earnings,100,50,2/22/2018
0E499E,earnings,100,50,2/22/2018
0F04E5,earnings,100,50,2/22/2018
0F04E5,earnings,100,50,2/22/2018
0F04E5,earnings,100,50,2/22/2018
0F04E5,earnings,100,50,2/22/2018
1096C6,earnings,100,50,2/22/2018
152AB9,conference-call,100,50,2/22/2018
15789A,revenue-volume-up,100,56,2/22/2018
16B183,earnings,100,50,2/22/2018
16F4D8,earnings,100,50,2/22/2018
182B8C,settlement,100,56,2/22/2018
182B8C,settlement,100,56,2/22/2018
1834C0,dividend,100,50,2/22/2018
1866B2,conference-call,100,50,2/22/2018
190B91,executive-appointment,100,54,2/22/2018
190B91,stock-splits,100,49,2/22/2018
19BF16,earnings-per-share-positive,100,69,2/22/2018
1B4F31,earnings-up,100,68,2/22/2018
1B4F31,earnings,100,50,2/22/2018
1B4F31,earnings,100,50,2/22/2018
1B4F31,earnings,100,50,2/22/2018
1B4F31,earnings,100,50,2/22/2018
1B9535,earnings,100,50,2/22/2018
1E5786,buybacks,100,74,2/22/2018
1EC3E8,executive-appointment,100,54,2/22/2018
1F3CFB,conference-participant,100,50,2/22/2018
1F464F,earnings,100,50,2/22/2018
1FC422,product-release,100,64,2/22/2018
2093B1,dividend-up,100,81,2/22/2018
21022F,earnings,100,50,2/22/2018
214051,executive-appointment,100,54,2/22/2018
225CA2,dividend,100,50,2/22/2018
228D42,partnership,100,61,2/22/2018
2.45E+15,dividend,100,50,2/22/2018
24CB56,conference-organizer,100,57,2/22/2018
24CB56,conference-organizer,100,57,2/22/2018
251988,product-release,100,64,2/22/2018
253B2F,earnings,100,50,2/22/2018
25AB8E,acquisition-acquiree,100,76,2/22/2018
29A4CC,dividend-up,100,81,2/22/2018
2A1009,earnings,100,50,2/22/2018
2BAE5F,earnings,100,50,2/22/2018
2BAE5F,earnings,100,50,2/22/2018
2BAE5F,earnings,100,50,2/22/2018
2DA92D,dividend,100,50,2/22/2018
2DDB22,earnings-guidance,100,50,2/22/2018
2E89AE,earnings,100,50,2/22/2018
2EC172,executive-appointment,100,54,2/22/2018
2F5256,dividend,100,50,2/22/2018
30AB63,conference-participant,100,50,2/22/2018
30DFD3,buybacks,100,74,2/22/2018
315EB0,conference-participant,100,50,2/22/2018
31803E,earnings,100,50,2/22/2018
319BE2,dividend,100,50,2/22/2018
319BE2,earnings,100,50,2/22/2018
33AD83,partnership,100,61,2/22/2018
34A959,revenues,100,50,2/22/2018
3.50E+27,dividend,100,50,2/22/2018
371C01,earnings,100,50,2/22/2018
371C01,earnings,100,50,2/22/2018
372037,dividend,100,50,2/22/2018
3798B9,conference-participant,100,50,2/22/2018
387375,earnings,100,50,2/22/2018
396D7C,earnings,100,50,2/22/2018
3A3948,earnings,100,50,2/22/2018
3A94DF,dividend-up,100,68,2/22/2018
3B2311,earnings,100,50,2/22/2018
3BE00F,dividend,100,50,2/22/2018
3CBA2A,conference-participant,100,50,2/22/2018
3DCECC,note-sale,100,52,2/22/2018
415188,dividend-up,100,81,2/22/2018
415188,earnings,100,50,2/22/2018
425BDC,legal-issues-defendant,100,22,2/22/2018
4290EF,dividend,100,50,2/22/2018
4455C4,public-offering,100,43,2/22/2018
44740A,conference-call,100,50,2/22/2018
45ABCC,revenue-up,100,78,2/22/2018
45ABCC,revenue-up,100,78,2/22/2018
45ABCC,revenue-up,100,78,2/22/2018
45ABCC,revenue-up,100,78,2/22/2018
46017C,earnings,100,50,2/22/2018
4649D5,earnings-guidance-up,100,83,2/22/2018
4A2457,conference-call,100,50,2/22/2018
4AC91D,earnings,100,50,2/22/2018
4AC91D,earnings,100,50,2/22/2018
4AC91D,earnings,100,50,2/22/2018
4AC91D,earnings,100,50,2/22/2018
4AC91D,earnings,100,50,2/22/2018
4AC91D,earnings,100,50,2/22/2018
4AC91D,earnings,100,50,2/22/2018
4BDCA7,clinical-trials-start,100,64,2/22/2018
4C1FA1,earnings,100,50,2/22/2018
4D8124,conference-call,100,50,2/22/2018
4DAF5F,buybacks,100,74,2/22/2018
4DAF5F,buybacks,100,74,2/22/2018
4E5784,earnings,100,50,2/22/2018
50070E,earnings,100,50,2/22/2018
504FE2,earnings,100,50,2/22/2018
5065B1,unit-acquisition-acquirer,100,49,2/22/2018
50D1EC,conference-participant,100,50,2/22/2018
510EA1,earnings,100,50,2/22/2018
52015A,earnings,100,50,2/22/2018
524CE4,earnings,100,50,2/22/2018
53F491,conference-participant,100,50,2/22/2018
54512F,earnings,100,50,2/22/2018
546A27,earnings,100,50,2/22/2018
54A713,dividend-up,100,55,2/22/2018
55CD6F,dividend,100,50,2/22/2018
56FB7C,earnings,100,50,2/22/2018
5704AC,earnings,100,50,2/22/2018
57DDB9,executive-appointment,100,54,2/22/2018
586BD7,earnings,100,50,2/22/2018
58B46F,earnings-per-share-positive,100,69,2/22/2018
58B46F,earnings,100,50,2/22/2018
58B46F,earnings,100,50,2/22/2018
58B46F,earnings,100,50,2/22/2018
58CA9A,conference-organizer,100,57,2/22/2018
5A423F,product-release,100,64,2/22/2018
5A9A82,earnings,100,50,2/22/2018
5A9A82,earnings,100,50,2/22/2018
5A9A82,earnings,100,50,2/22/2018
5A9A82,earnings,100,50,2/22/2018
5A9A82,earnings,100,50,2/22/2018
5B3FA2,earnings,100,50,2/22/2018
5C7601,dividend,100,50,2/22/2018
5F3E74,conference-participant,100,50,2/22/2018
6166D1,product-release,100,64,2/22/2018
619882,acquisition-acquirer,100,49,2/22/2018
61B81B,executive-appointment,100,54,2/22/2018
649CBD,earnings,100,50,2/22/2018
6634D9,earnings,100,50,2/22/2018
665D7D,conference-participant,100,50,2/22/2018
66CB62,earnings,100,50,2/22/2018
67A658,earnings,100,50,2/22/2018
6830FE,earnings,100,50,2/22/2018
68586A,conference-call,100,50,2/22/2018
694749,earnings,100,50,2/22/2018
6C987C,dividend,100,50,2/22/2018
6DC1D7,earnings,100,50,2/22/2018
6.00E+19,earnings,100,50,2/22/2018
6F0096,conference-call,100,50,2/22/2018
6F3FA8,dividend,100,50,2/22/2018
6F3FA8,executive-appointment,100,54,2/22/2018
70FCEF,earnings,100,50,2/22/2018
73BCBA,earnings,100,50,2/22/2018
73BCBA,earnings,100,50,2/22/2018
73BCBA,earnings,100,50,2/22/2018
73BCBA,earnings,100,50,2/22/2018
73F70F,earnings,100,50,2/22/2018
756045,dividend,100,50,2/22/2018
762A3E,conference-organizer,100,57,2/22/2018
763724,conference-call,100,50,2/22/2018
766047,dividend,100,50,2/22/2018
76959C,earnings,100,50,2/22/2018
76B926,earnings,100,50,2/22/2018
76D79A,earnings,100,50,2/22/2018
790C34,product-release,100,64,2/22/2018
7E0EB0,business-contract,100,69,2/22/2018
7F3669,conference-participant,100,50,2/22/2018
81A88D,earnings,100,50,2/22/2018
81A88D,dividend-up,100,81,2/22/2018
830BDB,earnings,100,50,2/22/2018
834152,clinical-trials-positive,100,87,2/22/2018
83E0AC,conference-call,100,50,2/22/2018
86F123,conference-call,100,50,2/22/2018
883D82,legal-issues-defendant,100,22,2/22/2018
883D82,legal-issues-defendant,100,22,2/22/2018
890FF4,conference-call,100,50,2/22/2018
8A0368,conference-call,100,50,2/22/2018
8B3B0E,earnings,100,50,2/22/2018
8BAA15,earnings,100,50,2/22/2018
8C6C1B,facility-open,100,65,2/22/2018
903AB4,earnings,100,50,2/22/2018
9087B9,acquisition-completed-acquirer,100,49,2/22/2018
911AB8,earnings,100,50,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
9196A2,conference-organizer,100,57,2/22/2018
93AD2E,executive-appointment,100,54,2/22/2018
94637C,legal-issues-defendant,100,22,2/22/2018
94756D,earnings,100,50,2/22/2018
954A47,dividend,100,50,2/22/2018
958938,partnership,100,61,2/22/2018
958938,earnings,100,50,2/22/2018
958938,partnership,100,61,2/22/2018
95DC1F,conference-call,100,50,2/22/2018
9.65E+07,earnings,100,50,2/22/2018
96A6CD,earnings,100,50,2/22/2018
98CAED,dividend,100,50,2/22/2018
990AD0,conference-organizer,100,57,2/22/2018
990AD0,executive-appointment,100,54,2/22/2018
9BF177,earnings,100,50,2/22/2018
9D3360,executive-appointment,100,54,2/22/2018
9DDE1B,earnings,100,50,2/22/2018
9DDE1B,earnings,100,50,2/22/2018
9DDE1B,dividend,100,50,2/22/2018
9E575E,earnings,100,50,2/22/2018
9E5C2C,earnings,100,50,2/22/2018
9E91C6,legal-issues-defendant,100,22,2/22/2018
9F048E,earnings,100,50,2/22/2018
9F5997,earnings,100,50,2/22/2018
9FB4B7,conference-call,100,50,2/22/2018
9FF5F1,conference-participant,100,50,2/22/2018
A1E3B3,conference-participant,100,50,2/22/2018
A247F5,conference-participant,100,50,2/22/2018
A38F30,earnings,100,50,2/22/2018
A398B9,earnings,100,50,2/22/2018
A4386C,conference-participant,100,50,2/22/2018
A5151E,earnings,100,50,2/22/2018
A52533,earnings,100,50,2/22/2018
A5A4F5,acquisition-acquirer,100,49,2/22/2018
A6213D,conference-call,100,50,2/22/2018
A6213D,executive-appointment,100,54,2/22/2018
A63387,acquisition-acquirer,100,49,2/22/2018
A666C8,award,100,58,2/22/2018
A7F0A5,earnings,100,50,2/22/2018
A80FE0,conference-participant,100,50,2/22/2018
A80FE0,conference-participant,100,50,2/22/2018
A80FE0,conference-participant,100,50,2/22/2018
AAC8B6,earnings,100,50,2/22/2018
AAEE21,public-offering,100,43,2/22/2018
AB4A7E,earnings,100,50,2/22/2018
AD3C93,legal-issues-defendant,100,22,2/22/2018
AEFC90,clinical-trials-start,100,64,2/22/2018
AFD1CA,earnings,100,50,2/22/2018
B1A85D,product-release,100,64,2/22/2018
B1DF3C,conference-participant,100,50,2/22/2018
B290A2,clinical-trials,100,56,2/22/2018
B381D8,earnings,100,50,2/22/2018
B3CB74,conference-organizer,100,57,2/22/2018
B3ED62,conference-call,100,50,2/22/2018
B7BDA3,earnings-up,100,68,2/22/2018
B934BF,dividend,100,50,2/22/2018
B9CD50,award,100,58,2/22/2018
BAAA60,dividend,100,50,2/22/2018
BB02FB,earnings-per-share-positive,100,69,2/22/2018
BB02FB,earnings-per-share,100,50,2/22/2018
BB02FB,earnings-per-share,100,50,2/22/2018
BB02FB,earnings-per-share,100,50,2/22/2018
BB02FB,earnings-per-share,100,50,2/22/2018
BCC13E,earnings,100,50,2/22/2018
BDEC1E,conference-call,100,50,2/22/2018
C0030A,earnings,100,50,2/22/2018
C07E05,earnings,100,50,2/22/2018
C41C25,merger-regulatory-approval,100,81,2/22/2018
C41C25,merger-regulatory-approval,100,81,2/22/2018
C4A432,earnings-up,100,68,2/22/2018
C5E100,conference-call,100,50,2/22/2018
C62AA4,dividend-up,100,81,2/22/2018
C6C702,earnings,100,50,2/22/2018
C8923A,earnings,100,50,2/22/2018
C951A2,business-contract,100,69,2/22/2018
C97B2D,note-sale,100,52,2/22/2018
CB22CD,revenue-up,100,69,2/22/2018
CB22CD,revenue-up,100,69,2/22/2018
CB22CD,revenue-up,100,69,2/22/2018
CB7AB2,earnings,100,50,2/22/2018
CBBFBF,executive-appointment,100,54,2/22/2018
CBBFBF,executive-appointment,100,54,2/22/2018
CBFFDD,business-contract,100,69,2/22/2018
CBFFDD,earnings,100,50,2/22/2018
CBFFDD,earnings,100,50,2/22/2018
CC176E,earnings,100,50,2/22/2018
CCB623,earnings,100,50,2/22/2018
CE4FD9,earnings,100,50,2/22/2018
CE4FD9,earnings,100,50,2/22/2018
CE4FD9,earnings,100,50,2/22/2018
CE4FD9,earnings,100,50,2/22/2018
CE4FD9,earnings,100,50,2/22/2018
CE4FD9,earnings,100,50,2/22/2018
CFF15D,partnership,100,61,2/22/2018
CFF15D,acquisition-interest-acquiree,100,82,2/22/2018
CFF57D,conference-call,100,50,2/22/2018
D13F1C,conference-call,100,50,2/22/2018
D27FAB,conference-call,100,50,2/22/2018
D29F43,dividend,100,50,2/22/2018
D56D6D,revenues,100,50,2/22/2018
D56D6D,earnings,100,50,2/22/2018
D56D6D,earnings,100,50,2/22/2018
D58A11,conference-participant,100,50,2/22/2018
D64C6D,conference-call,100,50,2/22/2018
D6534D,dividend,100,50,2/22/2018
D697DE,conference-participant,100,50,2/22/2018
D6EAA3,dividend,100,50,2/22/2018
D8442A,facility-open,100,65,2/22/2018
DA199F,earnings,100,50,2/22/2018
DB9829,earnings-up,100,68,2/22/2018
DB9829,earnings,100,50,2/22/2018
DB9829,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBB28E,earnings,100,50,2/22/2018
DBFB51,conference-call,100,50,2/22/2018
DD0F15,conference-call,100,50,2/22/2018
DF11D9,conference-participant,100,50,2/22/2018
E10D31,dividend,100,50,2/22/2018
E10D31,earnings,100,50,2/22/2018
E124EB,executive-appointment,100,54,2/22/2018
E13782,executive-appointment,100,54,2/22/2018
E2CFD2,earnings,100,50,2/22/2018
E30B34,conference-participant,100,50,2/22/2018
E35610,earnings,100,50,2/22/2018
E592F0,conference-participant,100,50,2/22/2018
E74FED,earnings,100,50,2/22/2018
E8A49A,executive-appointment,100,54,2/22/2018
E8A49A,partnership,100,61,2/22/2018
E8A49A,partnership,100,61,2/22/2018
EB36DE,executive-death,100,31,2/22/2018
EB61C4,executive-appointment,100,54,2/22/2018
ED3CA8,earnings,100,50,2/22/2018
ED9C04,settlement,100,56,2/22/2018
ED9C04,settlement,100,56,2/22/2018
EF25A5,earnings,100,50,2/22/2018
EF25A5,earnings,100,50,2/22/2018
EF25A5,earnings,100,50,2/22/2018
EF25A5,earnings,100,50,2/22/2018
F11638,revenue-up,100,65,2/22/2018
F11638,revenue-up,100,69,2/22/2018
F11638,revenue-up,100,69,2/22/2018
F11638,revenue-up,100,69,2/22/2018
F11638,revenue-up,100,69,2/22/2018
F66B58,conference-call,100,50,2/22/2018
F6E248,executive-appointment,100,54,2/22/2018
F7FCA4,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F80389,earnings,100,50,2/22/2018
F83279,earnings-guidance,100,50,2/22/2018
F83279,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F92DBC,earnings,100,50,2/22/2018
F93C8A,earnings,100,50,2/22/2018
F93C8A,earnings,100,50,2/22/2018
F93C8A,earnings,100,50,2/22/2018
F93C8A,earnings,100,50,2/22/2018
F93C8A,earnings,100,50,2/22/2018
FAE021,product-release,100,64,2/22/2018
FBD92D,earnings,100,50,2/22/2018
FC80E6,earnings,100,50,2/22/2018
FD6926,earnings,100,50,2/22/2018
FD6926,dividend,100,50,2/22/2018
FDF1C0,dividend,100,50,2/22/2018
FF6644,business-contract,100,69,2/22/2018
FF6644,business-contract,100,69,2/22/2018
0325B7,conference-call,100,50,2/23/2018
06C826,conference-call,100,50,2/23/2018
06C826,conference-call,100,50,2/23/2018
070B45,conference-participant,100,50,2/23/2018
0968A5,conference-call,100,50,2/23/2018
099C88,earnings,100,50,2/23/2018
099C88,earnings,100,50,2/23/2018
099C88,earnings,100,50,2/23/2018
099C88,earnings,100,50,2/23/2018
099C88,earnings,100,50,2/23/2018
099C88,earnings,100,50,2/23/2018
09DE1F,earnings,100,50,2/23/2018
0BF198,earnings,100,50,2/23/2018
0BF528,note-sale,100,52,2/23/2018
0BF528,conference-participant,100,50,2/23/2018
0D03C8,conference-participant,100,50,2/23/2018
0E2992,dividend,100,50,2/23/2018
0EF1AF,earnings,100,50,2/23/2018
10C19B,conference-participant,100,50,2/23/2018
1272B3,executive-appointment,100,54,2/23/2018
12DE76,partnership,100,61,2/23/2018
16B882,earnings,100,50,2/23/2018
1921DD,government-contract,100,69,2/23/2018
1B637E,earnings,100,50,2/23/2018
1CB9D3,conference-call,100,50,2/23/2018
1F43A1,earnings,100,50,2/23/2018
1FE7F0,earnings,100,50,2/23/2018
223216,revenue-up,100,79,2/23/2018
225CA2,executive-appointment,100,54,2/23/2018
24CB56,conference-organizer,100,57,2/23/2018
267718,executive-appointment,100,54,2/23/2018
2920D5,conference-participant,100,50,2/23/2018
2A4131,earnings-positive,100,69,2/23/2018
2AE625,earnings,100,50,2/23/2018
30A565,legal-issues-defendant,100,22,2/23/2018
31AA84,conference-participant,100,50,2/23/2018
31DB20,dividend,100,50,2/23/2018
33AD83,conference-call,100,50,2/23/2018
342218,earnings,100,50,2/23/2018
355B19,earnings,100,50,2/23/2018
3.88E+02,earnings,100,50,2/23/2018
3B50FE,dividend,100,50,2/23/2018
3C3B6B,conference-participant,100,50,2/23/2018
3E39A5,earnings-guidance,100,50,2/23/2018
4DAF5F,buybacks,100,74,2/23/2018
4DAF5F,buybacks,100,74,2/23/2018
51888A,unit-acquisition-acquirer,100,49,2/23/2018
525A1C,conference-participant,100,50,2/23/2018
57DDB9,conference-participant,100,50,2/23/2018
57DDB9,executive-appointment,100,54,2/23/2018
596116,earnings,100,50,2/23/2018
5A9A82,capex-up,100,65,2/23/2018
5C2A47,partnership,100,61,2/23/2018
5C8D61,conference-participant,100,50,2/23/2018
5D02B7,dividend,100,50,2/23/2018
619882,conference-organizer,100,57,2/23/2018
62B1C6,earnings,100,50,2/23/2018
641F17,unit-acquisition-acquirer,100,49,2/23/2018
641F17,unit-acquisition-acquirer,100,49,2/23/2018
6830FE,product-release,100,64,2/23/2018
6E7060,earnings,100,50,2/23/2018
73BCBA,earnings,100,50,2/23/2018
76959C,executive-appointment,100,54,2/23/2018
76BD96,earnings,100,50,2/23/2018
771985,conference-participant,100,50,2/23/2018
78F9ED,dividend,100,50,2/23/2018
790D0D,dividend,100,50,2/23/2018
8.10E+32,legal-issues-defendant,100,22,2/23/2018
81EAD4,earnings,100,50,2/23/2018
87B81A,conference-participant,100,50,2/23/2018
883D82,legal-issues-defendant,100,22,2/23/2018
88611B,dividend,100,50,2/23/2018
8C6C1B,facility-open,100,65,2/23/2018
8E3F58,conference-participant,100,50,2/23/2018
8E82A6,dividend-up,100,81,2/23/2018
8F8F2F,dividend,100,50,2/23/2018
8FCA78,dividend-up,100,73,2/23/2018
8FCA78,earnings-up,100,68,2/23/2018
90D6A5,dividend,100,50,2/23/2018
9196A2,conference-organizer,100,57,2/23/2018
9196A2,conference-organizer,100,57,2/23/2018
9196A2,conference-organizer,100,57,2/23/2018
9196A2,conference-organizer,100,57,2/23/2018
9196A2,conference-organizer,100,57,2/23/2018
9196A2,conference-organizer,100,57,2/23/2018
92B625,conference-call,100,50,2/23/2018
9.36E+10,dividend,100,50,2/23/2018
9368BE,buybacks,100,74,2/23/2018
94637C,legal-issues-defendant,100,22,2/23/2018
95F59E,earnings,100,50,2/23/2018
967D92,dividend,100,50,2/23/2018
971334,earnings,100,50,2/23/2018
971334,dividend,100,50,2/23/2018
971334,executive-appointment,100,54,2/23/2018
980C14,board-meeting,100,51,2/23/2018
990AD0,conference-organizer,100,57,2/23/2018
9A602D,dividend,100,50,2/23/2018
9CA432,earnings,100,50,2/23/2018
9CA619,acquisition-acquirer,100,49,2/23/2018
9CF9B1,conference-participant,100,50,2/23/2018
9D2790,dividend,100,50,2/23/2018
9E91C6,legal-issues-defendant,100,22,2/23/2018
A350C1,board-meeting,100,51,2/23/2018
A3800A,legal-issues-defendant,100,22,2/23/2018
A3BFAA,merger-completed,100,66,2/23/2018
A5A4F5,acquisition-acquirer,100,49,2/23/2018
A790A5,dividend,100,50,2/23/2018
A94718,conference-call,100,50,2/23/2018
A96867,dividend-up,100,59,2/23/2018
ADD9DC,executive-resignation,100,44,2/23/2018
B0FE08,executive-appointment,100,54,2/23/2018
B3CB74,conference-organizer,100,57,2/23/2018
B3CB74,conference-organizer,100,57,2/23/2018
B3CB74,conference-organizer,100,57,2/23/2018
B54A74,conference-participant,100,50,2/23/2018
B560AF,earnings,100,50,2/23/2018
B560AF,earnings,100,50,2/23/2018
B560AF,earnings,100,50,2/23/2018
B5734D,conference-call,100,50,2/23/2018
B642E8,dividend,100,50,2/23/2018
B642E8,dividend,100,50,2/23/2018
B8F71F,executive-appointment,100,54,2/23/2018
B9CD50,conference-participant,100,50,2/23/2018
BCE9DA,dividend,100,50,2/23/2018
BCE9DA,dividend,100,50,2/23/2018
BE14CF,dividend,100,50,2/23/2018
C356AC,executive-resignation,100,44,2/23/2018
C5C137,dividend,100,50,2/23/2018
C6C702,conference-participant,100,50,2/23/2018
C6C702,earnings,100,50,2/23/2018
DC6EF3,private-placement,100,56,2/23/2018
DF204B,earnings-up,100,68,2/23/2018
DF204B,revenue-up,100,69,2/23/2018
DF204B,revenue-up,100,69,2/23/2018
E1E36F,dividend,100,50,2/23/2018
E84500,earnings,100,50,2/23/2018
ECD263,conference-participant,100,50,2/23/2018
EE6F1C,dividend,100,50,2/23/2018
EE967B,dividend,100,50,2/23/2018
EE967B,executive-appointment,100,54,2/23/2018
F0EEFB,operating-earnings,100,50,2/23/2018
FC4550,dividend,100,50,2/23/2018
594402,legal-issues-defendant,100,22,2/24/2018
12DE76,partnership,100,61,2/25/2018
12DE76,partnership,100,61,2/25/2018
12DE76,product-release,100,64,2/25/2018
12DE76,product-release,100,64,2/25/2018
12DE76,partnership,100,61,2/25/2018
12DE76,partnership,100,61,2/25/2018
12E454,partnership,100,61,2/25/2018
228D42,business-contract,100,69,2/25/2018
762A3E,conference-organizer,100,57,2/25/2018
77B8E9,conference-participant,100,50,2/25/2018
7C62A3,award,100,58,2/25/2018
ED9C04,partnership,100,61,2/25/2018
00067A,conference-participant,100,50,2/26/2018
9397,acquisition-completed-acquirer,100,49,2/26/2018
9397,acquisition-completed-acquirer,100,49,2/26/2018
00E601,conference-participant,100,50,2/26/2018
0157B1,partnership,100,61,2/26/2018
03D5F9,executive-appointment,100,54,2/26/2018
040DBB,earnings,100,50,2/26/2018
0624BE,dividend,100,50,2/26/2018
0C6861,conference-participant,100,50,2/26/2018
0DE3D5,earnings,100,50,2/26/2018
0E5223,earnings,100,50,2/26/2018
102F04,earnings,100,50,2/26/2018
1065BC,executive-appointment,100,54,2/26/2018
108A2B,earnings,100,50,2/26/2018
1220D2,regulatory-product-approval-granted,100,81,2/26/2018
12E454,partnership,100,61,2/26/2018
13A782,earnings,100,50,2/26/2018
152E1D,earnings,100,50,2/26/2018
152E1D,earnings,100,50,2/26/2018
152E1D,earnings,100,50,2/26/2018
152E1D,earnings,100,50,2/26/2018
152E1D,earnings,100,50,2/26/2018
15B10D,executive-appointment,100,54,2/26/2018
16AAE0,business-combination,100,54,2/26/2018
16AAE0,business-combination,100,54,2/26/2018
16AAE0,merger,100,66,2/26/2018
16F4D8,executive-appointment,100,54,2/26/2018
1748F6,earnings,100,50,2/26/2018
17EDA5,partnership,100,61,2/26/2018
17EDA5,partnership,100,61,2/26/2018
1A6A94,earnings,100,50,2/26/2018
1E5786,conference-participant,100,50,2/26/2018
1F716B,executive-resignation,100,44,2/26/2018
241AF7,earnings,100,50,2/26/2018
24CB56,conference-organizer,100,57,2/26/2018
250BEE,executive-appointment,100,54,2/26/2018
25DD05,conference-participant,100,50,2/26/2018
2667B6,business-contract,100,69,2/26/2018
2667B6,business-contract,100,69,2/26/2018
270B78,unit-acquisition-acquirer,100,49,2/26/2018
272704,conference-participant,100,50,2/26/2018
272704,conference-participant,100,50,2/26/2018
27A791,earnings,100,50,2/26/2018
297DA8,earnings,100,50,2/26/2018
2A1009,clinical-trials-start,100,64,2/26/2018
2A1009,clinical-trials-start,100,64,2/26/2018
2A1009,clinical-trials-start,100,64,2/26/2018
2BDC1C,conference-participant,100,50,2/26/2018
2C3348,earnings,100,50,2/26/2018
2CA60F,earnings,100,50,2/26/2018
314D88,earnings,100,50,2/26/2018
31AA84,earnings,100,50,2/26/2018
31AA84,earnings,100,50,2/26/2018
31AA84,earnings,100,50,2/26/2018
34B97A,conference-participant,100,50,2/26/2018
37E18B,earnings,100,50,2/26/2018
385DD4,unit-acquisition-acquirer,100,49,2/26/2018
385DD4,unit-acquisition-acquirer,100,49,2/26/2018
3A113F,executive-appointment,100,54,2/26/2018
3B20AB,award,100,58,2/26/2018
3B9886,conference-call,100,50,2/26/2018
3BC360,earnings,100,50,2/26/2018
422CE3,partnership,100,61,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43A74A,earnings,100,50,2/26/2018
43E8F5,earnings,100,50,2/26/2018
494EB9,executive-appointment,100,54,2/26/2018
49A344,executive-appointment,100,54,2/26/2018
4BDCA7,business-contract,100,69,2/26/2018
4DAF5F,buybacks,100,74,2/26/2018
4DAF5F,buybacks,100,74,2/26/2018
4ECD1A,earnings,100,50,2/26/2018
4F783B,joint-venture,100,62,2/26/2018
5225A4,acquisition-completed-acquiree,100,76,2/26/2018
5403F8,earnings,100,50,2/26/2018
5487B1,conference-participant,100,50,2/26/2018
55438C,investment-investor,100,55,2/26/2018
55C9B5,partnership,100,61,2/26/2018
56EA2B,conference-call,100,50,2/26/2018
56EFC7,executive-appointment,100,54,2/26/2018
57CAAB,executive-appointment,100,54,2/26/2018
57EF50,conference-call,100,50,2/26/2018
58CA9A,conference-organizer,100,57,2/26/2018
58CA9A,conference-organizer,100,57,2/26/2018
594402,legal-issues-defendant,100,22,2/26/2018
5A423F,earnings,100,50,2/26/2018
5B35C7,earnings,100,50,2/26/2018
5B35C7,earnings,100,50,2/26/2018
5B6C11,executive-appointment,100,54,2/26/2018
5BE42C,acquisition-completed-acquirer,100,49,2/26/2018
5D16CF,acquisition-completed-acquirer,100,49,2/26/2018
5D63F1,dividend,100,50,2/26/2018
5D63F1,facility-open,100,65,2/26/2018
5E6959,conference-participant,100,50,2/26/2018
5F9CE3,partnership,100,61,2/26/2018
619882,conference-organizer,100,57,2/26/2018
62CDDE,earnings,100,50,2/26/2018
633054,partnership,100,61,2/26/2018
64FF65,earnings,100,50,2/26/2018
665D7D,conference-participant,100,50,2/26/2018
66E04A,unit-acquisition-acquiree,100,76,2/26/2018
66E04A,unit-acquisition-acquiree,100,76,2/26/2018
67A658,asset-sale,100,62,2/26/2018
67A658,facility-sale,100,52,2/26/2018
68B03F,revenue-up,100,69,2/26/2018
68B03F,revenue-up,100,69,2/26/2018
68B03F,revenue-up,100,69,2/26/2018
68B03F,revenue-up,100,69,2/26/2018
68B03F,revenue-up,100,69,2/26/2018
68E3E0,dividend,100,50,2/26/2018
69C99E,clinical-trials-positive,100,87,2/26/2018
6B0E45,note-sale,100,52,2/26/2018
6BD606,earnings,100,50,2/26/2018
6E8864,operating-earnings,100,50,2/26/2018
6E8864,operating-earnings,100,50,2/26/2018
6E8864,operating-earnings,100,50,2/26/2018
73529F,conference-call,100,50,2/26/2018
746373,earnings,100,50,2/26/2018
747219,conference-participant,100,50,2/26/2018
747219,conference-participant,100,50,2/26/2018
747219,conference-participant,100,50,2/26/2018
762A3E,conference-organizer,100,57,2/26/2018
762A3E,conference-organizer,100,57,2/26/2018
763DBE,earnings,100,50,2/26/2018
7712CB,earnings,100,50,2/26/2018
790C34,product-release,100,64,2/26/2018
791EC1,earnings,100,50,2/26/2018
7A5097,earnings,100,50,2/26/2018
7B8CB5,earnings,100,50,2/26/2018
7C4168,earnings,100,50,2/26/2018
7E1D5D,product-release,100,64,2/26/2018
7F3669,product-release,100,64,2/26/2018
7FD8B9,conference-call,100,50,2/26/2018
810FAD,executive-resignation,100,44,2/26/2018
8303CD,product-release,100,64,2/26/2018
83066C,earnings,100,50,2/26/2018
838ADD,business-contract,100,69,2/26/2018
85CDC9,earnings,100,50,2/26/2018
86AA9C,business-contract,100,69,2/26/2018
881190,conference-participant,100,50,2/26/2018
88193E,earnings,100,50,2/26/2018
8A8E41,partnership,100,61,2/26/2018
8A8E41,conference-participant,100,50,2/26/2018
8B4A45,earnings,100,50,2/26/2018
8C6C1B,facility-open,100,65,2/26/2018
8D4486,partnership,100,61,2/26/2018
8DE74B,executive-appointment,100,54,2/26/2018
8DE74B,executive-appointment,100,54,2/26/2018
8E9CD8,public-offering,100,43,2/26/2018
8EEA28,conference-participant,100,50,2/26/2018
8F8F2F,earnings,100,50,2/26/2018
8F8F2F,earnings,100,50,2/26/2018
8F8F2F,earnings,100,50,2/26/2018
8FF2EF,board-meeting,100,51,2/26/2018
8FF57A,executive-appointment,100,54,2/26/2018
9196A2,conference-organizer,100,57,2/26/2018
9196A2,conference-organizer,100,57,2/26/2018
9196A2,conference-organizer,100,57,2/26/2018
92D757,conference-participant,100,50,2/26/2018
942165,earnings,100,50,2/26/2018
947B0B,earnings,100,50,2/26/2018
957A07,earnings,100,50,2/26/2018
97B027,conference-call,100,50,2/26/2018
980C14,earnings,100,50,2/26/2018
9A2760,earnings,100,50,2/26/2018
9BBFA5,conference-call,100,50,2/26/2018
9F37C5,dividend,100,50,2/26/2018
A26C26,conference-participant,100,50,2/26/2018
A47F2E,earnings,100,50,2/26/2018
A52B6B,earnings,100,50,2/26/2018
A58224,conference-participant,100,50,2/26/2018
A5A4F5,acquisition-acquirer,100,49,2/26/2018
A63387,conference-participant,100,50,2/26/2018
A70BF5,executive-appointment,100,54,2/26/2018
A80FE0,product-release,100,64,2/26/2018
A8CBDA,partnership,100,61,2/26/2018
A8FDE8,dividend,100,50,2/26/2018
AC3584,partnership,100,61,2/26/2018
AC642C,earnings,100,50,2/26/2018
AC642C,conference-participant,100,50,2/26/2018
AC642C,earnings,100,50,2/26/2018
AC642C,conference-participant,100,50,2/26/2018
AC7AAE,earnings,100,50,2/26/2018
ACD9A4,dividend,100,50,2/26/2018
ACF0B4,earnings,100,50,2/26/2018
AED6CF,conference-call,100,50,2/26/2018
AFF7B4,executive-appointment,100,54,2/26/2018
B05118,dividend,100,50,2/26/2018
B1A85D,stake-acquirer,100,48,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B3CB74,conference-organizer,100,57,2/26/2018
B48FC9,conference-participant,100,50,2/26/2018
B642E8,acquisition-regulatory-approval-acquirer,100,54,2/26/2018
B7202A,conference-call,100,50,2/26/2018
B803B1,conference-participant,100,50,2/26/2018
B934BF,earnings,100,50,2/26/2018
B98EFA,conference-participant,100,50,2/26/2018
BB58FF,conference-participant,100,50,2/26/2018
BC948D,conference-participant,100,50,2/26/2018
BCC13E,conference-participant,100,50,2/26/2018
BE14CF,earnings,100,50,2/26/2018
BF79F5,executive-appointment,100,54,2/26/2018
C4F9C6,earnings,100,50,2/26/2018
C54140,acquisition-interest-acquirer,100,46,2/26/2018
C598D7,stock-splits,100,49,2/26/2018
C5C0E9,executive-appointment,100,54,2/26/2018
C81E00,note-sale,100,52,2/26/2018
C97B2D,note-sale,100,52,2/26/2018
C98CDB,conference-participant,100,50,2/26/2018
CA14CC,earnings,100,50,2/26/2018
CBB77B,executive-resignation,100,44,2/26/2018
CBFFDD,executive-resignation,100,44,2/26/2018
CBFFDD,executive-resignation,100,44,2/26/2018
CDC817,conference-call,100,50,2/26/2018
CE1002,conference-participant,100,50,2/26/2018
CE4E6D,executive-appointment,100,54,2/26/2018
CE96E7,executive-appointment,100,54,2/26/2018
CF7292,legal-issues-defendant,100,22,2/26/2018
CFF97C,conference-participant,100,50,2/26/2018
CFF97C,acquisition-completed-acquirer,100,49,2/26/2018
D03C7A,earnings,100,50,2/26/2018
D06996,earnings,100,50,2/26/2018
D15833,dividend,100,50,2/26/2018
D2B9E5,executive-appointment,100,54,2/26/2018
D437C3,partnership,100,61,2/26/2018
D5938F,executive-appointment,100,54,2/26/2018
D64EDF,earnings,100,50,2/26/2018
D64EDF,earnings,100,50,2/26/2018
D64EDF,earnings,100,50,2/26/2018
D78CCD,product-release,100,64,2/26/2018
D8442A,legal-issues-defendant,100,22,2/26/2018
D8442A,legal-issues-defendant,100,22,2/26/2018
D854F3,conference-participant,100,50,2/26/2018
D9E036,business-contract,100,69,2/26/2018
DA9443,business-contract,100,69,2/26/2018
DB88A1,product-release,100,64,2/26/2018
DD1BA1,conference-participant,100,50,2/26/2018
DDEA6A,conference-participant,100,50,2/26/2018
DF18E6,conference-participant,100,50,2/26/2018
E11C41,earnings,100,50,2/26/2018
E20392,conference-participant,100,50,2/26/2018
E22FDE,earnings,100,50,2/26/2018
E30B34,partnership,100,61,2/26/2018
E30B34,executive-appointment,100,54,2/26/2018
E4CE73,product-release,100,64,2/26/2018
E68733,regulatory-product-approval-granted,100,81,2/26/2018
E68733,product-release,100,64,2/26/2018
E93A40,earnings,100,50,2/26/2018
EB43F4,earnings,100,50,2/26/2018
ECF4F8,executive-appointment,100,54,2/26/2018
ED3CA8,conference-participant,100,50,2/26/2018
ED7F13,conference-participant,100,50,2/26/2018
EE1E44,dividend,100,50,2/26/2018
EEA734,conference-participant,100,50,2/26/2018
F02170,conference-participant,100,50,2/26/2018
F1529C,conference-participant,100,50,2/26/2018
F30508,regulatory-product-approval-granted,100,81,2/26/2018
F44EA2,earnings,100,50,2/26/2018
F5D410,conference-participant,100,50,2/26/2018
F7935D,earnings,100,50,2/26/2018
F7ADEB,earnings,100,50,2/26/2018
F7ADEB,earnings,100,50,2/26/2018
F7ADEB,earnings,100,50,2/26/2018
F7ADEB,earnings,100,50,2/26/2018
F88147,orphan-drug-designation,100,76,2/26/2018
F8BA6C,public-offering,100,43,2/26/2018
F93C8A,capex-up,100,92,2/26/2018
FACF19,earnings-guidance,100,50,2/26/2018
FC1736,conference-participant,100,50,2/26/2018
FDF28E,executive-appointment,100,54,2/26/2018
FE609F,clinical-trials,100,56,2/26/2018
FF6644,business-contract,100,69,2/26/2018
FF6644,executive-appointment,100,54,2/26/2018
FFAB4A,earnings,100,50,2/26/2018
002A99,earnings,100,50,2/27/2018
02FC1A,earnings,100,50,2/27/2018
02FC1A,earnings,100,50,2/27/2018
0358AF,board-meeting,100,51,2/27/2018
03CF95,settlement,100,56,2/27/2018
053EFF,earnings,100,50,2/27/2018
0624BE,executive-appointment,100,54,2/27/2018
68396,earnings,100,50,2/27/2018
06C826,earnings,100,50,2/27/2018
06C826,earnings,100,50,2/27/2018
06EF42,facility-open,100,65,2/27/2018
08A40F,settlement,100,56,2/27/2018
0986B5,dividend,100,50,2/27/2018
0A9D0A,earnings,100,50,2/27/2018
0B400D,conference-call,100,50,2/27/2018
0C136E,dividend,100,50,2/27/2018
0CCCB7,dividend,100,50,2/27/2018
0E499E,partnership,100,61,2/27/2018
106394,conference-participant,100,50,2/27/2018
1096C6,award,100,58,2/27/2018
1220D2,earnings,100,50,2/27/2018
12A3A3,earnings-guidance,100,50,2/27/2018
12DE76,partnership,100,61,2/27/2018
12DE76,partnership,100,61,2/27/2018
12DE76,partnership,100,61,2/27/2018
12DE76,partnership,100,61,2/27/2018
147098,dividend,100,50,2/27/2018
147098,earnings,100,50,2/27/2018
14BA33,earnings,100,50,2/27/2018
165B86,earnings-up,100,68,2/27/2018
165B86,earnings,100,50,2/27/2018
165B86,earnings,100,50,2/27/2018
165B86,earnings,100,50,2/27/2018
165B86,earnings,100,50,2/27/2018
168A5D,conference-participant,100,50,2/27/2018
1782D5,earnings,100,50,2/27/2018
197612,earnings,100,50,2/27/2018
1A3E1B,conference-participant,100,50,2/27/2018
1B5FEA,partnership,100,61,2/27/2018
1BC12C,public-offering,100,43,2/27/2018
1E04A5,earnings,100,50,2/27/2018
1E04A5,earnings,100,50,2/27/2018
1E04A5,earnings,100,50,2/27/2018
1E5786,conference-participant,100,50,2/27/2018
1F19C8,fundraising,100,64,2/27/2018
1F43A1,conference-participant,100,50,2/27/2018
1FC422,conference-participant,100,50,2/27/2018
202E5A,earnings,100,50,2/27/2018
21245F,legal-issues-defendant,100,22,2/27/2018
228D42,partnership,100,61,2/27/2018
2571FA,earnings,100,50,2/27/2018
26008A,earnings-up,100,68,2/27/2018
26008A,earnings-up,100,68,2/27/2018
26008A,earnings-up,100,68,2/27/2018
28AF37,conference-participant,100,50,2/27/2018
2AA6A8,conference-call,100,50,2/27/2018
2BBE62,earnings,100,50,2/27/2018
2BBE62,earnings,100,50,2/27/2018
2BBE62,earnings,100,50,2/27/2018
2BF36E,earnings,100,50,2/27/2018
2CBB58,conference-participant,100,50,2/27/2018
2CC60C,conference-call,100,50,2/27/2018
2D485F,earnings,100,50,2/27/2018
2D485F,earnings,100,50,2/27/2018
2EC172,product-release,100,64,2/27/2018
2F7A7E,asset-sale,100,62,2/27/2018
2F9304,acquisition-acquirer,100,49,2/27/2018
2FDEE3,conference-participant,100,50,2/27/2018
30A565,legal-issues-defendant,100,22,2/27/2018
315EB0,note-sale,100,52,2/27/2018
32CB22,conference-participant,100,50,2/27/2018
3.20E+263,earnings,100,50,2/27/2018
32F943,conference-participant,100,50,2/27/2018
3390DE,executive-resignation,100,44,2/27/2018
36A1CB,earnings,100,50,2/27/2018
38FB49,dividend,100,50,2/27/2018
3A113F,earnings,100,50,2/27/2018
3B2311,earnings,100,50,2/27/2018
3C6CCC,earnings,100,50,2/27/2018
3D7971,earnings,100,50,2/27/2018
3E39A5,product-release,100,64,2/27/2018
3F4668,earnings,100,50,2/27/2018
3F868D,earnings,100,50,2/27/2018
425BDC,legal-issues-defendant,100,22,2/27/2018
429BFB,earnings,100,50,2/27/2018
43E8F5,executive-appointment,100,54,2/27/2018
46A16E,earnings,100,50,2/27/2018
49CC59,earnings,100,50,2/27/2018
4A6F00,partnership,100,61,2/27/2018
4B7006,earnings,100,50,2/27/2018
4BDCA7,earnings,100,50,2/27/2018
4BEB48,earnings,100,50,2/27/2018
4C92B9,earnings,100,50,2/27/2018
4DAF5F,buybacks,100,74,2/27/2018
4DAF5F,buybacks,100,74,2/27/2018
4ECD1A,earnings,100,50,2/27/2018
4F0A80,earnings,100,50,2/27/2018
514067,conference-participant,100,50,2/27/2018
514067,executive-appointment,100,54,2/27/2018
520632,business-contract,100,69,2/27/2018
5225A4,conference-participant,100,50,2/27/2018
52FB2F,earnings,100,50,2/27/2018
54512F,business-contract,100,69,2/27/2018
550D01,earnings,100,50,2/27/2018
55C9B5,partnership,100,61,2/27/2018
55CD6F,earnings,100,50,2/27/2018
567F3D,conference-participant,100,50,2/27/2018
56EFC7,dividend,100,50,2/27/2018
57DDB9,product-release,100,64,2/27/2018
57DDB9,product-release,100,64,2/27/2018
583223,earnings,100,50,2/27/2018
586BD7,conference-participant,100,50,2/27/2018
58CA9A,conference-organizer,100,57,2/27/2018
58CA9A,conference-organizer,100,57,2/27/2018
58CA9A,conference-organizer,100,57,2/27/2018
58CA9A,conference-organizer,100,57,2/27/2018
596116,earnings,100,50,2/27/2018
5A53BF,conference-call,100,50,2/27/2018
5B226B,credit-extension-recipient,100,69,2/27/2018
5B3FA2,conference-participant,100,50,2/27/2018
5CCDAD,earnings,100,50,2/27/2018
5D41E4,earnings,100,50,2/27/2018
5D41E4,earnings,100,50,2/27/2018
5D41E4,earnings,100,50,2/27/2018
5D41E4,earnings,100,50,2/27/2018
5FDBD0,earnings,100,50,2/27/2018
619882,conference-organizer,100,57,2/27/2018
627186,earnings,100,50,2/27/2018
64636E,conference-call,100,50,2/27/2018
64854A,business-contract,100,69,2/27/2018
65D0AA,legal-issues-defendant,100,22,2/27/2018
68AB62,earnings,100,50,2/27/2018
68E3E0,earnings,100,50,2/27/2018
68E3E0,earnings,100,50,2/27/2018
68E3E0,earnings,100,50,2/27/2018
68E3E0,earnings,100,50,2/27/2018
68E3E0,earnings,100,50,2/27/2018
68E3E0,earnings,100,50,2/27/2018
6B236C,conference-participant,100,50,2/27/2018
6B6375,earnings,100,50,2/27/2018
6B6375,public-offering,100,43,2/27/2018
6B67BD,earnings,100,50,2/27/2018
6CD55A,dividend,100,50,2/27/2018
6DD6BA,conference-participant,100,50,2/27/2018
6E8349,earnings,100,50,2/27/2018
6EA292,earnings,100,50,2/27/2018
701531,earnings,100,50,2/27/2018
709AED,conference-participant,100,50,2/27/2018
713810,partnership,100,61,2/27/2018
713810,conference-participant,100,50,2/27/2018
723548,earnings,100,50,2/27/2018
7255D2,earnings,100,50,2/27/2018
72609A,earnings,100,50,2/27/2018
7262F2,earnings,100,50,2/27/2018
7262F2,earnings,100,50,2/27/2018
73C9E2,conference-participant,100,50,2/27/2018
7410C3,earnings,100,50,2/27/2018
752A70,conference-participant,100,50,2/27/2018
762A3E,conference-organizer,100,57,2/27/2018
762A3E,conference-organizer,100,57,2/27/2018
762A3E,conference-organizer,100,57,2/27/2018
762A3E,conference-organizer,100,57,2/27/2018
762A3E,conference-organizer,100,57,2/27/2018
769F40,earnings,100,50,2/27/2018
76BECC,earnings,100,50,2/27/2018
7.83E+79,executive-appointment,100,54,2/27/2018
79167B,earnings,100,50,2/27/2018
7A3633,earnings,100,50,2/27/2018
7ADE57,conference-call,100,50,2/27/2018
7B8CB5,executive-appointment,100,54,2/27/2018
7CBC40,earnings,100,50,2/27/2018
7D35D8,buybacks,100,74,2/27/2018
7DD8CC,earnings,100,50,2/27/2018
7E0EB0,earnings,100,50,2/27/2018
805CD8,earnings,100,50,2/27/2018
81222C,conference-participant,100,50,2/27/2018
81EAD4,conference-participant,100,50,2/27/2018
82F088,earnings,100,50,2/27/2018
8377DB,dividend,100,50,2/27/2018
83E0AC,earnings,100,50,2/27/2018
850779,conference-participant,100,50,2/27/2018
858942,earnings,100,50,2/27/2018
85DA04,note-sale,100,52,2/27/2018
883D82,legal-issues-defendant,100,22,2/27/2018
883D82,legal-issues-defendant,100,22,2/27/2018
8A0368,conference-participant,100,50,2/27/2018
8AB37F,earnings,100,50,2/27/2018
8B9B3B,earnings,100,50,2/27/2018
8C6C1B,facility-open,100,65,2/27/2018
8CF6DD,conference-participant,100,50,2/27/2018
8DCF18,conference-participant,100,50,2/27/2018
903AB4,dividend,100,50,2/27/2018
925759,earnings,100,50,2/27/2018
92B625,earnings,100,50,2/27/2018
9.31E+77,earnings-up,100,68,2/27/2018
934029,conference-participant,100,50,2/27/2018
93D207,partnership,100,61,2/27/2018
947B0B,executive-appointment,100,54,2/27/2018
954A47,executive-appointment,100,54,2/27/2018
9592FB,earnings,100,50,2/27/2018
9.65E+09,earnings,100,50,2/27/2018
9.65E+09,executive-appointment,100,54,2/27/2018
967D92,earnings,100,50,2/27/2018
968103,executive-appointment,100,54,2/27/2018
97AF94,earnings,100,50,2/27/2018
990AD0,conference-organizer,100,57,2/27/2018
9934AD,earnings,100,50,2/27/2018
99ACAD,dividend,100,50,2/27/2018
99ACAD,earnings,100,50,2/27/2018
9ABD30,earnings,100,50,2/27/2018
9B4066,facility-sale,100,52,2/27/2018
9B5968,note-sale,100,52,2/27/2018
9B730A,conference-call,100,50,2/27/2018
9C25FF,earnings,100,50,2/27/2018
9D5D35,executive-appointment,100,54,2/27/2018
9D5FA4,earnings,100,50,2/27/2018
A1E3B3,partnership,100,61,2/27/2018
A1E3B3,earnings,100,50,2/27/2018
A43906,earnings,100,50,2/27/2018
A4CD53,earnings,100,50,2/27/2018
A5195E,earnings,100,50,2/27/2018
A5A4F5,acquisition-acquirer,100,49,2/27/2018
A5DD24,conference-participant,100,50,2/27/2018
A5DD24,earnings,100,50,2/27/2018
A5E715,dividend,100,50,2/27/2018
A6828A,business-contract,100,69,2/27/2018
A6828A,business-contract,100,69,2/27/2018
A6828A,business-contract,100,69,2/27/2018
A6828A,legal-issues-defendant,100,22,2/27/2018
A70BF5,dividend,100,50,2/27/2018
A80FE0,earnings,100,50,2/27/2018
A868C9,partnership,100,61,2/27/2018
A94637,revenue-up,100,69,2/27/2018
A94637,revenue-up,100,69,2/27/2018
A94718,earnings,100,50,2/27/2018
ABEE43,earnings,100,50,2/27/2018
AD22F2,conference-call,100,50,2/27/2018
AD3C93,legal-issues-defendant,100,22,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,earnings,100,50,2/27/2018
ADF092,acquisition-regulatory-approval-acquirer,100,54,2/27/2018
AECCA9,dividend,100,50,2/27/2018
AEF2C3,earnings,100,50,2/27/2018
AFEC35,conference-participant,100,50,2/27/2018
AFF7B4,executive-appointment,100,54,2/27/2018
B01111,earnings,100,50,2/27/2018
B01111,facility-open,100,65,2/27/2018
B05000,executive-appointment,100,54,2/27/2018
B3A166,conference-call,100,50,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3CB74,conference-organizer,100,57,2/27/2018
B3ED62,executive-appointment,100,54,2/27/2018
B3ED62,conference-participant,100,50,2/27/2018
B4F5F4,conference-call,100,50,2/27/2018
B5BA39,earnings,100,50,2/27/2018
B5BA39,earnings,100,50,2/27/2018
B5BA39,earnings,100,50,2/27/2018
B5BA39,earnings,100,50,2/27/2018
B5BA39,earnings,100,50,2/27/2018
B5BA39,earnings,100,50,2/27/2018
B5BA39,earnings,100,50,2/27/2018
B6082A,dividend,100,50,2/27/2018
B642E8,operating-earnings-positive,100,69,2/27/2018
B642E8,earnings,100,50,2/27/2018
B642E8,earnings,100,50,2/27/2018
B642E8,earnings,100,50,2/27/2018
B642E8,earnings,100,50,2/27/2018
B642E8,earnings,100,50,2/27/2018
B77F14,conference-call,100,50,2/27/2018
B840EF,earnings,100,50,2/27/2018
B840EF,earnings,100,50,2/27/2018
B9764A,conference-participant,100,50,2/27/2018
BBC05B,earnings,100,50,2/27/2018
BCC55F,patent-awarded,100,72,2/27/2018
C01737,earnings,100,50,2/27/2018
C062D4,conference-participant,100,50,2/27/2018
C27E19,dividend,100,50,2/27/2018
C3F99F,conference-call,100,50,2/27/2018
C407A0,earnings,100,50,2/27/2018
C584BE,earnings,100,50,2/27/2018
C5C0E9,conference-participant,100,50,2/27/2018
C5C137,earnings,100,50,2/27/2018
C65004,conference-participant,100,50,2/27/2018
C941DC,earnings,100,50,2/27/2018
CC339B,executive-appointment,100,54,2/27/2018
CC8F6E,conference-participant,100,50,2/27/2018
CD4DA8,conference-organizer,100,57,2/27/2018
CE1002,dividend,100,50,2/27/2018
CE4E6D,revenue-up,100,69,2/27/2018
CE4E6D,revenue-up,100,69,2/27/2018
CE4E6D,revenue-up,100,69,2/27/2018
CE4E6D,revenue-up,100,69,2/27/2018
CEC5B9,facility-close,100,47,2/27/2018
CF351E,earnings,100,50,2/27/2018
CFF15D,product-release,100,64,2/27/2018
CFF97C,credit-rating-upgrade-rater,20,50,2/27/2018
D07B07,conference-participant,100,50,2/27/2018
D0DE27,dividend,100,50,2/27/2018
D11C1C,earnings,100,50,2/27/2018
D21D8A,merger,100,66,2/27/2018
D25249,earnings,100,50,2/27/2018
D2B9E5,partnership,100,61,2/27/2018
D33270,partnership,100,61,2/27/2018
D3DE34,earnings,100,50,2/27/2018
D3FA2C,earnings,100,50,2/27/2018
D3FD6D,revenues,100,50,2/27/2018
D3FD6D,revenues,100,50,2/27/2018
D3FD6D,revenues,100,50,2/27/2018
D3FD6D,revenues,100,50,2/27/2018
D48275,conference-participant,100,50,2/27/2018
D6489C,partnership,100,61,2/27/2018
D75910,earnings,100,50,2/27/2018
D75910,earnings,100,50,2/27/2018
D75910,earnings,100,50,2/27/2018
D75910,earnings,100,50,2/27/2018
D8C09D,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9C07E,earnings,100,50,2/27/2018
D9E036,earnings,100,50,2/27/2018
DB7014,conference-participant,100,50,2/27/2018
DB7EC3,earnings,100,50,2/27/2018
DC0D18,executive-appointment,100,54,2/27/2018
DD7A96,conference-participant,100,50,2/27/2018
DE20DF,earnings,100,50,2/27/2018
E06265,earnings,100,50,2/27/2018
E12A6E,conference-participant,100,50,2/27/2018
E2F66E,earnings-up,100,68,2/27/2018
E2F66E,earnings-up,100,68,2/27/2018
E2F66E,earnings-up,100,68,2/27/2018
E2F66E,earnings-up,100,68,2/27/2018
E50F1C,dividend,100,50,2/27/2018
E68C3D,dividend-up,100,57,2/27/2018
E69BA5,earnings,100,50,2/27/2018
E754F0,earnings,100,50,2/27/2018
E82A2D,conference-participant,100,50,2/27/2018
E96E0B,earnings,100,50,2/27/2018
EB7FBF,conference-call,100,50,2/27/2018
ECF4F8,earnings,100,50,2/27/2018
ECF709,same-store-sales-up,100,52,2/27/2018
ECF709,same-store-sales-up,100,62,2/27/2018
ECF709,same-store-sales-up,100,62,2/27/2018
ED9C04,partnership,100,61,2/27/2018
EEA734,conference-call,100,50,2/27/2018
F2E253,earnings,100,50,2/27/2018
F2E253,earnings,100,50,2/27/2018
F2E253,earnings,100,50,2/27/2018
F2E253,earnings,100,50,2/27/2018
F2E253,earnings,100,50,2/27/2018
F3016C,earnings,100,50,2/27/2018
F3016C,earnings,100,50,2/27/2018
F3016C,earnings,100,50,2/27/2018
F3016C,earnings,100,50,2/27/2018
F39E1E,legal-issues-defendant,100,22,2/27/2018
F48947,earnings,100,50,2/27/2018
F5349B,executive-appointment,100,54,2/27/2018
F6581D,conference-call,100,50,2/27/2018
F7FCA4,conference-participant,100,50,2/27/2018
FB728F,earnings,100,50,2/27/2018
FB7724,earnings,100,50,2/27/2018
FC1A6E,conference-participant,100,50,2/27/2018
FD39EB,unit-acquisition-acquiree,100,76,2/27/2018
FD554E,dividend,100,50,2/27/2018
FD6926,conference-participant,100,50,2/27/2018
FEE4B0,partnership,100,61,2/27/2018
01478A,dividend-up,100,81,2/28/2018
0157B1,partnership,100,61,2/28/2018
03B8CF,facility-open,100,65,2/28/2018
0490C6,earnings,100,50,2/28/2018
55018,business-contract,100,69,2/28/2018
09062E,earnings,100,50,2/28/2018
0919B1,dividend,100,50,2/28/2018
0A7650,executive-appointment,100,54,2/28/2018
0C355F,earnings,100,50,2/28/2018
0C6861,conference-participant,100,50,2/28/2018
0CCCB7,earnings,100,50,2/28/2018
0D03C8,earnings,100,50,2/28/2018
0E439E,dividend-up,100,81,2/28/2018
0E499E,earnings,100,50,2/28/2018
0ED415,executive-appointment,100,54,2/28/2018
0FDE97,conference-participant,100,50,2/28/2018
108A2B,conference-participant,100,50,2/28/2018
108A2B,conference-participant,100,50,2/28/2018
13A782,earnings,100,50,2/28/2018
152B9E,executive-appointment,100,54,2/28/2018
1834C0,unit-acquisition-acquirer,100,49,2/28/2018
1A5957,executive-appointment,100,54,2/28/2018
1AB808,earnings,100,50,2/28/2018
1D3A00,earnings,100,50,2/28/2018
1DEBBE,earnings,100,50,2/28/2018
1E8A99,dividend,100,50,2/28/2018
1EA923,product-release,100,64,2/28/2018
2082EA,earnings,100,50,2/28/2018
249674,earnings,100,50,2/28/2018
249674,earnings,100,50,2/28/2018
249674,earnings,100,50,2/28/2018
249674,earnings,100,50,2/28/2018
24FA23,earnings,100,50,2/28/2018
2571FA,award,100,58,2/28/2018
25A6CC,earnings,100,50,2/28/2018
25A6CC,earnings,100,50,2/28/2018
25A6CC,earnings,100,50,2/28/2018
25A6CC,earnings,100,50,2/28/2018
2667B6,business-contract,100,69,2/28/2018
2667B6,business-contract,100,69,2/28/2018
270B78,earnings,100,50,2/28/2018
275300,public-offering,100,43,2/28/2018
284289,executive-appointment,100,54,2/28/2018
2920D5,conference-participant,100,50,2/28/2018
2E0496,product-release,100,64,2/28/2018
2F94A5,award,100,58,2/28/2018
315EB0,note-sale,100,52,2/28/2018
3471C0,earnings,100,50,2/28/2018
3471C0,executive-appointment,100,54,2/28/2018
3B8484,earnings-up,100,68,2/28/2018
3CCC90,executive-appointment,100,54,2/28/2018
3ED92D,conference-participant,100,50,2/28/2018
3F1C69,clinical-trials-start,100,64,2/28/2018
4017AD,dividend,100,50,2/28/2018
407878,earnings,100,50,2/28/2018
407878,earnings,100,50,2/28/2018
408089,partnership,100,61,2/28/2018
408380,earnings,100,50,2/28/2018
40B903,earnings,100,50,2/28/2018
41EC04,executive-resignation,100,44,2/28/2018
425BDC,legal-issues-defendant,100,22,2/28/2018
431B74,dividend,100,50,2/28/2018
431B74,dividend,100,50,2/28/2018
44A4FC,facility-upgrade,100,65,2/28/2018
4649D5,earnings,100,50,2/28/2018
468DD4,earnings,100,50,2/28/2018
4A2457,business-contract,100,69,2/28/2018
4A2457,acquisition-acquiree,100,76,2/28/2018
4A2457,acquisition-acquiree,100,76,2/28/2018
4A6F00,partnership,100,61,2/28/2018
4B6EF9,earnings,100,50,2/28/2018
4B6EF9,dividend,100,50,2/28/2018
4BEB48,conference-participant,100,50,2/28/2018
4D8124,conference-organizer,100,57,2/28/2018
4DAF5F,buybacks,100,74,2/28/2018
4DAF5F,buybacks,100,74,2/28/2018
4F9487,executive-appointment,100,54,2/28/2018
4FB770,conference-participant,100,50,2/28/2018
514067,earnings,100,50,2/28/2018
525A1C,conference-participant,100,50,2/28/2018
53A226,conference-participant,100,50,2/28/2018
55C289,dividend,100,50,2/28/2018
589846,conference-call,100,50,2/28/2018
58B46F,facility-close,100,47,2/28/2018
58CA9A,conference-organizer,100,57,2/28/2018
58CA9A,conference-organizer,100,57,2/28/2018
59B229,executive-appointment,100,54,2/28/2018
5AAE17,conference-call,100,50,2/28/2018
5D1329,conference-participant,100,50,2/28/2018
619882,conference-organizer,100,57,2/28/2018
66749D,conference-participant,100,50,2/28/2018
69C99E,earnings,100,50,2/28/2018
6F30F9,earnings,100,50,2/28/2018
701531,conference-participant,100,50,2/28/2018
704B78,earnings,100,50,2/28/2018
7448A3,earnings,100,50,2/28/2018
762A3E,conference-organizer,100,57,2/28/2018
762A3E,conference-organizer,100,57,2/28/2018
76E80F,revenues,100,50,2/28/2018
76E80F,revenues,100,50,2/28/2018
76E80F,revenues,100,50,2/28/2018
76E80F,partnership,100,61,2/28/2018
771985,asset-sale,100,62,2/28/2018
791EC1,unit-acquisition-acquirer,100,49,2/28/2018
7B9AFA,conference-participant,100,50,2/28/2018
7F3665,earnings,100,50,2/28/2018
80B32C,acquisition-completed-acquiree,100,76,2/28/2018
82B57E,executive-appointment,100,54,2/28/2018
86A1B9,dividend,100,50,2/28/2018
86F123,conference-call,100,50,2/28/2018
883D82,legal-issues-defendant,100,22,2/28/2018
895D56,earnings,100,50,2/28/2018
896771,earnings,100,50,2/28/2018
89E771,business-contract,100,69,2/28/2018
8A8E41,merger-completed,100,66,2/28/2018
8B3B0E,conference-participant,100,50,2/28/2018
8C5519,conference-participant,100,50,2/28/2018
8C6C1B,facility-open,100,65,2/28/2018
8D5145,acquisition-completed-acquirer,100,49,2/28/2018
8E3F58,earnings,100,50,2/28/2018
8E9CD8,public-offering,100,43,2/28/2018
8EDACA,earnings,100,50,2/28/2018
9196A2,conference-organizer,100,57,2/28/2018
92D230,conference-call,100,50,2/28/2018
966DBE,earnings,100,50,2/28/2018
966DBE,earnings,100,50,2/28/2018
966DBE,earnings,100,50,2/28/2018
966DBE,earnings,100,50,2/28/2018
966DBE,earnings,100,50,2/28/2018
966DBE,earnings,100,50,2/28/2018
966DBE,earnings,100,50,2/28/2018
966DBE,executive-appointment,100,54,2/28/2018
98CEBB,earnings,100,50,2/28/2018
9.97E+09,executive-appointment,100,54,2/28/2018
9A02C4,regulatory-investigation,100,22,2/28/2018
9B5968,note-sale,100,52,2/28/2018
9C5174,conference-participant,100,50,2/28/2018
9E575E,earnings,100,50,2/28/2018
9F5CBB,dividend,100,50,2/28/2018
9F6B1A,business-contract,100,69,2/28/2018
A05C43,business-contract,100,69,2/28/2018
A05C43,business-contract,100,69,2/28/2018
A05C43,earnings,100,50,2/28/2018
A0F146,earnings,100,50,2/28/2018
A28675,earnings,100,50,2/28/2018
A37D68,earnings,100,50,2/28/2018
A3800A,dividend,100,50,2/28/2018
A398F8,earnings,100,50,2/28/2018
A398F8,earnings,100,50,2/28/2018
A52533,executive-appointment,100,54,2/28/2018
A5A4F5,acquisition-acquirer,100,49,2/28/2018
A631A3,product-release,100,64,2/28/2018
A631A3,product-release,100,64,2/28/2018
A631A3,product-release,100,64,2/28/2018
A7102F,conference-participant,100,50,2/28/2018
A80FE0,partnership,100,61,2/28/2018
A8AC4C,earnings,100,50,2/28/2018
A8B137,conference-participant,100,50,2/28/2018
A9ED24,earnings,100,50,2/28/2018
ACC7D3,executive-appointment,100,54,2/28/2018
ACF0B4,earnings,100,50,2/28/2018
AD23DE,conference-call,100,50,2/28/2018
AD3C93,conference-participant,100,50,2/28/2018
AE4EEB,conference-participant,100,50,2/28/2018
AECCA9,earnings,100,50,2/28/2018
AECCA9,earnings,100,50,2/28/2018
AECCA9,earnings,100,50,2/28/2018
AECCA9,earnings,100,50,2/28/2018
AECCA9,earnings,100,50,2/28/2018
AECCA9,earnings,100,50,2/28/2018
B05118,product-release,100,64,2/28/2018
B09B1F,earnings,100,50,2/28/2018
B09B1F,earnings,100,50,2/28/2018
B09B1F,earnings,100,50,2/28/2018
B1A85D,earnings,100,50,2/28/2018
B2256A,earnings,100,50,2/28/2018
B2AA0A,earnings,100,50,2/28/2018
B2D492,earnings,100,50,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-call,100,50,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B3CB74,conference-organizer,100,57,2/28/2018
B5DE80,note-sale,100,52,2/28/2018
B66928,earnings,100,50,2/28/2018
B73395,conference-call,100,50,2/28/2018
B77F14,stake-acquiree,100,62,2/28/2018
B8F71F,dividend,100,50,2/28/2018
BB127B,earnings-up,100,68,2/28/2018
BC3AD2,dividend,100,50,2/28/2018
BCC55F,award,100,58,2/28/2018
BCC55F,award,100,58,2/28/2018
BDE867,earnings,100,50,2/28/2018
BDE867,earnings,100,50,2/28/2018
BDE867,earnings,100,50,2/28/2018
BDEF34,dividend,100,50,2/28/2018
C07E05,conference-participant,100,50,2/28/2018
C27E19,conference-participant,100,50,2/28/2018
C48574,earnings,100,50,2/28/2018
C4F9C6,conference-participant,100,50,2/28/2018
C7859D,conference-participant,100,50,2/28/2018
C81E00,acquisition-completed-acquirer,100,49,2/28/2018
C93C44,conference-participant,100,50,2/28/2018
C9D866,conference-participant,100,50,2/28/2018
C9F39B,executive-appointment,100,54,2/28/2018
CB6A9C,earnings,100,50,2/28/2018
CBA33B,acquisition-acquirer,100,49,2/28/2018
CC6F6E,partnership,100,61,2/28/2018
CC6F6E,partnership,100,61,2/28/2018
CD2A4D,earnings,100,50,2/28/2018
CE2791,earnings,100,50,2/28/2018
CE8251,partnership,100,61,2/28/2018
CE8251,partnership,100,61,2/28/2018
CE8251,partnership,100,61,2/28/2018
CEDFD5,conference-participant,100,50,2/28/2018
CFF97C,credit-rating-downgrade-rater,20,50,2/28/2018
D0909F,resource-discovery,100,88,2/28/2018
D09938,earnings,100,50,2/28/2018
D0DE27,earnings,100,50,2/28/2018
D139BC,dividend,100,50,2/28/2018
D139BC,conference-participant,100,50,2/28/2018
D33270,business-contract,100,69,2/28/2018
D33270,business-contract,100,69,2/28/2018
D33270,business-contract,100,69,2/28/2018
D3F64D,dividend,100,50,2/28/2018
D48275,conference-call,100,50,2/28/2018
D5AF19,trading-halt,100,43,2/28/2018
D6EAA3,partnership,100,61,2/28/2018
D77F7E,earnings,100,50,2/28/2018
D81463,earnings,100,50,2/28/2018
D81463,dividend,100,50,2/28/2018
D8760C,conference-participant,100,50,2/28/2018
D9FC89,dividend,100,50,2/28/2018
DD9E41,earnings,100,50,2/28/2018
E0339F,dividend,100,50,2/28/2018
E07573,earnings,100,50,2/28/2018
E07573,earnings,100,50,2/28/2018
E07573,earnings,100,50,2/28/2018
E07573,earnings,100,50,2/28/2018
E19A99,earnings,100,50,2/28/2018
E1C16B,dividend,100,50,2/28/2018
E1C16B,conference-participant,100,50,2/28/2018
E28D9C,earnings,100,50,2/28/2018
E28D9C,earnings,100,50,2/28/2018
E2CB7B,conference-participant,100,50,2/28/2018
E3E68E,product-release,100,64,2/28/2018
E4CE73,business-contract,100,69,2/28/2018
E68C3D,revenue-up,100,69,2/28/2018
E68C3D,revenues,100,50,2/28/2018
E68C3D,revenues,100,50,2/28/2018
E68C3D,revenues,100,50,2/28/2018
E6E012,conference-organizer,100,57,2/28/2018
E70531,resource-discovery,100,88,2/28/2018
E74B55,conference-call,100,50,2/28/2018
E82A2D,conference-participant,100,50,2/28/2018
E8846E,conference-organizer,100,57,2/28/2018
E8A49A,executive-appointment,100,54,2/28/2018
E8A49A,partnership,100,61,2/28/2018
E8A49A,partnership,100,61,2/28/2018
EB36DE,note-sale,100,52,2/28/2018
ED79D9,partnership,100,61,2/28/2018
ED7F13,earnings,100,50,2/28/2018
EF25A5,conference-participant,100,50,2/28/2018
EFA7B2,earnings,100,50,2/28/2018
F00285,earnings,100,50,2/28/2018
F02170,revenue-up,100,69,2/28/2018
F02170,revenue-up,100,69,2/28/2018
F02170,revenue-up,100,69,2/28/2018
F02170,revenue-up,100,69,2/28/2018
F02170,revenue-up,100,69,2/28/2018
F0A9DE,dividend,100,50,2/28/2018
F1CD47,dividend,100,50,2/28/2018
F4D241,earnings,100,50,2/28/2018
F5349B,earnings,100,50,2/28/2018
F5349B,dividend,100,50,2/28/2018
FACF19,partnership,100,61,2/28/2018
FE1A1D,earnings,100,50,2/28/2018
FE609F,conference-call,100,50,2/28/2018
002A99,fast-track-designation,100,81,3/1/2018
002A99,fast-track-designation,100,81,3/1/2018
00D6B5,earnings,100,50,3/1/2018
03D5F9,earnings,100,50,3/1/2018
07C69F,conference-participant,100,50,3/1/2018
07CA6A,spin-off,100,58,3/1/2018
95294,partnership,100,61,3/1/2018
0A59F8,partnership,100,61,3/1/2018
0A9D0A,earnings,100,50,3/1/2018
0AD2E3,earnings,100,50,3/1/2018
0B13E8,conference-call,100,50,3/1/2018
0B7375,conference-call,100,50,3/1/2018
0BC29E,executive-appointment,100,54,3/1/2018
0C6861,earnings,100,50,3/1/2018
0C6861,name-change,100,49,3/1/2018
0C6861,name-change,100,49,3/1/2018
0C6861,name-change,100,49,3/1/2018
0F0440,earnings,100,50,3/1/2018
0F0440,earnings,100,50,3/1/2018
1220D2,conference-participant,100,50,3/1/2018
12DE76,partnership,100,61,3/1/2018
12DE76,partnership,100,61,3/1/2018
135B09,business-contract,100,69,3/1/2018
147C38,dividend,100,50,3/1/2018
15789A,conference-participant,100,50,3/1/2018
16F4D8,business-contract,100,69,3/1/2018
1782D5,dividend,100,50,3/1/2018
180DA0,earnings,100,50,3/1/2018
180DA0,earnings,100,50,3/1/2018
182BE7,earnings,100,50,3/1/2018
1834C0,earnings,100,50,3/1/2018
184988,earnings,100,50,3/1/2018
1A3E1B,conference-call,100,50,3/1/2018
1CB9D3,earnings,100,50,3/1/2018
1CB9D3,earnings,100,50,3/1/2018
1CB9D3,earnings,100,50,3/1/2018
1CB9D3,earnings,100,50,3/1/2018
1CD09C,earnings,100,50,3/1/2018
1D1B07,earnings,100,50,3/1/2018
1D1B07,earnings,100,50,3/1/2018
1F08A6,conference-participant,100,50,3/1/2018
1F9258,earnings,100,50,3/1/2018
1FCC00,conference-call,100,50,3/1/2018
219B21,product-release,100,64,3/1/2018
228D42,business-contract,100,69,3/1/2018
228D42,partnership,100,61,3/1/2018
238302,board-meeting,100,51,3/1/2018
25102A,patent-infringement-plaintiff,100,47,3/1/2018
264EB3,merger-completed,100,66,3/1/2018
270B78,conference-participant,100,50,3/1/2018
275300,public-offering,100,43,3/1/2018
28DCF3,acquisition-completed-acquirer,100,49,3/1/2018
2B49F4,conference-call,100,50,3/1/2018
2B8179,earnings,100,50,3/1/2018
2BA977,dividend-up,100,56,3/1/2018
2C3348,earnings,100,50,3/1/2018
2CB4C9,facility-open,100,65,3/1/2018
2DDB22,earnings,100,50,3/1/2018
2E2E6E,dividend,100,50,3/1/2018
2F7474,acquisition-completed-acquirer,100,49,3/1/2018
2F7A7E,earnings,100,50,3/1/2018
2F9304,earnings,100,50,3/1/2018
31553A,public-offering,100,43,3/1/2018
32CB22,acquisition-acquirer,100,49,3/1/2018
32F24A,executive-appointment,100,54,3/1/2018
32F943,earnings,100,50,3/1/2018
3461CF,conference-participant,100,50,3/1/2018
35557B,earnings,100,50,3/1/2018
35557B,earnings,100,50,3/1/2018
372037,earnings,100,50,3/1/2018
389CFB,earnings,100,50,3/1/2018
396D7C,conference-participant,100,50,3/1/2018
3A3447,facility-open,100,65,3/1/2018
3C11C4,conference-participant,100,50,3/1/2018
3E70FC,acquisition-completed-acquirer,100,49,3/1/2018
3F1C69,clinical-trials-start,100,64,3/1/2018
4135F7,revenues,100,50,3/1/2018
415188,conference-participant,100,50,3/1/2018
41B53E,earnings,100,50,3/1/2018
41B53E,earnings,100,50,3/1/2018
41B53E,earnings,100,50,3/1/2018
420168,conference-participant,100,50,3/1/2018
422CE3,earnings,100,50,3/1/2018
44740A,earnings,100,50,3/1/2018
448BF3,earnings,100,50,3/1/2018
45444E,revenue-up,100,69,3/1/2018
45444E,revenue-up,100,69,3/1/2018
45444E,revenue-up,100,69,3/1/2018
45BC35,conference-participant,100,50,3/1/2018
46CF27,conference-participant,100,50,3/1/2018
4.60E+06,earnings,100,50,3/1/2018
4806CE,earnings,100,50,3/1/2018
499C75,earnings,100,50,3/1/2018
4A2457,government-contract,100,69,3/1/2018
4A3438,earnings,100,50,3/1/2018
4DAF5F,buybacks,100,74,3/1/2018
4DAF5F,buybacks,100,74,3/1/2018
4E4E75,earnings,100,50,3/1/2018
4E7C1F,conference-participant,100,50,3/1/2018
4ECD1A,buybacks,100,74,3/1/2018
4EE167,earnings,100,50,3/1/2018
4F0A80,dividend,100,50,3/1/2018
520632,conference-participant,100,50,3/1/2018
54512F,revenues,100,50,3/1/2018
54512F,revenues,100,50,3/1/2018
54512F,revenues,100,50,3/1/2018
545272,board-meeting,100,51,3/1/2018
546A27,earnings,100,50,3/1/2018
546A9C,executive-appointment,100,54,3/1/2018
5.47E+28,conference-participant,100,50,3/1/2018
54DF47,dividend,100,50,3/1/2018
55438C,executive-appointment,100,54,3/1/2018
556F08,earnings,100,50,3/1/2018
56765E,earnings,100,50,3/1/2018
56765E,earnings,100,50,3/1/2018
56765E,earnings,100,50,3/1/2018
56765E,earnings,100,50,3/1/2018
56765E,earnings,100,50,3/1/2018
56765E,earnings,100,50,3/1/2018
56765E,earnings,100,50,3/1/2018
57CAAB,clinical-trials-start,100,64,3/1/2018
57CAAB,clinical-trials-start,100,64,3/1/2018
57DDB9,product-release,100,64,3/1/2018
58CA9A,conference-organizer,100,57,3/1/2018
58CA9A,conference-organizer,100,57,3/1/2018
58CA9A,conference-organizer,100,57,3/1/2018
59872F,acquisition-interest-acquirer,100,46,3/1/2018
59872F,earnings,100,50,3/1/2018
5AF08A,acquisition-regulatory-approval-acquirer,100,54,3/1/2018
5B226B,revenue-up,100,74,3/1/2018
5B226B,revenue-up,100,74,3/1/2018
5B226B,revenue-up,100,74,3/1/2018
5BC2F4,executive-appointment,100,54,3/1/2018
5C2A47,partnership,100,61,3/1/2018
5DE5A5,conference-participant,100,50,3/1/2018
5DE5A5,dividend,100,50,3/1/2018
5E7E82,earnings-above-expectations,100,88,3/1/2018
601785,conference-participant,100,50,3/1/2018
61B81B,conference-call,100,50,3/1/2018
636BBF,award,100,58,3/1/2018
649CBD,earnings,100,50,3/1/2018
6830FE,product-release,100,64,3/1/2018
69FDFC,earnings,100,50,3/1/2018
69FDFC,earnings,100,50,3/1/2018
6B6375,public-offering,100,43,3/1/2018
6BDA0C,earnings,100,50,3/1/2018
6D1ADF,executive-appointment,100,54,3/1/2018
6DC1D7,dividend,100,50,3/1/2018
6E7060,executive-appointment,100,54,3/1/2018
6F22E7,conference-participant,100,50,3/1/2018
6F6559,acquisition-acquirer,100,49,3/1/2018
726DDF,earnings,100,50,3/1/2018
73529F,earnings,100,50,3/1/2018
73F7F9,earnings,100,50,3/1/2018
747219,earnings,100,50,3/1/2018
7.49E+07,earnings,100,50,3/1/2018
762A3E,conference-organizer,100,57,3/1/2018
763724,earnings,100,50,3/1/2018
76959C,earnings,100,50,3/1/2018
773A17,conference-participant,100,50,3/1/2018
7740DE,dividend,100,50,3/1/2018
7.83E+79,board-meeting,100,51,3/1/2018
7CD98F,dividend-up,100,81,3/1/2018
7FC386,earnings,100,50,3/1/2018
817ED9,dividend,100,50,3/1/2018
817ED9,earnings,100,50,3/1/2018
83E0AC,conference-call,100,50,3/1/2018
845533,earnings,100,50,3/1/2018
855DF7,earnings,100,50,3/1/2018
862941,earnings,100,50,3/1/2018
877C0C,earnings,100,50,3/1/2018
883D82,legal-issues-defendant,100,22,3/1/2018
883D82,legal-issues-defendant,100,22,3/1/2018
89F693,business-contract,100,69,3/1/2018
8A0368,earnings,100,50,3/1/2018
8A8E41,product-release,100,64,3/1/2018
8B1E11,earnings,100,50,3/1/2018
8B3B0E,dividend,100,50,3/1/2018
8C6C1B,facility-open,100,65,3/1/2018
8EEA28,earnings,100,50,3/1/2018
8EF425,dividend,100,50,3/1/2018
900356,conference-participant,100,50,3/1/2018
901327,dividend,100,50,3/1/2018
911AB8,business-contract,100,69,3/1/2018
911AB8,business-contract,100,69,3/1/2018
911AB8,business-contract,100,69,3/1/2018
911AB8,business-contract,100,69,3/1/2018
94563D,facility-open,100,65,3/1/2018
94637C,executive-appointment,100,54,3/1/2018
94637C,dividend-up,100,81,3/1/2018
94637C,dividend,100,50,3/1/2018
94983E,executive-appointment,100,54,3/1/2018
949D62,earnings,100,50,3/1/2018
95A92E,earnings,100,50,3/1/2018
95A92E,executive-resignation,100,44,3/1/2018
96A6CD,earnings,100,50,3/1/2018
96F126,business-contract,100,69,3/1/2018
96F126,product-release,100,64,3/1/2018
96F126,product-release,100,64,3/1/2018
9.86E+03,partnership,100,61,3/1/2018
9.86E+03,partnership,100,61,3/1/2018
997348,dividend,100,50,3/1/2018
99ACAD,business-contract,100,69,3/1/2018
9C8664,acquisition-completed-acquirer,100,49,3/1/2018
9C8BC3,note-sale,100,52,3/1/2018
9C8BC3,note-sale,100,52,3/1/2018
9CA619,conference-call,100,50,3/1/2018
9CDA4F,earnings,100,50,3/1/2018
9CE4C7,executive-appointment,100,54,3/1/2018
9D307D,conference-call,100,50,3/1/2018
9D6A24,note-sale,100,52,3/1/2018
9FB4B7,earnings,100,50,3/1/2018
A072C4,conference-call,100,50,3/1/2018
A0F146,unit-acquisition-acquiree,100,76,3/1/2018
A0F146,business-contract,100,69,3/1/2018
A0F146,acquisition-completed-acquirer,100,49,3/1/2018
A1BB98,earnings,100,50,3/1/2018
A3800A,earnings,100,50,3/1/2018
A5A4F5,acquisition-acquirer,100,49,3/1/2018
A631A3,earnings,100,50,3/1/2018
A63387,partnership,100,61,3/1/2018
A72AB6,conference-call,100,50,3/1/2018
A806FA,conference-participant,100,50,3/1/2018
A868C9,conference-participant,100,50,3/1/2018
AD23DE,earnings,100,50,3/1/2018
AD23DE,earnings,100,50,3/1/2018
AD23DE,earnings,100,50,3/1/2018
AD23DE,earnings,100,50,3/1/2018
AD23DE,earnings,100,50,3/1/2018
AD23DE,earnings,100,50,3/1/2018
AD23DE,earnings,100,50,3/1/2018
AD23DE,dividend,100,50,3/1/2018
AD9F1D,executive-appointment,100,54,3/1/2018
ADD9DC,facility-open,100,65,3/1/2018
AE4EEB,executive-resignation,100,44,3/1/2018
B04426,earnings,100,50,3/1/2018
B05118,earnings,100,50,3/1/2018
B1FC3B,earnings,100,50,3/1/2018
B303A6,executive-resignation,100,44,3/1/2018
B303A6,executive-resignation,100,44,3/1/2018
B3A166,earnings,100,50,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B3CB74,conference-organizer,100,57,3/1/2018
B5DE80,conference-participant,100,50,3/1/2018
B7FA9B,conference-participant,100,50,3/1/2018
B803B1,earnings,100,50,3/1/2018
B98EFA,operating-earnings,100,50,3/1/2018
BD44C9,earnings,100,50,3/1/2018
BDEC1E,earnings,100,50,3/1/2018
BE7BA4,earnings,100,50,3/1/2018
C0030A,conference-participant,100,50,3/1/2018
C22BE8,conference-call,100,50,3/1/2018
C36189,executive-appointment,100,54,3/1/2018
C3DE7D,earnings,100,50,3/1/2018
C45C1F,conference-participant,100,50,3/1/2018
C54140,earnings,100,50,3/1/2018
C54140,earnings,100,50,3/1/2018
C54140,earnings,100,50,3/1/2018
C54140,earnings,100,50,3/1/2018
C54140,earnings,100,50,3/1/2018
C5D2AE,acquisition-completed-acquirer,100,49,3/1/2018
C5D2AE,acquisition-completed-acquirer,100,49,3/1/2018
C5E100,earnings,100,50,3/1/2018
C8FAC7,earnings,100,50,3/1/2018
C8FAC7,earnings,100,50,3/1/2018
C8FAC7,dividend,100,50,3/1/2018
CB7AB2,conference-organizer,100,57,3/1/2018
CBB77B,business-contract,100,69,3/1/2018
CC0C78,earnings,100,50,3/1/2018
CDFCC9,earnings-guidance-down,100,19,3/1/2018
CDFCC9,acquisition-acquirer,100,49,3/1/2018
CDFCC9,acquisition-acquirer,100,49,3/1/2018
CF6A5A,partnership,100,61,3/1/2018
CF7292,conference-call,100,50,3/1/2018
D03C7A,executive-appointment,100,54,3/1/2018
D09938,buybacks,100,74,3/1/2018
D29B44,partnership,100,61,3/1/2018
D5AF19,trading-resumed,100,58,3/1/2018
D5B13D,conference-participant,100,50,3/1/2018
D650A7,conference-call,100,50,3/1/2018
D697DE,award,100,58,3/1/2018
D6EAA3,earnings,100,50,3/1/2018
D76AEF,dividend-up,100,59,3/1/2018
D76AEF,executive-appointment,100,54,3/1/2018
D90F43,partnership,100,61,3/1/2018
DA0CB8,dividend,100,50,3/1/2018
DA9443,earnings,100,50,3/1/2018
DAFED3,executive-appointment,100,54,3/1/2018
DC486E,stake-acquirer,100,48,3/1/2018
DC486E,stake-acquirer,100,48,3/1/2018
DC486E,stake-acquirer,100,48,3/1/2018
DF11D9,executive-appointment,100,54,3/1/2018
DF11D9,executive-appointment,100,54,3/1/2018
DF204B,conference-participant,100,50,3/1/2018
DFADDB,earnings,100,50,3/1/2018
E0339F,dividend,100,50,3/1/2018
E05026,conference-call,100,50,3/1/2018
E1C16B,partnership,100,61,3/1/2018
E30B34,conference-participant,100,50,3/1/2018
E41190,earnings,100,50,3/1/2018
E4CE73,earnings,100,50,3/1/2018
E754F0,executive-appointment,100,54,3/1/2018
E802CE,earnings,100,50,3/1/2018
E829E8,note-sale,100,52,3/1/2018
E866D2,partnership,100,61,3/1/2018
E8C557,earnings,100,50,3/1/2018
E90C84,dividend,100,50,3/1/2018
EAA0A7,earnings,100,50,3/1/2018
EB43F4,earnings,100,50,3/1/2018
EE1E44,conference-participant,100,50,3/1/2018
EE74E1,executive-appointment,100,54,3/1/2018
EF7163,earnings,100,50,3/1/2018
F0027C,earnings,100,50,3/1/2018
F0EEFB,earnings,100,50,3/1/2018
F1529C,conference-participant,100,50,3/1/2018
F2E253,buybacks,100,74,3/1/2018
F32F88,conference-participant,100,50,3/1/2018
F46EC9,conference-participant,100,50,3/1/2018
F51DB0,earnings,100,50,3/1/2018
F67165,conference-participant,100,50,3/1/2018
F9AA02,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD39EB,earnings,100,50,3/1/2018
FD4588,earnings,100,50,3/1/2018
FD554E,earnings,100,50,3/1/2018
FD9A97,conference-participant,100,50,3/1/2018
FDE409,revenues,100,50,3/1/2018
FDF799,debt-restructuring,100,59,3/1/2018
FE1A1D,partnership,100,61,3/1/2018
FE609F,earnings,100,50,3/1/2018
FE7A63,dividend,100,50,3/1/2018
FFE543,conference-participant,100,50,3/1/2018
070B45,award,100,58,3/2/2018
71860,conference-participant,100,50,3/2/2018
0A748B,earnings,100,50,3/2/2018
0BC853,earnings,100,50,3/2/2018
0C2A0D,business-contract,100,69,3/2/2018
0CE7F6,earnings,100,50,3/2/2018
0FC848,earnings,100,50,3/2/2018
1272B3,conference-participant,100,50,3/2/2018
12DE76,partnership,100,61,3/2/2018
12DE76,partnership,100,61,3/2/2018
12E454,partnership,100,61,3/2/2018
1348C9,asset-sale,100,62,3/2/2018
1348C9,unit-acquisition-completed-acquiree,100,67,3/2/2018
1490F3,dividend-up,100,81,3/2/2018
165B86,conference-participant,100,50,3/2/2018
168A5D,executive-appointment,100,54,3/2/2018
182BE7,conference-participant,100,50,3/2/2018
1834C0,conference-participant,100,50,3/2/2018
1AB023,earnings,100,50,3/2/2018
1AB023,earnings,100,50,3/2/2018
1AB023,earnings,100,50,3/2/2018
1F9258,conference-participant,100,50,3/2/2018
21245F,legal-issues-defendant,100,22,3/2/2018
25102A,conference-participant,100,50,3/2/2018
267718,partnership,100,61,3/2/2018
26CC63,earnings,100,50,3/2/2018
2A6DBE,clinical-trials,100,56,3/2/2018
2CC71C,conference-call,100,50,3/2/2018
2E1322,executive-appointment,100,54,3/2/2018
31553A,public-offering,100,43,3/2/2018
33E8C7,acquisition-completed-acquirer,100,49,3/2/2018
3461CF,credit-rating-upgrade-rater,20,50,3/2/2018
3471C0,conference-participant,100,50,3/2/2018
36C09B,conference-participant,100,50,3/2/2018
37B120,conference-call,100,50,3/2/2018
37E18B,earnings,100,50,3/2/2018
37E18B,earnings,100,50,3/2/2018
37E18B,earnings,100,50,3/2/2018
38C46F,dividend,100,50,3/2/2018
38FB49,conference-participant,100,50,3/2/2018
3A3447,facility-open,100,65,3/2/2018
3BB616,dividend,100,50,3/2/2018
425BDC,legal-issues-defendant,100,22,3/2/2018
431B74,acquisition-acquirer,100,49,3/2/2018
431B74,acquisition-acquirer,100,49,3/2/2018
4455C4,conference-participant,100,50,3/2/2018
44DDBD,public-offering,100,43,3/2/2018
4B49CF,reorganization-costs,100,47,3/2/2018
4C3FE9,earnings,100,50,3/2/2018
4DAF5F,buybacks,100,74,3/2/2018
4DAF5F,buybacks,100,74,3/2/2018
4E2D94,debt-extension-recipient,100,73,3/2/2018
4F9487,conference-participant,100,50,3/2/2018
50D1EC,award,100,58,3/2/2018
553949,executive-appointment,100,54,3/2/2018
55D0F3,unit-acquisition-completed-acquirer,100,49,3/2/2018
57356F,conference-participant,100,50,3/2/2018
57DDB9,conference-participant,100,50,3/2/2018
58CA9A,conference-organizer,100,57,3/2/2018
58CA9A,conference-organizer,100,57,3/2/2018
5E7E82,dividend,100,50,3/2/2018
6D2BF6,earnings,100,50,3/2/2018
6E7060,settlement,100,56,3/2/2018
6EB9DA,conference-participant,100,50,3/2/2018
722D55,executive-appointment,100,54,3/2/2018
723548,index-listing,100,76,3/2/2018
762A3E,conference-organizer,100,57,3/2/2018
762A3E,conference-organizer,100,57,3/2/2018
762A3E,conference-organizer,100,57,3/2/2018
762A3E,conference-organizer,100,57,3/2/2018
767F86,conference-participant,100,50,3/2/2018
7AB859,partnership,100,61,3/2/2018
7F9984,award,100,58,3/2/2018
804708,dividend,100,50,3/2/2018
83A065,index-listing,100,76,3/2/2018
877734,conference-call,100,50,3/2/2018
89E771,dividend,100,50,3/2/2018
89F693,award,100,58,3/2/2018
8C6C1B,facility-open,100,65,3/2/2018
8CF6DD,conference-call,100,50,3/2/2018
92D757,executive-appointment,100,54,3/2/2018
93633B,conference-participant,100,50,3/2/2018
97644E,acquisition-acquirer,100,49,3/2/2018
990AD0,conference-organizer,100,57,3/2/2018
9981C6,dividend-up,100,70,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
9E9147,earnings,100,50,3/2/2018
A495F7,partnership,100,61,3/2/2018
A5151E,conference-participant,100,50,3/2/2018
A5A4F5,acquisition-acquirer,100,49,3/2/2018
AA1EAA,conference-participant,100,50,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B3CB74,conference-organizer,100,57,3/2/2018
B77F14,earnings,100,50,3/2/2018
BE86A1,dividend,100,50,3/2/2018
BF79F5,executive-resignation,100,44,3/2/2018
BFE02C,dividend,100,50,3/2/2018
C22BE8,settlement,100,56,3/2/2018
C7859D,dividend,100,50,3/2/2018
C9E107,conference-participant,100,50,3/2/2018
CB89EA,conference-participant,100,50,3/2/2018
CBBFBF,award,100,58,3/2/2018
CBBFBF,award,100,58,3/2/2018
CC0C78,conference-participant,100,50,3/2/2018
CD4DA8,conference-organizer,100,57,3/2/2018
CD4DA8,conference-organizer,100,57,3/2/2018
CF7292,legal-issues-defendant,100,22,3/2/2018
CF7292,legal-issues-defendant,100,22,3/2/2018
CFF97C,credit-rating-upgrade-rater,20,50,3/2/2018
D1C26F,conference-participant,100,50,3/2/2018
D8DBA3,acquisition-acquirer,100,49,3/2/2018
D8DBA3,acquisition-acquirer,100,49,3/2/2018
DA0CB8,conference-participant,100,50,3/2/2018
DD0099,conference-participant,100,50,3/2/2018
DD7A96,dividend,100,50,3/2/2018
DF1F7A,dividend,100,50,3/2/2018
E05DC8,acquisition-completed-acquirer,100,49,3/2/2018
E6EDED,dividend,100,50,3/2/2018
E71AE6,conference-participant,100,50,3/2/2018
E71AE6,conference-participant,100,50,3/2/2018
EF5914,earnings,100,50,3/2/2018
F3016C,acquisition-acquirer,100,49,3/2/2018
F3D2EB,executive-resignation,100,44,3/2/2018
F4F46F,unit-acquisition-completed-acquiree,100,67,3/2/2018
F5349B,executive-appointment,100,54,3/2/2018
F57F6F,conference-organizer,100,57,3/2/2018
F6E1B5,conference-call,100,50,3/2/2018
F7ADEB,conference-participant,100,50,3/2/2018
FD2565,executive-resignation,100,44,3/2/2018
7AB859,fundraising,100,64,3/3/2018
CF7292,legal-issues-defendant,100,22,3/3/2018
126F95,legal-issues-defendant,100,22,3/4/2018
1D9E55,award,100,58,3/4/2018
0325B7,earnings,100,50,3/5/2018
036C6F,conference-call,100,50,3/5/2018
03FAA6,partnership,100,61,3/5/2018
0A0D9E,award,100,58,3/5/2018
0C2A0D,business-contract,100,69,3/5/2018
0E5223,public-offering,100,43,3/5/2018
0E5619,conference-call,100,50,3/5/2018
1080C0,earnings,100,50,3/5/2018
11A49E,conference-participant,100,50,3/5/2018
129DC8,shareholder-rights-plan-suspended,100,57,3/5/2018
159739,conference-call,100,50,3/5/2018
16B183,executive-appointment,100,54,3/5/2018
182B8C,conference-participant,100,50,3/5/2018
184866,conference-participant,100,50,3/5/2018
184988,executive-appointment,100,54,3/5/2018
1AF7E2,conference-participant,100,50,3/5/2018
1AF7E2,executive-resignation,100,44,3/5/2018
1F08A6,joint-venture,100,62,3/5/2018
1F9D90,conference-participant,100,50,3/5/2018
21268E,conference-participant,100,50,3/5/2018
232053,conference-participant,100,50,3/5/2018
2.45E+15,award,100,58,3/5/2018
24CB56,executive-resignation,100,44,3/5/2018
267718,executive-appointment,100,54,3/5/2018
26D8ED,conference-participant,100,50,3/5/2018
26FA41,conference-participant,100,50,3/5/2018
29CEBF,earnings,100,50,3/5/2018
2EB04E,partnership,100,61,3/5/2018
2F7A7E,public-offering,100,43,3/5/2018
30A565,legal-issues-defendant,100,22,3/5/2018
30DFD3,conference-participant,100,50,3/5/2018
31803E,conference-participant,100,50,3/5/2018
3301B7,buybacks,100,74,3/5/2018
367434,conference-participant,100,50,3/5/2018
383ADA,earnings,100,50,3/5/2018
3A3447,facility-open,100,65,3/5/2018
3DB18B,buybacks,100,74,3/5/2018
3DB18B,earnings,100,50,3/5/2018
3DDE54,conference-participant,100,50,3/5/2018
3EE65E,acquisition-acquirer,100,49,3/5/2018
4.03E+05,business-contract,100,69,3/5/2018
40F7DE,conference-participant,100,50,3/5/2018
41ED98,conference-call,100,50,3/5/2018
422CE3,partnership,100,61,3/5/2018
42978B,dividend,100,50,3/5/2018
442587,executive-appointment,100,54,3/5/2018
451D61,conference-participant,100,50,3/5/2018
4A2457,conference-participant,100,50,3/5/2018
4DAF5F,buybacks,100,74,3/5/2018
4DAF5F,buybacks,100,74,3/5/2018
4DD203,earnings,100,50,3/5/2018
52FB2F,conference-participant,100,50,3/5/2018
53A226,executive-appointment,100,54,3/5/2018
54512F,conference-participant,100,50,3/5/2018
548AC0,revenues,100,50,3/5/2018
548AC0,revenues,100,50,3/5/2018
548AC0,revenues,100,50,3/5/2018
55D0F3,earnings,100,50,3/5/2018
56EA2B,dividend,100,50,3/5/2018
57A854,conference-participant,100,50,3/5/2018
58CA9A,award,100,58,3/5/2018
58CA9A,conference-organizer,100,57,3/5/2018
58CA9A,conference-organizer,100,57,3/5/2018
59F0B0,conference-participant,100,50,3/5/2018
5B6C11,facility-open,100,65,3/5/2018
5D16CF,acquisition-completed-acquirer,100,49,3/5/2018
619882,partnership,100,61,3/5/2018
619882,conference-organizer,100,57,3/5/2018
619882,conference-organizer,100,57,3/5/2018
61A586,earnings,100,50,3/5/2018
62A48D,conference-call,100,50,3/5/2018
633043,earnings,100,50,3/5/2018
6634D9,executive-appointment,100,54,3/5/2018
665440,conference-call,100,50,3/5/2018
66667F,revenue-up,100,87,3/5/2018
6925EB,earnings,100,50,3/5/2018
6A171E,earnings,100,50,3/5/2018
701531,executive-appointment,100,54,3/5/2018
70CA28,conference-participant,100,50,3/5/2018
70CA28,conference-participant,100,50,3/5/2018
7.49E+07,conference-participant,100,50,3/5/2018
752A70,unit-acquisition-acquiree,100,76,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
762A3E,conference-organizer,100,57,3/5/2018
76BD96,executive-appointment,100,54,3/5/2018
76D79A,dividend,100,50,3/5/2018
789A7D,executive-appointment,100,54,3/5/2018
7999F3,conference-participant,100,50,3/5/2018
7A975D,award,100,58,3/5/2018
7AF5B8,partnership,100,61,3/5/2018
7BC92D,conference-participant,100,50,3/5/2018
7C4F43,conference-participant,100,50,3/5/2018
7C790D,earnings,100,50,3/5/2018
7F3A5F,campaign-ad-release,100,59,3/5/2018
7F9E16,earnings,100,50,3/5/2018
7FD8B9,conference-participant,100,50,3/5/2018
8.10E+32,dividend,100,50,3/5/2018
83066C,conference-participant,100,50,3/5/2018
86AA9C,investment-recipient,100,73,3/5/2018
883D82,legal-issues-defendant,100,22,3/5/2018
8C6C1B,facility-open,100,65,3/5/2018
93AD2E,executive-appointment,100,54,3/5/2018
943239,legal-issues-defendant,100,22,3/5/2018
94637C,conference-participant,100,50,3/5/2018
96F126,partnership,100,61,3/5/2018
9.74E+08,partnership,100,61,3/5/2018
97B027,conference-participant,100,50,3/5/2018
9C009A,conference-participant,100,50,3/5/2018
9E91C6,legal-issues-defendant,100,22,3/5/2018
9EA947,business-contract,100,69,3/5/2018
9EA947,business-contract,100,69,3/5/2018
9F6B1A,partnership,100,61,3/5/2018
A26EF7,conference-participant,100,50,3/5/2018
A3AAA5,dividend,100,50,3/5/2018
A433A5,private-placement,100,56,3/5/2018
A5A4F5,acquisition-acquirer,100,49,3/5/2018
A7102F,business-contract,100,69,3/5/2018
A806FA,joint-venture,100,62,3/5/2018
AC1952,ipo,100,71,3/5/2018
AC7AAE,earnings,100,50,3/5/2018
AD375D,conference-participant,100,50,3/5/2018
ADFB3A,conference-participant,100,50,3/5/2018
AE4125,conference-participant,100,50,3/5/2018
B04426,conference-participant,100,50,3/5/2018
B05000,executive-appointment,100,54,3/5/2018
B0D41A,earnings,100,50,3/5/2018
B13B68,conference-participant,100,50,3/5/2018
B1FC3B,government-contract,100,69,3/5/2018
B37FB4,public-offering,100,43,3/5/2018
B3CB74,conference-organizer,100,57,3/5/2018
B3CB74,conference-organizer,100,57,3/5/2018
B3CB74,conference-organizer,100,57,3/5/2018
B3CB74,conference-organizer,100,57,3/5/2018
B3CB74,conference-organizer,100,57,3/5/2018
B3CB74,conference-organizer,100,57,3/5/2018
B3CB74,conference-organizer,100,57,3/5/2018
B7BDA3,business-contract,100,69,3/5/2018
B7FA9B,earnings,100,50,3/5/2018
B7FA9B,earnings,100,50,3/5/2018
B7FA9B,earnings,100,50,3/5/2018
B7FA9B,earnings,100,50,3/5/2018
B80AD1,executive-appointment,100,54,3/5/2018
B83D67,conference-participant,100,50,3/5/2018
BA218A,executive-appointment,100,54,3/5/2018
BB127B,partnership,100,61,3/5/2018
BCC13E,partnership,100,61,3/5/2018
BCC13E,earnings,100,50,3/5/2018
C01737,clinical-trials,100,56,3/5/2018
C06EB6,fundraising,100,64,3/5/2018
C38440,executive-appointment,100,54,3/5/2018
C45C1F,public-offering,100,43,3/5/2018
C45CE7,buybacks,100,74,3/5/2018
C58D71,conference-participant,100,50,3/5/2018
C74887,conference-participant,100,50,3/5/2018
C83B88,partnership,100,61,3/5/2018
C97B2D,acquisition-acquirer,100,49,3/5/2018
C97B2D,conference-participant,100,50,3/5/2018
CAC8D0,asset-sale,100,62,3/5/2018
CB89EA,award,100,58,3/5/2018
CB89EA,award,100,58,3/5/2018
CBB77B,earnings,100,50,3/5/2018
CBCC6A,conference-organizer,100,57,3/5/2018
CC176E,conference-participant,100,50,3/5/2018
CF211D,conference-participant,100,50,3/5/2018
CF7292,legal-issues-defendant,100,22,3/5/2018
CF7292,legal-issues-defendant,100,22,3/5/2018
CF7292,legal-issues-defendant,100,22,3/5/2018
D07B07,earnings,100,50,3/5/2018
D07B07,earnings,100,50,3/5/2018
D11C1C,unit-acquisition-acquirer,100,49,3/5/2018
D15833,board-meeting,100,51,3/5/2018
D2B9E5,acquisition-acquiree,100,76,3/5/2018
D45285,market-entry,100,57,3/5/2018
D57D99,executive-appointment,100,54,3/5/2018
D697DE,earnings,100,50,3/5/2018
D721C6,facility-open,100,65,3/5/2018
DB9F70,earnings,100,50,3/5/2018
DBB28E,partnership,100,61,3/5/2018
DBB28E,acquisition-completed-acquirer,100,49,3/5/2018
DD1BA1,conference-organizer,100,57,3/5/2018
DD1BA1,business-contract,100,69,3/5/2018
DFADDB,conference-participant,100,50,3/5/2018
E2CFD2,executive-appointment,100,54,3/5/2018
E5752F,partnership,100,61,3/5/2018
E68E62,conference-participant,100,50,3/5/2018
E6EDED,conference-participant,100,50,3/5/2018
E7BF32,earnings,100,50,3/5/2018
E7BF32,earnings,100,50,3/5/2018
E8A49A,partnership,100,61,3/5/2018
E9C7C0,product-release,100,64,3/5/2018
EA79C7,patient-enrollment-complete,100,64,3/5/2018
ED9C04,conference-participant,100,50,3/5/2018
F4D241,conference-participant,100,50,3/5/2018
F5C8AB,product-release,100,64,3/5/2018
F5D410,acquisition-acquirer,100,49,3/5/2018
F5D410,acquisition-acquirer,100,49,3/5/2018
F66B58,earnings,100,50,3/5/2018
F6A987,dividend,100,50,3/5/2018
F6E248,clinical-trials,100,56,3/5/2018
F6E248,clinical-trials,100,56,3/5/2018
F6E248,clinical-trials,100,56,3/5/2018
F6E248,clinical-trials,100,56,3/5/2018
FA40E2,acquisition-interest-acquiree,100,82,3/5/2018
FC4550,dividend,100,50,3/5/2018
FD2565,conference-participant,100,50,3/5/2018
FD554E,dividend,100,50,3/5/2018
FEC475,business-contract,100,69,3/5/2018
FFCD0E,conference-call,100,50,3/5/2018
00326E,award,100,58,3/6/2018
20751,conference-participant,100,50,3/6/2018
02FC1A,conference-participant,100,50,3/6/2018
0358AF,dividend-up,100,81,3/6/2018
070B45,product-release,100,64,3/6/2018
0919B1,earnings,100,50,3/6/2018
0A0CF0,partnership,100,61,3/6/2018
0A77DB,partnership,100,61,3/6/2018
0B7375,conference-participant,100,50,3/6/2018
0E499E,conference-participant,100,50,3/6/2018
0E5223,public-offering,100,43,3/6/2018
1080C0,conference-participant,100,50,3/6/2018
1201B5,public-offering,100,43,3/6/2018
1272B3,earnings,100,50,3/6/2018
149301,executive-appointment,100,54,3/6/2018
14ED2B,conference-participant,100,50,3/6/2018
159739,dividend,100,50,3/6/2018
168A5D,executive-appointment,100,54,3/6/2018
196D18,conference-participant,100,50,3/6/2018
196D18,conference-participant,100,50,3/6/2018
1B4F31,business-contract,100,69,3/6/2018
1CD09C,conference-participant,100,50,3/6/2018
1D3A00,partnership,100,61,3/6/2018
1D943E,unit-acquisition-acquiree,100,76,3/6/2018
1E9A6D,note-sale,100,52,3/6/2018
1E9A6D,note-sale,100,52,3/6/2018
1F9D90,business-contract,100,69,3/6/2018
1FA886,buybacks,100,74,3/6/2018
202E5A,conference-participant,100,50,3/6/2018
21D903,executive-appointment,100,54,3/6/2018
24FA23,conference-participant,100,50,3/6/2018
251988,partnership,100,61,3/6/2018
279916,earnings,100,50,3/6/2018
2AA6A8,earnings,100,50,3/6/2018
2ABF77,conference-participant,100,50,3/6/2018
2F9304,executive-appointment,100,54,3/6/2018
2F98A5,business-contract-terminated,100,31,3/6/2018
314D88,earnings,100,50,3/6/2018
3587B4,award,100,58,3/6/2018
36A1CB,conference-participant,100,50,3/6/2018
36C09B,conference-call,100,50,3/6/2018
36E479,conference-participant,100,50,3/6/2018
3EE65E,earnings,100,50,3/6/2018
401072,conference-participant,100,50,3/6/2018
427F32,earnings,100,50,3/6/2018
485445,dividend,100,50,3/6/2018
4A6F00,partnership,100,61,3/6/2018
4A6F00,partnership,100,61,3/6/2018
4C3FE9,conference-participant,100,50,3/6/2018
4DAF5F,buybacks,100,74,3/6/2018
4DAF5F,buybacks,100,74,3/6/2018
55438C,business-contract,100,69,3/6/2018
55438C,acquisition-acquiree,100,76,3/6/2018
56277A,product-release,100,64,3/6/2018
56277A,product-release,100,64,3/6/2018
583A75,acquisition-acquirer,100,49,3/6/2018
583A75,revenue-volume,100,50,3/6/2018
58CA9A,conference-organizer,100,57,3/6/2018
5968F9,conference-participant,100,50,3/6/2018
5B7739,product-release,100,64,3/6/2018
5B7739,earnings,100,50,3/6/2018
5D41E4,executive-appointment,100,54,3/6/2018
5D41E4,executive-appointment,100,54,3/6/2018
5D41E4,executive-appointment,100,54,3/6/2018
5D63F1,partnership,100,61,3/6/2018
5F2FF7,conference-participant,100,50,3/6/2018
5F3D91,conference-participant,100,50,3/6/2018
6137BF,conference-participant,100,50,3/6/2018
619882,conference-organizer,100,57,3/6/2018
619882,conference-organizer,100,57,3/6/2018
619882,conference-organizer,100,57,3/6/2018
619882,conference-organizer,100,57,3/6/2018
62B1C6,earnings,100,50,3/6/2018
64E346,earnings,100,50,3/6/2018
665618,conference-participant,100,50,3/6/2018
694749,earnings,100,50,3/6/2018
6B6375,conference-participant,100,50,3/6/2018
6D2BF6,earnings,100,50,3/6/2018
6E705B,conference-participant,100,50,3/6/2018
6F0096,dividend,100,50,3/6/2018
6FCEF9,earnings,100,50,3/6/2018
70FCEF,earnings,100,50,3/6/2018
7448A3,conference-participant,100,50,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
762A3E,conference-organizer,100,57,3/6/2018
7710F3,conference-call,100,50,3/6/2018
7ACD98,award,100,58,3/6/2018
7ADE57,earnings,100,50,3/6/2018
7ADE57,earnings,100,50,3/6/2018
7ADE57,earnings,100,50,3/6/2018
7ADE57,earnings,100,50,3/6/2018
7ADE57,earnings,100,50,3/6/2018
7DA412,executive-appointment,100,54,3/6/2018
7DA412,executive-appointment,100,54,3/6/2018
7DD8CC,dividend,100,50,3/6/2018
7F3669,buybacks,100,74,3/6/2018
805CD8,conference-participant,100,50,3/6/2018
830BDB,conference-participant,100,50,3/6/2018
834152,earnings,100,50,3/6/2018
848C0B,earnings,100,50,3/6/2018
862941,conference-participant,100,50,3/6/2018
880C0C,earnings,100,50,3/6/2018
883D82,legal-issues-defendant,100,22,3/6/2018
8876D6,executive-resignation,100,44,3/6/2018
89FBB1,earnings,100,50,3/6/2018
8A0368,conference-participant,100,50,3/6/2018
8A8E41,dividend,100,50,3/6/2018
8C6C1B,facility-open,100,65,3/6/2018
8C6C1B,earnings-up,100,68,3/6/2018
8C6C1B,earnings,100,50,3/6/2018
8E0E32,acquisition-interest-acquirer,100,46,3/6/2018
8E0E32,acquisition-interest-acquirer,100,46,3/6/2018
901327,note-sale,100,52,3/6/2018
902670,executive-appointment,100,54,3/6/2018
925759,conference-participant,100,50,3/6/2018
931AE7,board-meeting,100,51,3/6/2018
947B0B,earnings,100,50,3/6/2018
9.74E+08,partnership,100,61,3/6/2018
97644E,executive-appointment,100,54,3/6/2018
990AD0,conference-organizer,100,57,3/6/2018
990AD0,conference-organizer,100,57,3/6/2018
994468,dividend,100,50,3/6/2018
9B730A,earnings,100,50,3/6/2018
9BF177,earnings,100,50,3/6/2018
9D5FA4,conference-participant,100,50,3/6/2018
9F048E,conference-participant,100,50,3/6/2018
A247F5,conference-participant,100,50,3/6/2018
A403CF,product-release,100,64,3/6/2018
A5A4F5,acquisition-acquirer,100,49,3/6/2018
A60354,dividend,100,50,3/6/2018
A666C8,product-release,100,64,3/6/2018
A6828A,conference-participant,100,50,3/6/2018
A74F6F,earnings,100,50,3/6/2018
A7F0A5,public-offering,100,43,3/6/2018
AC3584,revenue-up,100,82,3/6/2018
AC3584,revenue-up,100,82,3/6/2018
AC3584,revenue-up,100,82,3/6/2018
ACC7D3,conference-participant,100,50,3/6/2018
AD375D,conference-participant,100,50,3/6/2018
AD3C93,legal-issues-defendant,100,22,3/6/2018
ADF092,acquisition-completed-acquirer,100,49,3/6/2018
AEBB80,earnings,100,50,3/6/2018
AEFC90,conference-participant,100,50,3/6/2018
B01215,conference-call,100,50,3/6/2018
B08C51,earnings,100,50,3/6/2018
B0FE08,executive-appointment,100,54,3/6/2018
B2D799,earnings,100,50,3/6/2018
B37FB4,public-offering,100,43,3/6/2018
B3CB74,facility-open,100,65,3/6/2018
B7FA9B,conference-participant,100,50,3/6/2018
B803B1,note-sale,100,52,3/6/2018
B85DCE,conference-participant,100,50,3/6/2018
BAD655,earnings,100,50,3/6/2018
BAD655,earnings,100,50,3/6/2018
BAD655,earnings,100,50,3/6/2018
BB58FF,conference-participant,100,50,3/6/2018
BDA775,earnings,100,50,3/6/2018
C01737,earnings,100,50,3/6/2018
C0F70B,conference-participant,100,50,3/6/2018
C22BE8,earnings-up,100,68,3/6/2018
C22BE8,earnings,100,50,3/6/2018
C22BE8,earnings,100,50,3/6/2018
C2DD02,conference-call,100,50,3/6/2018
C356AC,executive-appointment,100,54,3/6/2018
C356AC,executive-appointment,100,54,3/6/2018
C3F99F,earnings,100,50,3/6/2018
C48574,conference-participant,100,50,3/6/2018
C4F9C6,board-meeting,100,51,3/6/2018
C584BE,conference-participant,100,50,3/6/2018
C5E100,conference-participant,100,50,3/6/2018
C81E00,product-release,100,64,3/6/2018
CAB222,earnings,100,50,3/6/2018
CAD7D9,conference-participant,100,50,3/6/2018
CBB77B,conference-participant,100,50,3/6/2018
CD051C,credit-extension-recipient,100,69,3/6/2018
CDAF5B,dividend,100,50,3/6/2018
CE4FD9,conference-participant,100,50,3/6/2018
CF3FF9,earnings,100,50,3/6/2018
CFF57D,earnings,100,50,3/6/2018
CFF57D,earnings,100,50,3/6/2018
CFF57D,earnings,100,50,3/6/2018
CFF57D,earnings,100,50,3/6/2018
CFF97C,buybacks,100,74,3/6/2018
D139BC,earnings,100,50,3/6/2018
D1C26F,conference-participant,100,50,3/6/2018
D518D8,dividend,100,50,3/6/2018
D56D6D,award,100,58,3/6/2018
D5AF19,partnership,100,61,3/6/2018
D78CCD,executive-appointment,100,54,3/6/2018
D7918D,conference-call,100,50,3/6/2018
D90F43,partnership,100,61,3/6/2018
DB5CA5,public-offering,100,43,3/6/2018
DB5CA5,public-offering,100,43,3/6/2018
DBB28E,product-release,100,64,3/6/2018
DC6EF3,asset-sale,100,62,3/6/2018
DD1BA1,business-contract,100,69,3/6/2018
DD682D,public-offering,100,43,3/6/2018
DDEA6A,earnings,100,50,3/6/2018
DE5611,earnings,100,50,3/6/2018
DF18E6,earnings,100,50,3/6/2018
E05026,earnings,100,50,3/6/2018
E124EB,product-release,100,64,3/6/2018
E13782,earnings,100,50,3/6/2018
E20BFE,revenues,100,50,3/6/2018
E20BFE,revenues,100,50,3/6/2018
E20BFE,revenues,100,50,3/6/2018
E2CB7B,earnings,100,50,3/6/2018
E4CE73,buybacks,100,74,3/6/2018
E68E62,earnings,100,50,3/6/2018
E68E62,earnings,100,50,3/6/2018
E74B55,partnership,100,61,3/6/2018
E9C7C0,partnership,100,61,3/6/2018
EA79C7,conference-participant,100,50,3/6/2018
EBD89A,buybacks,100,74,3/6/2018
ECDEB2,executive-resignation,100,44,3/6/2018
ED79D9,award,100,58,3/6/2018
EDF5CA,executive-appointment,100,54,3/6/2018
EE74E1,earnings-guidance,100,50,3/6/2018
F0027C,conference-participant,100,50,3/6/2018
F1EB39,earnings,100,50,3/6/2018
F1EB39,business-contract,100,69,3/6/2018
F40EE2,product-release,100,64,3/6/2018
F6581D,conference-participant,100,50,3/6/2018
F6DCE4,earnings,100,50,3/6/2018
F6E1B5,conference-participant,100,50,3/6/2018
FA35C6,index-listing,100,76,3/6/2018
FA40E2,business-contract-terminated,100,31,3/6/2018
FA40E2,acquisition-interest-acquiree,100,82,3/6/2018
FAE021,executive-appointment,100,54,3/6/2018
FBD92D,earnings,100,50,3/6/2018
FD6926,conference-participant,100,50,3/6/2018
FDF28E,executive-appointment,100,54,3/6/2018
FDF799,earnings,100,50,3/6/2018
FEE4B0,note-sale,100,52,3/6/2018
FEE4B0,note-sale,100,52,3/6/2018
001F1B,revenues,100,50,3/7/2018
0157B1,facility-open,100,65,3/7/2018
0157B1,partnership,100,61,3/7/2018
053EFF,earnings,100,50,3/7/2018
0624BE,earnings,100,50,3/7/2018
07C907,dividend,100,50,3/7/2018
95294,note-sale,100,52,3/7/2018
0A77DB,earnings,100,50,3/7/2018
0A9D0A,conference-participant,100,50,3/7/2018
0BF198,conference-participant,100,50,3/7/2018
0BF528,earnings,100,50,3/7/2018
0D03C8,conference-participant,100,50,3/7/2018
0DBB81,conference-participant,100,50,3/7/2018
0EF1AF,earnings,100,50,3/7/2018
0EF1AF,earnings,100,50,3/7/2018
0FABBD,conference-participant,100,50,3/7/2018
0FC848,spin-off,100,58,3/7/2018
0FE3A6,earnings,100,50,3/7/2018
1220D2,conference-participant,100,50,3/7/2018
143C52,earnings-up,100,68,3/7/2018
143C52,earnings,100,50,3/7/2018
143C52,earnings,100,50,3/7/2018
143C52,earnings,100,50,3/7/2018
14BA06,dividend-up,100,74,3/7/2018
14BA06,asset-sale,100,62,3/7/2018
17EDA5,legal-issues-defendant,100,22,3/7/2018
1866B2,dividend,100,50,3/7/2018
1AB023,conference-participant,100,50,3/7/2018
1AB023,conference-participant,100,50,3/7/2018
1AB023,conference-participant,100,50,3/7/2018
1BC12C,partnership,100,61,3/7/2018
1E83DE,earnings,100,50,3/7/2018
1EBF8D,partnership,100,61,3/7/2018
1FA886,acquisition-completed-acquiree,100,76,3/7/2018
2003A5,earnings,100,50,3/7/2018
2082EA,conference-participant,100,50,3/7/2018
2096DE,earnings,100,50,3/7/2018
232053,conference-call,100,50,3/7/2018
24FA23,earnings,100,50,3/7/2018
292A70,earnings,100,50,3/7/2018
295F9F,earnings,100,50,3/7/2018
2B8179,earnings,100,50,3/7/2018
2C681C,conference-call,100,50,3/7/2018
2C681C,conference-call,100,50,3/7/2018
2F7A7E,public-offering,100,43,3/7/2018
2F960F,earnings,100,50,3/7/2018
30A565,legal-issues-defendant,100,22,3/7/2018
30AB63,earnings-guidance,100,50,3/7/2018
349DA4,earnings,100,50,3/7/2018
367E1C,conference-participant,100,50,3/7/2018
36E479,clinical-trials,100,56,3/7/2018
384CD3,business-contract,100,69,3/7/2018
396D7C,earnings,100,50,3/7/2018
3B37F7,earnings,100,50,3/7/2018
3BA1BF,conference-call,100,50,3/7/2018
3CBA2A,facility-open,100,65,3/7/2018
3DD5E2,earnings,100,50,3/7/2018
416C55,conference-participant,100,50,3/7/2018
416C55,conference-participant,100,50,3/7/2018
425BDC,legal-issues-defendant,100,22,3/7/2018
43A060,partnership,100,61,3/7/2018
44ED36,reorganization,100,53,3/7/2018
44ED36,reorganization,100,53,3/7/2018
467F2C,conference-participant,100,50,3/7/2018
4C31F3,conference-call,100,50,3/7/2018
4C350A,conference-call,100,50,3/7/2018
4DAF5F,buybacks,100,74,3/7/2018
4DAF5F,buybacks,100,74,3/7/2018
504FE2,government-contract,100,69,3/7/2018
507AE7,award,100,58,3/7/2018
524CE4,conference-participant,100,50,3/7/2018
5340D0,legal-issues-defendant,100,22,3/7/2018
5487B1,dividend,100,50,3/7/2018
567F3D,business-combination,100,54,3/7/2018
57A854,conference-call,100,50,3/7/2018
594402,conference-participant,100,50,3/7/2018
5AAE17,earnings,100,50,3/7/2018
5C2A47,product-release,100,64,3/7/2018
609208,conference-call,100,50,3/7/2018
60FE03,public-offering,100,43,3/7/2018
619882,conference-organizer,100,57,3/7/2018
619882,conference-organizer,100,57,3/7/2018
619882,business-contract,100,69,3/7/2018
619882,conference-organizer,100,57,3/7/2018
619882,conference-organizer,100,57,3/7/2018
619882,conference-organizer,100,57,3/7/2018
62B1C6,earnings,100,50,3/7/2018
62B1C6,earnings,100,50,3/7/2018
67303E,conference-participant,100,50,3/7/2018
6810DE,earnings,100,50,3/7/2018
6830FE,partnership,100,61,3/7/2018
69C99E,earnings,100,50,3/7/2018
69CE71,award,100,58,3/7/2018
6.00E+19,business-contract,100,69,3/7/2018
6E8864,conference-participant,100,50,3/7/2018
704B78,conference-participant,100,50,3/7/2018
713810,business-contract,100,69,3/7/2018
713810,conference-participant,100,50,3/7/2018
7255D2,earnings,100,50,3/7/2018
72FCA3,executive-appointment,100,54,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
762A3E,conference-organizer,100,57,3/7/2018
769F40,earnings,100,50,3/7/2018
76F067,conference-participant,100,50,3/7/2018
76F067,dividend,100,50,3/7/2018
787D14,earnings-guidance,100,50,3/7/2018
787D14,dividend,100,50,3/7/2018
7BEA98,conference-call,100,50,3/7/2018
7BEA98,conference-call,100,50,3/7/2018
826FD6,earnings,100,50,3/7/2018
8303CD,executive-appointment,100,54,3/7/2018
8377DB,acquisition-completed-acquirer,100,49,3/7/2018
859D62,earnings-up,100,68,3/7/2018
859D62,earnings-up,100,68,3/7/2018
859D62,earnings-up,100,68,3/7/2018
859D62,earnings-up,100,68,3/7/2018
859D62,earnings-up,100,68,3/7/2018
859D62,earnings-up,100,68,3/7/2018
877C0C,conference-participant,100,50,3/7/2018
8AC740,dividend,100,50,3/7/2018
8C6C1B,facility-open,100,65,3/7/2018
8D5145,executive-appointment,100,54,3/7/2018
8D9993,facility-open,100,65,3/7/2018
8DBE73,note-sale,100,52,3/7/2018
8E4F9A,conference-participant,100,50,3/7/2018
8E4F9A,earnings,100,50,3/7/2018
934029,clinical-trials-start,100,64,3/7/2018
93965C,conference-participant,100,50,3/7/2018
94637C,business-contract,100,69,3/7/2018
94637C,conference-participant,100,50,3/7/2018
947B0B,conference-participant,100,50,3/7/2018
9592FB,earnings,100,50,3/7/2018
96A6CD,conference-participant,100,50,3/7/2018
96F126,facility-open,100,65,3/7/2018
990AD0,conference-organizer,100,57,3/7/2018
9978F1,conference-participant,100,50,3/7/2018
9A602D,unit-acquisition-acquiree,100,76,3/7/2018
9B4066,unit-acquisition-acquirer,100,49,3/7/2018
9EED50,award,100,58,3/7/2018
9F5CBB,executive-appointment,100,54,3/7/2018
A21649,dividend,100,50,3/7/2018
A26EF7,earnings,100,50,3/7/2018
A4BCDE,award,100,58,3/7/2018
A5A4F5,acquisition-acquirer,100,49,3/7/2018
A5DD24,conference-participant,100,50,3/7/2018
A70BF5,product-release,100,64,3/7/2018
A8FDE8,earnings,100,50,3/7/2018
B08954,dividend,100,50,3/7/2018
B1A85D,business-contract,100,69,3/7/2018
B1B10C,executive-appointment,100,54,3/7/2018
B1FC3B,earnings,100,50,3/7/2018
B1FC3B,dividend,100,50,3/7/2018
B3ED62,earnings,100,50,3/7/2018
B53C12,earnings,100,50,3/7/2018
B6CD92,executive-appointment,100,54,3/7/2018
B7202A,earnings,100,50,3/7/2018
B8EF97,earnings,100,50,3/7/2018
BFD0A7,conference-call,100,50,3/7/2018
C01737,conference-participant,100,50,3/7/2018
C356AC,product-release,100,64,3/7/2018
C425AE,facility-open,100,65,3/7/2018
C4F9C6,conference-participant,100,50,3/7/2018
C5D2AE,conference-participant,100,50,3/7/2018
C7FC95,business-contract,100,69,3/7/2018
C8923A,conference-participant,100,50,3/7/2018
CB89EA,earnings,100,50,3/7/2018
CBB77B,dividend,100,50,3/7/2018
CC3EC4,conference-participant,100,50,3/7/2018
CFD4B6,business-contract,100,69,3/7/2018
D064D5,earnings-up,100,68,3/7/2018
D0909F,dividend,100,50,3/7/2018
D0909F,dividend,100,50,3/7/2018
D2E553,earnings-up,100,68,3/7/2018
D2E553,earnings-up,100,68,3/7/2018
D854F3,dividend-up,100,81,3/7/2018
DA48E4,conference-participant,100,50,3/7/2018
DA9443,conference-participant,100,50,3/7/2018
DB5CA5,public-offering,100,43,3/7/2018
DBFB51,earnings,100,50,3/7/2018
DC2B00,executive-appointment,100,54,3/7/2018
DCD97F,dividend-up,100,81,3/7/2018
DF5F14,conference-call,100,50,3/7/2018
E05026,buybacks,100,74,3/7/2018
E06265,earnings,100,50,3/7/2018
E0647D,earnings,100,50,3/7/2018
E0647D,earnings,100,50,3/7/2018
E09997,executive-appointment,100,54,3/7/2018
E1C16B,executive-appointment,100,54,3/7/2018
E49AA3,acquisition-completed-acquirer,100,49,3/7/2018
E5752F,partnership,100,61,3/7/2018
EB6965,dividend-up,100,55,3/7/2018
EC99D0,award,100,58,3/7/2018
ED0D7C,business-combination,100,54,3/7/2018
EDD234,conference-call,100,50,3/7/2018
F0B335,clinical-trials-positive,100,87,3/7/2018
F0B335,conference-participant,100,50,3/7/2018
F748C7,partnership,100,61,3/7/2018
F769E9,conference-participant,100,50,3/7/2018
FBD92D,conference-participant,100,50,3/7/2018
FC1736,earnings,100,50,3/7/2018
FC8733,stake-acquirer,100,48,3/7/2018
20751,earnings,100,50,3/8/2018
0490C6,earnings-up,100,68,3/8/2018
0490C6,earnings,100,50,3/8/2018
0490C6,earnings,100,50,3/8/2018
0490C6,earnings,100,50,3/8/2018
0B13E8,earnings,100,50,3/8/2018
0B73A7,earnings,100,50,3/8/2018
0B73A7,earnings,100,50,3/8/2018
0F2BC9,earnings,100,50,3/8/2018
102F04,earnings,100,50,3/8/2018
106394,earnings,100,50,3/8/2018
129DC8,executive-appointment,100,54,3/8/2018
14391F,earnings,100,50,3/8/2018
152AB9,earnings,100,50,3/8/2018
152AB9,legal-issues-defendant,100,22,3/8/2018
15B10D,conference-call,100,50,3/8/2018
1748F6,earnings,100,50,3/8/2018
17EDA5,unit-acquisition-completed-acquirer,100,49,3/8/2018
1866B2,earnings,100,50,3/8/2018
1880C5,conference-call,100,50,3/8/2018
1AF7E2,earnings,100,50,3/8/2018
1B16C1,conference-call,100,50,3/8/2018
1CD708,dividend,100,50,3/8/2018
1EA923,executive-appointment,100,54,3/8/2018
1F3CFB,executive-appointment,100,54,3/8/2018
1F464F,earnings,100,50,3/8/2018
1F9258,revenue-up,100,83,3/8/2018
1FA886,product-release,100,64,3/8/2018
232053,executive-appointment,100,54,3/8/2018
2CC60C,revenue-up,100,69,3/8/2018
2CC71C,earnings,100,50,3/8/2018
2D643C,conference-participant,100,50,3/8/2018
2F94A5,partnership,100,61,3/8/2018
301493,earnings,100,50,3/8/2018
306623,conference-participant,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
30CBF9,earnings,100,50,3/8/2018
32CB22,executive-appointment,100,54,3/8/2018
337024,earnings,100,50,3/8/2018
337024,earnings,100,50,3/8/2018
33AD83,earnings,100,50,3/8/2018
36C09B,earnings,100,50,3/8/2018
371B0A,earnings,100,50,3/8/2018
371B0A,conference-participant,100,50,3/8/2018
371B0A,conference-participant,100,50,3/8/2018
37B120,earnings,100,50,3/8/2018
3A3447,facility-open,100,65,3/8/2018
3ACF46,earnings,100,50,3/8/2018
3ACF46,earnings,100,50,3/8/2018
3ACF46,earnings,100,50,3/8/2018
3ACF46,earnings,100,50,3/8/2018
3BC360,earnings,100,50,3/8/2018
3CBA2A,partnership,100,61,3/8/2018
3F1C69,earnings,100,50,3/8/2018
414FFF,executive-appointment,100,54,3/8/2018
41ED98,earnings,100,50,3/8/2018
422CE3,investment-investor,100,55,3/8/2018
458D2C,revenue-volume,100,50,3/8/2018
4.60E+06,earnings,100,50,3/8/2018
4885C8,unit-acquisition-acquiree,100,76,3/8/2018
494EB9,index-listing,100,76,3/8/2018
4B7006,board-meeting,100,51,3/8/2018
4C3FE9,earnings,100,50,3/8/2018
4DAF5F,buybacks,100,74,3/8/2018
4DAF5F,buybacks,100,74,3/8/2018
4FCC78,earnings,100,50,3/8/2018
4FCC78,earnings,100,50,3/8/2018
52BF94,conference-call,100,50,3/8/2018
52FB2F,facility-open,100,65,3/8/2018
53EF9E,dividend,100,50,3/8/2018
53EF9E,conference-participant,100,50,3/8/2018
54DF47,earnings,100,50,3/8/2018
550D01,facility-open,100,65,3/8/2018
556F08,conference-participant,100,50,3/8/2018
56277A,note-sale,100,52,3/8/2018
567F3D,conference-participant,100,50,3/8/2018
5704AC,note-sale,100,52,3/8/2018
58C2D4,earnings,100,50,3/8/2018
5968F9,regulatory-product-approval-granted,100,81,3/8/2018
5AF08A,unit-acquisition-completed-acquirer,100,49,3/8/2018
5B3FA2,earnings,100,50,3/8/2018
5B3FA2,earnings,100,50,3/8/2018
5B3FA2,earnings,100,50,3/8/2018
5EAA43,conference-participant,100,50,3/8/2018
60DD84,partnership,100,61,3/8/2018
60EA12,conference-participant,100,50,3/8/2018
60FE03,public-offering,100,43,3/8/2018
619882,conference-organizer,100,57,3/8/2018
619882,conference-organizer,100,57,3/8/2018
619882,conference-organizer,100,57,3/8/2018
619882,conference-organizer,100,57,3/8/2018
619882,conference-organizer,100,57,3/8/2018
61BCA7,public-offering,100,43,3/8/2018
64E615,conference-participant,100,50,3/8/2018
6830FE,earnings,100,50,3/8/2018
68586A,earnings,100,50,3/8/2018
68B03F,executive-appointment,100,54,3/8/2018
68B03F,executive-appointment,100,54,3/8/2018
68B03F,executive-appointment,100,54,3/8/2018
69FDFC,product-release,100,64,3/8/2018
69FDFC,product-release,100,64,3/8/2018
69FDFC,product-release,100,64,3/8/2018
69FDFC,product-release,100,64,3/8/2018
6.00E+19,legal-issues-plaintiff,100,44,3/8/2018
6E705B,partnership,100,61,3/8/2018
6E705B,executive-appointment,100,54,3/8/2018
6F6559,earnings,100,50,3/8/2018
71B0CF,earnings,100,50,3/8/2018
7273FF,board-meeting,100,51,3/8/2018
72DF04,conference-participant,100,50,3/8/2018
72FCA3,earnings,100,50,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
762A3E,conference-organizer,100,57,3/8/2018
76BD96,note-sale,100,52,3/8/2018
7740DE,same-store-sales-down,100,45,3/8/2018
793C11,executive-appointment,100,54,3/8/2018
7B6C88,award,100,58,3/8/2018
7B9212,earnings,100,50,3/8/2018
7E1D5D,partnership,100,61,3/8/2018
7FD8B9,earnings,100,50,3/8/2018
863350,earnings,100,50,3/8/2018
86A1B9,acquisition-acquirer,100,49,3/8/2018
86A1B9,acquisition-acquirer,100,49,3/8/2018
86A1B9,acquisition-interest-acquirer,100,46,3/8/2018
86A1B9,business-contract,100,69,3/8/2018
8B1F37,dividend,100,50,3/8/2018
8BFAA4,earnings,100,50,3/8/2018
8C6C1B,facility-open,100,65,3/8/2018
91E5EE,conference-participant,100,50,3/8/2018
92D757,executive-appointment,100,54,3/8/2018
949D62,earnings,100,50,3/8/2018
94C0B5,executive-appointment,100,54,3/8/2018
954004,conference-call,100,50,3/8/2018
95DC1F,earnings,100,50,3/8/2018
966ACE,conference-participant,100,50,3/8/2018
96BFF4,earnings,100,50,3/8/2018
96F126,business-contract,100,69,3/8/2018
990AD0,conference-organizer,100,57,3/8/2018
990AD0,conference-organizer,100,57,3/8/2018
9978F1,earnings,100,50,3/8/2018
9ABD30,earnings,100,50,3/8/2018
9B4066,unit-acquisition-acquirer,100,49,3/8/2018
9D56F2,partnership,100,61,3/8/2018
A072C4,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A1BB98,earnings,100,50,3/8/2018
A26C26,earnings,100,50,3/8/2018
A28675,earnings,100,50,3/8/2018
A37D68,earnings,100,50,3/8/2018
A52533,earnings,100,50,3/8/2018
A5A4F5,acquisition-acquirer,100,49,3/8/2018
A7102F,legal-issues-defendant,100,22,3/8/2018
A7102F,legal-issues-defendant,100,22,3/8/2018
A72AB6,earnings-up,100,68,3/8/2018
A7F0A5,public-offering,100,43,3/8/2018
AAEE21,note-sale,100,52,3/8/2018
AE4125,earnings,100,50,3/8/2018
B01215,earnings,100,50,3/8/2018
B04426,earnings,100,50,3/8/2018
B076A1,dividend,100,50,3/8/2018
B106FA,earnings,100,50,3/8/2018
B3ED62,buybacks,100,74,3/8/2018
B5734D,earnings,100,50,3/8/2018
B98EFA,revenue-up,100,69,3/8/2018
BAD9EA,conference-participant,100,50,3/8/2018
BD682F,dividend,100,50,3/8/2018
BDEC1E,conference-participant,100,50,3/8/2018
BE379D,earnings,100,50,3/8/2018
C22BE8,dividend,100,50,3/8/2018
C2609A,executive-appointment,100,54,3/8/2018
C2DD02,dividend,100,50,3/8/2018
C2E120,dividend,100,50,3/8/2018
C4706C,conference-participant,100,50,3/8/2018
C4F9C6,earnings,100,50,3/8/2018
C564E4,conference-participant,100,50,3/8/2018
C6C702,award,100,58,3/8/2018
C6C702,award,100,58,3/8/2018
C7AE14,executive-appointment,100,54,3/8/2018
C8923A,earnings-up,100,68,3/8/2018
C8923A,earnings,100,50,3/8/2018
C8923A,earnings,100,50,3/8/2018
C8A059,earnings,100,50,3/8/2018
C93C44,conference-participant,100,50,3/8/2018
CA1620,dividend,100,50,3/8/2018
CB89EA,conference-participant,100,50,3/8/2018
CBDB4D,conference-call,100,50,3/8/2018
CC3EC4,earnings,100,50,3/8/2018
CCB623,earnings,100,50,3/8/2018
CD2DA4,executive-appointment,100,54,3/8/2018
CD2DA4,earnings,100,50,3/8/2018
CE5C6E,earnings,100,50,3/8/2018
CFF15D,dividend-up,100,59,3/8/2018
D0909F,buybacks,100,74,3/8/2018
D15833,conference-call,100,50,3/8/2018
D15833,earnings-positive,100,69,3/8/2018
D15833,earnings,100,50,3/8/2018
D15833,earnings,100,50,3/8/2018
D1C26F,product-release,100,64,3/8/2018
D5AF19,partnership,100,61,3/8/2018
D6144F,conference-call,100,50,3/8/2018
D6144F,board-meeting,100,51,3/8/2018
DC0066,conference-participant,100,50,3/8/2018
DE4924,dividend,100,50,3/8/2018
DFADDB,earnings,100,50,3/8/2018
E41190,executive-resignation,100,44,3/8/2018
E82A2D,earnings,100,50,3/8/2018
E866D2,revenue-volume,100,50,3/8/2018
E8846E,earnings,100,50,3/8/2018
E8C557,earnings,100,50,3/8/2018
EE74E1,earnings-guidance,100,50,3/8/2018
F3816D,earnings,100,50,3/8/2018
F47871,earnings,100,50,3/8/2018
F6DCE4,executive-appointment,100,54,3/8/2018
F6E1B5,earnings,100,50,3/8/2018
F8BA6C,public-offering,100,43,3/8/2018
FACF19,executive-appointment,100,54,3/8/2018
FCA54E,earnings,100,50,3/8/2018
FD2565,earnings,100,50,3/8/2018
FE609F,public-offering,100,43,3/8/2018
FF5413,revenue-volume,100,50,3/8/2018
02ACBD,earnings,100,50,3/9/2018
03542C,earnings,100,50,3/9/2018
03B431,business-contract,100,69,3/9/2018
0968A5,earnings,100,50,3/9/2018
0B7375,earnings,100,50,3/9/2018
16B882,earnings,100,50,3/9/2018
188394,executive-appointment,100,54,3/9/2018
196D18,earnings,100,50,3/9/2018
196D18,earnings,100,50,3/9/2018
196D18,earnings,100,50,3/9/2018
196D18,earnings,100,50,3/9/2018
1AB023,earnings,100,50,3/9/2018
1AB023,earnings,100,50,3/9/2018
1AB023,earnings,100,50,3/9/2018
1F08A6,dividend,100,50,3/9/2018
1FCC00,dividend-up,100,70,3/9/2018
1FCC00,earnings-per-share-up,100,68,3/9/2018
1FCC00,earnings-per-share-up,100,68,3/9/2018
1FCC00,earnings-per-share-up,100,68,3/9/2018
1FCC00,earnings-per-share-up,100,68,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
251988,earnings,100,50,3/9/2018
2B8179,conference-participant,100,50,3/9/2018
2CC71C,conference-participant,100,50,3/9/2018
2E902B,conference-participant,100,50,3/9/2018
2EBA55,dividend,100,50,3/9/2018
367434,earnings,100,50,3/9/2018
367434,earnings,100,50,3/9/2018
37020C,dividend,100,50,3/9/2018
383ADA,earnings,100,50,3/9/2018
3A3447,facility-open,100,65,3/9/2018
3ACF46,conference-participant,100,50,3/9/2018
3F4497,acquisition-completed-acquirer,100,49,3/9/2018
427F32,dividend,100,50,3/9/2018
4DAF5F,buybacks,100,74,3/9/2018
4DAF5F,buybacks,100,74,3/9/2018
4E7C1F,business-contract,100,69,3/9/2018
4F9926,legal-issues-defendant,100,22,3/9/2018
5.43E+08,conference-participant,100,50,3/9/2018
5675EB,dividend,100,50,3/9/2018
619882,conference-organizer,100,57,3/9/2018
619882,conference-organizer,100,57,3/9/2018
619882,conference-organizer,100,57,3/9/2018
61BCA7,public-offering,100,43,3/9/2018
649CBD,index-listing,100,76,3/9/2018
6C4D2F,dividend,100,50,3/9/2018
6F3936,conference-call,100,50,3/9/2018
723548,index-listing,100,76,3/9/2018
762A3E,conference-organizer,100,57,3/9/2018
762A3E,conference-organizer,100,57,3/9/2018
762A3E,conference-organizer,100,57,3/9/2018
762A3E,conference-organizer,100,57,3/9/2018
762A3E,conference-organizer,100,57,3/9/2018
762A3E,conference-organizer,100,57,3/9/2018
762A3E,conference-organizer,100,57,3/9/2018
7ACBA4,earnings,100,50,3/9/2018
7B0BA6,award,100,58,3/9/2018
7D85A9,conference-participant,100,50,3/9/2018
877734,credit-extension-recipient,100,69,3/9/2018
883D82,legal-issues-defendant,100,22,3/9/2018
8FF2EF,note-sale,100,52,3/9/2018
934029,acquisition-completed-acquirer,100,49,3/9/2018
950CDB,earnings,100,50,3/9/2018
980C14,dividend,100,50,3/9/2018
9810C0,dividend,100,50,3/9/2018
9E5C2C,conference-participant,100,50,3/9/2018
9EED50,award,100,58,3/9/2018
9F5CBB,earnings,100,50,3/9/2018
A05C43,earnings,100,50,3/9/2018
A4CD53,earnings,100,50,3/9/2018
A4CD53,conference-participant,100,50,3/9/2018
A5A4F5,acquisition-acquirer,100,49,3/9/2018
A7102F,legal-issues-defendant,100,22,3/9/2018
B48D6A,earnings,100,50,3/9/2018
B48D6A,earnings,100,50,3/9/2018
B642E8,stake-acquirer,100,48,3/9/2018
B642E8,acquisition-completed-acquirer,100,49,3/9/2018
B762D3,earnings,100,50,3/9/2018
B762D3,earnings,100,50,3/9/2018
BB127B,partnership,100,61,3/9/2018
C1114B,executive-appointment,100,54,3/9/2018
C2E120,earnings,100,50,3/9/2018
C7AE14,executive-appointment,100,54,3/9/2018
C93C44,conference-participant,100,50,3/9/2018
CDAB24,award,100,58,3/9/2018
CFF15D,executive-appointment,100,54,3/9/2018
D622D5,operating-earnings,100,50,3/9/2018
DB5CA5,public-offering,100,43,3/9/2018
DDEA6A,conference-participant,100,50,3/9/2018
E68733,dividend,100,50,3/9/2018
E6BC2C,conference-participant,100,50,3/9/2018
E8846E,legal-issues-defendant,100,22,3/9/2018
EC1AF3,conference-participant,100,50,3/9/2018
ED2EFD,earnings,100,50,3/9/2018
EF7163,unit-acquisition-acquiree,100,76,3/9/2018
F3EDB4,earnings,100,50,3/9/2018
F6581D,earnings,100,50,3/9/2018
0CE7F6,legal-issues-defendant,100,22,3/10/2018
61A586,legal-issues-defendant,100,22,3/10/2018
A7102F,legal-issues-defendant,100,22,3/10/2018
AD3C93,legal-issues-defendant,100,22,3/10/2018
CF7292,legal-issues-defendant,100,22,3/10/2018
1EBF8D,business-contract,100,69,3/11/2018
C7FC95,partnership,100,61,3/11/2018
C7FC95,partnership,100,61,3/11/2018
00067A,conference-participant,100,50,3/12/2018
00326E,executive-appointment,100,54,3/12/2018
0325B7,market-entry,100,57,3/12/2018
03542C,earnings,100,50,3/12/2018
03D5F9,product-release,100,64,3/12/2018
06A456,conference-call,100,50,3/12/2018
0B13E8,public-offering,100,43,3/12/2018
0CE7F6,legal-issues-defendant,100,22,3/12/2018
0CE7F6,legal-issues-defendant,100,22,3/12/2018
0DBB81,earnings,100,50,3/12/2018
0E5619,earnings,100,50,3/12/2018
0F0693,earnings,100,50,3/12/2018
16FC89,dividend,100,50,3/12/2018
1F19C8,board-meeting,100,51,3/12/2018
1F716B,business-contract,100,69,3/12/2018
1FA886,buybacks,100,74,3/12/2018
21D903,executive-appointment,100,54,3/12/2018
21D903,earnings,100,50,3/12/2018
2262BD,executive-appointment,100,54,3/12/2018
267718,acquisition-acquiree,100,76,3/12/2018
279916,business-contract,100,69,3/12/2018
28DCA8,executive-appointment,100,54,3/12/2018
2C35B5,earnings,100,50,3/12/2018
2D2D43,executive-appointment,100,54,3/12/2018
2F7A7E,public-offering,100,43,3/12/2018
31643A,dividend,100,50,3/12/2018
36529A,earnings,100,50,3/12/2018
37B618,dividend,100,50,3/12/2018
3B318A,earnings,100,50,3/12/2018
3CBA2A,business-contract,100,69,3/12/2018
4.00E+163,public-offering,100,43,3/12/2018
4.00E+163,acquisition-acquirer,100,49,3/12/2018
41C528,conference-call,100,50,3/12/2018
49BBBC,executive-appointment,100,54,3/12/2018
4C31F3,earnings,100,50,3/12/2018
4E2D94,earnings-guidance,100,50,3/12/2018
4EE14A,earnings,100,50,3/12/2018
4F783B,earnings,100,50,3/12/2018
4F783B,earnings,100,50,3/12/2018
4F783B,earnings,100,50,3/12/2018
4F783B,earnings,100,50,3/12/2018
4F783B,earnings,100,50,3/12/2018
4F783B,earnings,100,50,3/12/2018
4F9926,partnership,100,61,3/12/2018
54F1D2,conference-organizer,100,57,3/12/2018
55438C,business-contract,100,69,3/12/2018
56277A,dividend,100,50,3/12/2018
57CAAB,conference-participant,100,50,3/12/2018
589846,product-release,100,64,3/12/2018
5A53BF,conference-participant,100,50,3/12/2018
5A53BF,executive-appointment,100,54,3/12/2018
5E1DF3,earnings,100,50,3/12/2018
5E6959,dividend,100,50,3/12/2018
619882,conference-organizer,100,57,3/12/2018
651C85,earnings,100,50,3/12/2018
66667F,trading-listing,100,61,3/12/2018
6844D2,executive-appointment,100,54,3/12/2018
69FDFC,acquisition-completed-acquirer,100,49,3/12/2018
69FDFC,acquisition-completed-acquirer,100,49,3/12/2018
69FDFC,product-release,100,64,3/12/2018
69FDFC,product-release,100,64,3/12/2018
6A171E,earnings,100,50,3/12/2018
6E8349,conference-participant,100,50,3/12/2018
756045,earnings,100,50,3/12/2018
756BB4,earnings,100,50,3/12/2018
762A3E,conference-organizer,100,57,3/12/2018
762A3E,conference-organizer,100,57,3/12/2018
762A3E,conference-organizer,100,57,3/12/2018
762A3E,conference-organizer,100,57,3/12/2018
762A3E,award,100,58,3/12/2018
767F86,conference-participant,100,50,3/12/2018
76959C,executive-appointment,100,54,3/12/2018
7710F3,earnings,100,50,3/12/2018
7ACD98,earnings,100,50,3/12/2018
7C4F43,executive-appointment,100,54,3/12/2018
7C4F43,earnings,100,50,3/12/2018
7E3F8F,partnership,100,61,3/12/2018
7F3A5F,partnership,100,61,3/12/2018
818A2F,earnings,100,50,3/12/2018
863350,product-release,100,64,3/12/2018
895D56,earnings,100,50,3/12/2018
8C6C1B,facility-open,100,65,3/12/2018
8FCA78,executive-appointment,100,54,3/12/2018
95C392,public-offering,100,43,3/12/2018
95DC1F,partnership,100,61,3/12/2018
97B027,executive-appointment,100,54,3/12/2018
97B027,earnings,100,50,3/12/2018
97B027,earnings,100,50,3/12/2018
97B027,earnings,100,50,3/12/2018
97B027,earnings,100,50,3/12/2018
990AD0,conference-organizer,100,57,3/12/2018
9C009A,earnings,100,50,3/12/2018
9CE4C7,product-release,100,64,3/12/2018
A29DBD,product-release,100,64,3/12/2018
A3800A,conference-participant,100,50,3/12/2018
A4A612,public-offering,100,43,3/12/2018
A52B6B,partnership,100,61,3/12/2018
A52B6B,partnership,100,61,3/12/2018
A5A4F5,acquisition-acquirer,100,49,3/12/2018
A60354,executive-resignation,100,44,3/12/2018
A65325,acquisition-completed-acquirer,100,49,3/12/2018
A7102F,legal-issues-defendant,100,22,3/12/2018
AA3AB8,earnings,100,50,3/12/2018
AC642C,earnings,100,50,3/12/2018
AC642C,earnings,100,50,3/12/2018
AED6CF,earnings,100,50,3/12/2018
AED6CF,earnings,100,50,3/12/2018
AED6CF,earnings,100,50,3/12/2018
AEFC90,clinical-trials-start,100,64,3/12/2018
AF93DE,conference-call,100,50,3/12/2018
B1A85D,executive-appointment,100,54,3/12/2018
B2206F,product-release,100,64,3/12/2018
B2206F,partnership,100,61,3/12/2018
B33E77,earnings,100,50,3/12/2018
B642E8,executive-resignation,100,44,3/12/2018
B642E8,executive-resignation,100,44,3/12/2018
B98EFA,conference-participant,100,50,3/12/2018
BA218A,partnership,100,61,3/12/2018
C05839,dividend,100,50,3/12/2018
C45C1F,public-offering,100,43,3/12/2018
C5E100,product-release,100,64,3/12/2018
C72B8F,hirings,100,65,3/12/2018
C83B88,partnership,100,61,3/12/2018
C8A248,executive-resignation,100,44,3/12/2018
C9881C,conference-call,100,50,3/12/2018
CBB77B,earnings,100,50,3/12/2018
CBB77B,earnings,100,50,3/12/2018
CBDB4D,partnership,100,61,3/12/2018
CBDB4D,partnership,100,61,3/12/2018
CBDB4D,partnership,100,61,3/12/2018
CBDB4D,partnership,100,61,3/12/2018
CBDB4D,partnership,100,61,3/12/2018
CC35BE,product-release,100,64,3/12/2018
CD4DA8,conference-organizer,100,57,3/12/2018
CDD75E,earnings-guidance,100,50,3/12/2018
CEDFD5,acquisition-acquirer,100,49,3/12/2018
CFD4B6,conference-participant,100,50,3/12/2018
D15833,unit-acquisition-acquirer,100,49,3/12/2018
D17C1B,executive-appointment,100,54,3/12/2018
D17C1B,revenue-volume,100,50,3/12/2018
D7918D,earnings,100,50,3/12/2018
D854F3,asset-sale,100,62,3/12/2018
D90441,earnings,100,50,3/12/2018
DB23C8,note-sale,100,52,3/12/2018
DB9F70,earnings,100,50,3/12/2018
DBEF02,acquisition-acquirer,100,49,3/12/2018
DD1BA1,executive-appointment,100,54,3/12/2018
E0207A,unit-acquisition-acquirer,100,49,3/12/2018
E09556,earnings,100,50,3/12/2018
E09997,earnings,100,50,3/12/2018
E11C41,executive-appointment,100,54,3/12/2018
E11C41,executive-appointment,100,54,3/12/2018
E259C7,conference-participant,100,50,3/12/2018
E4CE73,product-release,100,64,3/12/2018
E68733,regulatory-product-approval-granted,100,81,3/12/2018
E6D89E,executive-appointment,100,54,3/12/2018
E71AE6,earnings,100,50,3/12/2018
E71AE6,earnings,100,50,3/12/2018
E7BF32,earnings,100,50,3/12/2018
E7BF32,earnings,100,50,3/12/2018
E9C7C0,partnership,100,61,3/12/2018
E9FF33,executive-appointment,100,54,3/12/2018
EBD89A,conference-participant,100,50,3/12/2018
ED79D9,award,100,58,3/12/2018
ED7F13,dividend,100,50,3/12/2018
EE04F0,conference-call,100,50,3/12/2018
F3816D,clinical-trials-start,100,64,3/12/2018
FF227B,executive-appointment,100,54,3/12/2018
13528,partnership,100,61,3/13/2018
0157B1,partnership,100,61,3/13/2018
03542C,dividend,100,50,3/13/2018
09DE1F,acquisition-interest-acquirer,100,46,3/13/2018
0A0CF0,executive-appointment,100,54,3/13/2018
0CE7F6,legal-issues-defendant,100,22,3/13/2018
0D03C8,earnings,100,50,3/13/2018
0E3436,earnings,100,50,3/13/2018
159AE4,conference-call,100,50,3/13/2018
1866B2,executive-appointment,100,54,3/13/2018
19CAC7,conference-call,100,50,3/13/2018
1A3E1B,executive-appointment,100,54,3/13/2018
1B5FEA,conference-call,100,50,3/13/2018
1DEBBE,public-offering,100,43,3/13/2018
1E9A6D,executive-appointment,100,54,3/13/2018
202E5A,executive-appointment,100,54,3/13/2018
21245F,legal-issues-defendant,100,22,3/13/2018
228D42,dividend,100,50,3/13/2018
228D42,award,100,58,3/13/2018
250BEE,dividend,100,50,3/13/2018
25D3CE,conference-participant,100,50,3/13/2018
25DD05,dividend,100,50,3/13/2018
25DD05,dividend,100,50,3/13/2018
25DD05,public-offering,100,43,3/13/2018
274B8A,conference-call,100,50,3/13/2018
27A791,executive-appointment,100,54,3/13/2018
2920D5,earnings,100,50,3/13/2018
2BDC1C,earnings,100,50,3/13/2018
2BDC1C,earnings,100,50,3/13/2018
2BDC1C,earnings,100,50,3/13/2018
2E61CC,settlement,100,56,3/13/2018
2EBC0B,dividend,100,50,3/13/2018
301493,executive-appointment,100,54,3/13/2018
31AA84,award,100,58,3/13/2018
3471C0,partnership,100,61,3/13/2018
366C3B,unit-acquisition-completed-acquirer,100,49,3/13/2018
371B0A,conference-participant,100,50,3/13/2018
37B618,earnings,100,50,3/13/2018
37B618,earnings,100,50,3/13/2018
3C6CCC,earnings,100,50,3/13/2018
3D6933,pretax-earnings-up,100,81,3/13/2018
3D6933,pretax-earnings-up,100,81,3/13/2018
414FFF,conference-call,100,50,3/13/2018
41C36B,earnings,100,50,3/13/2018
42AABD,public-offering,100,43,3/13/2018
4C37C5,dividend,100,50,3/13/2018
4C37C5,executive-appointment,100,54,3/13/2018
4C92B9,acquisition-completed-acquirer,100,49,3/13/2018
4E2D94,note-sale,100,52,3/13/2018
4E2D94,note-sale,100,52,3/13/2018
4E4E75,executive-appointment,100,54,3/13/2018
5065B1,dividend-up,100,81,3/13/2018
54F1D2,board-meeting,100,51,3/13/2018
567F3D,conference-participant,100,50,3/13/2018
56EFC7,partnership,100,61,3/13/2018
58CA9A,earnings,100,50,3/13/2018
5A53BF,earnings,100,50,3/13/2018
5F3D91,earnings,100,50,3/13/2018
5F3D91,earnings,100,50,3/13/2018
5F3D91,earnings,100,50,3/13/2018
60FE03,conference-participant,100,50,3/13/2018
6166D1,conference-call,100,50,3/13/2018
619882,conference-organizer,100,57,3/13/2018
61BCA7,public-offering,100,43,3/13/2018
629F0F,buybacks,100,74,3/13/2018
64636E,earnings,100,50,3/13/2018
665440,earnings,100,50,3/13/2018
665440,earnings,100,50,3/13/2018
665440,earnings,100,50,3/13/2018
665D7D,clinical-trials-positive,100,87,3/13/2018
68E3E0,executive-appointment,100,54,3/13/2018
68E3E0,buybacks,100,74,3/13/2018
69CE71,acquisition-acquirer,100,49,3/13/2018
69CE71,acquisition-acquirer,100,49,3/13/2018
6A01DF,patent-awarded,100,72,3/13/2018
6BDA0C,executive-appointment,100,54,3/13/2018
71553E,earnings,100,50,3/13/2018
728737,dividend,100,50,3/13/2018
728737,dividend,100,50,3/13/2018
762A3E,conference-organizer,100,57,3/13/2018
762A3E,conference-organizer,100,57,3/13/2018
765913,executive-appointment,100,54,3/13/2018
76BD96,note-sale,100,52,3/13/2018
7BEA98,clinical-trials-start,100,64,3/13/2018
7BEA98,clinical-trials-start,100,64,3/13/2018
7BEA98,clinical-trials-start,100,64,3/13/2018
7BEA98,clinical-trials-start,100,64,3/13/2018
7C790D,conference-participant,100,50,3/13/2018
7CD98F,conference-participant,100,50,3/13/2018
83B1C8,conference-participant,100,50,3/13/2018
83B1C8,conference-participant,100,50,3/13/2018
8876D6,buybacks,100,74,3/13/2018
890FF4,conference-participant,100,50,3/13/2018
8E8E6E,buybacks,100,74,3/13/2018
8EF425,dividend,100,50,3/13/2018
9004C4,earnings,100,50,3/13/2018
903AB4,public-offering,100,43,3/13/2018
9087B9,earnings,100,50,3/13/2018
911CA9,business-contract,100,69,3/13/2018
911CA9,business-contract,100,69,3/13/2018
911CA9,business-contract,100,69,3/13/2018
911CA9,earnings,100,50,3/13/2018
911CA9,earnings,100,50,3/13/2018
9.31E+77,note-sale,100,52,3/13/2018
934029,conference-participant,100,50,3/13/2018
94637C,executive-appointment,100,54,3/13/2018
94637C,legal-issues-defendant,100,22,3/13/2018
95C392,public-offering,100,43,3/13/2018
97693A,conference-call,100,50,3/13/2018
97AAF6,executive-resignation,100,44,3/13/2018
9.86E+03,partnership,100,61,3/13/2018
98D33E,earnings,100,50,3/13/2018
990AD0,conference-organizer,100,57,3/13/2018
9934AD,conference-participant,100,50,3/13/2018
9A2760,earnings,100,50,3/13/2018
9B5968,acquisition-acquiree,100,76,3/13/2018
9B5968,acquisition-acquiree,100,76,3/13/2018
9B5968,acquisition-acquiree,100,76,3/13/2018
9BF177,partnership,100,61,3/13/2018
9D56F2,conference-call,100,50,3/13/2018
A4A612,public-offering,100,43,3/13/2018
A5A4F5,acquisition-acquirer,100,49,3/13/2018
A63387,award,100,58,3/13/2018
AA1EAA,dividend,100,50,3/13/2018
AC1952,ipo-pricing,100,50,3/13/2018
AD22F2,earnings,100,50,3/13/2018
B01111,earnings,100,50,3/13/2018
B08C51,earnings,100,50,3/13/2018
B1DF3C,public-offering,100,43,3/13/2018
B76C82,earnings,100,50,3/13/2018
BAD9EA,earnings,100,50,3/13/2018
BB58FF,conference-participant,100,50,3/13/2018
BE645B,conference-participant,100,50,3/13/2018
BF5959,executive-appointment,100,54,3/13/2018
BF5959,executive-appointment,100,54,3/13/2018
C99CC8,executive-appointment,100,54,3/13/2018
CAD7D9,conference-call,100,50,3/13/2018
CBDB4D,earnings,100,50,3/13/2018
CBFFDD,conference-participant,100,50,3/13/2018
CDD75E,executive-appointment,100,54,3/13/2018
CEC08B,partnership,100,61,3/13/2018
CF6A5A,earnings,100,50,3/13/2018
CFF15D,acquisition-interest-acquiree,100,82,3/13/2018
D139BC,dividend,100,50,3/13/2018
D75910,dividend,100,50,3/13/2018
D75910,executive-appointment,100,54,3/13/2018
D78BF1,award,100,58,3/13/2018
DC0D18,public-offering,100,43,3/13/2018
DD1BA1,partnership,100,61,3/13/2018
DDEA6A,earnings,100,50,3/13/2018
E12A6E,executive-appointment,100,54,3/13/2018
E13782,earnings,100,50,3/13/2018
E592F0,product-release,100,64,3/13/2018
F0B2B5,executive-appointment,100,54,3/13/2018
F0B2B5,executive-appointment,100,54,3/13/2018
F0B2B5,executive-appointment,100,54,3/13/2018
F0EEFB,conference-participant,100,50,3/13/2018
F32F88,executive-appointment,100,54,3/13/2018
F39E1E,legal-issues-defendant,100,22,3/13/2018
F5349B,executive-appointment,100,54,3/13/2018
F5D410,partnership,100,61,3/13/2018
F5D410,partnership,100,61,3/13/2018
F5D410,conference-participant,100,50,3/13/2018
F88147,earnings,100,50,3/13/2018
FD6926,conference-participant,100,50,3/13/2018
FDE409,executive-appointment,100,54,3/13/2018
FE609F,public-offering,100,43,3/13/2018
FFCD0E,earnings,100,50,3/13/2018
00326D,dividend,100,50,3/14/2018
13528,earnings,100,50,3/14/2018
02ACBD,earnings,100,50,3/14/2018
03FB17,partnership,100,61,3/14/2018
06A456,earnings,100,50,3/14/2018
07C69F,buybacks,100,74,3/14/2018
07EC43,buybacks,100,74,3/14/2018
98977,public-offering,100,43,3/14/2018
099C88,government-contract,100,69,3/14/2018
09DE1F,acquisition-failed-acquirer,100,41,3/14/2018
0CADBC,earnings,100,50,3/14/2018
0F2BC9,business-contract,100,69,3/14/2018
0FC848,earnings,100,50,3/14/2018
108FDA,acquisition-acquirer,100,49,3/14/2018
108FDA,acquisition-acquirer,100,49,3/14/2018
119CB6,award,100,58,3/14/2018
1279ED,earnings,100,50,3/14/2018
14391F,earnings,100,50,3/14/2018
14391F,earnings,100,50,3/14/2018
14391F,earnings,100,50,3/14/2018
1.79E+10,conference-call,100,50,3/14/2018
17EDA5,executive-appointment,100,54,3/14/2018
1880C5,earnings,100,50,3/14/2018
18D9FA,earnings,100,50,3/14/2018
190BE6,earnings,100,50,3/14/2018
1DEBBE,public-offering,100,43,3/14/2018
1E1125,conference-organizer,100,57,3/14/2018
1E1125,conference-organizer,100,57,3/14/2018
1F19C8,acquisition-acquirer,100,49,3/14/2018
2082EA,conference-participant,100,50,3/14/2018
25DD05,public-offering,100,43,3/14/2018
270305,executive-appointment,100,54,3/14/2018
27C10F,earnings,100,50,3/14/2018
27C10F,earnings,100,50,3/14/2018
28DCA8,executive-appointment,100,54,3/14/2018
292A70,dividend,100,50,3/14/2018
2BDC1C,conference-participant,100,50,3/14/2018
2C681C,executive-appointment,100,54,3/14/2018
2C681C,executive-appointment,100,54,3/14/2018
2C7505,clinical-trials,100,56,3/14/2018
2C7505,clinical-trials,100,56,3/14/2018
2EB04E,sponsorship,100,57,3/14/2018
2EB04E,partnership,100,61,3/14/2018
2EC172,executive-appointment,100,54,3/14/2018
2FDEE3,dividend,100,50,3/14/2018
341759,clinical-trials-suspended,100,24,3/14/2018
367434,patent-awarded,100,72,3/14/2018
39FB23,product-price-raise,100,57,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3BA1BF,earnings,100,50,3/14/2018
3D9999,executive-appointment,100,54,3/14/2018
401072,clinical-trials-start,100,64,3/14/2018
408380,earnings,100,50,3/14/2018
4.00E+163,public-offering,100,43,3/14/2018
416C55,conference-participant,100,50,3/14/2018
42AABD,public-offering,100,43,3/14/2018
42AABD,business-contract,100,69,3/14/2018
46017C,business-contract,100,69,3/14/2018
4DD203,earnings,100,50,3/14/2018
4E6F5A,earnings,100,50,3/14/2018
4E6F5A,earnings,100,50,3/14/2018
4EEB00,conference-participant,100,50,3/14/2018
510EA1,public-offering,100,43,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,earnings,100,50,3/14/2018
52D936,trading-resumed,100,58,3/14/2018
52D936,trading-resumed,100,58,3/14/2018
52D936,trading-resumed,100,58,3/14/2018
57A854,conference-participant,100,50,3/14/2018
57F3DA,conference-participant,100,50,3/14/2018
589846,earnings,100,50,3/14/2018
594402,conference-participant,100,50,3/14/2018
5A0FF1,earnings,100,50,3/14/2018
5BFE94,unit-acquisition-completed-acquirer,100,49,3/14/2018
5D1329,earnings,100,50,3/14/2018
5F9CE3,partnership,100,61,3/14/2018
66A667,earnings,100,50,3/14/2018
69CE71,dividend,100,50,3/14/2018
6A171E,executive-appointment,100,54,3/14/2018
6CB7F9,buybacks,100,74,3/14/2018
6DD6BA,note-sale,100,52,3/14/2018
7239BB,executive-appointment,100,54,3/14/2018
7239BB,conference-call,100,50,3/14/2018
762A3E,conference-organizer,100,57,3/14/2018
7823A3,note-sale,100,52,3/14/2018
787D14,earnings,100,50,3/14/2018
7A975D,earnings,100,50,3/14/2018
7BEA98,earnings,100,50,3/14/2018
7BEA98,earnings,100,50,3/14/2018
7C4F43,clinical-trials,100,56,3/14/2018
7DA412,award,100,58,3/14/2018
7E3F8F,partnership,100,61,3/14/2018
83E0AC,conference-participant,100,50,3/14/2018
877734,earnings,100,50,3/14/2018
877734,earnings,100,50,3/14/2018
883D82,legal-issues-defendant,100,22,3/14/2018
895D56,conference-participant,100,50,3/14/2018
8B8656,earnings,100,50,3/14/2018
8B8656,business-contract,100,69,3/14/2018
8C311A,executive-appointment,100,54,3/14/2018
8D4486,partnership,100,61,3/14/2018
8D4486,partnership,100,61,3/14/2018
8D4486,business-contract,100,69,3/14/2018
8DCF18,conference-participant,100,50,3/14/2018
8F6995,public-offering,100,43,3/14/2018
8FF2EF,earnings,100,50,3/14/2018
8FF57A,earnings,100,50,3/14/2018
92B625,conference-participant,100,50,3/14/2018
944B2E,earnings,100,50,3/14/2018
94637C,earnings,100,50,3/14/2018
9470CC,earnings,100,50,3/14/2018
94983E,executive-appointment,100,54,3/14/2018
967D92,facility-sale,100,52,3/14/2018
990AD0,conference-organizer,100,57,3/14/2018
9EBAFA,acquisition-acquirer,100,49,3/14/2018
A2CAF7,executive-appointment,100,54,3/14/2018
A433A5,earnings,100,50,3/14/2018
A495F7,earnings,100,50,3/14/2018
A52B6B,acquisition-interest-acquirer,100,46,3/14/2018
A5A4F5,acquisition-acquirer,100,49,3/14/2018
A6FB29,legal-issues-defendant,100,22,3/14/2018
AEF2C3,conference-participant,100,50,3/14/2018
AF93DE,earnings,100,50,3/14/2018
AF93DE,earnings,100,50,3/14/2018
AF93DE,earnings,100,50,3/14/2018
AF93DE,earnings,100,50,3/14/2018
B1DF3C,public-offering,100,43,3/14/2018
B33E77,earnings,100,50,3/14/2018
B73395,earnings,100,50,3/14/2018
B73395,earnings,100,50,3/14/2018
B73395,earnings,100,50,3/14/2018
B73395,earnings,100,50,3/14/2018
B73395,earnings,100,50,3/14/2018
B80AD1,conference-participant,100,50,3/14/2018
BAD655,clinical-trials,100,56,3/14/2018
BCC55F,patent-awarded,100,72,3/14/2018
C01737,clinical-trials,100,56,3/14/2018
C06EB6,conference-participant,100,50,3/14/2018
C5C0E9,executive-appointment,100,54,3/14/2018
C83B88,conference-call,100,50,3/14/2018
C97B2D,conference-participant,100,50,3/14/2018
CBCC6A,conference-organizer,100,57,3/14/2018
CBCC6A,conference-organizer,100,57,3/14/2018
CBCC6A,conference-organizer,100,57,3/14/2018
CFF15D,acquisition-failed-acquiree,100,21,3/14/2018
D5938F,conference-participant,100,50,3/14/2018
D650A7,dividend,100,50,3/14/2018
D78CCD,acquisition-acquirer,100,49,3/14/2018
DC0D18,public-offering,100,43,3/14/2018
DD682D,public-offering,100,43,3/14/2018
DF5F14,earnings,100,50,3/14/2018
E16133,earnings,100,50,3/14/2018
E74B55,earnings,100,50,3/14/2018
E754F0,earnings,100,50,3/14/2018
E8D221,earnings,100,50,3/14/2018
EA79C7,earnings,100,50,3/14/2018
EBC84C,conference-participant,100,50,3/14/2018
ED0D7C,acquisition-acquiree,100,76,3/14/2018
EEA734,earnings,100,50,3/14/2018
F24FF0,earnings,100,50,3/14/2018
F4CDA3,conference-participant,100,50,3/14/2018
F4E882,executive-appointment,100,54,3/14/2018
F748C7,dividend-up,100,60,3/14/2018
F748C7,earnings,100,50,3/14/2018
F8BA6C,clinical-trials-start,100,64,3/14/2018
FC9869,earnings,100,50,3/14/2018
20751,earnings,100,50,3/15/2018
040DBB,conference-participant,100,50,3/15/2018
054B55,dividend,100,50,3/15/2018
95294,executive-appointment,100,54,3/15/2018
95294,dividend,100,50,3/15/2018
98977,public-offering,100,43,3/15/2018
09DE1F,earnings,100,50,3/15/2018
0B13E8,public-offering,100,43,3/15/2018
0B4D10,dividend,100,50,3/15/2018
0C6293,earnings,100,50,3/15/2018
106394,dividend,100,50,3/15/2018
138DDE,dividend,100,50,3/15/2018
15789A,revenues,100,50,3/15/2018
15789A,earnings,100,50,3/15/2018
15789A,earnings,100,50,3/15/2018
15789A,earnings,100,50,3/15/2018
15B10D,earnings,100,50,3/15/2018
17EDA5,dividend,100,50,3/15/2018
17EDA5,partnership,100,61,3/15/2018
17EDA5,partnership,100,61,3/15/2018
197019,business-combination,100,54,3/15/2018
19C105,dividend,100,50,3/15/2018
1A9DE1,dividend-up,100,81,3/15/2018
1AD9CC,earnings,100,50,3/15/2018
1AF7E2,dividend,100,50,3/15/2018
1B16C1,earnings,100,50,3/15/2018
1B5FEA,executive-appointment,100,54,3/15/2018
1B9535,conference-participant,100,50,3/15/2018
1F43A1,dividend-up,100,81,3/15/2018
238302,dividend,100,50,3/15/2018
26CC63,earnings,100,50,3/15/2018
26CC63,earnings,100,50,3/15/2018
26CC63,earnings,100,50,3/15/2018
282C18,dividend,100,50,3/15/2018
2CC60C,executive-appointment,100,54,3/15/2018
2CD1E0,award,100,58,3/15/2018
2EBC0B,legal-issues-defendant,100,22,3/15/2018
301493,award,100,58,3/15/2018
31AA84,dividend,100,50,3/15/2018
341759,legal-issues-defendant,100,22,3/15/2018
36C09B,clinical-trials,100,56,3/15/2018
3C7F5F,earnings,100,50,3/15/2018
3E39A5,revenues,100,50,3/15/2018
3F1C69,earnings,100,50,3/15/2018
420168,dividend,100,50,3/15/2018
4A6F00,partnership,100,61,3/15/2018
4C37C5,partnership,100,61,3/15/2018
4EEB00,clinical-trials,100,56,3/15/2018
510EA1,public-offering,100,43,3/15/2018
54DF47,dividend,100,50,3/15/2018
54F271,acquisition-acquirer,100,49,3/15/2018
55438C,investment-investor,100,55,3/15/2018
55D0F3,earnings,100,50,3/15/2018
5704AC,dividend,100,50,3/15/2018
57A854,earnings,100,50,3/15/2018
57A854,earnings,100,50,3/15/2018
587EDF,conference-call,100,50,3/15/2018
58C2D4,executive-appointment,100,54,3/15/2018
5A423F,conference-participant,100,50,3/15/2018
5FE4B6,conference-participant,100,50,3/15/2018
60FE03,clinical-trials,100,56,3/15/2018
60FE03,earnings,100,50,3/15/2018
619882,dividend,100,50,3/15/2018
627186,conference-participant,100,50,3/15/2018
641F17,earnings,100,50,3/15/2018
64854A,conference-participant,100,50,3/15/2018
657097,dividend,100,50,3/15/2018
65D0AA,conference-participant,100,50,3/15/2018
6810DE,earnings,100,50,3/15/2018
693ECD,conference-participant,100,50,3/15/2018
69CE71,partnership,100,61,3/15/2018
6EA292,dividend,100,50,3/15/2018
71B0CF,earnings,100,50,3/15/2018
766047,note-sale,100,52,3/15/2018
7AB859,government-contract,100,69,3/15/2018
7BEA98,conference-participant,100,50,3/15/2018
7BEA98,conference-participant,100,50,3/15/2018
7D5FD6,executive-appointment,100,54,3/15/2018
7EA323,earnings,100,50,3/15/2018
7FC386,dividend,100,50,3/15/2018
8377DB,executive-appointment,100,54,3/15/2018
8A8E41,partnership,100,61,3/15/2018
8D0EEA,earnings,100,50,3/15/2018
8E4250,conference-call,100,50,3/15/2018
8F6995,public-offering,100,43,3/15/2018
9196A2,dividend,100,50,3/15/2018
925759,partnership,100,61,3/15/2018
925759,partnership,100,61,3/15/2018
92D230,earnings,100,50,3/15/2018
934029,executive-appointment,100,54,3/15/2018
95DC1F,buybacks,100,74,3/15/2018
96BFF4,earnings,100,50,3/15/2018
96F126,business-contract,100,69,3/15/2018
9.74E+08,partnership,100,61,3/15/2018
97644E,earnings,100,50,3/15/2018
986AF6,earnings-guidance,100,50,3/15/2018
98A286,conference-call,100,50,3/15/2018
990AD0,conference-organizer,100,57,3/15/2018
9C25FF,note-sale,100,52,3/15/2018
9C25FF,note-sale,100,52,3/15/2018
9D307D,earnings,100,50,3/15/2018
9F18FA,unit-acquisition-acquirer,100,49,3/15/2018
9F18FA,unit-acquisition-acquirer,100,49,3/15/2018
A5A4F5,acquisition-acquirer,100,49,3/15/2018
A5A4F5,conference-call,100,50,3/15/2018
A5A4F5,conference-call,100,50,3/15/2018
A871B0,earnings,100,50,3/15/2018
AC642C,earnings,100,50,3/15/2018
AC642C,earnings,100,50,3/15/2018
ADFB3A,conference-call,100,50,3/15/2018
AE4EEB,dividend-up,100,81,3/15/2018
AEBB80,dividend,100,50,3/15/2018
B09B1F,award,100,58,3/15/2018
B1A85D,award,100,58,3/15/2018
B381D8,legal-issues-plaintiff,100,44,3/15/2018
B4C673,partnership,100,61,3/15/2018
B8F71F,earnings,100,50,3/15/2018
BAD9EA,earnings,100,50,3/15/2018
BBBB41,conference-participant,100,50,3/15/2018
BFD0A7,earnings,100,50,3/15/2018
C48574,revenue-up,100,69,3/15/2018
C48574,revenue-up,100,69,3/15/2018
C48574,revenue-up,100,69,3/15/2018
C9F39B,dividend-up,100,61,3/15/2018
CBCC6A,conference-organizer,100,57,3/15/2018
CBCC6A,conference-organizer,100,57,3/15/2018
CC6F6E,earnings,100,50,3/15/2018
CC8F6E,legal-issues-defendant,100,22,3/15/2018
CDD75E,earnings,100,50,3/15/2018
CF3FF9,earnings,100,50,3/15/2018
CF7292,earnings,100,50,3/15/2018
CFF15D,partnership,100,61,3/15/2018
CFF15D,partnership,100,61,3/15/2018
CFF15D,partnership,100,61,3/15/2018
D296C6,dividend,100,50,3/15/2018
D2E553,dividend,100,50,3/15/2018
D6144F,earnings,100,50,3/15/2018
D697DE,earnings,100,50,3/15/2018
D69D42,dividend,100,50,3/15/2018
D854F3,conference-call,100,50,3/15/2018
D8ECA1,earnings,100,50,3/15/2018
D9164D,executive-appointment,100,54,3/15/2018
D9164D,executive-appointment,100,54,3/15/2018
D96202,conference-call,100,50,3/15/2018
D96202,legal-issues-defendant,100,22,3/15/2018
DB2E4E,earnings,100,50,3/15/2018
DB88A1,product-release,100,64,3/15/2018
DC2B00,earnings,100,50,3/15/2018
E124EB,earnings,100,50,3/15/2018
E26FC3,business-contract,100,69,3/15/2018
E28D9C,conference-participant,100,50,3/15/2018
E70531,executive-resignation,100,44,3/15/2018
E8846E,partnership,100,61,3/15/2018
E8B315,dividend-up,100,69,3/15/2018
EC70EC,note-sale,100,52,3/15/2018
EC70EC,note-sale,100,52,3/15/2018
ECA300,earnings,100,50,3/15/2018
ECA300,earnings,100,50,3/15/2018
ECDEB2,dividend-up,100,81,3/15/2018
ED4560,earnings,100,50,3/15/2018
EF5914,revenue-up,100,69,3/15/2018
EF5914,earnings,100,50,3/15/2018
EF5914,earnings,100,50,3/15/2018
EF5914,earnings,100,50,3/15/2018
EF5914,earnings,100,50,3/15/2018
EF5914,earnings,100,50,3/15/2018
F3816D,earnings,100,50,3/15/2018
F47871,earnings,100,50,3/15/2018
F5D059,conference-call,100,50,3/15/2018
F6DCE4,dividend,100,50,3/15/2018
F80389,dividend,100,50,3/15/2018
F90EE5,partnership,100,61,3/15/2018
FC1736,revenues,100,50,3/15/2018
FC1736,revenues,100,50,3/15/2018
FC1A6E,legal-issues-defendant,100,22,3/15/2018
FC1A6E,legal-issues-defendant,100,22,3/15/2018
FCA54E,executive-resignation,100,44,3/15/2018
FCA54E,earnings,100,50,3/15/2018
FD9A97,conference-participant,100,50,3/15/2018
00E601,facility-sale,100,52,3/16/2018
0CE7F6,legal-issues-defendant,100,22,3/16/2018
1080C0,conference-participant,100,50,3/16/2018
143C52,executive-appointment,100,54,3/16/2018
17EDA5,partnership,100,61,3/16/2018
17EDA5,partnership,100,61,3/16/2018
20403D,earnings,100,50,3/16/2018
20BEEA,earnings-guidance,100,50,3/16/2018
24A89A,earnings,100,50,3/16/2018
24A89A,earnings,100,50,3/16/2018
25D3CE,earnings,100,50,3/16/2018
2920D5,conference-participant,100,50,3/16/2018
2E902B,dividend,100,50,3/16/2018
339F20,dividend,100,50,3/16/2018
3B9886,earnings,100,50,3/16/2018
3BA1BF,conference-participant,100,50,3/16/2018
44209A,settlement,100,56,3/16/2018
45444E,board-meeting,100,51,3/16/2018
4591D3,partnership,100,61,3/16/2018
479930,executive-appointment,100,54,3/16/2018
57DDB9,conference-participant,100,50,3/16/2018
5CC29D,conference-call,100,50,3/16/2018
5D0337,partnership,100,61,3/16/2018
5DD486,acquisition-interest-acquirer,100,46,3/16/2018
767F86,conference-participant,100,50,3/16/2018
7823A3,note-sale,100,52,3/16/2018
7B9212,earnings,100,50,3/16/2018
826FD6,dividend,100,50,3/16/2018
883D82,legal-issues-defendant,100,22,3/16/2018
902255,conference-participant,100,50,3/16/2018
940C3D,business-combination,100,54,3/16/2018
967D92,board-meeting,100,51,3/16/2018
990AD0,conference-organizer,100,57,3/16/2018
990AD0,conference-organizer,100,57,3/16/2018
9EA947,conference-participant,100,50,3/16/2018
A398B9,note-sale,100,52,3/16/2018
A3F598,settlement,100,56,3/16/2018
A3F598,settlement,100,56,3/16/2018
A3F598,settlement,100,56,3/16/2018
A5A4F5,acquisition-acquirer,100,49,3/16/2018
A6828A,acquisition-acquiree,100,76,3/16/2018
A6828A,acquisition-acquiree,100,76,3/16/2018
A6828A,acquisition-acquiree,100,76,3/16/2018
A6FC89,ipo-considered,100,60,3/16/2018
A871B0,earnings,100,50,3/16/2018
A94637,executive-resignation,100,44,3/16/2018
AC1952,ipo-completed,100,76,3/16/2018
AE7D16,earnings,100,50,3/16/2018
B37FB4,earnings,100,50,3/16/2018
B48FC9,partnership,100,61,3/16/2018
B4B281,executive-appointment,100,54,3/16/2018
B4B281,earnings,100,50,3/16/2018
B4F5F4,earnings,100,50,3/16/2018
B7202A,conference-participant,100,50,3/16/2018
B762D3,dividend,100,50,3/16/2018
B9CD50,acquisition-interest-acquirer,100,46,3/16/2018
BE379D,conference-call,100,50,3/16/2018
C27E19,board-meeting,100,51,3/16/2018
C2DD02,earnings,100,50,3/16/2018
C2E39B,earnings,100,50,3/16/2018
C74887,earnings,100,50,3/16/2018
C8257F,award,100,58,3/16/2018
CBCC6A,conference-organizer,100,57,3/16/2018
CBCC6A,conference-organizer,100,57,3/16/2018
CF351E,dividend,100,50,3/16/2018
D11C1C,dividend-up,100,61,3/16/2018
D13F1C,revenue-up,100,69,3/16/2018
D13F1C,revenue-up,100,69,3/16/2018
D13F1C,revenue-up,100,69,3/16/2018
D13F1C,revenue-up,100,69,3/16/2018
D13F1C,revenue-up,100,69,3/16/2018
D29B44,award,100,58,3/16/2018
D3FA2C,dividend,100,50,3/16/2018
DC0D18,public-offering,100,43,3/16/2018
DD0F15,earnings,100,50,3/16/2018
E592F0,acquisition-completed-acquirer,100,49,3/16/2018
EA4E68,dividend,100,50,3/16/2018
EC70EC,unit-acquisition-acquiree,100,76,3/16/2018
EC99D0,conference-call,100,50,3/16/2018
ECD263,earnings,100,50,3/16/2018
1E1125,legal-issues-defendant,100,22,3/17/2018
AC7C4F,earnings-guidance-up,100,83,3/18/2018
AC7C4F,acquisition-acquirer,100,49,3/18/2018
001F1B,acquisition-acquirer,100,49,3/19/2018
02FC1A,clinical-trials-positive,100,87,3/19/2018
036C6F,conference-participant,100,50,3/19/2018
040DBB,dividend,100,50,3/19/2018
0B6EED,earnings,100,50,3/19/2018
0B6EED,earnings,100,50,3/19/2018
0B6EED,earnings,100,50,3/19/2018
0C2A0D,earnings-guidance-up,100,83,3/19/2018
0C2A0D,earnings-guidance-up,100,83,3/19/2018
108A2B,dividend,100,50,3/19/2018
12E454,partnership,100,61,3/19/2018
12E454,legal-issues-defendant,100,22,3/19/2018
12E454,legal-issues-defendant,100,22,3/19/2018
12E454,legal-issues-defendant,100,22,3/19/2018
1748B3,acquisition-acquiree,100,76,3/19/2018
180DA0,business-contract,100,69,3/19/2018
19BF16,earnings,100,50,3/19/2018
1C2593,facility-open,100,65,3/19/2018
1EC3E8,executive-appointment,100,54,3/19/2018
1F43A1,executive-appointment,100,54,3/19/2018
1FA886,buybacks,100,74,3/19/2018
1FAF22,acquisition-completed-acquirer,100,49,3/19/2018
1FAF22,unit-acquisition-acquirer,100,49,3/19/2018
21022F,executive-resignation,100,44,3/19/2018
2262BD,conference-participant,100,50,3/19/2018
228D42,partnership,100,61,3/19/2018
2E61CC,business-contract,100,69,3/19/2018
33AD83,acquisition-completed-acquiree,100,76,3/19/2018
37E18B,acquisition-regulatory-approval-acquirer,100,54,3/19/2018
3.88E+02,unit-acquisition-acquiree,100,76,3/19/2018
3B37F7,buybacks,100,74,3/19/2018
3B8484,acquisition-acquirer,100,49,3/19/2018
3C8A04,conference-call,100,50,3/19/2018
3ED92D,executive-resignation,100,44,3/19/2018
46A16E,facility-sale,100,52,3/19/2018
4A6F00,partnership,100,61,3/19/2018
4BDCA7,public-offering,100,43,3/19/2018
4C92B9,business-contract,100,69,3/19/2018
4E6F5A,partnership,100,61,3/19/2018
507AE7,acquisition-acquirer,100,49,3/19/2018
54F271,executive-appointment,100,54,3/19/2018
553949,acquisition-completed-acquirer,100,49,3/19/2018
56277A,executive-appointment,100,54,3/19/2018
56B7C1,executive-appointment,100,54,3/19/2018
589846,sponsorship,100,57,3/19/2018
5D16CF,acquisition-completed-acquirer,100,49,3/19/2018
6166D1,dividend,100,50,3/19/2018
6474BA,acquisition-completed-acquiree,100,76,3/19/2018
657097,earnings,100,50,3/19/2018
66749D,earnings-guidance-up,100,83,3/19/2018
66ECFD,partnership,100,61,3/19/2018
69C99E,conference-participant,100,50,3/19/2018
70FCEF,executive-appointment,100,54,3/19/2018
769F40,executive-appointment,100,54,3/19/2018
76F067,executive-resignation,100,44,3/19/2018
775439,earnings,100,50,3/19/2018
7A0EC4,executive-appointment,100,54,3/19/2018
7ACBA4,dividend,100,50,3/19/2018
7E1D5D,product-release,100,64,3/19/2018
8377DB,product-release,100,64,3/19/2018
83A065,dividend,100,50,3/19/2018
86AA9C,unit-acquisition-acquirer,100,49,3/19/2018
86AA9C,unit-acquisition-acquirer,100,49,3/19/2018
8876D6,conference-participant,100,50,3/19/2018
8876D6,conference-participant,100,50,3/19/2018
8C5519,executive-appointment,100,54,3/19/2018
8CF6DD,executive-appointment,100,54,3/19/2018
8D4486,business-contract,100,69,3/19/2018
8D4486,business-contract,100,69,3/19/2018
903AB4,public-offering,100,43,3/19/2018
9196A2,acquisition-completed-acquirer,100,49,3/19/2018
9196A2,facility-open,100,65,3/19/2018
92B625,conference-participant,100,50,3/19/2018
92D757,partnership,100,61,3/19/2018
92D757,unit-acquisition-completed-acquiree,100,67,3/19/2018
949D62,conference-participant,100,50,3/19/2018
990AD0,conference-organizer,100,57,3/19/2018
99ACAD,product-release,100,64,3/19/2018
99ACAD,executive-resignation,100,44,3/19/2018
9B5968,partnership,100,61,3/19/2018
9B5968,executive-appointment,100,54,3/19/2018
9BB35A,business-contract,100,69,3/19/2018
9CA619,acquisition-regulatory-approval-acquirer,100,54,3/19/2018
9CA619,dividend,100,50,3/19/2018
9CF9B1,executive-appointment,100,54,3/19/2018
A1EAC8,executive-appointment,100,54,3/19/2018
A5A4F5,acquisition-acquirer,100,49,3/19/2018
A6213D,executive-appointment,100,54,3/19/2018
A63387,executive-appointment,100,54,3/19/2018
A65325,acquisition-completed-acquirer,100,49,3/19/2018
A9ED24,dividend,100,50,3/19/2018
AC7C4F,business-contract,100,69,3/19/2018
ACC7D3,earnings,100,50,3/19/2018
ACC7D3,earnings,100,50,3/19/2018
AD375D,dividend,100,50,3/19/2018
AED61E,earnings,100,50,3/19/2018
B1FC3B,business-contract,100,69,3/19/2018
B290A2,earnings,100,50,3/19/2018
B46E12,dividend,100,50,3/19/2018
B4703C,executive-appointment,100,54,3/19/2018
B66928,executive-appointment,100,54,3/19/2018
B7202A,executive-appointment,100,54,3/19/2018
B73395,buybacks,100,74,3/19/2018
B80AD1,earnings,100,50,3/19/2018
B8F71F,note-sale,100,52,3/19/2018
C01737,public-offering,100,43,3/19/2018
C3BCD5,business-contract,100,69,3/19/2018
C3BCD5,business-contract,100,69,3/19/2018
C3BCD5,business-contract,100,69,3/19/2018
C4F9C6,conference-participant,100,50,3/19/2018
C5C137,product-release,100,64,3/19/2018
C8923A,executive-appointment,100,54,3/19/2018
C99CC8,business-contract,100,69,3/19/2018
CBA33B,executive-appointment,100,54,3/19/2018
CBCC6A,conference-organizer,100,57,3/19/2018
CDC217,earnings,100,50,3/19/2018
CDC817,earnings,100,50,3/19/2018
CE5C6E,clinical-trials-positive,100,87,3/19/2018
CFD4B6,conference-participant,100,50,3/19/2018
D78BF1,dividend,100,50,3/19/2018
D88EF3,executive-appointment,100,54,3/19/2018
D9E036,conference-participant,100,50,3/19/2018
DA9443,conference-participant,100,50,3/19/2018
DC0066,conference-participant,100,50,3/19/2018
DDB002,conference-participant,100,50,3/19/2018
E0339F,earnings,100,50,3/19/2018
E11C41,dividend,100,50,3/19/2018
E124EB,conference-call,100,50,3/19/2018
E26FC3,executive-appointment,100,54,3/19/2018
E30B34,executive-appointment,100,54,3/19/2018
E3E68E,product-release,100,64,3/19/2018
E8846E,acquisition-acquiree,100,76,3/19/2018
EB5E78,product-release,100,64,3/19/2018
EF5BED,executive-appointment,100,54,3/19/2018
EF7163,credit-extension-recipient,100,69,3/19/2018
F32F88,partnership,100,61,3/19/2018
F47871,clinical-trials,100,56,3/19/2018
F47871,clinical-trials,100,56,3/19/2018
F4F46F,award,100,58,3/19/2018
F6DE54,asset-sale,100,62,3/19/2018
F88147,earnings,100,50,3/19/2018
FC1A6E,legal-issues-defendant,100,22,3/19/2018
03FB17,acquisition-interest-acquirer,100,46,3/20/2018
55018,conference-call,100,50,3/20/2018
07CA6A,executive-appointment,100,54,3/20/2018
0CE7F6,legal-issues-defendant,100,22,3/20/2018
1096C6,award,100,58,3/20/2018
12E454,legal-issues-defendant,100,22,3/20/2018
12E454,legal-issues-defendant,100,22,3/20/2018
12E454,legal-issues-defendant,100,22,3/20/2018
152AB9,legal-issues-defendant,100,22,3/20/2018
17EDA5,business-contract,100,69,3/20/2018
1E7785,conference-participant,100,50,3/20/2018
1E83DE,product-release,100,64,3/20/2018
1EA923,conference-participant,100,50,3/20/2018
1EBF8D,executive-appointment,100,54,3/20/2018
1F3CFB,market-entry,100,57,3/20/2018
228D42,partnership,100,61,3/20/2018
263216,dividend,100,50,3/20/2018
26E3BA,private-placement,100,56,3/20/2018
275300,dividend,100,50,3/20/2018
27BFA1,fundraising,100,64,3/20/2018
2EB04E,partnership,100,61,3/20/2018
2F24A5,earnings,100,50,3/20/2018
301493,legal-issues-defendant,100,22,3/20/2018
3.14E+47,dividend,100,50,3/20/2018
32F943,product-release,100,64,3/20/2018
3461CF,award,100,58,3/20/2018
349DA4,conference-participant,100,50,3/20/2018
34B97A,executive-appointment,100,54,3/20/2018
367434,conference-participant,100,50,3/20/2018
3C75D6,earnings-positive,100,69,3/20/2018
3C75D6,earnings,100,50,3/20/2018
3C75D6,earnings,100,50,3/20/2018
449A26,conference-call,100,50,3/20/2018
45BC35,executive-appointment,100,54,3/20/2018
4AC91D,product-release,100,64,3/20/2018
4BDCA7,public-offering,100,43,3/20/2018
53F491,earnings,100,50,3/20/2018
545272,dividend,100,50,3/20/2018
550D01,facility-open,100,65,3/20/2018
55D0F3,conference-participant,100,50,3/20/2018
58CA9A,executive-appointment,100,54,3/20/2018
596116,conference-participant,100,50,3/20/2018
5B97B2,dividend-guidance,100,50,3/20/2018
616E3B,conference-call,100,50,3/20/2018
619882,executive-appointment,100,54,3/20/2018
619882,dividend,100,50,3/20/2018
636639,executive-appointment,100,54,3/20/2018
66ECFD,earnings,100,50,3/20/2018
6844D2,earnings,100,50,3/20/2018
6844D2,earnings,100,50,3/20/2018
6844D2,earnings,100,50,3/20/2018
68AB62,conference-call,100,50,3/20/2018
69CE71,executive-appointment,100,54,3/20/2018
69FDFC,product-release,100,64,3/20/2018
69FDFC,product-release,100,64,3/20/2018
6F6559,award,100,58,3/20/2018
71B0CF,conference-participant,100,50,3/20/2018
71E2EF,facility-open,100,65,3/20/2018
73C521,earnings,100,50,3/20/2018
7B1E50,dividend,100,50,3/20/2018
7E1D5D,award,100,58,3/20/2018
7F3A5F,executive-appointment,100,54,3/20/2018
804708,legal-issues-defendant,100,22,3/20/2018
81222C,conference-participant,100,50,3/20/2018
8B6E7E,executive-appointment,100,54,3/20/2018
8D4486,product-release,100,64,3/20/2018
8D4486,product-release,100,64,3/20/2018
8D4486,partnership,100,61,3/20/2018
911AB8,conference-call,100,50,3/20/2018
911CA9,conference-participant,100,50,3/20/2018
931AE7,conference-participant,100,50,3/20/2018
9C8BC3,business-contract,100,69,3/20/2018
9C8BC3,credit-rating-upgrade,100,77,3/20/2018
9D307D,conference-participant,100,50,3/20/2018
A2CAF7,executive-appointment,100,54,3/20/2018
A5A4F5,acquisition-acquirer,100,49,3/20/2018
A63820,executive-appointment,100,54,3/20/2018
A6828A,conference-call,100,50,3/20/2018
A6828A,executive-resignation,100,44,3/20/2018
A6FB29,earnings,100,50,3/20/2018
AA7FE0,conference-call,100,50,3/20/2018
ADD9DC,earnings,100,50,3/20/2018
AFD1CA,facility-open,100,65,3/20/2018
B1FC3B,business-contract,100,69,3/20/2018
B5DE80,conference-call,100,50,3/20/2018
BB127B,acquisition-acquirer,100,49,3/20/2018
BB127B,acquisition-acquirer,100,49,3/20/2018
BCC55F,product-release,100,64,3/20/2018
BDF85E,earnings,100,50,3/20/2018
BE7BA4,conference-participant,100,50,3/20/2018
C32A39,earnings-guidance,100,50,3/20/2018
C58D71,earnings,100,50,3/20/2018
C7FC95,business-contract,100,69,3/20/2018
C85A72,executive-appointment,100,54,3/20/2018
C85A72,executive-appointment,100,54,3/20/2018
CE5C6E,public-offering,100,43,3/20/2018
CFF97C,credit-rating-upgrade-rater,20,50,3/20/2018
D08D2C,conference-call,100,50,3/20/2018
D1CFC8,partnership,100,61,3/20/2018
D1CFC8,partnership,100,61,3/20/2018
D1CFC8,earnings,100,50,3/20/2018
D5B13D,earnings,100,50,3/20/2018
D650A7,conference-participant,100,50,3/20/2018
D697DE,board-meeting,100,51,3/20/2018
D7AC6E,dividend,100,50,3/20/2018
D9E036,business-contract,100,69,3/20/2018
DB9829,dividend,100,50,3/20/2018
E16133,earnings,100,50,3/20/2018
E1C16B,legal-issues-defendant,100,22,3/20/2018
E2F130,conference-call,100,50,3/20/2018
E61888,dividend,100,50,3/20/2018
E8A49A,market-share-gain,100,81,3/20/2018
E8A49A,executive-appointment,100,54,3/20/2018
ECF709,buybacks,100,74,3/20/2018
EDD234,executive-appointment,100,54,3/20/2018
F3816D,conference-participant,100,50,3/20/2018
F3D2EB,dividend,100,50,3/20/2018
F3EDB4,earnings,100,50,3/20/2018
F3EDB4,earnings,100,50,3/20/2018
F4CDA3,dividend,100,50,3/20/2018
F72E4B,board-meeting,100,51,3/20/2018
FC1A6E,legal-issues-defendant,100,22,3/20/2018
00D6B5,business-contract,100,69,3/21/2018
20751,conference-participant,100,50,3/21/2018
053EFF,acquisition-acquiree,100,76,3/21/2018
0A0CF0,dividend,100,50,3/21/2018
0A0CF0,earnings,100,50,3/21/2018
0AB700,dividend,100,50,3/21/2018
0E5619,legal-issues-plaintiff,100,44,3/21/2018
0F0693,conference-participant,100,50,3/21/2018
1216D1,dividend-up,100,81,3/21/2018
12E454,legal-issues-defendant,100,22,3/21/2018
12E454,legal-issues-defendant,100,22,3/21/2018
18D9FA,market-entry,100,57,3/21/2018
1A5D5D,stake-acquirer,100,48,3/21/2018
1EBF8D,regulatory-product-review-positive,100,73,3/21/2018
205AD5,earnings,100,50,3/21/2018
228D42,partnership,100,61,3/21/2018
239106,unit-acquisition-acquirer,100,49,3/21/2018
292A70,earnings-up,100,68,3/21/2018
2C7505,partnership,100,61,3/21/2018
2F1299,partnership,100,61,3/21/2018
30A565,legal-issues-defendant,100,22,3/21/2018
31553A,executive-appointment,100,54,3/21/2018
34B97A,executive-appointment,100,54,3/21/2018
372037,index-listing,100,76,3/21/2018
39D9DA,conference-call,100,50,3/21/2018
39FB23,earnings,100,50,3/21/2018
3C6CCC,partnership,100,61,3/21/2018
3F868D,executive-appointment,100,54,3/21/2018
4.00E+163,public-offering,100,43,3/21/2018
41C528,earnings,100,50,3/21/2018
425BDC,legal-issues-defendant,100,22,3/21/2018
42978B,conference-call,100,50,3/21/2018
44DDBD,public-offering,100,43,3/21/2018
4BDCA7,conference-participant,100,50,3/21/2018
520632,conference-call,100,50,3/21/2018
55438C,product-release,100,64,3/21/2018
56EA2B,executive-appointment,100,54,3/21/2018
589803,partnership,100,61,3/21/2018
5D41E4,public-offering,100,43,3/21/2018
5D41E4,public-offering,100,43,3/21/2018
5DD486,conference-call,100,50,3/21/2018
5FF95F,executive-appointment,100,54,3/21/2018
609208,earnings,100,50,3/21/2018
60FE03,clinical-trials-start,100,64,3/21/2018
62A48D,conference-participant,100,50,3/21/2018
63E8D5,dividend,100,50,3/21/2018
64E346,executive-appointment,100,54,3/21/2018
665D7D,partnership,100,61,3/21/2018
66E3C0,conference-participant,100,50,3/21/2018
693ECD,executive-appointment,100,54,3/21/2018
69CE71,donation,100,54,3/21/2018
6F22E7,unit-acquisition-completed-acquiree,100,67,3/21/2018
6F22E7,credit-extension-recipient,100,69,3/21/2018
6F3936,earnings,100,50,3/21/2018
6F3936,earnings,100,50,3/21/2018
6F3936,earnings,100,50,3/21/2018
6F3936,earnings,100,50,3/21/2018
6F3936,earnings,100,50,3/21/2018
6F3936,earnings,100,50,3/21/2018
6F3936,earnings,100,50,3/21/2018
6F3936,earnings,100,50,3/21/2018
717DB4,earnings-guidance-up,100,83,3/21/2018
7255D2,note-sale,100,52,3/21/2018
75768D,earnings,100,50,3/21/2018
75768D,earnings,100,50,3/21/2018
75768D,earnings,100,50,3/21/2018
75768D,earnings,100,50,3/21/2018
75768D,earnings,100,50,3/21/2018
75768D,executive-appointment,100,54,3/21/2018
76D79A,executive-appointment,100,54,3/21/2018
775439,dividend-up,100,81,3/21/2018
7A5097,earnings,100,50,3/21/2018
7E0EB0,conference-participant,100,50,3/21/2018
7E1D5D,acquisition-acquirer,100,49,3/21/2018
804708,legal-issues-defendant,100,22,3/21/2018
83066C,public-offering,100,43,3/21/2018
859D62,executive-appointment,100,54,3/21/2018
883D82,legal-issues-defendant,100,22,3/21/2018
895D56,index-listing,100,76,3/21/2018
89F693,award,100,58,3/21/2018
8D4486,partnership,100,61,3/21/2018
8D4486,partnership,100,61,3/21/2018
8E4F9A,conference-participant,100,50,3/21/2018
911ACB,executive-resignation,100,44,3/21/2018
934CC3,partnership,100,61,3/21/2018
950CDB,dividend,100,50,3/21/2018
9548BB,earnings,100,50,3/21/2018
9B5968,dividend,100,50,3/21/2018
9B5968,dividend,100,50,3/21/2018
9CA432,product-release,100,64,3/21/2018
9CA619,earnings,100,50,3/21/2018
A5A4F5,acquisition-acquirer,100,49,3/21/2018
A87CD6,conference-participant,100,50,3/21/2018
AD23DE,executive-appointment,100,54,3/21/2018
B1FC3B,business-contract,100,69,3/21/2018
B6082A,conference-call,100,50,3/21/2018
BDF2BD,earnings,100,50,3/21/2018
BDF2BD,earnings,100,50,3/21/2018
BDF2BD,earnings,100,50,3/21/2018
BDF2BD,earnings,100,50,3/21/2018
BDF2BD,earnings,100,50,3/21/2018
C01737,public-offering,100,43,3/21/2018
C062D4,business-contract,100,69,3/21/2018
C951A2,acquisition-acquiree,100,76,3/21/2018
C9A96E,executive-appointment,100,54,3/21/2018
CE5C6E,public-offering,100,43,3/21/2018
CF7292,legal-issues-defendant,100,22,3/21/2018
CFE5BE,note-sale,100,52,3/21/2018
D29B44,partnership,100,61,3/21/2018
D6489C,business-contract,100,69,3/21/2018
D64C6D,executive-appointment,100,54,3/21/2018
DA0A9E,conference-call,100,50,3/21/2018
DB88A1,earnings,100,50,3/21/2018
DD0F15,conference-participant,100,50,3/21/2018
DD9E41,partnership,100,61,3/21/2018
DF11D9,executive-resignation,100,44,3/21/2018
E2CB7B,earnings,100,50,3/21/2018
E4CE73,award,100,58,3/21/2018
E959F3,earnings,100,50,3/21/2018
EB7FBF,dividend,100,50,3/21/2018
ED79D9,dividend,100,50,3/21/2018
EDD234,earnings,100,50,3/21/2018
EF7163,dividend,100,50,3/21/2018
F5349B,executive-appointment,100,54,3/21/2018
F85CC0,dividend,100,50,3/21/2018
FAE021,investment-investor,100,55,3/21/2018
FF227B,conference-call,100,50,3/21/2018
0157B1,partnership,100,61,3/22/2018
01D03F,regulatory-product-approval-granted,100,81,3/22/2018
03596A,partnership,100,61,3/22/2018
0A77DB,earnings,100,50,3/22/2018
0C2A0D,business-contract,100,69,3/22/2018
0F0693,public-offering,100,43,3/22/2018
12E454,legal-issues-defendant,100,22,3/22/2018
159739,conference-call,100,50,3/22/2018
16FC89,earnings,100,50,3/22/2018
1921DD,partnership,100,61,3/22/2018
1921DD,partnership,100,61,3/22/2018
1A9DE1,dividend,100,50,3/22/2018
1AB023,conference-participant,100,50,3/22/2018
1AB023,conference-participant,100,50,3/22/2018
1AB023,conference-participant,100,50,3/22/2018
1B637E,business-contract,100,69,3/22/2018
26CC63,business-contract,100,69,3/22/2018
279916,business-contract,100,69,3/22/2018
2BC05E,partnership,100,61,3/22/2018
2EC172,executive-resignation,100,44,3/22/2018
2EC172,executive-resignation,100,44,3/22/2018
3.20E+263,clinical-trials,100,56,3/22/2018
3390DE,conference-call,100,50,3/22/2018
33FD66,earnings,100,50,3/22/2018
3B20AB,partnership,100,61,3/22/2018
3C7F5F,product-release,100,64,3/22/2018
3FACA7,earnings,100,50,3/22/2018
44209A,legal-issues-defendant,100,22,3/22/2018
46A16E,conference-participant,100,50,3/22/2018
49BBBC,earnings,100,50,3/22/2018
4C37C5,conference-call,100,50,3/22/2018
510EA6,earnings,100,50,3/22/2018
510EA6,earnings,100,50,3/22/2018
53F491,dividend,100,50,3/22/2018
5.47E+28,conference-participant,100,50,3/22/2018
56277A,conference-call,100,50,3/22/2018
56EA2B,executive-appointment,100,54,3/22/2018
59F0B0,conference-call,100,50,3/22/2018
5BC2F4,executive-appointment,100,54,3/22/2018
5C7601,earnings,100,50,3/22/2018
5CC29D,dividend,100,50,3/22/2018
5E7E82,executive-appointment,100,54,3/22/2018
5EF130,executive-appointment,100,54,3/22/2018
62A48D,earnings,100,50,3/22/2018
633043,dividend,100,50,3/22/2018
6474BA,earnings,100,50,3/22/2018
665D7D,clinical-trials,100,56,3/22/2018
694749,buybacks,100,74,3/22/2018
72FCA3,earnings,100,50,3/22/2018
72FCA3,earnings,100,50,3/22/2018
72FCA3,earnings,100,50,3/22/2018
72FCA3,earnings,100,50,3/22/2018
7740DE,earnings,100,50,3/22/2018
7740DE,earnings,100,50,3/22/2018
7771D7,earnings,100,50,3/22/2018
7AB859,executive-appointment,100,54,3/22/2018
7AB859,executive-appointment,100,54,3/22/2018
7ADE57,dividend,100,50,3/22/2018
7BC92D,earnings,100,50,3/22/2018
8.10E+32,partnership,100,61,3/22/2018
83066C,public-offering,100,43,3/22/2018
859D62,note-sale,100,52,3/22/2018
863350,earnings,100,50,3/22/2018
8B2C4A,merger-regulatory-approval,100,81,3/22/2018
8DCF18,executive-appointment,100,54,3/22/2018
92D757,executive-appointment,100,54,3/22/2018
92D9C9,dividend,100,50,3/22/2018
94563D,conference-participant,100,50,3/22/2018
954004,earnings,100,50,3/22/2018
968B00,partnership,100,61,3/22/2018
968B00,partnership,100,61,3/22/2018
9.82E+06,earnings,100,50,3/22/2018
9.86E+03,partnership,100,61,3/22/2018
9.86E+03,partnership,100,61,3/22/2018
98A286,earnings-per-share,100,50,3/22/2018
98CEBB,partnership,100,61,3/22/2018
9BBFA5,earnings,100,50,3/22/2018
9E91C6,legal-issues-defendant,100,22,3/22/2018
9E91C6,legal-issues-defendant,100,22,3/22/2018
A350C1,dividend,100,50,3/22/2018
A43906,conference-call,100,50,3/22/2018
A5A4F5,acquisition-acquirer,100,49,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A5A4F5,earnings,100,50,3/22/2018
A6213D,executive-appointment,100,54,3/22/2018
A6213D,legal-issues-defendant,100,22,3/22/2018
A63820,earnings,100,50,3/22/2018
A761FE,conference-call,100,50,3/22/2018
AC775C,conference-participant,100,50,3/22/2018
ADD9DC,facility-open,100,65,3/22/2018
AED6CF,executive-appointment,100,54,3/22/2018
B1FC3B,business-contract,100,69,3/22/2018
B48FC9,product-release,100,64,3/22/2018
B614F8,joint-venture,100,62,3/22/2018
BB5271,award,100,58,3/22/2018
BE5935,note-sale,100,52,3/22/2018
BFAEB4,earnings,100,50,3/22/2018
BFE02C,conference-call,100,50,3/22/2018
C2E39B,earnings,100,50,3/22/2018
C81E00,conference-call,100,50,3/22/2018
C8FAC7,note-sale,100,52,3/22/2018
CBB77B,award,100,58,3/22/2018
CFF97C,credit-rating-upgrade-rater,20,50,3/22/2018
D139BC,note-sale,100,52,3/22/2018
D1AE3B,conference-call,100,50,3/22/2018
D21D8A,dividend,100,50,3/22/2018
D4AC65,product-release,100,64,3/22/2018
D622D5,dividend,100,50,3/22/2018
D64C6D,earnings,100,50,3/22/2018
D8ECA1,board-meeting,100,51,3/22/2018
DD1BA1,executive-appointment,100,54,3/22/2018
DDCB34,conference-participant,100,50,3/22/2018
DE20DF,partnership,100,61,3/22/2018
E114F4,award,100,58,3/22/2018
E1E093,partnership,100,61,3/22/2018
E21871,conference-participant,100,50,3/22/2018
E35610,hirings,100,65,3/22/2018
E5752F,partnership,100,61,3/22/2018
E5752F,executive-appointment,100,54,3/22/2018
E6BC2C,executive-appointment,100,54,3/22/2018
EB7FBF,earnings,100,50,3/22/2018
EB7FBF,earnings,100,50,3/22/2018
EB7FBF,earnings,100,50,3/22/2018
EB7FBF,earnings,100,50,3/22/2018
EE6F1C,business-contract,100,69,3/22/2018
EF25A5,partnership,100,61,3/22/2018
EF5BED,executive-appointment,100,54,3/22/2018
F02170,business-contract,100,69,3/22/2018
F1CD47,earnings,100,50,3/22/2018
F7FCA4,conference-participant,100,50,3/22/2018
FD9526,conference-call,100,50,3/22/2018
FDF799,earnings,100,50,3/22/2018
0CE7F6,legal-issues-defendant,100,22,3/23/2018
0CE7F6,legal-issues-defendant,100,22,3/23/2018
0CE7F6,legal-issues-defendant,100,22,3/23/2018
0E5223,conference-participant,100,50,3/23/2018
0F0693,public-offering,100,43,3/23/2018
12E454,legal-issues-defendant,100,22,3/23/2018
12E454,legal-issues-defendant,100,22,3/23/2018
1FC422,conference-call,100,50,3/23/2018
251988,earnings,100,50,3/23/2018
2C3348,patient-enrollment-start,100,58,3/23/2018
3A3447,facility-open,100,65,3/23/2018
3BC360,conference-participant,100,50,3/23/2018
3DDE54,conference-participant,100,50,3/23/2018
3F4497,dividend,100,50,3/23/2018
44209A,legal-issues-defendant,100,22,3/23/2018
44209A,legal-issues-defendant,100,22,3/23/2018
44DDBD,public-offering,100,43,3/23/2018
4B3555,dividend,100,50,3/23/2018
4C3FE9,conference-participant,100,50,3/23/2018
4F9926,product-release,100,64,3/23/2018
51527B,legal-issues-defendant,100,22,3/23/2018
58CA9A,award,100,58,3/23/2018
5D41E4,public-offering,100,43,3/23/2018
5D41E4,public-offering,100,43,3/23/2018
68E6E9,facility-open,100,65,3/23/2018
694749,business-contract,100,69,3/23/2018
6DBBBC,executive-appointment,100,54,3/23/2018
6F30F9,dividend,100,50,3/23/2018
7255D2,note-sale,100,52,3/23/2018
76E80F,dividend,100,50,3/23/2018
773A17,executive-appointment,100,54,3/23/2018
8.10E+32,legal-verdict-disfavored,100,22,3/23/2018
8817D5,conference-call,100,50,3/23/2018
990AD0,conference-organizer,100,57,3/23/2018
9E91C6,legal-issues-defendant,100,22,3/23/2018
A52533,facility-open,100,65,3/23/2018
A5A4F5,acquisition-acquirer,100,49,3/23/2018
A94637,product-price-raise,100,57,3/23/2018
ABBAD1,earnings,100,50,3/23/2018
AFDF2E,acquisition-completed-acquirer,100,49,3/23/2018
B5766D,conference-call,100,50,3/23/2018
B8DD94,conference-participant,100,50,3/23/2018
B9BDE8,facility-open,100,65,3/23/2018
BB0787,executive-appointment,100,54,3/23/2018
BE14CF,board-meeting,100,51,3/23/2018
BE5935,note-sale,100,52,3/23/2018
C27E19,earnings,100,50,3/23/2018
C2E426,executive-appointment,100,54,3/23/2018
CE5664,board-meeting,100,51,3/23/2018
CFF15D,board-meeting,100,51,3/23/2018
D139BC,public-offering,100,43,3/23/2018
D78CCD,award,100,58,3/23/2018
DB23C8,conference-participant,100,50,3/23/2018
DC486E,earnings,100,50,3/23/2018
DCD97F,business-contract,100,69,3/23/2018
DD682D,public-offering,100,43,3/23/2018
EAA0A7,product-release,100,64,3/23/2018
F5D410,earnings,100,50,3/23/2018
F6DE54,acquisition-acquirer,100,49,3/23/2018
FC1A6E,legal-issues-defendant,100,22,3/23/2018
44209A,legal-issues-defendant,100,22,3/24/2018
0157B1,partnership,100,61,3/26/2018
0B2071,dividend-up,100,81,3/26/2018
0B400D,earnings,100,50,3/26/2018
0B400D,earnings,100,50,3/26/2018
0B400D,earnings,100,50,3/26/2018
0B400D,earnings,100,50,3/26/2018
0BC29E,executive-appointment,100,54,3/26/2018
0BC29E,product-release,100,64,3/26/2018
0BC29E,earnings,100,50,3/26/2018
0E439E,earnings,100,50,3/26/2018
0E5619,conference-participant,100,50,3/26/2018
12E454,legal-issues-defendant,100,22,3/26/2018
168A5D,facility-open,100,65,3/26/2018
1A2D9F,partnership,100,61,3/26/2018
1FA886,buybacks,100,74,3/26/2018
228D42,partnership,100,61,3/26/2018
228D42,partnership,100,61,3/26/2018
2571FA,conference-participant,100,50,3/26/2018
284289,conference-participant,100,50,3/26/2018
2A1009,executive-appointment,100,54,3/26/2018
2BF36E,acquisition-acquirer,100,49,3/26/2018
31553A,earnings,100,50,3/26/2018
35B907,dividend,100,50,3/26/2018
36C09B,conference-participant,100,50,3/26/2018
39692D,name-change,100,49,3/26/2018
39692D,name-change,100,49,3/26/2018
39692D,name-change,100,49,3/26/2018
3A4BDB,dividend-up,100,59,3/26/2018
43A74A,business-contract,100,69,3/26/2018
449447,conference-participant,100,50,3/26/2018
49A344,earnings,100,50,3/26/2018
4A6F00,product-release,100,64,3/26/2018
4B49CF,conference-call,100,50,3/26/2018
4B5054,conference-call,100,50,3/26/2018
4B6EF9,credit-extension-recipient,100,69,3/26/2018
4C7DB5,earnings,100,50,3/26/2018
51D876,credit-rating-upgrade,100,65,3/26/2018
53A226,executive-appointment,100,54,3/26/2018
5.43E+08,public-offering,100,43,3/26/2018
567F3D,conference-call,100,50,3/26/2018
5A64D5,investment-investor,100,55,3/26/2018
5BC2F4,earnings,100,50,3/26/2018
5D0337,earnings,100,50,3/26/2018
5F3D91,conference-participant,100,50,3/26/2018
60EA12,earnings,100,50,3/26/2018
69C99E,conference-participant,100,50,3/26/2018
6F6559,earnings,100,50,3/26/2018
6F6559,earnings,100,50,3/26/2018
6F6559,earnings,100,50,3/26/2018
6F6559,earnings,100,50,3/26/2018
723548,dividend,100,50,3/26/2018
72C2CE,public-offering,100,43,3/26/2018
73A71F,earnings,100,50,3/26/2018
73A71F,earnings-guidance,100,50,3/26/2018
746373,conference-call,100,50,3/26/2018
793C11,partnership,100,61,3/26/2018
7999F3,executive-appointment,100,54,3/26/2018
7D5FD6,earnings,100,50,3/26/2018
83B1C8,conference-participant,100,50,3/26/2018
863350,public-offering,100,43,3/26/2018
877734,earnings,100,50,3/26/2018
88923D,product-release,100,64,3/26/2018
8D9993,dividend-up,100,81,3/26/2018
931AE7,executive-appointment,100,54,3/26/2018
93AD2E,conference-call,100,50,3/26/2018
96F126,product-release,100,64,3/26/2018
97B027,facility-open,100,65,3/26/2018
990AD0,conference-organizer,100,57,3/26/2018
9.92E+94,product-release,100,64,3/26/2018
9CA619,public-offering,100,43,3/26/2018
9EBAFA,public-offering,100,43,3/26/2018
9F37C5,dividend,100,50,3/26/2018
A52B6B,acquisition-completed-acquirer,100,49,3/26/2018
A5A4F5,acquisition-acquirer,100,49,3/26/2018
A6213D,award,100,58,3/26/2018
A7102F,legal-issues-defendant,100,22,3/26/2018
AA98ED,conference-call,100,50,3/26/2018
AD9F1D,conference-call,100,50,3/26/2018
ADF092,earnings,100,50,3/26/2018
B13B68,note-sale,100,52,3/26/2018
B1FC3B,business-contract,100,69,3/26/2018
B2D799,public-offering,100,43,3/26/2018
B48FC9,public-offering,100,43,3/26/2018
B604DF,partnership,100,61,3/26/2018
B80AD1,earnings,100,50,3/26/2018
C407A0,note-sale,100,52,3/26/2018
C407A0,note-sale,100,52,3/26/2018
C4A432,dividend,100,50,3/26/2018
C97B2D,conference-call,100,50,3/26/2018
C9881C,partnership,100,61,3/26/2018
C99CC8,conference-participant,100,50,3/26/2018
C9F39B,unit-acquisition-acquiree,100,76,3/26/2018
CD4DA8,executive-appointment,100,54,3/26/2018
CDAF5B,conference-call,100,50,3/26/2018
CE5C6E,public-offering,100,43,3/26/2018
CFF97C,credit-rating-upgrade-rater,20,50,3/26/2018
D15833,dividend,100,50,3/26/2018
D6853F,business-contract,100,69,3/26/2018
D8442A,patent-infringement-defendant,100,26,3/26/2018
D8ECA1,public-offering,100,43,3/26/2018
D9B1C9,executive-appointment,100,54,3/26/2018
DC2B00,facility-upgrade,100,65,3/26/2018
DC2B00,note-sale,100,52,3/26/2018
E09997,buybacks,100,74,3/26/2018
E09E2B,partnership,100,61,3/26/2018
E4CE73,partnership,100,61,3/26/2018
EAA0A7,executive-appointment,100,54,3/26/2018
ED2A5E,board-meeting,100,51,3/26/2018
EE6F1C,product-release,100,64,3/26/2018
EE6F1C,product-release,100,64,3/26/2018
F1529C,conference-call,100,50,3/26/2018
F7935D,earnings,100,50,3/26/2018
00067A,executive-appointment,100,54,3/27/2018
00D6B5,note-sale,100,52,3/27/2018
00D6B5,note-sale,100,52,3/27/2018
00E601,earnings,100,50,3/27/2018
061A3B,product-price-raise,100,57,3/27/2018
07EC43,award,100,58,3/27/2018
0B57D7,conference-call,100,50,3/27/2018
0C466B,acquisition-acquirer,100,49,3/27/2018
0F65C9,board-meeting,100,51,3/27/2018
12A3A3,revenue-up,100,69,3/27/2018
12A3A3,revenue-up,100,69,3/27/2018
12A3A3,revenue-up,100,69,3/27/2018
12A3A3,revenue-up,100,69,3/27/2018
12E454,legal-issues-defendant,100,22,3/27/2018
12E454,partnership,100,61,3/27/2018
15B10D,conference-participant,100,50,3/27/2018
1B5FEA,earnings,100,50,3/27/2018
1B9535,credit-extension-recipient,100,69,3/27/2018
1BC12C,product-release,100,64,3/27/2018
1C2593,product-release,100,64,3/27/2018
1D943E,business-contract,100,69,3/27/2018
1EBF8D,fast-track-designation,100,81,3/27/2018
21D903,executive-appointment,100,54,3/27/2018
24C48B,acquisition-acquirer,100,49,3/27/2018
24C48B,acquisition-acquirer,100,49,3/27/2018
2B0AF4,conference-call,100,50,3/27/2018
33FD66,product-release,100,64,3/27/2018
341759,legal-issues-defendant,100,22,3/27/2018
3471C0,executive-resignation,100,44,3/27/2018
35AE32,conference-participant,100,50,3/27/2018
36529A,regulatory-product-application,100,69,3/27/2018
37727A,dividend-up,100,81,3/27/2018
37B120,executive-appointment,100,54,3/27/2018
3A3447,facility-open,100,65,3/27/2018
3ACF46,conference-participant,100,50,3/27/2018
3BCF24,dividend,100,50,3/27/2018
3F4497,conference-call,100,50,3/27/2018
408089,earnings,100,50,3/27/2018
442587,partnership,100,61,3/27/2018
453282,conference-call,100,50,3/27/2018
49914B,conference-call,100,50,3/27/2018
51888A,asset-sale,100,62,3/27/2018
54512F,partnership,100,61,3/27/2018
58B46F,conference-call,100,50,3/27/2018
5D41E4,public-offering,100,43,3/27/2018
5D41E4,public-offering,100,43,3/27/2018
6844D2,acquisition-acquirer,100,49,3/27/2018
6ED519,dividend,100,50,3/27/2018
6FCEF9,earnings,100,50,3/27/2018
70FCEF,executive-appointment,100,54,3/27/2018
72C2CE,public-offering,100,43,3/27/2018
7520CC,executive-appointment,100,54,3/27/2018
75F665,conference-call,100,50,3/27/2018
7B8CB5,executive-appointment,100,54,3/27/2018
7B9212,dividend,100,50,3/27/2018
7E2DE6,earnings,100,50,3/27/2018
82B57E,executive-appointment,100,54,3/27/2018
863350,public-offering,100,43,3/27/2018
8AB37F,executive-appointment,100,54,3/27/2018
8C5519,earnings,100,50,3/27/2018
8D4486,product-release,100,64,3/27/2018
91C82E,conference-call,100,50,3/27/2018
92D3A0,conference-call,100,50,3/27/2018
940C3D,business-contract,100,69,3/27/2018
94637C,regulatory-product-approval-granted,100,81,3/27/2018
94C0B5,conference-call,100,50,3/27/2018
95DC1F,executive-appointment,100,54,3/27/2018
97693A,earnings,100,50,3/27/2018
977A1E,dividend,100,50,3/27/2018
977A1E,public-offering,100,43,3/27/2018
98CAED,unit-acquisition-completed-acquirer,100,49,3/27/2018
990AD0,executive-appointment,100,54,3/27/2018
9A02C4,conference-call,100,50,3/27/2018
9A602D,conference-call,100,50,3/27/2018
9CA619,public-offering,100,43,3/27/2018
9D56F2,earnings-up,100,68,3/27/2018
9D56F2,earnings-up,100,68,3/27/2018
9D56F2,earnings-up,100,68,3/27/2018
9D56F2,earnings-up,100,68,3/27/2018
9D56F2,earnings-up,100,68,3/27/2018
9E3224,dividend,100,50,3/27/2018
9EBAFA,public-offering,100,43,3/27/2018
A017F4,ipo-pricing,100,50,3/27/2018
A398B9,partnership,100,61,3/27/2018
A48593,executive-appointment,100,54,3/27/2018
A5A4F5,acquisition-acquirer,100,49,3/27/2018
A6213D,conference-call,100,50,3/27/2018
A6828A,patent-infringement-defendant,100,26,3/27/2018
A6FB29,earnings,100,50,3/27/2018
A72FD9,earnings,100,50,3/27/2018
A8B137,earnings-guidance,100,50,3/27/2018
B1FC3B,partnership,100,61,3/27/2018
C7859D,conference-call,100,50,3/27/2018
C8257F,unit-acquisition-acquirer,100,49,3/27/2018
C951A2,regulatory-product-approval-granted,100,81,3/27/2018
CAB222,public-offering,100,43,3/27/2018
CEC08B,acquisition-acquirer,100,49,3/27/2018
CF6A5A,partnership,100,61,3/27/2018
D6EAA3,executive-appointment,100,54,3/27/2018
D6EAA3,conference-call,100,50,3/27/2018
D8ECA1,business-contract,100,69,3/27/2018
D8ECA1,business-contract,100,69,3/27/2018
DD682D,note-sale,100,52,3/27/2018
E09997,conference-participant,100,50,3/27/2018
E09E2B,partnership,100,61,3/27/2018
E6EDED,conference-call,100,50,3/27/2018
E9E6FD,merger-regulatory-approval,100,81,3/27/2018
F0B2B5,executive-appointment,100,54,3/27/2018
F0B335,clinical-trials-positive,100,87,3/27/2018
F0B877,conference-call,100,50,3/27/2018
F6A945,earnings,100,50,3/27/2018
01478A,board-meeting,100,51,3/28/2018
018C11,conference-call,100,50,3/28/2018
02FC1A,public-offering,100,43,3/28/2018
0358AF,partnership,100,61,3/28/2018
03F5A4,dividend-up,100,81,3/28/2018
05AF14,dividend,100,50,3/28/2018
083F72,executive-appointment,100,54,3/28/2018
099C88,business-contract,100,69,3/28/2018
0A7650,dividend,100,50,3/28/2018
0E2992,conference-call,100,50,3/28/2018
0FC848,spin-off,100,58,3/28/2018
1065BC,acquisition-acquirer,100,49,3/28/2018
12DE76,executive-appointment,100,54,3/28/2018
16C7F0,conference-call,100,50,3/28/2018
1EC3E8,executive-appointment,100,54,3/28/2018
200D8B,conference-participant,100,50,3/28/2018
202E5A,clinical-trials-start,100,64,3/28/2018
21245F,partnership,100,61,3/28/2018
21DED4,conference-call,100,50,3/28/2018
25102A,dividend-up,100,66,3/28/2018
25102A,dividend-up,100,66,3/28/2018
25102A,product-release,100,64,3/28/2018
25102A,product-release,100,64,3/28/2018
272704,earnings,100,50,3/28/2018
2AA6A8,executive-appointment,100,54,3/28/2018
2B9DBB,executive-appointment,100,54,3/28/2018
2C7505,clinical-trials,100,56,3/28/2018
2C7505,clinical-trials-start,100,64,3/28/2018
2D981A,earnings,100,50,3/28/2018
31AA84,executive-appointment,100,54,3/28/2018
341759,legal-issues-defendant,100,22,3/28/2018
341759,legal-issues-defendant,100,22,3/28/2018
341759,legal-issues-defendant,100,22,3/28/2018
34A959,partnership,100,61,3/28/2018
353DBB,conference-call,100,50,3/28/2018
370C50,product-price-raise,100,57,3/28/2018
3CCC90,conference-call,100,50,3/28/2018
3DDE54,earnings,100,50,3/28/2018
414FFF,earnings,100,50,3/28/2018
44209A,legal-issues-defendant,100,22,3/28/2018
44209A,legal-issues-defendant,100,22,3/28/2018
449217,dividend,100,50,3/28/2018
49F4D0,dividend,100,50,3/28/2018
4AE584,revenue-up,100,69,3/28/2018
4AE584,revenue-up,100,69,3/28/2018
4B49CF,earnings,100,50,3/28/2018
4B49CF,earnings,100,50,3/28/2018
4B49CF,earnings,100,50,3/28/2018
4E4E75,fraud-defendant,100,20,3/28/2018
4EEB00,conference-participant,100,50,3/28/2018
4F9487,dividend-up,100,77,3/28/2018
504FE2,conference-call,100,50,3/28/2018
5.43E+08,public-offering,100,43,3/28/2018
54F1D2,conference-participant,100,50,3/28/2018
55438C,earnings,100,50,3/28/2018
55438C,conference-call,100,50,3/28/2018
62A48D,revenue-up,100,78,3/28/2018
62CDDE,acquisition-acquirer,100,49,3/28/2018
62CDDE,acquisition-acquirer,100,49,3/28/2018
62CDDE,acquisition-acquirer,100,49,3/28/2018
636BBF,award,100,58,3/28/2018
657097,earnings,100,50,3/28/2018
67303E,business-contract,100,69,3/28/2018
6C4D2F,merger,100,66,3/28/2018
713810,board-meeting,100,51,3/28/2018
7239BB,earnings,100,50,3/28/2018
756045,executive-resignation,100,44,3/28/2018
756BB4,earnings,100,50,3/28/2018
75F665,merger-regulatory-approval,100,81,3/28/2018
77B8E9,partnership,100,61,3/28/2018
77B8E9,partnership,100,61,3/28/2018
7A0EC4,ipo-considered,100,60,3/28/2018
7A975D,earnings,100,50,3/28/2018
7A975D,earnings,100,50,3/28/2018
7A975D,earnings,100,50,3/28/2018
7F2922,partnership,100,61,3/28/2018
830BDB,regulatory-product-approval-granted,100,81,3/28/2018
850779,earnings,100,50,3/28/2018
8665BA,partnership,100,61,3/28/2018
902670,earnings-guidance,100,50,3/28/2018
96F126,business-contract,100,69,3/28/2018
977A1E,public-offering,100,43,3/28/2018
98CEBB,partnership,100,61,3/28/2018
9D30A8,demand-increase,100,83,3/28/2018
9D56F2,dividend,100,50,3/28/2018
A26C26,dividend,100,50,3/28/2018
A5A4F5,acquisition-acquirer,100,49,3/28/2018
A65325,award,100,58,3/28/2018
AC7C4F,acquisition-failed-acquirer,100,41,3/28/2018
AD23DE,executive-appointment,100,54,3/28/2018
AD23DE,executive-appointment,100,54,3/28/2018
AD23DE,executive-appointment,100,54,3/28/2018
AED61E,executive-appointment,100,54,3/28/2018
AED6CF,unit-acquisition-acquirer,100,49,3/28/2018
B2D492,credit-extension-recipient,100,69,3/28/2018
B2D799,public-offering-suspended,100,24,3/28/2018
B48FC9,public-offering,100,43,3/28/2018
C2609A,product-release,100,64,3/28/2018
C9881C,partnership,100,61,3/28/2018
C9F39B,conference-call,100,50,3/28/2018
CAB222,public-offering,100,43,3/28/2018
CAC8D0,headquarters-change,100,50,3/28/2018
CC0C78,conference-participant,100,50,3/28/2018
CEDFD5,earnings,100,50,3/28/2018
D3CEDF,executive-appointment,100,54,3/28/2018
D4463B,dividend,100,50,3/28/2018
D78CCD,executive-appointment,100,54,3/28/2018
D93A25,earnings-guidance,100,50,3/28/2018
DAFED3,conference-call,100,50,3/28/2018
DB88A1,earnings,100,50,3/28/2018
DC0066,earnings,100,50,3/28/2018
DD0099,earnings,100,50,3/28/2018
DD0F15,legal-issues-defendant,100,22,3/28/2018
DD0F15,legal-issues-defendant,100,22,3/28/2018
E0207A,merger-regulatory-approval,100,81,3/28/2018
E09E2B,partnership,100,61,3/28/2018
E49AA3,acquisition-completed-acquirer,100,49,3/28/2018
E49AA3,acquisition-completed-acquirer,100,49,3/28/2018
E49AA3,acquisition-completed-acquirer,100,49,3/28/2018
E99180,dividend,100,50,3/28/2018
ECD263,executive-appointment,100,54,3/28/2018
ED9C04,executive-appointment,100,54,3/28/2018
EF5BED,conference-call,100,50,3/28/2018
F05B1B,executive-appointment,100,54,3/28/2018
F05B1B,executive-appointment,100,54,3/28/2018
F43A11,conference-call,100,50,3/28/2018
FACF19,earnings,100,50,3/28/2018
FC01C0,acquisition-acquirer,100,49,3/28/2018
FDD3FC,earnings,100,50,3/28/2018
FF227B,earnings,100,50,3/28/2018
02FC1A,public-offering,100,43,3/29/2018
054B55,executive-appointment,100,54,3/29/2018
05AF14,earnings,100,50,3/29/2018
061A3B,earnings,100,50,3/29/2018
07EC43,award,100,58,3/29/2018
083F72,earnings,100,50,3/29/2018
0BC17A,conference-call,100,50,3/29/2018
0BF198,regulatory-product-application,100,69,3/29/2018
0BF198,regulatory-product-application,100,69,3/29/2018
0C2A0D,award,100,58,3/29/2018
10943B,conference-call,100,50,3/29/2018
10C19B,conference-call,100,50,3/29/2018
1490F3,earnings-guidance,100,50,3/29/2018
16F4D8,conference-call,100,50,3/29/2018
1880C5,clinical-trials-filed,100,60,3/29/2018
1D1B07,earnings,100,50,3/29/2018
1D1B07,earnings,100,50,3/29/2018
1D943E,executive-appointment,100,54,3/29/2018
1FA886,buybacks,100,74,3/29/2018
26E3BA,earnings,100,50,3/29/2018
27BFA1,conference-call,100,50,3/29/2018
2BDC1C,conference-participant,100,50,3/29/2018
2EB04E,partnership,100,61,3/29/2018
2EB88B,acquisition-acquirer,100,49,3/29/2018
2F7474,dividend,100,50,3/29/2018
341759,legal-issues-defendant,100,22,3/29/2018
341759,earnings,100,50,3/29/2018
341759,earnings,100,50,3/29/2018
3461CF,credit-rating-downgrade-rater,20,50,3/29/2018
3A3447,facility-open,100,65,3/29/2018
3DC887,product-release,100,64,3/29/2018
3F6A9C,award,100,58,3/29/2018
3FBC9B,executive-appointment,100,54,3/29/2018
434F38,earnings,100,50,3/29/2018
45ABCC,product-release,100,64,3/29/2018
4EC4C1,conference-call,100,50,3/29/2018
4EEB00,conference-call,100,50,3/29/2018
55C9B5,conference-call,100,50,3/29/2018
57CAAB,executive-appointment,100,54,3/29/2018
589846,partnership,100,61,3/29/2018
5B97B2,executive-appointment,100,54,3/29/2018
5BC2F4,executive-appointment,100,54,3/29/2018
5CCDAD,credit-extension-recipient,100,69,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-interest-acquirer,100,46,3/29/2018
5DD486,acquisition-acquirer,100,49,3/29/2018
5DD486,acquisition-acquirer,100,49,3/29/2018
5DD486,acquisition-acquirer,100,49,3/29/2018
5DD486,acquisition-acquirer,100,49,3/29/2018
601785,earnings,100,50,3/29/2018
61BCA7,earnings,100,50,3/29/2018
627186,earnings,100,50,3/29/2018
62CDDE,acquisition-acquirer,100,49,3/29/2018
66A667,dividend,100,50,3/29/2018
6810DE,conference-participant,100,50,3/29/2018
6A3C35,dividend,100,50,3/29/2018
6BF593,conference-call,100,50,3/29/2018
6D9B53,ipo-pricing,100,50,3/29/2018
722D55,executive-appointment,100,54,3/29/2018
762A3E,conference-organizer,100,57,3/29/2018
77B8E9,clinical-trials,100,56,3/29/2018
7A10FF,executive-appointment,100,54,3/29/2018
7B0BA6,business-contract,100,69,3/29/2018
7BC92D,earnings-up,100,68,3/29/2018
7CBC40,executive-appointment,100,54,3/29/2018
7CBC40,executive-appointment,100,54,3/29/2018
7EA323,earnings,100,50,3/29/2018
7EA323,earnings,100,50,3/29/2018
7EA323,earnings,100,50,3/29/2018
7EA323,earnings,100,50,3/29/2018
868808,dividend,100,50,3/29/2018
893904,earnings,100,50,3/29/2018
8B8656,conference-participant,100,50,3/29/2018
8D4486,facility-open,100,65,3/29/2018
8D9993,shareholder-rights-plan-suspended,100,57,3/29/2018
93633B,dividend,100,50,3/29/2018
96A6CD,executive-appointment,100,54,3/29/2018
9810C0,earnings-guidance,100,50,3/29/2018
98CAED,earnings,100,50,3/29/2018
9934AD,conference-call,100,50,3/29/2018
9D3360,buybacks,100,74,3/29/2018
9F5CBB,dividend,100,50,3/29/2018
A1EAC8,business-contract,100,69,3/29/2018
A52533,product-release,100,64,3/29/2018
A5A4F5,acquisition-acquirer,100,49,3/29/2018
A63387,business-contract,100,69,3/29/2018
A70BF5,board-meeting,100,51,3/29/2018
A7102F,legal-issues-defendant,100,22,3/29/2018
A761FE,earnings,100,50,3/29/2018
A79F7D,earnings,100,50,3/29/2018
A9ED24,executive-appointment,100,54,3/29/2018
ADFB3A,earnings,100,50,3/29/2018
AFDF2E,earnings-revision,100,29,3/29/2018
AFDF2E,earnings-revision,100,29,3/29/2018
AFF43F,earnings,100,50,3/29/2018
B0998E,executive-appointment,100,54,3/29/2018
BBAE2A,conference-call,100,50,3/29/2018
BD9668,conference-call,100,50,3/29/2018
BE14CF,conference-call,100,50,3/29/2018
BE645B,earnings,100,50,3/29/2018
C03C8B,conference-call,100,50,3/29/2018
C93C44,earnings,100,50,3/29/2018
C9D866,credit-extension-recipient,100,69,3/29/2018
CA212F,earnings,100,50,3/29/2018
CC6F6E,earnings,100,50,3/29/2018
CC6F6E,earnings,100,50,3/29/2018
CC6F6E,earnings,100,50,3/29/2018
CC6F6E,earnings,100,50,3/29/2018
CFF97C,credit-rating-upgrade-rater,20,50,3/29/2018
D5AF19,earnings,100,50,3/29/2018
D6EAA3,product-release,100,64,3/29/2018
D8ECA1,legal-issues-defendant,100,22,3/29/2018
DF204B,credit-extension-recipient,100,69,3/29/2018
E261E9,earnings,100,50,3/29/2018
E2F130,earnings,100,50,3/29/2018
EF1AD9,conference-call,100,50,3/29/2018
EF77A3,conference-call,100,50,3/29/2018
F0B877,executive-appointment,100,54,3/29/2018
F4F46F,business-contract,100,69,3/29/2018
F50BAB,earnings-guidance,100,50,3/29/2018
F72E4B,board-meeting,100,51,3/29/2018
F82D37,conference-call,100,50,3/29/2018
F8BA6C,conference-participant,100,50,3/29/2018
FA36A4,conference-call,100,50,3/29/2018
FC9869,business-contract,100,69,3/29/2018
FC9869,business-contract,100,69,3/29/2018
FC9A88,dividend-up,100,74,3/29/2018
FC9A88,dividend-up,100,74,3/29/2018
FEC475,conference-call,100,50,3/29/2018
FF4BA4,earnings,100,50,3/29/2018
0CC01F,earnings,100,50,3/30/2018
12DE76,award,100,58,3/30/2018
165B3A,private-placement,100,56,3/30/2018
251988,dividend,100,50,3/30/2018
2CB4C9,business-contract,100,69,3/30/2018
2CB4C9,business-contract,100,69,3/30/2018
2CB4C9,business-contract,100,69,3/30/2018
41EC04,legal-issues-defendant,100,22,3/30/2018
42DC93,executive-appointment,100,54,3/30/2018
44209A,legal-issues-defendant,100,22,3/30/2018
4E4E75,legal-issues-defendant,100,22,3/30/2018
4E4E75,legal-issues-defendant,100,22,3/30/2018
5B3FA2,product-release,100,64,3/30/2018
5EC388,earnings,100,50,3/30/2018
717DB4,executive-resignation,100,44,3/30/2018
789ADD,earnings,100,50,3/30/2018
82C202,business-contract,100,69,3/30/2018
862941,clinical-trials-start,100,64,3/30/2018
93D207,executive-resignation,100,44,3/30/2018
A15C71,facility-open,100,65,3/30/2018
A1A317,facility-open,100,65,3/30/2018
A1EAC8,executive-appointment,100,54,3/30/2018
A806FA,executive-appointment,100,54,3/30/2018
C598D7,conference-call,100,50,3/30/2018
D65A13,executive-appointment,100,54,3/30/2018
D65A13,executive-appointment,100,54,3/30/2018
D8ECA1,legal-issues-defendant,100,22,3/30/2018
D8ECA1,legal-issues-defendant,100,22,3/30/2018
D8ECA1,legal-issues-defendant,100,22,3/30/2018
DC6EF3,earnings,100,50,3/30/2018
E829E8,conference-call,100,50,3/30/2018
E9FF33,earnings,100,50,3/30/2018
F32F88,executive-resignation,100,44,3/30/2018
FACCF6,equity-shelf-registration,100,43,3/30/2018
341759,legal-issues-defendant,100,22,3/31/2018
4E4E75,legal-issues-defendant,100,22,3/31/2018
55438C,joint-venture,100,62,3/31/2018
55438C,joint-venture,100,62,3/31/2018
CF7292,legal-issues-defendant,100,22,3/31/2018
77B8E9,clinical-trials,100,56,4/1/2018
00067A,earnings,100,50,4/2/2018
003B70,operating-earnings,100,50,4/2/2018
20751,conference-participant,100,50,4/2/2018
04CCCD,dividend,100,50,4/2/2018
081AB9,buybacks,100,74,4/2/2018
0BD970,earnings,100,50,4/2/2018
0C136E,earnings,100,50,4/2/2018
0DBB81,business-contract,100,69,4/2/2018
0FC848,stake-acquiree,100,62,4/2/2018
10C19B,dividend-up,100,81,4/2/2018
11A49E,executive-appointment,100,54,4/2/2018
12E454,earnings,100,50,4/2/2018
1348C9,earnings-guidance,100,50,4/2/2018
15789A,unit-acquisition-acquirer,100,49,4/2/2018
157D9F,conference-call,100,50,4/2/2018
184988,conference-participant,100,50,4/2/2018
190B91,earnings,100,50,4/2/2018
1921DD,unit-acquisition-acquiree,100,76,4/2/2018
19CAC7,acquisition-acquirer,100,49,4/2/2018
1A2D9F,earnings,100,50,4/2/2018
1A6A94,award,100,58,4/2/2018
1AE482,partnership,100,61,4/2/2018
1B4F31,executive-appointment,100,54,4/2/2018
1EBF8D,conference-call,100,50,4/2/2018
1F716B,conference-call,100,50,4/2/2018
1FC422,partnership,100,61,4/2/2018
1FC422,earnings,100,50,4/2/2018
219B21,business-contract,100,69,4/2/2018
221AD7,earnings,100,50,4/2/2018
239106,unit-acquisition-acquirer,100,49,4/2/2018
24A89A,executive-appointment,100,54,4/2/2018
24A89A,executive-appointment,100,54,4/2/2018
250BEE,conference-call,100,50,4/2/2018
25102A,conference-call,100,50,4/2/2018
28DCF3,acquisition-completed-acquirer,100,49,4/2/2018
2C19A4,dividend,100,50,4/2/2018
2F24A5,executive-appointment,100,54,4/2/2018
338544,conference-call,100,50,4/2/2018
341759,legal-issues-defendant,100,22,4/2/2018
342218,conference-call,100,50,4/2/2018
34B411,earnings,100,50,4/2/2018
3E15F6,conference-call,100,50,4/2/2018
3F6A9C,award,100,58,4/2/2018
417BF9,conference-participant,100,50,4/2/2018
41B53E,dividend,100,50,4/2/2018
42DC93,earnings,100,50,4/2/2018
434F38,executive-appointment,100,54,4/2/2018
449447,earnings,100,50,4/2/2018
46CF27,earnings,100,50,4/2/2018
4.60E+06,revenue-up,100,83,4/2/2018
4.91E+58,award,100,58,4/2/2018
49914B,legal-verdict-favored,100,78,4/2/2018
4E4E75,legal-issues-defendant,100,22,4/2/2018
4FCC78,dividend,100,50,4/2/2018
5.43E+08,public-offering,100,43,4/2/2018
5.47E+28,earnings,100,50,4/2/2018
55438C,partnership,100,61,4/2/2018
55C9B5,executive-appointment,100,54,4/2/2018
56765E,debt-extension-recipient,100,73,4/2/2018
5704AC,earnings,100,50,4/2/2018
58CA9A,dividend,100,50,4/2/2018
59B229,earnings,100,50,4/2/2018
59C539,conference-call,100,50,4/2/2018
5F2FF7,board-meeting,100,51,4/2/2018
619882,earnings,100,50,4/2/2018
665618,dividend-up,100,66,4/2/2018
68BA15,dividend,100,50,4/2/2018
694749,executive-appointment,100,54,4/2/2018
6BDA0C,executive-resignation,100,44,4/2/2018
6E1E61,conference-call,100,50,4/2/2018
6EB9DA,executive-appointment,100,54,4/2/2018
763724,dividend,100,50,4/2/2018
765913,earnings,100,50,4/2/2018
7BC92D,conference-participant,100,50,4/2/2018
8.10E+32,conference-call,100,50,4/2/2018
810FAD,conference-call,100,50,4/2/2018
8303CD,conference-participant,100,50,4/2/2018
84A6B9,earnings,100,50,4/2/2018
85AD00,conference-call,100,50,4/2/2018
873DB9,sanctions-target,100,19,4/2/2018
8.79E+06,executive-appointment,100,54,4/2/2018
88D80A,earnings,100,50,4/2/2018
8DCBBB,conference-call,100,50,4/2/2018
8EDACA,executive-appointment,100,54,4/2/2018
94637C,conference-organizer,100,57,4/2/2018
9470CC,facility-open,100,65,4/2/2018
9.62E+76,earnings,100,50,4/2/2018
965360,earnings,100,50,4/2/2018
967D92,conference-call,100,50,4/2/2018
96A6CD,conference-participant,100,50,4/2/2018
9D6A24,conference-call,100,50,4/2/2018
9F37C5,dividend,100,50,4/2/2018
A350C1,executive-appointment,100,54,4/2/2018
A433A5,conference-participant,100,50,4/2/2018
A5B913,earnings,100,50,4/2/2018
A5DD24,executive-appointment,100,54,4/2/2018
A65325,conference-call,100,50,4/2/2018
A79F7D,executive-appointment,100,54,4/2/2018
A79F7D,patent-filing,100,64,4/2/2018
A79F7D,earnings,100,50,4/2/2018
A80FE0,conference-call,100,50,4/2/2018
A8B137,product-recall,100,29,4/2/2018
AF93DE,executive-appointment,100,54,4/2/2018
AFD1CA,partnership,100,61,4/2/2018
AFEC35,earnings,100,50,4/2/2018
AFF7B4,conference-call,100,50,4/2/2018
B08954,conference-call,100,50,4/2/2018
B2D492,earnings,100,50,4/2/2018
B33E77,conference-participant,100,50,4/2/2018
B33E77,acquisition-acquiree,100,76,4/2/2018
B5734D,debt-restructuring,100,59,4/2/2018
B6CD92,dividend,100,50,4/2/2018
B934BF,executive-appointment,100,54,4/2/2018
BA218A,conference-call,100,50,4/2/2018
BB88B6,earnings,100,50,4/2/2018
BE86A1,partnership,100,61,4/2/2018
BEB756,conference-call,100,50,4/2/2018
BF5959,conference-call,100,50,4/2/2018
BF5959,conference-call,100,50,4/2/2018
C3BCD5,executive-appointment,100,54,4/2/2018
C3BCD5,executive-appointment,100,54,4/2/2018
C41C25,merger-completed,100,66,4/2/2018
C66B44,product-release,100,64,4/2/2018
C7AE14,dividend,100,50,4/2/2018
C93C44,conference-participant,100,50,4/2/2018
C99CC8,executive-appointment,100,54,4/2/2018
CAC8D0,earnings,100,50,4/2/2018
CBCC6A,executive-appointment,100,54,4/2/2018
CC8F6E,regulatory-product-approval-granted,100,81,4/2/2018
CDC217,earnings,100,50,4/2/2018
CE8A7B,operating-earnings,100,50,4/2/2018
D17C1B,executive-appointment,100,54,4/2/2018
D6489C,award,100,58,4/2/2018
D65A13,regulatory-product-approval-granted,100,81,4/2/2018
D8DBA3,merger-completed,100,66,4/2/2018
DD1BA1,business-contract,100,69,4/2/2018
DF01B1,acquisition-completed-acquirer,100,49,4/2/2018
DF1F7A,conference-call,100,50,4/2/2018
E10D31,conference-call,100,50,4/2/2018
E12A6E,earnings,100,50,4/2/2018
E30B34,earnings-guidance,100,50,4/2/2018
E4CE73,business-contract,100,69,4/2/2018
E829E8,award,100,58,4/2/2018
E8846E,unit-acquisition-acquiree,100,76,4/2/2018
E8A49A,stake-acquiree,100,62,4/2/2018
E8A49A,stake-acquiree,100,62,4/2/2018
E8A49A,stake-acquiree,100,62,4/2/2018
E8A49A,stake-acquiree,100,62,4/2/2018
E8A49A,stake-acquiree,100,62,4/2/2018
E9C7C0,buybacks,100,74,4/2/2018
EAEA91,dividend,100,50,4/2/2018
EAEA91,earnings,100,50,4/2/2018
EDF5CA,executive-appointment,100,54,4/2/2018
F04E05,merger-completed,100,66,4/2/2018
F05B1B,earnings,100,50,4/2/2018
F05B1B,earnings,100,50,4/2/2018
F05B1B,earnings,100,50,4/2/2018
F05B1B,earnings,100,50,4/2/2018
F39E1E,executive-appointment,100,54,4/2/2018
F40EE2,award,100,58,4/2/2018
F6581D,unit-acquisition-acquiree,100,76,4/2/2018
F6A392,operating-earnings,100,50,4/2/2018
F72E4B,executive-appointment,100,54,4/2/2018
FB728F,executive-appointment,100,54,4/2/2018
FD4588,acquisition-acquirer,100,49,4/2/2018
FDC7E6,buybacks,100,74,4/2/2018
FEE4B0,earnings,100,50,4/2/2018
FF6644,conference-call,100,50,4/2/2018
053EFF,acquisition-regulatory-approval-acquiree,100,81,4/3/2018
081AB9,conference-call,100,50,4/3/2018
95294,private-placement,100,56,4/3/2018
099C88,business-contract,100,69,4/3/2018
099C88,business-contract,100,69,4/3/2018
0B7375,conference-participant,100,50,4/3/2018
0E3436,executive-appointment,100,54,4/3/2018
0F0440,award,100,58,4/3/2018
0FC848,executive-appointment,100,54,4/3/2018
1151F4,conference-call,100,50,4/3/2018
1201B5,conference-participant,100,50,4/3/2018
135B09,conference-call,100,50,4/3/2018
14BA06,earnings,100,50,4/3/2018
1782D5,conference-call,100,50,4/3/2018
18D9FA,patent-awarded,100,72,4/3/2018
1B637E,executive-appointment,100,54,4/3/2018
1BC12C,product-release,100,64,4/3/2018
1BC12C,product-release,100,64,4/3/2018
1BC12C,product-release,100,64,4/3/2018
1DE526,conference-call,100,50,4/3/2018
1F9D90,investment-investor,100,55,4/3/2018
1F9D90,earnings,100,50,4/3/2018
21153F,unit-acquisition-completed-acquiree,100,67,4/3/2018
21153F,unit-acquisition-completed-acquiree,100,67,4/3/2018
21153F,acquisition-completed-acquiree,100,76,4/3/2018
21245F,legal-issues-defendant,100,22,4/3/2018
228D42,partnership,100,61,4/3/2018
2667B6,earnings,100,50,4/3/2018
26E3BA,conference-participant,100,50,4/3/2018
279916,award,100,58,4/3/2018
284289,earnings-guidance,100,50,4/3/2018
29CEBF,earnings-guidance,100,50,4/3/2018
2.90E+62,unit-acquisition-completed-acquirer,100,49,4/3/2018
2.90E+62,unit-acquisition-acquirer,100,49,4/3/2018
2D643C,conference-call,100,50,4/3/2018
2F7474,conference-call,100,50,4/3/2018
315EB0,acquisition-completed-acquirer,100,49,4/3/2018
326EDD,award,100,58,4/3/2018
33AD83,product-release,100,64,4/3/2018
341759,legal-issues-defendant,100,22,4/3/2018
341759,legal-issues-defendant,100,22,4/3/2018
341759,legal-issues-defendant,100,22,4/3/2018
370C50,conference-call,100,50,4/3/2018
37727A,conference-call,100,50,4/3/2018
384CD3,unit-acquisition-completed-acquirer,100,49,4/3/2018
38C46F,dividend,100,50,4/3/2018
39BFF6,conference-call,100,50,4/3/2018
3AF7FD,conference-call,100,50,4/3/2018
4135F7,conference-call,100,50,4/3/2018
41EC04,legal-issues-defendant,100,22,4/3/2018
44209A,legal-issues-defendant,100,22,4/3/2018
442587,business-contract,100,69,4/3/2018
442587,business-contract,100,69,4/3/2018
4C6C63,earnings,100,50,4/3/2018
4D8124,conference-call,100,50,4/3/2018
4E4E75,legal-issues-defendant,100,22,4/3/2018
4E4E75,legal-issues-defendant,100,22,4/3/2018
4E4E75,legal-issues-defendant,100,22,4/3/2018
4F783B,asset-sale,100,62,4/3/2018
504FE2,conference-call,100,50,4/3/2018
51D876,unit-acquisition-acquirer,100,49,4/3/2018
51D876,award,100,58,4/3/2018
532D47,conference-call,100,50,4/3/2018
55438C,demand-increase,100,83,4/3/2018
55438C,business-contract,100,69,4/3/2018
5675EB,acquisition-completed-acquirer,100,49,4/3/2018
56B7C1,dividend,100,50,4/3/2018
57356F,credit-extension-recipient,100,69,4/3/2018
57356F,executive-appointment,100,54,4/3/2018
5EAA43,partnership,100,61,4/3/2018
5FE4B6,executive-appointment,100,54,4/3/2018
629F0F,executive-appointment,100,54,4/3/2018
636BBF,earnings,100,50,4/3/2018
63F892,earnings,100,50,4/3/2018
649CBD,partnership,100,61,4/3/2018
68E6E9,earnings,100,50,4/3/2018
6B0E45,dividend,100,50,4/3/2018
701531,clinical-trials-start,100,64,4/3/2018
72FCA3,award,100,58,4/3/2018
75F982,partnership,100,61,4/3/2018
79340A,earnings,100,50,4/3/2018
7A975D,dividend,100,50,4/3/2018
7B0BA6,earnings,100,50,4/3/2018
7B6EB1,earnings,100,50,4/3/2018
8665BA,conference-call,100,50,4/3/2018
883D82,legal-issues-defendant,100,22,4/3/2018
8A8E41,executive-appointment,100,54,4/3/2018
8E82A6,unit-acquisition-completed-acquiree,100,67,4/3/2018
8E82A6,unit-acquisition-acquiree,100,76,4/3/2018
92B047,acquisition-completed-acquirer,100,49,4/3/2018
931AE7,clinical-trials-start,100,64,4/3/2018
94637C,partnership,100,61,4/3/2018
947B0B,conference-participant,100,50,4/3/2018
949625,conference-call,100,50,4/3/2018
968103,earnings,100,50,4/3/2018
9C25FF,legal-issues-defendant,100,22,4/3/2018
9CA432,conference-call,100,50,4/3/2018
9CA4C6,conference-call,100,50,4/3/2018
9CA619,public-offering,100,43,4/3/2018
9D3360,conference-call,100,50,4/3/2018
9E98F2,earnings,100,50,4/3/2018
9E98F2,earnings,100,50,4/3/2018
9F048E,acquisition-acquirer,100,49,4/3/2018
A017F4,ipo-completed,100,76,4/3/2018
A26EF7,conference-participant,100,50,4/3/2018
A70BF5,earnings,100,50,4/3/2018
A7102F,joint-venture,100,62,4/3/2018
A79F7D,executive-appointment,100,54,4/3/2018
A7CCF0,conference-call,100,50,4/3/2018
A8E2FE,executive-appointment,100,54,4/3/2018
ACD9A4,acquisition-acquirer,100,49,4/3/2018
AD3C93,executive-appointment,100,54,4/3/2018
AD9F1D,acquisition-acquirer,100,49,4/3/2018
AFD1CA,partnership,100,61,4/3/2018
AFF7B4,executive-appointment,100,54,4/3/2018
B13B68,acquisition-completed-acquirer,100,49,4/3/2018
B13B68,note-sale,100,52,4/3/2018
B2E6B5,conference-call,100,50,4/3/2018
B4C673,partnership,100,61,4/3/2018
B80AD1,executive-appointment,100,54,4/3/2018
BA218A,legal-issues-defendant,100,22,4/3/2018
BAAA60,conference-call,100,50,4/3/2018
BB5271,executive-appointment,100,54,4/3/2018
BF5959,revenue-up,100,79,4/3/2018
BF5959,revenue-up,100,79,4/3/2018
C66B44,legal-issues-defendant,100,22,4/3/2018
C7863D,conference-call,100,50,4/3/2018
C8FAC7,merger-completed,100,66,4/3/2018
C951A2,earnings,100,50,4/3/2018
C97B2D,acquisition-acquirer,100,49,4/3/2018
C9E107,earnings,100,50,4/3/2018
CAD7D9,earnings,100,50,4/3/2018
CB7AB2,earnings,100,50,4/3/2018
CC176E,earnings,100,50,4/3/2018
CD06A2,earnings,100,50,4/3/2018
CD2DA4,acquisition-acquirer,100,49,4/3/2018
CF6A5A,earnings,100,50,4/3/2018
CFF97C,earnings-guidance,100,50,4/3/2018
D1173F,conference-call,100,50,4/3/2018
D1C26F,conference-participant,100,50,4/3/2018
D54E62,conference-call,100,50,4/3/2018
D56D6D,executive-appointment,100,54,4/3/2018
D598E7,business-contract,100,69,4/3/2018
D622D5,unit-acquisition-acquirer,100,49,4/3/2018
D6853F,conference-call,100,50,4/3/2018
D78CCD,acquisition-completed-acquirer,100,49,4/3/2018
D88EF3,conference-call,100,50,4/3/2018
D8ECA1,legal-issues-defendant,100,22,4/3/2018
D8ECA1,legal-issues-defendant,100,22,4/3/2018
D93A25,business-contract,100,69,4/3/2018
DAC66A,merger-completed,100,66,4/3/2018
DB396B,conference-call,100,50,4/3/2018
DCD97F,business-contract,100,69,4/3/2018
DCD97F,acquisition-completed-acquirer,100,49,4/3/2018
DCD97F,partnership,100,61,4/3/2018
DD1BA1,business-contract,100,69,4/3/2018
DDCB34,executive-appointment,100,54,4/3/2018
DF11D9,conference-call,100,50,4/3/2018
DF532D,conference-call,100,50,4/3/2018
DFADDB,conference-participant,100,50,4/3/2018
E0207A,public-offering,100,43,4/3/2018
E0207A,public-offering,100,43,4/3/2018
E22FDE,conference-participant,100,50,4/3/2018
E2CB7B,executive-appointment,100,54,4/3/2018
E87676,executive-appointment,100,54,4/3/2018
E8846E,executive-appointment,100,54,4/3/2018
E8C557,conference-participant,100,50,4/3/2018
ED79D9,acquisition-acquirer,100,49,4/3/2018
EE74E1,earnings,100,50,4/3/2018
F3D2EB,executive-appointment,100,54,4/3/2018
F4CDA3,unit-acquisition-acquirer,100,49,4/3/2018
FC80E6,acquisition-completed-acquirer,100,49,4/3/2018
FDC7E6,conference-call,100,50,4/3/2018
FE7A63,earnings,100,50,4/3/2018
FFCD0E,executive-appointment,100,54,4/3/2018
00D6B5,executive-appointment,100,54,4/4/2018
0157B1,partnership,100,61,4/4/2018
0157B1,facility-open,100,65,4/4/2018
31025,earnings,100,50,4/4/2018
034B61,partnership,100,61,4/4/2018
03B8CF,executive-appointment,100,54,4/4/2018
078D52,dividend,100,50,4/4/2018
0BA8CE,executive-appointment,100,54,4/4/2018
0CBC4D,earnings,100,50,4/4/2018
0DE3D5,conference-call,100,50,4/4/2018
12DE76,regulatory-product-approval-granted,100,81,4/4/2018
147C38,investment-investor,100,55,4/4/2018
152E1D,partnership,100,61,4/4/2018
188394,conference-call,100,50,4/4/2018
1C2593,partnership,100,61,4/4/2018
1D3A00,product-release,100,64,4/4/2018
1F08A6,conference-call,100,50,4/4/2018
1F352C,earnings,100,50,4/4/2018
1FAF22,conference-call,100,50,4/4/2018
200D8B,award,100,58,4/4/2018
206852,conference-call,100,50,4/4/2018
25102A,trading-listing,100,61,4/4/2018
275300,conference-call,100,50,4/4/2018
28DCA8,earnings-guidance,100,50,4/4/2018
2A9C0A,conference-call,100,50,4/4/2018
2AE625,conference-call,100,50,4/4/2018
2D485F,executive-appointment,100,54,4/4/2018
2D485F,earnings,100,50,4/4/2018
2D76CE,earnings,100,50,4/4/2018
2D76CE,earnings,100,50,4/4/2018
2EC172,conference-call,100,50,4/4/2018
2F7A7E,conference-call,100,50,4/4/2018
315EB0,partnership,100,61,4/4/2018
31AA84,executive-appointment,100,54,4/4/2018
31F25C,conference-call,100,50,4/4/2018
370C50,award,100,58,4/4/2018
387375,earnings,100,50,4/4/2018
3B20AB,product-release,100,64,4/4/2018
3B37F7,executive-appointment,100,54,4/4/2018
3D9999,earnings,100,50,4/4/2018
40B903,dividend,100,50,4/4/2018
41785E,dividend,100,50,4/4/2018
417BF9,conference-call,100,50,4/4/2018
42AABD,business-contract,100,69,4/4/2018
47752F,earnings,100,50,4/4/2018
4A6F00,partnership,100,61,4/4/2018
4BBA23,earnings-guidance,100,50,4/4/2018
4D8313,conference-call,100,50,4/4/2018
4E4E75,product-release,100,64,4/4/2018
4E4E75,legal-issues-defendant,100,22,4/4/2018
52015A,dividend,100,50,4/4/2018
58CA9A,executive-appointment,100,54,4/4/2018
5DD486,partnership,100,61,4/4/2018
619882,business-contract,100,69,4/4/2018
61B81B,dividend,100,50,4/4/2018
6284B5,earnings-guidance,100,50,4/4/2018
65D0AA,conference-participant,100,50,4/4/2018
66A667,earnings,100,50,4/4/2018
69E8E1,conference-call,100,50,4/4/2018
69E8E1,conference-call,100,50,4/4/2018
69E8E1,conference-call,100,50,4/4/2018
6A3C35,asset-sale,100,62,4/4/2018
6D9B53,ipo-completed,100,76,4/4/2018
724F84,acquisition-completed-acquirer,100,49,4/4/2018
7771D7,earnings,100,50,4/4/2018
7A3633,earnings,100,50,4/4/2018
86478F,earnings,100,50,4/4/2018
8802B4,conference-call,100,50,4/4/2018
8D5145,earnings,100,50,4/4/2018
8EF425,conference-call,100,50,4/4/2018
9196A2,conference-call,100,50,4/4/2018
91C82E,earnings,100,50,4/4/2018
91C82E,earnings,100,50,4/4/2018
91C82E,earnings,100,50,4/4/2018
91C82E,earnings,100,50,4/4/2018
92B047,conference-call,100,50,4/4/2018
93633B,conference-call,100,50,4/4/2018
93D207,earnings,100,50,4/4/2018
949625,dividend,100,50,4/4/2018
986AF6,conference-call,100,50,4/4/2018
98CEBB,business-contract,100,69,4/4/2018
9B71A7,executive-appointment,100,54,4/4/2018
9BB35A,conference-call,100,50,4/4/2018
9CA619,public-offering,100,43,4/4/2018
9E5C2C,conference-call,100,50,4/4/2018
9F03CF,conference-call,100,50,4/4/2018
A02FB1,conference-call,100,50,4/4/2018
A3800A,business-contract,100,69,4/4/2018
A3F598,settlement,100,56,4/4/2018
A3F598,settlement,100,56,4/4/2018
A4A612,conference-call,100,50,4/4/2018
A5A4F5,acquisition-acquirer,100,49,4/4/2018
A631A3,product-release,100,64,4/4/2018
AA7FE0,earnings,100,50,4/4/2018
AA7FE0,earnings,100,50,4/4/2018
AA7FE0,earnings,100,50,4/4/2018
AA7FE0,earnings,100,50,4/4/2018
AA7FE0,earnings,100,50,4/4/2018
AB7F05,earnings,100,50,4/4/2018
AFEC35,facility-open,100,65,4/4/2018
B05000,earnings,100,50,4/4/2018
B7202A,conference-participant,100,50,4/4/2018
B840EF,earnings,100,50,4/4/2018
BCC55F,executive-appointment,100,54,4/4/2018
BD15E8,conference-call,100,50,4/4/2018
BE645B,conference-participant,100,50,4/4/2018
C0200F,earnings,100,50,4/4/2018
C062D4,note-sale,100,52,4/4/2018
C230FE,earnings,100,50,4/4/2018
C3DE7D,note-sale,100,52,4/4/2018
C3EE99,earnings,100,50,4/4/2018
C5C137,executive-resignation,100,44,4/4/2018
C5D2AE,earnings,100,50,4/4/2018
C9D866,conference-call,100,50,4/4/2018
CAB222,partnership,100,61,4/4/2018
CD4DA8,executive-appointment,100,54,4/4/2018
D06755,earnings,100,50,4/4/2018
D17F7E,earnings,100,50,4/4/2018
D437C3,earnings,100,50,4/4/2018
D8760C,conference-call,100,50,4/4/2018
D88EF3,note-sale,100,52,4/4/2018
DB7FA7,conference-call,100,50,4/4/2018
DC0998,conference-call,100,50,4/4/2018
DC5299,conference-call,100,50,4/4/2018
DEF058,unit-acquisition-acquirer,100,49,4/4/2018
E05026,executive-appointment,100,54,4/4/2018
ED0402,earnings,100,50,4/4/2018
ED5171,earnings,100,50,4/4/2018
ED79D9,partnership,100,61,4/4/2018
EDF5CA,conference-call,100,50,4/4/2018
F02D0A,earnings,100,50,4/4/2018
F1529C,executive-appointment,100,54,4/4/2018
F30508,partnership,100,61,4/4/2018
F30508,conference-call,100,50,4/4/2018
F32F88,conference-call,100,50,4/4/2018
F4E992,conference-call,100,50,4/4/2018
F5D059,dividend,100,50,4/4/2018
FA044A,conference-call,100,50,4/4/2018
FC1736,conference-participant,100,50,4/4/2018
FC4550,dividend,100,50,4/4/2018
FE7A63,dividend,100,50,4/4/2018
FF6644,product-release,100,64,4/4/2018
001F1B,earnings,100,50,4/5/2018
001F1B,earnings,100,50,4/5/2018
0358AF,earnings,100,50,4/5/2018
040DBB,unit-acquisition-completed-acquirer,100,49,4/5/2018
07CA6A,conference-call,100,50,4/5/2018
099A92,conference-call,100,50,4/5/2018
09F623,conference-participant,100,50,4/5/2018
0C8D82,conference-call,100,50,4/5/2018
105D00,conference-call,100,50,4/5/2018
119CB6,conference-call,100,50,4/5/2018
1279ED,executive-appointment,100,54,4/5/2018
143C52,note-sale,100,52,4/5/2018
152B9E,earnings-guidance,100,50,4/5/2018
1A3E1B,trading-halt,100,43,4/5/2018
1B9535,conference-call,100,50,4/5/2018
1DE526,executive-appointment,100,54,4/5/2018
20BEEA,conference-call,100,50,4/5/2018
21245F,product-release,100,64,4/5/2018
22C58E,earnings,100,50,4/5/2018
29A4CC,merger-completed,100,66,4/5/2018
301493,legal-issues-defendant,100,22,4/5/2018
30CBF9,executive-appointment,100,54,4/5/2018
3159AA,facility-open,100,65,4/5/2018
32CB22,conference-call,100,50,4/5/2018
387541,conference-call,100,50,4/5/2018
3DC887,earnings,100,50,4/5/2018
407878,earnings,100,50,4/5/2018
42978B,revenue-up,100,69,4/5/2018
43A74A,earnings,100,50,4/5/2018
44DDBD,executive-resignation,100,44,4/5/2018
458D2C,revenue-volume,100,50,4/5/2018
4806CE,earnings-guidance,100,50,4/5/2018
4885C8,executive-appointment,100,54,4/5/2018
4A2457,facility-open,100,65,4/5/2018
4C6C63,executive-appointment,100,54,4/5/2018
4FCC78,conference-call,100,50,4/5/2018
50070E,conference-call,100,50,4/5/2018
525A1C,award,100,58,4/5/2018
54512F,business-contract,100,69,4/5/2018
5487B1,conference-call,100,50,4/5/2018
55ACCB,executive-appointment,100,54,4/5/2018
55C9B5,executive-appointment,100,54,4/5/2018
58EA22,conference-participant,100,50,4/5/2018
5A423F,earnings,100,50,4/5/2018
5AF08A,conference-call,100,50,4/5/2018
5CC29D,earnings,100,50,4/5/2018
5F2FF7,earnings,100,50,4/5/2018
62EFEE,earnings,100,50,4/5/2018
64E346,conference-participant,100,50,4/5/2018
6.52E+64,earnings-guidance,100,50,4/5/2018
665D7D,patent-infringement-defendant,100,26,4/5/2018
68BA15,conference-call,100,50,4/5/2018
6D6B40,earnings,100,50,4/5/2018
70FCEF,executive-appointment,100,54,4/5/2018
723548,acquisition-completed-acquirer,100,49,4/5/2018
747219,earnings,100,50,4/5/2018
7.40E+289,dividend,100,50,4/5/2018
76B926,partnership,100,61,4/5/2018
7823A3,earnings,100,50,4/5/2018
7A51FE,conference-call,100,50,4/5/2018
7AB859,conference-call,100,50,4/5/2018
7CD98F,earnings-guidance,100,50,4/5/2018
7E1D5D,buybacks,100,74,4/5/2018
86A1B9,earnings,100,50,4/5/2018
880C0C,conference-call,100,50,4/5/2018
8A0368,public-offering,100,43,4/5/2018
8B6E7E,award,100,58,4/5/2018
9043FE,earnings,100,50,4/5/2018
9043FE,earnings,100,50,4/5/2018
90D6A5,earnings-guidance,100,50,4/5/2018
922F0C,earnings,100,50,4/5/2018
934029,conference-call,100,50,4/5/2018
940C3D,business-contract,100,69,4/5/2018
94756D,earnings,100,50,4/5/2018
9C5174,earnings,100,50,4/5/2018
9E298A,conference-call,100,50,4/5/2018
9F71E5,acquisition-acquirer,100,49,4/5/2018
A072C4,conference-participant,100,50,4/5/2018
A072C4,public-offering,100,43,4/5/2018
A1A317,conference-call,100,50,4/5/2018
A1EAC8,conference-call,100,50,4/5/2018
A350C1,earnings-guidance,100,50,4/5/2018
A3800A,facility-open,100,65,4/5/2018
A398B9,earnings,100,50,4/5/2018
A3F598,conference-call,100,50,4/5/2018
A4386C,earnings,100,50,4/5/2018
A5A4F5,acquisition-acquirer,100,49,4/5/2018
A75D43,conference-call,100,50,4/5/2018
A87CD6,earnings,100,50,4/5/2018
A99576,conference-call,100,50,4/5/2018
AA847A,conference-call,100,50,4/5/2018
B05118,product-release,100,64,4/5/2018
B446B8,earnings,100,50,4/5/2018
B4703C,conference-call,100,50,4/5/2018
B604DF,earnings-guidance,100,50,4/5/2018
BB5271,executive-appointment,100,54,4/5/2018
C3DE7D,note-sale,100,52,4/5/2018
C41C25,earnings,100,50,4/5/2018
C54140,earnings,100,50,4/5/2018
C9881C,executive-appointment,100,54,4/5/2018
CB22CD,conference-call,100,50,4/5/2018
CBBFBF,partnership,100,61,4/5/2018
CBBFBF,partnership,100,61,4/5/2018
CEC08B,public-offering,100,43,4/5/2018
D139BC,conference-call,100,50,4/5/2018
D78BF1,executive-appointment,100,54,4/5/2018
D7AC6E,earnings,100,50,4/5/2018
DB23C8,joint-venture,100,62,4/5/2018
DBB28E,dividend-up,100,81,4/5/2018
E30A8F,earnings,100,50,4/5/2018
E35610,earnings-guidance,100,50,4/5/2018
E3E68E,conference-call,100,50,4/5/2018
E94704,conference-call,100,50,4/5/2018
E959F3,earnings,100,50,4/5/2018
E9E6FD,conference-call,100,50,4/5/2018
EAEBF3,note-sale,100,52,4/5/2018
ED0402,executive-appointment,100,54,4/5/2018
ED3CA8,conference-call,100,50,4/5/2018
F1CD47,conference-participant,100,50,4/5/2018
F43A11,earnings,100,50,4/5/2018
F5D059,earnings-up,100,68,4/5/2018
F5D059,earnings-up,100,68,4/5/2018
F5D059,earnings-up,100,68,4/5/2018
F5D059,earnings-up,100,68,4/5/2018
F5D059,executive-appointment,100,54,4/5/2018
F5D410,conference-organizer,100,57,4/5/2018
F721A7,earnings,100,50,4/5/2018
F721A7,earnings,100,50,4/5/2018
FE89E0,conference-call,100,50,4/5/2018
FF5413,earnings,100,50,4/5/2018
001F1B,revenues,100,50,4/6/2018
001F1B,executive-appointment,100,54,4/6/2018
00D6B5,note-sale,100,52,4/6/2018
48590,earnings,100,50,4/6/2018
0E499E,regulatory-product-approval-granted,100,81,4/6/2018
0F04E5,earnings,100,50,4/6/2018
1748B3,conference-call,100,50,4/6/2018
1A3E1B,unit-acquisition-acquirer,100,49,4/6/2018
21153F,board-meeting,100,51,4/6/2018
21153F,board-meeting,100,51,4/6/2018
267718,partnership,100,61,4/6/2018
29A4CC,conference-call,100,50,4/6/2018
2BC05E,business-contract,100,69,4/6/2018
2DB344,earnings,100,50,4/6/2018
319BE2,executive-appointment,100,54,4/6/2018
384CD3,earnings,100,50,4/6/2018
458D2C,earnings-guidance,100,50,4/6/2018
4A6F00,business-contract,100,69,4/6/2018
4EC4C1,earnings,100,50,4/6/2018
4EC4C1,earnings,100,50,4/6/2018
4EC4C1,earnings,100,50,4/6/2018
4EC4C1,earnings,100,50,4/6/2018
51D876,conference-call,100,50,4/6/2018
5546DA,conference-call,100,50,4/6/2018
5675EB,earnings,100,50,4/6/2018
583A75,conference-call,100,50,4/6/2018
5E6959,executive-appointment,100,54,4/6/2018
5E6959,conference-call,100,50,4/6/2018
5F9CE3,earnings,100,50,4/6/2018
6166D1,partnership,100,61,4/6/2018
62B20A,conference-call,100,50,4/6/2018
665618,conference-call,100,50,4/6/2018
665D7D,conference-call,100,50,4/6/2018
68BA15,acquisition-acquirer,100,49,4/6/2018
6D9B53,conference-participant,100,50,4/6/2018
70FCEF,partnership,100,61,4/6/2018
72609A,conference-call,100,50,4/6/2018
73C521,unit-acquisition-acquiree,100,76,4/6/2018
741937,earnings,100,50,4/6/2018
7.44E+09,earnings-guidance,100,50,4/6/2018
7B1E50,bankruptcy-unit,100,10,4/6/2018
804708,legal-issues-defendant,100,22,4/6/2018
80D744,conference-call,100,50,4/6/2018
82E58A,earnings-guidance,100,50,4/6/2018
8A0368,public-offering,100,43,4/6/2018
8B2C4A,conference-call,100,50,4/6/2018
8E0E32,earnings,100,50,4/6/2018
92B625,public-offering,100,43,4/6/2018
980C14,conference-call,100,50,4/6/2018
9CDA4F,executive-appointment,100,54,4/6/2018
A072C4,public-offering,100,43,4/6/2018
A16DEA,earnings,100,50,4/6/2018
A1EAC8,executive-appointment,100,54,4/6/2018
A41450,dividend,100,50,4/6/2018
A5A4F5,acquisition-acquirer,100,49,4/6/2018
A8CBDA,conference-call,100,50,4/6/2018
AED61E,executive-appointment,100,54,4/6/2018
AFDF2E,dividend,100,50,4/6/2018
BB5142,earnings,100,50,4/6/2018
CB88B3,earnings,100,50,4/6/2018
CEC08B,public-offering,100,43,4/6/2018
D3F64D,earnings-guidance,100,50,4/6/2018
D501DC,dividend,100,50,4/6/2018
D8ECA1,executive-appointment,100,54,4/6/2018
E1E093,product-release,100,64,4/6/2018
E68C3D,executive-appointment,100,54,4/6/2018
E866D2,revenue-volume,100,50,4/6/2018
ECDEB2,conference-call,100,50,4/6/2018
ED0D7C,conference-call,100,50,4/6/2018
F5349B,business-contract,100,69,4/6/2018
F7902B,earnings,100,50,4/6/2018
F8C5D7,legal-issues-defendant,100,22,4/6/2018
FBD92D,reverse-stock-splits,100,51,4/6/2018
FC1B7B,conference-call,100,50,4/6/2018
FD0CA4,conference-call,100,50,4/6/2018
FD4588,conference-call,100,50,4/6/2018
15B10D,product-release,100,64,4/7/2018
15B10D,product-release,100,64,4/7/2018
15B10D,product-release,100,64,4/7/2018
228D42,executive-appointment,100,54,4/7/2018
7AB859,resource-discovery,100,88,4/7/2018
D8ECA1,legal-issues-defendant,100,22,4/7/2018
2D981A,clinical-trials,100,56,4/8/2018
00326E,conference-call,100,50,4/9/2018
00D6B5,executive-appointment,100,54,4/9/2018
03CF95,partnership,100,61,4/9/2018
03FAA6,earnings,100,50,4/9/2018
03FB17,earnings,100,50,4/9/2018
048B70,conference-call,100,50,4/9/2018
106394,board-meeting,100,51,4/9/2018
12E454,legal-issues-defendant,100,22,4/9/2018
15B10D,partnership,100,61,4/9/2018
1748B3,acquisition-acquirer,100,49,4/9/2018
1748B3,acquisition-acquirer,100,49,4/9/2018
1A9DE1,acquisition-acquiree,100,76,4/9/2018
1A9DE1,acquisition-acquiree,100,76,4/9/2018
1BDB2A,conference-call,100,50,4/9/2018
1D5C51,product-release,100,64,4/9/2018
1D5C51,product-release,100,64,4/9/2018
1D9E55,earnings,100,50,4/9/2018
1F19C8,conference-call,100,50,4/9/2018
1FA886,buybacks,100,74,4/9/2018
25102A,legal-issues-defendant,100,22,4/9/2018
25DD05,conference-call,100,50,4/9/2018
2B0AF4,earnings-guidance-up,100,83,4/9/2018
2B0AF4,earnings-guidance-up,100,83,4/9/2018
2E902B,conference-call,100,50,4/9/2018
2F9304,acquisition-completed-acquirer,100,49,4/9/2018
314D88,product-release,100,64,4/9/2018
326EDD,conference-call,100,50,4/9/2018
3.20E+263,clinical-trials,100,56,4/9/2018
32F24A,conference-call,100,50,4/9/2018
3B8484,acquisition-acquirer,100,49,4/9/2018
3CCC90,executive-appointment,100,54,4/9/2018
3DD5E2,conference-call,100,50,4/9/2018
3DE4D1,conference-call,100,50,4/9/2018
3F4668,executive-appointment,100,54,4/9/2018
425BDC,conference-call,100,50,4/9/2018
43A060,partnership,100,61,4/9/2018
45BC35,earnings-guidance,100,50,4/9/2018
4AE584,board-meeting,100,51,4/9/2018
4B3555,earnings,100,50,4/9/2018
5088A5,earnings,100,50,4/9/2018
57356F,conference-call,100,50,4/9/2018
589803,earnings,100,50,4/9/2018
5BE42C,conference-call,100,50,4/9/2018
5D63F1,conference-call,100,50,4/9/2018
5DA8B3,trading-listing,100,61,4/9/2018
657097,unit-acquisition-acquirer,100,49,4/9/2018
66749D,earnings,100,50,4/9/2018
66E04A,public-offering,100,43,4/9/2018
67529E,conference-call,100,50,4/9/2018
6844D2,partnership,100,61,4/9/2018
6844D2,product-release,100,64,4/9/2018
68586A,unit-acquisition-acquirer,100,49,4/9/2018
6B0E45,conference-call,100,50,4/9/2018
6F0A63,earnings-guidance,100,50,4/9/2018
6F5DD2,conference-participant,100,50,4/9/2018
70CA28,campaign-ad-release,100,59,4/9/2018
70FCEF,executive-appointment,100,54,4/9/2018
71E2EF,earnings,100,50,4/9/2018
726DDF,legal-issues-defendant,100,22,4/9/2018
72C2CE,conference-call,100,50,4/9/2018
72CB93,earnings,100,50,4/9/2018
767F86,executive-resignation,100,44,4/9/2018
76B926,conference-call,100,50,4/9/2018
7712CB,conference-call,100,50,4/9/2018
771985,revenues,100,50,4/9/2018
790C34,product-release,100,64,4/9/2018
7B0BA6,executive-appointment,100,54,4/9/2018
7D7716,earnings,100,50,4/9/2018
81A88D,conference-call,100,50,4/9/2018
85CDC9,executive-appointment,100,54,4/9/2018
88923D,conference-call,100,50,4/9/2018
8BAA15,earnings,100,50,4/9/2018
8BE916,earnings,100,50,4/9/2018
8DBBE6,acquisition-completed-acquirer,100,49,4/9/2018
8E82A6,earnings,100,50,4/9/2018
915E7B,earnings-guidance,100,50,4/9/2018
9196A2,unit-acquisition-acquirer,100,49,4/9/2018
91C82E,partnership,100,61,4/9/2018
92B625,public-offering,100,43,4/9/2018
93965C,executive-appointment,100,54,4/9/2018
94563D,executive-appointment,100,54,4/9/2018
957A07,product-release,100,64,4/9/2018
957A07,earnings,100,50,4/9/2018
95DC1F,award,100,58,4/9/2018
96BFF4,executive-appointment,100,54,4/9/2018
972356,partnership,100,61,4/9/2018
99ACAD,earnings,100,50,4/9/2018
9C8BC3,conference-call,100,50,4/9/2018
9CE4C7,earnings,100,50,4/9/2018
9E0811,conference-organizer,100,57,4/9/2018
9E91C6,executive-appointment,100,54,4/9/2018
9EA947,conference-call,100,50,4/9/2018
9F048E,earnings,100,50,4/9/2018
A15C71,conference-call,100,50,4/9/2018
A47A7D,executive-appointment,100,54,4/9/2018
A5A4F5,acquisition-acquirer,100,49,4/9/2018
A7102F,executive-appointment,100,54,4/9/2018
A868C9,executive-appointment,100,54,4/9/2018
A8B137,executive-appointment,100,54,4/9/2018
AADE0B,unit-acquisition-acquirer,100,49,4/9/2018
AADE0B,conference-call,100,50,4/9/2018
AE4125,conference-call,100,50,4/9/2018
B2DAF6,earnings,100,50,4/9/2018
B4703C,dividend,100,50,4/9/2018
B83D67,executive-appointment,100,54,4/9/2018
B96637,conference-call,100,50,4/9/2018
B9CD50,earnings,100,50,4/9/2018
BB5271,conference-call,100,50,4/9/2018
C0F70B,earnings,100,50,4/9/2018
C45C1F,clinical-trials,100,56,4/9/2018
C4A241,conference-call,100,50,4/9/2018
C4A432,executive-appointment,100,54,4/9/2018
C8923A,private-placement,100,56,4/9/2018
C8FAC7,product-release,100,64,4/9/2018
CC6FF5,earnings,100,50,4/9/2018
CC6FF5,earnings,100,50,4/9/2018
CE96E7,conference-call,100,50,4/9/2018
CF211D,earnings,100,50,4/9/2018
CF351E,earnings,100,50,4/9/2018
CFF97C,analyst-ratings-change-positive-rater,20,50,4/9/2018
CFF97C,acquisition-completed-acquirer,100,49,4/9/2018
D0909F,earnings-guidance,100,50,4/9/2018
D17C1B,campaign-ad-release,100,59,4/9/2018
D57D99,executive-resignation,100,44,4/9/2018
D64EDF,merger-completed,100,66,4/9/2018
D64EDF,merger-completed,100,66,4/9/2018
D697DE,executive-appointment,100,54,4/9/2018
D8442A,product-release,100,64,4/9/2018
DD682D,earnings,100,50,4/9/2018
E074A0,earnings,100,50,4/9/2018
E11C41,conference-call,100,50,4/9/2018
E6BC2C,public-offering,100,43,4/9/2018
E70531,business-contract,100,69,4/9/2018
E866D2,award,100,58,4/9/2018
E8A49A,earnings,100,50,4/9/2018
E8B315,earnings,100,50,4/9/2018
ED9576,conference-call,100,50,4/9/2018
F05B1B,executive-appointment,100,54,4/9/2018
F05B1B,executive-appointment,100,54,4/9/2018
F1EB39,product-release,100,64,4/9/2018
F3016C,note-sale,100,52,4/9/2018
F4E992,revenue-up,100,69,4/9/2018
F4E992,earnings,100,50,4/9/2018
F83279,earnings,100,50,4/9/2018
F85CC0,earnings,100,50,4/9/2018
FF5413,revenue-volume,100,50,4/9/2018
00067A,acquisition-acquirer,100,49,4/10/2018
0157B1,partnership,100,61,4/10/2018
51332,earnings,100,50,4/10/2018
09062E,conference-call,100,50,4/10/2018
099C88,conference-call,100,50,4/10/2018
0C6861,conference-call,100,50,4/10/2018
0E64D4,stake-acquirer,100,48,4/10/2018
0FDE97,conference-call,100,50,4/10/2018
11A49E,conference-call,100,50,4/10/2018
12E454,legal-issues-defendant,100,22,4/10/2018
12F98C,executive-appointment,100,54,4/10/2018
12F98C,executive-appointment,100,54,4/10/2018
1748B3,public-offering,100,43,4/10/2018
1.79E+10,award,100,58,4/10/2018
1.79E+10,conference-call,100,50,4/10/2018
1A3E1B,trading-resumed,100,58,4/10/2018
1CDD1C,earnings-guidance,100,50,4/10/2018
1DA44F,conference-call,100,50,4/10/2018
1E9A6D,earnings,100,50,4/10/2018
1FE3CB,conference-call,100,50,4/10/2018
228D42,partnership,100,61,4/10/2018
25102A,board-meeting,100,51,4/10/2018
27C10F,executive-appointment,100,54,4/10/2018
2B7A40,earnings,100,50,4/10/2018
2CB4C9,earnings,100,50,4/10/2018
2D2D43,award,100,58,4/10/2018
2E61CC,dividend-up,100,81,4/10/2018
315EB0,conference-call,100,50,4/10/2018
31DB20,dividend,100,50,4/10/2018
3.30E+34,executive-appointment,100,54,4/10/2018
33FD66,executive-appointment,100,54,4/10/2018
3A3948,earnings,100,50,4/10/2018
3B20AB,partnership,100,61,4/10/2018
3BCF24,earnings,100,50,4/10/2018
3FBC9B,earnings,100,50,4/10/2018
4017AD,executive-appointment,100,54,4/10/2018
41785E,earnings,100,50,4/10/2018
442769,executive-appointment,100,54,4/10/2018
447FC6,conference-call,100,50,4/10/2018
45444E,earnings,100,50,4/10/2018
4591D3,conference-call,100,50,4/10/2018
467F2C,conference-call,100,50,4/10/2018
490D4B,executive-appointment,100,54,4/10/2018
49BBBC,partnership,100,61,4/10/2018
49CC59,acquisition-acquirer,100,49,4/10/2018
49CC59,acquisition-acquirer,100,49,4/10/2018
4AC91D,partnership,100,61,4/10/2018
4AC91D,executive-appointment,100,54,4/10/2018
4B3DC9,conference-call,100,50,4/10/2018
4D371E,earnings,100,50,4/10/2018
54512F,business-contract,100,69,4/10/2018
548AC0,conference-call,100,50,4/10/2018
55438C,product-release,100,64,4/10/2018
55438C,business-contract,100,69,4/10/2018
56632F,credit-extension-recipient,100,69,4/10/2018
56EA2B,executive-appointment,100,54,4/10/2018
5B35C7,earnings-up,100,68,4/10/2018
5B6C11,earnings,100,50,4/10/2018
5B7739,conference-call,100,50,4/10/2018
5C2A47,earnings-guidance,100,50,4/10/2018
5F1B7B,earnings,100,50,4/10/2018
5F1B7B,product-release,100,64,4/10/2018
605F40,award,100,58,4/10/2018
6137BF,conference-call,100,50,4/10/2018
619882,investment-investor,100,55,4/10/2018
627186,conference-participant,100,50,4/10/2018
6284B5,product-release,100,64,4/10/2018
639BD6,earnings-guidance,100,50,4/10/2018
64E615,award,100,58,4/10/2018
66E04A,note-sale,100,52,4/10/2018
6B494E,dividend,100,50,4/10/2018
6C4D2F,conference-call,100,50,4/10/2018
6CB7F9,conference-call,100,50,4/10/2018
6D0CAB,operating-earnings,100,50,4/10/2018
713810,partnership,100,61,4/10/2018
726DDF,legal-issues-defendant,100,22,4/10/2018
726EEA,product-release,100,64,4/10/2018
731675,product-release,100,64,4/10/2018
73C9E2,conference-call,100,50,4/10/2018
7.40E+289,earnings,100,50,4/10/2018
7.40E+289,earnings,100,50,4/10/2018
7.40E+289,earnings,100,50,4/10/2018
7.40E+289,earnings,100,50,4/10/2018
752A70,earnings,100,50,4/10/2018
767F86,earnings,100,50,4/10/2018
790C34,product-release,100,64,4/10/2018
7A10FF,earnings,100,50,4/10/2018
7E2DE6,earnings,100,50,4/10/2018
7E62B5,earnings-guidance,100,50,4/10/2018
810FAD,partnership,100,61,4/10/2018
881190,conference-call,100,50,4/10/2018
88193E,conference-call,100,50,4/10/2018
88350F,conference-call,100,50,4/10/2018
89B2E7,dividend,100,50,4/10/2018
89FBB1,conference-call,100,50,4/10/2018
8C311A,partnership,100,61,4/10/2018
8DCF18,conference-call,100,50,4/10/2018
8E93A4,conference-call,100,50,4/10/2018
92D3A0,dividend,100,50,4/10/2018
95DC1F,hirings,100,65,4/10/2018
965360,acquisition-acquirer,100,49,4/10/2018
968966,partnership,100,61,4/10/2018
96F126,partnership,100,61,4/10/2018
980C14,dividend,100,50,4/10/2018
98CAED,executive-appointment,100,54,4/10/2018
9B5968,executive-appointment,100,54,4/10/2018
9D65C1,earnings,100,50,4/10/2018
9EBAFA,conference-call,100,50,4/10/2018
A29DBD,conference-call,100,50,4/10/2018
A495F7,earnings,100,50,4/10/2018
A52B6B,acquisition-interest-acquirer,100,46,4/10/2018
A58224,conference-call,100,50,4/10/2018
A5A4F5,acquisition-acquirer,100,49,4/10/2018
A6213D,dividend,100,50,4/10/2018
A63387,executive-appointment,100,54,4/10/2018
A666C8,dividend,100,50,4/10/2018
A6FB29,legal-issues-defendant,100,22,4/10/2018
A746F6,conference-call,100,50,4/10/2018
AC7C4F,business-contract,100,69,4/10/2018
B01111,facility-open,100,65,4/10/2018
B0FE08,conference-call,100,50,4/10/2018
B1B10C,conference-call,100,50,4/10/2018
B2256A,conference-call,100,50,4/10/2018
B54A74,earnings,100,50,4/10/2018
B642E8,executive-appointment,100,54,4/10/2018
B642E8,executive-appointment,100,54,4/10/2018
B803B1,conference-call,100,50,4/10/2018
B83BCE,earnings,100,50,4/10/2018
B9CD50,acquisition-acquirer,100,49,4/10/2018
BB02FB,conference-call,100,50,4/10/2018
BC948D,conference-call,100,50,4/10/2018
BDE867,executive-appointment,100,54,4/10/2018
BE14CF,joint-venture,100,62,4/10/2018
BF5959,executive-appointment,100,54,4/10/2018
BF5959,executive-appointment,100,54,4/10/2018
C0030A,earnings,100,50,4/10/2018
C062D4,partnership,100,61,4/10/2018
C062D4,executive-appointment,100,54,4/10/2018
C16A8F,conference-call,100,50,4/10/2018
C2F597,executive-appointment,100,54,4/10/2018
C356AC,earnings,100,50,4/10/2018
C3DE7D,partnership,100,61,4/10/2018
C407A0,business-contract,100,69,4/10/2018
C5C0E9,earnings,100,50,4/10/2018
C81E00,campaign-ad-release,100,59,4/10/2018
CE4E6D,product-release,100,64,4/10/2018
CE4FD9,note-sale,100,52,4/10/2018
D17C1B,conference-call,100,50,4/10/2018
D4AC65,partnership,100,61,4/10/2018
D6EAA3,executive-appointment,100,54,4/10/2018
D78CCD,conference-call,100,50,4/10/2018
D82EF3,conference-call,100,50,4/10/2018
D8C09D,earnings-guidance,100,50,4/10/2018
DB06B0,earnings,100,50,4/10/2018
DB5CA5,earnings,100,50,4/10/2018
DC2F77,earnings,100,50,4/10/2018
DD1BA1,acquisition-acquirer,100,49,4/10/2018
DD7A96,conference-call,100,50,4/10/2018
DEF058,earnings,100,50,4/10/2018
DF01B1,conference-call,100,50,4/10/2018
E0D3BA,earnings,100,50,4/10/2018
E12A6E,dividend,100,50,4/10/2018
E15736,dividend,100,50,4/10/2018
E20392,executive-appointment,100,54,4/10/2018
E6D89E,earnings,100,50,4/10/2018
E6D89E,partnership,100,61,4/10/2018
E6D89E,partnership,100,61,4/10/2018
E6D89E,partnership,100,61,4/10/2018
E6D89E,partnership,100,61,4/10/2018
E6E012,earnings,100,50,4/10/2018
E8A49A,executive-appointment,100,54,4/10/2018
E90C84,conference-call,100,50,4/10/2018
EBC84C,earnings,100,50,4/10/2018
ED9C04,earnings,100,50,4/10/2018
EE6F1C,earnings,100,50,4/10/2018
F179ED,earnings,100,50,4/10/2018
F3816D,clinical-trials-start,100,64,4/10/2018
F3FCC3,conference-call,100,50,4/10/2018
F46EC9,earnings,100,50,4/10/2018
F47871,fast-track-designation,100,81,4/10/2018
F58C23,patient-enrollment-complete,100,64,4/10/2018
FC1B7B,earnings,100,50,4/10/2018
FDF28E,earnings,100,50,4/10/2018
0157B1,partnership,100,61,4/11/2018
03B8CF,partnership,100,61,4/11/2018
04996E,earnings,100,50,4/11/2018
04EB2F,board-meeting,100,51,4/11/2018
07C69F,conference-call,100,50,4/11/2018
07EC43,earnings-guidance,100,50,4/11/2018
09F623,conference-call,100,50,4/11/2018
0A9D0A,product-release,100,64,4/11/2018
0BA2EF,earnings,100,50,4/11/2018
11074E,conference-call,100,50,4/11/2018
12E454,legal-issues-defendant,100,22,4/11/2018
168A5D,theft,100,32,4/11/2018
16B183,conference-call,100,50,4/11/2018
190B91,executive-appointment,100,54,4/11/2018
1AD9CC,revenues,100,50,4/11/2018
1D5C51,conference-call,100,50,4/11/2018
1F3CFB,earnings,100,50,4/11/2018
2.45E+15,earnings,100,50,4/11/2018
251988,partnership,100,61,4/11/2018
2571FA,conference-call,100,50,4/11/2018
25A6CC,earnings,100,50,4/11/2018
26F31D,earnings,100,50,4/11/2018
275300,partnership,100,61,4/11/2018
2A17B1,conference-call,100,50,4/11/2018
2BD89C,legal-verdict-favored,100,78,4/11/2018
2C681C,public-offering,100,43,4/11/2018
30DFD3,conference-call,100,50,4/11/2018
31666F,dividend,100,50,4/11/2018
33E8C7,earnings,100,50,4/11/2018
34E9F9,dividend,100,50,4/11/2018
3696BF,conference-call,100,50,4/11/2018
371C01,conference-call,100,50,4/11/2018
3A113F,conference-call,100,50,4/11/2018
3CBA2A,facility-open,100,65,4/11/2018
3CBA2A,conference-call,100,50,4/11/2018
3D9999,partnership,100,61,4/11/2018
3DC887,executive-appointment,100,54,4/11/2018
415188,conference-call,100,50,4/11/2018
416C55,earnings,100,50,4/11/2018
417BF9,earnings,100,50,4/11/2018
490D4B,conference-call,100,50,4/11/2018
494EB9,earnings,100,50,4/11/2018
4AC91D,product-release,100,64,4/11/2018
4AC91D,product-release,100,64,4/11/2018
4AC91D,product-release,100,64,4/11/2018
4AC91D,partnership,100,61,4/11/2018
4AC91D,product-release,100,64,4/11/2018
4AC91D,product-release,100,64,4/11/2018
4AC91D,product-release,100,64,4/11/2018
4FB770,conference-call,100,50,4/11/2018
56B7C1,conference-call,100,50,4/11/2018
57F3DA,earnings,100,50,4/11/2018
58C2D4,earnings,100,50,4/11/2018
5B3415,conference-call,100,50,4/11/2018
5D63F1,partnership,100,61,4/11/2018
60DD84,conference-call,100,50,4/11/2018
6284B5,partnership,100,61,4/11/2018
66E04A,note-sale,100,52,4/11/2018
66E04A,public-offering,100,43,4/11/2018
66ECFD,dividend-up,100,81,4/11/2018
6D0CAB,business-contract,100,69,4/11/2018
6D9B53,executive-appointment,100,54,4/11/2018
6E7060,dividend,100,50,4/11/2018
6ED519,conference-call,100,50,4/11/2018
722D55,earnings,100,50,4/11/2018
73BCBA,conference-call,100,50,4/11/2018
73BCBA,executive-appointment,100,54,4/11/2018
73BCBA,executive-appointment,100,54,4/11/2018
767F86,dividend,100,50,4/11/2018
790C34,earnings,100,50,4/11/2018
7A5097,dividend,100,50,4/11/2018
7AB859,conference-call,100,50,4/11/2018
7AC86E,earnings-guidance,100,50,4/11/2018
7D97DE,conference-call,100,50,4/11/2018
81222C,earnings,100,50,4/11/2018
838ADD,earnings,100,50,4/11/2018
85CDC9,earnings,100,50,4/11/2018
85DE00,conference-call,100,50,4/11/2018
8B3B0E,conference-call,100,50,4/11/2018
8CF6DD,partnership,100,61,4/11/2018
8D4AE6,earnings,100,50,4/11/2018
8DBBE6,conference-call,100,50,4/11/2018
8F8F2F,conference-call,100,50,4/11/2018
91C82E,dividend,100,50,4/11/2018
92D3A0,earnings,100,50,4/11/2018
95A92E,partnership,100,61,4/11/2018
95C392,conference-call,100,50,4/11/2018
968B00,earnings,100,50,4/11/2018
979451,earnings,100,50,4/11/2018
9B0C9C,earnings,100,50,4/11/2018
9B71A7,earnings,100,50,4/11/2018
9B71A7,earnings,100,50,4/11/2018
9B71A7,earnings,100,50,4/11/2018
9CF9B1,earnings,100,50,4/11/2018
A5A4F5,dividend,100,50,4/11/2018
A5A4F5,dividend,100,50,4/11/2018
A6213D,earnings,100,50,4/11/2018
A666C8,executive-appointment,100,54,4/11/2018
AAEE21,conference-call,100,50,4/11/2018
ADF1B0,conference-call,100,50,4/11/2018
AF210D,earnings,100,50,4/11/2018
AF93DE,board-meeting,100,51,4/11/2018
B1FC3B,business-contract,100,69,4/11/2018
B37FB4,partnership,100,61,4/11/2018
BB02FB,award,100,58,4/11/2018
BB5271,partnership,100,61,4/11/2018
BB5271,partnership,100,61,4/11/2018
BBBB41,conference-call,100,50,4/11/2018
BC5680,earnings,100,50,4/11/2018
BDE867,operating-earnings,100,50,4/11/2018
C4706C,dividend,100,50,4/11/2018
C4C77F,dividend,100,50,4/11/2018
C659EB,conference-call,100,50,4/11/2018
C66B44,conference-call,100,50,4/11/2018
C6C702,conference-call,100,50,4/11/2018
C7AE14,conference-call,100,50,4/11/2018
C8257F,earnings-guidance,100,50,4/11/2018
C941DC,partnership,100,61,4/11/2018
CB6A9C,conference-call,100,50,4/11/2018
CB89EA,executive-appointment,100,54,4/11/2018
CBFFDD,partnership,100,61,4/11/2018
CF3FF9,clinical-trials,100,56,4/11/2018
D17C1B,revenue-volume,100,50,4/11/2018
D518D8,conference-call,100,50,4/11/2018
D7918D,earnings,100,50,4/11/2018
D7A953,earnings,100,50,4/11/2018
D8442A,legal-verdict-disfavored,100,22,4/11/2018
D8DA3D,conference-call,100,50,4/11/2018
D90F43,product-release,100,64,4/11/2018
D90F43,legal-issues-defendant,100,22,4/11/2018
D9164D,earnings,100,50,4/11/2018
DDC415,earnings,100,50,4/11/2018
DF6FDD,earnings-guidance,100,50,4/11/2018
E0207A,earnings,100,50,4/11/2018
E124EB,award,100,58,4/11/2018
E12A6E,note-sale,100,52,4/11/2018
E1E36F,earnings,100,50,4/11/2018
E3E68E,product-release,100,64,4/11/2018
E4CE73,government-contract,100,69,4/11/2018
E6BC2C,conference-call,100,50,4/11/2018
E74B55,conference-call,100,50,4/11/2018
E8E899,partnership,100,61,4/11/2018
E8E899,conference-call,100,50,4/11/2018
EB43F4,credit-extension-recipient,100,69,4/11/2018
ECF4F8,conference-call,100,50,4/11/2018
EF5BED,executive-appointment,100,54,4/11/2018
F42FAE,earnings,100,50,4/11/2018
F51DB0,conference-call,100,50,4/11/2018
F748C7,product-release,100,64,4/11/2018
FACF19,dividend,100,50,4/11/2018
FAEABE,earnings-per-share-positive,100,69,4/11/2018
FAEABE,earnings,100,50,4/11/2018
FAEABE,earnings,100,50,4/11/2018
FC9A88,conference-call,100,50,4/11/2018
FD4E8D,earnings,100,50,4/11/2018
FF4343,conference-call,100,50,4/11/2018
0157B1,partnership,100,61,4/12/2018
0157B1,conference-call,100,50,4/12/2018
03B431,conference-call,100,50,4/12/2018
71860,earnings,100,50,4/12/2018
0919B1,conference-call,100,50,4/12/2018
09DE1F,buybacks,100,74,4/12/2018
0A0D9E,conference-call,100,50,4/12/2018
0BC29E,business-contract,100,69,4/12/2018
0BC29E,executive-appointment,100,54,4/12/2018
0ED415,conference-call,100,50,4/12/2018
0FDE97,acquisition-completed-acquirer,100,49,4/12/2018
10C19B,earnings,100,50,4/12/2018
12DE76,executive-appointment,100,54,4/12/2018
12DE76,executive-appointment,100,54,4/12/2018
14391F,ipo,100,71,4/12/2018
15901B,product-release,100,64,4/12/2018
16B183,executive-appointment,100,54,4/12/2018
1748B3,public-offering,100,43,4/12/2018
1782D5,executive-resignation,100,44,4/12/2018
182BE7,conference-call,100,50,4/12/2018
184866,earnings,100,50,4/12/2018
1AF7E2,earnings,100,50,4/12/2018
1B4F31,earnings,100,50,4/12/2018
1BC12C,product-release,100,64,4/12/2018
1FA886,business-contract,100,69,4/12/2018
1FA886,business-contract,100,69,4/12/2018
2082EA,executive-appointment,100,54,4/12/2018
21022F,earnings,100,50,4/12/2018
21153F,note-sale,100,52,4/12/2018
21153F,note-sale,100,52,4/12/2018
21268E,conference-call,100,50,4/12/2018
221445,dividend,100,50,4/12/2018
225CA2,award,100,58,4/12/2018
29B702,earnings,100,50,4/12/2018
2C681C,public-offering,100,43,4/12/2018
2C681C,public-offering,100,43,4/12/2018
2D2D43,earnings,100,50,4/12/2018
2DA92D,earnings,100,50,4/12/2018
2EB88B,earnings,100,50,4/12/2018
2F94A5,product-release,100,64,4/12/2018
309922,conference-call,100,50,4/12/2018
33AD83,conference-call,100,50,4/12/2018
35AE32,partnership,100,61,4/12/2018
366A08,conference-call,100,50,4/12/2018
371B0A,conference-call,100,50,4/12/2018
3798B9,earnings,100,50,4/12/2018
3A3447,earnings,100,50,4/12/2018
3B20AB,dividend,100,50,4/12/2018
3DE4D1,investment-investor,100,55,4/12/2018
41EC04,conference-call,100,50,4/12/2018
423279,earnings-per-share-up,100,68,4/12/2018
447FC6,acquisition-acquirer,100,49,4/12/2018
44A4FC,facility-upgrade,100,65,4/12/2018
4649D5,award,100,58,4/12/2018
468DD4,executive-appointment,100,54,4/12/2018
479930,earnings,100,50,4/12/2018
479930,earnings,100,50,4/12/2018
4885C8,earnings,100,50,4/12/2018
490D4B,executive-appointment,100,54,4/12/2018
4.91E+58,conference-call,100,50,4/12/2018
4A2457,product-release,100,64,4/12/2018
4A5C8D,acquisition-completed-acquiree,100,76,4/12/2018
4A6F00,executive-appointment,100,54,4/12/2018
4B49CF,dividend-up,100,81,4/12/2018
4BEB48,earnings,100,50,4/12/2018
4C1FA1,conference-call,100,50,4/12/2018
4EE167,earnings,100,50,4/12/2018
514067,board-meeting,100,51,4/12/2018
52015A,conference-call,100,50,4/12/2018
524CE4,earnings,100,50,4/12/2018
5340D0,earnings,100,50,4/12/2018
5.47E+28,executive-appointment,100,54,4/12/2018
55438C,investment-investor,100,55,4/12/2018
55ACCB,earnings,100,50,4/12/2018
55C289,conference-call,100,50,4/12/2018
567F3D,dividend,100,50,4/12/2018
5BFE94,conference-call,100,50,4/12/2018
5C2A47,award,100,58,4/12/2018
5D16CF,conference-call,100,50,4/12/2018
5DD48B,product-release,100,64,4/12/2018
5F2FF7,earnings-positive,100,69,4/12/2018
5F2FF7,earnings-positive,100,69,4/12/2018
5F2FF7,earnings-positive,100,69,4/12/2018
5F2FF7,earnings-positive,100,69,4/12/2018
5F2FF7,earnings-positive,100,69,4/12/2018
5FE4B6,conference-call,100,50,4/12/2018
622DBE,executive-appointment,100,54,4/12/2018
622DBE,executive-appointment,100,54,4/12/2018
6F0096,conference-call,100,50,4/12/2018
719B43,executive-appointment,100,54,4/12/2018
726DDF,legal-issues-defendant,100,22,4/12/2018
728737,dividend,100,50,4/12/2018
72FCA3,dividend,100,50,4/12/2018
7448A3,conference-call,100,50,4/12/2018
756BB4,award,100,58,4/12/2018
75F982,dividend,100,50,4/12/2018
76CEFB,earnings,100,50,4/12/2018
7740DE,same-store-sales-up,100,56,4/12/2018
79167B,conference-call,100,50,4/12/2018
791D59,earnings,100,50,4/12/2018
7B9212,revenues,100,50,4/12/2018
7BAAE7,earnings,100,50,4/12/2018
7DA412,earnings,100,50,4/12/2018
8.22E+27,conference-call,100,50,4/12/2018
837C04,conference-call,100,50,4/12/2018
859281,earnings,100,50,4/12/2018
89F693,partnership,100,61,4/12/2018
89F693,partnership,100,61,4/12/2018
89F693,partnership,100,61,4/12/2018
8D4486,partnership,100,61,4/12/2018
8DE74B,conference-call,100,50,4/12/2018
8E9CD8,earnings,100,50,4/12/2018
8FE7A5,earnings,100,50,4/12/2018
900356,earnings-guidance,100,50,4/12/2018
971F7B,earnings,100,50,4/12/2018
9B0C9C,legal-issues-defendant,100,22,4/12/2018
9BB35A,ipo,100,71,4/12/2018
9BB35A,ipo,100,71,4/12/2018
9D5D35,earnings,100,50,4/12/2018
9EED50,conference-call,100,50,4/12/2018
9F5997,conference-call,100,50,4/12/2018
9FF5F1,earnings,100,50,4/12/2018
A247F5,earnings,100,50,4/12/2018
A5151E,earnings,100,50,4/12/2018
A666C8,earnings,100,50,4/12/2018
A6FC89,ipo-pricing,100,50,4/12/2018
A8B137,executive-appointment,100,54,4/12/2018
B13B68,earnings-guidance,100,50,4/12/2018
B1DF3C,earnings,100,50,4/12/2018
B1FC3B,business-contract,100,69,4/12/2018
B1FC3B,business-contract,100,69,4/12/2018
B7EB38,earnings,100,50,4/12/2018
B8EF97,revenues,100,50,4/12/2018
B934BF,conference-call,100,50,4/12/2018
BD682F,earnings,100,50,4/12/2018
BD682F,dividend,100,50,4/12/2018
BD8517,earnings,100,50,4/12/2018
BF79F5,conference-call,100,50,4/12/2018
C356AC,product-release,100,64,4/12/2018
C4452A,earnings-per-share-guidance,100,50,4/12/2018
CA3CB9,conference-call,100,50,4/12/2018
CAC8D0,earnings,100,50,4/12/2018
CB89EA,earnings,100,50,4/12/2018
CBBFBF,executive-appointment,100,54,4/12/2018
CDE118,earnings,100,50,4/12/2018
CDE51C,earnings,100,50,4/12/2018
CE5664,award,100,58,4/12/2018
CEC08B,earnings,100,50,4/12/2018
D08D2C,dividend-up,100,81,4/12/2018
D58A11,earnings,100,50,4/12/2018
D5AF19,earnings-per-share-positive,100,69,4/12/2018
D5AF19,earnings-per-share,100,50,4/12/2018
D5AF19,earnings-per-share,100,50,4/12/2018
D5AF19,earnings-per-share,100,50,4/12/2018
D5AF19,earnings-per-share,100,50,4/12/2018
D5AF19,earnings-per-share,100,50,4/12/2018
D5AF19,earnings-per-share,100,50,4/12/2018
D5AF19,earnings-per-share,100,50,4/12/2018
D6144F,executive-appointment,100,54,4/12/2018
D77F7E,earnings,100,50,4/12/2018
DB06B0,conference-call,100,50,4/12/2018
E05DC8,earnings,100,50,4/12/2018
E2CFD2,conference-call,100,50,4/12/2018
E6BC2C,public-offering,100,43,4/12/2018
E8846E,legal-issues-defendant,100,22,4/12/2018
EB6965,award,100,58,4/12/2018
ECDEB2,earnings-up,100,86,4/12/2018
EE967B,earnings,100,50,4/12/2018
EF77A3,earnings,100,50,4/12/2018
F5C78B,conference-call,100,50,4/12/2018
F702CA,acquisition-completed-acquirer,100,49,4/12/2018
F80389,earnings-guidance,100,50,4/12/2018
F8084B,earnings,100,50,4/12/2018
F88A04,earnings,100,50,4/12/2018
F8BDCE,earnings,100,50,4/12/2018
F8BDCE,earnings,100,50,4/12/2018
F90EE5,executive-appointment,100,54,4/12/2018
FA918D,earnings-guidance,100,50,4/12/2018
FC1A6E,facility-open,100,65,4/12/2018
FC4550,conference-call,100,50,4/12/2018
FD4BBE,earnings,100,50,4/12/2018
FFE543,earnings,100,50,4/12/2018
01478A,earnings-guidance,100,50,4/13/2018
98977,legal-verdict-favored,100,78,4/13/2018
0A7650,earnings,100,50,4/13/2018
0C2A0D,earnings,100,50,4/13/2018
0DC050,earnings,100,50,4/13/2018
12F98C,facility-open,100,65,4/13/2018
13C3E0,earnings,100,50,4/13/2018
168A5D,partnership,100,61,4/13/2018
1921DD,product-release,100,64,4/13/2018
221445,conference-call,100,50,4/13/2018
2CA60F,earnings,100,50,4/13/2018
2E0496,earnings,100,50,4/13/2018
2EBA55,dividend,100,50,4/13/2018
328250,conference-call,100,50,4/13/2018
35F4B5,earnings,100,50,4/13/2018
3BE00F,earnings,100,50,4/13/2018
420168,earnings,100,50,4/13/2018
44ED36,dividend,100,50,4/13/2018
460C93,acquisition-completed-acquirer,100,49,4/13/2018
4C3FE9,clinical-trials,100,56,4/13/2018
58CA9A,executive-appointment,100,54,4/13/2018
58CA9A,earnings,100,50,4/13/2018
5A64D5,conference-call,100,50,4/13/2018
619882,earnings,100,50,4/13/2018
619882,dividend,100,50,4/13/2018
61B81B,earnings-positive,100,69,4/13/2018
61B81B,earnings-positive,100,69,4/13/2018
61B81B,earnings-positive,100,69,4/13/2018
61B81B,earnings-positive,100,69,4/13/2018
61B81B,earnings-positive,100,69,4/13/2018
61B81B,earnings-positive,100,69,4/13/2018
61B81B,earnings-positive,100,69,4/13/2018
629F0F,dividend,100,50,4/13/2018
69345C,legal-issues-defendant,100,22,4/13/2018
69CE71,executive-appointment,100,54,4/13/2018
6BC6F9,partnership,100,61,4/13/2018
6CC55E,earnings,100,50,4/13/2018
6CDFC6,conference-call,100,50,4/13/2018
6DC1D7,conference-call,100,50,4/13/2018
726DDF,legal-issues-defendant,100,22,4/13/2018
73C9E2,stake-acquirer,100,48,4/13/2018
75F665,acquisition-completed-acquirer,100,49,4/13/2018
77B8E9,clinical-trials,100,56,4/13/2018
7D5384,conference-call,100,50,4/13/2018
860AB6,earnings,100,50,4/13/2018
88611B,earnings,100,50,4/13/2018
9087B9,earnings,100,50,4/13/2018
9196A2,product-release,100,64,4/13/2018
93F143,earnings,100,50,4/13/2018
94637C,partnership,100,61,4/13/2018
97AF94,dividend,100,50,4/13/2018
9AF3DC,conference-call,100,50,4/13/2018
9B0C9C,conference-participant,100,50,4/13/2018
9C8BC3,dividend,100,50,4/13/2018
9D4EC7,conference-call,100,50,4/13/2018
9FD2D9,earnings-guidance,100,50,4/13/2018
A1EAC8,executive-appointment,100,54,4/13/2018
B7BDA3,conference-call,100,50,4/13/2018
BE7BA4,conference-call,100,50,4/13/2018
C7859D,earnings-up,100,68,4/13/2018
C7859D,earnings,100,50,4/13/2018
C7859D,earnings,100,50,4/13/2018
C7859D,earnings,100,50,4/13/2018
C7859D,earnings,100,50,4/13/2018
C83B88,partnership,100,61,4/13/2018
C8A248,award,100,58,4/13/2018
C9881C,executive-appointment,100,54,4/13/2018
CC0C78,executive-appointment,100,54,4/13/2018
CDC217,private-placement,100,56,4/13/2018
CDFCC9,acquisition-regulatory-approval-acquirer,100,54,4/13/2018
CE5664,earnings,100,50,4/13/2018
CF6A5A,earnings,100,50,4/13/2018
D65A13,conference-call,100,50,4/13/2018
D8442A,legal-issues-defendant,100,22,4/13/2018
DC0D18,earnings,100,50,4/13/2018
DCD97F,conference-call,100,50,4/13/2018
E4158B,earnings,100,50,4/13/2018
E592F0,earnings,100,50,4/13/2018
E6A53A,earnings,100,50,4/13/2018
E6D89E,partnership,100,61,4/13/2018
E70531,supply-increase,100,74,4/13/2018
E8846E,earnings,100,50,4/13/2018
EB6965,conference-call,100,50,4/13/2018
ECD263,partnership,100,61,4/13/2018
EEEA9F,earnings,100,50,4/13/2018
EF7163,conference-call,100,50,4/13/2018
F4E882,earnings,100,50,4/13/2018
FC80E6,conference-call,100,50,4/13/2018
2C7505,clinical-trials-positive,100,87,4/14/2018
2C7505,clinical-trials-positive,100,87,4/14/2018
726DDF,legal-issues-defendant,100,22,4/14/2018
E19A99,patent-infringement-plaintiff,100,47,4/14/2018
0157B1,partnership,100,61,4/15/2018
649CBD,clinical-trials,100,56,4/15/2018
649CBD,clinical-trials,100,56,4/15/2018
00D6B5,conference-call,100,50,4/16/2018
0142B5,conference-call,100,50,4/16/2018
01D03F,regulatory-product-approval-granted,100,81,4/16/2018
04EB2F,earnings,100,50,4/16/2018
61366,earnings,100,50,4/16/2018
07EC43,partnership,100,61,4/16/2018
0BD4E8,conference-call,100,50,4/16/2018
0CC01F,earnings,100,50,4/16/2018
0F2BC9,conference-call,100,50,4/16/2018
1065BC,conference-call,100,50,4/16/2018
147C38,dividend-up,100,81,4/16/2018
14ED2B,executive-appointment,100,54,4/16/2018
17EDA5,partnership,100,61,4/16/2018
1921DD,partnership,100,61,4/16/2018
1A9DE1,earnings,100,50,4/16/2018
1D943E,earnings,100,50,4/16/2018
1E9A6D,dividend,100,50,4/16/2018
1EC3E8,executive-appointment,100,54,4/16/2018
1FA886,buybacks,100,74,4/16/2018
1FA886,buybacks,100,74,4/16/2018
20403D,dividend-up,100,81,4/16/2018
228D42,executive-appointment,100,54,4/16/2018
228D42,partnership,100,61,4/16/2018
25102A,business-contract,100,69,4/16/2018
25102A,business-contract,100,69,4/16/2018
25102A,acquisition-completed-acquiree,100,76,4/16/2018
25102A,asset-sale,100,62,4/16/2018
26D8ED,conference-call,100,50,4/16/2018
272704,earnings-up,100,68,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
272704,earnings,100,50,4/16/2018
27C10F,earnings,100,50,4/16/2018
295F9F,conference-call,100,50,4/16/2018
2BBE62,earnings,100,50,4/16/2018
2C681C,public-offering,100,43,4/16/2018
2C681C,public-offering,100,43,4/16/2018
341759,legal-issues-defendant,100,22,4/16/2018
34A959,acquisition-acquirer,100,49,4/16/2018
34A959,acquisition-acquirer,100,49,4/16/2018
34B97A,conference-call,100,50,4/16/2018
3.50E+27,earnings,100,50,4/16/2018
370C50,earnings,100,50,4/16/2018
385DD4,product-release,100,64,4/16/2018
385DD4,product-release,100,64,4/16/2018
385DD4,product-release,100,64,4/16/2018
387541,dividend,100,50,4/16/2018
3DCECC,partnership,100,61,4/16/2018
3DCECC,partnership,100,61,4/16/2018
442769,conference-call,100,50,4/16/2018
44A4FC,earnings,100,50,4/16/2018
458D2C,legal-issues-defendant,100,22,4/16/2018
458D2C,legal-issues-defendant,100,22,4/16/2018
46A16E,conference-call,100,50,4/16/2018
4A2457,award,100,58,4/16/2018
4A6F00,partnership,100,61,4/16/2018
4A6F00,partnership,100,61,4/16/2018
4AE584,unit-acquisition-acquirer,100,49,4/16/2018
4B6EF9,earnings,100,50,4/16/2018
4E5784,earnings,100,50,4/16/2018
50070E,conference-organizer,100,57,4/16/2018
51527B,conference-call,100,50,4/16/2018
5225A4,conference-organizer,100,57,4/16/2018
5403F8,earnings,100,50,4/16/2018
545272,conference-call,100,50,4/16/2018
55C9B5,executive-appointment,100,54,4/16/2018
5A0FF1,earnings,100,50,4/16/2018
5C7601,executive-appointment,100,54,4/16/2018
5EC388,earnings,100,50,4/16/2018
6.18E+08,award,100,58,4/16/2018
61A586,earnings,100,50,4/16/2018
62A48D,conference-participant,100,50,4/16/2018
67303E,partnership,100,61,4/16/2018
6844D2,executive-resignation,100,44,4/16/2018
68B03F,earnings,100,50,4/16/2018
69345C,earnings,100,50,4/16/2018
69CE71,partnership,100,61,4/16/2018
69CE71,executive-appointment,100,54,4/16/2018
6B5379,earnings,100,50,4/16/2018
6CF43C,earnings,100,50,4/16/2018
6E8864,note-sale,100,52,4/16/2018
6F0A63,unit-acquisition-acquirer,100,49,4/16/2018
726DDF,conference-call,100,50,4/16/2018
73529F,conference-call,100,50,4/16/2018
76E80F,product-release,100,64,4/16/2018
7B6C88,earnings,100,50,4/16/2018
7C4F43,clinical-trials,100,56,4/16/2018
7C790D,conference-call,100,50,4/16/2018
7CBC40,earnings,100,50,4/16/2018
7E1D5D,partnership,100,61,4/16/2018
7F3A5F,business-contract,100,69,4/16/2018
7FD8B9,product-release,100,64,4/16/2018
8303CD,conference-call,100,50,4/16/2018
85DA04,partnership,100,61,4/16/2018
85DA04,earnings,100,50,4/16/2018
883D82,legal-issues-defendant,100,22,4/16/2018
89F693,earnings,100,50,4/16/2018
8B6E7E,conference-call,100,50,4/16/2018
8D4486,partnership,100,61,4/16/2018
8E0E32,conference-participant,100,50,4/16/2018
901327,earnings,100,50,4/16/2018
91E5EE,earnings,100,50,4/16/2018
93965C,earnings,100,50,4/16/2018
945DE6,earnings,100,50,4/16/2018
94637C,partnership,100,61,4/16/2018
94637C,partnership,100,61,4/16/2018
967D92,conference-call,100,50,4/16/2018
9.74E+08,earnings,100,50,4/16/2018
97693A,executive-appointment,100,54,4/16/2018
990AD0,earnings,100,50,4/16/2018
990AD0,earnings,100,50,4/16/2018
9B0C9C,conference-participant,100,50,4/16/2018
9B5968,partnership,100,61,4/16/2018
9CE4C7,hirings,100,65,4/16/2018
9E91C6,legal-issues-defendant,100,22,4/16/2018
9E91C6,settlement,100,56,4/16/2018
9F62D1,earnings,100,50,4/16/2018
A1EAC8,business-contract,100,69,4/16/2018
A666C8,partnership,100,61,4/16/2018
A6828A,partnership,100,61,4/16/2018
A6FC89,ipo-completed,100,76,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A746F6,earnings-per-share-positive,100,69,4/16/2018
A74F6F,conference-call,100,50,4/16/2018
A9ED24,conference-call,100,50,4/16/2018
AA5C8E,earnings,100,50,4/16/2018
AE4125,product-release,100,64,4/16/2018
AFF7B4,dividend,100,50,4/16/2018
B05118,earnings,100,50,4/16/2018
B1FC3B,product-release,100,64,4/16/2018
B290A2,public-offering,100,43,4/16/2018
B642E8,executive-appointment,100,54,4/16/2018
BB0587,conference-call,100,50,4/16/2018
BCC55F,board-meeting,100,51,4/16/2018
C3BAE7,earnings,100,50,4/16/2018
C45C1F,clinical-trials-start,100,64,4/16/2018
C8257F,partnership,100,61,4/16/2018
C97B2D,acquisition-acquirer,100,49,4/16/2018
C97B2D,acquisition-acquirer,100,49,4/16/2018
C99CC8,executive-appointment,100,54,4/16/2018
C9F39B,executive-appointment,100,54,4/16/2018
CDE51C,product-release,100,64,4/16/2018
CDEDFE,board-meeting,100,51,4/16/2018
CE1002,partnership,100,61,4/16/2018
CE4FD9,conference-call,100,50,4/16/2018
CF211D,earnings,100,50,4/16/2018
CF7292,legal-issues-defendant,100,22,4/16/2018
CFD4B6,product-release,100,64,4/16/2018
CFF15D,earnings-guidance,100,50,4/16/2018
D06996,earnings,100,50,4/16/2018
D0DE27,earnings,100,50,4/16/2018
D13F1C,acquisition-acquirer,100,49,4/16/2018
D13F1C,merger,100,66,4/16/2018
D17C1B,executive-appointment,100,54,4/16/2018
D1AE3B,earnings,100,50,4/16/2018
D33D8C,earnings-up,100,68,4/16/2018
D33D8C,earnings-up,100,68,4/16/2018
D33D8C,earnings-up,100,68,4/16/2018
D33D8C,earnings-up,100,68,4/16/2018
D33D8C,earnings-up,100,68,4/16/2018
D3C794,earnings,100,50,4/16/2018
D3CEDF,earnings-guidance,100,50,4/16/2018
D57D99,earnings,100,50,4/16/2018
D598E7,conference-call,100,50,4/16/2018
DA199F,unit-acquisition-acquiree,100,76,4/16/2018
DD9E41,earnings,100,50,4/16/2018
DDB002,conference-call,100,50,4/16/2018
E0207A,acquisition-completed-acquirer,100,49,4/16/2018
E0207A,acquisition-completed-acquirer,100,49,4/16/2018
E0F4E5,facility-open,100,65,4/16/2018
E610CD,ipo,100,71,4/16/2018
E8C557,board-meeting,100,51,4/16/2018
E90C84,conference-call,100,50,4/16/2018
EA62FC,conference-call,100,50,4/16/2018
EB5E78,conference-call,100,50,4/16/2018
ECD263,earnings,100,50,4/16/2018
F30508,partnership,100,61,4/16/2018
F30508,partnership,100,61,4/16/2018
F48947,earnings,100,50,4/16/2018
F8DE55,earnings,100,50,4/16/2018
F93C8A,dividend,100,50,4/16/2018
FAE021,earnings,100,50,4/16/2018
FAE021,earnings,100,50,4/16/2018
FDD3FC,clinical-trials,100,56,4/16/2018
FEE4B0,partnership,100,61,4/16/2018
FF6644,partnership,100,61,4/16/2018
03596A,earnings,100,50,4/17/2018
03D5F9,earnings,100,50,4/17/2018
0560D8,earnings,100,50,4/17/2018
0AB700,earnings,100,50,4/17/2018
0AB700,dividend-up,100,81,4/17/2018
0B57D7,earnings,100,50,4/17/2018
0C355F,conference-call,100,50,4/17/2018
0CCCB7,conference-call,100,50,4/17/2018
0D26E0,acquisition-completed-acquirer,100,49,4/17/2018
0F65C9,conference-call,100,50,4/17/2018
1272B3,earnings,100,50,4/17/2018
12DE76,partnership,100,61,4/17/2018
12DE76,partnership,100,61,4/17/2018
147C38,executive-appointment,100,54,4/17/2018
17EDA5,business-contract,100,69,4/17/2018
1834C0,earnings-guidance,100,50,4/17/2018
18EC17,earnings,100,50,4/17/2018
19CAC7,earnings,100,50,4/17/2018
19CAC7,earnings,100,50,4/17/2018
1F9258,executive-appointment,100,54,4/17/2018
1FCC00,executive-resignation,100,44,4/17/2018
205AD5,earnings,100,50,4/17/2018
205AD5,earnings,100,50,4/17/2018
205AD5,earnings,100,50,4/17/2018
205AD5,earnings,100,50,4/17/2018
214051,earnings,100,50,4/17/2018
2158DF,earnings,100,50,4/17/2018
228D42,partnership,100,61,4/17/2018
228D42,partnership,100,61,4/17/2018
238302,conference-call,100,50,4/17/2018
251988,product-release,100,64,4/17/2018
29A4CC,earnings,100,50,4/17/2018
29A4CC,earnings,100,50,4/17/2018
29A4CC,earnings,100,50,4/17/2018
29A4CC,earnings,100,50,4/17/2018
29A4CC,earnings,100,50,4/17/2018
29A4CC,earnings,100,50,4/17/2018
2C35B5,clinical-trials,100,56,4/17/2018
2CC71C,clinical-trials,100,56,4/17/2018
3.14E+47,earnings-positive,100,69,4/17/2018
3.14E+47,earnings,100,50,4/17/2018
3.14E+47,earnings,100,50,4/17/2018
3.14E+47,earnings,100,50,4/17/2018
3.14E+47,earnings,100,50,4/17/2018
3.14E+47,earnings,100,50,4/17/2018
3.14E+47,earnings,100,50,4/17/2018
3.30E+34,earnings,100,50,4/17/2018
3.30E+34,earnings,100,50,4/17/2018
3.30E+34,earnings,100,50,4/17/2018
349DA4,earnings,100,50,4/17/2018
36E479,clinical-trials-start,100,64,4/17/2018
373B06,earnings,100,50,4/17/2018
384CD3,business-contract,100,69,4/17/2018
3A3447,facility-open,100,65,4/17/2018
3CBA2A,facility-close,100,47,4/17/2018
3CCC90,earnings,100,50,4/17/2018
3CCC90,dividend,100,50,4/17/2018
3F4668,earnings,100,50,4/17/2018
408380,earnings,100,50,4/17/2018
414FFF,partnership,100,61,4/17/2018
423279,board-meeting,100,51,4/17/2018
429BFB,conference-call,100,50,4/17/2018
435ACE,dividend,100,50,4/17/2018
44209A,legal-issues-defendant,100,22,4/17/2018
442769,settlement,100,56,4/17/2018
4455C4,conference-call,100,50,4/17/2018
458D2C,legal-issues-defendant,100,22,4/17/2018
458D2C,legal-issues-defendant,100,22,4/17/2018
46017C,conference-call,100,50,4/17/2018
4649D5,conference-call,100,50,4/17/2018
4B6EF9,unit-acquisition-acquirer,100,49,4/17/2018
4F9926,product-release,100,64,4/17/2018
513A86,earnings,100,50,4/17/2018
51888A,earnings-per-share-positive,100,69,4/17/2018
5225A4,executive-appointment,100,54,4/17/2018
562853,conference-call,100,50,4/17/2018
56765E,earnings,100,50,4/17/2018
56EFC7,executive-appointment,100,54,4/17/2018
57B174,conference-call,100,50,4/17/2018
57CAAB,earnings,100,50,4/17/2018
59C539,dividend-up,100,64,4/17/2018
5CCDAD,earnings,100,50,4/17/2018
64FF65,asset-sale,100,62,4/17/2018
6B236C,conference-call,100,50,4/17/2018
6D3B7B,earnings,100,50,4/17/2018
6D4636,conference-call,100,50,4/17/2018
6E8864,note-sale,100,52,4/17/2018
6F92A9,board-meeting,100,51,4/17/2018
701531,earnings,100,50,4/17/2018
713810,partnership,100,61,4/17/2018
75F982,partnership,100,61,4/17/2018
762B8D,dividend,100,50,4/17/2018
76D79A,earnings-guidance,100,50,4/17/2018
789A7D,earnings,100,50,4/17/2018
78A1BB,earnings-up,100,78,4/17/2018
78A1BB,executive-appointment,100,54,4/17/2018
791D59,executive-appointment,100,54,4/17/2018
7A10FF,facility-open,100,65,4/17/2018
7ACD98,earnings-guidance,100,50,4/17/2018
7BC92D,public-offering,100,43,4/17/2018
7C75FD,conference-call,100,50,4/17/2018
7D35D8,earnings-guidance,100,50,4/17/2018
7F2922,earnings,100,50,4/17/2018
7F3A5F,earnings,100,50,4/17/2018
7F9984,executive-appointment,100,54,4/17/2018
83066C,conference-call,100,50,4/17/2018
83A065,conference-call,100,50,4/17/2018
850779,earnings-per-share-positive,100,69,4/17/2018
850779,earnings-per-share-positive,100,69,4/17/2018
850779,earnings-per-share-positive,100,69,4/17/2018
883D82,legal-issues-defendant,100,22,4/17/2018
896771,earnings,100,50,4/17/2018
89FBB1,dividend-up,100,57,4/17/2018
8BFAA4,conference-call,100,50,4/17/2018
8C5519,earnings,100,50,4/17/2018
8C5519,earnings,100,50,4/17/2018
8C5519,earnings,100,50,4/17/2018
8C5519,earnings,100,50,4/17/2018
8C5519,earnings,100,50,4/17/2018
8CF6DD,earnings,100,50,4/17/2018
8D4486,partnership,100,61,4/17/2018
8D4486,earnings,100,50,4/17/2018
8D4486,earnings,100,50,4/17/2018
8D4486,earnings,100,50,4/17/2018
8D4486,earnings,100,50,4/17/2018
8DDA23,dividend,100,50,4/17/2018
8FF2EF,earnings,100,50,4/17/2018
925759,business-contract,100,69,4/17/2018
925759,business-contract,100,69,4/17/2018
931AE7,public-offering,100,43,4/17/2018
9368BE,conference-call,100,50,4/17/2018
95F59E,earnings,100,50,4/17/2018
96F126,earnings,100,50,4/17/2018
977A1E,merger,100,66,4/17/2018
977A1E,merger,100,66,4/17/2018
97AAF6,earnings,100,50,4/17/2018
986AF6,executive-resignation,100,44,4/17/2018
990AD0,conference-organizer,100,57,4/17/2018
990AD0,conference-organizer,100,57,4/17/2018
9CA4C6,dividend,100,50,4/17/2018
9CA4C6,earnings-up,100,68,4/17/2018
A23747,earnings,100,50,4/17/2018
A3800A,earnings,100,50,4/17/2018
A48593,conference-call,100,50,4/17/2018
A4D173,conference-call,100,50,4/17/2018
A4D173,conference-call,100,50,4/17/2018
A631A3,partnership,100,61,4/17/2018
A746F6,dividend,100,50,4/17/2018
A9ED24,dividend,100,50,4/17/2018
AFD1CA,conference-call,100,50,4/17/2018
AFF43F,earnings-up,100,68,4/17/2018
AFF43F,earnings-up,100,68,4/17/2018
AFF43F,earnings-up,100,68,4/17/2018
AFF43F,earnings-up,100,68,4/17/2018
AFF43F,earnings-up,100,68,4/17/2018
AFF43F,earnings-up,100,68,4/17/2018
AFF43F,dividend,100,50,4/17/2018
B2DAF6,product-release,100,64,4/17/2018
B2DAF6,product-release,100,64,4/17/2018
B2DAF6,product-release,100,64,4/17/2018
B560AF,dividend,100,50,4/17/2018
B72BE9,conference-call,100,50,4/17/2018
B96DF5,earnings,100,50,4/17/2018
B9CD50,award,100,58,4/17/2018
BB0787,executive-appointment,100,54,4/17/2018
BB5271,award,100,58,4/17/2018
BDD12C,dividend-up,100,81,4/17/2018
BDD12C,board-meeting,100,51,4/17/2018
BE14CF,conference-participant,100,50,4/17/2018
C0BA36,conference-call,100,50,4/17/2018
C407A0,earnings,100,50,4/17/2018
C45CE7,earnings,100,50,4/17/2018
C4A912,conference-call,100,50,4/17/2018
C62AA4,conference-call,100,50,4/17/2018
C8257F,earnings,100,50,4/17/2018
C8257F,earnings,100,50,4/17/2018
C83B88,product-release,100,64,4/17/2018
C941DC,conference-call,100,50,4/17/2018
CC35BE,business-contract,100,69,4/17/2018
CC35BE,business-contract,100,69,4/17/2018
CC35BE,business-contract,100,69,4/17/2018
CC8F6E,earnings,100,50,4/17/2018
CD4DA8,conference-call,100,50,4/17/2018
CE2791,conference-call,100,50,4/17/2018
CFF15D,dividend,100,50,4/17/2018
D1AE3B,dividend,100,50,4/17/2018
D1C26F,executive-appointment,100,54,4/17/2018
D45285,conference-call,100,50,4/17/2018
D63B0F,conference-call,100,50,4/17/2018
D9E036,acquisition-acquirer,100,49,4/17/2018
DF532D,earnings,100,50,4/17/2018
DF532D,earnings,100,50,4/17/2018
E1BD05,earnings,100,50,4/17/2018
E26FC3,earnings-up,100,68,4/17/2018
E30A8F,product-release,100,64,4/17/2018
E3E68E,hirings,100,65,4/17/2018
E82A2D,conference-participant,100,50,4/17/2018
E87676,conference-call,100,50,4/17/2018
E93A40,earnings,100,50,4/17/2018
EB36DE,conference-call,100,50,4/17/2018
EF5BED,executive-appointment,100,54,4/17/2018
EFD406,conference-call,100,50,4/17/2018
F0EEFB,operating-earnings,100,50,4/17/2018
F3016C,earnings,100,50,4/17/2018
F3EDB4,dividend,100,50,4/17/2018
F48947,conference-participant,100,50,4/17/2018
F57F6F,earnings,100,50,4/17/2018
F6E248,earnings,100,50,4/17/2018
F6FA6A,earnings,100,50,4/17/2018
F8DE55,earnings,100,50,4/17/2018
FD39EB,earnings,100,50,4/17/2018
FF227B,clinical-trials,100,56,4/17/2018
0157B1,partnership,100,61,4/18/2018
03F5A4,earnings-up,100,87,4/18/2018
03F5A4,earnings,100,50,4/18/2018
03F5A4,earnings,100,50,4/18/2018
0986B5,earnings,100,50,4/18/2018
98977,earnings,100,50,4/18/2018
099A02,earnings,100,50,4/18/2018
099A02,earnings,100,50,4/18/2018
0B4D10,earnings,100,50,4/18/2018
0C4131,conference-call,100,50,4/18/2018
0C466B,earnings,100,50,4/18/2018
0C466B,earnings,100,50,4/18/2018
0E2992,partnership,100,61,4/18/2018
0FABBD,conference-call,100,50,4/18/2018
0FDE97,award,100,58,4/18/2018
108A2B,conference-call,100,50,4/18/2018
1220D2,earnings,100,50,4/18/2018
126F95,earnings,100,50,4/18/2018
126F95,earnings,100,50,4/18/2018
126F95,earnings,100,50,4/18/2018
126F95,earnings,100,50,4/18/2018
147C38,earnings,100,50,4/18/2018
149301,earnings,100,50,4/18/2018
165B3A,earnings-positive,100,69,4/18/2018
1748B3,earnings,100,50,4/18/2018
1748B3,earnings,100,50,4/18/2018
1748B3,earnings,100,50,4/18/2018
1748B3,earnings,100,50,4/18/2018
1748B3,earnings,100,50,4/18/2018
1748B3,earnings,100,50,4/18/2018
1A2D9F,earnings,100,50,4/18/2018
1A9DE1,earnings-up,100,68,4/18/2018
1A9DE1,earnings-up,100,68,4/18/2018
1A9DE1,earnings,100,50,4/18/2018
1AB808,earnings,100,50,4/18/2018
1BC12C,product-release,100,64,4/18/2018
1BC12C,credit-extension-recipient,100,69,4/18/2018
1FA8F7,earnings-positive,100,69,4/18/2018
20BEEA,earnings,100,50,4/18/2018
20BEEA,earnings,100,50,4/18/2018
20BEEA,earnings,100,50,4/18/2018
2.45E+15,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
275300,earnings,100,50,4/18/2018
27BFA1,earnings-up,100,68,4/18/2018
27BFA1,earnings,100,50,4/18/2018
27BFA1,earnings,100,50,4/18/2018
27BFA1,earnings,100,50,4/18/2018
27BFA1,earnings,100,50,4/18/2018
28AF37,earnings,100,50,4/18/2018
29B702,acquisition-regulatory-approval-acquirer,100,54,4/18/2018
2DB344,earnings,100,50,4/18/2018
2F1299,conference-call,100,50,4/18/2018
2F960F,conference-call,100,50,4/18/2018
314D88,executive-appointment,100,54,4/18/2018
3159AA,workforce-salary-increase,100,44,4/18/2018
315EB0,executive-appointment,100,54,4/18/2018
315EB0,acquisition-completed-acquirer,100,49,4/18/2018
31A7CC,earnings-up,100,68,4/18/2018
32CB22,earnings,100,50,4/18/2018
342218,dividend,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
34B411,earnings,100,50,4/18/2018
366A08,dividend,100,50,4/18/2018
36A1CB,conference-call,100,50,4/18/2018
36C09B,clinical-trials,100,56,4/18/2018
370C50,dividend-up,100,67,4/18/2018
372037,conference-call,100,50,4/18/2018
3A3447,dividend,100,50,4/18/2018
3BB616,earnings,100,50,4/18/2018
3C11C4,earnings,100,50,4/18/2018
3DCECC,conference-call,100,50,4/18/2018
4.03E+05,unit-acquisition-acquirer,100,49,4/18/2018
408089,dividend,100,50,4/18/2018
423279,dividend,100,50,4/18/2018
43E8F5,conference-call,100,50,4/18/2018
47FCF2,investment-investor,100,55,4/18/2018
48F795,earnings,100,50,4/18/2018
4B3676,earnings,100,50,4/18/2018
4BDCA7,clinical-trials,100,56,4/18/2018
4BDCA7,partnership,100,61,4/18/2018
4C37C5,earnings-per-share-positive,100,69,4/18/2018
4C37C5,earnings-per-share,100,50,4/18/2018
4C37C5,earnings-per-share,100,50,4/18/2018
4C3FE9,fast-track-designation,100,81,4/18/2018
4C6C63,business-contract,100,69,4/18/2018
4C92B9,conference-call,100,50,4/18/2018
4D203E,earnings,100,50,4/18/2018
4E7C1F,award,100,58,4/18/2018
4EC4C1,executive-appointment,100,54,4/18/2018
4F9926,business-contract,100,69,4/18/2018
514067,conference-call,100,50,4/18/2018
51F541,conference-call,100,50,4/18/2018
520632,earnings,100,50,4/18/2018
520632,earnings,100,50,4/18/2018
520632,earnings,100,50,4/18/2018
520632,earnings,100,50,4/18/2018
525A1C,earnings,100,50,4/18/2018
53F491,earnings-per-share-positive,100,69,4/18/2018
550D01,conference-call,100,50,4/18/2018
556F08,earnings,100,50,4/18/2018
55C9B5,partnership,100,61,4/18/2018
589F5A,dividend,100,50,4/18/2018
59A832,conference-call,100,50,4/18/2018
5A64D5,dividend,100,50,4/18/2018
5E7E82,partnership,100,61,4/18/2018
5F6D73,earnings,100,50,4/18/2018
5F6D73,earnings,100,50,4/18/2018
5F6D73,earnings,100,50,4/18/2018
5F6D73,earnings,100,50,4/18/2018
605F40,acquisition-completed-acquirer,100,49,4/18/2018
60FE03,clinical-trials,100,56,4/18/2018
6166D1,earnings,100,50,4/18/2018
6166D1,earnings,100,50,4/18/2018
6166D1,earnings,100,50,4/18/2018
6166D1,earnings,100,50,4/18/2018
6166D1,earnings,100,50,4/18/2018
6166D1,earnings,100,50,4/18/2018
6166D1,earnings,100,50,4/18/2018
6166D1,earnings,100,50,4/18/2018
619882,conference-participant,100,50,4/18/2018
61BCA7,business-contract,100,69,4/18/2018
622DBE,conference-call,100,50,4/18/2018
62CDDE,conference-call,100,50,4/18/2018
633043,earnings,100,50,4/18/2018
636639,spin-off,100,58,4/18/2018
64FF65,conference-call,100,50,4/18/2018
6634D9,earnings,100,50,4/18/2018
665D7D,conference-participant,100,50,4/18/2018
66E04A,facility-open,100,65,4/18/2018
66ECFD,executive-appointment,100,54,4/18/2018
68E3E0,conference-call,100,50,4/18/2018
6ABCB8,earnings,100,50,4/18/2018
6BC6F9,earnings,100,50,4/18/2018
6D156D,earnings,100,50,4/18/2018
6D1ADF,conference-call,100,50,4/18/2018
6E7060,conference-call,100,50,4/18/2018
6F0096,earnings,100,50,4/18/2018
6F0096,earnings,100,50,4/18/2018
6F0096,earnings,100,50,4/18/2018
6F3FA8,conference-call,100,50,4/18/2018
731675,earnings,100,50,4/18/2018
7410C3,earnings,100,50,4/18/2018
752A70,facility-sale,100,52,4/18/2018
7710F3,product-release,100,64,4/18/2018
775439,earnings,100,50,4/18/2018
7B6C88,partnership,100,61,4/18/2018
7B9AFA,earnings,100,50,4/18/2018
7C62A3,conference-call,100,50,4/18/2018
7E3F8F,earnings,100,50,4/18/2018
7F3A5F,market-entry,100,57,4/18/2018
7F3A5F,market-entry,100,57,4/18/2018
8275FE,earnings,100,50,4/18/2018
830BDB,conference-call,100,50,4/18/2018
8.79E+06,earnings,100,50,4/18/2018
87B81A,earnings,100,50,4/18/2018
8A8E41,executive-appointment,100,54,4/18/2018
8AB37F,conference-call,100,50,4/18/2018
8BE916,earnings-up,100,68,4/18/2018
8BE916,earnings-up,100,68,4/18/2018
8BE916,earnings-up,100,68,4/18/2018
8BE916,earnings-up,100,68,4/18/2018
8BE916,earnings-up,100,68,4/18/2018
8BE916,earnings-up,100,68,4/18/2018
8D4486,earnings,100,50,4/18/2018
8E82A6,conference-participant,100,50,4/18/2018
92B047,earnings,100,50,4/18/2018
93D207,dividend,100,50,4/18/2018
93D207,executive-appointment,100,54,4/18/2018
942165,earnings,100,50,4/18/2018
954A47,earnings-positive,100,69,4/18/2018
9.62E+76,earnings,100,50,4/18/2018
9.62E+76,earnings,100,50,4/18/2018
9.62E+76,earnings,100,50,4/18/2018
9.65E+09,conference-call,100,50,4/18/2018
9.86E+03,earnings,100,50,4/18/2018
986AF6,conference-call,100,50,4/18/2018
99028D,conference-call,100,50,4/18/2018
9.92E+94,earnings,100,50,4/18/2018
9981C6,earnings,100,50,4/18/2018
9B0C9C,earnings,100,50,4/18/2018
9C25FF,partnership,100,61,4/18/2018
9C5BA5,conference-call,100,50,4/18/2018
9C5BA5,conference-call,100,50,4/18/2018
9D5FA4,earnings,100,50,4/18/2018
9E91C6,executive-appointment,100,54,4/18/2018
9E98F2,earnings,100,50,4/18/2018
9E98F2,earnings,100,50,4/18/2018
9E98F2,earnings,100,50,4/18/2018
A01664,earnings,100,50,4/18/2018
A29A46,conference-call,100,50,4/18/2018
A398F8,earnings,100,50,4/18/2018
A8AC4C,conference-call,100,50,4/18/2018
A8CBDA,board-meeting,100,51,4/18/2018
AA09AD,earnings,100,50,4/18/2018
AA5C8E,dividend-up,100,83,4/18/2018
AA5C8E,dividend-up,100,83,4/18/2018
AA5C8E,dividend-up,100,83,4/18/2018
AA5C8E,dividend-up,100,83,4/18/2018
AA5C8E,dividend-up,100,83,4/18/2018
AA5C8E,dividend-up,100,83,4/18/2018
AABEA0,dividend,100,50,4/18/2018
AB7F05,earnings,100,50,4/18/2018
AB7F05,earnings,100,50,4/18/2018
AB7F05,earnings,100,50,4/18/2018
AD3C93,earnings,100,50,4/18/2018
AFD7DD,conference-call,100,50,4/18/2018
B3ED62,conference-call,100,50,4/18/2018
B446B8,partnership,100,61,4/18/2018
B5BA39,earnings,100,50,4/18/2018
BA218A,earnings-up,100,74,4/18/2018
BBF349,earnings,100,50,4/18/2018
BCC55F,conference-call,100,50,4/18/2018
C037A8,conference-call,100,50,4/18/2018
C15F8F,conference-participant,100,50,4/18/2018
C32A39,dividend,100,50,4/18/2018
C38440,earnings,100,50,4/18/2018
C3BAE7,acquisition-completed-acquirer,100,49,4/18/2018
C3CF29,earnings,100,50,4/18/2018
C3F99F,public-offering,100,43,4/18/2018
C48574,public-offering,100,43,4/18/2018
C4F9C6,clinical-trials,100,56,4/18/2018
C7FC95,partnership,100,61,4/18/2018
C93C44,conference-participant,100,50,4/18/2018
C98CDB,earnings,100,50,4/18/2018
C99CC8,earnings,100,50,4/18/2018
C9F39B,earnings,100,50,4/18/2018
C9F39B,earnings,100,50,4/18/2018
C9F39B,earnings,100,50,4/18/2018
C9F39B,earnings,100,50,4/18/2018
C9F39B,earnings,100,50,4/18/2018
CBBFBF,earnings,100,50,4/18/2018
CC0C78,note-sale,100,52,4/18/2018
CC176E,conference-participant,100,50,4/18/2018
CDC217,trading-delisting,100,36,4/18/2018
CEC5B9,conference-call,100,50,4/18/2018
D0C79E,acquisition-interest-acquirer,100,46,4/18/2018
D21D8A,earnings-up,100,68,4/18/2018
D21D8A,earnings,100,50,4/18/2018
D21D8A,earnings,100,50,4/18/2018
D21D8A,earnings,100,50,4/18/2018
D21D8A,earnings,100,50,4/18/2018
D21D8A,earnings,100,50,4/18/2018
D27FAB,conference-call,100,50,4/18/2018
D437C3,earnings,100,50,4/18/2018
D4AC65,facility-open,100,65,4/18/2018
D64EDF,earnings,100,50,4/18/2018
D6853F,business-contract,100,69,4/18/2018
D78CCD,product-release,100,64,4/18/2018
D93A25,earnings,100,50,4/18/2018
DDCB34,conference-call,100,50,4/18/2018
E0339F,unit-acquisition-acquiree,100,76,4/18/2018
E393B0,earnings,100,50,4/18/2018
E67C2C,earnings,100,50,4/18/2018
E829E8,earnings,100,50,4/18/2018
E8846E,earnings-up,100,68,4/18/2018
E8846E,conference-organizer,100,57,4/18/2018
E90C84,earnings,100,50,4/18/2018
E96E0B,earnings,100,50,4/18/2018
EAA0A7,earnings,100,50,4/18/2018
EAEBF3,dividend,100,50,4/18/2018
EAEBF3,conference-call,100,50,4/18/2018
EBD89A,conference-call,100,50,4/18/2018
ED7F13,earnings,100,50,4/18/2018
F0B2B5,conference-call,100,50,4/18/2018
F11638,product-release,100,64,4/18/2018
F1C04C,conference-call,100,50,4/18/2018
F5349B,earnings,100,50,4/18/2018
F6E248,unit-acquisition-acquirer,100,49,4/18/2018
F7902B,unit-acquisition-completed-acquirer,100,49,4/18/2018
F95726,earnings,100,50,4/18/2018
FBD92D,partnership,100,61,4/18/2018
FFAB4A,earnings,100,50,4/18/2018
00698D,dividend,100,50,4/19/2018
0157B1,revenue-up,100,79,4/19/2018
03B431,award,100,58,4/19/2018
48590,partnership,100,61,4/19/2018
0560D8,product-release,100,64,4/19/2018
07C907,earnings,100,50,4/19/2018
07C907,earnings,100,50,4/19/2018
07EC43,acquisition-completed-acquirer,100,49,4/19/2018
083F72,dividend,100,50,4/19/2018
099C88,unit-acquisition-acquirer,100,49,4/19/2018
09F623,dividend-up,100,81,4/19/2018
0A7650,earnings-up,100,68,4/19/2018
0A7650,earnings-up,100,68,4/19/2018
0A7650,earnings-up,100,68,4/19/2018
0A7650,earnings-up,100,68,4/19/2018
0BB9E5,earnings,100,50,4/19/2018
0BC17A,dividend,100,50,4/19/2018
0BC17A,earnings,100,50,4/19/2018
0C8D82,earnings,100,50,4/19/2018
0CE204,earnings,100,50,4/19/2018
0F2BC9,business-contract,100,69,4/19/2018
105D00,earnings-positive,100,69,4/19/2018
105D00,earnings-positive,100,69,4/19/2018
105D00,earnings-positive,100,69,4/19/2018
105D00,earnings-positive,100,69,4/19/2018
105D00,earnings-positive,100,69,4/19/2018
105D00,earnings-positive,100,69,4/19/2018
108FDA,earnings,100,50,4/19/2018
1.79E+10,conference-call,100,50,4/19/2018
182B8C,conference-call,100,50,4/19/2018
1880C5,patient-enrollment-start,100,58,4/19/2018
190B91,partnership,100,61,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A3E1B,earnings,100,50,4/19/2018
1A6A94,dividend,100,50,4/19/2018
1A6A94,conference-call,100,50,4/19/2018
1BC12C,executive-appointment,100,54,4/19/2018
1DB6A6,earnings,100,50,4/19/2018
1DEBBE,earnings,100,50,4/19/2018
1E04A5,earnings,100,50,4/19/2018
1E5786,earnings-up,100,82,4/19/2018
1FA886,business-contract,100,69,4/19/2018
2096DE,earnings,100,50,4/19/2018
20BEEA,conference-call,100,50,4/19/2018
228D42,partnership,100,61,4/19/2018
24CB56,earnings-positive,100,69,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
24CB56,earnings,100,50,4/19/2018
267718,board-meeting,100,51,4/19/2018
267718,partnership,100,61,4/19/2018
26CC63,dividend,100,50,4/19/2018
2950FF,earnings,100,50,4/19/2018
2A1009,conference-call,100,50,4/19/2018
2A6DBE,executive-appointment,100,54,4/19/2018
2B5483,earnings,100,50,4/19/2018
2BAE5F,acquisition-acquirer,100,49,4/19/2018
2C19A4,conference-call,100,50,4/19/2018
2E61CC,unit-acquisition-acquirer,100,49,4/19/2018
2E61CC,unit-acquisition-acquirer,100,49,4/19/2018
2E61CC,earnings,100,50,4/19/2018
2E61CC,earnings,100,50,4/19/2018
2E61CC,earnings,100,50,4/19/2018
2E61CC,earnings,100,50,4/19/2018
2E61CC,earnings,100,50,4/19/2018
2E61CC,earnings,100,50,4/19/2018
2F6782,conference-call,100,50,4/19/2018
2F7474,earnings,100,50,4/19/2018
301493,legal-issues-defendant,100,22,4/19/2018
306623,conference-call,100,50,4/19/2018
31553A,earnings,100,50,4/19/2018
3159AA,conference-call,100,50,4/19/2018
31666F,earnings,100,50,4/19/2018
32F24A,earnings,100,50,4/19/2018
339F20,earnings,100,50,4/19/2018
3.30E+34,dividend-up,100,81,4/19/2018
343996,dividend,100,50,4/19/2018
343996,dividend,100,50,4/19/2018
34B411,acquisition-acquirer,100,49,4/19/2018
34E9F9,conference-call,100,50,4/19/2018
39FB23,earnings,100,50,4/19/2018
39FB23,earnings,100,50,4/19/2018
39FB23,earnings,100,50,4/19/2018
39FB23,partnership,100,61,4/19/2018
39FB23,dividend,100,50,4/19/2018
39FB23,earnings,100,50,4/19/2018
3AF7FD,conference-participant,100,50,4/19/2018
3B3549,business-contract,100,69,4/19/2018
3BC360,conference-call,100,50,4/19/2018
3C3B6B,earnings,100,50,4/19/2018
3C3B6B,partnership,100,61,4/19/2018
3C7F5F,facility-open,100,65,4/19/2018
3CCC90,partnership,100,61,4/19/2018
3ED92D,conference-call,100,50,4/19/2018
3F6A9C,conference-call,100,50,4/19/2018
3F868D,conference-call,100,50,4/19/2018
41B53E,conference-call,100,50,4/19/2018
435ACE,conference-call,100,50,4/19/2018
449A26,earnings-positive,100,69,4/19/2018
449A26,dividend,100,50,4/19/2018
44DDBD,conference-call,100,50,4/19/2018
453282,earnings-per-share-positive,100,69,4/19/2018
499C75,conference-call,100,50,4/19/2018
4EEE7E,earnings,100,50,4/19/2018
4F0A80,acquisition-acquirer,100,49,4/19/2018
4F9926,partnership,100,61,4/19/2018
504FE2,executive-appointment,100,54,4/19/2018
510EA6,executive-appointment,100,54,4/19/2018
5225A4,earnings,100,50,4/19/2018
5225A4,earnings,100,50,4/19/2018
5225A4,earnings,100,50,4/19/2018
5225A4,earnings,100,50,4/19/2018
5225A4,earnings,100,50,4/19/2018
5480A7,earnings,100,50,4/19/2018
54DF47,earnings-guidance,100,50,4/19/2018
5876DC,dividend,100,50,4/19/2018
59C539,earnings,100,50,4/19/2018
5B226B,acquisition-acquirer,100,49,4/19/2018
5B226B,market-entry,100,57,4/19/2018
5B97B2,earnings-up,100,68,4/19/2018
5B97B2,earnings,100,50,4/19/2018
5B97B2,earnings,100,50,4/19/2018
5B97B2,earnings,100,50,4/19/2018
5B97B2,earnings,100,50,4/19/2018
5C8D61,earnings,100,50,4/19/2018
5DE5A5,earnings-up,100,68,4/19/2018
5DE5A5,earnings,100,50,4/19/2018
5DE5A5,earnings,100,50,4/19/2018
5F6D73,dividend-up,100,81,4/19/2018
5F9CE3,earnings,100,50,4/19/2018
5FF95F,earnings,100,50,4/19/2018
601785,dividend,100,50,4/19/2018
619882,conference-participant,100,50,4/19/2018
622037,earnings,100,50,4/19/2018
62B1C6,dividend,100,50,4/19/2018
62B20A,earnings,100,50,4/19/2018
636931,earnings,100,50,4/19/2018
6474BA,earnings-positive,100,69,4/19/2018
6474BA,earnings,100,50,4/19/2018
6474BA,earnings,100,50,4/19/2018
6474BA,earnings,100,50,4/19/2018
6474BA,earnings,100,50,4/19/2018
6474BA,earnings,100,50,4/19/2018
6474BA,earnings,100,50,4/19/2018
6474BA,earnings,100,50,4/19/2018
6474BA,earnings,100,50,4/19/2018
66667F,revenue-up,100,77,4/19/2018
69C99E,executive-appointment,100,54,4/19/2018
6B5379,dividend-up,100,81,4/19/2018
6CD55A,earnings,100,50,4/19/2018
6E705B,award,100,58,4/19/2018
6E8349,earnings,100,50,4/19/2018
6EB9DA,earnings,100,50,4/19/2018
6EB9DA,earnings,100,50,4/19/2018
6EB9DA,earnings,100,50,4/19/2018
6F3936,business-contract,100,69,4/19/2018
704B78,earnings,100,50,4/19/2018
7273FF,earnings,100,50,4/19/2018
7520CC,earnings,100,50,4/19/2018
75F982,legal-issues-defendant,100,22,4/19/2018
762A3E,conference-call,100,50,4/19/2018
762B8D,earnings,100,50,4/19/2018
76F067,earnings,100,50,4/19/2018
7.83E+79,earnings,100,50,4/19/2018
7A3633,acquisition-acquirer,100,49,4/19/2018
7B4B91,conference-call,100,50,4/19/2018
7B6C88,partnership,100,61,4/19/2018
7BAAE7,dividend,100,50,4/19/2018
7DD8CC,conference-call,100,50,4/19/2018
804708,conference-call,100,50,4/19/2018
804708,conference-call,100,50,4/19/2018
804708,executive-appointment,100,54,4/19/2018
845655,conference-call,100,50,4/19/2018
855DF7,dividend-up,100,81,4/19/2018
859281,dividend,100,50,4/19/2018
859281,earnings,100,50,4/19/2018
860AB6,conference-call,100,50,4/19/2018
89B2E7,earnings,100,50,4/19/2018
8A8E41,acquisition-acquirer,100,49,4/19/2018
8DBE73,conference-call,100,50,4/19/2018
8DDA23,earnings-positive,100,69,4/19/2018
8E82A6,force-majeure,100,25,4/19/2018
907ED2,earnings,100,50,4/19/2018
92D6A5,earnings,100,50,4/19/2018
92D9C9,earnings-guidance,100,50,4/19/2018
931AE7,public-offering,100,43,4/19/2018
93633B,earnings,100,50,4/19/2018
93633B,earnings,100,50,4/19/2018
93633B,earnings,100,50,4/19/2018
93633B,earnings,100,50,4/19/2018
94563D,earnings,100,50,4/19/2018
945DE6,dividend,100,50,4/19/2018
94756D,earnings,100,50,4/19/2018
966DBE,earnings,100,50,4/19/2018
968966,partnership,100,61,4/19/2018
97644E,earnings,100,50,4/19/2018
97AAF6,dividend,100,50,4/19/2018
986AF6,earnings,100,50,4/19/2018
986AF6,earnings,100,50,4/19/2018
989E2F,earnings,100,50,4/19/2018
989E2F,earnings,100,50,4/19/2018
9C25FF,legal-issues-defendant,100,22,4/19/2018
9C25FF,earnings-guidance,100,50,4/19/2018
9C25FF,legal-issues-defendant,100,22,4/19/2018
9C25FF,legal-issues-defendant,100,22,4/19/2018
9CDA4F,earnings,100,50,4/19/2018
9D30A8,earnings,100,50,4/19/2018
9E298A,dividend,100,50,4/19/2018
9E91C6,legal-issues-defendant,100,22,4/19/2018
A4B899,conference-call,100,50,4/19/2018
A52533,earnings,100,50,4/19/2018
A5628C,earnings,100,50,4/19/2018
A63387,acquisition-acquiree,100,76,4/19/2018
A70BF5,campaign-ad-release,100,59,4/19/2018
A7F0A5,earnings,100,50,4/19/2018
A8B137,product-recall,100,29,4/19/2018
AA7FE0,executive-appointment,100,54,4/19/2018
AB4A7E,earnings,100,50,4/19/2018
AC775C,conference-call,100,50,4/19/2018
ACDF88,partnership,100,61,4/19/2018
AFDF2E,earnings-revision,100,29,4/19/2018
B09B1F,conference-call,100,50,4/19/2018
B1FC3B,business-contract,100,69,4/19/2018
B4F5F4,conference-call,100,50,4/19/2018
B5766D,earnings,100,50,4/19/2018
B5766D,earnings,100,50,4/19/2018
B5766D,earnings,100,50,4/19/2018
B5766D,earnings,100,50,4/19/2018
B5766D,earnings,100,50,4/19/2018
B5766D,earnings,100,50,4/19/2018
B604DF,earnings,100,50,4/19/2018
B604DF,earnings,100,50,4/19/2018
B604DF,earnings,100,50,4/19/2018
B7FA9B,conference-call,100,50,4/19/2018
B8F71F,executive-appointment,100,54,4/19/2018
B9CD50,award,100,58,4/19/2018
BDD12C,earnings,100,50,4/19/2018
BFCACF,conference-call,100,50,4/19/2018
BFEA04,conference-call,100,50,4/19/2018
C29715,earnings,100,50,4/19/2018
C29715,earnings,100,50,4/19/2018
C3F99F,public-offering,100,43,4/19/2018
C41C25,earnings,100,50,4/19/2018
C4706C,conference-call,100,50,4/19/2018
C48574,public-offering,100,43,4/19/2018
C5E100,conference-call,100,50,4/19/2018
C72B8F,conference-call,100,50,4/19/2018
C9B932,earnings,100,50,4/19/2018
C9E107,dividend,100,50,4/19/2018
CA1620,earnings,100,50,4/19/2018
CC0C78,note-sale,100,52,4/19/2018
CE1002,dividend,100,50,4/19/2018
CEC5B9,dividend,100,50,4/19/2018
CFD4B6,conference-call,100,50,4/19/2018
D0C79E,acquisition-interest-acquirer,100,46,4/19/2018
D0C79E,acquisition-interest-acquirer,100,46,4/19/2018
D1C0B9,earnings,100,50,4/19/2018
D33D8C,dividend,100,50,4/19/2018
D48275,earnings,100,50,4/19/2018
D650A7,earnings,100,50,4/19/2018
D78BF1,revenue-up,100,69,4/19/2018
D7A953,executive-appointment,100,54,4/19/2018
D81D54,trading-resumed,100,58,4/19/2018
D81D54,trading-resumed,100,58,4/19/2018
D81D54,trading-resumed,100,58,4/19/2018
D9B1C9,settlement,100,56,4/19/2018
DB7EC3,earnings,100,50,4/19/2018
DD3BB1,earnings,100,50,4/19/2018
E09E2B,conference-call,100,50,4/19/2018
E124EB,earnings,100,50,4/19/2018
E124EB,earnings,100,50,4/19/2018
E124EB,earnings,100,50,4/19/2018
E19A99,earnings,100,50,4/19/2018
E1E093,unit-acquisition-acquiree,100,76,4/19/2018
E28D9C,conference-call,100,50,4/19/2018
E49AA3,earnings,100,50,4/19/2018
E5D914,conference-call,100,50,4/19/2018
E6EDED,earnings,100,50,4/19/2018
E754F0,earnings,100,50,4/19/2018
E84500,dividend-up,100,81,4/19/2018
E8B315,earnings-positive,100,69,4/19/2018
E94704,earnings,100,50,4/19/2018
E94704,earnings,100,50,4/19/2018
E94704,earnings,100,50,4/19/2018
E94704,earnings,100,50,4/19/2018
E94704,earnings,100,50,4/19/2018
EB2F14,earnings,100,50,4/19/2018
EB61C4,dividend,100,50,4/19/2018
EB7FBF,note-sale,100,52,4/19/2018
EB7FBF,note-sale,100,52,4/19/2018
EBC84C,earnings,100,50,4/19/2018
EBC84C,earnings,100,50,4/19/2018
EBC84C,earnings,100,50,4/19/2018
EBC84C,earnings,100,50,4/19/2018
EBC84C,earnings,100,50,4/19/2018
EF1AD9,dividend,100,50,4/19/2018
EF1AD9,earnings,100,50,4/19/2018
EF1AD9,earnings,100,50,4/19/2018
EF1AD9,earnings,100,50,4/19/2018
EF5BED,dividend,100,50,4/19/2018
EF5BED,earnings-positive,100,69,4/19/2018
EF5BED,earnings,100,50,4/19/2018
EF5BED,earnings,100,50,4/19/2018
EF5BED,earnings,100,50,4/19/2018
EF5BED,earnings,100,50,4/19/2018
F24FF0,conference-call,100,50,4/19/2018
F4E882,executive-appointment,100,54,4/19/2018
F4F46F,conference-call,100,50,4/19/2018
F702CA,earnings-up,100,68,4/19/2018
F702CA,earnings-up,100,68,4/19/2018
F702CA,earnings-up,100,68,4/19/2018
F702CA,earnings-up,100,68,4/19/2018
F702CA,earnings-up,100,68,4/19/2018
F7935D,orphan-drug-designation,100,76,4/19/2018
F93C8A,conference-call,100,50,4/19/2018
FA35C6,earnings,100,50,4/19/2018
FAB97A,earnings,100,50,4/19/2018
FACF19,partnership,100,61,4/19/2018
FB728F,dividend,100,50,4/19/2018
FB7724,earnings,100,50,4/19/2018
FBD92D,product-release,100,64,4/19/2018
FD0CA4,earnings,100,50,4/19/2018
FD39EB,dividend,100,50,4/19/2018
FD6926,conference-call,100,50,4/19/2018
02870F,conference-call,100,50,4/20/2018
43862,conference-call,100,50,4/20/2018
053EFF,trading-halt,100,43,4/20/2018
06EF42,conference-call,100,50,4/20/2018
108BD2,dividend,100,50,4/20/2018
139303,conference-call,100,50,4/20/2018
19C105,earnings,100,50,4/20/2018
1F43A1,earnings,100,50,4/20/2018
228D42,partnership,100,61,4/20/2018
239106,conference-call,100,50,4/20/2018
24A89A,orphan-drug-designation,100,76,4/20/2018
24A89A,orphan-drug-designation,100,76,4/20/2018
2B9DBB,conference-call,100,50,4/20/2018
2C7505,settlement,100,56,4/20/2018
2F98A5,dividend,100,50,4/20/2018
319BE2,conference-call,100,50,4/20/2018
34A959,earnings,100,50,4/20/2018
370C50,executive-appointment,100,54,4/20/2018
370C50,executive-appointment,100,54,4/20/2018
3A3447,facility-open,100,65,4/20/2018
3D9999,earnings-positive,100,69,4/20/2018
4C7DB5,earnings,100,50,4/20/2018
4F9926,product-release,100,64,4/20/2018
52FB2F,donation,100,54,4/20/2018
55438C,board-meeting,100,51,4/20/2018
56632F,earnings,100,50,4/20/2018
5BC2F4,earnings-per-share-up,100,77,4/20/2018
5BC2F4,earnings-per-share,100,50,4/20/2018
5BC2F4,earnings-per-share,100,50,4/20/2018
5BC2F4,earnings-per-share,100,50,4/20/2018
5BC2F4,earnings-per-share,100,50,4/20/2018
5D63F1,dividend,100,50,4/20/2018
5DE5A5,conference-participant,100,50,4/20/2018
5E6959,earnings-up,100,68,4/20/2018
5F2FF7,executive-appointment,100,54,4/20/2018
616E3B,earnings,100,50,4/20/2018
616E3B,earnings,100,50,4/20/2018
616E3B,earnings,100,50,4/20/2018
616E3B,earnings,100,50,4/20/2018
61E975,conference-call,100,50,4/20/2018
62B1C6,earnings,100,50,4/20/2018
647143,dividend,100,50,4/20/2018
66CB62,earnings,100,50,4/20/2018
66E04A,facility-open,100,65,4/20/2018
69CE71,conference-call,100,50,4/20/2018
6A01DF,earnings,100,50,4/20/2018
6BD606,earnings,100,50,4/20/2018
6CC55E,legal-issues-defendant,100,22,4/20/2018
6-Dec-05,legal-issues-plaintiff,100,44,4/20/2018
6-Dec-05,legal-issues-plaintiff,100,44,4/20/2018
72609A,earnings,100,50,4/20/2018
72609A,earnings,100,50,4/20/2018
72609A,earnings,100,50,4/20/2018
726EEA,earnings,100,50,4/20/2018
73C521,earnings,100,50,4/20/2018
73C521,earnings,100,50,4/20/2018
73C521,earnings,100,50,4/20/2018
73C521,earnings,100,50,4/20/2018
73C521,earnings,100,50,4/20/2018
73C521,earnings,100,50,4/20/2018
746373,conference-participant,100,50,4/20/2018
76BD96,conference-call,100,50,4/20/2018
7BC92D,public-offering,100,43,4/20/2018
7F0372,earnings,100,50,4/20/2018
8.10E+32,executive-appointment,100,54,4/20/2018
84AB66,ipo-pricing,100,50,4/20/2018
881190,revenue-up,100,69,4/20/2018
881190,revenue-up,100,69,4/20/2018
881190,revenue-up,100,69,4/20/2018
88350F,executive-appointment,100,54,4/20/2018
8B2C4A,earnings,100,50,4/20/2018
8B2C4A,earnings,100,50,4/20/2018
8B2C4A,earnings,100,50,4/20/2018
8B2C4A,earnings,100,50,4/20/2018
8B2C4A,earnings,100,50,4/20/2018
8B2C4A,earnings,100,50,4/20/2018
8B2C4A,earnings,100,50,4/20/2018
911ACB,earnings,100,50,4/20/2018
925759,partnership,100,61,4/20/2018
925759,partnership,100,61,4/20/2018
940C3D,earnings,100,50,4/20/2018
95DC1F,asset-sale,100,62,4/20/2018
997348,earnings,100,50,4/20/2018
997348,earnings,100,50,4/20/2018
9B0C9C,conference-participant,100,50,4/20/2018
9C25FF,partnership,100,61,4/20/2018
9C25FF,legal-issues-defendant,100,22,4/20/2018
9C25FF,legal-issues-defendant,100,22,4/20/2018
9D6A24,dividend,100,50,4/20/2018
9E98F2,executive-appointment,100,54,4/20/2018
A0F146,conference-call,100,50,4/20/2018
A21649,conference-call,100,50,4/20/2018
A3800A,legal-issues-defendant,100,22,4/20/2018
A41450,earnings,100,50,4/20/2018
A60354,conference-call,100,50,4/20/2018
A63820,executive-appointment,100,54,4/20/2018
A806FA,earnings-guidance,100,50,4/20/2018
A8CBDA,dividend,100,50,4/20/2018
AADE0B,conference-call,100,50,4/20/2018
AC7C4F,product-release,100,64,4/20/2018
AD3008,executive-appointment,100,54,4/20/2018
AEBB80,earnings,100,50,4/20/2018
B0998E,earnings,100,50,4/20/2018
B2D799,settlement,100,56,4/20/2018
B37FB4,earnings-up,100,68,4/20/2018
B48D6A,executive-appointment,100,54,4/20/2018
B619CB,executive-appointment,100,54,4/20/2018
B7202A,conference-call,100,50,4/20/2018
B8DD94,conference-call,100,50,4/20/2018
BBC05B,operating-earnings,100,50,4/20/2018
BFE02C,earnings-positive,100,69,4/20/2018
C0200F,earnings,100,50,4/20/2018
C0200F,earnings,100,50,4/20/2018
C188F8,executive-appointment,100,54,4/20/2018
C83B88,partnership,100,61,4/20/2018
C8A059,earnings,100,50,4/20/2018
CC339B,earnings,100,50,4/20/2018
CDAB24,earnings,100,50,4/20/2018
CDC817,executive-appointment,100,54,4/20/2018
CE1002,earnings,100,50,4/20/2018
CE1002,earnings,100,50,4/20/2018
CE1002,earnings,100,50,4/20/2018
CE1002,earnings,100,50,4/20/2018
CEDFD5,partnership,100,61,4/20/2018
CEDFD5,partnership,100,61,4/20/2018
D25249,conference-call,100,50,4/20/2018
D29F43,conference-call,100,50,4/20/2018
D4AC65,unit-acquisition-acquirer,100,49,4/20/2018
D82EF3,acquisition-acquirer,100,49,4/20/2018
D8442A,stock-loss,100,40,4/20/2018
D88EF3,partnership,100,61,4/20/2018
DAC66A,earnings,100,50,4/20/2018
DD1BA1,earnings,100,50,4/20/2018
DFADDB,settlement,100,56,4/20/2018
DFADDB,settlement,100,56,4/20/2018
E0A84E,business-contract,100,69,4/20/2018
E5752F,earnings,100,50,4/20/2018
E6E012,dividend,100,50,4/20/2018
E8846E,conference-organizer,100,57,4/20/2018
E8D221,dividend-up,100,56,4/20/2018
EA4E68,earnings,100,50,4/20/2018
ECDEB2,earnings,100,50,4/20/2018
ECDEB2,earnings,100,50,4/20/2018
ECDEB2,earnings,100,50,4/20/2018
ECDEB2,earnings,100,50,4/20/2018
ECDEB2,earnings,100,50,4/20/2018
ECDEB2,earnings,100,50,4/20/2018
EF25A5,earnings,100,50,4/20/2018
F72E4B,private-placement,100,56,4/20/2018
F82D37,earnings-up,100,68,4/20/2018
F82D37,earnings,100,50,4/20/2018
FA40E2,dividend,100,50,4/20/2018
FDF799,earnings,100,50,4/20/2018
FF6644,earnings,100,50,4/20/2018
FF6644,earnings,100,50,4/20/2018
FF6644,earnings,100,50,4/20/2018
FF6644,earnings,100,50,4/20/2018
FF6644,earnings,100,50,4/20/2018
FF6644,earnings,100,50,4/20/2018
FF6644,earnings,100,50,4/20/2018
425BDC,legal-issues-defendant,100,22,4/21/2018
4E4E75,legal-issues-defendant,100,22,4/21/2018
CC8F6E,legal-issues-defendant,100,22,4/21/2018
D8ECA1,legal-issues-defendant,100,22,4/21/2018
D90F43,settlement,100,56,4/21/2018
00E601,executive-resignation,100,44,4/23/2018
03CF95,business-contract,100,69,4/23/2018
05AF14,product-release,100,64,4/23/2018
06C826,note-sale,100,52,4/23/2018
06C826,note-sale,100,52,4/23/2018
75172,conference-call,100,50,4/23/2018
08A40F,earnings-positive,100,69,4/23/2018
08A40F,earnings-positive,100,69,4/23/2018
08A40F,earnings-positive,100,69,4/23/2018
08A40F,earnings-positive,100,69,4/23/2018
08A40F,earnings-positive,100,69,4/23/2018
08A40F,earnings-positive,100,69,4/23/2018
08A40F,earnings-positive,100,69,4/23/2018
0BD4E8,executive-resignation,100,44,4/23/2018
0C2A0D,product-release,100,64,4/23/2018
0D26E0,earnings-up,100,83,4/23/2018
0D26E0,earnings-up,100,83,4/23/2018
0D26E0,earnings-up,100,83,4/23/2018
0D26E0,earnings-up,100,83,4/23/2018
0F2BC9,board-meeting,100,51,4/23/2018
1348C9,earnings,100,50,4/23/2018
1348C9,earnings,100,50,4/23/2018
1348C9,earnings,100,50,4/23/2018
1348C9,earnings,100,50,4/23/2018
135B09,unit-acquisition-acquirer,100,49,4/23/2018
15789A,revenue-volume-up,100,59,4/23/2018
159739,earnings,100,50,4/23/2018
16B183,executive-resignation,100,44,4/23/2018
19BF16,earnings,100,50,4/23/2018
19BF16,earnings,100,50,4/23/2018
19BF16,earnings,100,50,4/23/2018
1E68B3,executive-appointment,100,54,4/23/2018
1EA923,executive-appointment,100,54,4/23/2018
1FE3CB,earnings-up,100,68,4/23/2018
206852,earnings,100,50,4/23/2018
25102A,ipo-completed,100,76,4/23/2018
25102A,ipo-completed,100,76,4/23/2018
25AB8E,conference-call,100,50,4/23/2018
27A791,earnings,100,50,4/23/2018
27B191,facility-open,100,65,4/23/2018
2A9C0A,earnings-positive,100,69,4/23/2018
2B49F4,earnings,100,50,4/23/2018
2B49F4,earnings,100,50,4/23/2018
2B49F4,earnings,100,50,4/23/2018
2B49F4,earnings,100,50,4/23/2018
2C7505,orphan-drug-designation,100,76,4/23/2018
2D2D43,partnership,100,61,4/23/2018
2E902B,revenues,100,50,4/23/2018
2E902B,earnings,100,50,4/23/2018
2E902B,earnings,100,50,4/23/2018
2E902B,earnings,100,50,4/23/2018
309922,earnings,100,50,4/23/2018
314D88,public-offering,100,43,4/23/2018
31803E,regulatory-product-application,100,69,4/23/2018
32F943,earnings,100,50,4/23/2018
33AD83,partnership,100,61,4/23/2018
3461CF,credit-rating-upgrade-rater,20,50,4/23/2018
367E1C,earnings,100,50,4/23/2018
37E18B,acquisition-completed-acquirer,100,49,4/23/2018
38FB49,earnings,100,50,4/23/2018
38FB49,earnings,100,50,4/23/2018
38FB49,earnings,100,50,4/23/2018
38FB49,earnings,100,50,4/23/2018
38FB49,earnings,100,50,4/23/2018
38FB49,earnings,100,50,4/23/2018
38FB49,earnings,100,50,4/23/2018
38FB49,earnings,100,50,4/23/2018
3A3447,facility-open,100,65,4/23/2018
3A4BDB,earnings-up,100,68,4/23/2018
3C6CCC,earnings,100,50,4/23/2018
3C8A04,earnings,100,50,4/23/2018
3DB18B,earnings,100,50,4/23/2018
3DE4D1,earnings,100,50,4/23/2018
41A93D,earnings,100,50,4/23/2018
427F32,conference-call,100,50,4/23/2018
43A060,executive-appointment,100,54,4/23/2018
44740A,conference-call,100,50,4/23/2018
47FCF2,investment-investor,100,55,4/23/2018
487B7A,executive-appointment,100,54,4/23/2018
49914B,earnings,100,50,4/23/2018
4A6F00,partnership,100,61,4/23/2018
4A6F00,partnership,100,61,4/23/2018
4A6F00,expenses,100,50,4/23/2018
4C5CC9,conference-call,100,50,4/23/2018
4D371E,earnings,100,50,4/23/2018
4DD09F,earnings,100,50,4/23/2018
4F9487,earnings-positive,100,69,4/23/2018
50070E,conference-organizer,100,57,4/23/2018
51D876,credit-rating-upgrade,100,64,4/23/2018
53F491,award,100,58,4/23/2018
54A646,earnings-up,100,68,4/23/2018
553949,conference-call,100,50,4/23/2018
55438C,investment-investor,100,55,4/23/2018
55D0F3,earnings,100,50,4/23/2018
583223,earnings,100,50,4/23/2018
5876DC,earnings,100,50,4/23/2018
58B46F,merger,100,66,4/23/2018
58B46F,merger,100,66,4/23/2018
58B46F,merger,100,66,4/23/2018
58B46F,merger,100,66,4/23/2018
5D41E4,product-release,100,64,4/23/2018
5E6959,product-release,100,64,4/23/2018
5EAA43,dividend,100,50,4/23/2018
60FE03,partnership,100,61,4/23/2018
62B1C6,dividend,100,50,4/23/2018
62B1C6,dividend,100,50,4/23/2018
62B1C6,earnings,100,50,4/23/2018
62B1C6,earnings,100,50,4/23/2018
647143,earnings,100,50,4/23/2018
647143,earnings,100,50,4/23/2018
647143,earnings,100,50,4/23/2018
647143,earnings,100,50,4/23/2018
64854A,regulatory-product-approval-granted,100,81,4/23/2018
64E615,conference-call,100,50,4/23/2018
64FF65,business-contract,100,69,4/23/2018
68B03F,earnings-up,100,68,4/23/2018
68B03F,earnings,100,50,4/23/2018
68B03F,earnings,100,50,4/23/2018
69C99E,patient-enrollment-start,100,58,4/23/2018
69FDFC,product-release,100,64,4/23/2018
69FDFC,award,100,58,4/23/2018
69FDFC,award,100,58,4/23/2018
6CB7F9,earnings,100,50,4/23/2018
6D0CAB,executive-resignation,100,44,4/23/2018
6D4636,earnings,100,50,4/23/2018
6D4636,earnings,100,50,4/23/2018
6DD6BA,earnings,100,50,4/23/2018
6DD6BA,earnings,100,50,4/23/2018
6DD6BA,earnings,100,50,4/23/2018
6-Dec-05,legal-issues-dismissed-plaintiff,100,44,4/23/2018
7032D0,earnings,100,50,4/23/2018
713810,partnership,100,61,4/23/2018
726DDF,conference-call,100,50,4/23/2018
73529F,conference-call,100,50,4/23/2018
73A71F,award,100,58,4/23/2018
7.44E+09,dividend,100,50,4/23/2018
75F665,earnings,100,50,4/23/2018
762A3E,conference-organizer,100,57,4/23/2018
76B926,earnings,100,50,4/23/2018
76B926,earnings,100,50,4/23/2018
7B1156,earnings-guidance,100,50,4/23/2018
7B1E50,earnings,100,50,4/23/2018
7F3665,earnings,100,50,4/23/2018
7F3669,earnings,100,50,4/23/2018
82F088,conference-call,100,50,4/23/2018
84A6B9,earnings-up,100,84,4/23/2018
859281,earnings,100,50,4/23/2018
859281,earnings,100,50,4/23/2018
859281,earnings,100,50,4/23/2018
859281,earnings,100,50,4/23/2018
859281,earnings,100,50,4/23/2018
8665BA,investment-investor,100,55,4/23/2018
893904,conference-participant,100,50,4/23/2018
895D56,conference-call,100,50,4/23/2018
8A8E41,earnings,100,50,4/23/2018
8AB37F,partnership,100,61,4/23/2018
8BAA15,executive-appointment,100,54,4/23/2018
8C1238,conference-call,100,50,4/23/2018
8E3F58,earnings,100,50,4/23/2018
8E82A6,conference-participant,100,50,4/23/2018
8E93A4,earnings,100,50,4/23/2018
8FCA78,acquisition-completed-acquirer,100,49,4/23/2018
903AB4,earnings,100,50,4/23/2018
911CA9,clinical-trials,100,56,4/23/2018
94C0B5,earnings,100,50,4/23/2018
9592FB,earnings,100,50,4/23/2018
972356,business-contract,100,69,4/23/2018
97B027,conference-call,100,50,4/23/2018
9A02C4,earnings,100,50,4/23/2018
9A02C4,dividend-up,100,81,4/23/2018
9B0C9C,conference-participant,100,50,4/23/2018
9BB35A,conference-call,100,50,4/23/2018
9CDA4F,business-contract,100,69,4/23/2018
9CDA4F,business-contract,100,69,4/23/2018
9CE4C7,earnings,100,50,4/23/2018
9D2790,earnings,100,50,4/23/2018
9F18FA,earnings,100,50,4/23/2018
9F18FA,earnings,100,50,4/23/2018
A3BFAA,dividend,100,50,4/23/2018
A4A612,earnings-up,100,68,4/23/2018
A4A612,earnings,100,50,4/23/2018
A4A612,earnings,100,50,4/23/2018
A5A4F5,product-release,100,64,4/23/2018
A5A4F5,product-release,100,64,4/23/2018
A6213D,legal-issues-defendant,100,22,4/23/2018
A63387,conference-call,100,50,4/23/2018
AA98ED,earnings,100,50,4/23/2018
AC3584,earnings,100,50,4/23/2018
AC642C,conference-participant,100,50,4/23/2018
AD1ACF,conference-call,100,50,4/23/2018
AD23DE,conference-call,100,50,4/23/2018
B08C51,earnings,100,50,4/23/2018
B1A85D,earnings,100,50,4/23/2018
B1B10C,executive-appointment,100,54,4/23/2018
B2206F,earnings,100,50,4/23/2018
B290A2,public-offering,100,43,4/23/2018
B2F431,earnings-positive,100,69,4/23/2018
B560AF,government-contract,100,69,4/23/2018
B5766D,dividend-up,100,81,4/23/2018
B604DF,earnings,100,50,4/23/2018
B604DF,earnings,100,50,4/23/2018
B604DF,earnings,100,50,4/23/2018
B604DF,dividend,100,50,4/23/2018
B604DF,dividend,100,50,4/23/2018
B604DF,earnings,100,50,4/23/2018
B642E8,earnings,100,50,4/23/2018
B8DD94,executive-appointment,100,54,4/23/2018
B8F71F,executive-appointment,100,54,4/23/2018
B96637,conference-call,100,50,4/23/2018
B9764A,conference-call,100,50,4/23/2018
BB58FF,conference-call,100,50,4/23/2018
BC3AD2,earnings,100,50,4/23/2018
BDD12C,earnings,100,50,4/23/2018
BDE867,executive-appointment,100,54,4/23/2018
BDF2BD,conference-call,100,50,4/23/2018
C15DB3,dividend,100,50,4/23/2018
C2F597,earnings,100,50,4/23/2018
C3BCD5,business-contract,100,69,4/23/2018
C3BCD5,business-contract,100,69,4/23/2018
C598D7,revenue-up,100,58,4/23/2018
C598D7,revenues,100,50,4/23/2018
C598D7,revenues,100,50,4/23/2018
C598D7,revenues,100,50,4/23/2018
C65004,conference-participant,100,50,4/23/2018
C9F39B,executive-appointment,100,54,4/23/2018
CBFFDD,product-release,100,64,4/23/2018
CC35BE,product-release,100,64,4/23/2018
CC6FF5,earnings,100,50,4/23/2018
CC8F6E,legal-issues-defendant,100,22,4/23/2018
CC8F6E,legal-issues-defendant,100,22,4/23/2018
CC8F6E,legal-issues-defendant,100,22,4/23/2018
CC8F6E,legal-issues-defendant,100,22,4/23/2018
CC8F6E,legal-issues-defendant,100,22,4/23/2018
CC8F6E,fraud-defendant,100,20,4/23/2018
CD2DA4,executive-appointment,100,54,4/23/2018
CF6A5A,earnings,100,50,4/23/2018
CFE5BE,earnings-up,100,68,4/23/2018
CFE5BE,earnings-up,100,68,4/23/2018
CFE5BE,earnings-up,100,68,4/23/2018
CFE5BE,earnings-up,100,68,4/23/2018
CFE5BE,earnings-up,100,68,4/23/2018
CFE5BE,earnings-up,100,68,4/23/2018
CFE5BE,earnings-up,100,68,4/23/2018
D04D9F,conference-call,100,50,4/23/2018
D0DFE5,earnings,100,50,4/23/2018
D0DFE5,earnings,100,50,4/23/2018
D17C1B,partnership,100,61,4/23/2018
D17C1B,partnership,100,61,4/23/2018
D33270,partnership,100,61,4/23/2018
D3FA2C,conference-call,100,50,4/23/2018
D3FD6D,conference-call,100,50,4/23/2018
D77F7E,partnership,100,61,4/23/2018
D7A953,executive-appointment,100,54,4/23/2018
D8760C,earnings-up,100,68,4/23/2018
D8760C,earnings,100,50,4/23/2018
D8760C,earnings,100,50,4/23/2018
D8760C,earnings,100,50,4/23/2018
D8760C,earnings,100,50,4/23/2018
D9E036,business-contract,100,69,4/23/2018
DF46C5,dividend,100,50,4/23/2018
DF46C5,earnings-guidance-up,100,83,4/23/2018
DF46C5,earnings,100,50,4/23/2018
DF46C5,earnings,100,50,4/23/2018
DF46C5,earnings,100,50,4/23/2018
DF5F14,note-sale,100,52,4/23/2018
E1E093,patent-awarded,100,72,4/23/2018
E2CB7B,earnings,100,50,4/23/2018
E2F66E,earnings-guidance,100,50,4/23/2018
E3E68E,executive-appointment,100,54,4/23/2018
E4158B,earnings,100,50,4/23/2018
E4158B,earnings,100,50,4/23/2018
E4158B,earnings,100,50,4/23/2018
E4158B,earnings,100,50,4/23/2018
E4158B,earnings,100,50,4/23/2018
E68733,partnership,100,61,4/23/2018
E68733,joint-venture,100,62,4/23/2018
E70531,earnings,100,50,4/23/2018
E84500,earnings,100,50,4/23/2018
E866D2,partnership,100,61,4/23/2018
E87676,dividend,100,50,4/23/2018
EB61C4,earnings,100,50,4/23/2018
EC1AF3,conference-call,100,50,4/23/2018
ED0402,revenue-up,100,70,4/23/2018
ED0402,revenue-up,100,70,4/23/2018
ED0402,revenue-up,100,70,4/23/2018
ED0402,revenue-up,100,70,4/23/2018
F04E05,earnings,100,50,4/23/2018
F0A9DE,earnings,100,50,4/23/2018
F44EA2,earnings,100,50,4/23/2018
F5349B,earnings,100,50,4/23/2018
F5349B,award,100,58,4/23/2018
F5C78B,dividend,100,50,4/23/2018
F5C78B,earnings,100,50,4/23/2018
F6E1B5,executive-appointment,100,54,4/23/2018
F80FF9,conference-call,100,50,4/23/2018
F85CC0,conference-participant,100,50,4/23/2018
F9CAF8,conference-call,100,50,4/23/2018
FAB97A,executive-appointment,100,54,4/23/2018
FACF19,market-entry,100,57,4/23/2018
FAE021,executive-appointment,100,54,4/23/2018
FE1A1D,partnership,100,61,4/23/2018
FF6644,dividend,100,50,4/23/2018
13528,product-release,100,64,4/24/2018
0157B1,partnership,100,61,4/24/2018
03B8CF,earnings,100,50,4/24/2018
03B8CF,earnings,100,50,4/24/2018
03B8CF,earnings,100,50,4/24/2018
03B8CF,earnings,100,50,4/24/2018
040DBB,earnings,100,50,4/24/2018
053EFF,conference-call,100,50,4/24/2018
55018,earnings-positive,100,69,4/24/2018
55018,earnings,100,50,4/24/2018
55018,earnings,100,50,4/24/2018
55018,earnings,100,50,4/24/2018
55018,earnings,100,50,4/24/2018
55018,earnings,100,50,4/24/2018
55018,earnings,100,50,4/24/2018
55018,earnings,100,50,4/24/2018
55018,earnings,100,50,4/24/2018
070B45,earnings,100,50,4/24/2018
0A9D0A,earnings,100,50,4/24/2018
0DC050,index-listing,100,76,4/24/2018
0F0440,donation,100,54,4/24/2018
102727,earnings,100,50,4/24/2018
102727,earnings,100,50,4/24/2018
102727,earnings,100,50,4/24/2018
102727,earnings,100,50,4/24/2018
102F04,earnings,100,50,4/24/2018
16B882,earnings,100,50,4/24/2018
16FC89,earnings,100,50,4/24/2018
184866,clinical-trials,100,56,4/24/2018
1921DD,partnership,100,61,4/24/2018
1880C5,product-release,100,64,4/24/2018
188394,dividend,100,50,4/24/2018
1A3E1B,dividend,100,50,4/24/2018
1A9DE1,earnings,100,50,4/24/2018
1A9DE1,earnings,100,50,4/24/2018
1A9DE1,earnings,100,50,4/24/2018
1A9DE1,earnings,100,50,4/24/2018
1BDB2A,earnings,100,50,4/24/2018
1E4FB9,conference-participant,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1E9A6D,earnings,100,50,4/24/2018
1F9D90,earnings,100,50,4/24/2018
202E5A,conference-call,100,50,4/24/2018
219B21,conference-call,100,50,4/24/2018
221445,earnings,100,50,4/24/2018
2262BD,earnings,100,50,4/24/2018
228D42,business-contract,100,69,4/24/2018
239106,unit-acquisition-acquirer,100,49,4/24/2018
241AF7,conference-call,100,50,4/24/2018
249674,conference-call,100,50,4/24/2018
24C48B,conference-call,100,50,4/24/2018
25102A,exchange-compliance-authority,100,50,4/24/2018
251988,business-contract,100,69,4/24/2018
2571FA,executive-appointment,100,54,4/24/2018
2667B6,earnings,100,50,4/24/2018
26DC29,partnership,100,61,4/24/2018
270B78,executive-appointment,100,54,4/24/2018
282C18,earnings,100,50,4/24/2018
28B730,earnings,100,50,4/24/2018
2.90E+62,business-contract,100,69,4/24/2018
2ABF77,conference-call,100,50,4/24/2018
2C7505,clinical-trials,100,56,4/24/2018
2C7505,clinical-trials,100,56,4/24/2018
2CA60F,executive-appointment,100,54,4/24/2018
2CB4C9,earnings,100,50,4/24/2018
2D643C,dividend,100,50,4/24/2018
2DDB22,executive-appointment,100,54,4/24/2018
2E2E6E,earnings,100,50,4/24/2018
2E2E6E,earnings-up,100,68,4/24/2018
2E2E6E,earnings-up,100,68,4/24/2018
2E2E6E,earnings-up,100,68,4/24/2018
2F5256,earnings,100,50,4/24/2018
2F960F,unit-acquisition-acquirer,100,49,4/24/2018
30E01D,earnings,100,50,4/24/2018
31803E,earnings,100,50,4/24/2018
31A7CC,dividend,100,50,4/24/2018
332F87,earnings-per-share-up,100,75,4/24/2018
332F87,earnings-per-share-up,100,68,4/24/2018
332F87,earnings-per-share-up,100,68,4/24/2018
332F87,earnings-per-share-up,100,68,4/24/2018
332F87,earnings-per-share-up,100,68,4/24/2018
339F20,earnings,100,50,4/24/2018
33FD66,award,100,58,4/24/2018
341759,legal-issues-defendant,100,22,4/24/2018
343996,earnings,100,50,4/24/2018
3461CF,dividend,100,50,4/24/2018
35B907,earnings,100,50,4/24/2018
35B907,earnings,100,50,4/24/2018
36C09B,clinical-trials,100,56,4/24/2018
39BFF6,earnings,100,50,4/24/2018
39BFF6,earnings,100,50,4/24/2018
39BFF6,earnings,100,50,4/24/2018
3A3948,earnings,100,50,4/24/2018
3B37F7,executive-appointment,100,54,4/24/2018
3BCF24,earnings-up,100,68,4/24/2018
3DCECC,partnership,100,61,4/24/2018
3F4497,earnings,100,50,4/24/2018
3F6A9C,dividend,100,50,4/24/2018
408089,earnings,100,50,4/24/2018
41785E,earnings,100,50,4/24/2018
417BF9,business-contract,100,69,4/24/2018
417BF9,business-contract,100,69,4/24/2018
420168,earnings,100,50,4/24/2018
4290EF,earnings,100,50,4/24/2018
42AABD,conference-call,100,50,4/24/2018
442769,award,100,58,4/24/2018
44A4FC,investment-investor,100,55,4/24/2018
45444E,acquisition-completed-acquirer,100,49,4/24/2018
4591D3,revenues,100,50,4/24/2018
4885C8,dividend,100,50,4/24/2018
492117,earnings,100,50,4/24/2018
49914B,earnings,100,50,4/24/2018
49F4D0,board-meeting,100,51,4/24/2018
4A5C8D,partnership,100,61,4/24/2018
4B3DC9,earnings-positive,100,69,4/24/2018
4C37C5,dividend,100,50,4/24/2018
4D72C8,conference-call,100,50,4/24/2018
4D8313,executive-appointment,100,54,4/24/2018
5225A4,product-release,100,64,4/24/2018
5225A4,product-release,100,64,4/24/2018
5675EB,dividend,100,50,4/24/2018
5675EB,earnings-up,100,68,4/24/2018
583A75,earnings,100,50,4/24/2018
594402,earnings,100,50,4/24/2018
5D63F1,partnership,100,61,4/24/2018
5EAA43,conference-call,100,50,4/24/2018
5F60CE,earnings,100,50,4/24/2018
5FE4B6,conference-participant,100,50,4/24/2018
6137BF,earnings,100,50,4/24/2018
6137BF,earnings,100,50,4/24/2018
64854A,conference-call,100,50,4/24/2018
65CF8E,dividend,100,50,4/24/2018
69FDFC,partnership,100,61,4/24/2018
6B0E45,dividend,100,50,4/24/2018
6C4D2F,dividend-up,100,81,4/24/2018
6C4D2F,dividend-up,100,81,4/24/2018
6C4D2F,dividend-up,100,81,4/24/2018
6C4D2F,dividend-up,100,81,4/24/2018
6C4D2F,dividend-up,100,81,4/24/2018
6C4D2F,dividend-up,100,81,4/24/2018
6C987C,earnings-up,100,68,4/24/2018
6C987C,earnings-up,100,68,4/24/2018
6C987C,earnings-up,100,68,4/24/2018
6C987C,earnings-up,100,68,4/24/2018
6C987C,earnings-up,100,68,4/24/2018
6CC55E,partnership,100,61,4/24/2018
6D3B7B,dividend-up,100,81,4/24/2018
6E8864,conference-call,100,50,4/24/2018
713810,partnership,100,61,4/24/2018
717DB4,earnings,100,50,4/24/2018
752A70,earnings,100,50,4/24/2018
75F665,dividend-up,100,81,4/24/2018
75F665,earnings-up,100,68,4/24/2018
75F665,earnings,100,50,4/24/2018
75F665,earnings,100,50,4/24/2018
75F665,earnings,100,50,4/24/2018
75F665,earnings,100,50,4/24/2018
75F665,earnings,100,50,4/24/2018
75F665,earnings,100,50,4/24/2018
75F665,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
767F86,earnings,100,50,4/24/2018
76E80F,partnership,100,61,4/24/2018
76F067,earnings,100,50,4/24/2018
76F067,earnings,100,50,4/24/2018
7B0BA6,dividend,100,50,4/24/2018
7B492C,conference-call,100,50,4/24/2018
7B6C88,earnings,100,50,4/24/2018
7C75FD,earnings,100,50,4/24/2018
7D35D8,earnings,100,50,4/24/2018
7D35D8,earnings,100,50,4/24/2018
7D5FD6,earnings,100,50,4/24/2018
7F9E16,conference-call,100,50,4/24/2018
817ED9,facility-open,100,65,4/24/2018
81EAD4,conference-call,100,50,4/24/2018
81F4BE,earnings,100,50,4/24/2018
81F4BE,earnings,100,50,4/24/2018
81F4BE,earnings,100,50,4/24/2018
81F4BE,earnings,100,50,4/24/2018
82C202,earnings,100,50,4/24/2018
8377DB,earnings,100,50,4/24/2018
83B1C8,executive-appointment,100,54,4/24/2018
845533,earnings,100,50,4/24/2018
84AB66,ipo-completed,100,76,4/24/2018
85AD00,earnings-up,100,68,4/24/2018
862941,earnings,100,50,4/24/2018
8CF6DD,dividend-up,100,81,4/24/2018
8D4486,dividend-up,100,81,4/24/2018
8D4486,dividend-up,100,81,4/24/2018
8E82A6,partnership,100,61,4/24/2018
8EEA28,dividend,100,50,4/24/2018
911AB8,dividend,100,50,4/24/2018
92D6A5,dividend,100,50,4/24/2018
92D757,acquisition-acquirer,100,49,4/24/2018
9.31E+77,conference-call,100,50,4/24/2018
945DE6,earnings-per-share-positive,100,69,4/24/2018
945DE6,earnings-per-share-positive,100,69,4/24/2018
9470CC,earnings,100,50,4/24/2018
9548BB,revenue-up,100,69,4/24/2018
9548BB,earnings,100,50,4/24/2018
9548BB,earnings,100,50,4/24/2018
958938,public-offering,100,43,4/24/2018
95C575,earnings,100,50,4/24/2018
965360,earnings,100,50,4/24/2018
965360,earnings,100,50,4/24/2018
965360,earnings,100,50,4/24/2018
965360,earnings,100,50,4/24/2018
965360,earnings,100,50,4/24/2018
965360,earnings,100,50,4/24/2018
965360,earnings,100,50,4/24/2018
96F126,earnings,100,50,4/24/2018
96F126,earnings,100,50,4/24/2018
97644E,legal-issues-defendant,100,22,4/24/2018
97AF94,earnings,100,50,4/24/2018
98CAED,dividend,100,50,4/24/2018
98CAED,earnings,100,50,4/24/2018
98CAED,earnings,100,50,4/24/2018
98CAED,earnings,100,50,4/24/2018
98CEBB,earnings,100,50,4/24/2018
9ABD30,earnings,100,50,4/24/2018
9C25FF,legal-issues-defendant,100,22,4/24/2018
9CA619,acquisition-completed-acquirer,100,49,4/24/2018
9E4A5F,earnings,100,50,4/24/2018
9E575E,earnings,100,50,4/24/2018
9E91C6,earnings,100,50,4/24/2018
9F18FA,acquisition-completed-acquirer,100,49,4/24/2018
9F18FA,acquisition-completed-acquirer,100,49,4/24/2018
9FB4B7,conference-call,100,50,4/24/2018
A05C43,earnings,100,50,4/24/2018
A4D173,earnings,100,50,4/24/2018
A4D173,earnings,100,50,4/24/2018
A52B6B,acquisition-completed-acquirer,100,49,4/24/2018
A6213D,conference-call,100,50,4/24/2018
A65325,earnings-positive,100,69,4/24/2018
A65325,earnings,100,50,4/24/2018
A65325,earnings,100,50,4/24/2018
A65325,earnings,100,50,4/24/2018
A65325,earnings,100,50,4/24/2018
A65325,earnings,100,50,4/24/2018
A6828A,conference-participant,100,50,4/24/2018
A6ABE9,earnings-positive,100,69,4/24/2018
A7102F,conference-call,100,50,4/24/2018
A8B137,earnings,100,50,4/24/2018
A8B137,earnings,100,50,4/24/2018
A8B137,earnings,100,50,4/24/2018
A8B137,earnings,100,50,4/24/2018
A8B137,earnings,100,50,4/24/2018
AABEA0,earnings-up,100,68,4/24/2018
ABBAD1,executive-resignation,100,44,4/24/2018
AC642C,earnings,100,50,4/24/2018
AC642C,earnings,100,50,4/24/2018
ACC7D3,public-offering,100,43,4/24/2018
ACD9A4,earnings,100,50,4/24/2018
AD9F1D,earnings,100,50,4/24/2018
AD9F1D,earnings,100,50,4/24/2018
AD9F1D,earnings,100,50,4/24/2018
AD9F1D,earnings,100,50,4/24/2018
AD9F1D,earnings,100,50,4/24/2018
AD9F1D,earnings,100,50,4/24/2018
AD9F1D,earnings,100,50,4/24/2018
AE4EEB,earnings,100,50,4/24/2018
B08C51,earnings,100,50,4/24/2018
B0FE08,dividend-up,100,81,4/24/2018
B4C673,conference-call,100,50,4/24/2018
B6082A,conference-participant,100,50,4/24/2018
B6082A,earnings,100,50,4/24/2018
B619CB,executive-appointment,100,54,4/24/2018
B8DD94,conference-call,100,50,4/24/2018
B8EF97,dividend-up,100,81,4/24/2018
B8F71F,earnings,100,50,4/24/2018
B96637,operating-earnings,100,50,4/24/2018
BB127B,investment-investor,100,55,4/24/2018
BB5142,revenue-up,100,69,4/24/2018
BCC13E,earnings,100,50,4/24/2018
BD15E8,earnings,100,50,4/24/2018
BD9668,earnings,100,50,4/24/2018
BDD12C,unit-acquisition-acquiree,100,76,4/24/2018
BDD12C,unit-acquisition-acquiree,100,76,4/24/2018
BFE02C,award,100,58,4/24/2018
C32A39,earnings,100,50,4/24/2018
C356AC,partnership,100,61,4/24/2018
C38440,conference-participant,100,50,4/24/2018
C3F99F,earnings,100,50,4/24/2018
C41C25,dividend,100,50,4/24/2018
C45CE7,earnings,100,50,4/24/2018
C6C702,partnership,100,61,4/24/2018
C6C702,partnership,100,61,4/24/2018
C83B88,executive-appointment,100,54,4/24/2018
C8A248,executive-appointment,100,54,4/24/2018
C8A248,partnership,100,61,4/24/2018
C951A2,partnership,100,61,4/24/2018
C9E107,earnings,100,50,4/24/2018
CBA33B,dividend,100,50,4/24/2018
CC8F6E,legal-issues-defendant,100,22,4/24/2018
CC8F6E,fraud-defendant,100,20,4/24/2018
CD06A2,dividend,100,50,4/24/2018
CDAF5B,operating-earnings,100,50,4/24/2018
CDAF5B,operating-earnings,100,50,4/24/2018
CDAF5B,operating-earnings,100,50,4/24/2018
CE4FD9,trading-halt,100,43,4/24/2018
CE4FD9,trading-resumed,100,58,4/24/2018
CEDFD5,revenues,100,50,4/24/2018
CEDFD5,revenues,100,50,4/24/2018
CEDFD5,revenues,100,50,4/24/2018
CEDFD5,revenues,100,50,4/24/2018
CF9054,earnings,100,50,4/24/2018
CFF97C,analyst-ratings-change-positive-rater,20,50,4/24/2018
D1173F,earnings,100,50,4/24/2018
D1173F,earnings,100,50,4/24/2018
D1173F,earnings,100,50,4/24/2018
D1173F,earnings,100,50,4/24/2018
D1173F,earnings,100,50,4/24/2018
D11C1C,analyst-ratings-change-positive,100,78,4/24/2018
D139BC,earnings,100,50,4/24/2018
D17C1B,earnings,100,50,4/24/2018
D17C1B,earnings,100,50,4/24/2018
D29B44,earnings,100,50,4/24/2018
D33D8C,award,100,58,4/24/2018
D3DE34,earnings,100,50,4/24/2018
D437C3,product-release,100,64,4/24/2018
D4AC65,partnership,100,61,4/24/2018
D56E4C,conference-organizer,100,57,4/24/2018
D6489C,product-release,100,64,4/24/2018
D6489C,product-release,100,64,4/24/2018
D697DE,product-release,100,64,4/24/2018
D697DE,product-release,100,64,4/24/2018
D854DD,conference-call,100,50,4/24/2018
D8ECA1,stake-acquirer,100,48,4/24/2018
D9B1C9,investment-investor,100,55,4/24/2018
D9B1C9,dividend,100,50,4/24/2018
D9CAF0,earnings,100,50,4/24/2018
D9E036,business-contract,100,69,4/24/2018
DA91AE,conference-participant,100,50,4/24/2018
DB7FA7,dividend,100,50,4/24/2018
DC486E,earnings,100,50,4/24/2018
DC486E,earnings,100,50,4/24/2018
DC486E,earnings,100,50,4/24/2018
DC486E,earnings,100,50,4/24/2018
DCD97F,market-entry,100,57,4/24/2018
DDB002,earnings,100,50,4/24/2018
DF11D9,earnings,100,50,4/24/2018
DF204B,conference-call,100,50,4/24/2018
E06265,conference-call,100,50,4/24/2018
E0647D,earnings,100,50,4/24/2018
E0647D,earnings,100,50,4/24/2018
E074A0,dividend,100,50,4/24/2018
E15736,conference-call,100,50,4/24/2018
E2CFD2,partnership,100,61,4/24/2018
E38906,public-offering,100,43,4/24/2018
E3E68E,product-release,100,64,4/24/2018
E4CE73,partnership,100,61,4/24/2018
E50F1C,earnings-up,100,68,4/24/2018
E69BA5,conference-call,100,50,4/24/2018
E6D89E,earnings,100,50,4/24/2018
E6D89E,earnings,100,50,4/24/2018
E6D89E,earnings,100,50,4/24/2018
E6D89E,earnings,100,50,4/24/2018
E6E012,revenues,100,50,4/24/2018
E82A2D,conference-call,100,50,4/24/2018
E8846E,partnership,100,61,4/24/2018
E8846E,conference-organizer,100,57,4/24/2018
E8846E,executive-appointment,100,54,4/24/2018
E8846E,dividend,100,50,4/24/2018
E8846E,conference-organizer,100,57,4/24/2018
E8846E,conference-organizer,100,57,4/24/2018
E9E6FD,earnings,100,50,4/24/2018
E9FF33,earnings,100,50,4/24/2018
ECD263,note-sale,100,52,4/24/2018
ECDEB2,earnings,100,50,4/24/2018
ED0D7C,dividend,100,50,4/24/2018
ED79D9,executive-appointment,100,54,4/24/2018
EDF5CA,earnings,100,50,4/24/2018
EDF5CA,earnings,100,50,4/24/2018
EDF5CA,earnings,100,50,4/24/2018
EDF5CA,earnings,100,50,4/24/2018
EDF5CA,earnings,100,50,4/24/2018
EF5BED,executive-appointment,100,54,4/24/2018
EF5BED,executive-appointment,100,54,4/24/2018
EFD406,partnership,100,61,4/24/2018
F04E05,dividend,100,50,4/24/2018
F04E05,executive-appointment,100,54,4/24/2018
F0B2B5,earnings,100,50,4/24/2018
F24FF0,earnings,100,50,4/24/2018
F30508,earnings-up,100,68,4/24/2018
F30508,earnings-up,100,68,4/24/2018
F30508,earnings-up,100,68,4/24/2018
F30508,earnings-up,100,68,4/24/2018
F40EE2,earnings,100,50,4/24/2018
F5349B,unit-acquisition-acquiree,100,76,4/24/2018
F5A214,earnings,100,50,4/24/2018
F5D410,earnings,100,50,4/24/2018
F6A945,earnings,100,50,4/24/2018
F6DE54,earnings,100,50,4/24/2018
F7ADEB,conference-call,100,50,4/24/2018
F8C5D7,legal-issues-defendant,100,22,4/24/2018
FA044A,earnings,100,50,4/24/2018
FBD92D,exchange-compliance,100,76,4/24/2018
FC01C0,acquisition-acquirer,100,49,4/24/2018
FC1A6E,legal-issues-defendant,100,22,4/24/2018
FC4550,earnings,100,50,4/24/2018
FE7A63,earnings,100,50,4/24/2018
FE7A63,earnings,100,50,4/24/2018
FE7A63,earnings,100,50,4/24/2018
FE7A63,earnings,100,50,4/24/2018
FE7A63,earnings,100,50,4/24/2018
FE7A63,earnings,100,50,4/24/2018
FE7A63,earnings,100,50,4/24/2018
00E601,operating-earnings,100,50,4/25/2018
018C11,earnings,100,50,4/25/2018
03CF95,earnings,100,50,4/25/2018
03CF95,earnings,100,50,4/25/2018
03CF95,earnings,100,50,4/25/2018
03CF95,earnings,100,50,4/25/2018
03CF95,earnings,100,50,4/25/2018
03CF95,partnership,100,61,4/25/2018
43862,executive-appointment,100,54,4/25/2018
68396,earnings,100,50,4/25/2018
06C826,note-sale,100,52,4/25/2018
71860,earnings,100,50,4/25/2018
081AB9,dividend,100,50,4/25/2018
081AB9,earnings,100,50,4/25/2018
099C88,unit-acquisition-completed-acquirer,100,49,4/25/2018
0A1D77,earnings-positive,100,69,4/25/2018
0A1D77,earnings,100,50,4/25/2018
0A1D77,earnings,100,50,4/25/2018
0A1D77,earnings,100,50,4/25/2018
0A1D77,earnings,100,50,4/25/2018
0B13E8,conference-call,100,50,4/25/2018
0BF198,conference-call,100,50,4/25/2018
0C136E,earnings,100,50,4/25/2018
0CBC4D,revenues,100,50,4/25/2018
0CE7F6,legal-issues-defendant,100,22,4/25/2018
0E2992,earnings,100,50,4/25/2018
0E439E,earnings,100,50,4/25/2018
0E439E,earnings,100,50,4/25/2018
0E439E,earnings,100,50,4/25/2018
0E5223,conference-call,100,50,4/25/2018
0E6027,earnings-positive,100,69,4/25/2018
0FDE97,executive-appointment,100,54,4/25/2018
10943B,earnings,100,50,4/25/2018
1096C6,earnings,100,50,4/25/2018
1216D1,earnings,100,50,4/25/2018
12731D,conference-call,100,50,4/25/2018
12E454,legal-issues-defendant,100,22,4/25/2018
12E454,earnings,100,50,4/25/2018
12E454,earnings,100,50,4/25/2018
1348C9,dividend,100,50,4/25/2018
147C38,dividend,100,50,4/25/2018
152B9E,earnings,100,50,4/25/2018
156A99,earnings,100,50,4/25/2018
16F4D8,earnings,100,50,4/25/2018
16F4D8,earnings,100,50,4/25/2018
16F4D8,earnings,100,50,4/25/2018
16F4D8,earnings,100,50,4/25/2018
1782D5,earnings,100,50,4/25/2018
1866B2,conference-call,100,50,4/25/2018
1921DD,business-contract,100,69,4/25/2018
196D18,executive-appointment,100,54,4/25/2018
196D18,executive-appointment,100,54,4/25/2018
197019,earnings,100,50,4/25/2018
1A5957,earnings,100,50,4/25/2018
1AB023,market-entry,100,57,4/25/2018
1AB023,market-entry,100,57,4/25/2018
1AB023,market-entry,100,57,4/25/2018
1B5FEA,conference-call,100,50,4/25/2018
1BC12C,dividend,100,50,4/25/2018
1CD09C,conference-call,100,50,4/25/2018
1CD708,earnings,100,50,4/25/2018
1D5C51,earnings,100,50,4/25/2018
1DA44F,earnings-up,100,68,4/25/2018
1DA44F,earnings,100,50,4/25/2018
1DA44F,earnings,100,50,4/25/2018
1DA44F,earnings,100,50,4/25/2018
1E1125,earnings,100,50,4/25/2018
1E5786,dividend-up,100,71,4/25/2018
1E83DE,partnership,100,61,4/25/2018
1E8A99,earnings,100,50,4/25/2018
1F2B5D,earnings,100,50,4/25/2018
1F2B5D,earnings,100,50,4/25/2018
1F2B5D,earnings,100,50,4/25/2018
1F2B5D,earnings,100,50,4/25/2018
1F2B5D,earnings,100,50,4/25/2018
1FA886,partnership,100,61,4/25/2018
1FA886,partnership,100,61,4/25/2018
2031CE,earnings,100,50,4/25/2018
2031CE,earnings,100,50,4/25/2018
2031CE,earnings,100,50,4/25/2018
2031CE,earnings,100,50,4/25/2018
20D00A,earnings,100,50,4/25/2018
221AD7,product-release,100,64,4/25/2018
221AD7,earnings,100,50,4/25/2018
221AD7,regulatory-product-approval-granted,100,81,4/25/2018
2491BC,earnings,100,50,4/25/2018
2491BC,earnings,100,50,4/25/2018
25102A,earnings,100,50,4/25/2018
25102A,earnings,100,50,4/25/2018
25102A,earnings,100,50,4/25/2018
25102A,earnings,100,50,4/25/2018
25102A,earnings,100,50,4/25/2018
25102A,earnings,100,50,4/25/2018
251988,earnings,100,50,4/25/2018
251988,earnings,100,50,4/25/2018
251988,earnings,100,50,4/25/2018
251988,earnings,100,50,4/25/2018
251988,earnings,100,50,4/25/2018
25A6CC,revenue-up,100,69,4/25/2018
25A6CC,revenue-up,100,69,4/25/2018
25A6CC,revenue-up,100,69,4/25/2018
264EB3,earnings,100,50,4/25/2018
264EB3,earnings,100,50,4/25/2018
264EB3,earnings,100,50,4/25/2018
264EB3,earnings,100,50,4/25/2018
264EB3,earnings,100,50,4/25/2018
267718,executive-appointment,100,54,4/25/2018
267718,executive-appointment,100,54,4/25/2018
26F31D,partnership,100,61,4/25/2018
270305,earnings,100,50,4/25/2018
270305,earnings,100,50,4/25/2018
270305,earnings,100,50,4/25/2018
270305,dividend,100,50,4/25/2018
28DCF3,earnings-up,100,93,4/25/2018
28DCF3,earnings,100,50,4/25/2018
2.90E+62,earnings,100,50,4/25/2018
2.90E+62,earnings,100,50,4/25/2018
2.90E+62,earnings,100,50,4/25/2018
2.90E+62,earnings,100,50,4/25/2018
2.90E+62,earnings,100,50,4/25/2018
2.90E+62,dividend,100,50,4/25/2018
2A17B1,earnings-up,100,68,4/25/2018
2A17B1,earnings-up,100,68,4/25/2018
2A17B1,earnings-up,100,68,4/25/2018
2B0AF4,earnings,100,50,4/25/2018
2BF36E,conference-call,100,50,4/25/2018
2BF36E,dividend,100,50,4/25/2018
2D2D43,dividend,100,50,4/25/2018
2D485F,dividend,100,50,4/25/2018
2D643C,earnings,100,50,4/25/2018
2DDB22,earnings-guidance,100,50,4/25/2018
2F94A5,earnings,100,50,4/25/2018
2FEA66,operating-earnings,100,50,4/25/2018
30DFD3,earnings,100,50,4/25/2018
31AA84,award,100,58,4/25/2018
31DB20,earnings,100,50,4/25/2018
31F25C,earnings-up,100,68,4/25/2018
326EDD,earnings,100,50,4/25/2018
33E8C7,earnings,100,50,4/25/2018
33E8C7,earnings,100,50,4/25/2018
3461CF,executive-appointment,100,54,4/25/2018
34B411,dividend,100,50,4/25/2018
3.73E+87,revenue-up,100,69,4/25/2018
3.73E+87,earnings,100,50,4/25/2018
37727A,earnings,100,50,4/25/2018
37727A,earnings,100,50,4/25/2018
37727A,earnings,100,50,4/25/2018
37727A,earnings,100,50,4/25/2018
37727A,earnings,100,50,4/25/2018
37B120,earnings,100,50,4/25/2018
387541,earnings,100,50,4/25/2018
3A113F,earnings,100,50,4/25/2018
3BB616,earnings,100,50,4/25/2018
3D9999,dividend,100,50,4/25/2018
401072,earnings,100,50,4/25/2018
416C55,earnings,100,50,4/25/2018
41B0E2,earnings,100,50,4/25/2018
41D61C,earnings,100,50,4/25/2018
425BDC,earnings,100,50,4/25/2018
43A060,business-contract,100,69,4/25/2018
4455C4,earnings,100,50,4/25/2018
4455C4,earnings,100,50,4/25/2018
4455C4,earnings,100,50,4/25/2018
4455C4,earnings,100,50,4/25/2018
447FC6,earnings,100,50,4/25/2018
447FC6,earnings,100,50,4/25/2018
447FC6,earnings,100,50,4/25/2018
447FC6,earnings,100,50,4/25/2018
458D2C,legal-issues-defendant,100,22,4/25/2018
458D2C,legal-issues-defendant,100,22,4/25/2018
458D2C,legal-issues-defendant,100,22,4/25/2018
458D2C,earnings,100,50,4/25/2018
45ABCC,product-release,100,64,4/25/2018
46017C,conference-participant,100,50,4/25/2018
468DD4,earnings,100,50,4/25/2018
47752F,earnings,100,50,4/25/2018
47752F,earnings,100,50,4/25/2018
47752F,earnings,100,50,4/25/2018
47752F,earnings,100,50,4/25/2018
49CC59,conference-call,100,50,4/25/2018
4AC91D,partnership,100,61,4/25/2018
4B3555,earnings,100,50,4/25/2018
4B5054,dividend-up,100,81,4/25/2018
4BD6DB,earnings,100,50,4/25/2018
4C6C63,earnings,100,50,4/25/2018
4C6C63,earnings,100,50,4/25/2018
4C6C63,earnings,100,50,4/25/2018
4C6C63,earnings,100,50,4/25/2018
4D8313,revenue-up,100,69,4/25/2018
4D8313,revenue-up,100,69,4/25/2018
4D8313,revenue-up,100,69,4/25/2018
4E7C1F,earnings,100,50,4/25/2018
4E7C1F,earnings,100,50,4/25/2018
4E7C1F,earnings,100,50,4/25/2018
50070E,conference-call,100,50,4/25/2018
51B442,acquisition-acquirer,100,49,4/25/2018
51E682,earnings,100,50,4/25/2018
51F541,earnings,100,50,4/25/2018
532D47,earnings,100,50,4/25/2018
54A646,dividend,100,50,4/25/2018
55438C,earnings-up,100,68,4/25/2018
55438C,earnings-up,100,68,4/25/2018
55438C,earnings-up,100,68,4/25/2018
55438C,earnings-up,100,68,4/25/2018
55438C,earnings-up,100,68,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,earnings,100,50,4/25/2018
55438C,business-contract,100,69,4/25/2018
55C289,earnings,100,50,4/25/2018
56AFF4,dividend,100,50,4/25/2018
58CA9A,dividend,100,50,4/25/2018
58EA22,executive-appointment,100,54,4/25/2018
5A9F54,earnings-up,100,68,4/25/2018
5A9F54,earnings-up,100,68,4/25/2018
5A9F54,earnings-up,100,68,4/25/2018
5AAE17,conference-call,100,50,4/25/2018
5B3FA2,earnings,100,50,4/25/2018
5BFE94,earnings,100,50,4/25/2018
60DD84,revenue-up,100,69,4/25/2018
6.18E+08,earnings,100,50,4/25/2018
662682,earnings,100,50,4/25/2018
665440,conference-call,100,50,4/25/2018
673C9A,conference-call,100,50,4/25/2018
67529E,earnings-positive,100,69,4/25/2018
67529E,earnings-positive,100,69,4/25/2018
67529E,earnings-positive,100,69,4/25/2018
67529E,earnings-positive,100,69,4/25/2018
67529E,earnings-positive,100,69,4/25/2018
67529E,earnings-positive,100,69,4/25/2018
67529E,earnings-positive,100,69,4/25/2018
69345C,earnings,100,50,4/25/2018
69345C,earnings,100,50,4/25/2018
69345C,earnings,100,50,4/25/2018
694749,earnings,100,50,4/25/2018
69FDFC,executive-appointment,100,54,4/25/2018
6ACFBF,earnings,100,50,4/25/2018
6BDA0C,conference-call,100,50,4/25/2018
6CF43C,earnings,100,50,4/25/2018
6DDA15,earnings,100,50,4/25/2018
6E1E61,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6E7060,earnings,100,50,4/25/2018
6EB9DA,dividend-up,100,56,4/25/2018
6EB9DA,executive-appointment,100,54,4/25/2018
6F0A63,executive-resignation,100,44,4/25/2018
6F0A63,earnings,100,50,4/25/2018
713810,product-release,100,64,4/25/2018
728737,earnings,100,50,4/25/2018
729368,earnings,100,50,4/25/2018
72EF75,earnings,100,50,4/25/2018
73C521,dividend,100,50,4/25/2018
73C521,executive-appointment,100,54,4/25/2018
7448A3,earnings,100,50,4/25/2018
746373,earnings,100,50,4/25/2018
746373,earnings,100,50,4/25/2018
76B926,dividend,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
771985,earnings,100,50,4/25/2018
78F9ED,conference-call,100,50,4/25/2018
791D59,conference-participant,100,50,4/25/2018
791EC1,conference-call,100,50,4/25/2018
7A2A49,executive-appointment,100,54,4/25/2018
7A5097,conference-call,100,50,4/25/2018
7AB859,earnings,100,50,4/25/2018
7AB859,earnings,100,50,4/25/2018
7AB859,earnings,100,50,4/25/2018
7AB859,earnings,100,50,4/25/2018
7AB859,earnings,100,50,4/25/2018
7AC86E,earnings-up,100,68,4/25/2018
7AC86E,earnings,100,50,4/25/2018
7B0BA6,conference-organizer,100,57,4/25/2018
7B9AFA,revenue-up,100,58,4/25/2018
7B9AFA,revenue-up,100,58,4/25/2018
7BC92D,business-contract,100,69,4/25/2018
7DA412,earnings,100,50,4/25/2018
7DA412,executive-resignation,100,44,4/25/2018
7E62B5,earnings,100,50,4/25/2018
804708,executive-appointment,100,54,4/25/2018
8.10E+205,earnings-guidance,100,50,4/25/2018
830BDB,earnings,100,50,4/25/2018
83598E,dividend,100,50,4/25/2018
83598E,earnings,100,50,4/25/2018
838ADD,earnings,100,50,4/25/2018
838ADD,earnings,100,50,4/25/2018
838ADD,earnings,100,50,4/25/2018
838ADD,earnings,100,50,4/25/2018
838ADD,earnings,100,50,4/25/2018
84920B,earnings,100,50,4/25/2018
855DF7,conference-call,100,50,4/25/2018
860AB6,dividend,100,50,4/25/2018
860AB6,dividend,100,50,4/25/2018
8665BA,earnings,100,50,4/25/2018
877734,conference-call,100,50,4/25/2018
896771,earnings,100,50,4/25/2018
89FBB1,product-release,100,64,4/25/2018
8B1E11,earnings,100,50,4/25/2018
8C1238,earnings,100,50,4/25/2018
8C1238,earnings,100,50,4/25/2018
8C1238,earnings,100,50,4/25/2018
8C1238,earnings,100,50,4/25/2018
8C1238,earnings,100,50,4/25/2018
8E4250,earnings,100,50,4/25/2018
8E93A4,dividend,100,50,4/25/2018
8FF2EF,conference-call,100,50,4/25/2018
922F0C,earnings-per-share-up,100,74,4/25/2018
93D207,earnings,100,50,4/25/2018
942165,dividend-up,100,81,4/25/2018
94637C,regulatory-product-approval-granted,100,81,4/25/2018
96F126,dividend,100,50,4/25/2018
972356,earnings,100,50,4/25/2018
972356,earnings,100,50,4/25/2018
972356,earnings,100,50,4/25/2018
972356,earnings,100,50,4/25/2018
9.92E+94,earnings,100,50,4/25/2018
9.92E+94,earnings,100,50,4/25/2018
9.92E+94,earnings,100,50,4/25/2018
99ACAD,dividend,100,50,4/25/2018
9B0C9C,earnings-up,100,68,4/25/2018
9F37C5,dividend,100,50,4/25/2018
9F37C5,earnings,100,50,4/25/2018
9F6B1A,earnings-up,100,68,4/25/2018
A15C71,facility-upgrade,100,65,4/25/2018
A1EAC8,executive-appointment,100,54,4/25/2018
A2CAF7,earnings,100,50,4/25/2018
A350C1,operating-earnings,100,50,4/25/2018
A350C1,operating-earnings,100,50,4/25/2018
A350C1,operating-earnings,100,50,4/25/2018
A350C1,operating-earnings,100,50,4/25/2018
A350C1,operating-earnings,100,50,4/25/2018
A350C1,operating-earnings,100,50,4/25/2018
A429A5,earnings-positive,100,69,4/25/2018
A43906,dividend,100,50,4/25/2018
A4CD53,earnings,100,50,4/25/2018
A63820,earnings-per-share-up,100,74,4/25/2018
A63820,earnings-per-share,100,50,4/25/2018
A666C8,earnings,100,50,4/25/2018
A666C8,earnings,100,50,4/25/2018
A666C8,earnings,100,50,4/25/2018
A7102F,conference-participant,100,50,4/25/2018
A8B137,dividend,100,50,4/25/2018
A99576,earnings,100,50,4/25/2018
AA1EAA,earnings,100,50,4/25/2018
AA847A,earnings,100,50,4/25/2018
AADE0B,dividend,100,50,4/25/2018
ABBAD1,earnings,100,50,4/25/2018
AC7C4F,business-contract,100,69,4/25/2018
AD23DE,earnings,100,50,4/25/2018
AD23DE,earnings,100,50,4/25/2018
AD23DE,earnings,100,50,4/25/2018
AD23DE,earnings,100,50,4/25/2018
AD23DE,earnings,100,50,4/25/2018
AD3008,earnings,100,50,4/25/2018
AD3C93,earnings,100,50,4/25/2018
ADF092,partnership,100,61,4/25/2018
ADF092,partnership,100,61,4/25/2018
AFEC35,earnings,100,50,4/25/2018
AFEC35,executive-appointment,100,54,4/25/2018
B08C51,executive-resignation,100,44,4/25/2018
B48FC9,earnings,100,50,4/25/2018
B4C673,dividend,100,50,4/25/2018
B66928,earnings,100,50,4/25/2018
BAAA60,earnings,100,50,4/25/2018
BB07E4,earnings,100,50,4/25/2018
BB88B6,earnings,100,50,4/25/2018
BBAE2A,acquisition-acquirer,100,49,4/25/2018
BBAE2A,earnings,100,50,4/25/2018
BC3AD2,earnings,100,50,4/25/2018
BC3AD2,earnings,100,50,4/25/2018
BC3AD2,earnings,100,50,4/25/2018
BC3AD2,earnings,100,50,4/25/2018
BC3AD2,earnings,100,50,4/25/2018
BC3AD2,earnings,100,50,4/25/2018
BC3AD2,earnings,100,50,4/25/2018
BC4876,dividend,100,50,4/25/2018
BFCACF,earnings,100,50,4/25/2018
BFE02C,conference-participant,100,50,4/25/2018
C05839,earnings,100,50,4/25/2018
C05839,earnings,100,50,4/25/2018
C05839,earnings,100,50,4/25/2018
C05839,earnings,100,50,4/25/2018
C16A8F,executive-appointment,100,54,4/25/2018
C2609A,dividend,100,50,4/25/2018
C65004,earnings,100,50,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,acquisition-interest-acquirer,100,46,4/25/2018
C83B88,earnings,100,50,4/25/2018
C83B88,earnings,100,50,4/25/2018
C83B88,earnings,100,50,4/25/2018
C83B88,earnings,100,50,4/25/2018
C83B88,earnings,100,50,4/25/2018
C8923A,earnings,100,50,4/25/2018
C8923A,regulatory-product-approval-granted,100,81,4/25/2018
C8A248,dividend,100,50,4/25/2018
C97B2D,earnings,100,50,4/25/2018
C9B932,earnings,100,50,4/25/2018
C9B932,earnings,100,50,4/25/2018
CB88B3,earnings,100,50,4/25/2018
CBA33B,earnings,100,50,4/25/2018
CBBFBF,dividend-up,100,70,4/25/2018
CBBFBF,dividend-up,100,70,4/25/2018
CC0C78,earnings,100,50,4/25/2018
CC35BE,earnings,100,50,4/25/2018
CC8F6E,legal-issues-defendant,100,22,4/25/2018
CCB623,partnership,100,61,4/25/2018
CD4DA8,earnings-up,100,68,4/25/2018
CD4DA8,earnings,100,50,4/25/2018
CD4DA8,earnings,100,50,4/25/2018
CD4DA8,earnings,100,50,4/25/2018
CD4DA8,earnings,100,50,4/25/2018
CD4DA8,earnings,100,50,4/25/2018
CD4DA8,earnings,100,50,4/25/2018
CD4DA8,earnings,100,50,4/25/2018
CDC817,earnings,100,50,4/25/2018
CE5664,product-release,100,64,4/25/2018
CFF15D,earnings,100,50,4/25/2018
CFF15D,earnings,100,50,4/25/2018
D17F7E,earnings,100,50,4/25/2018
D17F7E,earnings,100,50,4/25/2018
D17F7E,earnings,100,50,4/25/2018
D17F7E,earnings,100,50,4/25/2018
D17F7E,earnings,100,50,4/25/2018
D1C26F,partnership,100,61,4/25/2018
D3CEDF,regulatory-investigation,100,22,4/25/2018
D3CEDF,legal-issues-defendant,100,22,4/25/2018
D501DC,earnings,100,50,4/25/2018
D54E62,dividend,100,50,4/25/2018
D58A11,earnings,100,50,4/25/2018
D58A11,earnings,100,50,4/25/2018
D58A11,earnings,100,50,4/25/2018
D5A350,earnings,100,50,4/25/2018
D6489C,executive-appointment,100,54,4/25/2018
D6EAA3,dividend,100,50,4/25/2018
D6EAA3,award,100,58,4/25/2018
D7A953,earnings,100,50,4/25/2018
DB396B,earnings,100,50,4/25/2018
DB396B,earnings,100,50,4/25/2018
DB396B,dividend,100,50,4/25/2018
DB5CA5,executive-appointment,100,54,4/25/2018
DC0998,earnings,100,50,4/25/2018
DC0998,earnings,100,50,4/25/2018
DC0998,earnings,100,50,4/25/2018
DC0998,earnings,100,50,4/25/2018
DCD97F,earnings,100,50,4/25/2018
DD7A96,earnings,100,50,4/25/2018
DE20DF,dividend,100,50,4/25/2018
E00373,earnings,100,50,4/25/2018
E00373,acquisition-acquirer,100,49,4/25/2018
E0339F,dividend,100,50,4/25/2018
E07573,dividend,100,50,4/25/2018
E09997,conference-call,100,50,4/25/2018
E15736,conference-call,100,50,4/25/2018
E40FB6,earnings,100,50,4/25/2018
E40FB6,earnings,100,50,4/25/2018
E40FB6,earnings,100,50,4/25/2018
E40FB6,earnings,100,50,4/25/2018
E5D914,earnings,100,50,4/25/2018
E5D914,earnings,100,50,4/25/2018
E68C3D,facility-open,100,65,4/25/2018
E70531,dividend,100,50,4/25/2018
E829E8,earnings-per-share-positive,100,69,4/25/2018
E8B21D,dividend-up,100,81,4/25/2018
E99180,earnings,100,50,4/25/2018
ECA300,business-contract,100,69,4/25/2018
ECDEB2,executive-appointment,100,54,4/25/2018
ED2A5E,conference-call,100,50,4/25/2018
ED2EFD,dividend,100,50,4/25/2018
ED79D9,conference-call,100,50,4/25/2018
ED9576,earnings,100,50,4/25/2018
F0027C,patient-enrollment-complete,100,64,4/25/2018
F02D0A,dividend,100,50,4/25/2018
F0B877,earnings,100,50,4/25/2018
F11638,earnings,100,50,4/25/2018
F18844,executive-appointment,100,54,4/25/2018
F1CD47,earnings,100,50,4/25/2018
F3016C,note-sale,100,52,4/25/2018
F30508,partnership,100,61,4/25/2018
F31B13,dividend-up,100,74,4/25/2018
F4E882,patent-infringement-defendant,100,26,4/25/2018
F4E882,patent-infringement-defendant,100,26,4/25/2018
F4E882,patent-infringement-defendant,100,26,4/25/2018
F50BAB,earnings,100,50,4/25/2018
F50BAB,earnings,100,50,4/25/2018
F50BAB,earnings,100,50,4/25/2018
F50BAB,earnings,100,50,4/25/2018
F5349B,award,100,58,4/25/2018
F72E4B,earnings,100,50,4/25/2018
F72E4B,earnings,100,50,4/25/2018
F72E4B,earnings,100,50,4/25/2018
F72E4B,earnings,100,50,4/25/2018
F7902B,earnings,100,50,4/25/2018
F7902B,earnings,100,50,4/25/2018
F8C5D7,legal-issues-defendant,100,22,4/25/2018
F90EE5,earnings,100,50,4/25/2018
FA918D,executive-appointment,100,54,4/25/2018
FA918D,dividend,100,50,4/25/2018
FC1B7B,earnings,100,50,4/25/2018
FD4E8D,revenues,100,50,4/25/2018
FD4E8D,earnings,100,50,4/25/2018
FDC7E6,earnings,100,50,4/25/2018
FDC7E6,dividend,100,50,4/25/2018
FE1A1D,operating-earnings,100,50,4/25/2018
FEE4B0,dividend,100,50,4/25/2018
FFCD0E,revenue-up,100,70,4/25/2018
00FC70,conference-call,100,50,4/26/2018
13528,earnings,100,50,4/26/2018
01478A,earnings,100,50,4/26/2018
0157B1,revenue-up,100,78,4/26/2018
0157B1,revenue-up,100,78,4/26/2018
0157B1,revenue-up,100,78,4/26/2018
0157B1,revenue-up,100,78,4/26/2018
0157B1,revenue-up,100,78,4/26/2018
0157B1,revenue-up,100,78,4/26/2018
01D03F,partnership,100,61,4/26/2018
0358AF,revenue-up,100,69,4/26/2018
03D5F9,earnings,100,50,4/26/2018
03FB17,earnings,100,50,4/26/2018
51332,dividend,100,50,4/26/2018
0560D8,dividend,100,50,4/26/2018
61366,earnings,100,50,4/26/2018
061A3B,earnings,100,50,4/26/2018
061A3B,earnings,100,50,4/26/2018
061A3B,earnings,100,50,4/26/2018
07CA6A,earnings,100,50,4/26/2018
083F72,conference-call,100,50,4/26/2018
08A40F,executive-appointment,100,54,4/26/2018
099C88,earnings,100,50,4/26/2018
099C88,earnings,100,50,4/26/2018
0B2071,earnings,100,50,4/26/2018
0B400D,earnings-guidance,100,50,4/26/2018
0B9E6F,earnings,100,50,4/26/2018
0BC853,earnings,100,50,4/26/2018
0BD4E8,business-contract,100,69,4/26/2018
0C2A0D,award,100,58,4/26/2018
0C2A0D,dividend-guidance,100,50,4/26/2018
0DC050,earnings,100,50,4/26/2018
0DC050,earnings,100,50,4/26/2018
0DC050,earnings,100,50,4/26/2018
0E499E,earnings,100,50,4/26/2018
0EC508,earnings,100,50,4/26/2018
0ED415,earnings,100,50,4/26/2018
0ED415,earnings,100,50,4/26/2018
0ED415,earnings,100,50,4/26/2018
0F04E5,earnings,100,50,4/26/2018
0F04E5,earnings,100,50,4/26/2018
0F04E5,earnings,100,50,4/26/2018
0F04E5,earnings,100,50,4/26/2018
0F91FC,earnings,100,50,4/26/2018
105D00,dividend-up,100,81,4/26/2018
106394,executive-appointment,100,54,4/26/2018
1065BC,earnings,100,50,4/26/2018
1151F4,earnings,100,50,4/26/2018
1151F4,earnings,100,50,4/26/2018
1151F4,earnings,100,50,4/26/2018
1151F4,earnings,100,50,4/26/2018
1151F4,earnings,100,50,4/26/2018
1151F4,earnings,100,50,4/26/2018
1151F4,earnings,100,50,4/26/2018
129DC8,earnings,100,50,4/26/2018
129DC8,earnings,100,50,4/26/2018
129DC8,earnings,100,50,4/26/2018
13C3E0,earnings-positive,100,69,4/26/2018
14391F,ipo-pricing,100,50,4/26/2018
1490F3,earnings,100,50,4/26/2018
1490F3,earnings,100,50,4/26/2018
1490F3,earnings,100,50,4/26/2018
1490F3,earnings,100,50,4/26/2018
1490F3,earnings,100,50,4/26/2018
1490F3,earnings,100,50,4/26/2018
152AB9,conference-call,100,50,4/26/2018
159AE4,earnings,100,50,4/26/2018
159AE4,earnings,100,50,4/26/2018
159AE4,earnings,100,50,4/26/2018
159AE4,earnings,100,50,4/26/2018
1.79E+10,dividend,100,50,4/26/2018
1.79E+10,earnings,100,50,4/26/2018
182B8C,earnings,100,50,4/26/2018
184866,earnings,100,50,4/26/2018
197019,dividend,100,50,4/26/2018
197019,acquisition-interest-acquiree,100,82,4/26/2018
1AF7E2,earnings,100,50,4/26/2018
1AF7E2,earnings,100,50,4/26/2018
1C599A,earnings,100,50,4/26/2018
1DE526,earnings,100,50,4/26/2018
1E68B3,earnings,100,50,4/26/2018
1F9258,award,100,58,4/26/2018
1FAF22,earnings,100,50,4/26/2018
1FAF22,earnings,100,50,4/26/2018
1FAF22,earnings,100,50,4/26/2018
1FAF22,earnings,100,50,4/26/2018
1FC422,earnings,100,50,4/26/2018
200D8B,buybacks,100,74,4/26/2018
2082EA,conference-call,100,50,4/26/2018
20DC4E,earnings,100,50,4/26/2018
21DED4,revenues,100,50,4/26/2018
21DED4,revenues,100,50,4/26/2018
21DED4,revenues,100,50,4/26/2018
21DED4,revenues,100,50,4/26/2018
21DED4,revenues,100,50,4/26/2018
21DED4,revenues,100,50,4/26/2018
227F04,conference-participant,100,50,4/26/2018
22C58E,earnings,100,50,4/26/2018
24D81E,earnings,100,50,4/26/2018
250BEE,asset-sale,100,62,4/26/2018
253B2F,conference-call,100,50,4/26/2018
25529C,earnings,100,50,4/26/2018
26FA41,earnings,100,50,4/26/2018
2720AB,ipo,100,71,4/26/2018
272472,earnings,100,50,4/26/2018
272704,dividend,100,50,4/26/2018
284289,earnings,100,50,4/26/2018
29B702,earnings,100,50,4/26/2018
2.90E+62,executive-appointment,100,54,4/26/2018
2A4131,earnings,100,50,4/26/2018
2AA6A8,conference-call,100,50,4/26/2018
2BA977,earnings,100,50,4/26/2018
2BA977,earnings,100,50,4/26/2018
2BA977,earnings,100,50,4/26/2018
2BA977,earnings,100,50,4/26/2018
2BA977,earnings,100,50,4/26/2018
2BA977,earnings,100,50,4/26/2018
2CA60F,partnership,100,61,4/26/2018
2DA92D,earnings,100,50,4/26/2018
2EB88B,earnings-above-expectations,100,88,4/26/2018
2EB88B,earnings,100,50,4/26/2018
2EB88B,earnings,100,50,4/26/2018
2EB88B,earnings,100,50,4/26/2018
2EB88B,earnings,100,50,4/26/2018
2EB88B,earnings,100,50,4/26/2018
301493,conference-call,100,50,4/26/2018
314D88,public-offering,100,43,4/26/2018
319BE2,dividend-up,100,81,4/26/2018
319BE2,earnings,100,50,4/26/2018
31AA84,earnings,100,50,4/26/2018
328250,earnings,100,50,4/26/2018
3390DE,earnings,100,50,4/26/2018
34E9F9,earnings,100,50,4/26/2018
34E9F9,earnings,100,50,4/26/2018
34E9F9,earnings,100,50,4/26/2018
34E9F9,earnings,100,50,4/26/2018
35AE32,earnings,100,50,4/26/2018
36529A,regulatory-product-approval-granted,100,81,4/26/2018
366A08,earnings,100,50,4/26/2018
366A08,earnings,100,50,4/26/2018
366A08,earnings,100,50,4/26/2018
366A08,earnings,100,50,4/26/2018
366A08,earnings,100,50,4/26/2018
366A08,earnings,100,50,4/26/2018
366A08,earnings,100,50,4/26/2018
366A08,earnings,100,50,4/26/2018
371C01,earnings,100,50,4/26/2018
371C01,earnings,100,50,4/26/2018
373B06,dividend,100,50,4/26/2018
384CD3,conference-participant,100,50,4/26/2018
389CFB,conference-call,100,50,4/26/2018
39692D,earnings,100,50,4/26/2018
39BFF6,dividend,100,50,4/26/2018
3A113F,conference-participant,100,50,4/26/2018
3A94DF,earnings,100,50,4/26/2018
3B20AB,earnings,100,50,4/26/2018
3B2311,earnings,100,50,4/26/2018
3B8484,earnings,100,50,4/26/2018
3BB616,earnings,100,50,4/26/2018
3BB616,earnings,100,50,4/26/2018
3BB616,earnings,100,50,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3CBA2A,earnings-up,100,68,4/26/2018
3E15F6,earnings,100,50,4/26/2018
3E15F6,earnings,100,50,4/26/2018
3E15F6,earnings,100,50,4/26/2018
3E15F6,earnings,100,50,4/26/2018
3F868D,earnings,100,50,4/26/2018
408089,partnership,100,61,4/26/2018
434F38,earnings,100,50,4/26/2018
43A060,earnings,100,50,4/26/2018
43A74A,acquisition-completed-acquirer,100,49,4/26/2018
449217,earnings-positive,100,69,4/26/2018
449217,earnings,100,50,4/26/2018
449217,earnings,100,50,4/26/2018
449217,earnings,100,50,4/26/2018
44A4FC,reorganization,100,53,4/26/2018
44DDBD,earnings,100,50,4/26/2018
4591D3,conference-participant,100,50,4/26/2018
45ABCC,earnings,100,50,4/26/2018
46CF27,earnings,100,50,4/26/2018
46CF27,earnings,100,50,4/26/2018
46CF27,earnings,100,50,4/26/2018
46CF27,earnings,100,50,4/26/2018
46CF27,earnings,100,50,4/26/2018
46CF27,earnings,100,50,4/26/2018
46CF27,earnings,100,50,4/26/2018
479930,earnings,100,50,4/26/2018
4806CE,acquisition-interest-acquirer,100,46,4/26/2018
4806CE,earnings,100,50,4/26/2018
4885C8,earnings,100,50,4/26/2018
490D4B,executive-resignation,100,44,4/26/2018
4A3438,conference-call,100,50,4/26/2018
4A6F00,partnership,100,61,4/26/2018
4A6F00,partnership,100,61,4/26/2018
4A6F00,partnership,100,61,4/26/2018
4BBA23,operating-earnings,100,50,4/26/2018
4C1FA1,earnings,100,50,4/26/2018
4C1FA1,earnings,100,50,4/26/2018
4C1FA1,earnings,100,50,4/26/2018
4C1FA1,earnings,100,50,4/26/2018
4C1FA1,earnings,100,50,4/26/2018
4C6C63,dividend,100,50,4/26/2018
4D371E,dividend,100,50,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4D7BD8,earnings-per-share-positive,100,69,4/26/2018
4DD203,conference-call,100,50,4/26/2018
4E2D94,earnings,100,50,4/26/2018
4E2D94,dividend,100,50,4/26/2018
4E913D,earnings,100,50,4/26/2018
4EE167,earnings,100,50,4/26/2018
4EE167,earnings,100,50,4/26/2018
507AE7,earnings,100,50,4/26/2018
51888A,dividend,100,50,4/26/2018
519FE0,earnings,100,50,4/26/2018
52015A,earnings,100,50,4/26/2018
545272,acquisition-acquirer,100,49,4/26/2018
553949,executive-appointment,100,54,4/26/2018
55438C,business-contract,100,69,4/26/2018
55438C,business-contract,100,69,4/26/2018
55438C,product-release,100,64,4/26/2018
5546DA,earnings,100,50,4/26/2018
55C9B5,partnership,100,61,4/26/2018
56277A,earnings,100,50,4/26/2018
567F3D,earnings,100,50,4/26/2018
567F3D,earnings,100,50,4/26/2018
567F3D,earnings,100,50,4/26/2018
57356F,earnings,100,50,4/26/2018
57356F,earnings,100,50,4/26/2018
57356F,earnings,100,50,4/26/2018
57CAAB,earnings,100,50,4/26/2018
57F3DA,earnings,100,50,4/26/2018
57F3DA,earnings,100,50,4/26/2018
586BD7,conference-call,100,50,4/26/2018
586FFD,revenues,100,50,4/26/2018
586FFD,revenues,100,50,4/26/2018
589F5A,earnings,100,50,4/26/2018
58B46F,board-meeting,100,51,4/26/2018
58B46F,dividend,100,50,4/26/2018
596116,earnings,100,50,4/26/2018
59B229,earnings,100,50,4/26/2018
59B229,earnings,100,50,4/26/2018
59B229,earnings,100,50,4/26/2018
59B229,earnings,100,50,4/26/2018
5A423F,earnings,100,50,4/26/2018
5A64D5,earnings,100,50,4/26/2018
5B35C7,earnings,100,50,4/26/2018
5B3FA2,partnership,100,61,4/26/2018
5B6C11,earnings,100,50,4/26/2018
5BFE94,dividend,100,50,4/26/2018
5C8D61,earnings,100,50,4/26/2018
5C8D61,earnings,100,50,4/26/2018
5C8D61,earnings,100,50,4/26/2018
5D02B7,earnings,100,50,4/26/2018
5D0337,earnings,100,50,4/26/2018
5D16CF,earnings,100,50,4/26/2018
5D87DF,earnings,100,50,4/26/2018
5DA8B3,earnings,100,50,4/26/2018
5DD486,earnings-up,100,68,4/26/2018
5DD486,earnings,100,50,4/26/2018
5DD48B,earnings,100,50,4/26/2018
5DD48B,earnings,100,50,4/26/2018
5FE4B6,earnings,100,50,4/26/2018
5FE4B6,earnings,100,50,4/26/2018
60EA12,dividend,100,50,4/26/2018
60EA12,earnings-up,100,68,4/26/2018
60EA12,earnings,100,50,4/26/2018
619882,conference-organizer,100,57,4/26/2018
622037,dividend,100,50,4/26/2018
6284B5,earnings,100,50,4/26/2018
62EFEE,earnings-up,100,68,4/26/2018
63E8D5,earnings,100,50,4/26/2018
63E8D5,earnings,100,50,4/26/2018
641F17,earnings,100,50,4/26/2018
641F17,earnings,100,50,4/26/2018
641F17,earnings,100,50,4/26/2018
641F17,earnings,100,50,4/26/2018
641F17,earnings,100,50,4/26/2018
64636E,earnings,100,50,4/26/2018
65CF8E,earnings,100,50,4/26/2018
662682,dividend-up,100,81,4/26/2018
665D7D,earnings,100,50,4/26/2018
66E04A,earnings,100,50,4/26/2018
66E04A,earnings,100,50,4/26/2018
66E04A,earnings,100,50,4/26/2018
66E04A,earnings,100,50,4/26/2018
66E04A,earnings,100,50,4/26/2018
66E04A,earnings,100,50,4/26/2018
66E04A,earnings,100,50,4/26/2018
66E3C0,revenue-up,100,74,4/26/2018
66E3C0,revenue-up,100,74,4/26/2018
67A658,dividend,100,50,4/26/2018
67A658,dividend,100,50,4/26/2018
68586A,conference-call,100,50,4/26/2018
69C99E,clinical-trials-positive,100,87,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
69E8E1,earnings,100,50,4/26/2018
6A961B,earnings,100,50,4/26/2018
6B0784,conference-call,100,50,4/26/2018
6B5379,earnings,100,50,4/26/2018
6B5379,earnings,100,50,4/26/2018
6B5379,earnings,100,50,4/26/2018
6B67BD,earnings,100,50,4/26/2018
6C987C,dividend-up,100,67,4/26/2018
6CC55E,conference-participant,100,50,4/26/2018
6CDFC6,earnings,100,50,4/26/2018
6DC1D7,earnings,100,50,4/26/2018
6.00E+19,conference-call,100,50,4/26/2018
6E8349,earnings,100,50,4/26/2018
6EB9DA,donation,100,54,4/26/2018
713810,business-contract,100,69,4/26/2018
719477,conference-participant,100,50,4/26/2018
726DDF,legal-issues-defendant,100,22,4/26/2018
72CB93,earnings,100,50,4/26/2018
72F0FC,executive-appointment,100,54,4/26/2018
73529F,earnings,100,50,4/26/2018
735388,earnings,100,50,4/26/2018
73BCBA,product-release,100,64,4/26/2018
73BCBA,earnings,100,50,4/26/2018
73BCBA,earnings,100,50,4/26/2018
73BCBA,earnings,100,50,4/26/2018
73C9E2,earnings,100,50,4/26/2018
742AAB,conference-call,100,50,4/26/2018
747219,conference-participant,100,50,4/26/2018
762A3E,earnings-up,100,68,4/26/2018
762A3E,dividend,100,50,4/26/2018
763724,conference-call,100,50,4/26/2018
769F40,earnings,100,50,4/26/2018
76CEFB,earnings,100,50,4/26/2018
782B46,earnings,100,50,4/26/2018
782B46,dividend,100,50,4/26/2018
782B46,buybacks,100,74,4/26/2018
79167B,earnings,100,50,4/26/2018
79167B,earnings,100,50,4/26/2018
79167B,earnings,100,50,4/26/2018
791D59,revenues,100,50,4/26/2018
791D59,revenues,100,50,4/26/2018
791D59,revenues,100,50,4/26/2018
791D59,revenues,100,50,4/26/2018
791D59,revenues,100,50,4/26/2018
791D59,revenues,100,50,4/26/2018
7B1E50,executive-appointment,100,54,4/26/2018
7B4B91,earnings,100,50,4/26/2018
7BAAE7,earnings-per-share-positive,100,69,4/26/2018
7BAAE7,earnings,100,50,4/26/2018
7C75FD,dividend,100,50,4/26/2018
7D5384,earnings,100,50,4/26/2018
7D5384,earnings,100,50,4/26/2018
7D5384,earnings,100,50,4/26/2018
7D5384,earnings,100,50,4/26/2018
7DD584,earnings,100,50,4/26/2018
7E0EB0,earnings,100,50,4/26/2018
7FC386,earnings,100,50,4/26/2018
7FD8B9,conference-call,100,50,4/26/2018
80D744,earnings,100,50,4/26/2018
81222C,conference-participant,100,50,4/26/2018
81A88D,earnings,100,50,4/26/2018
8.22E+27,earnings,100,50,4/26/2018
8303CD,earnings,100,50,4/26/2018
837C04,earnings,100,50,4/26/2018
837C04,dividend-up,100,81,4/26/2018
86478F,earnings,100,50,4/26/2018
8665BA,product-release,100,64,4/26/2018
86BAC7,earnings,100,50,4/26/2018
86F123,conference-call,100,50,4/26/2018
87486A,conference-call,100,50,4/26/2018
8817D5,earnings-up,100,68,4/26/2018
8A0368,conference-call,100,50,4/26/2018
8AC740,conference-call,100,50,4/26/2018
8B3B0E,earnings,100,50,4/26/2018
8BAA15,earnings,100,50,4/26/2018
8BAA15,earnings,100,50,4/26/2018
8D5145,earnings,100,50,4/26/2018
8DAAB9,earnings-up,100,68,4/26/2018
8DE56F,earnings,100,50,4/26/2018
8DE56F,earnings,100,50,4/26/2018
8DE74B,earnings,100,50,4/26/2018
8E0E32,earnings,100,50,4/26/2018
8E0E32,earnings,100,50,4/26/2018
8E0E32,earnings,100,50,4/26/2018
8E10BF,board-meeting,100,51,4/26/2018
8E8E6E,earnings,100,50,4/26/2018
8F3231,earnings,100,50,4/26/2018
902255,earnings,100,50,4/26/2018
902670,dividend,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
911AB8,earnings,100,50,4/26/2018
934029,earnings,100,50,4/26/2018
93C130,earnings,100,50,4/26/2018
93C130,dividend,100,50,4/26/2018
94208D,ipo-pricing,100,50,4/26/2018
943239,earnings,100,50,4/26/2018
94563D,earnings,100,50,4/26/2018
94563D,earnings,100,50,4/26/2018
94563D,earnings,100,50,4/26/2018
94563D,earnings,100,50,4/26/2018
94563D,earnings,100,50,4/26/2018
94637C,earnings,100,50,4/26/2018
94637C,partnership,100,61,4/26/2018
94637C,earnings,100,50,4/26/2018
94756D,conference-participant,100,50,4/26/2018
947B0B,earnings,100,50,4/26/2018
94983E,executive-appointment,100,54,4/26/2018
949D62,earnings,100,50,4/26/2018
958938,public-offering,100,43,4/26/2018
9673BD,conference-call,100,50,4/26/2018
979451,earnings,100,50,4/26/2018
9810C0,earnings,100,50,4/26/2018
98D33E,dividend,100,50,4/26/2018
990AD0,earnings,100,50,4/26/2018
9934AD,earnings,100,50,4/26/2018
9.97E+09,earnings,100,50,4/26/2018
99ACAD,business-contract,100,69,4/26/2018
9B5968,earnings,100,50,4/26/2018
9B5968,earnings,100,50,4/26/2018
9BB35A,trading-listing,100,61,4/26/2018
9C25FF,partnership,100,61,4/26/2018
9CDA4F,earnings,100,50,4/26/2018
9CF9B1,earnings,100,50,4/26/2018
9D307D,earnings,100,50,4/26/2018
9D4EC7,revenue-up,100,57,4/26/2018
9D4EC7,revenue-up,100,57,4/26/2018
9D4EC7,revenue-up,100,57,4/26/2018
9E298A,earnings,100,50,4/26/2018
9E298A,earnings,100,50,4/26/2018
9E298A,earnings,100,50,4/26/2018
9EED50,earnings,100,50,4/26/2018
9F03CF,earnings,100,50,4/26/2018
9F03CF,earnings,100,50,4/26/2018
9F03CF,earnings,100,50,4/26/2018
9F03CF,earnings,100,50,4/26/2018
9F03CF,earnings,100,50,4/26/2018
9F5CBB,conference-call,100,50,4/26/2018
A02FB1,earnings,100,50,4/26/2018
A16DEA,market-entry,100,57,4/26/2018
A1A317,earnings-per-share-positive,100,69,4/26/2018
A204A7,ipo-pricing,100,50,4/26/2018
A247F5,earnings-per-share-positive,100,69,4/26/2018
A247F5,earnings-per-share-positive,100,69,4/26/2018
A247F5,earnings-per-share-positive,100,69,4/26/2018
A3800A,legal-issues-defendant,100,22,4/26/2018
A398B9,earnings,100,50,4/26/2018
A398B9,earnings,100,50,4/26/2018
A398B9,earnings,100,50,4/26/2018
A4386C,dividend,100,50,4/26/2018
A5151E,earnings,100,50,4/26/2018
A5195E,earnings,100,50,4/26/2018
A5B913,earnings,100,50,4/26/2018
A5B913,earnings,100,50,4/26/2018
A5B913,earnings,100,50,4/26/2018
A6828A,dividend-up,100,81,4/26/2018
A75D43,earnings,100,50,4/26/2018
A7CCF0,earnings,100,50,4/26/2018
A7CCF0,earnings,100,50,4/26/2018
A806FA,executive-appointment,100,54,4/26/2018
A8CBDA,earnings-positive,100,69,4/26/2018
A94637,revenues,100,50,4/26/2018
AA247D,executive-appointment,100,54,4/26/2018
AA3AB8,earnings,100,50,4/26/2018
ABEE43,earnings,100,50,4/26/2018
AC1952,earnings,100,50,4/26/2018
AD375D,earnings,100,50,4/26/2018
AD6141,ipo,100,71,4/26/2018
AFD1CA,earnings,100,50,4/26/2018
B076A1,conference-call,100,50,4/26/2018
B08954,earnings,100,50,4/26/2018
B106FA,earnings,100,50,4/26/2018
B1B10C,earnings,100,50,4/26/2018
B1B10C,earnings,100,50,4/26/2018
B1B10C,earnings,100,50,4/26/2018
B53C12,conference-call,100,50,4/26/2018
B619CB,earnings-positive,100,69,4/26/2018
B6CD92,earnings,100,50,4/26/2018
BAAA60,dividend,100,50,4/26/2018
BB02FB,earnings-per-share-positive,100,69,4/26/2018
BB02FB,earnings-per-share,100,50,4/26/2018
BB02FB,earnings-per-share,100,50,4/26/2018
BB02FB,earnings-per-share,100,50,4/26/2018
BBBB41,dividend,100,50,4/26/2018
BD682F,earnings,100,50,4/26/2018
BD8517,earnings,100,50,4/26/2018
BDD12C,public-offering,100,43,4/26/2018
BDEF34,earnings,100,50,4/26/2018
BDEF34,earnings,100,50,4/26/2018
BDEF34,earnings,100,50,4/26/2018
BDEF34,earnings,100,50,4/26/2018
BDEF34,earnings,100,50,4/26/2018
BDEF34,earnings,100,50,4/26/2018
BE14CF,earnings,100,50,4/26/2018
BEB756,earnings,100,50,4/26/2018
BF79F5,earnings,100,50,4/26/2018
BF79F5,earnings,100,50,4/26/2018
BF79F5,earnings,100,50,4/26/2018
C01737,earnings,100,50,4/26/2018
C062D4,dividend,100,50,4/26/2018
C0F70B,product-release,100,64,4/26/2018
C1114B,conference-call,100,50,4/26/2018
C16A8F,dividend,100,50,4/26/2018
C4F567,revenue-up,100,69,4/26/2018
C4F567,revenue-up,100,69,4/26/2018
C4F567,revenue-up,100,69,4/26/2018
C4F567,revenue-up,100,69,4/26/2018
C4F9C6,clinical-trials,100,56,4/26/2018
C5D2AE,earnings,100,50,4/26/2018
C72B8F,earnings,100,50,4/26/2018
C81E00,operating-earnings,100,50,4/26/2018
CB22CD,revenue-up,100,69,4/26/2018
CB22CD,revenue-up,100,69,4/26/2018
CB9E13,conference-call,100,50,4/26/2018
CC176E,earnings,100,50,4/26/2018
CCB623,earnings,100,50,4/26/2018
CDEDFE,earnings,100,50,4/26/2018
CE4E6D,conference-call,100,50,4/26/2018
CE4FD9,conference-call,100,50,4/26/2018
CE4FD9,acquisition-acquirer,100,49,4/26/2018
CE4FD9,earnings,100,50,4/26/2018
CE4FD9,earnings,100,50,4/26/2018
CE4FD9,earnings,100,50,4/26/2018
CE4FD9,earnings,100,50,4/26/2018
CE96E7,earnings,100,50,4/26/2018
CE96E7,earnings,100,50,4/26/2018
CE96E7,earnings,100,50,4/26/2018
CFF15D,partnership,100,61,4/26/2018
CFF97C,earnings,100,50,4/26/2018
CFF97C,earnings,100,50,4/26/2018
CFF97C,earnings,100,50,4/26/2018
CFF97C,earnings,100,50,4/26/2018
CFF97C,analyst-ratings-change-positive-rater,20,50,4/26/2018
D06755,conference-participant,100,50,4/26/2018
D0909F,stake-acquirer,100,48,4/26/2018
D0909F,donation,100,54,4/26/2018
D13F1C,conference-call,100,50,4/26/2018
D15833,dividend,100,50,4/26/2018
D296C6,earnings,100,50,4/26/2018
D33270,business-contract,100,69,4/26/2018
D3CEDF,legal-issues-defendant,100,22,4/26/2018
D4070C,earnings,100,50,4/26/2018
D4AC65,conference-call,100,50,4/26/2018
D518D8,earnings,100,50,4/26/2018
D518D8,earnings,100,50,4/26/2018
D518D8,earnings,100,50,4/26/2018
D518D8,earnings,100,50,4/26/2018
D697DE,earnings,100,50,4/26/2018
D7F569,earnings,100,50,4/26/2018
D8760C,dividend,100,50,4/26/2018
D89753,merger,100,66,4/26/2018
D8F347,earnings-up,100,68,4/26/2018
D8F347,earnings-up,100,68,4/26/2018
D9B1C9,earnings,100,50,4/26/2018
D9B1C9,earnings,100,50,4/26/2018
DA199F,earnings,100,50,4/26/2018
DA48E4,earnings-up,100,68,4/26/2018
DA48E4,earnings,100,50,4/26/2018
DA48E4,earnings,100,50,4/26/2018
DA48E4,earnings,100,50,4/26/2018
DA48E4,earnings,100,50,4/26/2018
DA48E4,earnings,100,50,4/26/2018
DA90E1,earnings,100,50,4/26/2018
DAFED3,earnings-up,100,68,4/26/2018
DAFED3,earnings-up,100,68,4/26/2018
DAFED3,earnings-up,100,68,4/26/2018
DB9F70,conference-participant,100,50,4/26/2018
DBCA3F,earnings,100,50,4/26/2018
DD0099,earnings,100,50,4/26/2018
DDC415,earnings,100,50,4/26/2018
DDC415,earnings,100,50,4/26/2018
DDCB34,dividend,100,50,4/26/2018
DDCB34,earnings,100,50,4/26/2018
DE4924,conference-call,100,50,4/26/2018
DEF058,earnings-up,100,68,4/26/2018
DEF058,earnings,100,50,4/26/2018
DF5F14,public-offering,100,43,4/26/2018
DF6FDD,earnings,100,50,4/26/2018
DF6FDD,earnings,100,50,4/26/2018
DF6FDD,earnings,100,50,4/26/2018
DF6FDD,earnings,100,50,4/26/2018
DF6FDD,earnings,100,50,4/26/2018
DF6FDD,trading-listing,100,61,4/26/2018
E05DC8,earnings,100,50,4/26/2018
E0A84E,facility-open,100,65,4/26/2018
E10D31,dividend,100,50,4/26/2018
E259C7,revenue-up,100,69,4/26/2018
E259C7,revenue-up,100,69,4/26/2018
E259C7,revenue-up,100,69,4/26/2018
E259C7,revenue-up,100,69,4/26/2018
E4CE73,partnership,100,61,4/26/2018
E610CD,ipo-pricing,100,50,4/26/2018
E71AE6,conference-participant,100,50,4/26/2018
E7BF32,earnings,100,50,4/26/2018
E7BF32,earnings,100,50,4/26/2018
E866D2,earnings-positive,100,69,4/26/2018
E866D2,earnings-positive,100,69,4/26/2018
E866D2,earnings-positive,100,69,4/26/2018
E866D2,earnings-positive,100,69,4/26/2018
E866D2,earnings-positive,100,69,4/26/2018
E866D2,earnings-positive,100,69,4/26/2018
E8E899,earnings,100,50,4/26/2018
E94704,dividend,100,50,4/26/2018
EBD89A,earnings,100,50,4/26/2018
ECF4F8,earnings,100,50,4/26/2018
ECF709,earnings,100,50,4/26/2018
ED8676,earnings,100,50,4/26/2018
ED8676,dividend,100,50,4/26/2018
EDF5CA,dividend,100,50,4/26/2018
EE1E44,earnings-up,100,68,4/26/2018
EE1E44,earnings-up,100,68,4/26/2018
EE1E44,earnings-up,100,68,4/26/2018
EE1E44,earnings-up,100,68,4/26/2018
EE6F1C,product-release,100,64,4/26/2018
EEA6B3,dividend,100,50,4/26/2018
EEEA9F,earnings-up,100,68,4/26/2018
EEEA9F,earnings,100,50,4/26/2018
EEEA9F,earnings,100,50,4/26/2018
EEEA9F,earnings,100,50,4/26/2018
EF5914,earnings,100,50,4/26/2018
EF77A3,executive-appointment,100,54,4/26/2018
EF77A3,dividend,100,50,4/26/2018
F0027C,earnings,100,50,4/26/2018
F02170,government-contract,100,69,4/26/2018
F15E41,earnings,100,50,4/26/2018
F15E41,earnings,100,50,4/26/2018
F15E41,earnings,100,50,4/26/2018
F15E41,earnings,100,50,4/26/2018
F1C04C,conference-participant,100,50,4/26/2018
F40EE2,dividend,100,50,4/26/2018
F4D241,earnings,100,50,4/26/2018
F4E882,earnings,100,50,4/26/2018
F793FA,earnings,100,50,4/26/2018
F7FCA4,merger-completed,100,66,4/26/2018
F80389,earnings,100,50,4/26/2018
F88A04,earnings,100,50,4/26/2018
F8C5D7,legal-issues-defendant,100,22,4/26/2018
F8C5D7,legal-issues-defendant,100,22,4/26/2018
F8C5D7,legal-issues-defendant,100,22,4/26/2018
FA918D,earnings,100,50,4/26/2018
FAE021,earnings-per-share-positive,100,69,4/26/2018
FAE021,earnings-per-share-positive,100,69,4/26/2018
FAE021,earnings-per-share-positive,100,69,4/26/2018
FAE021,earnings-per-share-positive,100,69,4/26/2018
FB728F,conference-call,100,50,4/26/2018
FC1F9D,earnings,100,50,4/26/2018
FC80E6,earnings,100,50,4/26/2018
FC9A88,earnings-up,100,68,4/26/2018
FD4BBE,earnings,100,50,4/26/2018
FD4BBE,earnings,100,50,4/26/2018
FD4BBE,earnings,100,50,4/26/2018
FD9526,earnings-guidance-up,100,83,4/26/2018
FE89E0,earnings,100,50,4/26/2018
FF5413,earnings-positive,100,69,4/26/2018
FF5413,earnings-positive,100,69,4/26/2018
0157B1,revenue-up,100,78,4/27/2018
0325B7,conference-call,100,50,4/27/2018
58828,operating-earnings,100,50,4/27/2018
0FDE97,earnings,100,50,4/27/2018
0FDE97,earnings,100,50,4/27/2018
0FDE97,earnings,100,50,4/27/2018
0FDE97,earnings,100,50,4/27/2018
0FDE97,earnings,100,50,4/27/2018
10673F,earnings-up,100,68,4/27/2018
10673F,earnings,100,50,4/27/2018
1279ED,conference-call,100,50,4/27/2018
12E454,product-release,100,64,4/27/2018
138DDE,earnings,100,50,4/27/2018
139303,earnings,100,50,4/27/2018
165B86,acquisition-acquirer,100,49,4/27/2018
19C105,earnings,100,50,4/27/2018
19C105,earnings,100,50,4/27/2018
19C105,earnings,100,50,4/27/2018
19CAC7,executive-appointment,100,54,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1A9DE1,earnings,100,50,4/27/2018
1D3A00,dividend,100,50,4/27/2018
1D5C51,partnership,100,61,4/27/2018
21D903,earnings,100,50,4/27/2018
223216,revenue-up,100,81,4/27/2018
228D42,partnership,100,61,4/27/2018
25102A,exchange-noncompliance-authority,100,50,4/27/2018
251988,board-meeting,100,51,4/27/2018
26DC29,award,100,58,4/27/2018
272472,dividend,100,50,4/27/2018
28DCF3,earnings,100,50,4/27/2018
2B9DBB,earnings,100,50,4/27/2018
2EBA55,conference-call,100,50,4/27/2018
338544,earnings,100,50,4/27/2018
3461CF,earnings,100,50,4/27/2018
3461CF,credit-rating-upgrade-rater,20,50,4/27/2018
3461CF,credit-rating-upgrade-rater,20,50,4/27/2018
34A959,joint-venture,100,62,4/27/2018
34A959,joint-venture,100,62,4/27/2018
34B97A,conference-participant,100,50,4/27/2018
383ADA,earnings,100,50,4/27/2018
3.88E+02,earnings,100,50,4/27/2018
3E39A5,dividend,100,50,4/27/2018
3FACA7,earnings-positive,100,69,4/27/2018
3FACA7,earnings,100,50,4/27/2018
3FACA7,earnings,100,50,4/27/2018
422A82,earnings,100,50,4/27/2018
422A82,earnings,100,50,4/27/2018
422A82,earnings,100,50,4/27/2018
4290EF,dividend,100,50,4/27/2018
44ED36,conference-call,100,50,4/27/2018
458D2C,legal-issues-defendant,100,22,4/27/2018
460C93,earnings,100,50,4/27/2018
47752F,acquisition-completed-acquirer,100,49,4/27/2018
47FCF2,earnings,100,50,4/27/2018
4B5054,earnings,100,50,4/27/2018
4C31F3,conference-call,100,50,4/27/2018
4D971D,ipo,100,71,4/27/2018
54512F,earnings,100,50,4/27/2018
55C9B5,executive-appointment,100,54,4/27/2018
57EF50,dividend,100,50,4/27/2018
587EDF,earnings,100,50,4/27/2018
5BE42C,dividend,100,50,4/27/2018
5D41E4,award,100,58,4/27/2018
5D41E4,award,100,58,4/27/2018
5F2FF7,dividend,100,50,4/27/2018
619882,conference-organizer,100,57,4/27/2018
61E975,dividend,100,50,4/27/2018
636639,earnings,100,50,4/27/2018
636639,earnings,100,50,4/27/2018
636639,earnings,100,50,4/27/2018
6D3B7B,executive-appointment,100,54,4/27/2018
6E705B,ownership-increase-owner,100,56,4/27/2018
6F6559,dividend-up,100,62,4/27/2018
7032D0,earnings,100,50,4/27/2018
72EF75,dividend,100,50,4/27/2018
72F0FC,dividend,100,50,4/27/2018
72F0FC,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,earnings,100,50,4/27/2018
7999F3,business-contract,100,69,4/27/2018
7A0EC4,ipo-pricing,100,50,4/27/2018
7A10FF,executive-appointment,100,54,4/27/2018
8665BA,partnership,100,61,4/27/2018
890FF4,business-contract,100,69,4/27/2018
8A8E41,executive-appointment,100,54,4/27/2018
8B9B3B,clinical-trials,100,56,4/27/2018
8F6995,earnings-guidance,100,50,4/27/2018
900356,earnings-guidance-up,100,83,4/27/2018
911AB8,executive-appointment,100,54,4/27/2018
92D9C9,earnings,100,50,4/27/2018
9.36E+10,executive-appointment,100,54,4/27/2018
9.36E+10,executive-appointment,100,54,4/27/2018
965360,earnings,100,50,4/27/2018
977A1E,earnings,100,50,4/27/2018
9AF3DC,dividend,100,50,4/27/2018
9D6A24,earnings-up,100,68,4/27/2018
9D6A24,earnings,100,50,4/27/2018
9D6A24,earnings,100,50,4/27/2018
9D6A24,earnings,100,50,4/27/2018
9D6A24,earnings,100,50,4/27/2018
A2CA3F,dividend,100,50,4/27/2018
A47F2E,earnings,100,50,4/27/2018
A806FA,dividend,100,50,4/27/2018
A94718,conference-call,100,50,4/27/2018
AFEC35,facility-open,100,65,4/27/2018
B48FC9,product-release,100,64,4/27/2018
BCC55F,conference-participant,100,50,4/27/2018
C230FE,earnings-per-share-positive,100,69,4/27/2018
C230FE,earnings-per-share,100,50,4/27/2018
C4A912,board-meeting,100,51,4/27/2018
C7FC95,partnership,100,61,4/27/2018
CBA33B,award,100,58,4/27/2018
CBCC6A,earnings,100,50,4/27/2018
CBCC6A,earnings,100,50,4/27/2018
CC8F6E,conference-participant,100,50,4/27/2018
CC8F6E,legal-issues-defendant,100,22,4/27/2018
CCBBAD,earnings,100,50,4/27/2018
CD051C,product-release,100,64,4/27/2018
CF351E,earnings,100,50,4/27/2018
CF351E,earnings,100,50,4/27/2018
CFF97C,credit-rating-upgrade-rater,20,50,4/27/2018
D54E62,earnings-positive,100,69,4/27/2018
D54E62,earnings-positive,100,69,4/27/2018
D54E62,earnings-positive,100,69,4/27/2018
D56D6D,award,100,58,4/27/2018
D77F7E,business-contract,100,69,4/27/2018
D77F7E,business-contract,100,69,4/27/2018
D7F569,dividend,100,50,4/27/2018
D854F3,earnings,100,50,4/27/2018
D854F3,executive-appointment,100,54,4/27/2018
D88EF3,earnings,100,50,4/27/2018
D88EF3,earnings,100,50,4/27/2018
D88EF3,earnings,100,50,4/27/2018
D88EF3,earnings,100,50,4/27/2018
D88EF3,earnings,100,50,4/27/2018
D8DBA3,operating-earnings,100,50,4/27/2018
D9164D,dividend,100,50,4/27/2018
DA0A9E,earnings,100,50,4/27/2018
DAFED3,award,100,58,4/27/2018
DBEF02,earnings,100,50,4/27/2018
DBFB51,conference-call,100,50,4/27/2018
E30B34,earnings,100,50,4/27/2018
E70531,earnings-up,100,66,4/27/2018
E70531,earnings-up,100,66,4/27/2018
E70531,earnings-up,100,66,4/27/2018
E70531,earnings-up,100,66,4/27/2018
EB6965,earnings,100,50,4/27/2018
EB6965,earnings,100,50,4/27/2018
EB6965,earnings,100,50,4/27/2018
EB6965,earnings,100,50,4/27/2018
EB6965,earnings,100,50,4/27/2018
EB6965,earnings,100,50,4/27/2018
EC70EC,earnings,100,50,4/27/2018
EC70EC,earnings,100,50,4/27/2018
ECF4F8,executive-appointment,100,54,4/27/2018
ED0D7C,earnings,100,50,4/27/2018
ED0D7C,earnings,100,50,4/27/2018
ED0D7C,earnings,100,50,4/27/2018
ED0D7C,earnings,100,50,4/27/2018
ED79D9,facility-open,100,65,4/27/2018
EE6F1C,dividend,100,50,4/27/2018
EE6F1C,executive-appointment,100,54,4/27/2018
F4CDA3,conference-call,100,50,4/27/2018
F6E248,regulatory-product-review-positive,100,73,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F6FA6A,earnings,100,50,4/27/2018
F7FCA4,dividend,100,50,4/27/2018
F8C5D7,legal-issues-defendant,100,22,4/27/2018
F8C5D7,legal-issues-defendant,100,22,4/27/2018
FA36A4,earnings,100,50,4/27/2018
FBD92D,stake-acquiree,100,62,4/27/2018
FD4588,conference-participant,100,50,4/27/2018
FEE4B0,award,100,58,4/27/2018
FF4343,facility-open,100,65,4/27/2018
FF4BA4,earnings,100,50,4/27/2018
FF4BA4,earnings,100,50,4/27/2018
FF4BA4,earnings,100,50,4/27/2018
FF4BA4,earnings,100,50,4/27/2018
FF4BA4,earnings,100,50,4/27/2018
BB0587,strike,100,25,4/28/2018
57DDB9,business-combination,100,54,4/29/2018
57DDB9,business-combination,100,54,4/29/2018
57DDB9,business-combination,100,54,4/29/2018
790C34,earnings,100,50,4/29/2018
8C5519,acquisition-acquirer,100,49,4/29/2018
8C5519,acquisition-acquirer,100,49,4/29/2018
8C5519,acquisition-acquirer,100,49,4/29/2018
8C5519,acquisition-acquirer,100,49,4/29/2018
01478A,executive-resignation,100,44,4/30/2018
0157B1,hirings,100,65,4/30/2018
20751,conference-participant,100,50,4/30/2018
02870F,earnings-up,100,68,4/30/2018
02870F,earnings-up,100,68,4/30/2018
02870F,earnings-up,100,68,4/30/2018
03B8CF,regulatory-product-approval-granted,100,81,4/30/2018
0560D8,conference-participant,100,50,4/30/2018
09062E,executive-appointment,100,54,4/30/2018
099C88,business-contract,100,69,4/30/2018
0A1D77,executive-appointment,100,54,4/30/2018
0A6824,dividend,100,50,4/30/2018
0BA8CE,executive-appointment,100,54,4/30/2018
0BD4E8,earnings,100,50,4/30/2018
0BD4E8,earnings,100,50,4/30/2018
0BD4E8,earnings,100,50,4/30/2018
0BD4E8,earnings,100,50,4/30/2018
0BF528,conference-call,100,50,4/30/2018
0C2A0D,earnings,100,50,4/30/2018
119CB6,executive-appointment,100,54,4/30/2018
12731D,conference-call,100,50,4/30/2018
180DA0,earnings,100,50,4/30/2018
180DA0,earnings,100,50,4/30/2018
18D9FA,private-placement,100,56,4/30/2018
1CB9D3,settlement,100,56,4/30/2018
1D943E,earnings,100,50,4/30/2018
1E5786,executive-appointment,100,54,4/30/2018
1F716B,earnings-guidance-up,100,83,4/30/2018
1F716B,legal-issues-defendant,100,22,4/30/2018
1F716B,fraud-defendant,100,20,4/30/2018
2082EA,product-release,100,64,4/30/2018
2093B1,earnings,100,50,4/30/2018
20DC4E,dividend,100,50,4/30/2018
21DED4,dividend,100,50,4/30/2018
228D42,product-release,100,64,4/30/2018
228D42,executive-appointment,100,54,4/30/2018
239106,earnings-per-share-positive,100,69,4/30/2018
239106,earnings-per-share-positive,100,69,4/30/2018
25A6CC,conference-participant,100,50,4/30/2018
2667B6,dividend,100,50,4/30/2018
26D8ED,earnings,100,50,4/30/2018
26F31D,earnings,100,50,4/30/2018
26F31D,earnings,100,50,4/30/2018
26F31D,earnings,100,50,4/30/2018
26F31D,earnings,100,50,4/30/2018
26F31D,earnings,100,50,4/30/2018
270305,earnings,100,50,4/30/2018
275300,conference-participant,100,50,4/30/2018
27A791,earnings,100,50,4/30/2018
27BFA1,dividend,100,50,4/30/2018
2CA60F,partnership,100,61,4/30/2018
2D2D43,earnings,100,50,4/30/2018
2D485F,executive-appointment,100,54,4/30/2018
2D643C,award,100,58,4/30/2018
2EC172,executive-appointment,100,54,4/30/2018
30AB63,earnings,100,50,4/30/2018
367E1C,earnings,100,50,4/30/2018
37020C,earnings-guidance,100,50,4/30/2018
370C50,business-contract,100,69,4/30/2018
384CD3,unit-acquisition-acquiree,100,76,4/30/2018
3B37F7,conference-call,100,50,4/30/2018
3BE00F,conference-participant,100,50,4/30/2018
3DED49,conference-call,100,50,4/30/2018
3E39A5,earnings-guidance,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
43A74A,earnings,100,50,4/30/2018
46017C,conference-participant,100,50,4/30/2018
485445,earnings,100,50,4/30/2018
490D4B,earnings,100,50,4/30/2018
490D4B,earnings,100,50,4/30/2018
494EB9,earnings,100,50,4/30/2018
4A2457,conference-call,100,50,4/30/2018
4A5C8D,conference-call,100,50,4/30/2018
4A6F00,partnership,100,61,4/30/2018
4A6F00,partnership,100,61,4/30/2018
4A6F00,partnership,100,61,4/30/2018
4B5054,conference-organizer,100,57,4/30/2018
4BDCA7,conference-call,100,50,4/30/2018
4C350A,credit-extension-recipient,100,69,4/30/2018
4D8E5E,earnings,100,50,4/30/2018
5088A5,earnings,100,50,4/30/2018
514067,earnings,100,50,4/30/2018
5.43E+08,earnings,100,50,4/30/2018
553949,earnings,100,50,4/30/2018
55438C,business-contract,100,69,4/30/2018
55438C,dividend,100,50,4/30/2018
57A854,earnings,100,50,4/30/2018
57DDB9,conference-call,100,50,4/30/2018
594402,acquisition-acquirer,100,49,4/30/2018
594402,acquisition-acquirer,100,49,4/30/2018
5BE42C,earnings,100,50,4/30/2018
5D16CF,acquisition-completed-acquirer,100,49,4/30/2018
5D41E4,conference-call,100,50,4/30/2018
5D41E4,conference-call,100,50,4/30/2018
5E1DF3,market-entry,100,57,4/30/2018
62A48D,executive-resignation,100,44,4/30/2018
6844D2,executive-appointment,100,54,4/30/2018
6ABCB8,earnings,100,50,4/30/2018
6B0E45,facility-open,100,65,4/30/2018
6D6B40,earnings,100,50,4/30/2018
6F39FC,conference-call,100,50,4/30/2018
709AED,dividend,100,50,4/30/2018
709AED,earnings,100,50,4/30/2018
709AED,earnings,100,50,4/30/2018
709AED,earnings,100,50,4/30/2018
709AED,earnings,100,50,4/30/2018
70FCEF,partnership,100,61,4/30/2018
713810,business-contract,100,69,4/30/2018
71553E,public-offering,100,43,4/30/2018
722D55,executive-appointment,100,54,4/30/2018
72C2CE,earnings,100,50,4/30/2018
747219,conference-participant,100,50,4/30/2018
763DBE,conference-participant,100,50,4/30/2018
791EC1,acquisition-acquirer,100,49,4/30/2018
791EC1,earnings,100,50,4/30/2018
797C20,conference-call,100,50,4/30/2018
7AB859,acquisition-acquiree,100,76,4/30/2018
7AB859,acquisition-acquiree,100,76,4/30/2018
7ADE57,partnership,100,61,4/30/2018
7C4168,earnings,100,50,4/30/2018
7CBC40,earnings,100,50,4/30/2018
7CBC40,earnings,100,50,4/30/2018
7CBC40,earnings,100,50,4/30/2018
7CBC40,earnings,100,50,4/30/2018
7E1D5D,partnership,100,61,4/30/2018
7EA323,earnings,100,50,4/30/2018
7F3A5F,product-release,100,64,4/30/2018
7F3A5F,product-release,100,64,4/30/2018
8.10E+32,merger-completed,100,66,4/30/2018
8.10E+32,executive-appointment,100,54,4/30/2018
82B57E,earnings,100,50,4/30/2018
8377DB,executive-appointment,100,54,4/30/2018
838ADD,conference-participant,100,50,4/30/2018
850779,dividend,100,50,4/30/2018
850779,conference-participant,100,50,4/30/2018
860AB6,earnings,100,50,4/30/2018
86AA9C,settlement,100,56,4/30/2018
8802B4,earnings,100,50,4/30/2018
883D82,earnings,100,50,4/30/2018
895D56,business-contract,100,69,4/30/2018
89F693,executive-appointment,100,54,4/30/2018
8F6995,earnings,100,50,4/30/2018
8FE7A5,earnings,100,50,4/30/2018
93965C,earnings,100,50,4/30/2018
93965C,earnings,100,50,4/30/2018
940C3D,business-contract,100,69,4/30/2018
94208D,ipo-completed,100,76,4/30/2018
94208D,ipo-completed,100,76,4/30/2018
94983E,product-release,100,64,4/30/2018
9.54E+32,earnings,100,50,4/30/2018
9.54E+32,earnings,100,50,4/30/2018
958938,public-offering,100,43,4/30/2018
968966,acquisition-acquiree,100,76,4/30/2018
968B00,earnings-positive,100,69,4/30/2018
968B00,earnings-positive,100,69,4/30/2018
96A6CD,earnings,100,50,4/30/2018
96F126,facility-open,100,65,4/30/2018
96F126,business-contract,100,69,4/30/2018
979451,business-contract,100,69,4/30/2018
9B0C9C,award,100,58,4/30/2018
9B4066,unit-acquisition-acquirer,100,49,4/30/2018
9BF177,business-contract,100,69,4/30/2018
9C25FF,legal-issues-defendant,100,22,4/30/2018
9C8664,earnings,100,50,4/30/2018
9D5D35,earnings,100,50,4/30/2018
9D5D35,earnings,100,50,4/30/2018
9EA947,earnings,100,50,4/30/2018
9EED50,merger,100,66,4/30/2018
9EED50,merger,100,66,4/30/2018
9F5CBB,dividend,100,50,4/30/2018
A01664,partnership,100,61,4/30/2018
A247F5,note-sale,100,52,4/30/2018
A2CA3F,earnings,100,50,4/30/2018
A38F30,earnings,100,50,4/30/2018
A47F2E,earnings,100,50,4/30/2018
A4B899,executive-appointment,100,54,4/30/2018
A6213D,product-release,100,64,4/30/2018
A868C9,executive-appointment,100,54,4/30/2018
A871B0,earnings,100,50,4/30/2018
A96867,earnings-up,100,56,4/30/2018
A96867,earnings-positive,100,69,4/30/2018
A96867,earnings-positive,100,69,4/30/2018
A96867,earnings-positive,100,69,4/30/2018
A96867,earnings-positive,100,69,4/30/2018
A96867,earnings-positive,100,69,4/30/2018
A96867,earnings-positive,100,69,4/30/2018
A96867,earnings-positive,100,69,4/30/2018
ACC7D3,public-offering,100,43,4/30/2018
ADF1B0,earnings,100,50,4/30/2018
ADF1B0,earnings,100,50,4/30/2018
ADF1B0,earnings,100,50,4/30/2018
ADF1B0,earnings,100,50,4/30/2018
AF93DE,conference-call,100,50,4/30/2018
B076A1,earnings,100,50,4/30/2018
B076A1,earnings,100,50,4/30/2018
B076A1,earnings,100,50,4/30/2018
B290A2,earnings,100,50,4/30/2018
B2DAF6,earnings,100,50,4/30/2018
B2DAF6,earnings,100,50,4/30/2018
B33E77,earnings,100,50,4/30/2018
B3A166,conference-call,100,50,4/30/2018
B560AF,earnings,100,50,4/30/2018
B560AF,earnings,100,50,4/30/2018
B560AF,earnings,100,50,4/30/2018
B5DE80,earnings,100,50,4/30/2018
B5DE80,earnings,100,50,4/30/2018
B72BE9,revenues,100,50,4/30/2018
B72BE9,revenues,100,50,4/30/2018
B72BE9,revenues,100,50,4/30/2018
B9CD50,executive-appointment,100,54,4/30/2018
BB5271,earnings,100,50,4/30/2018
BB88B6,award,100,58,4/30/2018
BC4876,earnings,100,50,4/30/2018
BE379D,earnings,100,50,4/30/2018
BE5935,earnings-revision,100,29,4/30/2018
BE86A1,earnings-up,100,71,4/30/2018
C062D4,earnings,100,50,4/30/2018
C062D4,earnings,100,50,4/30/2018
C062D4,earnings,100,50,4/30/2018
C062D4,earnings,100,50,4/30/2018
C062D4,earnings,100,50,4/30/2018
C0F70B,earnings,100,50,4/30/2018
C188F8,executive-appointment,100,54,4/30/2018
C4A432,conference-call,100,50,4/30/2018
C4F9C6,earnings,100,50,4/30/2018
C4FBDC,earnings,100,50,4/30/2018
C97B2D,acquisition-completed-acquirer,100,49,4/30/2018
C9C62A,earnings,100,50,4/30/2018
CC8F6E,legal-issues-defendant,100,22,4/30/2018
CCBBAD,merger-completed,100,66,4/30/2018
CF6A5A,facility-open,100,65,4/30/2018
CFF97C,executive-appointment,100,54,4/30/2018
D06996,earnings,100,50,4/30/2018
D09938,earnings,100,50,4/30/2018
D0DE27,earnings,100,50,4/30/2018
D15833,conference-call,100,50,4/30/2018
D25249,acquisition-acquirer,100,49,4/30/2018
D25249,acquisition-acquirer,100,49,4/30/2018
D25249,acquisition-acquirer,100,49,4/30/2018
D3C794,earnings,100,50,4/30/2018
D45285,earnings,100,50,4/30/2018
D45285,earnings,100,50,4/30/2018
D57D99,earnings,100,50,4/30/2018
D6489C,award,100,58,4/30/2018
D64C6D,executive-appointment,100,54,4/30/2018
D6534D,acquisition-completed-acquirer,100,49,4/30/2018
D6534D,conference-call,100,50,4/30/2018
D6534D,conference-call,100,50,4/30/2018
D77F7E,campaign-ad-release,100,59,4/30/2018
D8ECA1,board-meeting,100,51,4/30/2018
D9164D,earnings,100,50,4/30/2018
DD9E41,earnings,100,50,4/30/2018
DD9E41,earnings,100,50,4/30/2018
DD9E41,earnings,100,50,4/30/2018
DD9E41,earnings,100,50,4/30/2018
DD9E41,earnings,100,50,4/30/2018
E2F66E,earnings,100,50,4/30/2018
E610CD,ipo-completed,100,76,4/30/2018
E68733,regulatory-product-approval-granted,100,81,4/30/2018
E69BA5,partnership,100,61,4/30/2018
E69BA5,partnership,100,61,4/30/2018
E70531,acquisition-interest-acquirer,100,46,4/30/2018
E82A2D,earnings-up,100,68,4/30/2018
E8846E,conference-organizer,100,57,4/30/2018
E8846E,conference-organizer,100,57,4/30/2018
E8846E,conference-organizer,100,57,4/30/2018
E8B21D,earnings-up,100,68,4/30/2018
E8B21D,earnings-up,100,68,4/30/2018
E8B21D,earnings-up,100,68,4/30/2018
E8B21D,earnings-up,100,68,4/30/2018
E959F3,dividend,100,50,4/30/2018
EA62FC,dividend-up,100,81,4/30/2018
EE74E1,earnings-per-share-positive,100,69,4/30/2018
EE74E1,earnings-per-share-positive,100,69,4/30/2018
EE74E1,earnings-per-share-positive,100,69,4/30/2018
EEBCEF,dividend,100,50,4/30/2018
EEEA9F,public-offering,100,43,4/30/2018
F0EEFB,business-contract,100,69,4/30/2018
F3FCC3,dividend,100,50,4/30/2018
F46EC9,conference-participant,100,50,4/30/2018
F58C23,conference-organizer,100,57,4/30/2018
F5D410,public-offering,100,43,4/30/2018
F6E248,partnership,100,61,4/30/2018
F82D37,partnership,100,61,4/30/2018
F82D37,note-sale,100,52,4/30/2018
FACCF6,earnings,100,50,4/30/2018
FAEABE,dividend,100,50,4/30/2018
FB7724,earnings-up,100,68,4/30/2018
FD4588,partnership,100,61,4/30/2018
FDF1C0,earnings,100,50,4/30/2018
FDF1C0,earnings,100,50,4/30/2018
FDF1C0,earnings,100,50,4/30/2018
FDF1C0,earnings,100,50,4/30/2018
FDF1C0,earnings,100,50,4/30/2018
FF4343,earnings-positive,100,69,4/30/2018
FFAB4A,earnings,100,50,4/30/2018
00326E,partnership,100,61,5/1/2018
13528,dividend,100,50,5/1/2018
0142B5,acquisition-completed-acquirer,100,49,5/1/2018
0157B1,partnership,100,61,5/1/2018
0560D8,earnings,100,50,5/1/2018
0560D8,earnings,100,50,5/1/2018
0560D8,earnings,100,50,5/1/2018
099A92,partnership,100,61,5/1/2018
09F623,earnings,100,50,5/1/2018
0A0D9E,conference-participant,100,50,5/1/2018
0BF198,conference-participant,100,50,5/1/2018
0C2A0D,partnership,100,61,5/1/2018
0C4131,acquisition-completed-acquirer,100,49,5/1/2018
0E499E,conference-participant,100,50,5/1/2018
0F65C9,earnings,100,50,5/1/2018
0F65C9,dividend,100,50,5/1/2018
1080C0,earnings,100,50,5/1/2018
1220D2,conference-participant,100,50,5/1/2018
1272B3,earnings,100,50,5/1/2018
12DE76,acquisition-interest-acquirer,100,46,5/1/2018
131443,earnings,100,50,5/1/2018
131443,earnings,100,50,5/1/2018
131443,earnings,100,50,5/1/2018
131443,earnings,100,50,5/1/2018
131443,earnings,100,50,5/1/2018
1348C9,unit-acquisition-completed-acquiree,100,67,5/1/2018
14BA06,earnings,100,50,5/1/2018
14BA06,earnings,100,50,5/1/2018
14BA06,earnings,100,50,5/1/2018
14BA06,earnings,100,50,5/1/2018
14BA06,earnings,100,50,5/1/2018
14BA06,earnings,100,50,5/1/2018
14BA33,earnings,100,50,5/1/2018
157D9F,executive-appointment,100,54,5/1/2018
165B86,conference-call,100,50,5/1/2018
168A5D,product-release,100,64,5/1/2018
168A5D,facility-open,100,65,5/1/2018
16AAE0,earnings,100,50,5/1/2018
180DA0,dividend,100,50,5/1/2018
184866,partnership,100,61,5/1/2018
18D9FA,business-contract,100,69,5/1/2018
18D9FA,partnership,100,61,5/1/2018
190B91,earnings,100,50,5/1/2018
190B91,earnings,100,50,5/1/2018
190B91,earnings,100,50,5/1/2018
190B91,earnings,100,50,5/1/2018
1921DD,partnership,100,61,5/1/2018
1A5D5D,earnings,100,50,5/1/2018
1A5D5D,earnings,100,50,5/1/2018
1A5D5D,earnings,100,50,5/1/2018
1A5D5D,earnings,100,50,5/1/2018
1A5D5D,earnings,100,50,5/1/2018
1EBF8D,earnings,100,50,5/1/2018
1F716B,legal-issues-defendant,100,22,5/1/2018
1F9D90,conference-participant,100,50,5/1/2018
2082EA,executive-appointment,100,54,5/1/2018
214051,earnings-up,100,68,5/1/2018
214051,earnings-up,100,68,5/1/2018
214051,earnings-up,100,68,5/1/2018
214051,earnings-up,100,68,5/1/2018
214051,earnings-up,100,68,5/1/2018
214051,earnings-up,100,68,5/1/2018
214051,earnings-up,100,68,5/1/2018
214051,earnings-up,100,68,5/1/2018
267718,earnings,100,50,5/1/2018
267718,earnings,100,50,5/1/2018
267718,earnings,100,50,5/1/2018
267718,earnings,100,50,5/1/2018
267718,earnings,100,50,5/1/2018
267718,earnings,100,50,5/1/2018
267718,earnings,100,50,5/1/2018
270305,merger-completed,100,66,5/1/2018
270B78,earnings,100,50,5/1/2018
28DCF3,note-sale,100,52,5/1/2018
2950FF,earnings-guidance-up,100,83,5/1/2018
295F9F,earnings,100,50,5/1/2018
2A6DBE,executive-appointment,100,54,5/1/2018
2A9C0A,acquisition-completed-acquirer,100,49,5/1/2018
2B7A40,earnings-per-share-positive,100,69,5/1/2018
2B7A40,earnings-positive,100,69,5/1/2018
2B7A40,earnings-positive,100,69,5/1/2018
2B7A40,earnings-positive,100,69,5/1/2018
2C3348,executive-appointment,100,54,5/1/2018
2DDB22,earnings,100,50,5/1/2018
2E0496,earnings,100,50,5/1/2018
2EC172,earnings,100,50,5/1/2018
2EC172,earnings,100,50,5/1/2018
2EC172,earnings,100,50,5/1/2018
2EC172,earnings,100,50,5/1/2018
2EC172,earnings,100,50,5/1/2018
2EC172,earnings,100,50,5/1/2018
2F24A5,earnings,100,50,5/1/2018
2F6782,conference-participant,100,50,5/1/2018
2F6782,dividend,100,50,5/1/2018
33FD66,earnings,100,50,5/1/2018
33FD66,earnings,100,50,5/1/2018
33FD66,earnings,100,50,5/1/2018
33FD66,earnings,100,50,5/1/2018
343996,earnings,100,50,5/1/2018
343996,earnings,100,50,5/1/2018
3461CF,conference-participant,100,50,5/1/2018
349DA4,conference-participant,100,50,5/1/2018
34B97A,earnings,100,50,5/1/2018
34B97A,earnings,100,50,5/1/2018
34B97A,earnings,100,50,5/1/2018
34B97A,earnings,100,50,5/1/2018
3.50E+27,earnings,100,50,5/1/2018
36A1CB,earnings,100,50,5/1/2018
36A1CB,earnings,100,50,5/1/2018
373B06,earnings,100,50,5/1/2018
38FB49,dividend,100,50,5/1/2018
396D7C,earnings,100,50,5/1/2018
3B9886,product-release,100,64,5/1/2018
3BE00F,earnings,100,50,5/1/2018
3BE00F,earnings,100,50,5/1/2018
3BE00F,earnings,100,50,5/1/2018
3C11C4,acquisition-acquirer,100,49,5/1/2018
3E39A5,conference-participant,100,50,5/1/2018
3F6A9C,earnings,100,50,5/1/2018
4.03E+05,earnings-up,100,68,5/1/2018
4.03E+05,earnings,100,50,5/1/2018
4.03E+05,earnings,100,50,5/1/2018
4.03E+05,dividend,100,50,5/1/2018
41EC04,earnings,100,50,5/1/2018
41EC04,earnings,100,50,5/1/2018
41EC04,earnings,100,50,5/1/2018
429BFB,earnings,100,50,5/1/2018
43A74A,asset-sale,100,62,5/1/2018
44A4FC,earnings,100,50,5/1/2018
453282,unit-acquisition-acquirer,100,49,5/1/2018
4649D5,earnings,100,50,5/1/2018
467F2C,earnings,100,50,5/1/2018
4BD6DB,acquisition-completed-acquirer,100,49,5/1/2018
4C5CC9,dividend-up,100,64,5/1/2018
4DD203,executive-resignation,100,44,5/1/2018
4EE14A,acquisition-completed-acquirer,100,49,5/1/2018
4EEB00,conference-participant,100,50,5/1/2018
4FB770,earnings,100,50,5/1/2018
513A86,earnings,100,50,5/1/2018
524CE4,conference-participant,100,50,5/1/2018
53EF9E,earnings,100,50,5/1/2018
53EF9E,earnings,100,50,5/1/2018
5.47E+28,conference-participant,100,50,5/1/2018
54A713,earnings,100,50,5/1/2018
54F271,earnings,100,50,5/1/2018
55438C,unit-acquisition-acquirer,100,49,5/1/2018
55438C,unit-acquisition-acquirer,100,49,5/1/2018
55438C,acquisition-acquirer,100,49,5/1/2018
562853,earnings,100,50,5/1/2018
56632F,earnings,100,50,5/1/2018
56632F,earnings,100,50,5/1/2018
56632F,earnings,100,50,5/1/2018
586BD7,conference-participant,100,50,5/1/2018
596116,earnings,100,50,5/1/2018
5968F9,conference-organizer,100,57,5/1/2018
59A832,earnings,100,50,5/1/2018
5A53BF,conference-call,100,50,5/1/2018
5B15E1,earnings,100,50,5/1/2018
5B3415,patent-awarded,100,72,5/1/2018
5C7601,unit-acquisition-acquirer,100,49,5/1/2018
5CCDAD,earnings,100,50,5/1/2018
5D1329,earnings,100,50,5/1/2018
5F1B7B,earnings,100,50,5/1/2018
6137BF,buybacks,100,74,5/1/2018
619882,conference-organizer,100,57,5/1/2018
61BCA7,earnings,100,50,5/1/2018
62A48D,earnings,100,50,5/1/2018
639BD6,revenues,100,50,5/1/2018
639BD6,revenues,100,50,5/1/2018
639BD6,revenues,100,50,5/1/2018
64E615,earnings-up,100,68,5/1/2018
64E615,earnings,100,50,5/1/2018
64E615,earnings,100,50,5/1/2018
66749D,earnings-up,100,68,5/1/2018
66749D,earnings-up,100,68,5/1/2018
66749D,earnings-up,100,68,5/1/2018
66749D,earnings-up,100,68,5/1/2018
66A667,acquisition-acquirer,100,49,5/1/2018
69494C,conference-call,100,50,5/1/2018
69C99E,earnings,100,50,5/1/2018
6B494E,earnings,100,50,5/1/2018
6B6375,executive-appointment,100,54,5/1/2018
6CC55E,earnings,100,50,5/1/2018
6E705B,partnership,100,61,5/1/2018
6F6559,partnership,100,61,5/1/2018
701531,earnings,100,50,5/1/2018
70FCEF,executive-appointment,100,54,5/1/2018
726DDF,legal-issues-defendant,100,22,5/1/2018
732449,earnings,100,50,5/1/2018
7410C3,earnings,100,50,5/1/2018
7448A3,conference-participant,100,50,5/1/2018
762A3E,award,100,58,5/1/2018
765913,earnings,100,50,5/1/2018
76D79A,earnings,100,50,5/1/2018
7823A3,earnings,100,50,5/1/2018
7823A3,earnings,100,50,5/1/2018
7823A3,earnings,100,50,5/1/2018
7823A3,earnings,100,50,5/1/2018
7823A3,earnings,100,50,5/1/2018
7A10FF,earnings,100,50,5/1/2018
7B0BA6,earnings,100,50,5/1/2018
7B0BA6,earnings,100,50,5/1/2018
7B0BA6,earnings,100,50,5/1/2018
7B0BA6,earnings,100,50,5/1/2018
7B0BA6,earnings,100,50,5/1/2018
7BC92D,conference-participant,100,50,5/1/2018
7BEA98,conference-call,100,50,5/1/2018
7BEA98,conference-call,100,50,5/1/2018
7D5384,executive-appointment,100,54,5/1/2018
7E0EB0,award,100,58,5/1/2018
7F3669,conference-participant,100,50,5/1/2018
7F9984,earnings,100,50,5/1/2018
7F9BE2,dividend,100,50,5/1/2018
7FDE1C,conference-call,100,50,5/1/2018
805CD8,conference-call,100,50,5/1/2018
805CD8,patient-enrollment-complete,100,64,5/1/2018
81EAD4,earnings,100,50,5/1/2018
81EAD4,earnings,100,50,5/1/2018
81EAD4,earnings,100,50,5/1/2018
81EAD4,earnings,100,50,5/1/2018
824CCA,conference-call,100,50,5/1/2018
82B57E,unit-acquisition-completed-acquirer,100,49,5/1/2018
83598E,earnings,100,50,5/1/2018
835C86,dividend,100,50,5/1/2018
83B1C8,earnings,100,50,5/1/2018
83E0AC,conference-call,100,50,5/1/2018
85DE00,conference-participant,100,50,5/1/2018
8665BA,business-contract,100,69,5/1/2018
86AA9C,earnings,100,50,5/1/2018
8.79E+06,earnings,100,50,5/1/2018
88193E,earnings,100,50,5/1/2018
88350F,earnings-per-share-up,100,68,5/1/2018
88350F,earnings-per-share-up,100,68,5/1/2018
88350F,earnings-per-share-up,100,68,5/1/2018
89FBB1,earnings,100,50,5/1/2018
89FBB1,earnings,100,50,5/1/2018
8DCBBB,earnings,100,50,5/1/2018
8DCBBB,earnings,100,50,5/1/2018
8E9CD8,earnings-up,100,68,5/1/2018
8E9CD8,earnings,100,50,5/1/2018
8E9CD8,earnings,100,50,5/1/2018
8E9CD8,earnings,100,50,5/1/2018
8E9CD8,earnings,100,50,5/1/2018
8EEA28,earnings,100,50,5/1/2018
8F6995,dividend,100,50,5/1/2018
8F8F2F,earnings,100,50,5/1/2018
8F8F2F,earnings,100,50,5/1/2018
8FCA78,earnings-up,100,68,5/1/2018
902255,dividend,100,50,5/1/2018
911CA9,partnership,100,61,5/1/2018
9368BE,earnings,100,50,5/1/2018
9548BB,dividend,100,50,5/1/2018
958938,board-meeting,100,51,5/1/2018
958938,conference-call,100,50,5/1/2018
95DE39,earnings,100,50,5/1/2018
95DE39,earnings,100,50,5/1/2018
965360,dividend,100,50,5/1/2018
968966,partnership,100,61,5/1/2018
971334,earnings,100,50,5/1/2018
971334,earnings,100,50,5/1/2018
971334,earnings,100,50,5/1/2018
971334,earnings,100,50,5/1/2018
971334,earnings,100,50,5/1/2018
972356,partnership,100,61,5/1/2018
980C14,earnings,100,50,5/1/2018
990AD0,earnings,100,50,5/1/2018
990AD0,conference-organizer,100,57,5/1/2018
990AD0,conference-organizer,100,57,5/1/2018
990AD0,conference-organizer,100,57,5/1/2018
9.92E+94,business-contract,100,69,5/1/2018
99DC8D,conference-call,100,50,5/1/2018
9A2760,earnings,100,50,5/1/2018
9A602D,earnings-per-share-positive,100,69,5/1/2018
9A602D,earnings-per-share-positive,100,69,5/1/2018
9A602D,earnings-per-share-positive,100,69,5/1/2018
9A602D,earnings-per-share-positive,100,69,5/1/2018
9A602D,earnings-per-share-positive,100,69,5/1/2018
9A602D,earnings-per-share-positive,100,69,5/1/2018
9B730A,conference-call,100,50,5/1/2018
9C25FF,legal-issues-defendant,100,22,5/1/2018
9C5BA5,conference-participant,100,50,5/1/2018
9CA432,earnings,100,50,5/1/2018
9D65C1,partnership,100,61,5/1/2018
9F18FA,earnings,100,50,5/1/2018
9F18FA,earnings,100,50,5/1/2018
9F18FA,note-sale,100,52,5/1/2018
9F18FA,note-sale,100,52,5/1/2018
9F6B1A,partnership,100,61,5/1/2018
9FF5F1,earnings,100,50,5/1/2018
A05C43,earnings,100,50,5/1/2018
A05C43,earnings,100,50,5/1/2018
A05C43,earnings,100,50,5/1/2018
A05C43,earnings,100,50,5/1/2018
A15C71,earnings,100,50,5/1/2018
A15C71,earnings,100,50,5/1/2018
A15C71,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A16DEA,earnings,100,50,5/1/2018
A1EAC8,dividend,100,50,5/1/2018
A23747,earnings-up,100,68,5/1/2018
A247F5,note-sale,100,52,5/1/2018
A41450,earnings,100,50,5/1/2018
A433A5,business-contract,100,69,5/1/2018
A47A7D,earnings,100,50,5/1/2018
A4D173,dividend,100,50,5/1/2018
A4D173,dividend,100,50,5/1/2018
A4F67C,earnings,100,50,5/1/2018
A5195E,regulatory-product-approval-granted,100,81,5/1/2018
A5DD24,unit-acquisition-completed-acquiree,100,67,5/1/2018
A5DD24,conference-participant,100,50,5/1/2018
A790A5,dividend,100,50,5/1/2018
A80FE0,earnings,100,50,5/1/2018
A87CD6,earnings,100,50,5/1/2018
A87CD6,dividend,100,50,5/1/2018
A8CBDA,conference-participant,100,50,5/1/2018
A94718,earnings,100,50,5/1/2018
AA98ED,unit-acquisition-acquirer,100,49,5/1/2018
AAC8B6,conference-call,100,50,5/1/2018
AADE0B,earnings,100,50,5/1/2018
AC7AAE,earnings,100,50,5/1/2018
ACC7D3,earnings,100,50,5/1/2018
ACDF88,conference-call,100,50,5/1/2018
ACDF88,conference-call,100,50,5/1/2018
ACF77B,dividend-up,100,81,5/1/2018
AE7D16,earnings,100,50,5/1/2018
AEF2C3,revenues,100,50,5/1/2018
AEFC90,clinical-trials,100,56,5/1/2018
AFF7B4,earnings,100,50,5/1/2018
AFF7B4,earnings,100,50,5/1/2018
AFF7B4,earnings,100,50,5/1/2018
AFF7B4,earnings,100,50,5/1/2018
B04426,conference-participant,100,50,5/1/2018
B05118,dividend,100,50,5/1/2018
B13B68,product-release,100,64,5/1/2018
B303A6,dividend,100,50,5/1/2018
B37FB4,executive-appointment,100,54,5/1/2018
B381D8,earnings,100,50,5/1/2018
B73395,conference-call,100,50,5/1/2018
B77F14,conference-call,100,50,5/1/2018
B77F14,partnership,100,61,5/1/2018
BB0587,earnings,100,50,5/1/2018
BB0787,earnings,100,50,5/1/2018
BBBB41,earnings-up,100,68,5/1/2018
BBBB41,earnings-up,100,68,5/1/2018
BBBB41,earnings-up,100,68,5/1/2018
BBBB41,earnings-up,100,68,5/1/2018
BBBB41,earnings-up,100,68,5/1/2018
BBBB41,note-sale,100,52,5/1/2018
BBC05B,operating-earnings,100,50,5/1/2018
BC5680,earnings-up,100,68,5/1/2018
BC5680,earnings-up,100,68,5/1/2018
BDA775,earnings,100,50,5/1/2018
BE14CF,acquisition-completed-acquirer,100,49,5/1/2018
C0BA36,earnings,100,50,5/1/2018
C0F70B,conference-participant,100,50,5/1/2018
C16A8F,earnings,100,50,5/1/2018
C16A8F,earnings,100,50,5/1/2018
C16A8F,earnings,100,50,5/1/2018
C16A8F,earnings,100,50,5/1/2018
C2609A,earnings,100,50,5/1/2018
C27E19,operating-earnings,100,50,5/1/2018
C3CF29,earnings,100,50,5/1/2018
C3CF29,earnings,100,50,5/1/2018
C3CF29,earnings,100,50,5/1/2018
C3F99F,earnings,100,50,5/1/2018
C45C1F,conference-participant,100,50,5/1/2018
C4A912,earnings,100,50,5/1/2018
C4A912,earnings,100,50,5/1/2018
C4A912,earnings,100,50,5/1/2018
C54140,partnership,100,61,5/1/2018
C564E4,conference-call,100,50,5/1/2018
C598D7,acquisition-acquirer,100,49,5/1/2018
C5C0E9,earnings,100,50,5/1/2018
C659EB,earnings,100,50,5/1/2018
C659EB,earnings,100,50,5/1/2018
C659EB,earnings,100,50,5/1/2018
C81E00,conference-participant,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C85A72,revenues,100,50,5/1/2018
C941DC,earnings,100,50,5/1/2018
C99CC8,earnings,100,50,5/1/2018
C9E04B,conference-call,100,50,5/1/2018
CAB222,conference-call,100,50,5/1/2018
CBDB4D,conference-call,100,50,5/1/2018
CBFFDD,partnership,100,61,5/1/2018
CBFFDD,partnership,100,61,5/1/2018
CC6FF5,partnership,100,61,5/1/2018
CD2A4D,conference-participant,100,50,5/1/2018
CDE118,earnings,100,50,5/1/2018
CDE51C,earnings,100,50,5/1/2018
CE1002,conference-participant,100,50,5/1/2018
CF3FF9,earnings,100,50,5/1/2018
CFF97C,dividend,100,50,5/1/2018
D08D2C,earnings,100,50,5/1/2018
D08D2C,earnings,100,50,5/1/2018
D08D2C,earnings,100,50,5/1/2018
D08D2C,earnings,100,50,5/1/2018
D0DFE5,executive-appointment,100,54,5/1/2018
D139BC,conference-call,100,50,5/1/2018
D15833,earnings-positive,100,69,5/1/2018
D56D6D,earnings,100,50,5/1/2018
D63B0F,acquisition-acquirer,100,49,5/1/2018
D8442A,earnings,100,50,5/1/2018
D8442A,earnings,100,50,5/1/2018
D8442A,earnings,100,50,5/1/2018
D854F3,conference-participant,100,50,5/1/2018
D854F3,campaign-ad-release,100,59,5/1/2018
DB06B0,trading-resumed,100,58,5/1/2018
DC2F77,dividend,100,50,5/1/2018
DDEA6A,earnings,100,50,5/1/2018
DF11D9,conference-participant,100,50,5/1/2018
DF5F14,conference-call,100,50,5/1/2018
DF6FDD,government-contract,100,69,5/1/2018
E0207A,earnings,100,50,5/1/2018
E074A0,earnings,100,50,5/1/2018
E07573,earnings,100,50,5/1/2018
E07573,earnings,100,50,5/1/2018
E07573,earnings,100,50,5/1/2018
E10D31,earnings,100,50,5/1/2018
E12A6E,earnings,100,50,5/1/2018
E15736,earnings,100,50,5/1/2018
E1BD05,revenues,100,50,5/1/2018
E1BD05,revenues,100,50,5/1/2018
E41190,conference-call,100,50,5/1/2018
E61888,conference-call,100,50,5/1/2018
E68733,regulatory-product-approval-granted,100,81,5/1/2018
E69BA5,earnings,100,50,5/1/2018
E6A53A,earnings,100,50,5/1/2018
E87676,revenues,100,50,5/1/2018
E8846E,conference-organizer,100,57,5/1/2018
E8A49A,earnings,100,50,5/1/2018
E8E899,conference-participant,100,50,5/1/2018
E93A40,earnings,100,50,5/1/2018
E94704,conference-participant,100,50,5/1/2018
E9E6FD,acquisition-completed-acquirer,100,49,5/1/2018
EB36DE,earnings,100,50,5/1/2018
EC99D0,earnings,100,50,5/1/2018
ED9C04,earnings,100,50,5/1/2018
ED9C04,earnings,100,50,5/1/2018
ED9C04,earnings,100,50,5/1/2018
ED9C04,earnings,100,50,5/1/2018
F3016C,acquisition-completed-acquirer,100,49,5/1/2018
F3816D,conference-participant,100,50,5/1/2018
F3FCC3,earnings,100,50,5/1/2018
F46EC9,revenue-up,100,57,5/1/2018
F47871,public-offering,100,43,5/1/2018
F48947,earnings,100,50,5/1/2018
F48947,earnings,100,50,5/1/2018
F5D410,public-offering,100,43,5/1/2018
F6DE54,acquisition-completed-acquirer,100,49,5/1/2018
F6E248,earnings,100,50,5/1/2018
F6E248,dividend,100,50,5/1/2018
F73DD1,earnings,100,50,5/1/2018
F73DD1,earnings,100,50,5/1/2018
F73DD1,earnings,100,50,5/1/2018
F73DD1,earnings,100,50,5/1/2018
F73DD1,earnings,100,50,5/1/2018
F73DD1,earnings,100,50,5/1/2018
FC1736,executive-appointment,100,54,5/1/2018
FC1A6E,revenues,100,50,5/1/2018
FC1A6E,revenues,100,50,5/1/2018
FC1A6E,revenues,100,50,5/1/2018
FD0CA4,dividend,100,50,5/1/2018
FD4588,earnings,100,50,5/1/2018
FD4588,earnings,100,50,5/1/2018
FD4588,earnings,100,50,5/1/2018
FD6926,conference-participant,100,50,5/1/2018
FD9A97,business-contract,100,69,5/1/2018
FF227B,conference-participant,100,50,5/1/2018
FF4343,facility-open,100,65,5/1/2018
FF4BA4,executive-appointment,100,54,5/1/2018
FF6644,executive-appointment,100,54,5/1/2018
FF6644,executive-appointment,100,54,5/1/2018
FFCD0E,conference-call,100,50,5/1/2018
00067A,earnings,100,50,5/2/2018
002A99,earnings,100,50,5/2/2018
00698D,conference-participant,100,50,5/2/2018
0157B1,partnership,100,61,5/2/2018
03B431,earnings,100,50,5/2/2018
43862,conference-participant,100,50,5/2/2018
048B70,earnings,100,50,5/2/2018
048B70,earnings,100,50,5/2/2018
048B70,earnings,100,50,5/2/2018
048B70,earnings,100,50,5/2/2018
0490C6,earnings,100,50,5/2/2018
053EFF,earnings,100,50,5/2/2018
68396,earnings,100,50,5/2/2018
06C826,note-sale,100,52,5/2/2018
07CA6A,dividend,100,50,5/2/2018
07EC43,conference-participant,100,50,5/2/2018
98977,earnings,100,50,5/2/2018
099A92,earnings,100,50,5/2/2018
0A6824,earnings,100,50,5/2/2018
0B4D10,earnings,100,50,5/2/2018
0B4D10,acquisition-acquirer,100,49,5/2/2018
0B7375,conference-call,100,50,5/2/2018
0BA8CE,earnings,100,50,5/2/2018
0BC29E,earnings,100,50,5/2/2018
0BC29E,earnings,100,50,5/2/2018
0BC29E,earnings,100,50,5/2/2018
0BC29E,earnings,100,50,5/2/2018
0BC29E,earnings,100,50,5/2/2018
0BC29E,earnings,100,50,5/2/2018
0BF198,earnings,100,50,5/2/2018
0CADBC,earnings,100,50,5/2/2018
0DE3D5,operating-earnings,100,50,5/2/2018
0F0440,executive-appointment,100,54,5/2/2018
11074E,earnings,100,50,5/2/2018
1220D2,earnings,100,50,5/2/2018
12731D,earnings,100,50,5/2/2018
12DE76,conference-call,100,50,5/2/2018
12DE76,conference-call,100,50,5/2/2018
135B09,earnings-up,100,68,5/2/2018
135B09,earnings,100,50,5/2/2018
135B09,earnings,100,50,5/2/2018
135B09,earnings,100,50,5/2/2018
135B09,earnings,100,50,5/2/2018
13C3E0,product-release,100,64,5/2/2018
147C38,earnings,100,50,5/2/2018
149301,dividend,100,50,5/2/2018
14BA33,conference-participant,100,50,5/2/2018
14ED2B,dividend,100,50,5/2/2018
14ED2B,revenue-up,100,68,5/2/2018
15B10D,conference-call,100,50,5/2/2018
16B183,operating-earnings,100,50,5/2/2018
17EDA5,partnership,100,61,5/2/2018
17EDA5,partnership,100,61,5/2/2018
17EDA5,partnership,100,61,5/2/2018
184988,earnings,100,50,5/2/2018
1880C5,conference-organizer,100,57,5/2/2018
188394,earnings,100,50,5/2/2018
1A3E1B,unit-acquisition-acquiree,100,76,5/2/2018
1AB023,conference-call,100,50,5/2/2018
1AB023,conference-call,100,50,5/2/2018
1AB023,conference-call,100,50,5/2/2018
1AB808,revenue-up,100,74,5/2/2018
1B637E,earnings,100,50,5/2/2018
1DEBBE,earnings,100,50,5/2/2018
1F19C8,earnings-positive,100,69,5/2/2018
1F19C8,earnings-positive,100,69,5/2/2018
1F19C8,earnings-positive,100,69,5/2/2018
1F19C8,earnings-positive,100,69,5/2/2018
1F19C8,earnings-positive,100,69,5/2/2018
1FAF22,partnership,100,61,5/2/2018
2158DF,earnings,100,50,5/2/2018
2158DF,earnings,100,50,5/2/2018
2158DF,earnings,100,50,5/2/2018
2158DF,earnings,100,50,5/2/2018
225CA2,business-contract,100,69,5/2/2018
225CA2,government-contract,100,69,5/2/2018
225CA2,government-contract,100,69,5/2/2018
225CA2,executive-resignation,100,44,5/2/2018
227F04,earnings,100,50,5/2/2018
228D42,partnership,100,61,5/2/2018
228D42,partnership,100,61,5/2/2018
22C58E,conference-participant,100,50,5/2/2018
24FA23,earnings,100,50,5/2/2018
250BEE,dividend,100,50,5/2/2018
2571FA,earnings,100,50,5/2/2018
2571FA,earnings,100,50,5/2/2018
2571FA,earnings,100,50,5/2/2018
25DD05,earnings,100,50,5/2/2018
263216,earnings,100,50,5/2/2018
263216,earnings,100,50,5/2/2018
263216,earnings,100,50,5/2/2018
263216,earnings,100,50,5/2/2018
263216,earnings,100,50,5/2/2018
263216,earnings,100,50,5/2/2018
267718,partnership,100,61,5/2/2018
27B191,conference-call,100,50,5/2/2018
28DCA8,earnings,100,50,5/2/2018
28DCA8,earnings,100,50,5/2/2018
28DCA8,earnings,100,50,5/2/2018
2920D5,conference-participant,100,50,5/2/2018
2920D5,earnings,100,50,5/2/2018
297DA8,earnings,100,50,5/2/2018
29CEBF,earnings,100,50,5/2/2018
29CEBF,earnings,100,50,5/2/2018
29CEBF,earnings,100,50,5/2/2018
2B7A40,conference-participant,100,50,5/2/2018
2BAE5F,earnings,100,50,5/2/2018
2C3348,earnings,100,50,5/2/2018
2C681C,conference-call,100,50,5/2/2018
2C681C,conference-call,100,50,5/2/2018
2E89AE,conference-participant,100,50,5/2/2018
2F1299,dividend,100,50,5/2/2018
2F6782,earnings,100,50,5/2/2018
2F9304,earnings,100,50,5/2/2018
2FDEE3,earnings,100,50,5/2/2018
314D88,earnings,100,50,5/2/2018
315EB0,earnings,100,50,5/2/2018
315EB0,earnings,100,50,5/2/2018
315EB0,earnings,100,50,5/2/2018
315EB0,earnings,100,50,5/2/2018
315EB0,earnings,100,50,5/2/2018
315EB0,earnings,100,50,5/2/2018
315EB0,dividend,100,50,5/2/2018
3224CC,earnings,100,50,5/2/2018
33AD83,partnership,100,61,5/2/2018
33FD66,product-release,100,64,5/2/2018
342218,earnings,100,50,5/2/2018
342218,earnings,100,50,5/2/2018
3461CF,executive-appointment,100,54,5/2/2018
349DA4,earnings,100,50,5/2/2018
349DA4,earnings,100,50,5/2/2018
349DA4,earnings,100,50,5/2/2018
35F4B5,earnings-up,100,68,5/2/2018
35F4B5,earnings-up,100,68,5/2/2018
372037,dividend,100,50,5/2/2018
372037,earnings,100,50,5/2/2018
372037,earnings,100,50,5/2/2018
3798B9,earnings,100,50,5/2/2018
384CD3,earnings,100,50,5/2/2018
3.88E+02,dividend,100,50,5/2/2018
38C46F,dividend,100,50,5/2/2018
3A3447,investment-investor,100,55,5/2/2018
3A3447,earnings,100,50,5/2/2018
3BB616,acquisition-acquirer,100,49,5/2/2018
3CBA2A,business-contract,100,69,5/2/2018
3D9999,partnership,100,61,5/2/2018
3DCECC,earnings,100,50,5/2/2018
3DCECC,earnings,100,50,5/2/2018
3DD5E2,conference-participant,100,50,5/2/2018
3E149C,executive-appointment,100,54,5/2/2018
3F1C69,earnings,100,50,5/2/2018
401072,earnings,100,50,5/2/2018
4135F7,revenues,100,50,5/2/2018
41A93D,earnings-up,100,68,5/2/2018
41ED98,conference-call,100,50,5/2/2018
429BFB,conference-participant,100,50,5/2/2018
43E8F5,earnings,100,50,5/2/2018
442769,earnings,100,50,5/2/2018
442769,earnings,100,50,5/2/2018
442769,earnings,100,50,5/2/2018
442769,earnings,100,50,5/2/2018
44740A,earnings,100,50,5/2/2018
448BF3,earnings,100,50,5/2/2018
47FCF2,executive-appointment,100,54,5/2/2018
485445,dividend,100,50,5/2/2018
49A344,earnings,100,50,5/2/2018
49A344,earnings,100,50,5/2/2018
4BDCA7,conference-participant,100,50,5/2/2018
4C1FA1,executive-appointment,100,54,5/2/2018
4C1FA1,executive-appointment,100,54,5/2/2018
4C350A,earnings,100,50,5/2/2018
4C350A,earnings,100,50,5/2/2018
4D8124,dividend,100,50,5/2/2018
4E5784,buybacks,100,74,5/2/2018
4F0A80,earnings,100,50,5/2/2018
5065B1,unit-acquisition-acquirer,100,49,5/2/2018
51D876,earnings,100,50,5/2/2018
51D876,earnings,100,50,5/2/2018
51D876,earnings,100,50,5/2/2018
51D876,earnings,100,50,5/2/2018
51D876,earnings,100,50,5/2/2018
52BF94,earnings,100,50,5/2/2018
52BF94,earnings,100,50,5/2/2018
52BF94,earnings,100,50,5/2/2018
52FB2F,earnings,100,50,5/2/2018
55C9B5,earnings,100,50,5/2/2018
55CD6F,operating-earnings,100,50,5/2/2018
56B7C1,earnings,100,50,5/2/2018
587EDF,earnings-up,100,79,5/2/2018
587EDF,earnings-up,100,79,5/2/2018
587EDF,earnings-up,100,79,5/2/2018
587EDF,earnings-up,100,79,5/2/2018
587EDF,earnings-up,100,79,5/2/2018
587EDF,earnings-up,100,79,5/2/2018
589846,acquisition-acquirer,100,49,5/2/2018
594402,earnings,100,50,5/2/2018
59B229,executive-appointment,100,54,5/2/2018
5AAE17,earnings,100,50,5/2/2018
5AF08A,earnings,100,50,5/2/2018
5B3FA2,product-release,100,64,5/2/2018
5C7601,earnings,100,50,5/2/2018
5DE5A5,conference-participant,100,50,5/2/2018
5F1B7B,debt-extension-recipient,100,73,5/2/2018
5FDBD0,operating-earnings,100,50,5/2/2018
605F40,earnings,100,50,5/2/2018
619882,conference-organizer,100,57,5/2/2018
61E975,earnings-positive,100,69,5/2/2018
64854A,earnings,100,50,5/2/2018
64854A,earnings,100,50,5/2/2018
64FF65,earnings,100,50,5/2/2018
665D7D,conference-participant,100,50,5/2/2018
66CB62,operating-earnings,100,50,5/2/2018
66ECFD,earnings,100,50,5/2/2018
66ECFD,earnings,100,50,5/2/2018
66ECFD,earnings,100,50,5/2/2018
66ECFD,earnings,100,50,5/2/2018
66ECFD,earnings,100,50,5/2/2018
66ECFD,earnings,100,50,5/2/2018
67303E,earnings,100,50,5/2/2018
676FFD,earnings,100,50,5/2/2018
68E6E9,earnings,100,50,5/2/2018
69CE71,earnings,100,50,5/2/2018
69CE71,earnings,100,50,5/2/2018
69CE71,earnings,100,50,5/2/2018
69CE71,earnings,100,50,5/2/2018
69CE71,earnings,100,50,5/2/2018
69CE71,earnings,100,50,5/2/2018
6A01DF,earnings,100,50,5/2/2018
6B0E45,earnings,100,50,5/2/2018
6BF593,earnings-guidance-up,100,83,5/2/2018
6D156D,earnings,100,50,5/2/2018
6D1ADF,earnings,100,50,5/2/2018
6ED519,earnings,100,50,5/2/2018
6ED519,earnings,100,50,5/2/2018
6ED519,private-placement,100,56,5/2/2018
6F39FC,dividend,100,50,5/2/2018
705636,revenues,100,50,5/2/2018
705636,dividend,100,50,5/2/2018
719477,earnings,100,50,5/2/2018
719477,earnings,100,50,5/2/2018
719477,earnings,100,50,5/2/2018
722D55,earnings,100,50,5/2/2018
722D55,earnings,100,50,5/2/2018
722D55,earnings,100,50,5/2/2018
722DE3,earnings,100,50,5/2/2018
722DE3,earnings,100,50,5/2/2018
7273FF,earnings,100,50,5/2/2018
731675,revenues,100,50,5/2/2018
731675,revenues,100,50,5/2/2018
731675,revenues,100,50,5/2/2018
73A213,earnings,100,50,5/2/2018
73A71F,dividend,100,50,5/2/2018
762A3E,conference-organizer,100,57,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
78F9ED,earnings,100,50,5/2/2018
790D0D,earnings,100,50,5/2/2018
797C20,dividend,100,50,5/2/2018
7A0EC4,ipo-completed,100,76,5/2/2018
7A3633,earnings,100,50,5/2/2018
7AB859,business-contract,100,69,5/2/2018
7C62A3,earnings,100,50,5/2/2018
7D85A9,earnings,100,50,5/2/2018
7E3F8F,earnings,100,50,5/2/2018
7E3F8F,earnings,100,50,5/2/2018
7E3F8F,earnings,100,50,5/2/2018
7F3A5F,earnings-up,100,68,5/2/2018
7F3A5F,earnings,100,50,5/2/2018
7F3A5F,earnings,100,50,5/2/2018
7F3A5F,earnings,100,50,5/2/2018
80C400,conference-call,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
8.10E+32,earnings,100,50,5/2/2018
810FAD,earnings-up,100,68,5/2/2018
830BDB,conference-participant,100,50,5/2/2018
85CDC9,earnings,100,50,5/2/2018
85CDC9,partnership,100,61,5/2/2018
85CDC9,partnership,100,61,5/2/2018
85DE00,dividend,100,50,5/2/2018
85DE00,earnings,100,50,5/2/2018
86F123,conference-call,100,50,5/2/2018
87B81A,revenues,100,50,5/2/2018
87B81A,revenues,100,50,5/2/2018
87B81A,revenues,100,50,5/2/2018
87B81A,dividend,100,50,5/2/2018
890FF4,conference-call,100,50,5/2/2018
8A0368,executive-appointment,100,54,5/2/2018
8A0368,conference-participant,100,50,5/2/2018
8AB37F,revenue-up,100,89,5/2/2018
8AB37F,earnings,100,50,5/2/2018
8AB37F,private-placement,100,56,5/2/2018
8B6E7E,earnings-up,100,68,5/2/2018
8B6E7E,earnings,100,50,5/2/2018
8B6E7E,earnings,100,50,5/2/2018
8B6E7E,earnings,100,50,5/2/2018
8C5519,dividend,100,50,5/2/2018
8DAAB9,dividend-up,100,82,5/2/2018
8DAAB9,executive-resignation,100,44,5/2/2018
8DE74B,dividend-up,100,81,5/2/2018
8E4F9A,conference-call,100,50,5/2/2018
8E8E6E,trading-halt,100,43,5/2/2018
8E8E6E,trading-resumed,100,58,5/2/2018
8EF425,earnings,100,50,5/2/2018
8EF425,earnings,100,50,5/2/2018
8EF425,earnings,100,50,5/2/2018
8EF425,earnings,100,50,5/2/2018
8EF425,earnings,100,50,5/2/2018
8EF425,earnings,100,50,5/2/2018
901327,earnings,100,50,5/2/2018
901327,earnings,100,50,5/2/2018
901327,earnings,100,50,5/2/2018
901327,earnings,100,50,5/2/2018
902670,earnings,100,50,5/2/2018
902670,earnings,100,50,5/2/2018
902670,earnings,100,50,5/2/2018
902670,earnings,100,50,5/2/2018
9196A2,conference-organizer,100,57,5/2/2018
92005C,ipo-pricing,100,50,5/2/2018
92B625,conference-call,100,50,5/2/2018
934029,conference-participant,100,50,5/2/2018
93D207,partnership,100,61,5/2/2018
94637C,partnership,100,61,5/2/2018
949625,earnings,100,50,5/2/2018
94C0B5,dividend-up,100,81,5/2/2018
9.65E+09,earnings,100,50,5/2/2018
9.65E+07,conference-call,100,50,5/2/2018
968103,earnings,100,50,5/2/2018
968966,earnings,100,50,5/2/2018
96A6CD,conference-participant,100,50,5/2/2018
96BFF4,earnings,100,50,5/2/2018
9.74E+08,earnings,100,50,5/2/2018
9.74E+08,earnings,100,50,5/2/2018
9.74E+08,earnings,100,50,5/2/2018
99028D,earnings,100,50,5/2/2018
990AD0,conference-organizer,100,57,5/2/2018
990AD0,conference-organizer,100,57,5/2/2018
990AD0,conference-organizer,100,57,5/2/2018
990AD0,conference-organizer,100,57,5/2/2018
990AD0,conference-organizer,100,57,5/2/2018
990AD0,conference-organizer,100,57,5/2/2018
990AD0,conference-organizer,100,57,5/2/2018
99ACAD,earnings,100,50,5/2/2018
99ACAD,earnings,100,50,5/2/2018
99ACAD,earnings,100,50,5/2/2018
99ACAD,earnings,100,50,5/2/2018
9B0C9C,legal-issues-defendant,100,22,5/2/2018
9B4066,dividend,100,50,5/2/2018
9B730A,fast-track-designation,100,81,5/2/2018
9BB35A,dividend,100,50,5/2/2018
9BB35A,earnings-per-share-positive,100,69,5/2/2018
9BB35A,earnings-per-share,100,50,5/2/2018
9BB35A,earnings-per-share,100,50,5/2/2018
9E5C2C,asset-sale,100,62,5/2/2018
9E5C2C,executive-appointment,100,54,5/2/2018
9F048E,earnings,100,50,5/2/2018
9F048E,earnings,100,50,5/2/2018
9F048E,earnings,100,50,5/2/2018
9F048E,earnings,100,50,5/2/2018
9F18FA,note-sale,100,52,5/2/2018
9F18FA,note-sale,100,52,5/2/2018
9F5997,buybacks,100,74,5/2/2018
9F5997,earnings,100,50,5/2/2018
9FB4B7,earnings,100,50,5/2/2018
A01664,conference-participant,100,50,5/2/2018
A1BB98,conference-call,100,50,5/2/2018
A247F5,conference-participant,100,50,5/2/2018
A398F8,earnings,100,50,5/2/2018
A3AAA5,earnings,100,50,5/2/2018
A3F598,earnings,100,50,5/2/2018
A3F598,earnings,100,50,5/2/2018
A3F598,earnings,100,50,5/2/2018
A3F598,earnings,100,50,5/2/2018
A4386C,executive-appointment,100,54,5/2/2018
A47F2E,public-offering,100,43,5/2/2018
A4CD53,executive-appointment,100,54,5/2/2018
A52B6B,earnings,100,50,5/2/2018
A5DD24,earnings,100,50,5/2/2018
A6213D,facility-open,100,65,5/2/2018
A63387,revenue-up,100,69,5/2/2018
A63387,earnings,100,50,5/2/2018
A63387,earnings,100,50,5/2/2018
A63387,earnings,100,50,5/2/2018
A70BF5,earnings,100,50,5/2/2018
A70BF5,earnings,100,50,5/2/2018
A70BF5,earnings,100,50,5/2/2018
A70BF5,earnings,100,50,5/2/2018
A70BF5,earnings,100,50,5/2/2018
A7102F,executive-appointment,100,54,5/2/2018
A806FA,earnings,100,50,5/2/2018
A806FA,earnings,100,50,5/2/2018
A806FA,earnings,100,50,5/2/2018
A8AC4C,earnings,100,50,5/2/2018
AA09AD,earnings,100,50,5/2/2018
AAEE21,earnings,100,50,5/2/2018
AD1ACF,investment-investor,100,55,5/2/2018
ADFB3A,conference-participant,100,50,5/2/2018
B04426,conference-call,100,50,5/2/2018
B09B1F,earnings-up,100,68,5/2/2018
B09B1F,earnings,100,50,5/2/2018
B09B1F,earnings,100,50,5/2/2018
B0D41A,conference-participant,100,50,5/2/2018
B0FE08,earnings-up,100,68,5/2/2018
B0FE08,earnings-up,100,68,5/2/2018
B0FE08,earnings-up,100,68,5/2/2018
B0FE08,earnings-up,100,68,5/2/2018
B1A85D,earnings,100,50,5/2/2018
B1A85D,executive-appointment,100,54,5/2/2018
B2E6B5,dividend,100,50,5/2/2018
B2E6B5,earnings,100,50,5/2/2018
B2E6B5,earnings,100,50,5/2/2018
B2E6B5,earnings,100,50,5/2/2018
B303A6,earnings,100,50,5/2/2018
B303A6,earnings,100,50,5/2/2018
B303A6,earnings,100,50,5/2/2018
B303A6,earnings,100,50,5/2/2018
B4C673,earnings-up,100,68,5/2/2018
B7202A,conference-participant,100,50,5/2/2018
B840EF,earnings,100,50,5/2/2018
B934BF,earnings,100,50,5/2/2018
B9764A,conference-participant,100,50,5/2/2018
B98EFA,operating-earnings,100,50,5/2/2018
B9CD50,conference-participant,100,50,5/2/2018
BB127B,acquisition-completed-acquirer,100,49,5/2/2018
BB58FF,earnings-up,100,68,5/2/2018
BFD0A7,conference-call,100,50,5/2/2018
C03C8B,earnings,100,50,5/2/2018
C03C8B,earnings,100,50,5/2/2018
C03C8B,earnings,100,50,5/2/2018
C03C8B,earnings,100,50,5/2/2018
C03C8B,earnings,100,50,5/2/2018
C188F8,earnings,100,50,5/2/2018
C2E426,earnings,100,50,5/2/2018
C356AC,dividend,100,50,5/2/2018
C356AC,earnings,100,50,5/2/2018
C356AC,earnings,100,50,5/2/2018
C356AC,earnings,100,50,5/2/2018
C356AC,earnings,100,50,5/2/2018
C38440,earnings,100,50,5/2/2018
C38440,earnings,100,50,5/2/2018
C3DE7D,earnings,100,50,5/2/2018
C4C77F,executive-appointment,100,54,5/2/2018
C50B26,conference-call,100,50,5/2/2018
C584BE,earnings,100,50,5/2/2018
C5C137,earnings,100,50,5/2/2018
C5D2AE,conference-participant,100,50,5/2/2018
C5E100,earnings,100,50,5/2/2018
C5E100,earnings,100,50,5/2/2018
C62AA4,earnings,100,50,5/2/2018
C7AE14,earnings,100,50,5/2/2018
C7FC95,executive-appointment,100,54,5/2/2018
C951A2,earnings,100,50,5/2/2018
C951A2,earnings,100,50,5/2/2018
C951A2,earnings,100,50,5/2/2018
C951A2,earnings,100,50,5/2/2018
C951A2,earnings,100,50,5/2/2018
C98CDB,earnings,100,50,5/2/2018
C99CC8,earnings,100,50,5/2/2018
C99CC8,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
C9D866,earnings,100,50,5/2/2018
CA14CC,earnings,100,50,5/2/2018
CA14CC,earnings,100,50,5/2/2018
CA99D7,conference-call,100,50,5/2/2018
CB6A9C,earnings,100,50,5/2/2018
CB7AB2,earnings,100,50,5/2/2018
CBBFBF,earnings,100,50,5/2/2018
CBBFBF,earnings,100,50,5/2/2018
CBFFDD,conference-participant,100,50,5/2/2018
CC3EC4,conference-call,100,50,5/2/2018
CD2A4D,earnings,100,50,5/2/2018
CDAB24,earnings-up,100,68,5/2/2018
CDD75E,earnings-guidance,100,50,5/2/2018
CE5C6E,earnings,100,50,5/2/2018
CE96E7,dividend,100,50,5/2/2018
CEC5B9,buybacks,100,74,5/2/2018
CFE5BE,executive-appointment,100,54,5/2/2018
D04D9F,earnings,100,50,5/2/2018
D06755,earnings,100,50,5/2/2018
D06755,earnings,100,50,5/2/2018
D06755,earnings,100,50,5/2/2018
D20C8F,earnings,100,50,5/2/2018
D296C6,earnings,100,50,5/2/2018
D2B9E5,earnings,100,50,5/2/2018
D2B9E5,earnings,100,50,5/2/2018
D2B9E5,earnings,100,50,5/2/2018
D2B9E5,earnings,100,50,5/2/2018
D2B9E5,earnings,100,50,5/2/2018
D2C0B6,earnings,100,50,5/2/2018
D5A350,dividend,100,50,5/2/2018
D6144F,conference-call,100,50,5/2/2018
D650A7,dividend-up,100,81,5/2/2018
D650A7,operating-earnings-up,100,79,5/2/2018
D650A7,operating-earnings-up,100,79,5/2/2018
D650A7,operating-earnings-up,100,79,5/2/2018
D6853F,dividend,100,50,5/2/2018
D77F7E,executive-appointment,100,54,5/2/2018
D854DD,earnings,100,50,5/2/2018
D96202,earnings,100,50,5/2/2018
DB7014,operating-earnings,100,50,5/2/2018
DB9F70,conference-participant,100,50,5/2/2018
DD3BB1,earnings,100,50,5/2/2018
DDCB34,conference-participant,100,50,5/2/2018
DDEA6A,conference-participant,100,50,5/2/2018
E06265,earnings,100,50,5/2/2018
E16133,conference-call,100,50,5/2/2018
E1E36F,earnings,100,50,5/2/2018
E1E36F,earnings,100,50,5/2/2018
E1E36F,earnings,100,50,5/2/2018
E1E36F,earnings,100,50,5/2/2018
E1E36F,earnings,100,50,5/2/2018
E1E36F,earnings,100,50,5/2/2018
E20392,earnings,100,50,5/2/2018
E21871,earnings,100,50,5/2/2018
E28D9C,earnings,100,50,5/2/2018
E30A8F,earnings,100,50,5/2/2018
E30A8F,earnings,100,50,5/2/2018
E30A8F,earnings,100,50,5/2/2018
E30A8F,earnings,100,50,5/2/2018
E35610,earnings,100,50,5/2/2018
E35610,earnings,100,50,5/2/2018
E35610,earnings,100,50,5/2/2018
E3E68E,earnings,100,50,5/2/2018
E68733,regulatory-product-approval-granted,100,81,5/2/2018
E68C3D,earnings,100,50,5/2/2018
E74B55,earnings,100,50,5/2/2018
E74B55,index-listing,100,76,5/2/2018
E8C557,earnings,100,50,5/2/2018
E96E0B,conference-participant,100,50,5/2/2018
EA62FC,conference-participant,100,50,5/2/2018
EC99D0,dividend,100,50,5/2/2018
ED79D9,acquisition-acquirer,100,49,5/2/2018
EE6F1C,earnings-up,100,68,5/2/2018
EE6F1C,earnings,100,50,5/2/2018
EE6F1C,earnings,100,50,5/2/2018
EEBCEF,earnings,100,50,5/2/2018
EEEA9F,public-offering,100,43,5/2/2018
F02D0A,earnings-per-share-positive,100,69,5/2/2018
F02D0A,earnings,100,50,5/2/2018
F0B335,earnings,100,50,5/2/2018
F0B335,legal-issues-defendant,100,22,5/2/2018
F0EEFB,earnings,100,50,5/2/2018
F1C04C,operating-earnings,100,50,5/2/2018
F2E253,dividend,100,50,5/2/2018
F32F88,conference-participant,100,50,5/2/2018
F3816D,earnings,100,50,5/2/2018
F4CDA3,earnings,100,50,5/2/2018
F4CDA3,earnings,100,50,5/2/2018
F4CDA3,earnings,100,50,5/2/2018
F4CDA3,earnings,100,50,5/2/2018
F4CDA3,earnings,100,50,5/2/2018
F72E4B,business-contract,100,69,5/2/2018
F73DD1,dividend,100,50,5/2/2018
F80FF9,product-release,100,64,5/2/2018
F88A04,dividend,100,50,5/2/2018
F8C5D7,earnings,100,50,5/2/2018
F8C5D7,earnings,100,50,5/2/2018
F8C5D7,earnings,100,50,5/2/2018
F8C5D7,earnings,100,50,5/2/2018
F8C5D7,earnings,100,50,5/2/2018
F8C5D7,earnings,100,50,5/2/2018
F8C5D7,earnings,100,50,5/2/2018
F93C8A,earnings,100,50,5/2/2018
FA35C6,earnings,100,50,5/2/2018
FBD92D,earnings,100,50,5/2/2018
FD2565,conference-call,100,50,5/2/2018
FEC475,earnings,100,50,5/2/2018
00067A,conference-participant,100,50,5/3/2018
00326D,conference-call,100,50,5/3/2018
00326E,earnings,100,50,5/3/2018
003B70,executive-appointment,100,54,5/3/2018
9397,earnings,100,50,5/3/2018
9397,earnings,100,50,5/3/2018
0142B5,earnings-per-share-positive,100,69,5/3/2018
036C6F,conference-call,100,50,5/3/2018
03FAA6,earnings,100,50,5/3/2018
03FAA6,earnings,100,50,5/3/2018
03FAA6,earnings,100,50,5/3/2018
03FAA6,earnings,100,50,5/3/2018
03FAA6,earnings,100,50,5/3/2018
48590,earnings,100,50,5/3/2018
55018,dividend,100,50,5/3/2018
58828,earnings-per-share-up,100,75,5/3/2018
84625,dividend-up,100,54,5/3/2018
09062E,conference-participant,100,50,5/3/2018
099C88,government-contract,100,69,5/3/2018
0A77DB,earnings,100,50,5/3/2018
0A9D0A,dividend,100,50,5/3/2018
0C136E,partnership,100,61,5/3/2018
0C6861,board-meeting,100,51,5/3/2018
0C6861,board-meeting,100,51,5/3/2018
0CADBC,dividend,100,50,5/3/2018
0CE204,earnings,100,50,5/3/2018
0D03C8,earnings,100,50,5/3/2018
0E439E,dividend,100,50,5/3/2018
0E499E,earnings,100,50,5/3/2018
0E5619,conference-call,100,50,5/3/2018
0F2BC9,earnings,100,50,5/3/2018
0FABBD,earnings-up,100,68,5/3/2018
106394,earnings,100,50,5/3/2018
1080C0,conference-participant,100,50,5/3/2018
138DDE,earnings,100,50,5/3/2018
13C3E0,business-contract,100,69,5/3/2018
13C3E0,business-contract,100,69,5/3/2018
13C3E0,business-contract,100,69,5/3/2018
147C38,dividend,100,50,5/3/2018
149301,earnings,100,50,5/3/2018
14BA06,conference-participant,100,50,5/3/2018
15789A,earnings,100,50,5/3/2018
15789A,earnings,100,50,5/3/2018
16C544,earnings,100,50,5/3/2018
196D18,conference-participant,100,50,5/3/2018
1A5957,earnings,100,50,5/3/2018
1A5957,earnings,100,50,5/3/2018
1A5957,earnings,100,50,5/3/2018
1A5957,earnings,100,50,5/3/2018
1A6A94,earnings,100,50,5/3/2018
1B16C1,earnings-guidance,100,50,5/3/2018
1B4F31,earnings,100,50,5/3/2018
1B4F31,earnings,100,50,5/3/2018
1B4F31,earnings,100,50,5/3/2018
1B4F31,earnings,100,50,5/3/2018
1B637E,dividend,100,50,5/3/2018
1B9535,earnings,100,50,5/3/2018
1D9E55,earnings,100,50,5/3/2018
1E04A5,earnings-up,100,68,5/3/2018
1E04A5,earnings,100,50,5/3/2018
1E04A5,earnings,100,50,5/3/2018
1EBF8D,partnership,100,61,5/3/2018
1F08A6,earnings,100,50,5/3/2018
1F3CFB,earnings,100,50,5/3/2018
1F3CFB,executive-resignation,100,44,5/3/2018
1F464F,earnings,100,50,5/3/2018
1F716B,legal-issues-defendant,100,22,5/3/2018
1F9258,earnings,100,50,5/3/2018
1FC422,conference-participant,100,50,5/3/2018
2096DE,earnings,100,50,5/3/2018
21022F,earnings,100,50,5/3/2018
219B21,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
225CA2,earnings,100,50,5/3/2018
23207A,conference-call,100,50,5/3/2018
2.45E+15,dividend,100,50,5/3/2018
249674,executive-appointment,100,54,5/3/2018
24C48B,partnership,100,61,5/3/2018
24C48B,dividend,100,50,5/3/2018
253B2F,earnings,100,50,5/3/2018
253B2F,earnings,100,50,5/3/2018
25AB8E,partnership,100,61,5/3/2018
27C10F,earnings,100,50,5/3/2018
27C10F,earnings,100,50,5/3/2018
27C10F,earnings,100,50,5/3/2018
2A1009,earnings,100,50,5/3/2018
2AA6A8,earnings,100,50,5/3/2018
2B5483,earnings,100,50,5/3/2018
2BAE5F,conference-call,100,50,5/3/2018
2BC05E,dividend,100,50,5/3/2018
2BDC1C,earnings,100,50,5/3/2018
2C19A4,earnings,100,50,5/3/2018
2C19A4,earnings,100,50,5/3/2018
2C19A4,earnings,100,50,5/3/2018
2C7505,earnings,100,50,5/3/2018
2CA60F,earnings,100,50,5/3/2018
2F7A7E,earnings,100,50,5/3/2018
2F94A5,executive-resignation,100,44,5/3/2018
3159AA,earnings,100,50,5/3/2018
31803E,earnings,100,50,5/3/2018
32F943,earnings,100,50,5/3/2018
32F943,partnership,100,61,5/3/2018
32F943,partnership,100,61,5/3/2018
34A959,revenues,100,50,5/3/2018
3587B4,earnings,100,50,5/3/2018
3587B4,earnings,100,50,5/3/2018
3587B4,earnings,100,50,5/3/2018
3587B4,earnings,100,50,5/3/2018
371B0A,earnings,100,50,5/3/2018
37B618,earnings,100,50,5/3/2018
383ADA,earnings,100,50,5/3/2018
385DD4,product-release,100,64,5/3/2018
387375,earnings,100,50,5/3/2018
3ACF46,earnings,100,50,5/3/2018
3ACF46,earnings,100,50,5/3/2018
3ACF46,earnings,100,50,5/3/2018
3ACF46,earnings,100,50,5/3/2018
3B20AB,conference-participant,100,50,5/3/2018
3B2311,earnings,100,50,5/3/2018
3B37F7,conference-organizer,100,57,5/3/2018
3B8484,earnings-up,100,68,5/3/2018
3BE00F,dividend,100,50,5/3/2018
3C7F5F,earnings,100,50,5/3/2018
3C7F5F,earnings,100,50,5/3/2018
3DC887,earnings,100,50,5/3/2018
3DDE54,earnings,100,50,5/3/2018
3DDE54,earnings,100,50,5/3/2018
3DDE54,earnings,100,50,5/3/2018
3DDE54,earnings,100,50,5/3/2018
3DDE54,earnings,100,50,5/3/2018
3E39A5,conference-participant,100,50,5/3/2018
3E70FC,earnings,100,50,5/3/2018
3ED92D,earnings,100,50,5/3/2018
3ED92D,earnings,100,50,5/3/2018
3ED92D,earnings,100,50,5/3/2018
3ED92D,earnings,100,50,5/3/2018
3ED92D,earnings,100,50,5/3/2018
3ED92D,earnings,100,50,5/3/2018
3ED92D,earnings,100,50,5/3/2018
3F4668,executive-appointment,100,54,5/3/2018
4017AD,earnings,100,50,5/3/2018
408380,earnings,100,50,5/3/2018
415188,dividend,100,50,5/3/2018
415188,earnings,100,50,5/3/2018
45444E,business-contract,100,69,5/3/2018
45BC35,partnership,100,61,5/3/2018
46017C,earnings,100,50,5/3/2018
4.60E+06,earnings,100,50,5/3/2018
4.91E+58,patent-awarded,100,72,5/3/2018
499C75,earnings,100,50,5/3/2018
499C75,earnings,100,50,5/3/2018
499C75,earnings,100,50,5/3/2018
49CC59,earnings,100,50,5/3/2018
49CC59,executive-resignation,100,44,5/3/2018
49F4D0,earnings,100,50,5/3/2018
4A3438,earnings,100,50,5/3/2018
4A3438,earnings,100,50,5/3/2018
4A3438,earnings,100,50,5/3/2018
4BEB48,earnings,100,50,5/3/2018
4BEB48,earnings,100,50,5/3/2018
4BEB48,earnings,100,50,5/3/2018
4BEB48,earnings,100,50,5/3/2018
4D8124,earnings,100,50,5/3/2018
4D8124,earnings,100,50,5/3/2018
4E5784,earnings,100,50,5/3/2018
4EEE7E,earnings,100,50,5/3/2018
4F783B,dividend,100,50,5/3/2018
50070E,conference-organizer,100,57,5/3/2018
50070E,earnings,100,50,5/3/2018
50070E,conference-organizer,100,57,5/3/2018
504FE2,earnings,100,50,5/3/2018
507AE7,dividend,100,50,5/3/2018
524CE4,earnings,100,50,5/3/2018
525A1C,executive-appointment,100,54,5/3/2018
525A1C,earnings,100,50,5/3/2018
525A1C,earnings,100,50,5/3/2018
525A1C,earnings,100,50,5/3/2018
525A1C,earnings,100,50,5/3/2018
525A1C,earnings,100,50,5/3/2018
525A1C,earnings,100,50,5/3/2018
53E575,conference-call,100,50,5/3/2018
54512F,earnings,100,50,5/3/2018
546A27,earnings,100,50,5/3/2018
5487B1,earnings,100,50,5/3/2018
5487B1,earnings,100,50,5/3/2018
5487B1,earnings,100,50,5/3/2018
5487B1,earnings,100,50,5/3/2018
548AC0,earnings,100,50,5/3/2018
54A713,dividend,100,50,5/3/2018
54DF47,earnings-guidance-up,100,83,5/3/2018
55438C,business-contract,100,69,5/3/2018
55ACCB,earnings,100,50,5/3/2018
55ACCB,earnings,100,50,5/3/2018
55ACCB,earnings,100,50,5/3/2018
56277A,conference-participant,100,50,5/3/2018
562853,conference-participant,100,50,5/3/2018
56765E,earnings,100,50,5/3/2018
56FB7C,dividend-up,100,81,5/3/2018
5704AC,operating-earnings,100,50,5/3/2018
57634F,earnings,100,50,5/3/2018
57B174,earnings,100,50,5/3/2018
57B174,earnings,100,50,5/3/2018
57B174,earnings,100,50,5/3/2018
57B174,earnings,100,50,5/3/2018
57B174,earnings,100,50,5/3/2018
583223,earnings,100,50,5/3/2018
586BD7,earnings,100,50,5/3/2018
589803,earnings,100,50,5/3/2018
58C2D4,earnings,100,50,5/3/2018
5968F9,earnings,100,50,5/3/2018
5A0FF1,earnings,100,50,5/3/2018
5A0FF1,earnings,100,50,5/3/2018
5A9A82,earnings,100,50,5/3/2018
5A9A82,earnings,100,50,5/3/2018
5A9A82,earnings,100,50,5/3/2018
5A9A82,earnings,100,50,5/3/2018
5B3FA2,conference-participant,100,50,5/3/2018
5C8D61,conference-participant,100,50,5/3/2018
5F3E74,earnings,100,50,5/3/2018
619882,conference-organizer,100,57,5/3/2018
619882,conference-organizer,100,57,5/3/2018
619882,conference-organizer,100,57,5/3/2018
619882,product-release,100,64,5/3/2018
619882,conference-participant,100,50,5/3/2018
619882,conference-organizer,100,57,5/3/2018
619882,conference-organizer,100,57,5/3/2018
62B1C6,earnings,100,50,5/3/2018
63F892,earnings,100,50,5/3/2018
641F17,dividend,100,50,5/3/2018
649CBD,earnings,100,50,5/3/2018
6.52E+64,earnings,100,50,5/3/2018
6810DE,earnings,100,50,5/3/2018
68B03F,executive-appointment,100,54,5/3/2018
68E3E0,earnings,100,50,5/3/2018
68E3E0,earnings,100,50,5/3/2018
68E3E0,earnings,100,50,5/3/2018
68E3E0,earnings,100,50,5/3/2018
69345C,conference-participant,100,50,5/3/2018
69494C,earnings,100,50,5/3/2018
69C99E,board-meeting,100,51,5/3/2018
6A3C35,earnings,100,50,5/3/2018
6A3C35,earnings,100,50,5/3/2018
6A3C35,earnings,100,50,5/3/2018
6A3C35,earnings,100,50,5/3/2018
6B0784,earnings,100,50,5/3/2018
6BD606,dividend,100,50,5/3/2018
6CDFC6,executive-appointment,100,54,5/3/2018
6D2BF6,partnership,100,61,5/3/2018
6E705B,executive-appointment,100,54,5/3/2018
6EA292,earnings,100,50,5/3/2018
6F92A9,earnings,100,50,5/3/2018
704B78,earnings,100,50,5/3/2018
705636,buybacks,100,74,5/3/2018
71553E,public-offering,100,43,5/3/2018
71B0CF,earnings,100,50,5/3/2018
724F84,conference-organizer,100,57,5/3/2018
7255D2,earnings,100,50,5/3/2018
73A71F,earnings,100,50,5/3/2018
73BCBA,executive-appointment,100,54,5/3/2018
741937,earnings-up,100,68,5/3/2018
741937,earnings,100,50,5/3/2018
741937,earnings,100,50,5/3/2018
742AAB,earnings,100,50,5/3/2018
7.44E+09,earnings-positive,100,69,5/3/2018
7.44E+09,earnings,100,50,5/3/2018
7.44E+09,earnings,100,50,5/3/2018
7.44E+09,earnings,100,50,5/3/2018
7.44E+09,earnings,100,50,5/3/2018
743C70,earnings,100,50,5/3/2018
743C70,earnings,100,50,5/3/2018
7.49E+07,earnings,100,50,5/3/2018
763724,earnings-up,100,68,5/3/2018
763724,executive-appointment,100,54,5/3/2018
767F86,product-release,100,64,5/3/2018
76BECC,conference-call,100,50,5/3/2018
787D14,earnings-guidance,100,50,5/3/2018
789ADD,earnings,100,50,5/3/2018
789ADD,earnings,100,50,5/3/2018
789ADD,earnings,100,50,5/3/2018
79340A,earnings,100,50,5/3/2018
793C11,earnings,100,50,5/3/2018
793C11,earnings,100,50,5/3/2018
793C11,earnings,100,50,5/3/2018
7AC86E,dividend,100,50,5/3/2018
7B0BA6,business-contract,100,69,5/3/2018
7B492C,earnings,100,50,5/3/2018
7B6EB1,earnings,100,50,5/3/2018
7B8CB5,earnings,100,50,5/3/2018
7B9AFA,conference-participant,100,50,5/3/2018
7BC92D,earnings,100,50,5/3/2018
7C4F43,earnings,100,50,5/3/2018
7CD98F,earnings,100,50,5/3/2018
7DC1C4,earnings,100,50,5/3/2018
7F9BE2,earnings,100,50,5/3/2018
7FD8B9,conference-participant,100,50,5/3/2018
80C400,earnings,100,50,5/3/2018
8.10E+32,executive-appointment,100,54,5/3/2018
810FAD,conference-participant,100,50,5/3/2018
8.10E+205,earnings,100,50,5/3/2018
835C86,earnings,100,50,5/3/2018
838ADD,dividend,100,50,5/3/2018
83A065,earnings,100,50,5/3/2018
83E0AC,dividend,100,50,5/3/2018
86A1B9,earnings-up,100,68,5/3/2018
86A1B9,earnings-up,100,68,5/3/2018
86A1B9,earnings-up,100,68,5/3/2018
86A1B9,earnings-up,100,68,5/3/2018
893904,conference-participant,100,50,5/3/2018
8A0368,earnings,100,50,5/3/2018
8A0368,earnings,100,50,5/3/2018
8A0368,earnings,100,50,5/3/2018
8A0368,earnings,100,50,5/3/2018
8A8E41,board-meeting,100,51,5/3/2018
8AC740,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B1F37,earnings,100,50,5/3/2018
8B3B0E,dividend,100,50,5/3/2018
8DBBE6,earnings,100,50,5/3/2018
8DE56F,earnings,100,50,5/3/2018
8DE56F,earnings,100,50,5/3/2018
8FF57A,business-contract,100,69,5/3/2018
9043FE,earnings,100,50,5/3/2018
9043FE,earnings,100,50,5/3/2018
905356,conference-call,100,50,5/3/2018
9196A2,conference-organizer,100,57,5/3/2018
93AD2E,earnings,100,50,5/3/2018
944B2E,note-sale,100,52,5/3/2018
944B2E,note-sale,100,52,5/3/2018
9470CC,earnings,100,50,5/3/2018
947B0B,business-contract,100,69,5/3/2018
947B0B,earnings,100,50,5/3/2018
94983E,earnings,100,50,5/3/2018
95C392,earnings,100,50,5/3/2018
9.62E+76,dividend-up,100,81,5/3/2018
9673BD,dividend,100,50,5/3/2018
967D92,earnings,100,50,5/3/2018
971F7B,earnings,100,50,5/3/2018
971F7B,earnings,100,50,5/3/2018
971F7B,earnings,100,50,5/3/2018
971F7B,earnings,100,50,5/3/2018
97AAF6,earnings,100,50,5/3/2018
97AAF6,earnings,100,50,5/3/2018
9.86E+03,earnings,100,50,5/3/2018
990AD0,conference-organizer,100,57,5/3/2018
990AD0,conference-organizer,100,57,5/3/2018
9.92E+94,executive-appointment,100,54,5/3/2018
9.97E+09,earnings,100,50,5/3/2018
9A602D,dividend,100,50,5/3/2018
9AF3DC,earnings,100,50,5/3/2018
9C25FF,earnings,100,50,5/3/2018
9C5174,revenue-up,100,70,5/3/2018
9C5174,revenues,100,50,5/3/2018
9C8BC3,partnership,100,61,5/3/2018
9D30A8,earnings,100,50,5/3/2018
9E3224,earnings,100,50,5/3/2018
9F03CF,note-sale,100,52,5/3/2018
9F5997,conference-participant,100,50,5/3/2018
9F71E5,revenue-up,100,69,5/3/2018
9F71E5,dividend,100,50,5/3/2018
9FD2D9,earnings,100,50,5/3/2018
9FD2D9,earnings,100,50,5/3/2018
9FD2D9,earnings,100,50,5/3/2018
A072C4,conference-call,100,50,5/3/2018
A1E3B3,earnings,100,50,5/3/2018
A1EAC8,earnings,100,50,5/3/2018
A28675,earnings,100,50,5/3/2018
A3800A,dividend,100,50,5/3/2018
A3BFAA,executive-appointment,100,54,5/3/2018
A4386C,earnings,100,50,5/3/2018
A4386C,earnings,100,50,5/3/2018
A4386C,earnings,100,50,5/3/2018
A4386C,earnings,100,50,5/3/2018
A43906,earnings,100,50,5/3/2018
A43906,earnings,100,50,5/3/2018
A47F2E,clinical-trials,100,56,5/3/2018
A4B899,earnings-up,100,68,5/3/2018
A52533,earnings,100,50,5/3/2018
A6828A,conference-participant,100,50,5/3/2018
A753BB,earnings,100,50,5/3/2018
A7F0A5,earnings,100,50,5/3/2018
A94637,revenues,100,50,5/3/2018
A94637,revenues,100,50,5/3/2018
AB4A7E,earnings,100,50,5/3/2018
ABBAD1,business-contract,100,69,5/3/2018
AC3584,revenue-up,100,79,5/3/2018
AC3584,revenue-up,100,79,5/3/2018
AC642C,earnings,100,50,5/3/2018
AC642C,earnings,100,50,5/3/2018
AD23DE,board-meeting,100,51,5/3/2018
AD23DE,dividend,100,50,5/3/2018
ADD9DC,facility-open,100,65,5/3/2018
AEBB80,earnings,100,50,5/3/2018
AF210D,joint-venture,100,62,5/3/2018
AF93DE,earnings,100,50,5/3/2018
B05118,earnings,100,50,5/3/2018
B0998E,earnings-up,100,68,5/3/2018
B0998E,earnings,100,50,5/3/2018
B0998E,earnings,100,50,5/3/2018
B0998E,earnings,100,50,5/3/2018
B0998E,earnings,100,50,5/3/2018
B0B969,conference-call,100,50,5/3/2018
B0D41A,earnings,100,50,5/3/2018
B106FA,earnings,100,50,5/3/2018
B13B68,partnership,100,61,5/3/2018
B2D492,earnings,100,50,5/3/2018
B3ED62,executive-appointment,100,54,5/3/2018
B3ED62,earnings,100,50,5/3/2018
B5BA39,earnings,100,50,5/3/2018
B5BA39,earnings,100,50,5/3/2018
B5BA39,earnings,100,50,5/3/2018
B5BA39,earnings,100,50,5/3/2018
B5BA39,earnings,100,50,5/3/2018
B5BA39,earnings,100,50,5/3/2018
B5BA39,dividend,100,50,5/3/2018
BAD9EA,executive-appointment,100,54,5/3/2018
BD44C9,earnings,100,50,5/3/2018
BD8517,note-sale,100,52,5/3/2018
BDEC1E,earnings,100,50,5/3/2018
BE7BA4,earnings,100,50,5/3/2018
BF79F5,dividend-up,100,81,5/3/2018
BFEA04,earnings,100,50,5/3/2018
BFEA04,earnings,100,50,5/3/2018
BFEA04,earnings,100,50,5/3/2018
BFEA04,earnings,100,50,5/3/2018
C0030A,earnings,100,50,5/3/2018
C0030A,earnings,100,50,5/3/2018
C0030A,earnings,100,50,5/3/2018
C0030A,earnings,100,50,5/3/2018
C0030A,earnings,100,50,5/3/2018
C01737,earnings,100,50,5/3/2018
C01737,earnings,100,50,5/3/2018
C06EB6,earnings,100,50,5/3/2018
C2DD02,conference-call,100,50,5/3/2018
C624A1,earnings,100,50,5/3/2018
C624A1,earnings,100,50,5/3/2018
C6C702,earnings,100,50,5/3/2018
C8923A,conference-participant,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C8A248,earnings,100,50,5/3/2018
C9A96E,earnings,100,50,5/3/2018
CA212F,dividend,100,50,5/3/2018
CA3CB9,earnings,100,50,5/3/2018
CC8F6E,legal-issues-defendant,100,22,5/3/2018
CEC08B,earnings-up,100,68,5/3/2018
CEC5B9,earnings,100,50,5/3/2018
CEC5B9,earnings,100,50,5/3/2018
CEC5B9,earnings,100,50,5/3/2018
CED4D0,earnings,100,50,5/3/2018
CFD4B6,earnings-up,100,68,5/3/2018
CFD4B6,earnings,100,50,5/3/2018
CFD4B6,earnings,100,50,5/3/2018
D03C7A,earnings,100,50,5/3/2018
D11C1C,conference-call,100,50,5/3/2018
D17C1B,market-entry,100,57,5/3/2018
D25249,earnings,100,50,5/3/2018
D29B44,earnings,100,50,5/3/2018
D29B44,earnings,100,50,5/3/2018
D29B44,earnings,100,50,5/3/2018
D29B44,earnings,100,50,5/3/2018
D29B44,earnings,100,50,5/3/2018
D29B44,earnings,100,50,5/3/2018
D29B44,partnership,100,61,5/3/2018
D29B44,product-release,100,64,5/3/2018
D3CEDF,legal-issues-defendant,100,22,5/3/2018
D3CEDF,legal-issues-defendant,100,22,5/3/2018
D4070C,board-meeting,100,51,5/3/2018
D4070C,dividend,100,50,5/3/2018
D65A13,revenue-up,100,77,5/3/2018
D65A13,revenues,100,50,5/3/2018
D65A13,revenue-up,100,77,5/3/2018
D6853F,earnings,100,50,5/3/2018
D6853F,earnings,100,50,5/3/2018
D8DA3D,earnings,100,50,5/3/2018
D8DA3D,earnings,100,50,5/3/2018
D8DA3D,earnings,100,50,5/3/2018
D8DA3D,earnings,100,50,5/3/2018
D8DA3D,earnings,100,50,5/3/2018
D8DA3D,earnings,100,50,5/3/2018
D8ECA1,earnings,100,50,5/3/2018
DA9443,earnings,100,50,5/3/2018
DB5CA5,dividend,100,50,5/3/2018
DBB28E,partnership,100,61,5/3/2018
DC0D18,earnings,100,50,5/3/2018
DC0D18,earnings,100,50,5/3/2018
DC0D18,earnings,100,50,5/3/2018
DC2F77,earnings,100,50,5/3/2018
DC5299,operating-earnings,100,50,5/3/2018
DD682D,earnings,100,50,5/3/2018
DE20DF,operating-earnings,100,50,5/3/2018
DE4924,dividend,100,50,5/3/2018
DE4924,earnings,100,50,5/3/2018
E11C41,earnings,100,50,5/3/2018
E22FDE,partnership,100,61,5/3/2018
E2CFD2,earnings,100,50,5/3/2018
E2CFD2,partnership,100,61,5/3/2018
E393B0,acquisition-acquirer,100,49,5/3/2018
E393B0,acquisition-acquirer,100,49,5/3/2018
E49AA3,earnings,100,50,5/3/2018
E592F0,earnings,100,50,5/3/2018
E592F0,earnings,100,50,5/3/2018
E592F0,earnings,100,50,5/3/2018
E592F0,earnings,100,50,5/3/2018
E67C2C,earnings,100,50,5/3/2018
E74FED,earnings,100,50,5/3/2018
E7BF32,earnings,100,50,5/3/2018
E7BF32,earnings,100,50,5/3/2018
E8846E,facility-upgrade,100,65,5/3/2018
E9C7C0,partnership,100,61,5/3/2018
EAA0A7,earnings,100,50,5/3/2018
EAA0A7,earnings,100,50,5/3/2018
EAA0A7,earnings,100,50,5/3/2018
EAA0A7,earnings,100,50,5/3/2018
EAEBF3,earnings,100,50,5/3/2018
EAEBF3,business-contract,100,69,5/3/2018
EB5E78,earnings-above-expectations,100,88,5/3/2018
EB5E78,earnings-above-expectations,100,88,5/3/2018
EB5E78,earnings-above-expectations,100,88,5/3/2018
EB5E78,earnings-above-expectations,100,88,5/3/2018
EC70EC,earnings,100,50,5/3/2018
EC70EC,earnings,100,50,5/3/2018
EC70EC,earnings,100,50,5/3/2018
EC70EC,earnings,100,50,5/3/2018
EC70EC,earnings,100,50,5/3/2018
ED3CA8,earnings,100,50,5/3/2018
ED4560,earnings,100,50,5/3/2018
EFD406,earnings,100,50,5/3/2018
EFD406,earnings,100,50,5/3/2018
EFD406,earnings,100,50,5/3/2018
EFD406,earnings,100,50,5/3/2018
EFD406,earnings,100,50,5/3/2018
EFD406,earnings,100,50,5/3/2018
F0027C,earnings,100,50,5/3/2018
F1C04C,dividend,100,50,5/3/2018
F47871,public-offering,100,43,5/3/2018
F47871,earnings,100,50,5/3/2018
F4F46F,earnings,100,50,5/3/2018
F51DB0,earnings,100,50,5/3/2018
F5D410,conference-participant,100,50,5/3/2018
F721A7,earnings,100,50,5/3/2018
F721A7,earnings,100,50,5/3/2018
F7935D,earnings,100,50,5/3/2018
F7FCA4,earnings,100,50,5/3/2018
F7FCA4,earnings,100,50,5/3/2018
F7FCA4,earnings,100,50,5/3/2018
F8084B,earnings,100,50,5/3/2018
F80FF9,earnings,100,50,5/3/2018
F83279,earnings,100,50,5/3/2018
F83279,earnings,100,50,5/3/2018
F85CC0,earnings,100,50,5/3/2018
FAB97A,earnings,100,50,5/3/2018
FADF1A,conference-call,100,50,5/3/2018
FC4550,dividend,100,50,5/3/2018
FD39EB,earnings,100,50,5/3/2018
FD4BBE,conference-participant,100,50,5/3/2018
FD6926,earnings,100,50,5/3/2018
FD6926,earnings,100,50,5/3/2018
FD6926,earnings,100,50,5/3/2018
FD6926,earnings,100,50,5/3/2018
FD6926,earnings,100,50,5/3/2018
FEE4B0,earnings-up,100,68,5/3/2018
FEE4B0,earnings-up,100,68,5/3/2018
FEE4B0,earnings-up,100,68,5/3/2018
FEE4B0,earnings-up,100,68,5/3/2018
FF4343,conference-participant,100,50,5/3/2018
FF6644,product-release,100,64,5/3/2018
FF9FF6,acquisition-completed-acquirer,100,49,5/3/2018
FF9FF6,acquisition-completed-acquirer,100,49,5/3/2018
FF9FF6,acquisition-completed-acquirer,100,49,5/3/2018
02ACBD,conference-call,100,50,5/4/2018
0325B7,earnings,100,50,5/4/2018
03542C,earnings,100,50,5/4/2018
06A456,conference-call,100,50,5/4/2018
71860,conference-participant,100,50,5/4/2018
84625,earnings,100,50,5/4/2018
84625,earnings,100,50,5/4/2018
09062E,earnings,100,50,5/4/2018
09062E,earnings,100,50,5/4/2018
95294,earnings,100,50,5/4/2018
0AD2E3,earnings,100,50,5/4/2018
0BF528,conference-participant,100,50,5/4/2018
0C6293,conference-call,100,50,5/4/2018
157D9F,earnings,100,50,5/4/2018
157D9F,earnings,100,50,5/4/2018
157D9F,earnings,100,50,5/4/2018
157D9F,earnings,100,50,5/4/2018
16AAE0,earnings,100,50,5/4/2018
17EDA5,business-contract,100,69,5/4/2018
1834C0,dividend,100,50,5/4/2018
1CB9D3,conference-call,100,50,5/4/2018
1D943E,executive-appointment,100,54,5/4/2018
1F43A1,earnings,100,50,5/4/2018
221AD7,facility-open,100,65,5/4/2018
221AD7,facility-open,100,65,5/4/2018
225CA2,business-contract,100,69,5/4/2018
2720AB,ipo-pricing,100,50,5/4/2018
272704,conference-participant,100,50,5/4/2018
27BFA1,unit-acquisition-completed-acquirer,100,49,5/4/2018
2AE625,earnings,100,50,5/4/2018
2CC71C,conference-participant,100,50,5/4/2018
2E902B,conference-participant,100,50,5/4/2018
3301B7,earnings,100,50,5/4/2018
353DBB,dividend,100,50,5/4/2018
36C09B,conference-call,100,50,5/4/2018
385DD4,dividend-up,100,81,5/4/2018
41C528,conference-call,100,50,5/4/2018
43A74A,conference-participant,100,50,5/4/2018
442587,earnings,100,50,5/4/2018
442587,earnings,100,50,5/4/2018
449A26,executive-appointment,100,54,5/4/2018
450ECB,acquisition-acquirer,100,49,5/4/2018
4E5784,conference-participant,100,50,5/4/2018
4F9487,conference-participant,100,50,5/4/2018
51888A,board-meeting,100,51,5/4/2018
58B46F,earnings-per-share-positive,100,69,5/4/2018
5A0FF1,conference-participant,100,50,5/4/2018
619882,conference-organizer,100,57,5/4/2018
619882,conference-organizer,100,57,5/4/2018
62B1C6,earnings,100,50,5/4/2018
636639,dividend,100,50,5/4/2018
6634D9,earnings,100,50,5/4/2018
6B236C,dividend,100,50,5/4/2018
6BD606,earnings-positive,100,69,5/4/2018
6D2BF6,earnings,100,50,5/4/2018
6F30F9,earnings,100,50,5/4/2018
71553E,earnings,100,50,5/4/2018
726EEA,earnings-up,100,68,5/4/2018
726EEA,earnings-up,100,68,5/4/2018
726EEA,earnings-up,100,68,5/4/2018
726EEA,earnings-up,100,68,5/4/2018
726EEA,earnings-up,100,68,5/4/2018
73A71F,executive-appointment,100,54,5/4/2018
767F86,executive-appointment,100,54,5/4/2018
767F86,conference-participant,100,50,5/4/2018
76BD96,earnings,100,50,5/4/2018
76BD96,earnings,100,50,5/4/2018
76BD96,earnings,100,50,5/4/2018
789A7D,dividend,100,50,5/4/2018
7A5D58,executive-appointment,100,54,5/4/2018
7ACBA4,earnings,100,50,5/4/2018
7BAAE7,dividend,100,50,5/4/2018
7F2922,earnings,100,50,5/4/2018
82E58A,earnings,100,50,5/4/2018
8B9B3B,earnings,100,50,5/4/2018
8E8E6E,donation,100,54,5/4/2018
8E93A4,facility-open,100,65,5/4/2018
925759,earnings,100,50,5/4/2018
925759,earnings,100,50,5/4/2018
92D757,earnings,100,50,5/4/2018
94983E,conference-participant,100,50,5/4/2018
95F59E,earnings,100,50,5/4/2018
9981C6,earnings-up,100,68,5/4/2018
9E98F2,conference-participant,100,50,5/4/2018
9F03CF,dividend,100,50,5/4/2018
A16DEA,conference-participant,100,50,5/4/2018
A3800A,legal-issues-defendant,100,22,5/4/2018
A60354,earnings,100,50,5/4/2018
A60354,earnings,100,50,5/4/2018
A60354,earnings,100,50,5/4/2018
A6FC89,conference-call,100,50,5/4/2018
A7102F,legal-issues-defendant,100,22,5/4/2018
A74F6F,revenues,100,50,5/4/2018
A74F6F,revenues,100,50,5/4/2018
ACD9A4,dividend,100,50,5/4/2018
AD9F1D,dividend,100,50,5/4/2018
AFEC35,facility-open,100,65,5/4/2018
B2AA0A,earnings,100,50,5/4/2018
B4B281,conference-call,100,50,5/4/2018
B77F14,earnings,100,50,5/4/2018
B77F14,earnings,100,50,5/4/2018
B77F14,earnings,100,50,5/4/2018
B7BDA3,earnings,100,50,5/4/2018
B7BDA3,earnings,100,50,5/4/2018
B7EB38,earnings,100,50,5/4/2018
B7EB38,earnings,100,50,5/4/2018
BE14CF,dividend,100,50,5/4/2018
C0200F,dividend-up,100,59,5/4/2018
C15F8F,executive-appointment,100,54,5/4/2018
C6C702,conference-participant,100,50,5/4/2018
C81E00,conference-participant,100,50,5/4/2018
C9881C,award,100,58,5/4/2018
C9C62A,earnings,100,50,5/4/2018
CC8F6E,legal-issues-defendant,100,22,5/4/2018
CE2791,earnings,100,50,5/4/2018
CF6A5A,dividend,100,50,5/4/2018
CFD4B6,dividend,100,50,5/4/2018
D3CEDF,legal-issues-defendant,100,22,5/4/2018
D3CEDF,legal-issues-defendant,100,22,5/4/2018
D3CEDF,legal-issues-defendant,100,22,5/4/2018
D3FD6D,revenues,100,50,5/4/2018
D3FD6D,earnings,100,50,5/4/2018
D3FD6D,earnings,100,50,5/4/2018
D57D99,dividend,100,50,5/4/2018
D9E036,earnings,100,50,5/4/2018
D9E036,earnings,100,50,5/4/2018
D9E036,earnings,100,50,5/4/2018
D9E036,earnings,100,50,5/4/2018
DA0A9E,dividend,100,50,5/4/2018
DB23C8,earnings,100,50,5/4/2018
DB23C8,earnings,100,50,5/4/2018
DB23C8,earnings,100,50,5/4/2018
DF204B,conference-participant,100,50,5/4/2018
E20392,executive-appointment,100,54,5/4/2018
E2F130,dividend,100,50,5/4/2018
E5F0A8,ipo-pricing,100,50,5/4/2018
E802CE,conference-call,100,50,5/4/2018
E8846E,conference-organizer,100,57,5/4/2018
E8846E,conference-organizer,100,57,5/4/2018
E8846E,conference-organizer,100,57,5/4/2018
E8846E,conference-organizer,100,57,5/4/2018
E8846E,settlement,100,56,5/4/2018
EB6965,executive-appointment,100,54,5/4/2018
ED79D9,facility-upgrade,100,65,5/4/2018
EF7163,earnings,100,50,5/4/2018
F0B335,conference-participant,100,50,5/4/2018
F1529C,earnings-up,100,68,5/4/2018
F1EB39,regulatory-product-approval-granted,100,81,5/4/2018
F5D410,public-offering,100,43,5/4/2018
F6581D,earnings,100,50,5/4/2018
F8C5D7,legal-issues-defendant,100,22,5/4/2018
FE609F,conference-call,100,50,5/4/2018
FE89E0,dividend,100,50,5/4/2018
FF6644,executive-appointment,100,54,5/4/2018
FF6644,executive-appointment,100,54,5/4/2018
9548BB,executive-appointment,100,54,5/5/2018
D8ECA1,legal-issues-defendant,100,22,5/5/2018
0CE7F6,legal-issues-defendant,100,22,5/6/2018
1F716B,legal-issues-defendant,100,22,5/6/2018
2BF36E,earnings,100,50,5/6/2018
2BF36E,earnings,100,50,5/6/2018
341759,legal-issues-defendant,100,22,5/6/2018
44209A,legal-issues-defendant,100,22,5/6/2018
458D2C,legal-issues-defendant,100,22,5/6/2018
4E4E75,legal-issues-defendant,100,22,5/6/2018
4E4E75,legal-issues-defendant,100,22,5/6/2018
726DDF,legal-issues-defendant,100,22,5/6/2018
9C25FF,legal-issues-defendant,100,22,5/6/2018
CC8F6E,legal-issues-defendant,100,22,5/6/2018
001F1B,revenues,100,50,5/7/2018
00326D,earnings,100,50,5/7/2018
0157B1,business-contract,100,69,5/7/2018
02870F,partnership,100,61,5/7/2018
040DBB,earnings,100,50,5/7/2018
040DBB,earnings,100,50,5/7/2018
040DBB,earnings,100,50,5/7/2018
040DBB,earnings,100,50,5/7/2018
048B70,public-offering,100,43,5/7/2018
04996E,earnings,100,50,5/7/2018
04996E,earnings,100,50,5/7/2018
07C69F,earnings,100,50,5/7/2018
07EC43,earnings,100,50,5/7/2018
07EC43,earnings,100,50,5/7/2018
07EC43,earnings,100,50,5/7/2018
07EC43,earnings,100,50,5/7/2018
95294,product-release,100,64,5/7/2018
98977,conference-participant,100,50,5/7/2018
099A92,executive-appointment,100,54,5/7/2018
0C6861,conference-participant,100,50,5/7/2018
0FABBD,public-offering,100,43,5/7/2018
11A49E,earnings,100,50,5/7/2018
1201B5,earnings,100,50,5/7/2018
12A3A3,dividend-up,100,64,5/7/2018
13A782,earnings,100,50,5/7/2018
152E1D,earnings,100,50,5/7/2018
152E1D,earnings,100,50,5/7/2018
152E1D,earnings,100,50,5/7/2018
152E1D,earnings,100,50,5/7/2018
152E1D,earnings,100,50,5/7/2018
165B86,unit-acquisition-completed-acquirer,100,49,5/7/2018
18D9FA,conference-call,100,50,5/7/2018
1921DD,business-contract,100,69,5/7/2018
197612,earnings,100,50,5/7/2018
1D943E,buybacks,100,74,5/7/2018
228D42,product-release,100,64,5/7/2018
228D42,product-release,100,64,5/7/2018
228D42,partnership,100,61,5/7/2018
241AF7,earnings,100,50,5/7/2018
250BEE,earnings,100,50,5/7/2018
250BEE,earnings,100,50,5/7/2018
250BEE,earnings,100,50,5/7/2018
250BEE,earnings,100,50,5/7/2018
250BEE,earnings,100,50,5/7/2018
27C10F,public-offering,100,43,5/7/2018
2.90E+62,conference-participant,100,50,5/7/2018
2B9DBB,conference-participant,100,50,5/7/2018
2CC71C,conference-call,100,50,5/7/2018
2E89AE,earnings,100,50,5/7/2018
2FF046,earnings,100,50,5/7/2018
2FF046,earnings,100,50,5/7/2018
2FF046,earnings,100,50,5/7/2018
306623,earnings,100,50,5/7/2018
31DB20,earnings,100,50,5/7/2018
32F943,partnership,100,61,5/7/2018
3.30E+34,executive-appointment,100,54,5/7/2018
36529A,earnings,100,50,5/7/2018
396D7C,conference-participant,100,50,5/7/2018
3AF7FD,dividend,100,50,5/7/2018
3B37F7,earnings,100,50,5/7/2018
3B37F7,earnings,100,50,5/7/2018
3B37F7,earnings,100,50,5/7/2018
3C6CCC,earnings,100,50,5/7/2018
3C6CCC,earnings,100,50,5/7/2018
3C6CCC,earnings,100,50,5/7/2018
3C6CCC,earnings,100,50,5/7/2018
3C7F5F,business-contract,100,69,5/7/2018
3CBA2A,partnership,100,61,5/7/2018
3CBA2A,partnership,100,61,5/7/2018
3D6933,pretax-earnings-positive,100,69,5/7/2018
3D6933,pretax-earnings-positive,100,69,5/7/2018
3D7971,earnings,100,50,5/7/2018
3D7971,earnings,100,50,5/7/2018
3D7971,earnings,100,50,5/7/2018
3D7971,earnings,100,50,5/7/2018
3D7971,earnings,100,50,5/7/2018
3D7971,earnings,100,50,5/7/2018
3DB18B,earnings,100,50,5/7/2018
3EE65E,earnings,100,50,5/7/2018
427F32,earnings,100,50,5/7/2018
42AABD,earnings,100,50,5/7/2018
435ACE,earnings,100,50,5/7/2018
442769,conference-participant,100,50,5/7/2018
44ED36,earnings,100,50,5/7/2018
45444E,earnings,100,50,5/7/2018
458D2C,legal-issues-defendant,100,22,5/7/2018
458D2C,revenue-volume,100,50,5/7/2018
47752F,investment-investor,100,55,5/7/2018
4806CE,facility-open,100,65,5/7/2018
485445,business-combination,100,54,5/7/2018
485445,business-combination,100,54,5/7/2018
485445,earnings,100,50,5/7/2018
485445,earnings,100,50,5/7/2018
485445,earnings,100,50,5/7/2018
485445,earnings,100,50,5/7/2018
485445,business-combination,100,54,5/7/2018
485445,business-combination,100,54,5/7/2018
4BDCA7,earnings,100,50,5/7/2018
4C31F3,earnings,100,50,5/7/2018
4C31F3,earnings,100,50,5/7/2018
4C31F3,earnings,100,50,5/7/2018
4EEB00,product-release,100,64,5/7/2018
50070E,acquisition-acquiree,100,76,5/7/2018
50070E,conference-organizer,100,57,5/7/2018
50070E,conference-organizer,100,57,5/7/2018
514067,public-offering,100,43,5/7/2018
51B442,earnings,100,50,5/7/2018
51E682,dividend,100,50,5/7/2018
5403F8,earnings,100,50,5/7/2018
5.43E+08,conference-participant,100,50,5/7/2018
546A9C,conference-call,100,50,5/7/2018
54F271,revenue-up,100,69,5/7/2018
56277A,conference-participant,100,50,5/7/2018
57A854,executive-appointment,100,54,5/7/2018
57EF50,conference-call,100,50,5/7/2018
583A75,revenue-volume,100,50,5/7/2018
59872F,conference-call,100,50,5/7/2018
59B229,buybacks,100,74,5/7/2018
5B3415,earnings,100,50,5/7/2018
5B3415,earnings,100,50,5/7/2018
5E1DF3,earnings-up,100,68,5/7/2018
5F60CE,earnings,100,50,5/7/2018
5FF95F,facility-close,100,47,5/7/2018
619882,conference-organizer,100,57,5/7/2018
619882,conference-organizer,100,57,5/7/2018
619882,conference-organizer,100,57,5/7/2018
619882,conference-organizer,100,57,5/7/2018
619882,conference-organizer,100,57,5/7/2018
619882,conference-organizer,100,57,5/7/2018
61A586,earnings,100,50,5/7/2018
633043,earnings,100,50,5/7/2018
651C85,earnings,100,50,5/7/2018
665440,earnings,100,50,5/7/2018
665440,earnings,100,50,5/7/2018
6810DE,earnings,100,50,5/7/2018
6810DE,conference-participant,100,50,5/7/2018
6A171E,earnings,100,50,5/7/2018
6BC6F9,executive-resignation,100,44,5/7/2018
6BC6F9,revenue-up,100,71,5/7/2018
6BC6F9,revenue-up,100,69,5/7/2018
6BC6F9,revenue-up,100,69,5/7/2018
6D0CAB,earnings,100,50,5/7/2018
6D9B53,private-placement,100,56,5/7/2018
6D9B53,conference-participant,100,50,5/7/2018
6F0A63,note-sale,100,52,5/7/2018
6F0A63,note-sale,100,52,5/7/2018
6F39FC,earnings,100,50,5/7/2018
6F3FA8,earnings,100,50,5/7/2018
6F3FA8,earnings,100,50,5/7/2018
6F3FA8,earnings,100,50,5/7/2018
6F3FA8,earnings,100,50,5/7/2018
71553E,public-offering,100,43,5/7/2018
73A213,earnings,100,50,5/7/2018
73A213,earnings,100,50,5/7/2018
75768D,executive-appointment,100,54,5/7/2018
7710F3,earnings,100,50,5/7/2018
7712CB,earnings,100,50,5/7/2018
7712CB,earnings,100,50,5/7/2018
77B8E9,partnership,100,61,5/7/2018
797C20,earnings,100,50,5/7/2018
7A51FE,earnings,100,50,5/7/2018
7AB859,partnership,100,61,5/7/2018
7AC86E,business-contract,100,69,5/7/2018
7B1156,earnings,100,50,5/7/2018
7BC92D,executive-appointment,100,54,5/7/2018
7C790D,earnings,100,50,5/7/2018
7CBC40,executive-appointment,100,54,5/7/2018
7D5FD6,conference-participant,100,50,5/7/2018
7F3669,earnings,100,50,5/7/2018
7F9E16,earnings-up,100,68,5/7/2018
83066C,earnings,100,50,5/7/2018
83E0AC,earnings,100,50,5/7/2018
84920B,partnership,100,61,5/7/2018
84A6B9,conference-participant,100,50,5/7/2018
860AB6,acquisition-completed-acquiree,100,76,5/7/2018
87486A,earnings,100,50,5/7/2018
87486A,earnings,100,50,5/7/2018
87486A,earnings,100,50,5/7/2018
87486A,earnings,100,50,5/7/2018
890FF4,earnings,100,50,5/7/2018
890FF4,earnings,100,50,5/7/2018
890FF4,earnings,100,50,5/7/2018
890FF4,earnings,100,50,5/7/2018
890FF4,earnings,100,50,5/7/2018
890FF4,earnings,100,50,5/7/2018
893904,executive-appointment,100,54,5/7/2018
8BFAA4,acquisition-completed-acquirer,100,49,5/7/2018
8E3F58,earnings,100,50,5/7/2018
8EF425,note-sale,100,52,5/7/2018
9087B9,earnings,100,50,5/7/2018
915E7B,earnings,100,50,5/7/2018
91E5EE,earnings,100,50,5/7/2018
92005C,ipo-completed,100,76,5/7/2018
92D230,conference-call,100,50,5/7/2018
957A07,earnings,100,50,5/7/2018
968966,dividend,100,50,5/7/2018
96A6CD,earnings,100,50,5/7/2018
96F126,government-contract,100,69,5/7/2018
97B027,earnings-up,100,68,5/7/2018
97B027,earnings-up,100,68,5/7/2018
97B027,earnings-up,100,68,5/7/2018
98D33E,same-store-sales,100,50,5/7/2018
990AD0,conference-organizer,100,57,5/7/2018
990AD0,conference-organizer,100,57,5/7/2018
990AD0,conference-organizer,100,57,5/7/2018
990AD0,conference-organizer,100,57,5/7/2018
9978F1,earnings,100,50,5/7/2018
9B5968,executive-appointment,100,54,5/7/2018
9BB35A,conference-participant,100,50,5/7/2018
9C009A,earnings,100,50,5/7/2018
9C5BA5,earnings,100,50,5/7/2018
9CE4C7,conference-participant,100,50,5/7/2018
9D2790,earnings,100,50,5/7/2018
9D2790,earnings,100,50,5/7/2018
9D2790,earnings,100,50,5/7/2018
9D2790,earnings,100,50,5/7/2018
9D2790,earnings,100,50,5/7/2018
9D2790,earnings,100,50,5/7/2018
9D65C1,earnings,100,50,5/7/2018
9DDE1B,earnings,100,50,5/7/2018
9DDE1B,earnings,100,50,5/7/2018
A37D68,product-release,100,64,5/7/2018
A3800A,earnings,100,50,5/7/2018
A3F598,merger-regulatory-approval,100,81,5/7/2018
A3F598,merger-regulatory-approval,100,81,5/7/2018
A3F598,merger-regulatory-approval,100,81,5/7/2018
A58224,conference-participant,100,50,5/7/2018
A63387,business-contract,100,69,5/7/2018
A8FDE8,earnings,100,50,5/7/2018
A8FDE8,dividend,100,50,5/7/2018
AAC8B6,earnings,100,50,5/7/2018
AFF43F,note-sale,100,52,5/7/2018
B01111,facility-open,100,65,5/7/2018
B1B10C,executive-appointment,100,54,5/7/2018
B48FC9,partnership,100,61,5/7/2018
B642E8,earnings,100,50,5/7/2018
B642E8,earnings,100,50,5/7/2018
B73395,conference-participant,100,50,5/7/2018
B73395,earnings,100,50,5/7/2018
B73395,earnings,100,50,5/7/2018
B73395,earnings,100,50,5/7/2018
B73395,earnings,100,50,5/7/2018
B73395,earnings,100,50,5/7/2018
B803B1,conference-participant,100,50,5/7/2018
B9764A,partnership,100,61,5/7/2018
B9764A,earnings,100,50,5/7/2018
B9CD50,earnings,100,50,5/7/2018
BB88B6,partnership,100,61,5/7/2018
BBBB41,conference-participant,100,50,5/7/2018
BC948D,conference-participant,100,50,5/7/2018
BCC55F,executive-appointment,100,54,5/7/2018
BCE9DA,earnings,100,50,5/7/2018
BCE9DA,earnings,100,50,5/7/2018
BCE9DA,earnings,100,50,5/7/2018
BCE9DA,earnings,100,50,5/7/2018
BDE867,earnings,100,50,5/7/2018
BDE867,earnings,100,50,5/7/2018
BDE867,earnings,100,50,5/7/2018
C0200F,executive-appointment,100,54,5/7/2018
C188F8,unit-acquisition-acquirer,100,49,5/7/2018
C188F8,earnings,100,50,5/7/2018
C4F9C6,executive-appointment,100,54,5/7/2018
C564E4,earnings,100,50,5/7/2018
C65004,revenues,100,50,5/7/2018
C65004,revenues,100,50,5/7/2018
C97B2D,conference-participant,100,50,5/7/2018
CB89EA,executive-appointment,100,54,5/7/2018
CDC817,conference-participant,100,50,5/7/2018
CE5664,dividend-up,100,72,5/7/2018
CE8251,executive-appointment,100,54,5/7/2018
CF6A5A,executive-appointment,100,54,5/7/2018
D29B44,conference-participant,100,50,5/7/2018
D3CEDF,legal-issues-defendant,100,22,5/7/2018
D4AC65,earnings,100,50,5/7/2018
D4AC65,earnings,100,50,5/7/2018
D4AC65,earnings,100,50,5/7/2018
D4AC65,earnings,100,50,5/7/2018
D4AC65,earnings,100,50,5/7/2018
D4AC65,earnings,100,50,5/7/2018
D5B13D,earnings,100,50,5/7/2018
D60BB2,dividend,100,50,5/7/2018
D64C6D,executive-appointment,100,54,5/7/2018
D75910,conference-call,100,50,5/7/2018
D77F7E,facility-open,100,65,5/7/2018
D78BF1,executive-appointment,100,54,5/7/2018
D7918D,operating-earnings,100,50,5/7/2018
D81463,earnings,100,50,5/7/2018
D82EF3,conference-participant,100,50,5/7/2018
D88EF3,business-contract,100,69,5/7/2018
D8ECA1,executive-appointment,100,54,5/7/2018
D9E036,conference-participant,100,50,5/7/2018
DA48E4,unit-acquisition-completed-acquirer,100,49,5/7/2018
DA91AE,earnings,100,50,5/7/2018
DB06B0,partnership,100,61,5/7/2018
DC1405,ipo-completed,100,76,5/7/2018
DC2F77,conference-participant,100,50,5/7/2018
DFADDB,conference-call,100,50,5/7/2018
E124EB,conference-participant,100,50,5/7/2018
E13782,earnings,100,50,5/7/2018
E2CB7B,business-contract,100,69,5/7/2018
E30B34,facility-open,100,65,5/7/2018
E68733,executive-appointment,100,54,5/7/2018
E68C3D,partnership,100,61,5/7/2018
E802CE,earnings,100,50,5/7/2018
E802CE,earnings,100,50,5/7/2018
E8846E,conference-organizer,100,57,5/7/2018
E8846E,conference-organizer,100,57,5/7/2018
E8846E,executive-appointment,100,54,5/7/2018
E8846E,conference-organizer,100,57,5/7/2018
E8846E,conference-organizer,100,57,5/7/2018
E8846E,conference-organizer,100,57,5/7/2018
E8E899,buybacks,100,74,5/7/2018
EA62FC,earnings,100,50,5/7/2018
EB43F4,earnings,100,50,5/7/2018
ED2EFD,earnings,100,50,5/7/2018
ED79D9,acquisition-completed-acquirer,100,49,5/7/2018
ED7F13,dividend,100,50,5/7/2018
EE04F0,conference-call,100,50,5/7/2018
EE1E44,conference-participant,100,50,5/7/2018
EE967B,earnings,100,50,5/7/2018
EE967B,earnings,100,50,5/7/2018
EEA6B3,partnership,100,61,5/7/2018
EF5BED,executive-appointment,100,54,5/7/2018
F02170,earnings,100,50,5/7/2018
F0B335,legal-issues-defendant,100,22,5/7/2018
F30508,dividend,100,50,5/7/2018
F32F88,dividend,100,50,5/7/2018
F44EA2,earnings,100,50,5/7/2018
F47871,public-offering,100,43,5/7/2018
F769E9,conference-call,100,50,5/7/2018
FD0CA4,conference-participant,100,50,5/7/2018
FD554E,conference-call,100,50,5/7/2018
FD6926,dividend,100,50,5/7/2018
FF227B,earnings,100,50,5/7/2018
00698D,conference-call,100,50,5/8/2018
034B61,executive-appointment,100,54,5/8/2018
03542C,earnings,100,50,5/8/2018
03596A,earnings,100,50,5/8/2018
03B8CF,dividend,100,50,5/8/2018
048B70,public-offering,100,43,5/8/2018
04EB2F,earnings,100,50,5/8/2018
55018,asset-sale,100,62,5/8/2018
05D148,government-contract,100,69,5/8/2018
06A456,stake-acquirer,100,48,5/8/2018
06C826,conference-call,100,50,5/8/2018
070B45,earnings,100,50,5/8/2018
71860,product-release,100,64,5/8/2018
75172,earnings,100,50,5/8/2018
07C907,dividend,100,50,5/8/2018
0919B1,earnings,100,50,5/8/2018
099C88,business-contract,100,69,5/8/2018
09DE1F,earnings,100,50,5/8/2018
0A9D0A,earnings,100,50,5/8/2018
0B400D,earnings,100,50,5/8/2018
0B400D,earnings,100,50,5/8/2018
0B400D,earnings,100,50,5/8/2018
0C355F,earnings,100,50,5/8/2018
0C355F,earnings,100,50,5/8/2018
0C355F,earnings,100,50,5/8/2018
0C6293,earnings,100,50,5/8/2018
0C6293,earnings,100,50,5/8/2018
0C6293,earnings,100,50,5/8/2018
0CCCB7,earnings,100,50,5/8/2018
0E5223,operating-earnings,100,50,5/8/2018
0FC848,earnings,100,50,5/8/2018
0FE3A6,earnings,100,50,5/8/2018
102F04,earnings,100,50,5/8/2018
1080C0,earnings,100,50,5/8/2018
1096C6,partnership,100,61,5/8/2018
1279ED,earnings,100,50,5/8/2018
12DE76,partnership,100,61,5/8/2018
12DE76,partnership,100,61,5/8/2018
131443,dividend,100,50,5/8/2018
135B09,executive-resignation,100,44,5/8/2018
157D9F,public-offering,100,43,5/8/2018
165B86,earnings,100,50,5/8/2018
1834C0,unit-acquisition-acquirer,100,49,5/8/2018
1834C0,earnings,100,50,5/8/2018
1866B2,dividend,100,50,5/8/2018
1A3E1B,conference-participant,100,50,5/8/2018
1B9535,conference-participant,100,50,5/8/2018
1C599A,earnings,100,50,5/8/2018
1CD09C,conference-participant,100,50,5/8/2018
1CD708,dividend,100,50,5/8/2018
1CDD1C,earnings,100,50,5/8/2018
1E4FB9,earnings,100,50,5/8/2018
1E4FB9,executive-appointment,100,54,5/8/2018
1EBF8D,partnership,100,61,5/8/2018
1FAF22,dividend-up,100,81,5/8/2018
202E5A,earnings,100,50,5/8/2018
2082EA,earnings,100,50,5/8/2018
2262BD,earnings,100,50,5/8/2018
24C48B,earnings,100,50,5/8/2018
25102A,exchange-compliance-authority,100,50,5/8/2018
267718,partnership,100,61,5/8/2018
26FA41,conference-participant,100,50,5/8/2018
270B78,earnings,100,50,5/8/2018
2720AB,ipo-completed,100,76,5/8/2018
28AF37,earnings,100,50,5/8/2018
28AF37,earnings,100,50,5/8/2018
28AF37,earnings,100,50,5/8/2018
28AF37,earnings,100,50,5/8/2018
28B730,earnings,100,50,5/8/2018
2AA6A8,conference-participant,100,50,5/8/2018
2ABF77,earnings,100,50,5/8/2018
2ABF77,earnings,100,50,5/8/2018
2B9DBB,executive-appointment,100,54,5/8/2018
2BBE62,earnings,100,50,5/8/2018
2BBE62,earnings,100,50,5/8/2018
2BBE62,earnings,100,50,5/8/2018
2C3348,earnings,100,50,5/8/2018
2C7505,clinical-trials,100,56,5/8/2018
2D485F,earnings,100,50,5/8/2018
2D485F,earnings,100,50,5/8/2018
2DA92D,buybacks,100,74,5/8/2018
2EBA55,earnings,100,50,5/8/2018
2F1299,earnings,100,50,5/8/2018
2F1299,earnings,100,50,5/8/2018
2F1299,earnings,100,50,5/8/2018
2F1299,earnings,100,50,5/8/2018
2F1299,earnings,100,50,5/8/2018
2F1299,earnings,100,50,5/8/2018
2F960F,earnings,100,50,5/8/2018
301493,legal-issues-defendant,100,22,5/8/2018
31803E,conference-participant,100,50,5/8/2018
337024,earnings,100,50,5/8/2018
337024,earnings,100,50,5/8/2018
3461CF,executive-appointment,100,54,5/8/2018
355B19,earnings,100,50,5/8/2018
36A1CB,dividend,100,50,5/8/2018
36C09B,earnings,100,50,5/8/2018
385DD4,earnings,100,50,5/8/2018
389CFB,earnings,100,50,5/8/2018
3A94DF,conference-participant,100,50,5/8/2018
3B20AB,business-contract,100,69,5/8/2018
3B318A,conference-participant,100,50,5/8/2018
3B50FE,conference-call,100,50,5/8/2018
3BA1BF,conference-call,100,50,5/8/2018
3BA1BF,conference-participant,100,50,5/8/2018
3C11C4,earnings,100,50,5/8/2018
3C3B6B,conference-participant,100,50,5/8/2018
3DCECC,product-release,100,64,5/8/2018
40B903,earnings,100,50,5/8/2018
4.00E+163,earnings,100,50,5/8/2018
41C36B,earnings,100,50,5/8/2018
41C528,earnings,100,50,5/8/2018
41C528,earnings,100,50,5/8/2018
422CE3,dividend,100,50,5/8/2018
42AABD,conference-participant,100,50,5/8/2018
42AABD,public-offering,100,43,5/8/2018
435ACE,conference-participant,100,50,5/8/2018
43E8F5,conference-participant,100,50,5/8/2018
46A16E,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
47FCF2,earnings,100,50,5/8/2018
48F795,earnings,100,50,5/8/2018
4.91E+58,earnings-up,100,68,5/8/2018
4.91E+58,earnings-up,100,68,5/8/2018
4.91E+58,earnings-up,100,68,5/8/2018
4.91E+58,earnings-up,100,68,5/8/2018
4.91E+58,earnings-up,100,68,5/8/2018
4.91E+58,earnings-up,100,68,5/8/2018
4.91E+58,earnings-up,100,68,5/8/2018
4B6EF9,earnings,100,50,5/8/2018
4B6EF9,dividend,100,50,5/8/2018
4C37C5,dividend,100,50,5/8/2018
4C5CC9,earnings-guidance-up,100,83,5/8/2018
4C5CC9,earnings-guidance-up,100,83,5/8/2018
4C5CC9,earnings-guidance-up,100,83,5/8/2018
4C5CC9,earnings-guidance-up,100,83,5/8/2018
4C92B9,earnings,100,50,5/8/2018
4D971D,ipo-pricing,100,50,5/8/2018
4DD09F,earnings-positive,100,69,5/8/2018
4DD09F,earnings-positive,100,69,5/8/2018
4E6F5A,earnings,100,50,5/8/2018
50070E,conference-organizer,100,57,5/8/2018
5065B1,earnings,100,50,5/8/2018
545272,earnings,100,50,5/8/2018
550D01,earnings,100,50,5/8/2018
550D01,earnings,100,50,5/8/2018
553949,executive-appointment,100,54,5/8/2018
556F08,earnings,100,50,5/8/2018
55D0F3,earnings,100,50,5/8/2018
56FB7C,earnings,100,50,5/8/2018
57EF50,earnings-up,100,68,5/8/2018
587EDF,note-sale,100,52,5/8/2018
5A53BF,earnings,100,50,5/8/2018
5A9A82,public-offering,100,43,5/8/2018
5C2A47,earnings,100,50,5/8/2018
5CEE02,earnings,100,50,5/8/2018
5DD486,dividend,100,50,5/8/2018
5F2FF7,business-contract,100,69,5/8/2018
5F3D91,earnings,100,50,5/8/2018
5F3D91,earnings,100,50,5/8/2018
5F3D91,earnings,100,50,5/8/2018
5F60CE,earnings-positive,100,69,5/8/2018
619882,conference-organizer,100,57,5/8/2018
619882,conference-organizer,100,57,5/8/2018
619882,conference-organizer,100,57,5/8/2018
619882,conference-organizer,100,57,5/8/2018
619882,conference-organizer,100,57,5/8/2018
619882,conference-organizer,100,57,5/8/2018
619882,conference-organizer,100,57,5/8/2018
622DBE,earnings,100,50,5/8/2018
62CDDE,earnings,100,50,5/8/2018
64636E,earnings,100,50,5/8/2018
649CBD,clinical-trials-start,100,64,5/8/2018
6.52E+64,facility-open,100,65,5/8/2018
665D7D,conference-participant,100,50,5/8/2018
66749D,dividend-up,100,81,5/8/2018
67303E,conference-participant,100,50,5/8/2018
673C9A,earnings,100,50,5/8/2018
67B052,ipo-pricing,100,50,5/8/2018
67B923,earnings,100,50,5/8/2018
6844D2,acquisition-acquirer,100,49,5/8/2018
68AB62,earnings,100,50,5/8/2018
68BA15,earnings,100,50,5/8/2018
6925EB,earnings,100,50,5/8/2018
693ECD,earnings,100,50,5/8/2018
69C99E,earnings,100,50,5/8/2018
6A961B,earnings,100,50,5/8/2018
6B0784,conference-participant,100,50,5/8/2018
6B0E45,public-offering,100,43,5/8/2018
6B0E45,public-offering,100,43,5/8/2018
6B6375,earnings,100,50,5/8/2018
6B67BD,earnings,100,50,5/8/2018
6BDA0C,dividend,100,50,5/8/2018
6E8864,operating-earnings,100,50,5/8/2018
6ED519,dividend,100,50,5/8/2018
717DB4,acquisition-acquirer,100,49,5/8/2018
717DB4,acquisition-acquirer,100,49,5/8/2018
717DB4,earnings,100,50,5/8/2018
717DB4,earnings,100,50,5/8/2018
717DB4,earnings,100,50,5/8/2018
71E2EF,earnings,100,50,5/8/2018
726DDF,earnings,100,50,5/8/2018
72CB93,conference-participant,100,50,5/8/2018
762A3E,conference-organizer,100,57,5/8/2018
76CEFB,public-offering,100,43,5/8/2018
7712CB,earnings,100,50,5/8/2018
7712CB,earnings,100,50,5/8/2018
7712CB,earnings,100,50,5/8/2018
7712CB,earnings,100,50,5/8/2018
7734AC,dividend,100,50,5/8/2018
77B8E9,conference-participant,100,50,5/8/2018
787D14,earnings,100,50,5/8/2018
7ACD98,earnings,100,50,5/8/2018
7B492C,executive-appointment,100,54,5/8/2018
7DD8CC,earnings,100,50,5/8/2018
7E3F8F,conference-participant,100,50,5/8/2018
7F3665,earnings,100,50,5/8/2018
7FDE1C,earnings,100,50,5/8/2018
80D744,dividend,100,50,5/8/2018
81222C,earnings,100,50,5/8/2018
818A2F,earnings,100,50,5/8/2018
82C202,earnings,100,50,5/8/2018
82E58A,dividend,100,50,5/8/2018
834152,earnings,100,50,5/8/2018
83B1C8,earnings,100,50,5/8/2018
83E0AC,conference-call,100,50,5/8/2018
845533,earnings,100,50,5/8/2018
848C0B,earnings,100,50,5/8/2018
858942,earnings-up,100,68,5/8/2018
85CDC9,conference-participant,100,50,5/8/2018
877734,earnings,100,50,5/8/2018
877734,earnings,100,50,5/8/2018
877734,earnings,100,50,5/8/2018
877734,earnings,100,50,5/8/2018
880C0C,earnings,100,50,5/8/2018
881190,dividend-up,100,81,5/8/2018
885758,executive-appointment,100,54,5/8/2018
895D56,operating-earnings,100,50,5/8/2018
8AB37F,private-placement,100,56,5/8/2018
8C311A,earnings,100,50,5/8/2018
8D4486,partnership,100,61,5/8/2018
8D4486,partnership,100,61,5/8/2018
8D4486,partnership,100,61,5/8/2018
8D4AE6,dividend,100,50,5/8/2018
8D5145,dividend,100,50,5/8/2018
8E0E32,dividend,100,50,5/8/2018
8E82A6,dividend,100,50,5/8/2018
90D6A5,earnings,100,50,5/8/2018
90D6A5,earnings,100,50,5/8/2018
90D6A5,earnings,100,50,5/8/2018
9196A2,product-release,100,64,5/8/2018
931AE7,earnings,100,50,5/8/2018
9.31E+77,earnings,100,50,5/8/2018
93F143,dividend,100,50,5/8/2018
9470CC,conference-participant,100,50,5/8/2018
958938,earnings,100,50,5/8/2018
95A92E,earnings,100,50,5/8/2018
95C575,dividend,100,50,5/8/2018
966DBE,earnings,100,50,5/8/2018
966DBE,earnings,100,50,5/8/2018
966DBE,earnings,100,50,5/8/2018
966DBE,earnings,100,50,5/8/2018
966DBE,earnings,100,50,5/8/2018
968B00,dividend,100,50,5/8/2018
96F126,executive-appointment,100,54,5/8/2018
971F7B,conference-participant,100,50,5/8/2018
97AF94,earnings,100,50,5/8/2018
9.86E+03,product-release,100,64,5/8/2018
986AF6,board-meeting,100,51,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
990AD0,conference-organizer,100,57,5/8/2018
99DC8D,dividend,100,50,5/8/2018
99DC8D,earnings,100,50,5/8/2018
9B4066,unit-acquisition-acquirer,100,49,5/8/2018
9B5968,executive-appointment,100,54,5/8/2018
9B730A,earnings,100,50,5/8/2018
9D5FA4,earnings,100,50,5/8/2018
9E4A5F,earnings,100,50,5/8/2018
9E575E,earnings,100,50,5/8/2018
9E575E,earnings,100,50,5/8/2018
9E575E,earnings,100,50,5/8/2018
9E98F2,conference-participant,100,50,5/8/2018
9EBAFA,earnings,100,50,5/8/2018
9F18FA,note-sale,100,52,5/8/2018
9F18FA,note-sale,100,52,5/8/2018
9F62D1,dividend,100,50,5/8/2018
A01664,conference-participant,100,50,5/8/2018
A0F146,earnings,100,50,5/8/2018
A21649,earnings,100,50,5/8/2018
A26EF7,credit-extension-recipient,100,69,5/8/2018
A3F598,settlement,100,56,5/8/2018
A3F598,settlement,100,56,5/8/2018
A3F598,settlement,100,56,5/8/2018
A43906,conference-participant,100,50,5/8/2018
A48593,earnings,100,50,5/8/2018
A5195E,earnings,100,50,5/8/2018
A6828A,conference-organizer,100,57,5/8/2018
A7102F,earnings-up,100,68,5/8/2018
A7102F,earnings,100,50,5/8/2018
A7102F,earnings,100,50,5/8/2018
A7102F,earnings,100,50,5/8/2018
A79F7D,earnings,100,50,5/8/2018
A868C9,business-contract,100,69,5/8/2018
A9ED24,earnings,100,50,5/8/2018
A9ED24,earnings,100,50,5/8/2018
A9ED24,earnings,100,50,5/8/2018
A9ED24,earnings,100,50,5/8/2018
AC642C,conference-participant,100,50,5/8/2018
AC775C,earnings,100,50,5/8/2018
AC775C,earnings,100,50,5/8/2018
AC775C,earnings,100,50,5/8/2018
AC7AAE,earnings,100,50,5/8/2018
ACF0B4,earnings,100,50,5/8/2018
ADF092,earnings,100,50,5/8/2018
ADF092,earnings,100,50,5/8/2018
ADFB3A,earnings,100,50,5/8/2018
AE4125,earnings,100,50,5/8/2018
AE4125,earnings,100,50,5/8/2018
AE7D16,earnings,100,50,5/8/2018
AEFC90,earnings,100,50,5/8/2018
AFD7DD,earnings,100,50,5/8/2018
AFD7DD,earnings,100,50,5/8/2018
B1DF3C,earnings,100,50,5/8/2018
B2D799,earnings,100,50,5/8/2018
B37FB4,conference-participant,100,50,5/8/2018
B381D8,earnings,100,50,5/8/2018
B446B8,earnings,100,50,5/8/2018
B446B8,earnings,100,50,5/8/2018
B446B8,earnings,100,50,5/8/2018
B54A74,earnings,100,50,5/8/2018
B54A74,executive-appointment,100,54,5/8/2018
B76C82,earnings,100,50,5/8/2018
B7FA9B,earnings,100,50,5/8/2018
B80AD1,conference-participant,100,50,5/8/2018
B83BCE,earnings,100,50,5/8/2018
B98EFA,earnings,100,50,5/8/2018
B98EFA,earnings,100,50,5/8/2018
B98EFA,earnings,100,50,5/8/2018
BAD655,earnings,100,50,5/8/2018
BAD9EA,earnings,100,50,5/8/2018
BB127B,conference-call,100,50,5/8/2018
BCC13E,earnings,100,50,5/8/2018
BE379D,conference-call,100,50,5/8/2018
C062D4,partnership,100,61,5/8/2018
C062D4,partnership,100,61,5/8/2018
C062D4,conference-participant,100,50,5/8/2018
C07E05,earnings,100,50,5/8/2018
C15F8F,executive-resignation,100,44,5/8/2018
C15F8F,earnings,100,50,5/8/2018
C2E39B,earnings,100,50,5/8/2018
C2F597,earnings,100,50,5/8/2018
C2F597,earnings,100,50,5/8/2018
C3BAE7,earnings,100,50,5/8/2018
C3BAE7,earnings,100,50,5/8/2018
C3BAE7,earnings,100,50,5/8/2018
C3BAE7,earnings,100,50,5/8/2018
C3BAE7,earnings,100,50,5/8/2018
C407A0,earnings,100,50,5/8/2018
C4A241,earnings-up,100,68,5/8/2018
C4A241,earnings,100,50,5/8/2018
C4A241,earnings,100,50,5/8/2018
C4A241,earnings,100,50,5/8/2018
C4F9C6,earnings,100,50,5/8/2018
C50B26,earnings,100,50,5/8/2018
C659EB,product-release,100,64,5/8/2018
C659EB,product-release,100,64,5/8/2018
C66B44,earnings,100,50,5/8/2018
C8923A,earnings,100,50,5/8/2018
C8A059,earnings,100,50,5/8/2018
C9D866,conference-participant,100,50,5/8/2018
C9E04B,earnings,100,50,5/8/2018
CA212F,earnings,100,50,5/8/2018
CB22CD,dividend,100,50,5/8/2018
CB89EA,earnings,100,50,5/8/2018
CB9E13,earnings,100,50,5/8/2018
CBB77B,executive-appointment,100,54,5/8/2018
CBDB4D,earnings,100,50,5/8/2018
CC6FF5,product-release,100,64,5/8/2018
CC8F6E,earnings,100,50,5/8/2018
CDAF5B,reverse-stock-splits,100,51,5/8/2018
CDFCC9,dividend,100,50,5/8/2018
CDFCC9,earnings,100,50,5/8/2018
CDFCC9,earnings,100,50,5/8/2018
CDFCC9,earnings,100,50,5/8/2018
CDFCC9,earnings,100,50,5/8/2018
CDFCC9,earnings,100,50,5/8/2018
CE1002,conference-participant,100,50,5/8/2018
CE5664,earnings,100,50,5/8/2018
CE5664,earnings,100,50,5/8/2018
CE5664,earnings,100,50,5/8/2018
CE5C6E,earnings,100,50,5/8/2018
CF3FF9,earnings,100,50,5/8/2018
CFF97C,sanctions-target,100,19,5/8/2018
D09938,earnings,100,50,5/8/2018
D11C1C,operating-earnings,100,50,5/8/2018
D139BC,dividend,100,50,5/8/2018
D13F1C,revenue-up,100,69,5/8/2018
D13F1C,revenue-up,100,69,5/8/2018
D13F1C,revenue-up,100,69,5/8/2018
D13F1C,revenue-up,100,69,5/8/2018
D29F43,earnings,100,50,5/8/2018
D3CEDF,earnings,100,50,5/8/2018
D3CEDF,earnings,100,50,5/8/2018
D3CEDF,earnings,100,50,5/8/2018
D3CEDF,earnings,100,50,5/8/2018
D58A11,conference-participant,100,50,5/8/2018
D63B0F,earnings,100,50,5/8/2018
D63B0F,earnings,100,50,5/8/2018
D63B0F,earnings,100,50,5/8/2018
D63B0F,dividend,100,50,5/8/2018
D6534D,earnings,100,50,5/8/2018
D6534D,earnings,100,50,5/8/2018
D6EAA3,earnings,100,50,5/8/2018
D6EAA3,earnings,100,50,5/8/2018
D6EAA3,earnings,100,50,5/8/2018
D6EAA3,earnings,100,50,5/8/2018
D8442A,partnership,100,61,5/8/2018
D8C09D,earnings,100,50,5/8/2018
D8ECA1,earnings,100,50,5/8/2018
D8ECA1,earnings,100,50,5/8/2018
D8ECA1,earnings,100,50,5/8/2018
D8ECA1,earnings,100,50,5/8/2018
D90441,earnings,100,50,5/8/2018
DA0CB8,earnings,100,50,5/8/2018
DA48E4,conference-participant,100,50,5/8/2018
DB06B0,earnings,100,50,5/8/2018
DB9F70,earnings,100,50,5/8/2018
DBB28E,conference-call,100,50,5/8/2018
DBCA3F,executive-appointment,100,54,5/8/2018
DC0998,product-release,100,64,5/8/2018
DDCB34,earnings,100,50,5/8/2018
DDEA6A,operating-earnings,100,50,5/8/2018
DF01B1,earnings,100,50,5/8/2018
DF01B1,earnings,100,50,5/8/2018
DF01B1,earnings,100,50,5/8/2018
DF01B1,earnings,100,50,5/8/2018
DF1F7A,earnings,100,50,5/8/2018
DF5F14,earnings,100,50,5/8/2018
E0647D,earnings,100,50,5/8/2018
E0647D,earnings,100,50,5/8/2018
E0647D,earnings,100,50,5/8/2018
E0647D,earnings,100,50,5/8/2018
E0647D,earnings,100,50,5/8/2018
E074A0,executive-resignation,100,44,5/8/2018
E124EB,dividend,100,50,5/8/2018
E15736,earnings,100,50,5/8/2018
E22FDE,earnings,100,50,5/8/2018
E41190,earnings,100,50,5/8/2018
E41190,earnings,100,50,5/8/2018
E41190,earnings,100,50,5/8/2018
E41190,earnings,100,50,5/8/2018
E5F0A8,ipo-completed,100,76,5/8/2018
E61888,earnings,100,50,5/8/2018
E68E62,conference-participant,100,50,5/8/2018
E866D2,revenue-volume,100,50,5/8/2018
E96E0B,earnings,100,50,5/8/2018
EC1AF3,earnings,100,50,5/8/2018
ED2A5E,earnings,100,50,5/8/2018
ED2A5E,earnings,100,50,5/8/2018
ED2A5E,earnings,100,50,5/8/2018
ED2A5E,earnings,100,50,5/8/2018
ED2A5E,earnings,100,50,5/8/2018
ED2A5E,earnings,100,50,5/8/2018
ED2A5E,earnings,100,50,5/8/2018
ED4560,executive-appointment,100,54,5/8/2018
EDD234,conference-call,100,50,5/8/2018
EF45B6,earnings,100,50,5/8/2018
F0B335,legal-issues-defendant,100,22,5/8/2018
F0B335,legal-issues-defendant,100,22,5/8/2018
F0B335,legal-issues-defendant,100,22,5/8/2018
F0B335,legal-issues-defendant,100,22,5/8/2018
F179ED,earnings,100,50,5/8/2018
F179ED,earnings,100,50,5/8/2018
F179ED,earnings,100,50,5/8/2018
F179ED,earnings,100,50,5/8/2018
F1EB39,conference-participant,100,50,5/8/2018
F2E253,earnings,100,50,5/8/2018
F2E253,earnings,100,50,5/8/2018
F2E253,earnings,100,50,5/8/2018
F2E253,earnings,100,50,5/8/2018
F2E253,earnings,100,50,5/8/2018
F3016C,earnings,100,50,5/8/2018
F3016C,earnings,100,50,5/8/2018
F3016C,earnings,100,50,5/8/2018
F39E1E,earnings,100,50,5/8/2018
F4D241,earnings,100,50,5/8/2018
F57F6F,earnings,100,50,5/8/2018
F58C23,earnings,100,50,5/8/2018
F58C23,earnings,100,50,5/8/2018
F5C8AB,earnings-per-share-positive,100,69,5/8/2018
F5C8AB,earnings-per-share-positive,100,69,5/8/2018
F6A987,earnings,100,50,5/8/2018
F6DA75,earnings,100,50,5/8/2018
F6E248,conference-participant,100,50,5/8/2018
F769E9,earnings,100,50,5/8/2018
F7902B,partnership,100,61,5/8/2018
F7902B,partnership,100,61,5/8/2018
F7935D,conference-participant,100,50,5/8/2018
F7ADEB,earnings,100,50,5/8/2018
F7ADEB,earnings,100,50,5/8/2018
F7ADEB,earnings,100,50,5/8/2018
F9AA02,earnings,100,50,5/8/2018
FC1A6E,conference-participant,100,50,5/8/2018
FC4550,dividend,100,50,5/8/2018
FD2565,earnings,100,50,5/8/2018
FDD3FC,earnings,100,50,5/8/2018
FDF28E,earnings,100,50,5/8/2018
FEC475,dividend,100,50,5/8/2018
FFCD0E,earnings,100,50,5/8/2018
00067A,conference-participant,100,50,5/9/2018
002A99,earnings,100,50,5/9/2018
0157B1,partnership,100,61,5/9/2018
20751,conference-call,100,50,5/9/2018
02ACBD,earnings,100,50,5/9/2018
02FC1A,conference-participant,100,50,5/9/2018
034B61,partnership,100,61,5/9/2018
0358AF,conference-participant,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03B8CF,earnings,100,50,5/9/2018
03CF95,partnership,100,61,5/9/2018
03CF95,partnership,100,61,5/9/2018
48590,partnership,100,61,5/9/2018
0490C6,earnings,100,50,5/9/2018
0490C6,earnings,100,50,5/9/2018
0490C6,earnings,100,50,5/9/2018
054E7E,earnings,100,50,5/9/2018
06C826,earnings,100,50,5/9/2018
06C826,earnings,100,50,5/9/2018
0B13E8,executive-resignation,100,44,5/9/2018
0B4D10,dividend,100,50,5/9/2018
0B7375,earnings,100,50,5/9/2018
0BC29E,board-meeting,100,51,5/9/2018
0BD970,earnings,100,50,5/9/2018
0CCCB7,dividend-up,100,64,5/9/2018
0CE7F6,earnings,100,50,5/9/2018
0DBB81,conference-participant,100,50,5/9/2018
0DBB81,clinical-trials,100,56,5/9/2018
0E5619,earnings,100,50,5/9/2018
0F0693,earnings,100,50,5/9/2018
0FDE97,product-release,100,64,5/9/2018
106394,business-contract,100,69,5/9/2018
1096C6,earnings,100,50,5/9/2018
125212,earnings,100,50,5/9/2018
135B09,dividend,100,50,5/9/2018
14391F,earnings,100,50,5/9/2018
14391F,earnings,100,50,5/9/2018
14391F,earnings,100,50,5/9/2018
147098,earnings,100,50,5/9/2018
1490F3,dividend,100,50,5/9/2018
14BA06,conference-participant,100,50,5/9/2018
15789A,earnings-up,100,68,5/9/2018
16B882,earnings,100,50,5/9/2018
182BE7,earnings,100,50,5/9/2018
1866B2,earnings,100,50,5/9/2018
1880C5,earnings,100,50,5/9/2018
18D9FA,earnings,100,50,5/9/2018
1AB023,earnings,100,50,5/9/2018
1AB023,earnings,100,50,5/9/2018
1AB023,earnings,100,50,5/9/2018
1AD9CC,revenues,100,50,5/9/2018
1B16C1,earnings,100,50,5/9/2018
1BDB2A,executive-appointment,100,54,5/9/2018
1CB9D3,earnings,100,50,5/9/2018
1CD09C,earnings,100,50,5/9/2018
1D943E,executive-appointment,100,54,5/9/2018
1DB6A6,dividend,100,50,5/9/2018
1DEBBE,investment-investor,100,55,5/9/2018
1E7785,earnings,100,50,5/9/2018
1E7785,earnings,100,50,5/9/2018
1E7785,earnings,100,50,5/9/2018
1E7785,earnings,100,50,5/9/2018
1E7785,earnings,100,50,5/9/2018
1E7785,earnings,100,50,5/9/2018
1E7785,earnings,100,50,5/9/2018
2003A5,earnings,100,50,5/9/2018
221AD7,legal-issues-defendant,100,22,5/9/2018
238302,earnings,100,50,5/9/2018
24C48B,acquisition-acquirer,100,49,5/9/2018
24CB56,dividend,100,50,5/9/2018
24FA23,earnings,100,50,5/9/2018
25AB8E,earnings,100,50,5/9/2018
25AB8E,earnings,100,50,5/9/2018
25AB8E,earnings,100,50,5/9/2018
25AB8E,earnings,100,50,5/9/2018
25AB8E,earnings,100,50,5/9/2018
25AB8E,earnings,100,50,5/9/2018
26DC29,executive-appointment,100,54,5/9/2018
279916,conference-participant,100,50,5/9/2018
297DA8,earnings,100,50,5/9/2018
2B0AF4,dividend,100,50,5/9/2018
2B8179,earnings,100,50,5/9/2018
2C681C,earnings,100,50,5/9/2018
2C681C,earnings,100,50,5/9/2018
2CA60F,executive-appointment,100,54,5/9/2018
2CBB58,conference-call,100,50,5/9/2018
2CC60C,conference-call,100,50,5/9/2018
2CC71C,earnings,100,50,5/9/2018
2D643C,partnership,100,61,5/9/2018
2D981A,earnings,100,50,5/9/2018
2E1322,earnings,100,50,5/9/2018
2E1322,earnings,100,50,5/9/2018
2E61CC,note-sale,100,52,5/9/2018
306623,dividend,100,50,5/9/2018
315EB0,partnership,100,61,5/9/2018
315EB0,partnership,100,61,5/9/2018
3471C0,earnings,100,50,5/9/2018
3471C0,earnings,100,50,5/9/2018
3471C0,earnings,100,50,5/9/2018
3471C0,earnings,100,50,5/9/2018
3587B4,dividend,100,50,5/9/2018
35AE32,earnings,100,50,5/9/2018
35AE32,earnings,100,50,5/9/2018
35AE32,earnings,100,50,5/9/2018
35AE32,earnings,100,50,5/9/2018
35F4B5,dividend,100,50,5/9/2018
367E1C,conference-participant,100,50,5/9/2018
36E479,earnings,100,50,5/9/2018
37B120,earnings,100,50,5/9/2018
37E18B,earnings,100,50,5/9/2018
396D7C,earnings,100,50,5/9/2018
3A113F,public-offering,100,43,5/9/2018
3A113F,public-offering,100,43,5/9/2018
3BC360,earnings,100,50,5/9/2018
3BC360,earnings,100,50,5/9/2018
3BC360,earnings,100,50,5/9/2018
3BC360,earnings,100,50,5/9/2018
3C75D6,earnings-up,100,68,5/9/2018
3C75D6,earnings,100,50,5/9/2018
3C75D6,earnings,100,50,5/9/2018
3E39A5,revenues,100,50,5/9/2018
3F1C69,earnings,100,50,5/9/2018
3FACA7,dividend-up,100,81,5/9/2018
41B53E,earnings,100,50,5/9/2018
41B53E,earnings,100,50,5/9/2018
41B53E,earnings,100,50,5/9/2018
41ED98,earnings,100,50,5/9/2018
42978B,conference-call,100,50,5/9/2018
42AABD,public-offering,100,43,5/9/2018
43A060,revenue-up,100,69,5/9/2018
43A060,revenue-up,100,69,5/9/2018
43A060,revenue-up,100,69,5/9/2018
44A4FC,conference-participant,100,50,5/9/2018
458D2C,legal-issues-defendant,100,22,5/9/2018
468DD4,earnings,100,50,5/9/2018
490D4B,legal-issues-defendant,100,22,5/9/2018
4A6F00,partnership,100,61,5/9/2018
4B7006,earnings,100,50,5/9/2018
4D371E,conference-participant,100,50,5/9/2018
4F783B,earnings,100,50,5/9/2018
4F783B,earnings,100,50,5/9/2018
4F783B,earnings,100,50,5/9/2018
4F783B,earnings,100,50,5/9/2018
4FCC78,earnings,100,50,5/9/2018
50070E,conference-organizer,100,57,5/9/2018
50070E,conference-organizer,100,57,5/9/2018
50D1EC,earnings,100,50,5/9/2018
51F541,dividend,100,50,5/9/2018
52FB2F,earnings,100,50,5/9/2018
52FB2F,earnings,100,50,5/9/2018
52FB2F,earnings,100,50,5/9/2018
52FB2F,earnings,100,50,5/9/2018
5.43E+08,business-contract,100,69,5/9/2018
54F1D2,earnings,100,50,5/9/2018
583223,acquisition-completed-acquirer,100,49,5/9/2018
583223,conference-participant,100,50,5/9/2018
5876DC,earnings,100,50,5/9/2018
59872F,product-release,100,64,5/9/2018
5A9A82,public-offering,100,43,5/9/2018
5B226B,revenue-up,100,76,5/9/2018
5B226B,revenue-up,100,76,5/9/2018
5B226B,revenue-up,100,76,5/9/2018
5B3FA2,earnings,100,50,5/9/2018
5B7739,earnings,100,50,5/9/2018
5C2A47,earnings,100,50,5/9/2018
5D41E4,earnings,100,50,5/9/2018
5DD486,board-meeting,100,51,5/9/2018
5F1B7B,debt-extension-recipient,100,73,5/9/2018
6.18E+08,earnings,100,50,5/9/2018
6.18E+08,earnings,100,50,5/9/2018
6.18E+08,earnings,100,50,5/9/2018
619882,conference-organizer,100,57,5/9/2018
619882,conference-organizer,100,57,5/9/2018
619882,conference-organizer,100,57,5/9/2018
619882,conference-organizer,100,57,5/9/2018
619882,conference-organizer,100,57,5/9/2018
619882,conference-organizer,100,57,5/9/2018
619882,conference-organizer,100,57,5/9/2018
61A586,legal-issues-defendant,100,22,5/9/2018
629F0F,earnings,100,50,5/9/2018
657097,earnings,100,50,5/9/2018
68E6E9,dividend,100,50,5/9/2018
694749,earnings,100,50,5/9/2018
694749,earnings,100,50,5/9/2018
694749,earnings,100,50,5/9/2018
6BDA0C,earnings,100,50,5/9/2018
6BDA0C,earnings,100,50,5/9/2018
6BDA0C,earnings,100,50,5/9/2018
6BDA0C,earnings,100,50,5/9/2018
6DDA15,earnings,100,50,5/9/2018
6DDA15,earnings,100,50,5/9/2018
6DDA15,earnings,100,50,5/9/2018
6DDA15,earnings,100,50,5/9/2018
6DDA15,earnings,100,50,5/9/2018
6DDA15,earnings,100,50,5/9/2018
6E8864,conference-participant,100,50,5/9/2018
6E8864,conference-participant,100,50,5/9/2018
6F22E7,conference-call,100,50,5/9/2018
713810,stake-acquirer,100,48,5/9/2018
713810,stake-acquirer,100,48,5/9/2018
71553E,earnings,100,50,5/9/2018
724F84,earnings,100,50,5/9/2018
7255D2,earnings,100,50,5/9/2018
7262F2,earnings,100,50,5/9/2018
7262F2,earnings,100,50,5/9/2018
72CB93,conference-participant,100,50,5/9/2018
747219,dividend,100,50,5/9/2018
756045,earnings,100,50,5/9/2018
762B8D,earnings,100,50,5/9/2018
76959C,earnings,100,50,5/9/2018
769F40,earnings,100,50,5/9/2018
769F40,earnings,100,50,5/9/2018
769F40,earnings,100,50,5/9/2018
76BECC,earnings,100,50,5/9/2018
76BECC,earnings,100,50,5/9/2018
76BECC,earnings,100,50,5/9/2018
76CEFB,public-offering,100,43,5/9/2018
789A7D,earnings,100,50,5/9/2018
790D0D,dividend,100,50,5/9/2018
7B6C88,award,100,58,5/9/2018
7B6C88,award,100,58,5/9/2018
7BEA98,earnings,100,50,5/9/2018
7E1D5D,earnings,100,50,5/9/2018
7F3A5F,facility-open,100,65,5/9/2018
805CD8,earnings,100,50,5/9/2018
80D744,executive-appointment,100,54,5/9/2018
81EAD4,conference-participant,100,50,5/9/2018
82F088,earnings,100,50,5/9/2018
82F088,partnership,100,61,5/9/2018
855DF7,earnings,100,50,5/9/2018
85DA04,earnings,100,50,5/9/2018
85DA04,earnings,100,50,5/9/2018
85DA04,earnings,100,50,5/9/2018
85DA04,earnings,100,50,5/9/2018
8665BA,conference-participant,100,50,5/9/2018
88193E,conference-participant,100,50,5/9/2018
88611B,earnings,100,50,5/9/2018
88923D,earnings,100,50,5/9/2018
88923D,earnings,100,50,5/9/2018
88923D,earnings,100,50,5/9/2018
89F693,executive-appointment,100,54,5/9/2018
8AB37F,conference-participant,100,50,5/9/2018
8B3B0E,executive-appointment,100,54,5/9/2018
8B9B3B,earnings,100,50,5/9/2018
8BFAA4,earnings,100,50,5/9/2018
8BFAA4,earnings,100,50,5/9/2018
8BFAA4,earnings,100,50,5/9/2018
8DE56F,partnership,100,61,5/9/2018
8DE56F,partnership,100,61,5/9/2018
902255,earnings,100,50,5/9/2018
902255,earnings,100,50,5/9/2018
92B625,business-contract,100,69,5/9/2018
92B625,earnings,100,50,5/9/2018
92D757,dividend,100,50,5/9/2018
93D207,partnership,100,61,5/9/2018
93D207,partnership,100,61,5/9/2018
947B0B,conference-participant,100,50,5/9/2018
957A07,conference-participant,100,50,5/9/2018
9673BD,earnings,100,50,5/9/2018
9673BD,earnings,100,50,5/9/2018
9673BD,earnings,100,50,5/9/2018
968966,product-release,100,64,5/9/2018
96BFF4,earnings,100,50,5/9/2018
96BFF4,earnings,100,50,5/9/2018
97644E,earnings,100,50,5/9/2018
97644E,earnings,100,50,5/9/2018
97644E,earnings,100,50,5/9/2018
97644E,earnings,100,50,5/9/2018
977A1E,dividend,100,50,5/9/2018
9810C0,conference-participant,100,50,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
990AD0,conference-organizer,100,57,5/9/2018
9B4066,unit-acquisition-acquirer,100,49,5/9/2018
9B730A,conference-participant,100,50,5/9/2018
9BB35A,conference-participant,100,50,5/9/2018
9BB35A,award,100,58,5/9/2018
9BB35A,earnings,100,50,5/9/2018
9CA619,executive-appointment,100,54,5/9/2018
9F5CBB,earnings,100,50,5/9/2018
9FB4B7,business-contract,100,69,5/9/2018
A26EF7,earnings,100,50,5/9/2018
A26EF7,earnings,100,50,5/9/2018
A29DBD,earnings,100,50,5/9/2018
A350C1,conference-participant,100,50,5/9/2018
A433A5,earnings,100,50,5/9/2018
A495F7,facility-open,100,65,5/9/2018
A495F7,earnings,100,50,5/9/2018
A4CD53,earnings,100,50,5/9/2018
A4CD53,earnings,100,50,5/9/2018
A666C8,award,100,58,5/9/2018
A871B0,earnings,100,50,5/9/2018
A871B0,business-contract,100,69,5/9/2018
AAEE21,note-sale,100,52,5/9/2018
AB7F05,executive-appointment,100,54,5/9/2018
ACF0B4,earnings,100,50,5/9/2018
AD3008,earnings,100,50,5/9/2018
ADF1B0,executive-appointment,100,54,5/9/2018
AFF43F,note-sale,100,52,5/9/2018
B04426,earnings,100,50,5/9/2018
B106FA,conference-participant,100,50,5/9/2018
B1DF3C,conference-participant,100,50,5/9/2018
B2256A,earnings,100,50,5/9/2018
B303A6,partnership,100,61,5/9/2018
B33E77,earnings,100,50,5/9/2018
B37FB4,dividend,100,50,5/9/2018
B3A166,earnings,100,50,5/9/2018
B48FC9,revenue-up,100,92,5/9/2018
B48FC9,revenue-up,100,92,5/9/2018
B66928,dividend,100,50,5/9/2018
B66928,earnings,100,50,5/9/2018
B66928,earnings,100,50,5/9/2018
B66928,earnings,100,50,5/9/2018
B66928,earnings,100,50,5/9/2018
B7202A,earnings,100,50,5/9/2018
B7202A,earnings,100,50,5/9/2018
B803B1,earnings,100,50,5/9/2018
B80AD1,campaign-ad-release,100,59,5/9/2018
BB0587,dividend,100,50,5/9/2018
BBF349,earnings,100,50,5/9/2018
BBF349,earnings,100,50,5/9/2018
BBF349,earnings,100,50,5/9/2018
BD8517,executive-appointment,100,54,5/9/2018
BDEC1E,conference-participant,100,50,5/9/2018
BE5935,earnings,100,50,5/9/2018
C06EB6,earnings,100,50,5/9/2018
C2DD02,earnings,100,50,5/9/2018
C2E120,earnings,100,50,5/9/2018
C3EE99,conference-call,100,50,5/9/2018
C425AE,earnings,100,50,5/9/2018
C584BE,earnings,100,50,5/9/2018
C83B88,dividend,100,50,5/9/2018
C83B88,partnership,100,61,5/9/2018
C941DC,conference-participant,100,50,5/9/2018
C941DC,conference-participant,100,50,5/9/2018
CAB222,earnings,100,50,5/9/2018
CB22CD,conference-participant,100,50,5/9/2018
CB89EA,conference-participant,100,50,5/9/2018
CBFFDD,earnings,100,50,5/9/2018
CC0C78,earnings,100,50,5/9/2018
CC35BE,earnings,100,50,5/9/2018
CC35BE,earnings,100,50,5/9/2018
CC35BE,earnings,100,50,5/9/2018
CC35BE,earnings,100,50,5/9/2018
CC35BE,earnings,100,50,5/9/2018
CCB623,earnings,100,50,5/9/2018
CD06A2,conference-participant,100,50,5/9/2018
CDE118,dividend,100,50,5/9/2018
CDFCC9,conference-participant,100,50,5/9/2018
CFF15D,buybacks,100,74,5/9/2018
D0DE27,dividend-up,100,54,5/9/2018
D1C26F,product-release,100,64,5/9/2018
D2E553,earnings,100,50,5/9/2018
D3FA2C,earnings,100,50,5/9/2018
D5938F,earnings,100,50,5/9/2018
D5AF19,partnership,100,61,5/9/2018
D6144F,earnings,100,50,5/9/2018
D77F7E,executive-appointment,100,54,5/9/2018
D78BF1,dividend-up,100,81,5/9/2018
D90F43,partnership,100,61,5/9/2018
DB2E4E,earnings,100,50,5/9/2018
DF18E6,earnings,100,50,5/9/2018
DF204B,revenues,100,50,5/9/2018
E09997,earnings,100,50,5/9/2018
E16133,earnings,100,50,5/9/2018
E19A99,earnings,100,50,5/9/2018
E1BD05,conference-participant,100,50,5/9/2018
E259C7,buybacks,100,74,5/9/2018
E4CE73,conference-call,100,50,5/9/2018
E5752F,earnings,100,50,5/9/2018
E5752F,earnings,100,50,5/9/2018
E5752F,earnings,100,50,5/9/2018
E5752F,earnings,100,50,5/9/2018
E5752F,earnings,100,50,5/9/2018
E69BA5,dividend,100,50,5/9/2018
E829E8,conference-participant,100,50,5/9/2018
E8C557,earnings,100,50,5/9/2018
EA79C7,earnings,100,50,5/9/2018
EBC84C,conference-participant,100,50,5/9/2018
ED7F13,earnings,100,50,5/9/2018
ED8676,conference-participant,100,50,5/9/2018
EE6F1C,business-contract,100,69,5/9/2018
EEEA9F,conference-participant,100,50,5/9/2018
EF5914,revenues,100,50,5/9/2018
EF5BED,capital-increase,100,43,5/9/2018
F00285,earnings,100,50,5/9/2018
F18844,dividend,100,50,5/9/2018
F18844,earnings,100,50,5/9/2018
F3016C,conference-participant,100,50,5/9/2018
F3816D,earnings,100,50,5/9/2018
F4D241,conference-participant,100,50,5/9/2018
F5349B,earnings,100,50,5/9/2018
F5349B,unit-acquisition-acquiree,100,76,5/9/2018
F5349B,dividend,100,50,5/9/2018
F5C8AB,dividend,100,50,5/9/2018
F5D410,note-sale,100,52,5/9/2018
F6E248,executive-appointment,100,54,5/9/2018
F72E4B,business-contract,100,69,5/9/2018
F88147,earnings,100,50,5/9/2018
F90EE5,executive-appointment,100,54,5/9/2018
FB728F,earnings,100,50,5/9/2018
FBD92D,earnings-up,100,68,5/9/2018
FBD92D,earnings,100,50,5/9/2018
FBD92D,earnings,100,50,5/9/2018
FC9869,earnings,100,50,5/9/2018
FD554E,earnings,100,50,5/9/2018
FD554E,conference-participant,100,50,5/9/2018
FF5413,dividend,100,50,5/9/2018
FF5413,revenue-volume,100,50,5/9/2018
FF6644,executive-appointment,100,54,5/9/2018
00D6B5,earnings,100,50,5/10/2018
00E601,dividend,100,50,5/10/2018
02ACBD,earnings,100,50,5/10/2018
02FC1A,earnings,100,50,5/10/2018
02FC1A,earnings,100,50,5/10/2018
036C6F,earnings-up,100,68,5/10/2018
036C6F,earnings-up,100,68,5/10/2018
036C6F,earnings-up,100,68,5/10/2018
04CCCD,revenue-up,100,69,5/10/2018
05D148,earnings,100,50,5/10/2018
083F72,earnings,100,50,5/10/2018
0A748B,earnings,100,50,5/10/2018
0A748B,earnings,100,50,5/10/2018
0B400D,public-offering,100,43,5/10/2018
0C6861,earnings,100,50,5/10/2018
0E5619,conference-participant,100,50,5/10/2018
0FABBD,public-offering,100,43,5/10/2018
12DE76,executive-appointment,100,54,5/10/2018
12DE76,acquisition-completed-acquirer,100,49,5/10/2018
152AB9,earnings,100,50,5/10/2018
157D9F,public-offering,100,43,5/10/2018
157D9F,public-offering,100,43,5/10/2018
15B10D,earnings,100,50,5/10/2018
15B10D,earnings,100,50,5/10/2018
15B10D,earnings,100,50,5/10/2018
184988,conference-participant,100,50,5/10/2018
196D18,earnings,100,50,5/10/2018
197612,executive-appointment,100,54,5/10/2018
1AE482,earnings,100,50,5/10/2018
1AE482,earnings,100,50,5/10/2018
1AE482,earnings,100,50,5/10/2018
1B5FEA,earnings,100,50,5/10/2018
1BDB2A,dividend-up,100,81,5/10/2018
1D943E,conference-participant,100,50,5/10/2018
1DA44F,dividend-up,100,81,5/10/2018
1F08A6,sponsorship,100,57,5/10/2018
1FE7F0,earnings,100,50,5/10/2018
1FE7F0,earnings,100,50,5/10/2018
1FE7F0,earnings,100,50,5/10/2018
1FE7F0,earnings,100,50,5/10/2018
232053,earnings,100,50,5/10/2018
232053,conference-participant,100,50,5/10/2018
23207A,earnings,100,50,5/10/2018
249674,earnings,100,50,5/10/2018
249674,earnings,100,50,5/10/2018
249674,earnings,100,50,5/10/2018
24CB56,conference-participant,100,50,5/10/2018
25D3CE,earnings,100,50,5/10/2018
2A1009,board-meeting,100,51,5/10/2018
2CA60F,partnership,100,61,5/10/2018
301493,earnings,100,50,5/10/2018
301493,earnings,100,50,5/10/2018
314D88,conference-participant,100,50,5/10/2018
314D88,product-release,100,64,5/10/2018
314D88,earnings,100,50,5/10/2018
31AA84,earnings,100,50,5/10/2018
31AA84,earnings,100,50,5/10/2018
31AA84,earnings,100,50,5/10/2018
341759,earnings,100,50,5/10/2018
36E479,earnings,100,50,5/10/2018
3B37F7,conference-organizer,100,57,5/10/2018
3C3B6B,earnings,100,50,5/10/2018
3DE4D1,dividend,100,50,5/10/2018
4017AD,earnings,100,50,5/10/2018
407878,earnings,100,50,5/10/2018
442769,executive-appointment,100,54,5/10/2018
448BF3,earnings,100,50,5/10/2018
449A26,executive-appointment,100,54,5/10/2018
45ABCC,revenue-up,100,74,5/10/2018
45ABCC,revenue-up,100,74,5/10/2018
45ABCC,revenue-up,100,74,5/10/2018
4.60E+06,earnings,100,50,5/10/2018
4A3438,award,100,58,5/10/2018
4C3FE9,earnings,100,50,5/10/2018
4D72C8,business-contract,100,69,5/10/2018
4D72C8,earnings,100,50,5/10/2018
4D971D,ipo-completed,100,76,5/10/2018
4DD203,earnings,100,50,5/10/2018
50070E,conference-participant,100,50,5/10/2018
510EA1,earnings,100,50,5/10/2018
510EA1,business-contract,100,69,5/10/2018
5.43E+08,business-contract,100,69,5/10/2018
5.43E+08,business-contract,100,69,5/10/2018
546A27,earnings,100,50,5/10/2018
5.47E+28,earnings,100,50,5/10/2018
57A854,earnings,100,50,5/10/2018
57DDB9,conference-participant,100,50,5/10/2018
587EDF,note-sale,100,52,5/10/2018
58C2D4,conference-participant,100,50,5/10/2018
5B226B,dividend,100,50,5/10/2018
5D0337,executive-appointment,100,54,5/10/2018
5D63F1,earnings,100,50,5/10/2018
5EAA43,earnings,100,50,5/10/2018
60FE03,earnings,100,50,5/10/2018
619882,conference-organizer,100,57,5/10/2018
619882,conference-organizer,100,57,5/10/2018
619882,conference-organizer,100,57,5/10/2018
619882,conference-organizer,100,57,5/10/2018
619882,conference-organizer,100,57,5/10/2018
62A48D,earnings,100,50,5/10/2018
649CBD,earnings,100,50,5/10/2018
649CBD,earnings,100,50,5/10/2018
649CBD,earnings,100,50,5/10/2018
66A667,award,100,58,5/10/2018
68586A,earnings,100,50,5/10/2018
69345C,executive-appointment,100,54,5/10/2018
69FDFC,earnings,100,50,5/10/2018
6D0CAB,dividend,100,50,5/10/2018
6.00E+19,earnings,100,50,5/10/2018
6F22E7,partnership,100,61,5/10/2018
6FCEF9,earnings,100,50,5/10/2018
709AED,product-release,100,64,5/10/2018
71B0CF,earnings,100,50,5/10/2018
7239BB,conference-call,100,50,5/10/2018
726DDF,earnings,100,50,5/10/2018
728737,dividend,100,50,5/10/2018
747219,earnings,100,50,5/10/2018
763DBE,earnings,100,50,5/10/2018
76BD96,note-sale,100,52,5/10/2018
76F067,conference-participant,100,50,5/10/2018
7710F3,earnings,100,50,5/10/2018
773A17,earnings,100,50,5/10/2018
7740DE,same-store-sales-down,100,44,5/10/2018
791EC1,acquisition-acquirer,100,49,5/10/2018
7B9212,revenues,100,50,5/10/2018
7BC92D,earnings,100,50,5/10/2018
7C4F43,earnings,100,50,5/10/2018
7D5FD6,dividend,100,50,5/10/2018
7D7716,earnings,100,50,5/10/2018
7D7716,earnings,100,50,5/10/2018
7D7716,earnings,100,50,5/10/2018
7D7716,earnings,100,50,5/10/2018
7D7716,earnings,100,50,5/10/2018
7D85A9,dividend,100,50,5/10/2018
7FD8B9,earnings,100,50,5/10/2018
82B57E,earnings,100,50,5/10/2018
82B57E,dividend,100,50,5/10/2018
85DE00,conference-participant,100,50,5/10/2018
862941,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86AA9C,earnings,100,50,5/10/2018
86BAC7,dividend-up,100,81,5/10/2018
8802B4,product-release,100,64,5/10/2018
883D82,earnings,100,50,5/10/2018
893904,earnings,100,50,5/10/2018
89F693,earnings,100,50,5/10/2018
89F693,legal-issues-defendant,100,22,5/10/2018
8C6C1B,conference-call,100,50,5/10/2018
8D0EEA,earnings,100,50,5/10/2018
8D4486,partnership,100,61,5/10/2018
8DBE73,revenues,100,50,5/10/2018
8DBE73,revenues,100,50,5/10/2018
8DBE73,revenues,100,50,5/10/2018
8DCF18,earnings,100,50,5/10/2018
8DCF18,earnings,100,50,5/10/2018
8E8E6E,buybacks,100,74,5/10/2018
8E9CD8,executive-appointment,100,54,5/10/2018
902670,business-contract,100,69,5/10/2018
911CA9,earnings,100,50,5/10/2018
911CA9,earnings,100,50,5/10/2018
9196A2,conference-organizer,100,57,5/10/2018
922F0C,dividend-up,100,71,5/10/2018
92D230,earnings,100,50,5/10/2018
92D230,earnings,100,50,5/10/2018
92D230,earnings,100,50,5/10/2018
92D230,earnings,100,50,5/10/2018
92D230,earnings,100,50,5/10/2018
92D230,earnings,100,50,5/10/2018
92D757,earnings,100,50,5/10/2018
943239,earnings,100,50,5/10/2018
944B2E,earnings,100,50,5/10/2018
944B2E,earnings,100,50,5/10/2018
944B2E,earnings,100,50,5/10/2018
944B2E,earnings,100,50,5/10/2018
944B2E,earnings,100,50,5/10/2018
94563D,partnership,100,61,5/10/2018
949D62,earnings,100,50,5/10/2018
95DC1F,conference-participant,100,50,5/10/2018
9.62E+76,executive-appointment,100,54,5/10/2018
9.65E+07,earnings,100,50,5/10/2018
9.65E+07,earnings,100,50,5/10/2018
980C14,dividend,100,50,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
990AD0,conference-organizer,100,57,5/10/2018
9ABD30,executive-appointment,100,54,5/10/2018
9ABD30,earnings,100,50,5/10/2018
9C5BA5,dividend,100,50,5/10/2018
9C5BA5,executive-appointment,100,54,5/10/2018
9C5BA5,executive-appointment,100,54,5/10/2018
9D307D,earnings,100,50,5/10/2018
9E5C2C,earnings,100,50,5/10/2018
9EA947,dividend,100,50,5/10/2018
9F048E,earnings,100,50,5/10/2018
A017F4,conference-participant,100,50,5/10/2018
A072C4,earnings,100,50,5/10/2018
A1BB98,earnings,100,50,5/10/2018
A1BB98,earnings,100,50,5/10/2018
A1BB98,earnings,100,50,5/10/2018
A1BB98,earnings,100,50,5/10/2018
A1BB98,earnings,100,50,5/10/2018
A1BB98,earnings,100,50,5/10/2018
A1BB98,earnings,100,50,5/10/2018
A1EAC8,partnership,100,61,5/10/2018
A1EAC8,partnership,100,61,5/10/2018
A28675,earnings,100,50,5/10/2018
A350C1,dividend,100,50,5/10/2018
A350C1,dividend,100,50,5/10/2018
AADE0B,acquisition-acquirer,100,49,5/10/2018
ACC7D3,earnings,100,50,5/10/2018
AD1ACF,dividend,100,50,5/10/2018
AD22F2,executive-appointment,100,54,5/10/2018
AD6141,ipo-pricing,100,50,5/10/2018
ADD9DC,facility-open,100,65,5/10/2018
AFF43F,conference-participant,100,50,5/10/2018
B01215,conference-call,100,50,5/10/2018
B0B969,earnings,100,50,5/10/2018
B0D41A,earnings,100,50,5/10/2018
B13B68,earnings,100,50,5/10/2018
B4F5F4,conference-call,100,50,5/10/2018
B53C12,earnings,100,50,5/10/2018
B54A74,conference-participant,100,50,5/10/2018
B80AD1,earnings,100,50,5/10/2018
B8EF97,revenues,100,50,5/10/2018
B8F71F,partnership,100,61,5/10/2018
BB127B,product-release,100,64,5/10/2018
BC5680,partnership,100,61,5/10/2018
BDE867,dividend,100,50,5/10/2018
BDE867,executive-appointment,100,54,5/10/2018
BDF2BD,earnings,100,50,5/10/2018
BDF2BD,earnings,100,50,5/10/2018
BDF2BD,earnings,100,50,5/10/2018
BDF2BD,earnings,100,50,5/10/2018
BFD0A7,earnings,100,50,5/10/2018
BFD0A7,earnings,100,50,5/10/2018
BFD0A7,earnings,100,50,5/10/2018
C037A8,earnings,100,50,5/10/2018
C1114B,earnings,100,50,5/10/2018
C2F597,conference-participant,100,50,5/10/2018
C36189,earnings,100,50,5/10/2018
C4706C,earnings,100,50,5/10/2018
C54140,earnings,100,50,5/10/2018
C58D71,earnings,100,50,5/10/2018
C58D71,earnings,100,50,5/10/2018
C659EB,dividend,100,50,5/10/2018
C8A059,executive-appointment,100,54,5/10/2018
C941DC,product-release,100,64,5/10/2018
CDC817,earnings,100,50,5/10/2018
CDD75E,earnings,100,50,5/10/2018
CE5664,product-release,100,64,5/10/2018
CE5C6E,conference-participant,100,50,5/10/2018
CFF97C,credit-rating-confirmation-rater,20,50,5/10/2018
D17C1B,revenue-volume,100,50,5/10/2018
D17F7E,dividend,100,50,5/10/2018
D27FAB,earnings,100,50,5/10/2018
D4AC65,product-release,100,64,5/10/2018
D598E7,executive-appointment,100,54,5/10/2018
D63B0F,unit-acquisition-acquirer,100,49,5/10/2018
D64C6D,dividend,100,50,5/10/2018
D697DE,earnings,100,50,5/10/2018
D77F7E,earnings,100,50,5/10/2018
D854DD,dividend,100,50,5/10/2018
D854F3,dividend,100,50,5/10/2018
D8F347,dividend,100,50,5/10/2018
D9E036,executive-appointment,100,54,5/10/2018
DA91AE,conference-participant,100,50,5/10/2018
DB5CA5,earnings,100,50,5/10/2018
DB9F70,business-contract,100,69,5/10/2018
DBFB51,earnings,100,50,5/10/2018
DC486E,dividend,100,50,5/10/2018
DD0F15,earnings,100,50,5/10/2018
DD1BA1,partnership,100,61,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DD1BA1,earnings,100,50,5/10/2018
DF01B1,conference-participant,100,50,5/10/2018
E09E2B,earnings,100,50,5/10/2018
E09E2B,earnings,100,50,5/10/2018
E09E2B,earnings,100,50,5/10/2018
E0D3BA,earnings,100,50,5/10/2018
E114F4,conference-call,100,50,5/10/2018
E21871,dividend,100,50,5/10/2018
E28D9C,conference-participant,100,50,5/10/2018
E68733,earnings,100,50,5/10/2018
E71AE6,earnings,100,50,5/10/2018
E74B55,partnership,100,61,5/10/2018
E754F0,earnings,100,50,5/10/2018
E82A2D,dividend,100,50,5/10/2018
EB43F4,earnings,100,50,5/10/2018
ECD263,partnership,100,61,5/10/2018
ED9576,dividend,100,50,5/10/2018
EE6F1C,business-contract,100,69,5/10/2018
EEA734,earnings,100,50,5/10/2018
EF25A5,earnings,100,50,5/10/2018
EF25A5,earnings,100,50,5/10/2018
EF25A5,earnings,100,50,5/10/2018
EFA7B2,earnings,100,50,5/10/2018
F0B335,legal-issues-defendant,100,22,5/10/2018
F30508,acquisition-acquirer,100,49,5/10/2018
F30508,acquisition-acquirer,100,49,5/10/2018
F40EE2,facility-open,100,65,5/10/2018
F46EC9,dividend,100,50,5/10/2018
F47871,earnings,100,50,5/10/2018
F4CDA3,unit-acquisition-acquiree,100,76,5/10/2018
F6E1B5,earnings,100,50,5/10/2018
F702CA,partnership,100,61,5/10/2018
FAE021,board-meeting,100,51,5/10/2018
FAE021,award,100,58,5/10/2018
FAE021,dividend,100,50,5/10/2018
FC1F9D,dividend-up,100,65,5/10/2018
FC1F9D,executive-appointment,100,54,5/10/2018
FCA54E,earnings,100,50,5/10/2018
FDF799,earnings,100,50,5/10/2018
FDF799,earnings,100,50,5/10/2018
FDF799,earnings,100,50,5/10/2018
FE609F,earnings,100,50,5/10/2018
0624BE,earnings,100,50,5/11/2018
0B400D,public-offering,100,43,5/11/2018
0FABBD,conference-participant,100,50,5/11/2018
106394,equity-shelf-registration,100,43,5/11/2018
1DA44F,executive-appointment,100,54,5/11/2018
24A89A,earnings,100,50,5/11/2018
24A89A,earnings,100,50,5/11/2018
2C35B5,earnings,100,50,5/11/2018
2EBC0B,buybacks,100,74,5/11/2018
35557B,dividend,100,50,5/11/2018
39FB23,legal-issues-defendant,100,22,5/11/2018
3B9886,conference-call,100,50,5/11/2018
3BE00F,conference-participant,100,50,5/11/2018
43A74A,conference-participant,100,50,5/11/2018
447FC6,award,100,58,5/11/2018
4AE584,earnings,100,50,5/11/2018
504FE2,dividend,100,50,5/11/2018
56632F,dividend,100,50,5/11/2018
57B174,dividend,100,50,5/11/2018
58C2D4,index-listing,100,76,5/11/2018
5D02B7,dividend,100,50,5/11/2018
5F2FF7,conference-participant,100,50,5/11/2018
619882,conference-organizer,100,57,5/11/2018
619882,conference-organizer,100,57,5/11/2018
619882,conference-organizer,100,57,5/11/2018
619882,conference-organizer,100,57,5/11/2018
619882,conference-organizer,100,57,5/11/2018
619882,conference-organizer,100,57,5/11/2018
619882,conference-organizer,100,57,5/11/2018
619882,conference-organizer,100,57,5/11/2018
67B052,ipo-completed,100,76,5/11/2018
68E3E0,conference-participant,100,50,5/11/2018
6.00E+19,business-contract,100,69,5/11/2018
70CA28,product-release,100,64,5/11/2018
717DB4,conference-participant,100,50,5/11/2018
726DDF,legal-issues-defendant,100,22,5/11/2018
76959C,conference-participant,100,50,5/11/2018
7AF5B8,earnings,100,50,5/11/2018
7BEA98,conference-participant,100,50,5/11/2018
7EA323,earnings,100,50,5/11/2018
7EA323,earnings,100,50,5/11/2018
7EA323,earnings,100,50,5/11/2018
89F693,legal-issues-defendant,100,22,5/11/2018
89F693,legal-issues-defendant,100,22,5/11/2018
8A8E41,note-acquisition,100,66,5/11/2018
90D6A5,dividend,100,50,5/11/2018
940C3D,dividend,100,50,5/11/2018
95DC1F,partnership,100,61,5/11/2018
98CEBB,earnings,100,50,5/11/2018
990AD0,conference-organizer,100,57,5/11/2018
990AD0,conference-organizer,100,57,5/11/2018
990AD0,conference-organizer,100,57,5/11/2018
990AD0,conference-organizer,100,57,5/11/2018
990AD0,conference-organizer,100,57,5/11/2018
990AD0,conference-organizer,100,57,5/11/2018
990AD0,conference-organizer,100,57,5/11/2018
9C25FF,legal-issues-defendant,100,22,5/11/2018
9C25FF,legal-issues-defendant,100,22,5/11/2018
9E5C2C,conference-participant,100,50,5/11/2018
AEFC90,clinical-trials,100,56,5/11/2018
B9BDE8,earnings-up,100,83,5/11/2018
BBF349,conference-participant,100,50,5/11/2018
BCE9DA,dividend,100,50,5/11/2018
BCE9DA,dividend,100,50,5/11/2018
BD9668,dividend-up,100,81,5/11/2018
BF5959,conference-call,100,50,5/11/2018
BFE02C,conference-participant,100,50,5/11/2018
C22BE8,conference-call,100,50,5/11/2018
C27E19,dividend,100,50,5/11/2018
C5F463,business-contract,100,69,5/11/2018
C62AA4,dividend,100,50,5/11/2018
C83B88,executive-appointment,100,54,5/11/2018
C93C44,earnings,100,50,5/11/2018
CC8F6E,legal-issues-defendant,100,22,5/11/2018
D1C0B9,conference-participant,100,50,5/11/2018
D3CEDF,legal-issues-defendant,100,22,5/11/2018
D42DBA,executive-appointment,100,54,5/11/2018
D6489C,executive-appointment,100,54,5/11/2018
D77F7E,business-contract,100,69,5/11/2018
D8442A,product-release,100,64,5/11/2018
DD682D,dividend,100,50,5/11/2018
DF1F7A,dividend,100,50,5/11/2018
E2CB7B,conference-participant,100,50,5/11/2018
E30B34,conference-participant,100,50,5/11/2018
E68E62,earnings,100,50,5/11/2018
E6BC2C,conference-call,100,50,5/11/2018
E866D2,award,100,58,5/11/2018
E90C84,dividend,100,50,5/11/2018
EE04F0,earnings,100,50,5/11/2018
EE04F0,earnings,100,50,5/11/2018
EE04F0,earnings,100,50,5/11/2018
EE04F0,earnings,100,50,5/11/2018
EE04F0,legal-issues-defendant,100,22,5/11/2018
EE967B,dividend,100,50,5/11/2018
EFA7B2,business-contract,100,69,5/11/2018
F05B1B,earnings,100,50,5/11/2018
F30508,conference-participant,100,50,5/11/2018
FF4343,dividend,100,50,5/11/2018
862941,conference-participant,100,50,5/12/2018
890FF4,conference-participant,100,50,5/12/2018
990AD0,conference-organizer,100,57,5/12/2018
990AD0,conference-organizer,100,57,5/12/2018
DF01B1,legal-verdict-favored,100,78,5/12/2018
225CA2,business-contract-terminated,100,31,5/13/2018
225CA2,business-contract-terminated,100,31,5/13/2018
31F25C,merger,100,66,5/13/2018
31F25C,merger,100,66,5/13/2018
06A456,executive-appointment,100,54,5/14/2018
099A02,executive-appointment,100,54,5/14/2018
099A92,dividend,100,50,5/14/2018
099C88,business-contract,100,69,5/14/2018
0A77DB,earnings,100,50,5/14/2018
0BC29E,executive-appointment,100,54,5/14/2018
0D03C8,earnings,100,50,5/14/2018
0DBB81,earnings,100,50,5/14/2018
0E5619,regulatory-product-approval-granted,100,81,5/14/2018
0EF1AF,conference-call,100,50,5/14/2018
1201B5,conference-call,100,50,5/14/2018
1272B3,unit-acquisition-acquirer,100,49,5/14/2018
131443,joint-venture,100,62,5/14/2018
147C38,business-contract,100,69,5/14/2018
15789A,conference-participant,100,50,5/14/2018
1D3A00,conference-call,100,50,5/14/2018
1E7785,conference-participant,100,50,5/14/2018
1EA923,conference-participant,100,50,5/14/2018
1F716B,executive-appointment,100,54,5/14/2018
1FA886,executive-resignation,100,44,5/14/2018
1FAF22,regulatory-product-approval-granted,100,81,5/14/2018
1FC422,earnings,100,50,5/14/2018
20BEEA,acquisition-acquirer,100,49,5/14/2018
21D903,patient-enrollment-complete,100,64,5/14/2018
21D903,earnings,100,50,5/14/2018
228D42,partnership,100,61,5/14/2018
228D42,partnership,100,61,5/14/2018
239106,conference-participant,100,50,5/14/2018
24A89A,executive-appointment,100,54,5/14/2018
2667B6,note-sale,100,52,5/14/2018
2.90E+62,executive-resignation,100,44,5/14/2018
2DA92D,dividend,100,50,5/14/2018
2F98A5,acquisition-completed-acquirer,100,49,5/14/2018
306623,conference-participant,100,50,5/14/2018
315EB0,facility-upgrade,100,65,5/14/2018
31AA84,executive-appointment,100,54,5/14/2018
31F25C,merger,100,66,5/14/2018
341759,legal-issues-defendant,100,22,5/14/2018
37020C,earnings,100,50,5/14/2018
37020C,earnings,100,50,5/14/2018
37020C,earnings,100,50,5/14/2018
37020C,earnings,100,50,5/14/2018
37020C,earnings,100,50,5/14/2018
37020C,earnings,100,50,5/14/2018
37E18B,operating-earnings,100,50,5/14/2018
39D9DA,conference-call,100,50,5/14/2018
3B37F7,note-sale,100,52,5/14/2018
3B37F7,note-sale,100,52,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3BA1BF,earnings,100,50,5/14/2018
3C7F5F,partnership,100,61,5/14/2018
3E70FC,executive-appointment,100,54,5/14/2018
414FFF,conference-call,100,50,5/14/2018
416C55,conference-participant,100,50,5/14/2018
417BF9,business-contract,100,69,5/14/2018
41A93D,conference-participant,100,50,5/14/2018
425BDC,note-sale,100,52,5/14/2018
425BDC,note-sale,100,52,5/14/2018
427F32,public-offering,100,43,5/14/2018
4595EF,conference-call,100,50,5/14/2018
46A16E,conference-participant,100,50,5/14/2018
4AC91D,dividend,100,50,5/14/2018
4D229C,earnings,100,50,5/14/2018
4F9926,partnership,100,61,5/14/2018
4F9926,partnership,100,61,5/14/2018
50070E,conference-organizer,100,57,5/14/2018
50D1EC,partnership,100,61,5/14/2018
514067,public-offering,100,43,5/14/2018
546A27,conference-participant,100,50,5/14/2018
546A9C,earnings,100,50,5/14/2018
553949,dividend,100,50,5/14/2018
55438C,donation,100,54,5/14/2018
567F3D,conference-participant,100,50,5/14/2018
5C7601,board-meeting,100,51,5/14/2018
5C7601,partnership,100,61,5/14/2018
5F9CE3,dividend,100,50,5/14/2018
616E3B,dividend,100,50,5/14/2018
619882,conference-organizer,100,57,5/14/2018
619882,conference-organizer,100,57,5/14/2018
61BCA7,executive-appointment,100,54,5/14/2018
64854A,unit-acquisition-acquirer,100,49,5/14/2018
66E04A,partnership,100,61,5/14/2018
66E04A,partnership,100,61,5/14/2018
66E04A,partnership,100,61,5/14/2018
66E04A,partnership,100,61,5/14/2018
67303E,partnership,100,61,5/14/2018
693ECD,earnings,100,50,5/14/2018
6B236C,earnings,100,50,5/14/2018
6D2BF6,earnings,100,50,5/14/2018
724F84,conference-organizer,100,57,5/14/2018
726EEA,unit-acquisition-acquiree,100,76,5/14/2018
72CB93,executive-appointment,100,54,5/14/2018
769F40,conference-participant,100,50,5/14/2018
791D59,note-sale,100,52,5/14/2018
7AF907,clinical-trials-start,100,64,5/14/2018
7B0BA6,note-sale,100,52,5/14/2018
7B0BA6,note-sale,100,52,5/14/2018
7C790D,conference-participant,100,50,5/14/2018
817ED9,earnings,100,50,5/14/2018
8.10E+205,executive-appointment,100,54,5/14/2018
877C0C,conference-participant,100,50,5/14/2018
8B9B3B,conference-participant,100,50,5/14/2018
8DBBE6,conference-participant,100,50,5/14/2018
8E10BF,earnings,100,50,5/14/2018
8E82A6,conference-participant,100,50,5/14/2018
8F8F2F,dividend,100,50,5/14/2018
8FF2EF,executive-appointment,100,54,5/14/2018
92005C,executive-appointment,100,54,5/14/2018
9470CC,conference-participant,100,50,5/14/2018
94983E,dividend,100,50,5/14/2018
9592FB,earnings,100,50,5/14/2018
966ACE,conference-participant,100,50,5/14/2018
968966,conference-organizer,100,57,5/14/2018
979451,public-offering,100,43,5/14/2018
98CEBB,earnings,100,50,5/14/2018
98CEBB,business-contract,100,69,5/14/2018
990AD0,conference-organizer,100,57,5/14/2018
990AD0,conference-organizer,100,57,5/14/2018
990AD0,conference-organizer,100,57,5/14/2018
99DC8D,executive-resignation,100,44,5/14/2018
9C5BA5,headquarters-change,100,50,5/14/2018
9E298A,conference-participant,100,50,5/14/2018
9F048E,conference-participant,100,50,5/14/2018
A017F4,earnings,100,50,5/14/2018
A6828A,unit-acquisition-acquirer,100,49,5/14/2018
AAC8B6,dividend,100,50,5/14/2018
AC7C4F,business-contract,100,69,5/14/2018
AECCA9,conference-call,100,50,5/14/2018
B01215,earnings,100,50,5/14/2018
B05000,conference-participant,100,50,5/14/2018
B1DF3C,public-offering,100,43,5/14/2018
B1DF3C,public-offering,100,43,5/14/2018
B76C82,executive-appointment,100,54,5/14/2018
BE645B,earnings,100,50,5/14/2018
BE7BA4,credit-extension-recipient,100,69,5/14/2018
C2E39B,earnings,100,50,5/14/2018
C2E39B,earnings,100,50,5/14/2018
C2E39B,earnings,100,50,5/14/2018
C2E39B,earnings,100,50,5/14/2018
C97B2D,conference-participant,100,50,5/14/2018
CD051C,earnings,100,50,5/14/2018
CD051C,earnings,100,50,5/14/2018
CD051C,earnings,100,50,5/14/2018
CD051C,earnings,100,50,5/14/2018
CD051C,earnings,100,50,5/14/2018
CD4DA8,conference-organizer,100,57,5/14/2018
CEC08B,acquisition-completed-acquirer,100,49,5/14/2018
CFF97C,conference-participant,100,50,5/14/2018
D07B07,earnings,100,50,5/14/2018
D13F1C,product-release,100,64,5/14/2018
D20C8F,public-offering,100,43,5/14/2018
D518D8,dividend,100,50,5/14/2018
D5938F,private-placement,100,56,5/14/2018
D6489C,business-contract,100,69,5/14/2018
D70365,earnings,100,50,5/14/2018
D93A25,note-sale,100,52,5/14/2018
D93A25,note-sale,100,52,5/14/2018
D9B1C9,executive-appointment,100,54,5/14/2018
D9E036,note-sale,100,52,5/14/2018
DA48E4,product-release,100,64,5/14/2018
DC0066,earnings,100,50,5/14/2018
DC6EF3,earnings,100,50,5/14/2018
DDC415,conference-participant,100,50,5/14/2018
DFADDB,earnings,100,50,5/14/2018
E0207A,conference-participant,100,50,5/14/2018
E13782,earnings,100,50,5/14/2018
E20392,conference-participant,100,50,5/14/2018
E2CB7B,earnings,100,50,5/14/2018
ED79D9,acquisition-completed-acquirer,100,49,5/14/2018
ED79D9,earnings,100,50,5/14/2018
EFA7B2,earnings,100,50,5/14/2018
F0B335,legal-issues-defendant,100,22,5/14/2018
F179ED,note-sale,100,52,5/14/2018
F6DCE4,executive-appointment,100,54,5/14/2018
F7935D,earnings,100,50,5/14/2018
F7935D,earnings,100,50,5/14/2018
FD4588,award,100,58,5/14/2018
FDD3FC,conference-participant,100,50,5/14/2018
FF227B,earnings,100,50,5/14/2018
0157B1,partnership,100,61,5/15/2018
0157B1,partnership,100,61,5/15/2018
0157B1,partnership,100,61,5/15/2018
0157B1,partnership,100,61,5/15/2018
036C6F,dividend,100,50,5/15/2018
0490C6,conference-participant,100,50,5/15/2018
06A456,stake-acquirer,100,48,5/15/2018
07EC43,partnership,100,61,5/15/2018
09062E,partnership,100,61,5/15/2018
0919B1,dividend,100,50,5/15/2018
0968A5,conference-call,100,50,5/15/2018
0B13E8,earnings,100,50,5/15/2018
0BC17A,stock-splits,100,49,5/15/2018
0BD4E8,merger,100,66,5/15/2018
0E64D4,earnings,100,50,5/15/2018
0EF1AF,earnings,100,50,5/15/2018
0F0693,conference-participant,100,50,5/15/2018
168A5D,executive-appointment,100,54,5/15/2018
197612,executive-appointment,100,54,5/15/2018
1D943E,business-contract,100,69,5/15/2018
202E5A,executive-appointment,100,54,5/15/2018
2082EA,regulatory-product-application,100,69,5/15/2018
21268E,earnings,100,50,5/15/2018
26008A,conference-call,100,50,5/15/2018
26E3BA,earnings,100,50,5/15/2018
2.89E+11,dividend,100,50,5/15/2018
2920D5,conference-participant,100,50,5/15/2018
2A6DBE,earnings,100,50,5/15/2018
2B9DBB,dividend,100,50,5/15/2018
2C7505,executive-appointment,100,54,5/15/2018
2DA92D,executive-appointment,100,54,5/15/2018
2E1322,conference-participant,100,50,5/15/2018
2E902B,dividend-up,100,72,5/15/2018
3.20E+263,operating-earnings,100,50,5/15/2018
341759,clinical-trials,100,56,5/15/2018
355B19,dividend,100,50,5/15/2018
39FB23,legal-issues-defendant,100,22,5/15/2018
3B318A,conference-call,100,50,5/15/2018
3C8A04,dividend,100,50,5/15/2018
3DD5E2,conference-participant,100,50,5/15/2018
3ED92D,note-sale,100,52,5/15/2018
41785E,conference-participant,100,50,5/15/2018
41C528,executive-appointment,100,54,5/15/2018
449447,revenue-up,100,79,5/15/2018
45444E,legal-issues-defendant,100,22,5/15/2018
494EB9,dividend,100,50,5/15/2018
4AC91D,earnings,100,50,5/15/2018
4AC91D,partnership,100,61,5/15/2018
504FE2,executive-appointment,100,54,5/15/2018
51B442,earnings,100,50,5/15/2018
5480A7,dividend,100,50,5/15/2018
619882,conference-organizer,100,57,5/15/2018
619882,dividend,100,50,5/15/2018
619882,dividend,100,50,5/15/2018
665440,public-offering,100,43,5/15/2018
665440,public-offering,100,43,5/15/2018
6B0784,conference-participant,100,50,5/15/2018
6F5DD2,earnings,100,50,5/15/2018
70FCEF,executive-appointment,100,54,5/15/2018
72FCA3,debt-reduction,100,74,5/15/2018
76BD96,public-offering,100,43,5/15/2018
791D59,note-sale,100,52,5/15/2018
7BEA98,conference-participant,100,50,5/15/2018
7C75FD,note-sale,100,52,5/15/2018
7C790D,conference-participant,100,50,5/15/2018
7E3F8F,public-offering,100,43,5/15/2018
8.10E+32,dividend,100,50,5/15/2018
81222C,conference-participant,100,50,5/15/2018
82FD6D,conference-call,100,50,5/15/2018
84AB66,earnings-positive,100,69,5/15/2018
877C0C,product-release,100,64,5/15/2018
88D80A,earnings,100,50,5/15/2018
89E771,earnings,100,50,5/15/2018
8EDACA,conference-call,100,50,5/15/2018
8FCA78,dividend,100,50,5/15/2018
903AB4,dividend-up,100,81,5/15/2018
92D757,executive-appointment,100,54,5/15/2018
931AE7,conference-participant,100,50,5/15/2018
94637C,conference-participant,100,50,5/15/2018
954004,facility-open,100,65,5/15/2018
97644E,partnership,100,61,5/15/2018
97B027,market-entry,100,57,5/15/2018
990AD0,conference-organizer,100,57,5/15/2018
990AD0,conference-organizer,100,57,5/15/2018
9A2760,earnings,100,50,5/15/2018
9D4EC7,dividend-up,100,81,5/15/2018
9E575E,conference-participant,100,50,5/15/2018
A26C26,earnings,100,50,5/15/2018
A26EF7,conference-participant,100,50,5/15/2018
A403CF,earnings,100,50,5/15/2018
A6828A,partnership,100,61,5/15/2018
A70BF5,dividend,100,50,5/15/2018
A70BF5,executive-resignation,100,44,5/15/2018
A79F7D,earnings,100,50,5/15/2018
A80FE0,note-sale,100,52,5/15/2018
A8CBDA,conference-participant,100,50,5/15/2018
ACDF88,earnings,100,50,5/15/2018
ACDF88,earnings,100,50,5/15/2018
ACDF88,earnings,100,50,5/15/2018
ACDF88,earnings,100,50,5/15/2018
AFDF2E,earnings,100,50,5/15/2018
AFDF2E,earnings,100,50,5/15/2018
AFDF2E,earnings,100,50,5/15/2018
B01111,earnings,100,50,5/15/2018
B05000,earnings-up,100,68,5/15/2018
B05000,earnings,100,50,5/15/2018
B08954,earnings,100,50,5/15/2018
B08C51,product-release,100,64,5/15/2018
B1A85D,executive-appointment,100,54,5/15/2018
B2206F,acquisition-acquirer,100,49,5/15/2018
B2DAF6,product-release,100,64,5/15/2018
B2DAF6,product-release,100,64,5/15/2018
B2DAF6,product-release,100,64,5/15/2018
B3CB74,facility-open,100,65,5/15/2018
B48D6A,earnings,100,50,5/15/2018
B6082A,dividend-up,100,72,5/15/2018
B76C82,earnings,100,50,5/15/2018
BB5271,note-sale,100,52,5/15/2018
C03C8B,dividend,100,50,5/15/2018
C0BA36,facility-open,100,65,5/15/2018
C3BCD5,dividend,100,50,5/15/2018
C425AE,business-contract,100,69,5/15/2018
C4C77F,conference-call,100,50,5/15/2018
C8A248,dividend,100,50,5/15/2018
CC35BE,partnership,100,61,5/15/2018
CC3EC4,earnings,100,50,5/15/2018
CDC217,earnings,100,50,5/15/2018
CE8A7B,earnings,100,50,5/15/2018
CF6A5A,earnings,100,50,5/15/2018
D139BC,earnings,100,50,5/15/2018
D1AE3B,dividend,100,50,5/15/2018
D1C26F,partnership,100,61,5/15/2018
D20C8F,public-offering,100,43,5/15/2018
D25249,dividend,100,50,5/15/2018
D296C6,dividend,100,50,5/15/2018
D33D8C,dividend,100,50,5/15/2018
D56D6D,dividend,100,50,5/15/2018
D76AEF,conference-call,100,50,5/15/2018
D8442A,product-release,100,64,5/15/2018
DB5CA5,executive-appointment,100,54,5/15/2018
DB9829,dividend,100,50,5/15/2018
DC0066,conference-participant,100,50,5/15/2018
DC6EF3,asset-sale,100,62,5/15/2018
DE5611,conference-call,100,50,5/15/2018
DF11D9,conference-participant,100,50,5/15/2018
E06265,dividend,100,50,5/15/2018
E261E9,earnings,100,50,5/15/2018
E30B34,unit-acquisition-acquirer,100,49,5/15/2018
E3E68E,award,100,58,5/15/2018
E4158B,dividend,100,50,5/15/2018
E49AA3,dividend,100,50,5/15/2018
E6D89E,acquisition-acquirer,100,49,5/15/2018
E8846E,donation,100,54,5/15/2018
E8C557,conference-participant,100,50,5/15/2018
EC4E82,earnings-up,100,68,5/15/2018
EC4E82,earnings-up,100,68,5/15/2018
ECF709,executive-appointment,100,54,5/15/2018
ED7F13,note-sale,100,52,5/15/2018
EDD234,earnings,100,50,5/15/2018
EE74E1,award,100,58,5/15/2018
EEA734,business-contract,100,69,5/15/2018
F179ED,note-sale,100,52,5/15/2018
F209B4,earnings,100,50,5/15/2018
F30508,clinical-trials-complete,100,56,5/15/2018
F4E992,conference-participant,100,50,5/15/2018
F6A392,earnings,100,50,5/15/2018
F6E248,facility-open,100,65,5/15/2018
F88147,earnings,100,50,5/15/2018
F9CAF8,earnings-per-share-up,100,73,5/15/2018
F9CAF8,earnings-per-share,100,50,5/15/2018
F9CAF8,earnings-per-share,100,50,5/15/2018
FADF1A,earnings,100,50,5/15/2018
FC1B7B,dividend-up,100,59,5/15/2018
FCA54E,earnings,100,50,5/15/2018
FD4588,conference-participant,100,50,5/15/2018
FD9526,dividend,100,50,5/15/2018
0142B5,dividend,100,50,5/16/2018
0157B1,product-recall,100,29,5/16/2018
0157B1,facility-open,100,65,5/16/2018
20751,patient-enrollment-start,100,58,5/16/2018
053EFF,dividend,100,50,5/16/2018
05D148,clinical-trials-positive,100,87,5/16/2018
0A7650,dividend,100,50,5/16/2018
0BF528,partnership,100,61,5/16/2018
1151F4,dividend,100,50,5/16/2018
1216D1,stock-splits,100,49,5/16/2018
12DE76,earnings,100,50,5/16/2018
12DE76,earnings,100,50,5/16/2018
12DE76,earnings,100,50,5/16/2018
12DE76,earnings,100,50,5/16/2018
12DE76,earnings,100,50,5/16/2018
12DE76,earnings,100,50,5/16/2018
197612,dividend,100,50,5/16/2018
2031CE,dividend,100,50,5/16/2018
20403D,dividend,100,50,5/16/2018
225CA2,executive-appointment,100,54,5/16/2018
249674,conference-participant,100,50,5/16/2018
27B191,dividend,100,50,5/16/2018
284289,buybacks,100,74,5/16/2018
29A4CC,dividend,100,50,5/16/2018
2B8179,executive-appointment,100,54,5/16/2018
2C35B5,business-contract,100,69,5/16/2018
2D643C,conference-participant,100,50,5/16/2018
3.50E+27,executive-appointment,100,54,5/16/2018
371B0A,conference-participant,100,50,5/16/2018
384CD3,dividend,100,50,5/16/2018
3A3447,conference-participant,100,50,5/16/2018
3B37F7,conference-organizer,100,57,5/16/2018
3B37F7,conference-organizer,100,57,5/16/2018
3B37F7,conference-organizer,100,57,5/16/2018
3DB18B,conference-participant,100,50,5/16/2018
431B74,trading-halt,100,43,5/16/2018
431B74,trading-resumed,100,58,5/16/2018
448BF3,clinical-trials,100,56,5/16/2018
45444E,legal-issues-defendant,100,22,5/16/2018
4591D3,buybacks,100,74,5/16/2018
45ABCC,conference-participant,100,50,5/16/2018
46017C,conference-participant,100,50,5/16/2018
4.60E+06,investment-investor,100,55,5/16/2018
4A2457,business-contract,100,69,5/16/2018
4A3438,award,100,58,5/16/2018
4A6F00,product-release,100,64,5/16/2018
4AE584,revenues,100,50,5/16/2018
4AE584,revenues,100,50,5/16/2018
4ECD1A,earnings,100,50,5/16/2018
589846,conference-call,100,50,5/16/2018
5A9A82,dividend-guidance,100,50,5/16/2018
5BC2F4,dividend,100,50,5/16/2018
5BC2F4,dividend,100,50,5/16/2018
5D87DF,dividend,100,50,5/16/2018
61B81B,conference-participant,100,50,5/16/2018
64854A,executive-appointment,100,54,5/16/2018
67303E,clinical-trials,100,56,5/16/2018
6A961B,business-contract,100,69,5/16/2018
6A961B,executive-appointment,100,54,5/16/2018
6F22E7,earnings,100,50,5/16/2018
7032D0,dividend,100,50,5/16/2018
724F84,conference-organizer,100,57,5/16/2018
72CB93,product-release,100,64,5/16/2018
72CB93,partnership,100,61,5/16/2018
73F70F,dividend,100,50,5/16/2018
7448A3,dividend,100,50,5/16/2018
747219,conference-participant,100,50,5/16/2018
762A3E,conference-organizer,100,57,5/16/2018
762A3E,conference-organizer,100,57,5/16/2018
763DBE,regulatory-product-approval-granted,100,81,5/16/2018
76BD96,public-offering,100,43,5/16/2018
76BD96,note-sale,100,52,5/16/2018
76E80F,conference-call,100,50,5/16/2018
76F067,regulatory-product-approval-granted,100,81,5/16/2018
76F067,regulatory-product-approval-granted,100,81,5/16/2018
76F067,regulatory-product-approval-granted,100,81,5/16/2018
7710F3,conference-participant,100,50,5/16/2018
7999F3,dividend,100,50,5/16/2018
7999F3,dividend,100,50,5/16/2018
7A10FF,dividend,100,50,5/16/2018
7AF907,earnings,100,50,5/16/2018
7B8CB5,dividend,100,50,5/16/2018
7C4F43,clinical-trials-start,100,64,5/16/2018
7E3F8F,public-offering,100,43,5/16/2018
8.10E+32,executive-appointment,100,54,5/16/2018
818A2F,dividend,100,50,5/16/2018
82C202,note-sale,100,52,5/16/2018
863350,facility-open,100,65,5/16/2018
896771,market-entry,100,57,5/16/2018
896771,business-contract,100,69,5/16/2018
896771,partnership,100,61,5/16/2018
896771,partnership,100,61,5/16/2018
8D4486,partnership,100,61,5/16/2018
8D9993,conference-call,100,50,5/16/2018
8DE56F,business-contract,100,69,5/16/2018
8DE56F,business-contract,100,69,5/16/2018
8FF2EF,earnings,100,50,5/16/2018
923D93,product-release,100,64,5/16/2018
944B2E,conference-participant,100,50,5/16/2018
947B0B,clinical-trials,100,56,5/16/2018
958938,regulatory-product-approval-granted,100,81,5/16/2018
9.74E+08,business-contract,100,69,5/16/2018
97FE80,merger,100,66,5/16/2018
98A286,earnings,100,50,5/16/2018
990AD0,conference-organizer,100,57,5/16/2018
990AD0,conference-organizer,100,57,5/16/2018
994468,dividend,100,50,5/16/2018
9FA83B,executive-appointment,100,54,5/16/2018
A01664,earnings,100,50,5/16/2018
A3800A,conference-participant,100,50,5/16/2018
A868C9,executive-appointment,100,54,5/16/2018
AC7C4F,product-release,100,64,5/16/2018
ACDF88,conference-participant,100,50,5/16/2018
AD9F1D,conference-participant,100,50,5/16/2018
ADF1B0,executive-appointment,100,54,5/16/2018
AE79CD,executive-appointment,100,54,5/16/2018
AFF7B4,conference-participant,100,50,5/16/2018
B076A1,buybacks,100,74,5/16/2018
B076A1,dividend,100,50,5/16/2018
B2D492,executive-appointment,100,54,5/16/2018
B4C673,partnership,100,61,5/16/2018
B934BF,executive-appointment,100,54,5/16/2018
BD682F,dividend,100,50,5/16/2018
C03C8B,acquisition-acquirer,100,49,5/16/2018
C03C8B,acquisition-acquirer,100,49,5/16/2018
C15F8F,public-offering,100,43,5/16/2018
C32A39,dividend,100,50,5/16/2018
C5C137,earnings,100,50,5/16/2018
C5C137,earnings,100,50,5/16/2018
C5C137,earnings,100,50,5/16/2018
C5C137,earnings,100,50,5/16/2018
C8257F,award,100,58,5/16/2018
C8257F,award,100,58,5/16/2018
C8A248,business-contract,100,69,5/16/2018
C8A248,business-contract,100,69,5/16/2018
C98CDB,conference-participant,100,50,5/16/2018
C9A96E,dividend,100,50,5/16/2018
CA99D7,earnings,100,50,5/16/2018
CBFFDD,business-contract,100,69,5/16/2018
CCB623,executive-appointment,100,54,5/16/2018
CCBBAD,dividend,100,50,5/16/2018
D07B07,patent-awarded,100,72,5/16/2018
D5AF19,partnership,100,61,5/16/2018
D721C6,dividend,100,50,5/16/2018
DA48E4,dividend,100,50,5/16/2018
DB9F70,conference-participant,100,50,5/16/2018
E16133,executive-appointment,100,54,5/16/2018
E9C7C0,earnings,100,50,5/16/2018
E9E6FD,note-sale,100,52,5/16/2018
ECDEB2,dividend,100,50,5/16/2018
ECF4F8,executive-appointment,100,54,5/16/2018
ED79D9,dividend,100,50,5/16/2018
ED7F13,note-sale,100,52,5/16/2018
F1529C,partnership,100,61,5/16/2018
F3EDB4,business-contract,100,69,5/16/2018
F5D410,conference-participant,100,50,5/16/2018
F85CC0,dividend,100,50,5/16/2018
F93C8A,dividend,100,50,5/16/2018
FB728F,conference-participant,100,50,5/16/2018
FC80E6,dividend,100,50,5/16/2018
FD6926,product-release,100,64,5/16/2018
02ACBD,conference-participant,100,50,5/17/2018
31025,executive-appointment,100,54,5/17/2018
06A456,conference-call,100,50,5/17/2018
099C88,dividend,100,50,5/17/2018
0B57D7,dividend,100,50,5/17/2018
0BA8CE,executive-resignation,100,44,5/17/2018
0BF198,executive-appointment,100,54,5/17/2018
0C2A0D,award,100,58,5/17/2018
0E5223,conference-participant,100,50,5/17/2018
119CB6,dividend,100,50,5/17/2018
131443,product-release,100,64,5/17/2018
143C52,conference-call,100,50,5/17/2018
184866,partnership,100,61,5/17/2018
1C2593,executive-appointment,100,54,5/17/2018
1FAF22,conference-participant,100,50,5/17/2018
1FC422,legal-issues-defendant,100,22,5/17/2018
200D8B,earnings,100,50,5/17/2018
21F9CA,earnings,100,50,5/17/2018
275300,dividend,100,50,5/17/2018
2BC05E,conference-participant,100,50,5/17/2018
2BC05E,conference-participant,100,50,5/17/2018
2CB4C9,executive-appointment,100,54,5/17/2018
2CB4C9,executive-resignation,100,44,5/17/2018
2DB344,dividend,100,50,5/17/2018
2F98A5,conference-call,100,50,5/17/2018
30AB63,earnings-guidance,100,50,5/17/2018
3461CF,analyst-ratings-change-positive-rater,20,50,5/17/2018
3.50E+27,dividend,100,50,5/17/2018
370C50,product-price-raise,100,57,5/17/2018
385DD4,facility-open,100,65,5/17/2018
397A8F,earnings,100,50,5/17/2018
3B37F7,note-sale,100,52,5/17/2018
3C7F5F,dividend,100,50,5/17/2018
3ED92D,conference-participant,100,50,5/17/2018
4.03E+05,acquisition-acquirer,100,49,5/17/2018
422CE3,earnings,100,50,5/17/2018
422CE3,earnings,100,50,5/17/2018
422CE3,earnings,100,50,5/17/2018
422CE3,earnings,100,50,5/17/2018
422CE3,earnings,100,50,5/17/2018
425BDC,note-sale,100,52,5/17/2018
425BDC,note-sale,100,52,5/17/2018
449447,conference-participant,100,50,5/17/2018
458D2C,legal-issues-defendant,100,22,5/17/2018
490D4B,executive-appointment,100,54,5/17/2018
49BBBC,conference-participant,100,50,5/17/2018
4E7C1F,business-contract,100,69,5/17/2018
4ECD1A,earnings,100,50,5/17/2018
4ECD1A,earnings,100,50,5/17/2018
50070E,conference-organizer,100,57,5/17/2018
50070E,conference-organizer,100,57,5/17/2018
51B442,public-offering,100,43,5/17/2018
553949,business-contract,100,69,5/17/2018
55CD6F,dividend,100,50,5/17/2018
57A854,business-contract,100,69,5/17/2018
57A854,business-contract,100,69,5/17/2018
5B35C7,dividend,100,50,5/17/2018
5C2A47,conference-participant,100,50,5/17/2018
5F9CE3,executive-appointment,100,54,5/17/2018
5FE4B6,dividend,100,50,5/17/2018
641F17,note-sale,100,52,5/17/2018
6830FE,earnings,100,50,5/17/2018
6E705B,executive-appointment,100,54,5/17/2018
6E8349,dividend,100,50,5/17/2018
6EB9DA,conference-participant,100,50,5/17/2018
6F3936,conference-call,100,50,5/17/2018
6F3FA8,dividend,100,50,5/17/2018
6F3FA8,executive-appointment,100,54,5/17/2018
713810,revenue-volume-up,100,74,5/17/2018
717DB4,conference-participant,100,50,5/17/2018
766047,dividend,100,50,5/17/2018
76F067,regulatory-product-approval-granted,100,81,5/17/2018
76F067,regulatory-product-approval-granted,100,81,5/17/2018
7A0EC4,conference-call,100,50,5/17/2018
7CD98F,dividend,100,50,5/17/2018
7E1D5D,product-release,100,64,5/17/2018
817ED9,partnership,100,61,5/17/2018
8377DB,partnership,100,61,5/17/2018
8377DB,conference-call,100,50,5/17/2018
83E0AC,product-release,100,64,5/17/2018
85AD00,dividend,100,50,5/17/2018
8A8E41,product-release,100,64,5/17/2018
8B3B0E,conference-participant,100,50,5/17/2018
8BAA15,executive-appointment,100,54,5/17/2018
9196A2,conference-organizer,100,57,5/17/2018
92D757,product-release,100,64,5/17/2018
934029,executive-appointment,100,54,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,earnings,100,50,5/17/2018
9.36E+10,executive-appointment,100,54,5/17/2018
947B0B,clinical-trials,100,56,5/17/2018
954A47,dividend,100,50,5/17/2018
95DC1F,partnership,100,61,5/17/2018
97693A,conference-call,100,50,5/17/2018
990AD0,conference-organizer,100,57,5/17/2018
990AD0,conference-organizer,100,57,5/17/2018
9C25FF,legal-issues-defendant,100,22,5/17/2018
9E0811,conference-call,100,50,5/17/2018
A21649,dividend,100,50,5/17/2018
A5151E,conference-participant,100,50,5/17/2018
A52B6B,conference-participant,100,50,5/17/2018
A9ED24,dividend,100,50,5/17/2018
AA98ED,buybacks,100,74,5/17/2018
ACDF88,dividend,100,50,5/17/2018
AD22F2,conference-call,100,50,5/17/2018
AD3C93,product-release,100,64,5/17/2018
ADD9DC,facility-open,100,65,5/17/2018
AFD7DD,dividend,100,50,5/17/2018
B1B10C,dividend,100,50,5/17/2018
B33E77,clinical-trials,100,56,5/17/2018
B7BDA3,acquisition-interest-acquirer,100,46,5/17/2018
BB0787,dividend,100,50,5/17/2018
BB5271,note-sale,100,52,5/17/2018
BD15E8,dividend,100,50,5/17/2018
C0BA36,conference-participant,100,50,5/17/2018
C15DB3,merger,100,66,5/17/2018
C22BE8,earnings-up,100,68,5/17/2018
C22BE8,earnings,100,50,5/17/2018
C22BE8,earnings,100,50,5/17/2018
C45CE7,dividend-up,100,81,5/17/2018
C941DC,product-release,100,64,5/17/2018
CD2DA4,conference-participant,100,50,5/17/2018
CDAB24,unit-acquisition-acquirer,100,49,5/17/2018
CF7292,conference-call,100,50,5/17/2018
CFD4B6,grant-recipient,100,63,5/17/2018
D3F64D,dividend,100,50,5/17/2018
D6534D,dividend,100,50,5/17/2018
D74613,unit-acquisition-acquirer,100,49,5/17/2018
D77F7E,conference-participant,100,50,5/17/2018
D8DA3D,dividend,100,50,5/17/2018
D8ECA1,award,100,58,5/17/2018
D93A25,note-sale,100,52,5/17/2018
DAFED3,dividend,100,50,5/17/2018
DB7EC3,ownership-decrease-owner,100,46,5/17/2018
DB9829,earnings,100,50,5/17/2018
DF11D9,executive-appointment,100,54,5/17/2018
E0207A,business-contract,100,69,5/17/2018
E28D9C,conference-participant,100,50,5/17/2018
E3656D,acquisition-acquirer,100,49,5/17/2018
E3656D,conference-call,100,50,5/17/2018
E6A53A,dividend-up,100,61,5/17/2018
E8846E,conference-participant,100,50,5/17/2018
E8846E,conference-participant,100,50,5/17/2018
EB2F14,dividend,100,50,5/17/2018
EDD234,earnings,100,50,5/17/2018
EEA6B3,conference-participant,100,50,5/17/2018
EF1AD9,product-release,100,64,5/17/2018
EF45B6,dividend,100,50,5/17/2018
EF5BED,executive-appointment,100,54,5/17/2018
F1529C,earnings,100,50,5/17/2018
F1529C,dividend,100,50,5/17/2018
F179ED,conference-participant,100,50,5/17/2018
F6A987,dividend,100,50,5/17/2018
F92DBC,conference-organizer,100,57,5/17/2018
FD9A97,earnings,100,50,5/17/2018
13528,trading-delisting,100,36,5/18/2018
95294,award,100,58,5/18/2018
0C136E,dividend,100,50,5/18/2018
1F3CFB,conference-participant,100,50,5/18/2018
2667B6,business-contract,100,69,5/18/2018
2B49F4,dividend,100,50,5/18/2018
2CB4C9,earnings,100,50,5/18/2018
31AA84,award,100,58,5/18/2018
341759,clinical-trials,100,56,5/18/2018
3ED92D,note-sale,100,52,5/18/2018
4017AD,executive-appointment,100,54,5/18/2018
417BF9,conference-call,100,50,5/18/2018
42312F,earnings,100,50,5/18/2018
427F32,public-offering,100,43,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings-positive,100,69,5/18/2018
431B74,earnings,100,50,5/18/2018
431B74,earnings,100,50,5/18/2018
431B74,earnings,100,50,5/18/2018
431B74,earnings,100,50,5/18/2018
431B74,earnings,100,50,5/18/2018
431B74,earnings,100,50,5/18/2018
444CC8,settlement,100,56,5/18/2018
4AC91D,acquisition-interest-acquiree,100,82,5/18/2018
5088A5,executive-appointment,100,54,5/18/2018
543900,executive-appointment,100,54,5/18/2018
5BE42C,executive-appointment,100,54,5/18/2018
5D02B7,conference-call,100,50,5/18/2018
5D16CF,buybacks,100,74,5/18/2018
5E6959,conference-participant,100,50,5/18/2018
5FE4B6,executive-resignation,100,44,5/18/2018
75F665,dividend,100,50,5/18/2018
80C400,buybacks,100,74,5/18/2018
82C202,note-sale,100,52,5/18/2018
89F693,legal-issues-defendant,100,22,5/18/2018
89F693,legal-issues-defendant,100,22,5/18/2018
8E10BF,conference-participant,100,50,5/18/2018
91E5EE,dividend,100,50,5/18/2018
91E5EE,conference-participant,100,50,5/18/2018
9D56F2,conference-participant,100,50,5/18/2018
9E3224,acquisition-completed-acquirer,100,49,5/18/2018
A01664,executive-appointment,100,54,5/18/2018
A16DEA,dividend,100,50,5/18/2018
A4B899,executive-appointment,100,54,5/18/2018
A4B899,dividend,100,50,5/18/2018
A4BCDE,conference-participant,100,50,5/18/2018
A631A3,earnings,100,50,5/18/2018
A94637,dividend-up,100,71,5/18/2018
ACF0B4,acquisition-acquirer,100,49,5/18/2018
B2AA0A,business-contract,100,69,5/18/2018
B37FB4,acquisition-acquirer,100,49,5/18/2018
C5C137,executive-appointment,100,54,5/18/2018
C5C137,dividend,100,50,5/18/2018
C8A248,executive-resignation,100,44,5/18/2018
CDE118,donation,100,54,5/18/2018
CF3FF9,partnership,100,61,5/18/2018
D17C1B,executive-resignation,100,44,5/18/2018
D2B9E5,partnership,100,61,5/18/2018
D3CEDF,legal-issues-defendant,100,22,5/18/2018
D45285,executive-appointment,100,54,5/18/2018
D54E62,business-contract,100,69,5/18/2018
D64EDF,award,100,58,5/18/2018
D9E036,note-sale,100,52,5/18/2018
DAC66A,dividend,100,50,5/18/2018
DB23C8,conference-participant,100,50,5/18/2018
DD7A96,dividend,100,50,5/18/2018
DF42A0,conference-call,100,50,5/18/2018
E0207A,dividend,100,50,5/18/2018
E259C7,conference-participant,100,50,5/18/2018
E26FC3,dividend,100,50,5/18/2018
E35610,executive-appointment,100,54,5/18/2018
E829E8,board-meeting,100,51,5/18/2018
E866D2,product-release,100,64,5/18/2018
E8846E,dividend,100,50,5/18/2018
EAA0A7,partnership,100,61,5/18/2018
F46EC9,conference-participant,100,50,5/18/2018
F6FA6A,executive-appointment,100,54,5/18/2018
F88A04,facility-upgrade,100,65,5/18/2018
FF4BA4,dividend,100,50,5/18/2018
4ECD1A,dividend,100,50,5/19/2018
89F693,legal-issues-defendant,100,22,5/19/2018
001F1B,unit-acquisition-acquirer,100,49,5/21/2018
002A99,clinical-trials-start,100,64,5/21/2018
03FAA6,acquisition-completed-acquirer,100,49,5/21/2018
06C826,acquisition-acquirer,100,49,5/21/2018
07CA6A,executive-appointment,100,54,5/21/2018
0FABBD,conference-participant,100,50,5/21/2018
1096C6,note-sale,100,52,5/21/2018
126F95,dividend,100,50,5/21/2018
12E454,product-release,100,64,5/21/2018
12E454,legal-issues-defendant,100,22,5/21/2018
147C38,asset-sale,100,62,5/21/2018
1921DD,merger,100,66,5/21/2018
1921DD,merger,100,66,5/21/2018
1921DD,merger,100,66,5/21/2018
1921DD,merger,100,66,5/21/2018
1B637E,note-sale,100,52,5/21/2018
225CA2,dividend,100,50,5/21/2018
25102A,exchange-noncompliance-authority,100,50,5/21/2018
25102A,conference-participant,100,50,5/21/2018
2B5483,conference-participant,100,50,5/21/2018
2CA60F,executive-appointment,100,54,5/21/2018
2CA60F,public-offering,100,43,5/21/2018
2F6782,conference-participant,100,50,5/21/2018
31F25C,public-offering,100,43,5/21/2018
3390DE,executive-appointment,100,54,5/21/2018
33AD83,conference-call,100,50,5/21/2018
37020C,conference-participant,100,50,5/21/2018
371B0A,conference-participant,100,50,5/21/2018
39692D,award,100,58,5/21/2018
39692D,award,100,58,5/21/2018
39FB23,legal-issues-defendant,100,22,5/21/2018
3B37F7,conference-organizer,100,57,5/21/2018
3DE4D1,executive-appointment,100,54,5/21/2018
422CE3,facility-open,100,65,5/21/2018
468DD4,conference-participant,100,50,5/21/2018
49BBBC,buybacks,100,74,5/21/2018
49F4D0,dividend,100,50,5/21/2018
4A2457,business-contract,100,69,5/21/2018
4A3438,conference-participant,100,50,5/21/2018
4D8124,partnership,100,61,5/21/2018
4E6F5A,public-offering,100,43,5/21/2018
4E6F5A,loan-recipient,100,59,5/21/2018
4F9926,acquisition-acquirer,100,49,5/21/2018
4FF163,executive-appointment,100,54,5/21/2018
50070E,conference-organizer,100,57,5/21/2018
5065B1,unit-acquisition-acquirer,100,49,5/21/2018
50D1EC,public-offering,100,43,5/21/2018
514067,executive-appointment,100,54,5/21/2018
51D876,executive-appointment,100,54,5/21/2018
53A226,earnings,100,50,5/21/2018
54DF47,public-offering,100,43,5/21/2018
55C289,dividend,100,50,5/21/2018
57DDB9,merger,100,66,5/21/2018
5EF130,conference-call,100,50,5/21/2018
62A48D,executive-appointment,100,54,5/21/2018
6CF43C,executive-appointment,100,54,5/21/2018
6E705B,legal-issues-defendant,100,22,5/21/2018
73A71F,public-offering,100,43,5/21/2018
7A3633,note-sale,100,52,5/21/2018
7ADE57,executive-appointment,100,54,5/21/2018
810FAD,dividend,100,50,5/21/2018
810FAD,executive-appointment,100,54,5/21/2018
8377DB,merger,100,66,5/21/2018
8377DB,merger,100,66,5/21/2018
85AD00,executive-appointment,100,54,5/21/2018
86A1B9,business-contract,100,69,5/21/2018
89F693,product-release,100,64,5/21/2018
8AB37F,conference-participant,100,50,5/21/2018
8B8656,conference-participant,100,50,5/21/2018
8BFAA4,dividend,100,50,5/21/2018
8FF57A,partnership,100,61,5/21/2018
905356,earnings-per-share-positive,100,69,5/21/2018
905356,earnings,100,50,5/21/2018
905356,earnings,100,50,5/21/2018
93965C,conference-participant,100,50,5/21/2018
945DE6,merger,100,66,5/21/2018
945DE6,merger,100,66,5/21/2018
945DE6,merger,100,66,5/21/2018
945DE6,merger,100,66,5/21/2018
9470CC,public-offering,100,43,5/21/2018
9.74E+08,business-contract,100,69,5/21/2018
97644E,legal-issues-defendant,100,22,5/21/2018
97644E,legal-issues-defendant,100,22,5/21/2018
990AD0,conference-organizer,100,57,5/21/2018
9ABD30,public-offering,100,43,5/21/2018
9C25FF,legal-issues-defendant,100,22,5/21/2018
9D3360,board-meeting,100,51,5/21/2018
A1EAC8,conference-participant,100,50,5/21/2018
A746F6,executive-appointment,100,54,5/21/2018
ADD9DC,earnings,100,50,5/21/2018
AEFC90,clinical-trials,100,56,5/21/2018
B72BE9,dividend,100,50,5/21/2018
B7BBFF,conference-call,100,50,5/21/2018
B7EB38,conference-participant,100,50,5/21/2018
B98EFA,conference-participant,100,50,5/21/2018
BB127B,executive-appointment,100,54,5/21/2018
C188F8,regulatory-product-approval-granted,100,81,5/21/2018
C36189,public-offering,100,43,5/21/2018
C3DE7D,earnings,100,50,5/21/2018
C4A432,dividend,100,50,5/21/2018
C4F567,conference-organizer,100,57,5/21/2018
C9881C,buybacks,100,74,5/21/2018
CD2DA4,conference-participant,100,50,5/21/2018
CDEDFE,trading-listing,100,61,5/21/2018
CE5C6E,conference-participant,100,50,5/21/2018
CFF15D,product-release,100,64,5/21/2018
CFF15D,product-release,100,64,5/21/2018
CFF97C,credit-rating-upgrade-rater,20,50,5/21/2018
D1AE3B,executive-appointment,100,54,5/21/2018
D1C0B9,conference-participant,100,50,5/21/2018
D56D6D,revenues,100,50,5/21/2018
D56D6D,earnings,100,50,5/21/2018
D56D6D,earnings,100,50,5/21/2018
D6144F,product-release,100,64,5/21/2018
D8442A,legal-issues-defendant,100,22,5/21/2018
DA91AE,award,100,58,5/21/2018
DE20DF,executive-appointment,100,54,5/21/2018
DE20DF,partnership,100,61,5/21/2018
E1E36F,dividend-up,100,58,5/21/2018
E30A8F,note-sale,100,52,5/21/2018
E754F0,conference-participant,100,50,5/21/2018
E8C557,executive-appointment,100,54,5/21/2018
E9E6FD,note-sale,100,52,5/21/2018
E9FF33,executive-appointment,100,54,5/21/2018
EB7FBF,conference-call,100,50,5/21/2018
EBD89A,conference-participant,100,50,5/21/2018
ED7F13,conference-participant,100,50,5/21/2018
F4E882,note-sale,100,52,5/21/2018
F5C78B,public-offering,100,43,5/21/2018
F7935D,conference-participant,100,50,5/21/2018
FC01C0,facility-open,100,65,5/21/2018
FD39EB,note-sale,100,52,5/21/2018
FE89E0,conference-participant,100,50,5/21/2018
FF6644,conference-participant,100,50,5/21/2018
0157B1,partnership,100,61,5/22/2018
03B8CF,conference-organizer,100,57,5/22/2018
07CA6A,investment-investor,100,55,5/22/2018
0986B5,dividend,100,50,5/22/2018
0BC17A,conference-participant,100,50,5/22/2018
0BC853,earnings,100,50,5/22/2018
0BF198,conference-participant,100,50,5/22/2018
0CE7F6,dividend,100,50,5/22/2018
0EC508,executive-appointment,100,54,5/22/2018
0F0440,earnings,100,50,5/22/2018
0F0440,earnings,100,50,5/22/2018
0FE3A6,asset-sale,100,62,5/22/2018
147098,dividend,100,50,5/22/2018
159739,dividend,100,50,5/22/2018
159AE4,conference-call,100,50,5/22/2018
17EDA5,partnership,100,61,5/22/2018
17EDA5,partnership,100,61,5/22/2018
1921DD,stock-gain,100,63,5/22/2018
1D1B07,executive-appointment,100,54,5/22/2018
1D1B07,executive-appointment,100,54,5/22/2018
1D943E,unit-acquisition-acquirer,100,49,5/22/2018
1DDEDA,conference-call,100,50,5/22/2018
1EBF8D,dividend,100,50,5/22/2018
228D42,partnership,100,61,5/22/2018
228D42,partnership,100,61,5/22/2018
253B2F,conference-participant,100,50,5/22/2018
2667B6,business-contract,100,69,5/22/2018
279916,earnings,100,50,5/22/2018
27BFA1,public-offering,100,43,5/22/2018
295F9F,conference-participant,100,50,5/22/2018
2CA60F,public-offering,100,43,5/22/2018
2CBB58,operating-earnings-up,100,64,5/22/2018
2CBB58,operating-earnings-up,100,64,5/22/2018
2CBB58,operating-earnings-up,100,64,5/22/2018
2CBB58,operating-earnings-up,100,64,5/22/2018
31DB20,dividend,100,50,5/22/2018
3.30E+34,unit-acquisition-acquirer,100,49,5/22/2018
37B120,conference-participant,100,50,5/22/2018
396D7C,regulatory-product-approval-granted,100,81,5/22/2018
39FB23,legal-issues-defendant,100,22,5/22/2018
39FB23,legal-issues-defendant,100,22,5/22/2018
39FB23,legal-issues-defendant,100,22,5/22/2018
39FB23,legal-issues-defendant,100,22,5/22/2018
3B37F7,conference-participant,100,50,5/22/2018
3B50FE,earnings,100,50,5/22/2018
3B50FE,earnings,100,50,5/22/2018
3B50FE,earnings,100,50,5/22/2018
3DE4D1,supply-guidance-increase,100,74,5/22/2018
3EE65E,earnings,100,50,5/22/2018
40B903,same-store-sales-up,100,62,5/22/2018
4.00E+163,executive-appointment,100,54,5/22/2018
417BF9,earnings,100,50,5/22/2018
45444E,business-contract,100,69,5/22/2018
4A6F00,partnership,100,61,5/22/2018
4A6F00,partnership,100,61,5/22/2018
4C350A,conference-call,100,50,5/22/2018
4C37C5,partnership,100,61,5/22/2018
4C6C63,product-release,100,64,5/22/2018
4C6C63,product-release,100,64,5/22/2018
4D8E5E,merger,100,66,5/22/2018
4DD09F,business-contract,100,69,5/22/2018
4E6F5A,public-offering,100,43,5/22/2018
4F0A80,stock-splits,100,49,5/22/2018
50070E,conference-organizer,100,57,5/22/2018
50070E,conference-organizer,100,57,5/22/2018
51B442,public-offering,100,43,5/22/2018
59C539,executive-appointment,100,54,5/22/2018
5F3E74,conference-participant,100,50,5/22/2018
61A586,executive-appointment,100,54,5/22/2018
665D7D,conference-participant,100,50,5/22/2018
67B923,earnings,100,50,5/22/2018
68E3E0,dividend-up,100,52,5/22/2018
69C99E,conference-participant,100,50,5/22/2018
69FDFC,award,100,58,5/22/2018
6CD55A,dividend,100,50,5/22/2018
713810,antitrust-settlement,100,60,5/22/2018
719477,dividend,100,50,5/22/2018
724F84,acquisition-acquirer,100,49,5/22/2018
73A71F,partnership,100,61,5/22/2018
73A71F,note-sale,100,52,5/22/2018
73C9E2,conference-participant,100,50,5/22/2018
756BB4,earnings,100,50,5/22/2018
762A3E,conference-organizer,100,57,5/22/2018
762A3E,conference-organizer,100,57,5/22/2018
762A3E,conference-organizer,100,57,5/22/2018
76E80F,executive-appointment,100,54,5/22/2018
78A1BB,dividend,100,50,5/22/2018
791D59,conference-participant,100,50,5/22/2018
80C400,product-release,100,64,5/22/2018
810A4B,conference-participant,100,50,5/22/2018
8.10E+32,buybacks,100,74,5/22/2018
85CDC9,executive-appointment,100,54,5/22/2018
86A1B9,conference-participant,100,50,5/22/2018
89F693,legal-issues-defendant,100,22,5/22/2018
8BAA15,revenue-guidance,100,50,5/22/2018
8E93A4,acquisition-acquirer,100,49,5/22/2018
8E93A4,acquisition-acquirer,100,49,5/22/2018
8EDACA,earnings,100,50,5/22/2018
8EF425,dividend,100,50,5/22/2018
95C392,public-offering,100,43,5/22/2018
96F126,business-contract,100,69,5/22/2018
97644E,legal-issues-defendant,100,22,5/22/2018
97644E,legal-issues-defendant,100,22,5/22/2018
97644E,legal-issues-defendant,100,22,5/22/2018
990AD0,conference-organizer,100,57,5/22/2018
9934AD,conference-participant,100,50,5/22/2018
99ACAD,partnership,100,61,5/22/2018
9ABD30,public-offering,100,43,5/22/2018
9BB35A,earnings,100,50,5/22/2018
9BB35A,earnings,100,50,5/22/2018
9BB35A,earnings,100,50,5/22/2018
9BB35A,earnings,100,50,5/22/2018
9DDE1B,dividend-up,100,81,5/22/2018
9F71E5,executive-appointment,100,54,5/22/2018
A37D68,earnings,100,50,5/22/2018
A631A3,conference-participant,100,50,5/22/2018
A80FE0,conference-participant,100,50,5/22/2018
AA847A,executive-appointment,100,54,5/22/2018
AB4A7E,conference-participant,100,50,5/22/2018
ACDF88,conference-participant,100,50,5/22/2018
AFD1CA,facility-open,100,65,5/22/2018
B01111,dividend,100,50,5/22/2018
B2D492,conference-participant,100,50,5/22/2018
BDE867,trading-listing,100,61,5/22/2018
BFE02C,conference-participant,100,50,5/22/2018
C03C8B,conference-participant,100,50,5/22/2018
C07E05,earnings,100,50,5/22/2018
C22BE8,dividend,100,50,5/22/2018
C2DD02,conference-participant,100,50,5/22/2018
C3DE7D,product-release,100,64,5/22/2018
C3EE99,award,100,58,5/22/2018
C8257F,dividend,100,50,5/22/2018
CBBFBF,note-sale,100,52,5/22/2018
CC6FF5,partnership,100,61,5/22/2018
CC8F6E,legal-issues-defendant,100,22,5/22/2018
CDD75E,executive-appointment,100,54,5/22/2018
CDD75E,executive-appointment,100,54,5/22/2018
CFE5BE,dividend,100,50,5/22/2018
CFF15D,patent-infringement-defendant,100,26,5/22/2018
D139BC,conference-participant,100,50,5/22/2018
D2C0B6,earnings,100,50,5/22/2018
D33270,business-contract,100,69,5/22/2018
D75910,earnings,100,50,5/22/2018
D75910,earnings,100,50,5/22/2018
D75910,earnings,100,50,5/22/2018
D75910,earnings,100,50,5/22/2018
D75910,earnings,100,50,5/22/2018
D8442A,product-release,100,64,5/22/2018
DA199F,buybacks,100,74,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DBB28E,earnings,100,50,5/22/2018
DDCB34,product-release,100,64,5/22/2018
DE20DF,partnership,100,61,5/22/2018
E20BFE,earnings-per-share-up,100,93,5/22/2018
E20BFE,earnings-per-share-up,100,93,5/22/2018
E38906,public-offering,100,43,5/22/2018
E71AE6,executive-appointment,100,54,5/22/2018
EC99D0,business-contract,100,69,5/22/2018
EC99D0,business-contract,100,69,5/22/2018
EC99D0,partnership,100,61,5/22/2018
EC99D0,partnership,100,61,5/22/2018
ECF709,same-store-sales-up,100,51,5/22/2018
ECF709,same-store-sales-up,100,62,5/22/2018
ECF709,same-store-sales-up,100,62,5/22/2018
ED4560,conference-participant,100,50,5/22/2018
F0B335,legal-issues-defendant,100,22,5/22/2018
F11638,revenue-up,100,65,5/22/2018
F11638,revenue-up,100,69,5/22/2018
F11638,revenue-up,100,69,5/22/2018
F11638,revenue-up,100,69,5/22/2018
F11638,revenue-up,100,69,5/22/2018
F11638,revenue-up,100,69,5/22/2018
F39E1E,earnings,100,50,5/22/2018
F5D410,government-contract,100,69,5/22/2018
F5D410,business-contract,100,69,5/22/2018
F6DCE4,conference-call,100,50,5/22/2018
FB728F,earnings,100,50,5/22/2018
FD39EB,note-sale,100,52,5/22/2018
FDF28E,conference-participant,100,50,5/22/2018
00FC70,dividend,100,50,5/23/2018
01478A,dividend,100,50,5/23/2018
03596A,business-contract,100,69,5/23/2018
04EB2F,conference-participant,100,50,5/23/2018
0624BE,dividend,100,50,5/23/2018
07EC43,conference-participant,100,50,5/23/2018
0919B1,executive-resignation,100,44,5/23/2018
0BF528,partnership,100,61,5/23/2018
0BF528,partnership,100,61,5/23/2018
1096C6,note-sale,100,52,5/23/2018
1096C6,conference-participant,100,50,5/23/2018
12E454,business-contract,100,69,5/23/2018
138DDE,conference-participant,100,50,5/23/2018
15B10D,business-contract,100,69,5/23/2018
168A5D,award,100,58,5/23/2018
1748F6,earnings,100,50,5/23/2018
1A3E1B,conference-participant,100,50,5/23/2018
1B4F31,executive-appointment,100,54,5/23/2018
1D943E,conference-participant,100,50,5/23/2018
1E83DE,earnings,100,50,5/23/2018
221783,ipo-pricing,100,50,5/23/2018
24CB56,conference-organizer,100,57,5/23/2018
25DD05,conference-participant,100,50,5/23/2018
2667B6,hirings,100,65,5/23/2018
2667B6,hirings,100,65,5/23/2018
26CC63,market-entry,100,57,5/23/2018
27C10F,award,100,58,5/23/2018
2920D5,earnings,100,50,5/23/2018
292A70,dividend,100,50,5/23/2018
295F9F,executive-appointment,100,54,5/23/2018
2C35B5,public-offering,100,43,5/23/2018
2DDB22,conference-participant,100,50,5/23/2018
2E61CC,note-sale,100,52,5/23/2018
2E61CC,note-sale,100,52,5/23/2018
2E61CC,note-sale,100,52,5/23/2018
2F5256,dividend,100,50,5/23/2018
2FEA66,dividend,100,50,5/23/2018
31803E,conference-participant,100,50,5/23/2018
326EDD,dividend-up,100,57,5/23/2018
332F87,merger,100,66,5/23/2018
384CD3,conference-participant,100,50,5/23/2018
39FB23,legal-issues-defendant,100,22,5/23/2018
3A113F,conference-participant,100,50,5/23/2018
3C11C4,conference-participant,100,50,5/23/2018
3CCC90,executive-appointment,100,54,5/23/2018
3F1C69,business-contract,100,69,5/23/2018
415188,award,100,58,5/23/2018
41785E,business-contract,100,69,5/23/2018
417BF9,rights-issue,100,43,5/23/2018
423279,business-contract,100,69,5/23/2018
427F32,conference-participant,100,50,5/23/2018
43E8F5,conference-participant,100,50,5/23/2018
49914B,earnings-guidance,100,50,5/23/2018
49BBBC,earnings,100,50,5/23/2018
4A2457,business-contract,100,69,5/23/2018
4D203E,dividend,100,50,5/23/2018
4D971D,dividend,100,50,5/23/2018
4E7C1F,conference-participant,100,50,5/23/2018
514067,conference-participant,100,50,5/23/2018
5487B1,dividend,100,50,5/23/2018
56EA2B,executive-appointment,100,54,5/23/2018
57A854,conference-participant,100,50,5/23/2018
6D9B53,conference-participant,100,50,5/23/2018
701531,award,100,58,5/23/2018
719B43,settlement,100,56,5/23/2018
726DDF,buybacks,100,74,5/23/2018
726EEA,dividend,100,50,5/23/2018
728737,public-offering,100,43,5/23/2018
762A3E,conference-organizer,100,57,5/23/2018
76E80F,revenues,100,50,5/23/2018
76E80F,revenues,100,50,5/23/2018
76E80F,revenues,100,50,5/23/2018
7A3633,note-sale,100,52,5/23/2018
7ACD98,award,100,58,5/23/2018
7C62A3,buybacks,100,74,5/23/2018
7C75FD,note-sale,100,52,5/23/2018
7E1D5D,earnings,100,50,5/23/2018
7E1D5D,earnings,100,50,5/23/2018
7E1D5D,earnings,100,50,5/23/2018
817ED9,dividend,100,50,5/23/2018
880C0C,conference-call,100,50,5/23/2018
89F693,facility-open,100,65,5/23/2018
89F693,facility-open,100,65,5/23/2018
89F693,legal-issues-defendant,100,22,5/23/2018
8B4A45,earnings,100,50,5/23/2018
8C6C1B,dividend,100,50,5/23/2018
8D4486,hirings,100,65,5/23/2018
8D4486,hirings,100,65,5/23/2018
8D4486,hirings,100,65,5/23/2018
8D9993,executive-appointment,100,54,5/23/2018
8E82A6,conference-participant,100,50,5/23/2018
91E5EE,award,100,58,5/23/2018
91E5EE,award,100,58,5/23/2018
91E5EE,award,100,58,5/23/2018
92D230,executive-appointment,100,54,5/23/2018
92D230,executive-appointment,100,54,5/23/2018
934CC3,earnings,100,50,5/23/2018
93F143,award,100,58,5/23/2018
94756D,conference-participant,100,50,5/23/2018
95C392,public-offering,100,43,5/23/2018
95DC1F,partnership,100,61,5/23/2018
95DC1F,partnership,100,61,5/23/2018
9.65E+09,conference-participant,100,50,5/23/2018
965360,business-contract,100,69,5/23/2018
967D92,dividend,100,50,5/23/2018
97644E,legal-issues-defendant,100,22,5/23/2018
98A286,earnings-per-share-positive,100,69,5/23/2018
997348,dividend,100,50,5/23/2018
9BF177,earnings,100,50,5/23/2018
A1EAC8,executive-appointment,100,54,5/23/2018
A631A3,partnership,100,61,5/23/2018
A63820,facility-open,100,65,5/23/2018
A7102F,conference-participant,100,50,5/23/2018
A72FD9,earnings,100,50,5/23/2018
A761FE,conference-call,100,50,5/23/2018
A868C9,conference-call,100,50,5/23/2018
A8CBDA,product-release,100,64,5/23/2018
AA09AD,executive-appointment,100,54,5/23/2018
B4B281,earnings,100,50,5/23/2018
B4B281,earnings,100,50,5/23/2018
B76C82,dividend,100,50,5/23/2018
B934BF,dividend-up,100,81,5/23/2018
BC3AD2,dividend,100,50,5/23/2018
BDEF34,dividend,100,50,5/23/2018
C0F70B,conference-participant,100,50,5/23/2018
C38440,buybacks,100,74,5/23/2018
C3DE7D,product-release,100,64,5/23/2018
C5C0E9,conference-participant,100,50,5/23/2018
C5C137,executive-appointment,100,54,5/23/2018
C5D2AE,conference-participant,100,50,5/23/2018
C8257F,executive-appointment,100,54,5/23/2018
C8A248,facility-open,100,65,5/23/2018
C941DC,product-release,100,64,5/23/2018
C9D866,conference-participant,100,50,5/23/2018
C9E107,conference-participant,100,50,5/23/2018
CB89EA,product-release,100,64,5/23/2018
CD2DA4,executive-appointment,100,54,5/23/2018
CDD75E,trading-halt,100,43,5/23/2018
D2B9E5,facility-open,100,65,5/23/2018
D48275,conference-call,100,50,5/23/2018
D54E62,legal-issues-dismissed-defendant,100,79,5/23/2018
D5AF19,dividend,100,50,5/23/2018
D697DE,conference-participant,100,50,5/23/2018
D69D42,earnings,100,50,5/23/2018
D81463,dividend,100,50,5/23/2018
DA199F,name-change,100,49,5/23/2018
DAFED3,executive-appointment,100,54,5/23/2018
DE5611,dividend-up,100,56,5/23/2018
DF42A0,earnings,100,50,5/23/2018
DF42A0,earnings,100,50,5/23/2018
DF42A0,earnings,100,50,5/23/2018
DF42A0,earnings,100,50,5/23/2018
DF6FDD,dividend,100,50,5/23/2018
DF6FDD,executive-appointment,100,54,5/23/2018
E0207A,business-contract,100,69,5/23/2018
E05026,conference-call,100,50,5/23/2018
E114F4,earnings,100,50,5/23/2018
E4CE73,award,100,58,5/23/2018
E610CD,earnings,100,50,5/23/2018
E610CD,earnings,100,50,5/23/2018
EAEBF3,joint-venture,100,62,5/23/2018
ED3CA8,executive-appointment,100,54,5/23/2018
ED79D9,acquisition-acquirer,100,49,5/23/2018
EF5BED,conference-participant,100,50,5/23/2018
F0B335,clinical-trials,100,56,5/23/2018
F0B335,clinical-trials,100,56,5/23/2018
F1529C,conference-participant,100,50,5/23/2018
F30508,executive-resignation,100,44,5/23/2018
F32F88,conference-participant,100,50,5/23/2018
F4E882,note-sale,100,52,5/23/2018
F4F46F,conference-participant,100,50,5/23/2018
F51DB0,public-offering,100,43,5/23/2018
F5C78B,public-offering,100,43,5/23/2018
F6DCE4,earnings,100,50,5/23/2018
F6DCE4,earnings,100,50,5/23/2018
F6DCE4,earnings,100,50,5/23/2018
F6DCE4,earnings,100,50,5/23/2018
F6E248,conference-participant,100,50,5/23/2018
F748C7,earnings-up,100,68,5/23/2018
FC1B7B,conference-participant,100,50,5/23/2018
FF6644,product-release,100,64,5/23/2018
00698D,earnings,100,50,5/24/2018
00FC70,earnings,100,50,5/24/2018
03FAA6,product-release,100,64,5/24/2018
03FAA6,product-release,100,64,5/24/2018
070B45,conference-participant,100,50,5/24/2018
0919B1,executive-appointment,100,54,5/24/2018
0919B1,executive-appointment,100,54,5/24/2018
0B9E6F,executive-appointment,100,54,5/24/2018
0BC29E,executive-appointment,100,54,5/24/2018
0E2992,dividend,100,50,5/24/2018
10943B,conference-participant,100,50,5/24/2018
14833D,ipo-pricing,100,50,5/24/2018
159739,conference-call,100,50,5/24/2018
16B183,dividend,100,50,5/24/2018
1A6A94,earnings,100,50,5/24/2018
1B637E,note-sale,100,52,5/24/2018
1D1B07,conference-participant,100,50,5/24/2018
1F716B,executive-resignation,100,44,5/24/2018
1FCC00,conference-call,100,50,5/24/2018
200D8B,earnings,100,50,5/24/2018
228D42,product-release,100,64,5/24/2018
238302,conference-participant,100,50,5/24/2018
24CB56,conference-organizer,100,57,5/24/2018
24CB56,conference-organizer,100,57,5/24/2018
24CB56,executive-resignation,100,44,5/24/2018
26F31D,executive-appointment,100,54,5/24/2018
2720AB,conference-call,100,50,5/24/2018
275300,conference-participant,100,50,5/24/2018
2.90E+62,conference-participant,100,50,5/24/2018
2B49F4,conference-call,100,50,5/24/2018
2B8179,executive-appointment,100,54,5/24/2018
2C35B5,public-offering,100,43,5/24/2018
2CA60F,partnership,100,61,5/24/2018
2CA60F,partnership,100,61,5/24/2018
2CB4C9,dividend,100,50,5/24/2018
2E902B,conference-participant,100,50,5/24/2018
2F9304,earnings,100,50,5/24/2018
30DFD3,conference-participant,100,50,5/24/2018
3461CF,partnership,100,61,5/24/2018
36529A,fast-track-designation,100,81,5/24/2018
37B120,regulatory-product-approval-granted,100,81,5/24/2018
3ED92D,executive-appointment,100,54,5/24/2018
4017AD,dividend,100,50,5/24/2018
42DC93,conference-participant,100,50,5/24/2018
46017C,conference-participant,100,50,5/24/2018
4A2457,business-contract,100,69,5/24/2018
4A5C8D,earnings,100,50,5/24/2018
4D371E,conference-participant,100,50,5/24/2018
4FB770,dividend-up,100,60,5/24/2018
50070E,conference-organizer,100,57,5/24/2018
53E575,earnings,100,50,5/24/2018
556F08,conference-participant,100,50,5/24/2018
586BD7,conference-participant,100,50,5/24/2018
58CA9A,conference-participant,100,50,5/24/2018
59872F,earnings,100,50,5/24/2018
5DD48B,product-release,100,64,5/24/2018
5DE5A5,conference-participant,100,50,5/24/2018
5E7E82,earnings-above-expectations,100,88,5/24/2018
5EF130,earnings,100,50,5/24/2018
5EF130,earnings,100,50,5/24/2018
5EF130,earnings,100,50,5/24/2018
5EF130,earnings,100,50,5/24/2018
60EA12,conference-participant,100,50,5/24/2018
6137BF,conference-participant,100,50,5/24/2018
61A586,legal-issues-defendant,100,22,5/24/2018
6284B5,dividend,100,50,5/24/2018
64E346,earnings,100,50,5/24/2018
64E346,earnings,100,50,5/24/2018
64E346,earnings,100,50,5/24/2018
64E346,earnings,100,50,5/24/2018
64E346,earnings,100,50,5/24/2018
6CC55E,conference-participant,100,50,5/24/2018
6DC1D7,dividend,100,50,5/24/2018
6F39FC,conference-participant,100,50,5/24/2018
6FCEF9,earnings,100,50,5/24/2018
701531,conference-participant,100,50,5/24/2018
719477,buybacks,100,74,5/24/2018
719477,buybacks,100,74,5/24/2018
7239BB,earnings,100,50,5/24/2018
7239BB,credit-extension-recipient,100,69,5/24/2018
728737,public-offering,100,43,5/24/2018
728737,conference-participant,100,50,5/24/2018
767F86,ownership-increase-owner,100,56,5/24/2018
773A17,revenue-up,100,55,5/24/2018
773A17,revenue-up,100,69,5/24/2018
773A17,revenue-up,100,69,5/24/2018
7740DE,earnings-up,100,68,5/24/2018
7740DE,dividend,100,50,5/24/2018
7823A3,conference-participant,100,50,5/24/2018
78F9ED,dividend,100,50,5/24/2018
79340A,conference-participant,100,50,5/24/2018
7A10FF,conference-participant,100,50,5/24/2018
7BC92D,revenue-up,100,69,5/24/2018
7CBC40,conference-participant,100,50,5/24/2018
7F3669,conference-participant,100,50,5/24/2018
817ED9,earnings,100,50,5/24/2018
817ED9,earnings,100,50,5/24/2018
817ED9,earnings,100,50,5/24/2018
817ED9,earnings,100,50,5/24/2018
830BDB,regulatory-product-approval-granted,100,81,5/24/2018
8377DB,executive-appointment,100,54,5/24/2018
859D62,earnings,100,50,5/24/2018
859D62,dividend,100,50,5/24/2018
85DE00,conference-participant,100,50,5/24/2018
863350,earnings,100,50,5/24/2018
8665BA,dividend,100,50,5/24/2018
86AA9C,executive-appointment,100,54,5/24/2018
8AC740,conference-participant,100,50,5/24/2018
8C6C1B,earnings,100,50,5/24/2018
8C6C1B,earnings,100,50,5/24/2018
8D4486,partnership,100,61,5/24/2018
8D4486,partnership,100,61,5/24/2018
8D4486,partnership,100,61,5/24/2018
901327,dividend,100,50,5/24/2018
9087B9,partnership,100,61,5/24/2018
90D6A5,asset-sale,100,62,5/24/2018
9196A2,conference-organizer,100,57,5/24/2018
94637C,conference-organizer,100,57,5/24/2018
94756D,facility-open,100,65,5/24/2018
9.54E+32,dividend,100,50,5/24/2018
9592FB,conference-participant,100,50,5/24/2018
971334,executive-appointment,100,54,5/24/2018
971334,dividend,100,50,5/24/2018
971334,executive-appointment,100,54,5/24/2018
990AD0,conference-organizer,100,57,5/24/2018
990AD0,conference-organizer,100,57,5/24/2018
9.97E+09,dividend,100,50,5/24/2018
99ACAD,executive-appointment,100,54,5/24/2018
9B71A7,executive-appointment,100,54,5/24/2018
9BF177,conference-participant,100,50,5/24/2018
9C25FF,legal-issues-defendant,100,22,5/24/2018
9D2790,dividend,100,50,5/24/2018
9D30A8,business-contract,100,69,5/24/2018
9D30A8,business-contract,100,69,5/24/2018
A1E3B3,earnings,100,50,5/24/2018
A1E3B3,earnings,100,50,5/24/2018
A1E3B3,earnings,100,50,5/24/2018
A1E3B3,earnings,100,50,5/24/2018
A47F2E,conference-participant,100,50,5/24/2018
A52533,conference-participant,100,50,5/24/2018
A52533,facility-open,100,65,5/24/2018
A60354,dividend-up,100,81,5/24/2018
A666C8,award,100,58,5/24/2018
A6FB29,legal-issues-defendant,100,22,5/24/2018
A790A5,executive-appointment,100,54,5/24/2018
AA98ED,conference-participant,100,50,5/24/2018
AC7C4F,earnings-guidance,100,50,5/24/2018
ADD9DC,facility-open,100,65,5/24/2018
AFF7B4,buybacks,100,74,5/24/2018
B2206F,earnings,100,50,5/24/2018
B5734D,conference-call,100,50,5/24/2018
B5DE80,unit-acquisition-completed-acquiree,100,67,5/24/2018
B5DE80,unit-acquisition-completed-acquiree,100,67,5/24/2018
BB58FF,executive-appointment,100,54,5/24/2018
BDE867,conference-participant,100,50,5/24/2018
BE7BA4,conference-participant,100,50,5/24/2018
BFEA04,partnership,100,61,5/24/2018
C062D4,acquisition-acquirer,100,49,5/24/2018
C4A241,business-contract,100,69,5/24/2018
C4A432,earnings-up,100,68,5/24/2018
C4A432,executive-resignation,100,44,5/24/2018
C8257F,award,100,58,5/24/2018
C98CDB,business-contract,100,69,5/24/2018
C9A96E,executive-appointment,100,54,5/24/2018
C9E04B,executive-appointment,100,54,5/24/2018
CA99D7,dividend-up,100,81,5/24/2018
CAD7D9,executive-appointment,100,54,5/24/2018
CB7AB2,business-contract,100,69,5/24/2018
CC339B,dividend,100,50,5/24/2018
CC35BE,award,100,58,5/24/2018
CCB623,business-contract,100,69,5/24/2018
CDC817,conference-participant,100,50,5/24/2018
CDD75E,legal-issues-defendant,100,22,5/24/2018
CDD75E,legal-issues-defendant,100,22,5/24/2018
CDFCC9,note-sale,100,52,5/24/2018
D03C7A,dividend,100,50,5/24/2018
D15833,dividend,100,50,5/24/2018
D76AEF,executive-appointment,100,54,5/24/2018
D8DBA3,dividend-up,100,81,5/24/2018
D9E036,note-sale,100,52,5/24/2018
DB9829,earnings-up,100,68,5/24/2018
DB9829,earnings,100,50,5/24/2018
DB9829,earnings,100,50,5/24/2018
DB9829,earnings,100,50,5/24/2018
E124EB,conference-participant,100,50,5/24/2018
E1C16B,dividend,100,50,5/24/2018
E30B34,dividend,100,50,5/24/2018
E38906,public-offering,100,43,5/24/2018
E67C2C,conference-participant,100,50,5/24/2018
E68733,earnings,100,50,5/24/2018
E6D89E,legal-issues-defendant,100,22,5/24/2018
E6EDED,dividend,100,50,5/24/2018
E71AE6,conference-participant,100,50,5/24/2018
E82A2D,public-offering,100,43,5/24/2018
EB43F4,settlement,100,56,5/24/2018
ED2EFD,executive-resignation,100,44,5/24/2018
ED3CA8,conference-participant,100,50,5/24/2018
ED79D9,partnership,100,61,5/24/2018
F1CD47,dividend,100,50,5/24/2018
F43A11,credit-extension-recipient,100,69,5/24/2018
F43A11,credit-extension-recipient,100,69,5/24/2018
F47871,business-contract,100,69,5/24/2018
F51DB0,public-offering,100,43,5/24/2018
F66B58,conference-call,100,50,5/24/2018
F82D37,executive-appointment,100,54,5/24/2018
F9CAF8,dividend,100,50,5/24/2018
FA40E2,executive-appointment,100,54,5/24/2018
FAE021,product-release,100,64,5/24/2018
FC01C0,conference-participant,100,50,5/24/2018
FC1F9D,conference-participant,100,50,5/24/2018
FD4588,executive-appointment,100,54,5/24/2018
FD6926,business-contract,100,69,5/24/2018
FDF799,press-conference-organizer,100,50,5/24/2018
13528,unit-acquisition-acquirer,100,49,5/25/2018
02870F,dividend,100,50,5/25/2018
036C6F,conference-call,100,50,5/25/2018
0CE7F6,earnings,100,50,5/25/2018
10673F,dividend,100,50,5/25/2018
1096C6,note-sale,100,52,5/25/2018
1E9A6D,executive-appointment,100,54,5/25/2018
22C58E,sponsorship,100,57,5/25/2018
31AA84,partnership,100,61,5/25/2018
3A94DF,dividend,100,50,5/25/2018
3B20AB,conference-participant,100,50,5/25/2018
3B9886,earnings,100,50,5/25/2018
3B9886,earnings,100,50,5/25/2018
3C7F5F,dividend,100,50,5/25/2018
425BDC,business-contract,100,69,5/25/2018
4EE167,conference-participant,100,50,5/25/2018
5C7601,dividend,100,50,5/25/2018
5D41E4,conference-participant,100,50,5/25/2018
5E7E82,dividend,100,50,5/25/2018
7B9212,earnings,100,50,5/25/2018
7BC92D,conference-participant,100,50,5/25/2018
87B81A,conference-participant,100,50,5/25/2018
89F693,legal-issues-defendant,100,22,5/25/2018
9196A2,conference-organizer,100,57,5/25/2018
990AD0,conference-organizer,100,57,5/25/2018
990AD0,conference-organizer,100,57,5/25/2018
9F03CF,partnership,100,61,5/25/2018
9F5997,conference-participant,100,50,5/25/2018
A3AAA5,conference-participant,100,50,5/25/2018
A6213D,conference-call,100,50,5/25/2018
A96867,dividend,100,50,5/25/2018
AD23DE,conference-participant,100,50,5/25/2018
BCC13E,conference-participant,100,50,5/25/2018
BCC55F,conference-participant,100,50,5/25/2018
C584BE,legal-issues-defendant,100,22,5/25/2018
CDD75E,legal-issues-defendant,100,22,5/25/2018
CFF97C,credit-rating-upgrade-rater,20,50,5/25/2018
D2B9E5,facility-open,100,65,5/25/2018
D65A13,index-listing,100,76,5/25/2018
DF204B,dividend,100,50,5/25/2018
E4CE73,conference-participant,100,50,5/25/2018
E82A2D,public-offering,100,43,5/25/2018
F5C78B,public-offering,100,43,5/25/2018
FAE021,executive-appointment,100,54,5/25/2018
0157B1,facility-open,100,65,5/26/2018
2B49F4,business-contract,100,69,5/27/2018
2BF36E,conference-participant,100,50,5/27/2018
4C37C5,campaign-ad-release,100,59,5/28/2018
85DA04,trading-halt,100,43,5/28/2018
CC8F6E,legal-issues-defendant,100,22,5/28/2018
CC8F6E,acquisition-acquirer,100,49,5/28/2018
CC8F6E,business-contract,100,69,5/28/2018
CFF15D,partnership,100,61,5/28/2018
0157B1,product-release,100,64,5/29/2018
20751,conference-participant,100,50,5/29/2018
02FC1A,conference-participant,100,50,5/29/2018
68396,conference-participant,100,50,5/29/2018
0968A5,earnings,100,50,5/29/2018
0A1D77,executive-appointment,100,54,5/29/2018
1096C6,executive-appointment,100,54,5/29/2018
1096C6,executive-appointment,100,54,5/29/2018
12A3A3,earnings-guidance,100,50,5/29/2018
14833D,ipo-completed,100,76,5/29/2018
15789A,conference-participant,100,50,5/29/2018
1880C5,regulatory-product-approval-granted,100,81,5/29/2018
190BE6,earnings,100,50,5/29/2018
1921DD,partnership,100,61,5/29/2018
1AB023,facility-open,100,65,5/29/2018
1AB023,facility-open,100,65,5/29/2018
1AB023,facility-open,100,65,5/29/2018
1D9E55,executive-appointment,100,54,5/29/2018
1DDEDA,earnings,100,50,5/29/2018
1DDEDA,earnings,100,50,5/29/2018
1F716B,executive-appointment,100,54,5/29/2018
1FA886,partnership,100,61,5/29/2018
2031CE,executive-appointment,100,54,5/29/2018
2158DF,conference-participant,100,50,5/29/2018
221445,dividend,100,50,5/29/2018
227F04,conference-participant,100,50,5/29/2018
22C58E,conference-participant,100,50,5/29/2018
24CB56,conference-organizer,100,57,5/29/2018
25102A,conference-participant,100,50,5/29/2018
251988,partnership,100,61,5/29/2018
26008A,revenue-up,100,69,5/29/2018
26008A,revenue-up,100,69,5/29/2018
26008A,revenue-up,100,69,5/29/2018
26E3BA,conference-participant,100,50,5/29/2018
270305,executive-death,100,31,5/29/2018
30E01D,executive-appointment,100,54,5/29/2018
338544,executive-appointment,100,54,5/29/2018
39FB23,legal-issues-defendant,100,22,5/29/2018
39FB23,legal-issues-defendant,100,22,5/29/2018
3F1C69,conference-participant,100,50,5/29/2018
3F4668,executive-appointment,100,54,5/29/2018
434F38,unit-acquisition-acquirer,100,49,5/29/2018
442769,conference-participant,100,50,5/29/2018
4.60E+06,conference-participant,100,50,5/29/2018
4A2457,award,100,58,5/29/2018
4A5C8D,conference-participant,100,50,5/29/2018
4AC91D,earnings,100,50,5/29/2018
4AC91D,earnings,100,50,5/29/2018
4AC91D,executive-appointment,100,54,5/29/2018
4C1FA1,dividend,100,50,5/29/2018
4E5784,partnership,100,61,5/29/2018
4E5784,partnership,100,61,5/29/2018
4E6F5A,conference-participant,100,50,5/29/2018
4F9926,business-contract,100,69,5/29/2018
50070E,conference-organizer,100,57,5/29/2018
50070E,conference-organizer,100,57,5/29/2018
50070E,conference-organizer,100,57,5/29/2018
50070E,conference-organizer,100,57,5/29/2018
50070E,conference-organizer,100,57,5/29/2018
54DF47,debt-reduction,100,74,5/29/2018
556F08,conference-participant,100,50,5/29/2018
5FDBD0,credit-extension-recipient,100,69,5/29/2018
6474BA,dividend-up,100,65,5/29/2018
6634D9,partnership,100,61,5/29/2018
6634D9,executive-appointment,100,54,5/29/2018
665D7D,conference-participant,100,50,5/29/2018
6C4D2F,acquisition-acquirer,100,49,5/29/2018
6-Dec-05,executive-appointment,100,54,5/29/2018
6-Dec-05,executive-appointment,100,54,5/29/2018
70FCEF,executive-appointment,100,54,5/29/2018
728737,public-offering,100,43,5/29/2018
7410C3,executive-appointment,100,54,5/29/2018
762A3E,conference-organizer,100,57,5/29/2018
763DBE,conference-participant,100,50,5/29/2018
7B6EB1,acquisition-acquirer,100,49,5/29/2018
7F3669,executive-appointment,100,54,5/29/2018
85CDC9,regulatory-product-approval-granted,100,81,5/29/2018
893904,executive-appointment,100,54,5/29/2018
8B2C4A,acquisition-completed-acquirer,100,49,5/29/2018
8E82A6,conference-participant,100,50,5/29/2018
8FCA78,facility-open,100,65,5/29/2018
8FCA78,facility-open,100,65,5/29/2018
9196A2,conference-organizer,100,57,5/29/2018
9196A2,conference-organizer,100,57,5/29/2018
92005C,earnings,100,50,5/29/2018
954004,conference-call,100,50,5/29/2018
95DC1F,facility-open,100,65,5/29/2018
990AD0,conference-organizer,100,57,5/29/2018
990AD0,conference-organizer,100,57,5/29/2018
9934AD,executive-appointment,100,54,5/29/2018
9B730A,executive-appointment,100,54,5/29/2018
9BF177,conference-participant,100,50,5/29/2018
9C5174,conference-participant,100,50,5/29/2018
9E575E,executive-resignation,100,44,5/29/2018
9E575E,conference-participant,100,50,5/29/2018
9F37C5,dividend,100,50,5/29/2018
9F5997,acquisition-acquirer,100,49,5/29/2018
9F71E5,acquisition-acquirer,100,49,5/29/2018
A072C4,conference-participant,100,50,5/29/2018
A398B9,partnership,100,61,5/29/2018
A403CF,earnings,100,50,5/29/2018
A403CF,dividend,100,50,5/29/2018
A6828A,conference-participant,100,50,5/29/2018
A7A0BD,executive-appointment,100,54,5/29/2018
A7CCF0,executive-appointment,100,54,5/29/2018
A80FE0,conference-participant,100,50,5/29/2018
A80FE0,conference-participant,100,50,5/29/2018
AADE0B,unit-acquisition-acquirer,100,49,5/29/2018
AE7D16,product-release,100,64,5/29/2018
AFF7B4,note-sale,100,52,5/29/2018
B1FC3B,business-contract,100,69,5/29/2018
B3CB74,conference-organizer,100,57,5/29/2018
B9764A,conference-participant,100,50,5/29/2018
BB0787,conference-participant,100,50,5/29/2018
BB127B,earnings-up,100,68,5/29/2018
BDF85E,earnings,100,50,5/29/2018
C0F70B,award,100,58,5/29/2018
C41C25,merger-completed,100,66,5/29/2018
C4A912,patent-awarded,100,72,5/29/2018
C4C77F,executive-appointment,100,54,5/29/2018
C5F463,partnership,100,61,5/29/2018
CBFFDD,product-release,100,64,5/29/2018
CC8F6E,legal-issues-defendant,100,22,5/29/2018
CDFCC9,acquisition-completed-acquirer,100,49,5/29/2018
CFD4B6,conference-participant,100,50,5/29/2018
CFD4B6,business-contract,100,69,5/29/2018
D3F64D,conference-participant,100,50,5/29/2018
D598E7,earnings,100,50,5/29/2018
D6489C,partnership,100,61,5/29/2018
D65A13,conference-participant,100,50,5/29/2018
D76AEF,dividend,100,50,5/29/2018
D76AEF,earnings,100,50,5/29/2018
D854F3,conference-participant,100,50,5/29/2018
DB06B0,partnership,100,61,5/29/2018
DCD97F,business-contract,100,69,5/29/2018
DDEA6A,conference-participant,100,50,5/29/2018
DE20DF,executive-appointment,100,54,5/29/2018
DF5F14,conference-participant,100,50,5/29/2018
DFADDB,conference-participant,100,50,5/29/2018
E16133,conference-participant,100,50,5/29/2018
E38906,conference-participant,100,50,5/29/2018
E4CE73,conference-participant,100,50,5/29/2018
E8B315,merger,100,66,5/29/2018
E96E0B,conference-participant,100,50,5/29/2018
E9E6FD,executive-appointment,100,54,5/29/2018
EB5E78,conference-participant,100,50,5/29/2018
EEA734,executive-appointment,100,54,5/29/2018
F1EB39,conference-participant,100,50,5/29/2018
F40EE2,award,100,58,5/29/2018
F48947,conference-participant,100,50,5/29/2018
F721A7,acquisition-acquirer,100,49,5/29/2018
F721A7,acquisition-acquirer,100,49,5/29/2018
F7902B,conference-participant,100,50,5/29/2018
FBD92D,partnership,100,61,5/29/2018
FD554E,dividend,100,50,5/29/2018
FD9526,facility-sale,100,52,5/29/2018
FDD3FC,executive-appointment,100,54,5/29/2018
02ACBD,conference-participant,100,50,5/30/2018
040DBB,conference-participant,100,50,5/30/2018
68396,dividend-up,100,53,5/30/2018
95294,partnership,100,61,5/30/2018
0A7650,note-sale,100,52,5/30/2018
0A9D0A,conference-participant,100,50,5/30/2018
0B7375,conference-participant,100,50,5/30/2018
0E3436,earnings,100,50,5/30/2018
0E439E,credit-extension-recipient,100,69,5/30/2018
0EF1AF,product-release,100,64,5/30/2018
12DE76,dividend,100,50,5/30/2018
1834C0,unit-acquisition-acquirer,100,49,5/30/2018
188394,executive-appointment,100,54,5/30/2018
1921DD,partnership,100,61,5/30/2018
1A6A94,conference-participant,100,50,5/30/2018
1CD09C,conference-participant,100,50,5/30/2018
1D3A00,earnings,100,50,5/30/2018
1D3A00,earnings,100,50,5/30/2018
1D3A00,earnings,100,50,5/30/2018
1DEBBE,executive-appointment,100,54,5/30/2018
1E9A6D,conference-participant,100,50,5/30/2018
1F19C8,fundraising,100,64,5/30/2018
1FAF22,product-release,100,64,5/30/2018
202E5A,partnership,100,61,5/30/2018
2082EA,executive-appointment,100,54,5/30/2018
21245F,conference-participant,100,50,5/30/2018
21245F,executive-appointment,100,54,5/30/2018
223216,facility-open,100,65,5/30/2018
228D42,partnership,100,61,5/30/2018
25102A,conference-organizer,100,57,5/30/2018
263216,dividend,100,50,5/30/2018
27A791,conference-participant,100,50,5/30/2018
27B191,earnings,100,50,5/30/2018
2C35B5,conference-participant,100,50,5/30/2018
2DA92D,facility-open,100,65,5/30/2018
2F94A5,facility-close,100,47,5/30/2018
314D88,conference-participant,100,50,5/30/2018
31643A,earnings,100,50,5/30/2018
31643A,earnings,100,50,5/30/2018
31643A,earnings,100,50,5/30/2018
31803E,regulatory-product-approval-granted,100,81,5/30/2018
339F20,dividend-up,100,81,5/30/2018
3.30E+34,workforce-salary-increase,100,44,5/30/2018
3B2311,public-offering,100,43,5/30/2018
3E15F6,dividend,100,50,5/30/2018
407878,board-meeting,100,51,5/30/2018
414FFF,revenues,100,50,5/30/2018
414FFF,revenues,100,50,5/30/2018
414FFF,revenues,100,50,5/30/2018
414FFF,revenues,100,50,5/30/2018
414FFF,revenues,100,50,5/30/2018
414FFF,revenues,100,50,5/30/2018
414FFF,revenues,100,50,5/30/2018
414FFF,revenues,100,50,5/30/2018
416C55,partnership,100,61,5/30/2018
431B74,dividend-up,100,81,5/30/2018
431B74,dividend-up,100,81,5/30/2018
46017C,conference-participant,100,50,5/30/2018
49914B,executive-appointment,100,54,5/30/2018
49A344,facility-open,100,65,5/30/2018
4A6F00,partnership,100,61,5/30/2018
4A6F00,partnership,100,61,5/30/2018
4E5784,conference-participant,100,50,5/30/2018
4FCC78,unit-acquisition-completed-acquirer,100,49,5/30/2018
50070E,conference-organizer,100,57,5/30/2018
50070E,conference-organizer,100,57,5/30/2018
50070E,conference-organizer,100,57,5/30/2018
50070E,conference-organizer,100,57,5/30/2018
54A713,conference-participant,100,50,5/30/2018
54F1D2,conference-organizer,100,57,5/30/2018
567F3D,conference-participant,100,50,5/30/2018
589846,earnings,100,50,5/30/2018
5D41E4,executive-appointment,100,54,5/30/2018
619882,partnership,100,61,5/30/2018
61B81B,conference-participant,100,50,5/30/2018
6284B5,unit-acquisition-acquirer,100,49,5/30/2018
64854A,conference-participant,100,50,5/30/2018
649CBD,clinical-trials,100,56,5/30/2018
68BA15,conference-participant,100,50,5/30/2018
6925EB,conference-participant,100,50,5/30/2018
69FDFC,executive-appointment,100,54,5/30/2018
6EB9DA,executive-resignation,100,44,5/30/2018
6F22E7,conference-participant,100,50,5/30/2018
6F3936,earnings,100,50,5/30/2018
6F3936,earnings,100,50,5/30/2018
6F3936,earnings,100,50,5/30/2018
6F3936,earnings,100,50,5/30/2018
6F3936,earnings,100,50,5/30/2018
6F3936,earnings,100,50,5/30/2018
724F84,public-offering,100,43,5/30/2018
7A5097,earnings,100,50,5/30/2018
7A51FE,partnership,100,61,5/30/2018
7B8CB5,conference-participant,100,50,5/30/2018
7C4F43,conference-participant,100,50,5/30/2018
7C790D,conference-participant,100,50,5/30/2018
7E1D5D,partnership,100,61,5/30/2018
7F3A5F,partnership,100,61,5/30/2018
7F3A5F,conference-participant,100,50,5/30/2018
8.10E+32,acquisition-interest-acquirer,100,46,5/30/2018
82FD6D,earnings,100,50,5/30/2018
855DF7,conference-participant,100,50,5/30/2018
877C0C,regulatory-product-approval-granted,100,81,5/30/2018
87B81A,conference-participant,100,50,5/30/2018
895D56,executive-appointment,100,54,5/30/2018
89E771,earnings,100,50,5/30/2018
89F693,legal-issues-defendant,100,22,5/30/2018
9004C4,earnings,100,50,5/30/2018
9004C4,earnings,100,50,5/30/2018
9004C4,board-meeting,100,51,5/30/2018
9196A2,conference-organizer,100,57,5/30/2018
9196A2,conference-organizer,100,57,5/30/2018
9196A2,conference-organizer,100,57,5/30/2018
9196A2,conference-organizer,100,57,5/30/2018
9196A2,conference-organizer,100,57,5/30/2018
9.31E+77,conference-participant,100,50,5/30/2018
95F59E,conference-participant,100,50,5/30/2018
966ACE,conference-participant,100,50,5/30/2018
990AD0,conference-organizer,100,57,5/30/2018
990AD0,conference-organizer,100,57,5/30/2018
990AD0,conference-organizer,100,57,5/30/2018
990AD0,conference-organizer,100,57,5/30/2018
990AD0,conference-organizer,100,57,5/30/2018
9.92E+94,dividend,100,50,5/30/2018
9978F1,conference-participant,100,50,5/30/2018
9BBFA5,conference-call,100,50,5/30/2018
9C8BC3,product-release,100,64,5/30/2018
9E9147,executive-appointment,100,54,5/30/2018
9F5CBB,dividend,100,50,5/30/2018
9FD2D9,conference-participant,100,50,5/30/2018
A204A7,earnings,100,50,5/30/2018
A247F5,conference-participant,100,50,5/30/2018
A350C1,conference-participant,100,50,5/30/2018
A403CF,executive-appointment,100,54,5/30/2018
A5E715,dividend,100,50,5/30/2018
A631A3,conference-participant,100,50,5/30/2018
A6828A,clinical-trials-start,100,64,5/30/2018
A761FE,earnings,100,50,5/30/2018
A761FE,earnings,100,50,5/30/2018
A868C9,business-contract,100,69,5/30/2018
A8B137,acquisition-acquirer,100,49,5/30/2018
A8CBDA,conference-participant,100,50,5/30/2018
A8CBDA,conference-participant,100,50,5/30/2018
AA3AB8,earnings,100,50,5/30/2018
AA98ED,partnership,100,61,5/30/2018
ACDF88,partnership,100,61,5/30/2018
ADFB3A,conference-participant,100,50,5/30/2018
AEFC90,conference-participant,100,50,5/30/2018
AEFC90,patient-enrollment-complete,100,64,5/30/2018
B01111,earnings,100,50,5/30/2018
B05118,conference-participant,100,50,5/30/2018
B1FC3B,award,100,58,5/30/2018
B1FC3B,business-contract,100,69,5/30/2018
B303A6,partnership,100,61,5/30/2018
B48FC9,conference-participant,100,50,5/30/2018
B7202A,conference-participant,100,50,5/30/2018
B7BBFF,earnings,100,50,5/30/2018
B9CD50,conference-participant,100,50,5/30/2018
BCC13E,public-offering,100,43,5/30/2018
BDEC1E,conference-participant,100,50,5/30/2018
BE14CF,conference-participant,100,50,5/30/2018
BE645B,clinical-trials,100,56,5/30/2018
C06EB6,conference-participant,100,50,5/30/2018
C15F8F,conference-participant,100,50,5/30/2018
C2DD02,public-offering,100,43,5/30/2018
C3F99F,executive-appointment,100,54,5/30/2018
C584BE,legal-issues-defendant,100,22,5/30/2018
C7AE14,award,100,58,5/30/2018
C83B88,product-release,100,64,5/30/2018
C8A248,conference-participant,100,50,5/30/2018
C941DC,conference-participant,100,50,5/30/2018
CB89EA,product-release,100,64,5/30/2018
CE4FD9,conference-participant,100,50,5/30/2018
CE5664,product-release,100,64,5/30/2018
CFF15D,partnership,100,61,5/30/2018
D09938,buybacks,100,74,5/30/2018
D2C0B6,conference-participant,100,50,5/30/2018
D3CEDF,legal-issues-defendant,100,22,5/30/2018
D5B13D,conference-participant,100,50,5/30/2018
D6853F,legal-issues-defendant,100,22,5/30/2018
DB88A1,award,100,58,5/30/2018
DC1405,conference-participant,100,50,5/30/2018
DC437D,earnings,100,50,5/30/2018
DF532D,conference-participant,100,50,5/30/2018
DF6FDD,conference-participant,100,50,5/30/2018
E06265,conference-participant,100,50,5/30/2018
E124EB,conference-participant,100,50,5/30/2018
E20392,conference-participant,100,50,5/30/2018
E26FC3,executive-appointment,100,54,5/30/2018
E4CE73,earnings,100,50,5/30/2018
E68C3D,revenue-above-expectations,100,86,5/30/2018
E68C3D,revenues,100,50,5/30/2018
E68C3D,revenues,100,50,5/30/2018
E68C3D,revenues,100,50,5/30/2018
E68E62,conference-participant,100,50,5/30/2018
E7BF32,conference-participant,100,50,5/30/2018
E7BF32,conference-participant,100,50,5/30/2018
E82A2D,public-offering,100,43,5/30/2018
EAA0A7,conference-participant,100,50,5/30/2018
EBC84C,conference-participant,100,50,5/30/2018
ED79D9,unit-acquisition-acquirer,100,49,5/30/2018
F02170,revenue-up,100,69,5/30/2018
F02170,revenue-up,100,69,5/30/2018
F02170,revenue-up,100,69,5/30/2018
F02170,revenue-up,100,69,5/30/2018
F0B335,conference-participant,100,50,5/30/2018
F3816D,conference-participant,100,50,5/30/2018
F5D410,conference-participant,100,50,5/30/2018
F6E248,conference-participant,100,50,5/30/2018
F8BA6C,executive-appointment,100,54,5/30/2018
FA36A4,conference-participant,100,50,5/30/2018
FACF19,earnings-guidance,100,50,5/30/2018
FAE021,product-release,100,64,5/30/2018
FB728F,conference-participant,100,50,5/30/2018
FD6926,conference-participant,100,50,5/30/2018
FD9A97,conference-participant,100,50,5/30/2018
FD9A97,dividend,100,50,5/30/2018
13528,earnings,100,50,5/31/2018
06A456,earnings-per-share-above-expectations,100,83,5/31/2018
070B45,debt-restructuring,100,59,5/31/2018
71860,conference-participant,100,50,5/31/2018
0BC17A,stock-splits,100,49,5/31/2018
0BC17A,executive-appointment,100,54,5/31/2018
0E499E,conference-participant,100,50,5/31/2018
143C52,earnings,100,50,5/31/2018
16C544,dividend,100,50,5/31/2018
1880C5,conference-participant,100,50,5/31/2018
196D18,conference-participant,100,50,5/31/2018
197019,merger,100,66,5/31/2018
197019,merger,100,66,5/31/2018
1BC12C,stake-acquiree,100,62,5/31/2018
1D1B07,earnings,100,50,5/31/2018
1D1B07,earnings,100,50,5/31/2018
1E4FB9,award,100,58,5/31/2018
1EBF8D,partnership,100,61,5/31/2018
1FA8F7,acquisition-acquirer,100,49,5/31/2018
202E5A,conference-participant,100,50,5/31/2018
2082EA,conference-participant,100,50,5/31/2018
21D903,conference-participant,100,50,5/31/2018
21F9CA,revenues,100,50,5/31/2018
228D42,partnership,100,61,5/31/2018
228D42,partnership,100,61,5/31/2018
228D42,partnership,100,61,5/31/2018
2491BC,partnership,100,61,5/31/2018
24A89A,facility-open,100,65,5/31/2018
25A6CC,executive-appointment,100,54,5/31/2018
2667B6,conference-participant,100,50,5/31/2018
2720AB,earnings,100,50,5/31/2018
2920D5,executive-appointment,100,54,5/31/2018
29B702,acquisition-completed-acquirer,100,49,5/31/2018
2CC60C,revenues,100,50,5/31/2018
2D643C,conference-participant,100,50,5/31/2018
2D981A,conference-participant,100,50,5/31/2018
2E36AD,conference-participant,100,50,5/31/2018
3.20E+263,business-contract,100,69,5/31/2018
3301B7,business-contract,100,69,5/31/2018
3461CF,analyst-ratings-change-positive-rater,20,50,5/31/2018
3461CF,executive-appointment,100,54,5/31/2018
371B0A,conference-participant,100,50,5/31/2018
385DD4,conference-participant,100,50,5/31/2018
396D7C,conference-participant,100,50,5/31/2018
39FB23,legal-issues-defendant,100,22,5/31/2018
39FB23,legal-issues-defendant,100,22,5/31/2018
3A113F,index-listing,100,76,5/31/2018
3EE65E,conference-participant,100,50,5/31/2018
401072,conference-participant,100,50,5/31/2018
41785E,index-listing,100,76,5/31/2018
41A93D,conference-participant,100,50,5/31/2018
41A93D,conference-participant,100,50,5/31/2018
442769,settlement,100,56,5/31/2018
450ECB,acquisition-completed-acquirer,100,49,5/31/2018
458D2C,legal-issues-defendant,100,22,5/31/2018
45ABCC,conference-participant,100,50,5/31/2018
4A3438,acquisition-completed-acquirer,100,49,5/31/2018
4A6F00,partnership,100,61,5/31/2018
4A6F00,partnership,100,61,5/31/2018
4B7006,earnings,100,50,5/31/2018
4BDCA7,conference-participant,100,50,5/31/2018
4E4E75,conference-call,100,50,5/31/2018
4EEB00,conference-participant,100,50,5/31/2018
4FB770,note-sale,100,52,5/31/2018
4FCC78,conference-participant,100,50,5/31/2018
50070E,conference-organizer,100,57,5/31/2018
50070E,conference-organizer,100,57,5/31/2018
50070E,conference-organizer,100,57,5/31/2018
504FE2,conference-participant,100,50,5/31/2018
55D0F3,conference-participant,100,50,5/31/2018
57DDB9,merger,100,66,5/31/2018
583223,acquisition-completed-acquirer,100,49,5/31/2018
5B3FA2,conference-participant,100,50,5/31/2018
5D0337,executive-appointment,100,54,5/31/2018
5D16CF,acquisition-completed-acquirer,100,49,5/31/2018
5DE5A5,conference-participant,100,50,5/31/2018
5F2FF7,conference-participant,100,50,5/31/2018
5F3D91,conference-participant,100,50,5/31/2018
6284B5,partnership,100,61,5/31/2018
649CBD,clinical-trials-filed,100,60,5/31/2018
657097,partnership,100,61,5/31/2018
67B052,earnings,100,50,5/31/2018
6830FE,earnings,100,50,5/31/2018
68B03F,executive-appointment,100,54,5/31/2018
6-Dec-05,executive-appointment,100,54,5/31/2018
70FCEF,executive-appointment,100,54,5/31/2018
724F84,public-offering,100,43,5/31/2018
76F067,partnership,100,61,5/31/2018
790C34,product-release,100,64,5/31/2018
791EC1,acquisition-acquirer,100,49,5/31/2018
7A2A49,conference-call,100,50,5/31/2018
7A975D,conference-participant,100,50,5/31/2018
7AC86E,executive-appointment,100,54,5/31/2018
7C75FD,note-sale,100,52,5/31/2018
7D5FD6,conference-participant,100,50,5/31/2018
7DD8CC,conference-participant,100,50,5/31/2018
81222C,facility-open,100,65,5/31/2018
834152,conference-participant,100,50,5/31/2018
88923D,partnership,100,61,5/31/2018
890FF4,conference-participant,100,50,5/31/2018
89F693,legal-issues-defendant,100,22,5/31/2018
8CF6DD,conference-call,100,50,5/31/2018
8EEA28,conference-participant,100,50,5/31/2018
9196A2,conference-organizer,100,57,5/31/2018
9196A2,conference-organizer,100,57,5/31/2018
9196A2,conference-organizer,100,57,5/31/2018
9196A2,conference-organizer,100,57,5/31/2018
9196A2,conference-organizer,100,57,5/31/2018
9196A2,conference-organizer,100,57,5/31/2018
92D757,conference-participant,100,50,5/31/2018
96F126,investment-investor,100,55,5/31/2018
97644E,legal-issues-defendant,100,22,5/31/2018
97693A,earnings,100,50,5/31/2018
990AD0,conference-organizer,100,57,5/31/2018
990AD0,conference-organizer,100,57,5/31/2018
9A2760,conference-participant,100,50,5/31/2018
9B0C9C,legal-issues-defendant,100,22,5/31/2018
9B5968,executive-appointment,100,54,5/31/2018
9C25FF,legal-issues-defendant,100,22,5/31/2018
9D5FA4,conference-participant,100,50,5/31/2018
9EBAFA,public-offering,100,43,5/31/2018
9FF5F1,conference-participant,100,50,5/31/2018
A1E3B3,conference-participant,100,50,5/31/2018
A350C1,partnership,100,61,5/31/2018
A47A7D,partnership,100,61,5/31/2018
A5151E,acquisition-completed-acquirer,100,49,5/31/2018
A631A3,earnings,100,50,5/31/2018
A631A3,earnings,100,50,5/31/2018
A631A3,earnings,100,50,5/31/2018
A631A3,earnings,100,50,5/31/2018
A631A3,earnings,100,50,5/31/2018
A631A3,earnings,100,50,5/31/2018
A6FC89,earnings-positive,100,69,5/31/2018
A72AB6,earnings-above-expectations,100,88,5/31/2018
A72FD9,product-release,100,64,5/31/2018
A8CBDA,conference-participant,100,50,5/31/2018
AA247D,credit-extension-provider,100,57,5/31/2018
AD22F2,earnings,100,50,5/31/2018
AD22F2,earnings,100,50,5/31/2018
AD22F2,earnings,100,50,5/31/2018
AED6CF,conference-participant,100,50,5/31/2018
AFF7B4,conference-participant,100,50,5/31/2018
B290A2,conference-participant,100,50,5/31/2018
B5DE80,conference-participant,100,50,5/31/2018
B83D67,board-meeting,100,51,5/31/2018
B85DCE,conference-participant,100,50,5/31/2018
B8EF97,earnings,100,50,5/31/2018
B8F71F,dividend-up,100,81,5/31/2018
B9764A,partnership,100,61,5/31/2018
BB0587,conference-participant,100,50,5/31/2018
BE645B,conference-participant,100,50,5/31/2018
BEA527,reverse-stock-splits,100,51,5/31/2018
BFE02C,acquisition-acquirer,100,49,5/31/2018
BFE02C,conference-participant,100,50,5/31/2018
C2DD02,public-offering,100,43,5/31/2018
C3F99F,conference-participant,100,50,5/31/2018
C4A241,executive-appointment,100,54,5/31/2018
C584BE,legal-issues-defendant,100,22,5/31/2018
C584BE,legal-issues-defendant,100,22,5/31/2018
C624A1,conference-participant,100,50,5/31/2018
C74887,conference-participant,100,50,5/31/2018
C81E00,clinical-trials,100,56,5/31/2018
CB89EA,award,100,58,5/31/2018
CC6F6E,earnings,100,50,5/31/2018
CC6F6E,earnings,100,50,5/31/2018
CC6F6E,earnings,100,50,5/31/2018
CC8F6E,conference-participant,100,50,5/31/2018
CDC817,debt-renegotiation,100,59,5/31/2018
CDFCC9,earnings-guidance,100,50,5/31/2018
CE4E6D,product-release,100,64,5/31/2018
CEC5B9,product-release,100,64,5/31/2018
CEDFD5,executive-appointment,100,54,5/31/2018
CEDFD5,executive-appointment,100,54,5/31/2018
CF211D,earnings,100,50,5/31/2018
CF7292,earnings,100,50,5/31/2018
D2B9E5,dividend,100,50,5/31/2018
D2B9E5,conference-participant,100,50,5/31/2018
D42DBA,earnings,100,50,5/31/2018
D42DBA,earnings,100,50,5/31/2018
D6144F,partnership,100,61,5/31/2018
D64C6D,conference-call,100,50,5/31/2018
D6853F,legal-issues-defendant,100,22,5/31/2018
D77F7E,acquisition-completed-acquirer,100,49,5/31/2018
D77F7E,acquisition-completed-acquirer,100,49,5/31/2018
DA0CB8,dividend,100,50,5/31/2018
DBB28E,partnership,100,61,5/31/2018
DC0066,conference-participant,100,50,5/31/2018
DC2B00,earnings,100,50,5/31/2018
DD682D,acquisition-completed-acquirer,100,49,5/31/2018
DE5611,earnings,100,50,5/31/2018
E49AA3,executive-appointment,100,54,5/31/2018
E8846E,executive-appointment,100,54,5/31/2018
E9C7C0,conference-participant,100,50,5/31/2018
ED79D9,acquisition-completed-acquirer,100,49,5/31/2018
EE1E44,dividend,100,50,5/31/2018
EE74E1,partnership,100,61,5/31/2018
F0A9DE,dividend,100,50,5/31/2018
F0B335,legal-issues-defendant,100,22,5/31/2018
F43A11,conference-call,100,50,5/31/2018
F6581D,conference-participant,100,50,5/31/2018
F793FA,merger-regulatory-approval,100,81,5/31/2018
FD9A97,earnings,100,50,5/31/2018
FDF1C0,dividend,100,50,5/31/2018
FEE4B0,conference-participant,100,50,5/31/2018
FF227B,conference-participant,100,50,5/31/2018
FF6644,executive-appointment,100,54,5/31/2018
0142B5,executive-appointment,100,54,6/1/2018
01478A,acquisition-completed-acquirer,100,49,6/1/2018
0624BE,earnings,100,50,6/1/2018
0DBB81,conference-participant,100,50,6/1/2018
12A3A3,facility-open,100,65,6/1/2018
13A782,conference-participant,100,50,6/1/2018
1782D5,dividend,100,50,6/1/2018
1B9535,conference-participant,100,50,6/1/2018
1FCC00,dividend,100,50,6/1/2018
1FCC00,earnings,100,50,6/1/2018
1FCC00,earnings,100,50,6/1/2018
1FCC00,earnings,100,50,6/1/2018
1FE7F0,dividend,100,50,6/1/2018
239106,conference-participant,100,50,6/1/2018
25102A,reverse-stock-splits,100,51,6/1/2018
25102A,conference-organizer,100,57,6/1/2018
25102A,conference-organizer,100,57,6/1/2018
26DC29,ipo-considered,100,60,6/1/2018
2A6DBE,conference-participant,100,50,6/1/2018
2ABF77,conference-participant,100,50,6/1/2018
2CC71C,conference-participant,100,50,6/1/2018
2E2E6E,dividend,100,50,6/1/2018
32F943,regulatory-product-review-negative,100,26,6/1/2018
396D7C,conference-call,100,50,6/1/2018
3BB616,acquisition-completed-acquirer,100,49,6/1/2018
417BF9,rights-issue,100,43,6/1/2018
453282,unit-acquisition-acquirer,100,49,6/1/2018
45BC35,conference-participant,100,50,6/1/2018
490D4B,facility-open,100,65,6/1/2018
4A5C8D,acquisition-completed-acquirer,100,49,6/1/2018
50070E,conference-organizer,100,57,6/1/2018
50070E,conference-organizer,100,57,6/1/2018
50070E,conference-organizer,100,57,6/1/2018
5.47E+28,conference-participant,100,50,6/1/2018
54DF47,dividend,100,50,6/1/2018
57A854,conference-participant,100,50,6/1/2018
583A75,product-release,100,64,6/1/2018
59A832,dividend,100,50,6/1/2018
59C539,acquisition-completed-acquiree,100,76,6/1/2018
5A53BF,conference-call,100,50,6/1/2018
5C8D61,conference-participant,100,50,6/1/2018
6A171E,business-contract,100,69,6/1/2018
73F70F,conference-call,100,50,6/1/2018
76D79A,spin-off,100,58,6/1/2018
771985,conference-participant,100,50,6/1/2018
7B9AFA,conference-participant,100,50,6/1/2018
7C75FD,conference-call,100,50,6/1/2018
804708,dividend,100,50,6/1/2018
89E771,dividend,100,50,6/1/2018
8E93A4,acquisition-completed-acquirer,100,49,6/1/2018
8EEA28,facility-sale,100,52,6/1/2018
8EF425,dividend,100,50,6/1/2018
9087B9,dividend,100,50,6/1/2018
9196A2,partnership,100,61,6/1/2018
990AD0,conference-organizer,100,57,6/1/2018
990AD0,conference-organizer,100,57,6/1/2018
990AD0,conference-organizer,100,57,6/1/2018
990AD0,conference-organizer,100,57,6/1/2018
9981C6,dividend,100,50,6/1/2018
9F6B1A,partnership,100,61,6/1/2018
9FF5F1,acquisition-acquirer,100,49,6/1/2018
A41450,business-contract,100,69,6/1/2018
A52B6B,revenue-up,100,69,6/1/2018
A52B6B,earnings,100,50,6/1/2018
A6213D,partnership,100,61,6/1/2018
A7102F,executive-appointment,100,54,6/1/2018
AAC8B6,acquisition-regulatory-approval-acquirer,100,54,6/1/2018
AE4EEB,conference-participant,100,50,6/1/2018
B0D41A,conference-participant,100,50,6/1/2018
B1B10C,acquisition-acquirer,100,49,6/1/2018
B1FC3B,government-contract,100,69,6/1/2018
B1FC3B,earnings,100,50,6/1/2018
B4703C,executive-appointment,100,54,6/1/2018
BBBB41,conference-participant,100,50,6/1/2018
BCC13E,public-offering,100,43,6/1/2018
BCE9DA,executive-appointment,100,54,6/1/2018
BCE9DA,executive-appointment,100,54,6/1/2018
BFE02C,conference-call,100,50,6/1/2018
C01737,conference-participant,100,50,6/1/2018
C062D4,conference-participant,100,50,6/1/2018
C15F8F,conference-participant,100,50,6/1/2018
C188F8,regulatory-product-approval-granted,100,81,6/1/2018
C2609A,business-contract,100,69,6/1/2018
C27E19,conference-participant,100,50,6/1/2018
C3BCD5,executive-resignation,100,44,6/1/2018
C54140,partnership,100,61,6/1/2018
C584BE,legal-issues-defendant,100,22,6/1/2018
C7859D,dividend,100,50,6/1/2018
CAC8D0,facility-open,100,65,6/1/2018
CC8F6E,clinical-trials,100,56,6/1/2018
CFF15D,partnership,100,61,6/1/2018
D1CFC8,conference-call,100,50,6/1/2018
D78CCD,acquisition-completed-acquirer,100,49,6/1/2018
DB5CA5,facility-open,100,65,6/1/2018
DD682D,acquisition-completed-acquirer,100,49,6/1/2018
DD7A96,conference-participant,100,50,6/1/2018
DF01B1,executive-appointment,100,54,6/1/2018
DF11D9,unit-acquisition-completed-acquirer,100,49,6/1/2018
DF6FDD,conference-participant,100,50,6/1/2018
E0207A,unit-acquisition-completed-acquirer,100,49,6/1/2018
E0339F,earnings,100,50,6/1/2018
E05DC8,conference-participant,100,50,6/1/2018
E11C41,dividend,100,50,6/1/2018
E69BA5,acquisition-completed-acquirer,100,49,6/1/2018
E70531,executive-resignation,100,44,6/1/2018
ED0D7C,acquisition-completed-acquiree,100,76,6/1/2018
F02170,conference-participant,100,50,6/1/2018
F1529C,conference-participant,100,50,6/1/2018
F2E253,product-release,100,64,6/1/2018
F3016C,conference-participant,100,50,6/1/2018
F4D241,conference-participant,100,50,6/1/2018
F57F6F,conference-organizer,100,57,6/1/2018
F57F6F,conference-organizer,100,57,6/1/2018
FD554E,dividend,100,50,6/1/2018
FF6644,conference-participant,100,50,6/1/2018
39FB23,legal-issues-defendant,100,22,6/2/2018
9196A2,conference-organizer,100,57,6/2/2018
9B0C9C,legal-issues-defendant,100,22,6/2/2018
D29B44,legal-issues-defendant,100,22,6/2/2018
E8846E,conference-participant,100,50,6/2/2018
FDD3FC,clinical-trials,100,56,6/2/2018
89F693,legal-issues-defendant,100,22,6/3/2018
00067A,conference-participant,100,50,6/4/2018
002A99,clinical-trials,100,56,6/4/2018
002A99,conference-participant,100,50,6/4/2018
018C11,conference-participant,100,50,6/4/2018
03B8CF,asset-sale,100,62,6/4/2018
03B8CF,acquisition-completed-acquiree,100,76,6/4/2018
03B8CF,executive-appointment,100,54,6/4/2018
040DBB,dividend,100,50,6/4/2018
0490C6,conference-participant,100,50,6/4/2018
099C88,conference-participant,100,50,6/4/2018
0A1D77,executive-appointment,100,54,6/4/2018
0BF528,conference-participant,100,50,6/4/2018
0C466B,acquisition-completed-acquirer,100,49,6/4/2018
0E5619,regulatory-product-approval-granted,100,81,6/4/2018
0E5619,conference-participant,100,50,6/4/2018
0EC508,conference-participant,100,50,6/4/2018
102F04,acquisition-completed-acquirer,100,49,6/4/2018
11A49E,conference-participant,100,50,6/4/2018
14BA06,conference-participant,100,50,6/4/2018
16FC89,dividend,100,50,6/4/2018
1834C0,conference-participant,100,50,6/4/2018
1921DD,partnership,100,61,6/4/2018
1D943E,conference-participant,100,50,6/4/2018
1F19C8,executive-appointment,100,54,6/4/2018
2158DF,partnership,100,61,6/4/2018
228D42,acquisition-acquirer,100,49,6/4/2018
228D42,acquisition-acquirer,100,49,6/4/2018
228D42,acquisition-acquirer,100,49,6/4/2018
232053,conference-participant,100,50,6/4/2018
23207A,conference-participant,100,50,6/4/2018
25102A,partnership,100,61,6/4/2018
26CC63,earnings,100,50,6/4/2018
292A70,acquisition-acquirer,100,49,6/4/2018
2A6DBE,clinical-trials,100,56,6/4/2018
2C7505,orphan-drug-designation,100,76,6/4/2018
2DC88B,ipo,100,71,6/4/2018
33AD83,earnings,100,50,6/4/2018
3461CF,conference-participant,100,50,6/4/2018
36C09B,executive-appointment,100,54,6/4/2018
38C46F,dividend,100,50,6/4/2018
39FB23,legal-issues-defendant,100,22,6/4/2018
3BE00F,conference-participant,100,50,6/4/2018
3DD5E2,partnership,100,61,6/4/2018
401072,partnership,100,61,6/4/2018
423279,executive-resignation,100,44,6/4/2018
427F32,dividend,100,50,6/4/2018
42AABD,acquisition-acquirer,100,49,6/4/2018
42DC93,executive-appointment,100,54,6/4/2018
458D2C,legal-issues-defendant,100,22,6/4/2018
4649D5,executive-appointment,100,54,6/4/2018
479930,conference-participant,100,50,6/4/2018
4EE167,executive-appointment,100,54,6/4/2018
50070E,conference-organizer,100,57,6/4/2018
514067,executive-appointment,100,54,6/4/2018
52FB2F,executive-appointment,100,54,6/4/2018
54512F,conference-participant,100,50,6/4/2018
553949,executive-appointment,100,54,6/4/2018
56EA2B,dividend,100,50,6/4/2018
5968F9,conference-participant,100,50,6/4/2018
5DA8B3,merger,100,66,6/4/2018
5DA8B3,public-offering,100,43,6/4/2018
5E6959,acquisition-completed-acquirer,100,49,6/4/2018
5E6959,executive-appointment,100,54,6/4/2018
601785,conference-participant,100,50,6/4/2018
60FE03,conference-participant,100,50,6/4/2018
619882,conference-organizer,100,57,6/4/2018
62CDDE,acquisition-completed-acquirer,100,49,6/4/2018
68AB62,conference-call,100,50,6/4/2018
6BF593,executive-appointment,100,54,6/4/2018
6D2BF6,executive-appointment,100,54,6/4/2018
6E705B,executive-appointment,100,54,6/4/2018
6E8864,partnership,100,61,6/4/2018
713810,stake-acquiree,100,62,6/4/2018
71553E,conference-participant,100,50,6/4/2018
726DDF,legal-issues-defendant,100,22,6/4/2018
73A71F,product-price-raise,100,57,6/4/2018
76E80F,executive-resignation,100,44,6/4/2018
789ADD,conference-participant,100,50,6/4/2018
7A51FE,executive-appointment,100,54,6/4/2018
7AB859,executive-appointment,100,54,6/4/2018
7B9212,dividend,100,50,6/4/2018
7BC92D,product-release,100,64,6/4/2018
7F2922,executive-appointment,100,54,6/4/2018
82B57E,executive-appointment,100,54,6/4/2018
82FD6D,conference-participant,100,50,6/4/2018
85DE00,conference-participant,100,50,6/4/2018
8665BA,facility-open,100,65,6/4/2018
88350F,donation,100,54,6/4/2018
893904,conference-participant,100,50,6/4/2018
94983E,acquisition-acquirer,100,49,6/4/2018
94983E,conference-participant,100,50,6/4/2018
9.54E+32,facility-open,100,65,6/4/2018
957A07,conference-participant,100,50,6/4/2018
957A07,acquisition-acquirer,100,49,6/4/2018
968966,partnership,100,61,6/4/2018
968966,partnership,100,61,6/4/2018
990AD0,conference-organizer,100,57,6/4/2018
990AD0,conference-organizer,100,57,6/4/2018
990AD0,conference-organizer,100,57,6/4/2018
9.92E+94,business-contract,100,69,6/4/2018
9B730A,index-listing,100,76,6/4/2018
A16DEA,conference-participant,100,50,6/4/2018
A4CD53,legal-issues-defendant,100,22,6/4/2018
A5151E,conference-participant,100,50,6/4/2018
A52B6B,earnings,100,50,6/4/2018
A63387,executive-appointment,100,54,6/4/2018
A6FB29,earnings,100,50,6/4/2018
AA09AD,partnership,100,61,6/4/2018
AA09AD,partnership,100,61,6/4/2018
AA09AD,partnership,100,61,6/4/2018
AD1ACF,unit-acquisition-acquirer,100,49,6/4/2018
AED61E,earnings,100,50,6/4/2018
B05000,product-release,100,64,6/4/2018
B13B68,conference-participant,100,50,6/4/2018
B1FC3B,fundraising,100,64,6/4/2018
B48D6A,conference-participant,100,50,6/4/2018
B4F5F4,acquisition-acquirer,100,49,6/4/2018
B98EFA,conference-participant,100,50,6/4/2018
BB58FF,note-sale,100,52,6/4/2018
BE14CF,conference-participant,100,50,6/4/2018
C32A39,award,100,58,6/4/2018
C4706C,conference-participant,100,50,6/4/2018
C564E4,conference-participant,100,50,6/4/2018
C584BE,legal-issues-defendant,100,22,6/4/2018
C584BE,legal-issues-defendant,100,22,6/4/2018
C5C137,partnership,100,61,6/4/2018
C5C137,partnership,100,61,6/4/2018
C5C137,partnership,100,61,6/4/2018
C6C702,award,100,58,6/4/2018
C6C702,award,100,58,6/4/2018
CDAF5B,spin-off,100,58,6/4/2018
CDE51C,product-release,100,64,6/4/2018
CFF57D,acquisition-completed-acquirer,100,49,6/4/2018
D29B44,executive-appointment,100,54,6/4/2018
D33270,executive-appointment,100,54,6/4/2018
D622D5,dividend,100,50,6/4/2018
D6EAA3,conference-call,100,50,6/4/2018
DB88A1,earnings,100,50,6/4/2018
DBB28E,partnership,100,61,6/4/2018
DBB28E,partnership,100,61,6/4/2018
DBCA3F,market-entry,100,57,6/4/2018
DE4924,acquisition-completed-acquirer,100,49,6/4/2018
DE5611,conference-participant,100,50,6/4/2018
E09E2B,partnership,100,61,6/4/2018
E0F4E5,legal-issues-defendant,100,22,6/4/2018
E13782,public-offering,100,43,6/4/2018
E1BD05,partnership,100,61,6/4/2018
E1E093,clinical-trials-start,100,64,6/4/2018
E21871,executive-appointment,100,54,6/4/2018
E28D9C,conference-participant,100,50,6/4/2018
E2F66E,business-contract,100,69,6/4/2018
E3656D,earnings,100,50,6/4/2018
EBD89A,conference-participant,100,50,6/4/2018
ECF4F8,conference-participant,100,50,6/4/2018
EF1AD9,conference-participant,100,50,6/4/2018
F0B335,legal-issues-defendant,100,22,6/4/2018
F32F88,conference-participant,100,50,6/4/2018
F3FCC3,acquisition-completed-acquirer,100,49,6/4/2018
F40EE2,acquisition-completed-acquirer,100,49,6/4/2018
F66B58,earnings,100,50,6/4/2018
F6E1B5,executive-appointment,100,54,6/4/2018
F6E248,clinical-trials,100,56,6/4/2018
F7935D,executive-appointment,100,54,6/4/2018
F9AA02,business-contract,100,69,6/4/2018
F9AA02,business-contract,100,69,6/4/2018
FA35C6,product-release,100,64,6/4/2018
FD2565,clinical-trials,100,56,6/4/2018
FD6926,merger,100,66,6/4/2018
FDD3FC,public-offering,100,43,6/4/2018
43862,public-offering,100,43,6/5/2018
06C826,conference-participant,100,50,6/5/2018
078D52,revenue-up,100,69,6/5/2018
078D52,revenue-up,100,69,6/5/2018
0C355F,executive-appointment,100,54,6/5/2018
12E454,partnership,100,61,6/5/2018
159AE4,executive-appointment,100,54,6/5/2018
1A3E1B,conference-participant,100,50,6/5/2018
1A3E1B,conference-call,100,50,6/5/2018
1AB023,conference-participant,100,50,6/5/2018
1AB023,conference-participant,100,50,6/5/2018
1AB023,conference-participant,100,50,6/5/2018
1EC3E8,executive-appointment,100,54,6/5/2018
1FC422,legal-issues-defendant,100,22,6/5/2018
1FC422,legal-issues-defendant,100,22,6/5/2018
1FCC00,buybacks,100,74,6/5/2018
200D8B,conference-participant,100,50,6/5/2018
2093B1,dividend,100,50,6/5/2018
2491BC,partnership,100,61,6/5/2018
24FA23,patient-enrollment-complete,100,64,6/5/2018
279916,earnings,100,50,6/5/2018
29CEBF,acquisition-acquirer,100,49,6/5/2018
2E902B,partnership,100,61,6/5/2018
2EB04E,partnership,100,61,6/5/2018
2EC172,conference-participant,100,50,6/5/2018
3224CC,conference-participant,100,50,6/5/2018
32F943,conference-participant,100,50,6/5/2018
3390DE,conference-participant,100,50,6/5/2018
36C09B,conference-participant,100,50,6/5/2018
39FB23,legal-issues-defendant,100,22,6/5/2018
3B318A,conference-participant,100,50,6/5/2018
3C3B6B,product-release,100,64,6/5/2018
3C3B6B,conference-participant,100,50,6/5/2018
3D7971,dividend,100,50,6/5/2018
3DC887,product-release,100,64,6/5/2018
3F868D,patent-infringement-plaintiff,100,47,6/5/2018
41C36B,public-offering,100,43,6/5/2018
42DC93,executive-resignation,100,44,6/5/2018
435ACE,note-sale,100,52,6/5/2018
43A060,partnership,100,61,6/5/2018
49BBBC,partnership,100,61,6/5/2018
4B7006,award,100,58,6/5/2018
4B7006,award,100,58,6/5/2018
4B7006,award,100,58,6/5/2018
4E7C1F,product-release,100,64,6/5/2018
50070E,conference-organizer,100,57,6/5/2018
50070E,conference-organizer,100,57,6/5/2018
50070E,conference-organizer,100,57,6/5/2018
52015A,executive-appointment,100,54,6/5/2018
5.43E+08,conference-participant,100,50,6/5/2018
5.47E+28,clinical-trials,100,56,6/5/2018
55438C,investment-investor,100,55,6/5/2018
5B226B,unit-acquisition-completed-acquirer,100,49,6/5/2018
5DE5A5,conference-participant,100,50,6/5/2018
5E7E82,partnership,100,61,6/5/2018
60DD84,conference-participant,100,50,6/5/2018
619882,conference-organizer,100,57,6/5/2018
665D7D,partnership,100,61,6/5/2018
69C99E,clinical-trials-start,100,64,6/5/2018
6B0784,conference-participant,100,50,6/5/2018
6F0096,dividend,100,50,6/5/2018
70FCEF,earnings,100,50,6/5/2018
72CB93,conference-participant,100,50,6/5/2018
73BCBA,conference-participant,100,50,6/5/2018
767F86,conference-participant,100,50,6/5/2018
76D79A,dividend,100,50,6/5/2018
7999F3,conference-participant,100,50,6/5/2018
7A0EC4,conference-participant,100,50,6/5/2018
7ACD98,award,100,58,6/5/2018
7ADE57,conference-call,100,50,6/5/2018
7B492C,conference-participant,100,50,6/5/2018
7B8CB5,conference-participant,100,50,6/5/2018
7E3F8F,campaign-ad-release,100,59,6/5/2018
7FD8B9,product-release,100,64,6/5/2018
804708,legal-issues-defendant,100,22,6/5/2018
83B1C8,legal-issues-defendant,100,22,6/5/2018
85CDC9,conference-participant,100,50,6/5/2018
88193E,conference-participant,100,50,6/5/2018
8A8E41,product-release,100,64,6/5/2018
8CF6DD,conference-participant,100,50,6/5/2018
8E10BF,conference-participant,100,50,6/5/2018
8EDACA,conference-participant,100,50,6/5/2018
9196A2,conference-organizer,100,57,6/5/2018
9196A2,conference-organizer,100,57,6/5/2018
9196A2,conference-organizer,100,57,6/5/2018
9196A2,conference-organizer,100,57,6/5/2018
92005C,conference-participant,100,50,6/5/2018
93D207,business-contract,100,69,6/5/2018
9.82E+06,earnings,100,50,6/5/2018
9B71A7,executive-appointment,100,54,6/5/2018
9C25FF,legal-issues-defendant,100,22,6/5/2018
9F71E5,executive-appointment,100,54,6/5/2018
9FA83B,conference-participant,100,50,6/5/2018
A37D68,earnings,100,50,6/5/2018
A398B9,conference-participant,100,50,6/5/2018
A43906,conference-participant,100,50,6/5/2018
A65325,unit-acquisition-acquirer,100,49,6/5/2018
AC7C4F,business-contract,100,69,6/5/2018
ADD9DC,earnings,100,50,6/5/2018
AECCA9,dividend,100,50,6/5/2018
B1FC3B,partnership,100,61,6/5/2018
B37FB4,conference-participant,100,50,6/5/2018
B4528F,earnings,100,50,6/5/2018
B4528F,earnings,100,50,6/5/2018
B4528F,earnings,100,50,6/5/2018
B7EB38,conference-participant,100,50,6/5/2018
BB127B,board-meeting,100,51,6/5/2018
BCC13E,public-offering,100,43,6/5/2018
BE5935,conference-participant,100,50,6/5/2018
C584BE,legal-issues-defendant,100,22,6/5/2018
C598D7,acquisition-acquirer,100,49,6/5/2018
C66B44,partnership,100,61,6/5/2018
C6C702,facility-open,100,65,6/5/2018
C6C702,facility-open,100,65,6/5/2018
C6C702,conference-participant,100,50,6/5/2018
CDAF5B,dividend,100,50,6/5/2018
CEDFD5,partnership,100,61,6/5/2018
CFF15D,partnership,100,61,6/5/2018
D3CEDF,legal-issues-defendant,100,22,6/5/2018
D58A11,product-release,100,64,6/5/2018
D6853F,legal-issues-defendant,100,22,6/5/2018
D9E036,conference-participant,100,50,6/5/2018
DAFED3,executive-appointment,100,54,6/5/2018
DD1BA1,partnership,100,61,6/5/2018
DD1BA1,executive-appointment,100,54,6/5/2018
DDCB34,conference-participant,100,50,6/5/2018
E05026,earnings,100,50,6/5/2018
E1E093,product-release,100,64,6/5/2018
E8846E,unit-acquisition-acquiree,100,76,6/5/2018
E8E899,partnership,100,61,6/5/2018
ECA300,earnings,100,50,6/5/2018
EE6F1C,product-release,100,64,6/5/2018
EE74E1,award,100,58,6/5/2018
F24FF0,earnings,100,50,6/5/2018
F4CDA3,unit-acquisition-acquirer,100,49,6/5/2018
FACF19,executive-appointment,100,54,6/5/2018
FC01C0,conference-participant,100,50,6/5/2018
FC1B7B,acquisition-regulatory-approval-acquirer,100,54,6/5/2018
FC1B7B,acquisition-regulatory-approval-acquirer,100,54,6/5/2018
FC4550,dividend,100,50,6/5/2018
FDF799,executive-appointment,100,54,6/5/2018
00698D,conference-participant,100,50,6/6/2018
9397,conference-participant,100,50,6/6/2018
01D03F,partnership,100,61,6/6/2018
0BF528,earnings-up,100,68,6/6/2018
0C355F,conference-participant,100,50,6/6/2018
0F91FC,executive-appointment,100,54,6/6/2018
14BA06,dividend,100,50,6/6/2018
14BA06,executive-appointment,100,54,6/6/2018
14BA33,dividend,100,50,6/6/2018
15789A,award,100,58,6/6/2018
1748F6,earnings,100,50,6/6/2018
190B91,partnership,100,61,6/6/2018
1921DD,product-recall,100,29,6/6/2018
197019,merger,100,66,6/6/2018
1B9535,conference-participant,100,50,6/6/2018
1E04A5,conference-participant,100,50,6/6/2018
1E83DE,earnings,100,50,6/6/2018
1E83DE,executive-appointment,100,54,6/6/2018
1F9D90,conference-participant,100,50,6/6/2018
1FC422,conference-participant,100,50,6/6/2018
205AD5,dividend-up,100,81,6/6/2018
2082EA,conference-participant,100,50,6/6/2018
228D42,partnership,100,61,6/6/2018
22C58E,partnership,100,61,6/6/2018
2491BC,note-sale,100,52,6/6/2018
24C48B,partnership,100,61,6/6/2018
24C48B,partnership,100,61,6/6/2018
24FA23,public-offering,100,43,6/6/2018
25102A,conference-organizer,100,57,6/6/2018
25102A,conference-organizer,100,57,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
251988,earnings,100,50,6/6/2018
279916,conference-participant,100,50,6/6/2018
2920D5,conference-participant,100,50,6/6/2018
292A70,earnings,100,50,6/6/2018
2B8179,conference-participant,100,50,6/6/2018
2C19A4,conference-participant,100,50,6/6/2018
2CC60C,dividend,100,50,6/6/2018
2F1299,partnership,100,61,6/6/2018
33AD83,product-release,100,64,6/6/2018
39FB23,legal-issues-defendant,100,22,6/6/2018
3C11C4,conference-participant,100,50,6/6/2018
3ED92D,conference-participant,100,50,6/6/2018
40B903,dividend,100,50,6/6/2018
416C55,conference-participant,100,50,6/6/2018
416C55,dividend,100,50,6/6/2018
429BFB,conference-participant,100,50,6/6/2018
449447,executive-appointment,100,54,6/6/2018
458D2C,legal-issues-defendant,100,22,6/6/2018
458D2C,revenue-volume,100,50,6/6/2018
490D4B,executive-appointment,100,54,6/6/2018
4A6F00,partnership,100,61,6/6/2018
4C3FE9,conference-participant,100,50,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
50070E,conference-organizer,100,57,6/6/2018
514067,conference-participant,100,50,6/6/2018
52BF94,conference-call,100,50,6/6/2018
55438C,investment-investor,100,55,6/6/2018
567F3D,acquisition-interest-acquirer,100,46,6/6/2018
56EA2B,award,100,58,6/6/2018
57CAAB,conference-participant,100,50,6/6/2018
589803,partnership,100,61,6/6/2018
589803,partnership,100,61,6/6/2018
589846,partnership,100,61,6/6/2018
5DD486,conference-call,100,50,6/6/2018
5E1DF3,partnership,100,61,6/6/2018
619882,conference-organizer,100,57,6/6/2018
61B81B,conference-call,100,50,6/6/2018
636BBF,earnings,100,50,6/6/2018
64E346,conference-participant,100,50,6/6/2018
66ECFD,executive-appointment,100,54,6/6/2018
6810DE,conference-participant,100,50,6/6/2018
6830FE,partnership,100,61,6/6/2018
69345C,product-release,100,64,6/6/2018
69FDFC,note-sale,100,52,6/6/2018
6E7060,public-offering,100,43,6/6/2018
73F7F9,conference-call,100,50,6/6/2018
756BB4,earnings,100,50,6/6/2018
762A3E,note-sale,100,52,6/6/2018
79167B,conference-call,100,50,6/6/2018
791D59,award,100,58,6/6/2018
7B1E50,executive-appointment,100,54,6/6/2018
7F0372,executive-appointment,100,54,6/6/2018
810FAD,conference-participant,100,50,6/6/2018
826FD6,earnings,100,50,6/6/2018
858942,executive-appointment,100,54,6/6/2018
859D62,earnings-up,100,68,6/6/2018
859D62,earnings-up,100,68,6/6/2018
859D62,earnings-up,100,68,6/6/2018
859D62,earnings-up,100,68,6/6/2018
859D62,earnings-up,100,68,6/6/2018
859D62,earnings-up,100,68,6/6/2018
877C0C,conference-participant,100,50,6/6/2018
89B2E7,dividend,100,50,6/6/2018
89F693,legal-issues-defendant,100,22,6/6/2018
89F693,executive-resignation,100,44,6/6/2018
8B3B0E,award,100,58,6/6/2018
8B8656,earnings,100,50,6/6/2018
8D4486,partnership,100,61,6/6/2018
8D4486,partnership,100,61,6/6/2018
9196A2,conference-organizer,100,57,6/6/2018
9196A2,conference-organizer,100,57,6/6/2018
9196A2,conference-organizer,100,57,6/6/2018
9196A2,conference-organizer,100,57,6/6/2018
934029,conference-participant,100,50,6/6/2018
9.36E+10,executive-appointment,100,54,6/6/2018
949625,conference-participant,100,50,6/6/2018
94983E,executive-appointment,100,54,6/6/2018
96F126,business-contract,100,69,6/6/2018
97644E,legal-issues-defendant,100,22,6/6/2018
97644E,legal-issues-defendant,100,22,6/6/2018
990AD0,conference-organizer,100,57,6/6/2018
990AD0,conference-organizer,100,57,6/6/2018
9978F1,public-offering,100,43,6/6/2018
9A2760,conference-participant,100,50,6/6/2018
9B0C9C,legal-issues-defendant,100,22,6/6/2018
9BF177,earnings,100,50,6/6/2018
9C25FF,legal-issues-defendant,100,22,6/6/2018
9C25FF,executive-appointment,100,54,6/6/2018
9E91C6,executive-appointment,100,54,6/6/2018
A204A7,earnings,100,50,6/6/2018
A3800A,business-contract,100,69,6/6/2018
A38F30,note-sale,100,52,6/6/2018
A4CD53,partnership,100,61,6/6/2018
A65325,acquisition-interest-acquirer,100,46,6/6/2018
A6828A,partnership,100,61,6/6/2018
A6FB29,legal-issues-defendant,100,22,6/6/2018
A72FD9,earnings,100,50,6/6/2018
AADE0B,acquisition-completed-acquirer,100,49,6/6/2018
AC7C4F,business-contract,100,69,6/6/2018
AD3008,conference-participant,100,50,6/6/2018
AECCA9,earnings,100,50,6/6/2018
AECCA9,earnings,100,50,6/6/2018
AECCA9,earnings,100,50,6/6/2018
AECCA9,earnings,100,50,6/6/2018
AECCA9,earnings,100,50,6/6/2018
AECCA9,earnings,100,50,6/6/2018
AECCA9,earnings,100,50,6/6/2018
B1FC3B,earnings,100,50,6/6/2018
B1FC3B,dividend,100,50,6/6/2018
B446B8,partnership,100,61,6/6/2018
B4C673,conference-participant,100,50,6/6/2018
B642E8,award,100,58,6/6/2018
B83D67,conference-participant,100,50,6/6/2018
BB127B,partnership,100,61,6/6/2018
BDEF34,merger-regulatory-approval,100,81,6/6/2018
BDF2BD,conference-participant,100,50,6/6/2018
C03C8B,partnership,100,61,6/6/2018
C03C8B,partnership,100,61,6/6/2018
C03C8B,conference-participant,100,50,6/6/2018
C72B8F,award,100,58,6/6/2018
C7859D,conference-participant,100,50,6/6/2018
C98CDB,conference-participant,100,50,6/6/2018
CBB77B,dividend,100,50,6/6/2018
CC8F6E,legal-issues-defendant,100,22,6/6/2018
CDFCC9,conference-participant,100,50,6/6/2018
CE5664,note-sale,100,52,6/6/2018
CFD4B6,conference-participant,100,50,6/6/2018
D064D5,earnings,100,50,6/6/2018
D0909F,dividend,100,50,6/6/2018
D0909F,dividend,100,50,6/6/2018
D13F1C,acquisition-completed-acquirer,100,49,6/6/2018
D13F1C,acquisition-completed-acquirer,100,49,6/6/2018
D13F1C,acquisition-completed-acquirer,100,49,6/6/2018
D13F1C,acquisition-completed-acquirer,100,49,6/6/2018
D1CFC8,partnership,100,61,6/6/2018
D2E553,earnings-up,100,68,6/6/2018
D2E553,earnings-up,100,68,6/6/2018
D6853F,legal-issues-defendant,100,22,6/6/2018
D6853F,legal-issues-defendant,100,22,6/6/2018
D6853F,legal-issues-defendant,100,22,6/6/2018
DA91AE,dividend,100,50,6/6/2018
DCD97F,dividend,100,50,6/6/2018
DD1BA1,executive-appointment,100,54,6/6/2018
E09556,conference-call,100,50,6/6/2018
E124EB,partnership,100,61,6/6/2018
E1BD05,conference-participant,100,50,6/6/2018
E592F0,award,100,58,6/6/2018
E592F0,award,100,58,6/6/2018
E70531,unit-acquisition-acquirer,100,49,6/6/2018
E71AE6,executive-appointment,100,54,6/6/2018
E866D2,revenue-volume,100,50,6/6/2018
EBD89A,business-contract,100,69,6/6/2018
EF5BED,conference-participant,100,50,6/6/2018
F57F6F,executive-appointment,100,54,6/6/2018
F92DBC,partnership,100,61,6/6/2018
FC1B7B,acquisition-completed-acquirer,100,49,6/6/2018
FC1B7B,acquisition-completed-acquirer,100,49,6/6/2018
00067A,business-contract,100,69,6/7/2018
001F1B,earnings-guidance,100,50,6/7/2018
002A99,patient-enrollment-complete,100,64,6/7/2018
01D03F,regulatory-product-approval-granted,100,81,6/7/2018
03FB17,dividend,100,50,6/7/2018
43862,public-offering,100,43,6/7/2018
070B45,conference-participant,100,50,6/7/2018
09DE1F,earnings,100,50,6/7/2018
0A6824,acquisition-interest-acquirer,100,46,6/7/2018
0B73A7,earnings,100,50,6/7/2018
0B73A7,earnings,100,50,6/7/2018
0BD4E8,dividend,100,50,6/7/2018
0BF198,conference-participant,100,50,6/7/2018
12DE76,product-release,100,64,6/7/2018
12DE76,product-release,100,64,6/7/2018
1.79E+10,executive-appointment,100,54,6/7/2018
184988,clinical-trials-start,100,64,6/7/2018
188394,partnership,100,61,6/7/2018
1921DD,partnership,100,61,6/7/2018
197019,acquisition-interest-acquiree,100,82,6/7/2018
1A5D5D,acquisition-acquiree,100,76,6/7/2018
1AD9CC,earnings,100,50,6/7/2018
1BC12C,award,100,58,6/7/2018
1E83DE,legal-issues-defendant,100,22,6/7/2018
1E83DE,legal-issues-defendant,100,22,6/7/2018
1E83DE,legal-issues-defendant,100,22,6/7/2018
1EBF8D,partnership,100,61,6/7/2018
1EBF8D,partnership,100,61,6/7/2018
1FC422,legal-issues-defendant,100,22,6/7/2018
228D42,donation,100,54,6/7/2018
241AF7,dividend,100,50,6/7/2018
24C48B,acquisition-acquirer,100,49,6/7/2018
25102A,conference-organizer,100,57,6/7/2018
251988,partnership,100,61,6/7/2018
25DD05,dividend,100,50,6/7/2018
25DD05,dividend,100,50,6/7/2018
28B730,executive-appointment,100,54,6/7/2018
2F98A5,earnings,100,50,6/7/2018
301493,legal-issues-defendant,100,22,6/7/2018
31643A,dividend,100,50,6/7/2018
32F943,executive-appointment,100,54,6/7/2018
39FB23,legal-issues-defendant,100,22,6/7/2018
3B318A,earnings,100,50,6/7/2018
3B318A,executive-appointment,100,54,6/7/2018
41C36B,public-offering,100,43,6/7/2018
45BC35,note-sale,100,52,6/7/2018
4806CE,acquisition-interest-acquirer,100,46,6/7/2018
4A6F00,partnership,100,61,6/7/2018
4A6F00,partnership,100,61,6/7/2018
50070E,conference-organizer,100,57,6/7/2018
50070E,conference-organizer,100,57,6/7/2018
50070E,conference-organizer,100,57,6/7/2018
50070E,conference-organizer,100,57,6/7/2018
504FE2,executive-appointment,100,54,6/7/2018
56277A,conference-participant,100,50,6/7/2018
5968F9,conference-participant,100,50,6/7/2018
5B15E1,conference-participant,100,50,6/7/2018
5B97B2,public-offering,100,43,6/7/2018
5CCDAD,conference-participant,100,50,6/7/2018
5E6959,acquisition-acquirer,100,49,6/7/2018
609208,stake-acquirer,100,48,6/7/2018
64636E,conference-participant,100,50,6/7/2018
665618,conference-participant,100,50,6/7/2018
6B6375,executive-appointment,100,54,6/7/2018
6E7060,public-offering,100,43,6/7/2018
726EEA,conference-participant,100,50,6/7/2018
731675,acquisition-acquirer,100,49,6/7/2018
76F067,conference-participant,100,50,6/7/2018
7740DE,same-store-sales-up,100,59,6/7/2018
789A7D,executive-appointment,100,54,6/7/2018
7A0EC4,earnings,100,50,6/7/2018
7A10FF,conference-participant,100,50,6/7/2018
7A10FF,unit-acquisition-completed-acquirer,100,49,6/7/2018
7B9212,revenues,100,50,6/7/2018
805CD8,business-contract,100,69,6/7/2018
83B1C8,conference-participant,100,50,6/7/2018
85DE00,acquisition-acquirer,100,49,6/7/2018
862941,conference-participant,100,50,6/7/2018
863350,earnings,100,50,6/7/2018
86BAC7,board-meeting,100,51,6/7/2018
89F693,product-release,100,64,6/7/2018
8A8E41,dividend,100,50,6/7/2018
8E10BF,executive-appointment,100,54,6/7/2018
902670,earnings-guidance,100,50,6/7/2018
911CA9,partnership,100,61,6/7/2018
911CA9,partnership,100,61,6/7/2018
911CA9,partnership,100,61,6/7/2018
9196A2,conference-organizer,100,57,6/7/2018
9196A2,conference-organizer,100,57,6/7/2018
9196A2,conference-organizer,100,57,6/7/2018
92005C,earnings,100,50,6/7/2018
94637C,earnings,100,50,6/7/2018
95DC1F,conference-call,100,50,6/7/2018
96A6CD,orphan-drug-designation,100,76,6/7/2018
971F7B,acquisition-completed-acquirer,100,49,6/7/2018
97693A,buybacks,100,74,6/7/2018
979451,conference-participant,100,50,6/7/2018
986AF6,dividend,100,50,6/7/2018
9978F1,public-offering,100,43,6/7/2018
9E0811,earnings,100,50,6/7/2018
A204A7,conference-participant,100,50,6/7/2018
A21649,dividend,100,50,6/7/2018
A247F5,conference-participant,100,50,6/7/2018
A398F8,conference-participant,100,50,6/7/2018
A495F7,government-contract,100,69,6/7/2018
A4BCDE,dividend,100,50,6/7/2018
A6213D,business-contract,100,69,6/7/2018
A6828A,product-release,100,64,6/7/2018
A790A5,conference-call,100,50,6/7/2018
A868C9,revenue-up,100,58,6/7/2018
A868C9,revenue-up,100,69,6/7/2018
A868C9,revenue-up,100,69,6/7/2018
A868C9,revenue-up,100,69,6/7/2018
A868C9,revenue-up,100,69,6/7/2018
AA7FE0,conference-call,100,50,6/7/2018
AC7C4F,product-release,100,64,6/7/2018
AD23DE,conference-participant,100,50,6/7/2018
ADD9DC,facility-open,100,65,6/7/2018
B0998E,business-contract,100,69,6/7/2018
B37FB4,partnership,100,61,6/7/2018
B5734D,earnings,100,50,6/7/2018
B83D67,orphan-drug-designation,100,76,6/7/2018
B8EF97,revenues,100,50,6/7/2018
BB58FF,note-sale,100,52,6/7/2018
BFAEB4,award,100,58,6/7/2018
C4452A,dividend,100,50,6/7/2018
CC8F6E,legal-issues-defendant,100,22,6/7/2018
CD06A2,conference-participant,100,50,6/7/2018
CD2DA4,earnings,100,50,6/7/2018
CE1002,conference-participant,100,50,6/7/2018
D07B07,public-offering,100,43,6/7/2018
D3CEDF,legal-issues-defendant,100,22,6/7/2018
D4AC65,note-sale,100,52,6/7/2018
D6853F,legal-issues-defendant,100,22,6/7/2018
D69D42,executive-appointment,100,54,6/7/2018
D76AEF,conference-participant,100,50,6/7/2018
D8DA3D,executive-appointment,100,54,6/7/2018
DB88A1,earnings,100,50,6/7/2018
DB88A1,earnings,100,50,6/7/2018
DB88A1,earnings,100,50,6/7/2018
DB88A1,earnings,100,50,6/7/2018
DB88A1,earnings,100,50,6/7/2018
DB88A1,earnings,100,50,6/7/2018
DB88A1,earnings,100,50,6/7/2018
DC1405,earnings,100,50,6/7/2018
E13782,public-offering,100,43,6/7/2018
E2F130,partnership,100,61,6/7/2018
E49AA3,product-release,100,64,6/7/2018
E49AA3,product-release,100,64,6/7/2018
E70531,business-contract,100,69,6/7/2018
E8A49A,partnership,100,61,6/7/2018
EAA0A7,executive-appointment,100,54,6/7/2018
EE74E1,executive-appointment,100,54,6/7/2018
EEEA9F,conference-participant,100,50,6/7/2018
EF5BED,executive-appointment,100,54,6/7/2018
F0B335,legal-issues-defendant,100,22,6/7/2018
F11638,conference-participant,100,50,6/7/2018
F1529C,conference-call,100,50,6/7/2018
F43A11,earnings,100,50,6/7/2018
F4F46F,partnership,100,61,6/7/2018
F92DBC,business-contract,100,69,6/7/2018
FC9A88,product-release,100,64,6/7/2018
FDD3FC,public-offering,100,43,6/7/2018
FEBFE1,earnings,100,50,6/7/2018
FF5413,revenue-volume,100,50,6/7/2018
20751,executive-appointment,100,54,6/8/2018
0CC62B,conference-participant,100,50,6/8/2018
106394,conference-participant,100,50,6/8/2018
152E1D,conference-participant,100,50,6/8/2018
184866,clinical-trials,100,56,6/8/2018
1921DD,dividend,100,50,6/8/2018
1921DD,dividend,100,50,6/8/2018
1E83DE,conference-participant,100,50,6/8/2018
1E83DE,legal-issues-defendant,100,22,6/8/2018
1E83DE,legal-issues-defendant,100,22,6/8/2018
1E83DE,legal-issues-defendant,100,22,6/8/2018
1F08A6,dividend,100,50,6/8/2018
1F716B,partnership,100,61,6/8/2018
1FA886,conference-participant,100,50,6/8/2018
1FA886,conference-participant,100,50,6/8/2018
1FA886,conference-participant,100,50,6/8/2018
1FA886,conference-participant,100,50,6/8/2018
24C48B,index-listing,100,76,6/8/2018
24CB56,earnings,100,50,6/8/2018
2A1009,conference-participant,100,50,6/8/2018
2E902B,conference-participant,100,50,6/8/2018
2EBA55,dividend,100,50,6/8/2018
31803E,conference-participant,100,50,6/8/2018
39FB23,legal-issues-defendant,100,22,6/8/2018
3BB616,dividend-up,100,81,6/8/2018
3D9999,conference-participant,100,50,6/8/2018
3D9999,acquisition-completed-acquirer,100,49,6/8/2018
3DDE54,conference-participant,100,50,6/8/2018
423279,conference-participant,100,50,6/8/2018
435ACE,conference-participant,100,50,6/8/2018
43A74A,conference-participant,100,50,6/8/2018
45ABCC,product-release,100,64,6/8/2018
50070E,conference-organizer,100,57,6/8/2018
50070E,conference-organizer,100,57,6/8/2018
50070E,conference-organizer,100,57,6/8/2018
520632,dividend,100,50,6/8/2018
553949,executive-appointment,100,54,6/8/2018
59872F,conference-participant,100,50,6/8/2018
619882,conference-organizer,100,57,6/8/2018
620381,ipo-considered,100,60,6/8/2018
665D7D,regulatory-product-approval-granted,100,81,6/8/2018
6A6BDC,earnings,100,50,6/8/2018
6A6BDC,dividend,100,50,6/8/2018
6CF43C,dividend,100,50,6/8/2018
6DBBBC,conference-organizer,100,57,6/8/2018
6F5DD2,regulatory-product-approval-granted,100,81,6/8/2018
7448A3,conference-participant,100,50,6/8/2018
752A70,unit-acquisition-acquirer,100,49,6/8/2018
7823A3,conference-participant,100,50,6/8/2018
9196A2,conference-organizer,100,57,6/8/2018
9196A2,conference-organizer,100,57,6/8/2018
93C130,buybacks,100,74,6/8/2018
94C0B5,conference-call,100,50,6/8/2018
950CDB,earnings,100,50,6/8/2018
977A1E,award,100,58,6/8/2018
980C14,dividend,100,50,6/8/2018
990AD0,product-release,100,64,6/8/2018
A495F7,award,100,58,6/8/2018
B762D3,earnings,100,50,6/8/2018
B762D3,earnings,100,50,6/8/2018
B762D3,earnings,100,50,6/8/2018
BEA527,reverse-stock-splits,100,51,6/8/2018
C45C1F,executive-appointment,100,54,6/8/2018
C584BE,legal-issues-defendant,100,22,6/8/2018
CA1620,dividend-up,100,56,6/8/2018
CA1620,dividend-up,100,56,6/8/2018
CE5664,note-sale,100,52,6/8/2018
CF211D,earnings,100,50,6/8/2018
CFF15D,legal-issues-defendant,100,22,6/8/2018
CFF97C,conference-participant,100,50,6/8/2018
CFF97C,conference-participant,100,50,6/8/2018
D07B07,public-offering,100,43,6/8/2018
D622D5,operating-earnings,100,50,6/8/2018
D6853F,legal-issues-defendant,100,22,6/8/2018
D9164D,buybacks,100,74,6/8/2018
DDB002,conference-participant,100,50,6/8/2018
E2CB7B,conference-participant,100,50,6/8/2018
E5752F,conference-participant,100,50,6/8/2018
E70531,executive-resignation,100,44,6/8/2018
E70531,executive-resignation,100,44,6/8/2018
E84500,executive-resignation,100,44,6/8/2018
E8846E,earnings,100,50,6/8/2018
EA62FC,conference-participant,100,50,6/8/2018
F3816D,clinical-trials,100,56,6/8/2018
F46EC9,conference-participant,100,50,6/8/2018
F4D241,executive-appointment,100,54,6/8/2018
FE7A63,dividend,100,50,6/8/2018
06A456,conference-call,100,50,6/9/2018
45444E,legal-issues-defendant,100,22,6/9/2018
50070E,conference-organizer,100,57,6/9/2018
EB36DE,business-contract,100,69,6/9/2018
01D03F,product-release,100,64,6/11/2018
034B61,partnership,100,61,6/11/2018
034B61,partnership,100,61,6/11/2018
03542C,dividend,100,50,6/11/2018
03596A,unit-acquisition-acquiree,100,76,6/11/2018
43862,public-offering,100,43,6/11/2018
71860,executive-appointment,100,54,6/11/2018
84625,partnership,100,61,6/11/2018
0BA2EF,earnings,100,50,6/11/2018
0BA2EF,earnings,100,50,6/11/2018
0C136E,business-contract,100,69,6/11/2018
168A5D,partnership,100,61,6/11/2018
19BF16,conference-participant,100,50,6/11/2018
1E83DE,legal-issues-defendant,100,22,6/11/2018
202E5A,conference-participant,100,50,6/11/2018
21022F,executive-appointment,100,54,6/11/2018
250BEE,dividend,100,50,6/11/2018
25102A,conference-organizer,100,57,6/11/2018
2C3348,patient-enrollment-complete,100,64,6/11/2018
2F9304,acquisition-acquirer,100,49,6/11/2018
37B618,unit-acquisition-acquirer,100,49,6/11/2018
39FB23,legal-issues-defendant,100,22,6/11/2018
3A3447,facility-open,100,65,6/11/2018
3BB616,note-sale,100,52,6/11/2018
3CBA2A,product-release,100,64,6/11/2018
3CBA2A,product-release,100,64,6/11/2018
416C55,partnership,100,61,6/11/2018
42DC93,legal-issues-defendant,100,22,6/11/2018
45444E,legal-issues-defendant,100,22,6/11/2018
45444E,legal-issues-defendant,100,22,6/11/2018
458D2C,legal-issues-defendant,100,22,6/11/2018
4649D5,public-offering,100,43,6/11/2018
467F2C,conference-participant,100,50,6/11/2018
46CF27,acquisition-acquirer,100,49,6/11/2018
46CF27,acquisition-acquirer,100,49,6/11/2018
4A2457,unit-acquisition-completed-acquiree,100,67,6/11/2018
4A2457,unit-acquisition-completed-acquiree,100,67,6/11/2018
4A2457,unit-acquisition-completed-acquiree,100,67,6/11/2018
4A2457,unit-acquisition-completed-acquiree,100,67,6/11/2018
4A6F00,partnership,100,61,6/11/2018
4B7006,acquisition-acquirer,100,49,6/11/2018
4C6C63,settlement,100,56,6/11/2018
50070E,conference-organizer,100,57,6/11/2018
50070E,conference-organizer,100,57,6/11/2018
51888A,business-contract,100,69,6/11/2018
5225A4,conference-participant,100,50,6/11/2018
52BF94,executive-appointment,100,54,6/11/2018
5546DA,merger,100,66,6/11/2018
583A75,revenue-volume,100,50,6/11/2018
583A75,revenue-volume,100,50,6/11/2018
587EDF,unit-acquisition-acquirer,100,49,6/11/2018
59F0B0,conference-call,100,50,6/11/2018
5B97B2,public-offering,100,43,6/11/2018
5D16CF,acquisition-completed-acquirer,100,49,6/11/2018
5E6959,dividend,100,50,6/11/2018
5F9CE3,product-release,100,64,6/11/2018
619882,conference-organizer,100,57,6/11/2018
619882,conference-organizer,100,57,6/11/2018
619882,product-release,100,64,6/11/2018
619882,product-release,100,64,6/11/2018
6844D2,dividend,100,50,6/11/2018
68B03F,partnership,100,61,6/11/2018
6B0E45,public-offering,100,43,6/11/2018
6E8864,conference-participant,100,50,6/11/2018
6ED519,private-placement,100,56,6/11/2018
726DDF,name-change,100,49,6/11/2018
72FCA3,executive-appointment,100,54,6/11/2018
756045,executive-appointment,100,54,6/11/2018
762A3E,note-sale,100,52,6/11/2018
762B8D,index-listing,100,76,6/11/2018
7A975D,earnings,100,50,6/11/2018
7B8CB5,debt-extension-recipient,100,73,6/11/2018
834152,public-offering,100,43,6/11/2018
863350,public-offering,100,43,6/11/2018
911AB8,drilling,100,68,6/11/2018
9196A2,conference-organizer,100,57,6/11/2018
944B2E,asset-sale,100,62,6/11/2018
94637C,conference-participant,100,50,6/11/2018
95DC1F,partnership,100,61,6/11/2018
96BFF4,executive-appointment,100,54,6/11/2018
96F126,product-release,100,64,6/11/2018
97644E,legal-issues-defendant,100,22,6/11/2018
9978F1,public-offering,100,43,6/11/2018
9B0C9C,legal-issues-defendant,100,22,6/11/2018
9C25FF,legal-issues-defendant,100,22,6/11/2018
9F6B1A,acquisition-acquirer,100,49,6/11/2018
A26C26,earnings,100,50,6/11/2018
A47F2E,public-offering,100,43,6/11/2018
A63820,earnings,100,50,6/11/2018
A65325,public-offering,100,43,6/11/2018
A6FB29,earnings-up,100,68,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A6FB29,earnings,100,50,6/11/2018
A9ED24,conference-participant,100,50,6/11/2018
AADE0B,stake-acquirer,100,48,6/11/2018
AADE0B,stake-acquirer,100,48,6/11/2018
AADE0B,stake-acquirer,100,48,6/11/2018
AC3584,index-listing,100,76,6/11/2018
AE4125,executive-appointment,100,54,6/11/2018
B5DE80,conference-call,100,50,6/11/2018
BBBB41,conference-participant,100,50,6/11/2018
BDF85E,revenue-up,100,69,6/11/2018
BDF85E,executive-resignation,100,44,6/11/2018
C32A39,donation,100,54,6/11/2018
C3BCD5,buybacks,100,74,6/11/2018
C9881C,conference-call,100,50,6/11/2018
CB7AB2,executive-appointment,100,54,6/11/2018
CC8F6E,legal-issues-defendant,100,22,6/11/2018
CDFCC9,conference-participant,100,50,6/11/2018
CFB6CA,executive-appointment,100,54,6/11/2018
CFF15D,legal-issues-defendant,100,22,6/11/2018
CFF15D,legal-issues-defendant,100,22,6/11/2018
CFF15D,legal-issues-defendant,100,22,6/11/2018
CFF15D,legal-issues-defendant,100,22,6/11/2018
CFF15D,legal-issues-defendant,100,22,6/11/2018
D1CFC8,product-release,100,64,6/11/2018
D29B44,legal-issues-defendant,100,22,6/11/2018
D2C0B6,award,100,58,6/11/2018
D437C3,partnership,100,61,6/11/2018
D58A11,conference-participant,100,50,6/11/2018
D5A350,index-listing,100,76,6/11/2018
DB9F70,clinical-trials-start,100,64,6/11/2018
DD1BA1,business-contract,100,69,6/11/2018
DE4924,public-offering,100,43,6/11/2018
E09556,earnings,100,50,6/11/2018
E09556,earnings,100,50,6/11/2018
E09556,earnings,100,50,6/11/2018
E114F4,business-contract,100,69,6/11/2018
E13782,public-offering,100,43,6/11/2018
E2CB7B,public-offering,100,43,6/11/2018
E2CFD2,conference-participant,100,50,6/11/2018
E4CE73,partnership,100,61,6/11/2018
E4CE73,product-release,100,64,6/11/2018
E592F0,product-release,100,64,6/11/2018
E8C557,executive-appointment,100,54,6/11/2018
ECF4F8,trading-listing,100,61,6/11/2018
F0B335,legal-issues-defendant,100,22,6/11/2018
F1C04C,conference-participant,100,50,6/11/2018
F32F88,executive-appointment,100,54,6/11/2018
F5349B,executive-appointment,100,54,6/11/2018
FD2565,conference-participant,100,50,6/11/2018
FDD3FC,public-offering,100,43,6/11/2018
FDE409,earnings,100,50,6/11/2018
FEBFE1,earnings,100,50,6/11/2018
00326D,dividend,100,50,6/12/2018
9397,regulatory-investigation-completed-sanction,100,24,6/12/2018
0358AF,dividend,100,50,6/12/2018
054E7E,executive-appointment,100,54,6/12/2018
71860,partnership,100,61,6/12/2018
09DE1F,partnership,100,61,6/12/2018
09DE1F,partnership,100,61,6/12/2018
0F0440,donation,100,54,6/12/2018
0FDE97,executive-appointment,100,54,6/12/2018
12DE76,product-release,100,64,6/12/2018
12DE76,product-release,100,64,6/12/2018
12F98C,earnings,100,50,6/12/2018
12F98C,earnings,100,50,6/12/2018
16F4D8,conference-participant,100,50,6/12/2018
1.79E+10,conference-call,100,50,6/12/2018
190BE6,earnings-per-share-above-expectations,100,83,6/12/2018
190BE6,earnings-per-share-above-expectations,100,83,6/12/2018
190BE6,earnings-per-share-above-expectations,100,83,6/12/2018
190BE6,earnings-per-share-above-expectations,100,83,6/12/2018
19CAC7,conference-call,100,50,6/12/2018
1E83DE,legal-issues-defendant,100,22,6/12/2018
1E83DE,legal-issues-defendant,100,22,6/12/2018
20BEEA,dividend,100,50,6/12/2018
24FA23,public-offering,100,43,6/12/2018
28B730,executive-appointment,100,54,6/12/2018
2EBC0B,dividend,100,50,6/12/2018
2F5256,unit-acquisition-acquirer,100,49,6/12/2018
3159AA,facility-open,100,65,6/12/2018
3CBA2A,conference-participant,100,50,6/12/2018
3DCECC,conference-participant,100,50,6/12/2018
40F7DE,earnings,100,50,6/12/2018
442587,executive-appointment,100,54,6/12/2018
45444E,legal-issues-defendant,100,22,6/12/2018
45444E,legal-issues-defendant,100,22,6/12/2018
45444E,legal-issues-defendant,100,22,6/12/2018
47FCF2,unit-acquisition-acquiree,100,76,6/12/2018
4806CE,award,100,58,6/12/2018
49A344,executive-appointment,100,54,6/12/2018
4AE584,unit-acquisition-acquirer,100,49,6/12/2018
4E4E75,executive-appointment,100,54,6/12/2018
4E4E75,dividend,100,50,6/12/2018
5065B1,dividend,100,50,6/12/2018
51D876,acquisition-acquirer,100,49,6/12/2018
51E682,product-release,100,64,6/12/2018
52FB2F,conference-participant,100,50,6/12/2018
53A226,conference-participant,100,50,6/12/2018
55D0F3,executive-resignation,100,44,6/12/2018
56EA2B,note-sale,100,52,6/12/2018
56EA2B,note-sale,100,52,6/12/2018
594402,partnership,100,61,6/12/2018
594402,partnership,100,61,6/12/2018
5B6C11,dividend,100,50,6/12/2018
5DE5A5,conference-participant,100,50,6/12/2018
619882,conference-organizer,100,57,6/12/2018
619882,conference-organizer,100,57,6/12/2018
619882,conference-organizer,100,57,6/12/2018
6.52E+64,legal-issues-defendant,100,22,6/12/2018
6.52E+64,legal-issues-defendant,100,22,6/12/2018
6.52E+64,legal-issues-defendant,100,22,6/12/2018
69345C,partnership,100,61,6/12/2018
6B0E45,public-offering,100,43,6/12/2018
7A2A49,earnings,100,50,6/12/2018
7A5097,dividend,100,50,6/12/2018
7A51FE,public-offering,100,43,6/12/2018
7ACBA4,dividend,100,50,6/12/2018
7ACD98,facility-open,100,65,6/12/2018
7ADE57,earnings,100,50,6/12/2018
7AF5B8,partnership,100,61,6/12/2018
7E3F8F,public-offering,100,43,6/12/2018
863350,public-offering,100,43,6/12/2018
885758,ipo-considered,100,60,6/12/2018
8A8E41,partnership,100,61,6/12/2018
8EEA28,earnings,100,50,6/12/2018
9196A2,conference-organizer,100,57,6/12/2018
954004,earnings,100,50,6/12/2018
95C392,executive-appointment,100,54,6/12/2018
990AD0,regulatory-investigation,100,22,6/12/2018
9B730A,fast-track-designation,100,81,6/12/2018
9BF177,business-contract,100,69,6/12/2018
9E5C2C,public-offering,100,43,6/12/2018
A1A317,executive-appointment,100,54,6/12/2018
A247F5,patent-awarded,100,72,6/12/2018
A3BFAA,merger,100,66,6/12/2018
A3F598,merger,100,66,6/12/2018
A3F598,merger,100,66,6/12/2018
A3F598,merger,100,66,6/12/2018
A43906,executive-appointment,100,54,6/12/2018
A47F2E,public-offering,100,43,6/12/2018
A5628C,executive-appointment,100,54,6/12/2018
A631A3,product-release,100,64,6/12/2018
A631A3,product-release,100,64,6/12/2018
A65325,public-offering,100,43,6/12/2018
A6828A,acquisition-acquiree,100,76,6/12/2018
A6828A,acquisition-acquiree,100,76,6/12/2018
A6828A,acquisition-acquiree,100,76,6/12/2018
A868C9,business-contract,100,69,6/12/2018
AA09AD,executive-appointment,100,54,6/12/2018
AA98ED,unit-acquisition-completed-acquirer,100,49,6/12/2018
AAEE21,conference-participant,100,50,6/12/2018
AC642C,index-listing,100,76,6/12/2018
AED6CF,earnings,100,50,6/12/2018
AFD1CA,facility-open,100,65,6/12/2018
B85DCE,conference-participant,100,50,6/12/2018
BB127B,investment-investor,100,55,6/12/2018
C06EB6,clinical-trials-start,100,64,6/12/2018
C06EB6,clinical-trials-start,100,64,6/12/2018
C3F99F,clinical-trials,100,56,6/12/2018
C7AE14,award,100,58,6/12/2018
C93C44,executive-appointment,100,54,6/12/2018
C93C44,executive-appointment,100,54,6/12/2018
CBFFDD,executive-appointment,100,54,6/12/2018
CBFFDD,executive-appointment,100,54,6/12/2018
CFF15D,legal-issues-defendant,100,22,6/12/2018
CFF15D,legal-issues-defendant,100,22,6/12/2018
CFF15D,legal-issues-defendant,100,22,6/12/2018
D07B07,public-offering,100,43,6/12/2018
D17C1B,revenue-volume,100,50,6/12/2018
D1C26F,executive-appointment,100,54,6/12/2018
D4AC65,product-release,100,64,6/12/2018
D9E036,conference-participant,100,50,6/12/2018
DA48E4,product-release,100,64,6/12/2018
DBB28E,partnership,100,61,6/12/2018
DD1BA1,partnership,100,61,6/12/2018
DF5F14,dividend-up,100,58,6/12/2018
E28D9C,conference-participant,100,50,6/12/2018
E84500,unit-acquisition-acquiree,100,76,6/12/2018
EF25A5,executive-appointment,100,54,6/12/2018
EFA7B2,product-release,100,64,6/12/2018
F1EB39,earnings,100,50,6/12/2018
F5349B,executive-appointment,100,54,6/12/2018
FA40E2,earnings,100,50,6/12/2018
FF6644,product-release,100,64,6/12/2018
0157B1,partnership,100,61,6/13/2018
07EC43,executive-appointment,100,54,6/13/2018
0BD4E8,merger-regulatory-approval,100,81,6/13/2018
0BD4E8,acquisition-regulatory-approval-acquirer,100,54,6/13/2018
0C8D82,executive-appointment,100,54,6/13/2018
0D03C8,executive-appointment,100,54,6/13/2018
1201B5,market-entry,100,57,6/13/2018
15789A,public-offering,100,43,6/13/2018
184866,conference-participant,100,50,6/13/2018
1880C5,executive-appointment,100,54,6/13/2018
1F716B,legal-issues-defendant,100,22,6/13/2018
1FC422,legal-issues-defendant,100,22,6/13/2018
228D42,business-contract,100,69,6/13/2018
228D42,dividend,100,50,6/13/2018
2667B6,dividend,100,50,6/13/2018
275300,executive-appointment,100,54,6/13/2018
275300,executive-appointment,100,54,6/13/2018
28B730,executive-appointment,100,54,6/13/2018
2920D5,asset-sale,100,62,6/13/2018
2BAE5F,acquisition-interest-acquirer,100,46,6/13/2018
2CA60F,partnership,100,61,6/13/2018
2DC88B,ipo-pricing,100,50,6/13/2018
2FDEE3,dividend,100,50,6/13/2018
3587B4,partnership,100,61,6/13/2018
37B618,dividend,100,50,6/13/2018
3A3447,facility-open,100,65,6/13/2018
3FACA7,facility-upgrade,100,65,6/13/2018
40F7DE,conference-participant,100,50,6/13/2018
44A4FC,executive-appointment,100,54,6/13/2018
45444E,legal-issues-defendant,100,22,6/13/2018
45444E,legal-issues-defendant,100,22,6/13/2018
45444E,legal-issues-defendant,100,22,6/13/2018
45444E,legal-issues-defendant,100,22,6/13/2018
458D2C,legal-issues-defendant,100,22,6/13/2018
4649D5,public-offering,100,43,6/13/2018
4A2457,government-contract,100,69,6/13/2018
4AC91D,executive-appointment,100,54,6/13/2018
4BD6DB,public-offering,100,43,6/13/2018
55C9B5,partnership,100,61,6/13/2018
58B46F,partnership,100,61,6/13/2018
58CA9A,conference-organizer,100,57,6/13/2018
58CA9A,earnings,100,50,6/13/2018
5FF95F,business-contract,100,69,6/13/2018
6166D1,conference-call,100,50,6/13/2018
619882,conference-organizer,100,57,6/13/2018
619882,conference-organizer,100,57,6/13/2018
619882,conference-organizer,100,57,6/13/2018
6.52E+64,legal-issues-defendant,100,22,6/13/2018
6.52E+64,legal-issues-defendant,100,22,6/13/2018
66A667,earnings,100,50,6/13/2018
6F3936,legal-issues-defendant,100,22,6/13/2018
6F6559,earnings,100,50,6/13/2018
70CA28,conference-participant,100,50,6/13/2018
70FCEF,earnings,100,50,6/13/2018
728737,dividend,100,50,6/13/2018
728737,dividend,100,50,6/13/2018
767F86,dividend-up,100,81,6/13/2018
767F86,dividend-up,100,81,6/13/2018
767F86,dividend-up,100,81,6/13/2018
787D14,acquisition-acquirer,100,49,6/13/2018
7BEA98,conference-participant,100,50,6/13/2018
7E3F8F,public-offering,100,43,6/13/2018
7FC386,dividend-up,100,81,6/13/2018
817ED9,executive-appointment,100,54,6/13/2018
84920B,buybacks,100,74,6/13/2018
895D56,business-contract,100,69,6/13/2018
89F693,award,100,58,6/13/2018
8A8E41,facility-open,100,65,6/13/2018
8AC740,dividend,100,50,6/13/2018
8E10BF,executive-appointment,100,54,6/13/2018
8FF2EF,earnings,100,50,6/13/2018
91E5EE,clinical-trials-start,100,64,6/13/2018
92005C,index-listing,100,76,6/13/2018
934029,clinical-trials-start,100,64,6/13/2018
94983E,partnership,100,61,6/13/2018
9.62E+76,executive-appointment,100,54,6/13/2018
968966,award,100,58,6/13/2018
9C25FF,product-release,100,64,6/13/2018
9D5D35,acquisition-acquirer,100,49,6/13/2018
9D5D35,acquisition-acquirer,100,49,6/13/2018
9E3224,public-offering,100,43,6/13/2018
A3AAA5,dividend,100,50,6/13/2018
A63387,executive-firing,100,36,6/13/2018
A63820,earnings,100,50,6/13/2018
A6FB29,note-sale,100,52,6/13/2018
B1A85D,partnership,100,61,6/13/2018
BF79F5,award,100,58,6/13/2018
C4A432,product-release,100,64,6/13/2018
C50B26,acquisition-acquirer,100,49,6/13/2018
C54140,buybacks,100,74,6/13/2018
C5C137,executive-appointment,100,54,6/13/2018
C83B88,acquisition-interest-acquirer,100,46,6/13/2018
C8A248,business-contract,100,69,6/13/2018
CDFCC9,partnership,100,61,6/13/2018
CE5664,note-sale,100,52,6/13/2018
CFF15D,legal-issues-defendant,100,22,6/13/2018
D8DA3D,conference-call,100,50,6/13/2018
DF6FDD,executive-appointment,100,54,6/13/2018
E30A8F,award,100,58,6/13/2018
E49AA3,product-release,100,64,6/13/2018
E49AA3,product-release,100,64,6/13/2018
E68733,product-release,100,64,6/13/2018
E8E899,earnings,100,50,6/13/2018
E9C7C0,product-release,100,64,6/13/2018
EEBCEF,award,100,58,6/13/2018
EF5BED,executive-appointment,100,54,6/13/2018
F5D410,partnership,100,61,6/13/2018
F6DCE4,dividend-up,100,53,6/13/2018
F7FCA4,conference-participant,100,50,6/13/2018
F93C8A,business-contract,100,69,6/13/2018
FC1B7B,business-contract,100,69,6/13/2018
FDD3FC,conference-participant,100,50,6/13/2018
FEC475,executive-appointment,100,54,6/13/2018
FF6644,conference-call,100,50,6/13/2018
0157B1,partnership,100,61,6/14/2018
0157B1,partnership,100,61,6/14/2018
03596A,business-contract,100,69,6/14/2018
03596A,business-contract,100,69,6/14/2018
48590,partnership,100,61,6/14/2018
48590,executive-appointment,100,54,6/14/2018
06A456,executive-appointment,100,54,6/14/2018
07EC43,award,100,58,6/14/2018
0B4D10,dividend,100,50,6/14/2018
0BD4E8,acquisition-completed-acquirer,100,49,6/14/2018
0BD4E8,acquisition-completed-acquirer,100,49,6/14/2018
0BD4E8,merger-completed,100,66,6/14/2018
0DBB81,patient-enrollment-complete,100,64,6/14/2018
106394,dividend,100,50,6/14/2018
1080C0,conference-participant,100,50,6/14/2018
1490F3,facility-open,100,65,6/14/2018
154272,ipo-pricing,100,50,6/14/2018
15789A,public-offering,100,43,6/14/2018
1.79E+10,facility-open,100,65,6/14/2018
19BF16,executive-appointment,100,54,6/14/2018
1F43A1,dividend-up,100,81,6/14/2018
1F716B,legal-issues-defendant,100,22,6/14/2018
1FC422,legal-issues-defendant,100,22,6/14/2018
200D8B,executive-appointment,100,54,6/14/2018
205AD5,earnings,100,50,6/14/2018
2082EA,conference-participant,100,50,6/14/2018
251988,acquisition-completed-acquirer,100,49,6/14/2018
26CC63,earnings,100,50,6/14/2018
26CC63,earnings,100,50,6/14/2018
26CC63,earnings,100,50,6/14/2018
26DC29,executive-appointment,100,54,6/14/2018
274B8A,conference-call,100,50,6/14/2018
275300,credit-extension-recipient,100,69,6/14/2018
31803E,partnership,100,61,6/14/2018
31803E,partnership,100,61,6/14/2018
31AA84,dividend,100,50,6/14/2018
396D7C,executive-appointment,100,54,6/14/2018
40F7DE,earnings,100,50,6/14/2018
420168,dividend,100,50,6/14/2018
45444E,legal-issues-defendant,100,22,6/14/2018
45444E,legal-issues-defendant,100,22,6/14/2018
47FCF2,unit-acquisition-acquiree,100,76,6/14/2018
4.91E+58,executive-appointment,100,54,6/14/2018
54DF47,dividend,100,50,6/14/2018
56277A,dividend,100,50,6/14/2018
57356F,conference-participant,100,50,6/14/2018
596116,dividend,100,50,6/14/2018
619882,conference-organizer,100,57,6/14/2018
619882,conference-organizer,100,57,6/14/2018
619882,conference-organizer,100,57,6/14/2018
619882,conference-organizer,100,57,6/14/2018
619882,conference-organizer,100,57,6/14/2018
619882,conference-organizer,100,57,6/14/2018
641F17,earnings,100,50,6/14/2018
6.52E+64,legal-issues-defendant,100,22,6/14/2018
6.52E+64,legal-issues-defendant,100,22,6/14/2018
6.52E+64,legal-issues-defendant,100,22,6/14/2018
665D7D,dividend,100,50,6/14/2018
67B052,conference-participant,100,50,6/14/2018
6BF593,dividend,100,50,6/14/2018
72FCA3,executive-appointment,100,54,6/14/2018
72FCA3,earnings,100,50,6/14/2018
7771D7,earnings,100,50,6/14/2018
7A10FF,investment-investor,100,55,6/14/2018
7A51FE,public-offering,100,43,6/14/2018
7B0BA6,executive-appointment,100,54,6/14/2018
7C4F43,executive-appointment,100,54,6/14/2018
8B1F37,dividend-up,100,81,6/14/2018
8D0EEA,conference-participant,100,50,6/14/2018
8E8E6E,note-sale,100,52,6/14/2018
8E8E6E,note-sale,100,52,6/14/2018
93AD2E,earnings,100,50,6/14/2018
940C3D,business-contract,100,69,6/14/2018
94637C,dividend,100,50,6/14/2018
986AF6,earnings-guidance,100,50,6/14/2018
9AF3DC,product-recall,100,29,6/14/2018
9C25FF,executive-appointment,100,54,6/14/2018
9D56F2,conference-call,100,50,6/14/2018
A48593,index-listing,100,76,6/14/2018
A7102F,business-contract,100,69,6/14/2018
A75D43,executive-appointment,100,54,6/14/2018
AA1EAA,dividend,100,50,6/14/2018
AD23DE,executive-appointment,100,54,6/14/2018
AD375D,dividend,100,50,6/14/2018
AE4EEB,dividend,100,50,6/14/2018
AEBB80,dividend,100,50,6/14/2018
AFD1CA,conference-participant,100,50,6/14/2018
AFF7B4,legal-issues-defendant,100,22,6/14/2018
AFF7B4,legal-issues-defendant,100,22,6/14/2018
BB5271,executive-appointment,100,54,6/14/2018
C05839,dividend,100,50,6/14/2018
C2DD02,dividend,100,50,6/14/2018
C83B88,partnership,100,61,6/14/2018
C9881C,revenue-up,100,69,6/14/2018
C9881C,revenue-up,100,69,6/14/2018
C9881C,revenue-up,100,69,6/14/2018
CBCC6A,executive-appointment,100,54,6/14/2018
CD051C,earnings,100,50,6/14/2018
CD051C,earnings,100,50,6/14/2018
CD051C,earnings,100,50,6/14/2018
CD051C,earnings,100,50,6/14/2018
CE4E6D,executive-appointment,100,54,6/14/2018
CF6A5A,product-release,100,64,6/14/2018
CF9054,executive-appointment,100,54,6/14/2018
CFF15D,legal-issues-defendant,100,22,6/14/2018
CFF15D,legal-issues-defendant,100,22,6/14/2018
CFF57D,conference-call,100,50,6/14/2018
D04D9F,conference-participant,100,50,6/14/2018
D296C6,dividend,100,50,6/14/2018
D78BF1,conference-participant,100,50,6/14/2018
D854DD,executive-appointment,100,54,6/14/2018
DAC66A,merger-completed,100,66,6/14/2018
DB396B,acquisition-acquirer,100,49,6/14/2018
DB396B,acquisition-acquirer,100,49,6/14/2018
DB396B,acquisition-acquirer,100,49,6/14/2018
DBB7ED,clinical-trials-start,100,64,6/14/2018
DE4924,public-offering,100,43,6/14/2018
E0F4E5,index-listing,100,76,6/14/2018
E71AE6,conference-participant,100,50,6/14/2018
E959F3,earnings,100,50,6/14/2018
EA4E68,dividend,100,50,6/14/2018
EA79C7,conference-participant,100,50,6/14/2018
EC99D0,award,100,58,6/14/2018
EC99D0,award,100,58,6/14/2018
EC99D0,conference-call,100,50,6/14/2018
ECD263,earnings,100,50,6/14/2018
EE74E1,partnership,100,61,6/14/2018
EF77A3,conference-call,100,50,6/14/2018
FD554E,conference-participant,100,50,6/14/2018
07EC43,buybacks,100,74,6/15/2018
0A748B,index-listing,100,76,6/15/2018
0E5223,conference-participant,100,50,6/15/2018
0FABBD,conference-participant,100,50,6/15/2018
108A2B,dividend,100,50,6/15/2018
138DDE,dividend,100,50,6/15/2018
1490F3,note-sale,100,52,6/15/2018
15B10D,business-contract,100,69,6/15/2018
1.79E+10,legal-issues-defendant,100,22,6/15/2018
1AB023,product-release,100,64,6/15/2018
1AB023,product-release,100,64,6/15/2018
1AB023,product-release,100,64,6/15/2018
1AF7E2,dividend,100,50,6/15/2018
1E83DE,legal-verdict-disfavored,100,22,6/15/2018
1FC422,legal-issues-defendant,100,22,6/15/2018
20BEEA,earnings-guidance,100,50,6/15/2018
282C18,dividend,100,50,6/15/2018
2C7505,clinical-trials,100,56,6/15/2018
2C7505,clinical-trials,100,56,6/15/2018
2F960F,executive-appointment,100,54,6/15/2018
339F20,dividend-up,100,58,6/15/2018
35B907,dividend-up,100,81,6/15/2018
3A3447,facility-open,100,65,6/15/2018
3C7F5F,earnings,100,50,6/15/2018
3DDE54,conference-participant,100,50,6/15/2018
45444E,legal-issues-defendant,100,22,6/15/2018
45444E,legal-issues-defendant,100,22,6/15/2018
4A2457,business-contract,100,69,6/15/2018
4D371E,award,100,58,6/15/2018
4D8313,dividend,100,50,6/15/2018
53F491,dividend,100,50,6/15/2018
553949,conference-participant,100,50,6/15/2018
5704AC,dividend,100,50,6/15/2018
58B46F,facility-open,100,65,6/15/2018
5A53BF,clinical-trials-positive,100,87,6/15/2018
60EA12,conference-participant,100,50,6/15/2018
619882,conference-organizer,100,57,6/15/2018
619882,conference-organizer,100,57,6/15/2018
619882,dividend,100,50,6/15/2018
657097,dividend,100,50,6/15/2018
775439,earnings,100,50,6/15/2018
7DD8CC,dividend,100,50,6/15/2018
826FD6,dividend,100,50,6/15/2018
855DF7,earnings,100,50,6/15/2018
8A8E41,business-contract,100,69,6/15/2018
8D4486,acquisition-acquirer,100,49,6/15/2018
8E4250,conference-call,100,50,6/15/2018
9196A2,dividend,100,50,6/15/2018
91C82E,conference-call,100,50,6/15/2018
990AD0,dividend,100,50,6/15/2018
9D30A8,business-contract,100,69,6/15/2018
9E3224,public-offering,100,43,6/15/2018
A38F30,conference-participant,100,50,6/15/2018
AFF7B4,legal-issues-defendant,100,22,6/15/2018
AFF7B4,legal-issues-defendant,100,22,6/15/2018
AFF7B4,legal-issues-defendant,100,22,6/15/2018
B48D6A,conference-participant,100,50,6/15/2018
B5BA39,executive-appointment,100,54,6/15/2018
B762D3,dividend,100,50,6/15/2018
BFAEB4,executive-resignation,100,44,6/15/2018
C83B88,acquisition-interest-acquirer,100,46,6/15/2018
C9F39B,dividend,100,50,6/15/2018
CBFFDD,settlement,100,56,6/15/2018
CBFFDD,settlement,100,56,6/15/2018
CD4DA8,acquisition-acquirer,100,49,6/15/2018
CD4DA8,acquisition-acquirer,100,49,6/15/2018
CF6A5A,earnings,100,50,6/15/2018
CFF97C,award,100,58,6/15/2018
D139BC,dividend,100,50,6/15/2018
D3FA2C,dividend,100,50,6/15/2018
D5AF19,facility-relocation,100,50,6/15/2018
D6853F,legal-issues-defendant,100,22,6/15/2018
D6853F,legal-issues-defendant,100,22,6/15/2018
D8442A,award,100,58,6/15/2018
D96202,conference-call,100,50,6/15/2018
DC5299,dividend,100,50,6/15/2018
DD0099,earnings,100,50,6/15/2018
E41190,index-listing,100,76,6/15/2018
E68733,regulatory-product-approval-granted,100,81,6/15/2018
EA62FC,executive-appointment,100,54,6/15/2018
EDF5CA,executive-resignation,100,44,6/15/2018
EF7163,dividend,100,50,6/15/2018
F294DD,dividend,100,50,6/15/2018
F3816D,clinical-trials,100,56,6/15/2018
F748C7,dividend,100,50,6/15/2018
F80389,dividend,100,50,6/15/2018
0C6293,legal-issues-defendant,100,22,6/16/2018
184866,clinical-trials,100,56,6/16/2018
1FC422,legal-verdict-disfavored,100,22,6/16/2018
6.52E+64,legal-issues-defendant,100,22,6/16/2018
803FED,legal-issues-defendant,100,22,6/16/2018
AFF7B4,legal-issues-defendant,100,22,6/16/2018
C584BE,legal-issues-defendant,100,22,6/16/2018
9B0C9C,legal-issues-defendant,100,22,6/17/2018
0157B1,settlement,100,56,6/18/2018
20751,executive-appointment,100,54,6/18/2018
03B8CF,market-entry,100,57,6/18/2018
43862,fast-track-designation,100,81,6/18/2018
0C6861,buybacks,100,74,6/18/2018
0CC01F,dividend,100,50,6/18/2018
0DBB81,public-offering,100,43,6/18/2018
0E499E,partnership,100,61,6/18/2018
15789A,public-offering,100,43,6/18/2018
159AE4,conference-participant,100,50,6/18/2018
165B3A,name-change,100,49,6/18/2018
16B183,partnership,100,61,6/18/2018
1834C0,unit-acquisition-acquirer,100,49,6/18/2018
1834C0,public-offering,100,43,6/18/2018
1CD09C,partnership,100,61,6/18/2018
1F19C8,market-entry,100,57,6/18/2018
1F43A1,merger,100,66,6/18/2018
1F43A1,merger,100,66,6/18/2018
214051,executive-appointment,100,54,6/18/2018
2158DF,business-contract,100,69,6/18/2018
225CA2,executive-appointment,100,54,6/18/2018
228D42,partnership,100,61,6/18/2018
228D42,partnership,100,61,6/18/2018
228D42,partnership,100,61,6/18/2018
24D81E,facility-open,100,65,6/18/2018
250BEE,award,100,58,6/18/2018
251988,partnership,100,61,6/18/2018
251988,product-release,100,64,6/18/2018
2DC88B,ipo-completed,100,76,6/18/2018
315EB0,partnership,100,61,6/18/2018
34A959,conference-participant,100,50,6/18/2018
36C09B,clinical-trials,100,56,6/18/2018
3A3447,facility-open,100,65,6/18/2018
451D61,clinical-trials-start,100,64,6/18/2018
4A6F00,partnership,100,61,6/18/2018
4A6F00,partnership,100,61,6/18/2018
4A6F00,partnership,100,61,6/18/2018
4A6F00,partnership,100,61,6/18/2018
4AC91D,product-release,100,64,6/18/2018
4D8313,executive-appointment,100,54,6/18/2018
5487B1,conference-participant,100,50,6/18/2018
57CAAB,facility-open,100,65,6/18/2018
5E1DF3,public-offering,100,43,6/18/2018
6166D1,executive-appointment,100,54,6/18/2018
619882,conference-organizer,100,57,6/18/2018
619882,conference-organizer,100,57,6/18/2018
6284B5,market-entry,100,57,6/18/2018
6284B5,market-entry,100,57,6/18/2018
67529E,acquisition-acquirer,100,49,6/18/2018
67529E,acquisition-acquirer,100,49,6/18/2018
6A171E,unit-acquisition-acquiree,100,76,6/18/2018
6-Dec-05,conference-participant,100,50,6/18/2018
6.00E+19,business-contract,100,69,6/18/2018
6F3936,partnership,100,61,6/18/2018
6FCEF9,dividend,100,50,6/18/2018
71B0CF,conference-participant,100,50,6/18/2018
76E80F,donation,100,54,6/18/2018
771985,business-contract,100,69,6/18/2018
773A17,product-release,100,64,6/18/2018
7AB859,acquisition-completed-acquirer,100,49,6/18/2018
7E1D5D,product-release,100,64,6/18/2018
7FDE1C,product-release,100,64,6/18/2018
82E58A,partnership,100,61,6/18/2018
837C04,executive-appointment,100,54,6/18/2018
83A065,dividend,100,50,6/18/2018
859D62,partnership,100,61,6/18/2018
8614A2,ipo,100,71,6/18/2018
893904,executive-appointment,100,54,6/18/2018
8A8E41,product-release,100,64,6/18/2018
8D4486,partnership,100,61,6/18/2018
8D9993,executive-appointment,100,54,6/18/2018
8E0E32,partnership,100,61,6/18/2018
8E8E6E,executive-appointment,100,54,6/18/2018
8E8E6E,note-sale,100,52,6/18/2018
925759,executive-appointment,100,54,6/18/2018
968966,executive-appointment,100,54,6/18/2018
9CA432,dividend,100,50,6/18/2018
9D30A8,business-contract,100,69,6/18/2018
A495F7,business-contract,100,69,6/18/2018
A5A4F5,acquisition-acquirer,100,49,6/18/2018
A666C8,executive-resignation,100,44,6/18/2018
A9ED24,dividend,100,50,6/18/2018
AADE0B,executive-appointment,100,54,6/18/2018
AADE0B,executive-appointment,100,54,6/18/2018
AADE0B,executive-appointment,100,54,6/18/2018
ACC7D3,executive-appointment,100,54,6/18/2018
ADF092,partnership,100,61,6/18/2018
AEF2C3,partnership,100,61,6/18/2018
AEFC90,patient-enrollment-complete,100,64,6/18/2018
AFF7B4,legal-issues-defendant,100,22,6/18/2018
B1FC3B,fundraising,100,64,6/18/2018
B8F71F,earnings,100,50,6/18/2018
C4FBDC,acquisition-acquiree,100,76,6/18/2018
C4FBDC,acquisition-acquiree,100,76,6/18/2018
C4FBDC,acquisition-acquiree,100,76,6/18/2018
C58D71,clinical-trials-start,100,64,6/18/2018
C83B88,conference-call,100,50,6/18/2018
C8FAC7,campaign-ad-release,100,59,6/18/2018
C9881C,executive-appointment,100,54,6/18/2018
CAC8D0,earnings,100,50,6/18/2018
CB6A9C,partnership,100,61,6/18/2018
CFF15D,legal-issues-defendant,100,22,6/18/2018
D11C1C,dividend,100,50,6/18/2018
D2E553,dividend,100,50,6/18/2018
D437C3,business-contract,100,69,6/18/2018
D598E7,conference-call,100,50,6/18/2018
D598E7,investment-investor,100,55,6/18/2018
DA9443,legal-issues-defendant,100,22,6/18/2018
DB2E4E,public-offering,100,43,6/18/2018
DF204B,unit-acquisition-acquirer,100,49,6/18/2018
E4CE73,partnership,100,61,6/18/2018
EAEBF3,conference-participant,100,50,6/18/2018
EB6965,dividend,100,50,6/18/2018
EC99D0,market-entry,100,57,6/18/2018
EC99D0,market-entry,100,57,6/18/2018
F30508,dividend,100,50,6/18/2018
F30508,dividend,100,50,6/18/2018
F4CDA3,dividend,100,50,6/18/2018
F80389,ownership-increase-owner,100,56,6/18/2018
FA35C6,partnership,100,61,6/18/2018
FC1736,partnership,100,61,6/18/2018
FC9A88,executive-appointment,100,54,6/18/2018
0157B1,legal-issues-defendant,100,22,6/19/2018
01D03F,merger,100,66,6/19/2018
03FAA6,partnership,100,61,6/19/2018
09F623,note-sale,100,52,6/19/2018
0A2EB8,dividend,100,50,6/19/2018
106394,unit-acquisition-acquirer,100,49,6/19/2018
143C9C,supply-decrease,100,28,6/19/2018
14BA06,earnings,100,50,6/19/2018
154272,ipo-completed,100,76,6/19/2018
156A99,index-listing,100,76,6/19/2018
168A5D,acquisition-acquiree,100,76,6/19/2018
168A5D,facility-open,100,65,6/19/2018
168A5D,partnership,100,61,6/19/2018
1834C0,public-offering,100,43,6/19/2018
1D943E,executive-appointment,100,54,6/19/2018
1F19C8,partnership,100,61,6/19/2018
1F9258,index-listing,100,76,6/19/2018
26DC29,award,100,58,6/19/2018
2EB04E,partnership,100,61,6/19/2018
2EB88B,acquisition-acquirer,100,49,6/19/2018
2EC172,partnership,100,61,6/19/2018
3.14E+47,dividend,100,50,6/19/2018
349DA4,executive-appointment,100,54,6/19/2018
39FB23,executive-appointment,100,54,6/19/2018
3BE00F,unit-acquisition-acquirer,100,49,6/19/2018
3BE00F,unit-acquisition-acquirer,100,49,6/19/2018
3BE00F,unit-acquisition-acquirer,100,49,6/19/2018
3C8A04,conference-call,100,50,6/19/2018
3CCC90,partnership,100,61,6/19/2018
449A26,acquisition-acquirer,100,49,6/19/2018
449A26,acquisition-acquirer,100,49,6/19/2018
49914B,conference-call,100,50,6/19/2018
4AC91D,dividend,100,50,6/19/2018
4BEB48,partnership,100,61,6/19/2018
545272,dividend,100,50,6/19/2018
545272,executive-appointment,100,54,6/19/2018
55438C,business-contract,100,69,6/19/2018
556F08,public-offering,100,43,6/19/2018
55ACCB,executive-appointment,100,54,6/19/2018
5675EB,dividend,100,50,6/19/2018
58B46F,conference-call,100,50,6/19/2018
5B97B2,dividend-guidance,100,50,6/19/2018
609208,conference-call,100,50,6/19/2018
6166D1,dividend,100,50,6/19/2018
6844D2,earnings,100,50,6/19/2018
69345C,legal-issues-defendant,100,22,6/19/2018
69FDFC,product-release,100,64,6/19/2018
6D4636,award,100,58,6/19/2018
7.40E+289,dividend,100,50,6/19/2018
76F067,regulatory-product-approval-granted,100,81,6/19/2018
76F067,regulatory-product-approval-granted,100,81,6/19/2018
77B8E9,patent-awarded,100,72,6/19/2018
7A10FF,executive-appointment,100,54,6/19/2018
7A51FE,public-offering,100,43,6/19/2018
7ACD98,hirings,100,65,6/19/2018
8377DB,dividend-up,100,81,6/19/2018
845533,product-release,100,64,6/19/2018
845533,product-release,100,64,6/19/2018
89F693,legal-issues-defendant,100,22,6/19/2018
8A0368,executive-appointment,100,54,6/19/2018
8A0368,executive-appointment,100,54,6/19/2018
8D4486,partnership,100,61,6/19/2018
966ACE,clinical-trials-start,100,64,6/19/2018
98CEBB,product-release,100,64,6/19/2018
9C5174,product-release,100,64,6/19/2018
9C5174,product-release,100,64,6/19/2018
9DDE1B,note-sale,100,52,6/19/2018
9E3224,dividend,100,50,6/19/2018
A28C54,acquisition-acquiree,100,76,6/19/2018
A28C54,acquisition-acquiree,100,76,6/19/2018
A5A4F5,conference-call,100,50,6/19/2018
A5A4F5,conference-call,100,50,6/19/2018
A5A4F5,acquisition-acquirer,100,49,6/19/2018
A6213D,unit-acquisition-acquirer,100,49,6/19/2018
A6213D,unit-acquisition-acquirer,100,49,6/19/2018
A6828A,conference-call,100,50,6/19/2018
A790A5,earnings,100,50,6/19/2018
A868C9,business-contract,100,69,6/19/2018
AC7C4F,executive-appointment,100,54,6/19/2018
AD6141,earnings,100,50,6/19/2018
AFF7B4,legal-issues-defendant,100,22,6/19/2018
B1FC3B,government-contract,100,69,6/19/2018
B37FB4,earnings,100,50,6/19/2018
B37FB4,acquisition-completed-acquirer,100,49,6/19/2018
B7BDA3,merger,100,66,6/19/2018
BBF349,acquisition-interest-acquiree,100,82,6/19/2018
BBF349,business-contract,100,69,6/19/2018
BD682F,dividend,100,50,6/19/2018
BDF2BD,partnership,100,61,6/19/2018
C27E19,earnings,100,50,6/19/2018
C38440,clinical-trials,100,56,6/19/2018
C7FC95,partnership,100,61,6/19/2018
C81E00,conference-call,100,50,6/19/2018
C83B88,partnership,100,61,6/19/2018
C9881C,acquisition-completed-acquirer,100,49,6/19/2018
C9A96E,executive-appointment,100,54,6/19/2018
CBDB4D,partnership,100,61,6/19/2018
CBDB4D,partnership,100,61,6/19/2018
CF351E,dividend,100,50,6/19/2018
CF6A5A,product-release,100,64,6/19/2018
D1AE3B,product-release,100,64,6/19/2018
D3CEDF,legal-issues-defendant,100,22,6/19/2018
D598E7,executive-appointment,100,54,6/19/2018
D6EAA3,award,100,58,6/19/2018
D75910,dividend,100,50,6/19/2018
D7AC6E,dividend,100,50,6/19/2018
D82EF3,partnership,100,61,6/19/2018
DA199F,earnings,100,50,6/19/2018
DA9443,conference-participant,100,50,6/19/2018
DB2E4E,public-offering,100,43,6/19/2018
DBB28E,product-release,100,64,6/19/2018
DE4924,public-offering,100,43,6/19/2018
DFADDB,index-listing,100,76,6/19/2018
E0207A,partnership,100,61,6/19/2018
E26FC3,earnings,100,50,6/19/2018
E8B21D,dividend,100,50,6/19/2018
EF5BED,executive-appointment,100,54,6/19/2018
EF5BED,executive-appointment,100,54,6/19/2018
F3D2EB,dividend,100,50,6/19/2018
F4CDA3,unit-acquisition-acquirer,100,49,6/19/2018
F5349B,executive-appointment,100,54,6/19/2018
FACF19,product-release,100,64,6/19/2018
FACF19,index-listing,100,76,6/19/2018
FD4588,award,100,58,6/19/2018
FDF799,index-listing,100,76,6/19/2018
FF6644,product-release,100,64,6/19/2018
00326D,conference-call,100,50,6/20/2018
02ACBD,product-release,100,64,6/20/2018
061A3B,product-price-raise,100,57,6/20/2018
71860,executive-appointment,100,54,6/20/2018
09DE1F,partnership,100,61,6/20/2018
0BC29E,acquisition-acquirer,100,49,6/20/2018
1080C0,executive-appointment,100,54,6/20/2018
1096C6,partnership,100,61,6/20/2018
12A3A3,executive-appointment,100,54,6/20/2018
16FC89,earnings,100,50,6/20/2018
1CF3A8,ipo-pricing,100,50,6/20/2018
1E83DE,legal-issues-defendant,100,22,6/20/2018
1F716B,legal-issues-defendant,100,22,6/20/2018
1F716B,legal-issues-defendant,100,22,6/20/2018
1FC422,legal-issues-defendant,100,22,6/20/2018
21153F,buybacks,100,74,6/20/2018
21153F,buybacks,100,74,6/20/2018
21153F,buybacks,100,74,6/20/2018
21153F,buybacks,100,74,6/20/2018
214051,executive-appointment,100,54,6/20/2018
228D42,product-release,100,64,6/20/2018
228D42,product-release,100,64,6/20/2018
228D42,product-release,100,64,6/20/2018
238302,dividend,100,50,6/20/2018
251988,product-release,100,64,6/20/2018
292A70,earnings,100,50,6/20/2018
2F24A5,earnings,100,50,6/20/2018
30DE64,ipo-pricing,100,50,6/20/2018
342218,dividend,100,50,6/20/2018
39D9DA,conference-call,100,50,6/20/2018
39FB23,legal-issues-defendant,100,22,6/20/2018
3A3447,facility-open,100,65,6/20/2018
4.00E+163,unit-acquisition-acquirer,100,49,6/20/2018
45444E,legal-issues-defendant,100,22,6/20/2018
458D2C,legal-issues-defendant,100,22,6/20/2018
458D2C,facility-open,100,65,6/20/2018
458D2C,legal-issues-defendant,100,22,6/20/2018
49BBBC,earnings,100,50,6/20/2018
4C37C5,conference-call,100,50,6/20/2018
51D876,acquisition-acquirer,100,49,6/20/2018
520632,conference-call,100,50,6/20/2018
556F08,public-offering,100,43,6/20/2018
56277A,conference-call,100,50,6/20/2018
5D63F1,facility-open,100,65,6/20/2018
6166D1,business-contract,100,69,6/20/2018
6166D1,business-contract,100,69,6/20/2018
619882,executive-appointment,100,54,6/20/2018
619882,executive-appointment,100,54,6/20/2018
64E615,buybacks,100,74,6/20/2018
73C521,earnings,100,50,6/20/2018
73F7F9,earnings,100,50,6/20/2018
75768D,earnings,100,50,6/20/2018
75768D,earnings,100,50,6/20/2018
75768D,earnings,100,50,6/20/2018
75768D,earnings,100,50,6/20/2018
75768D,earnings,100,50,6/20/2018
775439,dividend,100,50,6/20/2018
793C11,legal-issues-plaintiff,100,44,6/20/2018
7A0EC4,product-release,100,64,6/20/2018
8.10E+32,unit-acquisition-acquiree,100,76,6/20/2018
82B57E,award,100,58,6/20/2018
850779,partnership,100,61,6/20/2018
877C0C,settlement,100,56,6/20/2018
8A0368,executive-appointment,100,54,6/20/2018
8D4486,partnership,100,61,6/20/2018
911AB8,conference-call,100,50,6/20/2018
911AB8,stake-acquiree,100,62,6/20/2018
911ACB,dividend,100,50,6/20/2018
940C3D,earnings,100,50,6/20/2018
9D6A24,executive-appointment,100,54,6/20/2018
A26C26,public-offering,100,43,6/20/2018
A2A9BA,index-listing,100,76,6/20/2018
A350C1,public-offering,100,43,6/20/2018
A5A4F5,acquisition-acquirer,100,49,6/20/2018
AC7C4F,earnings-guidance,100,50,6/20/2018
AC7C4F,earnings-guidance,100,50,6/20/2018
AD23DE,product-release,100,64,6/20/2018
B1FC3B,award,100,58,6/20/2018
B642E8,dividend,100,50,6/20/2018
B77F14,product-release,100,64,6/20/2018
BD9668,executive-appointment,100,54,6/20/2018
C2E120,dividend,100,50,6/20/2018
C4A912,public-offering,100,43,6/20/2018
CFF15D,executive-appointment,100,54,6/20/2018
CFF15D,legal-issues-defendant,100,22,6/20/2018
CFF97C,unit-acquisition-acquirer,100,49,6/20/2018
D08D2C,conference-call,100,50,6/20/2018
D0909F,resource-discovery,100,88,6/20/2018
D1AE3B,executive-appointment,100,54,6/20/2018
D1CFC8,earnings,100,50,6/20/2018
D21D8A,dividend,100,50,6/20/2018
D2B9E5,product-release,100,64,6/20/2018
D42DBA,executive-appointment,100,54,6/20/2018
D63B0F,acquisition-acquirer,100,49,6/20/2018
D854DD,executive-appointment,100,54,6/20/2018
D8DBA3,executive-appointment,100,54,6/20/2018
DBB28E,partnership,100,61,6/20/2018
E05026,executive-appointment,100,54,6/20/2018
E124EB,conference-call,100,50,6/20/2018
E2F130,conference-call,100,50,6/20/2018
E30A8F,partnership,100,61,6/20/2018
E61888,dividend,100,50,6/20/2018
EB7FBF,dividend,100,50,6/20/2018
EBD89A,business-contract,100,69,6/20/2018
EBD89A,business-contract,100,69,6/20/2018
EE74E1,partnership,100,61,6/20/2018
EEA6B3,earnings,100,50,6/20/2018
EF5BED,conference-call,100,50,6/20/2018
F11638,product-release,100,64,6/20/2018
F7ADEB,public-offering,100,43,6/20/2018
02FC1A,clinical-trials-positive,100,87,6/21/2018
55018,conference-call,100,50,6/21/2018
0A6824,note-sale,100,52,6/21/2018
0BF528,award,100,58,6/21/2018
0DBB81,public-offering,100,43,6/21/2018
17EDA5,executive-appointment,100,54,6/21/2018
17EDA5,executive-resignation,100,44,6/21/2018
17EDA5,legal-issues-defendant,100,22,6/21/2018
190BE6,dividend,100,50,6/21/2018
1D9E55,debt-restructuring,100,59,6/21/2018
225CA2,executive-appointment,100,54,6/21/2018
228D42,product-release,100,64,6/21/2018
24CB56,regulatory-stress-test,100,50,6/21/2018
25102A,exchange-compliance-authority,100,50,6/21/2018
251988,partnership,100,61,6/21/2018
251988,merger-regulatory-approval,100,81,6/21/2018
26E3BA,business-contract,100,69,6/21/2018
2CA60F,partnership,100,61,6/21/2018
2CA60F,acquisition-acquirer,100,49,6/21/2018
2EBA55,capital-increase,100,43,6/21/2018
37727A,dividend,100,50,6/21/2018
39BFF6,executive-appointment,100,54,6/21/2018
3A3447,facility-open,100,65,6/21/2018
3F96D5,business-contract,100,69,6/21/2018
3FACA7,earnings,100,50,6/21/2018
401072,clinical-trials-start,100,64,6/21/2018
43A74A,earnings,100,50,6/21/2018
448215,ipo-pricing,100,50,6/21/2018
449A26,conference-call,100,50,6/21/2018
47752F,dividend,100,50,6/21/2018
4B49CF,conference-call,100,50,6/21/2018
4B6EF9,note-sale,100,52,6/21/2018
4BEB48,product-release,100,64,6/21/2018
4D371E,regulatory-stress-test,100,50,6/21/2018
4E4E75,earnings,100,50,6/21/2018
504FE2,conference-call,100,50,6/21/2018
550D01,note-sale,100,52,6/21/2018
55C9B5,partnership,100,61,6/21/2018
55C9B5,partnership,100,61,6/21/2018
57DDB9,executive-salary-cut,100,53,6/21/2018
5C7601,earnings,100,50,6/21/2018
6166D1,regulatory-stress-test,100,50,6/21/2018
6.18E+08,partnership,100,61,6/21/2018
619882,regulatory-stress-test,100,50,6/21/2018
620381,ipo-pricing,100,50,6/21/2018
627186,earnings,100,50,6/21/2018
633043,dividend,100,50,6/21/2018
63E8D5,dividend,100,50,6/21/2018
6.52E+64,partnership,100,61,6/21/2018
68586A,executive-resignation,100,44,6/21/2018
6D4636,award,100,58,6/21/2018
6EA292,dividend,100,50,6/21/2018
6F30F9,dividend,100,50,6/21/2018
726EEA,product-release,100,64,6/21/2018
790C34,market-entry,100,57,6/21/2018
7AC86E,dividend,100,50,6/21/2018
7ADE57,dividend-up,100,81,6/21/2018
84AB66,dividend,100,50,6/21/2018
86478F,dividend,100,50,6/21/2018
8AB85C,ipo-pricing,100,50,6/21/2018
900356,executive-appointment,100,54,6/21/2018
92D9C9,dividend,100,50,6/21/2018
92D9C9,public-offering,100,43,6/21/2018
9.39E+69,ipo-pricing,100,50,6/21/2018
950CDB,executive-appointment,100,54,6/21/2018
95DC1F,earnings,100,50,6/21/2018
95DC1F,earnings,100,50,6/21/2018
95DC1F,earnings,100,50,6/21/2018
95DC1F,earnings,100,50,6/21/2018
968B00,asset-sale,100,62,6/21/2018
9B0C9C,legal-issues-defendant,100,22,6/21/2018
9BBFA5,earnings,100,50,6/21/2018
9D307D,executive-resignation,100,44,6/21/2018
9D30A8,business-contract,100,69,6/21/2018
9F6B1A,acquisition-regulatory-approval-acquiree,100,81,6/21/2018
9FF5F1,partnership,100,61,6/21/2018
A1EAC8,facility-open,100,65,6/21/2018
A43906,conference-call,100,50,6/21/2018
A8B137,facility-open,100,65,6/21/2018
AADE0B,unit-acquisition-acquirer,100,49,6/21/2018
AC7C4F,business-contract,100,69,6/21/2018
ADF092,partnership,100,61,6/21/2018
AED61E,executive-appointment,100,54,6/21/2018
B96637,business-contract,100,69,6/21/2018
BA0442,public-offering,100,43,6/21/2018
BF79F5,executive-appointment,100,54,6/21/2018
C3BCD5,legal-issues-defendant,100,22,6/21/2018
CBDB4D,conference-call,100,50,6/21/2018
D29B44,index-listing,100,76,6/21/2018
D6489C,product-release,100,64,6/21/2018
D854F3,conference-call,100,50,6/21/2018
DA0A9E,conference-call,100,50,6/21/2018
DB2E4E,public-offering,100,43,6/21/2018
DBCA3F,executive-appointment,100,54,6/21/2018
DC0066,index-listing,100,76,6/21/2018
DD1BA1,sanctions-target,100,19,6/21/2018
E10D31,dividend,100,50,6/21/2018
E6BC2C,fundraising,100,64,6/21/2018
E8846E,award,100,58,6/21/2018
E8846E,regulatory-stress-test,100,50,6/21/2018
E8B315,dividend,100,50,6/21/2018
EB7FBF,earnings,100,50,6/21/2018
EBC84C,conference-participant,100,50,6/21/2018
ECDEB2,dividend,100,50,6/21/2018
F569FD,ipo-pricing,100,50,6/21/2018
F6A945,campaign-ad-release,100,59,6/21/2018
F6DCE4,legal-issues-defendant,100,22,6/21/2018
F7ADEB,public-offering,100,43,6/21/2018
FD9526,conference-call,100,50,6/21/2018
00326D,earnings,100,50,6/22/2018
00326E,executive-appointment,100,54,6/22/2018
0157B1,facility-open,100,65,6/22/2018
0358AF,conference-participant,100,50,6/22/2018
07EC43,conference-participant,100,50,6/22/2018
108BD2,index-listing,100,76,6/22/2018
1A3E1B,facility-upgrade,100,65,6/22/2018
1BC12C,fundraising,100,64,6/22/2018
1D3A00,dividend,100,50,6/22/2018
1E83DE,legal-issues-defendant,100,22,6/22/2018
1FC422,legal-issues-defendant,100,22,6/22/2018
26DC29,award,100,58,6/22/2018
275300,dividend,100,50,6/22/2018
3461CF,business-contract,100,69,6/22/2018
3F4497,dividend,100,50,6/22/2018
4C7DB5,earnings,100,50,6/22/2018
4EC4C1,conference-call,100,50,6/22/2018
5E1DF3,public-offering,100,43,6/22/2018
5EC388,stock-splits,100,49,6/22/2018
62B1C6,acquisition-completed-acquirer,100,49,6/22/2018
66ECFD,earnings,100,50,6/22/2018
6F3FA8,conference-participant,100,50,6/22/2018
71B0CF,public-offering,100,43,6/22/2018
746373,conference-call,100,50,6/22/2018
7E1D5D,merger-regulatory-approval,100,81,6/22/2018
7E2DE6,earnings,100,50,6/22/2018
82B57E,executive-appointment,100,54,6/22/2018
8817D5,conference-call,100,50,6/22/2018
8C6C1B,facility-open,100,65,6/22/2018
92D757,executive-appointment,100,54,6/22/2018
95DC1F,merger-completed,100,66,6/22/2018
95DC1F,merger-completed,100,66,6/22/2018
A6828A,executive-resignation,100,44,6/22/2018
A6828A,executive-appointment,100,54,6/22/2018
AA7FE0,earnings,100,50,6/22/2018
AA7FE0,earnings,100,50,6/22/2018
AA7FE0,earnings,100,50,6/22/2018
AA7FE0,earnings,100,50,6/22/2018
AAC8B6,acquisition-regulatory-approval-acquirer,100,54,6/22/2018
ACF0B4,acquisition-completed-acquirer,100,49,6/22/2018
AFF7B4,legal-issues-defendant,100,22,6/22/2018
AFF7B4,legal-issues-defendant,100,22,6/22/2018
BAD655,facility-open,100,65,6/22/2018
BDF2BD,conference-participant,100,50,6/22/2018
BE645B,facility-open,100,65,6/22/2018
BEA527,public-offering,100,43,6/22/2018
C3BCD5,legal-issues-defendant,100,22,6/22/2018
C3BCD5,legal-issues-defendant,100,22,6/22/2018
C3BCD5,legal-issues-defendant,100,22,6/22/2018
C3BCD5,legal-issues-defendant,100,22,6/22/2018
CE8251,executive-appointment,100,54,6/22/2018
CFF15D,partnership,100,61,6/22/2018
CFF15D,partnership,100,61,6/22/2018
CFF15D,legal-issues-defendant,100,22,6/22/2018
DB5CA5,donation,100,54,6/22/2018
E49AA3,product-release,100,64,6/22/2018
E68733,dividend-up,100,59,6/22/2018
E68E62,index-listing,100,76,6/22/2018
E8C557,executive-appointment,100,54,6/22/2018
F30508,acquisition-completed-acquirer,100,49,6/22/2018
F30508,acquisition-completed-acquirer,100,49,6/22/2018
F5349B,product-release,100,64,6/22/2018
F82D37,conference-call,100,50,6/22/2018
F95726,executive-appointment,100,54,6/22/2018
586BD7,earnings-positive,100,69,6/23/2018
97644E,legal-issues-defendant,100,22,6/23/2018
B83D67,clinical-trials,100,56,6/23/2018
B83D67,clinical-trials-start,100,64,6/23/2018
586BD7,earnings-positive,100,69,6/24/2018
9C5174,clinical-trials-positive,100,87,6/24/2018
9397,executive-appointment,100,54,6/25/2018
0157B1,partnership,100,61,6/25/2018
20751,index-listing,100,76,6/25/2018
02FC1A,public-offering,100,43,6/25/2018
03596A,unit-acquisition-completed-acquiree,100,67,6/25/2018
03D5F9,acquisition-acquirer,100,49,6/25/2018
03D5F9,acquisition-acquirer,100,49,6/25/2018
03D5F9,acquisition-acquirer,100,49,6/25/2018
03D5F9,acquisition-acquirer,100,49,6/25/2018
03D5F9,acquisition-acquirer,100,49,6/25/2018
03D5F9,business-contract,100,69,6/25/2018
061A3B,earnings,100,50,6/25/2018
099C88,government-contract,100,69,6/25/2018
0BA2EF,dividend,100,50,6/25/2018
0BC29E,executive-appointment,100,54,6/25/2018
0BC29E,earnings,100,50,6/25/2018
0BD4E8,executive-appointment,100,54,6/25/2018
0C136E,earnings,100,50,6/25/2018
0CC01F,earnings,100,50,6/25/2018
0DBB81,public-offering,100,43,6/25/2018
0E439E,earnings,100,50,6/25/2018
129DC8,buybacks,100,74,6/25/2018
15789A,index-listing,100,76,6/25/2018
190B91,product-release,100,64,6/25/2018
1B4F31,earnings-guidance-up,100,83,6/25/2018
1B4F31,earnings-guidance-up,100,83,6/25/2018
1CF3A8,ipo-completed,100,76,6/25/2018
228D42,partnership,100,61,6/25/2018
232053,partnership,100,61,6/25/2018
251988,acquisition-acquirer,100,49,6/25/2018
251988,earnings,100,50,6/25/2018
2D485F,earnings,100,50,6/25/2018
2D643C,executive-appointment,100,54,6/25/2018
2F9304,acquisition-completed-acquirer,100,49,6/25/2018
30DE64,clinical-trials-positive,100,87,6/25/2018
3390DE,conference-call,100,50,6/25/2018
3471C0,executive-appointment,100,54,6/25/2018
35B907,earnings,100,50,6/25/2018
35B907,earnings,100,50,6/25/2018
3A3447,facility-open,100,65,6/25/2018
3BB616,note-sale,100,52,6/25/2018
3C7F5F,business-contract,100,69,6/25/2018
3DDE54,earnings,100,50,6/25/2018
449447,index-listing,100,76,6/25/2018
49A344,earnings,100,50,6/25/2018
4A6F00,partnership,100,61,6/25/2018
4A6F00,partnership,100,61,6/25/2018
4B3555,dividend,100,50,6/25/2018
4C37C5,product-release,100,64,6/25/2018
4C37C5,legal-verdict-favored,100,78,6/25/2018
4E4E75,joint-venture,100,62,6/25/2018
55438C,dividend,100,50,6/25/2018
55C9B5,dividend,100,50,6/25/2018
587EDF,unit-acquisition-acquirer,100,49,6/25/2018
5F2FF7,product-release,100,64,6/25/2018
620381,ipo-completed,100,76,6/25/2018
62B1C6,acquisition-completed-acquirer,100,49,6/25/2018
64636E,index-listing,100,76,6/25/2018
665D7D,partnership,100,61,6/25/2018
67B052,index-listing,100,76,6/25/2018
693ECD,conference-call,100,50,6/25/2018
723548,dividend,100,50,6/25/2018
726DDF,acquisition-completed-acquirer,100,49,6/25/2018
726DDF,acquisition-completed-acquirer,100,49,6/25/2018
72C2CE,product-release,100,64,6/25/2018
7B0BA6,executive-appointment,100,54,6/25/2018
7BC92D,index-listing,100,76,6/25/2018
7BEA98,index-listing,100,76,6/25/2018
8377DB,facility-open,100,65,6/25/2018
89F693,legal-issues-defendant,100,22,6/25/2018
8AB85C,ipo-completed,100,76,6/25/2018
8B4A45,index-listing,100,76,6/25/2018
8BFAA4,conference-participant,100,50,6/25/2018
8C5519,earnings,100,50,6/25/2018
8C6C1B,facility-open,100,65,6/25/2018
8FE7A5,conference-participant,100,50,6/25/2018
902670,executive-appointment,100,54,6/25/2018
92B625,index-listing,100,76,6/25/2018
9.39E+69,ipo-completed,100,76,6/25/2018
947B0B,conference-call,100,50,6/25/2018
954004,executive-appointment,100,54,6/25/2018
9548BB,earnings,100,50,6/25/2018
965360,executive-appointment,100,54,6/25/2018
96F126,business-contract,100,69,6/25/2018
971F7B,conference-participant,100,50,6/25/2018
990AD0,product-release,100,64,6/25/2018
9978F1,index-listing,100,76,6/25/2018
9A602D,conference-call,100,50,6/25/2018
9B0C9C,legal-issues-defendant,100,22,6/25/2018
9F37C5,dividend,100,50,6/25/2018
A1EAC8,product-release,100,64,6/25/2018
A26C26,public-offering,100,43,6/25/2018
A47A7D,investment-investor,100,55,6/25/2018
A5195E,business-contract,100,69,6/25/2018
A5628C,executive-appointment,100,54,6/25/2018
A5A4F5,acquisition-acquirer,100,49,6/25/2018
A6828A,partnership,100,61,6/25/2018
AA98ED,conference-call,100,50,6/25/2018
AB7726,sponsorship,100,57,6/25/2018
ACC7D3,partnership,100,61,6/25/2018
AD9F1D,conference-call,100,50,6/25/2018
B08C51,acquisition-interest-acquiree,100,82,6/25/2018
B1FC3B,business-contract,100,69,6/25/2018
B37FB4,executive-appointment,100,54,6/25/2018
BCC13E,index-listing,100,76,6/25/2018
BE645B,index-listing,100,76,6/25/2018
C3BCD5,legal-issues-defendant,100,22,6/25/2018
C3BCD5,legal-issues-defendant,100,22,6/25/2018
C3BCD5,legal-issues-defendant,100,22,6/25/2018
C4A912,public-offering,100,43,6/25/2018
C4FBDC,legal-issues-defendant,100,22,6/25/2018
C8A248,dividend,100,50,6/25/2018
CBB77B,index-listing,100,76,6/25/2018
CC6FF5,partnership,100,61,6/25/2018
CC6FF5,partnership,100,61,6/25/2018
CC6FF5,partnership,100,61,6/25/2018
CC6FF5,product-release,100,64,6/25/2018
CC6FF5,product-release,100,64,6/25/2018
CDAF5B,conference-call,100,50,6/25/2018
CDC217,clinical-trials,100,56,6/25/2018
CE2791,partnership,100,61,6/25/2018
CEDFD5,earnings,100,50,6/25/2018
D06755,executive-appointment,100,54,6/25/2018
D15833,dividend,100,50,6/25/2018
D1AE3B,conference-call,100,50,6/25/2018
D5AF19,earnings,100,50,6/25/2018
D78BF1,award,100,58,6/25/2018
DA9443,index-listing,100,76,6/25/2018
DC486E,earnings,100,50,6/25/2018
DF11D9,conference-call,100,50,6/25/2018
E19A99,regulatory-product-approval-granted,100,81,6/25/2018
E8846E,product-release,100,64,6/25/2018
E8846E,settlement,100,56,6/25/2018
EFA7B2,legal-issues-defendant,100,22,6/25/2018
EFA7B2,legal-issues-defendant,100,22,6/25/2018
EFA7B2,legal-issues-defendant,100,22,6/25/2018
F1CD47,earnings,100,50,6/25/2018
F47871,executive-appointment,100,54,6/25/2018
F47871,executive-appointment,100,54,6/25/2018
F569FD,ipo-completed,100,76,6/25/2018
F5D059,conference-call,100,50,6/25/2018
F8BA6C,index-listing,100,76,6/25/2018
F90EE5,executive-appointment,100,54,6/25/2018
00698D,conference-organizer,100,57,6/26/2018
02FC1A,public-offering,100,43,6/26/2018
03B431,conference-participant,100,50,6/26/2018
48781,credit-extension-recipient,100,69,6/26/2018
054E7E,partnership,100,61,6/26/2018
054E7E,partnership,100,61,6/26/2018
099C88,business-contract,100,69,6/26/2018
0A59F8,product-release,100,64,6/26/2018
0A6824,unit-acquisition-acquirer,100,49,6/26/2018
0A7650,dividend,100,50,6/26/2018
10943B,conference-call,100,50,6/26/2018
12A3A3,revenue-up,100,69,6/26/2018
12A3A3,revenue-up,100,69,6/26/2018
12A3A3,revenue-up,100,69,6/26/2018
12A3A3,revenue-up,100,69,6/26/2018
17EDA5,acquisition-completed-acquiree,100,76,6/26/2018
1AB808,partnership,100,61,6/26/2018
1D943E,executive-appointment,100,54,6/26/2018
1E1125,credit-extension-provider,100,57,6/26/2018
21022F,facility-open,100,65,6/26/2018
21022F,facility-open,100,65,6/26/2018
21245F,executive-appointment,100,54,6/26/2018
228D42,partnership,100,61,6/26/2018
228D42,partnership,100,61,6/26/2018
250BEE,conference-call,100,50,6/26/2018
25102A,conference-call,100,50,6/26/2018
2.90E+62,business-contract,100,69,6/26/2018
2B0AF4,conference-call,100,50,6/26/2018
2BF36E,dividend,100,50,6/26/2018
2F98A5,partnership,100,61,6/26/2018
30DE64,ipo-completed,100,76,6/26/2018
3.30E+34,executive-appointment,100,54,6/26/2018
33E9D5,ipo-pricing,100,50,6/26/2018
3461CF,award,100,58,6/26/2018
34E9F9,business-contract,100,69,6/26/2018
384CD3,earnings,100,50,6/26/2018
3BCF24,dividend-up,100,70,6/26/2018
3E15F6,conference-call,100,50,6/26/2018
408089,facility-open,100,65,6/26/2018
449A26,executive-appointment,100,54,6/26/2018
44A4FC,executive-appointment,100,54,6/26/2018
451D61,partnership,100,61,6/26/2018
453282,conference-call,100,50,6/26/2018
47752F,business-contract,100,69,6/26/2018
4A6F00,partnership,100,61,6/26/2018
4C37C5,product-release,100,64,6/26/2018
4D8313,executive-appointment,100,54,6/26/2018
50D1EC,partnership,100,61,6/26/2018
553949,executive-appointment,100,54,6/26/2018
55C9B5,executive-appointment,100,54,6/26/2018
55C9B5,executive-appointment,100,54,6/26/2018
55C9B5,earnings,100,50,6/26/2018
567F3D,public-offering,100,43,6/26/2018
59872F,product-release,100,64,6/26/2018
5AF08A,product-release,100,64,6/26/2018
5DD48B,product-release,100,64,6/26/2018
5E1DF3,executive-appointment,100,54,6/26/2018
616E3B,conference-call,100,50,6/26/2018
6474BA,earnings,100,50,6/26/2018
6634D9,legal-issues-defendant,100,22,6/26/2018
6634D9,legal-issues-defendant,100,22,6/26/2018
6634D9,legal-issues-defendant,100,22,6/26/2018
6BC6F9,facility-open,100,65,6/26/2018
7255D2,executive-appointment,100,54,6/26/2018
791EC1,unit-acquisition-acquirer,100,49,6/26/2018
7D35D8,executive-appointment,100,54,6/26/2018
850779,earnings,100,50,6/26/2018
8665BA,conference-call,100,50,6/26/2018
8C6C1B,facility-open,100,65,6/26/2018
8D4486,partnership,100,61,6/26/2018
9196A2,executive-appointment,100,54,6/26/2018
91C82E,earnings-per-share-positive,100,69,6/26/2018
91C82E,earnings-per-share-positive,100,69,6/26/2018
91C82E,earnings-per-share-positive,100,69,6/26/2018
91C82E,earnings-per-share-positive,100,69,6/26/2018
91C82E,earnings-per-share-positive,100,69,6/26/2018
92D3A0,conference-call,100,50,6/26/2018
95DC1F,unit-acquisition-acquiree,100,76,6/26/2018
96F126,executive-appointment,100,54,6/26/2018
9A02C4,conference-call,100,50,6/26/2018
9B4066,facility-sale,100,52,6/26/2018
9CA619,dividend,100,50,6/26/2018
9D3360,award,100,58,6/26/2018
9D56F2,dividend,100,50,6/26/2018
9D65C1,executive-appointment,100,54,6/26/2018
A1EAC8,executive-appointment,100,54,6/26/2018
A6828A,business-contract,100,69,6/26/2018
B4F5F4,executive-appointment,100,54,6/26/2018
B77F14,business-contract,100,69,6/26/2018
B77F14,business-contract,100,69,6/26/2018
BD9668,conference-call,100,50,6/26/2018
BEA527,public-offering,100,43,6/26/2018
C2609A,product-release,100,64,6/26/2018
C3F99F,clinical-trials-start,100,64,6/26/2018
C425AE,executive-appointment,100,54,6/26/2018
C7859D,conference-call,100,50,6/26/2018
CFF97C,dividend,100,50,6/26/2018
CFF97C,credit-rating-affirmation-rater,20,50,6/26/2018
D77F7E,business-contract,100,69,6/26/2018
D88EF3,conference-call,100,50,6/26/2018
DB5CA5,earnings,100,50,6/26/2018
DB5CA5,award,100,58,6/26/2018
DCD97F,business-contract,100,69,6/26/2018
DF46C5,earnings,100,50,6/26/2018
E10D31,conference-call,100,50,6/26/2018
E8A49A,partnership,100,61,6/26/2018
E959F3,earnings,100,50,6/26/2018
ED2A5E,partnership,100,61,6/26/2018
EFA7B2,legal-issues-defendant,100,22,6/26/2018
EFA7B2,legal-issues-defendant,100,22,6/26/2018
F1EB39,earnings,100,50,6/26/2018
F3EDB4,earnings,100,50,6/26/2018
F4E992,executive-appointment,100,54,6/26/2018
F5D410,earnings,100,50,6/26/2018
F7ADEB,public-offering,100,43,6/26/2018
F92DBC,business-contract,100,69,6/26/2018
FAB97A,executive-appointment,100,54,6/26/2018
FC1B7B,partnership,100,61,6/26/2018
FC9A88,dividend-up,100,74,6/26/2018
05AF14,dividend,100,50,6/27/2018
05AF14,earnings,100,50,6/27/2018
07C69F,conference-call,100,50,6/27/2018
95294,business-contract,100,69,6/27/2018
0AB700,dividend,100,50,6/27/2018
0CADBC,dividend,100,50,6/27/2018
0E2992,conference-call,100,50,6/27/2018
1080C0,public-offering,100,43,6/27/2018
1272B3,partnership,100,61,6/27/2018
12E454,product-release,100,64,6/27/2018
15B10D,business-contract,100,69,6/27/2018
165B86,product-release,100,64,6/27/2018
16F4D8,conference-call,100,50,6/27/2018
1AC649,ipo-pricing,100,50,6/27/2018
1E83DE,partnership,100,61,6/27/2018
1EBF8D,conference-call,100,50,6/27/2018
1F716B,business-contract,100,69,6/27/2018
28DCA8,executive-appointment,100,54,6/27/2018
2BF36E,legal-issues-defendant,100,22,6/27/2018
2EC172,partnership,100,61,6/27/2018
2F7474,dividend,100,50,6/27/2018
31F25C,conference-call,100,50,6/27/2018
34B97A,conference-call,100,50,6/27/2018
37B120,regulatory-product-approval-granted,100,81,6/27/2018
3C6CCC,business-contract,100,69,6/27/2018
3C6CCC,business-contract,100,69,6/27/2018
3E15F6,trading-halt,100,43,6/27/2018
4.03E+05,partnership,100,61,6/27/2018
408089,earnings,100,50,6/27/2018
44209A,executive-appointment,100,54,6/27/2018
49F4D0,dividend,100,50,6/27/2018
4A6F00,partnership,100,61,6/27/2018
4F9487,dividend,100,50,6/27/2018
4F9926,business-contract,100,69,6/27/2018
53F491,earnings,100,50,6/27/2018
546A27,note-sale,100,52,6/27/2018
55438C,earnings,100,50,6/27/2018
55438C,conference-call,100,50,6/27/2018
567F3D,public-offering,100,43,6/27/2018
5D63F1,facility-open,100,65,6/27/2018
5FF95F,earnings,100,50,6/27/2018
6D156D,executive-appointment,100,54,6/27/2018
6F5DD2,business-contract,100,69,6/27/2018
6F5DD2,business-contract,100,69,6/27/2018
6F6559,earnings,100,50,6/27/2018
717DB4,conference-participant,100,50,6/27/2018
726DDF,legal-issues-defendant,100,22,6/27/2018
72CB93,executive-appointment,100,54,6/27/2018
7.45E+28,ipo-pricing,100,50,6/27/2018
76F067,clinical-trials,100,56,6/27/2018
7771D7,earnings,100,50,6/27/2018
7823A3,executive-appointment,100,54,6/27/2018
791EC1,acquisition-acquirer,100,49,6/27/2018
7A975D,earnings,100,50,6/27/2018
7A975D,earnings,100,50,6/27/2018
7A975D,earnings,100,50,6/27/2018
7ACD98,facility-open,100,65,6/27/2018
84A6B9,earnings,100,50,6/27/2018
8614A2,ipo-pricing,100,50,6/27/2018
890FF4,business-contract,100,69,6/27/2018
890FF4,partnership,100,61,6/27/2018
8C6C1B,facility-open,100,65,6/27/2018
8E10BF,clinical-trials-positive,100,87,6/27/2018
90B678,legal-issues-defendant,100,22,6/27/2018
90B678,legal-issues-defendant,100,22,6/27/2018
9196A2,conference-call,100,50,6/27/2018
91C82E,dividend,100,50,6/27/2018
923D93,facility-open,100,65,6/27/2018
923D93,facility-open,100,65,6/27/2018
9.31E+77,executive-appointment,100,54,6/27/2018
93633B,dividend-up,100,81,6/27/2018
9.39E+69,executive-appointment,100,54,6/27/2018
93C130,dividend,100,50,6/27/2018
97644E,legal-issues-defendant,100,22,6/27/2018
98CEBB,partnership,100,61,6/27/2018
9934AD,conference-call,100,50,6/27/2018
99ACAD,earnings,100,50,6/27/2018
9B71A7,earnings,100,50,6/27/2018
9B71A7,earnings,100,50,6/27/2018
9C25FF,business-contract,100,69,6/27/2018
9CA619,earnings,100,50,6/27/2018
A26C26,dividend,100,50,6/27/2018
A6213D,conference-call,100,50,6/27/2018
A6FB29,partnership,100,61,6/27/2018
A8E2FE,clinical-trials-start,100,64,6/27/2018
AA09AD,partnership,100,61,6/27/2018
AC7C4F,executive-appointment,100,54,6/27/2018
AD9F1D,facility-open,100,65,6/27/2018
AEF2C3,note-sale,100,52,6/27/2018
B1A85D,award,100,58,6/27/2018
B642E8,conference-organizer,100,57,6/27/2018
BBAE2A,conference-call,100,50,6/27/2018
BEB756,index-listing,100,76,6/27/2018
BFD0A7,board-meeting,100,51,6/27/2018
C48574,earnings,100,50,6/27/2018
C8A248,business-contract,100,69,6/27/2018
C93C44,patent-awarded,100,72,6/27/2018
C9F39B,conference-call,100,50,6/27/2018
CAC8D0,earnings,100,50,6/27/2018
CAC8D0,earnings,100,50,6/27/2018
CBFFDD,partnership,100,61,6/27/2018
CDC217,index-listing,100,76,6/27/2018
CE4FD9,business-contract,100,69,6/27/2018
CE4FD9,partnership,100,61,6/27/2018
CFF15D,executive-appointment,100,54,6/27/2018
CFF97C,credit-rating-affirmation-rater,20,50,6/27/2018
CFF97C,credit-rating-affirmation-rater,20,50,6/27/2018
CFF97C,credit-rating-affirmation-rater,20,50,6/27/2018
D4463B,dividend,100,50,6/27/2018
D93A25,earnings-guidance,100,50,6/27/2018
DB88A1,award,100,58,6/27/2018
DB9F70,clinical-trials,100,56,6/27/2018
DCD97F,government-contract,100,69,6/27/2018
E22FDE,business-contract,100,69,6/27/2018
E2F130,dividend-up,100,81,6/27/2018
E6EDED,conference-call,100,50,6/27/2018
E8E899,earnings,100,50,6/27/2018
E99180,dividend,100,50,6/27/2018
EB43F4,clinical-trials-start,100,64,6/27/2018
ED79D9,facility-open,100,65,6/27/2018
EFA7B2,legal-issues-defendant,100,22,6/27/2018
EFA7B2,legal-issues-defendant,100,22,6/27/2018
F179ED,product-release,100,64,6/27/2018
F50BAB,earnings,100,50,6/27/2018
F6DE54,executive-appointment,100,54,6/27/2018
FA40E2,acquisition-acquirer,100,49,6/27/2018
FA40E2,acquisition-acquirer,100,49,6/27/2018
FEC475,conference-call,100,50,6/27/2018
00E601,earnings,100,50,6/28/2018
03F5A4,dividend,100,50,6/28/2018
0F0693,merger,100,66,6/28/2018
1151F4,conference-call,100,50,6/28/2018
139303,partnership,100,61,6/28/2018
1490F3,earnings-guidance,100,50,6/28/2018
152E1D,product-release,100,64,6/28/2018
16C7F0,conference-call,100,50,6/28/2018
1921DD,partnership,100,61,6/28/2018
19BF16,earnings,100,50,6/28/2018
1A9DE1,dividend-up,100,70,6/28/2018
24CB56,dividend,100,50,6/28/2018
267718,dividend,100,50,6/28/2018
26DC29,ipo-pricing,100,50,6/28/2018
29CEBF,earnings-guidance,100,50,6/28/2018
2CBB58,acquisition-acquirer,100,49,6/28/2018
2EC172,conference-call,100,50,6/28/2018
301493,legal-issues-defendant,100,22,6/28/2018
31553A,earnings,100,50,6/28/2018
32CB22,partnership,100,61,6/28/2018
3461CF,product-release,100,64,6/28/2018
370C50,product-price-raise,100,57,6/28/2018
37727A,conference-call,100,50,6/28/2018
384CD3,business-contract,100,69,6/28/2018
385DD4,unit-acquisition-acquirer,100,49,6/28/2018
3C11C4,award,100,58,6/28/2018
3CBA2A,executive-resignation,100,44,6/28/2018
3E15F6,trading-resumed,100,58,6/28/2018
3F4497,conference-call,100,50,6/28/2018
448BF3,patient-enrollment-start,100,58,6/28/2018
4A5C8D,earnings-guidance-meet-expectations,100,59,6/28/2018
4B49CF,earnings,100,50,6/28/2018
4B49CF,earnings,100,50,6/28/2018
4B49CF,earnings,100,50,6/28/2018
4B49CF,earnings,100,50,6/28/2018
4B49CF,earnings,100,50,6/28/2018
4BBA23,earnings-guidance,100,50,6/28/2018
4C37C5,dividend-guidance-up,100,61,6/28/2018
53EF9E,dividend,100,50,6/28/2018
55C289,conference-call,100,50,6/28/2018
567F3D,conference-call,100,50,6/28/2018
57356F,conference-call,100,50,6/28/2018
58CA9A,partnership,100,61,6/28/2018
5AF08A,conference-call,100,50,6/28/2018
5D02B7,joint-venture,100,62,6/28/2018
5E6959,business-contract,100,69,6/28/2018
5F9CE3,business-contract,100,69,6/28/2018
601785,earnings,100,50,6/28/2018
619882,product-release,100,64,6/28/2018
619882,earnings,100,50,6/28/2018
6634D9,legal-issues-defendant,100,22,6/28/2018
6844D2,product-release,100,64,6/28/2018
6844D2,product-release,100,64,6/28/2018
68BA15,acquisition-acquirer,100,49,6/28/2018
6F0A63,earnings-guidance,100,50,6/28/2018
6F5DD2,public-offering,100,43,6/28/2018
72FCA3,earnings,100,50,6/28/2018
72FCA3,earnings,100,50,6/28/2018
72FCA3,earnings,100,50,6/28/2018
72FCA3,earnings,100,50,6/28/2018
7410C3,donation,100,54,6/28/2018
75F665,conference-call,100,50,6/28/2018
76BD96,note-sale,100,52,6/28/2018
79340A,earnings,100,50,6/28/2018
7A975D,dividend,100,50,6/28/2018
7AB859,executive-appointment,100,54,6/28/2018
7F3669,executive-resignation,100,44,6/28/2018
804708,legal-issues-defendant,100,22,6/28/2018
8.10E+32,conference-call,100,50,6/28/2018
8665BA,business-contract,100,69,6/28/2018
868808,dividend,100,50,6/28/2018
881190,executive-appointment,100,54,6/28/2018
8C6C1B,facility-open,100,65,6/28/2018
8E0E32,earnings,100,50,6/28/2018
8EF425,earnings,100,50,6/28/2018
8F3231,executive-appointment,100,54,6/28/2018
9196A2,dividend-up,100,81,6/28/2018
92B047,conference-call,100,50,6/28/2018
934029,conference-call,100,50,6/28/2018
93D207,executive-appointment,100,54,6/28/2018
93D207,earnings,100,50,6/28/2018
958938,executive-appointment,100,54,6/28/2018
95DC1F,partnership,100,61,6/28/2018
95DC1F,dividend-up,100,81,6/28/2018
9.62E+76,earnings,100,50,6/28/2018
967D92,conference-call,100,50,6/28/2018
968966,partnership,100,61,6/28/2018
96F126,dividend,100,50,6/28/2018
97B027,credit-extension-recipient,100,69,6/28/2018
9810C0,earnings-guidance,100,50,6/28/2018
98CAED,earnings,100,50,6/28/2018
990AD0,dividend,100,50,6/28/2018
9D3360,conference-call,100,50,6/28/2018
9D56F2,revenue-up,100,69,6/28/2018
9D6A24,unit-acquisition-acquiree,100,76,6/28/2018
9EED50,legal-issues-defendant,100,22,6/28/2018
9F6B1A,partnership,100,61,6/28/2018
A3800A,business-contract,100,69,6/28/2018
A403CF,product-release,100,64,6/28/2018
A5A4F5,acquisition-acquirer,100,49,6/28/2018
A631A3,partnership,100,61,6/28/2018
A631A3,partnership,100,61,6/28/2018
A65325,conference-call,100,50,6/28/2018
AE79CD,ipo-considered,100,60,6/28/2018
AEF2C3,note-sale,100,52,6/28/2018
AFDF2E,earnings-revision,100,29,6/28/2018
AFF43F,earnings,100,50,6/28/2018
AFF7B4,partnership,100,61,6/28/2018
B0B969,executive-appointment,100,54,6/28/2018
B446B8,product-release,100,64,6/28/2018
BB58FF,executive-resignation,100,44,6/28/2018
BCC55F,business-contract,100,69,6/28/2018
BE14CF,conference-call,100,50,6/28/2018
BEB756,conference-call,100,50,6/28/2018
C11C46,ipo-pricing,100,50,6/28/2018
C32A39,earnings-guidance,100,50,6/28/2018
C3BCD5,legal-issues-defendant,100,22,6/28/2018
C3DE7D,product-release,100,64,6/28/2018
C4452A,product-release,100,64,6/28/2018
C5C0E9,conference-participant,100,50,6/28/2018
C659EB,conference-call,100,50,6/28/2018
C8A248,award,100,58,6/28/2018
CC176E,earnings,100,50,6/28/2018
CC35BE,asset-sale,100,62,6/28/2018
CDAB24,executive-resignation,100,44,6/28/2018
CDAB24,executive-resignation,100,44,6/28/2018
CEDFD5,ownership-increase-owner,100,56,6/28/2018
CEDFD5,ownership-increase-owner,100,56,6/28/2018
CFF15D,legal-issues-defendant,100,22,6/28/2018
CFF57D,earnings,100,50,6/28/2018
CFF57D,earnings,100,50,6/28/2018
CFF57D,earnings,100,50,6/28/2018
CFF57D,earnings,100,50,6/28/2018
D1173F,conference-call,100,50,6/28/2018
D2B9E5,product-release,100,64,6/28/2018
D54E62,conference-call,100,50,6/28/2018
D5A350,index-listing,100,76,6/28/2018
D5B13D,executive-appointment,100,54,6/28/2018
D64C6D,earnings,100,50,6/28/2018
D88EF3,note-sale,100,52,6/28/2018
DB23C8,market-entry,100,57,6/28/2018
DD9E41,product-release,100,64,6/28/2018
E1C16B,product-release,100,64,6/28/2018
E2F130,earnings,100,50,6/28/2018
E3E68E,conference-call,100,50,6/28/2018
E4CE73,partnership,100,61,6/28/2018
E70531,acquisition-completed-acquirer,100,49,6/28/2018
EC99D0,product-release,100,64,6/28/2018
EC99D0,product-release,100,64,6/28/2018
ED79D9,acquisition-acquirer,100,49,6/28/2018
EEA734,executive-appointment,100,54,6/28/2018
EF1AD9,conference-call,100,50,6/28/2018
EF77A3,earnings,100,50,6/28/2018
EF77A3,earnings,100,50,6/28/2018
EF77A3,earnings,100,50,6/28/2018
EF77A3,dividend,100,50,6/28/2018
EFA7B2,legal-issues-defendant,100,22,6/28/2018
F2E253,asset-sale,100,62,6/28/2018
F30508,clinical-trials-positive,100,87,6/28/2018
F30508,conference-call,100,50,6/28/2018
F5349B,executive-appointment,100,54,6/28/2018
F5D059,business-contract,100,69,6/28/2018
F5D059,business-contract,100,69,6/28/2018
F6A945,earnings,100,50,6/28/2018
F6FA6A,legal-issues-defendant,100,22,6/28/2018
F80389,earnings-guidance,100,50,6/28/2018
FACF19,buybacks,100,74,6/28/2018
FACF19,earnings,100,50,6/28/2018
FC4550,conference-call,100,50,6/28/2018
FDF799,executive-appointment,100,54,6/28/2018
FEBFE1,orphan-drug-designation,100,76,6/28/2018
FEE4B0,earnings,100,50,6/28/2018
FF4BA4,earnings,100,50,6/28/2018
FF6644,award,100,58,6/28/2018
FF6644,business-contract,100,69,6/28/2018
0560D8,dividend-up,100,55,6/29/2018
061A3B,award,100,58,6/29/2018
07CA6A,acquisition-acquirer,100,49,6/29/2018
10C19B,conference-call,100,50,6/29/2018
1782D5,conference-call,100,50,6/29/2018
1D1B07,earnings,100,50,6/29/2018
1D1B07,earnings,100,50,6/29/2018
20BEEA,acquisition-completed-acquirer,100,49,6/29/2018
228D42,partnership,100,61,6/29/2018
251988,dividend,100,50,6/29/2018
272704,earnings,100,50,6/29/2018
28DCA8,earnings-guidance,100,50,6/29/2018
2AE625,conference-call,100,50,6/29/2018
2B7A40,acquisition-acquirer,100,49,6/29/2018
2BF36E,legal-issues-defendant,100,22,6/29/2018
2F7474,conference-call,100,50,6/29/2018
31643A,unit-acquisition-acquirer,100,49,6/29/2018
35557B,note-sale,100,52,6/29/2018
35557B,merger-regulatory-approval,100,81,6/29/2018
39FB23,earnings,100,50,6/29/2018
3CCC90,acquisition-completed-acquirer,100,49,6/29/2018
45444E,legal-issues-defendant,100,22,6/29/2018
4D8E5E,executive-appointment,100,54,6/29/2018
4EC4C1,earnings,100,50,6/29/2018
4EC4C1,earnings,100,50,6/29/2018
4EC4C1,earnings,100,50,6/29/2018
4EC4C1,earnings,100,50,6/29/2018
546A27,note-sale,100,52,6/29/2018
55C9B5,conference-call,100,50,6/29/2018
55D0F3,board-meeting,100,51,6/29/2018
567F3D,public-offering,100,43,6/29/2018
5B6C11,earnings,100,50,6/29/2018
5B7739,product-release,100,64,6/29/2018
5BC2F4,earnings,100,50,6/29/2018
6634D9,legal-issues-defendant,100,22,6/29/2018
66667F,partnership,100,61,6/29/2018
66667F,partnership,100,61,6/29/2018
66A667,dividend,100,50,6/29/2018
76BD96,note-sale,100,52,6/29/2018
7B492C,business-contract,100,69,6/29/2018
7D5FD6,earnings,100,50,6/29/2018
8.73E+09,earnings,100,50,6/29/2018
8.73E+09,earnings,100,50,6/29/2018
877C0C,legal-verdict-favored,100,78,6/29/2018
877C0C,legal-verdict-favored,100,78,6/29/2018
877C0C,earnings,100,50,6/29/2018
881190,conference-call,100,50,6/29/2018
89F693,product-release,100,64,6/29/2018
8C6C1B,facility-open,100,65,6/29/2018
8DCBBB,conference-call,100,50,6/29/2018
9196A2,regulatory-investigation,100,22,6/29/2018
93633B,index-listing,100,76,6/29/2018
9D6A24,conference-call,100,50,6/29/2018
9E98F2,earnings,100,50,6/29/2018
9F5CBB,dividend,100,50,6/29/2018
A72AB6,executive-appointment,100,54,6/29/2018
A80FE0,conference-call,100,50,6/29/2018
A8B137,earnings-guidance,100,50,6/29/2018
AFDF2E,dividend,100,50,6/29/2018
AFF7B4,conference-call,100,50,6/29/2018
BE86A1,dividend,100,50,6/29/2018
BEB756,index-listing,100,76,6/29/2018
C03C8B,conference-call,100,50,6/29/2018
C188F8,reorganization-unit,100,53,6/29/2018
C2609A,acquisition-completed-acquirer,100,49,6/29/2018
C598D7,conference-call,100,50,6/29/2018
C7863D,conference-call,100,50,6/29/2018
C8A248,executive-appointment,100,54,6/29/2018
C8A248,executive-appointment,100,54,6/29/2018
D8ECA1,business-contract,100,69,6/29/2018
D90F43,partnership,100,61,6/29/2018
E0A84E,partnership,100,61,6/29/2018
E3656D,conference-call,100,50,6/29/2018
E4CE73,conference-participant,100,50,6/29/2018
E829E8,conference-call,100,50,6/29/2018
E9FF33,executive-appointment,100,54,6/29/2018
EAEA91,dividend,100,50,6/29/2018
EC70EC,asset-sale,100,62,6/29/2018
EE04F0,legal-issues-defendant,100,22,6/29/2018
EFA7B2,legal-issues-defendant,100,22,6/29/2018
F6FA6A,trading-delisting,100,36,6/29/2018
FC1B7B,conference-call,100,50,6/29/2018
FF5413,business-contract,100,69,6/29/2018
AFF7B4,legal-issues-defendant,100,22,6/30/2018
D3CEDF,legal-issues-defendant,100,22,6/30/2018
6634D9,legal-issues-defendant,100,22,7/1/2018
00E601,joint-venture,100,62,7/2/2018
01478A,earnings-guidance,100,50,7/2/2018
04CCCD,dividend,100,50,7/2/2018
081AB9,buybacks,100,74,7/2/2018
081AB9,conference-call,100,50,7/2/2018
099C88,settlement,100,56,7/2/2018
099C88,regulatory-investigation,100,22,7/2/2018
0BC17A,conference-call,100,50,7/2/2018
0C6861,dividend,100,50,7/2/2018
1080C0,public-offering,100,43,7/2/2018
10C19B,dividend-up,100,81,7/2/2018
12E454,partnership,100,61,7/2/2018
12E454,earnings,100,50,7/2/2018
131443,acquisition-acquirer,100,49,7/2/2018
190B91,earnings,100,50,7/2/2018
1A2D9F,earnings,100,50,7/2/2018
1E5786,unit-acquisition-acquirer,100,49,7/2/2018
1F08A6,conference-call,100,50,7/2/2018
1F43A1,unit-acquisition-acquirer,100,49,7/2/2018
1F43A1,unit-acquisition-acquirer,100,49,7/2/2018
1FCC00,executive-appointment,100,54,7/2/2018
221AD7,earnings,100,50,7/2/2018
25102A,product-release,100,64,7/2/2018
25102A,product-release,100,64,7/2/2018
2571FA,conference-call,100,50,7/2/2018
29CEBF,acquisition-completed-acquirer,100,49,7/2/2018
2A9C0A,conference-call,100,50,7/2/2018
2B49F4,business-contract,100,69,7/2/2018
2B7A40,acquisition-acquirer,100,49,7/2/2018
2C19A4,dividend,100,50,7/2/2018
2DC88B,acquisition-acquirer,100,49,7/2/2018
301493,legal-issues-defendant,100,22,7/2/2018
3224CC,partnership,100,61,7/2/2018
326EDD,conference-call,100,50,7/2/2018
32CB22,executive-resignation,100,44,7/2/2018
32F24A,conference-call,100,50,7/2/2018
338544,conference-call,100,50,7/2/2018
33FD66,earnings,100,50,7/2/2018
342218,conference-call,100,50,7/2/2018
3461CF,credit-rating-upgrade-rater,20,50,7/2/2018
34B411,earnings,100,50,7/2/2018
34B97A,executive-appointment,100,54,7/2/2018
353DBB,conference-call,100,50,7/2/2018
39BFF6,conference-call,100,50,7/2/2018
39FB23,legal-issues-defendant,100,22,7/2/2018
3CCC90,conference-call,100,50,7/2/2018
4.03E+05,unit-acquisition-completed-acquirer,100,49,7/2/2018
4135F7,partnership,100,61,7/2/2018
41785E,earnings,100,50,7/2/2018
41B53E,dividend,100,50,7/2/2018
449447,acquisition-acquirer,100,49,7/2/2018
450ECB,earnings,100,50,7/2/2018
450ECB,earnings,100,50,7/2/2018
450ECB,earnings,100,50,7/2/2018
450ECB,earnings,100,50,7/2/2018
450ECB,earnings,100,50,7/2/2018
450ECB,earnings,100,50,7/2/2018
450ECB,earnings,100,50,7/2/2018
46CF27,earnings,100,50,7/2/2018
4.60E+06,revenue-up,100,91,7/2/2018
4B5054,conference-call,100,50,7/2/2018
4C1FA1,executive-appointment,100,54,7/2/2018
4FCC78,dividend,100,50,7/2/2018
51888A,business-contract,100,69,7/2/2018
55438C,product-release,100,64,7/2/2018
567F3D,acquisition-acquirer,100,49,7/2/2018
58CA9A,dividend,100,50,7/2/2018
59C539,conference-call,100,50,7/2/2018
609208,earnings,100,50,7/2/2018
60EA12,earnings,100,50,7/2/2018
619882,earnings,100,50,7/2/2018
6284B5,facility-open,100,65,7/2/2018
63F892,earnings,100,50,7/2/2018
6634D9,legal-issues-defendant,100,22,7/2/2018
665618,dividend,100,50,7/2/2018
68BA15,dividend,100,50,7/2/2018
68E6E9,earnings,100,50,7/2/2018
6B0E45,conference-call,100,50,7/2/2018
6E1E61,conference-call,100,50,7/2/2018
704B78,executive-appointment,100,54,7/2/2018
723548,dividend,100,50,7/2/2018
7273FF,unit-acquisition-acquiree,100,76,7/2/2018
73C9E2,acquisition-completed-acquirer,100,49,7/2/2018
73C9E2,acquisition-completed-acquirer,100,49,7/2/2018
7448A3,conference-call,100,50,7/2/2018
7.45E+28,ipo-completed,100,76,7/2/2018
763724,dividend,100,50,7/2/2018
765913,acquisition-completed-acquirer,100,49,7/2/2018
765913,earnings,100,50,7/2/2018
791EC1,unit-acquisition-acquirer,100,49,7/2/2018
7B4B91,executive-appointment,100,54,7/2/2018
7B8CB5,executive-appointment,100,54,7/2/2018
7D5FD6,conference-call,100,50,7/2/2018
7F3669,earnings,100,50,7/2/2018
810FAD,conference-call,100,50,7/2/2018
810FAD,conference-participant,100,50,7/2/2018
86A1B9,executive-appointment,100,54,7/2/2018
86A1B9,executive-appointment,100,54,7/2/2018
8B2C4A,acquisition-completed-acquirer,100,49,7/2/2018
8BE916,merger-completed,100,66,7/2/2018
8C6C1B,facility-open,100,65,7/2/2018
93633B,index-listing,100,76,7/2/2018
957A07,earnings,100,50,7/2/2018
95DC1F,unit-acquisition-acquiree,100,76,7/2/2018
95F59E,settlement,100,56,7/2/2018
968966,unit-acquisition-completed-acquiree,100,67,7/2/2018
986AF6,conference-call,100,50,7/2/2018
9B5968,executive-appointment,100,54,7/2/2018
9CA4C6,conference-call,100,50,7/2/2018
9F37C5,dividend,100,50,7/2/2018
A0F146,business-contract,100,69,7/2/2018
A41450,business-contract,100,69,7/2/2018
A52533,facility-open,100,65,7/2/2018
A5B913,earnings,100,50,7/2/2018
A6213D,product-release,100,64,7/2/2018
A6828A,partnership,100,61,7/2/2018
A7102F,joint-venture,100,62,7/2/2018
A746F6,conference-call,100,50,7/2/2018
A8B137,acquisition-completed-acquirer,100,49,7/2/2018
AA847A,conference-call,100,50,7/2/2018
AAC8B6,acquisition-completed-acquirer,100,49,7/2/2018
AB7726,executive-appointment,100,54,7/2/2018
ABBAD1,earnings,100,50,7/2/2018
ADD9DC,executive-appointment,100,54,7/2/2018
AFF7B4,legal-issues-defendant,100,22,7/2/2018
B09B1F,product-release,100,64,7/2/2018
B1B10C,conference-call,100,50,7/2/2018
B37FB4,acquisition-completed-acquirer,100,49,7/2/2018
B4703C,conference-call,100,50,7/2/2018
B72D2E,partnership,100,61,7/2/2018
B83BCE,executive-appointment,100,54,7/2/2018
BB0787,campaign-ad-release,100,59,7/2/2018
BB88B6,earnings,100,50,7/2/2018
BEB756,unit-acquisition-completed-acquirer,100,49,7/2/2018
C0200F,earnings,100,50,7/2/2018
C3BCD5,legal-issues-defendant,100,22,7/2/2018
C3BCD5,legal-issues-defendant,100,22,7/2/2018
C407A0,executive-appointment,100,54,7/2/2018
C598D7,acquisition-acquirer,100,49,7/2/2018
C7AE14,dividend,100,50,7/2/2018
C7FC95,partnership,100,61,7/2/2018
C97B2D,conference-call,100,50,7/2/2018
C9D866,conference-call,100,50,7/2/2018
CA99D7,executive-appointment,100,54,7/2/2018
CB7AB2,partnership,100,61,7/2/2018
CDAF5B,spin-off,100,58,7/2/2018
CF6A5A,earnings,100,50,7/2/2018
CFF15D,legal-issues-defendant,100,22,7/2/2018
D139BC,conference-call,100,50,7/2/2018
D13F1C,executive-appointment,100,54,7/2/2018
D4070C,executive-appointment,100,54,7/2/2018
D4AC65,acquisition-completed-acquirer,100,49,7/2/2018
D6853F,conference-call,100,50,7/2/2018
D78CCD,conference-call,100,50,7/2/2018
DA48E4,executive-appointment,100,54,7/2/2018
DC5299,conference-call,100,50,7/2/2018
DF1F7A,conference-call,100,50,7/2/2018
DF6FDD,business-contract,100,69,7/2/2018
E0339F,unit-acquisition-completed-acquiree,100,67,7/2/2018
E12A6E,earnings,100,50,7/2/2018
E1E093,product-release,100,64,7/2/2018
E261E9,loan-recipient,100,59,7/2/2018
E30B34,acquisition-acquirer,100,49,7/2/2018
E87676,unit-acquisition-acquirer,100,49,7/2/2018
E9C7C0,acquisition-acquiree,100,76,7/2/2018
EE04F0,legal-issues-defendant,100,22,7/2/2018
EE04F0,legal-issues-defendant,100,22,7/2/2018
EE04F0,legal-issues-defendant,100,22,7/2/2018
EE04F0,legal-issues-defendant,100,22,7/2/2018
EE74E1,earnings,100,50,7/2/2018
EFA7B2,legal-issues-defendant,100,22,7/2/2018
F0B335,legal-issues-defendant,100,22,7/2/2018
F0B335,legal-issues-defendant,100,22,7/2/2018
F4E882,earnings,100,50,7/2/2018
F5D410,business-contract,100,69,7/2/2018
F5D410,business-contract,100,69,7/2/2018
F85CC0,earnings,100,50,7/2/2018
FA044A,conference-call,100,50,7/2/2018
FC9A88,conference-call,100,50,7/2/2018
FDC7E6,buybacks,100,74,7/2/2018
FDC7E6,conference-call,100,50,7/2/2018
FE7A63,dividend,100,50,7/2/2018
099C88,business-contract,100,69,7/3/2018
0A59F8,partnership,100,61,7/3/2018
1348C9,earnings-guidance,100,50,7/3/2018
152B9E,earnings-guidance,100,50,7/3/2018
1DE526,executive-appointment,100,54,7/3/2018
1FAF22,conference-call,100,50,7/3/2018
21153F,partnership,100,61,7/3/2018
21153F,partnership,100,61,7/3/2018
21153F,business-contract,100,69,7/3/2018
221783,executive-appointment,100,54,7/3/2018
228D42,partnership,100,61,7/3/2018
228D42,partnership,100,61,7/3/2018
2667B6,earnings,100,50,7/3/2018
26DC29,ipo-completed,100,76,7/3/2018
26E3BA,index-listing,100,76,7/3/2018
27BFA1,conference-call,100,50,7/3/2018
2D643C,conference-call,100,50,7/3/2018
2F7474,executive-appointment,100,54,7/3/2018
3.14E+47,earnings,100,50,7/3/2018
33AD83,partnership,100,61,7/3/2018
36E479,clinical-trials-start,100,64,7/3/2018
37020C,dividend,100,50,7/3/2018
370C50,conference-call,100,50,7/3/2018
38C46F,dividend,100,50,7/3/2018
442587,business-contract,100,69,7/3/2018
44A4FC,acquisition-acquirer,100,49,7/3/2018
44A4FC,acquisition-acquirer,100,49,7/3/2018
44A4FC,acquisition-acquirer,100,49,7/3/2018
47752F,earnings,100,50,7/3/2018
49914B,asset-sale,100,62,7/3/2018
4B3555,earnings,100,50,7/3/2018
4D371E,earnings,100,50,7/3/2018
4FB770,conference-call,100,50,7/3/2018
504FE2,executive-appointment,100,54,7/3/2018
51B442,acquisition-acquirer,100,49,7/3/2018
532D47,earnings-guidance,100,50,7/3/2018
5340D0,conference-participant,100,50,7/3/2018
546A9C,conference-call,100,50,7/3/2018
58CA9A,unit-acquisition-completed-acquiree,100,67,7/3/2018
5D63F1,earnings,100,50,7/3/2018
639BD6,earnings-guidance,100,50,7/3/2018
64E615,acquisition-acquirer,100,49,7/3/2018
6.52E+64,earnings-guidance,100,50,7/3/2018
6634D9,legal-issues-defendant,100,22,7/3/2018
66A667,earnings,100,50,7/3/2018
6BF593,conference-call,100,50,7/3/2018
72FCA3,executive-appointment,100,54,7/3/2018
7AB859,private-placement,100,56,7/3/2018
7E1D5D,partnership,100,61,7/3/2018
7E1D5D,partnership,100,61,7/3/2018
8C6C1B,facility-open,100,65,7/3/2018
8D5145,earnings,100,50,7/3/2018
911AB8,unit-acquisition-completed-acquiree,100,67,7/3/2018
915E7B,earnings-guidance,100,50,7/3/2018
94983E,acquisition-acquirer,100,49,7/3/2018
9F03CF,executive-appointment,100,54,7/3/2018
A1EAC8,executive-appointment,100,54,7/3/2018
A5A4F5,acquisition-acquirer,100,49,7/3/2018
A70BF5,earnings,100,50,7/3/2018
A87CD6,acquisition-completed-acquirer,100,49,7/3/2018
A87CD6,earnings,100,50,7/3/2018
AB7F05,earnings,100,50,7/3/2018
AC7C4F,business-contract,100,69,7/3/2018
AF210D,joint-venture,100,62,7/3/2018
AFDF2E,earnings,100,50,7/3/2018
AFDF2E,earnings,100,50,7/3/2018
B5766D,conference-call,100,50,7/3/2018
B604DF,earnings-guidance,100,50,7/3/2018
B6082A,conference-call,100,50,7/3/2018
B6CD92,dividend-up,100,81,7/3/2018
B840EF,earnings,100,50,7/3/2018
BA218A,conference-call,100,50,7/3/2018
BB5142,earnings,100,50,7/3/2018
C3BCD5,legal-issues-defendant,100,22,7/3/2018
C5D2AE,earnings,100,50,7/3/2018
C951A2,earnings,100,50,7/3/2018
CD4DA8,conference-call,100,50,7/3/2018
CFF15D,legal-issues-defendant,100,22,7/3/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/3/2018
CFF97C,earnings-guidance,100,50,7/3/2018
D17F7E,earnings,100,50,7/3/2018
D60BB2,executive-appointment,100,54,7/3/2018
D6489C,award,100,58,7/3/2018
D6489C,award,100,58,7/3/2018
D64C6D,executive-appointment,100,54,7/3/2018
DC0998,executive-appointment,100,54,7/3/2018
DEF058,earnings,100,50,7/3/2018
DF532D,conference-call,100,50,7/3/2018
E1E093,product-release,100,64,7/3/2018
E30A8F,earnings,100,50,7/3/2018
E3E68E,award,100,58,7/3/2018
E9E6FD,conference-call,100,50,7/3/2018
E9FF33,earnings,100,50,7/3/2018
ECDEB2,earnings,100,50,7/3/2018
EDF5CA,conference-call,100,50,7/3/2018
EFA7B2,legal-issues-defendant,100,22,7/3/2018
F0B335,sponsorship,100,57,7/3/2018
F0B335,legal-issues-defendant,100,22,7/3/2018
F1EB39,facility-close,100,47,7/3/2018
F1EB39,partnership,100,61,7/3/2018
F294DD,earnings,100,50,7/3/2018
F4CDA3,unit-acquisition-acquirer,100,49,7/3/2018
F4E992,earnings,100,50,7/3/2018
F57F6F,acquisition-acquiree,100,76,7/3/2018
F57F6F,acquisition-acquiree,100,76,7/3/2018
F57F6F,acquisition-acquiree,100,76,7/3/2018
F57F6F,acquisition-acquiree,100,76,7/3/2018
F57F6F,acquisition-acquiree,100,76,7/3/2018
F57F6F,acquisition-acquiree,100,76,7/3/2018
F57F6F,acquisition-acquiree,100,76,7/3/2018
F8C5D7,legal-issues-defendant,100,22,7/3/2018
FA35C6,conference-participant,100,50,7/3/2018
FC4550,dividend,100,50,7/3/2018
FE89E0,business-contract,100,69,7/3/2018
0C28D1,executive-appointment,100,54,7/4/2018
228D42,business-contract,100,69,7/4/2018
2C7505,clinical-trials,100,56,7/4/2018
442587,business-contract,100,69,7/4/2018
A5A4F5,acquisition-acquirer,100,49,7/4/2018
EF5BED,executive-appointment,100,54,7/4/2018
FA40E2,asset-sale,100,62,7/4/2018
FA40E2,asset-sale,100,62,7/4/2018
00067A,earnings,100,50,7/5/2018
001F1B,earnings,100,50,7/5/2018
001F1B,earnings,100,50,7/5/2018
31025,earnings,100,50,7/5/2018
03B431,conference-call,100,50,7/5/2018
054B55,dividend,100,50,7/5/2018
55018,executive-appointment,100,54,7/5/2018
070B45,acquisition-acquirer,100,49,7/5/2018
070B45,acquisition-acquirer,100,49,7/5/2018
070B45,acquisition-acquirer,100,49,7/5/2018
070B45,acquisition-acquirer,100,49,7/5/2018
07CA6A,conference-call,100,50,7/5/2018
0CC62B,conference-call,100,50,7/5/2018
0F04E5,earnings,100,50,7/5/2018
0F04E5,index-listing,100,76,7/5/2018
105D00,conference-call,100,50,7/5/2018
119CB6,conference-call,100,50,7/5/2018
157D9F,conference-call,100,50,7/5/2018
188394,conference-call,100,50,7/5/2018
18EC17,regulatory-product-approval-granted,100,81,7/5/2018
1A6A94,conference-call,100,50,7/5/2018
1B9535,conference-call,100,50,7/5/2018
1E1125,regulatory-investigation,100,22,7/5/2018
1E83DE,legal-issues-defendant,100,22,7/5/2018
1F716B,conference-call,100,50,7/5/2018
206852,conference-call,100,50,7/5/2018
20BEEA,conference-call,100,50,7/5/2018
228D42,product-release,100,64,7/5/2018
228D42,product-release,100,64,7/5/2018
22C58E,earnings,100,50,7/5/2018
275300,conference-call,100,50,7/5/2018
29A4CC,conference-call,100,50,7/5/2018
2D76CE,earnings,100,50,7/5/2018
2D76CE,earnings,100,50,7/5/2018
2F7A7E,conference-call,100,50,7/5/2018
315EB0,conference-call,100,50,7/5/2018
32CB22,conference-call,100,50,7/5/2018
387541,conference-call,100,50,7/5/2018
3DC887,earnings,100,50,7/5/2018
434F38,earnings,100,50,7/5/2018
442587,partnership,100,61,7/5/2018
4806CE,earnings-guidance,100,50,7/5/2018
4A5C8D,conference-call,100,50,7/5/2018
4B6EF9,earnings,100,50,7/5/2018
550D01,conference-call,100,50,7/5/2018
55438C,partnership,100,61,7/5/2018
55438C,partnership,100,61,7/5/2018
564F3E,earnings,100,50,7/5/2018
56B7C1,dividend,100,50,7/5/2018
56EA2B,conference-call,100,50,7/5/2018
59B229,earnings,100,50,7/5/2018
5A0FF1,earnings,100,50,7/5/2018
5EC388,earnings,100,50,7/5/2018
5F2FF7,earnings,100,50,7/5/2018
61B81B,dividend-up,100,81,7/5/2018
61BCA7,earnings,100,50,7/5/2018
6284B5,earnings-guidance,100,50,7/5/2018
6.52E+64,legal-issues-defendant,100,22,7/5/2018
6634D9,legal-issues-defendant,100,22,7/5/2018
67529E,conference-call,100,50,7/5/2018
68BA15,conference-call,100,50,7/5/2018
693ECD,patent-awarded,100,72,7/5/2018
69E8E1,conference-call,100,50,7/5/2018
69E8E1,conference-call,100,50,7/5/2018
69E8E1,conference-call,100,50,7/5/2018
6BDA0C,executive-appointment,100,54,7/5/2018
6D0CAB,operating-earnings,100,50,7/5/2018
6D6B40,earnings,100,50,7/5/2018
76BECC,business-contract,100,69,7/5/2018
7823A3,facility-open,100,65,7/5/2018
7823A3,earnings,100,50,7/5/2018
7A3633,earnings,100,50,7/5/2018
7B0BA6,earnings,100,50,7/5/2018
7CD98F,earnings-guidance,100,50,7/5/2018
7F2922,earnings,100,50,7/5/2018
80D744,conference-call,100,50,7/5/2018
86A1B9,earnings,100,50,7/5/2018
8BAA15,product-release,100,64,7/5/2018
8BE916,earnings,100,50,7/5/2018
8C6C1B,facility-open,100,65,7/5/2018
8DBBE6,executive-appointment,100,54,7/5/2018
8DBBE6,conference-call,100,50,7/5/2018
8F8F2F,conference-call,100,50,7/5/2018
90B678,legal-issues-defendant,100,22,7/5/2018
90D6A5,earnings-guidance,100,50,7/5/2018
922F0C,earnings,100,50,7/5/2018
965360,earnings,100,50,7/5/2018
990AD0,dividend,100,50,7/5/2018
9BB35A,conference-call,100,50,7/5/2018
9CA432,conference-call,100,50,7/5/2018
9D65C1,earnings,100,50,7/5/2018
9E5C2C,conference-call,100,50,7/5/2018
A01664,earnings,100,50,7/5/2018
A017F4,conference-participant,100,50,7/5/2018
A1EAC8,conference-call,100,50,7/5/2018
A29A46,conference-call,100,50,7/5/2018
A398B9,earnings,100,50,7/5/2018
A4386C,earnings,100,50,7/5/2018
A5A4F5,acquisition-acquirer,100,49,7/5/2018
A99576,conference-call,100,50,7/5/2018
AAC8B6,dividend,100,50,7/5/2018
ADF092,earnings,100,50,7/5/2018
AF210D,earnings,100,50,7/5/2018
AFEC35,earnings,100,50,7/5/2018
B2206F,earnings,100,50,7/5/2018
B7EB38,earnings,100,50,7/5/2018
B96637,conference-call,100,50,7/5/2018
C41C25,earnings,100,50,7/5/2018
CA3CB9,conference-call,100,50,7/5/2018
CB22CD,conference-call,100,50,7/5/2018
CB7AB2,earnings,100,50,7/5/2018
CBFFDD,executive-appointment,100,54,7/5/2018
CD06A2,earnings,100,50,7/5/2018
CE5664,earnings,100,50,7/5/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/5/2018
D06755,earnings,100,50,7/5/2018
D0909F,earnings-guidance,100,50,7/5/2018
D13F1C,merger,100,66,7/5/2018
D27FAB,debt-extension-recipient,100,73,7/5/2018
D2B9E5,earnings,100,50,7/5/2018
D437C3,earnings,100,50,7/5/2018
D518D8,conference-call,100,50,7/5/2018
D6853F,legal-issues-defendant,100,22,7/5/2018
D854DD,conference-participant,100,50,7/5/2018
D8760C,conference-call,100,50,7/5/2018
DB06B0,earnings,100,50,7/5/2018
DB7FA7,conference-call,100,50,7/5/2018
DC2F77,earnings,100,50,7/5/2018
DF8855,executive-appointment,100,54,7/5/2018
E11C41,conference-call,100,50,7/5/2018
E35610,earnings-guidance,100,50,7/5/2018
E754F0,earnings,100,50,7/5/2018
E8846E,business-contract,100,69,7/5/2018
E94704,conference-call,100,50,7/5/2018
EE04F0,legal-issues-defendant,100,22,7/5/2018
F0B335,legal-issues-defendant,100,22,7/5/2018
F0B335,legal-issues-defendant,100,22,7/5/2018
F24FF0,acquisition-acquirer,100,49,7/5/2018
F32F88,conference-call,100,50,7/5/2018
F5D059,dividend,100,50,7/5/2018
FA36A4,conference-call,100,50,7/5/2018
FAB97A,earnings,100,50,7/5/2018
FACF19,fundraising,100,64,7/5/2018
FE89E0,conference-call,100,50,7/5/2018
FEE4B0,supply-decrease,100,28,7/5/2018
FF5413,earnings,100,50,7/5/2018
001F1B,revenues,100,50,7/6/2018
003B70,operating-earnings,100,50,7/6/2018
0358AF,earnings,100,50,7/6/2018
51332,product-release,100,64,7/6/2018
0A7650,conference-call,100,50,7/6/2018
0B57D7,conference-call,100,50,7/6/2018
0C6861,conference-call,100,50,7/6/2018
1748B3,conference-call,100,50,7/6/2018
1E83DE,legal-issues-defendant,100,22,7/6/2018
1F9D90,earnings,100,50,7/6/2018
1FC422,legal-issues-defendant,100,22,7/6/2018
251988,legal-issues-defendant,100,22,7/6/2018
2D2D43,earnings,100,50,7/6/2018
315EB0,facility-open,100,65,7/6/2018
3AF7FD,conference-call,100,50,7/6/2018
3BCF24,earnings,100,50,7/6/2018
4D8313,conference-call,100,50,7/6/2018
5675EB,earnings,100,50,7/6/2018
5E6959,conference-call,100,50,7/6/2018
6634D9,legal-issues-defendant,100,22,7/6/2018
741937,earnings,100,50,7/6/2018
7712CB,conference-call,100,50,7/6/2018
7D97DE,conference-call,100,50,7/6/2018
8.10E+32,dividend,100,50,7/6/2018
85AD00,conference-call,100,50,7/6/2018
89FBB1,dividend,100,50,7/6/2018
8C6C1B,facility-open,100,65,7/6/2018
8DCF18,conference-call,100,50,7/6/2018
A15C71,conference-call,100,50,7/6/2018
A350C1,earnings-guidance,100,50,7/6/2018
A41450,dividend,100,50,7/6/2018
A58224,conference-call,100,50,7/6/2018
A5A4F5,acquisition-acquirer,100,49,7/6/2018
A75D43,conference-call,100,50,7/6/2018
B08954,earnings,100,50,7/6/2018
B446B8,earnings,100,50,7/6/2018
B803B1,conference-call,100,50,7/6/2018
B9CD50,earnings,100,50,7/6/2018
BBBB41,conference-call,100,50,7/6/2018
BC948D,conference-call,100,50,7/6/2018
BDEF34,merger-completed,100,66,7/6/2018
CDD75E,legal-issues-defendant,100,22,7/6/2018
CF6A5A,product-release,100,64,7/6/2018
CFF15D,legal-issues-defendant,100,22,7/6/2018
D2C0B6,buybacks,100,74,7/6/2018
D65A13,conference-call,100,50,7/6/2018
DB5CA5,dividend-up,100,54,7/6/2018
ED0402,earnings,100,50,7/6/2018
ED9576,conference-call,100,50,7/6/2018
EF5BED,partnership,100,61,7/6/2018
F0B877,conference-call,100,50,7/6/2018
FD0CA4,conference-call,100,50,7/6/2018
D6853F,legal-issues-defendant,100,22,7/7/2018
44A4FC,acquisition-acquirer,100,49,7/8/2018
44A4FC,business-contract,100,69,7/8/2018
00326E,conference-call,100,50,7/9/2018
00D6B5,conference-call,100,50,7/9/2018
0157B1,hirings,100,65,7/9/2018
0157B1,hirings,100,65,7/9/2018
018C11,conference-call,100,50,7/9/2018
034B61,acquisition-acquirer,100,49,7/9/2018
034B61,acquisition-acquirer,100,49,7/9/2018
03B431,product-release,100,64,7/9/2018
03FAA6,earnings,100,50,7/9/2018
078D52,dividend,100,50,7/9/2018
0919B1,conference-call,100,50,7/9/2018
0A0D9E,conference-call,100,50,7/9/2018
0BD4E8,executive-appointment,100,54,7/9/2018
0C8D82,conference-call,100,50,7/9/2018
0CBC4D,earnings,100,50,7/9/2018
0DE3D5,conference-call,100,50,7/9/2018
0F2BC9,executive-appointment,100,54,7/9/2018
11A49E,clinical-trials-start,100,64,7/9/2018
1782D5,executive-appointment,100,54,7/9/2018
1AC649,business-contract,100,69,7/9/2018
1BDB2A,conference-call,100,50,7/9/2018
21D903,revenues,100,50,7/9/2018
21D903,unit-acquisition-acquiree,100,76,7/9/2018
25DD05,conference-call,100,50,7/9/2018
272472,executive-appointment,100,54,7/9/2018
2DB344,earnings,100,50,7/9/2018
2E902B,conference-call,100,50,7/9/2018
31AA84,executive-appointment,100,54,7/9/2018
34A959,business-contract,100,69,7/9/2018
36E479,clinical-trials-start,100,64,7/9/2018
382EAE,executive-appointment,100,54,7/9/2018
3BC360,public-offering,100,43,7/9/2018
3DD5E2,conference-call,100,50,7/9/2018
3F868D,conference-participant,100,50,7/9/2018
3FBC9B,unit-acquisition-acquiree,100,76,7/9/2018
4135F7,conference-call,100,50,7/9/2018
42AABD,conference-call,100,50,7/9/2018
458D2C,revenue-volume,100,50,7/9/2018
458D2C,earnings-guidance,100,50,7/9/2018
4591D3,product-release,100,64,7/9/2018
467F2C,conference-call,100,50,7/9/2018
4D8124,earnings,100,50,7/9/2018
4D8313,executive-appointment,100,54,7/9/2018
50070E,conference-call,100,50,7/9/2018
5088A5,earnings,100,50,7/9/2018
51888A,earnings,100,50,7/9/2018
52015A,dividend,100,50,7/9/2018
5.47E+28,public-offering,100,43,7/9/2018
5546DA,conference-call,100,50,7/9/2018
556F08,campaign-ad-release,100,59,7/9/2018
55C9B5,partnership,100,61,7/9/2018
583A75,conference-call,100,50,7/9/2018
589803,earnings,100,50,7/9/2018
5BE42C,executive-appointment,100,54,7/9/2018
5BFE94,conference-call,100,50,7/9/2018
5C2A47,earnings-guidance,100,50,7/9/2018
5C7601,product-release,100,64,7/9/2018
5D1956,ipo,100,71,7/9/2018
610D47,conference-call,100,50,7/9/2018
62B20A,conference-call,100,50,7/9/2018
62EFEE,earnings,100,50,7/9/2018
633054,partnership,100,61,7/9/2018
64E346,acquisition-acquirer,100,49,7/9/2018
6844D2,conference-call,100,50,7/9/2018
6BF593,conference-call,100,50,7/9/2018
6.00E+19,settlement,100,56,7/9/2018
6F3936,partnership,100,61,7/9/2018
713810,partnership,100,61,7/9/2018
71E2EF,earnings,100,50,7/9/2018
726DDF,conference-call,100,50,7/9/2018
72CB93,earnings,100,50,7/9/2018
73C9E2,conference-call,100,50,7/9/2018
771985,revenues,100,50,7/9/2018
77B8E9,clinical-trials,100,56,7/9/2018
77B8E9,clinical-trials,100,56,7/9/2018
791EC1,unit-acquisition-acquirer,100,49,7/9/2018
7AB859,conference-call,100,50,7/9/2018
7AB859,loan-recipient,100,59,7/9/2018
7ADE57,executive-appointment,100,54,7/9/2018
7B6EB1,earnings,100,50,7/9/2018
7FDE1C,product-release,100,64,7/9/2018
8.10E+32,executive-appointment,100,54,7/9/2018
81222C,executive-appointment,100,54,7/9/2018
81A88D,conference-call,100,50,7/9/2018
82C202,earnings,100,50,7/9/2018
82E58A,award,100,58,7/9/2018
8665BA,partnership,100,61,7/9/2018
88611B,earnings,100,50,7/9/2018
896771,business-contract,100,69,7/9/2018
8C6C1B,facility-open,100,65,7/9/2018
8DAAB9,earnings,100,50,7/9/2018
8E82A6,earnings,100,50,7/9/2018
8E8E6E,product-release,100,64,7/9/2018
8E93A4,conference-call,100,50,7/9/2018
949D62,earnings,100,50,7/9/2018
95DC1F,unit-acquisition-acquiree,100,76,7/9/2018
95DC1F,investment-investor,100,55,7/9/2018
96F126,partnership,100,61,7/9/2018
979451,earnings,100,50,7/9/2018
98CEBB,business-contract,100,69,7/9/2018
990AD0,earnings,100,50,7/9/2018
9C5174,partnership,100,61,7/9/2018
9C8BC3,conference-call,100,50,7/9/2018
9CDA4F,earnings,100,50,7/9/2018
9CDA4F,ownership-decrease-owner,100,46,7/9/2018
9CE4C7,earnings,100,50,7/9/2018
9CF9B1,earnings,100,50,7/9/2018
9F048E,earnings,100,50,7/9/2018
A4A612,conference-call,100,50,7/9/2018
A5A4F5,acquisition-acquirer,100,49,7/9/2018
A631A3,partnership,100,61,7/9/2018
A6828A,partnership,100,61,7/9/2018
A6828A,partnership,100,61,7/9/2018
A8CBDA,conference-call,100,50,7/9/2018
AB7726,award,100,58,7/9/2018
ACF77B,dividend,100,50,7/9/2018
ACF77B,buybacks,100,74,7/9/2018
B2256A,conference-call,100,50,7/9/2018
B2E6B5,conference-call,100,50,7/9/2018
B303A6,executive-appointment,100,54,7/9/2018
B3ED62,conference-call,100,50,7/9/2018
B4703C,dividend,100,50,7/9/2018
BB02FB,conference-call,100,50,7/9/2018
BEA527,partnership,100,61,7/9/2018
C356AC,earnings,100,50,7/9/2018
C45C1F,executive-appointment,100,54,7/9/2018
C5D2AE,executive-appointment,100,54,7/9/2018
C941DC,conference-call,100,50,7/9/2018
C9E107,earnings,100,50,7/9/2018
CB6A9C,conference-call,100,50,7/9/2018
CB88B3,earnings,100,50,7/9/2018
CBB77B,earnings,100,50,7/9/2018
CE96E7,conference-call,100,50,7/9/2018
D29F43,conference-call,100,50,7/9/2018
D3F64D,earnings-guidance,100,50,7/9/2018
D501DC,dividend,100,50,7/9/2018
DB06B0,acquisition-acquirer,100,49,7/9/2018
DC0998,conference-call,100,50,7/9/2018
DD7A96,conference-call,100,50,7/9/2018
E26FC3,executive-appointment,100,54,7/9/2018
E30B34,earnings-guidance,100,50,7/9/2018
E8846E,executive-resignation,100,44,7/9/2018
E8846E,product-release,100,64,7/9/2018
E8846E,product-release,100,64,7/9/2018
E8A49A,earnings,100,50,7/9/2018
E8B315,earnings,100,50,7/9/2018
EB5E78,conference-call,100,50,7/9/2018
F6E248,executive-appointment,100,54,7/9/2018
F7935D,executive-appointment,100,54,7/9/2018
FD4588,conference-call,100,50,7/9/2018
FE7A63,earnings,100,50,7/9/2018
FF5413,revenue-volume,100,50,7/9/2018
FF6644,executive-appointment,100,54,7/9/2018
003B70,executive-appointment,100,54,7/10/2018
13528,earnings,100,50,7/10/2018
48590,earnings,100,50,7/10/2018
048B70,conference-call,100,50,7/10/2018
58828,dividend,100,50,7/10/2018
09F623,conference-call,100,50,7/10/2018
0BD4E8,business-contract,100,69,7/10/2018
0C2A0D,earnings,100,50,7/10/2018
0DC050,earnings,100,50,7/10/2018
11074E,earnings,100,50,7/10/2018
11A49E,public-offering,100,43,7/10/2018
135B09,conference-call,100,50,7/10/2018
152AB9,executive-appointment,100,54,7/10/2018
15901B,patent-awarded,100,72,7/10/2018
18D9FA,loan-recipient,100,59,7/10/2018
1CDD1C,earnings-guidance,100,50,7/10/2018
1D9E55,earnings,100,50,7/10/2018
1DE526,conference-call,100,50,7/10/2018
1E9A6D,earnings,100,50,7/10/2018
21268E,conference-call,100,50,7/10/2018
228D42,partnership,100,61,7/10/2018
284289,earnings-guidance,100,50,7/10/2018
295F9F,executive-appointment,100,54,7/10/2018
2B7A40,earnings,100,50,7/10/2018
2E61CC,dividend,100,50,7/10/2018
2F1299,partnership,100,61,7/10/2018
309922,conference-call,100,50,7/10/2018
3461CF,dividend,100,50,7/10/2018
34E9F9,dividend,100,50,7/10/2018
34E9F9,conference-call,100,50,7/10/2018
367E1C,earnings,100,50,7/10/2018
387375,earnings,100,50,7/10/2018
396D7C,public-offering,100,43,7/10/2018
3A3447,facility-open,100,65,7/10/2018
3A3948,earnings,100,50,7/10/2018
3B37F7,executive-appointment,100,54,7/10/2018
3DE4D1,conference-call,100,50,7/10/2018
40F7DE,executive-appointment,100,54,7/10/2018
425BDC,conference-call,100,50,7/10/2018
43A74A,earnings,100,50,7/10/2018
44209A,legal-issues-defendant,100,22,7/10/2018
44209A,legal-issues-defendant,100,22,7/10/2018
442769,conference-call,100,50,7/10/2018
45444E,earnings,100,50,7/10/2018
490D4B,conference-call,100,50,7/10/2018
4.91E+58,executive-appointment,100,54,7/10/2018
4A2457,government-contract,100,69,7/10/2018
4A6F00,partnership,100,61,7/10/2018
4A6F00,partnership,100,61,7/10/2018
4B3DC9,conference-call,100,50,7/10/2018
4BEB48,earnings,100,50,7/10/2018
4C6C63,earnings,100,50,7/10/2018
50D1EC,earnings,100,50,7/10/2018
514067,executive-appointment,100,54,7/10/2018
54512F,partnership,100,61,7/10/2018
546A9C,earnings,100,50,7/10/2018
5487B1,conference-call,100,50,7/10/2018
583A75,product-release,100,64,7/10/2018
5B3415,conference-call,100,50,7/10/2018
5B35C7,earnings-up,100,68,7/10/2018
5B35C7,earnings-up,100,68,7/10/2018
5B7739,conference-call,100,50,7/10/2018
5BE42C,conference-call,100,50,7/10/2018
5CC29D,earnings,100,50,7/10/2018
5DD486,business-contract,100,69,7/10/2018
5F1B7B,earnings,100,50,7/10/2018
63F892,partnership,100,61,7/10/2018
6634D9,legal-issues-defendant,100,22,7/10/2018
665D7D,conference-call,100,50,7/10/2018
66E04A,product-release,100,64,7/10/2018
68E6E9,acquisition-acquirer,100,49,7/10/2018
6ABCB8,earnings,100,50,7/10/2018
6B494E,dividend,100,50,7/10/2018
6C4D2F,conference-call,100,50,7/10/2018
6CB7F9,conference-call,100,50,7/10/2018
6CF43C,earnings,100,50,7/10/2018
726DDF,asset-sale,100,62,7/10/2018
7.44E+09,earnings-guidance,100,50,7/10/2018
747219,earnings,100,50,7/10/2018
793C11,product-release,100,64,7/10/2018
7B6C88,executive-appointment,100,54,7/10/2018
7C62A3,note-sale,100,52,7/10/2018
7C62A3,note-sale,100,52,7/10/2018
7C62A3,note-sale,100,52,7/10/2018
7E1D5D,partnership,100,61,7/10/2018
7E2DE6,earnings,100,50,7/10/2018
7E3F8F,earnings,100,50,7/10/2018
7E62B5,earnings-guidance,100,50,7/10/2018
82E58A,dividend,100,50,7/10/2018
87486A,conference-call,100,50,7/10/2018
8802B4,conference-call,100,50,7/10/2018
88193E,product-release,100,64,7/10/2018
88923D,conference-call,100,50,7/10/2018
8B6E7E,acquisition-acquirer,100,49,7/10/2018
8C6C1B,facility-open,100,65,7/10/2018
8D4486,partnership,100,61,7/10/2018
8E0E32,dividend,100,50,7/10/2018
925759,partnership,100,61,7/10/2018
92D3A0,dividend,100,50,7/10/2018
9.36E+10,business-contract,100,69,7/10/2018
9368BE,conference-call,100,50,7/10/2018
940C3D,partnership,100,61,7/10/2018
9.54E+32,fundraising,100,64,7/10/2018
968103,earnings,100,50,7/10/2018
968966,executive-appointment,100,54,7/10/2018
968B00,earnings,100,50,7/10/2018
980C14,dividend,100,50,7/10/2018
98D33E,product-release,100,64,7/10/2018
9E298A,conference-call,100,50,7/10/2018
9EA947,conference-call,100,50,7/10/2018
9EBAFA,dividend-up,100,81,7/10/2018
9F03CF,conference-call,100,50,7/10/2018
9FD2D9,earnings-guidance,100,50,7/10/2018
A02FB1,conference-call,100,50,7/10/2018
A1A317,conference-call,100,50,7/10/2018
A5195E,merger-failed,100,21,7/10/2018
A5195E,merger-failed,100,21,7/10/2018
A52B6B,note-sale,100,52,7/10/2018
AADE0B,acquisition-acquirer,100,49,7/10/2018
AC7C4F,facility-open,100,65,7/10/2018
AD22F2,stake-acquirer,100,48,7/10/2018
AE4125,conference-call,100,50,7/10/2018
AE7D16,earnings,100,50,7/10/2018
B01111,facility-open,100,65,7/10/2018
B05000,executive-appointment,100,54,7/10/2018
B0FE08,conference-call,100,50,7/10/2018
B1FC3B,business-contract,100,69,7/10/2018
B54A74,earnings,100,50,7/10/2018
B7202A,executive-appointment,100,54,7/10/2018
B7BDA3,business-contract,100,69,7/10/2018
B934BF,public-offering,100,43,7/10/2018
BAAA60,conference-call,100,50,7/10/2018
BB0787,executive-appointment,100,54,7/10/2018
BB5271,conference-call,100,50,7/10/2018
BD15E8,conference-call,100,50,7/10/2018
C0F70B,earnings,100,50,7/10/2018
C230FE,earnings,100,50,7/10/2018
C4FBDC,donation,100,54,7/10/2018
C5C0E9,earnings,100,50,7/10/2018
C6C702,conference-call,100,50,7/10/2018
C8FAC7,partnership,100,61,7/10/2018
C99CC8,executive-appointment,100,54,7/10/2018
CAD7D9,conference-call,100,50,7/10/2018
CC35BE,asset-sale,100,62,7/10/2018
CC6FF5,earnings,100,50,7/10/2018
CE2791,conference-call,100,50,7/10/2018
CE4FD9,earnings,100,50,7/10/2018
CE5C6E,executive-appointment,100,54,7/10/2018
CF351E,earnings,100,50,7/10/2018
D17C1B,earnings,100,50,7/10/2018
D4070C,business-contract,100,69,7/10/2018
D598E7,demand-decrease,100,17,7/10/2018
D7AC6E,earnings,100,50,7/10/2018
D82EF3,conference-call,100,50,7/10/2018
D8C09D,earnings-guidance,100,50,7/10/2018
DA9443,executive-appointment,100,54,7/10/2018
DAFED3,earnings,100,50,7/10/2018
DB396B,conference-call,100,50,7/10/2018
DF01B1,conference-call,100,50,7/10/2018
E610CD,earnings,100,50,7/10/2018
E68C3D,partnership,100,61,7/10/2018
E6D89E,earnings,100,50,7/10/2018
E6E012,earnings,100,50,7/10/2018
E866D2,revenue-volume,100,50,7/10/2018
E87676,conference-call,100,50,7/10/2018
EAA0A7,earnings,100,50,7/10/2018
ED3CA8,conference-call,100,50,7/10/2018
ED5171,executive-appointment,100,54,7/10/2018
EE6F1C,business-contract,100,69,7/10/2018
EE967B,earnings,100,50,7/10/2018
F02D0A,earnings,100,50,7/10/2018
F2526D,ipo,100,71,7/10/2018
F3EDB4,earnings,100,50,7/10/2018
F3EDB4,dividend,100,50,7/10/2018
F3FCC3,conference-call,100,50,7/10/2018
F46EC9,partnership,100,61,7/10/2018
F4E992,earnings,100,50,7/10/2018
F5C78B,conference-call,100,50,7/10/2018
F8084B,earnings,100,50,7/10/2018
FAEABE,executive-appointment,100,54,7/10/2018
FB728F,conference-call,100,50,7/10/2018
FC1B7B,earnings,100,50,7/10/2018
08A40F,executive-appointment,100,54,7/11/2018
09DE1F,acquisition-acquirer,100,49,7/11/2018
09DE1F,acquisition-acquirer,100,49,7/11/2018
0FDE97,conference-call,100,50,7/11/2018
10C19B,earnings,100,50,7/11/2018
12E454,partnership,100,61,7/11/2018
12E454,partnership,100,61,7/11/2018
12E454,partnership,100,61,7/11/2018
1348C9,dividend,100,50,7/11/2018
16B183,conference-call,100,50,7/11/2018
1921DD,unit-acquisition-acquiree,100,76,7/11/2018
1AD9CC,revenues,100,50,7/11/2018
1FE3CB,conference-call,100,50,7/11/2018
200D8B,executive-resignation,100,44,7/11/2018
21DED4,conference-call,100,50,7/11/2018
239106,legal-issues-defendant,100,22,7/11/2018
239106,legal-issues-defendant,100,22,7/11/2018
239106,legal-issues-defendant,100,22,7/11/2018
2.45E+15,earnings,100,50,7/11/2018
24CB56,dividend,100,50,7/11/2018
251988,business-contract,100,69,7/11/2018
251988,partnership,100,61,7/11/2018
2950FF,earnings,100,50,7/11/2018
29A4CC,merger-regulatory-approval,100,81,7/11/2018
29B702,earnings,100,50,7/11/2018
2CB4C9,earnings,100,50,7/11/2018
2CBB58,conference-call,100,50,7/11/2018
2EB04E,partnership,100,61,7/11/2018
2EBA55,dividend,100,50,7/11/2018
30CBF9,partnership,100,61,7/11/2018
314D88,executive-resignation,100,44,7/11/2018
31666F,dividend,100,50,7/11/2018
33E8C7,earnings,100,50,7/11/2018
366A08,dividend,100,50,7/11/2018
371C01,conference-call,100,50,7/11/2018
37B120,public-offering,100,43,7/11/2018
39FB23,legal-issues-defendant,100,22,7/11/2018
3A113F,conference-call,100,50,7/11/2018
3A3447,facility-open,100,65,7/11/2018
3BE00F,earnings,100,50,7/11/2018
3CBA2A,conference-call,100,50,7/11/2018
3CCC90,executive-resignation,100,44,7/11/2018
3FACA7,dividend,100,50,7/11/2018
414FFF,product-release,100,64,7/11/2018
416291,conference-call,100,50,7/11/2018
416C55,earnings,100,50,7/11/2018
417BF9,executive-appointment,100,54,7/11/2018
434F38,joint-venture,100,62,7/11/2018
44209A,legal-issues-defendant,100,22,7/11/2018
51D876,earnings,100,50,7/11/2018
55ACCB,earnings,100,50,7/11/2018
56B7C1,conference-call,100,50,7/11/2018
589846,product-release,100,64,7/11/2018
5A423F,earnings,100,50,7/11/2018
5B3FA2,conference-participant,100,50,7/11/2018
5D63F1,facility-open,100,65,7/11/2018
5F9CE3,earnings,100,50,7/11/2018
605F40,conference-call,100,50,7/11/2018
60DD84,conference-call,100,50,7/11/2018
61E975,dividend,100,50,7/11/2018
627186,earnings,100,50,7/11/2018
665D7D,clinical-trials,100,56,7/11/2018
665D7D,clinical-trials,100,56,7/11/2018
66749D,earnings,100,50,7/11/2018
66E04A,facility-open,100,65,7/11/2018
68B03F,earnings,100,50,7/11/2018
69345C,partnership,100,61,7/11/2018
69CE71,dividend,100,50,7/11/2018
6B494E,dividend,100,50,7/11/2018
6ED519,conference-call,100,50,7/11/2018
70FCEF,executive-appointment,100,54,7/11/2018
70FCEF,executive-appointment,100,54,7/11/2018
728737,earnings,100,50,7/11/2018
7.40E+289,earnings,100,50,7/11/2018
7.40E+289,earnings,100,50,7/11/2018
7.40E+289,earnings,100,50,7/11/2018
752A70,earnings,100,50,7/11/2018
75F982,business-contract,100,69,7/11/2018
790C34,earnings,100,50,7/11/2018
7A10FF,earnings,100,50,7/11/2018
7BAAE7,award,100,58,7/11/2018
7D5FD6,partnership,100,61,7/11/2018
7DC1C4,earnings,100,50,7/11/2018
7F3A5F,earnings,100,50,7/11/2018
82E58A,earnings-guidance,100,50,7/11/2018
830BDB,conference-call,100,50,7/11/2018
859281,earnings,100,50,7/11/2018
88193E,conference-call,100,50,7/11/2018
89F693,legal-issues-defendant,100,22,7/11/2018
8C6C1B,facility-open,100,65,7/11/2018
9087B9,earnings,100,50,7/11/2018
92D3A0,earnings,100,50,7/11/2018
934029,clinical-trials,100,56,7/11/2018
934029,clinical-trials,100,56,7/11/2018
9.36E+10,insider-buy,100,61,7/11/2018
93633B,conference-call,100,50,7/11/2018
945DE6,dividend,100,50,7/11/2018
95C392,conference-call,100,50,7/11/2018
9A602D,product-release,100,64,7/11/2018
9C5174,earnings,100,50,7/11/2018
9D5D35,earnings,100,50,7/11/2018
9F5997,conference-call,100,50,7/11/2018
A072C4,executive-appointment,100,54,7/11/2018
A16DEA,earnings,100,50,7/11/2018
A3F598,conference-call,100,50,7/11/2018
A47F2E,earnings,100,50,7/11/2018
A5A4F5,acquisition-acquirer,100,49,7/11/2018
A5A4F5,product-release,100,64,7/11/2018
A8AC4C,conference-call,100,50,7/11/2018
A9ED24,conference-call,100,50,7/11/2018
ADFB3A,clinical-trials-start,100,64,7/11/2018
AFF7B4,executive-appointment,100,54,7/11/2018
B13B68,earnings-guidance,100,50,7/11/2018
B1DF3C,earnings,100,50,7/11/2018
B3A166,legal-issues-defendant,100,22,7/11/2018
B3A166,legal-issues-defendant,100,22,7/11/2018
B3A166,legal-issues-defendant,100,22,7/11/2018
B3A166,legal-issues-defendant,100,22,7/11/2018
B3A166,legal-issues-defendant,100,22,7/11/2018
B3A166,legal-issues-defendant,100,22,7/11/2018
B3A166,legal-issues-defendant,100,22,7/11/2018
B4703C,executive-appointment,100,54,7/11/2018
B8EF97,revenues,100,50,7/11/2018
B934BF,public-offering,100,43,7/11/2018
B934BF,conference-call,100,50,7/11/2018
B9764A,executive-appointment,100,54,7/11/2018
BB127B,product-release,100,64,7/11/2018
BBF349,partnership,100,61,7/11/2018
BC5680,earnings,100,50,7/11/2018
BCC55F,conference-call,100,50,7/11/2018
BE7BA4,conference-call,100,50,7/11/2018
C0030A,earnings,100,50,7/11/2018
C16A8F,conference-call,100,50,7/11/2018
C22BE8,settlement,100,56,7/11/2018
C38440,earnings,100,50,7/11/2018
C3EE99,earnings,100,50,7/11/2018
C4C77F,dividend,100,50,7/11/2018
C7AE14,conference-call,100,50,7/11/2018
C8257F,conference-call,100,50,7/11/2018
CDE118,earnings,100,50,7/11/2018
CDE51C,earnings,100,50,7/11/2018
CEC5B9,partnership,100,61,7/11/2018
D17C1B,partnership,100,61,7/11/2018
D6853F,legal-issues-defendant,100,22,7/11/2018
D77F7E,earnings,100,50,7/11/2018
D9164D,earnings,100,50,7/11/2018
DD682D,earnings,100,50,7/11/2018
DDC415,earnings,100,50,7/11/2018
E1E36F,earnings,100,50,7/11/2018
E68733,product-release,100,64,7/11/2018
E68733,regulatory-product-approval-granted,100,81,7/11/2018
E70531,product-release,100,64,7/11/2018
E74B55,conference-call,100,50,7/11/2018
E9C7C0,partnership,100,61,7/11/2018
EB6965,executive-appointment,100,54,7/11/2018
ECF4F8,conference-call,100,50,7/11/2018
F02170,award,100,58,7/11/2018
F0B2B5,executive-appointment,100,54,7/11/2018
F0B2B5,executive-appointment,100,54,7/11/2018
F0B2B5,executive-appointment,100,54,7/11/2018
F179ED,earnings,100,50,7/11/2018
F48947,earnings,100,50,7/11/2018
F51DB0,conference-call,100,50,7/11/2018
F6A945,earnings,100,50,7/11/2018
F7902B,earnings,100,50,7/11/2018
F7FCA4,executive-appointment,100,54,7/11/2018
FD4E8D,earnings,100,50,7/11/2018
FE89E0,executive-appointment,100,54,7/11/2018
FE89E0,dividend,100,50,7/11/2018
FFE543,earnings,100,50,7/11/2018
13528,earnings,100,50,7/12/2018
0157B1,partnership,100,61,7/12/2018
0157B1,conference-call,100,50,7/12/2018
01D03F,clinical-trials-filed,100,60,7/12/2018
03596A,business-contract,100,69,7/12/2018
03D5F9,earnings,100,50,7/12/2018
43862,conference-call,100,50,7/12/2018
61366,award,100,58,7/12/2018
61366,earnings,100,50,7/12/2018
71860,earnings,100,50,7/12/2018
0A0CF0,earnings,100,50,7/12/2018
0ED415,conference-call,100,50,7/12/2018
106394,acquisition-completed-acquirer,100,49,7/12/2018
13C3E0,earnings,100,50,7/12/2018
147C38,earnings,100,50,7/12/2018
168A5D,executive-appointment,100,54,7/12/2018
17EDA5,cyber-attacks-threat,100,25,7/12/2018
17EDA5,acquisition-acquirer,100,49,7/12/2018
1834C0,acquisition-completed-acquirer,100,49,7/12/2018
184866,earnings,100,50,7/12/2018
1921DD,partnership,100,61,7/12/2018
1AF7E2,earnings,100,50,7/12/2018
1B4F31,earnings,100,50,7/12/2018
1B637E,acquisition-completed-acquirer,100,49,7/12/2018
1DA44F,business-contract,100,69,7/12/2018
1DA44F,conference-call,100,50,7/12/2018
1E04A5,earnings,100,50,7/12/2018
21022F,earnings,100,50,7/12/2018
221445,conference-call,100,50,7/12/2018
26F31D,earnings,100,50,7/12/2018
295F9F,conference-call,100,50,7/12/2018
2A6DBE,clinical-trials,100,56,7/12/2018
2B49F4,dividend,100,50,7/12/2018
2B9DBB,executive-appointment,100,54,7/12/2018
2B9DBB,conference-call,100,50,7/12/2018
2EB88B,earnings,100,50,7/12/2018
301493,partnership,100,61,7/12/2018
315EB0,partnership,100,61,7/12/2018
3.50E+27,earnings,100,50,7/12/2018
366A08,conference-call,100,50,7/12/2018
3696BF,conference-call,100,50,7/12/2018
37B120,public-offering,100,43,7/12/2018
382EAE,conference-call,100,50,7/12/2018
384CD3,business-contract,100,69,7/12/2018
396D7C,public-offering,100,43,7/12/2018
3A3447,earnings,100,50,7/12/2018
3BB616,note-sale,100,52,7/12/2018
3BC360,public-offering,100,43,7/12/2018
3D9999,earnings,100,50,7/12/2018
408380,earnings,100,50,7/12/2018
4.00E+163,earnings,100,50,7/12/2018
415188,conference-call,100,50,7/12/2018
41EC04,conference-call,100,50,7/12/2018
423279,earnings-per-share-up,100,68,7/12/2018
44209A,legal-issues-defendant,100,22,7/12/2018
44A4FC,executive-appointment,100,54,7/12/2018
4649D5,conference-call,100,50,7/12/2018
479930,earnings,100,50,7/12/2018
49A344,business-contract,100,69,7/12/2018
4A6F00,partnership,100,61,7/12/2018
4B49CF,dividend-up,100,81,7/12/2018
4B49CF,executive-appointment,100,54,7/12/2018
4BDCA7,clinical-trials-start,100,64,7/12/2018
4C1FA1,earnings,100,50,7/12/2018
4DD09F,government-contract,100,69,7/12/2018
4EE167,earnings,100,50,7/12/2018
4FCC78,conference-call,100,50,7/12/2018
51527B,conference-call,100,50,7/12/2018
52015A,conference-call,100,50,7/12/2018
520632,regulatory-product-approval-granted,100,81,7/12/2018
53A226,earnings,100,50,7/12/2018
5403F8,earnings,100,50,7/12/2018
55C9B5,partnership,100,61,7/12/2018
55C9B5,partnership,100,61,7/12/2018
55C9B5,partnership,100,61,7/12/2018
56632F,dividend,100,50,7/12/2018
56632F,buybacks,100,74,7/12/2018
57CAAB,earnings,100,50,7/12/2018
58CA9A,award,100,58,7/12/2018
5D0337,earnings,100,50,7/12/2018
5D16CF,conference-call,100,50,7/12/2018
5F2FF7,earnings-positive,100,69,7/12/2018
5F2FF7,earnings-positive,100,69,7/12/2018
5F2FF7,earnings-positive,100,69,7/12/2018
5F2FF7,earnings-positive,100,69,7/12/2018
5F2FF7,earnings-positive,100,69,7/12/2018
5FE4B6,conference-call,100,50,7/12/2018
6137BF,conference-call,100,50,7/12/2018
657097,unit-acquisition-acquirer,100,49,7/12/2018
665618,conference-call,100,50,7/12/2018
665D7D,clinical-trials-filed,100,60,7/12/2018
6BC6F9,earnings,100,50,7/12/2018
6CC55E,earnings,100,50,7/12/2018
6D1ADF,conference-call,100,50,7/12/2018
6DC1D7,conference-call,100,50,7/12/2018
6F0096,earnings-per-share-guidance,100,50,7/12/2018
6F6559,dividend,100,50,7/12/2018
701531,earnings,100,50,7/12/2018
70FCEF,executive-appointment,100,54,7/12/2018
728737,dividend,100,50,7/12/2018
72C2CE,conference-call,100,50,7/12/2018
72FCA3,dividend,100,50,7/12/2018
73A71F,conference-call,100,50,7/12/2018
76B926,conference-call,100,50,7/12/2018
76CEFB,earnings,100,50,7/12/2018
7740DE,same-store-sales,100,50,7/12/2018
789A7D,earnings,100,50,7/12/2018
78F9ED,dividend,100,50,7/12/2018
791D59,earnings,100,50,7/12/2018
791EC1,conference-call,100,50,7/12/2018
791EC1,executive-appointment,100,54,7/12/2018
7A51FE,conference-call,100,50,7/12/2018
7B6C88,earnings,100,50,7/12/2018
7B9212,revenues,100,50,7/12/2018
7BAAE7,earnings,100,50,7/12/2018
7C75FD,acquisition-acquirer,100,49,7/12/2018
7D7716,earnings,100,50,7/12/2018
7D97DE,conference-call,100,50,7/12/2018
7DA412,earnings,100,50,7/12/2018
7F0372,earnings,100,50,7/12/2018
81222C,earnings,100,50,7/12/2018
837C04,conference-call,100,50,7/12/2018
838ADD,earnings,100,50,7/12/2018
85DE00,conference-call,100,50,7/12/2018
860AB6,earnings,100,50,7/12/2018
863350,executive-appointment,100,54,7/12/2018
88350F,conference-call,100,50,7/12/2018
896771,earnings,100,50,7/12/2018
89F693,legal-issues-defendant,100,22,7/12/2018
8B1F37,executive-appointment,100,54,7/12/2018
8B3B0E,conference-call,100,50,7/12/2018
8B6E7E,conference-call,100,50,7/12/2018
8B9B3B,clinical-trials-positive,100,87,7/12/2018
8BAA15,earnings,100,50,7/12/2018
8C6C1B,facility-open,100,65,7/12/2018
8D4AE6,earnings,100,50,7/12/2018
8DE74B,conference-call,100,50,7/12/2018
8E9CD8,earnings,100,50,7/12/2018
93965C,earnings,100,50,7/12/2018
93965C,partnership,100,61,7/12/2018
9470CC,earnings,100,50,7/12/2018
94756D,earnings,100,50,7/12/2018
949625,conference-call,100,50,7/12/2018
94983E,acquisition-acquirer,100,49,7/12/2018
971F7B,earnings,100,50,7/12/2018
980C14,conference-call,100,50,7/12/2018
9.92E+94,earnings,100,50,7/12/2018
9C5174,partnership,100,61,7/12/2018
9EED50,conference-call,100,50,7/12/2018
9F71E5,executive-appointment,100,54,7/12/2018
9FF5F1,earnings,100,50,7/12/2018
A247F5,earnings,100,50,7/12/2018
A5151E,earnings,100,50,7/12/2018
A5A4F5,acquisition-acquirer,100,49,7/12/2018
A6213D,dividend,100,50,7/12/2018
AA09AD,partnership,100,61,7/12/2018
AA09AD,partnership,100,61,7/12/2018
AA09AD,partnership,100,61,7/12/2018
AADE0B,conference-call,100,50,7/12/2018
AD3008,earnings,100,50,7/12/2018
ADD9DC,facility-open,100,65,7/12/2018
B1B10C,dividend,100,50,7/12/2018
B3A166,legal-issues-defendant,100,22,7/12/2018
B3A166,legal-issues-defendant,100,22,7/12/2018
B3A166,legal-issues-defendant,100,22,7/12/2018
B3A166,legal-issues-defendant,100,22,7/12/2018
BB5271,partnership,100,61,7/12/2018
BE379D,earnings,100,50,7/12/2018
BF79F5,conference-call,100,50,7/12/2018
C0030A,partnership,100,61,7/12/2018
C22BE8,executive-appointment,100,54,7/12/2018
C407A0,executive-appointment,100,54,7/12/2018
C4706C,dividend,100,50,7/12/2018
C48574,revenue-up,100,69,7/12/2018
C48574,revenue-up,100,69,7/12/2018
C48574,revenue-up,100,69,7/12/2018
C48574,revenue-up,100,69,7/12/2018
C4A912,conference-call,100,50,7/12/2018
C54140,earnings,100,50,7/12/2018
C598D7,dividend,100,50,7/12/2018
C62AA4,conference-call,100,50,7/12/2018
C7AE14,award,100,58,7/12/2018
C8257F,executive-appointment,100,54,7/12/2018
C83B88,acquisition-interest-acquirer,100,46,7/12/2018
C83B88,product-release,100,64,7/12/2018
C83B88,product-release,100,64,7/12/2018
C9F39B,executive-appointment,100,54,7/12/2018
CA212F,dividend-up,100,81,7/12/2018
CBDB4D,public-offering,100,43,7/12/2018
CBFFDD,executive-appointment,100,54,7/12/2018
CC6FF5,partnership,100,61,7/12/2018
CD2DA4,dividend,100,50,7/12/2018
CDC217,clinical-trials-start,100,64,7/12/2018
CEC08B,earnings,100,50,7/12/2018
CF211D,executive-appointment,100,54,7/12/2018
CFF15D,legal-issues-defendant,100,22,7/12/2018
CFF15D,dividend,100,50,7/12/2018
CFF15D,earnings-guidance,100,50,7/12/2018
D08D2C,dividend,100,50,7/12/2018
D17C1B,revenue-volume,100,50,7/12/2018
D3CEDF,earnings-guidance,100,50,7/12/2018
D64C6D,executive-appointment,100,54,7/12/2018
D7A953,earnings,100,50,7/12/2018
D90F43,partnership,100,61,7/12/2018
DC0D18,earnings,100,50,7/12/2018
DCD97F,conference-call,100,50,7/12/2018
DD682D,dividend,100,50,7/12/2018
E0207A,earnings,100,50,7/12/2018
E05DC8,earnings,100,50,7/12/2018
E074A0,earnings,100,50,7/12/2018
E12A6E,dividend,100,50,7/12/2018
E26FC3,trading-halt,100,43,7/12/2018
E2CFD2,conference-call,100,50,7/12/2018
E41190,conference-call,100,50,7/12/2018
E67C2C,earnings,100,50,7/12/2018
E6D89E,partnership,100,61,7/12/2018
E74B55,product-release,100,64,7/12/2018
ED9C04,earnings,100,50,7/12/2018
EE6F1C,earnings,100,50,7/12/2018
EF5BED,executive-appointment,100,54,7/12/2018
F2E253,executive-resignation,100,44,7/12/2018
F83279,earnings,100,50,7/12/2018
F85CC0,savings,100,74,7/12/2018
F88A04,earnings,100,50,7/12/2018
FA918D,earnings-guidance,100,50,7/12/2018
FC1736,earnings,100,50,7/12/2018
FC1B7B,executive-appointment,100,54,7/12/2018
FC80E6,conference-call,100,50,7/12/2018
FD4BBE,earnings,100,50,7/12/2018
13528,dividend,100,50,7/13/2018
0624BE,partnership,100,61,7/13/2018
07EC43,earnings-guidance,100,50,7/13/2018
083F72,conference-call,100,50,7/13/2018
099A92,conference-call,100,50,7/13/2018
0C4131,conference-call,100,50,7/13/2018
0D26E0,dividend,100,50,7/13/2018
13D576,executive-salary,100,52,7/13/2018
13D576,executive-salary,100,52,7/13/2018
16AAE0,merger-regulatory-approval,100,81,7/13/2018
16AAE0,merger-regulatory-approval,100,81,7/13/2018
16AAE0,merger,100,66,7/13/2018
1F19C8,conference-call,100,50,7/13/2018
1F716B,conference-call,100,50,7/13/2018
251988,award,100,58,7/13/2018
28DCF3,earnings,100,50,7/13/2018
2BBE62,earnings,100,50,7/13/2018
2CA60F,partnership,100,61,7/13/2018
2D2D43,executive-resignation,100,44,7/13/2018
2F98A5,dividend-up,100,81,7/13/2018
35F4B5,earnings,100,50,7/13/2018
35F4B5,facility-open,100,65,7/13/2018
371B0A,conference-call,100,50,7/13/2018
3A3447,acquisition-completed-acquirer,100,49,7/13/2018
3E39A5,earnings-guidance,100,50,7/13/2018
442587,business-contract,100,69,7/13/2018
44ED36,dividend,100,50,7/13/2018
4.91E+58,conference-call,100,50,7/13/2018
4D72C8,note-sale,100,52,7/13/2018
525A1C,earnings,100,50,7/13/2018
562853,conference-call,100,50,7/13/2018
57B174,dividend,100,50,7/13/2018
58CA9A,earnings,100,50,7/13/2018
5EAA43,conference-call,100,50,7/13/2018
619882,earnings,100,50,7/13/2018
619882,dividend,100,50,7/13/2018
61B81B,earnings-positive,100,69,7/13/2018
61B81B,earnings,100,50,7/13/2018
61B81B,earnings,100,50,7/13/2018
61B81B,earnings,100,50,7/13/2018
61B81B,earnings,100,50,7/13/2018
61B81B,earnings,100,50,7/13/2018
61B81B,earnings,100,50,7/13/2018
61E975,conference-call,100,50,7/13/2018
629F0F,dividend,100,50,7/13/2018
6634D9,legal-issues-defendant,100,22,7/13/2018
6CDFC6,conference-call,100,50,7/13/2018
6F0096,conference-call,100,50,7/13/2018
70FCEF,executive-appointment,100,54,7/13/2018
762B8D,dividend,100,50,7/13/2018
789ADD,earnings,100,50,7/13/2018
7D5384,conference-call,100,50,7/13/2018
7E0EB0,business-contract,100,69,7/13/2018
838ADD,dividend,100,50,7/13/2018
859D62,buybacks,100,74,7/13/2018
8665BA,dividend,100,50,7/13/2018
89F693,earnings,100,50,7/13/2018
8C6C1B,facility-open,100,65,7/13/2018
8DBBE6,executive-appointment,100,54,7/13/2018
8DBE73,conference-call,100,50,7/13/2018
900356,earnings-guidance,100,50,7/13/2018
91E5EE,earnings,100,50,7/13/2018
93F143,earnings,100,50,7/13/2018
96F126,product-release,100,64,7/13/2018
977A1E,merger-regulatory-approval,100,81,7/13/2018
97AF94,dividend,100,50,7/13/2018
9AF3DC,conference-call,100,50,7/13/2018
9C25FF,earnings-guidance,100,50,7/13/2018
9D4EC7,conference-call,100,50,7/13/2018
A47A7D,product-release,100,64,7/13/2018
A5A4F5,acquisition-acquirer,100,49,7/13/2018
A74F6F,conference-call,100,50,7/13/2018
A806FA,earnings-guidance,100,50,7/13/2018
AAEE21,executive-appointment,100,54,7/13/2018
AAEE21,executive-appointment,100,54,7/13/2018
AD9F1D,dividend-up,100,81,7/13/2018
AFF7B4,legal-issues-defendant,100,22,7/13/2018
B3A166,legal-issues-defendant,100,22,7/13/2018
B3A166,legal-issues-defendant,100,22,7/13/2018
B3A166,legal-issues-defendant,100,22,7/13/2018
B3A166,legal-issues-defendant,100,22,7/13/2018
B3A166,legal-issues-defendant,100,22,7/13/2018
B7BDA3,conference-call,100,50,7/13/2018
BB0587,conference-call,100,50,7/13/2018
C50B26,award,100,58,7/13/2018
C66B44,award,100,58,7/13/2018
C7859D,earnings-up,100,68,7/13/2018
C7859D,earnings,100,50,7/13/2018
C7859D,earnings,100,50,7/13/2018
C7859D,earnings,100,50,7/13/2018
C7859D,earnings,100,50,7/13/2018
C7859D,earnings,100,50,7/13/2018
D8DA3D,dividend,100,50,7/13/2018
DB5CA5,facility-open,100,65,7/13/2018
E4158B,earnings,100,50,7/13/2018
E592F0,earnings,100,50,7/13/2018
E82A2D,conference-call,100,50,7/13/2018
E8846E,earnings-positive,100,69,7/13/2018
E90C84,conference-call,100,50,7/13/2018
ED0D7C,conference-call,100,50,7/13/2018
F0EEFB,operating-earnings,100,50,7/13/2018
F5349B,earnings,100,50,7/13/2018
F6E248,earnings,100,50,7/13/2018
F8BDCE,earnings,100,50,7/13/2018
55438C,donation,100,54,7/15/2018
55438C,donation,100,54,7/15/2018
CFF15D,legal-issues-defendant,100,22,7/15/2018
0142B5,conference-call,100,50,7/16/2018
04EB2F,earnings,100,50,7/16/2018
099C88,conference-call,100,50,7/16/2018
0F2BC9,conference-call,100,50,7/16/2018
11074E,business-contract,100,69,7/16/2018
135B09,unit-acquisition-acquirer,100,49,7/16/2018
147C38,dividend,100,50,7/16/2018
14833D,earnings,100,50,7/16/2018
149301,earnings,100,50,7/16/2018
1921DD,partnership,100,61,7/16/2018
1C599A,earnings,100,50,7/16/2018
1C599A,note-sale,100,52,7/16/2018
1D943E,earnings,100,50,7/16/2018
1FA886,partnership,100,61,7/16/2018
1FA886,partnership,100,61,7/16/2018
2082EA,executive-appointment,100,54,7/16/2018
21DED4,buybacks,100,74,7/16/2018
228D42,partnership,100,61,7/16/2018
228D42,partnership,100,61,7/16/2018
228D42,partnership,100,61,7/16/2018
228D42,partnership,100,61,7/16/2018
228D42,product-release,100,64,7/16/2018
239106,legal-issues-defendant,100,22,7/16/2018
249674,conference-call,100,50,7/16/2018
25A6CC,earnings,100,50,7/16/2018
2667B6,partnership,100,61,7/16/2018
26D8ED,conference-call,100,50,7/16/2018
27C10F,earnings,100,50,7/16/2018
2A17B1,conference-call,100,50,7/16/2018
2ABF77,conference-call,100,50,7/16/2018
2E61CC,partnership,100,61,7/16/2018
2EBA55,executive-appointment,100,54,7/16/2018
301493,legal-issues-defendant,100,22,7/16/2018
30A565,legal-issues-defendant,100,22,7/16/2018
37020C,earnings-guidance,100,50,7/16/2018
370C50,dividend,100,50,7/16/2018
3798B9,earnings,100,50,7/16/2018
387541,dividend,100,50,7/16/2018
39FB23,legal-issues-defendant,100,22,7/16/2018
3B20AB,dividend,100,50,7/16/2018
3BA1BF,business-combination,100,54,7/16/2018
3BA1BF,business-combination,100,54,7/16/2018
3D9999,partnership,100,61,7/16/2018
3DB18B,earnings,100,50,7/16/2018
3DD5E2,public-offering,100,43,7/16/2018
4.03E+05,earnings-guidance,100,50,7/16/2018
416291,dividend,100,50,7/16/2018
427F32,conference-call,100,50,7/16/2018
429BFB,conference-call,100,50,7/16/2018
435ACE,conference-call,100,50,7/16/2018
45444E,legal-issues-defendant,100,22,7/16/2018
4595EF,conference-call,100,50,7/16/2018
46A16E,conference-call,100,50,7/16/2018
4A2457,award,100,58,7/16/2018
4A2457,award,100,58,7/16/2018
4A6F00,partnership,100,61,7/16/2018
4D971D,conference-call,100,50,7/16/2018
5225A4,conference-organizer,100,57,7/16/2018
55438C,business-contract,100,69,7/16/2018
55438C,business-contract,100,69,7/16/2018
556F08,earnings,100,50,7/16/2018
55C9B5,partnership,100,61,7/16/2018
55C9B5,partnership,100,61,7/16/2018
55C9B5,product-release,100,64,7/16/2018
56765E,earnings,100,50,7/16/2018
5704AC,earnings,100,50,7/16/2018
57B174,conference-call,100,50,7/16/2018
57DDB9,merger,100,66,7/16/2018
58C2D4,earnings,100,50,7/16/2018
59A832,partnership,100,61,7/16/2018
5A423F,conference-participant,100,50,7/16/2018
5EAA43,business-contract,100,69,7/16/2018
5EC388,earnings,100,50,7/16/2018
61A586,earnings,100,50,7/16/2018
633043,earnings,100,50,7/16/2018
64E615,conference-call,100,50,7/16/2018
64FF65,executive-appointment,100,54,7/16/2018
6634D9,legal-issues-defendant,100,22,7/16/2018
6634D9,legal-issues-defendant,100,22,7/16/2018
6810DE,executive-appointment,100,54,7/16/2018
69345C,earnings,100,50,7/16/2018
6B236C,conference-call,100,50,7/16/2018
6D0CAB,dividend,100,50,7/16/2018
6E705B,business-contract,100,69,7/16/2018
6E705B,business-contract,100,69,7/16/2018
704B78,earnings,100,50,7/16/2018
72DF04,earnings,100,50,7/16/2018
73BCBA,executive-appointment,100,54,7/16/2018
767F86,earnings,100,50,7/16/2018
787D14,executive-appointment,100,54,7/16/2018
78F9ED,conference-call,100,50,7/16/2018
7AC86E,earnings-guidance,100,50,7/16/2018
7B1E50,executive-appointment,100,54,7/16/2018
7C62A3,note-sale,100,52,7/16/2018
7C790D,conference-call,100,50,7/16/2018
7CBC40,earnings,100,50,7/16/2018
7D5384,executive-appointment,100,54,7/16/2018
8.10E+205,executive-appointment,100,54,7/16/2018
8.22E+27,conference-call,100,50,7/16/2018
8303CD,conference-call,100,50,7/16/2018
855DF7,conference-call,100,50,7/16/2018
85DA04,earnings,100,50,7/16/2018
860AB6,conference-call,100,50,7/16/2018
862941,executive-appointment,100,54,7/16/2018
893904,public-offering,100,43,7/16/2018
896771,acquisition-acquirer,100,49,7/16/2018
89FBB1,conference-call,100,50,7/16/2018
8C6C1B,facility-open,100,65,7/16/2018
8D4486,partnership,100,61,7/16/2018
8E3F58,earnings,100,50,7/16/2018
8FE7A5,earnings,100,50,7/16/2018
901327,earnings,100,50,7/16/2018
9043FE,earnings,100,50,7/16/2018
9043FE,earnings,100,50,7/16/2018
931AE7,executive-appointment,100,54,7/16/2018
94756D,conference-participant,100,50,7/16/2018
96F126,partnership,100,61,7/16/2018
96F126,partnership,100,61,7/16/2018
9.74E+08,earnings,100,50,7/16/2018
97AAF6,earnings,100,50,7/16/2018
990AD0,earnings,100,50,7/16/2018
9C8BC3,dividend,100,50,7/16/2018
9D5FA4,earnings,100,50,7/16/2018
9EBAFA,unit-acquisition-acquirer,100,49,7/16/2018
A29DBD,conference-call,100,50,7/16/2018
A3800A,earnings,100,50,7/16/2018
A47A7D,partnership,100,61,7/16/2018
A5A4F5,acquisition-acquirer,100,49,7/16/2018
A6213D,earnings,100,50,7/16/2018
A666C8,dividend,100,50,7/16/2018
A6828A,dividend,100,50,7/16/2018
A790A5,acquisition-acquirer,100,49,7/16/2018
A7CCF0,conference-call,100,50,7/16/2018
AA5C8E,earnings,100,50,7/16/2018
AAEE21,conference-call,100,50,7/16/2018
AC3584,partnership,100,61,7/16/2018
AD23DE,acquisition-acquirer,100,49,7/16/2018
AEBB80,earnings,100,50,7/16/2018
AFF7B4,dividend,100,50,7/16/2018
B05118,earnings,100,50,7/16/2018
B3A166,legal-issues-defendant,100,22,7/16/2018
B3A166,legal-issues-defendant,100,22,7/16/2018
B3A166,revenue-up,100,69,7/16/2018
B3A166,legal-issues-defendant,100,22,7/16/2018
B3A166,legal-issues-defendant,100,22,7/16/2018
B72BE9,conference-call,100,50,7/16/2018
B83BCE,earnings,100,50,7/16/2018
B83D67,clinical-trials-start,100,64,7/16/2018
BD682F,earnings,100,50,7/16/2018
C598D7,acquisition-acquirer,100,49,7/16/2018
C99CC8,executive-appointment,100,54,7/16/2018
C9E4EC,ipo,100,71,7/16/2018
CB6A9C,asset-sale,100,62,7/16/2018
CB6A9C,acquisition-acquiree,100,76,7/16/2018
CB6A9C,acquisition-acquiree,100,76,7/16/2018
CBB77B,earnings,100,50,7/16/2018
CBB77B,earnings,100,50,7/16/2018
CBFFDD,acquisition-acquirer,100,49,7/16/2018
CBFFDD,acquisition-acquirer,100,49,7/16/2018
CBFFDD,acquisition-acquirer,100,49,7/16/2018
CC35BE,business-contract,100,69,7/16/2018
CE8251,note-sale,100,52,7/16/2018
CF6A5A,earnings,100,50,7/16/2018
CFF15D,legal-issues-defendant,100,22,7/16/2018
D06996,earnings,100,50,7/16/2018
D0DE27,earnings,100,50,7/16/2018
D33270,facility-upgrade,100,65,7/16/2018
D3C794,earnings,100,50,7/16/2018
D3CEDF,executive-appointment,100,54,7/16/2018
D3FA2C,executive-appointment,100,54,7/16/2018
D5938F,executive-appointment,100,54,7/16/2018
D5AF19,earnings,100,50,7/16/2018
D63B0F,conference-call,100,50,7/16/2018
D6489C,executive-appointment,100,54,7/16/2018
D64EDF,earnings,100,50,7/16/2018
D6853F,business-contract,100,69,7/16/2018
DD9E41,earnings,100,50,7/16/2018
E5752F,executive-appointment,100,54,7/16/2018
E5D914,acquisition-acquirer,100,49,7/16/2018
E5D914,acquisition-acquirer,100,49,7/16/2018
E74FED,executive-appointment,100,54,7/16/2018
E8E899,note-sale,100,52,7/16/2018
EA62FC,conference-call,100,50,7/16/2018
EB6965,conference-call,100,50,7/16/2018
EBC84C,earnings,100,50,7/16/2018
ECD263,earnings,100,50,7/16/2018
ED79D9,unit-acquisition-completed-acquirer,100,49,7/16/2018
EF7163,conference-call,100,50,7/16/2018
F46EC9,earnings,100,50,7/16/2018
F6DE54,dividend,100,50,7/16/2018
F721A7,earnings,100,50,7/16/2018
F721A7,earnings,100,50,7/16/2018
F748C7,partnership,100,61,7/16/2018
F93C8A,dividend,100,50,7/16/2018
F9CAF8,earnings-guidance,100,50,7/16/2018
FAE021,earnings,100,50,7/16/2018
FC1A6E,earnings,100,50,7/16/2018
FD39EB,earnings,100,50,7/16/2018
FDF799,earnings,100,50,7/16/2018
FEC475,executive-appointment,100,54,7/16/2018
FEE4B0,executive-appointment,100,54,7/16/2018
00326D,executive-appointment,100,54,7/17/2018
13528,index-listing,100,76,7/17/2018
034B61,partnership,100,61,7/17/2018
034B61,partnership,100,61,7/17/2018
034B61,partnership,100,61,7/17/2018
03596A,earnings,100,50,7/17/2018
04996E,earnings,100,50,7/17/2018
054E7E,clinical-trials,100,56,7/17/2018
55018,acquisition-completed-acquiree,100,76,7/17/2018
0560D8,earnings,100,50,7/17/2018
07C907,earnings,100,50,7/17/2018
07C907,earnings,100,50,7/17/2018
07CA6A,dividend,100,50,7/17/2018
07CA6A,executive-appointment,100,54,7/17/2018
98977,earnings,100,50,7/17/2018
0FC848,partnership,100,61,7/17/2018
129DC8,executive-appointment,100,54,7/17/2018
152B9E,product-release,100,64,7/17/2018
15B10D,award,100,58,7/17/2018
182BE7,earnings,100,50,7/17/2018
1834C0,earnings-guidance,100,50,7/17/2018
1C2593,executive-appointment,100,54,7/17/2018
1CD09C,partnership,100,61,7/17/2018
1E7785,partnership,100,61,7/17/2018
1E9A6D,dividend-up,100,81,7/17/2018
1EC3E8,executive-appointment,100,54,7/17/2018
1F3CFB,earnings,100,50,7/17/2018
1FAF22,dividend,100,50,7/17/2018
205AD5,earnings,100,50,7/17/2018
205AD5,earnings,100,50,7/17/2018
205AD5,earnings,100,50,7/17/2018
205AD5,earnings,100,50,7/17/2018
2158DF,earnings,100,50,7/17/2018
21F9CA,earnings,100,50,7/17/2018
221783,earnings,100,50,7/17/2018
228D42,partnership,100,61,7/17/2018
228D42,business-combination,100,54,7/17/2018
238302,conference-call,100,50,7/17/2018
24FA23,clinical-trials,100,56,7/17/2018
272704,earnings-up,100,68,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
272704,earnings,100,50,7/17/2018
28DCA8,executive-appointment,100,54,7/17/2018
2C19A4,conference-call,100,50,7/17/2018
2CA60F,earnings,100,50,7/17/2018
2DDB22,earnings-guidance,100,50,7/17/2018
2E61CC,partnership,100,61,7/17/2018
2EBA55,conference-call,100,50,7/17/2018
2F1299,conference-call,100,50,7/17/2018
2F960F,conference-call,100,50,7/17/2018
3.14E+47,earnings-positive,100,69,7/17/2018
3.30E+34,earnings-up,100,68,7/17/2018
3.30E+34,earnings-up,100,68,7/17/2018
3.30E+34,earnings-up,100,68,7/17/2018
3461CF,credit-rating-upgrade-rater,20,50,7/17/2018
35B907,merger-completed,100,66,7/17/2018
373B06,earnings,100,50,7/17/2018
396D7C,public-offering,100,43,7/17/2018
39FB23,executive-appointment,100,54,7/17/2018
3A6D90,dividend,100,50,7/17/2018
3BB616,earnings,100,50,7/17/2018
3CCC90,dividend-up,100,81,7/17/2018
3DCECC,conference-call,100,50,7/17/2018
3DD5E2,public-offering,100,43,7/17/2018
3F1C69,public-offering,100,43,7/17/2018
3F4668,earnings,100,50,7/17/2018
4.03E+05,acquisition-completed-acquirer,100,49,7/17/2018
41B53E,acquisition-acquirer,100,49,7/17/2018
42EFC7,ipo-pricing,100,50,7/17/2018
442769,business-contract,100,69,7/17/2018
447FC6,conference-call,100,50,7/17/2018
47FCF2,earnings,100,50,7/17/2018
48F795,earnings,100,50,7/17/2018
4A2457,business-contract,100,69,7/17/2018
4C5CC9,conference-call,100,50,7/17/2018
4D203E,earnings,100,50,7/17/2018
4D72C8,conference-call,100,50,7/17/2018
4F1432,fundraising,100,64,7/17/2018
510EA6,earnings,100,50,7/17/2018
510EA6,earnings,100,50,7/17/2018
513A86,earnings,100,50,7/17/2018
53E575,conference-call,100,50,7/17/2018
55C9B5,partnership,100,61,7/17/2018
59C539,dividend,100,50,7/17/2018
5B15E1,conference-participant,100,50,7/17/2018
5CCDAD,earnings,100,50,7/17/2018
6166D1,executive-appointment,100,54,7/17/2018
66667F,revenue-up,100,86,7/17/2018
67B923,conference-call,100,50,7/17/2018
693ECD,earnings,100,50,7/17/2018
6C4D2F,earnings-up,100,68,7/17/2018
6C4D2F,earnings-up,100,68,7/17/2018
6C4D2F,earnings-up,100,68,7/17/2018
6C4D2F,earnings-up,100,68,7/17/2018
6C4D2F,earnings-up,100,68,7/17/2018
6C4D2F,earnings-up,100,68,7/17/2018
6C4D2F,earnings-up,100,68,7/17/2018
6D0CAB,product-release,100,64,7/17/2018
6D3B7B,earnings,100,50,7/17/2018
6.00E+19,business-contract,100,69,7/17/2018
713810,partnership,100,61,7/17/2018
72609A,conference-call,100,50,7/17/2018
73BCBA,conference-call,100,50,7/17/2018
76BD96,note-sale,100,52,7/17/2018
76BD96,note-sale,100,52,7/17/2018
793C11,partnership,100,61,7/17/2018
7AB859,award,100,58,7/17/2018
7B1E50,dividend,100,50,7/17/2018
7D35D8,earnings-guidance,100,50,7/17/2018
7D5384,acquisition-acquirer,100,49,7/17/2018
7DD8CC,conference-call,100,50,7/17/2018
850779,earnings-per-share-positive,100,69,7/17/2018
850779,earnings-per-share,100,50,7/17/2018
850779,earnings-per-share,100,50,7/17/2018
850779,earnings-per-share,100,50,7/17/2018
85CDC9,earnings,100,50,7/17/2018
896771,investment-investor,100,55,7/17/2018
8AB37F,conference-call,100,50,7/17/2018
8C5519,earnings,100,50,7/17/2018
8C5519,earnings,100,50,7/17/2018
8C5519,earnings,100,50,7/17/2018
8C5519,earnings,100,50,7/17/2018
8C5519,earnings,100,50,7/17/2018
8C5519,earnings,100,50,7/17/2018
8C6C1B,facility-open,100,65,7/17/2018
8CF6DD,earnings,100,50,7/17/2018
8D4486,facility-open,100,65,7/17/2018
8D9993,conference-call,100,50,7/17/2018
8DDA23,dividend,100,50,7/17/2018
8FF2EF,earnings,100,50,7/17/2018
90B678,legal-issues-defendant,100,22,7/17/2018
90B678,legal-issues-defendant,100,22,7/17/2018
92D6A5,dividend,100,50,7/17/2018
93D207,dividend,100,50,7/17/2018
95DC1F,executive-resignation,100,44,7/17/2018
96F126,partnership,100,61,7/17/2018
96F126,earnings,100,50,7/17/2018
96F126,partnership,100,61,7/17/2018
9.86E+03,earnings,100,50,7/17/2018
9.86E+03,facility-upgrade,100,65,7/17/2018
9BB35A,dividend,100,50,7/17/2018
9BB35A,earnings-per-share-positive,100,69,7/17/2018
9BB35A,earnings-per-share,100,50,7/17/2018
9BB35A,earnings-per-share,100,50,7/17/2018
9BB35A,earnings-per-share,100,50,7/17/2018
9BB35A,buybacks,100,74,7/17/2018
9BF177,partnership,100,61,7/17/2018
9CA4C6,dividend-up,100,81,7/17/2018
9CA4C6,earnings-up,100,68,7/17/2018
9D30A8,earnings,100,50,7/17/2018
9E0811,earnings,100,50,7/17/2018
9E4A5F,executive-appointment,100,54,7/17/2018
9F5CBB,public-offering,100,43,7/17/2018
A23747,earnings,100,50,7/17/2018
A28C54,executive-appointment,100,54,7/17/2018
A47A7D,partnership,100,61,7/17/2018
A4D173,conference-call,100,50,7/17/2018
A4D173,conference-call,100,50,7/17/2018
A52533,earnings,100,50,7/17/2018
A5A4F5,acquisition-acquirer,100,49,7/17/2018
A6213D,revenues,100,50,7/17/2018
A6828A,earnings,100,50,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A746F6,earnings-per-share-positive,100,69,7/17/2018
A9ED24,dividend,100,50,7/17/2018
AC642C,conference-participant,100,50,7/17/2018
ACC7D3,earnings,100,50,7/17/2018
AFD1CA,conference-call,100,50,7/17/2018
AFF43F,dividend-up,100,81,7/17/2018
AFF43F,earnings,100,50,7/17/2018
AFF7B4,legal-issues-defendant,100,22,7/17/2018
B1DF3C,business-combination,100,54,7/17/2018
B1FC3B,fundraising,100,64,7/17/2018
B4C673,conference-call,100,50,7/17/2018
B53C12,conference-call,100,50,7/17/2018
B560AF,dividend,100,50,7/17/2018
B96DF5,earnings,100,50,7/17/2018
BD8517,earnings,100,50,7/17/2018
BDD12C,earnings,100,50,7/17/2018
BDE867,operating-earnings,100,50,7/17/2018
C4A241,conference-call,100,50,7/17/2018
C50B26,executive-appointment,100,54,7/17/2018
C50B26,executive-appointment,100,54,7/17/2018
C8257F,earnings,100,50,7/17/2018
C83B88,facility-open,100,65,7/17/2018
CB9E13,conference-call,100,50,7/17/2018
CBB77B,executive-appointment,100,54,7/17/2018
CE1002,executive-appointment,100,54,7/17/2018
D1AE3B,dividend,100,50,7/17/2018
D33D8C,earnings-up,100,68,7/17/2018
D33D8C,earnings-up,100,68,7/17/2018
D33D8C,earnings-up,100,68,7/17/2018
D33D8C,earnings-up,100,68,7/17/2018
D33D8C,earnings-up,100,68,7/17/2018
D33D8C,earnings-up,100,68,7/17/2018
D3FA2C,conference-call,100,50,7/17/2018
D4AC65,conference-call,100,50,7/17/2018
D5AF19,dividend,100,50,7/17/2018
D96202,executive-appointment,100,54,7/17/2018
DC1405,earnings,100,50,7/17/2018
DDCB34,conference-call,100,50,7/17/2018
DF532D,earnings,100,50,7/17/2018
DF532D,earnings,100,50,7/17/2018
E26FC3,earnings-up,100,68,7/17/2018
E49AA3,legal-verdict-favored,100,78,7/17/2018
E49AA3,business-contract,100,69,7/17/2018
E6A53A,earnings,100,50,7/17/2018
E7BF32,executive-appointment,100,54,7/17/2018
E7BF32,executive-appointment,100,54,7/17/2018
E829E8,earnings,100,50,7/17/2018
E8A49A,product-release,100,64,7/17/2018
E8A49A,product-release,100,64,7/17/2018
E93A40,earnings,100,50,7/17/2018
E96E0B,earnings,100,50,7/17/2018
EB43F4,clinical-trials-start,100,64,7/17/2018
EBD89A,business-contract,100,69,7/17/2018
ED8676,executive-appointment,100,54,7/17/2018
EEEA9F,earnings,100,50,7/17/2018
F2526D,ipo-pricing,100,50,7/17/2018
F3016C,earnings,100,50,7/17/2018
F7ADEB,conference-call,100,50,7/17/2018
F7FCA4,conference-call,100,50,7/17/2018
FFAB4A,earnings,100,50,7/17/2018
0142B5,dividend,100,50,7/18/2018
0157B1,partnership,100,61,7/18/2018
03F5A4,earnings-positive,100,69,7/18/2018
09062E,conference-call,100,50,7/18/2018
0986B5,earnings,100,50,7/18/2018
0A0CF0,dividend,100,50,7/18/2018
0B4D10,earnings,100,50,7/18/2018
0BC29E,acquisition-completed-acquirer,100,49,7/18/2018
0BF528,acquisition-acquirer,100,49,7/18/2018
0C2A0D,partnership,100,61,7/18/2018
0C355F,conference-call,100,50,7/18/2018
0C466B,earnings,100,50,7/18/2018
0C466B,earnings,100,50,7/18/2018
0D03C8,earnings,100,50,7/18/2018
0EF1AF,executive-appointment,100,54,7/18/2018
0F65C9,conference-call,100,50,7/18/2018
1065BC,conference-call,100,50,7/18/2018
108A2B,conference-call,100,50,7/18/2018
1220D2,earnings,100,50,7/18/2018
14BA06,ownership-decrease-owner,100,46,7/18/2018
152AB9,conference-call,100,50,7/18/2018
165B3A,earnings-positive,100,69,7/18/2018
165B3A,earnings-positive,100,69,7/18/2018
165B3A,earnings-positive,100,69,7/18/2018
165B3A,earnings-positive,100,69,7/18/2018
168A5D,executive-appointment,100,54,7/18/2018
1748B3,earnings,100,50,7/18/2018
1748B3,earnings,100,50,7/18/2018
1748B3,earnings,100,50,7/18/2018
1748B3,earnings,100,50,7/18/2018
1748B3,earnings,100,50,7/18/2018
1748B3,earnings,100,50,7/18/2018
1921DD,partnership,100,61,7/18/2018
19CAC7,earnings,100,50,7/18/2018
19CAC7,earnings,100,50,7/18/2018
19CAC7,earnings,100,50,7/18/2018
1A2D9F,earnings,100,50,7/18/2018
1A9DE1,earnings-up,100,68,7/18/2018
1A9DE1,earnings-up,100,68,7/18/2018
1A9DE1,earnings-up,100,68,7/18/2018
1AB808,earnings,100,50,7/18/2018
1C599A,public-offering,100,43,7/18/2018
1D5C51,conference-call,100,50,7/18/2018
1DA44F,dividend-up,100,81,7/18/2018
1DEBBE,earnings,100,50,7/18/2018
1F43A1,unit-acquisition-acquirer,100,49,7/18/2018
1F43A1,unit-acquisition-acquirer,100,49,7/18/2018
1FA8F7,earnings-positive,100,69,7/18/2018
2031CE,executive-appointment,100,54,7/18/2018
21153F,partnership,100,61,7/18/2018
228D42,partnership,100,61,7/18/2018
23207A,executive-appointment,100,54,7/18/2018
239106,legal-issues-defendant,100,22,7/18/2018
2.45E+15,earnings,100,50,7/18/2018
25AB8E,legal-issues-defendant,100,22,7/18/2018
2720AB,conference-call,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
275300,earnings,100,50,7/18/2018
27B191,conference-call,100,50,7/18/2018
27BFA1,revenue-up,100,69,7/18/2018
27BFA1,revenue-up,100,69,7/18/2018
27BFA1,revenue-up,100,69,7/18/2018
27BFA1,revenue-up,100,69,7/18/2018
27BFA1,revenue-up,100,69,7/18/2018
27BFA1,revenue-up,100,69,7/18/2018
2A1009,conference-call,100,50,7/18/2018
2DB344,earnings,100,50,7/18/2018
301493,product-release,100,64,7/18/2018
3159AA,facility-open,100,65,7/18/2018
31A7CC,earnings,100,50,7/18/2018
31A7CC,earnings,100,50,7/18/2018
31A7CC,earnings,100,50,7/18/2018
32CB22,earnings-guidance-up,100,83,7/18/2018
339F20,earnings,100,50,7/18/2018
349DA4,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
34B411,earnings,100,50,7/18/2018
35AE32,earnings,100,50,7/18/2018
370C50,commodity-sell,100,45,7/18/2018
3BC360,conference-call,100,50,7/18/2018
3C11C4,earnings,100,50,7/18/2018
3CCC90,earnings,100,50,7/18/2018
3D9999,product-release,100,64,7/18/2018
3ED92D,executive-appointment,100,54,7/18/2018
3F6A9C,conference-call,100,50,7/18/2018
407878,earnings,100,50,7/18/2018
408089,dividend,100,50,7/18/2018
40F7DE,executive-appointment,100,54,7/18/2018
41A93D,earnings,100,50,7/18/2018
435ACE,executive-appointment,100,54,7/18/2018
43A74A,business-contract,100,69,7/18/2018
43E8F5,conference-call,100,50,7/18/2018
44209A,legal-issues-defendant,100,22,7/18/2018
449217,merger,100,66,7/18/2018
4885C8,earnings,100,50,7/18/2018
494EB9,earnings,100,50,7/18/2018
4A2457,partnership,100,61,7/18/2018
4A2457,partnership,100,61,7/18/2018
4A6F00,partnership,100,61,7/18/2018
4AE584,product-release,100,64,7/18/2018
4B3676,earnings,100,50,7/18/2018
4C37C5,earnings-per-share-positive,100,69,7/18/2018
4C37C5,earnings-per-share,100,50,7/18/2018
4C37C5,earnings-per-share,100,50,7/18/2018
4C6C63,dividend,100,50,7/18/2018
4DD09F,earnings,100,50,7/18/2018
51888A,revenues,100,50,7/18/2018
520632,earnings,100,50,7/18/2018
520632,earnings,100,50,7/18/2018
520632,earnings,100,50,7/18/2018
520632,earnings,100,50,7/18/2018
520632,earnings,100,50,7/18/2018
520632,earnings,100,50,7/18/2018
53F491,earnings-per-share-positive,100,69,7/18/2018
54DF47,public-offering,100,43,7/18/2018
55438C,business-contract,100,69,7/18/2018
55438C,business-contract,100,69,7/18/2018
56632F,earnings,100,50,7/18/2018
57F3DA,earnings,100,50,7/18/2018
589F5A,dividend,100,50,7/18/2018
59C539,dividend,100,50,7/18/2018
5B3415,earnings,100,50,7/18/2018
5F60CE,earnings,100,50,7/18/2018
5F6D73,earnings,100,50,7/18/2018
5F6D73,earnings,100,50,7/18/2018
5F6D73,earnings,100,50,7/18/2018
5F6D73,earnings,100,50,7/18/2018
5F6D73,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
6166D1,earnings,100,50,7/18/2018
622DBE,conference-call,100,50,7/18/2018
62B1C6,dividend,100,50,7/18/2018
6D156D,earnings,100,50,7/18/2018
6D9B53,conference-participant,100,50,7/18/2018
6E705B,executive-appointment,100,54,7/18/2018
6E8864,conference-call,100,50,7/18/2018
6EB9DA,earnings,100,50,7/18/2018
6EB9DA,earnings,100,50,7/18/2018
6EB9DA,earnings,100,50,7/18/2018
722D55,earnings,100,50,7/18/2018
7239BB,public-offering,100,43,7/18/2018
726EEA,earnings,100,50,7/18/2018
7273FF,earnings,100,50,7/18/2018
731675,earnings,100,50,7/18/2018
73529F,conference-call,100,50,7/18/2018
76D79A,earnings-guidance,100,50,7/18/2018
76DD0C,ipo-pricing,100,50,7/18/2018
76F067,partnership,100,61,7/18/2018
76F067,executive-appointment,100,54,7/18/2018
773A17,earnings,100,50,7/18/2018
775439,earnings,100,50,7/18/2018
787D14,executive-appointment,100,54,7/18/2018
793C11,partnership,100,61,7/18/2018
7ACD98,earnings-guidance,100,50,7/18/2018
7B9AFA,earnings,100,50,7/18/2018
7C62A3,conference-call,100,50,7/18/2018
7C75FD,conference-call,100,50,7/18/2018
7F3665,earnings,100,50,7/18/2018
7F9E16,conference-call,100,50,7/18/2018
804708,legal-issues-defendant,100,22,7/18/2018
8275FE,earnings-up,100,68,7/18/2018
845655,conference-call,100,50,7/18/2018
84A6B9,earnings-up,100,86,7/18/2018
86478F,earnings,100,50,7/18/2018
895D56,conference-call,100,50,7/18/2018
895D56,executive-appointment,100,54,7/18/2018
8C6C1B,facility-open,100,65,7/18/2018
8D4486,earnings,100,50,7/18/2018
8D4486,earnings,100,50,7/18/2018
8D4486,earnings,100,50,7/18/2018
8D4486,earnings,100,50,7/18/2018
90B678,legal-issues-defendant,100,22,7/18/2018
90B678,fraud-defendant,100,20,7/18/2018
92B047,earnings,100,50,7/18/2018
92D9C9,earnings-guidance,100,50,7/18/2018
93633B,earnings,100,50,7/18/2018
93633B,earnings,100,50,7/18/2018
93633B,earnings,100,50,7/18/2018
93633B,earnings,100,50,7/18/2018
93AD2E,facility-close,100,47,7/18/2018
940C3D,asset-sale,100,62,7/18/2018
942165,earnings,100,50,7/18/2018
954A47,earnings-positive,100,69,7/18/2018
9.54E+32,partnership,100,61,7/18/2018
95F59E,earnings,100,50,7/18/2018
9.62E+76,earnings,100,50,7/18/2018
9.62E+76,earnings,100,50,7/18/2018
9.62E+76,earnings,100,50,7/18/2018
9.65E+09,conference-call,100,50,7/18/2018
965360,earnings,100,50,7/18/2018
965360,earnings,100,50,7/18/2018
965360,earnings,100,50,7/18/2018
965360,earnings,100,50,7/18/2018
965360,earnings,100,50,7/18/2018
965360,earnings,100,50,7/18/2018
965360,earnings,100,50,7/18/2018
972356,earnings,100,50,7/18/2018
972356,earnings,100,50,7/18/2018
972356,earnings,100,50,7/18/2018
972356,earnings,100,50,7/18/2018
986AF6,conference-call,100,50,7/18/2018
9E98F2,earnings,100,50,7/18/2018
9E98F2,earnings,100,50,7/18/2018
9E98F2,earnings,100,50,7/18/2018
9F5CBB,public-offering,100,43,7/18/2018
9F71E5,acquisition-completed-acquirer,100,49,7/18/2018
A0F146,executive-appointment,100,54,7/18/2018
A21649,conference-call,100,50,7/18/2018
A2CAF7,earnings,100,50,7/18/2018
A398F8,earnings,100,50,7/18/2018
A47A7D,business-contract,100,69,7/18/2018
A495F7,earnings,100,50,7/18/2018
A5A4F5,acquisition-acquirer,100,49,7/18/2018
A790A5,unit-acquisition-acquirer,100,49,7/18/2018
AA09AD,earnings,100,50,7/18/2018
AA5C8E,dividend,100,50,7/18/2018
AA5C8E,dividend,100,50,7/18/2018
AA5C8E,dividend,100,50,7/18/2018
AA5C8E,dividend,100,50,7/18/2018
AA5C8E,dividend,100,50,7/18/2018
AA5C8E,dividend,100,50,7/18/2018
AABEA0,dividend,100,50,7/18/2018
AC775C,conference-call,100,50,7/18/2018
AC7C4F,business-contract,100,69,7/18/2018
ACC7D3,conference-participant,100,50,7/18/2018
ADF1B0,conference-call,100,50,7/18/2018
AEF2C3,conference-call,100,50,7/18/2018
AFEC35,facility-open,100,65,7/18/2018
B0B969,conference-call,100,50,7/18/2018
B1FC3B,business-contract,100,69,7/18/2018
B37FB4,executive-appointment,100,54,7/18/2018
B3A166,legal-issues-defendant,100,22,7/18/2018
B4F5F4,conference-call,100,50,7/18/2018
BB58FF,conference-call,100,50,7/18/2018
BB88B6,award,100,58,7/18/2018
BD682F,dividend,100,50,7/18/2018
C11C46,earnings,100,50,7/18/2018
C32A39,dividend,100,50,7/18/2018
C3DE7D,product-release,100,64,7/18/2018
C66B44,conference-call,100,50,7/18/2018
C8A059,earnings,100,50,7/18/2018
C98CDB,earnings,100,50,7/18/2018
C9B932,earnings,100,50,7/18/2018
C9E107,dividend-up,100,72,7/18/2018
C9F39B,earnings,100,50,7/18/2018
C9F39B,earnings,100,50,7/18/2018
C9F39B,earnings,100,50,7/18/2018
C9F39B,earnings,100,50,7/18/2018
C9F39B,earnings,100,50,7/18/2018
C9F39B,earnings,100,50,7/18/2018
C9F39B,earnings,100,50,7/18/2018
CA212F,earnings,100,50,7/18/2018
CA99D7,product-recall,100,29,7/18/2018
CBBFBF,earnings,100,50,7/18/2018
CBFFDD,product-release,100,64,7/18/2018
CBFFDD,product-release,100,64,7/18/2018
CC3EC4,conference-participant,100,50,7/18/2018
CDD75E,legal-issues-defendant,100,22,7/18/2018
CE1002,dividend-up,100,81,7/18/2018
CEC5B9,conference-call,100,50,7/18/2018
D1AE3B,earnings,100,50,7/18/2018
D20C8F,earnings,100,50,7/18/2018
D21D8A,earnings-up,100,68,7/18/2018
D21D8A,earnings,100,50,7/18/2018
D21D8A,earnings,100,50,7/18/2018
D21D8A,earnings,100,50,7/18/2018
D21D8A,earnings,100,50,7/18/2018
D21D8A,earnings,100,50,7/18/2018
D21D8A,earnings,100,50,7/18/2018
D27FAB,conference-call,100,50,7/18/2018
D2B9E5,product-release,100,64,7/18/2018
D2B9E5,product-release,100,64,7/18/2018
D3DE34,earnings,100,50,7/18/2018
D437C3,earnings,100,50,7/18/2018
D721C6,dividend,100,50,7/18/2018
D7918D,earnings,100,50,7/18/2018
D854F3,dividend,100,50,7/18/2018
D90F43,partnership,100,61,7/18/2018
D90F43,partnership,100,61,7/18/2018
D93A25,earnings,100,50,7/18/2018
DD3BB1,earnings,100,50,7/18/2018
E0339F,business-contract,100,69,7/18/2018
E1E093,partnership,100,61,7/18/2018
E592F0,buybacks,100,74,7/18/2018
E754F0,earnings,100,50,7/18/2018
EAEBF3,dividend,100,50,7/18/2018
EB36DE,conference-call,100,50,7/18/2018
ED2A5E,conference-call,100,50,7/18/2018
ED5171,earnings,100,50,7/18/2018
EEB5F9,ipo-pricing,100,50,7/18/2018
EF25A5,earnings,100,50,7/18/2018
F11638,acquisition-acquiree,100,76,7/18/2018
F1C04C,conference-call,100,50,7/18/2018
F30508,clinical-trials-positive,100,87,7/18/2018
F40EE2,executive-appointment,100,54,7/18/2018
F44EA2,earnings,100,50,7/18/2018
F4E992,partnership,100,61,7/18/2018
F57F6F,earnings,100,50,7/18/2018
F6FA6A,earnings,100,50,7/18/2018
F702CA,dividend,100,50,7/18/2018
FA40E2,dividend,100,50,7/18/2018
FAEABE,earnings-per-share-up,100,68,7/18/2018
FC9869,earnings-guidance-up,100,83,7/18/2018
FD39EB,dividend,100,50,7/18/2018
00698D,dividend,100,50,7/19/2018
13528,business-contract,100,69,7/19/2018
0157B1,partnership,100,61,7/19/2018
55018,earnings-positive,100,69,7/19/2018
06EF42,conference-call,100,50,7/19/2018
083F72,dividend,100,50,7/19/2018
0A0CF0,earnings,100,50,7/19/2018
0A0CF0,earnings,100,50,7/19/2018
0A0CF0,earnings,100,50,7/19/2018
0A0CF0,earnings,100,50,7/19/2018
0A0CF0,earnings,100,50,7/19/2018
0A7650,earnings-positive,100,69,7/19/2018
0A7650,earnings-positive,100,69,7/19/2018
0A7650,earnings-positive,100,69,7/19/2018
0A7650,earnings-positive,100,69,7/19/2018
0AB700,earnings,100,50,7/19/2018
0BB9E5,earnings,100,50,7/19/2018
0BC17A,dividend,100,50,7/19/2018
0BC17A,earnings,100,50,7/19/2018
0C8D82,earnings,100,50,7/19/2018
0CC01F,earnings,100,50,7/19/2018
0E5223,conference-call,100,50,7/19/2018
0F91FC,conference-call,100,50,7/19/2018
105D00,earnings-positive,100,69,7/19/2018
105D00,earnings-positive,100,69,7/19/2018
105D00,earnings-positive,100,69,7/19/2018
105D00,earnings-positive,100,69,7/19/2018
105D00,earnings-positive,100,69,7/19/2018
105D00,earnings-positive,100,69,7/19/2018
105D00,earnings-positive,100,69,7/19/2018
129DC8,conference-participant,100,50,7/19/2018
152E1D,conference-call,100,50,7/19/2018
1.79E+10,conference-call,100,50,7/19/2018
17EDA5,dividend,100,50,7/19/2018
182B8C,conference-call,100,50,7/19/2018
188394,dividend,100,50,7/19/2018
18EC17,earnings,100,50,7/19/2018
1921DD,business-contract,100,69,7/19/2018
19C105,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A3E1B,earnings,100,50,7/19/2018
1A6A94,dividend,100,50,7/19/2018
2096DE,earnings,100,50,7/19/2018
225CA2,dividend,100,50,7/19/2018
239106,legal-issues-defendant,100,22,7/19/2018
2491BC,executive-appointment,100,54,7/19/2018
24CB56,earnings-positive,100,69,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24CB56,earnings,100,50,7/19/2018
24D81E,earnings,100,50,7/19/2018
26CC63,dividend,100,50,7/19/2018
2720AB,acquisition-acquirer,100,49,7/19/2018
2CA60F,product-release,100,64,7/19/2018
2DA92D,conference-call,100,50,7/19/2018
2E0496,earnings,100,50,7/19/2018
2F6782,conference-call,100,50,7/19/2018
2F7474,earnings,100,50,7/19/2018
31553A,earnings,100,50,7/19/2018
3159AA,conference-call,100,50,7/19/2018
31666F,earnings,100,50,7/19/2018
31DB20,dividend,100,50,7/19/2018
31DB20,earnings,100,50,7/19/2018
328250,conference-call,100,50,7/19/2018
343996,dividend,100,50,7/19/2018
343996,dividend,100,50,7/19/2018
34A959,earnings,100,50,7/19/2018
370C50,earnings,100,50,7/19/2018
372037,conference-call,100,50,7/19/2018
37B120,earnings,100,50,7/19/2018
39BFF6,dividend,100,50,7/19/2018
39FB23,earnings,100,50,7/19/2018
39FB23,earnings,100,50,7/19/2018
39FB23,earnings,100,50,7/19/2018
39FB23,earnings,100,50,7/19/2018
3A3447,facility-open,100,65,7/19/2018
3B37F7,conference-call,100,50,7/19/2018
3C3B6B,earnings,100,50,7/19/2018
3C8A04,earnings,100,50,7/19/2018
3ED92D,conference-call,100,50,7/19/2018
3F1C69,clinical-trials-start,100,64,7/19/2018
3FBC9B,earnings,100,50,7/19/2018
41B53E,earnings,100,50,7/19/2018
420168,earnings,100,50,7/19/2018
4455C4,conference-call,100,50,7/19/2018
44740A,conference-call,100,50,7/19/2018
449A26,earnings-positive,100,69,7/19/2018
449A26,unit-acquisition-acquirer,100,49,7/19/2018
449A26,dividend,100,50,7/19/2018
44A4FC,earnings,100,50,7/19/2018
453282,earnings-per-share-positive,100,69,7/19/2018
487B7A,earnings-up,100,68,7/19/2018
4A2457,award,100,58,7/19/2018
4A2457,award,100,58,7/19/2018
4A6F00,partnership,100,61,7/19/2018
4A6F00,conference-organizer,100,57,7/19/2018
4E5784,earnings,100,50,7/19/2018
4EEE7E,earnings,100,50,7/19/2018
51F541,conference-call,100,50,7/19/2018
5225A4,earnings,100,50,7/19/2018
5225A4,earnings,100,50,7/19/2018
545272,conference-call,100,50,7/19/2018
5480A7,earnings,100,50,7/19/2018
54DF47,public-offering,100,43,7/19/2018
5876DC,dividend,100,50,7/19/2018
59C539,earnings,100,50,7/19/2018
5A53BF,earnings,100,50,7/19/2018
5A64D5,conference-call,100,50,7/19/2018
5B97B2,note-sale,100,52,7/19/2018
5B97B2,note-sale,100,52,7/19/2018
5B97B2,note-sale,100,52,7/19/2018
5B97B2,note-sale,100,52,7/19/2018
5B97B2,note-sale,100,52,7/19/2018
5B97B2,note-sale,100,52,7/19/2018
5BC2F4,earnings,100,50,7/19/2018
5BC2F4,dividend,100,50,7/19/2018
5BFE94,dividend,100,50,7/19/2018
5CC29D,dividend,100,50,7/19/2018
5D1956,ipo-pricing,100,50,7/19/2018
5DE5A5,earnings-up,100,68,7/19/2018
5DE5A5,earnings,100,50,7/19/2018
5DE5A5,earnings,100,50,7/19/2018
5F2FF7,joint-venture,100,62,7/19/2018
5F2FF7,joint-venture,100,62,7/19/2018
5F2FF7,joint-venture,100,62,7/19/2018
5F6D73,dividend-up,100,81,7/19/2018
5FF95F,earnings,100,50,7/19/2018
5FF95F,earnings-up,100,68,7/19/2018
5FF95F,earnings-up,100,68,7/19/2018
5FF95F,earnings-up,100,68,7/19/2018
5FF95F,earnings-up,100,68,7/19/2018
619882,conference-organizer,100,57,7/19/2018
622037,earnings,100,50,7/19/2018
636639,earnings,100,50,7/19/2018
636639,earnings,100,50,7/19/2018
636639,earnings,100,50,7/19/2018
636639,earnings,100,50,7/19/2018
636931,earnings,100,50,7/19/2018
6474BA,earnings-positive,100,69,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6474BA,earnings,100,50,7/19/2018
6559D8,ipo-completed,100,76,7/19/2018
67A658,business-contract,100,69,7/19/2018
69CE71,business-contract,100,69,7/19/2018
6B0784,conference-call,100,50,7/19/2018
6BDA0C,conference-call,100,50,7/19/2018
6C987C,earnings-up,100,82,7/19/2018
6.00E+19,conference-call,100,50,7/19/2018
6E8349,earnings,100,50,7/19/2018
6F3FA8,executive-appointment,100,54,7/19/2018
717DB4,earnings,100,50,7/19/2018
722D55,product-release,100,64,7/19/2018
7448A3,dividend,100,50,7/19/2018
7520CC,earnings,100,50,7/19/2018
762A3E,conference-call,100,50,7/19/2018
766047,dividend-up,100,70,7/19/2018
7.83E+79,earnings,100,50,7/19/2018
7BAAE7,dividend,100,50,7/19/2018
80C400,product-release,100,64,7/19/2018
82FD6D,conference-call,100,50,7/19/2018
8377DB,earnings,100,50,7/19/2018
83A065,conference-call,100,50,7/19/2018
855DF7,dividend,100,50,7/19/2018
893904,public-offering,100,43,7/19/2018
89B2E7,earnings,100,50,7/19/2018
8A0368,conference-call,100,50,7/19/2018
8BE916,earnings,100,50,7/19/2018
8C5519,asset-sale,100,62,7/19/2018
8C6C1B,facility-open,100,65,7/19/2018
8D4486,product-release,100,64,7/19/2018
8D4486,earnings,100,50,7/19/2018
8D4486,business-contract,100,69,7/19/2018
8DDA23,earnings-positive,100,69,7/19/2018
9043FE,note-sale,100,52,7/19/2018
9043FE,note-sale,100,52,7/19/2018
9043FE,note-sale,100,52,7/19/2018
9043FE,note-sale,100,52,7/19/2018
907ED2,earnings-up,100,68,7/19/2018
90B678,legal-issues-defendant,100,22,7/19/2018
92D6A5,earnings,100,50,7/19/2018
931AE7,executive-appointment,100,54,7/19/2018
94563D,partnership,100,61,7/19/2018
94563D,earnings,100,50,7/19/2018
94637C,partnership,100,61,7/19/2018
9.54E+32,dividend,100,50,7/19/2018
965360,dividend,100,50,7/19/2018
96F126,partnership,100,61,7/19/2018
97AAF6,dividend,100,50,7/19/2018
986AF6,earnings,100,50,7/19/2018
986AF6,earnings,100,50,7/19/2018
989E2F,earnings,100,50,7/19/2018
989E2F,earnings,100,50,7/19/2018
98CEBB,earnings,100,50,7/19/2018
98D33E,dividend,100,50,7/19/2018
990AD0,unit-acquisition-acquiree,100,76,7/19/2018
9.92E+94,earnings,100,50,7/19/2018
9.92E+94,earnings,100,50,7/19/2018
9.92E+94,earnings,100,50,7/19/2018
9981C6,earnings,100,50,7/19/2018
9BB35A,award,100,58,7/19/2018
9BB35A,conference-call,100,50,7/19/2018
9DDE1B,index-listing,100,76,7/19/2018
9E298A,dividend,100,50,7/19/2018
9E4A5F,earnings,100,50,7/19/2018
9E575E,earnings,100,50,7/19/2018
A15C71,executive-appointment,100,54,7/19/2018
A16DEA,executive-appointment,100,54,7/19/2018
A16DEA,dividend,100,50,7/19/2018
A350C1,business-contract,100,69,7/19/2018
A3F598,merger,100,66,7/19/2018
A3F598,merger,100,66,7/19/2018
A3F598,merger,100,66,7/19/2018
A403CF,earnings,100,50,7/19/2018
A48593,conference-call,100,50,7/19/2018
A4B899,conference-call,100,50,7/19/2018
A5628C,earnings-positive,100,69,7/19/2018
A5A4F5,acquisition-acquirer,100,49,7/19/2018
A60354,conference-call,100,50,7/19/2018
A72FD9,executive-appointment,100,54,7/19/2018
A7F0A5,earnings,100,50,7/19/2018
A8CBDA,dividend,100,50,7/19/2018
AB4A7E,earnings,100,50,7/19/2018
AD23DE,conference-call,100,50,7/19/2018
AD3C93,earnings,100,50,7/19/2018
AFD7DD,conference-call,100,50,7/19/2018
B0998E,earnings,100,50,7/19/2018
B09B1F,conference-call,100,50,7/19/2018
B2DAF6,earnings,100,50,7/19/2018
B2DAF6,executive-appointment,100,54,7/19/2018
B3A166,legal-issues-defendant,100,22,7/19/2018
B5766D,earnings,100,50,7/19/2018
B5766D,earnings,100,50,7/19/2018
B5766D,earnings,100,50,7/19/2018
B5766D,earnings,100,50,7/19/2018
B5766D,earnings,100,50,7/19/2018
B5766D,earnings,100,50,7/19/2018
B5BA39,earnings,100,50,7/19/2018
B7FA9B,conference-call,100,50,7/19/2018
B9CD50,executive-appointment,100,54,7/19/2018
BDF2BD,conference-call,100,50,7/19/2018
BE5935,earnings-revision,100,29,7/19/2018
BF79F5,facility-open,100,65,7/19/2018
BFAEB4,earnings,100,50,7/19/2018
BFEA04,conference-call,100,50,7/19/2018
C062D4,partnership,100,61,7/19/2018
C15DB3,revenue-up,100,69,7/19/2018
C15DB3,revenue-up,100,69,7/19/2018
C15F8F,executive-resignation,100,44,7/19/2018
C2609A,executive-appointment,100,54,7/19/2018
C2F597,earnings,100,50,7/19/2018
C3BAE7,acquisition-completed-acquirer,100,49,7/19/2018
C3BCD5,product-release,100,64,7/19/2018
C3BCD5,legal-issues-defendant,100,22,7/19/2018
C41C25,earnings,100,50,7/19/2018
C4FBDC,conference-call,100,50,7/19/2018
C584BE,legal-issues-defendant,100,22,7/19/2018
C5E100,conference-call,100,50,7/19/2018
C65004,executive-appointment,100,54,7/19/2018
C8257F,dividend,100,50,7/19/2018
C8923A,earnings,100,50,7/19/2018
C9732E,ipo-pricing,100,50,7/19/2018
C99CC8,earnings,100,50,7/19/2018
CA1620,earnings,100,50,7/19/2018
CB89EA,executive-appointment,100,54,7/19/2018
CC35BE,executive-appointment,100,54,7/19/2018
CCB623,executive-appointment,100,54,7/19/2018
CDAB24,conference-call,100,50,7/19/2018
CDFCC9,product-release,100,64,7/19/2018
CE8251,executive-resignation,100,44,7/19/2018
CFD4B6,conference-call,100,50,7/19/2018
D09938,executive-appointment,100,54,7/19/2018
D11C1C,market-entry,100,57,7/19/2018
D17F7E,dividend-up,100,81,7/19/2018
D25249,conference-call,100,50,7/19/2018
D296C6,earnings,100,50,7/19/2018
D48275,earnings,100,50,7/19/2018
D650A7,earnings,100,50,7/19/2018
D721C6,earnings,100,50,7/19/2018
D854F3,conference-call,100,50,7/19/2018
D8F347,earnings-up,100,68,7/19/2018
D8F347,earnings,100,50,7/19/2018
D8F347,earnings,100,50,7/19/2018
DA48E4,dividend,100,50,7/19/2018
E09E2B,conference-call,100,50,7/19/2018
E124EB,spin-off,100,58,7/19/2018
E124EB,earnings,100,50,7/19/2018
E124EB,earnings,100,50,7/19/2018
E124EB,earnings,100,50,7/19/2018
E19A99,earnings,100,50,7/19/2018
E1BD05,earnings,100,50,7/19/2018
E1C16B,executive-appointment,100,54,7/19/2018
E28D9C,conference-call,100,50,7/19/2018
E2F66E,earnings-guidance,100,50,7/19/2018
E38906,earnings,100,50,7/19/2018
E49AA3,earnings,100,50,7/19/2018
E6A53A,dividend,100,50,7/19/2018
E6EDED,earnings,100,50,7/19/2018
E70531,business-contract,100,69,7/19/2018
E84500,dividend,100,50,7/19/2018
E8A49A,executive-appointment,100,54,7/19/2018
E8B315,earnings-positive,100,69,7/19/2018
E90C84,conference-call,100,50,7/19/2018
E94704,earnings,100,50,7/19/2018
E94704,earnings,100,50,7/19/2018
E94704,earnings,100,50,7/19/2018
E94704,earnings,100,50,7/19/2018
E94704,earnings,100,50,7/19/2018
E96E0B,conference-participant,100,50,7/19/2018
EAEBF3,earnings,100,50,7/19/2018
EB2F14,dividend,100,50,7/19/2018
EB2F14,earnings,100,50,7/19/2018
EB5E78,earnings-above-expectations,100,88,7/19/2018
EB5E78,earnings-above-expectations,100,88,7/19/2018
EB5E78,earnings-above-expectations,100,88,7/19/2018
EB5E78,earnings-above-expectations,100,88,7/19/2018
EB61C4,dividend,100,50,7/19/2018
ED7F13,earnings,100,50,7/19/2018
EEA6B3,dividend,100,50,7/19/2018
EF1AD9,dividend,100,50,7/19/2018
EF1AD9,earnings,100,50,7/19/2018
EF1AD9,earnings,100,50,7/19/2018
EF1AD9,earnings,100,50,7/19/2018
EF5BED,dividend,100,50,7/19/2018
EF5BED,earnings-positive,100,69,7/19/2018
EF5BED,earnings,100,50,7/19/2018
EF5BED,earnings,100,50,7/19/2018
EF5BED,earnings,100,50,7/19/2018
EF5BED,earnings,100,50,7/19/2018
EFA7B2,legal-issues-defendant,100,22,7/19/2018
EFD406,conference-call,100,50,7/19/2018
F40EE2,dividend,100,50,7/19/2018
F4F46F,conference-call,100,50,7/19/2018
F5C78B,dividend,100,50,7/19/2018
F5D059,earnings,100,50,7/19/2018
F5D059,earnings,100,50,7/19/2018
F5D059,earnings,100,50,7/19/2018
F5D059,earnings,100,50,7/19/2018
F5D059,earnings,100,50,7/19/2018
F6A945,executive-appointment,100,54,7/19/2018
F6E248,partnership,100,61,7/19/2018
F702CA,earnings-up,100,68,7/19/2018
F702CA,earnings-up,100,68,7/19/2018
F702CA,earnings-up,100,68,7/19/2018
F702CA,earnings-up,100,68,7/19/2018
F702CA,earnings-up,100,68,7/19/2018
F702CA,earnings-up,100,68,7/19/2018
FA044A,earnings,100,50,7/19/2018
FA36A4,dividend,100,50,7/19/2018
FB728F,dividend,100,50,7/19/2018
FB7724,earnings,100,50,7/19/2018
FBD92D,earnings,100,50,7/19/2018
FD0CA4,earnings,100,50,7/19/2018
FD6926,conference-call,100,50,7/19/2018
FD9A97,earnings,100,50,7/19/2018
0157B1,facility-open,100,65,7/20/2018
01D03F,partnership,100,61,7/20/2018
01D03F,partnership,100,61,7/20/2018
02870F,conference-call,100,50,7/20/2018
95294,earnings,100,50,7/20/2018
099A02,earnings,100,50,7/20/2018
099A02,earnings,100,50,7/20/2018
0A7650,earnings,100,50,7/20/2018
0C6293,business-contract,100,69,7/20/2018
0C6293,business-contract,100,69,7/20/2018
0C6293,business-contract,100,69,7/20/2018
108BD2,earnings,100,50,7/20/2018
108FDA,earnings,100,50,7/20/2018
126F95,earnings,100,50,7/20/2018
126F95,earnings,100,50,7/20/2018
126F95,earnings,100,50,7/20/2018
126F95,earnings,100,50,7/20/2018
139303,conference-call,100,50,7/20/2018
1E83DE,legal-issues-defendant,100,22,7/20/2018
1F43A1,earnings,100,50,7/20/2018
223216,revenue-up,100,57,7/20/2018
239106,legal-issues-defendant,100,22,7/20/2018
239106,legal-issues-defendant,100,22,7/20/2018
24D81E,executive-appointment,100,54,7/20/2018
2BF36E,conference-call,100,50,7/20/2018
2D485F,dividend-up,100,57,7/20/2018
2F1299,product-release,100,64,7/20/2018
306623,conference-call,100,50,7/20/2018
319BE2,conference-call,100,50,7/20/2018
32F943,earnings,100,50,7/20/2018
39FB23,executive-appointment,100,54,7/20/2018
39FB23,executive-appointment,100,54,7/20/2018
3ED92D,conference-call,100,50,7/20/2018
41B0E2,executive-appointment,100,54,7/20/2018
42EFC7,ipo-completed,100,76,7/20/2018
4A6F00,partnership,100,61,7/20/2018
4C7DB5,earnings,100,50,7/20/2018
524CE4,earnings,100,50,7/20/2018
583223,earnings-guidance,100,50,7/20/2018
58CA9A,dividend,100,50,7/20/2018
5BC2F4,acquisition-acquirer,100,49,7/20/2018
5BC2F4,earnings-per-share-up,100,71,7/20/2018
5BC2F4,earnings-per-share,100,50,7/20/2018
5BC2F4,earnings-per-share,100,50,7/20/2018
5BC2F4,earnings-per-share,100,50,7/20/2018
5BC2F4,earnings-per-share,100,50,7/20/2018
5BFE94,earnings,100,50,7/20/2018
5D87DF,earnings,100,50,7/20/2018
62B1C6,dividend,100,50,7/20/2018
641F17,dividend,100,50,7/20/2018
647143,dividend,100,50,7/20/2018
6634D9,earnings,100,50,7/20/2018
66CB62,earnings,100,50,7/20/2018
6CD55A,earnings,100,50,7/20/2018
6F3FA8,conference-participant,100,50,7/20/2018
7032D0,earnings,100,50,7/20/2018
72F0FC,dividend,100,50,7/20/2018
72F0FC,buybacks,100,74,7/20/2018
72F0FC,earnings,100,50,7/20/2018
73C521,earnings,100,50,7/20/2018
73C521,earnings,100,50,7/20/2018
73C521,earnings,100,50,7/20/2018
73C521,earnings,100,50,7/20/2018
73C521,earnings,100,50,7/20/2018
73C521,earnings,100,50,7/20/2018
7410C3,earnings,100,50,7/20/2018
76BD96,conference-call,100,50,7/20/2018
76E80F,executive-appointment,100,54,7/20/2018
7A5097,conference-call,100,50,7/20/2018
7B4B91,conference-call,100,50,7/20/2018
7F3A5F,award,100,58,7/20/2018
859281,dividend,100,50,7/20/2018
87B81A,earnings,100,50,7/20/2018
88923D,partnership,100,61,7/20/2018
8BFAA4,conference-call,100,50,7/20/2018
8C6C1B,facility-open,100,65,7/20/2018
90B678,legal-issues-defendant,100,22,7/20/2018
90B678,legal-issues-defendant,100,22,7/20/2018
90B678,legal-issues-defendant,100,22,7/20/2018
911ACB,earnings,100,50,7/20/2018
940C3D,earnings,100,50,7/20/2018
96B4FF,ipo-pricing,100,50,7/20/2018
97644E,earnings,100,50,7/20/2018
997348,earnings,100,50,7/20/2018
997348,earnings,100,50,7/20/2018
9F5CBB,public-offering,100,43,7/20/2018
9F62D1,earnings,100,50,7/20/2018
A5A4F5,acquisition-acquirer,100,49,7/20/2018
A6213D,award,100,58,7/20/2018
A666C8,earnings,100,50,7/20/2018
B7202A,conference-call,100,50,7/20/2018
BFE02C,earnings-positive,100,69,7/20/2018
C0200F,earnings,100,50,7/20/2018
C29715,earnings,100,50,7/20/2018
C29715,earnings,100,50,7/20/2018
C3BAE7,earnings,100,50,7/20/2018
C5E100,conference-participant,100,50,7/20/2018
CC339B,earnings,100,50,7/20/2018
CE1002,earnings,100,50,7/20/2018
CE1002,earnings,100,50,7/20/2018
CE1002,earnings,100,50,7/20/2018
CE1002,earnings,100,50,7/20/2018
CE1002,earnings,100,50,7/20/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/20/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/20/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/20/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/20/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/20/2018
CFF97C,credit-rating-upgrade-rater,20,50,7/20/2018
D04D9F,conference-call,100,50,7/20/2018
D29B44,earnings,100,50,7/20/2018
D3FD6D,conference-call,100,50,7/20/2018
D6534D,conference-call,100,50,7/20/2018
D78CCD,earnings,100,50,7/20/2018
D78CCD,earnings,100,50,7/20/2018
D78CCD,earnings,100,50,7/20/2018
D78CCD,earnings,100,50,7/20/2018
D78CCD,earnings,100,50,7/20/2018
DA0A9E,dividend,100,50,7/20/2018
DB5CA5,business-contract,100,69,7/20/2018
DD1BA1,earnings,100,50,7/20/2018
DDB002,conference-call,100,50,7/20/2018
E1E36F,dividend,100,50,7/20/2018
E22FDE,earnings,100,50,7/20/2018
E5752F,earnings,100,50,7/20/2018
E5D914,conference-call,100,50,7/20/2018
E6E012,dividend,100,50,7/20/2018
E71AE6,orphan-drug-designation,100,76,7/20/2018
E8D221,dividend,100,50,7/20/2018
EB61C4,executive-appointment,100,54,7/20/2018
F0B877,executive-appointment,100,54,7/20/2018
F0EEFB,executive-appointment,100,54,7/20/2018
F2526D,ipo-completed,100,76,7/20/2018
F2E253,legal-issues-defendant,100,22,7/20/2018
F6FA6A,dividend,100,50,7/20/2018
F82D37,earnings-up,100,68,7/20/2018
F93C8A,conference-call,100,50,7/20/2018
FF4343,conference-call,100,50,7/20/2018
4D72C8,note-sale,100,52,7/21/2018
A3F598,merger,100,66,7/21/2018
A3F598,merger,100,66,7/21/2018
F2E253,legal-issues-defendant,100,22,7/21/2018
AFF7B4,legal-issues-defendant,100,22,7/22/2018
68396,executive-appointment,100,54,7/23/2018
0B13E8,public-offering,100,43,7/23/2018
0B2071,earnings,100,50,7/23/2018
0B2071,earnings,100,50,7/23/2018
0B400D,earnings-guidance,100,50,7/23/2018
0FABBD,conference-call,100,50,7/23/2018
1272B3,earnings,100,50,7/23/2018
1279ED,conference-call,100,50,7/23/2018
152AB9,conference-participant,100,50,7/23/2018
15789A,revenue-volume-up,100,55,7/23/2018
1F9D90,acquisition-acquirer,100,49,7/23/2018
1FE3CB,earnings,100,50,7/23/2018
206852,earnings,100,50,7/23/2018
2082EA,regulatory-product-approval-granted,100,81,7/23/2018
20BEEA,earnings-up,100,68,7/23/2018
20BEEA,earnings,100,50,7/23/2018
20BEEA,earnings,100,50,7/23/2018
219B21,conference-call,100,50,7/23/2018
21D903,earnings,100,50,7/23/2018
253B2F,conference-call,100,50,7/23/2018
25A6CC,revenue-up,100,69,7/23/2018
25A6CC,revenue-up,100,69,7/23/2018
25A6CC,revenue-up,100,69,7/23/2018
25A6CC,revenue-up,100,69,7/23/2018
2667B6,business-contract,100,69,7/23/2018
29A4CC,merger-regulatory-approval,100,81,7/23/2018
29A4CC,earnings,100,50,7/23/2018
29A4CC,earnings,100,50,7/23/2018
29A4CC,earnings,100,50,7/23/2018
29A4CC,earnings,100,50,7/23/2018
29A4CC,earnings,100,50,7/23/2018
29A4CC,earnings,100,50,7/23/2018
29A4CC,earnings,100,50,7/23/2018
2A9C0A,earnings-up,100,91,7/23/2018
2A9C0A,earnings,100,50,7/23/2018
2A9C0A,earnings,100,50,7/23/2018
2A9C0A,earnings,100,50,7/23/2018
2A9C0A,earnings,100,50,7/23/2018
2B49F4,earnings,100,50,7/23/2018
2B49F4,earnings,100,50,7/23/2018
2B49F4,earnings,100,50,7/23/2018
2B49F4,earnings,100,50,7/23/2018
2B7A40,acquisition-acquirer,100,49,7/23/2018
2C7505,clinical-trials,100,56,7/23/2018
2C7505,clinical-trials-start,100,64,7/23/2018
2DC88B,earnings,100,50,7/23/2018
2E902B,revenue-up,100,69,7/23/2018
2E902B,revenue-up,100,69,7/23/2018
2E902B,revenue-up,100,69,7/23/2018
2E902B,revenue-up,100,69,7/23/2018
2E902B,revenue-up,100,69,7/23/2018
309922,earnings,100,50,7/23/2018
30E01D,earnings,100,50,7/23/2018
31AA84,executive-appointment,100,54,7/23/2018
31F25C,earnings-up,100,68,7/23/2018
31F25C,earnings-up,100,68,7/23/2018
32C8CD,merger-regulatory-approval,100,81,7/23/2018
387541,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
38FB49,earnings,100,50,7/23/2018
3A4BDB,earnings-up,100,68,7/23/2018
3A4BDB,earnings-up,100,68,7/23/2018
3A4BDB,earnings-up,100,68,7/23/2018
3A4BDB,earnings-up,100,68,7/23/2018
3A4BDB,earnings-up,100,68,7/23/2018
3B37F7,partnership,100,61,7/23/2018
3DD5E2,public-offering,100,43,7/23/2018
3F1C69,public-offering,100,43,7/23/2018
420168,partnership,100,61,7/23/2018
42DC93,earnings,100,50,7/23/2018
44A4FC,public-offering,100,43,7/23/2018
451D61,conference-call,100,50,7/23/2018
4591D3,partnership,100,61,7/23/2018
46017C,conference-call,100,50,7/23/2018
49914B,earnings,100,50,7/23/2018
49CC59,conference-call,100,50,7/23/2018
4A5C8D,partnership,100,61,7/23/2018
4A6F00,partnership,100,61,7/23/2018
4A6F00,partnership,100,61,7/23/2018
4A6F00,partnership,100,61,7/23/2018
4A6F00,partnership,100,61,7/23/2018
4A6F00,partnership,100,61,7/23/2018
4A6F00,partnership,100,61,7/23/2018
4C37C5,dividend,100,50,7/23/2018
4D371E,earnings,100,50,7/23/2018
54A646,earnings-up,100,68,7/23/2018
54DF47,earnings-guidance,100,50,7/23/2018
553949,conference-call,100,50,7/23/2018
5675EB,conference-call,100,50,7/23/2018
56AFF4,dividend,100,50,7/23/2018
586BD7,conference-call,100,50,7/23/2018
586BD7,conference-call,100,50,7/23/2018
5A53BF,executive-appointment,100,54,7/23/2018
5A9F54,executive-appointment,100,54,7/23/2018
5BE42C,dividend,100,50,7/23/2018
5BE42C,earnings,100,50,7/23/2018
5C8D61,earnings,100,50,7/23/2018
5D1956,ipo-completed,100,76,7/23/2018
6166D1,executive-appointment,100,54,7/23/2018
6284B5,partnership,100,61,7/23/2018
6284B5,partnership,100,61,7/23/2018
62B20A,earnings,100,50,7/23/2018
647143,earnings,100,50,7/23/2018
647143,earnings,100,50,7/23/2018
647143,earnings,100,50,7/23/2018
647143,earnings,100,50,7/23/2018
6634D9,legal-issues-defendant,100,22,7/23/2018
67303E,public-offering,100,43,7/23/2018
67B923,campaign-ad-release,100,59,7/23/2018
68E3E0,conference-call,100,50,7/23/2018
693ECD,earnings,100,50,7/23/2018
693ECD,earnings,100,50,7/23/2018
6A01DF,earnings,100,50,7/23/2018
6A171E,executive-resignation,100,44,7/23/2018
6B5379,earnings,100,50,7/23/2018
6BD606,conference-call,100,50,7/23/2018
6D4636,conference-call,100,50,7/23/2018
6DD6BA,earnings,100,50,7/23/2018
6DD6BA,earnings,100,50,7/23/2018
6DD6BA,earnings,100,50,7/23/2018
6F0096,earnings,100,50,7/23/2018
6F0096,earnings,100,50,7/23/2018
6F0096,earnings,100,50,7/23/2018
6F0096,earnings,100,50,7/23/2018
70FCEF,executive-appointment,100,54,7/23/2018
73C521,executive-appointment,100,54,7/23/2018
76DD0C,ipo-completed,100,76,7/23/2018
7AB859,partnership,100,61,7/23/2018
7B1156,earnings-guidance,100,50,7/23/2018
83066C,conference-call,100,50,7/23/2018
859281,earnings,100,50,7/23/2018
859281,earnings,100,50,7/23/2018
859281,earnings,100,50,7/23/2018
859281,earnings,100,50,7/23/2018
859281,earnings,100,50,7/23/2018
859281,earnings,100,50,7/23/2018
85AD00,earnings-up,100,68,7/23/2018
862941,earnings,100,50,7/23/2018
86AA9C,acquisition-completed-acquirer,100,49,7/23/2018
8802B4,dividend,100,50,7/23/2018
881190,revenue-up,100,69,7/23/2018
881190,revenue-up,100,69,7/23/2018
881190,revenue-up,100,69,7/23/2018
88923D,partnership,100,61,7/23/2018
88923D,partnership,100,61,7/23/2018
8A8E41,earnings,100,50,7/23/2018
8C6C1B,facility-open,100,65,7/23/2018
8D9993,dividend,100,50,7/23/2018
8E93A4,earnings,100,50,7/23/2018
903AB4,earnings,100,50,7/23/2018
903AB4,earnings,100,50,7/23/2018
903AB4,earnings,100,50,7/23/2018
903AB4,earnings,100,50,7/23/2018
903AB4,earnings,100,50,7/23/2018
94637C,executive-resignation,100,44,7/23/2018
94C0B5,earnings,100,50,7/23/2018
958938,acquisition-acquirer,100,49,7/23/2018
958938,acquisition-acquirer,100,49,7/23/2018
958938,acquisition-acquirer,100,49,7/23/2018
958938,acquisition-acquirer,100,49,7/23/2018
968966,partnership,100,61,7/23/2018
96F126,hirings,100,65,7/23/2018
9.92E+94,executive-appointment,100,54,7/23/2018
9B5968,executive-appointment,100,54,7/23/2018
9C5BA5,conference-call,100,50,7/23/2018
9DDE1B,public-offering,100,43,7/23/2018
9EA947,dividend,100,50,7/23/2018
9F71E5,acquisition-completed-acquirer,100,49,7/23/2018
A0F146,conference-call,100,50,7/23/2018
A398B9,partnership,100,61,7/23/2018
A41450,earnings,100,50,7/23/2018
A4A612,earnings,100,50,7/23/2018
A5A4F5,acquisition-acquirer,100,49,7/23/2018
A7102F,conference-call,100,50,7/23/2018
AA98ED,earnings,100,50,7/23/2018
AD1ACF,conference-call,100,50,7/23/2018
ADF1B0,earnings,100,50,7/23/2018
ADF1B0,earnings,100,50,7/23/2018
B1A85D,earnings,100,50,7/23/2018
B2D492,earnings,100,50,7/23/2018
B2F431,earnings-positive,100,69,7/23/2018
B5766D,dividend,100,50,7/23/2018
B604DF,earnings,100,50,7/23/2018
B604DF,earnings,100,50,7/23/2018
B604DF,earnings,100,50,7/23/2018
B604DF,earnings,100,50,7/23/2018
B604DF,dividend-up,100,70,7/23/2018
B604DF,earnings,100,50,7/23/2018
B604DF,dividend-up,100,70,7/23/2018
B642E8,earnings,100,50,7/23/2018
BBC05B,operating-earnings,100,50,7/23/2018
BCC13E,earnings,100,50,7/23/2018
BDD12C,earnings,100,50,7/23/2018
C062D4,dividend,100,50,7/23/2018
C3CF29,earnings,100,50,7/23/2018
C45CE7,earnings,100,50,7/23/2018
C584BE,legal-issues-defendant,100,22,7/23/2018
C598D7,revenue-up,100,51,7/23/2018
C598D7,revenues,100,50,7/23/2018
C598D7,revenues,100,50,7/23/2018
C598D7,revenues,100,50,7/23/2018
C72B8F,conference-call,100,50,7/23/2018
C83B88,product-release,100,64,7/23/2018
C941DC,earnings,100,50,7/23/2018
CB6A9C,asset-sale,100,62,7/23/2018
CBBFBF,dividend,100,50,7/23/2018
CBCC6A,executive-appointment,100,54,7/23/2018
CC0C78,earnings,100,50,7/23/2018
CC6FF5,product-release,100,64,7/23/2018
CC6FF5,earnings,100,50,7/23/2018
CE8A7B,trading-halt,100,43,7/23/2018
CE8A7B,trading-resumed,100,58,7/23/2018
CEC5B9,dividend,100,50,7/23/2018
CF9054,earnings,100,50,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFE5BE,earnings-up,100,68,7/23/2018
CFF97C,product-release,100,64,7/23/2018
D06755,award,100,58,7/23/2018
D57D99,earnings,100,50,7/23/2018
D6853F,legal-issues-defendant,100,22,7/23/2018
D78BF1,revenues,100,50,7/23/2018
D854DD,conference-call,100,50,7/23/2018
D8760C,earnings-up,100,63,7/23/2018
D8760C,earnings,100,50,7/23/2018
D8760C,earnings,100,50,7/23/2018
D8760C,earnings,100,50,7/23/2018
D8760C,earnings,100,50,7/23/2018
D8760C,earnings,100,50,7/23/2018
D9E036,executive-appointment,100,54,7/23/2018
DA0A9E,acquisition-acquirer,100,49,7/23/2018
DAC66A,earnings,100,50,7/23/2018
DC0998,earnings,100,50,7/23/2018
DC0998,earnings,100,50,7/23/2018
DC0998,earnings,100,50,7/23/2018
DC0998,earnings,100,50,7/23/2018
DC2F77,dividend,100,50,7/23/2018
DD1BA1,award,100,58,7/23/2018
DF46C5,dividend,100,50,7/23/2018
DF46C5,earnings-guidance-up,100,83,7/23/2018
DF46C5,earnings,100,50,7/23/2018
DF46C5,earnings,100,50,7/23/2018
DF46C5,earnings,100,50,7/23/2018
E114F4,conference-call,100,50,7/23/2018
E1E093,partnership,100,61,7/23/2018
E20392,executive-appointment,100,54,7/23/2018
E4158B,earnings-positive,100,69,7/23/2018
E4158B,earnings,100,50,7/23/2018
E4158B,earnings,100,50,7/23/2018
E4158B,earnings,100,50,7/23/2018
E4158B,earnings,100,50,7/23/2018
E4158B,earnings,100,50,7/23/2018
E70531,earnings-guidance-up,100,83,7/23/2018
E70531,earnings,100,50,7/23/2018
E754F0,public-offering,100,43,7/23/2018
E87676,dividend,100,50,7/23/2018
EA62FC,dividend,100,50,7/23/2018
EB5E78,executive-appointment,100,54,7/23/2018
EB61C4,earnings,100,50,7/23/2018
ECDEB2,earnings,100,50,7/23/2018
ECDEB2,earnings,100,50,7/23/2018
ECDEB2,earnings,100,50,7/23/2018
ECDEB2,earnings,100,50,7/23/2018
ECDEB2,earnings,100,50,7/23/2018
ECDEB2,earnings,100,50,7/23/2018
ED79D9,award,100,58,7/23/2018
EDF5CA,conference-participant,100,50,7/23/2018
F04E05,dividend,100,50,7/23/2018
F24FF0,conference-call,100,50,7/23/2018
F2E253,shareholder-rights-plan,100,43,7/23/2018
F2E253,legal-issues-defendant,100,22,7/23/2018
F5C78B,earnings-up,100,68,7/23/2018
F5C78B,earnings,100,50,7/23/2018
F5C78B,earnings,100,50,7/23/2018
F5C78B,earnings,100,50,7/23/2018
F5C78B,earnings,100,50,7/23/2018
F5D059,executive-appointment,100,54,7/23/2018
F95726,earnings,100,50,7/23/2018
FA35C6,earnings,100,50,7/23/2018
FAEABE,dividend-up,100,56,7/23/2018
FC4550,earnings,100,50,7/23/2018
FD9526,executive-appointment,100,54,7/23/2018
FDF28E,earnings,100,50,7/23/2018
FF6644,business-contract,100,69,7/23/2018
00D6B5,conference-call,100,50,7/24/2018
13528,partnership,100,61,7/24/2018
13528,partnership,100,61,7/24/2018
13528,partnership,100,61,7/24/2018
0142B5,business-contract,100,69,7/24/2018
0157B1,partnership,100,61,7/24/2018
31025,earnings,100,50,7/24/2018
03542C,earnings,100,50,7/24/2018
03B8CF,earnings,100,50,7/24/2018
03B8CF,earnings,100,50,7/24/2018
03B8CF,earnings,100,50,7/24/2018
03B8CF,earnings,100,50,7/24/2018
03B8CF,earnings,100,50,7/24/2018
040DBB,earnings,100,50,7/24/2018
053EFF,conference-call,100,50,7/24/2018
68396,earnings,100,50,7/24/2018
070B45,product-release,100,64,7/24/2018
070B45,earnings,100,50,7/24/2018
0C2A0D,business-contract,100,69,7/24/2018
0C2A0D,dividend-guidance,100,50,7/24/2018
0C4131,earnings,100,50,7/24/2018
0C4131,earnings,100,50,7/24/2018
0C4131,earnings,100,50,7/24/2018
0C4131,earnings,100,50,7/24/2018
0CCCB7,conference-call,100,50,7/24/2018
0DC050,earnings,100,50,7/24/2018
0DC050,earnings,100,50,7/24/2018
0DC050,earnings,100,50,7/24/2018
0DC050,earnings,100,50,7/24/2018
0FC848,earnings,100,50,7/24/2018
0FDE97,business-contract,100,69,7/24/2018
102727,earnings,100,50,7/24/2018
1096C6,earnings,100,50,7/24/2018
12A3A3,product-release,100,64,7/24/2018
1348C9,earnings,100,50,7/24/2018
1348C9,earnings,100,50,7/24/2018
1348C9,earnings,100,50,7/24/2018
1348C9,earnings,100,50,7/24/2018
13C3E0,partnership,100,61,7/24/2018
16FC89,earnings,100,50,7/24/2018
17EDA5,partnership,100,61,7/24/2018
17EDA5,partnership,100,61,7/24/2018
17EDA5,partnership,100,61,7/24/2018
17EDA5,executive-appointment,100,54,7/24/2018
1921DD,partnership,100,61,7/24/2018
1A3E1B,dividend,100,50,7/24/2018
1BC12C,dividend,100,50,7/24/2018
1BDB2A,earnings,100,50,7/24/2018
1C599A,stake-acquirer,100,48,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1E9A6D,earnings,100,50,7/24/2018
1EBF8D,partnership,100,61,7/24/2018
1EBF8D,dividend,100,50,7/24/2018
1F9D90,earnings,100,50,7/24/2018
1FE3CB,merger,100,66,7/24/2018
1FE3CB,merger,100,66,7/24/2018
20BEEA,conference-call,100,50,7/24/2018
228D42,business-contract,100,69,7/24/2018
239106,conference-call,100,50,7/24/2018
241AF7,conference-call,100,50,7/24/2018
24C48B,conference-call,100,50,7/24/2018
251988,acquisition-acquirer,100,49,7/24/2018
251988,acquisition-completed-acquiree,100,76,7/24/2018
251988,acquisition-completed-acquiree,100,76,7/24/2018
251988,acquisition-completed-acquiree,100,76,7/24/2018
251988,acquisition-completed-acquiree,100,76,7/24/2018
251988,acquisition-completed-acquiree,100,76,7/24/2018
25A6CC,public-offering,100,43,7/24/2018
2667B6,earnings,100,50,7/24/2018
26FA41,revenues,100,50,7/24/2018
2720AB,earnings,100,50,7/24/2018
275300,conference-participant,100,50,7/24/2018
282C18,earnings,100,50,7/24/2018
28B730,earnings,100,50,7/24/2018
28DCF3,earnings-up,100,91,7/24/2018
28DCF3,acquisition-acquirer,100,49,7/24/2018
29B702,conference-participant,100,50,7/24/2018
2E2E6E,earnings,100,50,7/24/2018
2E2E6E,earnings-up,100,68,7/24/2018
2E2E6E,earnings-up,100,68,7/24/2018
2E2E6E,earnings-up,100,68,7/24/2018
2E2E6E,earnings-up,100,68,7/24/2018
2F5256,earnings,100,50,7/24/2018
31803E,earnings,100,50,7/24/2018
31A7CC,dividend-up,100,81,7/24/2018
31F25C,public-offering,100,43,7/24/2018
31F25C,public-offering,100,43,7/24/2018
332F87,earnings-per-share-up,100,68,7/24/2018
332F87,earnings-per-share-up,100,68,7/24/2018
332F87,earnings-per-share-up,100,68,7/24/2018
332F87,earnings-per-share-up,100,68,7/24/2018
332F87,earnings-per-share-up,100,68,7/24/2018
343996,earnings,100,50,7/24/2018
3461CF,partnership,100,61,7/24/2018
382EAE,partnership,100,61,7/24/2018
385DD4,business-contract,100,69,7/24/2018
39BFF6,earnings,100,50,7/24/2018
39BFF6,earnings,100,50,7/24/2018
39BFF6,earnings,100,50,7/24/2018
3A3447,dividend,100,50,7/24/2018
3A3948,earnings,100,50,7/24/2018
3C6CCC,earnings,100,50,7/24/2018
3D9999,ownership-increase-owner,100,56,7/24/2018
3DE4D1,earnings,100,50,7/24/2018
3E39A5,dividend,100,50,7/24/2018
3F6A9C,dividend,100,50,7/24/2018
3F868D,conference-call,100,50,7/24/2018
408089,earnings,100,50,7/24/2018
41785E,earnings,100,50,7/24/2018
44A4FC,public-offering,100,43,7/24/2018
450ECB,earnings,100,50,7/24/2018
453282,dividend,100,50,7/24/2018
458D2C,legal-issues-defendant,100,22,7/24/2018
4591D3,conference-call,100,50,7/24/2018
468DD4,earnings,100,50,7/24/2018
485445,earnings,100,50,7/24/2018
492117,earnings,100,50,7/24/2018
4A6F00,product-release,100,64,7/24/2018
4A6F00,partnership,100,61,7/24/2018
4A6F00,partnership,100,61,7/24/2018
4AC91D,business-contract,100,69,7/24/2018
4AC91D,business-contract,100,69,7/24/2018
4B3555,earnings,100,50,7/24/2018
4B3DC9,earnings-positive,100,69,7/24/2018
4C92B9,earnings,100,50,7/24/2018
514067,conference-call,100,50,7/24/2018
525A1C,partnership,100,61,7/24/2018
54F271,earnings,100,50,7/24/2018
55D0F3,earnings,100,50,7/24/2018
5675EB,dividend,100,50,7/24/2018
5675EB,earnings-up,100,68,7/24/2018
5675EB,earnings-up,100,68,7/24/2018
57634F,earnings,100,50,7/24/2018
57A854,earnings,100,50,7/24/2018
583A75,earnings,100,50,7/24/2018
58EA22,executive-appointment,100,54,7/24/2018
5AF08A,stake-acquirer,100,48,7/24/2018
5B3FA2,earnings,100,50,7/24/2018
5DA8B3,earnings,100,50,7/24/2018
5F9CE3,earnings,100,50,7/24/2018
6284B5,dividend,100,50,7/24/2018
62B1C6,earnings,100,50,7/24/2018
62B1C6,earnings,100,50,7/24/2018
662682,earnings,100,50,7/24/2018
67303E,public-offering,100,43,7/24/2018
6B0E45,dividend,100,50,7/24/2018
6CB7F9,earnings,100,50,7/24/2018
6CF43C,earnings,100,50,7/24/2018
6D0CAB,conference-participant,100,50,7/24/2018
6DDA15,earnings,100,50,7/24/2018
6F3936,partnership,100,61,7/24/2018
71553E,earnings,100,50,7/24/2018
72EF75,earnings,100,50,7/24/2018
732449,executive-appointment,100,54,7/24/2018
752A70,earnings,100,50,7/24/2018
75F665,earnings,100,50,7/24/2018
75F665,dividend,100,50,7/24/2018
762A3E,conference-organizer,100,57,7/24/2018
765913,earnings,100,50,7/24/2018
76F067,earnings,100,50,7/24/2018
7710F3,executive-appointment,100,54,7/24/2018
7823A3,partnership,100,61,7/24/2018
78A1BB,earnings-up,100,68,7/24/2018
7BC92D,conference-participant,100,50,7/24/2018
7D35D8,earnings,100,50,7/24/2018
7D35D8,earnings,100,50,7/24/2018
7D35D8,earnings,100,50,7/24/2018
7D5FD6,partnership,100,61,7/24/2018
7E3F8F,earnings,100,50,7/24/2018
7E3F8F,earnings,100,50,7/24/2018
7E3F8F,earnings,100,50,7/24/2018
7E3F8F,earnings,100,50,7/24/2018
80C400,conference-call,100,50,7/24/2018
81F4BE,earnings,100,50,7/24/2018
81F4BE,earnings,100,50,7/24/2018
82F088,conference-call,100,50,7/24/2018
85DA04,product-release,100,64,7/24/2018
85DE00,executive-appointment,100,54,7/24/2018
88611B,dividend,100,50,7/24/2018
89E771,partnership,100,61,7/24/2018
8CF6DD,executive-appointment,100,54,7/24/2018
8CF6DD,executive-resignation,100,44,7/24/2018
8D4486,partnership,100,61,7/24/2018
8DAAB9,earnings-up,100,68,7/24/2018
8DE56F,business-contract,100,69,7/24/2018
8DE56F,business-contract,100,69,7/24/2018
9043FE,note-sale,100,52,7/24/2018
9043FE,note-sale,100,52,7/24/2018
911AB8,dividend,100,50,7/24/2018
93D207,partnership,100,61,7/24/2018
93D207,partnership,100,61,7/24/2018
93F143,earnings,100,50,7/24/2018
93F143,earnings,100,50,7/24/2018
93F143,earnings,100,50,7/24/2018
93F143,earnings,100,50,7/24/2018
93F143,earnings,100,50,7/24/2018
945DE6,earnings,100,50,7/24/2018
945DE6,earnings,100,50,7/24/2018
945DE6,earnings,100,50,7/24/2018
94637C,partnership,100,61,7/24/2018
9548BB,earnings-per-share-up,100,68,7/24/2018
9548BB,earnings,100,50,7/24/2018
9548BB,earnings,100,50,7/24/2018
95C575,earnings,100,50,7/24/2018
96F126,earnings,100,50,7/24/2018
97693A,executive-appointment,100,54,7/24/2018
97AF94,earnings,100,50,7/24/2018
99ACAD,dividend,100,50,7/24/2018
99DC8D,conference-call,100,50,7/24/2018
9A02C4,earnings,100,50,7/24/2018
9A02C4,dividend,100,50,7/24/2018
9A2760,earnings,100,50,7/24/2018
9ABD30,earnings,100,50,7/24/2018
9BB35A,executive-appointment,100,54,7/24/2018
9CE4C7,earnings,100,50,7/24/2018
9DDE1B,public-offering,100,43,7/24/2018
9FB4B7,conference-call,100,50,7/24/2018
A15C71,acquisition-acquirer,100,49,7/24/2018
A1EAC8,dividend,100,50,7/24/2018
A3800A,dividend,100,50,7/24/2018
A433A5,earnings,100,50,7/24/2018
A4D173,earnings,100,50,7/24/2018
A4D173,earnings,100,50,7/24/2018
A52533,facility-open,100,65,7/24/2018
A5A4F5,acquisition-acquirer,100,49,7/24/2018
A5E715,earnings-per-share-positive,100,69,7/24/2018
A6213D,business-contract,100,69,7/24/2018
A63387,acquisition-completed-acquirer,100,49,7/24/2018
A65325,earnings-positive,100,69,7/24/2018
A65325,earnings,100,50,7/24/2018
A65325,earnings,100,50,7/24/2018
A65325,earnings,100,50,7/24/2018
A65325,earnings,100,50,7/24/2018
A65325,earnings,100,50,7/24/2018
A65325,earnings,100,50,7/24/2018
A6828A,sanctions-target,100,19,7/24/2018
A868C9,conference-call,100,50,7/24/2018
AAC8B6,conference-call,100,50,7/24/2018
AADE0B,dividend,100,50,7/24/2018
ACD9A4,earnings,100,50,7/24/2018
AE4EEB,earnings,100,50,7/24/2018
AE7D16,partnership,100,61,7/24/2018
B0FE08,dividend,100,50,7/24/2018
B1B10C,earnings,100,50,7/24/2018
B1B10C,earnings,100,50,7/24/2018
B1B10C,earnings,100,50,7/24/2018
B1FC3B,business-contract,100,69,7/24/2018
B290A2,fast-track-designation,100,81,7/24/2018
B303A6,dividend,100,50,7/24/2018
B33E77,earnings,100,50,7/24/2018
B37FB4,earnings-up,100,68,7/24/2018
B3A166,legal-issues-plaintiff,100,44,7/24/2018
B3A166,legal-issues-defendant,100,22,7/24/2018
B48FC9,earnings,100,50,7/24/2018
B66928,earnings,100,50,7/24/2018
B6CD92,earnings-up,100,68,7/24/2018
B6CD92,earnings,100,50,7/24/2018
B6CD92,earnings,100,50,7/24/2018
B6CD92,earnings,100,50,7/24/2018
B8A51F,ipo-pricing,100,50,7/24/2018
B8F71F,earnings,100,50,7/24/2018
B96637,conference-call,100,50,7/24/2018
BB5142,earnings-up,100,68,7/24/2018
BB58FF,conference-participant,100,50,7/24/2018
BBF349,partnership,100,61,7/24/2018
BBF349,earnings,100,50,7/24/2018
BC3AD2,earnings,100,50,7/24/2018
BC3AD2,earnings,100,50,7/24/2018
BCC55F,product-release,100,64,7/24/2018
BD15E8,earnings,100,50,7/24/2018
BD9668,merger-regulatory-approval,100,81,7/24/2018
BD9668,earnings-up,100,68,7/24/2018
C0BA36,conference-call,100,50,7/24/2018
C27E19,operating-earnings,100,50,7/24/2018
C32A39,earnings,100,50,7/24/2018
C41C25,dividend-up,100,55,7/24/2018
C62AA4,business-contract,100,69,7/24/2018
C6C702,product-release,100,64,7/24/2018
C6C702,product-release,100,64,7/24/2018
C81E00,operating-earnings,100,50,7/24/2018
C85A72,revenue-up,100,69,7/24/2018
C85A72,revenue-up,100,69,7/24/2018
C85A72,revenue-up,100,69,7/24/2018
C85A72,revenue-up,100,69,7/24/2018
C941DC,public-offering,100,43,7/24/2018
C9732E,ipo-completed,100,76,7/24/2018
CBA33B,dividend,100,50,7/24/2018
CBCC6A,executive-appointment,100,54,7/24/2018
CBCC6A,executive-appointment,100,54,7/24/2018
CD06A2,dividend,100,50,7/24/2018
CDC817,earnings,100,50,7/24/2018
D1173F,earnings,100,50,7/24/2018
D1173F,earnings,100,50,7/24/2018
D1173F,earnings,100,50,7/24/2018
D1173F,earnings,100,50,7/24/2018
D1173F,earnings,100,50,7/24/2018
D139BC,earnings,100,50,7/24/2018
D15833,dividend,100,50,7/24/2018
D17C1B,earnings,100,50,7/24/2018
D17C1B,earnings,100,50,7/24/2018
D17C1B,earnings,100,50,7/24/2018
D17F7E,earnings,100,50,7/24/2018
D17F7E,earnings,100,50,7/24/2018
D17F7E,earnings,100,50,7/24/2018
D17F7E,earnings,100,50,7/24/2018
D17F7E,earnings,100,50,7/24/2018
D17F7E,earnings,100,50,7/24/2018
D17F7E,earnings,100,50,7/24/2018
D296C6,earnings,100,50,7/24/2018
D501DC,earnings,100,50,7/24/2018
D5B13D,executive-appointment,100,54,7/24/2018
D6EAA3,dividend,100,50,7/24/2018
D88EF3,executive-appointment,100,54,7/24/2018
D9B1C9,dividend,100,50,7/24/2018
DBEF02,merger-regulatory-approval,100,81,7/24/2018
DBFB51,conference-call,100,50,7/24/2018
DC486E,earnings,100,50,7/24/2018
DC486E,earnings,100,50,7/24/2018
DC486E,earnings,100,50,7/24/2018
DC486E,earnings,100,50,7/24/2018
DD0F15,earnings,100,50,7/24/2018
DD682D,executive-appointment,100,54,7/24/2018
DDB002,earnings,100,50,7/24/2018
DE20DF,dividend,100,50,7/24/2018
DF18E6,executive-appointment,100,54,7/24/2018
DF204B,conference-call,100,50,7/24/2018
E00373,earnings,100,50,7/24/2018
E0339F,dividend,100,50,7/24/2018
E06265,conference-call,100,50,7/24/2018
E09997,conference-call,100,50,7/24/2018
E1C16B,dividend,100,50,7/24/2018
E30B34,earnings,100,50,7/24/2018
E50F1C,earnings-up,100,68,7/24/2018
E5752F,executive-appointment,100,54,7/24/2018
E5F0A8,earnings-positive,100,69,7/24/2018
E5F0A8,earnings,100,50,7/24/2018
E5F0A8,earnings,100,50,7/24/2018
E5F0A8,earnings,100,50,7/24/2018
E69BA5,conference-call,100,50,7/24/2018
E6E012,revenues,100,50,7/24/2018
E802CE,conference-call,100,50,7/24/2018
E87676,revenues,100,50,7/24/2018
E8846E,executive-appointment,100,54,7/24/2018
E8A49A,earnings,100,50,7/24/2018
E8B21D,earnings-up,100,68,7/24/2018
E8B21D,earnings-up,100,68,7/24/2018
E8B21D,earnings-up,100,68,7/24/2018
E8B21D,earnings-up,100,68,7/24/2018
E8B21D,earnings-up,100,68,7/24/2018
E8B21D,earnings-up,100,68,7/24/2018
E9E6FD,earnings,100,50,7/24/2018
E9FF33,earnings,100,50,7/24/2018
EC1AF3,conference-call,100,50,7/24/2018
ECDEB2,earnings,100,50,7/24/2018
ED0402,revenue-up,100,72,7/24/2018
ED0402,revenue-up,100,69,7/24/2018
ED0402,revenue-up,100,69,7/24/2018
ED0402,revenue-up,100,69,7/24/2018
ED0D7C,dividend,100,50,7/24/2018
ED79D9,conference-call,100,50,7/24/2018
EDF5CA,earnings,100,50,7/24/2018
EDF5CA,earnings,100,50,7/24/2018
EDF5CA,earnings,100,50,7/24/2018
EDF5CA,earnings,100,50,7/24/2018
EDF5CA,earnings,100,50,7/24/2018
EDF5CA,earnings,100,50,7/24/2018
F0A9DE,earnings,100,50,7/24/2018
F1529C,conference-organizer,100,57,7/24/2018
F179ED,product-release,100,64,7/24/2018
F2526D,executive-appointment,100,54,7/24/2018
F294DD,earnings,100,50,7/24/2018
F294DD,earnings,100,50,7/24/2018
F294DD,earnings,100,50,7/24/2018
F294DD,earnings,100,50,7/24/2018
F30508,earnings-positive,100,69,7/24/2018
F5A214,earnings,100,50,7/24/2018
F5D410,earnings,100,50,7/24/2018
FD9A97,conference-participant,100,50,7/24/2018
FE7A63,earnings,100,50,7/24/2018
FE7A63,earnings,100,50,7/24/2018
FE7A63,earnings,100,50,7/24/2018
FE7A63,earnings,100,50,7/24/2018
FE7A63,earnings,100,50,7/24/2018
FE7A63,earnings,100,50,7/24/2018
FE7A63,earnings,100,50,7/24/2018
FE7A63,acquisition-acquirer,100,49,7/24/2018
FE7A63,acquisition-acquirer,100,49,7/24/2018
FFCD0E,revenue-up,100,66,7/24/2018
0157B1,facility-open,100,65,7/25/2018
01D03F,clinical-trials-positive,100,87,7/25/2018
01D03F,clinical-trials-positive,100,87,7/25/2018
20751,executive-appointment,100,54,7/25/2018
0358AF,revenue-up,100,69,7/25/2018
03CF95,earnings,100,50,7/25/2018
03CF95,earnings,100,50,7/25/2018
03CF95,earnings,100,50,7/25/2018
03CF95,earnings,100,50,7/25/2018
03CF95,earnings,100,50,7/25/2018
03CF95,earnings,100,50,7/25/2018
04996E,earnings,100,50,7/25/2018
04996E,earnings,100,50,7/25/2018
71860,earnings,100,50,7/25/2018
081AB9,dividend,100,50,7/25/2018
081AB9,earnings,100,50,7/25/2018
09F623,stake-acquirer,100,48,7/25/2018
09F623,dividend-up,100,81,7/25/2018
0A1D77,earnings-positive,100,69,7/25/2018
0A1D77,earnings,100,50,7/25/2018
0A1D77,earnings,100,50,7/25/2018
0A1D77,earnings,100,50,7/25/2018
0A1D77,earnings,100,50,7/25/2018
0A1D77,earnings,100,50,7/25/2018
0A748B,earnings,100,50,7/25/2018
0BD4E8,conference-call,100,50,7/25/2018
0C136E,earnings,100,50,7/25/2018
0C2A0D,earnings,100,50,7/25/2018
0CBC4D,revenues,100,50,7/25/2018
0CC62B,earnings,100,50,7/25/2018
0CC62B,earnings,100,50,7/25/2018
0CC62B,earnings,100,50,7/25/2018
0CC62B,earnings,100,50,7/25/2018
0CE204,earnings,100,50,7/25/2018
0E2992,earnings,100,50,7/25/2018
0E439E,earnings,100,50,7/25/2018
0E439E,earnings,100,50,7/25/2018
0E439E,earnings,100,50,7/25/2018
0E439E,earnings,100,50,7/25/2018
0E499E,earnings,100,50,7/25/2018
0E6027,earnings-positive,100,69,7/25/2018
102F04,earnings,100,50,7/25/2018
10943B,earnings,100,50,7/25/2018
1096C6,conference-participant,100,50,7/25/2018
11A49E,fast-track-designation,100,81,7/25/2018
12731D,conference-call,100,50,7/25/2018
1279ED,index-listing,100,76,7/25/2018
12E454,earnings,100,50,7/25/2018
12E454,earnings,100,50,7/25/2018
147C38,dividend,100,50,7/25/2018
152B9E,earnings,100,50,7/25/2018
156A99,earnings,100,50,7/25/2018
15789A,earnings,100,50,7/25/2018
159739,earnings,100,50,7/25/2018
159AE4,executive-appointment,100,54,7/25/2018
16F4D8,earnings,100,50,7/25/2018
16F4D8,earnings,100,50,7/25/2018
16F4D8,earnings,100,50,7/25/2018
16F4D8,earnings,100,50,7/25/2018
16F4D8,earnings,100,50,7/25/2018
197019,earnings,100,50,7/25/2018
1A5957,unit-acquisition-acquirer,100,49,7/25/2018
1A5957,acquisition-acquirer,100,49,7/25/2018
1A5957,acquisition-acquirer,100,49,7/25/2018
1CD708,earnings,100,50,7/25/2018
1DE526,earnings,100,50,7/25/2018
1E5786,dividend-up,100,59,7/25/2018
1E8A99,earnings,100,50,7/25/2018
1FAF22,regulatory-product-approval-granted,100,81,7/25/2018
2031CE,earnings,100,50,7/25/2018
2031CE,earnings,100,50,7/25/2018
2031CE,earnings,100,50,7/25/2018
2031CE,earnings,100,50,7/25/2018
2031CE,earnings,100,50,7/25/2018
221445,earnings,100,50,7/25/2018
221AD7,market-entry,100,57,7/25/2018
221AD7,earnings,100,50,7/25/2018
24D81E,partnership,100,61,7/25/2018
24D81E,partnership,100,61,7/25/2018
24D81E,partnership,100,61,7/25/2018
250BEE,asset-sale,100,62,7/25/2018
25102A,dividend,100,50,7/25/2018
25102A,earnings,100,50,7/25/2018
25102A,earnings,100,50,7/25/2018
25102A,earnings,100,50,7/25/2018
25102A,earnings,100,50,7/25/2018
25102A,earnings,100,50,7/25/2018
25102A,earnings,100,50,7/25/2018
25102A,dividend,100,50,7/25/2018
25102A,earnings,100,50,7/25/2018
253B2F,business-contract,100,69,7/25/2018
25A6CC,public-offering,100,43,7/25/2018
25DD05,earnings,100,50,7/25/2018
264EB3,earnings,100,50,7/25/2018
2720AB,earnings,100,50,7/25/2018
2B0AF4,earnings,100,50,7/25/2018
2CB4C9,earnings,100,50,7/25/2018
2CC71C,conference-call,100,50,7/25/2018
2D2D43,dividend,100,50,7/25/2018
2D643C,earnings,100,50,7/25/2018
2F94A5,earnings,100,50,7/25/2018
30DFD3,earnings,100,50,7/25/2018
31AA84,earnings,100,50,7/25/2018
31F25C,public-offering,100,43,7/25/2018
326EDD,earnings,100,50,7/25/2018
33E8C7,earnings,100,50,7/25/2018
33E8C7,earnings,100,50,7/25/2018
33E8C7,earnings,100,50,7/25/2018
34B411,dividend-up,100,81,7/25/2018
34B97A,earnings,100,50,7/25/2018
34B97A,earnings,100,50,7/25/2018
34B97A,earnings,100,50,7/25/2018
34B97A,earnings,100,50,7/25/2018
36A1CB,conference-call,100,50,7/25/2018
370C50,product-price-raise,100,57,7/25/2018
373B06,dividend,100,50,7/25/2018
3.73E+87,revenues,100,50,7/25/2018
3.73E+87,revenues,100,50,7/25/2018
384CD3,earnings,100,50,7/25/2018
3A113F,earnings,100,50,7/25/2018
3BB616,earnings,100,50,7/25/2018
3F4668,executive-appointment,100,54,7/25/2018
401072,earnings,100,50,7/25/2018
416C55,earnings,100,50,7/25/2018
41A93D,conference-participant,100,50,7/25/2018
41B0E2,earnings,100,50,7/25/2018
41D61C,earnings,100,50,7/25/2018
425BDC,earnings,100,50,7/25/2018
4290EF,earnings,100,50,7/25/2018
429BFB,conference-participant,100,50,7/25/2018
44DDBD,conference-call,100,50,7/25/2018
450ECB,executive-appointment,100,54,7/25/2018
458D2C,earnings,100,50,7/25/2018
46017C,conference-participant,100,50,7/25/2018
47752F,earnings,100,50,7/25/2018
47752F,earnings,100,50,7/25/2018
47752F,earnings,100,50,7/25/2018
47752F,earnings,100,50,7/25/2018
4A2457,conference-call,100,50,7/25/2018
4A6F00,partnership,100,61,7/25/2018
4B5054,dividend,100,50,7/25/2018
4B6EF9,earnings,100,50,7/25/2018
4B6EF9,dividend,100,50,7/25/2018
4C1FA1,earnings,100,50,7/25/2018
4C1FA1,earnings,100,50,7/25/2018
4C1FA1,earnings,100,50,7/25/2018
4C1FA1,earnings,100,50,7/25/2018
4C1FA1,earnings,100,50,7/25/2018
4C1FA1,earnings,100,50,7/25/2018
4C6C63,earnings,100,50,7/25/2018
4C6C63,earnings,100,50,7/25/2018
4C6C63,earnings,100,50,7/25/2018
4C6C63,earnings,100,50,7/25/2018
4C6C63,earnings,100,50,7/25/2018
4D8313,revenue-up,100,69,7/25/2018
4D8313,revenue-up,100,69,7/25/2018
4D8313,revenue-up,100,69,7/25/2018
4E7C1F,earnings,100,50,7/25/2018
4E7C1F,earnings,100,50,7/25/2018
4E7C1F,earnings,100,50,7/25/2018
4F9487,earnings-positive,100,69,7/25/2018
50070E,conference-call,100,50,7/25/2018
504FE2,business-contract,100,69,7/25/2018
514067,conference-participant,100,50,7/25/2018
52D936,market-entry,100,57,7/25/2018
532D47,earnings,100,50,7/25/2018
54512F,earnings,100,50,7/25/2018
5487B1,executive-appointment,100,54,7/25/2018
548AC0,conference-call,100,50,7/25/2018
54A646,dividend,100,50,7/25/2018
55438C,earnings,100,50,7/25/2018
55438C,earnings,100,50,7/25/2018
55438C,earnings,100,50,7/25/2018
55438C,earnings,100,50,7/25/2018
55438C,earnings,100,50,7/25/2018
55C289,earnings,100,50,7/25/2018
57CAAB,earnings,100,50,7/25/2018
587EDF,earnings,100,50,7/25/2018
5968F9,earnings,100,50,7/25/2018
5A9F54,earnings-up,100,68,7/25/2018
5A9F54,earnings,100,50,7/25/2018
5A9F54,earnings,100,50,7/25/2018
5A9F54,earnings,100,50,7/25/2018
5AAE17,conference-call,100,50,7/25/2018
5AF08A,earnings,100,50,7/25/2018
5B226B,unit-acquisition-acquirer,100,49,7/25/2018
5CC29D,earnings,100,50,7/25/2018
5DD48B,earnings,100,50,7/25/2018
5EC388,conference-participant,100,50,7/25/2018
5F2FF7,product-release,100,64,7/25/2018
60DD84,revenues,100,50,7/25/2018
60DD84,revenues,100,50,7/25/2018
616E3B,earnings,100,50,7/25/2018
616E3B,earnings,100,50,7/25/2018
657097,earnings,100,50,7/25/2018
65CF8E,earnings,100,50,7/25/2018
66E04A,earnings,100,50,7/25/2018
66E04A,earnings,100,50,7/25/2018
66E04A,earnings,100,50,7/25/2018
66E04A,earnings,100,50,7/25/2018
66E04A,earnings,100,50,7/25/2018
66E04A,earnings,100,50,7/25/2018
66E04A,earnings,100,50,7/25/2018
66E3C0,revenue-up,100,73,7/25/2018
66E3C0,revenue-up,100,73,7/25/2018
66E3C0,revenue-up,100,73,7/25/2018
67529E,earnings,100,50,7/25/2018
67529E,earnings,100,50,7/25/2018
67529E,earnings,100,50,7/25/2018
67529E,earnings,100,50,7/25/2018
67529E,earnings,100,50,7/25/2018
67529E,earnings,100,50,7/25/2018
67529E,earnings,100,50,7/25/2018
67529E,earnings,100,50,7/25/2018
69345C,earnings,100,50,7/25/2018
69345C,earnings,100,50,7/25/2018
69345C,earnings,100,50,7/25/2018
69345C,earnings,100,50,7/25/2018
693ECD,patent-awarded,100,72,7/25/2018
694749,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69E8E1,earnings,100,50,7/25/2018
69FDFC,award,100,58,7/25/2018
6ABCB8,earnings,100,50,7/25/2018
6ACFBF,earnings,100,50,7/25/2018
6.00E+19,business-contract,100,69,7/25/2018
6E1E61,earnings,100,50,7/25/2018
6E7060,conference-call,100,50,7/25/2018
6EB9DA,dividend,100,50,7/25/2018
71553E,conference-participant,100,50,7/25/2018
728737,earnings,100,50,7/25/2018
73C521,dividend-up,100,81,7/25/2018
7.44E+09,dividend,100,50,7/25/2018
7448A3,earnings,100,50,7/25/2018
763724,conference-call,100,50,7/25/2018
76B926,earnings,100,50,7/25/2018
76B926,executive-resignation,100,44,7/25/2018
76DD0C,unit-acquisition-acquirer,100,49,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
771985,earnings,100,50,7/25/2018
787D14,executive-appointment,100,54,7/25/2018
7A10FF,earnings,100,50,7/25/2018
7AB859,earnings,100,50,7/25/2018
7AB859,earnings,100,50,7/25/2018
7AB859,earnings,100,50,7/25/2018
7AB859,earnings,100,50,7/25/2018
7AB859,earnings,100,50,7/25/2018
7AC86E,earnings-up,100,68,7/25/2018
7AC86E,earnings,100,50,7/25/2018
7B6C88,earnings,100,50,7/25/2018
7BEA98,public-offering,100,43,7/25/2018
7C75FD,dividend,100,50,7/25/2018
7E62B5,earnings,100,50,7/25/2018
7FD8B9,conference-call,100,50,7/25/2018
805CD8,conference-call,100,50,7/25/2018
838ADD,earnings,100,50,7/25/2018
838ADD,earnings,100,50,7/25/2018
838ADD,earnings,100,50,7/25/2018
838ADD,earnings,100,50,7/25/2018
838ADD,earnings,100,50,7/25/2018
838ADD,earnings,100,50,7/25/2018
845533,earnings,100,50,7/25/2018
84920B,earnings,100,50,7/25/2018
863350,facility-open,100,65,7/25/2018
8665BA,earnings,100,50,7/25/2018
885758,ipo-pricing,100,50,7/25/2018
89F693,product-release,100,64,7/25/2018
8BE916,conference-participant,100,50,7/25/2018
8C1238,conference-call,100,50,7/25/2018
8CF6DD,executive-appointment,100,54,7/25/2018
8D4486,partnership,100,61,7/25/2018
8E93A4,dividend,100,50,7/25/2018
8EEA28,dividend,100,50,7/25/2018
8F6995,earnings-guidance,100,50,7/25/2018
8F8F2F,earnings,100,50,7/25/2018
8FF2EF,conference-call,100,50,7/25/2018
902670,dividend,100,50,7/25/2018
907ED2,conference-organizer,100,57,7/25/2018
90B678,legal-issues-defendant,100,22,7/25/2018
90B678,legal-issues-defendant,100,22,7/25/2018
922F0C,earnings-per-share-up,100,77,7/25/2018
9.31E+77,conference-call,100,50,7/25/2018
93D207,unit-acquisition-acquirer,100,49,7/25/2018
93D207,earnings,100,50,7/25/2018
942165,dividend,100,50,7/25/2018
943239,earnings,100,50,7/25/2018
9592FB,earnings,100,50,7/25/2018
965360,earnings,100,50,7/25/2018
9673BD,conference-call,100,50,7/25/2018
97B027,conference-call,100,50,7/25/2018
98CAED,earnings,100,50,7/25/2018
98CAED,earnings,100,50,7/25/2018
98CAED,earnings,100,50,7/25/2018
98CAED,dividend,100,50,7/25/2018
9C25FF,earnings-estimate-upgrade,100,80,7/25/2018
9C8664,earnings,100,50,7/25/2018
9F37C5,dividend,100,50,7/25/2018
9F37C5,earnings,100,50,7/25/2018
9F6B1A,earnings,100,50,7/25/2018
9F6B1A,earnings,100,50,7/25/2018
9F6B1A,earnings,100,50,7/25/2018
9F6B1A,earnings,100,50,7/25/2018
9FF5F1,executive-appointment,100,54,7/25/2018
A02FB1,earnings,100,50,7/25/2018
A29A46,earnings,100,50,7/25/2018
A350C1,operating-earnings,100,50,7/25/2018
A350C1,operating-earnings,100,50,7/25/2018
A350C1,operating-earnings,100,50,7/25/2018
A350C1,operating-earnings,100,50,7/25/2018
A350C1,operating-earnings,100,50,7/25/2018
A350C1,operating-earnings,100,50,7/25/2018
A350C1,operating-earnings,100,50,7/25/2018
A398F8,conference-participant,100,50,7/25/2018
A47A7D,conference-participant,100,50,7/25/2018
A4CD53,earnings,100,50,7/25/2018
A5A4F5,acquisition-acquirer,100,49,7/25/2018
A6213D,conference-call,100,50,7/25/2018
A63387,conference-participant,100,50,7/25/2018
A6ABE9,earnings-positive,100,69,7/25/2018
A8AC4C,earnings,100,50,7/25/2018
A8B137,earnings,100,50,7/25/2018
A8B137,earnings,100,50,7/25/2018
A8B137,earnings,100,50,7/25/2018
A8B137,earnings,100,50,7/25/2018
A8B137,earnings,100,50,7/25/2018
A8B137,dividend,100,50,7/25/2018
AA847A,earnings,100,50,7/25/2018
AABEA0,earnings-up,100,68,7/25/2018
AB7F05,earnings,100,50,7/25/2018
AB7F05,earnings,100,50,7/25/2018
ABBAD1,earnings,100,50,7/25/2018
AD23DE,earnings,100,50,7/25/2018
AD23DE,earnings,100,50,7/25/2018
AD23DE,earnings,100,50,7/25/2018
AD23DE,earnings,100,50,7/25/2018
AD23DE,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AD9F1D,earnings,100,50,7/25/2018
AE79CD,ipo-pricing,100,50,7/25/2018
AFF7B4,legal-issues-defendant,100,22,7/25/2018
B106FA,earnings,100,50,7/25/2018
B6082A,earnings,100,50,7/25/2018
B7BBFF,conference-call,100,50,7/25/2018
B96637,operating-earnings,100,50,7/25/2018
BBAE2A,earnings,100,50,7/25/2018
BC4876,dividend,100,50,7/25/2018
BC5680,earnings-up,100,68,7/25/2018
BC5680,earnings-up,100,68,7/25/2018
BC5680,earnings-up,100,68,7/25/2018
BCC55F,conference-participant,100,50,7/25/2018
BE14CF,earnings,100,50,7/25/2018
BEB756,earnings,100,50,7/25/2018
C05839,earnings,100,50,7/25/2018
C05839,earnings,100,50,7/25/2018
C05839,earnings,100,50,7/25/2018
C05839,earnings,100,50,7/25/2018
C05839,earnings,100,50,7/25/2018
C1114B,conference-call,100,50,7/25/2018
C356AC,product-recall,100,29,7/25/2018
C38440,earnings,100,50,7/25/2018
C4FBDC,legal-issues-defendant,100,22,7/25/2018
C58D71,patient-enrollment-complete,100,64,7/25/2018
C83B88,product-release,100,64,7/25/2018
C83B88,product-release,100,64,7/25/2018
C97B2D,earnings,100,50,7/25/2018
C9B932,earnings,100,50,7/25/2018
C9E107,earnings-per-share-positive,100,69,7/25/2018
CA99D7,conference-call,100,50,7/25/2018
CB88B3,earnings,100,50,7/25/2018
CB89EA,earnings,100,50,7/25/2018
CBA33B,earnings,100,50,7/25/2018
CBCC6A,conference-organizer,100,57,7/25/2018
CBFFDD,conference-participant,100,50,7/25/2018
CBFFDD,conference-participant,100,50,7/25/2018
CC35BE,earnings,100,50,7/25/2018
CCB623,earnings,100,50,7/25/2018
CD4DA8,earnings-up,100,68,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CD4DA8,earnings,100,50,7/25/2018
CDAF5B,operating-earnings,100,50,7/25/2018
CDAF5B,operating-earnings,100,50,7/25/2018
CDAF5B,operating-earnings,100,50,7/25/2018
CDAF5B,operating-earnings,100,50,7/25/2018
CE4FD9,merger-regulatory-approval,100,81,7/25/2018
CE96E7,product-release,100,64,7/25/2018
CEDFD5,clinical-trials,100,56,7/25/2018
CEDFD5,clinical-trials,100,56,7/25/2018
CEDFD5,clinical-trials,100,56,7/25/2018
CEDFD5,clinical-trials,100,56,7/25/2018
CEDFD5,clinical-trials,100,56,7/25/2018
CEDFD5,clinical-trials,100,56,7/25/2018
CFE5BE,dividend,100,50,7/25/2018
CFF15D,earnings,100,50,7/25/2018
CFF15D,earnings,100,50,7/25/2018
D33D8C,dividend,100,50,7/25/2018
D4463B,earnings,100,50,7/25/2018
D45285,conference-call,100,50,7/25/2018
D54E62,dividend,100,50,7/25/2018
D56E4C,conference-call,100,50,7/25/2018
D5A350,earnings,100,50,7/25/2018
D7A953,earnings,100,50,7/25/2018
D9B1C9,earnings,100,50,7/25/2018
D9B1C9,earnings,100,50,7/25/2018
D9B1C9,earnings,100,50,7/25/2018
D9C07E,earnings,100,50,7/25/2018
DB396B,earnings,100,50,7/25/2018
DB396B,earnings,100,50,7/25/2018
DB396B,earnings,100,50,7/25/2018
DB396B,dividend,100,50,7/25/2018
DC6AA0,ipo-pricing,100,50,7/25/2018
DCD97F,earnings,100,50,7/25/2018
DD7A96,earnings,100,50,7/25/2018
DE20DF,business-contract,100,69,7/25/2018
DE4924,conference-call,100,50,7/25/2018
DF6FDD,earnings,100,50,7/25/2018
E07573,dividend,100,50,7/25/2018
E30A8F,award,100,58,7/25/2018
E5D914,earnings,100,50,7/25/2018
E5D914,earnings,100,50,7/25/2018
E68C3D,earnings,100,50,7/25/2018
E70531,dividend,100,50,7/25/2018
E71AE6,clinical-trials-start,100,64,7/25/2018
E7BF32,executive-appointment,100,54,7/25/2018
E7BF32,executive-appointment,100,54,7/25/2018
E829E8,earnings-per-share-positive,100,69,7/25/2018
E82A2D,dividend,100,50,7/25/2018
E90C84,earnings,100,50,7/25/2018
E99180,earnings,100,50,7/25/2018
EBC84C,earnings,100,50,7/25/2018
EBC84C,earnings,100,50,7/25/2018
EBC84C,earnings,100,50,7/25/2018
EBC84C,earnings,100,50,7/25/2018
EBC84C,earnings,100,50,7/25/2018
EBC84C,earnings,100,50,7/25/2018
EBC84C,earnings,100,50,7/25/2018
ECF4F8,earnings,100,50,7/25/2018
ED9576,earnings,100,50,7/25/2018
EFA7B2,earnings,100,50,7/25/2018
F0B2B5,conference-call,100,50,7/25/2018
F24FF0,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F294DD,earnings,100,50,7/25/2018
F40EE2,earnings,100,50,7/25/2018
F47871,executive-appointment,100,54,7/25/2018
F4E882,earnings,100,50,7/25/2018
F4F46F,award,100,58,7/25/2018
F50BAB,earnings,100,50,7/25/2018
F50BAB,earnings,100,50,7/25/2018
F50BAB,earnings,100,50,7/25/2018
F50BAB,earnings,100,50,7/25/2018
F6E248,executive-resignation,100,44,7/25/2018
F6E248,earnings,100,50,7/25/2018
F6E248,dividend,100,50,7/25/2018
F72E4B,earnings,100,50,7/25/2018
F72E4B,earnings,100,50,7/25/2018
F72E4B,earnings,100,50,7/25/2018
F72E4B,earnings,100,50,7/25/2018
F73DD1,earnings,100,50,7/25/2018
F7902B,earnings,100,50,7/25/2018
F7902B,earnings,100,50,7/25/2018
F7FCA4,executive-appointment,100,54,7/25/2018
F80389,earnings,100,50,7/25/2018
F93C8A,executive-appointment,100,54,7/25/2018
FA918D,dividend,100,50,7/25/2018
FACCF6,earnings,100,50,7/25/2018
FAE021,revenue-up,100,60,7/25/2018
FAE021,revenue-up,100,60,7/25/2018
FAE021,revenue-up,100,60,7/25/2018
FAE021,revenue-up,100,60,7/25/2018
FAE021,revenue-up,100,60,7/25/2018
FAE021,revenue-up,100,60,7/25/2018
FC1B7B,earnings,100,50,7/25/2018
FC9A88,earnings,100,50,7/25/2018
FD4E8D,revenues,100,50,7/25/2018
FD4E8D,revenues,100,50,7/25/2018
FD554E,investment-investor,100,55,7/25/2018
FDC7E6,dividend,100,50,7/25/2018
FDC7E6,earnings,100,50,7/25/2018
FE1A1D,revenue-volume-up,100,61,7/25/2018
FEE4B0,dividend,100,50,7/25/2018
FF4343,partnership,100,61,7/25/2018
FF4343,earnings,100,50,7/25/2018
FF4343,earnings,100,50,7/25/2018
FF4343,earnings,100,50,7/25/2018
FF4343,earnings,100,50,7/25/2018
FF4343,earnings,100,50,7/25/2018
FF4343,earnings,100,50,7/25/2018
FF4343,earnings,100,50,7/25/2018
FF4343,earnings,100,50,7/25/2018
00326D,unit-acquisition-acquiree,100,76,7/26/2018
9397,earnings,100,50,7/26/2018
01478A,earnings,100,50,7/26/2018
0157B1,partnership,100,61,7/26/2018
0157B1,revenue-up,100,76,7/26/2018
0157B1,revenue-up,100,76,7/26/2018
0157B1,revenue-up,100,76,7/26/2018
0157B1,revenue-up,100,76,7/26/2018
0157B1,revenue-up,100,76,7/26/2018
0157B1,revenue-up,100,76,7/26/2018
0325B7,conference-call,100,50,7/26/2018
51332,dividend,100,50,7/26/2018
55018,dividend,100,50,7/26/2018
55018,government-contract,100,69,7/26/2018
61366,earnings,100,50,7/26/2018
061A3B,earnings,100,50,7/26/2018
07CA6A,earnings,100,50,7/26/2018
0A9D0A,earnings,100,50,7/26/2018
0B13E8,public-offering,100,43,7/26/2018
0B2071,dividend,100,50,7/26/2018
0B57D7,earnings,100,50,7/26/2018
0B9E6F,earnings,100,50,7/26/2018
0BF198,conference-call,100,50,7/26/2018
0C28D1,earnings,100,50,7/26/2018
0C28D1,earnings,100,50,7/26/2018
0C28D1,earnings,100,50,7/26/2018
0C28D1,earnings,100,50,7/26/2018
0C28D1,earnings,100,50,7/26/2018
0C6293,conference-call,100,50,7/26/2018
0EC508,earnings,100,50,7/26/2018
0ED415,earnings,100,50,7/26/2018
0ED415,earnings,100,50,7/26/2018
0ED415,earnings,100,50,7/26/2018
0F04E5,earnings,100,50,7/26/2018
0F04E5,earnings,100,50,7/26/2018
0F04E5,earnings,100,50,7/26/2018
0F04E5,earnings,100,50,7/26/2018
105D00,dividend,100,50,7/26/2018
1065BC,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
1151F4,earnings,100,50,7/26/2018
119CB6,revenue-up,100,69,7/26/2018
125212,earnings,100,50,7/26/2018
129DC8,earnings,100,50,7/26/2018
129DC8,earnings,100,50,7/26/2018
129DC8,earnings,100,50,7/26/2018
12E454,legal-issues-defendant,100,22,7/26/2018
13C3E0,earnings-positive,100,69,7/26/2018
1490F3,earnings,100,50,7/26/2018
1490F3,earnings,100,50,7/26/2018
159AE4,earnings,100,50,7/26/2018
159AE4,earnings,100,50,7/26/2018
159AE4,earnings,100,50,7/26/2018
159AE4,earnings,100,50,7/26/2018
1748F6,acquisition-acquirer,100,49,7/26/2018
1748F6,acquisition-acquirer,100,49,7/26/2018
1748F6,business-contract,100,69,7/26/2018
1.79E+10,earnings,100,50,7/26/2018
1.79E+10,dividend,100,50,7/26/2018
180DA0,earnings,100,50,7/26/2018
180DA0,earnings,100,50,7/26/2018
182B8C,earnings,100,50,7/26/2018
184866,earnings,100,50,7/26/2018
1866B2,conference-call,100,50,7/26/2018
1AF7E2,earnings,100,50,7/26/2018
1B5FEA,conference-call,100,50,7/26/2018
1CD09C,conference-call,100,50,7/26/2018
1DA44F,earnings,100,50,7/26/2018
1DA44F,earnings,100,50,7/26/2018
1DA44F,earnings,100,50,7/26/2018
1DA44F,earnings,100,50,7/26/2018
1DA44F,earnings,100,50,7/26/2018
1DA44F,earnings,100,50,7/26/2018
1DB6A6,earnings,100,50,7/26/2018
1E68B3,earnings,100,50,7/26/2018
1F2B5D,conference-participant,100,50,7/26/2018
1FA886,earnings,100,50,7/26/2018
1FAF22,earnings,100,50,7/26/2018
1FAF22,earnings,100,50,7/26/2018
1FAF22,earnings,100,50,7/26/2018
1FAF22,earnings,100,50,7/26/2018
1FAF22,earnings,100,50,7/26/2018
1FAF22,earnings,100,50,7/26/2018
202E5A,conference-call,100,50,7/26/2018
20DC4E,earnings,100,50,7/26/2018
21DED4,revenues,100,50,7/26/2018
21DED4,revenues,100,50,7/26/2018
21DED4,revenues,100,50,7/26/2018
21DED4,revenues,100,50,7/26/2018
21DED4,revenues,100,50,7/26/2018
21DED4,revenues,100,50,7/26/2018
21DED4,revenues,100,50,7/26/2018
22C58E,earnings,100,50,7/26/2018
238302,index-listing,100,76,7/26/2018
24A89A,executive-appointment,100,54,7/26/2018
25102A,exchange-noncompliance-authority,100,50,7/26/2018
25AB8E,conference-call,100,50,7/26/2018
270305,dividend,100,50,7/26/2018
270305,earnings,100,50,7/26/2018
270305,earnings,100,50,7/26/2018
270305,earnings,100,50,7/26/2018
272472,earnings,100,50,7/26/2018
272704,dividend,100,50,7/26/2018
27A791,earnings,100,50,7/26/2018
284289,earnings,100,50,7/26/2018
297DA8,earnings,100,50,7/26/2018
29B702,earnings,100,50,7/26/2018
2.90E+62,earnings,100,50,7/26/2018
2.90E+62,earnings,100,50,7/26/2018
2.90E+62,earnings,100,50,7/26/2018
2.90E+62,earnings,100,50,7/26/2018
2.90E+62,earnings,100,50,7/26/2018
2.90E+62,dividend,100,50,7/26/2018
2A17B1,earnings-up,100,68,7/26/2018
2A17B1,earnings-up,100,68,7/26/2018
2A17B1,earnings-up,100,68,7/26/2018
2AE625,conference-participant,100,50,7/26/2018
2B9DBB,earnings,100,50,7/26/2018
2BA977,earnings,100,50,7/26/2018
2CB4C9,dividend,100,50,7/26/2018
2D2D43,earnings,100,50,7/26/2018
2DA92D,earnings,100,50,7/26/2018
2DDB22,earnings,100,50,7/26/2018
2EB88B,earnings,100,50,7/26/2018
2EB88B,earnings,100,50,7/26/2018
2EC172,earnings,100,50,7/26/2018
2EC172,earnings,100,50,7/26/2018
2EC172,earnings,100,50,7/26/2018
2EC172,earnings,100,50,7/26/2018
2EC172,earnings,100,50,7/26/2018
2EC172,earnings,100,50,7/26/2018
2F5256,dividend,100,50,7/26/2018
301493,earnings,100,50,7/26/2018
31643A,product-release,100,64,7/26/2018
319BE2,dividend-up,100,81,7/26/2018
319BE2,earnings,100,50,7/26/2018
328250,earnings,100,50,7/26/2018
32C8CD,merger-completed,100,66,7/26/2018
3390DE,earnings,100,50,7/26/2018
3461CF,credit-rating-upgrade-rater,20,50,7/26/2018
349DA4,conference-participant,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
366A08,earnings,100,50,7/26/2018
371C01,earnings,100,50,7/26/2018
371C01,earnings,100,50,7/26/2018
383ADA,earnings,100,50,7/26/2018
3.88E+02,dividend,100,50,7/26/2018
39692D,earnings,100,50,7/26/2018
3A94DF,earnings,100,50,7/26/2018
3B20AB,earnings,100,50,7/26/2018
3B2311,earnings,100,50,7/26/2018
3B8484,earnings,100,50,7/26/2018
3BB616,earnings,100,50,7/26/2018
3BB616,earnings,100,50,7/26/2018
3BB616,earnings,100,50,7/26/2018
3CBA2A,revenue-up,100,69,7/26/2018
3CBA2A,revenue-up,100,69,7/26/2018
3CBA2A,revenue-up,100,69,7/26/2018
3CBA2A,revenue-up,100,69,7/26/2018
3CBA2A,revenue-up,100,69,7/26/2018
3CBA2A,revenue-up,100,69,7/26/2018
3CBA2A,revenue-up,100,69,7/26/2018
3D9999,dividend,100,50,7/26/2018
3E15F6,earnings,100,50,7/26/2018
3E15F6,earnings,100,50,7/26/2018
3E15F6,earnings,100,50,7/26/2018
3E15F6,earnings,100,50,7/26/2018
3F6A9C,executive-appointment,100,54,7/26/2018
408380,earnings,100,50,7/26/2018
4.00E+163,unit-acquisition-completed-acquirer,100,49,7/26/2018
41EC04,earnings,100,50,7/26/2018
41EC04,earnings,100,50,7/26/2018
41EC04,earnings,100,50,7/26/2018
41EC04,earnings,100,50,7/26/2018
4290EF,dividend,100,50,7/26/2018
435ACE,dividend,100,50,7/26/2018
43A060,earnings,100,50,7/26/2018
44209A,legal-issues-defendant,100,22,7/26/2018
442769,earnings,100,50,7/26/2018
442769,earnings,100,50,7/26/2018
442769,earnings,100,50,7/26/2018
442769,earnings,100,50,7/26/2018
44740A,earnings,100,50,7/26/2018
449217,earnings-positive,100,69,7/26/2018
449217,earnings,100,50,7/26/2018
449217,earnings,100,50,7/26/2018
449217,earnings,100,50,7/26/2018
449217,earnings,100,50,7/26/2018
4595EF,earnings,100,50,7/26/2018
45ABCC,earnings,100,50,7/26/2018
4649D5,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
46CF27,earnings,100,50,7/26/2018
479930,earnings,100,50,7/26/2018
4806CE,earnings,100,50,7/26/2018
4806CE,earnings,100,50,7/26/2018
4A5C8D,earnings,100,50,7/26/2018
4A5C8D,earnings,100,50,7/26/2018
4BD6DB,earnings,100,50,7/26/2018
4D371E,dividend,100,50,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4D7BD8,earnings-up,100,68,7/26/2018
4E913D,earnings-up,100,65,7/26/2018
4EE167,earnings,100,50,7/26/2018
504FE2,earnings,100,50,7/26/2018
519FE0,earnings,100,50,7/26/2018
51E682,earnings,100,50,7/26/2018
52015A,earnings,100,50,7/26/2018
525A1C,earnings,100,50,7/26/2018
525A1C,earnings,100,50,7/26/2018
525A1C,earnings,100,50,7/26/2018
525A1C,earnings,100,50,7/26/2018
525A1C,earnings,100,50,7/26/2018
525A1C,earnings,100,50,7/26/2018
53A226,earnings,100,50,7/26/2018
53A226,partnership,100,61,7/26/2018
5546DA,earnings,100,50,7/26/2018
55C9B5,earnings,100,50,7/26/2018
567F3D,earnings,100,50,7/26/2018
567F3D,earnings,100,50,7/26/2018
567F3D,earnings,100,50,7/26/2018
57356F,earnings,100,50,7/26/2018
57356F,earnings,100,50,7/26/2018
57356F,earnings,100,50,7/26/2018
583223,earnings,100,50,7/26/2018
589F5A,earnings,100,50,7/26/2018
58B46F,dividend,100,50,7/26/2018
58C2D4,conference-participant,100,50,7/26/2018
594402,earnings,100,50,7/26/2018
596116,earnings,100,50,7/26/2018
59A832,conference-call,100,50,7/26/2018
59B229,earnings,100,50,7/26/2018
59B229,earnings,100,50,7/26/2018
59B229,earnings,100,50,7/26/2018
59B229,earnings,100,50,7/26/2018
5BC2F4,public-offering,100,43,7/26/2018
5D02B7,earnings,100,50,7/26/2018
5D0337,earnings,100,50,7/26/2018
5D16CF,earnings,100,50,7/26/2018
5DD486,earnings,100,50,7/26/2018
5E6959,earnings-up,100,68,7/26/2018
5FE4B6,earnings,100,50,7/26/2018
5FE4B6,earnings,100,50,7/26/2018
6137BF,earnings,100,50,7/26/2018
622037,dividend,100,50,7/26/2018
62EFEE,earnings-up,100,68,7/26/2018
63E8D5,earnings,100,50,7/26/2018
641F17,earnings,100,50,7/26/2018
641F17,earnings,100,50,7/26/2018
641F17,earnings,100,50,7/26/2018
641F17,earnings,100,50,7/26/2018
641F17,earnings,100,50,7/26/2018
641F17,earnings,100,50,7/26/2018
64854A,conference-call,100,50,7/26/2018
64E615,executive-appointment,100,54,7/26/2018
6.52E+64,earnings,100,50,7/26/2018
65CF8E,dividend,100,50,7/26/2018
662682,dividend,100,50,7/26/2018
665D7D,legal-issues-defendant,100,22,7/26/2018
68586A,conference-call,100,50,7/26/2018
6B0784,earnings,100,50,7/26/2018
6CDFC6,earnings,100,50,7/26/2018
6D156D,conference-participant,100,50,7/26/2018
6D9B53,business-contract,100,69,7/26/2018
6DC1D7,earnings,100,50,7/26/2018
6E8349,earnings,100,50,7/26/2018
6F3936,partnership,100,61,7/26/2018
6F3FA8,conference-call,100,50,7/26/2018
701531,earnings,100,50,7/26/2018
70FCEF,executive-appointment,100,54,7/26/2018
713810,government-contract,100,69,7/26/2018
719477,executive-resignation,100,44,7/26/2018
71B0CF,earnings,100,50,7/26/2018
724F84,earnings,100,50,7/26/2018
729368,earnings,100,50,7/26/2018
72CB93,earnings,100,50,7/26/2018
735388,earnings,100,50,7/26/2018
73BCBA,earnings,100,50,7/26/2018
73BCBA,earnings,100,50,7/26/2018
73BCBA,earnings,100,50,7/26/2018
73C521,executive-appointment,100,54,7/26/2018
73C9E2,earnings,100,50,7/26/2018
742AAB,conference-call,100,50,7/26/2018
762A3E,dividend,100,50,7/26/2018
762A3E,earnings,100,50,7/26/2018
76CEFB,executive-appointment,100,54,7/26/2018
76CEFB,earnings,100,50,7/26/2018
76F067,earnings,100,50,7/26/2018
791D59,executive-appointment,100,54,7/26/2018
791D59,revenues,100,50,7/26/2018
791D59,revenues,100,50,7/26/2018
791D59,revenues,100,50,7/26/2018
791D59,revenues,100,50,7/26/2018
791D59,revenues,100,50,7/26/2018
791D59,revenues,100,50,7/26/2018
791D59,revenues,100,50,7/26/2018
7AB859,business-contract,100,69,7/26/2018
7B0BA6,dividend,100,50,7/26/2018
7B4B91,earnings,100,50,7/26/2018
7B9AFA,revenues,100,50,7/26/2018
7B9AFA,revenues,100,50,7/26/2018
7B9AFA,revenues,100,50,7/26/2018
7BAAE7,earnings-positive,100,69,7/26/2018
7BEA98,public-offering,100,43,7/26/2018
7D5384,earnings,100,50,7/26/2018
7D5384,earnings,100,50,7/26/2018
7D5384,earnings,100,50,7/26/2018
7D5384,earnings,100,50,7/26/2018
7D5FD6,earnings,100,50,7/26/2018
7DC1C4,earnings,100,50,7/26/2018
7E0EB0,earnings,100,50,7/26/2018
7FC386,earnings,100,50,7/26/2018
80C400,earnings,100,50,7/26/2018
80D744,earnings,100,50,7/26/2018
81A88D,earnings,100,50,7/26/2018
81EAD4,business-contract,100,69,7/26/2018
8.22E+27,earnings,100,50,7/26/2018
8303CD,earnings,100,50,7/26/2018
83598E,dividend,100,50,7/26/2018
837C04,earnings,100,50,7/26/2018
837C04,dividend,100,50,7/26/2018
83B1C8,earnings,100,50,7/26/2018
84A6B9,executive-appointment,100,54,7/26/2018
859D62,executive-appointment,100,54,7/26/2018
860AB6,dividend,100,50,7/26/2018
860AB6,dividend,100,50,7/26/2018
86A1B9,legal-issues-defendant,100,22,7/26/2018
8802B4,executive-appointment,100,54,7/26/2018
8817D5,dividend,100,50,7/26/2018
8817D5,earnings,100,50,7/26/2018
893904,earnings,100,50,7/26/2018
8AC65D,ipo-pricing,100,50,7/26/2018
8AC740,conference-call,100,50,7/26/2018
8B3B0E,earnings,100,50,7/26/2018
8B6E7E,earnings,100,50,7/26/2018
8D0EEA,public-offering,100,43,7/26/2018
8D4486,business-contract,100,69,7/26/2018
8D4486,business-contract,100,69,7/26/2018
8D5145,earnings,100,50,7/26/2018
8DE74B,earnings,100,50,7/26/2018
8E0E32,earnings,100,50,7/26/2018
8E4250,earnings,100,50,7/26/2018
8E4F9A,conference-call,100,50,7/26/2018
8E82A6,dividend,100,50,7/26/2018
8E8E6E,conference-call,100,50,7/26/2018
8F3231,earnings,100,50,7/26/2018
90B678,legal-issues-defendant,100,22,7/26/2018
911AB8,stake-acquirer,100,48,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
911AB8,earnings,100,50,7/26/2018
913437,trading-halt,100,43,7/26/2018
913437,trading-halt,100,43,7/26/2018
92D9C9,earnings,100,50,7/26/2018
934029,earnings,100,50,7/26/2018
93C130,earnings,100,50,7/26/2018
93C130,dividend,100,50,7/26/2018
94563D,earnings,100,50,7/26/2018
94563D,earnings,100,50,7/26/2018
94563D,earnings,100,50,7/26/2018
94563D,earnings,100,50,7/26/2018
94563D,earnings,100,50,7/26/2018
94637C,earnings,100,50,7/26/2018
94756D,earnings,100,50,7/26/2018
9.54E+32,earnings,100,50,7/26/2018
9.54E+32,earnings,100,50,7/26/2018
966DBE,earnings,100,50,7/26/2018
966DBE,earnings,100,50,7/26/2018
966DBE,earnings,100,50,7/26/2018
9810C0,executive-appointment,100,54,7/26/2018
9810C0,earnings,100,50,7/26/2018
990AD0,earnings,100,50,7/26/2018
990AD0,dividend,100,50,7/26/2018
9.97E+09,earnings,100,50,7/26/2018
9B5968,earnings,100,50,7/26/2018
9B5968,earnings,100,50,7/26/2018
9CDA4F,earnings,100,50,7/26/2018
9CF9B1,earnings,100,50,7/26/2018
9D307D,earnings,100,50,7/26/2018
9D4EC7,revenue-up,100,61,7/26/2018
9D4EC7,revenue-up,100,61,7/26/2018
9D4EC7,revenue-up,100,61,7/26/2018
9E298A,earnings,100,50,7/26/2018
9E298A,earnings,100,50,7/26/2018
9E298A,earnings,100,50,7/26/2018
9EED50,earnings,100,50,7/26/2018
9F03CF,earnings,100,50,7/26/2018
9F03CF,dividend,100,50,7/26/2018
9F5CBB,conference-call,100,50,7/26/2018
A1A317,earnings,100,50,7/26/2018
A1A317,earnings,100,50,7/26/2018
A1A317,earnings,100,50,7/26/2018
A247F5,buybacks,100,74,7/26/2018
A247F5,earnings-per-share-positive,100,69,7/26/2018
A247F5,earnings-per-share-positive,100,69,7/26/2018
A247F5,earnings-per-share-positive,100,69,7/26/2018
A26C26,acquisition-acquirer,100,49,7/26/2018
A429A5,earnings-up,100,68,7/26/2018
A4386C,dividend,100,50,7/26/2018
A495F7,executive-appointment,100,54,7/26/2018
A5151E,earnings,100,50,7/26/2018
A5A4F5,acquisition-acquirer,100,49,7/26/2018
A5B913,earnings,100,50,7/26/2018
A5B913,earnings,100,50,7/26/2018
A5B913,earnings,100,50,7/26/2018
A631A3,award,100,58,7/26/2018
A63387,conference-call,100,50,7/26/2018
A63820,earnings,100,50,7/26/2018
A63820,earnings,100,50,7/26/2018
A63820,earnings,100,50,7/26/2018
A65325,executive-appointment,100,54,7/26/2018
A75D43,earnings,100,50,7/26/2018
A806FA,dividend,100,50,7/26/2018
A8CBDA,earnings-positive,100,69,7/26/2018
A94637,revenues,100,50,7/26/2018
A99576,earnings,100,50,7/26/2018
AADE0B,earnings,100,50,7/26/2018
AC1952,earnings,100,50,7/26/2018
AC1952,executive-appointment,100,54,7/26/2018
AD3008,conference-participant,100,50,7/26/2018
AD375D,earnings,100,50,7/26/2018
AD3C93,earnings,100,50,7/26/2018
AEF2C3,revenues,100,50,7/26/2018
AF93DE,conference-call,100,50,7/26/2018
AFD1CA,earnings,100,50,7/26/2018
B076A1,conference-call,100,50,7/26/2018
B08954,earnings,100,50,7/26/2018
B0B969,earnings,100,50,7/26/2018
B2206F,earnings,100,50,7/26/2018
B2D799,executive-appointment,100,54,7/26/2018
B446B8,earnings,100,50,7/26/2018
B446B8,earnings,100,50,7/26/2018
B446B8,earnings,100,50,7/26/2018
B5734D,business-contract,100,69,7/26/2018
B619CB,earnings-up,100,68,7/26/2018
B73395,conference-call,100,50,7/26/2018
B98EFA,operating-earnings,100,50,7/26/2018
BBBB41,dividend,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BC3AD2,earnings,100,50,7/26/2018
BCC13E,conference-participant,100,50,7/26/2018
BCC55F,executive-appointment,100,54,7/26/2018
BD682F,earnings,100,50,7/26/2018
BDEC1E,conference-call,100,50,7/26/2018
BDEF34,earnings,100,50,7/26/2018
BDEF34,earnings,100,50,7/26/2018
BDEF34,earnings,100,50,7/26/2018
BDEF34,earnings,100,50,7/26/2018
BDEF34,earnings,100,50,7/26/2018
BDEF34,earnings,100,50,7/26/2018
BF79F5,earnings,100,50,7/26/2018
BF79F5,earnings,100,50,7/26/2018
BF79F5,earnings,100,50,7/26/2018
BFD0A7,conference-call,100,50,7/26/2018
C0030A,earnings,100,50,7/26/2018
C0030A,earnings,100,50,7/26/2018
C0030A,earnings,100,50,7/26/2018
C0030A,earnings,100,50,7/26/2018
C11C46,conference-participant,100,50,7/26/2018
C16A8F,executive-appointment,100,54,7/26/2018
C2609A,dividend,100,50,7/26/2018
C425AE,conference-participant,100,50,7/26/2018
C4706C,conference-call,100,50,7/26/2018
C4F567,revenue-up,100,69,7/26/2018
C4F567,revenue-up,100,69,7/26/2018
C4F567,revenue-up,100,69,7/26/2018
C4F567,revenue-up,100,69,7/26/2018
C54140,partnership,100,61,7/26/2018
C584BE,legal-issues-defendant,100,22,7/26/2018
C5D2AE,earnings,100,50,7/26/2018
C72B8F,earnings,100,50,7/26/2018
C7FC95,earnings,100,50,7/26/2018
C83B88,earnings,100,50,7/26/2018
C83B88,earnings,100,50,7/26/2018
C83B88,earnings,100,50,7/26/2018
C83B88,earnings,100,50,7/26/2018
C83B88,earnings,100,50,7/26/2018
C83B88,earnings,100,50,7/26/2018
C83B88,dividend,100,50,7/26/2018
C8FAC7,earnings,100,50,7/26/2018
C8FAC7,earnings,100,50,7/26/2018
C941DC,public-offering,100,43,7/26/2018
C9E4EC,ipo-pricing,100,50,7/26/2018
CAB222,conference-call,100,50,7/26/2018
CB22CD,revenue-up,100,69,7/26/2018
CB22CD,revenue-up,100,69,7/26/2018
CCB623,conference-participant,100,50,7/26/2018
CDEDFE,earnings,100,50,7/26/2018
CDFCC9,product-release,100,64,7/26/2018
CE4FD9,conference-call,100,50,7/26/2018
CE96E7,earnings,100,50,7/26/2018
CE96E7,earnings,100,50,7/26/2018
CE96E7,earnings,100,50,7/26/2018
CE96E7,earnings,100,50,7/26/2018
CF6A5A,earnings,100,50,7/26/2018
CFF97C,earnings-guidance-up,100,83,7/26/2018
CFF97C,earnings,100,50,7/26/2018
CFF97C,earnings,100,50,7/26/2018
CFF97C,earnings,100,50,7/26/2018
CFF97C,earnings,100,50,7/26/2018
CFF97C,earnings,100,50,7/26/2018
D0DFE5,earnings,100,50,7/26/2018
D139BC,conference-call,100,50,7/26/2018
D13F1C,conference-call,100,50,7/26/2018
D25249,earnings,100,50,7/26/2018
D4070C,earnings,100,50,7/26/2018
D518D8,earnings,100,50,7/26/2018
D518D8,earnings,100,50,7/26/2018
D518D8,earnings,100,50,7/26/2018
D518D8,earnings,100,50,7/26/2018
D6489C,award,100,58,7/26/2018
D6534D,earnings-up,100,68,7/26/2018
D65A13,revenue-up,100,75,7/26/2018
D65A13,revenue-up,100,69,7/26/2018
D65A13,revenue-up,100,75,7/26/2018
D697DE,earnings,100,50,7/26/2018
D8760C,dividend,100,50,7/26/2018
D8F347,executive-appointment,100,54,7/26/2018
D8F347,dividend-up,100,60,7/26/2018
D96202,earnings,100,50,7/26/2018
D96202,dividend-up,100,81,7/26/2018
DA199F,earnings,100,50,7/26/2018
DA48E4,earnings-per-share-up,100,93,7/26/2018
DA90E1,earnings,100,50,7/26/2018
DAFED3,earnings-up,100,68,7/26/2018
DAFED3,earnings-up,100,68,7/26/2018
DAFED3,earnings-up,100,68,7/26/2018
DAFED3,earnings-up,100,68,7/26/2018
DB06B0,earnings,100,50,7/26/2018
DB06B0,earnings,100,50,7/26/2018
DB06B0,earnings,100,50,7/26/2018
DB06B0,earnings,100,50,7/26/2018
DB06B0,earnings,100,50,7/26/2018
DBB28E,partnership,100,61,7/26/2018
DBB28E,partnership,100,61,7/26/2018
DBCA3F,earnings,100,50,7/26/2018
DD0099,earnings-up,100,68,7/26/2018
DD9E41,patent-awarded,100,72,7/26/2018
DEF058,earnings,100,50,7/26/2018
E05DC8,earnings-up,100,68,7/26/2018
E10D31,earnings,100,50,7/26/2018
E124EB,earnings,100,50,7/26/2018
E1BD05,revenues,100,50,7/26/2018
E1BD05,revenues,100,50,7/26/2018
E2CB7B,earnings,100,50,7/26/2018
E40FB6,earnings,100,50,7/26/2018
E40FB6,earnings,100,50,7/26/2018
E40FB6,earnings,100,50,7/26/2018
E40FB6,earnings,100,50,7/26/2018
E40FB6,earnings,100,50,7/26/2018
E754F0,public-offering,100,43,7/26/2018
E7BF32,earnings,100,50,7/26/2018
E7BF32,earnings,100,50,7/26/2018
E866D2,earnings-positive,100,69,7/26/2018
E866D2,earnings-positive,100,69,7/26/2018
E866D2,earnings-positive,100,69,7/26/2018
E866D2,earnings-positive,100,69,7/26/2018
E866D2,earnings-positive,100,69,7/26/2018
E866D2,earnings-positive,100,69,7/26/2018
E866D2,earnings-positive,100,69,7/26/2018
E8D221,earnings,100,50,7/26/2018
EA4E68,earnings,100,50,7/26/2018
EC99D0,earnings,100,50,7/26/2018
ED0D7C,earnings,100,50,7/26/2018
ED0D7C,earnings,100,50,7/26/2018
ED0D7C,earnings,100,50,7/26/2018
ED0D7C,earnings,100,50,7/26/2018
ED2EFD,dividend,100,50,7/26/2018
ED8676,earnings,100,50,7/26/2018
ED8676,dividend,100,50,7/26/2018
EDF5CA,dividend,100,50,7/26/2018
EE1E44,earnings-up,100,68,7/26/2018
EE1E44,earnings-up,100,68,7/26/2018
EE1E44,earnings-up,100,68,7/26/2018
EE1E44,earnings-up,100,68,7/26/2018
EE1E44,earnings-up,100,68,7/26/2018
EF5BED,executive-appointment,100,54,7/26/2018
F0027C,earnings,100,50,7/26/2018
F04E05,earnings,100,50,7/26/2018
F179ED,conference-participant,100,50,7/26/2018
F1C04C,operating-earnings,100,50,7/26/2018
F31B13,dividend-up,100,74,7/26/2018
F6DCE4,executive-appointment,100,54,7/26/2018
F7FCA4,dividend-up,100,81,7/26/2018
F88A04,earnings,100,50,7/26/2018
FA918D,earnings,100,50,7/26/2018
FA918D,earnings,100,50,7/26/2018
FC1736,revenues,100,50,7/26/2018
FC1736,revenues,100,50,7/26/2018
FC1F9D,earnings,100,50,7/26/2018
FC80E6,earnings,100,50,7/26/2018
FC9869,earnings,100,50,7/26/2018
FD4BBE,earnings,100,50,7/26/2018
FD4BBE,earnings,100,50,7/26/2018
FD4BBE,earnings,100,50,7/26/2018
FD9526,earnings-guidance-up,100,83,7/26/2018
FD9526,earnings-guidance-up,100,83,7/26/2018
FE89E0,earnings,100,50,7/26/2018
FEC475,business-contract,100,69,7/26/2018
FF5413,earnings-positive,100,69,7/26/2018
FF5413,earnings-positive,100,69,7/26/2018
03FB17,earnings,100,50,7/27/2018
0A6824,dividend,100,50,7/27/2018
0F91FC,earnings,100,50,7/27/2018
0FDE97,earnings,100,50,7/27/2018
0FDE97,earnings,100,50,7/27/2018
0FDE97,earnings,100,50,7/27/2018
0FDE97,earnings,100,50,7/27/2018
0FDE97,earnings,100,50,7/27/2018
0FDE97,earnings,100,50,7/27/2018
0FDE97,earnings,100,50,7/27/2018
10673F,earnings,100,50,7/27/2018
10673F,earnings,100,50,7/27/2018
12A3A3,executive-appointment,100,54,7/27/2018
12E454,legal-issues-defendant,100,22,7/27/2018
12E454,legal-issues-defendant,100,22,7/27/2018
12E454,legal-issues-defendant,100,22,7/27/2018
139303,earnings,100,50,7/27/2018
157D9F,earnings,100,50,7/27/2018
157D9F,earnings,100,50,7/27/2018
157D9F,earnings,100,50,7/27/2018
157D9F,earnings,100,50,7/27/2018
157D9F,earnings,100,50,7/27/2018
1.79E+10,executive-appointment,100,54,7/27/2018
197612,conference-participant,100,50,7/27/2018
19C105,earnings,100,50,7/27/2018
19C105,earnings,100,50,7/27/2018
19C105,earnings,100,50,7/27/2018
19C105,dividend,100,50,7/27/2018
1A5957,earnings,100,50,7/27/2018
1CF3A8,conference-call,100,50,7/27/2018
1EBF8D,earnings,100,50,7/27/2018
2491BC,earnings,100,50,7/27/2018
2491BC,earnings,100,50,7/27/2018
2491BC,legal-issues-defendant,100,22,7/27/2018
272472,dividend,100,50,7/27/2018
28DCF3,earnings,100,50,7/27/2018
2CA60F,partnership,100,61,7/27/2018
2D643C,dividend-up,100,61,7/27/2018
338544,earnings,100,50,7/27/2018
3461CF,earnings,100,50,7/27/2018
3471C0,executive-appointment,100,54,7/27/2018
3.88E+02,earnings,100,50,7/27/2018
3D9999,earnings-positive,100,69,7/27/2018
3FACA7,earnings-positive,100,69,7/27/2018
3FACA7,earnings,100,50,7/27/2018
3FACA7,earnings,100,50,7/27/2018
3FACA7,earnings,100,50,7/27/2018
4017AD,earnings,100,50,7/27/2018
423279,dividend,100,50,7/27/2018
460C93,earnings,100,50,7/27/2018
4A3438,conference-call,100,50,7/27/2018
4B5054,earnings,100,50,7/27/2018
4C31F3,conference-call,100,50,7/27/2018
4D8E5E,conference-participant,100,50,7/27/2018
51B442,executive-appointment,100,54,7/27/2018
545272,merger-regulatory-approval,100,81,7/27/2018
545272,merger-regulatory-approval,100,81,7/27/2018
56277A,earnings,100,50,7/27/2018
562853,earnings,100,50,7/27/2018
57DDB9,conference-call,100,50,7/27/2018
5B6C11,earnings,100,50,7/27/2018
5BC2F4,public-offering,100,43,7/27/2018
5D41E4,conference-call,100,50,7/27/2018
5DE5A5,dividend,100,50,7/27/2018
6284B5,earnings,100,50,7/27/2018
6634D9,legal-issues-defendant,100,22,7/27/2018
665D7D,earnings,100,50,7/27/2018
66749D,acquisition-acquirer,100,49,7/27/2018
67303E,public-offering,100,43,7/27/2018
69CE71,conference-call,100,50,7/27/2018
6E7060,dividend,100,50,7/27/2018
7032D0,earnings,100,50,7/27/2018
7239BB,market-entry,100,57,7/27/2018
72EF75,dividend,100,50,7/27/2018
75768D,dividend,100,50,7/27/2018
787D14,earnings-guidance,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7999F3,earnings,100,50,7/27/2018
7FDE1C,conference-call,100,50,7/27/2018
81EAD4,conference-call,100,50,7/27/2018
82B57E,earnings,100,50,7/27/2018
850779,dividend-up,100,62,7/27/2018
86AA9C,earnings,100,50,7/27/2018
877734,conference-call,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8B2C4A,earnings,100,50,7/27/2018
8D0EEA,public-offering,100,43,7/27/2018
9004C4,conference-call,100,50,7/27/2018
902255,earnings,100,50,7/27/2018
92B625,conference-call,100,50,7/27/2018
9.36E+10,capital-increase-completed,100,61,7/27/2018
9934AD,earnings,100,50,7/27/2018
9AF3DC,dividend,100,50,7/27/2018
9D2790,dividend,100,50,7/27/2018
9D6A24,dividend,100,50,7/27/2018
A28C54,earnings,100,50,7/27/2018
A2CA3F,dividend,100,50,7/27/2018
A5195E,earnings,100,50,7/27/2018
A5A4F5,acquisition-acquirer,100,49,7/27/2018
A5E715,conference-participant,100,50,7/27/2018
A94718,conference-call,100,50,7/27/2018
ABEE43,earnings,100,50,7/27/2018
AFF7B4,legal-issues-defendant,100,22,7/27/2018
B604DF,executive-appointment,100,54,7/27/2018
B8A51F,ipo-completed,100,76,7/27/2018
B8DD94,conference-call,100,50,7/27/2018
C564E4,conference-call,100,50,7/27/2018
CB89EA,conference-participant,100,50,7/27/2018
CBCC6A,earnings,100,50,7/27/2018
CBCC6A,earnings,100,50,7/27/2018
CBFFDD,executive-appointment,100,54,7/27/2018
CBFFDD,executive-appointment,100,54,7/27/2018
CDD75E,legal-issues-defendant,100,22,7/27/2018
CDD75E,legal-issues-defendant,100,22,7/27/2018
CDD75E,legal-issues-defendant,100,22,7/27/2018
CE4FD9,earnings,100,50,7/27/2018
CE4FD9,earnings,100,50,7/27/2018
CE4FD9,earnings,100,50,7/27/2018
CE4FD9,earnings,100,50,7/27/2018
D54E62,earnings-positive,100,69,7/27/2018
D54E62,earnings-positive,100,69,7/27/2018
D54E62,earnings-positive,100,69,7/27/2018
D54E62,earnings-positive,100,69,7/27/2018
D54E62,buybacks,100,74,7/27/2018
D7F569,earnings,100,50,7/27/2018
D7F569,dividend,100,50,7/27/2018
D854DD,conference-participant,100,50,7/27/2018
D854F3,earnings,100,50,7/27/2018
D854F3,earnings,100,50,7/27/2018
D854F3,earnings,100,50,7/27/2018
DA0A9E,earnings,100,50,7/27/2018
DB396B,executive-appointment,100,54,7/27/2018
DBEF02,earnings,100,50,7/27/2018
DE5611,dividend,100,50,7/27/2018
E70531,earnings,100,50,7/27/2018
E70531,earnings,100,50,7/27/2018
E70531,earnings,100,50,7/27/2018
E70531,earnings,100,50,7/27/2018
E70531,earnings,100,50,7/27/2018
E82A2D,earnings-up,100,68,7/27/2018
EB61C4,executive-appointment,100,54,7/27/2018
EB6965,earnings,100,50,7/27/2018
EB6965,earnings,100,50,7/27/2018
EB6965,earnings,100,50,7/27/2018
EB6965,earnings,100,50,7/27/2018
EB6965,earnings,100,50,7/27/2018
EB6965,earnings,100,50,7/27/2018
EB6965,earnings,100,50,7/27/2018
EF5914,earnings,100,50,7/27/2018
F02D0A,dividend,100,50,7/27/2018
F0B877,earnings,100,50,7/27/2018
F5349B,legal-issues-defendant,100,22,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F6FA6A,earnings,100,50,7/27/2018
F793FA,earnings,100,50,7/27/2018
FA36A4,earnings,100,50,7/27/2018
FBDA0F,earnings,100,50,7/27/2018
FD0CA4,dividend,100,50,7/27/2018
FF4BA4,earnings,100,50,7/27/2018
FF4BA4,earnings,100,50,7/27/2018
FF4BA4,earnings,100,50,7/27/2018
FF4BA4,earnings,100,50,7/27/2018
FF4BA4,earnings,100,50,7/27/2018
FF6644,dividend,100,50,7/27/2018
12E454,legal-issues-defendant,100,22,7/28/2018
270B78,earnings,100,50,7/28/2018
3C7F5F,legal-issues-defendant,100,22,7/28/2018
4A6F00,product-release,100,64,7/28/2018
CCB623,partnership,100,61,7/28/2018
CDD75E,legal-issues-defendant,100,22,7/28/2018
F5349B,legal-issues-defendant,100,22,7/28/2018
F5349B,legal-issues-defendant,100,22,7/28/2018
12E454,legal-issues-defendant,100,22,7/29/2018
76CEFB,public-offering,100,43,7/29/2018
790C34,earnings,100,50,7/29/2018
7D35D8,legal-verdict-disfavored,100,22,7/29/2018
48781,earnings,100,50,7/30/2018
054E7E,clinical-trials-start,100,64,7/30/2018
07C69F,earnings,100,50,7/30/2018
099C88,earnings,100,50,7/30/2018
0B13E8,conference-call,100,50,7/30/2018
0C2A0D,acquisition-acquirer,100,49,7/30/2018
0C2A0D,business-contract,100,69,7/30/2018
0D26E0,note-sale,100,52,7/30/2018
0D26E0,earnings,100,50,7/30/2018
1080C0,earnings,100,50,7/30/2018
11074E,earnings,100,50,7/30/2018
12731D,conference-call,100,50,7/30/2018
12E454,legal-issues-defendant,100,22,7/30/2018
12E454,legal-issues-defendant,100,22,7/30/2018
138DDE,earnings,100,50,7/30/2018
147C38,unit-acquisition-acquiree,100,76,7/30/2018
152AB9,executive-appointment,100,54,7/30/2018
16B882,earnings,100,50,7/30/2018
1782D5,earnings,100,50,7/30/2018
197612,earnings,100,50,7/30/2018
1D943E,earnings,100,50,7/30/2018
1D943E,acquisition-acquirer,100,49,7/30/2018
1DDEDA,conference-call,100,50,7/30/2018
1E9A6D,executive-appointment,100,54,7/30/2018
1F08A6,facility-sale,100,52,7/30/2018
1F3CFB,executive-appointment,100,54,7/30/2018
1FC422,earnings,100,50,7/30/2018
2093B1,earnings,100,50,7/30/2018
20DC4E,dividend,100,50,7/30/2018
22C58E,conference-participant,100,50,7/30/2018
25A6CC,public-offering,100,43,7/30/2018
26F31D,earnings,100,50,7/30/2018
26F31D,earnings,100,50,7/30/2018
26F31D,earnings,100,50,7/30/2018
26F31D,earnings,100,50,7/30/2018
26F31D,earnings,100,50,7/30/2018
270305,earnings,100,50,7/30/2018
27C10F,market-entry,100,57,7/30/2018
2AA6A8,conference-call,100,50,7/30/2018
2CB4C9,unit-acquisition-acquirer,100,49,7/30/2018
2FEA66,operating-earnings,100,50,7/30/2018
30AB63,earnings,100,50,7/30/2018
30DE64,executive-appointment,100,54,7/30/2018
37020C,earnings,100,50,7/30/2018
37020C,earnings,100,50,7/30/2018
37020C,earnings,100,50,7/30/2018
37020C,earnings,100,50,7/30/2018
37020C,earnings,100,50,7/30/2018
37727A,earnings-guidance-up,100,83,7/30/2018
37727A,earnings,100,50,7/30/2018
37727A,earnings,100,50,7/30/2018
37727A,earnings,100,50,7/30/2018
37727A,earnings,100,50,7/30/2018
37727A,earnings,100,50,7/30/2018
387375,conference-participant,100,50,7/30/2018
389CFB,conference-call,100,50,7/30/2018
396D7C,earnings,100,50,7/30/2018
3AF7FD,dividend,100,50,7/30/2018
3BB616,partnership,100,61,7/30/2018
3C7F5F,legal-issues-defendant,100,22,7/30/2018
3C7F5F,legal-issues-defendant,100,22,7/30/2018
3DB18B,earnings,100,50,7/30/2018
3DE4D1,executive-appointment,100,54,7/30/2018
3DE4D1,executive-appointment,100,54,7/30/2018
3DED49,conference-call,100,50,7/30/2018
3F4668,executive-appointment,100,54,7/30/2018
422A82,regulatory-product-approval-granted,100,81,7/30/2018
427F32,earnings,100,50,7/30/2018
429BFB,earnings,100,50,7/30/2018
42AABD,earnings,100,50,7/30/2018
4455C4,earnings,100,50,7/30/2018
4455C4,earnings,100,50,7/30/2018
4455C4,earnings,100,50,7/30/2018
4455C4,earnings,100,50,7/30/2018
467F2C,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
47FCF2,earnings,100,50,7/30/2018
490D4B,earnings,100,50,7/30/2018
490D4B,partnership,100,61,7/30/2018
490D4B,partnership,100,61,7/30/2018
494EB9,earnings,100,50,7/30/2018
49A344,business-contract,100,69,7/30/2018
4A2457,conference-participant,100,50,7/30/2018
4A2457,conference-participant,100,50,7/30/2018
4BDCA7,conference-call,100,50,7/30/2018
4D203E,executive-appointment,100,54,7/30/2018
4D8E5E,earnings,100,50,7/30/2018
507AE7,executive-appointment,100,54,7/30/2018
507AE7,earnings,100,50,7/30/2018
5088A5,earnings,100,50,7/30/2018
51B442,earnings,100,50,7/30/2018
51F541,earnings,100,50,7/30/2018
5340D0,public-offering,100,43,7/30/2018
5.43E+08,earnings,100,50,7/30/2018
553949,earnings,100,50,7/30/2018
55D0F3,earnings,100,50,7/30/2018
57A854,executive-appointment,100,54,7/30/2018
57EF50,dividend,100,50,7/30/2018
583A75,partnership,100,61,7/30/2018
586BD7,earnings,100,50,7/30/2018
5968F9,earnings,100,50,7/30/2018
5AAE17,executive-appointment,100,54,7/30/2018
5B97B2,conference-participant,100,50,7/30/2018
5C8D61,earnings,100,50,7/30/2018
5C8D61,earnings,100,50,7/30/2018
5C8D61,earnings,100,50,7/30/2018
5EF130,conference-call,100,50,7/30/2018
5FDBD0,operating-earnings,100,50,7/30/2018
649CBD,product-release,100,64,7/30/2018
68B03F,earnings-up,100,68,7/30/2018
68B03F,earnings,100,50,7/30/2018
68B03F,earnings,100,50,7/30/2018
68B03F,earnings,100,50,7/30/2018
69FDFC,award,100,58,7/30/2018
6B494E,earnings,100,50,7/30/2018
6D4636,earnings,100,50,7/30/2018
6D4636,earnings,100,50,7/30/2018
6D4636,earnings,100,50,7/30/2018
6D6B40,earnings,100,50,7/30/2018
6F39FC,conference-call,100,50,7/30/2018
701531,executive-appointment,100,54,7/30/2018
704B78,earnings,100,50,7/30/2018
709AED,dividend,100,50,7/30/2018
709AED,earnings,100,50,7/30/2018
709AED,earnings,100,50,7/30/2018
709AED,earnings,100,50,7/30/2018
709AED,earnings,100,50,7/30/2018
7.44E+09,credit-extension-recipient,100,69,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
767F86,earnings,100,50,7/30/2018
76CEFB,public-offering,100,43,7/30/2018
782B46,earnings,100,50,7/30/2018
791EC1,earnings,100,50,7/30/2018
79340A,earnings,100,50,7/30/2018
797C20,conference-call,100,50,7/30/2018
7AF907,fast-track-designation,100,81,7/30/2018
7C4168,earnings,100,50,7/30/2018
7CBC40,earnings,100,50,7/30/2018
7CBC40,earnings,100,50,7/30/2018
7CBC40,earnings,100,50,7/30/2018
7CBC40,earnings,100,50,7/30/2018
7EA323,earnings,100,50,7/30/2018
7F3669,product-release,100,64,7/30/2018
7F3669,executive-appointment,100,54,7/30/2018
7F3669,earnings,100,50,7/30/2018
84AB66,earnings-positive,100,69,7/30/2018
860AB6,earnings,100,50,7/30/2018
86BAC7,earnings,100,50,7/30/2018
8802B4,earnings,100,50,7/30/2018
8AC65D,ipo-completed,100,76,7/30/2018
8C1238,earnings,100,50,7/30/2018
8E4F9A,conference-participant,100,50,7/30/2018
8E8E6E,joint-venture,100,62,7/30/2018
8E8E6E,partnership,100,61,7/30/2018
8E8E6E,joint-venture,100,62,7/30/2018
8FE7A5,earnings,100,50,7/30/2018
900356,earnings-up,100,68,7/30/2018
915E7B,earnings,100,50,7/30/2018
93965C,earnings,100,50,7/30/2018
957A07,conference-participant,100,50,7/30/2018
968B00,earnings-positive,100,69,7/30/2018
968B00,earnings-positive,100,69,7/30/2018
97644E,executive-appointment,100,54,7/30/2018
979451,earnings,100,50,7/30/2018
9D2790,earnings,100,50,7/30/2018
9D2790,executive-appointment,100,54,7/30/2018
9D5D35,earnings,100,50,7/30/2018
9D5D35,executive-appointment,100,54,7/30/2018
9DDE1B,earnings,100,50,7/30/2018
9EA947,earnings,100,50,7/30/2018
9F18FA,earnings,100,50,7/30/2018
9F18FA,earnings,100,50,7/30/2018
9F18FA,executive-appointment,100,54,7/30/2018
9F18FA,executive-appointment,100,54,7/30/2018
9F5CBB,dividend,100,50,7/30/2018
A15C71,earnings,100,50,7/30/2018
A1EAC8,conference-call,100,50,7/30/2018
A2CA3F,earnings,100,50,7/30/2018
A47A7D,earnings,100,50,7/30/2018
A47F2E,earnings,100,50,7/30/2018
A5A4F5,acquisition-acquirer,100,49,7/30/2018
A6FC89,conference-participant,100,50,7/30/2018
A79F7D,earnings,100,50,7/30/2018
A871B0,earnings,100,50,7/30/2018
A96867,earnings-up,100,83,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A96867,earnings-positive,100,69,7/30/2018
A9ED24,earnings,100,50,7/30/2018
A9ED24,earnings,100,50,7/30/2018
AAEE21,earnings,100,50,7/30/2018
AC642C,note-sale,100,52,7/30/2018
AC642C,note-sale,100,52,7/30/2018
AC642C,public-offering,100,43,7/30/2018
AC642C,public-offering,100,43,7/30/2018
AC7C4F,award,100,58,7/30/2018
AE79CD,ipo-completed,100,76,7/30/2018
AFF7B4,earnings,100,50,7/30/2018
AFF7B4,earnings,100,50,7/30/2018
AFF7B4,earnings,100,50,7/30/2018
AFF7B4,earnings,100,50,7/30/2018
B05118,product-release,100,64,7/30/2018
B05118,dividend,100,50,7/30/2018
B076A1,earnings,100,50,7/30/2018
B076A1,earnings,100,50,7/30/2018
B076A1,earnings,100,50,7/30/2018
B076A1,earnings,100,50,7/30/2018
B0D41A,earnings,100,50,7/30/2018
B1A85D,business-contract,100,69,7/30/2018
B72BE9,revenues,100,50,7/30/2018
B72BE9,revenues,100,50,7/30/2018
B72BE9,revenues,100,50,7/30/2018
BB02FB,earnings-per-share-positive,100,69,7/30/2018
BB02FB,earnings-per-share,100,50,7/30/2018
BB02FB,earnings-per-share,100,50,7/30/2018
BB02FB,earnings-per-share,100,50,7/30/2018
BC4876,earnings,100,50,7/30/2018
BD44C9,conference-organizer,100,57,7/30/2018
BE86A1,earnings-up,100,63,7/30/2018
C0F70B,earnings,100,50,7/30/2018
C2609A,executive-appointment,100,54,7/30/2018
C3BCD5,legal-issues-defendant,100,22,7/30/2018
C4A432,conference-call,100,50,7/30/2018
C4F9C6,earnings,100,50,7/30/2018
C4FBDC,earnings,100,50,7/30/2018
C50B26,earnings,100,50,7/30/2018
C54140,acquisition-acquirer,100,49,7/30/2018
C54140,acquisition-acquirer,100,49,7/30/2018
C624A1,earnings,100,50,7/30/2018
C624A1,earnings,100,50,7/30/2018
C72B8F,award,100,58,7/30/2018
C941DC,public-offering,100,43,7/30/2018
C941DC,conference-participant,100,50,7/30/2018
C97B2D,conference-participant,100,50,7/30/2018
C9C62A,earnings,100,50,7/30/2018
C9E04B,business-contract,100,69,7/30/2018
C9E04B,business-contract,100,69,7/30/2018
C9E04B,business-contract,100,69,7/30/2018
CCBBAD,earnings,100,50,7/30/2018
CD051C,conference-call,100,50,7/30/2018
CDD75E,legal-issues-defendant,100,22,7/30/2018
CDD75E,legal-issues-defendant,100,22,7/30/2018
CE5C6E,earnings,100,50,7/30/2018
D06996,earnings,100,50,7/30/2018
D0DE27,earnings,100,50,7/30/2018
D11C1C,conference-call,100,50,7/30/2018
D15833,conference-call,100,50,7/30/2018
D20C8F,executive-appointment,100,54,7/30/2018
D21D8A,conference-participant,100,50,7/30/2018
D25249,fundraising,100,64,7/30/2018
D3C794,earnings,100,50,7/30/2018
D58A11,earnings,100,50,7/30/2018
D598E7,earnings,100,50,7/30/2018
D6144F,conference-call,100,50,7/30/2018
D8DBA3,earnings,100,50,7/30/2018
D9B1C9,executive-appointment,100,54,7/30/2018
DC6AA0,ipo-completed,100,76,7/30/2018
DD9E41,earnings,100,50,7/30/2018
DD9E41,earnings,100,50,7/30/2018
DD9E41,earnings,100,50,7/30/2018
DD9E41,earnings,100,50,7/30/2018
DD9E41,earnings,100,50,7/30/2018
DD9E41,earnings,100,50,7/30/2018
DDB002,buybacks,100,74,7/30/2018
DF11D9,earnings,100,50,7/30/2018
E21871,acquisition-acquirer,100,49,7/30/2018
E6D89E,earnings,100,50,7/30/2018
E6D89E,earnings,100,50,7/30/2018
E6D89E,earnings,100,50,7/30/2018
E6D89E,earnings,100,50,7/30/2018
E84500,earnings,100,50,7/30/2018
E8E899,conference-participant,100,50,7/30/2018
ED8676,conference-participant,100,50,7/30/2018
EE74E1,partnership,100,61,7/30/2018
EEBCEF,dividend,100,50,7/30/2018
EF1AD9,buybacks,100,74,7/30/2018
EFA7B2,earnings,100,50,7/30/2018
F32F88,dividend,100,50,7/30/2018
F4CDA3,conference-call,100,50,7/30/2018
F5349B,legal-issues-defendant,100,22,7/30/2018
F6A945,earnings,100,50,7/30/2018
F9CAF8,earnings-per-share-up,100,71,7/30/2018
F9CAF8,earnings-per-share-up,100,71,7/30/2018
F9CAF8,earnings-per-share-up,100,71,7/30/2018
FC1A6E,earnings-per-share-positive,100,69,7/30/2018
FC1A6E,earnings-per-share,100,50,7/30/2018
FC1A6E,earnings-per-share,100,50,7/30/2018
FD2565,conference-call,100,50,7/30/2018
FD554E,executive-appointment,100,54,7/30/2018
FDF28E,acquisition-acquirer,100,49,7/30/2018
FDF28E,acquisition-acquirer,100,49,7/30/2018
FDF28E,earnings,100,50,7/30/2018
018C11,earnings,100,50,7/31/2018
01D03F,stake-acquirer,100,48,7/31/2018
02ACBD,legal-issues-defendant,100,22,7/31/2018
03B431,conference-participant,100,50,7/31/2018
03D5F9,earnings,100,50,7/31/2018
43862,conference-participant,100,50,7/31/2018
0490C6,earnings,100,50,7/31/2018
0560D8,earnings,100,50,7/31/2018
0560D8,earnings,100,50,7/31/2018
68396,earnings,100,50,7/31/2018
078D52,revenues,100,50,7/31/2018
078D52,revenues,100,50,7/31/2018
099C88,business-contract,100,69,7/31/2018
09F623,earnings,100,50,7/31/2018
0A77DB,partnership,100,61,7/31/2018
0BF528,conference-call,100,50,7/31/2018
0F65C9,earnings,100,50,7/31/2018
0F65C9,dividend,100,50,7/31/2018
1080C0,executive-appointment,100,54,7/31/2018
11074E,business-contract,100,69,7/31/2018
1272B3,conference-participant,100,50,7/31/2018
131443,earnings,100,50,7/31/2018
131443,earnings,100,50,7/31/2018
131443,earnings,100,50,7/31/2018
131443,earnings,100,50,7/31/2018
131443,earnings,100,50,7/31/2018
131443,earnings,100,50,7/31/2018
135B09,earnings,100,50,7/31/2018
135B09,earnings,100,50,7/31/2018
135B09,earnings,100,50,7/31/2018
135B09,earnings,100,50,7/31/2018
135B09,earnings,100,50,7/31/2018
149301,dividend,100,50,7/31/2018
14BA06,earnings,100,50,7/31/2018
14BA06,earnings,100,50,7/31/2018
14BA06,earnings,100,50,7/31/2018
14BA06,earnings,100,50,7/31/2018
14BA06,earnings,100,50,7/31/2018
14BA06,earnings,100,50,7/31/2018
14BA06,earnings,100,50,7/31/2018
14BA33,earnings,100,50,7/31/2018
15901B,patent-awarded,100,72,7/31/2018
1748B3,index-listing,100,76,7/31/2018
190B91,earnings,100,50,7/31/2018
190B91,earnings,100,50,7/31/2018
190B91,earnings,100,50,7/31/2018
190B91,earnings,100,50,7/31/2018
1921DD,clinical-trials-start,100,64,7/31/2018
19CAC7,executive-appointment,100,54,7/31/2018
1A5D5D,earnings,100,50,7/31/2018
1BDB2A,dividend,100,50,7/31/2018
1BDB2A,executive-appointment,100,54,7/31/2018
1CD09C,clinical-trials-filed,100,60,7/31/2018
1E1125,conference-organizer,100,57,7/31/2018
1E83DE,legal-verdict-disfavored,100,22,7/31/2018
1F716B,earnings-guidance-up,100,83,7/31/2018
1F9258,executive-appointment,100,54,7/31/2018
200D8B,executive-appointment,100,54,7/31/2018
21F9CA,revenues,100,50,7/31/2018
228D42,partnership,100,61,7/31/2018
250BEE,joint-venture,100,62,7/31/2018
25A6CC,conference-participant,100,50,7/31/2018
267718,regulatory-product-approval-granted,100,81,7/31/2018
267718,earnings,100,50,7/31/2018
267718,earnings,100,50,7/31/2018
267718,earnings,100,50,7/31/2018
267718,earnings,100,50,7/31/2018
267718,earnings,100,50,7/31/2018
267718,earnings,100,50,7/31/2018
267718,earnings,100,50,7/31/2018
26D8ED,earnings,100,50,7/31/2018
27A791,conference-participant,100,50,7/31/2018
2920D5,asset-sale,100,62,7/31/2018
2A1009,clinical-trials,100,56,7/31/2018
2B7A40,partnership,100,61,7/31/2018
2B7A40,earnings-per-share-positive,100,69,7/31/2018
2B7A40,earnings-positive,100,69,7/31/2018
2B7A40,earnings-positive,100,69,7/31/2018
2B7A40,earnings-positive,100,69,7/31/2018
2BAE5F,earnings,100,50,7/31/2018
2BAE5F,earnings,100,50,7/31/2018
2BAE5F,earnings,100,50,7/31/2018
2D643C,partnership,100,61,7/31/2018
2D981A,legal-issues-defendant,100,22,7/31/2018
2D981A,legal-issues-defendant,100,22,7/31/2018
2E0496,earnings,100,50,7/31/2018
2E61CC,earnings,100,50,7/31/2018
2F24A5,earnings,100,50,7/31/2018
2F6782,dividend,100,50,7/31/2018
2F98A5,earnings,100,50,7/31/2018
306623,acquisition-acquirer,100,49,7/31/2018
30DE64,conference-participant,100,50,7/31/2018
32CB22,acquisition-completed-acquirer,100,49,7/31/2018
32CB22,acquisition-completed-acquirer,100,49,7/31/2018
3461CF,executive-appointment,100,54,7/31/2018
3471C0,partnership,100,61,7/31/2018
35557B,merger-completed,100,66,7/31/2018
3.50E+27,earnings,100,50,7/31/2018
35F4B5,earnings-up,100,68,7/31/2018
35F4B5,earnings-up,100,68,7/31/2018
35F4B5,acquisition-acquirer,100,49,7/31/2018
367E1C,earnings,100,50,7/31/2018
373B06,earnings,100,50,7/31/2018
3798B9,earnings,100,50,7/31/2018
38FB49,dividend,100,50,7/31/2018
3BCF24,earnings,100,50,7/31/2018
3BE00F,earnings,100,50,7/31/2018
3BE00F,earnings,100,50,7/31/2018
3BE00F,earnings,100,50,7/31/2018
3BE00F,earnings,100,50,7/31/2018
3C7F5F,legal-issues-defendant,100,22,7/31/2018
3F1C69,earnings,100,50,7/31/2018
3F4497,earnings,100,50,7/31/2018
3F4668,revenue-up,100,69,7/31/2018
3F868D,earnings,100,50,7/31/2018
41C528,conference-call,100,50,7/31/2018
41ED98,conference-call,100,50,7/31/2018
420168,earnings,100,50,7/31/2018
43E8F5,clinical-trials-start,100,64,7/31/2018
448BF3,earnings,100,50,7/31/2018
44DDBD,earnings,100,50,7/31/2018
47752F,executive-appointment,100,54,7/31/2018
4A5C8D,executive-appointment,100,54,7/31/2018
4A6F00,product-release,100,64,7/31/2018
4AC91D,product-release,100,64,7/31/2018
4BBA23,operating-earnings,100,50,7/31/2018
4C37C5,legal-issues-defendant,100,22,7/31/2018
4C5CC9,dividend,100,50,7/31/2018
4DD203,conference-call,100,50,7/31/2018
4EE14A,earnings,100,50,7/31/2018
4EE14A,earnings,100,50,7/31/2018
4F9926,product-release,100,64,7/31/2018
4F9926,product-release,100,64,7/31/2018
4F9926,product-release,100,64,7/31/2018
4FB770,earnings,100,50,7/31/2018
504FE2,conference-participant,100,50,7/31/2018
504FE2,dividend,100,50,7/31/2018
513A86,earnings,100,50,7/31/2018
524CE4,regulatory-product-approval-granted,100,81,7/31/2018
52FB2F,earnings,100,50,7/31/2018
53E575,earnings,100,50,7/31/2018
53EF9E,earnings,100,50,7/31/2018
53EF9E,earnings,100,50,7/31/2018
54512F,earnings,100,50,7/31/2018
545272,merger-completed,100,66,7/31/2018
545272,merger-completed,100,66,7/31/2018
54A713,earnings,100,50,7/31/2018
56632F,earnings,100,50,7/31/2018
56632F,earnings,100,50,7/31/2018
56632F,earnings,100,50,7/31/2018
567F3D,acquisition-acquirer,100,49,7/31/2018
57634F,earnings,100,50,7/31/2018
57B174,earnings,100,50,7/31/2018
57B174,earnings,100,50,7/31/2018
57B174,earnings,100,50,7/31/2018
57B174,earnings,100,50,7/31/2018
57B174,earnings,100,50,7/31/2018
586BD7,conference-participant,100,50,7/31/2018
594402,regulatory-product-approval-granted,100,81,7/31/2018
596116,earnings,100,50,7/31/2018
5968F9,partnership,100,61,7/31/2018
5968F9,partnership,100,61,7/31/2018
5B15E1,earnings,100,50,7/31/2018
5B35C7,earnings,100,50,7/31/2018
5B35C7,earnings,100,50,7/31/2018
5BE42C,executive-appointment,100,54,7/31/2018
5CCDAD,earnings,100,50,7/31/2018
5EAA43,partnership,100,61,7/31/2018
5F1B7B,earnings,100,50,7/31/2018
5F60CE,earnings,100,50,7/31/2018
619882,conference-participant,100,50,7/31/2018
61BCA7,earnings,100,50,7/31/2018
64636E,earnings,100,50,7/31/2018
64E615,earnings,100,50,7/31/2018
64E615,earnings,100,50,7/31/2018
64E615,earnings,100,50,7/31/2018
64E615,earnings,100,50,7/31/2018
64FF65,conference-call,100,50,7/31/2018
6559D8,executive-appointment,100,54,7/31/2018
665D7D,legal-issues-defendant,100,22,7/31/2018
66749D,earnings-up,100,68,7/31/2018
66749D,earnings,100,50,7/31/2018
66749D,earnings,100,50,7/31/2018
66749D,earnings,100,50,7/31/2018
66749D,earnings,100,50,7/31/2018
67B923,earnings,100,50,7/31/2018
68E3E0,dividend,100,50,7/31/2018
69494C,conference-call,100,50,7/31/2018
69CE71,business-contract,100,69,7/31/2018
6A01DF,executive-appointment,100,54,7/31/2018
6B6375,conference-participant,100,50,7/31/2018
6B67BD,earnings,100,50,7/31/2018
6CC55E,earnings,100,50,7/31/2018
6D2BF6,earnings,100,50,7/31/2018
70CA28,conference-participant,100,50,7/31/2018
72609A,earnings,100,50,7/31/2018
72609A,earnings,100,50,7/31/2018
72609A,earnings,100,50,7/31/2018
7273FF,earnings,100,50,7/31/2018
728737,public-offering,100,43,7/31/2018
728737,public-offering,100,43,7/31/2018
7410C3,earnings,100,50,7/31/2018
7448A3,acquisition-acquirer,100,49,7/31/2018
7.45E+28,earnings,100,50,7/31/2018
769F40,earnings,100,50,7/31/2018
76BECC,conference-call,100,50,7/31/2018
76F067,dividend,100,50,7/31/2018
7710F3,earnings,100,50,7/31/2018
7734AC,dividend,100,50,7/31/2018
7823A3,earnings,100,50,7/31/2018
7823A3,earnings,100,50,7/31/2018
7823A3,earnings,100,50,7/31/2018
7823A3,earnings,100,50,7/31/2018
7823A3,earnings,100,50,7/31/2018
782B46,dividend,100,50,7/31/2018
791EC1,unit-acquisition-acquirer,100,49,7/31/2018
7A0EC4,acquisition-acquirer,100,49,7/31/2018
7A2A49,conference-call,100,50,7/31/2018
7B0BA6,earnings,100,50,7/31/2018
7B0BA6,earnings,100,50,7/31/2018
7B0BA6,earnings,100,50,7/31/2018
7B0BA6,earnings,100,50,7/31/2018
7B0BA6,earnings,100,50,7/31/2018
7B0BA6,earnings,100,50,7/31/2018
7B1E50,executive-resignation,100,44,7/31/2018
7B1E50,earnings,100,50,7/31/2018
7BC92D,earnings,100,50,7/31/2018
7C4F43,earnings,100,50,7/31/2018
7C75FD,earnings,100,50,7/31/2018
7D7716,earnings,100,50,7/31/2018
7D7716,earnings,100,50,7/31/2018
7D7716,earnings,100,50,7/31/2018
7D7716,earnings,100,50,7/31/2018
7D7716,earnings,100,50,7/31/2018
7D7716,earnings,100,50,7/31/2018
7F9984,earnings,100,50,7/31/2018
7F9BE2,dividend,100,50,7/31/2018
805CD8,legal-issues-defendant,100,22,7/31/2018
81EAD4,conference-participant,100,50,7/31/2018
835C86,dividend,100,50,7/31/2018
8.73E+09,revenue-up,100,69,7/31/2018
8.73E+09,revenue-up,100,69,7/31/2018
8.79E+06,executive-appointment,100,54,7/31/2018
880C0C,earnings,100,50,7/31/2018
88193E,earnings,100,50,7/31/2018
890FF4,conference-call,100,50,7/31/2018
8A8E41,business-contract,100,69,7/31/2018
8BAA15,unit-acquisition-completed-acquirer,100,49,7/31/2018
8D4486,dividend,100,50,7/31/2018
8D4486,dividend,100,50,7/31/2018
8E10BF,executive-appointment,100,54,7/31/2018
8EEA28,earnings,100,50,7/31/2018
902255,conference-participant,100,50,7/31/2018
90B678,legal-issues-defendant,100,22,7/31/2018
911CA9,patient-enrollment-start,100,58,7/31/2018
9196A2,product-release,100,64,7/31/2018
91E5EE,business-contract,100,69,7/31/2018
92005C,earnings,100,50,7/31/2018
94637C,regulatory-product-approval-granted,100,81,7/31/2018
95DC1F,executive-appointment,100,54,7/31/2018
9.65E+07,conference-call,100,50,7/31/2018
977A1E,merger-regulatory-approval,100,81,7/31/2018
977A1E,dividend,100,50,7/31/2018
990AD0,product-release,100,64,7/31/2018
9A602D,earnings-per-share-positive,100,69,7/31/2018
9A602D,earnings-per-share-positive,100,69,7/31/2018
9A602D,earnings-per-share-positive,100,69,7/31/2018
9A602D,earnings-per-share-positive,100,69,7/31/2018
9A602D,earnings-per-share-positive,100,69,7/31/2018
9A602D,earnings-per-share-positive,100,69,7/31/2018
9A602D,earnings-per-share-positive,100,69,7/31/2018
9C5BA5,business-contract,100,69,7/31/2018
9F048E,earnings,100,50,7/31/2018
9F048E,earnings,100,50,7/31/2018
9F048E,earnings,100,50,7/31/2018
9F048E,earnings,100,50,7/31/2018
9F048E,earnings,100,50,7/31/2018
9FF5F1,earnings,100,50,7/31/2018
A05C43,earnings,100,50,7/31/2018
A15C71,note-sale,100,52,7/31/2018
A16DEA,partnership,100,61,7/31/2018
A16DEA,product-release,100,64,7/31/2018
A204A7,earnings,100,50,7/31/2018
A23747,earnings-up,100,68,7/31/2018
A38F30,earnings,100,50,7/31/2018
A398B9,earnings,100,50,7/31/2018
A398B9,earnings,100,50,7/31/2018
A398B9,earnings,100,50,7/31/2018
A41450,business-contract,100,69,7/31/2018
A41450,earnings,100,50,7/31/2018
A4D173,dividend,100,50,7/31/2018
A4D173,dividend,100,50,7/31/2018
A4F67C,earnings,100,50,7/31/2018
A5A4F5,acquisition-acquirer,100,49,7/31/2018
A80FE0,earnings,100,50,7/31/2018
A87CD6,earnings,100,50,7/31/2018
A87CD6,dividend,100,50,7/31/2018
A94718,earnings,100,50,7/31/2018
AC642C,note-sale,100,52,7/31/2018
AC642C,note-sale,100,52,7/31/2018
AC7AAE,earnings,100,50,7/31/2018
ACDF88,conference-call,100,50,7/31/2018
ACDF88,conference-call,100,50,7/31/2018
B2206F,conference-participant,100,50,7/31/2018
B290A2,earnings,100,50,7/31/2018
B3A166,conference-call,100,50,7/31/2018
B77F14,conference-call,100,50,7/31/2018
B8A51F,conference-participant,100,50,7/31/2018
BB5271,earnings,100,50,7/31/2018
BBBB41,earnings-up,100,68,7/31/2018
BBBB41,earnings-up,100,68,7/31/2018
BBBB41,earnings-up,100,68,7/31/2018
BBBB41,earnings-up,100,68,7/31/2018
BBBB41,earnings-up,100,68,7/31/2018
BBBB41,earnings-up,100,68,7/31/2018
BBC05B,operating-earnings,100,50,7/31/2018
BD8517,earnings,100,50,7/31/2018
BE379D,conference-call,100,50,7/31/2018
BFCACF,conference-call,100,50,7/31/2018
C03C8B,acquisition-completed-acquirer,100,49,7/31/2018
C16A8F,earnings,100,50,7/31/2018
C16A8F,earnings,100,50,7/31/2018
C16A8F,earnings,100,50,7/31/2018
C16A8F,earnings,100,50,7/31/2018
C2E426,legal-issues-defendant,100,22,7/31/2018
C3CF29,earnings,100,50,7/31/2018
C3CF29,earnings,100,50,7/31/2018
C3CF29,earnings,100,50,7/31/2018
C45CE7,earnings,100,50,7/31/2018
C584BE,earnings,100,50,7/31/2018
C5C0E9,earnings,100,50,7/31/2018
C5D2AE,conference-participant,100,50,7/31/2018
C659EB,earnings,100,50,7/31/2018
C659EB,earnings,100,50,7/31/2018
C659EB,earnings,100,50,7/31/2018
C659EB,earnings,100,50,7/31/2018
C83B88,partnership,100,61,7/31/2018
C83B88,partnership,100,61,7/31/2018
C951A2,earnings,100,50,7/31/2018
C951A2,earnings,100,50,7/31/2018
C951A2,earnings,100,50,7/31/2018
C951A2,earnings,100,50,7/31/2018
C951A2,earnings,100,50,7/31/2018
C951A2,executive-appointment,100,54,7/31/2018
C99CC8,earnings,100,50,7/31/2018
C99CC8,earnings,100,50,7/31/2018
C99CC8,earnings,100,50,7/31/2018
C99CC8,earnings,100,50,7/31/2018
C9E04B,conference-call,100,50,7/31/2018
CAD7D9,earnings,100,50,7/31/2018
CB7AB2,award,100,58,7/31/2018
CBCC6A,conference-organizer,100,57,7/31/2018
CBDB4D,executive-appointment,100,54,7/31/2018
CBFFDD,earnings,100,50,7/31/2018
CBFFDD,earnings,100,50,7/31/2018
CC3EC4,earnings,100,50,7/31/2018
CC8F6E,acquisition-completed-acquirer,100,49,7/31/2018
CDD75E,legal-issues-defendant,100,22,7/31/2018
CDD75E,legal-issues-defendant,100,22,7/31/2018
CDE51C,earnings,100,50,7/31/2018
CDFCC9,partnership,100,61,7/31/2018
CE4E6D,conference-call,100,50,7/31/2018
CF351E,earnings,100,50,7/31/2018
CF351E,earnings,100,50,7/31/2018
CF351E,earnings,100,50,7/31/2018
CFF97C,award,100,58,7/31/2018
D04D9F,earnings,100,50,7/31/2018
D08D2C,earnings,100,50,7/31/2018
D08D2C,earnings,100,50,7/31/2018
D08D2C,earnings,100,50,7/31/2018
D08D2C,earnings,100,50,7/31/2018
D08D2C,earnings,100,50,7/31/2018
D09938,earnings,100,50,7/31/2018
D139BC,public-offering,100,43,7/31/2018
D15833,earnings-per-share-positive,100,69,7/31/2018
D2B9E5,earnings,100,50,7/31/2018
D2B9E5,earnings,100,50,7/31/2018
D2B9E5,earnings,100,50,7/31/2018
D2B9E5,earnings,100,50,7/31/2018
D56D6D,earnings,100,50,7/31/2018
D69D42,earnings,100,50,7/31/2018
D70365,business-combination,100,54,7/31/2018
D8442A,earnings,100,50,7/31/2018
D8442A,earnings,100,50,7/31/2018
D8442A,earnings,100,50,7/31/2018
D88EF3,earnings,100,50,7/31/2018
D88EF3,earnings,100,50,7/31/2018
D88EF3,earnings,100,50,7/31/2018
D88EF3,earnings,100,50,7/31/2018
D88EF3,earnings,100,50,7/31/2018
D88EF3,earnings,100,50,7/31/2018
D8ECA1,business-contract,100,69,7/31/2018
DA0CB8,earnings,100,50,7/31/2018
DD0F15,earnings,100,50,7/31/2018
DD1BA1,executive-appointment,100,54,7/31/2018
DD1BA1,partnership,100,61,7/31/2018
DDC415,earnings,100,50,7/31/2018
DDEA6A,earnings,100,50,7/31/2018
DE20DF,loan-recipient,100,59,7/31/2018
DF42A0,conference-call,100,50,7/31/2018
DF5F14,conference-call,100,50,7/31/2018
DF6FDD,partnership,100,61,7/31/2018
E0207A,unit-acquisition-acquirer,100,49,7/31/2018
E0647D,earnings,100,50,7/31/2018
E0647D,earnings,100,50,7/31/2018
E12A6E,earnings,100,50,7/31/2018
E15736,dividend,100,50,7/31/2018
E15736,public-offering,100,43,7/31/2018
E15736,conference-call,100,50,7/31/2018
E19A99,executive-appointment,100,54,7/31/2018
E21871,executive-appointment,100,54,7/31/2018
E259C7,dividend,100,50,7/31/2018
E2CB7B,product-release,100,64,7/31/2018
E41190,asset-sale,100,62,7/31/2018
E5752F,partnership,100,61,7/31/2018
E61888,conference-call,100,50,7/31/2018
E68733,regulatory-product-approval-granted,100,81,7/31/2018
E69BA5,earnings,100,50,7/31/2018
E6A53A,earnings,100,50,7/31/2018
E8A49A,executive-appointment,100,54,7/31/2018
E93A40,earnings,100,50,7/31/2018
E94704,conference-participant,100,50,7/31/2018
EB36DE,earnings,100,50,7/31/2018
ED79D9,executive-appointment,100,54,7/31/2018
ED9C04,earnings-up,100,68,7/31/2018
ED9C04,earnings,100,50,7/31/2018
ED9C04,earnings,100,50,7/31/2018
ED9C04,earnings,100,50,7/31/2018
ED9C04,earnings,100,50,7/31/2018
EE6F1C,earnings,100,50,7/31/2018
EE6F1C,earnings,100,50,7/31/2018
EE6F1C,earnings,100,50,7/31/2018
EEA734,earnings,100,50,7/31/2018
F0B2B5,earnings,100,50,7/31/2018
F11638,earnings,100,50,7/31/2018
F2E253,conference-call,100,50,7/31/2018
F39E1E,earnings,100,50,7/31/2018
F3FCC3,earnings,100,50,7/31/2018
F46EC9,revenue-up,100,58,7/31/2018
F47871,earnings,100,50,7/31/2018
F4D241,earnings,100,50,7/31/2018
F6DE54,earnings,100,50,7/31/2018
FADF1A,conference-call,100,50,7/31/2018
FD554E,conference-call,100,50,7/31/2018
FFAB4A,earnings,100,50,7/31/2018
FFCD0E,conference-call,100,50,7/31/2018
00067A,earnings,100,50,8/1/2018
002A99,earnings,100,50,8/1/2018
00326E,earnings,100,50,8/1/2018
00D6B5,earnings,100,50,8/1/2018
00E601,operating-earnings,100,50,8/1/2018
02870F,earnings-up,100,68,8/1/2018
02870F,earnings-up,100,68,8/1/2018
02870F,earnings-up,100,68,8/1/2018
02870F,earnings-up,100,68,8/1/2018
053EFF,earnings,100,50,8/1/2018
054E7E,conference-participant,100,50,8/1/2018
05D148,earnings,100,50,8/1/2018
061A3B,product-price-raise,100,57,8/1/2018
09062E,conference-participant,100,50,8/1/2018
98977,earnings,100,50,8/1/2018
099A92,earnings,100,50,8/1/2018
099C88,business-contract,100,69,8/1/2018
09DE1F,partnership,100,61,8/1/2018
0A6824,earnings,100,50,8/1/2018
0A77DB,earnings,100,50,8/1/2018
0A9D0A,dividend,100,50,8/1/2018
0B4D10,earnings,100,50,8/1/2018
0BA8CE,earnings,100,50,8/1/2018
0BC29E,partnership,100,61,8/1/2018
0BC29E,executive-appointment,100,54,8/1/2018
0EF1AF,conference-participant,100,50,8/1/2018
1220D2,earnings,100,50,8/1/2018
12731D,earnings,100,50,8/1/2018
12DE76,conference-call,100,50,8/1/2018
12DE76,conference-call,100,50,8/1/2018
12E454,legal-issues-defendant,100,22,8/1/2018
12E454,product-release,100,64,8/1/2018
149301,earnings,100,50,8/1/2018
15B10D,conference-call,100,50,8/1/2018
165B86,conference-call,100,50,8/1/2018
168A5D,donation,100,54,8/1/2018
16B183,operating-earnings,100,50,8/1/2018
184988,earnings,100,50,8/1/2018
1880C5,conference-organizer,100,57,8/1/2018
188394,earnings,100,50,8/1/2018
18EC17,executive-appointment,100,54,8/1/2018
1A5957,earnings,100,50,8/1/2018
1A5957,earnings,100,50,8/1/2018
1A5957,earnings,100,50,8/1/2018
1A5957,earnings,100,50,8/1/2018
1A5957,earnings,100,50,8/1/2018
1AB023,conference-call,100,50,8/1/2018
1AB023,conference-call,100,50,8/1/2018
1AB023,conference-call,100,50,8/1/2018
1AB808,revenue-up,100,84,8/1/2018
1AB808,revenue-up,100,84,8/1/2018
1AB808,revenue-up,100,84,8/1/2018
1B16C1,earnings-guidance,100,50,8/1/2018
1B637E,earnings,100,50,8/1/2018
1CB9D3,conference-call,100,50,8/1/2018
1D5C51,earnings,100,50,8/1/2018
1DEBBE,earnings,100,50,8/1/2018
1E04A5,acquisition-acquirer,100,49,8/1/2018
1E04A5,earnings-up,100,68,8/1/2018
1E04A5,earnings,100,50,8/1/2018
1E04A5,earnings,100,50,8/1/2018
1E04A5,earnings,100,50,8/1/2018
1EBF8D,executive-appointment,100,54,8/1/2018
1F08A6,earnings,100,50,8/1/2018
1F19C8,earnings-per-share-up,100,69,8/1/2018
1F19C8,earnings-up,100,69,8/1/2018
1F19C8,earnings-up,100,69,8/1/2018
1F19C8,earnings-up,100,69,8/1/2018
1F19C8,earnings-up,100,69,8/1/2018
1F19C8,earnings-up,100,69,8/1/2018
2082EA,partnership,100,61,8/1/2018
2082EA,conference-call,100,50,8/1/2018
20D00A,operating-earnings,100,50,8/1/2018
21268E,conference-participant,100,50,8/1/2018
21D903,earnings,100,50,8/1/2018
227F04,earnings,100,50,8/1/2018
228D42,partnership,100,61,8/1/2018
228D42,partnership,100,61,8/1/2018
228D42,partnership,100,61,8/1/2018
24CB56,earnings,100,50,8/1/2018
250BEE,dividend,100,50,8/1/2018
26DC29,executive-appointment,100,54,8/1/2018
272704,acquisition-completed-acquirer,100,49,8/1/2018
27BFA1,dividend,100,50,8/1/2018
28DCA8,earnings,100,50,8/1/2018
28DCA8,earnings,100,50,8/1/2018
28DCA8,earnings,100,50,8/1/2018
2950FF,earnings,100,50,8/1/2018
295F9F,earnings,100,50,8/1/2018
29CEBF,earnings,100,50,8/1/2018
29CEBF,earnings,100,50,8/1/2018
29CEBF,earnings,100,50,8/1/2018
2C681C,conference-call,100,50,8/1/2018
2C681C,conference-call,100,50,8/1/2018
2D485F,earnings,100,50,8/1/2018
2D485F,earnings,100,50,8/1/2018
2D981A,legal-issues-defendant,100,22,8/1/2018
2D981A,earnings,100,50,8/1/2018
2D981A,legal-issues-defendant,100,22,8/1/2018
2F1299,dividend,100,50,8/1/2018
2F5256,conference-participant,100,50,8/1/2018
2F6782,earnings,100,50,8/1/2018
2F7A7E,earnings,100,50,8/1/2018
2FDEE3,earnings,100,50,8/1/2018
306623,earnings,100,50,8/1/2018
315EB0,partnership,100,61,8/1/2018
31803E,conference-participant,100,50,8/1/2018
3224CC,earnings,100,50,8/1/2018
32F24A,earnings,100,50,8/1/2018
33FD66,earnings,100,50,8/1/2018
33FD66,earnings,100,50,8/1/2018
33FD66,earnings,100,50,8/1/2018
33FD66,earnings,100,50,8/1/2018
33FD66,earnings,100,50,8/1/2018
3461CF,campaign-ad-release,100,59,8/1/2018
35AE32,earnings,100,50,8/1/2018
35AE32,earnings,100,50,8/1/2018
35AE32,earnings,100,50,8/1/2018
35AE32,earnings,100,50,8/1/2018
383ADA,earnings,100,50,8/1/2018
3A3447,earnings,100,50,8/1/2018
3BC360,earnings,100,50,8/1/2018
3BC360,earnings,100,50,8/1/2018
3BC360,earnings,100,50,8/1/2018
3C3B6B,partnership,100,61,8/1/2018
3C6CCC,business-contract,100,69,8/1/2018
3C75D6,earnings,100,50,8/1/2018
3C75D6,earnings,100,50,8/1/2018
3C75D6,earnings,100,50,8/1/2018
3DE4D1,dividend,100,50,8/1/2018
3F4668,executive-appointment,100,54,8/1/2018
3F6A9C,earnings,100,50,8/1/2018
401072,earnings,100,50,8/1/2018
401072,conference-participant,100,50,8/1/2018
4135F7,merger-completed,100,66,8/1/2018
4135F7,merger-completed,100,66,8/1/2018
4135F7,merger-completed,100,66,8/1/2018
4135F7,merger-completed,100,66,8/1/2018
4135F7,merger-completed,100,66,8/1/2018
4135F7,merger-completed,100,66,8/1/2018
41A93D,earnings-guidance-up,100,83,8/1/2018
43E8F5,earnings,100,50,8/1/2018
442587,earnings,100,50,8/1/2018
442587,earnings,100,50,8/1/2018
444CC8,ipo-pricing,100,50,8/1/2018
447FC6,executive-appointment,100,54,8/1/2018
479930,conference-participant,100,50,8/1/2018
485445,dividend-up,100,56,8/1/2018
4885C8,dividend,100,50,8/1/2018
49A344,earnings,100,50,8/1/2018
49A344,earnings,100,50,8/1/2018
4A3438,conference-participant,100,50,8/1/2018
4A6F00,partnership,100,61,8/1/2018
4A6F00,partnership,100,61,8/1/2018
4AC91D,earnings,100,50,8/1/2018
4B7006,acquisition-completed-acquirer,100,49,8/1/2018
4B7006,acquisition-completed-acquirer,100,49,8/1/2018
4BDCA7,conference-participant,100,50,8/1/2018
4C3FE9,earnings,100,50,8/1/2018
4D8124,dividend,100,50,8/1/2018
4E2D94,earnings,100,50,8/1/2018
4E2D94,dividend,100,50,8/1/2018
4E6F5A,earnings,100,50,8/1/2018
50D1EC,partnership,100,61,8/1/2018
510EA1,conference-call,100,50,8/1/2018
514067,earnings,100,50,8/1/2018
52BF94,earnings,100,50,8/1/2018
52BF94,earnings,100,50,8/1/2018
52BF94,earnings,100,50,8/1/2018
54F271,revenues,100,50,8/1/2018
564F3E,earnings,100,50,8/1/2018
56B7C1,earnings,100,50,8/1/2018
56FB7C,dividend-up,100,81,8/1/2018
57EF50,conference-call,100,50,8/1/2018
587EDF,earnings-up,100,92,8/1/2018
587EDF,earnings-up,100,92,8/1/2018
587EDF,earnings-up,100,92,8/1/2018
587EDF,earnings-up,100,92,8/1/2018
587EDF,earnings-up,100,92,8/1/2018
587EDF,earnings-up,100,92,8/1/2018
589846,settlement,100,56,8/1/2018
594402,earnings,100,50,8/1/2018
59872F,executive-resignation,100,44,8/1/2018
5A0FF1,earnings,100,50,8/1/2018
5A423F,earnings,100,50,8/1/2018
5AAE17,earnings,100,50,8/1/2018
5C7601,earnings,100,50,8/1/2018
5D1329,earnings,100,50,8/1/2018
5EF130,earnings,100,50,8/1/2018
5F1B7B,conference-participant,100,50,8/1/2018
5F3D91,conference-participant,100,50,8/1/2018
5F60CE,earnings-positive,100,69,8/1/2018
605F40,earnings,100,50,8/1/2018
61E975,earnings-positive,100,69,8/1/2018
639BD6,revenues,100,50,8/1/2018
639BD6,revenues,100,50,8/1/2018
639BD6,revenues,100,50,8/1/2018
63F892,earnings,100,50,8/1/2018
649CBD,earnings,100,50,8/1/2018
665440,earnings,100,50,8/1/2018
665440,earnings,100,50,8/1/2018
665440,earnings,100,50,8/1/2018
665D7D,partnership,100,61,8/1/2018
66749D,conference-participant,100,50,8/1/2018
66CB62,operating-earnings,100,50,8/1/2018
66ECFD,earnings,100,50,8/1/2018
68BA15,earnings,100,50,8/1/2018
69C99E,earnings,100,50,8/1/2018
69CE71,product-release,100,64,8/1/2018
6A3C35,earnings,100,50,8/1/2018
6A3C35,earnings,100,50,8/1/2018
6A3C35,earnings,100,50,8/1/2018
6A3C35,earnings,100,50,8/1/2018
6B0E45,earnings,100,50,8/1/2018
6B6375,earnings,100,50,8/1/2018
6D156D,earnings,100,50,8/1/2018
6D1ADF,earnings,100,50,8/1/2018
6D3B7B,dividend,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,earnings,100,50,8/1/2018
6E7060,facility-close,100,47,8/1/2018
6E8864,operating-earnings,100,50,8/1/2018
6ED519,earnings,100,50,8/1/2018
6ED519,earnings,100,50,8/1/2018
6F0096,acquisition-acquirer,100,49,8/1/2018
6F0A63,earnings,100,50,8/1/2018
6F22E7,conference-call,100,50,8/1/2018
6F39FC,dividend,100,50,8/1/2018
709AED,partnership,100,61,8/1/2018
70FCEF,partnership,100,61,8/1/2018
713810,legal-issues-defendant,100,22,8/1/2018
722DE3,earnings,100,50,8/1/2018
722DE3,earnings,100,50,8/1/2018
7.45E+28,executive-appointment,100,54,8/1/2018
746373,earnings,100,50,8/1/2018
746373,earnings,100,50,8/1/2018
762A3E,executive-appointment,100,54,8/1/2018
763724,earnings-up,100,68,8/1/2018
773A17,revenue-up,100,69,8/1/2018
773A17,revenue-up,100,69,8/1/2018
773A17,revenue-up,100,69,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
78F9ED,earnings,100,50,8/1/2018
790D0D,executive-appointment,100,54,8/1/2018
790D0D,earnings,100,50,8/1/2018
791D59,partnership,100,61,8/1/2018
7A3633,earnings,100,50,8/1/2018
7AB859,partnership,100,61,8/1/2018
7AF5B8,clinical-trials-positive,100,87,8/1/2018
7B9AFA,conference-participant,100,50,8/1/2018
7C62A3,earnings,100,50,8/1/2018
7D5384,unit-acquisition-acquirer,100,49,8/1/2018
7DA412,earnings,100,50,8/1/2018
7F9E16,executive-resignation,100,44,8/1/2018
805CD8,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
8.10E+32,earnings,100,50,8/1/2018
810FAD,revenue-up,100,69,8/1/2018
810FAD,revenue-up,100,69,8/1/2018
810FAD,revenue-up,100,69,8/1/2018
810FAD,revenue-up,100,69,8/1/2018
810FAD,revenue-up,100,69,8/1/2018
810FAD,revenue-up,100,69,8/1/2018
8.10E+205,earnings-guidance,100,50,8/1/2018
85CDC9,earnings,100,50,8/1/2018
85DE00,acquisition-completed-acquirer,100,49,8/1/2018
8.79E+06,earnings,100,50,8/1/2018
88350F,earnings,100,50,8/1/2018
88350F,earnings,100,50,8/1/2018
88350F,earnings,100,50,8/1/2018
88350F,earnings,100,50,8/1/2018
885758,earnings,100,50,8/1/2018
896771,earnings,100,50,8/1/2018
8A0368,earnings,100,50,8/1/2018
8A0368,earnings,100,50,8/1/2018
8A0368,earnings,100,50,8/1/2018
8B1E11,earnings,100,50,8/1/2018
8B9B3B,earnings,100,50,8/1/2018
8D4486,business-contract,100,69,8/1/2018
8DBE73,revenues,100,50,8/1/2018
8DBE73,revenues,100,50,8/1/2018
8DBE73,revenues,100,50,8/1/2018
8DCBBB,earnings,100,50,8/1/2018
8DE56F,earnings,100,50,8/1/2018
8E9CD8,earnings-up,100,68,8/1/2018
8E9CD8,earnings,100,50,8/1/2018
8E9CD8,earnings,100,50,8/1/2018
8E9CD8,earnings,100,50,8/1/2018
8E9CD8,earnings,100,50,8/1/2018
8EF425,earnings,100,50,8/1/2018
8EF425,earnings,100,50,8/1/2018
8EF425,earnings,100,50,8/1/2018
8EF425,earnings,100,50,8/1/2018
8EF425,earnings,100,50,8/1/2018
8EF425,earnings,100,50,8/1/2018
8F6995,earnings-up,100,68,8/1/2018
901327,earnings,100,50,8/1/2018
901327,earnings,100,50,8/1/2018
901327,earnings,100,50,8/1/2018
901327,earnings,100,50,8/1/2018
902255,dividend,100,50,8/1/2018
902670,earnings,100,50,8/1/2018
902670,earnings,100,50,8/1/2018
902670,earnings,100,50,8/1/2018
902670,earnings,100,50,8/1/2018
949625,dividend,100,50,8/1/2018
94C0B5,dividend,100,50,8/1/2018
9.65E+09,earnings,100,50,8/1/2018
9673BD,dividend,100,50,8/1/2018
968966,earnings,100,50,8/1/2018
96A6CD,earnings,100,50,8/1/2018
977A1E,earnings,100,50,8/1/2018
980C14,earnings,100,50,8/1/2018
9.86E+03,earnings,100,50,8/1/2018
9978F1,earnings,100,50,8/1/2018
9B5968,executive-appointment,100,54,8/1/2018
9B730A,conference-call,100,50,8/1/2018
9C25FF,business-contract,100,69,8/1/2018
9C25FF,business-contract,100,69,8/1/2018
9D30A8,conference-participant,100,50,8/1/2018
9E91C6,earnings,100,50,8/1/2018
9F6B1A,business-contract,100,69,8/1/2018
9FB4B7,earnings,100,50,8/1/2018
A072C4,conference-call,100,50,8/1/2018
A28675,earnings,100,50,8/1/2018
A3800A,earnings-up,100,68,8/1/2018
A398F8,earnings,100,50,8/1/2018
A3F598,earnings,100,50,8/1/2018
A3F598,earnings,100,50,8/1/2018
A3F598,earnings,100,50,8/1/2018
A3F598,earnings,100,50,8/1/2018
A47A7D,executive-appointment,100,54,8/1/2018
A4A612,public-offering,100,43,8/1/2018
A5195E,public-offering,100,43,8/1/2018
A5A4F5,acquisition-acquirer,100,49,8/1/2018
A6FC89,earnings,100,50,8/1/2018
A70BF5,earnings,100,50,8/1/2018
A70BF5,earnings,100,50,8/1/2018
A70BF5,earnings,100,50,8/1/2018
A70BF5,earnings,100,50,8/1/2018
A70BF5,earnings,100,50,8/1/2018
A70BF5,earnings,100,50,8/1/2018
A7CCF0,earnings-up,100,68,8/1/2018
A7CCF0,earnings,100,50,8/1/2018
A7CCF0,earnings,100,50,8/1/2018
A806FA,earnings,100,50,8/1/2018
A806FA,earnings,100,50,8/1/2018
A806FA,earnings,100,50,8/1/2018
A806FA,earnings,100,50,8/1/2018
A80FE0,conference-participant,100,50,8/1/2018
A8FDE8,dividend,100,50,8/1/2018
AA09AD,earnings,100,50,8/1/2018
AA09AD,earnings,100,50,8/1/2018
AA3AB8,earnings,100,50,8/1/2018
AA98ED,dividend,100,50,8/1/2018
AB7726,acquisition-completed-acquirer,100,49,8/1/2018
AB7726,earnings,100,50,8/1/2018
AC3584,earnings,100,50,8/1/2018
AC642C,earnings,100,50,8/1/2018
AC642C,earnings,100,50,8/1/2018
AD3008,earnings,100,50,8/1/2018
AE7D16,partnership,100,61,8/1/2018
B01111,earnings,100,50,8/1/2018
B09B1F,earnings-up,100,68,8/1/2018
B09B1F,earnings,100,50,8/1/2018
B09B1F,earnings,100,50,8/1/2018
B0FE08,earnings,100,50,8/1/2018
B0FE08,earnings,100,50,8/1/2018
B0FE08,earnings,100,50,8/1/2018
B0FE08,earnings,100,50,8/1/2018
B1A85D,earnings,100,50,8/1/2018
B560AF,earnings,100,50,8/1/2018
B560AF,earnings,100,50,8/1/2018
B560AF,earnings,100,50,8/1/2018
B7BBFF,earnings,100,50,8/1/2018
B7EB38,earnings,100,50,8/1/2018
B840EF,earnings,100,50,8/1/2018
B840EF,executive-resignation,100,44,8/1/2018
B9CD50,conference-participant,100,50,8/1/2018
BBAE2A,dividend,100,50,8/1/2018
BCC55F,business-contract,100,69,8/1/2018
BFE02C,business-contract,100,69,8/1/2018
C062D4,earnings,100,50,8/1/2018
C062D4,earnings,100,50,8/1/2018
C062D4,earnings,100,50,8/1/2018
C062D4,earnings,100,50,8/1/2018
C062D4,earnings,100,50,8/1/2018
C062D4,earnings,100,50,8/1/2018
C07E05,revenues,100,50,8/1/2018
C230FE,earnings-per-share-up,100,68,8/1/2018
C230FE,earnings,100,50,8/1/2018
C2609A,earnings,100,50,8/1/2018
C29715,buybacks,100,74,8/1/2018
C2DD02,conference-call,100,50,8/1/2018
C3F99F,earnings,100,50,8/1/2018
C5C137,earnings,100,50,8/1/2018
C5F463,unit-acquisition-completed-acquirer,100,49,8/1/2018
C72B8F,executive-appointment,100,54,8/1/2018
C7AE14,earnings-up,100,68,8/1/2018
C99CC8,earnings,100,50,8/1/2018
C99CC8,earnings,100,50,8/1/2018
C99CC8,earnings,100,50,8/1/2018
C99CC8,earnings,100,50,8/1/2018
C99CC8,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
C9D866,earnings,100,50,8/1/2018
CA14CC,earnings,100,50,8/1/2018
CA14CC,earnings,100,50,8/1/2018
CA14CC,earnings,100,50,8/1/2018
CB9E13,earnings,100,50,8/1/2018
CBBFBF,earnings,100,50,8/1/2018
CBDB4D,conference-call,100,50,8/1/2018
CC176E,earnings,100,50,8/1/2018
CC3EC4,clinical-trials,100,56,8/1/2018
CC8F6E,earnings,100,50,8/1/2018
CD2A4D,earnings,100,50,8/1/2018
CDAB24,earnings,100,50,8/1/2018
CDD75E,legal-issues-defendant,100,22,8/1/2018
CDE118,earnings,100,50,8/1/2018
D06755,earnings,100,50,8/1/2018
D06755,earnings,100,50,8/1/2018
D06755,earnings,100,50,8/1/2018
D06755,earnings,100,50,8/1/2018
D06755,earnings,100,50,8/1/2018
D11C1C,operating-earnings,100,50,8/1/2018
D139BC,public-offering,100,43,8/1/2018
D20C8F,earnings,100,50,8/1/2018
D29F43,earnings,100,50,8/1/2018
D4AC65,earnings,100,50,8/1/2018
D4AC65,earnings,100,50,8/1/2018
D4AC65,earnings,100,50,8/1/2018
D4AC65,earnings,100,50,8/1/2018
D4AC65,earnings,100,50,8/1/2018
D5AF19,acquisition-completed-acquirer,100,49,8/1/2018
D5AF19,acquisition-completed-acquirer,100,49,8/1/2018
D650A7,dividend,100,50,8/1/2018
D650A7,earnings-per-share-up,100,89,8/1/2018
D650A7,earnings-per-share,100,50,8/1/2018
D650A7,earnings-per-share,100,50,8/1/2018
D6853F,dividend,100,50,8/1/2018
D76AEF,conference-call,100,50,8/1/2018
D77F7E,earnings,100,50,8/1/2018
D854DD,earnings,100,50,8/1/2018
D89753,merger-completed,100,66,8/1/2018
D8ECA1,business-contract,100,69,8/1/2018
DA91AE,conference-participant,100,50,8/1/2018
DB23C8,award,100,58,8/1/2018
DB7014,executive-resignation,100,44,8/1/2018
DB7014,operating-earnings,100,50,8/1/2018
DC2F77,earnings,100,50,8/1/2018
DC437D,earnings,100,50,8/1/2018
DCD97F,dividend,100,50,8/1/2018
DD3BB1,earnings,100,50,8/1/2018
DE4924,dividend,100,50,8/1/2018
DE4924,earnings,100,50,8/1/2018
DE4924,buybacks,100,74,8/1/2018
DFADDB,conference-call,100,50,8/1/2018
E05DC8,acquisition-completed-acquirer,100,49,8/1/2018
E06265,earnings,100,50,8/1/2018
E074A0,earnings,100,50,8/1/2018
E07573,earnings,100,50,8/1/2018
E07573,earnings,100,50,8/1/2018
E07573,earnings,100,50,8/1/2018
E114F4,earnings,100,50,8/1/2018
E114F4,earnings,100,50,8/1/2018
E114F4,earnings,100,50,8/1/2018
E124EB,reorganization-unit,100,53,8/1/2018
E15736,public-offering,100,43,8/1/2018
E16133,conference-call,100,50,8/1/2018
E1BD05,partnership,100,61,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1C16B,earnings-up,100,68,8/1/2018
E1E36F,earnings,100,50,8/1/2018
E1E36F,earnings,100,50,8/1/2018
E1E36F,earnings,100,50,8/1/2018
E1E36F,earnings,100,50,8/1/2018
E1E36F,earnings,100,50,8/1/2018
E1E36F,earnings,100,50,8/1/2018
E21871,earnings,100,50,8/1/2018
E28D9C,business-contract,100,69,8/1/2018
E28D9C,earnings,100,50,8/1/2018
E30A8F,earnings,100,50,8/1/2018
E30A8F,earnings,100,50,8/1/2018
E30A8F,earnings,100,50,8/1/2018
E30A8F,earnings,100,50,8/1/2018
E30A8F,earnings,100,50,8/1/2018
E3E68E,earnings,100,50,8/1/2018
E3E68E,executive-resignation,100,44,8/1/2018
E74FED,earnings,100,50,8/1/2018
E802CE,earnings,100,50,8/1/2018
E866D2,dividend,100,50,8/1/2018
E8846E,unit-acquisition-completed-acquiree,100,67,8/1/2018
E8846E,government-contract,100,69,8/1/2018
E8A49A,shareholder-rights-plan-suspended,100,57,8/1/2018
E8C557,earnings,100,50,8/1/2018
E8E899,executive-appointment,100,54,8/1/2018
EC99D0,executive-appointment,100,54,8/1/2018
ED2A5E,earnings,100,50,8/1/2018
ED2A5E,earnings,100,50,8/1/2018
ED2A5E,earnings,100,50,8/1/2018
ED2A5E,earnings,100,50,8/1/2018
ED2A5E,earnings,100,50,8/1/2018
ED2A5E,earnings,100,50,8/1/2018
ED2A5E,earnings,100,50,8/1/2018
ED79D9,acquisition-completed-acquirer,100,49,8/1/2018
EDD234,conference-call,100,50,8/1/2018
EE74E1,earnings-per-share-positive,100,69,8/1/2018
EE74E1,earnings-per-share-positive,100,69,8/1/2018
EE74E1,earnings-per-share-positive,100,69,8/1/2018
EEBCEF,earnings,100,50,8/1/2018
EEEA9F,earnings-up,100,68,8/1/2018
EEEA9F,earnings,100,50,8/1/2018
EEEA9F,earnings,100,50,8/1/2018
EEEA9F,earnings,100,50,8/1/2018
EFD406,earnings,100,50,8/1/2018
EFD406,earnings,100,50,8/1/2018
EFD406,earnings,100,50,8/1/2018
EFD406,earnings,100,50,8/1/2018
EFD406,earnings,100,50,8/1/2018
EFD406,earnings,100,50,8/1/2018
EFD406,earnings,100,50,8/1/2018
F05B1B,patient-enrollment-start,100,58,8/1/2018
F0EEFB,earnings,100,50,8/1/2018
F1529C,dividend-up,100,81,8/1/2018
F15E41,earnings,100,50,8/1/2018
F15E41,earnings,100,50,8/1/2018
F15E41,earnings,100,50,8/1/2018
F15E41,earnings,100,50,8/1/2018
F15E41,earnings,100,50,8/1/2018
F1CD47,earnings,100,50,8/1/2018
F2E253,dividend,100,50,8/1/2018
F32F88,earnings-up,100,68,8/1/2018
F3816D,earnings,100,50,8/1/2018
F48947,earnings,100,50,8/1/2018
F48947,earnings,100,50,8/1/2018
F57F6F,earnings,100,50,8/1/2018
F73DD1,earnings,100,50,8/1/2018
F73DD1,earnings,100,50,8/1/2018
F73DD1,earnings,100,50,8/1/2018
F73DD1,earnings,100,50,8/1/2018
F73DD1,earnings,100,50,8/1/2018
F73DD1,earnings,100,50,8/1/2018
F73DD1,earnings,100,50,8/1/2018
F793FA,acquisition-completed-acquirer,100,49,8/1/2018
F8C5D7,earnings,100,50,8/1/2018
F90EE5,earnings,100,50,8/1/2018
FA35C6,earnings,100,50,8/1/2018
FDD3FC,conference-participant,100,50,8/1/2018
FEC475,earnings,100,50,8/1/2018
0142B5,earnings-per-share-positive,100,69,8/2/2018
01478A,executive-appointment,100,54,8/2/2018
0157B1,partnership,100,61,8/2/2018
20751,earnings,100,50,8/2/2018
036C6F,conference-call,100,50,8/2/2018
03B431,earnings,100,50,8/2/2018
03FAA6,earnings,100,50,8/2/2018
03FAA6,earnings,100,50,8/2/2018
03FAA6,earnings,100,50,8/2/2018
03FAA6,earnings,100,50,8/2/2018
03FAA6,earnings,100,50,8/2/2018
48590,product-release,100,64,8/2/2018
48590,earnings,100,50,8/2/2018
048B70,earnings,100,50,8/2/2018
048B70,earnings,100,50,8/2/2018
048B70,earnings,100,50,8/2/2018
048B70,earnings,100,50,8/2/2018
0490C6,partnership,100,61,8/2/2018
070B45,product-recall,100,29,8/2/2018
71860,conference-participant,100,50,8/2/2018
07EC43,earnings,100,50,8/2/2018
07EC43,earnings,100,50,8/2/2018
07EC43,earnings,100,50,8/2/2018
07EC43,earnings,100,50,8/2/2018
099A92,dividend,100,50,8/2/2018
0A0D9E,executive-appointment,100,54,8/2/2018
0A0D9E,earnings,100,50,8/2/2018
0A0D9E,earnings,100,50,8/2/2018
0A0D9E,earnings,100,50,8/2/2018
0AD2E3,earnings-up,100,68,8/2/2018
0B7375,conference-call,100,50,8/2/2018
0BC29E,earnings,100,50,8/2/2018
0BC29E,earnings,100,50,8/2/2018
0BC29E,earnings,100,50,8/2/2018
0BC29E,earnings,100,50,8/2/2018
0BC29E,earnings,100,50,8/2/2018
0BC29E,earnings,100,50,8/2/2018
0BC29E,earnings,100,50,8/2/2018
0BC853,earnings,100,50,8/2/2018
0BC853,executive-appointment,100,54,8/2/2018
0BF198,earnings,100,50,8/2/2018
0C2A0D,conference-participant,100,50,8/2/2018
0CE204,partnership,100,61,8/2/2018
0E499E,earnings,100,50,8/2/2018
0EF1AF,conference-participant,100,50,8/2/2018
0F2BC9,earnings-guidance-up,100,83,8/2/2018
0F2BC9,earnings,100,50,8/2/2018
0F2BC9,earnings,100,50,8/2/2018
0FE3A6,earnings,100,50,8/2/2018
106394,earnings,100,50,8/2/2018
1220D2,executive-appointment,100,54,8/2/2018
12DE76,acquisition-interest-acquirer,100,46,8/2/2018
12DE76,acquisition-interest-acquirer,100,46,8/2/2018
12DE76,acquisition-interest-acquirer,100,46,8/2/2018
12DE76,acquisition-interest-acquirer,100,46,8/2/2018
12E454,partnership,100,61,8/2/2018
12E454,partnership,100,61,8/2/2018
143C52,executive-resignation,100,44,8/2/2018
16C544,earnings,100,50,8/2/2018
1834C0,dividend,100,50,8/2/2018
18D9FA,conference-call,100,50,8/2/2018
19BF16,earnings,100,50,8/2/2018
19BF16,earnings,100,50,8/2/2018
19BF16,earnings,100,50,8/2/2018
1A6A94,earnings,100,50,8/2/2018
1B4F31,earnings-up,100,68,8/2/2018
1B4F31,earnings,100,50,8/2/2018
1B4F31,earnings,100,50,8/2/2018
1B4F31,earnings,100,50,8/2/2018
1B4F31,earnings,100,50,8/2/2018
1B9535,earnings,100,50,8/2/2018
1D9E55,earnings,100,50,8/2/2018
1DEBBE,earnings,100,50,8/2/2018
1F9258,earnings,100,50,8/2/2018
2082EA,conference-participant,100,50,8/2/2018
2096DE,earnings,100,50,8/2/2018
21022F,earnings,100,50,8/2/2018
2158DF,executive-appointment,100,54,8/2/2018
219B21,earnings,100,50,8/2/2018
219B21,earnings,100,50,8/2/2018
219B21,earnings,100,50,8/2/2018
219B21,earnings,100,50,8/2/2018
239106,earnings-per-share-positive,100,69,8/2/2018
239106,earnings-per-share-positive,100,69,8/2/2018
239106,earnings-per-share-positive,100,69,8/2/2018
2.45E+15,dividend,100,50,8/2/2018
24FA23,earnings,100,50,8/2/2018
250BEE,earnings,100,50,8/2/2018
250BEE,earnings,100,50,8/2/2018
250BEE,earnings,100,50,8/2/2018
250BEE,earnings,100,50,8/2/2018
250BEE,earnings,100,50,8/2/2018
253B2F,earnings,100,50,8/2/2018
25529C,earnings,100,50,8/2/2018
2571FA,earnings,100,50,8/2/2018
2571FA,earnings,100,50,8/2/2018
2571FA,earnings,100,50,8/2/2018
267718,earnings,100,50,8/2/2018
270B78,executive-appointment,100,54,8/2/2018
270B78,earnings,100,50,8/2/2018
275300,dividend,100,50,8/2/2018
27C10F,earnings,100,50,8/2/2018
27C10F,earnings,100,50,8/2/2018
27C10F,earnings,100,50,8/2/2018
27C10F,earnings,100,50,8/2/2018
2A1009,earnings,100,50,8/2/2018
2A1009,earnings,100,50,8/2/2018
2A1009,earnings,100,50,8/2/2018
2A1009,earnings,100,50,8/2/2018
2B7A40,dividend,100,50,8/2/2018
2C19A4,earnings,100,50,8/2/2018
2C19A4,earnings,100,50,8/2/2018
2C19A4,earnings,100,50,8/2/2018
2C19A4,earnings,100,50,8/2/2018
2C3348,earnings,100,50,8/2/2018
2C7505,earnings,100,50,8/2/2018
2CA60F,earnings,100,50,8/2/2018
2CC71C,earnings,100,50,8/2/2018
2DC88B,earnings,100,50,8/2/2018
2E89AE,earnings,100,50,8/2/2018
2F9304,earnings,100,50,8/2/2018
3159AA,earnings,100,50,8/2/2018
31DB20,earnings,100,50,8/2/2018
337024,earnings,100,50,8/2/2018
337024,earnings,100,50,8/2/2018
3461CF,analyst-ratings-change-positive-rater,20,50,8/2/2018
34A959,revenues,100,50,8/2/2018
34E9F9,earnings,100,50,8/2/2018
34E9F9,earnings,100,50,8/2/2018
34E9F9,earnings,100,50,8/2/2018
34E9F9,earnings,100,50,8/2/2018
34E9F9,earnings,100,50,8/2/2018
35B907,merger-completed,100,66,8/2/2018
371B0A,earnings,100,50,8/2/2018
371B0A,earnings,100,50,8/2/2018
371B0A,earnings,100,50,8/2/2018
371B0A,earnings,100,50,8/2/2018
371B0A,earnings,100,50,8/2/2018
372037,dividend,100,50,8/2/2018
372037,earnings,100,50,8/2/2018
37B120,earnings,100,50,8/2/2018
37E18B,conference-call,100,50,8/2/2018
387375,earnings,100,50,8/2/2018
38C46F,dividend,100,50,8/2/2018
3ACF46,earnings,100,50,8/2/2018
3ACF46,earnings,100,50,8/2/2018
3ACF46,earnings,100,50,8/2/2018
3ACF46,earnings,100,50,8/2/2018
3B2311,earnings,100,50,8/2/2018
3B37F7,earnings,100,50,8/2/2018
3B37F7,earnings,100,50,8/2/2018
3B37F7,earnings,100,50,8/2/2018
3B37F7,earnings,100,50,8/2/2018
3B8484,earnings,100,50,8/2/2018
3BB616,partnership,100,61,8/2/2018
3C11C4,conference-participant,100,50,8/2/2018
3C7F5F,earnings,100,50,8/2/2018
3CBA2A,partnership,100,61,8/2/2018
3D9999,product-release,100,64,8/2/2018
3DC887,earnings,100,50,8/2/2018
3DDE54,earnings,100,50,8/2/2018
3DDE54,earnings,100,50,8/2/2018
3DDE54,earnings,100,50,8/2/2018
3DDE54,earnings,100,50,8/2/2018
3DDE54,earnings,100,50,8/2/2018
3DDE54,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
3ED92D,earnings,100,50,8/2/2018
40F7DE,conference-call,100,50,8/2/2018
434F38,earnings,100,50,8/2/2018
447FC6,earnings,100,50,8/2/2018
448215,earnings,100,50,8/2/2018
451D61,earnings,100,50,8/2/2018
46017C,earnings,100,50,8/2/2018
4.60E+06,earnings,100,50,8/2/2018
4885C8,earnings,100,50,8/2/2018
499C75,earnings,100,50,8/2/2018
499C75,earnings,100,50,8/2/2018
49A344,business-contract,100,69,8/2/2018
49A344,business-contract,100,69,8/2/2018
49F4D0,earnings,100,50,8/2/2018
4A2457,revenue-up,100,56,8/2/2018
4A2457,revenues,100,50,8/2/2018
4A2457,revenues,100,50,8/2/2018
4A2457,revenues,100,50,8/2/2018
4A2457,revenues,100,50,8/2/2018
4A6F00,partnership,100,61,8/2/2018
4B6EF9,unit-acquisition-acquirer,100,49,8/2/2018
4BEB48,partnership,100,61,8/2/2018
4C350A,earnings,100,50,8/2/2018
4C350A,earnings,100,50,8/2/2018
4C350A,conference-call,100,50,8/2/2018
4D8124,earnings,100,50,8/2/2018
4E5784,earnings,100,50,8/2/2018
4EEE7E,earnings,100,50,8/2/2018
4F783B,dividend,100,50,8/2/2018
50070E,earnings,100,50,8/2/2018
507AE7,dividend,100,50,8/2/2018
51D876,revenue-up,100,69,8/2/2018
524CE4,earnings,100,50,8/2/2018
546A27,earnings,100,50,8/2/2018
548AC0,earnings,100,50,8/2/2018
54A713,dividend,100,50,8/2/2018
55ACCB,earnings,100,50,8/2/2018
55ACCB,earnings,100,50,8/2/2018
55ACCB,earnings,100,50,8/2/2018
56765E,earnings,100,50,8/2/2018
567F3D,dividend,100,50,8/2/2018
5704AC,operating-earnings,100,50,8/2/2018
57F3DA,earnings,100,50,8/2/2018
583223,earnings,100,50,8/2/2018
5876DC,earnings,100,50,8/2/2018
589803,earnings,100,50,8/2/2018
5968F9,public-offering,100,43,8/2/2018
59872F,acquisition-interest-acquirer,100,46,8/2/2018
5A53BF,earnings,100,50,8/2/2018
5A64D5,earnings,100,50,8/2/2018
5AF08A,stake-acquirer,100,48,8/2/2018
5B3415,earnings,100,50,8/2/2018
5C8D61,conference-participant,100,50,8/2/2018
5D63F1,facility-open,100,65,8/2/2018
601785,dividend,100,50,8/2/2018
60EA12,dividend,100,50,8/2/2018
60EA12,revenue-up,100,69,8/2/2018
6137BF,conference-participant,100,50,8/2/2018
619882,conference-organizer,100,57,8/2/2018
619882,conference-organizer,100,57,8/2/2018
619882,conference-organizer,100,57,8/2/2018
62A48D,earnings,100,50,8/2/2018
62B1C6,earnings,100,50,8/2/2018
636639,executive-appointment,100,54,8/2/2018
636639,dividend-up,100,81,8/2/2018
657097,unit-acquisition-acquirer,100,49,8/2/2018
665618,conference-participant,100,50,8/2/2018
66ECFD,dividend,100,50,8/2/2018
67303E,earnings,100,50,8/2/2018
67B052,earnings,100,50,8/2/2018
6810DE,earnings,100,50,8/2/2018
68E3E0,earnings,100,50,8/2/2018
68E3E0,earnings,100,50,8/2/2018
68E3E0,earnings,100,50,8/2/2018
68E3E0,earnings,100,50,8/2/2018
68E3E0,earnings,100,50,8/2/2018
68E6E9,earnings,100,50,8/2/2018
69494C,earnings,100,50,8/2/2018
6A01DF,earnings,100,50,8/2/2018
6B5379,earnings,100,50,8/2/2018
6D3F35,ipo-pricing,100,50,8/2/2018
6D9B53,business-contract,100,69,8/2/2018
6.00E+19,earnings,100,50,8/2/2018
6E705B,product-release,100,64,8/2/2018
6F30F9,earnings,100,50,8/2/2018
6F92A9,earnings,100,50,8/2/2018
705636,revenues,100,50,8/2/2018
705636,dividend,100,50,8/2/2018
717DB4,earnings,100,50,8/2/2018
717DB4,earnings,100,50,8/2/2018
717DB4,earnings,100,50,8/2/2018
717DB4,earnings,100,50,8/2/2018
719477,earnings,100,50,8/2/2018
719477,earnings,100,50,8/2/2018
719477,earnings,100,50,8/2/2018
71E2EF,dividend,100,50,8/2/2018
7255D2,earnings,100,50,8/2/2018
726EEA,executive-appointment,100,54,8/2/2018
72C2CE,earnings,100,50,8/2/2018
73529F,earnings,100,50,8/2/2018
73A71F,earnings,100,50,8/2/2018
741937,revenue-up,100,69,8/2/2018
741937,earnings,100,50,8/2/2018
741937,earnings,100,50,8/2/2018
742AAB,earnings,100,50,8/2/2018
743C70,earnings,100,50,8/2/2018
762A3E,conference-organizer,100,57,8/2/2018
771985,acquisition-acquirer,100,49,8/2/2018
771985,acquisition-acquirer,100,49,8/2/2018
771985,acquisition-acquirer,100,49,8/2/2018
787D14,earnings,100,50,8/2/2018
789ADD,earnings,100,50,8/2/2018
789ADD,earnings,100,50,8/2/2018
789ADD,earnings,100,50,8/2/2018
789ADD,earnings,100,50,8/2/2018
791EC1,dividend,100,50,8/2/2018
793C11,earnings,100,50,8/2/2018
793C11,earnings,100,50,8/2/2018
793C11,earnings,100,50,8/2/2018
793C11,earnings,100,50,8/2/2018
797C20,dividend,100,50,8/2/2018
7B6EB1,earnings,100,50,8/2/2018
7B8CB5,earnings,100,50,8/2/2018
7BC92D,executive-appointment,100,54,8/2/2018
7BEA98,conference-call,100,50,8/2/2018
7CD98F,earnings,100,50,8/2/2018
7D85A9,earnings,100,50,8/2/2018
7F9BE2,earnings,100,50,8/2/2018
7F9E16,earnings-up,100,68,8/2/2018
810FAD,conference-participant,100,50,8/2/2018
82FD6D,earnings,100,50,8/2/2018
830BDB,earnings,100,50,8/2/2018
830BDB,earnings,100,50,8/2/2018
830BDB,earnings,100,50,8/2/2018
830BDB,earnings,100,50,8/2/2018
83A065,earnings,100,50,8/2/2018
83B1C8,earnings,100,50,8/2/2018
83E0AC,conference-call,100,50,8/2/2018
848C0B,earnings,100,50,8/2/2018
86A1B9,earnings-up,100,68,8/2/2018
86A1B9,earnings-up,100,68,8/2/2018
86A1B9,earnings-up,100,68,8/2/2018
86A1B9,earnings-up,100,68,8/2/2018
86A1B9,earnings-up,100,68,8/2/2018
86F123,conference-call,100,50,8/2/2018
87B81A,revenues,100,50,8/2/2018
87B81A,revenues,100,50,8/2/2018
87B81A,revenues,100,50,8/2/2018
87B81A,revenues,100,50,8/2/2018
87B81A,dividend,100,50,8/2/2018
88923D,earnings,100,50,8/2/2018
88923D,earnings,100,50,8/2/2018
88923D,earnings,100,50,8/2/2018
88923D,earnings,100,50,8/2/2018
88923D,earnings,100,50,8/2/2018
88923D,earnings,100,50,8/2/2018
893904,earnings,100,50,8/2/2018
89F693,earnings,100,50,8/2/2018
89F693,earnings,100,50,8/2/2018
89FBB1,earnings,100,50,8/2/2018
89FBB1,earnings,100,50,8/2/2018
89FBB1,earnings,100,50,8/2/2018
8A8E41,product-release,100,64,8/2/2018
8AB85C,clinical-trials-start,100,64,8/2/2018
8AC740,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8B1F37,earnings,100,50,8/2/2018
8BAA15,earnings,100,50,8/2/2018
8BAA15,earnings,100,50,8/2/2018
8BAA15,earnings,100,50,8/2/2018
8DBBE6,earnings,100,50,8/2/2018
8DE74B,dividend,100,50,8/2/2018
8E10BF,conference-participant,100,50,8/2/2018
8E8E6E,earnings,100,50,8/2/2018
9043FE,earnings,100,50,8/2/2018
9043FE,earnings,100,50,8/2/2018
911AB8,partnership,100,61,8/2/2018
92B625,earnings,100,50,8/2/2018
934CC3,award,100,58,8/2/2018
93AD2E,earnings,100,50,8/2/2018
94563D,business-contract,100,69,8/2/2018
9470CC,earnings,100,50,8/2/2018
947B0B,earnings,100,50,8/2/2018
94983E,earnings,100,50,8/2/2018
949D62,earnings,100,50,8/2/2018
9548BB,dividend-up,100,58,8/2/2018
958938,conference-call,100,50,8/2/2018
95C392,earnings,100,50,8/2/2018
967D92,earnings,100,50,8/2/2018
968966,dividend,100,50,8/2/2018
96BFF4,earnings,100,50,8/2/2018
971F7B,earnings,100,50,8/2/2018
971F7B,earnings,100,50,8/2/2018
971F7B,earnings,100,50,8/2/2018
971F7B,earnings,100,50,8/2/2018
971F7B,earnings,100,50,8/2/2018
9.74E+08,earnings,100,50,8/2/2018
9.74E+08,earnings,100,50,8/2/2018
9.74E+08,earnings,100,50,8/2/2018
9.74E+08,earnings,100,50,8/2/2018
97AAF6,earnings,100,50,8/2/2018
97AAF6,earnings,100,50,8/2/2018
97AAF6,earnings,100,50,8/2/2018
97AAF6,earnings,100,50,8/2/2018
9810C0,conference-participant,100,50,8/2/2018
9.97E+09,earnings,100,50,8/2/2018
9A602D,dividend,100,50,8/2/2018
9AF3DC,earnings,100,50,8/2/2018
9B4066,dividend-up,100,81,8/2/2018
9C25FF,partnership,100,61,8/2/2018
9C5174,revenue-up,100,63,8/2/2018
9C5174,revenues,100,50,8/2/2018
9D30A8,earnings,100,50,8/2/2018
9D6A24,earnings-up,100,68,8/2/2018
9D6A24,earnings-up,100,68,8/2/2018
9D6A24,earnings-up,100,68,8/2/2018
9D6A24,earnings-up,100,68,8/2/2018
9D6A24,earnings-up,100,68,8/2/2018
9E3224,earnings,100,50,8/2/2018
9E4A5F,earnings,100,50,8/2/2018
9E575E,earnings,100,50,8/2/2018
9E575E,earnings,100,50,8/2/2018
9E575E,earnings,100,50,8/2/2018
9F5997,earnings,100,50,8/2/2018
9F71E5,dividend,100,50,8/2/2018
A01664,earnings,100,50,8/2/2018
A05C43,executive-appointment,100,54,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A16DEA,earnings,100,50,8/2/2018
A1BB98,conference-call,100,50,8/2/2018
A1E3B3,earnings,100,50,8/2/2018
A1EAC8,earnings,100,50,8/2/2018
A21649,earnings,100,50,8/2/2018
A21649,public-offering,100,43,8/2/2018
A3AAA5,earnings,100,50,8/2/2018
A4386C,executive-appointment,100,54,8/2/2018
A4386C,earnings,100,50,8/2/2018
A4386C,earnings,100,50,8/2/2018
A4386C,earnings,100,50,8/2/2018
A4386C,earnings,100,50,8/2/2018
A43906,earnings,100,50,8/2/2018
A48593,conference-participant,100,50,8/2/2018
A48593,earnings-up,100,68,8/2/2018
A48593,earnings,100,50,8/2/2018
A495F7,partnership,100,61,8/2/2018
A4A612,public-offering,100,43,8/2/2018
A4B899,earnings,100,50,8/2/2018
A5151E,conference-participant,100,50,8/2/2018
A5195E,public-offering,100,43,8/2/2018
A52533,earnings,100,50,8/2/2018
A52B6B,earnings,100,50,8/2/2018
A5A4F5,acquisition-acquirer,100,49,8/2/2018
A60354,earnings,100,50,8/2/2018
A60354,earnings,100,50,8/2/2018
A6213D,conference-participant,100,50,8/2/2018
A63387,executive-appointment,100,54,8/2/2018
A7F0A5,earnings,100,50,8/2/2018
A8FDE8,earnings,100,50,8/2/2018
A94637,revenues,100,50,8/2/2018
A94637,revenues,100,50,8/2/2018
AA1EAA,earnings,100,50,8/2/2018
AB4A7E,earnings,100,50,8/2/2018
AC7C4F,business-contract,100,69,8/2/2018
AEBB80,earnings,100,50,8/2/2018
B04426,conference-call,100,50,8/2/2018
B05118,earnings,100,50,8/2/2018
B0998E,earnings-up,100,68,8/2/2018
B0998E,earnings,100,50,8/2/2018
B0998E,earnings,100,50,8/2/2018
B0998E,earnings,100,50,8/2/2018
B0998E,earnings,100,50,8/2/2018
B0998E,earnings,100,50,8/2/2018
B2D492,earnings,100,50,8/2/2018
B303A6,earnings,100,50,8/2/2018
B303A6,earnings,100,50,8/2/2018
B303A6,earnings,100,50,8/2/2018
B303A6,earnings,100,50,8/2/2018
B303A6,earnings,100,50,8/2/2018
B303A6,earnings,100,50,8/2/2018
B37FB4,partnership,100,61,8/2/2018
B381D8,earnings,100,50,8/2/2018
B3ED62,earnings,100,50,8/2/2018
B4C673,earnings-up,100,68,8/2/2018
B5DE80,earnings,100,50,8/2/2018
B77F14,earnings,100,50,8/2/2018
B77F14,earnings,100,50,8/2/2018
B98EFA,revenue-up,100,69,8/2/2018
BB0587,dividend,100,50,8/2/2018
BB07E4,dividend,100,50,8/2/2018
BDEC1E,earnings,100,50,8/2/2018
BDF85E,trading-halt,100,43,8/2/2018
BE7BA4,earnings,100,50,8/2/2018
BFEA04,earnings,100,50,8/2/2018
BFEA04,earnings,100,50,8/2/2018
BFEA04,earnings,100,50,8/2/2018
BFEA04,earnings,100,50,8/2/2018
C01737,earnings,100,50,8/2/2018
C03C8B,earnings,100,50,8/2/2018
C03C8B,earnings,100,50,8/2/2018
C03C8B,earnings,100,50,8/2/2018
C03C8B,earnings,100,50,8/2/2018
C03C8B,earnings,100,50,8/2/2018
C03C8B,earnings,100,50,8/2/2018
C03C8B,earnings,100,50,8/2/2018
C0F70B,conference-participant,100,50,8/2/2018
C1CBA4,ipo,100,71,8/2/2018
C2F597,earnings,100,50,8/2/2018
C3DE7D,earnings,100,50,8/2/2018
C4A241,earnings-up,100,68,8/2/2018
C4A241,earnings,100,50,8/2/2018
C4A241,earnings,100,50,8/2/2018
C4A241,earnings,100,50,8/2/2018
C4A241,earnings,100,50,8/2/2018
C4A912,earnings,100,50,8/2/2018
C4A912,earnings,100,50,8/2/2018
C4A912,earnings,100,50,8/2/2018
C4A912,earnings,100,50,8/2/2018
C54140,earnings,100,50,8/2/2018
C564E4,earnings,100,50,8/2/2018
C65004,conference-participant,100,50,8/2/2018
C6C702,earnings,100,50,8/2/2018
C83B88,patent-infringement-defendant,100,26,8/2/2018
C83B88,patent-infringement-defendant,100,26,8/2/2018
C83B88,patent-infringement-defendant,100,26,8/2/2018
C83B88,partnership,100,61,8/2/2018
C8923A,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C8A248,earnings,100,50,8/2/2018
C97B2D,acquisition-completed-acquirer,100,49,8/2/2018
C98CDB,earnings,100,50,8/2/2018
C9A96E,earnings,100,50,8/2/2018
CAB222,partnership,100,61,8/2/2018
CB22CD,dividend,100,50,8/2/2018
CB6A9C,earnings,100,50,8/2/2018
CC0C78,earnings,100,50,8/2/2018
CDC217,earnings,100,50,8/2/2018
CE96E7,dividend,100,50,8/2/2018
CEC08B,earnings-up,100,68,8/2/2018
CEC5B9,earnings,100,50,8/2/2018
CEC5B9,earnings,100,50,8/2/2018
CED4D0,earnings,100,50,8/2/2018
CF3FF9,earnings,100,50,8/2/2018
CFD4B6,earnings-positive,100,69,8/2/2018
CFF15D,legal-issues-defendant,100,22,8/2/2018
D25249,earnings,100,50,8/2/2018
D29B44,earnings,100,50,8/2/2018
D29F43,dividend,100,50,8/2/2018
D3DE34,earnings,100,50,8/2/2018
D4070C,dividend,100,50,8/2/2018
D45285,executive-appointment,100,54,8/2/2018
D57D99,dividend,100,50,8/2/2018
D6853F,business-contract,100,69,8/2/2018
D6853F,earnings,100,50,8/2/2018
D6853F,earnings,100,50,8/2/2018
D6853F,earnings,100,50,8/2/2018
D8DA3D,earnings,100,50,8/2/2018
D8DA3D,earnings,100,50,8/2/2018
D8DA3D,earnings,100,50,8/2/2018
D8DA3D,earnings,100,50,8/2/2018
D8DA3D,earnings,100,50,8/2/2018
D8DA3D,earnings,100,50,8/2/2018
D8DA3D,earnings,100,50,8/2/2018
D8ECA1,earnings,100,50,8/2/2018
D9164D,dividend,100,50,8/2/2018
D9164D,buybacks,100,74,8/2/2018
D9164D,earnings,100,50,8/2/2018
DA9443,earnings,100,50,8/2/2018
DB5CA5,earnings,100,50,8/2/2018
DBCA3F,executive-appointment,100,54,8/2/2018
DBFB51,executive-appointment,100,54,8/2/2018
DC0D18,earnings-up,100,68,8/2/2018
DC0D18,earnings-up,100,68,8/2/2018
DC0D18,earnings-up,100,68,8/2/2018
DC0D18,earnings-up,100,68,8/2/2018
DC437D,dividend,100,50,8/2/2018
DC5299,operating-earnings,100,50,8/2/2018
DCD97F,business-contract,100,69,8/2/2018
DD682D,unit-acquisition-acquiree,100,76,8/2/2018
DDCB34,dividend,100,50,8/2/2018
DDCB34,earnings,100,50,8/2/2018
DE20DF,operating-earnings,100,50,8/2/2018
E0207A,earnings,100,50,8/2/2018
E0207A,earnings,100,50,8/2/2018
E0207A,earnings,100,50,8/2/2018
E0207A,earnings,100,50,8/2/2018
E0D3BA,earnings,100,50,8/2/2018
E11C41,earnings,100,50,8/2/2018
E19A99,earnings,100,50,8/2/2018
E22FDE,conference-participant,100,50,8/2/2018
E259C7,revenue-up,100,69,8/2/2018
E259C7,revenue-up,100,69,8/2/2018
E259C7,revenue-up,100,69,8/2/2018
E259C7,revenue-up,100,69,8/2/2018
E259C7,revenue-up,100,69,8/2/2018
E2CFD2,earnings,100,50,8/2/2018
E2F66E,earnings,100,50,8/2/2018
E35610,earnings,100,50,8/2/2018
E35610,earnings,100,50,8/2/2018
E35610,earnings,100,50,8/2/2018
E38906,earnings,100,50,8/2/2018
E49AA3,earnings,100,50,8/2/2018
E4CE73,conference-call,100,50,8/2/2018
E5D914,conference-participant,100,50,8/2/2018
E67C2C,earnings,100,50,8/2/2018
E7BF32,earnings,100,50,8/2/2018
E7BF32,earnings,100,50,8/2/2018
E8C557,stake-acquirer,100,48,8/2/2018
E94704,dividend,100,50,8/2/2018
EB43F4,executive-appointment,100,54,8/2/2018
EC70EC,earnings,100,50,8/2/2018
EC70EC,earnings,100,50,8/2/2018
EC70EC,earnings,100,50,8/2/2018
EC70EC,earnings,100,50,8/2/2018
EC70EC,earnings,100,50,8/2/2018
EC70EC,earnings,100,50,8/2/2018
ED2EFD,earnings,100,50,8/2/2018
ED3CA8,earnings,100,50,8/2/2018
ED9576,dividend,100,50,8/2/2018
EEA734,conference-participant,100,50,8/2/2018
EF25A5,earnings,100,50,8/2/2018
EF25A5,earnings,100,50,8/2/2018
EF25A5,earnings,100,50,8/2/2018
EF25A5,earnings,100,50,8/2/2018
EF7163,earnings,100,50,8/2/2018
F0027C,earnings,100,50,8/2/2018
F02D0A,earnings,100,50,8/2/2018
F0B335,earnings,100,50,8/2/2018
F3816D,conference-participant,100,50,8/2/2018
F40EE2,award,100,58,8/2/2018
F44EA2,dividend-up,100,58,8/2/2018
F4CDA3,earnings,100,50,8/2/2018
F4CDA3,earnings,100,50,8/2/2018
F4CDA3,earnings,100,50,8/2/2018
F4CDA3,earnings,100,50,8/2/2018
F4CDA3,earnings,100,50,8/2/2018
F4CDA3,earnings,100,50,8/2/2018
F4CDA3,earnings,100,50,8/2/2018
F4F46F,earnings,100,50,8/2/2018
F51DB0,earnings,100,50,8/2/2018
F721A7,earnings,100,50,8/2/2018
F721A7,earnings,100,50,8/2/2018
F73DD1,dividend,100,50,8/2/2018
F7902B,conference-participant,100,50,8/2/2018
F7ADEB,conference-participant,100,50,8/2/2018
F7FCA4,earnings,100,50,8/2/2018
F7FCA4,earnings,100,50,8/2/2018
F8084B,earnings-positive,100,69,8/2/2018
F85CC0,earnings,100,50,8/2/2018
F88147,earnings,100,50,8/2/2018
F93C8A,earnings,100,50,8/2/2018
FAB97A,earnings,100,50,8/2/2018
FCA54E,earnings,100,50,8/2/2018
FD39EB,earnings,100,50,8/2/2018
FD4588,earnings,100,50,8/2/2018
FD4588,earnings,100,50,8/2/2018
FD4588,earnings,100,50,8/2/2018
FD6926,earnings,100,50,8/2/2018
FD6926,earnings,100,50,8/2/2018
FD6926,earnings,100,50,8/2/2018
FD6926,earnings,100,50,8/2/2018
FD6926,earnings,100,50,8/2/2018
FD6926,earnings,100,50,8/2/2018
FD6926,earnings,100,50,8/2/2018
FD6926,dividend,100,50,8/2/2018
FD9A97,dividend-up,100,81,8/2/2018
FDC7E6,trading-halt,100,43,8/2/2018
FDC7E6,trading-resumed,100,58,8/2/2018
FEE4B0,earnings-up,100,68,8/2/2018
FEE4B0,earnings-up,100,68,8/2/2018
FEE4B0,earnings-up,100,68,8/2/2018
FEE4B0,earnings-up,100,68,8/2/2018
FEE4B0,earnings-up,100,68,8/2/2018
FFAB4A,buybacks,100,74,8/2/2018
02ACBD,conference-call,100,50,8/3/2018
0325B7,earnings,100,50,8/3/2018
0E5619,conference-call,100,50,8/3/2018
12E454,partnership,100,61,8/3/2018
1D3A00,credit-extension-recipient,100,69,8/3/2018
1E83DE,conference-participant,100,50,8/3/2018
1F43A1,earnings,100,50,8/3/2018
228D42,partnership,100,61,8/3/2018
22C58E,acquisition-completed-acquiree,100,76,8/3/2018
25AB8E,earnings,100,50,8/3/2018
25AB8E,earnings,100,50,8/3/2018
25AB8E,earnings,100,50,8/3/2018
25AB8E,earnings,100,50,8/3/2018
25AB8E,earnings,100,50,8/3/2018
25AB8E,earnings,100,50,8/3/2018
25AB8E,earnings,100,50,8/3/2018
25DD05,business-contract,100,69,8/3/2018
297DA8,earnings,100,50,8/3/2018
2AE625,earnings,100,50,8/3/2018
2C3348,patient-enrollment-complete,100,64,8/3/2018
3.20E+263,earnings,100,50,8/3/2018
342218,earnings,100,50,8/3/2018
342218,earnings,100,50,8/3/2018
35F4B5,dividend,100,50,8/3/2018
3BB616,business-contract,100,69,8/3/2018
449217,earnings-positive,100,69,8/3/2018
44ED36,earnings,100,50,8/3/2018
4885C8,executive-appointment,100,54,8/3/2018
4A3438,earnings,100,50,8/3/2018
4A3438,earnings,100,50,8/3/2018
4A3438,earnings,100,50,8/3/2018
4A3438,earnings,100,50,8/3/2018
4EEB00,legal-issues-defendant,100,22,8/3/2018
50070E,conference-organizer,100,57,8/3/2018
5340D0,public-offering,100,43,8/3/2018
546A27,conference-participant,100,50,8/3/2018
550D01,unit-acquisition-acquirer,100,49,8/3/2018
56277A,executive-appointment,100,54,8/3/2018
58B46F,earnings-negative,100,33,8/3/2018
58EA22,executive-appointment,100,54,8/3/2018
619882,conference-organizer,100,57,8/3/2018
619882,conference-organizer,100,57,8/3/2018
62B1C6,earnings,100,50,8/3/2018
62CDDE,conference-call,100,50,8/3/2018
64E615,conference-participant,100,50,8/3/2018
651C85,earnings,100,50,8/3/2018
6.52E+64,legal-issues-defendant,100,22,8/3/2018
67303E,conference-participant,100,50,8/3/2018
6A6BDC,earnings,100,50,8/3/2018
6B236C,dividend,100,50,8/3/2018
6BD606,dividend,100,50,8/3/2018
6E705B,executive-appointment,100,54,8/3/2018
6EA292,earnings,100,50,8/3/2018
6F0096,stake-acquirer,100,48,8/3/2018
726EEA,earnings-up,100,68,8/3/2018
726EEA,earnings-up,100,68,8/3/2018
726EEA,earnings-up,100,68,8/3/2018
726EEA,earnings-up,100,68,8/3/2018
726EEA,earnings-up,100,68,8/3/2018
728737,public-offering,100,43,8/3/2018
76BD96,dividend,100,50,8/3/2018
7710F3,earnings,100,50,8/3/2018
7823A3,conference-participant,100,50,8/3/2018
789A7D,earnings,100,50,8/3/2018
7ACBA4,earnings,100,50,8/3/2018
7BAAE7,dividend,100,50,8/3/2018
7FDE1C,earnings,100,50,8/3/2018
81EAD4,earnings,100,50,8/3/2018
81EAD4,earnings,100,50,8/3/2018
81EAD4,earnings,100,50,8/3/2018
81EAD4,earnings,100,50,8/3/2018
87486A,earnings,100,50,8/3/2018
87486A,earnings,100,50,8/3/2018
87486A,earnings,100,50,8/3/2018
87486A,earnings,100,50,8/3/2018
8B1E11,executive-appointment,100,54,8/3/2018
905356,conference-call,100,50,8/3/2018
940C3D,dividend,100,50,8/3/2018
95F59E,earnings,100,50,8/3/2018
971334,earnings,100,50,8/3/2018
971334,earnings,100,50,8/3/2018
971334,earnings,100,50,8/3/2018
971334,earnings,100,50,8/3/2018
971334,earnings,100,50,8/3/2018
98D33E,earnings,100,50,8/3/2018
9B4066,unit-acquisition-acquirer,100,49,8/3/2018
A15C71,note-sale,100,52,8/3/2018
A1EAC8,business-contract,100,69,8/3/2018
A21649,public-offering,100,43,8/3/2018
A4BCDE,earnings,100,50,8/3/2018
A5A4F5,acquisition-acquirer,100,49,8/3/2018
A8CBDA,executive-appointment,100,54,8/3/2018
AC642C,conference-participant,100,50,8/3/2018
AC642C,note-sale,100,52,8/3/2018
AC642C,note-sale,100,52,8/3/2018
ACD9A4,executive-appointment,100,54,8/3/2018
AE7D16,earnings,100,50,8/3/2018
B05000,executive-appointment,100,54,8/3/2018
B1A85D,executive-appointment,100,54,8/3/2018
B3A166,legal-issues-defendant,100,22,8/3/2018
B4B281,conference-call,100,50,8/3/2018
B5BA39,dividend,100,50,8/3/2018
B5BA39,earnings,100,50,8/3/2018
B5BA39,earnings,100,50,8/3/2018
B5BA39,earnings,100,50,8/3/2018
B5BA39,earnings,100,50,8/3/2018
B5BA39,earnings,100,50,8/3/2018
B5BA39,earnings,100,50,8/3/2018
BD9668,dividend,100,50,8/3/2018
BDE867,earnings,100,50,8/3/2018
BDE867,earnings,100,50,8/3/2018
BDE867,earnings,100,50,8/3/2018
BFAEB4,executive-resignation,100,44,8/3/2018
C0200F,buybacks,100,74,8/3/2018
C15F8F,executive-appointment,100,54,8/3/2018
C188F8,business-contract,100,69,8/3/2018
C356AC,dividend,100,50,8/3/2018
C356AC,earnings,100,50,8/3/2018
C356AC,earnings,100,50,8/3/2018
C356AC,earnings,100,50,8/3/2018
C356AC,earnings,100,50,8/3/2018
C356AC,earnings,100,50,8/3/2018
C6C702,conference-participant,100,50,8/3/2018
C9A96E,acquisition-acquiree,100,76,8/3/2018
C9C62A,earnings,100,50,8/3/2018
CA3CB9,earnings,100,50,8/3/2018
CDD75E,conference-call,100,50,8/3/2018
CDD75E,legal-issues-defendant,100,22,8/3/2018
D0DFE5,facility-open,100,65,8/3/2018
D139BC,public-offering,100,43,8/3/2018
D3FD6D,revenues,100,50,8/3/2018
D3FD6D,earnings,100,50,8/3/2018
D3FD6D,earnings,100,50,8/3/2018
D57D99,conference-participant,100,50,8/3/2018
D75910,conference-call,100,50,8/3/2018
DA91AE,dividend,100,50,8/3/2018
DB23C8,earnings,100,50,8/3/2018
DB23C8,earnings,100,50,8/3/2018
DB23C8,earnings,100,50,8/3/2018
DEF058,business-contract,100,69,8/3/2018
E26FC3,dividend,100,50,8/3/2018
E8846E,credit-extension-provider,100,57,8/3/2018
E959F3,dividend,100,50,8/3/2018
EB43F4,earnings,100,50,8/3/2018
EBC84C,dividend,100,50,8/3/2018
EF45B6,earnings,100,50,8/3/2018
EFA7B2,legal-issues-defendant,100,22,8/3/2018
F1529C,earnings,100,50,8/3/2018
F1C04C,dividend,100,50,8/3/2018
F6581D,earnings,100,50,8/3/2018
F7935D,earnings,100,50,8/3/2018
F80FF9,conference-call,100,50,8/3/2018
FC4550,dividend,100,50,8/3/2018
FD9A97,earnings,100,50,8/3/2018
9D65C1,legal-issues-defendant,100,22,8/4/2018
9D65C1,legal-issues-defendant,100,22,8/4/2018
B05118,union-pact,100,61,8/5/2018
CDD75E,legal-issues-defendant,100,22,8/5/2018
13528,executive-appointment,100,54,8/6/2018
0157B1,partnership,100,61,8/6/2018
03542C,earnings,100,50,8/6/2018
054E7E,earnings,100,50,8/6/2018
09F623,conference-participant,100,50,8/6/2018
0BC29E,executive-appointment,100,54,8/6/2018
0BD4E8,executive-appointment,100,54,8/6/2018
0E5223,operating-earnings,100,50,8/6/2018
0FABBD,earnings-up,100,68,8/6/2018
1080C0,earnings,100,50,8/6/2018
13A782,earnings,100,50,8/6/2018
13D576,acquisition-completed-acquirer,100,49,8/6/2018
14833D,partnership,100,61,8/6/2018
165B86,conference-participant,100,50,8/6/2018
1880C5,campaign-ad-release,100,59,8/6/2018
18D9FA,earnings,100,50,8/6/2018
197019,acquisition-acquirer,100,49,8/6/2018
1DDEDA,earnings,100,50,8/6/2018
1EC3E8,executive-appointment,100,54,8/6/2018
1F3CFB,earnings,100,50,8/6/2018
1F3CFB,executive-resignation,100,44,8/6/2018
2158DF,earnings-up,100,68,8/6/2018
2158DF,earnings-up,100,68,8/6/2018
2158DF,earnings-up,100,68,8/6/2018
2158DF,earnings-up,100,68,8/6/2018
2158DF,earnings-up,100,68,8/6/2018
238302,earnings,100,50,8/6/2018
241AF7,earnings,100,50,8/6/2018
241AF7,executive-appointment,100,54,8/6/2018
249674,earnings,100,50,8/6/2018
249674,earnings,100,50,8/6/2018
249674,earnings,100,50,8/6/2018
249674,earnings,100,50,8/6/2018
24CB56,conference-organizer,100,57,8/6/2018
251988,partnership,100,61,8/6/2018
267718,business-contract,100,69,8/6/2018
27A791,earnings,100,50,8/6/2018
284289,conference-participant,100,50,8/6/2018
2AA6A8,earnings,100,50,8/6/2018
2B8179,fundraising,100,64,8/6/2018
2CBB58,conference-participant,100,50,8/6/2018
2CD1E0,investment-investor,100,55,8/6/2018
2EB04E,partnership,100,61,8/6/2018
2FF046,earnings,100,50,8/6/2018
2FF046,earnings,100,50,8/6/2018
2FF046,earnings,100,50,8/6/2018
306623,conference-participant,100,50,8/6/2018
349DA4,earnings,100,50,8/6/2018
349DA4,earnings,100,50,8/6/2018
349DA4,earnings,100,50,8/6/2018
3587B4,earnings,100,50,8/6/2018
36529A,earnings,100,50,8/6/2018
36C09B,conference-call,100,50,8/6/2018
37B618,earnings,100,50,8/6/2018
385DD4,earnings,100,50,8/6/2018
389CFB,earnings,100,50,8/6/2018
3ACF46,conference-participant,100,50,8/6/2018
3BA1BF,conference-call,100,50,8/6/2018
3D6933,pretax-earnings-positive,100,69,8/6/2018
3D6933,pretax-earnings-positive,100,69,8/6/2018
3D6933,pretax-earnings-positive,100,69,8/6/2018
3F1C69,executive-appointment,100,54,8/6/2018
41EC04,executive-appointment,100,54,8/6/2018
422CE3,executive-appointment,100,54,8/6/2018
427F32,dividend,100,50,8/6/2018
435ACE,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
43A74A,earnings,100,50,8/6/2018
444CC8,ipo-completed,100,76,8/6/2018
444CC8,ipo-completed,100,76,8/6/2018
44DDBD,public-offering,100,43,8/6/2018
44DDBD,public-offering,100,43,8/6/2018
458D2C,revenue-volume,100,50,8/6/2018
45BC35,conference-participant,100,50,8/6/2018
4BDCA7,earnings,100,50,8/6/2018
4C31F3,earnings,100,50,8/6/2018
4C31F3,earnings,100,50,8/6/2018
4C31F3,earnings,100,50,8/6/2018
4C37C5,partnership,100,61,8/6/2018
4E7C1F,acquisition-acquirer,100,49,8/6/2018
4EE14A,operating-earnings,100,50,8/6/2018
4EE14A,operating-earnings,100,50,8/6/2018
504FE2,executive-appointment,100,54,8/6/2018
5403F8,earnings,100,50,8/6/2018
54F271,public-offering,100,43,8/6/2018
55D0F3,earnings,100,50,8/6/2018
56AFF4,executive-resignation,100,44,8/6/2018
589803,partnership,100,61,8/6/2018
589803,partnership,100,61,8/6/2018
589803,partnership,100,61,8/6/2018
589803,partnership,100,61,8/6/2018
58C2D4,earnings,100,50,8/6/2018
5968F9,public-offering,100,43,8/6/2018
59872F,product-release,100,64,8/6/2018
5BC2F4,executive-appointment,100,54,8/6/2018
5C2A47,earnings,100,50,8/6/2018
5D0337,executive-appointment,100,54,8/6/2018
5D0337,buybacks,100,74,8/6/2018
5E1DF3,earnings-up,100,68,8/6/2018
619882,conference-organizer,100,57,8/6/2018
619882,conference-organizer,100,57,8/6/2018
61A586,earnings,100,50,8/6/2018
633043,earnings,100,50,8/6/2018
64854A,earnings,100,50,8/6/2018
64FF65,earnings,100,50,8/6/2018
67303E,partnership,100,61,8/6/2018
67303E,partnership,100,61,8/6/2018
67303E,partnership,100,61,8/6/2018
67303E,partnership,100,61,8/6/2018
6925EB,conference-participant,100,50,8/6/2018
6A171E,earnings,100,50,8/6/2018
6A3C35,note-sale,100,52,8/6/2018
6A3C35,public-offering,100,43,8/6/2018
6BC6F9,revenue-up,100,71,8/6/2018
6BC6F9,revenues,100,50,8/6/2018
6BC6F9,revenues,100,50,8/6/2018
6BD606,earnings-positive,100,69,8/6/2018
6CF43C,executive-appointment,100,54,8/6/2018
6D0CAB,earnings,100,50,8/6/2018
6E705B,executive-appointment,100,54,8/6/2018
6F0096,acquisition-acquirer,100,49,8/6/2018
6F39FC,earnings,100,50,8/6/2018
6F39FC,executive-appointment,100,54,8/6/2018
71E2EF,unit-acquisition-acquiree,100,76,8/6/2018
73C521,executive-appointment,100,54,8/6/2018
73F70F,conference-call,100,50,8/6/2018
7.44E+09,earnings,100,50,8/6/2018
762A3E,conference-organizer,100,57,8/6/2018
7712CB,earnings,100,50,8/6/2018
7712CB,market-entry,100,57,8/6/2018
7712CB,market-entry,100,57,8/6/2018
7712CB,earnings,100,50,8/6/2018
7712CB,earnings,100,50,8/6/2018
7712CB,earnings,100,50,8/6/2018
7712CB,earnings,100,50,8/6/2018
7712CB,earnings,100,50,8/6/2018
77B8E9,clinical-trials-start,100,64,8/6/2018
797C20,earnings,100,50,8/6/2018
7999F3,note-sale,100,52,8/6/2018
7999F3,note-sale,100,52,8/6/2018
7999F3,note-sale,100,52,8/6/2018
7A51FE,buybacks,100,74,8/6/2018
7A51FE,earnings,100,50,8/6/2018
7B1156,earnings,100,50,8/6/2018
7C790D,earnings,100,50,8/6/2018
7D5384,investment-investor,100,55,8/6/2018
7DA412,public-offering,100,43,8/6/2018
7F3A5F,partnership,100,61,8/6/2018
82C202,earnings,100,50,8/6/2018
83066C,earnings,100,50,8/6/2018
858942,earnings,100,50,8/6/2018
85DA04,earnings,100,50,8/6/2018
85DA04,earnings,100,50,8/6/2018
85DA04,earnings,100,50,8/6/2018
85DA04,earnings,100,50,8/6/2018
890FF4,executive-appointment,100,54,8/6/2018
890FF4,earnings,100,50,8/6/2018
890FF4,earnings,100,50,8/6/2018
890FF4,earnings,100,50,8/6/2018
890FF4,earnings,100,50,8/6/2018
890FF4,earnings,100,50,8/6/2018
890FF4,earnings,100,50,8/6/2018
8B9B3B,earnings,100,50,8/6/2018
8B9B3B,public-offering,100,43,8/6/2018
8E3F58,earnings,100,50,8/6/2018
9087B9,earnings,100,50,8/6/2018
91E5EE,earnings,100,50,8/6/2018
92D230,conference-call,100,50,8/6/2018
9368BE,earnings,100,50,8/6/2018
93D207,executive-appointment,100,54,8/6/2018
957A07,executive-appointment,100,54,8/6/2018
957A07,earnings,100,50,8/6/2018
968103,partnership,100,61,8/6/2018
968103,partnership,100,61,8/6/2018
979451,note-sale,100,52,8/6/2018
97B027,dividend,100,50,8/6/2018
97B027,earnings-up,100,68,8/6/2018
97B027,earnings-up,100,68,8/6/2018
97B027,earnings-up,100,68,8/6/2018
98CEBB,earnings,100,50,8/6/2018
98CEBB,business-contract,100,69,8/6/2018
9C5BA5,earnings,100,50,8/6/2018
9CE4C7,award,100,58,8/6/2018
9E4A5F,executive-appointment,100,54,8/6/2018
9F71E5,note-sale,100,52,8/6/2018
9FD2D9,earnings,100,50,8/6/2018
9FD2D9,earnings,100,50,8/6/2018
9FD2D9,earnings,100,50,8/6/2018
A204A7,expenses-down,100,61,8/6/2018
A495F7,earnings,100,50,8/6/2018
A5151E,executive-appointment,100,54,8/6/2018
A5195E,fast-track-designation,100,81,8/6/2018
A5A4F5,acquisition-acquirer,100,49,8/6/2018
A631A3,award,100,58,8/6/2018
A63387,dividend,100,50,8/6/2018
A7102F,earnings-up,100,68,8/6/2018
A7102F,earnings,100,50,8/6/2018
A7102F,earnings,100,50,8/6/2018
A7102F,earnings,100,50,8/6/2018
A7102F,earnings,100,50,8/6/2018
A871B0,earnings,100,50,8/6/2018
A8FDE8,buybacks,100,74,8/6/2018
AA98ED,executive-appointment,100,54,8/6/2018
AC642C,note-sale,100,52,8/6/2018
AC642C,note-sale,100,52,8/6/2018
ACD9A4,dividend,100,50,8/6/2018
ACF0B4,earnings,100,50,8/6/2018
AD375D,credit-extension-recipient,100,69,8/6/2018
ADF092,business-contract,100,69,8/6/2018
AF93DE,earnings,100,50,8/6/2018
B01111,facility-open,100,65,8/6/2018
B0D41A,earnings,100,50,8/6/2018
B106FA,earnings,100,50,8/6/2018
B1DF3C,earnings,100,50,8/6/2018
B1FC3B,business-contract,100,69,8/6/2018
B37FB4,executive-appointment,100,54,8/6/2018
B4C673,partnership,100,61,8/6/2018
B642E8,earnings,100,50,8/6/2018
B642E8,earnings,100,50,8/6/2018
B642E8,earnings,100,50,8/6/2018
B642E8,earnings,100,50,8/6/2018
B642E8,earnings,100,50,8/6/2018
B66928,executive-appointment,100,54,8/6/2018
B73395,earnings,100,50,8/6/2018
B73395,earnings,100,50,8/6/2018
B73395,earnings,100,50,8/6/2018
B73395,earnings,100,50,8/6/2018
B73395,earnings,100,50,8/6/2018
B73395,earnings,100,50,8/6/2018
B934BF,earnings-per-share-up,100,68,8/6/2018
B96637,conference-participant,100,50,8/6/2018
B9CD50,earnings,100,50,8/6/2018
BAD9EA,business-contract,100,69,8/6/2018
BB0587,earnings,100,50,8/6/2018
BB5271,partnership,100,61,8/6/2018
BBBB41,conference-participant,100,50,8/6/2018
BCC13E,revenues,100,50,8/6/2018
BCC13E,revenues,100,50,8/6/2018
BE5935,earnings,100,50,8/6/2018
C0200F,executive-resignation,100,44,8/6/2018
C11C46,revenue-up,100,76,8/6/2018
C11C46,revenue-up,100,69,8/6/2018
C11C46,revenue-up,100,69,8/6/2018
C3BCD5,earnings,100,50,8/6/2018
C50B26,earnings,100,50,8/6/2018
C85A72,public-offering,100,43,8/6/2018
C9D866,conference-participant,100,50,8/6/2018
CAC8D0,earnings-guidance,100,50,8/6/2018
CAC8D0,earnings-guidance,100,50,8/6/2018
CC3EC4,earnings,100,50,8/6/2018
CDD75E,legal-issues-defendant,100,22,8/6/2018
CDD75E,legal-issues-defendant,100,22,8/6/2018
CE5C6E,earnings,100,50,8/6/2018
CFD4B6,product-release,100,64,8/6/2018
D03C7A,earnings,100,50,8/6/2018
D25249,note-sale,100,52,8/6/2018
D57D99,earnings-meet-expectations,100,59,8/6/2018
D6489C,award,100,58,8/6/2018
D64EDF,earnings-above-expectations,100,88,8/6/2018
D64EDF,earnings,100,50,8/6/2018
D64EDF,earnings,100,50,8/6/2018
D64EDF,earnings,100,50,8/6/2018
D81463,earnings,100,50,8/6/2018
D81463,dividend,100,50,8/6/2018
D9E036,acquisition-completed-acquirer,100,49,8/6/2018
D9E036,earnings-positive,100,69,8/6/2018
D9E036,earnings,100,50,8/6/2018
D9E036,earnings,100,50,8/6/2018
D9E036,earnings,100,50,8/6/2018
DA91AE,earnings,100,50,8/6/2018
DB23C8,conference-participant,100,50,8/6/2018
DB5CA5,partnership,100,61,8/6/2018
DBFB51,earnings,100,50,8/6/2018
DDEA6A,business-contract,100,69,8/6/2018
DDEA6A,executive-appointment,100,54,8/6/2018
DE5611,conference-participant,100,50,8/6/2018
DF1F7A,earnings,100,50,8/6/2018
DF8855,business-combination,100,54,8/6/2018
DF8855,business-combination,100,54,8/6/2018
DF8855,business-combination,100,54,8/6/2018
DF8855,business-combination,100,54,8/6/2018
E09997,earnings,100,50,8/6/2018
E49AA3,product-release,100,64,8/6/2018
E829E8,executive-appointment,100,54,8/6/2018
EA62FC,earnings,100,50,8/6/2018
ED7F13,earnings,100,50,8/6/2018
EE04F0,conference-call,100,50,8/6/2018
EE6F1C,business-contract,100,69,8/6/2018
EE967B,earnings,100,50,8/6/2018
EF25A5,note-sale,100,52,8/6/2018
EFA7B2,legal-issues-defendant,100,22,8/6/2018
F179ED,earnings,100,50,8/6/2018
F179ED,earnings,100,50,8/6/2018
F179ED,earnings,100,50,8/6/2018
F179ED,earnings,100,50,8/6/2018
F3016C,conference-participant,100,50,8/6/2018
F3FCC3,dividend,100,50,8/6/2018
F44EA2,earnings,100,50,8/6/2018
F4F46F,partnership,100,61,8/6/2018
F6A987,earnings-up,100,68,8/6/2018
F9CAF8,dividend,100,50,8/6/2018
FBD92D,earnings-up,100,68,8/6/2018
FBD92D,earnings,100,50,8/6/2018
FBD92D,earnings,100,50,8/6/2018
FD2565,earnings,100,50,8/6/2018
FD554E,earnings,100,50,8/6/2018
FE1A1D,buybacks,100,74,8/6/2018
001F1B,revenues,100,50,8/7/2018
002A99,earnings,100,50,8/7/2018
00698D,executive-appointment,100,54,8/7/2018
0157B1,partnership,100,61,8/7/2018
20751,earnings,100,50,8/7/2018
02870F,facility-open,100,65,8/7/2018
03596A,earnings,100,50,8/7/2018
03FB17,dividend,100,50,8/7/2018
04EB2F,earnings,100,50,8/7/2018
06A456,conference-call,100,50,8/7/2018
06C826,conference-call,100,50,8/7/2018
06C826,conference-call,100,50,8/7/2018
070B45,earnings,100,50,8/7/2018
71860,award,100,58,8/7/2018
09062E,earnings,100,50,8/7/2018
09062E,earnings,100,50,8/7/2018
0919B1,earnings,100,50,8/7/2018
95294,partnership,100,61,8/7/2018
0B400D,earnings-up,100,68,8/7/2018
0C355F,earnings,100,50,8/7/2018
0C355F,earnings,100,50,8/7/2018
0C355F,earnings,100,50,8/7/2018
0C355F,earnings,100,50,8/7/2018
0C6293,executive-appointment,100,54,8/7/2018
0C6293,earnings,100,50,8/7/2018
0C6293,earnings,100,50,8/7/2018
0C6293,earnings,100,50,8/7/2018
0CADBC,earnings,100,50,8/7/2018
0E439E,dividend,100,50,8/7/2018
0FC848,earnings,100,50,8/7/2018
102F04,earnings,100,50,8/7/2018
1080C0,conference-participant,100,50,8/7/2018
108A2B,public-offering,100,43,8/7/2018
1096C6,earnings,100,50,8/7/2018
1272B3,earnings,100,50,8/7/2018
129DC8,executive-appointment,100,54,8/7/2018
138DDE,earnings,100,50,8/7/2018
13C3E0,executive-appointment,100,54,8/7/2018
147098,earnings,100,50,8/7/2018
14833D,earnings,100,50,8/7/2018
14BA06,conference-participant,100,50,8/7/2018
152AB9,earnings,100,50,8/7/2018
154272,earnings,100,50,8/7/2018
15901B,executive-appointment,100,54,8/7/2018
165B86,earnings,100,50,8/7/2018
16B183,fundraising,100,64,8/7/2018
1834C0,earnings,100,50,8/7/2018
1866B2,dividend,100,50,8/7/2018
1880C5,earnings,100,50,8/7/2018
1A2D9F,executive-appointment,100,54,8/7/2018
1AB808,public-offering,100,43,8/7/2018
1CDD1C,earnings,100,50,8/7/2018
1E4FB9,earnings,100,50,8/7/2018
1EBF8D,executive-resignation,100,44,8/7/2018
1F464F,earnings,100,50,8/7/2018
1FC422,legal-issues-defendant,100,22,8/7/2018
20403D,earnings,100,50,8/7/2018
21268E,earnings,100,50,8/7/2018
21268E,conference-participant,100,50,8/7/2018
214051,earnings,100,50,8/7/2018
228D42,partnership,100,61,8/7/2018
24C48B,earnings,100,50,8/7/2018
251988,acquisition-acquirer,100,49,8/7/2018
2571FA,conference-participant,100,50,8/7/2018
28AF37,earnings,100,50,8/7/2018
28B730,earnings,100,50,8/7/2018
2920D5,earnings,100,50,8/7/2018
29A4CC,executive-appointment,100,54,8/7/2018
2ABF77,earnings,100,50,8/7/2018
2ABF77,earnings,100,50,8/7/2018
2B5483,earnings,100,50,8/7/2018
2B8179,earnings,100,50,8/7/2018
2BBE62,earnings,100,50,8/7/2018
2BBE62,earnings,100,50,8/7/2018
2BBE62,earnings,100,50,8/7/2018
2BF36E,earnings,100,50,8/7/2018
2C3348,earnings,100,50,8/7/2018
2C35B5,conference-participant,100,50,8/7/2018
2CC60C,conference-call,100,50,8/7/2018
2EBA55,earnings,100,50,8/7/2018
2F1299,earnings-up,100,68,8/7/2018
2F1299,earnings-up,100,68,8/7/2018
2F1299,earnings-up,100,68,8/7/2018
2F1299,earnings-up,100,68,8/7/2018
2F1299,earnings-up,100,68,8/7/2018
2F1299,earnings-up,100,68,8/7/2018
2F1299,partnership,100,61,8/7/2018
2F960F,earnings,100,50,8/7/2018
31803E,earnings,100,50,8/7/2018
339F20,earnings,100,50,8/7/2018
339F20,earnings,100,50,8/7/2018
34A959,acquisition-completed-acquirer,100,49,8/7/2018
355B19,earnings,100,50,8/7/2018
36A1CB,earnings,100,50,8/7/2018
36A1CB,earnings,100,50,8/7/2018
36C09B,clinical-trials,100,56,8/7/2018
36C09B,earnings,100,50,8/7/2018
36E479,earnings,100,50,8/7/2018
396D7C,conference-participant,100,50,8/7/2018
3B20AB,executive-appointment,100,54,8/7/2018
3C11C4,earnings,100,50,8/7/2018
3C6CCC,earnings,100,50,8/7/2018
3C6CCC,earnings,100,50,8/7/2018
3C6CCC,earnings,100,50,8/7/2018
3C6CCC,earnings,100,50,8/7/2018
3C6CCC,earnings,100,50,8/7/2018
3D7971,dividend,100,50,8/7/2018
3DCECC,earnings,100,50,8/7/2018
3E15F6,dividend,100,50,8/7/2018
3E70FC,earnings,100,50,8/7/2018
3EE65E,earnings,100,50,8/7/2018
3F1C69,earnings,100,50,8/7/2018
4.03E+05,earnings-up,100,68,8/7/2018
4.03E+05,earnings-up,100,68,8/7/2018
4.03E+05,earnings-up,100,68,8/7/2018
4.03E+05,earnings-up,100,68,8/7/2018
4.03E+05,dividend,100,50,8/7/2018
40B903,earnings,100,50,8/7/2018
416291,earnings,100,50,8/7/2018
41C36B,earnings,100,50,8/7/2018
41C528,earnings,100,50,8/7/2018
427F32,executive-appointment,100,54,8/7/2018
448BF3,executive-appointment,100,54,8/7/2018
45444E,legal-issues-defendant,100,22,8/7/2018
45444E,earnings,100,50,8/7/2018
4591D3,revenue-up,100,53,8/7/2018
4591D3,revenues,100,50,8/7/2018
4591D3,revenues,100,50,8/7/2018
4591D3,revenues,100,50,8/7/2018
468DD4,earnings,100,50,8/7/2018
46A16E,earnings,100,50,8/7/2018
485445,business-contract,100,69,8/7/2018
485445,business-contract,100,69,8/7/2018
485445,earnings,100,50,8/7/2018
485445,earnings,100,50,8/7/2018
485445,earnings,100,50,8/7/2018
485445,earnings,100,50,8/7/2018
485445,earnings,100,50,8/7/2018
485445,earnings,100,50,8/7/2018
48F795,earnings,100,50,8/7/2018
4AE584,earnings,100,50,8/7/2018
4BEB48,earnings,100,50,8/7/2018
4BEB48,earnings,100,50,8/7/2018
4BEB48,earnings,100,50,8/7/2018
4BEB48,earnings,100,50,8/7/2018
4C3FE9,earnings,100,50,8/7/2018
4C5CC9,earnings-guidance-up,100,83,8/7/2018
4C5CC9,earnings-guidance-up,100,83,8/7/2018
4C5CC9,earnings-guidance-up,100,83,8/7/2018
4C5CC9,earnings-guidance-up,100,83,8/7/2018
4C92B9,earnings,100,50,8/7/2018
4DD09F,earnings,100,50,8/7/2018
4DD09F,earnings,100,50,8/7/2018
4DD09F,earnings,100,50,8/7/2018
4DD203,earnings,100,50,8/7/2018
4E6F5A,earnings,100,50,8/7/2018
4F0A80,earnings,100,50,8/7/2018
4FCC78,earnings,100,50,8/7/2018
50070E,conference-organizer,100,57,8/7/2018
504FE2,business-contract,100,69,8/7/2018
51B442,earnings,100,50,8/7/2018
52FB2F,earnings,100,50,8/7/2018
52FB2F,earnings,100,50,8/7/2018
52FB2F,earnings,100,50,8/7/2018
52FB2F,earnings,100,50,8/7/2018
545272,earnings,100,50,8/7/2018
5487B1,earnings,100,50,8/7/2018
5487B1,earnings,100,50,8/7/2018
5487B1,earnings,100,50,8/7/2018
5487B1,earnings,100,50,8/7/2018
54F1D2,earnings,100,50,8/7/2018
54F1D2,earnings,100,50,8/7/2018
550D01,earnings,100,50,8/7/2018
56FB7C,earnings,100,50,8/7/2018
583A75,revenue-volume,100,50,8/7/2018
594402,conference-participant,100,50,8/7/2018
59872F,conference-call,100,50,8/7/2018
59A832,earnings,100,50,8/7/2018
5A9A82,earnings,100,50,8/7/2018
5A9A82,earnings,100,50,8/7/2018
5A9A82,earnings,100,50,8/7/2018
5A9A82,earnings,100,50,8/7/2018
5C2A47,earnings,100,50,8/7/2018
5C2A47,conference-participant,100,50,8/7/2018
5CEE02,earnings,100,50,8/7/2018
5E7E82,partnership,100,61,8/7/2018
5EAA43,dividend,100,50,8/7/2018
5F3D91,earnings,100,50,8/7/2018
60FE03,earnings,100,50,8/7/2018
622DBE,earnings,100,50,8/7/2018
62CDDE,earnings,100,50,8/7/2018
63F892,business-contract,100,69,8/7/2018
64636E,earnings,100,50,8/7/2018
64854A,conference-participant,100,50,8/7/2018
6634D9,legal-issues-defendant,100,22,8/7/2018
66749D,dividend,100,50,8/7/2018
6925EB,earnings,100,50,8/7/2018
6B67BD,earnings,100,50,8/7/2018
6BDA0C,dividend-up,100,81,8/7/2018
6BF593,earnings-guidance-up,100,83,8/7/2018
6D2BF6,earnings,100,50,8/7/2018
6D3F35,ipo-completed,100,76,8/7/2018
6D4636,product-release,100,64,8/7/2018
6ED519,dividend,100,50,8/7/2018
6F3FA8,earnings,100,50,8/7/2018
6F3FA8,earnings,100,50,8/7/2018
6F3FA8,earnings,100,50,8/7/2018
6F3FA8,earnings,100,50,8/7/2018
70FCEF,executive-appointment,100,54,8/7/2018
71553E,earnings,100,50,8/7/2018
71E2EF,earnings,100,50,8/7/2018
726EEA,dividend,100,50,8/7/2018
763DBE,earnings,100,50,8/7/2018
76BECC,earnings,100,50,8/7/2018
76BECC,earnings,100,50,8/7/2018
76BECC,earnings,100,50,8/7/2018
76D79A,earnings,100,50,8/7/2018
76E80F,executive-appointment,100,54,8/7/2018
79167B,earnings,100,50,8/7/2018
79167B,earnings,100,50,8/7/2018
79167B,earnings,100,50,8/7/2018
7AB859,executive-appointment,100,54,8/7/2018
7ACD98,earnings,100,50,8/7/2018
7AF5B8,executive-appointment,100,54,8/7/2018
7C4F43,earnings,100,50,8/7/2018
7DA412,public-offering,100,43,8/7/2018
7F3665,earnings,100,50,8/7/2018
7F3A5F,earnings-up,100,68,8/7/2018
7F3A5F,earnings,100,50,8/7/2018
7F3A5F,earnings,100,50,8/7/2018
7F3A5F,earnings,100,50,8/7/2018
7F3A5F,earnings,100,50,8/7/2018
81222C,earnings,100,50,8/7/2018
818A2F,earnings,100,50,8/7/2018
818A2F,dividend,100,50,8/7/2018
8.10E+205,earnings,100,50,8/7/2018
82B57E,earnings,100,50,8/7/2018
82B57E,earnings,100,50,8/7/2018
82B57E,earnings,100,50,8/7/2018
82B57E,earnings,100,50,8/7/2018
82B57E,dividend,100,50,8/7/2018
82E58A,earnings,100,50,8/7/2018
82F088,partnership,100,61,8/7/2018
82F088,earnings,100,50,8/7/2018
83E0AC,earnings,100,50,8/7/2018
85DE00,dividend,100,50,8/7/2018
85DE00,earnings,100,50,8/7/2018
862941,earnings,100,50,8/7/2018
877734,earnings,100,50,8/7/2018
877734,earnings,100,50,8/7/2018
877734,earnings,100,50,8/7/2018
877734,earnings,100,50,8/7/2018
881190,dividend,100,50,8/7/2018
885758,earnings,100,50,8/7/2018
895D56,operating-earnings,100,50,8/7/2018
89E771,earnings,100,50,8/7/2018
8AB37F,revenue-up,100,87,8/7/2018
8AB37F,earnings,100,50,8/7/2018
8B9B3B,public-offering,100,43,8/7/2018
8C311A,earnings,100,50,8/7/2018
8D4486,business-contract,100,69,8/7/2018
8D5145,dividend,100,50,8/7/2018
8DCF18,earnings,100,50,8/7/2018
8DCF18,earnings,100,50,8/7/2018
902255,earnings,100,50,8/7/2018
902255,earnings,100,50,8/7/2018
902255,earnings,100,50,8/7/2018
90D6A5,earnings,100,50,8/7/2018
90D6A5,earnings,100,50,8/7/2018
90D6A5,earnings,100,50,8/7/2018
90D6A5,earnings,100,50,8/7/2018
911CA9,earnings,100,50,8/7/2018
911CA9,earnings,100,50,8/7/2018
925759,earnings,100,50,8/7/2018
92D757,earnings,100,50,8/7/2018
9.31E+77,earnings,100,50,8/7/2018
93D207,investment-investor,100,55,8/7/2018
9470CC,conference-participant,100,50,8/7/2018
9546A5,dividend,100,50,8/7/2018
95A92E,earnings,100,50,8/7/2018
95DC1F,executive-appointment,100,54,8/7/2018
9.65E+09,executive-appointment,100,54,8/7/2018
9.65E+07,earnings,100,50,8/7/2018
9.65E+07,earnings,100,50,8/7/2018
966ACE,conference-participant,100,50,8/7/2018
968103,earnings,100,50,8/7/2018
968B00,dividend,100,50,8/7/2018
97644E,unit-acquisition-acquirer,100,49,8/7/2018
990AD0,dividend,100,50,8/7/2018
9981C6,revenue-up,100,69,8/7/2018
9981C6,revenue-up,100,69,8/7/2018
99DC8D,dividend,100,50,8/7/2018
99DC8D,earnings,100,50,8/7/2018
9B0C9C,earnings,100,50,8/7/2018
9B0C9C,earnings,100,50,8/7/2018
9B0C9C,earnings,100,50,8/7/2018
9B730A,conference-call,100,50,8/7/2018
9C009A,earnings,100,50,8/7/2018
9C25FF,partnership,100,61,8/7/2018
9C25FF,partnership,100,61,8/7/2018
9CA432,earnings,100,50,8/7/2018
9D5FA4,earnings,100,50,8/7/2018
9D65C1,legal-issues-defendant,100,22,8/7/2018
9D65C1,legal-issues-defendant,100,22,8/7/2018
9D65C1,legal-issues-defendant,100,22,8/7/2018
9DDE1B,earnings,100,50,8/7/2018
9DDE1B,earnings,100,50,8/7/2018
9DDE1B,dividend,100,50,8/7/2018
9E0811,earnings,100,50,8/7/2018
9E91C6,executive-appointment,100,54,8/7/2018
9F18FA,earnings,100,50,8/7/2018
9F18FA,earnings,100,50,8/7/2018
A05C43,earnings,100,50,8/7/2018
A05C43,earnings,100,50,8/7/2018
A204A7,earnings,100,50,8/7/2018
A26EF7,earnings,100,50,8/7/2018
A26EF7,earnings,100,50,8/7/2018
A29DBD,earnings,100,50,8/7/2018
A47A7D,product-release,100,64,8/7/2018
A47F2E,public-offering,100,43,8/7/2018
A5195E,earnings,100,50,8/7/2018
A5A4F5,acquisition-acquirer,100,49,8/7/2018
A5DD24,earnings,100,50,8/7/2018
A631A3,partnership,100,61,8/7/2018
A63387,business-contract,100,69,8/7/2018
A6828A,conference-participant,100,50,8/7/2018
A74F6F,revenues,100,50,8/7/2018
A74F6F,revenues,100,50,8/7/2018
A868C9,revenues,100,50,8/7/2018
A868C9,revenues,100,50,8/7/2018
A868C9,revenues,100,50,8/7/2018
AC3584,product-release,100,64,8/7/2018
AC642C,earnings,100,50,8/7/2018
AC642C,earnings,100,50,8/7/2018
AC775C,earnings,100,50,8/7/2018
AC775C,earnings,100,50,8/7/2018
AC775C,earnings,100,50,8/7/2018
AC7AAE,earnings,100,50,8/7/2018
ACC7D3,earnings,100,50,8/7/2018
AD23DE,dividend,100,50,8/7/2018
ADF092,earnings,100,50,8/7/2018
AECCA9,conference-call,100,50,8/7/2018
AEFC90,earnings,100,50,8/7/2018
B0D41A,conference-participant,100,50,8/7/2018
B1DF3C,note-sale,100,52,8/7/2018
B2256A,earnings,100,50,8/7/2018
B2D799,earnings,100,50,8/7/2018
B33E77,earnings,100,50,8/7/2018
B48FC9,revenue-up,100,69,8/7/2018
B48FC9,revenue-up,100,69,8/7/2018
B54A74,earnings,100,50,8/7/2018
B5BA39,executive-appointment,100,54,8/7/2018
B66928,dividend,100,50,8/7/2018
B66928,earnings,100,50,8/7/2018
B66928,earnings,100,50,8/7/2018
B7FA9B,earnings,100,50,8/7/2018
B83BCE,earnings,100,50,8/7/2018
B9764A,earnings,100,50,8/7/2018
BB0787,conference-call,100,50,8/7/2018
BB127B,conference-call,100,50,8/7/2018
BCE9DA,earnings,100,50,8/7/2018
BCE9DA,earnings,100,50,8/7/2018
BCE9DA,earnings,100,50,8/7/2018
BDA775,earnings,100,50,8/7/2018
BDE867,asset-sale,100,62,8/7/2018
BE5935,business-contract,100,69,8/7/2018
C06EB6,earnings,100,50,8/7/2018
C0BA36,earnings,100,50,8/7/2018
C15F8F,earnings,100,50,8/7/2018
C27E19,dividend,100,50,8/7/2018
C2E39B,earnings,100,50,8/7/2018
C2E426,earnings,100,50,8/7/2018
C3BCD5,legal-issues-defendant,100,22,8/7/2018
C407A0,earnings,100,50,8/7/2018
C45C1F,conference-participant,100,50,8/7/2018
C4F9C6,earnings,100,50,8/7/2018
C584BE,earnings,100,50,8/7/2018
C659EB,conference-participant,100,50,8/7/2018
C74887,conference-participant,100,50,8/7/2018
C8257F,award,100,58,8/7/2018
C9E04B,earnings,100,50,8/7/2018
CAB222,earnings,100,50,8/7/2018
CB7AB2,earnings,100,50,8/7/2018
CB89EA,earnings,100,50,8/7/2018
CBFFDD,legal-issues-defendant,100,22,8/7/2018
CDD75E,legal-issues-defendant,100,22,8/7/2018
CE1002,unit-acquisition-acquirer,100,49,8/7/2018
CE5664,earnings,100,50,8/7/2018
CE5664,earnings,100,50,8/7/2018
CE5664,earnings,100,50,8/7/2018
CE96E7,partnership,100,61,8/7/2018
CFD4B6,conference-participant,100,50,8/7/2018
CFF15D,business-contract,100,69,8/7/2018
CFF57D,market-entry,100,57,8/7/2018
D20C8F,note-sale,100,52,8/7/2018
D20C8F,note-sale,100,52,8/7/2018
D20C8F,note-sale,100,52,8/7/2018
D2B9E5,note-sale,100,52,8/7/2018
D3CEDF,earnings,100,50,8/7/2018
D3CEDF,earnings,100,50,8/7/2018
D3CEDF,earnings,100,50,8/7/2018
D3CEDF,earnings,100,50,8/7/2018
D3FA2C,earnings,100,50,8/7/2018
D45285,earnings,100,50,8/7/2018
D58A11,conference-participant,100,50,8/7/2018
D63B0F,earnings,100,50,8/7/2018
D63B0F,earnings,100,50,8/7/2018
D63B0F,earnings,100,50,8/7/2018
D63B0F,dividend,100,50,8/7/2018
D64EDF,note-sale,100,52,8/7/2018
D6EAA3,earnings,100,50,8/7/2018
D6EAA3,earnings,100,50,8/7/2018
D6EAA3,earnings,100,50,8/7/2018
D6EAA3,earnings,100,50,8/7/2018
D6EAA3,earnings,100,50,8/7/2018
D6EAA3,product-release,100,64,8/7/2018
D78BF1,award,100,58,8/7/2018
D7A953,partnership,100,61,8/7/2018
D8C09D,earnings,100,50,8/7/2018
D90441,earnings,100,50,8/7/2018
DB396B,acquisition-completed-acquirer,100,49,8/7/2018
DC0998,executive-appointment,100,54,8/7/2018
DC1405,earnings,100,50,8/7/2018
DCD97F,executive-appointment,100,54,8/7/2018
DD682D,earnings,100,50,8/7/2018
DDEA6A,operating-earnings,100,50,8/7/2018
DDEA6A,legal-issues-defendant,100,22,8/7/2018
DEF058,earnings,100,50,8/7/2018
DEF058,earnings-up,100,68,8/7/2018
DEF058,earnings-up,100,68,8/7/2018
DF01B1,earnings,100,50,8/7/2018
DF01B1,earnings,100,50,8/7/2018
DF01B1,earnings,100,50,8/7/2018
DF01B1,earnings,100,50,8/7/2018
DF42A0,dividend,100,50,8/7/2018
DF42A0,earnings-up,100,68,8/7/2018
DF5F14,earnings,100,50,8/7/2018
E13782,earnings,100,50,8/7/2018
E206B0,executive-resignation,100,44,8/7/2018
E41190,earnings,100,50,8/7/2018
E41190,earnings,100,50,8/7/2018
E41190,earnings,100,50,8/7/2018
E41190,earnings,100,50,8/7/2018
E41190,earnings,100,50,8/7/2018
E74B55,partnership,100,61,8/7/2018
E74B55,earnings,100,50,8/7/2018
E96E0B,earnings,100,50,8/7/2018
E9C7C0,partnership,100,61,8/7/2018
EA79C7,earnings,100,50,8/7/2018
EAA0A7,earnings,100,50,8/7/2018
EAA0A7,earnings,100,50,8/7/2018
EAA0A7,earnings,100,50,8/7/2018
EAA0A7,earnings,100,50,8/7/2018
EAA0A7,executive-appointment,100,54,8/7/2018
EBD89A,conference-participant,100,50,8/7/2018
EC1AF3,earnings,100,50,8/7/2018
ED4560,earnings,100,50,8/7/2018
ED7F13,public-offering,100,43,8/7/2018
EEA734,earnings,100,50,8/7/2018
F00285,earnings,100,50,8/7/2018
F02170,earnings,100,50,8/7/2018
F1EB39,conference-participant,100,50,8/7/2018
F2E253,earnings,100,50,8/7/2018
F2E253,earnings,100,50,8/7/2018
F2E253,earnings,100,50,8/7/2018
F2E253,earnings,100,50,8/7/2018
F2E253,earnings,100,50,8/7/2018
F2E253,earnings,100,50,8/7/2018
F3016C,earnings-up,100,68,8/7/2018
F3016C,earnings,100,50,8/7/2018
F3016C,earnings,100,50,8/7/2018
F3016C,earnings,100,50,8/7/2018
F47871,earnings,100,50,8/7/2018
F4D241,earnings,100,50,8/7/2018
F5C8AB,earnings-per-share-positive,100,69,8/7/2018
F5C8AB,earnings-per-share,100,50,8/7/2018
F5C8AB,earnings-per-share,100,50,8/7/2018
F88A04,dividend,100,50,8/7/2018
F9AA02,earnings,100,50,8/7/2018
FB728F,earnings,100,50,8/7/2018
FB7724,earnings-up,100,68,8/7/2018
FC9A88,executive-appointment,100,54,8/7/2018
FDD3FC,earnings,100,50,8/7/2018
FE609F,conference-call,100,50,8/7/2018
FEC475,dividend,100,50,8/7/2018
FFCD0E,earnings,100,50,8/7/2018
0157B1,product-release,100,64,8/8/2018
20751,conference-participant,100,50,8/8/2018
02FC1A,earnings,100,50,8/8/2018
02FC1A,earnings,100,50,8/8/2018
06C826,earnings,100,50,8/8/2018
06C826,earnings,100,50,8/8/2018
083F72,earnings,100,50,8/8/2018
0BC29E,executive-appointment,100,54,8/8/2018
0BD4E8,earnings,100,50,8/8/2018
0BD4E8,earnings,100,50,8/8/2018
0BD4E8,earnings,100,50,8/8/2018
0BD4E8,earnings,100,50,8/8/2018
0BD970,earnings,100,50,8/8/2018
0C6861,earnings,100,50,8/8/2018
0CCCB7,dividend,100,50,8/8/2018
0CE204,earnings,100,50,8/8/2018
0DBB81,earnings,100,50,8/8/2018
0DE3D5,operating-earnings,100,50,8/8/2018
0E499E,conference-participant,100,50,8/8/2018
0E5619,earnings,100,50,8/8/2018
0F0693,earnings,100,50,8/8/2018
0F2BC9,public-offering,100,43,8/8/2018
108A2B,public-offering,100,43,8/8/2018
11A49E,earnings,100,50,8/8/2018
1279ED,earnings,100,50,8/8/2018
12E454,legal-issues-defendant,100,22,8/8/2018
131443,buybacks,100,74,8/8/2018
13D576,buybacks,100,74,8/8/2018
147C38,earnings,100,50,8/8/2018
15789A,earnings-up,100,68,8/8/2018
165B86,conference-participant,100,50,8/8/2018
16B183,business-contract,100,69,8/8/2018
16B183,business-contract,100,69,8/8/2018
1866B2,earnings,100,50,8/8/2018
18D9FA,public-offering,100,43,8/8/2018
1921DD,unit-acquisition-acquiree,100,76,8/8/2018
196D18,conference-participant,100,50,8/8/2018
197019,business-contract,100,69,8/8/2018
1AB023,earnings,100,50,8/8/2018
1AB023,earnings,100,50,8/8/2018
1AB023,earnings,100,50,8/8/2018
1AB808,public-offering,100,43,8/8/2018
1AD9CC,revenues,100,50,8/8/2018
1B16C1,earnings,100,50,8/8/2018
1BC12C,product-release,100,64,8/8/2018
1C599A,earnings,100,50,8/8/2018
1C599A,executive-appointment,100,54,8/8/2018
1CB9D3,earnings,100,50,8/8/2018
1CD4B5,earnings,100,50,8/8/2018
1DB6A6,dividend,100,50,8/8/2018
1E7785,earnings,100,50,8/8/2018
1E7785,earnings,100,50,8/8/2018
1E7785,earnings,100,50,8/8/2018
1E7785,earnings,100,50,8/8/2018
1E7785,earnings,100,50,8/8/2018
1E7785,earnings,100,50,8/8/2018
2003A5,earnings,100,50,8/8/2018
200D8B,earnings,100,50,8/8/2018
200D8B,earnings,100,50,8/8/2018
200D8B,earnings,100,50,8/8/2018
202E5A,earnings,100,50,8/8/2018
2082EA,earnings,100,50,8/8/2018
221783,earnings,100,50,8/8/2018
221783,earnings,100,50,8/8/2018
221783,earnings,100,50,8/8/2018
221783,earnings,100,50,8/8/2018
228D42,business-contract,100,69,8/8/2018
24CB56,conference-participant,100,50,8/8/2018
2571FA,acquisition-completed-acquirer,100,49,8/8/2018
263216,revenues,100,50,8/8/2018
263216,revenues,100,50,8/8/2018
263216,revenues,100,50,8/8/2018
263216,revenues,100,50,8/8/2018
263216,revenues,100,50,8/8/2018
263216,revenues,100,50,8/8/2018
27B191,dividend,100,50,8/8/2018
27B191,earnings,100,50,8/8/2018
27B191,earnings,100,50,8/8/2018
2BDC1C,earnings,100,50,8/8/2018
2C681C,earnings,100,50,8/8/2018
2C681C,earnings,100,50,8/8/2018
2E1322,earnings,100,50,8/8/2018
2E1322,product-release,100,64,8/8/2018
2E61CC,executive-appointment,100,54,8/8/2018
2E61CC,executive-appointment,100,54,8/8/2018
315EB0,earnings,100,50,8/8/2018
315EB0,earnings,100,50,8/8/2018
315EB0,earnings,100,50,8/8/2018
315EB0,earnings,100,50,8/8/2018
315EB0,earnings,100,50,8/8/2018
315EB0,earnings,100,50,8/8/2018
315EB0,dividend,100,50,8/8/2018
31643A,earnings,100,50,8/8/2018
31AA84,earnings,100,50,8/8/2018
31AA84,earnings,100,50,8/8/2018
31AA84,earnings,100,50,8/8/2018
326EDD,public-offering,100,43,8/8/2018
326EDD,public-offering,100,43,8/8/2018
326EDD,public-offering,100,43,8/8/2018
32F943,earnings,100,50,8/8/2018
3471C0,earnings,100,50,8/8/2018
3587B4,dividend,100,50,8/8/2018
396D7C,earnings,100,50,8/8/2018
3A3447,facility-open,100,65,8/8/2018
3BB616,partnership,100,61,8/8/2018
3D6933,note-sale,100,52,8/8/2018
3D6933,note-sale,100,52,8/8/2018
3D7971,earnings,100,50,8/8/2018
3D7971,earnings,100,50,8/8/2018
3D7971,earnings,100,50,8/8/2018
3D7971,earnings,100,50,8/8/2018
3D7971,earnings,100,50,8/8/2018
3D7971,earnings,100,50,8/8/2018
3DCECC,acquisition-acquirer,100,49,8/8/2018
3E39A5,revenues,100,50,8/8/2018
4017AD,earnings,100,50,8/8/2018
41B53E,earnings,100,50,8/8/2018
41B53E,earnings,100,50,8/8/2018
41B53E,earnings,100,50,8/8/2018
41ED98,earnings,100,50,8/8/2018
448215,earnings,100,50,8/8/2018
448BF3,earnings,100,50,8/8/2018
45444E,legal-issues-defendant,100,22,8/8/2018
4806CE,facility-open,100,65,8/8/2018
490D4B,executive-appointment,100,54,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,earnings-positive,100,69,8/8/2018
4.91E+58,partnership,100,61,8/8/2018
4C37C5,partnership,100,61,8/8/2018
4D229C,earnings,100,50,8/8/2018
4D72C8,earnings,100,50,8/8/2018
4EC4C1,stake-acquirer,100,48,8/8/2018
4EC4C1,stake-acquirer,100,48,8/8/2018
4EE14A,earnings,100,50,8/8/2018
4EE14A,earnings,100,50,8/8/2018
5065B1,earnings,100,50,8/8/2018
50D1EC,earnings,100,50,8/8/2018
510EA1,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
52D936,earnings,100,50,8/8/2018
5340D0,earnings,100,50,8/8/2018
53EF9E,dividend,100,50,8/8/2018
54DF47,earnings,100,50,8/8/2018
54F271,public-offering,100,43,8/8/2018
55CD6F,operating-earnings,100,50,8/8/2018
57EF50,earnings-up,100,68,8/8/2018
5A64D5,executive-appointment,100,54,8/8/2018
5B226B,revenue-up,100,78,8/8/2018
5B226B,revenue-up,100,78,8/8/2018
5B226B,revenue-up,100,78,8/8/2018
5B3FA2,earnings,100,50,8/8/2018
5D63F1,earnings,100,50,8/8/2018
5DD486,dividend,100,50,8/8/2018
5EAA43,earnings,100,50,8/8/2018
5F3E74,earnings,100,50,8/8/2018
620381,conference-participant,100,50,8/8/2018
649CBD,earnings,100,50,8/8/2018
649CBD,earnings,100,50,8/8/2018
649CBD,earnings,100,50,8/8/2018
6634D9,earnings,100,50,8/8/2018
6634D9,legal-issues-defendant,100,22,8/8/2018
676FFD,earnings,100,50,8/8/2018
68AB62,earnings,100,50,8/8/2018
694749,earnings,100,50,8/8/2018
694749,earnings,100,50,8/8/2018
694749,earnings,100,50,8/8/2018
694749,earnings,100,50,8/8/2018
694749,executive-appointment,100,54,8/8/2018
69C99E,earnings,100,50,8/8/2018
69CE71,earnings,100,50,8/8/2018
69CE71,earnings,100,50,8/8/2018
69CE71,earnings,100,50,8/8/2018
69CE71,earnings,100,50,8/8/2018
69CE71,earnings,100,50,8/8/2018
69CE71,earnings,100,50,8/8/2018
69CE71,earnings,100,50,8/8/2018
6B0E45,public-offering,100,43,8/8/2018
6DDA15,earnings,100,50,8/8/2018
6DDA15,earnings,100,50,8/8/2018
6DDA15,earnings,100,50,8/8/2018
6DDA15,earnings,100,50,8/8/2018
6DDA15,earnings,100,50,8/8/2018
6DDA15,earnings,100,50,8/8/2018
6F22E7,earnings,100,50,8/8/2018
71B0CF,conference-participant,100,50,8/8/2018
7262F2,earnings,100,50,8/8/2018
726DDF,earnings,100,50,8/8/2018
7.45E+28,earnings,100,50,8/8/2018
747219,dividend,100,50,8/8/2018
756045,earnings,100,50,8/8/2018
790D0D,dividend,100,50,8/8/2018
7BAAE7,executive-appointment,100,54,8/8/2018
7C4F43,conference-participant,100,50,8/8/2018
7D85A9,award,100,58,8/8/2018
7DD8CC,earnings,100,50,8/8/2018
7E1D5D,earnings,100,50,8/8/2018
7FD8B9,earnings,100,50,8/8/2018
817ED9,executive-appointment,100,54,8/8/2018
85DA04,award,100,58,8/8/2018
8614A2,earnings-up,100,68,8/8/2018
8614A2,earnings,100,50,8/8/2018
8614A2,earnings,100,50,8/8/2018
8614A2,earnings,100,50,8/8/2018
86BAC7,dividend,100,50,8/8/2018
8.79E+06,earnings,100,50,8/8/2018
883D82,earnings,100,50,8/8/2018
88611B,earnings,100,50,8/8/2018
88923D,award,100,58,8/8/2018
88923D,award,100,58,8/8/2018
8A8E41,partnership,100,61,8/8/2018
8BFAA4,earnings,100,50,8/8/2018
8BFAA4,earnings,100,50,8/8/2018
8BFAA4,earnings,100,50,8/8/2018
8D4AE6,dividend,100,50,8/8/2018
8E10BF,earnings,100,50,8/8/2018
92D757,executive-appointment,100,54,8/8/2018
92D757,dividend,100,50,8/8/2018
9.39E+69,conference-participant,100,50,8/8/2018
943239,earnings,100,50,8/8/2018
943239,earnings,100,50,8/8/2018
944B2E,earnings,100,50,8/8/2018
944B2E,earnings,100,50,8/8/2018
944B2E,earnings,100,50,8/8/2018
944B2E,earnings,100,50,8/8/2018
944B2E,earnings,100,50,8/8/2018
944B2E,earnings,100,50,8/8/2018
944B2E,earnings,100,50,8/8/2018
949625,earnings,100,50,8/8/2018
958938,earnings,100,50,8/8/2018
9592FB,earnings,100,50,8/8/2018
95DC1F,executive-appointment,100,54,8/8/2018
966DBE,earnings,100,50,8/8/2018
966DBE,earnings,100,50,8/8/2018
966DBE,earnings,100,50,8/8/2018
966DBE,earnings,100,50,8/8/2018
966DBE,earnings,100,50,8/8/2018
9673BD,earnings,100,50,8/8/2018
96A6CD,earnings,100,50,8/8/2018
97644E,earnings,100,50,8/8/2018
97644E,earnings,100,50,8/8/2018
97644E,earnings,100,50,8/8/2018
97644E,earnings,100,50,8/8/2018
97AF94,earnings,100,50,8/8/2018
99ACAD,earnings,100,50,8/8/2018
99ACAD,earnings,100,50,8/8/2018
9ABD30,earnings,100,50,8/8/2018
9B730A,earnings,100,50,8/8/2018
9B730A,public-offering,100,43,8/8/2018
9BB35A,earnings,100,50,8/8/2018
9BB35A,earnings,100,50,8/8/2018
9BB35A,earnings,100,50,8/8/2018
9BB35A,earnings,100,50,8/8/2018
9BB35A,earnings,100,50,8/8/2018
9D307D,executive-appointment,100,54,8/8/2018
9D65C1,legal-issues-defendant,100,22,8/8/2018
9D65C1,legal-issues-defendant,100,22,8/8/2018
9D65C1,legal-issues-defendant,100,22,8/8/2018
9D65C1,fraud-defendant,100,20,8/8/2018
9EBAFA,earnings,100,50,8/8/2018
9F5CBB,earnings,100,50,8/8/2018
A072C4,earnings,100,50,8/8/2018
A247F5,business-contract,100,69,8/8/2018
A28675,earnings,100,50,8/8/2018
A47F2E,public-offering,100,43,8/8/2018
A5A4F5,acquisition-acquirer,100,49,8/8/2018
A5A4F5,product-release,100,64,8/8/2018
A63387,earnings,100,50,8/8/2018
A63387,earnings,100,50,8/8/2018
A63387,earnings,100,50,8/8/2018
A63387,earnings,100,50,8/8/2018
AAC8B6,earnings,100,50,8/8/2018
ACF0B4,earnings,100,50,8/8/2018
AD23DE,business-contract,100,69,8/8/2018
AE4125,earnings,100,50,8/8/2018
AFF7B4,conference-participant,100,50,8/8/2018
B01215,conference-call,100,50,8/8/2018
B13B68,earnings,100,50,8/8/2018
B2E6B5,dividend,100,50,8/8/2018
B2E6B5,earnings,100,50,8/8/2018
B2E6B5,earnings,100,50,8/8/2018
B2E6B5,earnings,100,50,8/8/2018
B37FB4,executive-appointment,100,54,8/8/2018
B37FB4,dividend,100,50,8/8/2018
B3A166,earnings,100,50,8/8/2018
B4703C,partnership,100,61,8/8/2018
B7202A,earnings,100,50,8/8/2018
B803B1,earnings,100,50,8/8/2018
B80AD1,conference-participant,100,50,8/8/2018
B83BCE,executive-appointment,100,54,8/8/2018
B8EF97,revenues,100,50,8/8/2018
B8F71F,dividend,100,50,8/8/2018
BAAA60,earnings,100,50,8/8/2018
BAD655,earnings,100,50,8/8/2018
BB127B,executive-appointment,100,54,8/8/2018
BD44C9,earnings,100,50,8/8/2018
BDE867,dividend,100,50,8/8/2018
BFD0A7,product-release,100,64,8/8/2018
C1114B,earnings,100,50,8/8/2018
C1114B,earnings,100,50,8/8/2018
C1114B,earnings,100,50,8/8/2018
C2DD02,earnings,100,50,8/8/2018
C2E120,earnings,100,50,8/8/2018
C36189,earnings,100,50,8/8/2018
C3EE99,conference-call,100,50,8/8/2018
C3F99F,earnings,100,50,8/8/2018
C45CE7,dividend,100,50,8/8/2018
C5E100,earnings,100,50,8/8/2018
C5E100,earnings,100,50,8/8/2018
C62AA4,earnings,100,50,8/8/2018
C66B44,earnings,100,50,8/8/2018
C83B88,product-release,100,64,8/8/2018
CA212F,earnings,100,50,8/8/2018
CA99D7,earnings,100,50,8/8/2018
CBDB4D,earnings,100,50,8/8/2018
CBFFDD,legal-issues-defendant,100,22,8/8/2018
CBFFDD,legal-issues-defendant,100,22,8/8/2018
CC0C78,regulatory-product-approval-granted,100,81,8/8/2018
CC35BE,earnings,100,50,8/8/2018
CC35BE,earnings,100,50,8/8/2018
CC35BE,earnings,100,50,8/8/2018
CC35BE,earnings,100,50,8/8/2018
CC35BE,earnings,100,50,8/8/2018
CCB623,earnings,100,50,8/8/2018
CCB623,executive-appointment,100,54,8/8/2018
CDD75E,executive-appointment,100,54,8/8/2018
CDE118,dividend,100,50,8/8/2018
CE2791,unit-acquisition-acquirer,100,49,8/8/2018
CE2791,earnings,100,50,8/8/2018
CF6A5A,dividend,100,50,8/8/2018
CFF97C,credit-rating-upgrade-rater,20,50,8/8/2018
D09938,earnings,100,50,8/8/2018
D2C0B6,earnings,100,50,8/8/2018
D4070C,partnership,100,61,8/8/2018
D58A11,earnings,100,50,8/8/2018
D58A11,earnings,100,50,8/8/2018
D58A11,earnings,100,50,8/8/2018
D5A350,dividend,100,50,8/8/2018
D6144F,conference-participant,100,50,8/8/2018
D6144F,earnings,100,50,8/8/2018
D8ECA1,legal-issues-dismissed-defendant,100,79,8/8/2018
DA91AE,executive-appointment,100,54,8/8/2018
DAFED3,dividend,100,50,8/8/2018
DB2E4E,earnings,100,50,8/8/2018
DB9F70,earnings,100,50,8/8/2018
DF18E6,earnings,100,50,8/8/2018
DF204B,earnings-up,100,68,8/8/2018
DF204B,revenue-up,100,69,8/8/2018
DF204B,revenue-up,100,69,8/8/2018
DF6FDD,earnings,100,50,8/8/2018
DFADDB,earnings,100,50,8/8/2018
E0647D,earnings,100,50,8/8/2018
E0647D,earnings,100,50,8/8/2018
E0647D,earnings,100,50,8/8/2018
E0647D,earnings,100,50,8/8/2018
E0647D,earnings,100,50,8/8/2018
E15736,earnings,100,50,8/8/2018
E15736,earnings,100,50,8/8/2018
E20392,earnings,100,50,8/8/2018
E35610,conference-participant,100,50,8/8/2018
E3E68E,market-entry,100,57,8/8/2018
E5752F,earnings,100,50,8/8/2018
E5752F,earnings,100,50,8/8/2018
E5752F,earnings,100,50,8/8/2018
E5752F,earnings,100,50,8/8/2018
E5752F,earnings,100,50,8/8/2018
E610CD,earnings,100,50,8/8/2018
E610CD,earnings,100,50,8/8/2018
E68E62,earnings,100,50,8/8/2018
E69BA5,dividend,100,50,8/8/2018
E71AE6,earnings,100,50,8/8/2018
E866D2,revenue-volume,100,50,8/8/2018
E8C557,earnings,100,50,8/8/2018
E8E899,partnership,100,61,8/8/2018
ED79D9,product-release,100,64,8/8/2018
ED7F13,public-offering,100,43,8/8/2018
EF25A5,partnership,100,61,8/8/2018
EF5914,earnings,100,50,8/8/2018
F3816D,earnings,100,50,8/8/2018
F5349B,earnings,100,50,8/8/2018
F5349B,dividend,100,50,8/8/2018
F58C23,conference-participant,100,50,8/8/2018
F6DA75,earnings,100,50,8/8/2018
F90EE5,dividend,100,50,8/8/2018
FC80E6,dividend,100,50,8/8/2018
FE609F,private-placement,100,56,8/8/2018
FF227B,earnings,100,50,8/8/2018
FF227B,conference-participant,100,50,8/8/2018
FF5413,dividend,100,50,8/8/2018
00067A,asset-sale,100,62,8/9/2018
00698D,conference-call,100,50,8/9/2018
02ACBD,earnings,100,50,8/9/2018
036C6F,earnings-up,100,68,8/9/2018
036C6F,earnings-up,100,68,8/9/2018
036C6F,earnings-up,100,68,8/9/2018
0490C6,earnings,100,50,8/9/2018
0490C6,earnings,100,50,8/9/2018
0490C6,earnings,100,50,8/9/2018
04CCCD,revenue-up,100,69,8/9/2018
71860,award,100,58,8/9/2018
07CA6A,acquisition-completed-acquirer,100,49,8/9/2018
099C88,dividend,100,50,8/9/2018
0A9D0A,earnings,100,50,8/9/2018
0B4D10,dividend,100,50,8/9/2018
0B7375,earnings,100,50,8/9/2018
0CCCB7,earnings,100,50,8/9/2018
0CE7F6,earnings,100,50,8/9/2018
0D03C8,earnings,100,50,8/9/2018
0F2BC9,public-offering,100,43,8/9/2018
102F04,executive-appointment,100,54,8/9/2018
12A3A3,legal-verdict-favored,100,78,8/9/2018
12E454,partnership,100,61,8/9/2018
12E454,legal-issues-defendant,100,22,8/9/2018
152E1D,earnings,100,50,8/9/2018
152E1D,earnings,100,50,8/9/2018
152E1D,earnings,100,50,8/9/2018
152E1D,earnings,100,50,8/9/2018
152E1D,earnings,100,50,8/9/2018
152E1D,earnings,100,50,8/9/2018
15789A,conference-participant,100,50,8/9/2018
15B10D,earnings,100,50,8/9/2018
15B10D,earnings,100,50,8/9/2018
15B10D,earnings,100,50,8/9/2018
16B882,earnings,100,50,8/9/2018
17EDA5,partnership,100,61,8/9/2018
182BE7,earnings,100,50,8/9/2018
18D9FA,public-offering,100,43,8/9/2018
190B91,buybacks,100,74,8/9/2018
196D18,earnings,100,50,8/9/2018
1AC649,earnings,100,50,8/9/2018
1B4F31,business-contract,100,69,8/9/2018
1B5FEA,earnings,100,50,8/9/2018
1CD09C,earnings,100,50,8/9/2018
1CF3A8,earnings,100,50,8/9/2018
1F9258,earnings,100,50,8/9/2018
1FC422,legal-issues-defendant,100,22,8/9/2018
1FE7F0,earnings,100,50,8/9/2018
1FE7F0,earnings,100,50,8/9/2018
1FE7F0,earnings,100,50,8/9/2018
1FE7F0,earnings,100,50,8/9/2018
1FE7F0,earnings,100,50,8/9/2018
24A89A,earnings,100,50,8/9/2018
24A89A,earnings,100,50,8/9/2018
24FA23,earnings,100,50,8/9/2018
25D3CE,earnings,100,50,8/9/2018
2A1009,acquisition-acquirer,100,49,8/9/2018
2A17B1,dividend,100,50,8/9/2018
2A4131,earnings,100,50,8/9/2018
2A6DBE,earnings,100,50,8/9/2018
301493,earnings,100,50,8/9/2018
34B97A,public-offering,100,43,8/9/2018
366A08,executive-appointment,100,54,8/9/2018
36E479,earnings,100,50,8/9/2018
37E18B,operating-earnings,100,50,8/9/2018
385DD4,dividend,100,50,8/9/2018
3A3447,facility-open,100,65,8/9/2018
3C3B6B,earnings,100,50,8/9/2018
3DDE54,public-offering,100,43,8/9/2018
3FBC9B,operating-earnings,100,50,8/9/2018
407878,earnings,100,50,8/9/2018
40F7DE,earnings,100,50,8/9/2018
415188,dividend,100,50,8/9/2018
415188,earnings,100,50,8/9/2018
41785E,executive-appointment,100,54,8/9/2018
417BF9,conference-call,100,50,8/9/2018
42978B,conference-call,100,50,8/9/2018
43A060,earnings,100,50,8/9/2018
43A060,earnings,100,50,8/9/2018
43A060,earnings,100,50,8/9/2018
450ECB,earnings,100,50,8/9/2018
450ECB,executive-appointment,100,54,8/9/2018
45444E,legal-issues-defendant,100,22,8/9/2018
45ABCC,revenue-up,100,75,8/9/2018
45ABCC,revenue-up,100,75,8/9/2018
45ABCC,revenue-up,100,75,8/9/2018
4.60E+06,stake-acquiree,100,62,8/9/2018
4.60E+06,earnings,100,50,8/9/2018
47FCF2,unit-acquisition-completed-acquiree,100,67,8/9/2018
49BBBC,conference-participant,100,50,8/9/2018
49CC59,earnings,100,50,8/9/2018
4A6F00,partnership,100,61,8/9/2018
4A6F00,partnership,100,61,8/9/2018
4B7006,earnings,100,50,8/9/2018
4E4E75,conference-call,100,50,8/9/2018
4F783B,earnings,100,50,8/9/2018
4F783B,earnings,100,50,8/9/2018
4F783B,earnings,100,50,8/9/2018
4F783B,earnings,100,50,8/9/2018
4F783B,earnings,100,50,8/9/2018
50070E,conference-organizer,100,57,8/9/2018
5.43E+08,conference-participant,100,50,8/9/2018
5.47E+28,earnings,100,50,8/9/2018
556F08,earnings,100,50,8/9/2018
562853,dividend,100,50,8/9/2018
564F3E,dividend,100,50,8/9/2018
57A854,earnings,100,50,8/9/2018
594402,settlement,100,56,8/9/2018
5B3415,legal-issues-defendant,100,22,8/9/2018
5B7739,earnings,100,50,8/9/2018
5C7601,dividend,100,50,8/9/2018
620381,earnings,100,50,8/9/2018
6.52E+64,legal-issues-defendant,100,22,8/9/2018
6.52E+64,legal-issues-defendant,100,22,8/9/2018
6810DE,earnings,100,50,8/9/2018
68586A,earnings,100,50,8/9/2018
694749,executive-appointment,100,54,8/9/2018
69FDFC,earnings,100,50,8/9/2018
6B0E45,public-offering,100,43,8/9/2018
6B236C,earnings,100,50,8/9/2018
6BDA0C,earnings,100,50,8/9/2018
6BDA0C,earnings,100,50,8/9/2018
6BDA0C,earnings,100,50,8/9/2018
6BDA0C,earnings,100,50,8/9/2018
6C4D2F,dividend,100,50,8/9/2018
71B0CF,earnings,100,50,8/9/2018
7239BB,conference-call,100,50,8/9/2018
7255D2,earnings,100,50,8/9/2018
747219,earnings,100,50,8/9/2018
76959C,earnings,100,50,8/9/2018
769F40,earnings,100,50,8/9/2018
769F40,earnings,100,50,8/9/2018
769F40,earnings,100,50,8/9/2018
769F40,earnings,100,50,8/9/2018
7740DE,same-store-sales-up,100,52,8/9/2018
7A2A49,earnings,100,50,8/9/2018
7AF5B8,earnings,100,50,8/9/2018
7B9212,revenues,100,50,8/9/2018
7BEA98,earnings,100,50,8/9/2018
7D85A9,dividend,100,50,8/9/2018
82C202,acquisition-interest-acquirer,100,46,8/9/2018
82C202,acquisition-interest-acquirer,100,46,8/9/2018
834152,earnings,100,50,8/9/2018
83A065,public-offering,100,43,8/9/2018
83E0AC,conference-call,100,50,8/9/2018
845533,earnings,100,50,8/9/2018
855DF7,earnings,100,50,8/9/2018
86A1B9,business-contract,100,69,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
86AA9C,earnings,100,50,8/9/2018
877C0C,earnings,100,50,8/9/2018
88193E,partnership,100,61,8/9/2018
8BFAA4,dividend,100,50,8/9/2018
8C6C1B,conference-call,100,50,8/9/2018
8D0EEA,earnings,100,50,8/9/2018
8D4486,product-release,100,64,8/9/2018
8D4486,product-release,100,64,8/9/2018
8DAAB9,dividend,100,50,8/9/2018
8DE56F,earnings,100,50,8/9/2018
8E82A6,conference-participant,100,50,8/9/2018
8FCA78,dividend,100,50,8/9/2018
92005C,earnings,100,50,8/9/2018
92D230,earnings,100,50,8/9/2018
92D230,earnings,100,50,8/9/2018
92D230,earnings,100,50,8/9/2018
92D230,earnings,100,50,8/9/2018
92D230,earnings,100,50,8/9/2018
92D230,earnings,100,50,8/9/2018
92D230,earnings,100,50,8/9/2018
931AE7,earnings,100,50,8/9/2018
9.39E+69,earnings,100,50,8/9/2018
94563D,product-release,100,64,8/9/2018
947B0B,earnings,100,50,8/9/2018
96BFF4,earnings-positive,100,69,8/9/2018
96BFF4,earnings-positive,100,69,8/9/2018
96BFF4,earnings-positive,100,69,8/9/2018
9CE4C7,partnership,100,61,8/9/2018
9D307D,earnings,100,50,8/9/2018
9D65C1,legal-issues-defendant,100,22,8/9/2018
9D65C1,legal-issues-defendant,100,22,8/9/2018
9E5C2C,earnings,100,50,8/9/2018
9F048E,earnings,100,50,8/9/2018
9F048E,earnings,100,50,8/9/2018
A0F146,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A1BB98,earnings,100,50,8/9/2018
A26EF7,conference-participant,100,50,8/9/2018
A403CF,earnings,100,50,8/9/2018
A403CF,dividend,100,50,8/9/2018
A4CD53,earnings,100,50,8/9/2018
A4CD53,earnings,100,50,8/9/2018
A4CD53,earnings,100,50,8/9/2018
A5A4F5,acquisition-acquirer,100,49,8/9/2018
A631A3,earnings,100,50,8/9/2018
A753BB,earnings,100,50,8/9/2018
A790A5,conference-call,100,50,8/9/2018
A79F7D,executive-appointment,100,54,8/9/2018
A8E2FE,patent-filing,100,64,8/9/2018
AC3584,revenue-up,100,83,8/9/2018
AC3584,revenue-up,100,83,8/9/2018
AD1ACF,dividend,100,50,8/9/2018
ADD9DC,product-release,100,64,8/9/2018
ADFB3A,earnings,100,50,8/9/2018
AE79CD,conference-participant,100,50,8/9/2018
B04426,earnings,100,50,8/9/2018
B381D8,earnings,100,50,8/9/2018
B4528F,conference-call,100,50,8/9/2018
B4C673,partnership,100,61,8/9/2018
B4F5F4,conference-call,100,50,8/9/2018
B53C12,earnings,100,50,8/9/2018
B7BDA3,earnings,100,50,8/9/2018
B7BDA3,earnings,100,50,8/9/2018
B80AD1,earnings,100,50,8/9/2018
B8EF97,product-release,100,64,8/9/2018
B9764A,partnership,100,61,8/9/2018
BAAA60,dividend,100,50,8/9/2018
BB07E4,regulatory-product-approval-granted,100,81,8/9/2018
BB88B6,conference-participant,100,50,8/9/2018
BBF349,earnings,100,50,8/9/2018
BBF349,earnings,100,50,8/9/2018
BBF349,earnings,100,50,8/9/2018
BDF2BD,executive-appointment,100,54,8/9/2018
BDF2BD,earnings,100,50,8/9/2018
BDF2BD,earnings,100,50,8/9/2018
BDF2BD,earnings,100,50,8/9/2018
BDF2BD,earnings,100,50,8/9/2018
BDF2BD,earnings,100,50,8/9/2018
BE14CF,conference-participant,100,50,8/9/2018
BE645B,conference-participant,100,50,8/9/2018
BFD0A7,earnings,100,50,8/9/2018
BFD0A7,earnings,100,50,8/9/2018
BFD0A7,earnings,100,50,8/9/2018
C01737,earnings,100,50,8/9/2018
C01737,earnings,100,50,8/9/2018
C037A8,conference-call,100,50,8/9/2018
C3BAE7,earnings,100,50,8/9/2018
C3BAE7,earnings,100,50,8/9/2018
C3BAE7,earnings,100,50,8/9/2018
C3BAE7,earnings,100,50,8/9/2018
C3BAE7,earnings,100,50,8/9/2018
C3BAE7,earnings,100,50,8/9/2018
C4706C,earnings,100,50,8/9/2018
C58D71,earnings,100,50,8/9/2018
C58D71,earnings,100,50,8/9/2018
C659EB,dividend,100,50,8/9/2018
C8A059,earnings,100,50,8/9/2018
CAC8D0,merger-failed,100,21,8/9/2018
CAC8D0,merger-failed,100,21,8/9/2018
CAC8D0,donation,100,54,8/9/2018
CB9E13,executive-appointment,100,54,8/9/2018
CD051C,earnings,100,50,8/9/2018
CD051C,earnings,100,50,8/9/2018
CD051C,earnings,100,50,8/9/2018
CD051C,earnings,100,50,8/9/2018
CDD75E,legal-issues-defendant,100,22,8/9/2018
CDFCC9,dividend,100,50,8/9/2018
CDFCC9,earnings,100,50,8/9/2018
CDFCC9,earnings,100,50,8/9/2018
CDFCC9,earnings,100,50,8/9/2018
CDFCC9,earnings,100,50,8/9/2018
CDFCC9,earnings,100,50,8/9/2018
CF3FF9,earnings,100,50,8/9/2018
CFF97C,credit-rating-affirmation-rater,20,50,8/9/2018
D139BC,earnings,100,50,8/9/2018
D13F1C,earnings-up,100,68,8/9/2018
D13F1C,earnings-up,100,68,8/9/2018
D13F1C,earnings-up,100,68,8/9/2018
D13F1C,earnings-up,100,68,8/9/2018
D25249,note-sale,100,52,8/9/2018
D27FAB,earnings,100,50,8/9/2018
D64C6D,dividend,100,50,8/9/2018
D697DE,earnings,100,50,8/9/2018
D8DA3D,legal-issues-defendant,100,22,8/9/2018
D8ECA1,earnings,100,50,8/9/2018
D8ECA1,earnings,100,50,8/9/2018
D8ECA1,earnings,100,50,8/9/2018
D8ECA1,earnings,100,50,8/9/2018
D8ECA1,earnings,100,50,8/9/2018
D8ECA1,earnings,100,50,8/9/2018
D9E036,executive-appointment,100,54,8/9/2018
DC0066,earnings,100,50,8/9/2018
DC6AA0,conference-call,100,50,8/9/2018
DD1BA1,earnings,100,50,8/9/2018
DD3BB1,legal-issues-defendant,100,22,8/9/2018
DE5611,conference-call,100,50,8/9/2018
E16133,earnings,100,50,8/9/2018
E21871,acquisition-regulatory-approval-acquirer,100,54,8/9/2018
E2CB7B,earnings,100,50,8/9/2018
E3656D,earnings,100,50,8/9/2018
E8846E,conference-organizer,100,57,8/9/2018
E90C84,dividend,100,50,8/9/2018
E9C7C0,earnings,100,50,8/9/2018
E9C7C0,earnings,100,50,8/9/2018
E9C7C0,earnings,100,50,8/9/2018
E9C7C0,earnings,100,50,8/9/2018
E9C7C0,earnings,100,50,8/9/2018
E9C7C0,earnings,100,50,8/9/2018
EAEBF3,earnings,100,50,8/9/2018
EB43F4,earnings,100,50,8/9/2018
EC8116,operating-earnings,100,50,8/9/2018
EC99D0,business-contract,100,69,8/9/2018
EC99D0,business-contract,100,69,8/9/2018
EDD234,earnings,100,50,8/9/2018
EE04F0,earnings,100,50,8/9/2018
EE04F0,earnings,100,50,8/9/2018
EE04F0,earnings,100,50,8/9/2018
EE04F0,earnings,100,50,8/9/2018
F05B1B,earnings,100,50,8/9/2018
F509E2,ipo-pricing,100,50,8/9/2018
F5349B,merger-failed,100,21,8/9/2018
F5349B,merger-failed,100,21,8/9/2018
F5349B,fraud-defendant,100,20,8/9/2018
F5349B,legal-issues-defendant,100,22,8/9/2018
F5349B,legal-issues-defendant,100,22,8/9/2018
F569FD,earnings,100,50,8/9/2018
F6581D,earnings,100,50,8/9/2018
F6DCE4,executive-appointment,100,54,8/9/2018
F6E1B5,earnings,100,50,8/9/2018
F83279,earnings,100,50,8/9/2018
F83279,earnings,100,50,8/9/2018
FAE021,dividend,100,50,8/9/2018
FC1F9D,dividend,100,50,8/9/2018
FCA54E,earnings,100,50,8/9/2018
FDF799,earnings,100,50,8/9/2018
FDF799,earnings,100,50,8/9/2018
FF5413,revenue-volume,100,50,8/9/2018
0624BE,earnings,100,50,8/10/2018
84625,earnings,100,50,8/10/2018
84625,earnings,100,50,8/10/2018
84625,dividend,100,50,8/10/2018
0A59F8,partnership,100,61,8/10/2018
10C19B,executive-appointment,100,54,8/10/2018
1201B5,reverse-stock-splits,100,51,8/10/2018
12A3A3,dividend,100,50,8/10/2018
19CAC7,dividend-up,100,81,8/10/2018
1A3E1B,earnings,100,50,8/10/2018
1AB808,public-offering,100,43,8/10/2018
1DEBBE,executive-resignation,100,44,8/10/2018
21153F,buybacks,100,74,8/10/2018
21153F,buybacks,100,74,8/10/2018
2C35B5,earnings,100,50,8/10/2018
2D2D43,executive-resignation,100,44,8/10/2018
314D88,earnings,100,50,8/10/2018
315EB0,partnership,100,61,8/10/2018
319BE2,buybacks,100,74,8/10/2018
31AA84,earnings-up,100,68,8/10/2018
341759,earnings,100,50,8/10/2018
36A1CB,dividend,100,50,8/10/2018
3A3447,facility-open,100,65,8/10/2018
3B9886,conference-call,100,50,8/10/2018
3DDE54,public-offering,100,43,8/10/2018
3E149C,revenue-guidance,100,50,8/10/2018
3E149C,revenue-guidance,100,50,8/10/2018
453282,conference-participant,100,50,8/10/2018
51E682,dividend,100,50,8/10/2018
5F2FF7,analyst-ratings-change-positive-rater,20,50,8/10/2018
6.52E+64,legal-issues-defendant,100,22,8/10/2018
657097,earnings,100,50,8/10/2018
66E04A,facility-open,100,65,8/10/2018
713810,partnership,100,61,8/10/2018
787D14,fundraising,100,64,8/10/2018
789A7D,dividend,100,50,8/10/2018
7B492C,conference-call,100,50,8/10/2018
7F2922,earnings,100,50,8/10/2018
83A065,public-offering,100,43,8/10/2018
86478F,earnings,100,50,8/10/2018
86A1B9,merger,100,66,8/10/2018
890FF4,executive-appointment,100,54,8/10/2018
8D4486,partnership,100,61,8/10/2018
8F8F2F,dividend,100,50,8/10/2018
92D757,earnings,100,50,8/10/2018
9592FB,conference-participant,100,50,8/10/2018
96F126,business-contract,100,69,8/10/2018
980C14,dividend,100,50,8/10/2018
994468,dividend,100,50,8/10/2018
9B730A,public-offering,100,43,8/10/2018
9BBFA5,analyst-ratings-change-positive,100,78,8/10/2018
9D65C1,legal-issues-defendant,100,22,8/10/2018
9D65C1,legal-issues-defendant,100,22,8/10/2018
A1EAC8,business-contract,100,69,8/10/2018
A350C1,dividend,100,50,8/10/2018
A350C1,dividend,100,50,8/10/2018
A350C1,dividend,100,50,8/10/2018
A5A4F5,acquisition-acquirer,100,49,8/10/2018
B08C51,earnings,100,50,8/10/2018
B4528F,earnings,100,50,8/10/2018
B4528F,earnings,100,50,8/10/2018
B4C673,dividend,100,50,8/10/2018
B614F8,fundraising,100,64,8/10/2018
B642E8,executive-appointment,100,54,8/10/2018
BAD9EA,clinical-trials,100,56,8/10/2018
BF5959,conference-call,100,50,8/10/2018
C1CBA4,ipo-pricing,100,50,8/10/2018
C3BCD5,dividend,100,50,8/10/2018
CBFFDD,legal-issues-defendant,100,22,8/10/2018
CE4FD9,note-sale,100,52,8/10/2018
CFF15D,settlement,100,56,8/10/2018
D07B07,earnings,100,50,8/10/2018
D17C1B,revenue-volume,100,50,8/10/2018
D518D8,dividend,100,50,8/10/2018
D56D6D,dividend-up,100,81,8/10/2018
D6489C,legal-issues-defendant,100,22,8/10/2018
D6489C,legal-issues-defendant,100,22,8/10/2018
D88EF3,note-sale,100,52,8/10/2018
D8DA3D,legal-issues-defendant,100,22,8/10/2018
D8DA3D,legal-issues-defendant,100,22,8/10/2018
D8DA3D,legal-issues-defendant,100,22,8/10/2018
DD3BB1,legal-issues-defendant,100,22,8/10/2018
DD7A96,dividend,100,50,8/10/2018
DF1F7A,dividend,100,50,8/10/2018
E21871,acquisition-completed-acquirer,100,49,8/10/2018
E261E9,earnings,100,50,8/10/2018
E68733,earnings,100,50,8/10/2018
E8846E,conference-organizer,100,57,8/10/2018
EB43F4,conference-participant,100,50,8/10/2018
ECF709,earnings,100,50,8/10/2018
ED7F13,public-offering,100,43,8/10/2018
F30508,analyst-ratings-change-positive,100,78,8/10/2018
F5349B,legal-issues-defendant,100,22,8/10/2018
F5349B,legal-issues-defendant,100,22,8/10/2018
F5349B,legal-issues-defendant,100,22,8/10/2018
AFEC35,facility-open,100,65,8/11/2018
AFF7B4,legal-issues-defendant,100,22,8/11/2018
CDD75E,legal-issues-defendant,100,22,8/11/2018
D21D8A,merger-completed,100,66,8/11/2018
D6489C,legal-issues-defendant,100,22,8/11/2018
DD3BB1,legal-issues-defendant,100,22,8/11/2018
DD3BB1,legal-issues-defendant,100,22,8/11/2018
F5349B,legal-issues-defendant,100,22,8/11/2018
03B8CF,executive-appointment,100,54,8/13/2018
03D5F9,acquisition-completed-acquirer,100,49,8/13/2018
0624BE,partnership,100,61,8/13/2018
84625,buybacks,100,74,8/13/2018
0968A5,conference-call,100,50,8/13/2018
98977,executive-appointment,100,54,8/13/2018
09DE1F,earnings,100,50,8/13/2018
0EF1AF,conference-call,100,50,8/13/2018
0F2BC9,public-offering,100,43,8/13/2018
1096C6,partnership,100,61,8/13/2018
12DE76,product-release,100,64,8/13/2018
14391F,earnings,100,50,8/13/2018
14391F,earnings,100,50,8/13/2018
14391F,earnings,100,50,8/13/2018
16F4D8,business-contract,100,69,8/13/2018
18D9FA,public-offering,100,43,8/13/2018
1921DD,executive-appointment,100,54,8/13/2018
197019,acquisition-interest-acquiree,100,82,8/13/2018
1D3A00,conference-call,100,50,8/13/2018
1EC3E8,executive-appointment,100,54,8/13/2018
1FC422,earnings,100,50,8/13/2018
228D42,partnership,100,61,8/13/2018
26008A,conference-call,100,50,8/13/2018
2667B6,note-sale,100,52,8/13/2018
2667B6,public-offering,100,43,8/13/2018
2A1009,acquisition-acquirer,100,49,8/13/2018
2C35B5,patient-enrollment-complete,100,64,8/13/2018
2C7505,regulatory-product-approval-granted,100,81,8/13/2018
30DE64,earnings,100,50,8/13/2018
367434,earnings,100,50,8/13/2018
367434,earnings,100,50,8/13/2018
39692D,partnership,100,61,8/13/2018
3AF7FD,conference-participant,100,50,8/13/2018
3B8484,acquisition-acquirer,100,49,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3BA1BF,earnings,100,50,8/13/2018
3D9999,partnership,100,61,8/13/2018
414FFF,conference-call,100,50,8/13/2018
442769,conference-participant,100,50,8/13/2018
47FCF2,partnership,100,61,8/13/2018
4806CE,acquisition-interest-acquirer,100,46,8/13/2018
494EB9,dividend,100,50,8/13/2018
4E3D15,facility-sale,100,52,8/13/2018
50D1EC,public-offering,100,43,8/13/2018
50D1EC,public-offering,100,43,8/13/2018
55438C,executive-appointment,100,54,8/13/2018
58CA9A,partnership,100,61,8/13/2018
619882,partnership,100,61,8/13/2018
6.52E+64,executive-appointment,100,54,8/13/2018
6559D8,earnings,100,50,8/13/2018
662682,business-contract,100,69,8/13/2018
6E705B,executive-appointment,100,54,8/13/2018
728737,dividend,100,50,8/13/2018
72CB93,public-offering,100,43,8/13/2018
76E80F,partnership,100,61,8/13/2018
7B492C,executive-appointment,100,54,8/13/2018
7C790D,public-offering,100,43,8/13/2018
817ED9,earnings,100,50,8/13/2018
838ADD,acquisition-completed-acquirer,100,49,8/13/2018
86A1B9,merger-regulatory-approval,100,81,8/13/2018
87486A,public-offering,100,43,8/13/2018
880C0C,executive-appointment,100,54,8/13/2018
8A8E41,business-contract,100,69,8/13/2018
94983E,dividend,100,50,8/13/2018
9546A5,earnings,100,50,8/13/2018
957A07,executive-appointment,100,54,8/13/2018
95C392,executive-appointment,100,54,8/13/2018
979451,note-sale,100,52,8/13/2018
9D2790,earnings,100,50,8/13/2018
9D65C1,legal-issues-defendant,100,22,8/13/2018
9D65C1,legal-issues-defendant,100,22,8/13/2018
A017F4,earnings,100,50,8/13/2018
A15C71,acquisition-completed-acquirer,100,49,8/13/2018
A15C71,acquisition-completed-acquirer,100,49,8/13/2018
A16DEA,acquisition-acquiree,100,76,8/13/2018
A43906,conference-participant,100,50,8/13/2018
A47A7D,business-contract,100,69,8/13/2018
A5A4F5,acquisition-acquirer,100,49,8/13/2018
A6FB29,executive-appointment,100,54,8/13/2018
AD6141,earnings,100,50,8/13/2018
AD6141,dividend,100,50,8/13/2018
B01215,earnings,100,50,8/13/2018
B05000,earnings-up,100,68,8/13/2018
B05000,earnings,100,50,8/13/2018
B1FC3B,business-contract,100,69,8/13/2018
B3A166,legal-issues-defendant,100,22,8/13/2018
B8A51F,executive-appointment,100,54,8/13/2018
B9BDE8,earnings-positive,100,69,8/13/2018
BAD9EA,earnings,100,50,8/13/2018
BDEF34,executive-appointment,100,54,8/13/2018
BE645B,earnings,100,50,8/13/2018
C22BE8,executive-resignation,100,44,8/13/2018
C4706C,conference-participant,100,50,8/13/2018
CCBBAD,earnings,100,50,8/13/2018
CDAB24,executive-appointment,100,54,8/13/2018
CDD75E,legal-issues-defendant,100,22,8/13/2018
D1C26F,earnings,100,50,8/13/2018
D6489C,legal-issues-defendant,100,22,8/13/2018
D6489C,legal-issues-defendant,100,22,8/13/2018
D6489C,legal-issues-defendant,100,22,8/13/2018
D6489C,legal-issues-defendant,100,22,8/13/2018
DAFED3,facility-open,100,65,8/13/2018
DC6EF3,earnings,100,50,8/13/2018
DD3BB1,legal-issues-defendant,100,22,8/13/2018
DD3BB1,legal-issues-defendant,100,22,8/13/2018
DD3BB1,legal-issues-defendant,100,22,8/13/2018
DF204B,facility-open,100,65,8/13/2018
E4CE73,unit-acquisition-acquirer,100,49,8/13/2018
E5F0A8,merger,100,66,8/13/2018
E6BC2C,credit-extension-recipient,100,69,8/13/2018
E6BC2C,conference-call,100,50,8/13/2018
ECD263,executive-resignation,100,44,8/13/2018
F0EEFB,executive-resignation,100,44,8/13/2018
F4E882,executive-appointment,100,54,8/13/2018
F6A987,dividend,100,50,8/13/2018
F7ADEB,business-contract,100,69,8/13/2018
F7ADEB,business-contract,100,69,8/13/2018
F7ADEB,earnings,100,50,8/13/2018
F7ADEB,earnings,100,50,8/13/2018
F7ADEB,earnings,100,50,8/13/2018
F7ADEB,earnings,100,50,8/13/2018
F9CAF8,executive-appointment,100,54,8/13/2018
FC1F9D,executive-appointment,100,54,8/13/2018
FDE409,earnings,100,50,8/13/2018
FE609F,earnings,100,50,8/13/2018
13528,earnings,100,50,8/14/2018
03B8CF,dividend,100,50,8/14/2018
03FB17,earnings,100,50,8/14/2018
48590,partnership,100,61,8/14/2018
04996E,public-offering,100,43,8/14/2018
070B45,acquisition-completed-acquirer,100,49,8/14/2018
75172,conference-call,100,50,8/14/2018
07C907,dividend,100,50,8/14/2018
0919B1,dividend,100,50,8/14/2018
95294,business-contract,100,69,8/14/2018
0A77DB,earnings,100,50,8/14/2018
0B13E8,earnings,100,50,8/14/2018
0E5223,conference-participant,100,50,8/14/2018
0EF1AF,earnings,100,50,8/14/2018
12E454,legal-issues-defendant,100,22,8/14/2018
147098,dividend-up,100,63,8/14/2018
1490F3,dividend,100,50,8/14/2018
14ED2B,partnership,100,61,8/14/2018
15789A,partnership,100,61,8/14/2018
16B183,note-sale,100,52,8/14/2018
1AB808,partnership,100,61,8/14/2018
1C2593,conference-call,100,50,8/14/2018
1E9A6D,note-sale,100,52,8/14/2018
1E9A6D,note-sale,100,52,8/14/2018
1EBF8D,product-release,100,64,8/14/2018
24C48B,partnership,100,61,8/14/2018
26E3BA,earnings,100,50,8/14/2018
2920D5,conference-participant,100,50,8/14/2018
2EC172,product-release,100,64,8/14/2018
314D88,earnings,100,50,8/14/2018
33E8C7,buybacks,100,74,8/14/2018
34A959,index-listing,100,76,8/14/2018
370C50,product-price-raise,100,57,8/14/2018
3B318A,conference-call,100,50,8/14/2018
3C8A04,dividend,100,50,8/14/2018
4.03E+05,executive-resignation,100,44,8/14/2018
41785E,dividend,100,50,8/14/2018
417BF9,earnings,100,50,8/14/2018
449447,revenue-up,100,81,8/14/2018
46017C,note-sale,100,52,8/14/2018
4A2457,conference-participant,100,50,8/14/2018
4A6F00,partnership,100,61,8/14/2018
4AE584,revenues,100,50,8/14/2018
4AE584,revenues,100,50,8/14/2018
4AE584,revenues,100,50,8/14/2018
4D72C8,business-contract,100,69,8/14/2018
50070E,partnership,100,61,8/14/2018
5.47E+28,executive-appointment,100,54,8/14/2018
5480A7,dividend,100,50,8/14/2018
56EFC7,earnings,100,50,8/14/2018
586FFD,conference-call,100,50,8/14/2018
5D02B7,conference-call,100,50,8/14/2018
5E6959,public-offering,100,43,8/14/2018
62A48D,earnings,100,50,8/14/2018
673C9A,clinical-trials,100,56,8/14/2018
6ACFBF,executive-appointment,100,54,8/14/2018
6F5DD2,earnings,100,50,8/14/2018
6FCEF9,earnings,100,50,8/14/2018
713810,facility-open,100,65,8/14/2018
732449,earnings,100,50,8/14/2018
7.44E+09,note-sale,100,52,8/14/2018
7.49E+07,earnings,100,50,8/14/2018
7710F3,public-offering,100,43,8/14/2018
7AF907,earnings,100,50,8/14/2018
7BC92D,earnings,100,50,8/14/2018
7EA323,earnings,100,50,8/14/2018
7EA323,earnings,100,50,8/14/2018
7EA323,earnings,100,50,8/14/2018
850779,executive-appointment,100,54,8/14/2018
86A1B9,partnership,100,61,8/14/2018
88923D,award,100,58,8/14/2018
88923D,award,100,58,8/14/2018
88D80A,earnings,100,50,8/14/2018
8AB85C,earnings,100,50,8/14/2018
95C575,dividend,100,50,8/14/2018
96F126,business-contract,100,69,8/14/2018
98CEBB,award,100,58,8/14/2018
9A2760,earnings,100,50,8/14/2018
9B5968,unit-acquisition-acquirer,100,49,8/14/2018
9B5968,unit-acquisition-acquirer,100,49,8/14/2018
9B5968,acquisition-acquirer,100,49,8/14/2018
9B730A,public-offering,100,43,8/14/2018
9F62D1,dividend,100,50,8/14/2018
A05C43,conference-participant,100,50,8/14/2018
A47A7D,product-release,100,64,8/14/2018
A5A4F5,acquisition-acquirer,100,49,8/14/2018
A6213D,legal-issues-defendant,100,22,8/14/2018
A79F7D,earnings,100,50,8/14/2018
A868C9,business-contract,100,69,8/14/2018
ACDF88,earnings,100,50,8/14/2018
ACDF88,earnings,100,50,8/14/2018
ACDF88,earnings,100,50,8/14/2018
ACDF88,earnings,100,50,8/14/2018
ADD9DC,earnings,100,50,8/14/2018
B08C51,earnings,100,50,8/14/2018
B1FC3B,business-contract,100,69,8/14/2018
B3A166,legal-issues-defendant,100,22,8/14/2018
B3ED62,executive-appointment,100,54,8/14/2018
BB0787,earnings,100,50,8/14/2018
BB58FF,executive-appointment,100,54,8/14/2018
BB58FF,conference-participant,100,50,8/14/2018
BDE867,executive-appointment,100,54,8/14/2018
BFCACF,earnings,100,50,8/14/2018
C01737,patent-awarded,100,72,8/14/2018
C03C8B,note-sale,100,52,8/14/2018
C06EB6,earnings,100,50,8/14/2018
C1CBA4,ipo-completed,100,76,8/14/2018
C2E39B,earnings,100,50,8/14/2018
C2E39B,earnings,100,50,8/14/2018
C48574,earnings,100,50,8/14/2018
C7FC95,acquisition-completed-acquirer,100,49,8/14/2018
C83B88,partnership,100,61,8/14/2018
C93C44,earnings,100,50,8/14/2018
CDC217,earnings,100,50,8/14/2018
CDC817,earnings,100,50,8/14/2018
CDD75E,earnings,100,50,8/14/2018
CDE51C,product-release,100,64,8/14/2018
CE2791,note-sale,100,52,8/14/2018
CE8A7B,earnings,100,50,8/14/2018
CF6A5A,earnings,100,50,8/14/2018
D03C7A,dividend,100,50,8/14/2018
D1C26F,earnings-up,100,68,8/14/2018
D5B13D,earnings,100,50,8/14/2018
D70365,earnings,100,50,8/14/2018
D78BF1,executive-appointment,100,54,8/14/2018
DB7EC3,earnings,100,50,8/14/2018
DBB28E,conference-call,100,50,8/14/2018
DCD97F,business-contract,100,69,8/14/2018
DD3BB1,legal-issues-defendant,100,22,8/14/2018
E06265,dividend,100,50,8/14/2018
E07573,conference-participant,100,50,8/14/2018
E13782,earnings,100,50,8/14/2018
E15736,acquisition-acquirer,100,49,8/14/2018
E15736,acquisition-acquirer,100,49,8/14/2018
E15736,acquisition-acquirer,100,49,8/14/2018
E15736,acquisition-acquirer,100,49,8/14/2018
E592F0,earnings,100,50,8/14/2018
E829E8,executive-appointment,100,54,8/14/2018
EBD89A,conference-call,100,50,8/14/2018
ED79D9,earnings,100,50,8/14/2018
EEB5F9,earnings,100,50,8/14/2018
F02170,executive-appointment,100,54,8/14/2018
F1CD47,dividend,100,50,8/14/2018
F209B4,earnings,100,50,8/14/2018
F39E1E,earnings,100,50,8/14/2018
F509E2,ipo-completed,100,76,8/14/2018
F5349B,legal-issues-defendant,100,22,8/14/2018
F57F6F,revenues,100,50,8/14/2018
F6A392,earnings,100,50,8/14/2018
F6E248,executive-appointment,100,54,8/14/2018
F7935D,earnings,100,50,8/14/2018
F88147,earnings,100,50,8/14/2018
FADF1A,earnings,100,50,8/14/2018
FC9A88,executive-appointment,100,54,8/14/2018
FD9526,dividend,100,50,8/14/2018
FEC475,partnership,100,61,8/14/2018
FF227B,earnings,100,50,8/14/2018
FF4343,dividend,100,50,8/14/2018
00D6B5,dividend,100,50,8/15/2018
00FC70,conference-call,100,50,8/15/2018
13528,partnership,100,61,8/15/2018
0325B7,buybacks,100,74,8/15/2018
0358AF,acquisition-acquirer,100,49,8/15/2018
0358AF,acquisition-acquirer,100,49,8/15/2018
0358AF,acquisition-acquirer,100,49,8/15/2018
0358AF,acquisition-acquirer,100,49,8/15/2018
036C6F,dividend,100,50,8/15/2018
053EFF,dividend,100,50,8/15/2018
06A456,conference-call,100,50,8/15/2018
95294,board-meeting,100,51,8/15/2018
0B73A7,facility-close,100,47,8/15/2018
0B73A7,acquisition-completed-acquirer,100,49,8/15/2018
0B73A7,facility-close,100,47,8/15/2018
0B73A7,acquisition-completed-acquirer,100,49,8/15/2018
0CE7F6,partnership,100,61,8/15/2018
12DE76,earnings,100,50,8/15/2018
12DE76,earnings,100,50,8/15/2018
154272,executive-appointment,100,54,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
182546,earnings,100,50,8/15/2018
1A5957,acquisition-completed-acquirer,100,49,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
1D1B07,investment-investor,100,55,8/15/2018
23207A,business-contract,100,69,8/15/2018
249674,business-contract,100,69,8/15/2018
251988,acquisition-completed-acquirer,100,49,8/15/2018
2.89E+11,dividend,100,50,8/15/2018
292A70,dividend,100,50,8/15/2018
2B9DBB,dividend,100,50,8/15/2018
2BC05E,product-release,100,64,8/15/2018
2F5256,executive-resignation,100,44,8/15/2018
306623,dividend,100,50,8/15/2018
370C50,patent-awarded,100,72,8/15/2018
385DD4,partnership,100,61,8/15/2018
3A113F,conference-participant,100,50,8/15/2018
3DE4D1,product-price-raise,100,57,8/15/2018
43E8F5,conference-participant,100,50,8/15/2018
479930,fundraising,100,64,8/15/2018
4A5C8D,partnership,100,61,8/15/2018
4D371E,executive-appointment,100,54,8/15/2018
4ECD1A,earnings,100,50,8/15/2018
51F541,dividend,100,50,8/15/2018
53A226,dividend,100,50,8/15/2018
54512F,executive-appointment,100,54,8/15/2018
56632F,executive-appointment,100,54,8/15/2018
589846,conference-call,100,50,8/15/2018
5A64D5,dividend-up,100,81,8/15/2018
5B226B,dividend,100,50,8/15/2018
5D87DF,dividend,100,50,8/15/2018
609208,executive-appointment,100,54,8/15/2018
6166D1,executive-appointment,100,54,8/15/2018
6.18E+08,earnings,100,50,8/15/2018
6.18E+08,earnings,100,50,8/15/2018
6.18E+08,earnings,100,50,8/15/2018
619882,dividend,100,50,8/15/2018
62CDDE,partnership,100,61,8/15/2018
68BA15,acquisition-acquirer,100,49,8/15/2018
6A961B,dividend,100,50,8/15/2018
6F3936,conference-call,100,50,8/15/2018
7032D0,dividend-up,100,81,8/15/2018
723548,public-offering,100,43,8/15/2018
747219,conference-participant,100,50,8/15/2018
756045,unit-acquisition-acquirer,100,49,8/15/2018
762B8D,earnings,100,50,8/15/2018
76B926,dividend,100,50,8/15/2018
76E80F,conference-call,100,50,8/15/2018
7710F3,public-offering,100,43,8/15/2018
7A0EC4,earnings,100,50,8/15/2018
7B8CB5,dividend,100,50,8/15/2018
7C790D,public-offering,100,43,8/15/2018
7FD8B9,demand-guidance-increase,100,83,8/15/2018
7FD8B9,demand-guidance-increase,100,83,8/15/2018
80D744,dividend-up,100,81,8/15/2018
8.10E+32,dividend,100,50,8/15/2018
863350,earnings,100,50,8/15/2018
863350,facility-open,100,65,8/15/2018
8D4486,partnership,100,61,8/15/2018
8FF2EF,earnings,100,50,8/15/2018
8FF57A,earnings,100,50,8/15/2018
90B678,legal-issues-defendant,100,22,8/15/2018
922F0C,dividend,100,50,8/15/2018
934CC3,earnings,100,50,8/15/2018
934CC3,earnings,100,50,8/15/2018
954004,facility-open,100,65,8/15/2018
9.62E+76,executive-appointment,100,54,8/15/2018
9.62E+76,dividend,100,50,8/15/2018
9.86E+03,award,100,58,8/15/2018
98D33E,business-contract,100,69,8/15/2018
990AD0,conference-organizer,100,57,8/15/2018
9A02C4,regulatory-investigation,100,22,8/15/2018
9A02C4,regulatory-investigation,100,22,8/15/2018
9FA83B,earnings,100,50,8/15/2018
A47F2E,conference-participant,100,50,8/15/2018
A5A4F5,acquisition-acquirer,100,49,8/15/2018
A6213D,product-release,100,64,8/15/2018
A6828A,clinical-trials-positive,100,87,8/15/2018
AC642C,acquisition-completed-acquirer,100,49,8/15/2018
AC642C,acquisition-completed-acquirer,100,49,8/15/2018
ACDF88,partnership,100,61,8/15/2018
B05000,executive-appointment,100,54,8/15/2018
B1FC3B,business-contract,100,69,8/15/2018
B1FC3B,business-contract,100,69,8/15/2018
BD682F,dividend,100,50,8/15/2018
BDE867,unit-acquisition-acquiree,100,76,8/15/2018
C15F8F,conference-participant,100,50,8/15/2018
C32A39,dividend,100,50,8/15/2018
C5C137,earnings,100,50,8/15/2018
C5C137,earnings,100,50,8/15/2018
C5C137,earnings,100,50,8/15/2018
C5C137,earnings,100,50,8/15/2018
C5C137,earnings,100,50,8/15/2018
C8A248,dividend,100,50,8/15/2018
C951A2,business-contract,100,69,8/15/2018
CCBBAD,dividend,100,50,8/15/2018
CDD75E,legal-issues-defendant,100,22,8/15/2018
CEC08B,acquisition-acquirer,100,49,8/15/2018
CFF15D,product-release,100,64,8/15/2018
D17C1B,executive-appointment,100,54,8/15/2018
D6489C,legal-issues-defendant,100,22,8/15/2018
D697DE,award,100,58,8/15/2018
D697DE,award,100,58,8/15/2018
D76AEF,earnings,100,50,8/15/2018
D78BF1,dividend,100,50,8/15/2018
D8DBA3,dividend,100,50,8/15/2018
D8F347,executive-appointment,100,54,8/15/2018
DD3BB1,legal-issues-defendant,100,22,8/15/2018
DD3BB1,legal-issues-defendant,100,22,8/15/2018
DD3BB1,legal-issues-defendant,100,22,8/15/2018
DD3BB1,legal-issues-defendant,100,22,8/15/2018
DD3BB1,legal-issues-defendant,100,22,8/15/2018
DD3BB1,legal-issues-defendant,100,22,8/15/2018
E05026,conference-call,100,50,8/15/2018
E13782,legal-issues-defendant,100,22,8/15/2018
E1E093,patent-awarded,100,72,8/15/2018
E21871,dividend,100,50,8/15/2018
E35610,product-release,100,64,8/15/2018
E68733,campaign-ad-release,100,59,8/15/2018
E6BC2C,executive-appointment,100,54,8/15/2018
E6D89E,note-sale,100,52,8/15/2018
E829E8,dividend,100,50,8/15/2018
E8846E,joint-venture,100,62,8/15/2018
E8846E,conference-organizer,100,57,8/15/2018
EF45B6,dividend,100,50,8/15/2018
F40EE2,award,100,58,8/15/2018
F6581D,executive-appointment,100,54,8/15/2018
F80FF9,earnings,100,50,8/15/2018
FC1B7B,dividend,100,50,8/15/2018
FD1312,partnership,100,61,8/15/2018
58828,conference-call,100,50,8/16/2018
1065BC,dividend,100,50,8/16/2018
125212,public-offering,100,43,8/16/2018
135B09,dividend,100,50,8/16/2018
135B09,executive-appointment,100,54,8/16/2018
143C52,conference-call,100,50,8/16/2018
1.79E+10,executive-appointment,100,54,8/16/2018
1BC12C,product-release,100,64,8/16/2018
1EBF8D,regulatory-product-approval-granted,100,81,8/16/2018
2093B1,dividend,100,50,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
21153F,earnings-up,100,68,8/16/2018
2158DF,partnership,100,61,8/16/2018
267718,partnership,100,61,8/16/2018
267718,partnership,100,61,8/16/2018
26DC29,conference-call,100,50,8/16/2018
270305,executive-appointment,100,54,8/16/2018
284289,dividend,100,50,8/16/2018
2B7A40,acquisition-acquirer,100,49,8/16/2018
2B7A40,facility-open,100,65,8/16/2018
2B9DBB,executive-appointment,100,54,8/16/2018
2BC05E,dividend,100,50,8/16/2018
2F24A5,executive-appointment,100,54,8/16/2018
35557B,reverse-stock-splits,100,51,8/16/2018
36529A,private-placement,100,56,8/16/2018
370C50,product-price-raise,100,57,8/16/2018
3.73E+87,business-contract,100,69,8/16/2018
3EE65E,conference-participant,100,50,8/16/2018
407878,executive-appointment,100,54,8/16/2018
422CE3,earnings,100,50,8/16/2018
422CE3,earnings,100,50,8/16/2018
422CE3,earnings,100,50,8/16/2018
422CE3,earnings,100,50,8/16/2018
4A6F00,partnership,100,61,8/16/2018
4A6F00,partnership,100,61,8/16/2018
4D72C8,executive-appointment,100,54,8/16/2018
4ECD1A,earnings,100,50,8/16/2018
4ECD1A,earnings,100,50,8/16/2018
50070E,conference-organizer,100,57,8/16/2018
51D876,acquisition-acquirer,100,49,8/16/2018
543900,earnings,100,50,8/16/2018
58CA9A,business-contract,100,69,8/16/2018
58CA9A,conference-participant,100,50,8/16/2018
5D02B7,dividend,100,50,8/16/2018
5D41E4,executive-appointment,100,54,8/16/2018
5F3D91,public-offering,100,43,8/16/2018
62F41C,executive-resignation,100,44,8/16/2018
66E04A,facility-open,100,65,8/16/2018
6830FE,earnings,100,50,8/16/2018
6B5379,dividend,100,50,8/16/2018
6E8349,dividend,100,50,8/16/2018
713810,revenue-volume-up,100,77,8/16/2018
71E2EF,asset-sale,100,62,8/16/2018
72CB93,public-offering,100,43,8/16/2018
73C521,executive-appointment,100,54,8/16/2018
73F7F9,conference-call,100,50,8/16/2018
747219,conference-participant,100,50,8/16/2018
767F86,business-contract,100,69,8/16/2018
7AB859,partnership,100,61,8/16/2018
7B492C,earnings,100,50,8/16/2018
8.10E+32,conference-organizer,100,57,8/16/2018
88350F,partnership,100,61,8/16/2018
8FE7A5,executive-appointment,100,54,8/16/2018
905356,earnings-per-share-positive,100,69,8/16/2018
905356,earnings,100,50,8/16/2018
90B678,legal-issues-defendant,100,22,8/16/2018
954A47,dividend,100,50,8/16/2018
971334,dividend,100,50,8/16/2018
97693A,conference-call,100,50,8/16/2018
9.97E+09,dividend,100,50,8/16/2018
9E5C2C,board-meeting,100,51,8/16/2018
A1A317,buybacks,100,74,8/16/2018
A60354,dividend,100,50,8/16/2018
AC7C4F,earnings-guidance-up,100,83,8/16/2018
ACDF88,dividend,100,50,8/16/2018
B1FC3B,business-contract,100,69,8/16/2018
B1FC3B,business-contract,100,69,8/16/2018
B2DAF6,earnings,100,50,8/16/2018
B8DD94,executive-appointment,100,54,8/16/2018
BD15E8,acquisition-regulatory-approval-acquirer,100,54,8/16/2018
C22BE8,conference-call,100,50,8/16/2018
C5F463,unit-acquisition-completed-acquirer,100,49,8/16/2018
C62AA4,dividend,100,50,8/16/2018
CE4FD9,note-sale,100,52,8/16/2018
CF7292,conference-call,100,50,8/16/2018
D42DBA,executive-appointment,100,54,8/16/2018
D7918D,conference-participant,100,50,8/16/2018
DB9829,earnings,100,50,8/16/2018
DC1405,conference-participant,100,50,8/16/2018
DC2B00,conference-call,100,50,8/16/2018
DD3BB1,legal-issues-defendant,100,22,8/16/2018
DDEA6A,regulatory-product-approval-granted,100,81,8/16/2018
E0207A,executive-appointment,100,54,8/16/2018
E06265,executive-resignation,100,44,8/16/2018
E09E2B,earnings,100,50,8/16/2018
E09E2B,earnings,100,50,8/16/2018
E09E2B,earnings,100,50,8/16/2018
E22FDE,public-offering,100,43,8/16/2018
E3E68E,executive-appointment,100,54,8/16/2018
E8846E,conference-organizer,100,57,8/16/2018
F179ED,executive-appointment,100,54,8/16/2018
F46EC9,dividend,100,50,8/16/2018
F4E882,executive-appointment,100,54,8/16/2018
F66B58,conference-call,100,50,8/16/2018
F73DD1,executive-appointment,100,54,8/16/2018
F82D37,dividend,100,50,8/16/2018
F93C8A,dividend,100,50,8/16/2018
FBD92D,product-release,100,64,8/16/2018
FD554E,product-release,100,64,8/16/2018
FD9A97,conference-participant,100,50,8/16/2018
FEBFE1,orphan-drug-designation,100,76,8/16/2018
FFAB4A,acquisition-completed-acquirer,100,49,8/16/2018
125212,public-offering,100,43,8/17/2018
147C38,executive-appointment,100,54,8/17/2018
156A99,executive-appointment,100,54,8/17/2018
197019,acquisition-interest-acquirer,100,46,8/17/2018
1B9535,conference-participant,100,50,8/17/2018
1EBF8D,regulatory-product-approval-granted,100,81,8/17/2018
1EBF8D,product-release,100,64,8/17/2018
1EBF8D,product-release,100,64,8/17/2018
1EC3E8,executive-appointment,100,54,8/17/2018
2DB344,dividend,100,50,8/17/2018
301493,legal-issues-defendant,100,22,8/17/2018
34B97A,conference-participant,100,50,8/17/2018
355B19,dividend-up,100,81,8/17/2018
3A3447,facility-open,100,65,8/17/2018
3B20AB,conference-participant,100,50,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings-positive,100,69,8/17/2018
431B74,earnings,100,50,8/17/2018
431B74,earnings,100,50,8/17/2018
431B74,earnings,100,50,8/17/2018
431B74,earnings,100,50,8/17/2018
431B74,earnings,100,50,8/17/2018
431B74,earnings,100,50,8/17/2018
4F0A80,dividend,100,50,8/17/2018
50070E,conference-organizer,100,57,8/17/2018
51D876,executive-appointment,100,54,8/17/2018
5F9CE3,dividend,100,50,8/17/2018
665D7D,partnership,100,61,8/17/2018
6844D2,dividend,100,50,8/17/2018
76E80F,dividend,100,50,8/17/2018
78F776,business-combination,100,54,8/17/2018
817ED9,dividend,100,50,8/17/2018
8377DB,conference-participant,100,50,8/17/2018
8377DB,conference-call,100,50,8/17/2018
859D62,earnings,100,50,8/17/2018
86DFBD,earnings,100,50,8/17/2018
88611B,dividend,100,50,8/17/2018
8F3BCC,credit-extension-recipient,100,69,8/17/2018
9196A2,conference-organizer,100,57,8/17/2018
A4B899,dividend-up,100,69,8/17/2018
A4B899,executive-appointment,100,54,8/17/2018
A5A4F5,acquisition-acquirer,100,49,8/17/2018
B3A166,legal-issues-defendant,100,22,8/17/2018
B8EF97,dividend,100,50,8/17/2018
BBAE2A,acquisition-completed-acquirer,100,49,8/17/2018
BBF349,product-release,100,64,8/17/2018
BBF349,product-release,100,64,8/17/2018
BD15E8,dividend,100,50,8/17/2018
C9E4EC,earnings,100,50,8/17/2018
CA99D7,dividend,100,50,8/17/2018
D3F64D,conference-participant,100,50,8/17/2018
D78BF1,award,100,58,8/17/2018
DD3BB1,legal-issues-defendant,100,22,8/17/2018
DD3BB1,legal-issues-defendant,100,22,8/17/2018
DD3BB1,legal-issues-defendant,100,22,8/17/2018
E22FDE,public-offering,100,43,8/17/2018
E30B34,award,100,58,8/17/2018
E6D89E,note-sale,100,52,8/17/2018
E82A2D,conference-participant,100,50,8/17/2018
E8846E,dividend,100,50,8/17/2018
EB5E78,acquisition-completed-acquirer,100,49,8/17/2018
ED79D9,acquisition-completed-acquirer,100,49,8/17/2018
F5349B,legal-issues-defendant,100,22,8/17/2018
F7ADEB,conference-call,100,50,8/17/2018
713810,stake-acquirer,100,48,8/18/2018
CDD75E,legal-issues-defendant,100,22,8/18/2018
AFEC35,award,100,58,8/19/2018
00D6B5,acquisition-interest-acquirer,100,46,8/20/2018
13528,acquisition-acquirer,100,49,8/20/2018
13528,acquisition-acquirer,100,49,8/20/2018
036C6F,acquisition-acquirer,100,49,8/20/2018
04996E,public-offering,100,43,8/20/2018
070B45,product-release,100,64,8/20/2018
126F95,dividend,100,50,8/20/2018
14ED2B,dividend,100,50,8/20/2018
159AE4,conference-call,100,50,8/20/2018
1880C5,executive-appointment,100,54,8/20/2018
1BDB2A,conference-participant,100,50,8/20/2018
1E83DE,partnership,100,61,8/20/2018
2082EA,executive-appointment,100,54,8/20/2018
20BEEA,dividend,100,50,8/20/2018
228D42,partnership,100,61,8/20/2018
253B2F,business-contract,100,69,8/20/2018
29A4CC,merger-completed,100,66,8/20/2018
301493,legal-issues-defendant,100,22,8/20/2018
301493,legal-issues-defendant,100,22,8/20/2018
339F20,acquisition-acquirer,100,49,8/20/2018
3461CF,acquisition-completed-acquirer,100,49,8/20/2018
382EAE,business-contract,100,69,8/20/2018
3A3447,facility-open,100,65,8/20/2018
3DE4D1,partnership,100,61,8/20/2018
3F4668,fundraising,100,64,8/20/2018
3F4668,executive-appointment,100,54,8/20/2018
42312F,earnings,100,50,8/20/2018
43E8F5,executive-appointment,100,54,8/20/2018
444CC8,earnings,100,50,8/20/2018
444CC8,earnings,100,50,8/20/2018
4649D5,executive-appointment,100,54,8/20/2018
49BBBC,earnings,100,50,8/20/2018
4C5CC9,partnership,100,61,8/20/2018
51E682,executive-resignation,100,44,8/20/2018
553949,dividend,100,50,8/20/2018
616E3B,dividend,100,50,8/20/2018
665D7D,donation,100,54,8/20/2018
68E3E0,conference-participant,100,50,8/20/2018
6B5379,executive-resignation,100,44,8/20/2018
6D4636,bankruptcy,100,7,8/20/2018
713810,partnership,100,61,8/20/2018
719477,partnership,100,61,8/20/2018
75F665,dividend,100,50,8/20/2018
7A2A49,product-release,100,64,8/20/2018
7A5097,product-release,100,64,8/20/2018
7AB859,partnership,100,61,8/20/2018
7C790D,public-offering,100,43,8/20/2018
7D5FD6,executive-appointment,100,54,8/20/2018
8B3B0E,product-release,100,64,8/20/2018
8C5519,merger,100,66,8/20/2018
8EEA28,earnings,100,50,8/20/2018
8FE7A5,buybacks,100,74,8/20/2018
901327,dividend,100,50,8/20/2018
9196A2,partnership,100,61,8/20/2018
949625,executive-appointment,100,54,8/20/2018
990AD0,settlement,100,56,8/20/2018
990AD0,settlement,100,56,8/20/2018
9.92E+94,executive-appointment,100,54,8/20/2018
9.92E+94,executive-appointment,100,54,8/20/2018
A21649,dividend,100,50,8/20/2018
A28C54,business-contract,100,69,8/20/2018
A52533,facility-open,100,65,8/20/2018
A5A4F5,acquisition-acquirer,100,49,8/20/2018
A5A4F5,acquisition-acquirer,100,49,8/20/2018
A63387,government-contract,100,69,8/20/2018
A6828A,conference-call,100,50,8/20/2018
A9ED24,dividend,100,50,8/20/2018
AAC8B6,executive-appointment,100,54,8/20/2018
AD1ACF,acquisition-acquirer,100,49,8/20/2018
AD1ACF,acquisition-acquirer,100,49,8/20/2018
AD3C93,executive-appointment,100,54,8/20/2018
B09B1F,executive-appointment,100,54,8/20/2018
BCC13E,executive-appointment,100,54,8/20/2018
BDEC1E,executive-appointment,100,54,8/20/2018
C15DB3,dividend,100,50,8/20/2018
C15DB3,executive-appointment,100,54,8/20/2018
C6C702,public-offering,100,43,8/20/2018
C6C702,public-offering,100,43,8/20/2018
CB22CD,executive-appointment,100,54,8/20/2018
D56D6D,earnings,100,50,8/20/2018
D6853F,public-offering,100,43,8/20/2018
D9B1C9,executive-appointment,100,54,8/20/2018
DA48E4,business-contract,100,69,8/20/2018
DB5CA5,award,100,58,8/20/2018
DBCA3F,facility-open,100,65,8/20/2018
DD3BB1,legal-issues-defendant,100,22,8/20/2018
E4CE73,partnership,100,61,8/20/2018
ED79D9,award,100,58,8/20/2018
ED9576,award,100,58,8/20/2018
F7935D,executive-appointment,100,54,8/20/2018
FE89E0,business-contract,100,69,8/20/2018
FEC475,conference-participant,100,50,8/20/2018
018C11,facility-open,100,65,8/21/2018
0B4D10,acquisition-regulatory-approval-acquirer,100,54,8/21/2018
0BC29E,executive-appointment,100,54,8/21/2018
0CE7F6,dividend,100,50,8/21/2018
0D03C8,executive-appointment,100,54,8/21/2018
0F0440,earnings,100,50,8/21/2018
0F0440,earnings,100,50,8/21/2018
10673F,dividend,100,50,8/21/2018
1151F4,executive-appointment,100,54,8/21/2018
1EBF8D,partnership,100,61,8/21/2018
228D42,unit-acquisition-acquiree,100,76,8/21/2018
228D42,unit-acquisition-acquiree,100,76,8/21/2018
25102A,exchange-compliance-authority,100,50,8/21/2018
27C10F,business-contract,100,69,8/21/2018
28AF37,unit-acquisition-acquirer,100,49,8/21/2018
28DCA8,executive-appointment,100,54,8/21/2018
2C7505,patient-enrollment-complete,100,64,8/21/2018
2C7505,patient-enrollment-complete,100,64,8/21/2018
2F98A5,earnings,100,50,8/21/2018
32F24A,facility-sale,100,52,8/21/2018
3471C0,executive-appointment,100,54,8/21/2018
3A3447,facility-open,100,65,8/21/2018
3DC887,product-release,100,64,8/21/2018
3DC887,product-release,100,64,8/21/2018
49A344,business-contract,100,69,8/21/2018
49F4D0,dividend,100,50,8/21/2018
556F08,conference-participant,100,50,8/21/2018
56632F,business-contract,100,69,8/21/2018
57A854,conference-participant,100,50,8/21/2018
583A75,product-discontinued,100,48,8/21/2018
5A423F,conference-participant,100,50,8/21/2018
665D7D,legal-issues-defendant,100,22,8/21/2018
6D9B53,conference-participant,100,50,8/21/2018
719B43,executive-appointment,100,54,8/21/2018
756BB4,earnings,100,50,8/21/2018
76DD0C,earnings,100,50,8/21/2018
789ADD,conference-participant,100,50,8/21/2018
7B8CB5,index-listing,100,76,8/21/2018
7C75FD,acquisition-acquirer,100,49,8/21/2018
83598E,earnings,100,50,8/21/2018
89E771,earnings,100,50,8/21/2018
8AB85C,clinical-trials,100,56,8/21/2018
8C6C1B,donation,100,54,8/21/2018
8D4486,partnership,100,61,8/21/2018
9196A2,conference-organizer,100,57,8/21/2018
93D207,business-contract,100,69,8/21/2018
98A286,earnings,100,50,8/21/2018
990AD0,donation,100,54,8/21/2018
A5A4F5,acquisition-acquirer,100,49,8/21/2018
A666C8,product-release,100,64,8/21/2018
A72FD9,earnings,100,50,8/21/2018
A790A5,earnings,100,50,8/21/2018
A790A5,earnings,100,50,8/21/2018
A7F0A5,unit-acquisition-acquirer,100,49,8/21/2018
AD22F2,conference-call,100,50,8/21/2018
B614F8,equity-shelf-registration,100,43,8/21/2018
B9764A,earnings,100,50,8/21/2018
BDD12C,dividend,100,50,8/21/2018
C062D4,partnership,100,61,8/21/2018
C07E05,earnings,100,50,8/21/2018
C1CBA4,earnings-positive,100,69,8/21/2018
C3DE7D,earnings,100,50,8/21/2018
C3DE7D,acquisition-acquirer,100,49,8/21/2018
C7AE14,dividend-up,100,64,8/21/2018
C9A96E,dividend,100,50,8/21/2018
CB22CD,conference-participant,100,50,8/21/2018
CC8F6E,earnings,100,50,8/21/2018
CE5664,dividend,100,50,8/21/2018
D1AE3B,dividend,100,50,8/21/2018
D20C8F,note-sale,100,52,8/21/2018
D3F64D,executive-appointment,100,54,8/21/2018
D437C3,award,100,58,8/21/2018
D6489C,legal-issues-defendant,100,22,8/21/2018
D70365,unit-acquisition-acquirer,100,49,8/21/2018
D75910,earnings,100,50,8/21/2018
D90F43,partnership,100,61,8/21/2018
DD1BA1,business-contract,100,69,8/21/2018
DD3BB1,legal-issues-defendant,100,22,8/21/2018
E20BFE,revenues,100,50,8/21/2018
E20BFE,revenues,100,50,8/21/2018
E22FDE,public-offering,100,43,8/21/2018
E30B34,dividend,100,50,8/21/2018
E4158B,dividend-up,100,54,8/21/2018
E4CE73,earnings,100,50,8/21/2018
E68733,earnings,100,50,8/21/2018
E6BC2C,public-offering,100,43,8/21/2018
F18844,dividend,100,50,8/21/2018
F18844,earnings,100,50,8/21/2018
F18844,executive-appointment,100,54,8/21/2018
F2526D,earnings,100,50,8/21/2018
F44EA2,settlement,100,56,8/21/2018
F6DCE4,conference-call,100,50,8/21/2018
01478A,dividend,100,50,8/22/2018
02870F,partnership,100,61,8/22/2018
02870F,partnership,100,61,8/22/2018
03B431,conference-participant,100,50,8/22/2018
58828,revenue-up,100,55,8/22/2018
05AF14,executive-appointment,100,54,8/22/2018
0AD2E3,conference-participant,100,50,8/22/2018
0BC29E,dividend,100,50,8/22/2018
1096C6,conference-participant,100,50,8/22/2018
1151F4,dividend,100,50,8/22/2018
168A5D,award,100,58,8/22/2018
190BE6,earnings,100,50,8/22/2018
197612,dividend,100,50,8/22/2018
1E83DE,earnings,100,50,8/22/2018
2031CE,dividend-up,100,59,8/22/2018
251988,acquisition-completed-acquirer,100,49,8/22/2018
251988,acquisition-completed-acquirer,100,49,8/22/2018
263216,dividend,100,50,8/22/2018
267718,business-contract,100,69,8/22/2018
279916,earnings,100,50,8/22/2018
2B0AF4,dividend,100,50,8/22/2018
2B49F4,conference-participant,100,50,8/22/2018
2B5483,partnership,100,61,8/22/2018
2D2D43,conference-participant,100,50,8/22/2018
2F94A5,dividend,100,50,8/22/2018
31643A,product-release,100,64,8/22/2018
3DD5E2,conference-participant,100,50,8/22/2018
3E39A5,conference-participant,100,50,8/22/2018
416C55,business-contract,100,69,8/22/2018
422CE3,buybacks,100,74,8/22/2018
44740A,executive-appointment,100,54,8/22/2018
45BC35,business-contract,100,69,8/22/2018
45BC35,conference-call,100,50,8/22/2018
4A3438,product-release,100,64,8/22/2018
4B7006,award,100,58,8/22/2018
4B7006,award,100,58,8/22/2018
4B7006,award,100,58,8/22/2018
4D203E,dividend,100,50,8/22/2018
55CD6F,dividend,100,50,8/22/2018
586BD7,conference-participant,100,50,8/22/2018
586BD7,conference-participant,100,50,8/22/2018
5968F9,conference-participant,100,50,8/22/2018
64FF65,executive-appointment,100,54,8/22/2018
665440,executive-appointment,100,54,8/22/2018
665440,executive-appointment,100,54,8/22/2018
66749D,public-offering,100,43,8/22/2018
6.00E+19,executive-appointment,100,54,8/22/2018
6E705B,executive-appointment,100,54,8/22/2018
746373,conference-participant,100,50,8/22/2018
762A3E,conference-organizer,100,57,8/22/2018
766047,acquisition-acquirer,100,49,8/22/2018
766047,acquisition-acquirer,100,49,8/22/2018
766047,acquisition-acquirer,100,49,8/22/2018
766047,acquisition-acquirer,100,49,8/22/2018
76BECC,executive-appointment,100,54,8/22/2018
76E80F,revenues,100,50,8/22/2018
76E80F,revenues,100,50,8/22/2018
76E80F,revenues,100,50,8/22/2018
76E80F,executive-appointment,100,54,8/22/2018
78A1BB,dividend-up,100,81,8/22/2018
7A5097,earnings,100,50,8/22/2018
7AB859,partnership,100,61,8/22/2018
7E1D5D,earnings,100,50,8/22/2018
7E1D5D,earnings,100,50,8/22/2018
7E1D5D,earnings,100,50,8/22/2018
8.10E+32,executive-appointment,100,54,8/22/2018
8.10E+32,executive-appointment,100,54,8/22/2018
83066C,conference-participant,100,50,8/22/2018
83066C,conference-participant,100,50,8/22/2018
863350,facility-open,100,65,8/22/2018
895D56,award,100,58,8/22/2018
89E771,product-release,100,64,8/22/2018
8AC65D,conference-call,100,50,8/22/2018
8B8656,partnership,100,61,8/22/2018
8C5519,acquisition-completed-acquirer,100,49,8/22/2018
8C6C1B,dividend,100,50,8/22/2018
8D0EEA,conference-participant,100,50,8/22/2018
8E8E6E,executive-appointment,100,54,8/22/2018
8EDACA,conference-call,100,50,8/22/2018
9196A2,conference-organizer,100,57,8/22/2018
940C3D,unit-acquisition-acquiree,100,76,8/22/2018
96F126,executive-appointment,100,54,8/22/2018
99028D,acquisition-acquirer,100,49,8/22/2018
990AD0,conference-organizer,100,57,8/22/2018
9D65C1,legal-issues-defendant,100,22,8/22/2018
A26C26,earnings,100,50,8/22/2018
A37D68,product-release,100,64,8/22/2018
A47F2E,public-offering,100,43,8/22/2018
A5A4F5,acquisition-acquirer,100,49,8/22/2018
A7102F,conference-participant,100,50,8/22/2018
A761FE,conference-call,100,50,8/22/2018
A87CD6,conference-participant,100,50,8/22/2018
B3A166,legal-issues-defendant,100,22,8/22/2018
B73395,conference-participant,100,50,8/22/2018
B9764A,conference-participant,100,50,8/22/2018
C188F8,earnings,100,50,8/22/2018
C22BE8,earnings-up,100,68,8/22/2018
C22BE8,earnings,100,50,8/22/2018
C22BE8,earnings,100,50,8/22/2018
C22BE8,earnings,100,50,8/22/2018
C356AC,partnership,100,61,8/22/2018
C4C77F,conference-call,100,50,8/22/2018
C81E00,conference-participant,100,50,8/22/2018
C83B88,conference-participant,100,50,8/22/2018
D2C0B6,earnings,100,50,8/22/2018
D3F64D,dividend,100,50,8/22/2018
DA48E4,unit-acquisition-acquirer,100,49,8/22/2018
DBFB51,product-release,100,64,8/22/2018
DC0D18,acquisition-acquirer,100,49,8/22/2018
DC6AA0,earnings,100,50,8/22/2018
DDCB34,conference-participant,100,50,8/22/2018
DF6FDD,conference-participant,100,50,8/22/2018
E21871,note-sale,100,52,8/22/2018
E26FC3,executive-appointment,100,54,8/22/2018
E4CE73,conference-participant,100,50,8/22/2018
E68C3D,earnings-up,100,68,8/22/2018
E68C3D,earnings,100,50,8/22/2018
E68C3D,earnings,100,50,8/22/2018
E68C3D,earnings,100,50,8/22/2018
E68C3D,earnings,100,50,8/22/2018
E6BC2C,public-offering,100,43,8/22/2018
E754F0,conference-participant,100,50,8/22/2018
E8846E,conference-organizer,100,57,8/22/2018
E8846E,conference-organizer,100,57,8/22/2018
E8846E,conference-organizer,100,57,8/22/2018
F1EB39,earnings-guidance,100,50,8/22/2018
F6DCE4,earnings,100,50,8/22/2018
F6DCE4,earnings,100,50,8/22/2018
F6DCE4,earnings,100,50,8/22/2018
F6DCE4,earnings,100,50,8/22/2018
F748C7,earnings-up,100,68,8/22/2018
FA40E2,conference-participant,100,50,8/22/2018
FC1F9D,conference-participant,100,50,8/22/2018
FD6926,conference-participant,100,50,8/22/2018
00698D,earnings,100,50,8/23/2018
01D03F,regulatory-product-approval-granted,100,81,8/23/2018
053EFF,trading-resumed,100,58,8/23/2018
07EC43,acquisition-acquirer,100,49,8/23/2018
0A7650,dividend,100,50,8/23/2018
0E64D4,partnership,100,61,8/23/2018
12E454,product-release,100,64,8/23/2018
12E454,legal-issues-defendant,100,22,8/23/2018
1E1125,conference-organizer,100,57,8/23/2018
1FCC00,conference-call,100,50,8/23/2018
21DED4,acquisition-acquirer,100,49,8/23/2018
22C58E,conference-participant,100,50,8/23/2018
239106,executive-appointment,100,54,8/23/2018
274B8A,conference-call,100,50,8/23/2018
29A4CC,dividend,100,50,8/23/2018
2BA977,dividend-up,100,64,8/23/2018
2DA92D,dividend,100,50,8/23/2018
2E89AE,fraud-defendant,100,20,8/23/2018
2F9304,earnings,100,50,8/23/2018
301493,legal-issues-defendant,100,22,8/23/2018
30AB63,conference-participant,100,50,8/23/2018
31AA84,executive-appointment,100,54,8/23/2018
33AD83,conference-call,100,50,8/23/2018
3461CF,business-contract,100,69,8/23/2018
3461CF,credit-rating-upgrade-rater,20,50,8/23/2018
385DD4,product-release,100,64,8/23/2018
387541,executive-appointment,100,54,8/23/2018
397A8F,earnings,100,50,8/23/2018
3A3447,facility-open,100,65,8/23/2018
3DC887,index-listing,100,76,8/23/2018
4A5C8D,conference-participant,100,50,8/23/2018
4AC91D,earnings,100,50,8/23/2018
4AC91D,earnings,100,50,8/23/2018
4AC91D,earnings,100,50,8/23/2018
4AC91D,earnings,100,50,8/23/2018
4AC91D,earnings,100,50,8/23/2018
4AC91D,earnings,100,50,8/23/2018
4C37C5,product-release,100,64,8/23/2018
4D971D,dividend,100,50,8/23/2018
4E7C1F,conference-participant,100,50,8/23/2018
4ECD1A,dividend,100,50,8/23/2018
50070E,conference-organizer,100,57,8/23/2018
50070E,conference-organizer,100,57,8/23/2018
50070E,conference-organizer,100,57,8/23/2018
50070E,conference-organizer,100,57,8/23/2018
50070E,conference-organizer,100,57,8/23/2018
53A226,conference-participant,100,50,8/23/2018
553949,executive-appointment,100,54,8/23/2018
56EFC7,dividend,100,50,8/23/2018
57CAAB,executive-appointment,100,54,8/23/2018
586FFD,earnings,100,50,8/23/2018
589846,product-release,100,64,8/23/2018
58CA9A,conference-organizer,100,57,8/23/2018
59F0B0,conference-call,100,50,8/23/2018
5FE4B6,dividend,100,50,8/23/2018
5FF95F,unit-acquisition-acquirer,100,49,8/23/2018
6.18E+08,executive-appointment,100,54,8/23/2018
61BCA7,executive-appointment,100,54,8/23/2018
627186,conference-participant,100,50,8/23/2018
62A48D,award,100,58,8/23/2018
64E346,earnings,100,50,8/23/2018
6634D9,legal-issues-defendant,100,22,8/23/2018
66667F,partnership,100,61,8/23/2018
66749D,conference-participant,100,50,8/23/2018
66E04A,executive-appointment,100,54,8/23/2018
67303E,partnership,100,61,8/23/2018
67529E,acquisition-regulatory-approval-acquirer,100,54,8/23/2018
6C987C,dividend,100,50,8/23/2018
6F3FA8,conference-participant,100,50,8/23/2018
6FCEF9,executive-appointment,100,54,8/23/2018
7239BB,earnings,100,50,8/23/2018
72DF04,conference-participant,100,50,8/23/2018
73F70F,dividend,100,50,8/23/2018
75768D,executive-appointment,100,54,8/23/2018
7740DE,earnings-up,100,68,8/23/2018
7CD98F,conference-participant,100,50,8/23/2018
7EA323,executive-appointment,100,54,8/23/2018
7F0372,acquisition-acquirer,100,49,8/23/2018
7FD8B9,conference-participant,100,50,8/23/2018
817ED9,earnings,100,50,8/23/2018
817ED9,earnings,100,50,8/23/2018
817ED9,earnings,100,50,8/23/2018
817ED9,earnings,100,50,8/23/2018
82BB33,earnings,100,50,8/23/2018
83598E,acquisition-acquirer,100,49,8/23/2018
86F123,unit-acquisition-acquiree,100,76,8/23/2018
8B4A45,facility-open,100,65,8/23/2018
8C6C1B,earnings,100,50,8/23/2018
8C6C1B,earnings,100,50,8/23/2018
8FCA78,facility-open,100,65,8/23/2018
90B678,legal-issues-defendant,100,22,8/23/2018
913437,acquisition-acquirer,100,49,8/23/2018
9196A2,conference-organizer,100,57,8/23/2018
9196A2,conference-organizer,100,57,8/23/2018
92D757,business-contract,100,69,8/23/2018
93F143,dividend,100,50,8/23/2018
943239,conference-participant,100,50,8/23/2018
954004,conference-call,100,50,8/23/2018
9.74E+08,partnership,100,61,8/23/2018
97644E,partnership,100,61,8/23/2018
9BF177,earnings,100,50,8/23/2018
9C5BA5,dividend,100,50,8/23/2018
9D56F2,conference-participant,100,50,8/23/2018
9E98F2,product-release,100,64,8/23/2018
A01664,conference-participant,100,50,8/23/2018
A1E3B3,earnings,100,50,8/23/2018
A1E3B3,earnings,100,50,8/23/2018
A47F2E,public-offering,100,43,8/23/2018
A5A4F5,acquisition-acquirer,100,49,8/23/2018
A631A3,earnings,100,50,8/23/2018
A631A3,earnings,100,50,8/23/2018
A631A3,earnings,100,50,8/23/2018
A631A3,earnings,100,50,8/23/2018
A631A3,earnings,100,50,8/23/2018
A631A3,earnings,100,50,8/23/2018
A6FB29,conference-participant,100,50,8/23/2018
A761FE,executive-appointment,100,54,8/23/2018
AC7C4F,business-contract,100,69,8/23/2018
ACDF88,conference-participant,100,50,8/23/2018
B1FC3B,business-contract,100,69,8/23/2018
B4B281,earnings,100,50,8/23/2018
B4B281,earnings,100,50,8/23/2018
B4B281,earnings,100,50,8/23/2018
B80AD1,regulatory-product-approval-granted,100,81,8/23/2018
B934BF,dividend,100,50,8/23/2018
BB88B6,award,100,58,8/23/2018
BC3AD2,dividend,100,50,8/23/2018
C062D4,conference-participant,100,50,8/23/2018
C4A432,earnings-up,100,68,8/23/2018
C62AA4,unit-acquisition-acquirer,100,49,8/23/2018
C83B88,conference-participant,100,50,8/23/2018
CD4DA8,conference-organizer,100,57,8/23/2018
CFF57D,conference-call,100,50,8/23/2018
D5938F,earnings,100,50,8/23/2018
D6534D,dividend-up,100,81,8/23/2018
D90F43,market-entry,100,57,8/23/2018
DB9829,earnings-up,100,68,8/23/2018
DB9829,earnings,100,50,8/23/2018
DB9829,earnings,100,50,8/23/2018
DB9829,earnings,100,50,8/23/2018
DD682D,executive-appointment,100,54,8/23/2018
DF204B,dividend,100,50,8/23/2018
E0207A,dividend-up,100,64,8/23/2018
E10D31,dividend,100,50,8/23/2018
E1C16B,conference-participant,100,50,8/23/2018
E1C16B,conference-participant,100,50,8/23/2018
E38906,conference-participant,100,50,8/23/2018
E8846E,conference-organizer,100,57,8/23/2018
EB7D6C,merger-completed,100,66,8/23/2018
EBD89A,earnings,100,50,8/23/2018
ED2A5E,conference-participant,100,50,8/23/2018
EF25A5,partnership,100,61,8/23/2018
F0A9DE,dividend-up,100,81,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F11638,revenue-up,100,67,8/23/2018
F4F46F,conference-participant,100,50,8/23/2018
F509E2,conference-call,100,50,8/23/2018
FC1B7B,partnership,100,61,8/23/2018
FC4550,dividend,100,50,8/23/2018
FE89E0,conference-participant,100,50,8/23/2018
FF6644,earnings-guidance-up,100,83,8/23/2018
0157B1,partnership,100,61,8/24/2018
0624BE,dividend,100,50,8/24/2018
0A0D9E,conference-participant,100,50,8/24/2018
0BB9E5,dividend-up,100,81,8/24/2018
0CE7F6,earnings,100,50,8/24/2018
0E2992,dividend,100,50,8/24/2018
275300,conference-participant,100,50,8/24/2018
2E89AE,legal-issues-defendant,100,22,8/24/2018
2E89AE,legal-issues-defendant,100,22,8/24/2018
2E89AE,legal-issues-defendant,100,22,8/24/2018
301493,legal-issues-defendant,100,22,8/24/2018
31643A,dividend,100,50,8/24/2018
3390DE,conference-participant,100,50,8/24/2018
3.50E+27,dividend,100,50,8/24/2018
39692D,conference-participant,100,50,8/24/2018
3A3447,facility-open,100,65,8/24/2018
3B9886,earnings,100,50,8/24/2018
3B9886,earnings,100,50,8/24/2018
4FB770,dividend,100,50,8/24/2018
5088A5,executive-appointment,100,54,8/24/2018
5487B1,conference-participant,100,50,8/24/2018
55438C,merger-regulatory-approval,100,81,8/24/2018
5A64D5,award,100,58,8/24/2018
5A9A82,dividend-guidance,100,50,8/24/2018
5B35C7,dividend,100,50,8/24/2018
5D41E4,conference-participant,100,50,8/24/2018
5E6959,executive-appointment,100,54,8/24/2018
61B81B,conference-participant,100,50,8/24/2018
68AB62,conference-participant,100,50,8/24/2018
69CE71,facility-open,100,65,8/24/2018
7B9212,earnings,100,50,8/24/2018
7B9212,earnings,100,50,8/24/2018
7DD584,earnings,100,50,8/24/2018
7F2922,executive-appointment,100,54,8/24/2018
86A1B9,acquisition-acquirer,100,49,8/24/2018
86A1B9,acquisition-acquirer,100,49,8/24/2018
883D82,earnings,100,50,8/24/2018
89F693,earnings-up,100,68,8/24/2018
990AD0,conference-organizer,100,57,8/24/2018
9F37C5,earnings,100,50,8/24/2018
A4CD53,conference-participant,100,50,8/24/2018
A5A4F5,acquisition-acquirer,100,49,8/24/2018
A8CBDA,conference-participant,100,50,8/24/2018
A96867,dividend-up,100,62,8/24/2018
B5734D,conference-call,100,50,8/24/2018
BCE9DA,dividend,100,50,8/24/2018
BCE9DA,dividend,100,50,8/24/2018
C5C137,dividend,100,50,8/24/2018
C83B88,business-contract,100,69,8/24/2018
D76AEF,dividend,100,50,8/24/2018
D76AEF,executive-resignation,100,44,8/24/2018
DF18E6,orphan-drug-designation,100,76,8/24/2018
E68733,dividend,100,50,8/24/2018
ECA300,conference-call,100,50,8/24/2018
F57F6F,executive-appointment,100,54,8/24/2018
F57F6F,executive-appointment,100,54,8/24/2018
FD554E,dividend-up,100,81,8/24/2018
FF4BA4,dividend-up,100,56,8/24/2018
8876D6,partnership,100,61,8/26/2018
00067A,conference-participant,100,50,8/27/2018
01D03F,partnership,100,61,8/27/2018
03596A,executive-appointment,100,54,8/27/2018
070B45,executive-appointment,100,54,8/27/2018
0968A5,earnings,100,50,8/27/2018
17EDA5,business-contract,100,69,8/27/2018
1D1B07,conference-participant,100,50,8/27/2018
1D1B07,conference-participant,100,50,8/27/2018
1E1125,conference-organizer,100,57,8/27/2018
21153F,settlement,100,56,8/27/2018
21153F,settlement,100,56,8/27/2018
21153F,settlement,100,56,8/27/2018
21153F,settlement,100,56,8/27/2018
228D42,business-contract,100,69,8/27/2018
26008A,revenue-up,100,69,8/27/2018
26008A,revenue-up,100,69,8/27/2018
26008A,revenue-up,100,69,8/27/2018
2ABF77,conference-participant,100,50,8/27/2018
2E89AE,legal-issues-defendant,100,22,8/27/2018
2F94A5,campaign-ad-release,100,59,8/27/2018
2F960F,conference-participant,100,50,8/27/2018
342218,executive-appointment,100,54,8/27/2018
3AF7FD,earnings,100,50,8/27/2018
3C7F5F,legal-issues-defendant,100,22,8/27/2018
3C7F5F,legal-issues-defendant,100,22,8/27/2018
3F4668,spin-off,100,58,8/27/2018
3F4668,spin-off,100,58,8/27/2018
3FACA7,partnership,100,61,8/27/2018
425BDC,executive-appointment,100,54,8/27/2018
4591D3,executive-appointment,100,54,8/27/2018
4A5C8D,business-contract,100,69,8/27/2018
4A6F00,partnership,100,61,8/27/2018
55C289,dividend,100,50,8/27/2018
5D1329,conference-participant,100,50,8/27/2018
5F9CE3,business-contract,100,69,8/27/2018
6B236C,executive-resignation,100,44,8/27/2018
6-Dec-05,conference-participant,100,50,8/27/2018
70FCEF,earnings,100,50,8/27/2018
7448A3,conference-participant,100,50,8/27/2018
76D79A,executive-appointment,100,54,8/27/2018
76F067,regulatory-product-application,100,69,8/27/2018
76F067,regulatory-product-application,100,69,8/27/2018
76F067,regulatory-product-application,100,69,8/27/2018
7AB859,facility-upgrade,100,65,8/27/2018
7B1E50,business-contract,100,69,8/27/2018
7CD98F,dividend,100,50,8/27/2018
7F2922,facility-open,100,65,8/27/2018
7F3669,conference-participant,100,50,8/27/2018
810FAD,dividend,100,50,8/27/2018
810FAD,executive-appointment,100,54,8/27/2018
8303CD,executive-appointment,100,54,8/27/2018
835C86,earnings,100,50,8/27/2018
880C0C,executive-appointment,100,54,8/27/2018
8BE916,dividend,100,50,8/27/2018
8D4486,partnership,100,61,8/27/2018
931AE7,clinical-trials-start,100,64,8/27/2018
949D62,conference-participant,100,50,8/27/2018
971F7B,conference-participant,100,50,8/27/2018
99028D,conference-call,100,50,8/27/2018
9BBFA5,conference-call,100,50,8/27/2018
9E4A5F,executive-appointment,100,54,8/27/2018
9F37C5,dividend,100,50,8/27/2018
9FB4B7,conference-participant,100,50,8/27/2018
A631A3,product-release,100,64,8/27/2018
A631A3,product-release,100,64,8/27/2018
A631A3,product-release,100,64,8/27/2018
A631A3,product-release,100,64,8/27/2018
A631A3,acquisition-interest-acquirer,100,46,8/27/2018
A6828A,conference-call,100,50,8/27/2018
A6828A,conference-participant,100,50,8/27/2018
A6828A,conference-call,100,50,8/27/2018
A70BF5,conference-participant,100,50,8/27/2018
AD3C93,executive-appointment,100,54,8/27/2018
B8F71F,conference-participant,100,50,8/27/2018
BB0587,conference-participant,100,50,8/27/2018
BB58FF,executive-appointment,100,54,8/27/2018
BCE9DA,executive-appointment,100,54,8/27/2018
BCE9DA,executive-appointment,100,54,8/27/2018
C188F8,legal-issues-defendant,100,22,8/27/2018
C188F8,legal-issues-defendant,100,22,8/27/2018
C188F8,legal-issues-defendant,100,22,8/27/2018
C356AC,conference-participant,100,50,8/27/2018
C65004,earnings,100,50,8/27/2018
C83B88,award,100,58,8/27/2018
C99CC8,partnership,100,61,8/27/2018
C9D866,acquisition-completed-acquirer,100,49,8/27/2018
CA3CB9,acquisition-acquirer,100,49,8/27/2018
CE4FD9,trading-halt,100,43,8/27/2018
CFD4B6,conference-participant,100,50,8/27/2018
D07B07,conference-participant,100,50,8/27/2018
D15833,dividend,100,50,8/27/2018
D29B44,conference-participant,100,50,8/27/2018
D60BB2,dividend,100,50,8/27/2018
D90F43,partnership,100,61,8/27/2018
DBB28E,product-release,100,64,8/27/2018
DBB28E,hirings,100,65,8/27/2018
E09556,unit-acquisition-acquirer,100,49,8/27/2018
E1C16B,acquisition-acquirer,100,49,8/27/2018
E1C16B,dividend,100,50,8/27/2018
E8846E,conference-organizer,100,57,8/27/2018
EB5E78,conference-participant,100,50,8/27/2018
ECD263,executive-appointment,100,54,8/27/2018
EE1E44,dividend,100,50,8/27/2018
EE6F1C,dividend-up,100,70,8/27/2018
EF5BED,executive-appointment,100,54,8/27/2018
F509E2,earnings,100,50,8/27/2018
F7ADEB,conference-participant,100,50,8/27/2018
F8BA6C,conference-participant,100,50,8/27/2018
FC01C0,unit-acquisition-acquiree,100,76,8/27/2018
FDF28E,conference-participant,100,50,8/27/2018
FF6644,partnership,100,61,8/27/2018
03B8CF,partnership,100,61,8/28/2018
03CF95,partnership,100,61,8/28/2018
070B45,legal-issues-defendant,100,22,8/28/2018
75172,earnings,100,50,8/28/2018
0986B5,dividend,100,50,8/28/2018
0A59F8,partnership,100,61,8/28/2018
0A748B,public-offering,100,43,8/28/2018
0B7375,conference-participant,100,50,8/28/2018
0BC29E,conference-participant,100,50,8/28/2018
0E3436,earnings,100,50,8/28/2018
0F0693,executive-appointment,100,54,8/28/2018
0FC848,product-release,100,64,8/28/2018
11A49E,conference-participant,100,50,8/28/2018
12A3A3,earnings-guidance,100,50,8/28/2018
159739,dividend,100,50,8/28/2018
1C2593,earnings,100,50,8/28/2018
1D943E,executive-appointment,100,54,8/28/2018
1EC3E8,executive-appointment,100,54,8/28/2018
1F2B5D,conference-participant,100,50,8/28/2018
25A6CC,conference-participant,100,50,8/28/2018
27C10F,business-contract,100,69,8/28/2018
28AF37,earnings-up,100,68,8/28/2018
28AF37,earnings-up,100,68,8/28/2018
28AF37,earnings-up,100,68,8/28/2018
28AF37,earnings-up,100,68,8/28/2018
2CD1E0,investment-investor,100,55,8/28/2018
2F5256,unit-acquisition-acquirer,100,49,8/28/2018
30AB63,note-sale,100,52,8/28/2018
315EB0,award,100,58,8/28/2018
32C8CD,conference-participant,100,50,8/28/2018
33AD83,product-release,100,64,8/28/2018
33AD83,product-release,100,64,8/28/2018
3461CF,regulatory-investigation,100,22,8/28/2018
3461CF,regulatory-investigation,100,22,8/28/2018
3A94DF,dividend,100,50,8/28/2018
3C7F5F,legal-issues-defendant,100,22,8/28/2018
3CBA2A,business-contract,100,69,8/28/2018
3CBA2A,business-contract,100,69,8/28/2018
3E39A5,reorganization,100,53,8/28/2018
3EE65E,earnings,100,50,8/28/2018
44A4FC,earnings,100,50,8/28/2018
451D61,conference-participant,100,50,8/28/2018
4B3555,executive-appointment,100,54,8/28/2018
4C7DB5,asset-sale,100,62,8/28/2018
4EC4C1,executive-appointment,100,54,8/28/2018
514067,conference-participant,100,50,8/28/2018
5403F8,executive-appointment,100,54,8/28/2018
54F1D2,acquisition-interest-acquiree,100,82,8/28/2018
56EFC7,earnings,100,50,8/28/2018
58B46F,merger-regulatory-approval,100,81,8/28/2018
5A423F,patient-enrollment-complete,100,64,8/28/2018
5B226B,executive-appointment,100,54,8/28/2018
5B6C11,dividend,100,50,8/28/2018
5CEE02,acquisition-interest-acquirer,100,46,8/28/2018
5E7E82,earnings-above-expectations,100,88,8/28/2018
5F9CE3,business-contract,100,69,8/28/2018
6166D1,executive-appointment,100,54,8/28/2018
665D7D,conference-participant,100,50,8/28/2018
69C99E,conference-participant,100,50,8/28/2018
6CC55E,conference-participant,100,50,8/28/2018
6CD55A,dividend,100,50,8/28/2018
6-Dec-05,executive-appointment,100,54,8/28/2018
6FCEF9,earnings,100,50,8/28/2018
704B78,conference-participant,100,50,8/28/2018
704B78,conference-participant,100,50,8/28/2018
719477,conference-participant,100,50,8/28/2018
765913,partnership,100,61,8/28/2018
7AB859,partnership,100,61,8/28/2018
7AB859,partnership,100,61,8/28/2018
7C75FD,acquisition-acquirer,100,49,8/28/2018
7D5FD6,executive-appointment,100,54,8/28/2018
83598E,earnings,100,50,8/28/2018
85DE00,conference-participant,100,50,8/28/2018
8876D6,settlement,100,56,8/28/2018
89FBB1,conference-participant,100,50,8/28/2018
8A8E41,partnership,100,61,8/28/2018
8B1E11,award,100,58,8/28/2018
8E10BF,conference-participant,100,50,8/28/2018
8E82A6,executive-appointment,100,54,8/28/2018
913437,acquisition-acquirer,100,49,8/28/2018
9196A2,conference-organizer,100,57,8/28/2018
9196A2,conference-organizer,100,57,8/28/2018
9196A2,conference-organizer,100,57,8/28/2018
931AE7,conference-participant,100,50,8/28/2018
9.39E+69,conference-participant,100,50,8/28/2018
94637C,executive-appointment,100,54,8/28/2018
96F126,business-contract,100,69,8/28/2018
98A286,earnings-per-share-up,100,92,8/28/2018
98A286,earnings-per-share,100,50,8/28/2018
98A286,earnings-per-share,100,50,8/28/2018
9.92E+94,executive-appointment,100,54,8/28/2018
9C25FF,partnership,100,61,8/28/2018
9C5174,conference-participant,100,50,8/28/2018
9CA619,conference-call,100,50,8/28/2018
9D65C1,legal-issues-defendant,100,22,8/28/2018
9E5C2C,conference-participant,100,50,8/28/2018
9E98F2,partnership,100,61,8/28/2018
A26EF7,conference-participant,100,50,8/28/2018
A48593,partnership,100,61,8/28/2018
A5A4F5,acquisition-acquirer,100,49,8/28/2018
A5E715,dividend,100,50,8/28/2018
A6213D,conference-call,100,50,8/28/2018
A631A3,partnership,100,61,8/28/2018
A631A3,conference-participant,100,50,8/28/2018
A63387,business-contract,100,69,8/28/2018
A63820,product-release,100,64,8/28/2018
A6FB29,earnings,100,50,8/28/2018
A790A5,dividend,100,50,8/28/2018
AB4A7E,conference-participant,100,50,8/28/2018
ADF092,partnership,100,61,8/28/2018
AECCA9,dividend-up,100,81,8/28/2018
AED6CF,conference-call,100,50,8/28/2018
B3CB74,conference-organizer,100,57,8/28/2018
B3CB74,conference-organizer,100,57,8/28/2018
B4C673,product-release,100,64,8/28/2018
B83D67,conference-participant,100,50,8/28/2018
B98EFA,conference-participant,100,50,8/28/2018
BDF85E,earnings,100,50,8/28/2018
C188F8,legal-issues-defendant,100,22,8/28/2018
C188F8,earnings,100,50,8/28/2018
C22BE8,dividend,100,50,8/28/2018
C45C1F,conference-participant,100,50,8/28/2018
C4F9C6,conference-participant,100,50,8/28/2018
C93C44,conference-participant,100,50,8/28/2018
C9E4EC,earnings,100,50,8/28/2018
CB7AB2,award,100,58,8/28/2018
CB89EA,executive-appointment,100,54,8/28/2018
CBB77B,conference-participant,100,50,8/28/2018
CE4FD9,trading-resumed,100,58,8/28/2018
CE96E7,executive-appointment,100,54,8/28/2018
D04D9F,acquisition-acquirer,100,49,8/28/2018
D25249,merger-regulatory-approval,100,81,8/28/2018
D25249,merger-regulatory-approval,100,81,8/28/2018
D25249,index-listing,100,76,8/28/2018
D4AC65,product-release,100,64,8/28/2018
D60BB2,product-release,100,64,8/28/2018
D64C6D,conference-call,100,50,8/28/2018
D90F43,product-release,100,64,8/28/2018
DB88A1,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,earnings,100,50,8/28/2018
DBB28E,executive-appointment,100,54,8/28/2018
DD1BA1,conference-participant,100,50,8/28/2018
DD3BB1,legal-issues-defendant,100,22,8/28/2018
DD3BB1,legal-issues-defendant,100,22,8/28/2018
DF6FDD,executive-appointment,100,54,8/28/2018
E05026,earnings,100,50,8/28/2018
E074A0,dividend,100,50,8/28/2018
E21871,conference-participant,100,50,8/28/2018
E49AA3,dividend,100,50,8/28/2018
E8846E,conference-organizer,100,57,8/28/2018
E8846E,conference-organizer,100,57,8/28/2018
E8846E,conference-organizer,100,57,8/28/2018
EEA734,conference-participant,100,50,8/28/2018
EFD406,executive-appointment,100,54,8/28/2018
F02170,revenue-up,100,70,8/28/2018
F02170,revenue-up,100,69,8/28/2018
F02170,revenue-up,100,69,8/28/2018
F02170,revenue-up,100,69,8/28/2018
F02170,revenue-up,100,69,8/28/2018
F1CD47,conference-participant,100,50,8/28/2018
F2E253,facility-open,100,65,8/28/2018
F43A11,conference-call,100,50,8/28/2018
F6E248,executive-appointment,100,54,8/28/2018
FB7724,executive-appointment,100,54,8/28/2018
FC1736,earnings,100,50,8/28/2018
FC1F9D,donation,100,54,8/28/2018
FD6926,patient-enrollment-start,100,58,8/28/2018
20751,conference-participant,100,50,8/29/2018
05D148,conference-participant,100,50,8/29/2018
06A456,earnings-per-share-above-expectations,100,83,8/29/2018
070B45,legal-issues-defendant,100,22,8/29/2018
07EC43,conference-participant,100,50,8/29/2018
07EC43,hirings,100,65,8/29/2018
099C88,conference-participant,100,50,8/29/2018
0C6861,conference-participant,100,50,8/29/2018
0CC62B,conference-participant,100,50,8/29/2018
0E5223,conference-participant,100,50,8/29/2018
0E5619,conference-participant,100,50,8/29/2018
0F04E5,conference-participant,100,50,8/29/2018
1279ED,conference-participant,100,50,8/29/2018
184988,conference-participant,100,50,8/29/2018
1880C5,conference-participant,100,50,8/29/2018
1921DD,business-contract,100,69,8/29/2018
1D3A00,earnings,100,50,8/29/2018
1D3A00,earnings,100,50,8/29/2018
1D3A00,earnings,100,50,8/29/2018
239106,legal-issues-defendant,100,22,8/29/2018
239106,legal-issues-defendant,100,22,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
251988,earnings,100,50,8/29/2018
2B49F4,conference-call,100,50,8/29/2018
2BA977,conference-call,100,50,8/29/2018
2CC60C,revenues,100,50,8/29/2018
2D643C,conference-participant,100,50,8/29/2018
2E1322,conference-participant,100,50,8/29/2018
2E2E6E,dividend,100,50,8/29/2018
2EC172,executive-appointment,100,54,8/29/2018
2F5256,executive-appointment,100,54,8/29/2018
33AD83,product-release,100,64,8/29/2018
33AD83,product-release,100,64,8/29/2018
36529A,conference-participant,100,50,8/29/2018
37020C,dividend,100,50,8/29/2018
3F868D,unit-acquisition-acquirer,100,49,8/29/2018
4017AD,dividend,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
414FFF,revenues,100,50,8/29/2018
420168,conference-participant,100,50,8/29/2018
431B74,dividend,100,50,8/29/2018
431B74,dividend,100,50,8/29/2018
43A74A,conference-participant,100,50,8/29/2018
44209A,earnings,100,50,8/29/2018
45ABCC,product-release,100,64,8/29/2018
45ABCC,conference-participant,100,50,8/29/2018
46017C,conference-participant,100,50,8/29/2018
49BBBC,investment-investor,100,55,8/29/2018
4A6F00,partnership,100,61,8/29/2018
4A6F00,partnership,100,61,8/29/2018
4C3FE9,conference-participant,100,50,8/29/2018
50070E,conference-organizer,100,57,8/29/2018
50070E,conference-organizer,100,57,8/29/2018
54A646,dividend,100,50,8/29/2018
54F271,conference-participant,100,50,8/29/2018
57356F,conference-participant,100,50,8/29/2018
589846,earnings,100,50,8/29/2018
5E7E82,dividend,100,50,8/29/2018
5F2FF7,conference-participant,100,50,8/29/2018
6166D1,executive-appointment,100,54,8/29/2018
64E346,conference-participant,100,50,8/29/2018
665D7D,legal-issues-defendant,100,22,8/29/2018
66E04A,partnership,100,61,8/29/2018
67303E,conference-participant,100,50,8/29/2018
6E705B,conference-participant,100,50,8/29/2018
6F3936,earnings,100,50,8/29/2018
6F3936,earnings,100,50,8/29/2018
6F3936,earnings,100,50,8/29/2018
6F3936,earnings,100,50,8/29/2018
6F3936,earnings,100,50,8/29/2018
6F3936,earnings,100,50,8/29/2018
6F3936,earnings,100,50,8/29/2018
762A3E,conference-organizer,100,57,8/29/2018
762A3E,conference-organizer,100,57,8/29/2018
762A3E,conference-organizer,100,57,8/29/2018
762A3E,conference-organizer,100,57,8/29/2018
77B8E9,clinical-trials,100,56,8/29/2018
7AB859,partnership,100,61,8/29/2018
7C790D,conference-participant,100,50,8/29/2018
7E0EB0,conference-participant,100,50,8/29/2018
7F3669,business-contract,100,69,8/29/2018
82C202,conference-participant,100,50,8/29/2018
834152,conference-participant,100,50,8/29/2018
83B1C8,conference-participant,100,50,8/29/2018
863350,earnings,100,50,8/29/2018
863350,executive-appointment,100,54,8/29/2018
890FF4,award,100,58,8/29/2018
8C311A,partnership,100,61,8/29/2018
8D0EEA,conference-participant,100,50,8/29/2018
8EDACA,earnings,100,50,8/29/2018
8EDACA,buybacks,100,74,8/29/2018
9004C4,earnings,100,50,8/29/2018
911AB8,partnership,100,61,8/29/2018
9196A2,conference-organizer,100,57,8/29/2018
925759,conference-participant,100,50,8/29/2018
92B625,conference-participant,100,50,8/29/2018
9.31E+77,conference-participant,100,50,8/29/2018
96A6CD,conference-participant,100,50,8/29/2018
990AD0,conference-organizer,100,57,8/29/2018
9978F1,conference-participant,100,50,8/29/2018
9BB35A,conference-participant,100,50,8/29/2018
9CE4C7,conference-participant,100,50,8/29/2018
9D5FA4,conference-participant,100,50,8/29/2018
A072C4,conference-participant,100,50,8/29/2018
A204A7,conference-participant,100,50,8/29/2018
A5195E,conference-participant,100,50,8/29/2018
A5A4F5,acquisition-acquirer,100,49,8/29/2018
A70BF5,product-release,100,64,8/29/2018
A761FE,earnings,100,50,8/29/2018
AA3AB8,earnings,100,50,8/29/2018
AD6141,conference-participant,100,50,8/29/2018
ADFB3A,conference-participant,100,50,8/29/2018
AECCA9,earnings,100,50,8/29/2018
AECCA9,earnings,100,50,8/29/2018
AECCA9,earnings,100,50,8/29/2018
AECCA9,earnings,100,50,8/29/2018
AECCA9,earnings,100,50,8/29/2018
AECCA9,earnings,100,50,8/29/2018
AECCA9,earnings,100,50,8/29/2018
AEF2C3,conference-participant,100,50,8/29/2018
B01111,earnings,100,50,8/29/2018
B04426,conference-participant,100,50,8/29/2018
B0D41A,conference-participant,100,50,8/29/2018
B3A166,legal-issues-defendant,100,22,8/29/2018
B3CB74,conference-organizer,100,57,8/29/2018
B72BE9,dividend,100,50,8/29/2018
B7FA9B,unit-acquisition-acquirer,100,49,8/29/2018
B80AD1,conference-participant,100,50,8/29/2018
BB127B,earnings-up,100,68,8/29/2018
BFE02C,conference-participant,100,50,8/29/2018
C0F70B,conference-participant,100,50,8/29/2018
C1114B,executive-appointment,100,54,8/29/2018
C188F8,legal-issues-defendant,100,22,8/29/2018
C58D71,conference-participant,100,50,8/29/2018
C5C137,acquisition-acquirer,100,49,8/29/2018
C72B8F,conference-participant,100,50,8/29/2018
C8FAC7,partnership,100,61,8/29/2018
C941DC,executive-appointment,100,54,8/29/2018
C9732E,earnings,100,50,8/29/2018
C97B2D,conference-participant,100,50,8/29/2018
CB89EA,product-release,100,64,8/29/2018
CBB77B,conference-participant,100,50,8/29/2018
CC0C78,conference-participant,100,50,8/29/2018
CC339B,dividend,100,50,8/29/2018
CD4DA8,executive-appointment,100,54,8/29/2018
CDAB24,conference-participant,100,50,8/29/2018
CDAF5B,acquisition-acquirer,100,49,8/29/2018
CE5C6E,conference-participant,100,50,8/29/2018
CF6A5A,product-release,100,64,8/29/2018
CFF97C,credit-rating-downgrade-rater,20,50,8/29/2018
D4AC65,product-release,100,64,8/29/2018
D5938F,conference-participant,100,50,8/29/2018
DD1BA1,acquisition-acquirer,100,49,8/29/2018
DF6FDD,buybacks,100,74,8/29/2018
E4CE73,conference-participant,100,50,8/29/2018
E592F0,conference-participant,100,50,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-organizer,100,57,8/29/2018
E8846E,conference-participant,100,50,8/29/2018
EA79C7,conference-participant,100,50,8/29/2018
ECD263,executive-appointment,100,54,8/29/2018
EDF5CA,conference-participant,100,50,8/29/2018
F0027C,conference-participant,100,50,8/29/2018
F11638,conference-participant,100,50,8/29/2018
F569FD,conference-participant,100,50,8/29/2018
F5D410,conference-participant,100,50,8/29/2018
FC1A6E,conference-participant,100,50,8/29/2018
FD554E,dividend,100,50,8/29/2018
FD6926,conference-participant,100,50,8/29/2018
FDD3FC,conference-participant,100,50,8/29/2018
FF4BA4,conference-participant,100,50,8/29/2018
00067A,conference-participant,100,50,8/30/2018
00326E,product-release,100,64,8/30/2018
00E601,dividend,100,50,8/30/2018
03D5F9,award,100,58,8/30/2018
03FAA6,conference-participant,100,50,8/30/2018
0624BE,earnings,100,50,8/30/2018
09F623,conference-participant,100,50,8/30/2018
0A748B,public-offering,100,43,8/30/2018
0B57D7,dividend,100,50,8/30/2018
0CE7F6,executive-appointment,100,54,8/30/2018
1080C0,conference-participant,100,50,8/30/2018
108FDA,note-sale,100,52,8/30/2018
1201B5,earnings,100,50,8/30/2018
143C52,earnings,100,50,8/30/2018
159739,conference-call,100,50,8/30/2018
196D18,conference-participant,100,50,8/30/2018
1A3E1B,conference-participant,100,50,8/30/2018
1AC649,conference-participant,100,50,8/30/2018
1D9E55,executive-resignation,100,44,8/30/2018
202E5A,conference-participant,100,50,8/30/2018
21D903,unit-acquisition-completed-acquiree,100,67,8/30/2018
232053,executive-appointment,100,54,8/30/2018
25102A,conference-participant,100,50,8/30/2018
251988,product-release,100,64,8/30/2018
2667B6,conference-participant,100,50,8/30/2018
275300,conference-participant,100,50,8/30/2018
284289,conference-participant,100,50,8/30/2018
2920D5,dividend,100,50,8/30/2018
2BF36E,conference-participant,100,50,8/30/2018
2E89AE,legal-issues-defendant,100,22,8/30/2018
2E89AE,conference-participant,100,50,8/30/2018
315EB0,conference-participant,100,50,8/30/2018
3.20E+263,conference-participant,100,50,8/30/2018
33E9D5,earnings,100,50,8/30/2018
3461CF,acquisition-acquirer,100,49,8/30/2018
3461CF,acquisition-acquirer,100,49,8/30/2018
3.88E+02,executive-appointment,100,54,8/30/2018
3A3447,facility-open,100,65,8/30/2018
41785E,conference-participant,100,50,8/30/2018
42978B,revenue-up,100,69,8/30/2018
42978B,revenue-up,100,69,8/30/2018
42978B,revenue-up,100,69,8/30/2018
42EFC7,earnings,100,50,8/30/2018
43E8F5,executive-appointment,100,54,8/30/2018
44209A,earnings,100,50,8/30/2018
4455C4,conference-participant,100,50,8/30/2018
485445,conference-participant,100,50,8/30/2018
4A5C8D,revenue-up,100,69,8/30/2018
4A6F00,partnership,100,61,8/30/2018
4A6F00,partnership,100,61,8/30/2018
4E4E75,earnings,100,50,8/30/2018
4E5784,conference-participant,100,50,8/30/2018
50070E,conference-organizer,100,57,8/30/2018
50070E,conference-organizer,100,57,8/30/2018
50070E,conference-organizer,100,57,8/30/2018
50070E,conference-organizer,100,57,8/30/2018
504FE2,conference-participant,100,50,8/30/2018
50D1EC,conference-participant,100,50,8/30/2018
543900,earnings,100,50,8/30/2018
545272,conference-participant,100,50,8/30/2018
54F1D2,conference-organizer,100,57,8/30/2018
556F08,conference-participant,100,50,8/30/2018
55ACCB,executive-appointment,100,54,8/30/2018
57CAAB,partnership,100,61,8/30/2018
586BD7,conference-participant,100,50,8/30/2018
594402,acquisition-completed-acquirer,100,49,8/30/2018
59872F,earnings,100,50,8/30/2018
5C7601,conference-participant,100,50,8/30/2018
5C8D61,conference-participant,100,50,8/30/2018
5D1956,earnings,100,50,8/30/2018
5F1B7B,product-release,100,64,8/30/2018
60FE03,conference-participant,100,50,8/30/2018
6137BF,conference-participant,100,50,8/30/2018
673C9A,conference-call,100,50,8/30/2018
6830FE,earnings,100,50,8/30/2018
68586A,conference-participant,100,50,8/30/2018
69CE71,conference-participant,100,50,8/30/2018
6D156D,conference-participant,100,50,8/30/2018
6D4636,award,100,58,8/30/2018
6DD6BA,conference-participant,100,50,8/30/2018
6E705B,product-release,100,64,8/30/2018
6F3FA8,dividend,100,50,8/30/2018
717DB4,acquisition-acquirer,100,49,8/30/2018
72CB93,conference-participant,100,50,8/30/2018
73F7F9,earnings,100,50,8/30/2018
763DBE,patient-enrollment-complete,100,64,8/30/2018
763DBE,patient-enrollment-complete,100,64,8/30/2018
76D79A,dividend,100,50,8/30/2018
79340A,buybacks,100,74,8/30/2018
7ADE57,conference-call,100,50,8/30/2018
7B6C88,partnership,100,61,8/30/2018
7BC92D,conference-participant,100,50,8/30/2018
7E1D5D,conference-participant,100,50,8/30/2018
837C04,executive-appointment,100,54,8/30/2018
859D62,conference-participant,100,50,8/30/2018
87B81A,conference-participant,100,50,8/30/2018
8B3B0E,note-sale,100,52,8/30/2018
8CF6DD,conference-call,100,50,8/30/2018
8CF6DD,conference-participant,100,50,8/30/2018
90D6A5,dividend-up,100,81,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
9196A2,conference-organizer,100,57,8/30/2018
94637C,regulatory-product-approval-granted,100,81,8/30/2018
947B0B,conference-participant,100,50,8/30/2018
949625,conference-participant,100,50,8/30/2018
958938,conference-call,100,50,8/30/2018
95DC1F,conference-call,100,50,8/30/2018
966ACE,conference-participant,100,50,8/30/2018
966DBE,business-contract,100,69,8/30/2018
96B4FF,earnings,100,50,8/30/2018
96B4FF,earnings,100,50,8/30/2018
97693A,earnings,100,50,8/30/2018
977A1E,award,100,58,8/30/2018
9810C0,conference-participant,100,50,8/30/2018
990AD0,conference-organizer,100,57,8/30/2018
990AD0,conference-organizer,100,57,8/30/2018
997348,dividend,100,50,8/30/2018
9BF177,conference-participant,100,50,8/30/2018
9D65C1,legal-issues-defendant,100,22,8/30/2018
9F5CBB,dividend,100,50,8/30/2018
A5151E,conference-participant,100,50,8/30/2018
A5A4F5,acquisition-acquirer,100,49,8/30/2018
A63387,executive-appointment,100,54,8/30/2018
A63820,earnings,100,50,8/30/2018
A6FC89,earnings-up,100,68,8/30/2018
A6FC89,earnings,100,50,8/30/2018
A6FC89,earnings,100,50,8/30/2018
A6FC89,earnings,100,50,8/30/2018
A72AB6,earnings-per-share,100,50,8/30/2018
AA09AD,fundraising,100,64,8/30/2018
AEF2C3,conference-participant,100,50,8/30/2018
AEFC90,conference-participant,100,50,8/30/2018
AFF7B4,award,100,58,8/30/2018
B13B68,conference-participant,100,50,8/30/2018
B6082A,dividend,100,50,8/30/2018
B77F14,partnership,100,61,8/30/2018
BE645B,conference-participant,100,50,8/30/2018
C564E4,conference-participant,100,50,8/30/2018
C5C137,partnership,100,61,8/30/2018
C5D2AE,conference-participant,100,50,8/30/2018
C81E00,acquisition-acquirer,100,49,8/30/2018
C81E00,acquisition-acquirer,100,49,8/30/2018
C8923A,conference-participant,100,50,8/30/2018
C941DC,conference-participant,100,50,8/30/2018
CB6A9C,conference-participant,100,50,8/30/2018
CC6F6E,earnings,100,50,8/30/2018
CC6F6E,earnings,100,50,8/30/2018
CC6F6E,earnings,100,50,8/30/2018
CC6F6E,earnings,100,50,8/30/2018
CD2DA4,earnings,100,50,8/30/2018
CF7292,earnings,100,50,8/30/2018
CFD4B6,conference-participant,100,50,8/30/2018
CFF57D,earnings,100,50,8/30/2018
CFF57D,earnings,100,50,8/30/2018
CFF57D,earnings,100,50,8/30/2018
CFF57D,earnings,100,50,8/30/2018
D1CFC8,conference-call,100,50,8/30/2018
D42DBA,product-release,100,64,8/30/2018
D5938F,earnings,100,50,8/30/2018
D5938F,earnings,100,50,8/30/2018
D697DE,conference-participant,100,50,8/30/2018
D854DD,dividend,100,50,8/30/2018
D854F3,conference-participant,100,50,8/30/2018
DA9443,conference-participant,100,50,8/30/2018
DC0D18,acquisition-completed-acquirer,100,49,8/30/2018
DC2B00,earnings,100,50,8/30/2018
DC486E,product-release,100,64,8/30/2018
DD3BB1,legal-issues-defendant,100,22,8/30/2018
DDEA6A,conference-participant,100,50,8/30/2018
E22FDE,conference-participant,100,50,8/30/2018
E35610,conference-participant,100,50,8/30/2018
E35610,conference-participant,100,50,8/30/2018
E68C3D,conference-participant,100,50,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8846E,conference-organizer,100,57,8/30/2018
E8C557,conference-participant,100,50,8/30/2018
EDF5CA,buybacks,100,74,8/30/2018
EE74E1,partnership,100,61,8/30/2018
EE967B,dividend,100,50,8/30/2018
EF25A5,conference-participant,100,50,8/30/2018
F2E253,legal-issues-defendant,100,22,8/30/2018
F2E253,legal-issues-defendant,100,22,8/30/2018
F2E253,legal-issues-defendant,100,22,8/30/2018
F46EC9,conference-participant,100,50,8/30/2018
F46EC9,conference-participant,100,50,8/30/2018
F57F6F,conference-participant,100,50,8/30/2018
F58C23,conference-call,100,50,8/30/2018
F6E248,conference-participant,100,50,8/30/2018
F88147,conference-participant,100,50,8/30/2018
FD0CA4,conference-participant,100,50,8/30/2018
FD554E,conference-participant,100,50,8/30/2018
FDE409,revenues,100,50,8/30/2018
FDF1C0,dividend,100,50,8/30/2018
FF227B,conference-participant,100,50,8/30/2018
0157B1,stock-gain,100,63,8/31/2018
02870F,dividend,100,50,8/31/2018
0F0440,partnership,100,61,8/31/2018
159AE4,conference-participant,100,50,8/31/2018
1782D5,dividend,100,50,8/31/2018
1E1125,executive-appointment,100,54,8/31/2018
1FCC00,dividend,100,50,8/31/2018
1FCC00,earnings,100,50,8/31/2018
1FCC00,earnings,100,50,8/31/2018
1FCC00,earnings,100,50,8/31/2018
251988,product-release,100,64,8/31/2018
2E902B,conference-participant,100,50,8/31/2018
2EBC0B,award,100,58,8/31/2018
3A3447,facility-open,100,65,8/31/2018
3BA1BF,conference-participant,100,50,8/31/2018
3C7F5F,legal-issues-defendant,100,22,8/31/2018
434F38,patent-infringement-plaintiff,100,47,8/31/2018
45BC35,conference-participant,100,50,8/31/2018
46017C,partnership,100,61,8/31/2018
4FCC78,acquisition-completed-acquirer,100,49,8/31/2018
50070E,conference-organizer,100,57,8/31/2018
54DF47,dividend,100,50,8/31/2018
762A3E,conference-organizer,100,57,8/31/2018
76DD0C,earnings,100,50,8/31/2018
7740DE,dividend,100,50,8/31/2018
7B9AFA,conference-participant,100,50,8/31/2018
82FD6D,conference-participant,100,50,8/31/2018
877C0C,partnership,100,61,8/31/2018
877C0C,partnership,100,61,8/31/2018
877C0C,conference-participant,100,50,8/31/2018
8BE916,executive-appointment,100,54,8/31/2018
9196A2,conference-organizer,100,57,8/31/2018
93965C,partnership,100,61,8/31/2018
9810C0,dividend,100,50,8/31/2018
A1EAC8,executive-appointment,100,54,8/31/2018
A5A4F5,acquisition-acquirer,100,49,8/31/2018
A6828A,regulatory-product-approval-granted,100,81,8/31/2018
AE7D16,partnership,100,61,8/31/2018
AEFC90,clinical-trials-complete,100,56,8/31/2018
C188F8,legal-issues-defendant,100,22,8/31/2018
C188F8,legal-issues-defendant,100,22,8/31/2018
C7859D,dividend,100,50,8/31/2018
CC8F6E,conference-participant,100,50,8/31/2018
CD4DA8,executive-appointment,100,54,8/31/2018
CD4DA8,executive-appointment,100,54,8/31/2018
CF211D,earnings,100,50,8/31/2018
D3CEDF,partnership,100,61,8/31/2018
D56E4C,conference-participant,100,50,8/31/2018
D6489C,legal-issues-defendant,100,22,8/31/2018
D854DD,executive-appointment,100,54,8/31/2018
DB5CA5,merger,100,66,8/31/2018
DB5CA5,merger,100,66,8/31/2018
E2F130,asset-sale,100,62,8/31/2018
EC70EC,asset-sale,100,62,8/31/2018
F05B1B,conference-participant,100,50,8/31/2018
F2E253,legal-issues-defendant,100,22,8/31/2018
F2E253,legal-issues-defendant,100,22,8/31/2018
F2E253,legal-issues-defendant,100,22,8/31/2018
F2E253,legal-issues-defendant,100,22,8/31/2018
F2E253,legal-issues-defendant,100,22,8/31/2018
F4D241,conference-participant,100,50,8/31/2018
F509E2,conference-participant,100,50,8/31/2018
F5349B,legal-issues-defendant,100,22,8/31/2018
F88147,exchange-compliance,100,76,8/31/2018
239106,legal-issues-defendant,100,22,9/1/2018
D25249,acquisition-completed-acquirer,100,49,9/1/2018
D25249,acquisition-completed-acquirer,100,49,9/1/2018
F2E253,legal-issues-defendant,100,22,9/1/2018
65D0AA,conference-participant,100,50,9/2/2018
A5A4F5,acquisition-acquirer,100,49,9/3/2018
A6828A,regulatory-product-approval-granted,100,81,9/3/2018
B3A166,legal-issues-defendant,100,22,9/3/2018
EEA6B3,partnership,100,61,9/3/2018
01D03F,regulatory-product-approval-granted,100,81,9/4/2018
081AB9,conference-participant,100,50,9/4/2018
0C2A0D,product-release,100,64,9/4/2018
0CE204,partnership,100,61,9/4/2018
0CE204,partnership,100,61,9/4/2018
131443,product-release,100,64,9/4/2018
15789A,conference-participant,100,50,9/4/2018
159739,public-offering,100,43,9/4/2018
16B183,executive-appointment,100,54,9/4/2018
16F4D8,conference-participant,100,50,9/4/2018
17EDA5,partnership,100,61,9/4/2018
17EDA5,partnership,100,61,9/4/2018
184988,clinical-trials,100,56,9/4/2018
1D943E,acquisition-acquirer,100,49,9/4/2018
1DE526,conference-participant,100,50,9/4/2018
1E1125,conference-organizer,100,57,9/4/2018
1E9A6D,conference-participant,100,50,9/4/2018
1EC3E8,acquisition-completed-acquirer,100,49,9/4/2018
1F9D90,executive-appointment,100,54,9/4/2018
20BEEA,buybacks,100,74,9/4/2018
219B21,executive-resignation,100,44,9/4/2018
2262BD,earnings,100,50,9/4/2018
253B2F,buybacks,100,74,9/4/2018
26CC63,earnings,100,50,9/4/2018
26CC63,partnership,100,61,9/4/2018
2B9DBB,executive-appointment,100,54,9/4/2018
2C3348,clinical-trials-start,100,64,9/4/2018
2DC88B,conference-participant,100,50,9/4/2018
32CB22,executive-appointment,100,54,9/4/2018
32F943,conference-participant,100,50,9/4/2018
33AD83,executive-appointment,100,54,9/4/2018
3461CF,conference-participant,100,50,9/4/2018
370C50,product-price-raise,100,57,9/4/2018
371B0A,stake-acquirer,100,48,9/4/2018
3B50FE,conference-call,100,50,9/4/2018
3B8484,acquisition-acquirer,100,49,9/4/2018
3BA1BF,acquisition-interest-acquirer,100,46,9/4/2018
3FBC9B,asset-sale,100,62,9/4/2018
4.00E+163,acquisition-acquirer,100,49,9/4/2018
4A2457,business-contract,100,69,9/4/2018
4B3555,executive-appointment,100,54,9/4/2018
4B7006,earnings,100,50,9/4/2018
4EE14A,acquisition-acquirer,100,49,9/4/2018
4EE14A,acquisition-acquirer,100,49,9/4/2018
4F783B,executive-appointment,100,54,9/4/2018
514067,executive-appointment,100,54,9/4/2018
553949,acquisition-completed-acquirer,100,49,9/4/2018
56EA2B,dividend,100,50,9/4/2018
594402,partnership,100,61,9/4/2018
594402,partnership,100,61,9/4/2018
596116,asset-sale,100,62,9/4/2018
59A832,dividend,100,50,9/4/2018
5B3415,executive-appointment,100,54,9/4/2018
5EAA43,executive-appointment,100,54,9/4/2018
61BCA7,executive-appointment,100,54,9/4/2018
636BBF,product-release,100,64,9/4/2018
63F892,product-release,100,64,9/4/2018
63F892,product-release,100,64,9/4/2018
64E615,facility-open,100,65,9/4/2018
6634D9,partnership,100,61,9/4/2018
66749D,acquisition-completed-acquirer,100,49,9/4/2018
68AB62,conference-call,100,50,9/4/2018
693ECD,executive-appointment,100,54,9/4/2018
69494C,executive-appointment,100,54,9/4/2018
6B236C,conference-participant,100,50,9/4/2018
6C4D2F,merger-completed,100,66,9/4/2018
6F0096,dividend,100,50,9/4/2018
701531,note-sale,100,52,9/4/2018
717DB4,conference-participant,100,50,9/4/2018
73A213,earnings,100,50,9/4/2018
73F70F,earnings,100,50,9/4/2018
762A3E,executive-appointment,100,54,9/4/2018
763DBE,conference-participant,100,50,9/4/2018
76959C,conference-participant,100,50,9/4/2018
76DD0C,conference-participant,100,50,9/4/2018
77B8E9,conference-participant,100,50,9/4/2018
78F9ED,executive-appointment,100,54,9/4/2018
7A0EC4,acquisition-completed-acquirer,100,49,9/4/2018
7B0BA6,asset-sale,100,62,9/4/2018
8303CD,executive-appointment,100,54,9/4/2018
862941,executive-appointment,100,54,9/4/2018
8665BA,conference-participant,100,50,9/4/2018
86A1B9,executive-appointment,100,54,9/4/2018
896771,acquisition-completed-acquirer,100,49,9/4/2018
8B4A45,facility-open,100,65,9/4/2018
8E10BF,executive-appointment,100,54,9/4/2018
8EF425,dividend,100,50,9/4/2018
903AB4,dividend,100,50,9/4/2018
903AB4,public-offering,100,43,9/4/2018
915E7B,conference-participant,100,50,9/4/2018
9196A2,conference-organizer,100,57,9/4/2018
9196A2,conference-organizer,100,57,9/4/2018
9196A2,conference-organizer,100,57,9/4/2018
9196A2,conference-organizer,100,57,9/4/2018
9196A2,conference-organizer,100,57,9/4/2018
9196A2,conference-organizer,100,57,9/4/2018
9196A2,executive-appointment,100,54,9/4/2018
9196A2,conference-organizer,100,57,9/4/2018
92B625,partnership,100,61,9/4/2018
92B625,partnership,100,61,9/4/2018
934029,conference-participant,100,50,9/4/2018
934CC3,executive-appointment,100,54,9/4/2018
93AD2E,executive-appointment,100,54,9/4/2018
9592FB,conference-participant,100,50,9/4/2018
95C392,executive-appointment,100,54,9/4/2018
9.65E+09,executive-resignation,100,44,9/4/2018
965360,conference-participant,100,50,9/4/2018
96F126,business-contract,100,69,9/4/2018
977A1E,merger,100,66,9/4/2018
9CA432,conference-participant,100,50,9/4/2018
A38F30,executive-appointment,100,54,9/4/2018
A495F7,product-release,100,64,9/4/2018
A5A4F5,acquisition-acquirer,100,49,9/4/2018
A631A3,conference-participant,100,50,9/4/2018
A6FB29,conference-organizer,100,57,9/4/2018
A6FB29,earnings-up,100,68,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A6FB29,earnings,100,50,9/4/2018
A70BF5,dividend,100,50,9/4/2018
A8FDE8,executive-appointment,100,54,9/4/2018
AA3AB8,public-offering,100,43,9/4/2018
AC7C4F,business-contract,100,69,9/4/2018
AD22F2,earnings,100,50,9/4/2018
AD22F2,earnings,100,50,9/4/2018
AD22F2,earnings,100,50,9/4/2018
AD22F2,earnings,100,50,9/4/2018
AD22F2,earnings,100,50,9/4/2018
AD3C93,legal-issues-defendant,100,22,9/4/2018
AE4EEB,executive-resignation,100,44,9/4/2018
AED61E,earnings,100,50,9/4/2018
AFD1CA,facility-open,100,65,9/4/2018
B1A85D,executive-appointment,100,54,9/4/2018
B1FC3B,product-release,100,64,9/4/2018
B3CB74,settlement,100,56,9/4/2018
B8A51F,earnings,100,50,9/4/2018
BDEF34,dividend,100,50,9/4/2018
C0BA36,acquisition-completed-acquirer,100,49,9/4/2018
C3CF29,acquisition-completed-acquirer,100,49,9/4/2018
C72B8F,award,100,58,9/4/2018
C81E00,conference-participant,100,50,9/4/2018
CBB77B,earnings,100,50,9/4/2018
CDD75E,executive-appointment,100,54,9/4/2018
CDD75E,legal-issues-defendant,100,22,9/4/2018
CDFCC9,conference-participant,100,50,9/4/2018
CDFCC9,conference-participant,100,50,9/4/2018
CE8251,business-contract,100,69,9/4/2018
CEDFD5,patient-enrollment-start,100,58,9/4/2018
CEDFD5,patient-enrollment-start,100,58,9/4/2018
D03C7A,partnership,100,61,9/4/2018
D06996,acquisition-acquirer,100,49,9/4/2018
D82EF3,conference-participant,100,50,9/4/2018
DB23C8,executive-appointment,100,54,9/4/2018
E09997,conference-participant,100,50,9/4/2018
E28D9C,conference-participant,100,50,9/4/2018
E610CD,public-offering,100,43,9/4/2018
E8846E,conference-organizer,100,57,9/4/2018
E8846E,conference-organizer,100,57,9/4/2018
E8846E,investment-investor,100,55,9/4/2018
E96E0B,product-release,100,64,9/4/2018
E96E0B,stake-acquirer,100,48,9/4/2018
EAEBF3,conference-participant,100,50,9/4/2018
EF5BED,executive-appointment,100,54,9/4/2018
F0EEFB,conference-participant,100,50,9/4/2018
F3EDB4,earnings,100,50,9/4/2018
F43A11,earnings,100,50,9/4/2018
F47871,executive-appointment,100,54,9/4/2018
F6E248,business-contract,100,69,9/4/2018
FD4588,note-sale,100,52,9/4/2018
FE7A63,dividend,100,50,9/4/2018
FF6644,conference-participant,100,50,9/4/2018
FFE543,fraud-defendant,100,20,9/4/2018
FFE543,legal-issues-defendant,100,22,9/4/2018
FFE543,legal-issues-defendant,100,22,9/4/2018
68396,dividend,100,50,9/5/2018
099A92,conference-participant,100,50,9/5/2018
0A59F8,partnership,100,61,9/5/2018
0BA2EF,earnings,100,50,9/5/2018
0BA2EF,earnings,100,50,9/5/2018
10C19B,conference-participant,100,50,9/5/2018
12E454,product-release,100,64,9/5/2018
147C38,executive-appointment,100,54,9/5/2018
14833D,executive-appointment,100,54,9/5/2018
152E1D,conference-participant,100,50,9/5/2018
168A5D,product-release,100,64,9/5/2018
17EDA5,business-contract,100,69,9/5/2018
184866,conference-participant,100,50,9/5/2018
1921DD,business-contract,100,69,9/5/2018
1921DD,business-contract,100,69,9/5/2018
1BC12C,partnership,100,61,9/5/2018
1BC12C,partnership,100,61,9/5/2018
1BC12C,note-sale,100,52,9/5/2018
1D3A00,partnership,100,61,9/5/2018
1D9E55,acquisition-completed-acquirer,100,49,9/5/2018
1E1125,conference-organizer,100,57,9/5/2018
1E1125,conference-organizer,100,57,9/5/2018
1E1125,conference-organizer,100,57,9/5/2018
1E1125,conference-organizer,100,57,9/5/2018
1E1125,conference-organizer,100,57,9/5/2018
1E1125,conference-organizer,100,57,9/5/2018
1E1125,conference-organizer,100,57,9/5/2018
1E83DE,earnings,100,50,9/5/2018
1F9D90,conference-participant,100,50,9/5/2018
1FCC00,conference-participant,100,50,9/5/2018
206852,conference-participant,100,50,9/5/2018
21D903,earnings-guidance-up,100,83,9/5/2018
239106,legal-issues-defendant,100,22,9/5/2018
251988,business-contract,100,69,9/5/2018
267718,note-sale,100,52,9/5/2018
279916,earnings,100,50,9/5/2018
284289,executive-appointment,100,54,9/5/2018
31553A,partnership,100,61,9/5/2018
3301B7,acquisition-completed-acquirer,100,49,9/5/2018
33AD83,partnership,100,61,9/5/2018
33AD83,product-release,100,64,9/5/2018
34A959,partnership,100,61,9/5/2018
34A959,partnership,100,61,9/5/2018
34A959,partnership,100,61,9/5/2018
34A959,partnership,100,61,9/5/2018
35557B,conference-participant,100,50,9/5/2018
35AE32,partnership,100,61,9/5/2018
367E1C,conference-participant,100,50,9/5/2018
38C46F,dividend,100,50,9/5/2018
3DD5E2,product-release,100,64,9/5/2018
3E70FC,executive-appointment,100,54,9/5/2018
401072,conference-participant,100,50,9/5/2018
43A060,executive-appointment,100,54,9/5/2018
448215,dividend,100,50,9/5/2018
45ABCC,product-release,100,64,9/5/2018
467F2C,conference-participant,100,50,9/5/2018
4.60E+06,ownership-increase-owner,100,56,9/5/2018
49A344,business-contract,100,69,9/5/2018
49F4D0,conference-participant,100,50,9/5/2018
4BEB48,conference-participant,100,50,9/5/2018
50070E,conference-organizer,100,57,9/5/2018
50070E,conference-organizer,100,57,9/5/2018
51D876,acquisition-acquirer,100,49,9/5/2018
5225A4,conference-participant,100,50,9/5/2018
5487B1,dividend,100,50,9/5/2018
55438C,business-contract,100,69,9/5/2018
55438C,business-contract,100,69,9/5/2018
56EA2B,conference-call,100,50,9/5/2018
605F40,facility-open,100,65,9/5/2018
6166D1,executive-resignation,100,44,9/5/2018
6.18E+08,market-entry,100,57,9/5/2018
636BBF,earnings,100,50,9/5/2018
6559D8,executive-appointment,100,54,9/5/2018
66ECFD,award,100,58,9/5/2018
69345C,conference-participant,100,50,9/5/2018
6ED519,executive-appointment,100,54,9/5/2018
6F92A9,conference-participant,100,50,9/5/2018
7273FF,partnership,100,61,9/5/2018
728737,conference-participant,100,50,9/5/2018
756BB4,earnings-up,100,68,9/5/2018
756BB4,earnings,100,50,9/5/2018
756BB4,earnings,100,50,9/5/2018
756BB4,earnings,100,50,9/5/2018
762B8D,earnings,100,50,9/5/2018
76CEFB,public-offering,100,43,9/5/2018
7999F3,conference-participant,100,50,9/5/2018
7A0EC4,earnings,100,50,9/5/2018
7D35D8,conference-participant,100,50,9/5/2018
7D5FD6,dividend,100,50,9/5/2018
7FC386,dividend,100,50,9/5/2018
85CDC9,conference-participant,100,50,9/5/2018
85DA04,business-contract,100,69,9/5/2018
85DE00,conference-participant,100,50,9/5/2018
87486A,conference-participant,100,50,9/5/2018
893904,executive-appointment,100,54,9/5/2018
8AC65D,earnings,100,50,9/5/2018
8B8656,earnings,100,50,9/5/2018
8B8656,business-contract,100,69,9/5/2018
8B8656,partnership,100,61,9/5/2018
8BAA15,revenue-guidance,100,50,9/5/2018
8CF6DD,credit-extension-provider,100,57,9/5/2018
8DCF18,executive-appointment,100,54,9/5/2018
8FCA78,earnings-guidance-meet-expectations,100,59,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
9196A2,conference-organizer,100,57,9/5/2018
92005C,conference-participant,100,50,9/5/2018
94C0B5,executive-appointment,100,54,9/5/2018
957A07,business-contract,100,69,9/5/2018
958938,earnings,100,50,9/5/2018
958938,earnings,100,50,9/5/2018
966ACE,executive-appointment,100,54,9/5/2018
990AD0,conference-organizer,100,57,9/5/2018
9CA619,earnings-guidance-meet-expectations,100,59,9/5/2018
9D65C1,legal-issues-defendant,100,22,9/5/2018
A29DBD,note-sale,100,52,9/5/2018
A47A7D,conference-participant,100,50,9/5/2018
A5A4F5,dividend,100,50,9/5/2018
A5A4F5,dividend,100,50,9/5/2018
A5A4F5,acquisition-acquirer,100,49,9/5/2018
A6213D,conference-participant,100,50,9/5/2018
A72FD9,earnings,100,50,9/5/2018
A80FE0,conference-participant,100,50,9/5/2018
AAC8B6,conference-organizer,100,57,9/5/2018
AC7C4F,business-contract,100,69,9/5/2018
AD6141,conference-participant,100,50,9/5/2018
ADD9DC,earnings,100,50,9/5/2018
B01111,executive-appointment,100,54,9/5/2018
B3CB74,conference-organizer,100,57,9/5/2018
B7EB38,conference-participant,100,50,9/5/2018
C188F8,fraud-defendant,100,20,9/5/2018
C2609A,partnership,100,61,9/5/2018
C2609A,public-offering,100,43,9/5/2018
C38440,conference-participant,100,50,9/5/2018
C38440,executive-appointment,100,54,9/5/2018
C3BCD5,business-contract,100,69,9/5/2018
C65004,revenue-up,100,69,9/5/2018
C65004,earnings,100,50,9/5/2018
C74887,public-offering,100,43,9/5/2018
CA1620,legal-issues-defendant,100,22,9/5/2018
CA1620,legal-issues-defendant,100,22,9/5/2018
CBB77B,dividend,100,50,9/5/2018
CBFFDD,conference-participant,100,50,9/5/2018
CBFFDD,conference-participant,100,50,9/5/2018
CDAF5B,dividend,100,50,9/5/2018
CDD75E,legal-issues-defendant,100,22,9/5/2018
CDD75E,legal-issues-defendant,100,22,9/5/2018
D064D5,earnings,100,50,9/5/2018
D0909F,dividend,100,50,9/5/2018
D0909F,dividend,100,50,9/5/2018
D1C26F,business-contract,100,69,9/5/2018
D622D5,dividend,100,50,9/5/2018
D93A25,conference-participant,100,50,9/5/2018
D9C07E,executive-appointment,100,54,9/5/2018
DB5CA5,fundraising,100,64,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DB88A1,earnings,100,50,9/5/2018
DC486E,dividend,100,50,9/5/2018
DD1BA1,conference-participant,100,50,9/5/2018
DF204B,conference-participant,100,50,9/5/2018
E124EB,partnership,100,61,9/5/2018
E1E093,partnership,100,61,9/5/2018
E69BA5,conference-participant,100,50,9/5/2018
E866D2,partnership,100,61,9/5/2018
E8A49A,executive-appointment,100,54,9/5/2018
EC99D0,partnership,100,61,9/5/2018
EF5BED,executive-appointment,100,54,9/5/2018
EF77A3,earnings,100,50,9/5/2018
F1EB39,earnings,100,50,9/5/2018
F30508,clinical-trials-positive,100,87,9/5/2018
F46EC9,conference-participant,100,50,9/5/2018
F5349B,legal-issues-defendant,100,22,9/5/2018
F748C7,partnership,100,61,9/5/2018
FC01C0,executive-appointment,100,54,9/5/2018
FC4550,dividend,100,50,9/5/2018
FE609F,conference-participant,100,50,9/5/2018
FE7A63,conference-participant,100,50,9/5/2018
FEE4B0,executive-appointment,100,54,9/5/2018
FFE543,legal-issues-defendant,100,22,9/5/2018
FFE543,legal-issues-defendant,100,22,9/5/2018
FFE543,legal-issues-defendant,100,22,9/5/2018
FFE543,legal-issues-defendant,100,22,9/5/2018
13528,product-release,100,64,9/6/2018
0157B1,partnership,100,61,9/6/2018
034B61,partnership,100,61,9/6/2018
09DE1F,earnings,100,50,9/6/2018
0BF528,earnings-up,100,68,9/6/2018
0C6861,note-sale,100,52,9/6/2018
102F04,market-entry,100,57,9/6/2018
1201B5,revenue-up,100,92,9/6/2018
1201B5,revenue-up,100,92,9/6/2018
1201B5,revenue-up,100,92,9/6/2018
1272B3,unit-acquisition-acquirer,100,49,9/6/2018
12DE76,award,100,58,9/6/2018
15789A,conference-participant,100,50,9/6/2018
17EDA5,partnership,100,61,9/6/2018
1866B2,acquisition-acquirer,100,49,9/6/2018
1866B2,acquisition-acquirer,100,49,9/6/2018
1921DD,partnership,100,61,9/6/2018
1921DD,partnership,100,61,9/6/2018
1AD9CC,earnings,100,50,9/6/2018
1D9E55,conference-participant,100,50,9/6/2018
21245F,product-release,100,64,9/6/2018
221783,conference-participant,100,50,9/6/2018
228D42,partnership,100,61,9/6/2018
22C58E,partnership,100,61,9/6/2018
23207A,conference-call,100,50,9/6/2018
241AF7,dividend,100,50,9/6/2018
2571FA,executive-appointment,100,54,9/6/2018
26DC29,earnings,100,50,9/6/2018
279916,conference-participant,100,50,9/6/2018
2920D5,earnings,100,50,9/6/2018
2.90E+62,conference-participant,100,50,9/6/2018
2B7A40,business-contract,100,69,9/6/2018
2B8179,fundraising,100,64,9/6/2018
2BC05E,trading-halt,100,43,9/6/2018
2CC60C,dividend,100,50,9/6/2018
2E0496,conference-participant,100,50,9/6/2018
2E89AE,legal-issues-defendant,100,22,9/6/2018
31803E,conference-participant,100,50,9/6/2018
326EDD,dividend,100,50,9/6/2018
33AD83,earnings,100,50,9/6/2018
33AD83,partnership,100,61,9/6/2018
3461CF,credit-rating-upgrade-rater,20,50,9/6/2018
34A959,note-sale,100,52,9/6/2018
34B97A,unit-acquisition-acquirer,100,49,9/6/2018
3B37F7,note-sale,100,52,9/6/2018
3B37F7,note-sale,100,52,9/6/2018
3C7F5F,legal-issues-defendant,100,22,9/6/2018
3CBA2A,market-entry,100,57,9/6/2018
3CBA2A,market-entry,100,57,9/6/2018
3FBC9B,executive-appointment,100,54,9/6/2018
40B903,business-contract,100,69,9/6/2018
450ECB,acquisition-acquiree,100,76,9/6/2018
453282,conference-participant,100,50,9/6/2018
46A16E,buybacks,100,74,9/6/2018
4A2457,government-contract,100,69,9/6/2018
4A6F00,partnership,100,61,9/6/2018
4D371E,conference-participant,100,50,9/6/2018
52BF94,conference-call,100,50,9/6/2018
57CAAB,patient-enrollment-complete,100,64,9/6/2018
57CAAB,patient-enrollment-complete,100,64,9/6/2018
59872F,conference-participant,100,50,9/6/2018
605F40,executive-appointment,100,54,9/6/2018
609208,conference-call,100,50,9/6/2018
61A586,equity-shelf-registration,100,43,9/6/2018
622DBE,executive-appointment,100,54,9/6/2018
66E04A,facility-open,100,65,9/6/2018
67B052,conference-participant,100,50,9/6/2018
68BA15,acquisition-acquirer,100,49,9/6/2018
6A961B,earnings,100,50,9/6/2018
6B6375,partnership,100,61,9/6/2018
6CC55E,executive-resignation,100,44,9/6/2018
6DC1D7,dividend,100,50,9/6/2018
6E705B,conference-participant,100,50,9/6/2018
6E8864,conference-participant,100,50,9/6/2018
6F6559,product-release,100,64,9/6/2018
701531,note-sale,100,52,9/6/2018
70FCEF,earnings,100,50,9/6/2018
722D55,conference-participant,100,50,9/6/2018
72FCA3,partnership,100,61,9/6/2018
76CEFB,public-offering,100,43,9/6/2018
7740DE,same-store-sales-up,100,55,9/6/2018
7A5097,partnership,100,61,9/6/2018
7ADE57,earnings,100,50,9/6/2018
7ADE57,earnings,100,50,9/6/2018
7ADE57,earnings,100,50,9/6/2018
7ADE57,earnings,100,50,9/6/2018
7AF907,clinical-trials,100,56,9/6/2018
7B9212,revenues,100,50,9/6/2018
7C4F43,conference-participant,100,50,9/6/2018
7FDE1C,product-release,100,64,9/6/2018
80D744,conference-participant,100,50,9/6/2018
863350,public-offering,100,43,9/6/2018
88193E,conference-participant,100,50,9/6/2018
8A8E41,conference-participant,100,50,9/6/2018
8A8E41,dividend-up,100,81,9/6/2018
8A8E41,executive-appointment,100,54,9/6/2018
8C5519,dividend,100,50,9/6/2018
8C6C1B,facility-open,100,65,9/6/2018
8D0EEA,patient-enrollment-complete,100,64,9/6/2018
8D4486,partnership,100,61,9/6/2018
901327,business-contract,100,69,9/6/2018
902255,conference-participant,100,50,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
9196A2,conference-organizer,100,57,9/6/2018
91E5EE,conference-participant,100,50,9/6/2018
92D757,executive-appointment,100,54,9/6/2018
94637C,earnings,100,50,9/6/2018
954004,earnings,100,50,9/6/2018
95DC1F,partnership,100,61,9/6/2018
96B4FF,regulatory-product-approval-granted,100,81,9/6/2018
9.82E+06,earnings,100,50,9/6/2018
986AF6,buybacks,100,74,9/6/2018
98CEBB,business-contract,100,69,9/6/2018
98D33E,legal-issues-defendant,100,22,9/6/2018
99028D,earnings,100,50,9/6/2018
990AD0,conference-organizer,100,57,9/6/2018
9.97E+09,unit-acquisition-acquiree,100,76,9/6/2018
9B730A,conference-participant,100,50,9/6/2018
9BF177,earnings,100,50,9/6/2018
9BF177,executive-appointment,100,54,9/6/2018
9D30A8,executive-appointment,100,54,9/6/2018
9D6A24,merger,100,66,9/6/2018
9D6A24,merger,100,66,9/6/2018
9EBAFA,unit-acquisition-acquirer,100,49,9/6/2018
A1E3B3,conference-participant,100,50,9/6/2018
A247F5,conference-participant,100,50,9/6/2018
A4BCDE,dividend,100,50,9/6/2018
A52B6B,earnings,100,50,9/6/2018
A5A4F5,acquisition-acquirer,100,49,9/6/2018
A5DD24,conference-participant,100,50,9/6/2018
A6213D,product-recall,100,29,9/6/2018
A666C8,conference-participant,100,50,9/6/2018
A8B137,acquisition-acquirer,100,49,9/6/2018
AD23DE,conference-participant,100,50,9/6/2018
AEBB80,dividend,100,50,9/6/2018
B37FB4,conference-participant,100,50,9/6/2018
B3A166,legal-issues-defendant,100,22,9/6/2018
B5734D,earnings,100,50,9/6/2018
B5734D,earnings,100,50,9/6/2018
B5734D,earnings,100,50,9/6/2018
B642E8,dividend,100,50,9/6/2018
B8EF97,revenues,100,50,9/6/2018
BB127B,revenue-down,100,30,9/6/2018
BBBB41,conference-participant,100,50,9/6/2018
BE7BA4,asset-up,100,72,9/6/2018
C037A8,earnings,100,50,9/6/2018
C188F8,legal-issues-defendant,100,22,9/6/2018
C22BE8,partnership,100,61,9/6/2018
C2DD02,dividend,100,50,9/6/2018
C48574,revenue-up,100,69,9/6/2018
C48574,revenue-up,100,69,9/6/2018
C48574,revenue-up,100,69,9/6/2018
C48574,executive-appointment,100,54,9/6/2018
C65004,revenue-up,100,69,9/6/2018
C74887,public-offering,100,43,9/6/2018
C8923A,executive-appointment,100,54,9/6/2018
C9A96E,conference-participant,100,50,9/6/2018
C9E107,conference-participant,100,50,9/6/2018
CD2A4D,conference-participant,100,50,9/6/2018
CDD75E,legal-issues-defendant,100,22,9/6/2018
CE1002,conference-participant,100,50,9/6/2018
CFF97C,conference-participant,100,50,9/6/2018
CFF97C,conference-participant,100,50,9/6/2018
D1C0B9,hirings,100,65,9/6/2018
D296C6,dividend,100,50,9/6/2018
D42DBA,earnings,100,50,9/6/2018
D88EF3,executive-appointment,100,54,9/6/2018
D8F347,executive-appointment,100,54,9/6/2018
DAFED3,conference-participant,100,50,9/6/2018
DC0D18,acquisition-interest-acquirer,100,46,9/6/2018
DD3BB1,legal-issues-defendant,100,22,9/6/2018
DD3BB1,legal-issues-defendant,100,22,9/6/2018
DE5611,earnings,100,50,9/6/2018
E0207A,acquisition-acquirer,100,49,9/6/2018
E16133,conference-participant,100,50,9/6/2018
E20392,conference-participant,100,50,9/6/2018
E2CB7B,conference-participant,100,50,9/6/2018
E30B34,executive-appointment,100,54,9/6/2018
E3A829,ipo-pricing,100,50,9/6/2018
E49AA3,stake-acquirer,100,48,9/6/2018
E4CE73,partnership,100,61,9/6/2018
E94704,conference-participant,100,50,9/6/2018
EA62FC,conference-participant,100,50,9/6/2018
EC99D0,partnership,100,61,9/6/2018
EEEA9F,conference-participant,100,50,9/6/2018
EF5BED,conference-participant,100,50,9/6/2018
F1EB39,partnership,100,61,9/6/2018
F66B58,earnings,100,50,9/6/2018
F721A7,acquisition-completed-acquirer,100,49,9/6/2018
F721A7,acquisition-completed-acquirer,100,49,9/6/2018
F80389,business-contract,100,69,9/6/2018
FA40E2,earnings,100,50,9/6/2018
FACF19,partnership,100,61,9/6/2018
FACF19,partnership,100,61,9/6/2018
FC1B7B,conference-participant,100,50,9/6/2018
FC4550,conference-call,100,50,9/6/2018
FC9A88,executive-appointment,100,54,9/6/2018
FEC475,earnings,100,50,9/6/2018
FFE543,legal-issues-defendant,100,22,9/6/2018
02ACBD,executive-appointment,100,54,9/7/2018
054B55,earnings,100,50,9/7/2018
0BF528,product-release,100,64,9/7/2018
0BF528,conference-participant,100,50,9/7/2018
0C6861,legal-issues-defendant,100,22,9/7/2018
0C6861,legal-issues-defendant,100,22,9/7/2018
0C6861,legal-issues-defendant,100,22,9/7/2018
0DBB81,conference-participant,100,50,9/7/2018
0FABBD,index-listing,100,76,9/7/2018
1921DD,dividend,100,50,9/7/2018
1B5FEA,partnership,100,61,9/7/2018
1E83DE,conference-participant,100,50,9/7/2018
1EBF8D,conference-participant,100,50,9/7/2018
1F08A6,dividend,100,50,9/7/2018
1FC422,conference-participant,100,50,9/7/2018
221AD7,facility-open,100,65,9/7/2018
221AD7,facility-open,100,65,9/7/2018
295F9F,executive-appointment,100,54,9/7/2018
2C3348,trading-halt,100,43,9/7/2018
2D643C,conference-participant,100,50,9/7/2018
2EB04E,partnership,100,61,9/7/2018
2EBA55,dividend,100,50,9/7/2018
32F943,partnership,100,61,9/7/2018
34A959,note-sale,100,52,9/7/2018
3A3447,facility-open,100,65,9/7/2018
3B50FE,credit-extension-recipient,100,69,9/7/2018
420168,conference-participant,100,50,9/7/2018
4E7C1F,partnership,100,61,9/7/2018
50070E,conference-organizer,100,57,9/7/2018
50070E,conference-organizer,100,57,9/7/2018
50070E,conference-organizer,100,57,9/7/2018
50070E,conference-organizer,100,57,9/7/2018
50070E,conference-organizer,100,57,9/7/2018
53E575,name-change,100,49,9/7/2018
57DDB9,conference-participant,100,50,9/7/2018
665D7D,dividend,100,50,9/7/2018
67A658,dividend,100,50,9/7/2018
67A658,dividend,100,50,9/7/2018
752A70,executive-appointment,100,54,9/7/2018
76F067,conference-participant,100,50,9/7/2018
7B9AFA,conference-participant,100,50,9/7/2018
863350,public-offering,100,43,9/7/2018
8665BA,unit-acquisition-acquirer,100,49,9/7/2018
86A1B9,note-sale,100,52,9/7/2018
89E771,dividend,100,50,9/7/2018
8C6C1B,facility-open,100,65,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
9196A2,conference-organizer,100,57,9/7/2018
94983E,conference-participant,100,50,9/7/2018
97AF94,executive-appointment,100,54,9/7/2018
9CF9B1,conference-participant,100,50,9/7/2018
A16DEA,conference-participant,100,50,9/7/2018
A29DBD,note-sale,100,52,9/7/2018
A5A4F5,acquisition-acquirer,100,49,9/7/2018
AA3AB8,public-offering,100,43,9/7/2018
B762D3,earnings,100,50,9/7/2018
B762D3,earnings,100,50,9/7/2018
B762D3,earnings,100,50,9/7/2018
C4A912,executive-appointment,100,54,9/7/2018
C54140,conference-participant,100,50,9/7/2018
CA1620,legal-issues-defendant,100,22,9/7/2018
CB22CD,equity-shelf-registration,100,43,9/7/2018
CD06A2,conference-participant,100,50,9/7/2018
CD06A2,executive-appointment,100,54,9/7/2018
CDD75E,legal-issues-defendant,100,22,9/7/2018
D25249,dividend,100,50,9/7/2018
D622D5,operating-earnings,100,50,9/7/2018
D90F43,partnership,100,61,9/7/2018
D90F43,partnership,100,61,9/7/2018
D90F43,market-entry,100,57,9/7/2018
DB23C8,conference-participant,100,50,9/7/2018
DD3BB1,legal-issues-defendant,100,22,9/7/2018
E30B34,conference-participant,100,50,9/7/2018
E5752F,conference-participant,100,50,9/7/2018
E6EDED,dividend-up,100,81,9/7/2018
E8846E,earnings,100,50,9/7/2018
EB43F4,conference-participant,100,50,9/7/2018
ECA300,earnings,100,50,9/7/2018
EF1AD9,conference-participant,100,50,9/7/2018
FAB97A,partnership,100,61,9/7/2018
FEBFE1,ownership-increase-held,100,67,9/7/2018
FFE543,legal-issues-defendant,100,22,9/7/2018
90B678,legal-issues-defendant,100,22,9/8/2018
CA1620,legal-issues-defendant,100,22,9/8/2018
CA1620,legal-issues-defendant,100,22,9/8/2018
001F1B,earnings,100,50,9/10/2018
03B8CF,executive-appointment,100,54,9/10/2018
09DE1F,conference-participant,100,50,9/10/2018
0B13E8,executive-appointment,100,54,9/10/2018
0C6861,legal-issues-defendant,100,22,9/10/2018
0CBC4D,executive-appointment,100,54,9/10/2018
0CC62B,conference-call,100,50,9/10/2018
0CCCB7,executive-resignation,100,44,9/10/2018
1065BC,conference-participant,100,50,9/10/2018
1220D2,conference-participant,100,50,9/10/2018
12731D,note-sale,100,52,9/10/2018
12F98C,earnings,100,50,9/10/2018
12F98C,earnings,100,50,9/10/2018
15789A,executive-appointment,100,54,9/10/2018
17EDA5,partnership,100,61,9/10/2018
182BE7,conference-participant,100,50,9/10/2018
1921DD,dividend,100,50,9/10/2018
1921DD,dividend,100,50,9/10/2018
1921DD,dividend,100,50,9/10/2018
196D18,executive-appointment,100,54,9/10/2018
1DF15D,ipo,100,71,9/10/2018
1E83DE,product-release,100,64,9/10/2018
1EC3E8,executive-appointment,100,54,9/10/2018
2082EA,executive-appointment,100,54,9/10/2018
225CA2,executive-appointment,100,54,9/10/2018
225CA2,executive-appointment,100,54,9/10/2018
232053,product-release,100,64,9/10/2018
24C48B,product-release,100,64,9/10/2018
2C3348,legal-issues-defendant,100,22,9/10/2018
2C3348,legal-issues-defendant,100,22,9/10/2018
2E36AD,business-contract,100,69,9/10/2018
2E902B,conference-participant,100,50,9/10/2018
32CB22,acquisition-acquirer,100,49,9/10/2018
32CB22,acquisition-acquirer,100,49,9/10/2018
34B97A,executive-resignation,100,44,9/10/2018
385DD4,conference-participant,100,50,9/10/2018
3B2311,acquisition-completed-acquirer,100,49,9/10/2018
3BA1BF,conference-participant,100,50,9/10/2018
3DD5E2,conference-participant,100,50,9/10/2018
4.00E+163,partnership,100,61,9/10/2018
4.00E+163,partnership,100,61,9/10/2018
444CC8,earnings,100,50,9/10/2018
444CC8,earnings,100,50,9/10/2018
4D229C,executive-resignation,100,44,9/10/2018
51D876,conference-participant,100,50,9/10/2018
543900,executive-appointment,100,54,9/10/2018
5480A7,facility-open,100,65,9/10/2018
55D0F3,conference-participant,100,50,9/10/2018
56277A,conference-participant,100,50,9/10/2018
57A854,conference-participant,100,50,9/10/2018
57CAAB,executive-appointment,100,54,9/10/2018
583A75,revenue-volume,100,50,9/10/2018
59872F,business-contract,100,69,9/10/2018
59B229,executive-appointment,100,54,9/10/2018
5A0FF1,business-contract,100,69,9/10/2018
5B6C11,partnership,100,61,9/10/2018
5C7601,executive-appointment,100,54,9/10/2018
5EAA43,executive-appointment,100,54,9/10/2018
5EAA43,business-contract,100,69,9/10/2018
662682,executive-appointment,100,54,9/10/2018
665618,conference-participant,100,50,9/10/2018
6A01DF,public-offering,100,43,9/10/2018
6D3F35,conference-participant,100,50,9/10/2018
76F067,business-contract,100,69,9/10/2018
7B8CB5,conference-participant,100,50,9/10/2018
82E58A,executive-appointment,100,54,9/10/2018
82E58A,dividend-up,100,81,9/10/2018
885758,product-release,100,64,9/10/2018
88D80A,buybacks,100,74,9/10/2018
8BFAA4,public-offering,100,43,9/10/2018
8C6C1B,facility-open,100,65,9/10/2018
8D4486,partnership,100,61,9/10/2018
8D4486,partnership,100,61,9/10/2018
8DCF18,executive-appointment,100,54,9/10/2018
8E9CD8,conference-participant,100,50,9/10/2018
9043FE,debt-extension-recipient,100,73,9/10/2018
9043FE,debt-extension-recipient,100,73,9/10/2018
911AB8,stake-acquirer,100,48,9/10/2018
9196A2,conference-organizer,100,57,9/10/2018
9196A2,conference-organizer,100,57,9/10/2018
9196A2,conference-organizer,100,57,9/10/2018
9196A2,conference-organizer,100,57,9/10/2018
9196A2,conference-organizer,100,57,9/10/2018
9196A2,conference-organizer,100,57,9/10/2018
9196A2,conference-organizer,100,57,9/10/2018
93D207,executive-appointment,100,54,9/10/2018
954004,facility-open,100,65,9/10/2018
9.74E+08,executive-resignation,100,44,9/10/2018
980C14,dividend,100,50,9/10/2018
990AD0,conference-organizer,100,57,9/10/2018
9B4066,unit-acquisition-acquirer,100,49,9/10/2018
9B5968,partnership,100,61,9/10/2018
9C5174,executive-appointment,100,54,9/10/2018
A26C26,earnings,100,50,9/10/2018
A2CA3F,buybacks,100,74,9/10/2018
A47A7D,business-contract,100,69,9/10/2018
A52533,facility-open,100,65,9/10/2018
A5A4F5,acquisition-acquirer,100,49,9/10/2018
AA09AD,executive-appointment,100,54,9/10/2018
AA98ED,product-release,100,64,9/10/2018
AED6CF,earnings,100,50,9/10/2018
AED6CF,earnings,100,50,9/10/2018
B05118,product-release,100,64,9/10/2018
B09B1F,product-release,100,64,9/10/2018
B2206F,partnership,100,61,9/10/2018
B3CB74,partnership,100,61,9/10/2018
B642E8,executive-appointment,100,54,9/10/2018
B642E8,executive-appointment,100,54,9/10/2018
C425AE,earnings,100,50,9/10/2018
C74887,public-offering,100,43,9/10/2018
C8257F,executive-appointment,100,54,9/10/2018
C83B88,business-contract,100,69,9/10/2018
C83B88,business-contract,100,69,9/10/2018
C9881C,conference-call,100,50,9/10/2018
CA1620,legal-issues-defendant,100,22,9/10/2018
CBB77B,earnings,100,50,9/10/2018
CBB77B,earnings,100,50,9/10/2018
CD2A4D,executive-resignation,100,44,9/10/2018
CF211D,earnings,100,50,9/10/2018
CF6A5A,partnership,100,61,9/10/2018
D08D2C,conference-call,100,50,9/10/2018
D4AC65,product-release,100,64,9/10/2018
D4AC65,product-release,100,64,9/10/2018
D4AC65,product-release,100,64,9/10/2018
D4AC65,product-release,100,64,9/10/2018
D4AC65,product-release,100,64,9/10/2018
DBB28E,note-sale,100,52,9/10/2018
E05026,facility-open,100,65,9/10/2018
E09E2B,product-release,100,64,9/10/2018
E124EB,conference-participant,100,50,9/10/2018
E1E093,partnership,100,61,9/10/2018
E28D9C,executive-appointment,100,54,9/10/2018
E41190,executive-appointment,100,54,9/10/2018
E74B55,product-release,100,64,9/10/2018
E74B55,product-release,100,64,9/10/2018
E84500,business-contract,100,69,9/10/2018
EF5BED,executive-appointment,100,54,9/10/2018
F02170,conference-participant,100,50,9/10/2018
F1529C,conference-participant,100,50,9/10/2018
F3816D,conference-participant,100,50,9/10/2018
F4F46F,product-release,100,64,9/10/2018
F58C23,earnings,100,50,9/10/2018
F58C23,earnings,100,50,9/10/2018
F5D059,conference-call,100,50,9/10/2018
F82D37,executive-appointment,100,54,9/10/2018
FACF19,unit-acquisition-acquirer,100,49,9/10/2018
FCA54E,patent-filing,100,64,9/10/2018
FD4BBE,note-sale,100,52,9/10/2018
01D03F,business-contract,100,69,9/11/2018
0B4D10,public-offering,100,43,9/11/2018
0BC853,earnings,100,50,9/11/2018
0C6861,legal-issues-defendant,100,22,9/11/2018
0FABBD,index-listing,100,76,9/11/2018
1EBF8D,partnership,100,61,9/11/2018
2082EA,executive-appointment,100,54,9/11/2018
21D903,conference-participant,100,50,9/11/2018
21DED4,acquisition-completed-acquirer,100,49,9/11/2018
2262BD,earnings,100,50,9/11/2018
228D42,facility-open,100,65,9/11/2018
250BEE,dividend,100,50,9/11/2018
26008A,award,100,58,9/11/2018
2920D5,business-contract,100,69,9/11/2018
2C3348,legal-issues-defendant,100,22,9/11/2018
2C3348,legal-issues-defendant,100,22,9/11/2018
2E61CC,award,100,58,9/11/2018
2EBA55,capital-increase,100,43,9/11/2018
2EBA55,capital-increase,100,43,9/11/2018
2EBC0B,dividend,100,50,9/11/2018
31AA84,conference-participant,100,50,9/11/2018
31F25C,public-offering,100,43,9/11/2018
328250,partnership,100,61,9/11/2018
3B37F7,executive-appointment,100,54,9/11/2018
3B37F7,note-sale,100,52,9/11/2018
3D9999,partnership,100,61,9/11/2018
458D2C,revenue-volume,100,50,9/11/2018
4A3438,product-release,100,64,9/11/2018
50070E,conference-organizer,100,57,9/11/2018
53EF9E,conference-participant,100,50,9/11/2018
53F491,conference-participant,100,50,9/11/2018
5704AC,dividend-up,100,81,9/11/2018
57CAAB,conference-participant,100,50,9/11/2018
61B81B,conference-call,100,50,9/11/2018
6559D8,conference-participant,100,50,9/11/2018
6B6375,executive-appointment,100,54,9/11/2018
6CC55E,business-contract,100,69,9/11/2018
722DE3,business-contract,100,69,9/11/2018
72FCA3,earnings,100,50,9/11/2018
73BCBA,executive-appointment,100,54,9/11/2018
76F067,conference-participant,100,50,9/11/2018
775439,earnings,100,50,9/11/2018
7A0EC4,public-offering,100,43,9/11/2018
7A0EC4,note-sale,100,52,9/11/2018
7AB859,facility-upgrade,100,65,9/11/2018
7B492C,conference-participant,100,50,9/11/2018
7BC92D,executive-appointment,100,54,9/11/2018
83598E,conference-participant,100,50,9/11/2018
862941,conference-participant,100,50,9/11/2018
89B2E7,dividend,100,50,9/11/2018
8C6C1B,facility-open,100,65,9/11/2018
9196A2,conference-organizer,100,57,9/11/2018
9196A2,conference-organizer,100,57,9/11/2018
91E5EE,dividend,100,50,9/11/2018
9.36E+10,executive-appointment,100,54,9/11/2018
990AD0,acquisition-acquiree,100,76,9/11/2018
990AD0,conference-organizer,100,57,9/11/2018
9D4EC7,dividend,100,50,9/11/2018
9E5C2C,note-sale,100,52,9/11/2018
A398B9,partnership,100,61,9/11/2018
A3AAA5,dividend,100,50,9/11/2018
A5A4F5,acquisition-acquirer,100,49,9/11/2018
A806FA,joint-venture,100,62,9/11/2018
ACF77B,dividend,100,50,9/11/2018
B09B1F,conference-participant,100,50,9/11/2018
B48FC9,executive-appointment,100,54,9/11/2018
B8A51F,executive-appointment,100,54,9/11/2018
BFE02C,dividend,100,50,9/11/2018
C05839,unit-acquisition-acquiree,100,76,9/11/2018
C188F8,legal-issues-defendant,100,22,9/11/2018
C7859D,public-offering,100,43,9/11/2018
C81E00,acquisition-acquirer,100,49,9/11/2018
C81E00,acquisition-acquirer,100,49,9/11/2018
C99CC8,partnership,100,61,9/11/2018
CAD7D9,conference-call,100,50,9/11/2018
CF351E,dividend,100,50,9/11/2018
CF6A5A,executive-appointment,100,54,9/11/2018
D48275,conference-call,100,50,9/11/2018
DD3BB1,legal-issues-defendant,100,22,9/11/2018
DE5611,acquisition-acquirer,100,49,9/11/2018
DF5F14,dividend,100,50,9/11/2018
E124EB,dividend,100,50,9/11/2018
E2CFD2,conference-participant,100,50,9/11/2018
E3A829,ipo-completed,100,76,9/11/2018
E610CD,public-offering,100,43,9/11/2018
E8E899,earnings,100,50,9/11/2018
EAEBF3,executive-appointment,100,54,9/11/2018
ED7F13,dividend,100,50,9/11/2018
EEA6B3,conference-participant,100,50,9/11/2018
EF5BED,executive-appointment,100,54,9/11/2018
F294DD,earnings,100,50,9/11/2018
F4F46F,award,100,58,9/11/2018
F6DE54,business-contract,100,69,9/11/2018
FACF19,earnings-guidance,100,50,9/11/2018
002A99,fast-track-designation,100,81,9/12/2018
00326D,dividend,100,50,9/12/2018
00FC70,dividend-up,100,81,9/12/2018
0157B1,partnership,100,61,9/12/2018
0157B1,partnership,100,61,9/12/2018
03B431,executive-appointment,100,54,9/12/2018
05AF14,executive-appointment,100,54,9/12/2018
09DE1F,acquisition-acquirer,100,49,9/12/2018
0B4D10,public-offering,100,43,9/12/2018
0BA2EF,dividend,100,50,9/12/2018
0BD4E8,dividend,100,50,9/12/2018
0BF528,partnership,100,61,9/12/2018
0C6861,legal-issues-defendant,100,22,9/12/2018
108FDA,acquisition-regulatory-approval-acquirer,100,54,9/12/2018
1490F3,executive-appointment,100,54,9/12/2018
14BA06,dividend,100,50,9/12/2018
14BA33,conference-participant,100,50,9/12/2018
152FA5,executive-appointment,100,54,9/12/2018
16C544,dividend,100,50,9/12/2018
1.79E+10,conference-call,100,50,9/12/2018
1AB808,clinical-trials,100,56,9/12/2018
1FA886,partnership,100,61,9/12/2018
2082EA,executive-appointment,100,54,9/12/2018
25DD05,dividend,100,50,9/12/2018
25DD05,dividend,100,50,9/12/2018
2BAE5F,executive-appointment,100,54,9/12/2018
2BC05E,trading-resumed,100,58,9/12/2018
2C3348,legal-issues-defendant,100,22,9/12/2018
2C7505,legal-issues-defendant,100,22,9/12/2018
2FDEE3,dividend,100,50,9/12/2018
30AB63,conference-participant,100,50,9/12/2018
315EB0,executive-appointment,100,54,9/12/2018
31F25C,public-offering,100,43,9/12/2018
33AD83,reorganization-unit,100,53,9/12/2018
384CD3,dividend,100,50,9/12/2018
3DE4D1,executive-appointment,100,54,9/12/2018
414FFF,award,100,58,9/12/2018
450ECB,partnership,100,61,9/12/2018
4C37C5,legal-issues-defendant,100,22,9/12/2018
4E7C1F,executive-appointment,100,54,9/12/2018
4EEB00,conference-participant,100,50,9/12/2018
50070E,conference-organizer,100,57,9/12/2018
57DDB9,product-release,100,64,9/12/2018
589846,partnership,100,61,9/12/2018
58CA9A,earnings,100,50,9/12/2018
59B229,conference-organizer,100,57,9/12/2018
5B6C11,executive-appointment,100,54,9/12/2018
6166D1,executive-appointment,100,54,9/12/2018
636BBF,partnership,100,61,9/12/2018
66ECFD,award,100,58,9/12/2018
68E3E0,unit-acquisition-acquiree,100,76,9/12/2018
693ECD,conference-participant,100,50,9/12/2018
6A01DF,public-offering,100,43,9/12/2018
6B494E,facility-upgrade,100,65,9/12/2018
6E705B,partnership,100,61,9/12/2018
767F86,conference-participant,100,50,9/12/2018
7A5097,dividend,100,50,9/12/2018
7E1D5D,product-release,100,64,9/12/2018
804708,executive-appointment,100,54,9/12/2018
8A8E41,conference-participant,100,50,9/12/2018
8A8E41,executive-appointment,100,54,9/12/2018
8A8E41,product-release,100,64,9/12/2018
8AC65D,partnership,100,61,9/12/2018
8AC740,dividend,100,50,9/12/2018
8C6C1B,facility-open,100,65,9/12/2018
8E4F9A,business-contract-terminated,100,31,9/12/2018
9196A2,partnership,100,61,9/12/2018
9196A2,conference-organizer,100,57,9/12/2018
9196A2,conference-organizer,100,57,9/12/2018
945DE6,note-sale,100,52,9/12/2018
94637C,dividend,100,50,9/12/2018
949625,conference-participant,100,50,9/12/2018
9546A5,executive-appointment,100,54,9/12/2018
965360,executive-appointment,100,54,9/12/2018
990AD0,conference-organizer,100,57,9/12/2018
9D65C1,legal-issues-defendant,100,22,9/12/2018
9D65C1,earnings,100,50,9/12/2018
9D65C1,earnings,100,50,9/12/2018
9D65C1,earnings,100,50,9/12/2018
9E0811,public-offering,100,43,9/12/2018
9F03CF,unit-acquisition-acquirer,100,49,9/12/2018
A05C43,partnership,100,61,9/12/2018
A5A4F5,acquisition-acquirer,100,49,9/12/2018
A72AB6,partnership,100,61,9/12/2018
AA7FE0,conference-call,100,50,9/12/2018
AC7C4F,product-release,100,64,9/12/2018
B076A1,dividend,100,50,9/12/2018
B762D3,dividend,100,50,9/12/2018
BB88B6,partnership,100,61,9/12/2018
C36189,executive-appointment,100,54,9/12/2018
C50B26,executive-appointment,100,54,9/12/2018
C7859D,public-offering,100,43,9/12/2018
C8257F,partnership,100,61,9/12/2018
C85A72,business-contract,100,69,9/12/2018
C8A248,investment-investor,100,55,9/12/2018
C8A248,investment-investor,100,55,9/12/2018
C9881C,product-release,100,64,9/12/2018
CA1620,dividend,100,50,9/12/2018
CDAF5B,dividend,100,50,9/12/2018
CE1002,stake-acquirer,100,48,9/12/2018
CFF97C,credit-rating-set-rater,20,50,9/12/2018
D8442A,product-release,100,64,9/12/2018
D8442A,product-release,100,64,9/12/2018
D90F43,press-conference-organizer,100,50,9/12/2018
D9E036,conference-participant,100,50,9/12/2018
DA199F,board-meeting,100,51,9/12/2018
DD1BA1,partnership,100,61,9/12/2018
DD3BB1,legal-issues-defendant,100,22,9/12/2018
E4CE73,partnership,100,61,9/12/2018
E5752F,executive-appointment,100,54,9/12/2018
E866D2,revenue-volume,100,50,9/12/2018
E8D221,earnings,100,50,9/12/2018
EAEBF3,business-contract,100,69,9/12/2018
ED3CA8,public-offering,100,43,9/12/2018
EE6F1C,executive-appointment,100,54,9/12/2018
EF5BED,executive-appointment,100,54,9/12/2018
F0B877,conference-call,100,50,9/12/2018
F0B877,executive-appointment,100,54,9/12/2018
F1EB39,conference-participant,100,50,9/12/2018
F4E992,award,100,58,9/12/2018
F51DB0,public-offering,100,43,9/12/2018
F5D410,earnings,100,50,9/12/2018
F6E248,partnership,100,61,9/12/2018
FC4550,public-offering,100,43,9/12/2018
FF5413,revenue-volume,100,50,9/12/2018
00FC70,earnings,100,50,9/13/2018
036C6F,acquisition-acquirer,100,49,9/13/2018
0624BE,executive-appointment,100,54,9/13/2018
07EC43,award,100,58,9/13/2018
149301,public-offering,100,43,9/13/2018
16B183,dividend,100,50,9/13/2018
1866B2,executive-appointment,100,54,9/13/2018
1AE482,earnings,100,50,9/13/2018
1AE482,earnings,100,50,9/13/2018
1AE482,earnings,100,50,9/13/2018
1B637E,dividend,100,50,9/13/2018
1CD708,dividend,100,50,9/13/2018
1D1B07,earnings,100,50,9/13/2018
1D1B07,earnings,100,50,9/13/2018
228D42,business-contract,100,69,9/13/2018
23207A,earnings,100,50,9/13/2018
251988,executive-appointment,100,54,9/13/2018
2C3348,legal-issues-defendant,100,22,9/13/2018
2C3348,legal-issues-defendant,100,22,9/13/2018
2C3348,legal-issues-defendant,100,22,9/13/2018
2C7505,legal-issues-defendant,100,22,9/13/2018
2CB4C9,legal-issues-defendant,100,22,9/13/2018
2CBB58,conference-participant,100,50,9/13/2018
2E902B,dividend,100,50,9/13/2018
30AB63,earnings-guidance,100,50,9/13/2018
31553A,conference-call,100,50,9/13/2018
339F20,executive-appointment,100,54,9/13/2018
33E9D5,earnings,100,50,9/13/2018
3461CF,partnership,100,61,9/13/2018
34B411,merger-regulatory-approval,100,81,9/13/2018
37B618,dividend,100,50,9/13/2018
41785E,buybacks,100,74,9/13/2018
427F32,executive-appointment,100,54,9/13/2018
4A6F00,partnership,100,61,9/13/2018
4A6F00,partnership,100,61,9/13/2018
4A6F00,partnership,100,61,9/13/2018
4A6F00,partnership,100,61,9/13/2018
4E6F5A,clinical-trials-filed,100,60,9/13/2018
520632,dividend,100,50,9/13/2018
53F491,dividend,100,50,9/13/2018
55438C,donation,100,54,9/13/2018
56277A,dividend,100,50,9/13/2018
596116,conference-participant,100,50,9/13/2018
5968F9,campaign-ad-release,100,59,9/13/2018
5968F9,campaign-ad-release,100,59,9/13/2018
5A9F54,partnership,100,61,9/13/2018
5CC29D,conference-call,100,50,9/13/2018
6.18E+08,conference-participant,100,50,9/13/2018
627186,earnings,100,50,9/13/2018
629F0F,earnings,100,50,9/13/2018
641F17,earnings,100,50,9/13/2018
6830FE,business-contract,100,69,9/13/2018
68E6E9,buybacks,100,74,9/13/2018
693ECD,patent-awarded,100,72,9/13/2018
69FDFC,conference-participant,100,50,9/13/2018
6ABCB8,dividend,100,50,9/13/2018
6CC55E,clinical-trials-positive,100,87,9/13/2018
713810,partnership,100,61,9/13/2018
71E2EF,business-contract,100,69,9/13/2018
7255D2,conference-participant,100,50,9/13/2018
7ACBA4,dividend,100,50,9/13/2018
7D5FD6,partnership,100,61,9/13/2018
7DD8CC,dividend,100,50,9/13/2018
8B1F37,dividend,100,50,9/13/2018
8B3B0E,dividend,100,50,9/13/2018
8B4A45,facility-open,100,65,9/13/2018
8BFAA4,public-offering,100,43,9/13/2018
8C6C1B,facility-open,100,65,9/13/2018
8D4486,partnership,100,61,9/13/2018
8E93A4,facility-open,100,65,9/13/2018
8EDACA,conference-participant,100,50,9/13/2018
8FF2EF,earnings,100,50,9/13/2018
9043FE,debt-extension-recipient,100,73,9/13/2018
9043FE,debt-extension-recipient,100,73,9/13/2018
934CC3,partnership,100,61,9/13/2018
94637C,business-contract,100,69,9/13/2018
94756D,conference-participant,100,50,9/13/2018
94C0B5,conference-call,100,50,9/13/2018
9548BB,executive-resignation,100,44,9/13/2018
95DC1F,earnings,100,50,9/13/2018
95DC1F,earnings,100,50,9/13/2018
95DC1F,earnings,100,50,9/13/2018
95DC1F,earnings,100,50,9/13/2018
98CEBB,business-contract,100,69,9/13/2018
990AD0,conference-organizer,100,57,9/13/2018
9CA432,product-release,100,64,9/13/2018
9D56F2,conference-call,100,50,9/13/2018
9E0811,public-offering,100,43,9/13/2018
9F5997,business-contract,100,69,9/13/2018
9F5CBB,business-contract,100,69,9/13/2018
A21649,dividend,100,50,9/13/2018
A5A4F5,acquisition-acquirer,100,49,9/13/2018
AA247D,executive-appointment,100,54,9/13/2018
AB7726,executive-appointment,100,54,9/13/2018
ADD9DC,facility-open,100,65,9/13/2018
AE7D16,product-release,100,64,9/13/2018
B0D41A,business-contract,100,69,9/13/2018
B5BA39,index-listing,100,76,9/13/2018
B83D67,fast-track-designation,100,81,9/13/2018
BB127B,product-release,100,64,9/13/2018
BB127B,partnership,100,61,9/13/2018
BBC05B,conference-participant,100,50,9/13/2018
BC5680,acquisition-completed-acquirer,100,49,9/13/2018
C188F8,legal-issues-defendant,100,22,9/13/2018
C188F8,legal-issues-defendant,100,22,9/13/2018
C188F8,legal-issues-defendant,100,22,9/13/2018
C407A0,facility-open,100,65,9/13/2018
C45C1F,executive-appointment,100,54,9/13/2018
C66B44,partnership,100,61,9/13/2018
C83B88,conference-call,100,50,9/13/2018
C9881C,revenue-up,100,69,9/13/2018
C9881C,revenue-up,100,69,9/13/2018
C9881C,revenue-up,100,69,9/13/2018
CBDB4D,business-contract,100,69,9/13/2018
CD4DA8,headquarters-change,100,50,9/13/2018
D17C1B,revenue-volume,100,50,9/13/2018
D1CFC8,partnership,100,61,9/13/2018
D296C6,dividend,100,50,9/13/2018
D29F43,executive-appointment,100,54,9/13/2018
D518D8,executive-appointment,100,54,9/13/2018
D54E62,business-contract,100,69,9/13/2018
D6489C,partnership,100,61,9/13/2018
D6853F,business-contract,100,69,9/13/2018
D6853F,business-contract,100,69,9/13/2018
D77F7E,partnership,100,61,9/13/2018
D8ECA1,facility-open,100,65,9/13/2018
D90F43,press-conference-organizer,100,50,9/13/2018
DB7014,conference-participant,100,50,9/13/2018
DBFB51,product-release,100,64,9/13/2018
DCD97F,product-release,100,64,9/13/2018
DD9E41,partnership,100,61,9/13/2018
E26FC3,revenues,100,50,9/13/2018
E30A8F,executive-appointment,100,54,9/13/2018
E3656D,conference-participant,100,50,9/13/2018
E393B0,ipo-pricing,100,50,9/13/2018
E8B21D,dividend,100,50,9/13/2018
EB6965,dividend,100,50,9/13/2018
EC4E82,acquisition-completed-acquirer,100,49,9/13/2018
EC99D0,conference-call,100,50,9/13/2018
EF77A3,conference-participant,100,50,9/13/2018
F4E882,executive-appointment,100,54,9/13/2018
F51DB0,public-offering,100,43,9/13/2018
F66B58,conference-participant,100,50,9/13/2018
F6DCE4,hirings,100,65,9/13/2018
FC1736,conference-participant,100,50,9/13/2018
FC1736,revenues,100,50,9/13/2018
FC1736,earnings,100,50,9/13/2018
FD9A97,conference-participant,100,50,9/13/2018
FDF28E,executive-appointment,100,54,9/13/2018
FF6644,conference-call,100,50,9/13/2018
FFE543,legal-issues-defendant,100,22,9/13/2018
00067A,donation,100,54,9/14/2018
13528,partnership,100,61,9/14/2018
03FB17,acquisition-completed-acquirer,100,49,9/14/2018
099C88,conference-participant,100,50,9/14/2018
0FDE97,award,100,58,9/14/2018
138DDE,dividend,100,50,9/14/2018
139303,executive-appointment,100,54,9/14/2018
15B10D,product-release,100,64,9/14/2018
17EDA5,dividend,100,50,9/14/2018
196D18,clinical-trials,100,56,9/14/2018
1AF7E2,dividend,100,50,9/14/2018
239106,legal-issues-defendant,100,22,9/14/2018
250BEE,conference-call,100,50,9/14/2018
253B2F,conference-participant,100,50,9/14/2018
26E3BA,private-placement,100,56,9/14/2018
282C18,dividend,100,50,9/14/2018
2C3348,legal-issues-defendant,100,22,9/14/2018
2C3348,legal-issues-defendant,100,22,9/14/2018
2C3348,fraud-defendant,100,20,9/14/2018
2C3348,legal-issues-defendant,100,22,9/14/2018
2C3348,legal-issues-defendant,100,22,9/14/2018
2C7505,legal-issues-defendant,100,22,9/14/2018
31AA84,dividend,100,50,9/14/2018
3BB616,dividend,100,50,9/14/2018
3C7F5F,legal-issues-defendant,100,22,9/14/2018
3CBA2A,partnership,100,61,9/14/2018
4E3D15,facility-sale,100,52,9/14/2018
5065B1,dividend,100,50,9/14/2018
546A27,legal-issues-defendant,100,22,9/14/2018
546A27,legal-issues-defendant,100,22,9/14/2018
54DF47,dividend,100,50,9/14/2018
58CA9A,regulatory-investigation,100,22,9/14/2018
58CA9A,regulatory-investigation,100,22,9/14/2018
5D63F1,dividend,100,50,9/14/2018
619882,conference-participant,100,50,9/14/2018
619882,conference-participant,100,50,9/14/2018
619882,conference-participant,100,50,9/14/2018
619882,dividend,100,50,9/14/2018
657097,dividend,100,50,9/14/2018
66A667,earnings,100,50,9/14/2018
6830FE,award,100,58,9/14/2018
6BF593,dividend,100,50,9/14/2018
6D3B7B,dividend,100,50,9/14/2018
6ED519,legal-issues-defendant,100,22,9/14/2018
6F0096,conference-participant,100,50,9/14/2018
6FCEF9,dividend,100,50,9/14/2018
70FCEF,executive-appointment,100,54,9/14/2018
728737,dividend,100,50,9/14/2018
728737,dividend,100,50,9/14/2018
76DD0C,index-listing,100,76,9/14/2018
7999F3,dividend,100,50,9/14/2018
7A0EC4,public-offering,100,43,9/14/2018
826FD6,dividend,100,50,9/14/2018
86A1B9,donation,100,54,9/14/2018
8AB85C,clinical-trials,100,56,9/14/2018
8C6C1B,facility-open,100,65,9/14/2018
90B678,legal-issues-defendant,100,22,9/14/2018
940C3D,earnings,100,50,9/14/2018
94563D,executive-appointment,100,54,9/14/2018
967D92,dividend,100,50,9/14/2018
986AF6,earnings-guidance,100,50,9/14/2018
990AD0,conference-organizer,100,57,9/14/2018
9CA432,ownership-increase-owner,100,56,9/14/2018
A15C71,public-offering,100,43,9/14/2018
A5A4F5,acquisition-acquirer,100,49,9/14/2018
A6828A,award,100,58,9/14/2018
A9ED24,dividend,100,50,9/14/2018
AE4EEB,dividend,100,50,9/14/2018
B3A6A1,partnership,100,61,9/14/2018
B5766D,donation,100,54,9/14/2018
B642E8,executive-appointment,100,54,9/14/2018
BB5271,product-release,100,64,9/14/2018
C74887,earnings,100,50,9/14/2018
C8A059,executive-appointment,100,54,9/14/2018
C9B932,award,100,58,9/14/2018
C9F39B,dividend-up,100,55,9/14/2018
CA1620,legal-issues-defendant,100,22,9/14/2018
CFF97C,credit-rating-affirmation-rater,20,50,9/14/2018
D139BC,dividend,100,50,9/14/2018
D3FA2C,dividend,100,50,9/14/2018
D6489C,legal-issues-defendant,100,22,9/14/2018
D69D42,dividend,100,50,9/14/2018
D6EAA3,conference-call,100,50,9/14/2018
D96202,conference-call,100,50,9/14/2018
DBEF02,acquisition-completed-acquirer,100,49,9/14/2018
DC5299,dividend,100,50,9/14/2018
DD3BB1,legal-issues-defendant,100,22,9/14/2018
E11C41,dividend,100,50,9/14/2018
EA4E68,dividend,100,50,9/14/2018
ECD263,earnings,100,50,9/14/2018
EF7163,dividend,100,50,9/14/2018
F294DD,dividend,100,50,9/14/2018
F30508,merger,100,66,9/14/2018
F748C7,dividend,100,50,9/14/2018
F85CC0,dividend,100,50,9/14/2018
FEE4B0,index-listing,100,76,9/14/2018
15B10D,partnership,100,61,9/15/2018
205AD5,donation,100,54,9/15/2018
2C3348,legal-issues-defendant,100,22,9/15/2018
92D757,asset-sale,100,62,9/16/2018
0157B1,partnership,100,61,9/17/2018
02870F,partnership,100,61,9/17/2018
03542C,dividend,100,50,9/17/2018
0358AF,executive-appointment,100,54,9/17/2018
0CC01F,dividend,100,50,9/17/2018
0E3436,executive-appointment,100,54,9/17/2018
0F2BC9,government-contract,100,69,9/17/2018
106394,dividend,100,50,9/17/2018
12E454,product-release,100,64,9/17/2018
168A5D,facility-open,100,65,9/17/2018
16FC89,dividend,100,50,9/17/2018
1834C0,unit-acquisition-acquirer,100,49,9/17/2018
18D9FA,conference-participant,100,50,9/17/2018
1A6A94,merger,100,66,9/17/2018
1B5FEA,conference-participant,100,50,9/17/2018
1F19C8,hirings,100,65,9/17/2018
1FA886,partnership,100,61,9/17/2018
20BEEA,earnings-guidance,100,50,9/17/2018
25102A,business-contract,100,69,9/17/2018
251988,business-contract,100,69,9/17/2018
297DA8,product-release,100,64,9/17/2018
2C3348,legal-issues-defendant,100,22,9/17/2018
2F1299,unit-acquisition-acquiree,100,76,9/17/2018
2F7A7E,executive-appointment,100,54,9/17/2018
2F9304,executive-appointment,100,54,9/17/2018
2F9304,note-sale,100,52,9/17/2018
2FDEE3,conference-participant,100,50,9/17/2018
30DFD3,executive-appointment,100,54,9/17/2018
31553A,award,100,58,9/17/2018
3A3447,facility-open,100,65,9/17/2018
3A3447,facility-open,100,65,9/17/2018
3B8484,acquisition-acquirer,100,49,9/17/2018
3BB616,unit-acquisition-acquirer,100,49,9/17/2018
3F868D,executive-appointment,100,54,9/17/2018
40B903,stock-splits,100,49,9/17/2018
40B903,executive-appointment,100,54,9/17/2018
416291,dividend,100,50,9/17/2018
449A26,partnership,100,61,9/17/2018
4591D3,conference-participant,100,50,9/17/2018
49CC59,buybacks,100,74,9/17/2018
546A27,legal-issues-defendant,100,22,9/17/2018
556F08,conference-participant,100,50,9/17/2018
55C9B5,dividend,100,50,9/17/2018
58B46F,conference-call,100,50,9/17/2018
594402,business-contract,100,69,9/17/2018
5D0337,executive-appointment,100,54,9/17/2018
5D41E4,conference-participant,100,50,9/17/2018
5FE4B6,conference-participant,100,50,9/17/2018
6166D1,conference-call,100,50,9/17/2018
62A48D,conference-participant,100,50,9/17/2018
633043,dividend,100,50,9/17/2018
665440,executive-appointment,100,54,9/17/2018
665D7D,conference-call,100,50,9/17/2018
66E04A,partnership,100,61,9/17/2018
66E04A,partnership,100,61,9/17/2018
66E3C0,conference-participant,100,50,9/17/2018
6844D2,earnings-up,100,68,9/17/2018
6C4D2F,ipo,100,71,9/17/2018
6CF43C,dividend,100,50,9/17/2018
6F0A63,note-sale,100,52,9/17/2018
701531,conference-participant,100,50,9/17/2018
713810,product-release,100,64,9/17/2018
713810,product-release,100,64,9/17/2018
713810,product-release,100,64,9/17/2018
72609A,stock-splits,100,49,9/17/2018
726EEA,product-release,100,64,9/17/2018
756BB4,partnership,100,61,9/17/2018
75768D,unit-acquisition-acquiree,100,76,9/17/2018
762A3E,executive-appointment,100,54,9/17/2018
762B8D,conference-participant,100,50,9/17/2018
7712CB,acquisition-completed-acquirer,100,49,9/17/2018
7712CB,acquisition-completed-acquirer,100,49,9/17/2018
787D14,executive-appointment,100,54,9/17/2018
7F3A5F,partnership,100,61,9/17/2018
817ED9,hirings,100,65,9/17/2018
83A065,dividend,100,50,9/17/2018
859281,dividend,100,50,9/17/2018
8B4A45,market-entry,100,57,9/17/2018
8C6C1B,facility-open,100,65,9/17/2018
8D4486,partnership,100,61,9/17/2018
8EEA28,conference-organizer,100,57,9/17/2018
9196A2,dividend,100,50,9/17/2018
92D757,executive-appointment,100,54,9/17/2018
9.36E+10,executive-appointment,100,54,9/17/2018
990AD0,conference-organizer,100,57,9/17/2018
990AD0,conference-organizer,100,57,9/17/2018
9B0C9C,conference-participant,100,50,9/17/2018
9BF177,conference-participant,100,50,9/17/2018
9CA432,dividend,100,50,9/17/2018
9D2790,executive-appointment,100,54,9/17/2018
9E3224,dividend,100,50,9/17/2018
9EBAFA,acquisition-acquirer,100,49,9/17/2018
A433A5,conference-participant,100,50,9/17/2018
A4386C,conference-participant,100,50,9/17/2018
A5A4F5,acquisition-acquirer,100,49,9/17/2018
A70BF5,executive-appointment,100,54,9/17/2018
A80FE0,executive-appointment,100,54,9/17/2018
AA1EAA,dividend,100,50,9/17/2018
AD1ACF,executive-appointment,100,54,9/17/2018
AD375D,dividend,100,50,9/17/2018
B0D41A,partnership,100,61,9/17/2018
B5DE80,conference-call,100,50,9/17/2018
BB0587,executive-appointment,100,54,9/17/2018
BB127B,revenue-down,100,30,9/17/2018
BD682F,dividend,100,50,9/17/2018
BDD12C,executive-appointment,100,54,9/17/2018
C2F597,spin-off,100,58,9/17/2018
C45C1F,clinical-trials,100,56,9/17/2018
C45C1F,public-offering,100,43,9/17/2018
C83B88,executive-appointment,100,54,9/17/2018
C83B88,partnership,100,61,9/17/2018
C9D866,executive-appointment,100,54,9/17/2018
CDFCC9,legal-issues-defendant,100,22,9/17/2018
CDFCC9,legal-issues-defendant,100,22,9/17/2018
CE5C6E,clinical-trials,100,56,9/17/2018
CF6A5A,earnings,100,50,9/17/2018
D33270,product-release,100,64,9/17/2018
D77F7E,acquisition-acquirer,100,49,9/17/2018
D77F7E,acquisition-acquirer,100,49,9/17/2018
D77F7E,acquisition-acquirer,100,49,9/17/2018
D77F7E,acquisition-acquirer,100,49,9/17/2018
D77F7E,acquisition-acquirer,100,49,9/17/2018
D77F7E,acquisition-acquirer,100,49,9/17/2018
DA0CB8,dividend,100,50,9/17/2018
DD3BB1,legal-issues-defendant,100,22,9/17/2018
E30B34,facility-open,100,65,9/17/2018
E68733,executive-appointment,100,54,9/17/2018
EDF5CA,conference-participant,100,50,9/17/2018
F11638,partnership,100,61,9/17/2018
F5349B,executive-appointment,100,54,9/17/2018
F80389,dividend,100,50,9/17/2018
07EC43,acquisition-acquirer,100,49,9/18/2018
84625,executive-appointment,100,54,9/18/2018
108A2B,dividend,100,50,9/18/2018
1272B3,conference-participant,100,50,9/18/2018
16F4D8,conference-participant,100,50,9/18/2018
1.79E+10,revenue-guidance,100,50,9/18/2018
17EDA5,partnership,100,61,9/18/2018
1921DD,product-release,100,64,9/18/2018
1B637E,acquisition-acquirer,100,49,9/18/2018
20BEEA,unit-acquisition-completed-acquirer,100,49,9/18/2018
222BF9,earnings,100,50,9/18/2018
228D42,partnership,100,61,9/18/2018
228D42,partnership,100,61,9/18/2018
228D42,dividend-up,100,81,9/18/2018
24FA23,clinical-trials-positive,100,87,9/18/2018
25102A,exchange-compliance-authority,100,50,9/18/2018
2.89E+11,note-sale,100,52,9/18/2018
2FEA66,dividend,100,50,9/18/2018
3.14E+47,dividend,100,50,9/18/2018
31553A,award,100,58,9/18/2018
3461CF,partnership,100,61,9/18/2018
349DA4,conference-participant,100,50,9/18/2018
370C50,product-price-raise,100,57,9/18/2018
39FB23,award,100,58,9/18/2018
3A94DF,buybacks,100,74,9/18/2018
3B50FE,earnings,100,50,9/18/2018
3C8A04,conference-call,100,50,9/18/2018
3DDE54,earnings,100,50,9/18/2018
416C55,conference-organizer,100,57,9/18/2018
420168,dividend-up,100,69,9/18/2018
447FC6,executive-appointment,100,54,9/18/2018
4A2457,business-contract,100,69,9/18/2018
4A6F00,partnership,100,61,9/18/2018
4A6F00,partnership,100,61,9/18/2018
4A6F00,partnership,100,61,9/18/2018
4A6F00,partnership,100,61,9/18/2018
55C9B5,partnership,100,61,9/18/2018
55C9B5,settlement,100,56,9/18/2018
5675EB,dividend,100,50,9/18/2018
56B7C1,conference-participant,100,50,9/18/2018
5B97B2,dividend-guidance,100,50,9/18/2018
6166D1,dividend,100,50,9/18/2018
619882,dividend,100,50,9/18/2018
665440,executive-appointment,100,54,9/18/2018
665440,executive-appointment,100,54,9/18/2018
66749D,acquisition-completed-acquirer,100,49,9/18/2018
68586A,conference-participant,100,50,9/18/2018
68E6E9,earnings,100,50,9/18/2018
69494C,executive-appointment,100,54,9/18/2018
6F6559,earnings,100,50,9/18/2018
719477,dividend,100,50,9/18/2018
762A3E,conference-organizer,100,57,9/18/2018
77B8E9,conference-participant,100,50,9/18/2018
7AB859,executive-appointment,100,54,9/18/2018
7AB859,executive-appointment,100,54,9/18/2018
7AB859,executive-appointment,100,54,9/18/2018
7AB859,executive-appointment,100,54,9/18/2018
7AB859,executive-appointment,100,54,9/18/2018
7B1E50,dividend,100,50,9/18/2018
7BC92D,partnership,100,61,9/18/2018
7BEA98,executive-appointment,100,54,9/18/2018
87B81A,executive-resignation,100,44,9/18/2018
88193E,product-release,100,64,9/18/2018
8B3B0E,acquisition-completed-acquirer,100,49,9/18/2018
8B6E7E,conference-participant,100,50,9/18/2018
8BFAA4,public-offering,100,43,9/18/2018
8C6C1B,facility-open,100,65,9/18/2018
8E10BF,executive-appointment,100,54,9/18/2018
93D207,settlement,100,56,9/18/2018
94637C,regulatory-product-approval-granted,100,81,9/18/2018
957A07,conference-participant,100,50,9/18/2018
97693A,executive-appointment,100,54,9/18/2018
990AD0,dividend,100,50,9/18/2018
990AD0,conference-organizer,100,57,9/18/2018
990AD0,conference-organizer,100,57,9/18/2018
9B4066,unit-acquisition-acquirer,100,49,9/18/2018
9B5968,acquisition-acquirer,100,49,9/18/2018
9B5968,acquisition-acquirer,100,49,9/18/2018
9B5968,acquisition-acquirer,100,49,9/18/2018
9CA619,earnings,100,50,9/18/2018
9CDA4F,executive-appointment,100,54,9/18/2018
A5A4F5,acquisition-acquirer,100,49,9/18/2018
A6213D,partnership,100,61,9/18/2018
A6828A,regulatory-product-application,100,69,9/18/2018
A871B0,conference-participant,100,50,9/18/2018
AD9F1D,facility-open,100,65,9/18/2018
AED61E,conference-participant,100,50,9/18/2018
B1DF3C,partnership,100,61,9/18/2018
B37FB4,earnings,100,50,9/18/2018
B48FC9,conference-participant,100,50,9/18/2018
B642E8,business-contract,100,69,9/18/2018
B642E8,business-contract,100,69,9/18/2018
BB127B,award,100,58,9/18/2018
BFAEB4,conference-call,100,50,9/18/2018
C05839,dividend,100,50,9/18/2018
CB7AB2,partnership,100,61,9/18/2018
CDFCC9,legal-issues-defendant,100,22,9/18/2018
CDFCC9,legal-issues-defendant,100,22,9/18/2018
CDFCC9,legal-issues-defendant,100,22,9/18/2018
CDFCC9,legal-issues-defendant,100,22,9/18/2018
CDFCC9,legal-issues-defendant,100,22,9/18/2018
D697DE,executive-appointment,100,54,9/18/2018
DB9829,dividend,100,50,9/18/2018
DCD97F,partnership,100,61,9/18/2018
DD1BA1,acquisition-acquiree,100,76,9/18/2018
DD3BB1,legal-issues-defendant,100,22,9/18/2018
DD3BB1,legal-issues-defendant,100,22,9/18/2018
DD3BB1,legal-issues-defendant,100,22,9/18/2018
DD7A96,conference-participant,100,50,9/18/2018
DF11D9,executive-appointment,100,54,9/18/2018
DF18E6,conference-participant,100,50,9/18/2018
E0207A,partnership,100,61,9/18/2018
E0339F,earnings,100,50,9/18/2018
E15736,public-offering,100,43,9/18/2018
E26FC3,earnings,100,50,9/18/2018
E38906,conference-participant,100,50,9/18/2018
E393B0,ipo-completed,100,76,9/18/2018
E61888,dividend,100,50,9/18/2018
E68733,clinical-trials,100,56,9/18/2018
ECD263,partnership,100,61,9/18/2018
ECD263,executive-appointment,100,54,9/18/2018
ECF709,same-store-sales-up,100,52,9/18/2018
ECF709,same-store-sales-up,100,62,9/18/2018
ECF709,same-store-sales-up,100,62,9/18/2018
ED79D9,legal-issues-plaintiff,100,44,9/18/2018
EF1AD9,business-contract,100,69,9/18/2018
EF5BED,earnings,100,50,9/18/2018
EF77A3,earnings,100,50,9/18/2018
F3D2EB,dividend,100,50,9/18/2018
F4F46F,partnership,100,61,9/18/2018
F5349B,partnership,100,61,9/18/2018
F6E1B5,patent-infringement-plaintiff,100,47,9/18/2018
F702CA,donation,100,54,9/18/2018
F769E9,earnings,100,50,9/18/2018
F793FA,facility-open,100,65,9/18/2018
F8BA6C,executive-appointment,100,54,9/18/2018
FACF19,donation,100,54,9/18/2018
FDD3FC,executive-appointment,100,54,9/18/2018
FEC475,executive-appointment,100,54,9/18/2018
00067A,partnership,100,61,9/19/2018
00067A,partnership,100,61,9/19/2018
95294,note-sale,100,52,9/19/2018
0C6861,legal-issues-defendant,100,22,9/19/2018
0C6861,legal-issues-defendant,100,22,9/19/2018
0CC01F,award,100,58,9/19/2018
0F0440,donation,100,54,9/19/2018
1F3CFB,conference-participant,100,50,9/19/2018
1F43A1,dividend-up,100,81,9/19/2018
2158DF,product-release,100,64,9/19/2018
219B21,acquisition-completed-acquirer,100,49,9/19/2018
21DED4,note-sale,100,52,9/19/2018
232053,conference-participant,100,50,9/19/2018
24FA23,public-offering,100,43,9/19/2018
25A6CC,conference-participant,100,50,9/19/2018
263216,executive-appointment,100,54,9/19/2018
275300,dividend,100,50,9/19/2018
31553A,earnings,100,50,9/19/2018
31DB20,unit-acquisition-acquiree,100,76,9/19/2018
3587B4,business-contract,100,69,9/19/2018
3BE00F,dividend,100,50,9/19/2018
435ACE,conference-participant,100,50,9/19/2018
43E8F5,conference-participant,100,50,9/19/2018
442587,executive-appointment,100,54,9/19/2018
44DDBD,public-offering,100,43,9/19/2018
46017C,conference-participant,100,50,9/19/2018
467F2C,product-release,100,64,9/19/2018
4E4E75,dividend,100,50,9/19/2018
520632,conference-call,100,50,9/19/2018
5340D0,public-offering,100,43,9/19/2018
5.47E+28,conference-participant,100,50,9/19/2018
57EF50,executive-appointment,100,54,9/19/2018
609208,earnings,100,50,9/19/2018
619882,executive-appointment,100,54,9/19/2018
627186,conference-participant,100,50,9/19/2018
63E8D5,dividend,100,50,9/19/2018
6.52E+64,executive-appointment,100,54,9/19/2018
6F30F9,dividend,100,50,9/19/2018
71B0CF,clinical-trials,100,56,9/19/2018
775439,dividend-up,100,64,9/19/2018
7AF907,conference-participant,100,50,9/19/2018
7B1E50,executive-appointment,100,54,9/19/2018
7B1E50,executive-appointment,100,54,9/19/2018
835C86,executive-resignation,100,44,9/19/2018
8377DB,dividend,100,50,9/19/2018
88350F,business-contract,100,69,9/19/2018
8B4A45,earnings,100,50,9/19/2018
8C6C1B,facility-open,100,65,9/19/2018
8E8E6E,business-contract,100,69,9/19/2018
911ACB,dividend,100,50,9/19/2018
9196A2,award,100,58,9/19/2018
93633B,executive-appointment,100,54,9/19/2018
93633B,dividend,100,50,9/19/2018
9546A5,dividend,100,50,9/19/2018
977A1E,acquisition-interest-acquirer,100,46,9/19/2018
990AD0,conference-organizer,100,57,9/19/2018
9A2760,executive-appointment,100,54,9/19/2018
9BBFA5,executive-appointment,100,54,9/19/2018
9D65C1,legal-issues-defendant,100,22,9/19/2018
A4CD53,conference-participant,100,50,9/19/2018
A5A4F5,acquisition-acquirer,100,49,9/19/2018
A631A3,award,100,58,9/19/2018
A6828A,conference-call,100,50,9/19/2018
ADFB3A,conference-participant,100,50,9/19/2018
BB0787,award,100,58,9/19/2018
C1114B,executive-resignation,100,44,9/19/2018
C62AA4,business-contract,100,69,9/19/2018
CAC8D0,earnings,100,50,9/19/2018
CB7AB2,product-release,100,64,9/19/2018
CC6FF5,product-release,100,64,9/19/2018
CDFCC9,legal-issues-defendant,100,22,9/19/2018
CDFCC9,legal-issues-defendant,100,22,9/19/2018
CE2791,acquisition-completed-acquirer,100,49,9/19/2018
CE96E7,facility-open,100,65,9/19/2018
CE96E7,facility-open,100,65,9/19/2018
CFF97C,credit-rating-set-rater,20,50,9/19/2018
D0DE27,dividend,100,50,9/19/2018
D11C1C,dividend,100,50,9/19/2018
D21D8A,dividend,100,50,9/19/2018
D8DBA3,dividend,100,50,9/19/2018
DC0066,business-contract,100,69,9/19/2018
DC0066,public-offering,100,43,9/19/2018
DF18E6,fast-track-designation,100,81,9/19/2018
E124EB,product-release,100,64,9/19/2018
E26FC3,donation,100,54,9/19/2018
ED3CA8,conference-participant,100,50,9/19/2018
ED79D9,dividend,100,50,9/19/2018
F6DCE4,dividend,100,50,9/19/2018
00698D,executive-appointment,100,54,9/20/2018
0157B1,partnership,100,61,9/20/2018
0157B1,product-release,100,64,9/20/2018
0157B1,product-release,100,64,9/20/2018
0157B1,product-release,100,64,9/20/2018
0157B1,product-release,100,64,9/20/2018
03CF95,acquisition-completed-acquirer,100,49,9/20/2018
0A0CF0,earnings,100,50,9/20/2018
0C28D1,partnership,100,61,9/20/2018
0C28D1,partnership,100,61,9/20/2018
0C355F,partnership,100,61,9/20/2018
12DE76,dividend,100,50,9/20/2018
12E454,facility-open,100,65,9/20/2018
131443,business-contract,100,69,9/20/2018
14BA33,dividend,100,50,9/20/2018
1748F6,earnings,100,50,9/20/2018
190B91,note-sale,100,52,9/20/2018
190B91,note-sale,100,52,9/20/2018
190B91,note-sale,100,52,9/20/2018
1CD09C,conference-participant,100,50,9/20/2018
1DF15D,public-offering,100,43,9/20/2018
1F08A6,conference-participant,100,50,9/20/2018
1FAF22,conference-call,100,50,9/20/2018
200D8B,conference-participant,100,50,9/20/2018
205AD5,earnings,100,50,9/20/2018
228D42,partnership,100,61,9/20/2018
228D42,partnership,100,61,9/20/2018
238302,dividend,100,50,9/20/2018
2C3348,legal-issues-defendant,100,22,9/20/2018
2F24A5,earnings,100,50,9/20/2018
3461CF,credit-rating-upgrade-rater,20,50,9/20/2018
37727A,dividend,100,50,9/20/2018
385DD4,partnership,100,61,9/20/2018
39D9DA,conference-call,100,50,9/20/2018
3B37F7,conference-organizer,100,57,9/20/2018
3C7F5F,legal-issues-defendant,100,22,9/20/2018
3FACA7,earnings,100,50,9/20/2018
41EC04,reorganization,100,53,9/20/2018
41EC04,reorganization,100,53,9/20/2018
420168,conference-participant,100,50,9/20/2018
47752F,dividend,100,50,9/20/2018
49BBBC,earnings,100,50,9/20/2018
49BBBC,executive-appointment,100,54,9/20/2018
49CC59,asset-sale,100,62,9/20/2018
4B49CF,conference-call,100,50,9/20/2018
4C37C5,conference-call,100,50,9/20/2018
4C7DB5,earnings,100,50,9/20/2018
4EE167,conference-participant,100,50,9/20/2018
4F9926,partnership,100,61,9/20/2018
504FE2,conference-call,100,50,9/20/2018
545272,dividend,100,50,9/20/2018
589846,product-release,100,64,9/20/2018
5B226B,stock-splits,100,49,9/20/2018
5BC2F4,public-offering,100,43,9/20/2018
633043,public-offering,100,43,9/20/2018
665D7D,legal-issues-defendant,100,22,9/20/2018
66ECFD,earnings,100,50,9/20/2018
6B0E45,credit-rating-upgrade,100,77,9/20/2018
6B494E,unit-acquisition-acquirer,100,49,9/20/2018
6B5379,product-release,100,64,9/20/2018
6BC6F9,business-contract,100,69,9/20/2018
6BC6F9,business-contract,100,69,9/20/2018
6E705B,campaign-ad-release,100,59,9/20/2018
6EA292,dividend,100,50,9/20/2018
6F0096,product-release,100,64,9/20/2018
70FCEF,executive-appointment,100,54,9/20/2018
713810,product-release,100,64,9/20/2018
7262F2,conference-participant,100,50,9/20/2018
746373,conference-call,100,50,9/20/2018
747219,conference-participant,100,50,9/20/2018
75768D,business-contract,100,69,9/20/2018
762A3E,award,100,58,9/20/2018
76F067,partnership,100,61,9/20/2018
7A51FE,product-release,100,64,9/20/2018
810FAD,conference-participant,100,50,9/20/2018
8377DB,donation,100,54,9/20/2018
845533,public-offering,100,43,9/20/2018
84AB66,dividend,100,50,9/20/2018
863350,facility-open,100,65,9/20/2018
8665BA,product-release,100,64,9/20/2018
893904,conference-participant,100,50,9/20/2018
8C6C1B,facility-open,100,65,9/20/2018
8D0EEA,conference-participant,100,50,9/20/2018
8E4250,conference-call,100,50,9/20/2018
91C82E,conference-call,100,50,9/20/2018
92D9C9,dividend,100,50,9/20/2018
9.31E+77,conference-participant,100,50,9/20/2018
9.54E+32,dividend-up,100,65,9/20/2018
95DC1F,dividend,100,50,9/20/2018
97644E,partnership,100,61,9/20/2018
97AAF6,unit-acquisition-acquirer,100,49,9/20/2018
97AAF6,unit-acquisition-acquirer,100,49,9/20/2018
990AD0,conference-organizer,100,57,9/20/2018
9BBFA5,earnings,100,50,9/20/2018
9C009A,executive-appointment,100,54,9/20/2018
A43906,conference-call,100,50,9/20/2018
A5A4F5,acquisition-acquirer,100,49,9/20/2018
A5A4F5,conference-call,100,50,9/20/2018
A5A4F5,conference-call,100,50,9/20/2018
A63387,business-contract,100,69,9/20/2018
A666C8,executive-appointment,100,54,9/20/2018
AB4A7E,conference-participant,100,50,9/20/2018
AD9F1D,facility-open,100,65,9/20/2018
AE3113,executive-appointment,100,54,9/20/2018
B0998E,conference-participant,100,50,9/20/2018
B0D41A,public-offering,100,43,9/20/2018
B48D6A,clinical-trials-positive,100,87,9/20/2018
B619CB,executive-appointment,100,54,9/20/2018
B642E8,unit-acquisition-acquiree,100,76,9/20/2018
B642E8,unit-acquisition-acquiree,100,76,9/20/2018
B642E8,asset-sale,100,62,9/20/2018
B7BDA3,merger-completed,100,66,9/20/2018
B8F71F,earnings,100,50,9/20/2018
BB127B,partnership,100,61,9/20/2018
BB127B,partnership,100,61,9/20/2018
BCC55F,acquisition-acquirer,100,49,9/20/2018
BCC55F,acquisition-acquirer,100,49,9/20/2018
BDCC11,ipo-pricing,100,50,9/20/2018
BDD12C,partnership,100,61,9/20/2018
C16A8F,executive-appointment,100,54,9/20/2018
C188F8,legal-issues-defendant,100,22,9/20/2018
C27E19,earnings,100,50,9/20/2018
C81E00,conference-call,100,50,9/20/2018
C83B88,award,100,58,9/20/2018
C93C44,clinical-trials-positive,100,87,9/20/2018
C9881C,acquisition-acquirer,100,49,9/20/2018
CA1620,conference-call,100,50,9/20/2018
CBB77B,conference-participant,100,50,9/20/2018
CBCC6A,conference-organizer,100,57,9/20/2018
CDFCC9,legal-issues-defendant,100,22,9/20/2018
CDFCC9,legal-issues-defendant,100,22,9/20/2018
CE5C6E,conference-participant,100,50,9/20/2018
CE8251,partnership,100,61,9/20/2018
D0DE27,conference-participant,100,50,9/20/2018
D1CFC8,acquisition-acquirer,100,49,9/20/2018
D1CFC8,earnings,100,50,9/20/2018
D2E553,earnings-up,100,68,9/20/2018
D2E553,earnings-up,100,68,9/20/2018
D2E553,earnings-up,100,68,9/20/2018
D3CEDF,partnership,100,61,9/20/2018
D60BB2,partnership,100,61,9/20/2018
D8DA3D,award,100,58,9/20/2018
DDCB34,conference-participant,100,50,9/20/2018
DF6FDD,partnership,100,61,9/20/2018
E68733,acquisition-acquirer,100,49,9/20/2018
E866D2,donation,100,54,9/20/2018
E8846E,executive-appointment,100,54,9/20/2018
E8846E,conference-organizer,100,57,9/20/2018
E8B315,dividend,100,50,9/20/2018
E8B315,merger,100,66,9/20/2018
E8B315,merger,100,66,9/20/2018
ECDEB2,dividend,100,50,9/20/2018
EEA6B3,earnings,100,50,9/20/2018
EF1AD9,conference-call,100,50,9/20/2018
EF45B6,note-sale,100,52,9/20/2018
F2E253,legal-issues-defendant,100,22,9/20/2018
F3816D,conference-participant,100,50,9/20/2018
F4D241,unit-acquisition-acquirer,100,49,9/20/2018
F5349B,legal-issues-defendant,100,22,9/20/2018
F93C8A,public-offering,100,43,9/20/2018
061A3B,executive-appointment,100,54,9/21/2018
06A456,partnership,100,61,9/21/2018
0BC29E,unit-acquisition-acquirer,100,49,9/21/2018
0BC29E,unit-acquisition-acquiree,100,76,9/21/2018
0C6861,legal-issues-defendant,100,22,9/21/2018
10AE08,earnings,100,50,9/21/2018
159AE4,conference-participant,100,50,9/21/2018
205AD5,donation,100,54,9/21/2018
2571FA,product-release,100,64,9/21/2018
28AF37,conference-participant,100,50,9/21/2018
2C3348,legal-issues-defendant,100,22,9/21/2018
326EDD,conference-participant,100,50,9/21/2018
32F943,regulatory-product-review-negative,100,26,9/21/2018
339F20,dividend,100,50,9/21/2018
39FB23,executive-appointment,100,54,9/21/2018
3B37F7,conference-organizer,100,57,9/21/2018
3BE00F,unit-acquisition-acquiree,100,76,9/21/2018
3F4497,executive-appointment,100,54,9/21/2018
4398A2,ipo-pricing,100,50,9/21/2018
449A26,conference-call,100,50,9/21/2018
453282,conference-call,100,50,9/21/2018
4A6F00,partnership,100,61,9/21/2018
4A6F00,partnership,100,61,9/21/2018
4D8313,dividend,100,50,9/21/2018
4FCC78,conference-call,100,50,9/21/2018
55438C,product-release,100,64,9/21/2018
5C7601,earnings,100,50,9/21/2018
5D41E4,executive-appointment,100,54,9/21/2018
633043,public-offering,100,43,9/21/2018
665D7D,donation,100,54,9/21/2018
665D7D,legal-issues-defendant,100,22,9/21/2018
665D7D,legal-issues-defendant,100,22,9/21/2018
665D7D,legal-issues-defendant,100,22,9/21/2018
713810,partnership,100,61,9/21/2018
713810,donation,100,54,9/21/2018
713810,partnership,100,61,9/21/2018
771985,product-release,100,64,9/21/2018
845533,public-offering,100,43,9/21/2018
877C0C,earnings,100,50,9/21/2018
8817D5,conference-call,100,50,9/21/2018
88193E,executive-appointment,100,54,9/21/2018
896771,facility-open,100,65,9/21/2018
8A0368,executive-appointment,100,54,9/21/2018
8C6C1B,facility-open,100,65,9/21/2018
8C6C1B,donation,100,54,9/21/2018
8FF57A,executive-appointment,100,54,9/21/2018
911AB8,conference-call,100,50,9/21/2018
990AD0,conference-organizer,100,57,9/21/2018
990AD0,conference-organizer,100,57,9/21/2018
990AD0,conference-organizer,100,57,9/21/2018
A26EF7,stake-acquirer,100,48,9/21/2018
A5A4F5,acquisition-acquirer,100,49,9/21/2018
A6828A,clinical-trials,100,56,9/21/2018
A8CBDA,business-contract,100,69,9/21/2018
B0D41A,public-offering,100,43,9/21/2018
B1FC3B,earnings,100,50,9/21/2018
BCC13E,conference-participant,100,50,9/21/2018
BFAEB4,facility-open,100,65,9/21/2018
C16A8F,conference-call,100,50,9/21/2018
C45C1F,public-offering,100,43,9/21/2018
CA1620,legal-issues-defendant,100,22,9/21/2018
D17F7E,unit-acquisition-acquirer,100,49,9/21/2018
D8ECA1,legal-verdict-disfavored,100,22,9/21/2018
DA0A9E,conference-call,100,50,9/21/2018
DA199F,earnings,100,50,9/21/2018
DB5CA5,settlement,100,56,9/21/2018
DC0066,public-offering,100,43,9/21/2018
DC486E,earnings,100,50,9/21/2018
DF8855,executive-appointment,100,54,9/21/2018
E30B34,note-sale,100,52,9/21/2018
E49AA3,government-contract,100,69,9/21/2018
E68733,acquisition-acquirer,100,49,9/21/2018
ED4560,conference-participant,100,50,9/21/2018
F67165,conference-participant,100,50,9/21/2018
F82D37,conference-call,100,50,9/21/2018
FA40E2,dividend,100,50,9/21/2018
FEBFE1,conference-participant,100,50,9/21/2018
FFE543,legal-issues-defendant,100,22,9/21/2018
2C3348,legal-issues-defendant,100,22,9/22/2018
2C3348,legal-verdict-disfavored,100,22,9/22/2018
F2E253,legal-issues-defendant,100,22,9/22/2018
FFE543,legal-issues-defendant,100,22,9/22/2018
665D7D,legal-issues-defendant,100,22,9/23/2018
EA62FC,executive-resignation,100,44,9/23/2018
20751,conference-participant,100,50,9/24/2018
31025,award,100,58,9/24/2018
0490C6,legal-issues-defendant,100,22,9/24/2018
0490C6,conference-participant,100,50,9/24/2018
07EC43,executive-appointment,100,54,9/24/2018
0CADBC,executive-appointment,100,54,9/24/2018
0E439E,earnings,100,50,9/24/2018
12E454,partnership,100,61,9/24/2018
139303,executive-appointment,100,54,9/24/2018
1490F3,public-offering,100,43,9/24/2018
15901B,conference-participant,100,50,9/24/2018
188394,earnings,100,50,9/24/2018
19CAC7,conference-call,100,50,9/24/2018
19CAC7,executive-resignation,100,44,9/24/2018
1C2593,public-offering,100,43,9/24/2018
1D1B07,executive-appointment,100,54,9/24/2018
1D1B07,executive-appointment,100,54,9/24/2018
1DF15D,ipo-completed,100,76,9/24/2018
21DED4,dividend,100,50,9/24/2018
222BF9,earnings,100,50,9/24/2018
228D42,partnership,100,61,9/24/2018
251988,earnings,100,50,9/24/2018
251988,product-release,100,64,9/24/2018
292A70,executive-appointment,100,54,9/24/2018
2B8179,conference-participant,100,50,9/24/2018
2C3348,legal-issues-defendant,100,22,9/24/2018
2C3348,legal-issues-defendant,100,22,9/24/2018
366A08,conference-organizer,100,57,9/24/2018
384CD3,earnings,100,50,9/24/2018
3A3447,facility-open,100,65,9/24/2018
3B37F7,conference-organizer,100,57,9/24/2018
3B37F7,conference-organizer,100,57,9/24/2018
40F7DE,conference-participant,100,50,9/24/2018
4.91E+58,product-release,100,64,9/24/2018
49914B,conference-call,100,50,9/24/2018
4A2457,government-contract,100,69,9/24/2018
4A5C8D,partnership,100,61,9/24/2018
4A6F00,partnership,100,61,9/24/2018
4A6F00,partnership,100,61,9/24/2018
4AC91D,product-release,100,64,9/24/2018
4AC91D,product-release,100,64,9/24/2018
4B3555,dividend,100,50,9/24/2018
4BBA23,executive-resignation,100,44,9/24/2018
4C3FE9,conference-participant,100,50,9/24/2018
4C6C63,acquisition-acquirer,100,49,9/24/2018
4C6C63,acquisition-acquirer,100,49,9/24/2018
514067,conference-participant,100,50,9/24/2018
55438C,partnership,100,61,9/24/2018
57DDB9,executive-appointment,100,54,9/24/2018
57DDB9,executive-appointment,100,54,9/24/2018
586BD7,conference-participant,100,50,9/24/2018
5BC2F4,earnings,100,50,9/24/2018
5C7601,executive-appointment,100,54,9/24/2018
5D1329,conference-participant,100,50,9/24/2018
5E6959,dividend,100,50,9/24/2018
5EAA43,executive-appointment,100,54,9/24/2018
620381,index-listing,100,76,9/24/2018
649CBD,partnership,100,61,9/24/2018
665D7D,legal-issues-defendant,100,22,9/24/2018
665D7D,legal-issues-defendant,100,22,9/24/2018
6925EB,public-offering,100,43,9/24/2018
69C99E,conference-participant,100,50,9/24/2018
69CE71,merger,100,66,9/24/2018
6B236C,conference-participant,100,50,9/24/2018
723548,dividend,100,50,9/24/2018
72DF04,award,100,58,9/24/2018
7A51FE,conference-call,100,50,9/24/2018
83A065,executive-appointment,100,54,9/24/2018
860AB6,stake-acquirer,100,48,9/24/2018
877C0C,conference-participant,100,50,9/24/2018
88923D,executive-appointment,100,54,9/24/2018
88923D,executive-appointment,100,54,9/24/2018
8C5519,conference-participant,100,50,9/24/2018
8C6C1B,facility-open,100,65,9/24/2018
92005C,conference-participant,100,50,9/24/2018
925759,clinical-trials-positive,100,87,9/24/2018
925759,business-contract,100,69,9/24/2018
925759,executive-appointment,100,54,9/24/2018
9.54E+32,executive-resignation,100,44,9/24/2018
96F126,executive-appointment,100,54,9/24/2018
977A1E,revenue-volume,100,50,9/24/2018
990AD0,conference-organizer,100,57,9/24/2018
990AD0,conference-organizer,100,57,9/24/2018
9A2760,public-offering,100,43,9/24/2018
9A602D,conference-call,100,50,9/24/2018
9B0C9C,conference-participant,100,50,9/24/2018
9C5174,earnings,100,50,9/24/2018
9E575E,conference-participant,100,50,9/24/2018
9F37C5,dividend,100,50,9/24/2018
9F6B1A,partnership,100,61,9/24/2018
A1EAC8,government-contract,100,69,9/24/2018
A5A4F5,acquisition-acquirer,100,49,9/24/2018
A63820,campaign-ad-release,100,59,9/24/2018
A8CBDA,conference-call,100,50,9/24/2018
A8E72A,ipo,100,71,9/24/2018
AA98ED,conference-call,100,50,9/24/2018
ACC7D3,conference-participant,100,50,9/24/2018
ADFB3A,clinical-trials-start,100,64,9/24/2018
AE79CD,index-listing,100,76,9/24/2018
AFD1CA,conference-participant,100,50,9/24/2018
AFDF2E,earnings-revision,100,29,9/24/2018
AFF7B4,conference-call,100,50,9/24/2018
B1FC3B,business-contract,100,69,9/24/2018
B2206F,executive-appointment,100,54,9/24/2018
B303A6,dividend,100,50,9/24/2018
B303A6,executive-appointment,100,54,9/24/2018
B5DE80,unit-acquisition-acquirer,100,49,9/24/2018
B6082A,conference-call,100,50,9/24/2018
B7EB38,earnings,100,50,9/24/2018
BAD655,conference-participant,100,50,9/24/2018
BAD9EA,layoffs,100,43,9/24/2018
BB127B,product-release,100,64,9/24/2018
BDE867,revenue-guidance-up,100,81,9/24/2018
C03C8B,conference-participant,100,50,9/24/2018
C36189,conference-participant,100,50,9/24/2018
C3F99F,conference-participant,100,50,9/24/2018
C4A432,dividend,100,50,9/24/2018
C97B2D,regulatory-product-approval-granted,100,81,9/24/2018
C9D866,conference-participant,100,50,9/24/2018
CB7AB2,award,100,58,9/24/2018
CE5C6E,clinical-trials-positive,100,87,9/24/2018
CF7292,executive-appointment,100,54,9/24/2018
CFD4B6,conference-participant,100,50,9/24/2018
CFF97C,partnership,100,61,9/24/2018
D1CFC8,conference-call,100,50,9/24/2018
D5AF19,unit-acquisition-acquirer,100,49,9/24/2018
D650A7,executive-appointment,100,54,9/24/2018
D8442A,product-release,100,64,9/24/2018
D8442A,acquisition-acquirer,100,49,9/24/2018
DAFED3,earnings,100,50,9/24/2018
DD3BB1,legal-issues-defendant,100,22,9/24/2018
DF5F14,name-change,100,49,9/24/2018
E1E093,business-contract,100,69,9/24/2018
E49AA3,product-release,100,64,9/24/2018
E8C557,buybacks,100,74,9/24/2018
F1529C,conference-call,100,50,9/24/2018
F4CDA3,dividend,100,50,9/24/2018
F58C23,executive-appointment,100,54,9/24/2018
0157B1,partnership,100,61,9/25/2018
0157B1,partnership,100,61,9/25/2018
099C88,business-contract,100,69,9/25/2018
0A59F8,partnership,100,61,9/25/2018
0A7650,dividend,100,50,9/25/2018
0B57D7,conference-call,100,50,9/25/2018
0BA8CE,buybacks,100,74,9/25/2018
0C136E,earnings,100,50,9/25/2018
0CE204,partnership,100,61,9/25/2018
0DBB81,conference-participant,100,50,9/25/2018
0F0440,partnership,100,61,9/25/2018
0F04E5,product-release,100,64,9/25/2018
0F04E5,product-release,100,64,9/25/2018
12A3A3,revenue-up,100,69,9/25/2018
12A3A3,revenue-up,100,69,9/25/2018
12A3A3,revenue-up,100,69,9/25/2018
12A3A3,revenue-up,100,69,9/25/2018
12A3A3,revenue-up,100,69,9/25/2018
12E454,partnership,100,61,9/25/2018
13A782,conference-participant,100,50,9/25/2018
1490F3,public-offering,100,43,9/25/2018
14BA06,earnings,100,50,9/25/2018
15B10D,conference-participant,100,50,9/25/2018
184866,conference-participant,100,50,9/25/2018
184988,conference-participant,100,50,9/25/2018
196D18,conference-participant,100,50,9/25/2018
1A3E1B,executive-appointment,100,54,9/25/2018
1B637E,partnership,100,61,9/25/2018
1F3CFB,partnership,100,61,9/25/2018
2082EA,conference-participant,100,50,9/25/2018
228D42,partnership,100,61,9/25/2018
228D42,partnership,100,61,9/25/2018
228D42,partnership,100,61,9/25/2018
228D42,partnership,100,61,9/25/2018
228D42,partnership,100,61,9/25/2018
22C58E,product-release,100,64,9/25/2018
251988,business-contract,100,69,9/25/2018
251988,donation,100,54,9/25/2018
2571FA,conference-participant,100,50,9/25/2018
284289,partnership,100,61,9/25/2018
2.90E+62,business-contract,100,69,9/25/2018
2B0AF4,conference-call,100,50,9/25/2018
2BBE62,product-recall,100,29,9/25/2018
2BDC1C,business-contract,100,69,9/25/2018
2C681C,clinical-trials-start,100,64,9/25/2018
2C681C,clinical-trials-start,100,64,9/25/2018
3159AA,facility-open,100,65,9/25/2018
31F25C,conference-call,100,50,9/25/2018
3461CF,executive-appointment,100,54,9/25/2018
34B97A,donation,100,54,9/25/2018
36529A,conference-participant,100,50,9/25/2018
36C09B,clinical-trials,100,56,9/25/2018
37B120,conference-participant,100,50,9/25/2018
396D7C,conference-participant,100,50,9/25/2018
39FB23,earnings,100,50,9/25/2018
3A3447,facility-open,100,65,9/25/2018
3B37F7,conference-organizer,100,57,9/25/2018
3B37F7,conference-organizer,100,57,9/25/2018
3B37F7,conference-organizer,100,57,9/25/2018
3B37F7,conference-organizer,100,57,9/25/2018
3B37F7,conference-organizer,100,57,9/25/2018
3BCF24,dividend,100,50,9/25/2018
408089,earnings,100,50,9/25/2018
41EC04,executive-appointment,100,54,9/25/2018
4398A2,ipo-completed,100,76,9/25/2018
447FC6,executive-appointment,100,54,9/25/2018
448BF3,conference-participant,100,50,9/25/2018
499C75,award,100,58,9/25/2018
49A344,earnings,100,50,9/25/2018
49F4D0,dividend,100,50,9/25/2018
4A6F00,business-contract,100,69,9/25/2018
4EEB00,conference-participant,100,50,9/25/2018
510EA6,earnings,100,50,9/25/2018
510EA6,earnings,100,50,9/25/2018
524CE4,executive-appointment,100,54,9/25/2018
55438C,acquisition-completed-acquirer,100,49,9/25/2018
57A854,conference-participant,100,50,9/25/2018
5968F9,conference-participant,100,50,9/25/2018
59872F,award,100,58,9/25/2018
5B6C11,award,100,58,9/25/2018
5DD486,product-release,100,64,9/25/2018
5F3E74,business-contract,100,69,9/25/2018
5F9CE3,unit-acquisition-acquirer,100,49,9/25/2018
665D7D,legal-issues-defendant,100,22,9/25/2018
66CB62,note-sale,100,52,9/25/2018
66ECFD,partnership,100,61,9/25/2018
673C9A,earnings,100,50,9/25/2018
6925EB,public-offering,100,43,9/25/2018
6D2BF6,conference-participant,100,50,9/25/2018
6-Dec-05,conference-participant,100,50,9/25/2018
71B0CF,clinical-trials-start,100,64,9/25/2018
72CB93,conference-participant,100,50,9/25/2018
72FCA3,earnings,100,50,9/25/2018
72FCA3,earnings,100,50,9/25/2018
72FCA3,earnings,100,50,9/25/2018
72FCA3,earnings,100,50,9/25/2018
73C521,earnings,100,50,9/25/2018
762A3E,award,100,58,9/25/2018
7A975D,earnings,100,50,9/25/2018
7D5FD6,earnings,100,50,9/25/2018
7DA412,earnings,100,50,9/25/2018
7F3A5F,note-sale,100,52,9/25/2018
8.10E+32,executive-appointment,100,54,9/25/2018
817ED9,partnership,100,61,9/25/2018
81EAD4,partnership,100,61,9/25/2018
8303CD,executive-appointment,100,54,9/25/2018
838ADD,conference-participant,100,50,9/25/2018
850779,earnings,100,50,9/25/2018
85CDC9,conference-participant,100,50,9/25/2018
8AB85C,conference-participant,100,50,9/25/2018
8B3B0E,executive-appointment,100,54,9/25/2018
8C5519,acquisition-completed-acquirer,100,49,9/25/2018
8C5519,earnings,100,50,9/25/2018
8C6C1B,facility-open,100,65,9/25/2018
8EF425,dividend,100,50,9/25/2018
8F6995,dividend,100,50,9/25/2018
9196A2,conference-call,100,50,9/25/2018
92D3A0,conference-call,100,50,9/25/2018
966ACE,patient-enrollment-complete,100,64,9/25/2018
96F126,business-contract,100,69,9/25/2018
9810C0,earnings-guidance,100,50,9/25/2018
9A02C4,conference-call,100,50,9/25/2018
9ABD30,regulatory-product-approval-granted,100,81,9/25/2018
9CA619,dividend,100,50,9/25/2018
9D56F2,dividend,100,50,9/25/2018
9F6B1A,earnings,100,50,9/25/2018
9FB4B7,conference-participant,100,50,9/25/2018
A350C1,executive-appointment,100,54,9/25/2018
A398B9,conference-participant,100,50,9/25/2018
A4B899,acquisition-interest-acquirer,100,46,9/25/2018
A5195E,conference-participant,100,50,9/25/2018
A5A4F5,acquisition-acquirer,100,49,9/25/2018
A6213D,conference-call,100,50,9/25/2018
A631A3,product-release,100,64,9/25/2018
A631A3,partnership,100,61,9/25/2018
A63387,business-contract,100,69,9/25/2018
A70BF5,earnings,100,50,9/25/2018
A868C9,business-contract,100,69,9/25/2018
A87CD6,earnings,100,50,9/25/2018
A8CBDA,business-contract,100,69,9/25/2018
AC7AAE,executive-appointment,100,54,9/25/2018
AD375D,executive-appointment,100,54,9/25/2018
AD9F1D,executive-resignation,100,44,9/25/2018
ADF092,partnership,100,61,9/25/2018
AEF2C3,regulatory-investigation,100,22,9/25/2018
AEF2C3,settlement,100,56,9/25/2018
AEFC90,conference-participant,100,50,9/25/2018
B0D41A,conference-participant,100,50,9/25/2018
B0D41A,public-offering,100,43,9/25/2018
B9CD50,product-release,100,64,9/25/2018
BB127B,partnership,100,61,9/25/2018
BB88B6,partnership,100,61,9/25/2018
BC5680,acquisition-acquirer,100,49,9/25/2018
BC5680,acquisition-acquirer,100,49,9/25/2018
BDEC1E,executive-appointment,100,54,9/25/2018
BFAEB4,earnings,100,50,9/25/2018
C74887,conference-participant,100,50,9/25/2018
C7859D,conference-call,100,50,9/25/2018
C7863D,conference-call,100,50,9/25/2018
C8257F,partnership,100,61,9/25/2018
C83B88,stake-acquirer,100,48,9/25/2018
C8A248,facility-open,100,65,9/25/2018
C99CC8,business-contract,100,69,9/25/2018
C9D866,public-offering,100,43,9/25/2018
CA1620,legal-issues-defendant,100,22,9/25/2018
CBA33B,index-listing,100,76,9/25/2018
CDAA0E,ipo-pricing,100,50,9/25/2018
CDD75E,legal-issues-defendant,100,22,9/25/2018
D64C6D,earnings,100,50,9/25/2018
D6853F,ownership-decrease-owner,100,46,9/25/2018
D75910,dividend,100,50,9/25/2018
D88EF3,conference-call,100,50,9/25/2018
DA9443,conference-participant,100,50,9/25/2018
DB88A1,partnership,100,61,9/25/2018
DC0066,public-offering,100,43,9/25/2018
DCD97F,business-contract,100,69,9/25/2018
DDEA6A,conference-participant,100,50,9/25/2018
DF11D9,conference-call,100,50,9/25/2018
E0A84E,product-release,100,64,9/25/2018
E22FDE,conference-participant,100,50,9/25/2018
E829E8,award,100,58,9/25/2018
E82A2D,executive-appointment,100,54,9/25/2018
E8E899,investment-investor,100,55,9/25/2018
EB7FBF,conference-call,100,50,9/25/2018
ED79D9,business-contract,100,69,9/25/2018
F0EEFB,business-contract,100,69,9/25/2018
F15E41,investment-investor,100,55,9/25/2018
F15E41,investment-investor,100,55,9/25/2018
F2E253,legal-issues-defendant,100,22,9/25/2018
F3816D,conference-participant,100,50,9/25/2018
F3EDB4,earnings,100,50,9/25/2018
F3EDB4,earnings,100,50,9/25/2018
FC9A88,dividend,100,50,9/25/2018
FCA54E,executive-appointment,100,54,9/25/2018
FD9526,conference-call,100,50,9/25/2018
FF227B,clinical-trials,100,56,9/25/2018
FF6644,partnership,100,61,9/25/2018
FF6644,partnership,100,61,9/25/2018
0358AF,dividend,100,50,9/26/2018
03F5A4,dividend-up,100,81,9/26/2018
05AF14,earnings,100,50,9/26/2018
05AF14,dividend,100,50,9/26/2018
07C69F,conference-call,100,50,9/26/2018
07C69F,dividend,100,50,9/26/2018
07CA6A,partnership,100,61,9/26/2018
95294,acquisition-acquirer,100,49,9/26/2018
0A0CF0,dividend,100,50,9/26/2018
0B7375,conference-participant,100,50,9/26/2018
0B7375,public-offering,100,43,9/26/2018
0B73A7,executive-appointment,100,54,9/26/2018
0B73A7,executive-appointment,100,54,9/26/2018
0CADBC,dividend,100,50,9/26/2018
0CC01F,earnings,100,50,9/26/2018
0E2992,conference-call,100,50,9/26/2018
152FA5,ipo,100,71,9/26/2018
168A5D,facility-open,100,65,9/26/2018
1C2593,public-offering,100,43,9/26/2018
1FAF22,regulatory-product-approval-granted,100,81,9/26/2018
221783,earnings,100,50,9/26/2018
228D42,partnership,100,61,9/26/2018
228D42,partnership,100,61,9/26/2018
228D42,partnership,100,61,9/26/2018
228D42,partnership,100,61,9/26/2018
251988,partnership,100,61,9/26/2018
251988,award,100,58,9/26/2018
264EB3,executive-appointment,100,54,9/26/2018
2C3348,legal-issues-defendant,100,22,9/26/2018
2C681C,conference-participant,100,50,9/26/2018
2C681C,conference-participant,100,50,9/26/2018
2C7505,legal-issues-defendant,100,22,9/26/2018
2F7474,dividend,100,50,9/26/2018
2F7A7E,conference-call,100,50,9/26/2018
3461CF,credit-rating-upgrade-rater,20,50,9/26/2018
3461CF,partnership,100,61,9/26/2018
34A959,executive-appointment,100,54,9/26/2018
3696BF,executive-appointment,100,54,9/26/2018
36E479,conference-participant,100,50,9/26/2018
385DD4,executive-appointment,100,54,9/26/2018
387541,conference-call,100,50,9/26/2018
3A3447,facility-open,100,65,9/26/2018
3A3948,executive-appointment,100,54,9/26/2018
3CCC90,executive-appointment,100,54,9/26/2018
3D9999,earnings,100,50,9/26/2018
431B74,acquisition-completed-acquirer,100,49,9/26/2018
431B74,acquisition-completed-acquirer,100,49,9/26/2018
449217,merger-regulatory-approval,100,81,9/26/2018
449A26,acquisition-acquirer,100,49,9/26/2018
4DD203,executive-appointment,100,54,9/26/2018
4E4E75,product-release,100,64,9/26/2018
4F9487,dividend-up,100,59,9/26/2018
50D1EC,award,100,58,9/26/2018
50D1EC,executive-appointment,100,54,9/26/2018
525A1C,award,100,58,9/26/2018
543900,dividend,100,50,9/26/2018
54512F,conference-call,100,50,9/26/2018
55438C,earnings,100,50,9/26/2018
55438C,conference-call,100,50,9/26/2018
56EA2B,credit-rating-upgrade,100,77,9/26/2018
616E3B,conference-call,100,50,9/26/2018
633054,business-contract,100,69,9/26/2018
665D7D,legal-issues-defendant,100,22,9/26/2018
6830FE,product-release,100,64,9/26/2018
6BC6F9,business-contract,100,69,9/26/2018
6BC6F9,business-contract,100,69,9/26/2018
6BF593,conference-call,100,50,9/26/2018
6C4D2F,ipo-pricing,100,50,9/26/2018
6C4D2F,ipo-pricing,100,50,9/26/2018
6F0096,business-contract,100,69,9/26/2018
731675,merger-regulatory-approval,100,81,9/26/2018
75768D,earnings,100,50,9/26/2018
765913,earnings,100,50,9/26/2018
76E80F,partnership,100,61,9/26/2018
7ACD98,award,100,58,9/26/2018
7B9AFA,unit-acquisition-acquirer,100,49,9/26/2018
7C4F43,conference-participant,100,50,9/26/2018
7DD584,business-contract,100,69,9/26/2018
7DD584,business-contract,100,69,9/26/2018
83B1C8,conference-participant,100,50,9/26/2018
83E0AC,dividend,100,50,9/26/2018
868808,dividend,100,50,9/26/2018
88193E,patient-enrollment-start,100,58,9/26/2018
8C6C1B,facility-open,100,65,9/26/2018
902670,earnings-guidance,100,50,9/26/2018
907ED2,dividend-up,100,81,9/26/2018
93AD2E,earnings,100,50,9/26/2018
96A6CD,conference-participant,100,50,9/26/2018
9981C6,dividend-up,100,81,9/26/2018
9A2760,public-offering,100,43,9/26/2018
9AF3DC,conference-organizer,100,57,9/26/2018
9B5968,dividend,100,50,9/26/2018
9B5968,dividend,100,50,9/26/2018
9B71A7,earnings,100,50,9/26/2018
9B71A7,earnings,100,50,9/26/2018
9D65C1,legal-issues-defendant,100,22,9/26/2018
9F71E5,executive-appointment,100,54,9/26/2018
A5A4F5,acquisition-acquirer,100,49,9/26/2018
A631A3,award,100,58,9/26/2018
A65325,conference-call,100,50,9/26/2018
AA7FE0,earnings,100,50,9/26/2018
AA7FE0,earnings,100,50,9/26/2018
AA7FE0,earnings,100,50,9/26/2018
AA7FE0,earnings,100,50,9/26/2018
AA7FE0,earnings,100,50,9/26/2018
ABBAD1,earnings,100,50,9/26/2018
AD9F1D,conference-call,100,50,9/26/2018
AFF43F,buybacks,100,74,9/26/2018
B1FC3B,executive-appointment,100,54,9/26/2018
B1FC3B,dividend,100,50,9/26/2018
B1FC3B,earnings,100,50,9/26/2018
BDEC1E,conference-participant,100,50,9/26/2018
C06EB6,public-offering,100,43,9/26/2018
C1114B,stake-acquirer,100,48,9/26/2018
C188F8,legal-issues-defendant,100,22,9/26/2018
C2E120,dividend,100,50,9/26/2018
C4A432,product-release,100,64,9/26/2018
C564E4,conference-participant,100,50,9/26/2018
C8923A,conference-participant,100,50,9/26/2018
C951A2,acquisition-acquirer,100,49,9/26/2018
C97B2D,product-release,100,64,9/26/2018
C9D866,public-offering,100,43,9/26/2018
CD4DA8,earnings-guidance,100,50,9/26/2018
CDAA0E,product-release,100,64,9/26/2018
CDFCC9,legal-issues-defendant,100,22,9/26/2018
CDFCC9,fraud-defendant,100,20,9/26/2018
CDFCC9,legal-issues-defendant,100,22,9/26/2018
D15833,dividend,100,50,9/26/2018
D4463B,dividend,100,50,9/26/2018
D598E7,conference-call,100,50,9/26/2018
D598E7,conference-call,100,50,9/26/2018
D6EAA3,product-release,100,64,9/26/2018
D6EAA3,award,100,58,9/26/2018
D6EAA3,executive-appointment,100,54,9/26/2018
D7AC6E,conference-call,100,50,9/26/2018
D93A25,earnings-guidance,100,50,9/26/2018
DC0066,conference-participant,100,50,9/26/2018
DD3BB1,legal-issues-defendant,100,22,9/26/2018
DF11D9,executive-appointment,100,54,9/26/2018
E114F4,executive-appointment,100,54,9/26/2018
E1C16B,product-release,100,64,9/26/2018
E20392,conference-participant,100,50,9/26/2018
E30B34,executive-appointment,100,54,9/26/2018
E71AE6,conference-participant,100,50,9/26/2018
E8846E,donation,100,54,9/26/2018
E8C557,conference-participant,100,50,9/26/2018
E90C84,note-sale,100,52,9/26/2018
E99180,dividend,100,50,9/26/2018
E9C7C0,partnership,100,61,9/26/2018
ECF709,buybacks,100,74,9/26/2018
ED79D9,acquisition-acquirer,100,49,9/26/2018
ED79D9,acquisition-acquirer,100,49,9/26/2018
F30508,business-contract,100,69,9/26/2018
F5349B,legal-issues-defendant,100,22,9/26/2018
F5349B,legal-issues-defendant,100,22,9/26/2018
F6FA6A,business-contract,100,69,9/26/2018
F83279,dividend-up,100,81,9/26/2018
FC01C0,acquisition-acquirer,100,49,9/26/2018
FF227B,conference-participant,100,50,9/26/2018
FFE543,legal-issues-defendant,100,22,9/26/2018
00326E,donation,100,54,9/27/2018
0157B1,market-entry,100,57,9/27/2018
0157B1,business-contract,100,69,9/27/2018
0157B1,market-entry,100,57,9/27/2018
02870F,award,100,58,9/27/2018
03596A,partnership,100,61,9/27/2018
48590,earnings,100,50,9/27/2018
070B45,product-release,100,64,9/27/2018
095A04,executive-appointment,100,54,9/27/2018
0A0CF0,earnings,100,50,9/27/2018
0B73A7,acquisition-completed-acquirer,100,49,9/27/2018
0B73A7,acquisition-completed-acquirer,100,49,9/27/2018
0B73A7,acquisition-completed-acquirer,100,49,9/27/2018
0B73A7,acquisition-completed-acquirer,100,49,9/27/2018
0FC848,conference-participant,100,50,9/27/2018
10943B,conference-call,100,50,9/27/2018
1490F3,earnings-guidance,100,50,9/27/2018
165B86,conference-participant,100,50,9/27/2018
1921DD,partnership,100,61,9/27/2018
1A2D9F,executive-appointment,100,54,9/27/2018
1A6A94,partnership,100,61,9/27/2018
1A9DE1,dividend,100,50,9/27/2018
1DEBBE,facility-open,100,65,9/27/2018
1F9258,conference-participant,100,50,9/27/2018
251988,partnership,100,61,9/27/2018
267718,dividend,100,50,9/27/2018
26CC63,donation,100,54,9/27/2018
29CEBF,earnings-guidance,100,50,9/27/2018
2B8179,fast-track-designation,100,81,9/27/2018
2BAE5F,partnership,100,61,9/27/2018
2C7505,legal-issues-defendant,100,22,9/27/2018
2C7505,clinical-trials-positive,100,87,9/27/2018
2C7505,legal-issues-defendant,100,22,9/27/2018
2C7505,legal-issues-defendant,100,22,9/27/2018
2C7505,legal-issues-defendant,100,22,9/27/2018
2E36AD,conference-participant,100,50,9/27/2018
2F7474,conference-call,100,50,9/27/2018
3390DE,conference-call,100,50,9/27/2018
33FD66,earnings,100,50,9/27/2018
3461CF,partnership,100,61,9/27/2018
37E18B,executive-appointment,100,54,9/27/2018
3A3447,facility-open,100,65,9/27/2018
3B37F7,conference-organizer,100,57,9/27/2018
3B37F7,conference-organizer,100,57,9/27/2018
3CCC90,executive-appointment,100,54,9/27/2018
416C55,partnership,100,61,9/27/2018
49A344,executive-appointment,100,54,9/27/2018
4B49CF,earnings,100,50,9/27/2018
4B49CF,earnings,100,50,9/27/2018
4B49CF,earnings,100,50,9/27/2018
4B49CF,earnings,100,50,9/27/2018
4B49CF,earnings,100,50,9/27/2018
53A226,product-release,100,64,9/27/2018
53F491,earnings,100,50,9/27/2018
567F3D,conference-call,100,50,9/27/2018
5AF08A,conference-call,100,50,9/27/2018
5CC29D,dividend,100,50,9/27/2018
605F40,facility-upgrade,100,65,9/27/2018
60FE03,conference-participant,100,50,9/27/2018
627186,earnings,100,50,9/27/2018
636BBF,executive-appointment,100,54,9/27/2018
64E346,partnership,100,61,9/27/2018
665440,government-contract,100,69,9/27/2018
665D7D,legal-issues-defendant,100,22,9/27/2018
66ECFD,award,100,58,9/27/2018
67529E,merger-regulatory-approval,100,81,9/27/2018
6ED519,legal-issues-defendant,100,22,9/27/2018
70FCEF,executive-appointment,100,54,9/27/2018
732A9B,ipo-pricing,100,50,9/27/2018
747219,earnings,100,50,9/27/2018
756BB4,buybacks,100,74,9/27/2018
763DBE,conference-participant,100,50,9/27/2018
789ADD,earnings,100,50,9/27/2018
791EC1,unit-acquisition-acquirer,100,49,9/27/2018
7ADE57,dividend,100,50,9/27/2018
7B0BA6,earnings,100,50,9/27/2018
8AB37F,partnership,100,61,9/27/2018
8BAA15,award,100,58,9/27/2018
8C6C1B,facility-open,100,65,9/27/2018
8E0E32,earnings,100,50,9/27/2018
8E82A6,investment-investor,100,55,9/27/2018
8E82A6,conference-participant,100,50,9/27/2018
8E9CD8,earnings-guidance,100,50,9/27/2018
903AB4,private-placement,100,56,9/27/2018
9.62E+76,earnings,100,50,9/27/2018
967D92,acquisition-acquirer,100,49,9/27/2018
968103,earnings,100,50,9/27/2018
96F126,dividend,100,50,9/27/2018
98D33E,legal-issues-defendant,100,22,9/27/2018
9D3360,conference-call,100,50,9/27/2018
9D56F2,revenue-up,100,69,9/27/2018
A26EF7,conference-participant,100,50,9/27/2018
A5A4F5,acquisition-acquirer,100,49,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
A5A4F5,earnings,100,50,9/27/2018
ADD9DC,facility-open,100,65,9/27/2018
ADF092,earnings,100,50,9/27/2018
AE7D16,facility-open,100,65,9/27/2018
AFF43F,earnings,100,50,9/27/2018
B46E12,dividend-up,100,72,9/27/2018
B8F71F,product-release,100,64,9/27/2018
BAD655,business-contract,100,69,9/27/2018
BB127B,partnership,100,61,9/27/2018
BD9668,executive-resignation,100,44,9/27/2018
BE5935,executive-resignation,100,44,9/27/2018
BFD0A7,conference-participant,100,50,9/27/2018
BFE02C,executive-appointment,100,54,9/27/2018
C06EB6,public-offering,100,43,9/27/2018
C06EB6,conference-participant,100,50,9/27/2018
C2F597,executive-appointment,100,54,9/27/2018
C356AC,partnership,100,61,9/27/2018
C36189,clinical-trials-start,100,64,9/27/2018
C564E4,clinical-trials-positive,100,87,9/27/2018
C5F463,merger-regulatory-approval,100,81,9/27/2018
C5F463,business-contract,100,69,9/27/2018
C5F463,merger-regulatory-approval,100,81,9/27/2018
C83B88,partnership,100,61,9/27/2018
C941DC,conference-participant,100,50,9/27/2018
C9D866,credit-rating-upgrade,100,77,9/27/2018
CA1620,legal-issues-defendant,100,22,9/27/2018
CAC8D0,earnings,100,50,9/27/2018
CC176E,earnings,100,50,9/27/2018
CDFCC9,legal-issues-defendant,100,22,9/27/2018
CE4FD9,earnings,100,50,9/27/2018
CE96E7,conference-call,100,50,9/27/2018
CFF97C,credit-rating-upgrade-rater,20,50,9/27/2018
D437C3,partnership,100,61,9/27/2018
DD0F15,legal-issues-defendant,100,22,9/27/2018
DD0F15,legal-issues-defendant,100,22,9/27/2018
DD3BB1,legal-issues-defendant,100,22,9/27/2018
DF46C5,earnings,100,50,9/27/2018
E10D31,conference-call,100,50,9/27/2018
E22FDE,business-contract,100,69,9/27/2018
E8E899,earnings,100,50,9/27/2018
ECF709,executive-resignation,100,44,9/27/2018
EE6F1C,product-release,100,64,9/27/2018
EF5BED,executive-appointment,100,54,9/27/2018
F0B2B5,partnership,100,61,9/27/2018
F0EEFB,note-sale,100,52,9/27/2018
F1529C,business-contract,100,69,9/27/2018
F2E253,legal-issues-defendant,100,22,9/27/2018
F3816D,executive-appointment,100,54,9/27/2018
F4F46F,partnership,100,61,9/27/2018
F58C23,conference-participant,100,50,9/27/2018
F6DCE4,partnership,100,61,9/27/2018
F80389,earnings-guidance,100,50,9/27/2018
FA40E2,earnings-positive,100,69,9/27/2018
FA40E2,earnings-positive,100,69,9/27/2018
FA40E2,earnings,100,50,9/27/2018
FA40E2,earnings,100,50,9/27/2018
FA40E2,earnings,100,50,9/27/2018
FF4BA4,earnings,100,50,9/27/2018
51332,executive-appointment,100,54,9/28/2018
55018,conference-call,100,50,9/28/2018
0A9D0A,settlement,100,56,9/28/2018
0B73A7,earnings,100,50,9/28/2018
0B73A7,earnings,100,50,9/28/2018
0C6861,executive-appointment,100,54,9/28/2018
0C6861,executive-appointment,100,54,9/28/2018
0C6861,legal-issues-defendant,100,22,9/28/2018
10C19B,conference-call,100,50,9/28/2018
1E1125,settlement,100,56,9/28/2018
1E1125,settlement,100,56,9/28/2018
221783,stake-acquirer,100,48,9/28/2018
228D42,partnership,100,61,9/28/2018
25102A,conference-call,100,50,9/28/2018
251988,dividend,100,50,9/28/2018
26E3BA,executive-appointment,100,54,9/28/2018
27BFA1,conference-call,100,50,9/28/2018
2C3348,legal-issues-defendant,100,22,9/28/2018
2C7505,legal-issues-defendant,100,22,9/28/2018
2C7505,clinical-trials-filed,100,60,9/28/2018
2C7505,legal-issues-defendant,100,22,9/28/2018
2C7505,legal-issues-defendant,100,22,9/28/2018
2C7505,legal-issues-defendant,100,22,9/28/2018
2D485F,earnings,100,50,9/28/2018
36C09B,conference-participant,100,50,9/28/2018
3A3447,facility-open,100,65,9/28/2018
3B37F7,conference-organizer,100,57,9/28/2018
3B37F7,conference-organizer,100,57,9/28/2018
3C7F5F,legal-issues-defendant,100,22,9/28/2018
3CCC90,conference-call,100,50,9/28/2018
3F4497,dividend,100,50,9/28/2018
4806CE,award,100,58,9/28/2018
48F795,revenue-guidance-up,100,83,9/28/2018
543900,legal-issues-defendant,100,22,9/28/2018
543900,legal-issues-defendant,100,22,9/28/2018
55C9B5,conference-call,100,50,9/28/2018
57DDB9,conference-participant,100,50,9/28/2018
5EC388,earnings,100,50,9/28/2018
6474BA,earnings,100,50,9/28/2018
665D7D,legal-issues-defendant,100,22,9/28/2018
66A667,dividend,100,50,9/28/2018
6810DE,conference-participant,100,50,9/28/2018
6830FE,conference-organizer,100,57,9/28/2018
6925EB,public-offering,100,43,9/28/2018
69C99E,public-offering,100,43,9/28/2018
6A3C35,dividend,100,50,9/28/2018
704B78,conference-participant,100,50,9/28/2018
73F7F9,board-meeting,100,51,9/28/2018
7410C3,executive-appointment,100,54,9/28/2018
75F665,conference-call,100,50,9/28/2018
7FEEE1,ipo-pricing,100,50,9/28/2018
83066C,conference-participant,100,50,9/28/2018
8C6C1B,facility-open,100,65,9/28/2018
92D757,conference-participant,100,50,9/28/2018
96F126,product-price-cut,100,49,9/28/2018
9C25FF,legal-issues-defendant,100,22,9/28/2018
9CA432,conference-call,100,50,9/28/2018
9CE4C7,loan-provider,100,57,9/28/2018
9F5997,facility-upgrade,100,65,9/28/2018
9F5CBB,dividend,100,50,9/28/2018
A26C26,dividend,100,50,9/28/2018
A5A4F5,acquisition-acquirer,100,49,9/28/2018
A8B137,earnings-guidance,100,50,9/28/2018
AA98ED,legal-issues-defendant,100,22,9/28/2018
B290A2,conference-participant,100,50,9/28/2018
B4528F,conference-participant,100,50,9/28/2018
B48D6A,conference-participant,100,50,9/28/2018
B7202A,conference-participant,100,50,9/28/2018
BD9668,conference-call,100,50,9/28/2018
BDEC1E,regulatory-product-application,100,69,9/28/2018
BE86A1,dividend-up,100,63,9/28/2018
C03C8B,conference-call,100,50,9/28/2018
C188F8,legal-issues-defendant,100,22,9/28/2018
C81E00,regulatory-investigation,100,22,9/28/2018
C81E00,regulatory-investigation,100,22,9/28/2018
C81E00,regulatory-investigation,100,22,9/28/2018
C81E00,regulatory-investigation,100,22,9/28/2018
C9A96E,executive-appointment,100,54,9/28/2018
C9F39B,conference-call,100,50,9/28/2018
CC35BE,asset-sale,100,62,9/28/2018
CC35BE,acquisition-completed-acquiree,100,76,9/28/2018
CDAA0E,ipo-completed,100,76,9/28/2018
CDE118,donation,100,54,9/28/2018
D1173F,conference-call,100,50,9/28/2018
D5AF19,stock-splits,100,49,9/28/2018
DC5299,conference-call,100,50,9/28/2018
DD3BB1,legal-issues-defendant,100,22,9/28/2018
DD3BB1,legal-issues-defendant,100,22,9/28/2018
DD3BB1,legal-issues-defendant,100,22,9/28/2018
DD3BB1,legal-issues-defendant,100,22,9/28/2018
DD3BB1,legal-issues-defendant,100,22,9/28/2018
DE4924,conference-participant,100,50,9/28/2018
E30B34,award,100,58,9/28/2018
E9FF33,earnings,100,50,9/28/2018
F5349B,legal-issues-defendant,100,22,9/28/2018
F6FA6A,earnings,100,50,9/28/2018
FA36A4,conference-call,100,50,9/28/2018
FACF19,business-contract,100,69,9/28/2018
FACF19,regulatory-investigation,100,22,9/28/2018
FACF19,regulatory-investigation,100,22,9/28/2018
FF6644,dividend-guidance-up,100,60,9/28/2018
FF9FF6,public-offering,100,43,9/28/2018
FF9FF6,public-offering,100,43,9/28/2018
2C7505,legal-issues-defendant,100,22,9/29/2018
543900,legal-issues-defendant,100,22,9/29/2018
6C4D2F,ipo-completed,100,76,9/29/2018
D7918D,earnings,100,50,9/29/2018
DD3BB1,settlement,100,56,9/29/2018
DD3BB1,settlement,100,56,9/29/2018
00E601,executive-appointment,100,54,10/1/2018
01D03F,partnership,100,61,10/1/2018
03B8CF,product-release,100,64,10/1/2018
03B8CF,product-release,100,64,10/1/2018
03FAA6,conference-participant,100,50,10/1/2018
04CCCD,dividend,100,50,10/1/2018
053EFF,business-contract,100,69,10/1/2018
061A3B,earnings,100,50,10/1/2018
075CF7,executive-appointment,100,54,10/1/2018
07CA6A,note-sale,100,52,10/1/2018
95294,unit-acquisition-completed-acquirer,100,49,10/1/2018
95294,acquisition-completed-acquirer,100,49,10/1/2018
0B9E6F,executive-appointment,100,54,10/1/2018
0BF198,conference-participant,100,50,10/1/2018
0C4131,note-sale,100,52,10/1/2018
0C6861,dividend,100,50,10/1/2018
0C8D82,business-contract,100,69,10/1/2018
10C19B,dividend-up,100,81,10/1/2018
12DE76,acquisition-completed-acquirer,100,49,10/1/2018
12DE76,acquisition-completed-acquirer,100,49,10/1/2018
12DE76,partnership,100,61,10/1/2018
12E454,earnings,100,50,10/1/2018
15901B,product-release,100,64,10/1/2018
16FC89,earnings,100,50,10/1/2018
190B91,earnings,100,50,10/1/2018
1921DD,executive-appointment,100,54,10/1/2018
19BF16,earnings,100,50,10/1/2018
1CD4B5,clinical-trials,100,56,10/1/2018
1E04A5,note-sale,100,52,10/1/2018
1E9A6D,business-contract,100,69,10/1/2018
1EBF8D,partnership,100,61,10/1/2018
1EBF8D,partnership,100,61,10/1/2018
1EBF8D,partnership,100,61,10/1/2018
1F716B,unit-acquisition-completed-acquiree,100,67,10/1/2018
1F716B,acquisition-completed-acquiree,100,76,10/1/2018
1FA8F7,merger-completed,100,66,10/1/2018
202E5A,clinical-trials,100,56,10/1/2018
221AD7,earnings,100,50,10/1/2018
228D42,partnership,100,61,10/1/2018
228D42,partnership,100,61,10/1/2018
228D42,partnership,100,61,10/1/2018
24FA23,clinical-trials,100,56,10/1/2018
25A6CC,unit-acquisition-acquirer,100,49,10/1/2018
25A6CC,acquisition-acquirer,100,49,10/1/2018
25AB8E,settlement,100,56,10/1/2018
270305,executive-appointment,100,54,10/1/2018
28DCA8,earnings-guidance,100,50,10/1/2018
2C19A4,dividend,100,50,10/1/2018
2C7505,fraud-defendant,100,20,10/1/2018
2C7505,legal-issues-defendant,100,22,10/1/2018
2F5256,unit-acquisition-completed-acquirer,100,49,10/1/2018
2F6782,note-sale,100,52,10/1/2018
2F9304,product-release,100,64,10/1/2018
326EDD,conference-call,100,50,10/1/2018
332F87,acquisition-completed-acquirer,100,49,10/1/2018
338544,conference-call,100,50,10/1/2018
34A959,acquisition-completed-acquirer,100,49,10/1/2018
34B411,merger-completed,100,66,10/1/2018
34B411,earnings,100,50,10/1/2018
382EAE,conference-call,100,50,10/1/2018
3B318A,earnings,100,50,10/1/2018
3BE00F,unit-acquisition-completed-acquirer,100,49,10/1/2018
3CCC90,product-release,100,64,10/1/2018
3CCC90,product-release,100,64,10/1/2018
3F4668,spin-off,100,58,10/1/2018
401072,clinical-trials,100,56,10/1/2018
41B53E,dividend,100,50,10/1/2018
42DC93,earnings,100,50,10/1/2018
449A26,acquisition-completed-acquirer,100,49,10/1/2018
44ED36,business-contract,100,69,10/1/2018
46CF27,earnings,100,50,10/1/2018
4.60E+06,revenue-up,100,87,10/1/2018
4B5054,conference-call,100,50,10/1/2018
4C92B9,executive-appointment,100,54,10/1/2018
4FCC78,dividend,100,50,10/1/2018
50070E,partnership,100,61,10/1/2018
52D936,executive-appointment,100,54,10/1/2018
54DF47,market-entry,100,57,10/1/2018
55438C,partnership,100,61,10/1/2018
5546DA,merger-completed,100,66,10/1/2018
5546DA,fundraising,100,64,10/1/2018
5546DA,trading-resumed,100,58,10/1/2018
5546DA,fundraising,100,64,10/1/2018
56277A,conference-call,100,50,10/1/2018
57356F,conference-call,100,50,10/1/2018
57CAAB,business-contract,100,69,10/1/2018
58CA9A,dividend,100,50,10/1/2018
59B229,earnings,100,50,10/1/2018
59C539,conference-call,100,50,10/1/2018
5B15E1,executive-appointment,100,54,10/1/2018
5BC2F4,acquisition-completed-acquirer,100,49,10/1/2018
5BC2F4,acquisition-completed-acquirer,100,49,10/1/2018
5C8D61,conference-participant,100,50,10/1/2018
5D16CF,acquisition-completed-acquirer,100,49,10/1/2018
5D63F1,earnings,100,50,10/1/2018
633054,partnership,100,61,10/1/2018
665618,dividend,100,50,10/1/2018
665D7D,legal-issues-defendant,100,22,10/1/2018
67529E,acquisition-completed-acquirer,100,49,10/1/2018
68BA15,dividend,100,50,10/1/2018
6D0CAB,acquisition-acquirer,100,49,10/1/2018
6D9B53,conference-participant,100,50,10/1/2018
6-Dec-05,earnings,100,50,10/1/2018
6E1E61,conference-call,100,50,10/1/2018
70FCEF,executive-appointment,100,54,10/1/2018
717DB4,acquisition-completed-acquirer,100,49,10/1/2018
719477,conference-call,100,50,10/1/2018
723548,dividend,100,50,10/1/2018
756045,unit-acquisition-completed-acquirer,100,49,10/1/2018
763724,dividend,100,50,10/1/2018
771985,acquisition-completed-acquirer,100,49,10/1/2018
787D14,conference-participant,100,50,10/1/2018
789A7D,donation,100,54,10/1/2018
789A7D,conference-call,100,50,10/1/2018
790C34,acquisition-completed-acquirer,100,49,10/1/2018
7ADE57,executive-appointment,100,54,10/1/2018
7B6EB1,earnings,100,50,10/1/2018
8.10E+32,conference-call,100,50,10/1/2018
810FAD,conference-call,100,50,10/1/2018
83598E,acquisition-acquirer,100,49,10/1/2018
85AD00,conference-call,100,50,10/1/2018
8665BA,conference-call,100,50,10/1/2018
880C0C,conference-call,100,50,10/1/2018
89F693,executive-appointment,100,54,10/1/2018
89F693,executive-appointment,100,54,10/1/2018
8BE916,acquisition-completed-acquirer,100,49,10/1/2018
8C6C1B,facility-open,100,65,10/1/2018
8D4486,business-contract,100,69,10/1/2018
8D4486,settlement,100,56,10/1/2018
8D4486,product-release,100,64,10/1/2018
900356,executive-appointment,100,54,10/1/2018
901327,partnership,100,61,10/1/2018
9087B9,dividend,100,50,10/1/2018
957A07,earnings,100,50,10/1/2018
977A1E,business-contract,100,69,10/1/2018
986AF6,conference-call,100,50,10/1/2018
98CAED,earnings,100,50,10/1/2018
9E3224,acquisition-completed-acquirer,100,49,10/1/2018
9E98F2,earnings,100,50,10/1/2018
9EED50,acquisition-completed-acquirer,100,49,10/1/2018
9F048E,conference-organizer,100,57,10/1/2018
9F37C5,dividend,100,50,10/1/2018
9FB4B7,executive-appointment,100,54,10/1/2018
A017F4,conference-participant,100,50,10/1/2018
A1BB98,executive-appointment,100,54,10/1/2018
A1EAC8,business-contract,100,69,10/1/2018
A29DBD,acquisition-completed-acquirer,100,49,10/1/2018
A48593,credit-extension-recipient,100,69,10/1/2018
A5A4F5,acquisition-acquirer,100,49,10/1/2018
A5B913,earnings,100,50,10/1/2018
A6213D,acquisition-acquiree,100,76,10/1/2018
A6213D,legal-issues-defendant,100,22,10/1/2018
A72AB6,executive-appointment,100,54,10/1/2018
A761FE,acquisition-completed-acquirer,100,49,10/1/2018
A80FE0,conference-call,100,50,10/1/2018
AA09AD,executive-appointment,100,54,10/1/2018
AA847A,conference-call,100,50,10/1/2018
AC642C,earnings-guidance,100,50,10/1/2018
AC642C,earnings-guidance,100,50,10/1/2018
B1B10C,conference-call,100,50,10/1/2018
B5BA39,executive-appointment,100,54,10/1/2018
B604DF,earnings-guidance,100,50,10/1/2018
B803B1,dividend,100,50,10/1/2018
BB07E4,note-sale,100,52,10/1/2018
BB88B6,earnings,100,50,10/1/2018
BCC55F,executive-appointment,100,54,10/1/2018
BE379D,conference-participant,100,50,10/1/2018
BEB756,conference-call,100,50,10/1/2018
C188F8,product-release,100,64,10/1/2018
C3BCD5,note-sale,100,52,10/1/2018
C58D71,patient-enrollment-complete,100,64,10/1/2018
C598D7,conference-call,100,50,10/1/2018
C5D2AE,earnings,100,50,10/1/2018
C7AE14,dividend,100,50,10/1/2018
C97B2D,conference-call,100,50,10/1/2018
C9F39B,credit-extension-provider,100,57,10/1/2018
CC339B,executive-appointment,100,54,10/1/2018
CDAB24,acquisition-completed-acquirer,100,49,10/1/2018
CDD75E,executive-appointment,100,54,10/1/2018
CFF57D,executive-resignation,100,44,10/1/2018
D0C79E,executive-appointment,100,54,10/1/2018
D1AE3B,conference-call,100,50,10/1/2018
D20C8F,note-sale,100,52,10/1/2018
D20C8F,note-sale,100,52,10/1/2018
D4AC65,product-release,100,64,10/1/2018
D6853F,conference-call,100,50,10/1/2018
D77F7E,product-release,100,64,10/1/2018
D77F7E,product-release,100,64,10/1/2018
D854F3,conference-call,100,50,10/1/2018
D96202,executive-appointment,100,54,10/1/2018
DEF058,unit-acquisition-acquirer,100,49,10/1/2018
DF1F7A,conference-call,100,50,10/1/2018
E0207A,acquisition-completed-acquirer,100,49,10/1/2018
E11C41,conference-call,100,50,10/1/2018
E124EB,conference-call,100,50,10/1/2018
E21871,asset-sale,100,62,10/1/2018
E21871,unit-acquisition-completed-acquiree,100,67,10/1/2018
E30B34,acquisition-completed-acquirer,100,49,10/1/2018
E6EDED,conference-call,100,50,10/1/2018
E9C7C0,acquisition-completed-acquiree,100,76,10/1/2018
E9E6FD,conference-call,100,50,10/1/2018
EB2F14,merger,100,66,10/1/2018
EB2F14,merger,100,66,10/1/2018
EC8116,dividend,100,50,10/1/2018
EF5BED,executive-appointment,100,54,10/1/2018
F509E2,executive-appointment,100,54,10/1/2018
F6A945,earnings,100,50,10/1/2018
F6FA6A,acquisition-completed-acquirer,100,49,10/1/2018
F702CA,executive-appointment,100,54,10/1/2018
F702CA,acquisition-completed-acquirer,100,49,10/1/2018
FAB97A,earnings,100,50,10/1/2018
FE89E0,stake-acquiree,100,62,10/1/2018
FEC475,conference-call,100,50,10/1/2018
FF6644,spin-off,100,58,10/1/2018
00326D,conference-call,100,50,10/2/2018
00698D,conference-organizer,100,57,10/2/2018
13528,earnings,100,50,10/2/2018
01478A,earnings-guidance,100,50,10/2/2018
0157B1,workforce-salary-increase,100,44,10/2/2018
018C11,conference-call,100,50,10/2/2018
078D52,dividend,100,50,10/2/2018
0BC17A,conference-call,100,50,10/2/2018
0C136E,partnership,100,61,10/2/2018
0C6861,legal-issues-defendant,100,22,10/2/2018
10943B,conference-call,100,50,10/2/2018
126F95,executive-appointment,100,54,10/2/2018
12E454,legal-issues-defendant,100,22,10/2/2018
147C38,donation,100,54,10/2/2018
152B9E,earnings-guidance,100,50,10/2/2018
168A5D,product-release,100,64,10/2/2018
16C7F0,conference-call,100,50,10/2/2018
16F4D8,conference-call,100,50,10/2/2018
1921DD,unit-acquisition-acquiree,100,76,10/2/2018
196D18,clinical-trials,100,56,10/2/2018
1B637E,executive-appointment,100,54,10/2/2018
1CDD1C,product-release,100,64,10/2/2018
1FAF22,partnership,100,61,10/2/2018
2158DF,partnership,100,61,10/2/2018
22C58E,earnings,100,50,10/2/2018
239106,unit-acquisition-acquirer,100,49,10/2/2018
25102A,partnership,100,61,10/2/2018
25DD05,note-sale,100,52,10/2/2018
25DD05,public-offering,100,43,10/2/2018
2667B6,earnings,100,50,10/2/2018
26E3BA,executive-appointment,100,54,10/2/2018
270305,merger-completed,100,66,10/2/2018
2AE625,conference-call,100,50,10/2/2018
2C7505,product-release,100,64,10/2/2018
2C7505,product-release,100,64,10/2/2018
2CB4C9,executive-appointment,100,54,10/2/2018
2F6782,note-sale,100,52,10/2/2018
3.14E+47,earnings,100,50,10/2/2018
31643A,facility-close,100,47,10/2/2018
342218,conference-call,100,50,10/2/2018
38C46F,dividend,100,50,10/2/2018
39BFF6,conference-call,100,50,10/2/2018
3B37F7,executive-appointment,100,54,10/2/2018
3B37F7,conference-organizer,100,57,10/2/2018
3B37F7,conference-organizer,100,57,10/2/2018
3C7F5F,legal-issues-defendant,100,22,10/2/2018
3C7F5F,earnings,100,50,10/2/2018
3C7F5F,legal-issues-defendant,100,22,10/2/2018
3E15F6,conference-call,100,50,10/2/2018
3F4497,conference-call,100,50,10/2/2018
3F4668,executive-appointment,100,54,10/2/2018
4.03E+05,unit-acquisition-acquirer,100,49,10/2/2018
4.03E+05,executive-appointment,100,54,10/2/2018
408380,earnings,100,50,10/2/2018
415188,conference-call,100,50,10/2/2018
41785E,earnings,100,50,10/2/2018
48F795,legal-issues-defendant,100,22,10/2/2018
48F795,legal-issues-defendant,100,22,10/2/2018
48F795,legal-issues-defendant,100,22,10/2/2018
4A2457,award,100,58,10/2/2018
4A6F00,conference-participant,100,50,10/2/2018
4AC91D,business-contract,100,69,10/2/2018
4EEE7E,business-contract,100,69,10/2/2018
4F9487,acquisition-regulatory-approval-acquirer,100,54,10/2/2018
51888A,earnings,100,50,10/2/2018
51E682,conference-call,100,50,10/2/2018
52015A,dividend,100,50,10/2/2018
52FB2F,partnership,100,61,10/2/2018
532D47,earnings-guidance,100,50,10/2/2018
546A9C,conference-call,100,50,10/2/2018
55438C,partnership,100,61,10/2/2018
55C289,conference-call,100,50,10/2/2018
56B7C1,dividend,100,50,10/2/2018
5A0FF1,earnings,100,50,10/2/2018
5A53BF,public-offering,100,43,10/2/2018
5B6C11,executive-appointment,100,54,10/2/2018
5BC2F4,product-release,100,64,10/2/2018
5BE42C,conference-call,100,50,10/2/2018
5CC29D,earnings,100,50,10/2/2018
60EA12,earnings,100,50,10/2/2018
6284B5,unit-acquisition-acquiree,100,76,10/2/2018
6284B5,acquisition-acquiree,100,76,10/2/2018
63F892,earnings,100,50,10/2/2018
6830FE,conference-organizer,100,57,10/2/2018
6B0E45,conference-call,100,50,10/2/2018
6D6B40,earnings,100,50,10/2/2018
6F3936,facility-open,100,65,10/2/2018
6F6559,earnings,100,50,10/2/2018
6F6559,earnings,100,50,10/2/2018
6F6559,earnings,100,50,10/2/2018
6F6559,earnings,100,50,10/2/2018
713810,business-contract,100,69,10/2/2018
731675,acquisition-completed-acquirer,100,49,10/2/2018
73529F,debt-extension-recipient,100,73,10/2/2018
7710F3,executive-appointment,100,54,10/2/2018
79340A,earnings,100,50,10/2/2018
7AB859,product-release,100,64,10/2/2018
7AB859,product-release,100,64,10/2/2018
7AB859,product-release,100,64,10/2/2018
7AB859,product-release,100,64,10/2/2018
7AB859,product-release,100,64,10/2/2018
7AB859,product-release,100,64,10/2/2018
7AB859,product-release,100,64,10/2/2018
7E2DE6,facility-open,100,65,10/2/2018
803FED,executive-appointment,100,54,10/2/2018
82F088,acquisition-completed-acquirer,100,49,10/2/2018
8665BA,business-contract,100,69,10/2/2018
8B2C4A,conference-call,100,50,10/2/2018
8C5519,asset-sale,100,62,10/2/2018
8C6C1B,facility-open,100,65,10/2/2018
8E82A6,earnings,100,50,10/2/2018
8EF425,earnings,100,50,10/2/2018
92D757,conference-participant,100,50,10/2/2018
93D207,earnings,100,50,10/2/2018
95F59E,product-release,100,64,10/2/2018
967D92,conference-call,100,50,10/2/2018
9B5968,partnership,100,61,10/2/2018
9B730A,conference-participant,100,50,10/2/2018
9CA4C6,conference-call,100,50,10/2/2018
9E98F2,partnership,100,61,10/2/2018
A5A4F5,acquisition-acquirer,100,49,10/2/2018
A6213D,revenue-volume-up,100,69,10/2/2018
A6828A,acquisition-completed-acquiree,100,76,10/2/2018
A75D43,earnings,100,50,10/2/2018
AA7FE0,executive-appointment,100,54,10/2/2018
AA98ED,legal-issues-defendant,100,22,10/2/2018
AA98ED,legal-issues-defendant,100,22,10/2/2018
AE3113,ipo-pricing,100,50,10/2/2018
AFEC35,earnings,100,50,10/2/2018
B1DF3C,legal-issues-defendant,100,22,10/2/2018
B4703C,conference-call,100,50,10/2/2018
B6CD92,dividend,100,50,10/2/2018
B80AD1,public-offering,100,43,10/2/2018
B96637,conference-call,100,50,10/2/2018
BB5271,conference-call,100,50,10/2/2018
BDD12C,award,100,58,10/2/2018
BE14CF,trading-halt,100,43,10/2/2018
BE14CF,conference-call,100,50,10/2/2018
C22BE8,business-contract,100,69,10/2/2018
C659EB,executive-appointment,100,54,10/2/2018
C9D866,conference-call,100,50,10/2/2018
C9E04B,partnership,100,61,10/2/2018
C9E04B,partnership,100,61,10/2/2018
C9E04B,partnership,100,61,10/2/2018
CAD7D9,earnings,100,50,10/2/2018
CB6A9C,partnership,100,61,10/2/2018
CD06A2,earnings,100,50,10/2/2018
CDAF5B,conference-call,100,50,10/2/2018
CDFCC9,legal-issues-defendant,100,22,10/2/2018
CE4FD9,earnings,100,50,10/2/2018
D04D9F,acquisition-completed-acquirer,100,49,10/2/2018
D064D5,dividend,100,50,10/2/2018
D1C26F,executive-appointment,100,54,10/2/2018
D296C6,partnership,100,61,10/2/2018
D2B9E5,earnings,100,50,10/2/2018
D33270,executive-appointment,100,54,10/2/2018
D5AF19,earnings,100,50,10/2/2018
DB5CA5,donation,100,54,10/2/2018
DC5299,note-sale,100,52,10/2/2018
DF532D,conference-call,100,50,10/2/2018
E0D3BA,earnings,100,50,10/2/2018
E12A6E,earnings,100,50,10/2/2018
E1E093,partnership,100,61,10/2/2018
E30B34,earnings-guidance,100,50,10/2/2018
E35610,earnings-guidance,100,50,10/2/2018
E4CE73,partnership,100,61,10/2/2018
E5D914,product-release,100,64,10/2/2018
E5D914,product-release,100,64,10/2/2018
E6BC2C,conference-participant,100,50,10/2/2018
E6D89E,partnership,100,61,10/2/2018
E82A2D,conference-call,100,50,10/2/2018
EAEA91,dividend,100,50,10/2/2018
EBC84C,product-release,100,64,10/2/2018
EBD89A,business-contract,100,69,10/2/2018
ED0D7C,conference-call,100,50,10/2/2018
EDF5CA,conference-call,100,50,10/2/2018
EF7163,conference-call,100,50,10/2/2018
F2E253,legal-issues-defendant,100,22,10/2/2018
F50BAB,earnings,100,50,10/2/2018
F5349B,legal-issues-defendant,100,22,10/2/2018
F6E1B5,executive-appointment,100,54,10/2/2018
F6E248,partnership,100,61,10/2/2018
FC1B7B,conference-call,100,50,10/2/2018
FD0CA4,conference-call,100,50,10/2/2018
FD4588,conference-call,100,50,10/2/2018
FDC7E6,buybacks,100,74,10/2/2018
FF5413,executive-appointment,100,54,10/2/2018
FFE543,legal-issues-defendant,100,22,10/2/2018
00067A,partnership,100,61,10/3/2018
00067A,earnings,100,50,10/3/2018
003B70,operating-earnings,100,50,10/3/2018
0157B1,market-entry,100,57,10/3/2018
0157B1,partnership,100,61,10/3/2018
20751,executive-appointment,100,54,10/3/2018
31025,earnings,100,50,10/3/2018
48590,executive-appointment,100,54,10/3/2018
0A0D9E,executive-resignation,100,44,10/3/2018
0AB700,dividend,100,50,10/3/2018
0F2BC9,business-contract,100,69,10/3/2018
1272B3,executive-appointment,100,54,10/3/2018
12DE76,partnership,100,61,10/3/2018
1348C9,earnings-guidance,100,50,10/3/2018
15B10D,award,100,58,10/3/2018
168A5D,executive-resignation,100,44,10/3/2018
1A2D9F,earnings,100,50,10/3/2018
1E04A5,note-sale,100,52,10/3/2018
1E4FB9,award,100,58,10/3/2018
1F08A6,conference-call,100,50,10/3/2018
1F716B,conference-call,100,50,10/3/2018
1F9D90,earnings,100,50,10/3/2018
2158DF,partnership,100,61,10/3/2018
21D903,earnings,100,50,10/3/2018
225CA2,executive-appointment,100,54,10/3/2018
275300,conference-call,100,50,10/3/2018
29A4CC,conference-call,100,50,10/3/2018
2C7505,legal-issues-defendant,100,22,10/3/2018
2C7505,legal-issues-defendant,100,22,10/3/2018
2C7505,legal-issues-defendant,100,22,10/3/2018
2D643C,conference-call,100,50,10/3/2018
32CB22,conference-call,100,50,10/3/2018
3587B4,business-contract,100,69,10/3/2018
37727A,conference-call,100,50,10/3/2018
3ACF46,acquisition-acquirer,100,49,10/3/2018
3B37F7,conference-organizer,100,57,10/3/2018
3B37F7,conference-organizer,100,57,10/3/2018
3B37F7,conference-organizer,100,57,10/3/2018
3B37F7,business-contract,100,69,10/3/2018
4.03E+05,product-release,100,64,10/3/2018
414FFF,partnership,100,61,10/3/2018
444CC8,product-release,100,64,10/3/2018
47752F,earnings,100,50,10/3/2018
47752F,earnings,100,50,10/3/2018
48F795,legal-issues-defendant,100,22,10/3/2018
48F795,legal-issues-defendant,100,22,10/3/2018
48F795,fraud-defendant,100,20,10/3/2018
4A6F00,partnership,100,61,10/3/2018
4AC91D,earnings-guidance,100,50,10/3/2018
4AC91D,earnings-guidance,100,50,10/3/2018
4AC91D,earnings-guidance,100,50,10/3/2018
4B3555,earnings,100,50,10/3/2018
4B6EF9,earnings,100,50,10/3/2018
4E7C1F,executive-appointment,100,54,10/3/2018
4FB770,conference-call,100,50,10/3/2018
50070E,conference-organizer,100,57,10/3/2018
504FE2,executive-appointment,100,54,10/3/2018
550D01,conference-call,100,50,10/3/2018
5A423F,public-offering,100,43,10/3/2018
5A423F,earnings,100,50,10/3/2018
5A53BF,public-offering,100,43,10/3/2018
5CCDAD,executive-appointment,100,54,10/3/2018
5D63F1,facility-open,100,65,10/3/2018
5E7E82,executive-appointment,100,54,10/3/2018
619882,conference-participant,100,50,10/3/2018
61BCA7,earnings,100,50,10/3/2018
636BBF,merger,100,66,10/3/2018
636BBF,merger,100,66,10/3/2018
657097,public-offering,100,43,10/3/2018
66A667,earnings-up,100,68,10/3/2018
66A667,earnings,100,50,10/3/2018
66A667,earnings,100,50,10/3/2018
66A667,earnings,100,50,10/3/2018
68BA15,public-offering,100,43,10/3/2018
69E8E1,conference-call,100,50,10/3/2018
69E8E1,conference-call,100,50,10/3/2018
69E8E1,conference-call,100,50,10/3/2018
69FDFC,award,100,58,10/3/2018
70FCEF,executive-appointment,100,54,10/3/2018
73529F,conference-call,100,50,10/3/2018
763DBE,business-contract,100,69,10/3/2018
7E1D5D,partnership,100,61,10/3/2018
7E2DE6,earnings,100,50,10/3/2018
805CD8,conference-participant,100,50,10/3/2018
84A6B9,earnings,100,50,10/3/2018
87486A,conference-call,100,50,10/3/2018
88350F,conference-call,100,50,10/3/2018
8A0368,product-release,100,64,10/3/2018
8A8E41,business-contract,100,69,10/3/2018
8B3B0E,note-sale,100,52,10/3/2018
8B3B0E,note-sale,100,52,10/3/2018
8C6C1B,facility-open,100,65,10/3/2018
8D5145,earnings,100,50,10/3/2018
8DCBBB,conference-call,100,50,10/3/2018
915E7B,earnings-guidance,100,50,10/3/2018
91C82E,earnings-per-share-positive,100,69,10/3/2018
91C82E,earnings-per-share-positive,100,69,10/3/2018
91C82E,earnings-per-share-positive,100,69,10/3/2018
91C82E,earnings-per-share-positive,100,69,10/3/2018
91C82E,earnings-per-share-positive,100,69,10/3/2018
922F0C,earnings,100,50,10/3/2018
92B047,conference-call,100,50,10/3/2018
934029,conference-call,100,50,10/3/2018
949625,dividend,100,50,10/3/2018
971334,business-contract,100,69,10/3/2018
97FE80,fundraising,100,64,10/3/2018
9AF3DC,conference-call,100,50,10/3/2018
9BB35A,conference-call,100,50,10/3/2018
9D65C1,legal-issues-defendant,100,22,10/3/2018
9D6A24,conference-call,100,50,10/3/2018
9F03CF,conference-call,100,50,10/3/2018
A02FB1,conference-call,100,50,10/3/2018
A29DBD,business-contract,100,69,10/3/2018
A403CF,executive-appointment,100,54,10/3/2018
A4386C,earnings,100,50,10/3/2018
A47F2E,earnings,100,50,10/3/2018
A48593,acquisition-acquirer,100,49,10/3/2018
A52B6B,acquisition-interest-acquirer,100,46,10/3/2018
A5A4F5,acquisition-acquirer,100,49,10/3/2018
A8AC4C,conference-call,100,50,10/3/2018
AA98ED,legal-issues-defendant,100,22,10/3/2018
AA98ED,legal-issues-defendant,100,22,10/3/2018
AC3584,partnership,100,61,10/3/2018
AC3584,partnership,100,61,10/3/2018
AD9F1D,credit-extension-recipient,100,69,10/3/2018
B76C82,settlement,100,56,10/3/2018
B80AD1,public-offering,100,43,10/3/2018
B98EFA,conference-participant,100,50,10/3/2018
BA218A,conference-call,100,50,10/3/2018
BAD655,patent-awarded,100,72,10/3/2018
BBAE2A,conference-call,100,50,10/3/2018
BD15E8,conference-call,100,50,10/3/2018
BE14CF,trading-resumed,100,58,10/3/2018
BE7BA4,asset-up,100,72,10/3/2018
C0200F,earnings,100,50,10/3/2018
C188F8,legal-issues-defendant,100,22,10/3/2018
C188F8,legal-issues-defendant,100,22,10/3/2018
C32A39,earnings-guidance,100,50,10/3/2018
C3EE99,earnings,100,50,10/3/2018
C4A241,facility-open,100,65,10/3/2018
C659EB,conference-call,100,50,10/3/2018
C951A2,earnings,100,50,10/3/2018
CA212F,earnings,100,50,10/3/2018
CB88B3,earnings,100,50,10/3/2018
CC6FF5,product-release,100,64,10/3/2018
CDFCC9,legal-issues-defendant,100,22,10/3/2018
CF3FF9,clinical-trials,100,56,10/3/2018
CF6A5A,earnings,100,50,10/3/2018
D06755,earnings,100,50,10/3/2018
D07B07,regulatory-product-approval-granted,100,81,10/3/2018
D139BC,conference-call,100,50,10/3/2018
D1C26F,conference-participant,100,50,10/3/2018
D4AC65,executive-appointment,100,54,10/3/2018
D82EF3,conference-call,100,50,10/3/2018
DB5CA5,earnings,100,50,10/3/2018
DB7FA7,conference-call,100,50,10/3/2018
DC2F77,earnings,100,50,10/3/2018
E0A84E,partnership,100,61,10/3/2018
E26FC3,dividend,100,50,10/3/2018
E30A8F,earnings,100,50,10/3/2018
E38906,clinical-trials,100,56,10/3/2018
E74B55,conference-call,100,50,10/3/2018
EBC84C,earnings,100,50,10/3/2018
ED5171,earnings,100,50,10/3/2018
ED9576,earnings,100,50,10/3/2018
EE74E1,business-contract,100,69,10/3/2018
EF5914,partnership,100,61,10/3/2018
EF5BED,executive-appointment,100,54,10/3/2018
EF77A3,executive-appointment,100,54,10/3/2018
EF77A3,dividend,100,50,10/3/2018
F02D0A,earnings,100,50,10/3/2018
F0EEFB,note-sale,100,52,10/3/2018
F30508,conference-call,100,50,10/3/2018
F40EE2,dividend,100,50,10/3/2018
F5349B,legal-issues-defendant,100,22,10/3/2018
F5D059,earnings,100,50,10/3/2018
F6E248,clinical-trials,100,56,10/3/2018
F6E248,earnings,100,50,10/3/2018
FA044A,conference-call,100,50,10/3/2018
FC1A6E,legal-issues-defendant,100,22,10/3/2018
FC1A6E,legal-issues-defendant,100,22,10/3/2018
FC9A88,conference-call,100,50,10/3/2018
FD554E,executive-appointment,100,54,10/3/2018
FFE543,legal-issues-defendant,100,22,10/3/2018
00326D,earnings,100,50,10/4/2018
00E601,earnings,100,50,10/4/2018
0157B1,partnership,100,61,10/4/2018
03FAA6,partnership,100,61,10/4/2018
07CA6A,conference-call,100,50,10/4/2018
07EC43,business-contract,100,69,10/4/2018
105D00,conference-call,100,50,10/4/2018
131443,business-contract,100,69,10/4/2018
165B86,product-release,100,64,10/4/2018
1782D5,conference-call,100,50,10/4/2018
1A6A94,ownership-decrease-owner,100,46,10/4/2018
1A6A94,ownership-decrease-owner,100,46,10/4/2018
1A6A94,conference-call,100,50,10/4/2018
1B9535,conference-call,100,50,10/4/2018
1D1B07,earnings,100,50,10/4/2018
1E1125,conference-organizer,100,57,10/4/2018
1E7785,conference-participant,100,50,10/4/2018
1E9A6D,earnings,100,50,10/4/2018
1FAF22,conference-participant,100,50,10/4/2018
1FE3CB,index-listing,100,76,10/4/2018
206852,conference-call,100,50,10/4/2018
21153F,settlement,100,56,10/4/2018
21153F,settlement,100,56,10/4/2018
228D42,acquisition-acquiree,100,76,10/4/2018
228D42,partnership,100,61,10/4/2018
228D42,partnership,100,61,10/4/2018
2491BC,partnership,100,61,10/4/2018
2491BC,partnership,100,61,10/4/2018
24FA23,clinical-trials,100,56,10/4/2018
2.90E+62,earnings,100,50,10/4/2018
2A1009,acquisition-completed-acquirer,100,49,10/4/2018
2A1009,acquisition-completed-acquirer,100,49,10/4/2018
2A9C0A,conference-call,100,50,10/4/2018
2C3348,legal-issues-defendant,100,22,10/4/2018
2E36AD,business-contract,100,69,10/4/2018
30A565,legal-issues-defendant,100,22,10/4/2018
30A565,legal-issues-defendant,100,22,10/4/2018
315EB0,facility-open,100,65,10/4/2018
315EB0,conference-call,100,50,10/4/2018
31DB20,dividend,100,50,10/4/2018
3471C0,executive-appointment,100,54,10/4/2018
34B97A,conference-call,100,50,10/4/2018
353DBB,conference-call,100,50,10/4/2018
36529A,conference-participant,100,50,10/4/2018
36C09B,legal-issues-defendant,100,22,10/4/2018
36C09B,legal-issues-defendant,100,22,10/4/2018
36C09B,legal-issues-defendant,100,22,10/4/2018
370C50,executive-appointment,100,54,10/4/2018
3A3948,earnings,100,50,10/4/2018
3DC887,earnings,100,50,10/4/2018
3ED92D,executive-appointment,100,54,10/4/2018
4017AD,executive-appointment,100,54,10/4/2018
4017AD,executive-appointment,100,54,10/4/2018
414FFF,partnership,100,61,10/4/2018
41785E,conference-organizer,100,57,10/4/2018
434F38,earnings,100,50,10/4/2018
44A4FC,investment-investor,100,55,10/4/2018
45ABCC,product-release,100,64,10/4/2018
485445,business-contract,100,69,10/4/2018
48F795,legal-issues-defendant,100,22,10/4/2018
48F795,legal-issues-defendant,100,22,10/4/2018
4A5C8D,conference-call,100,50,10/4/2018
4B49CF,dividend,100,50,10/4/2018
4D8124,earnings,100,50,10/4/2018
4D8313,conference-call,100,50,10/4/2018
4E7C1F,partnership,100,61,10/4/2018
50070E,conference-call,100,50,10/4/2018
51D876,earnings,100,50,10/4/2018
543900,legal-issues-defendant,100,22,10/4/2018
5A423F,public-offering,100,43,10/4/2018
5F2FF7,earnings,100,50,10/4/2018
61B81B,dividend,100,50,10/4/2018
61BCA7,business-contract,100,69,10/4/2018
6284B5,earnings-guidance,100,50,10/4/2018
657097,public-offering,100,43,10/4/2018
665440,business-contract,100,69,10/4/2018
665D7D,legal-issues-defendant,100,22,10/4/2018
66667F,business-contract,100,69,10/4/2018
68BA15,public-offering,100,43,10/4/2018
69CE71,dividend,100,50,10/4/2018
6D0CAB,operating-earnings,100,50,10/4/2018
6F0A63,earnings-guidance,100,50,10/4/2018
72FCA3,dividend,100,50,10/4/2018
73C9E2,conference-call,100,50,10/4/2018
77B8E9,orphan-drug-designation,100,76,10/4/2018
7823A3,earnings,100,50,10/4/2018
7.83E+79,hirings,100,65,10/4/2018
79167B,conference-call,100,50,10/4/2018
7B492C,executive-appointment,100,54,10/4/2018
7B9AFA,earnings,100,50,10/4/2018
7CD98F,earnings-guidance,100,50,10/4/2018
7DC1C4,partnership,100,61,10/4/2018
7F3A5F,partnership,100,61,10/4/2018
7F3A5F,note-sale,100,52,10/4/2018
7FDE1C,product-release,100,64,10/4/2018
805CD8,patient-enrollment-complete,100,64,10/4/2018
80D744,conference-call,100,50,10/4/2018
81222C,revenues,100,50,10/4/2018
817ED9,executive-appointment,100,54,10/4/2018
81A88D,conference-call,100,50,10/4/2018
830BDB,conference-call,100,50,10/4/2018
838ADD,dividend,100,50,10/4/2018
85AD00,acquisition-acquiree,100,76,10/4/2018
863350,facility-open,100,65,10/4/2018
881190,conference-call,100,50,10/4/2018
8C6C1B,facility-open,100,65,10/4/2018
8DAAB9,earnings,100,50,10/4/2018
8E9CD8,earnings,100,50,10/4/2018
8F8F2F,conference-call,100,50,10/4/2018
911ACB,acquisition-acquirer,100,49,10/4/2018
91C82E,dividend,100,50,10/4/2018
990AD0,product-release,100,64,10/4/2018
990AD0,product-release,100,64,10/4/2018
9D65C1,legal-issues-defendant,100,22,10/4/2018
9F048E,earnings,100,50,10/4/2018
9F71E5,acquisition-completed-acquirer,100,49,10/4/2018
A16DEA,earnings,100,50,10/4/2018
A5151E,earnings,100,50,10/4/2018
A5A4F5,acquisition-acquirer,100,49,10/4/2018
A63387,partnership,100,61,10/4/2018
A6828A,business-contract,100,69,10/4/2018
A6828A,business-contract,100,69,10/4/2018
A6828A,business-contract,100,69,10/4/2018
A6FB29,legal-issues-defendant,100,22,10/4/2018
A8E72A,ipo-pricing,100,50,10/4/2018
AA847A,executive-appointment,100,54,10/4/2018
AA98ED,legal-issues-defendant,100,22,10/4/2018
AB4A7E,earnings,100,50,10/4/2018
AD3008,index-listing,100,76,10/4/2018
AEFC90,business-contract,100,69,10/4/2018
AEFC90,business-contract,100,69,10/4/2018
AEFC90,business-contract,100,69,10/4/2018
B08954,earnings,100,50,10/4/2018
B0D41A,executive-appointment,100,54,10/4/2018
B5BA39,award,100,58,10/4/2018
B8EF97,earnings,100,50,10/4/2018
BAAA60,conference-call,100,50,10/4/2018
BDF85E,trading-resumed,100,58,10/4/2018
C0030A,business-contract,100,69,10/4/2018
C41C25,earnings,100,50,10/4/2018
C4C77F,market-entry,100,57,10/4/2018
C7863D,note-sale,100,52,10/4/2018
C98CDB,product-release,100,64,10/4/2018
C9E107,earnings,100,50,10/4/2018
CA1620,legal-issues-defendant,100,22,10/4/2018
CB22CD,conference-call,100,50,10/4/2018
CB6A9C,conference-call,100,50,10/4/2018
CDFCC9,legal-issues-defendant,100,22,10/4/2018
CFF97C,business-contract,100,69,10/4/2018
CFF97C,earnings-guidance,100,50,10/4/2018
D3F64D,earnings-guidance,100,50,10/4/2018
D518D8,conference-call,100,50,10/4/2018
D54E62,conference-call,100,50,10/4/2018
D6489C,partnership,100,61,10/4/2018
D6489C,legal-issues-defendant,100,22,10/4/2018
D8760C,conference-call,100,50,10/4/2018
D8DA3D,dividend,100,50,10/4/2018
DA199F,earnings,100,50,10/4/2018
DA48E4,product-release,100,64,10/4/2018
DCD97F,business-contract,100,69,10/4/2018
DD3BB1,legal-issues-defendant,100,22,10/4/2018
E1E093,facility-open,100,65,10/4/2018
E3E68E,conference-call,100,50,10/4/2018
E74B55,executive-resignation,100,44,10/4/2018
E829E8,conference-call,100,50,10/4/2018
E8846E,executive-resignation,100,44,10/4/2018
E94704,conference-call,100,50,10/4/2018
EB61C4,conference-call,100,50,10/4/2018
ED0402,earnings,100,50,10/4/2018
ED3CA8,conference-call,100,50,10/4/2018
F4CDA3,unit-acquisition-acquirer,100,49,10/4/2018
F4E882,earnings,100,50,10/4/2018
F5C78B,conference-call,100,50,10/4/2018
F5D059,dividend-up,100,81,10/4/2018
F7ADEB,conference-call,100,50,10/4/2018
FAB97A,business-contract,100,69,10/4/2018
FC1A6E,legal-issues-defendant,100,22,10/4/2018
FC1B7B,unit-acquisition-completed-acquiree,100,67,10/4/2018
FC4550,dividend,100,50,10/4/2018
FE89E0,conference-call,100,50,10/4/2018
FEE4B0,earnings,100,50,10/4/2018
FF9FF6,public-offering,100,43,10/4/2018
FF9FF6,public-offering,100,43,10/4/2018
001F1B,revenues,100,50,10/5/2018
0358AF,earnings,100,50,10/5/2018
0490C6,market-entry,100,57,10/5/2018
51332,earnings,100,50,10/5/2018
06C826,acquisition-acquirer,100,49,10/5/2018
0A0D9E,conference-call,100,50,10/5/2018
0C136E,dividend,100,50,10/5/2018
0C6861,legal-issues-defendant,100,22,10/5/2018
0C8D82,conference-call,100,50,10/5/2018
108FDA,acquisition-completed-acquirer,100,49,10/5/2018
119CB6,conference-call,100,50,10/5/2018
15901B,product-release,100,64,10/5/2018
1748B3,conference-call,100,50,10/5/2018
1DA44F,conference-call,100,50,10/5/2018
1E9A6D,asset-sale,100,62,10/5/2018
20BEEA,conference-call,100,50,10/5/2018
228D42,partnership,100,61,10/5/2018
228D42,partnership,100,61,10/5/2018
272704,earnings,100,50,10/5/2018
2DB344,earnings,100,50,10/5/2018
32F943,business-contract,100,69,10/5/2018
32F943,business-contract,100,69,10/5/2018
341759,conference-participant,100,50,10/5/2018
36C09B,legal-issues-defendant,100,22,10/5/2018
36C09B,legal-issues-defendant,100,22,10/5/2018
36C09B,legal-issues-defendant,100,22,10/5/2018
36C09B,legal-issues-defendant,100,22,10/5/2018
370C50,conference-call,100,50,10/5/2018
371B0A,conference-call,100,50,10/5/2018
3A3447,facility-open,100,65,10/5/2018
3C7F5F,legal-issues-defendant,100,22,10/5/2018
3E15F6,trading-halt,100,43,10/5/2018
3FACA7,product-release,100,64,10/5/2018
3FACA7,dividend,100,50,10/5/2018
42DC93,executive-appointment,100,54,10/5/2018
458D2C,revenue-volume,100,50,10/5/2018
458D2C,earnings-guidance,100,50,10/5/2018
4A3438,product-release,100,64,10/5/2018
4BDCA7,clinical-trials,100,56,10/5/2018
4C3FE9,clinical-trials,100,56,10/5/2018
4D371E,earnings,100,50,10/5/2018
51888A,unit-acquisition-acquirer,100,49,10/5/2018
545272,executive-appointment,100,54,10/5/2018
564F3E,earnings,100,50,10/5/2018
5675EB,earnings,100,50,10/5/2018
58B46F,note-sale,100,52,10/5/2018
58B46F,merger-regulatory-approval,100,81,10/5/2018
5A53BF,public-offering,100,43,10/5/2018
5B6C11,earnings,100,50,10/5/2018
5BFE94,conference-call,100,50,10/5/2018
5DD486,conference-call,100,50,10/5/2018
5E6959,conference-call,100,50,10/5/2018
5F9CE3,asset-sale,100,62,10/5/2018
5F9CE3,earnings,100,50,10/5/2018
62B20A,conference-call,100,50,10/5/2018
64E615,executive-appointment,100,54,10/5/2018
67529E,conference-call,100,50,10/5/2018
713810,partnership,100,61,10/5/2018
7D7716,earnings,100,50,10/5/2018
8.22E+27,conference-call,100,50,10/5/2018
8.79E+06,earnings,100,50,10/5/2018
8C6C1B,facility-open,100,65,10/5/2018
8E8E6E,executive-resignation,100,44,10/5/2018
949625,conference-call,100,50,10/5/2018
965360,acquisition-acquirer,100,49,10/5/2018
965360,acquisition-acquirer,100,49,10/5/2018
980C14,conference-call,100,50,10/5/2018
9BB35A,award,100,58,10/5/2018
9D30A8,product-release,100,64,10/5/2018
9E5C2C,conference-call,100,50,10/5/2018
9FD2D9,earnings-guidance,100,50,10/5/2018
A23747,earnings,100,50,10/5/2018
A398B9,earnings,100,50,10/5/2018
A41450,dividend,100,50,10/5/2018
A4A612,conference-call,100,50,10/5/2018
A5A4F5,acquisition-acquirer,100,49,10/5/2018
A7102F,award,100,58,10/5/2018
A7102F,earnings-up,100,68,10/5/2018
A75D43,facility-open,100,65,10/5/2018
A99576,conference-call,100,50,10/5/2018
AA98ED,legal-issues-defendant,100,22,10/5/2018
AD9F1D,dividend,100,50,10/5/2018
AE3113,ipo-completed,100,76,10/5/2018
AFBEB4,ipo-pricing,100,50,10/5/2018
AFDF2E,dividend,100,50,10/5/2018
B446B8,earnings,100,50,10/5/2018
B5766D,conference-call,100,50,10/5/2018
B8EF97,sanctions-target,100,19,10/5/2018
BB5142,earnings,100,50,10/5/2018
BFE02C,conference-call,100,50,10/5/2018
C062D4,conference-call,100,50,10/5/2018
C83B88,partnership,100,61,10/5/2018
D501DC,dividend,100,50,10/5/2018
D63B0F,conference-call,100,50,10/5/2018
D78CCD,conference-call,100,50,10/5/2018
D8C09D,earnings-guidance,100,50,10/5/2018
DB06B0,product-release,100,64,10/5/2018
E0207A,earnings,100,50,10/5/2018
E1C16B,acquisition-completed-acquirer,100,49,10/5/2018
E866D2,revenue-volume,100,50,10/5/2018
EFD406,fundraising,100,64,10/5/2018
F47871,regulatory-product-approval-granted,100,81,10/5/2018
F7902B,earnings,100,50,10/5/2018
FE89E0,executive-appointment,100,54,10/5/2018
FE89E0,dividend-up,100,81,10/5/2018
36C09B,legal-issues-defendant,100,22,10/6/2018
665D7D,legal-verdict-disfavored,100,22,10/6/2018
9D65C1,legal-issues-defendant,100,22,10/6/2018
CC6FF5,earnings,100,50,10/6/2018
00D6B5,conference-call,100,50,10/8/2018
054E7E,clinical-trials,100,56,10/8/2018
07EC43,award,100,58,10/8/2018
0A7650,conference-call,100,50,10/8/2018
0A9D0A,executive-appointment,100,54,10/8/2018
0C6861,conference-call,100,50,10/8/2018
0CBC4D,earnings,100,50,10/8/2018
0DE3D5,conference-call,100,50,10/8/2018
1151F4,conference-call,100,50,10/8/2018
168A5D,partnership,100,61,10/8/2018
1.79E+10,facility-open,100,65,10/8/2018
17EDA5,partnership,100,61,10/8/2018
228D42,partnership,100,61,10/8/2018
2491BC,partnership,100,61,10/8/2018
25A6CC,earnings,100,50,10/8/2018
26F31D,earnings-guidance-up,100,83,10/8/2018
26F31D,earnings-guidance-up,100,83,10/8/2018
2C3348,legal-issues-defendant,100,22,10/8/2018
2C3348,legal-issues-defendant,100,22,10/8/2018
2C7505,legal-issues-defendant,100,22,10/8/2018
2CA60F,award,100,58,10/8/2018
2D981A,clinical-trials,100,56,10/8/2018
2E902B,conference-call,100,50,10/8/2018
30A565,legal-issues-defendant,100,22,10/8/2018
3461CF,business-contract,100,69,10/8/2018
36C09B,legal-issues-defendant,100,22,10/8/2018
36C09B,legal-issues-defendant,100,22,10/8/2018
39FB23,earnings,100,50,10/8/2018
3A3447,facility-open,100,65,10/8/2018
3AF7FD,conference-call,100,50,10/8/2018
3B20AB,campaign-ad-release,100,59,10/8/2018
3B318A,legal-issues-defendant,100,22,10/8/2018
3CBA2A,executive-appointment,100,54,10/8/2018
3CCC90,executive-appointment,100,54,10/8/2018
3DD5E2,conference-call,100,50,10/8/2018
3DE4D1,conference-call,100,50,10/8/2018
3ED92D,product-release,100,64,10/8/2018
407878,acquisition-acquirer,100,49,10/8/2018
427F32,executive-appointment,100,54,10/8/2018
442769,product-release,100,64,10/8/2018
44A4FC,earnings,100,50,10/8/2018
44DDBD,buybacks,100,74,10/8/2018
45BC35,earnings-guidance,100,50,10/8/2018
467F2C,conference-call,100,50,10/8/2018
48F795,fraud-defendant,100,20,10/8/2018
490D4B,partnership,100,61,10/8/2018
4.91E+58,conference-call,100,50,10/8/2018
494EB9,earnings,100,50,10/8/2018
49A344,partnership,100,61,10/8/2018
4A2457,government-contract,100,69,10/8/2018
4A6F00,legal-issues-defendant,100,22,10/8/2018
4AC91D,product-release,100,64,10/8/2018
5088A5,earnings,100,50,10/8/2018
524CE4,earnings,100,50,10/8/2018
5403F8,earnings,100,50,10/8/2018
543900,legal-issues-defendant,100,22,10/8/2018
589803,earnings,100,50,10/8/2018
5D0337,earnings,100,50,10/8/2018
5D1956,earnings,100,50,10/8/2018
5E1DF3,buybacks,100,74,10/8/2018
610D47,conference-call,100,50,10/8/2018
63F892,partnership,100,61,10/8/2018
63F892,partnership,100,61,10/8/2018
63F892,partnership,100,61,10/8/2018
69FDFC,product-release,100,64,10/8/2018
71E2EF,earnings,100,50,10/8/2018
773A17,product-release,100,64,10/8/2018
78F9ED,conference-call,100,50,10/8/2018
7F3665,unit-acquisition-completed-acquirer,100,49,10/8/2018
826FD6,earnings,100,50,10/8/2018
85CDC9,clinical-trials-start,100,64,10/8/2018
85CDC9,clinical-trials-start,100,64,10/8/2018
896771,earnings,100,50,10/8/2018
8A8E41,product-release,100,64,10/8/2018
8BAA15,earnings,100,50,10/8/2018
8BE916,earnings,100,50,10/8/2018
8BFAA4,conference-call,100,50,10/8/2018
8C6C1B,facility-open,100,65,10/8/2018
8D4AE6,executive-appointment,100,54,10/8/2018
8DBBE6,conference-call,100,50,10/8/2018
8E10BF,clinical-trials-filed,100,60,10/8/2018
90D6A5,earnings-guidance,100,50,10/8/2018
9368BE,conference-call,100,50,10/8/2018
940C3D,partnership,100,61,10/8/2018
940C3D,partnership,100,61,10/8/2018
9548BB,earnings,100,50,10/8/2018
95DC1F,partnership,100,61,10/8/2018
965360,earnings,100,50,10/8/2018
9.74E+08,executive-appointment,100,54,10/8/2018
9.74E+08,executive-appointment,100,54,10/8/2018
9934AD,conference-call,100,50,10/8/2018
9C8BC3,conference-call,100,50,10/8/2018
9CA432,conference-call,100,50,10/8/2018
9CE4C7,earnings,100,50,10/8/2018
9D65C1,earnings,100,50,10/8/2018
9D65C1,legal-issues-defendant,100,22,10/8/2018
A3F598,conference-call,100,50,10/8/2018
A58224,conference-call,100,50,10/8/2018
A5A4F5,acquisition-acquirer,100,49,10/8/2018
A9ED24,conference-call,100,50,10/8/2018
B1FC3B,fundraising,100,64,10/8/2018
B1FC3B,business-contract,100,69,10/8/2018
B2256A,conference-call,100,50,10/8/2018
B7FA9B,conference-participant,100,50,10/8/2018
B803B1,conference-call,100,50,10/8/2018
B840EF,earnings,100,50,10/8/2018
B9CD50,earnings,100,50,10/8/2018
BBBB41,conference-call,100,50,10/8/2018
BC948D,conference-call,100,50,10/8/2018
C0200F,award,100,58,10/8/2018
C0F70B,earnings,100,50,10/8/2018
C230FE,earnings,100,50,10/8/2018
C356AC,earnings,100,50,10/8/2018
C4A241,conference-call,100,50,10/8/2018
C81E00,partnership,100,61,10/8/2018
C9D866,partnership,100,61,10/8/2018
D2B9E5,executive-appointment,100,54,10/8/2018
D2B9E5,acquisition-acquirer,100,49,10/8/2018
D4AC65,acquisition-acquirer,100,49,10/8/2018
D6489C,legal-issues-defendant,100,22,10/8/2018
D76AEF,executive-appointment,100,54,10/8/2018
D77F7E,earnings,100,50,10/8/2018
DB88A1,executive-appointment,100,54,10/8/2018
DCD97F,business-contract,100,69,10/8/2018
DCD97F,conference-call,100,50,10/8/2018
DD7A96,conference-call,100,50,10/8/2018
E610CD,earnings,100,50,10/8/2018
E8A49A,earnings,100,50,10/8/2018
E8C557,executive-appointment,100,54,10/8/2018
EC99D0,executive-appointment,100,54,10/8/2018
F1EB39,partnership,100,61,10/8/2018
F57F6F,revenues,100,50,10/8/2018
F83279,earnings,100,50,10/8/2018
FC1B7B,earnings,100,50,10/8/2018
FF5413,earnings,100,50,10/8/2018
FF5413,revenue-volume,100,50,10/8/2018
0157B1,partnership,100,61,10/9/2018
054B55,campaign-ad-release,100,59,10/9/2018
081AB9,conference-call,100,50,10/9/2018
099A92,dividend,100,50,10/9/2018
09F623,conference-call,100,50,10/9/2018
0A0CF0,partnership,100,61,10/9/2018
0DC050,earnings,100,50,10/9/2018
0F04E5,earnings,100,50,10/9/2018
0FC848,executive-appointment,100,54,10/9/2018
11074E,conference-call,100,50,10/9/2018
131443,buybacks,100,74,10/9/2018
139303,executive-appointment,100,54,10/9/2018
14833D,earnings,100,50,10/9/2018
156A99,equity-shelf-registration,100,43,10/9/2018
1AB808,partnership,100,61,10/9/2018
1BDB2A,conference-call,100,50,10/9/2018
20D00A,buybacks,100,74,10/9/2018
21268E,conference-call,100,50,10/9/2018
21DED4,conference-call,100,50,10/9/2018
238302,note-sale,100,52,10/9/2018
251988,partnership,100,61,10/9/2018
251988,partnership,100,61,10/9/2018
251988,partnership,100,61,10/9/2018
251988,partnership,100,61,10/9/2018
251988,partnership,100,61,10/9/2018
25DD05,conference-call,100,50,10/9/2018
279916,partnership,100,61,10/9/2018
279916,partnership,100,61,10/9/2018
2C7505,legal-issues-defendant,100,22,10/9/2018
2CB4C9,earnings,100,50,10/9/2018
2E61CC,dividend,100,50,10/9/2018
2EC172,conference-call,100,50,10/9/2018
30A565,legal-issues-defendant,100,22,10/9/2018
3159AA,product-release,100,64,10/9/2018
343996,executive-resignation,100,44,10/9/2018
343996,executive-appointment,100,54,10/9/2018
367E1C,partnership,100,61,10/9/2018
3A3447,facility-open,100,65,10/9/2018
3A3948,award,100,58,10/9/2018
3A3948,award,100,58,10/9/2018
3ACF46,business-contract,100,69,10/9/2018
3C6CCC,business-contract,100,69,10/9/2018
3CCC90,executive-appointment,100,54,10/9/2018
3E15F6,trading-resumed,100,58,10/9/2018
42AABD,conference-call,100,50,10/9/2018
43A74A,earnings,100,50,10/9/2018
44209A,earnings,100,50,10/9/2018
450ECB,executive-appointment,100,54,10/9/2018
4591D3,conference-call,100,50,10/9/2018
45ABCC,executive-appointment,100,54,10/9/2018
485445,facility-open,100,65,10/9/2018
49A344,executive-appointment,100,54,10/9/2018
4A6F00,legal-issues-defendant,100,22,10/9/2018
4B3DC9,conference-call,100,50,10/9/2018
4BEB48,earnings,100,50,10/9/2018
4C6C63,earnings,100,50,10/9/2018
4C6C63,dividend-up,100,60,10/9/2018
50D1EC,earnings,100,50,10/9/2018
543900,legal-issues-defendant,100,22,10/9/2018
5487B1,conference-call,100,50,10/9/2018
55438C,acquisition-completed-acquirer,100,49,10/9/2018
5546DA,conference-call,100,50,10/9/2018
55C9B5,business-contract,100,69,10/9/2018
55C9B5,partnership,100,61,10/9/2018
56B7C1,conference-call,100,50,10/9/2018
583A75,conference-call,100,50,10/9/2018
5B226B,legal-issues-defendant,100,22,10/9/2018
5B35C7,earnings-up,100,68,10/9/2018
5B35C7,earnings-up,100,68,10/9/2018
5B35C7,earnings-up,100,68,10/9/2018
5C2A47,earnings-guidance,100,50,10/9/2018
60DD84,conference-call,100,50,10/9/2018
6137BF,conference-call,100,50,10/9/2018
639BD6,earnings-guidance,100,50,10/9/2018
64E615,conference-call,100,50,10/9/2018
662682,conference-call,100,50,10/9/2018
665D7D,legal-issues-defendant,100,22,10/9/2018
6B494E,dividend,100,50,10/9/2018
6C4D2F,conference-call,100,50,10/9/2018
6CB7F9,conference-call,100,50,10/9/2018
6D156D,earnings,100,50,10/9/2018
7.44E+09,product-price-raise,100,57,10/9/2018
767F86,earnings,100,50,10/9/2018
771985,revenues,100,50,10/9/2018
7ADE57,acquisition-acquirer,100,49,10/9/2018
7F3669,earnings,100,50,10/9/2018
855DF7,conference-call,100,50,10/9/2018
86478F,earnings,100,50,10/9/2018
8802B4,conference-call,100,50,10/9/2018
88193E,partnership,100,61,10/9/2018
88193E,partnership,100,61,10/9/2018
88923D,conference-call,100,50,10/9/2018
88923D,conference-call,100,50,10/9/2018
8A8E41,business-contract,100,69,10/9/2018
8B3B0E,conference-call,100,50,10/9/2018
8C6C1B,facility-open,100,65,10/9/2018
8E0E32,buybacks,100,74,10/9/2018
8E3F58,partnership,100,61,10/9/2018
8E93A4,conference-call,100,50,10/9/2018
8FE7A5,earnings,100,50,10/9/2018
900356,earnings-guidance,100,50,10/9/2018
9087B9,earnings,100,50,10/9/2018
92D3A0,dividend,100,50,10/9/2018
934CC3,partnership,100,61,10/9/2018
93633B,conference-call,100,50,10/9/2018
990AD0,earnings,100,50,10/9/2018
9C8BC3,executive-appointment,100,54,10/9/2018
9D5FA4,earnings,100,50,10/9/2018
9EA947,conference-call,100,50,10/9/2018
9EBAFA,dividend-up,100,81,10/9/2018
9F5997,conference-call,100,50,10/9/2018
A15C71,conference-call,100,50,10/9/2018
A28C54,partnership,100,61,10/9/2018
A29DBD,executive-appointment,100,54,10/9/2018
A350C1,earnings-guidance,100,50,10/9/2018
A37D68,product-release,100,64,10/9/2018
A37D68,product-release,100,64,10/9/2018
A5A4F5,rights-issue,100,43,10/9/2018
A5A4F5,rights-issue,100,43,10/9/2018
A5A4F5,acquisition-acquirer,100,49,10/9/2018
A7A0BD,exchange-noncompliance,100,24,10/9/2018
A806FA,earnings-guidance,100,50,10/9/2018
AC7C4F,business-contract,100,69,10/9/2018
ACDCFA,exchange-noncompliance,100,24,10/9/2018
ACDF88,executive-appointment,100,54,10/9/2018
AD9F1D,award,100,58,10/9/2018
AFDF2E,earnings,100,50,10/9/2018
AFDF2E,earnings,100,50,10/9/2018
B076A1,conference-participant,100,50,10/9/2018
B1A85D,acquisition-acquirer,100,49,10/9/2018
B1FC3B,business-contract,100,69,10/9/2018
B2206F,earnings,100,50,10/9/2018
B2D492,earnings,100,50,10/9/2018
B4703C,dividend-up,100,81,10/9/2018
B54A74,earnings,100,50,10/9/2018
B934BF,conference-call,100,50,10/9/2018
BDD12C,executive-appointment,100,54,10/9/2018
C1114B,partnership,100,61,10/9/2018
C3DE7D,partnership,100,61,10/9/2018
C3DE7D,partnership,100,61,10/9/2018
C45C1F,clinical-trials,100,56,10/9/2018
C4706C,business-contract,100,69,10/9/2018
C5C0E9,earnings,100,50,10/9/2018
C6C702,conference-call,100,50,10/9/2018
C7AE14,conference-call,100,50,10/9/2018
C83B88,partnership,100,61,10/9/2018
C8923A,executive-appointment,100,54,10/9/2018
C98CDB,executive-appointment,100,54,10/9/2018
CB7AB2,earnings,100,50,10/9/2018
CC6FF5,product-release,100,64,10/9/2018
CC6FF5,award,100,58,10/9/2018
CDAF5B,executive-appointment,100,54,10/9/2018
CDAF5B,name-change,100,49,10/9/2018
CFF15D,executive-appointment,100,54,10/9/2018
D0909F,earnings-guidance,100,50,10/9/2018
D17C1B,earnings,100,50,10/9/2018
D17F7E,earnings,100,50,10/9/2018
D3CEDF,earnings-guidance,100,50,10/9/2018
D598E7,executive-appointment,100,54,10/9/2018
D69D42,earnings,100,50,10/9/2018
D70365,earnings,100,50,10/9/2018
D7AC6E,dividend,100,50,10/9/2018
D9164D,earnings,100,50,10/9/2018
DB06B0,earnings,100,50,10/9/2018
DBB28E,partnership,100,61,10/9/2018
DBFB51,partnership,100,61,10/9/2018
DBFB51,partnership,100,61,10/9/2018
DCD97F,facility-open,100,65,10/9/2018
DD0099,earnings,100,50,10/9/2018
DD682D,earnings,100,50,10/9/2018
DD9E41,business-contract,100,69,10/9/2018
DEF058,earnings,100,50,10/9/2018
E0A84E,acquisition-completed-acquirer,100,49,10/9/2018
E21871,earnings,100,50,10/9/2018
E2F130,conference-call,100,50,10/9/2018
E6D89E,earnings,100,50,10/9/2018
E6E012,earnings,100,50,10/9/2018
E754F0,earnings,100,50,10/9/2018
E8A49A,partnership,100,61,10/9/2018
E8A49A,partnership,100,61,10/9/2018
E8B315,earnings,100,50,10/9/2018
EC99D0,partnership,100,61,10/9/2018
ECDEB2,earnings,100,50,10/9/2018
ECF4F8,conference-call,100,50,10/9/2018
ED0D7C,conference-participant,100,50,10/9/2018
EE74E1,earnings,100,50,10/9/2018
F47871,note-sale,100,52,10/9/2018
F5349B,earnings,100,50,10/9/2018
FA40E2,public-offering,100,43,10/9/2018
FA40E2,public-offering,100,43,10/9/2018
FDC7E6,conference-call,100,50,10/9/2018
FE7A63,earnings,100,50,10/9/2018
FF6644,facility-upgrade,100,65,10/9/2018
00067A,business-contract,100,69,10/10/2018
13528,business-contract,100,69,10/10/2018
0157B1,partnership,100,61,10/10/2018
0157B1,partnership,100,61,10/10/2018
20751,executive-appointment,100,54,10/10/2018
07EC43,earnings-guidance,100,50,10/10/2018
095A04,ipo-pricing,100,50,10/10/2018
099A92,conference-call,100,50,10/10/2018
099C88,dividend,100,50,10/10/2018
0E3436,acquisition-acquirer,100,49,10/10/2018
0F2BC9,conference-call,100,50,10/10/2018
1201B5,public-offering,100,43,10/10/2018
1272B3,earnings,100,50,10/10/2018
16B183,conference-call,100,50,10/10/2018
182BE7,business-contract,100,69,10/10/2018
1AD9CC,revenues,100,50,10/10/2018
1BC12C,executive-appointment,100,54,10/10/2018
1EBF8D,conference-call,100,50,10/10/2018
1F08A6,earnings-guidance,100,50,10/10/2018
1FE3CB,conference-call,100,50,10/10/2018
228D42,partnership,100,61,10/10/2018
228D42,partnership,100,61,10/10/2018
228D42,partnership,100,61,10/10/2018
228D42,partnership,100,61,10/10/2018
238302,public-offering,100,43,10/10/2018
239106,unit-acquisition-acquirer,100,49,10/10/2018
2.45E+15,earnings,100,50,10/10/2018
24CB56,regulatory-stress-test,100,50,10/10/2018
24D81E,executive-appointment,100,54,10/10/2018
2571FA,conference-call,100,50,10/10/2018
2667B6,award,100,58,10/10/2018
2667B6,dividend-up,100,81,10/10/2018
2667B6,executive-appointment,100,54,10/10/2018
26F31D,partnership,100,61,10/10/2018
26F31D,partnership,100,61,10/10/2018
279916,business-contract,100,69,10/10/2018
27B191,conference-call,100,50,10/10/2018
284289,earnings-guidance,100,50,10/10/2018
2B0AF4,executive-appointment,100,54,10/10/2018
2C7505,executive-appointment,100,54,10/10/2018
2CBB58,conference-call,100,50,10/10/2018
2CC60C,hirings,100,65,10/10/2018
2E0496,earnings,100,50,10/10/2018
306623,unit-acquisition-acquirer,100,49,10/10/2018
309922,conference-call,100,50,10/10/2018
30AB63,earnings-up,100,68,10/10/2018
30DFD3,conference-call,100,50,10/10/2018
31666F,dividend,100,50,10/10/2018
31AA84,partnership,100,61,10/10/2018
32F24A,conference-call,100,50,10/10/2018
33E8C7,earnings,100,50,10/10/2018
35557B,reverse-stock-splits,100,51,10/10/2018
366A08,dividend,100,50,10/10/2018
371C01,conference-call,100,50,10/10/2018
37E18B,conference-participant,100,50,10/10/2018
387375,earnings,100,50,10/10/2018
3A6D90,executive-resignation,100,44,10/10/2018
3B20AB,dividend,100,50,10/10/2018
3C7F5F,legal-issues-defendant,100,22,10/10/2018
3CBA2A,partnership,100,61,10/10/2018
3D9999,partnership,100,61,10/10/2018
42DC93,unit-acquisition-acquirer,100,49,10/10/2018
45444E,earnings,100,50,10/10/2018
46017C,conference-call,100,50,10/10/2018
4885C8,earnings,100,50,10/10/2018
48F795,legal-issues-defendant,100,22,10/10/2018
499C75,award,100,58,10/10/2018
4A2457,business-contract,100,69,10/10/2018
4A6F00,partnership,100,61,10/10/2018
4A6F00,partnership,100,61,10/10/2018
510EA6,buybacks,100,74,10/10/2018
546A9C,earnings,100,50,10/10/2018
55438C,investment-investor,100,55,10/10/2018
59872F,partnership,100,61,10/10/2018
5A53BF,clinical-trials,100,56,10/10/2018
5A64D5,dividend,100,50,10/10/2018
5B97B2,earnings,100,50,10/10/2018
5F3E74,public-offering,100,43,10/10/2018
5F9CE3,acquisition-completed-acquirer,100,49,10/10/2018
605F40,conference-call,100,50,10/10/2018
62EFEE,earnings,100,50,10/10/2018
665618,conference-call,100,50,10/10/2018
6810DE,clinical-trials,100,56,10/10/2018
68B03F,earnings,100,50,10/10/2018
69345C,earnings,100,50,10/10/2018
6A3C35,executive-appointment,100,54,10/10/2018
6D0CAB,partnership,100,61,10/10/2018
6D3F35,conference-call,100,50,10/10/2018
6F0096,conference-call,100,50,10/10/2018
704B78,public-offering,100,43,10/10/2018
70FCEF,executive-appointment,100,54,10/10/2018
713810,business-contract,100,69,10/10/2018
726DDF,conference-call,100,50,10/10/2018
741937,earnings,100,50,10/10/2018
7.44E+09,earnings-guidance,100,50,10/10/2018
767F86,dividend,100,50,10/10/2018
767F86,dividend,100,50,10/10/2018
76B926,conference-call,100,50,10/10/2018
790C34,earnings,100,50,10/10/2018
7A10FF,earnings,100,50,10/10/2018
7A3633,earnings,100,50,10/10/2018
7A3633,executive-resignation,100,44,10/10/2018
7AB859,conference-call,100,50,10/10/2018
7E62B5,earnings-guidance,100,50,10/10/2018
7F3A5F,earnings,100,50,10/10/2018
817ED9,partnership,100,61,10/10/2018
82C202,acquisition-completed-acquirer,100,49,10/10/2018
860AB6,earnings,100,50,10/10/2018
863350,facility-open,100,65,10/10/2018
88611B,earnings,100,50,10/10/2018
89FBB1,conference-call,100,50,10/10/2018
8C6C1B,facility-open,100,65,10/10/2018
8D4486,partnership,100,61,10/10/2018
8DCF18,conference-call,100,50,10/10/2018
9043FE,earnings,100,50,10/10/2018
9043FE,earnings,100,50,10/10/2018
911AB8,partnership,100,61,10/10/2018
922F0C,merger,100,66,10/10/2018
925759,partnership,100,61,10/10/2018
92D3A0,earnings,100,50,10/10/2018
931AE7,clinical-trials-start,100,64,10/10/2018
94563D,business-contract,100,69,10/10/2018
949625,joint-venture,100,62,10/10/2018
9.54E+32,partnership,100,61,10/10/2018
95C392,conference-call,100,50,10/10/2018
966ACE,executive-appointment,100,54,10/10/2018
980C14,dividend,100,50,10/10/2018
9C25FF,partnership,100,61,10/10/2018
9D30A8,earnings,100,50,10/10/2018
9E98F2,product-release,100,64,10/10/2018
9EED50,conference-call,100,50,10/10/2018
9F18FA,acquisition-acquirer,100,49,10/10/2018
9F18FA,acquisition-acquirer,100,49,10/10/2018
9F18FA,acquisition-acquirer,100,49,10/10/2018
9F18FA,acquisition-acquirer,100,49,10/10/2018
9F18FA,acquisition-acquirer,100,49,10/10/2018
9F18FA,acquisition-acquirer,100,49,10/10/2018
A01664,earnings,100,50,10/10/2018
A1A317,conference-call,100,50,10/10/2018
A495F7,earnings,100,50,10/10/2018
A5A4F5,acquisition-acquirer,100,49,10/10/2018
A666C8,dividend-up,100,81,10/10/2018
A8E72A,ipo-completed,100,76,10/10/2018
AB7F05,earnings,100,50,10/10/2018
AF210D,earnings,100,50,10/10/2018
AFBEB4,ipo-completed,100,76,10/10/2018
B01111,partnership,100,61,10/10/2018
B13B68,earnings-guidance,100,50,10/10/2018
B1DF3C,earnings,100,50,10/10/2018
B1FC3B,business-contract,100,69,10/10/2018
B2E6B5,conference-call,100,50,10/10/2018
B37FB4,acquisition-acquirer,100,49,10/10/2018
B614F8,patent-awarded,100,72,10/10/2018
B83BCE,earnings,100,50,10/10/2018
B8EF97,revenues,100,50,10/10/2018
BB02FB,conference-call,100,50,10/10/2018
BDD12C,executive-appointment,100,54,10/10/2018
C0030A,earnings,100,50,10/10/2018
C03C8B,dividend,100,50,10/10/2018
C188F8,legal-issues-defendant,100,22,10/10/2018
C188F8,legal-issues-defendant,100,22,10/10/2018
C32A39,donation,100,54,10/10/2018
C38440,earnings,100,50,10/10/2018
C4A432,award,100,58,10/10/2018
C54140,earnings,100,50,10/10/2018
C598D7,dividend-up,100,57,10/10/2018
CD4DA8,executive-appointment,100,54,10/10/2018
CDAA0E,credit-extension-recipient,100,69,10/10/2018
CDE118,earnings,100,50,10/10/2018
CDE51C,earnings,100,50,10/10/2018
CDFCC9,legal-issues-defendant,100,22,10/10/2018
CE5664,earnings,100,50,10/10/2018
CEC08B,earnings,100,50,10/10/2018
D17C1B,revenue-volume,100,50,10/10/2018
D3DE34,earnings,100,50,10/10/2018
D437C3,earnings,100,50,10/10/2018
D6489C,partnership,100,61,10/10/2018
D6853F,earnings,100,50,10/10/2018
D7A953,earnings,100,50,10/10/2018
D90F43,partnership,100,61,10/10/2018
D90F43,partnership,100,61,10/10/2018
DB5CA5,investment-investor,100,55,10/10/2018
DC0998,conference-call,100,50,10/10/2018
DCD97F,product-release,100,64,10/10/2018
DDC415,earnings,100,50,10/10/2018
DF6FDD,earnings,100,50,10/10/2018
E09E2B,partnership,100,61,10/10/2018
E09E2B,business-contract,100,69,10/10/2018
E12A6E,dividend,100,50,10/10/2018
E1E36F,earnings,100,50,10/10/2018
E30B34,award,100,58,10/10/2018
E754F0,product-release,100,64,10/10/2018
E99180,business-contract,100,69,10/10/2018
EB6965,executive-resignation,100,44,10/10/2018
EBD89A,business-contract,100,69,10/10/2018
EC99D0,partnership,100,61,10/10/2018
ED9C04,earnings,100,50,10/10/2018
EF25A5,award,100,58,10/10/2018
F6FA6A,dividend,100,50,10/10/2018
F6FF0D,ipo-pricing,100,50,10/10/2018
F6FF0D,executive-appointment,100,54,10/10/2018
F721A7,earnings,100,50,10/10/2018
F721A7,earnings,100,50,10/10/2018
FB728F,conference-call,100,50,10/10/2018
FC1A6E,legal-issues-defendant,100,22,10/10/2018
FDF28E,earnings,100,50,10/10/2018
FF4343,executive-appointment,100,54,10/10/2018
00067A,donation,100,54,10/11/2018
0157B1,partnership,100,61,10/11/2018
0157B1,settlement,100,56,10/11/2018
0157B1,conference-call,100,50,10/11/2018
03CF95,partnership,100,61,10/11/2018
03FAA6,earnings,100,50,10/11/2018
48590,partnership,100,61,10/11/2018
61366,earnings,100,50,10/11/2018
95294,dividend,100,50,10/11/2018
0C6861,legal-issues-defendant,100,22,10/11/2018
105D00,executive-appointment,100,54,10/11/2018
125212,executive-appointment,100,54,10/11/2018
1279ED,conference-call,100,50,10/11/2018
135B09,conference-call,100,50,10/11/2018
13C3E0,earnings,100,50,10/11/2018
143C52,hirings,100,65,10/11/2018
17EDA5,executive-appointment,100,54,10/11/2018
180DA0,award,100,58,10/11/2018
190B91,award,100,58,10/11/2018
1B4F31,earnings,100,50,10/11/2018
1CDD1C,earnings-guidance,100,50,10/11/2018
1E1125,conference-organizer,100,57,10/11/2018
2158DF,executive-appointment,100,54,10/11/2018
228D42,partnership,100,61,10/11/2018
24C48B,executive-appointment,100,54,10/11/2018
26F31D,partnership,100,61,10/11/2018
2720AB,conference-call,100,50,10/11/2018
29B702,earnings,100,50,10/11/2018
2A1009,conference-call,100,50,10/11/2018
2A17B1,conference-call,100,50,10/11/2018
2BA977,conference-call,100,50,10/11/2018
2DA92D,earnings,100,50,10/11/2018
2E89AE,operating-earnings,100,50,10/11/2018
328250,conference-call,100,50,10/11/2018
33AD83,partnership,100,61,10/11/2018
35F4B5,earnings,100,50,10/11/2018
36C09B,legal-issues-defendant,100,22,10/11/2018
3A113F,conference-call,100,50,10/11/2018
3AF7FD,conference-participant,100,50,10/11/2018
3B318A,legal-issues-defendant,100,22,10/11/2018
3B318A,legal-issues-defendant,100,22,10/11/2018
3B318A,legal-issues-defendant,100,22,10/11/2018
3B318A,legal-issues-defendant,100,22,10/11/2018
3CBA2A,acquisition-acquiree,100,76,10/11/2018
3FBC9B,earnings,100,50,10/11/2018
4135F7,conference-call,100,50,10/11/2018
416291,conference-call,100,50,10/11/2018
41785E,conference-organizer,100,57,10/11/2018
420168,earnings,100,50,10/11/2018
423279,earnings-per-share-positive,100,69,10/11/2018
43A060,earnings,100,50,10/11/2018
479930,earnings,100,50,10/11/2018
4806CE,earnings-guidance,100,50,10/11/2018
48F795,legal-issues-defendant,100,22,10/11/2018
48F795,legal-issues-defendant,100,22,10/11/2018
4A2457,business-contract,100,69,10/11/2018
4A6F00,partnership,100,61,10/11/2018
4A6F00,legal-issues-defendant,100,22,10/11/2018
4A6F00,product-release,100,64,10/11/2018
4AC91D,product-release,100,64,10/11/2018
4C1FA1,earnings,100,50,10/11/2018
4D971D,conference-call,100,50,10/11/2018
4E5784,earnings,100,50,10/11/2018
4EE167,earnings,100,50,10/11/2018
52015A,conference-call,100,50,10/11/2018
53A226,partnership,100,61,10/11/2018
543900,legal-issues-defendant,100,22,10/11/2018
55ACCB,earnings,100,50,10/11/2018
58C2D4,earnings,100,50,10/11/2018
58CA9A,award,100,58,10/11/2018
5A423F,earnings,100,50,10/11/2018
5D16CF,conference-call,100,50,10/11/2018
5D41E4,executive-appointment,100,54,10/11/2018
5EAA43,business-contract,100,69,10/11/2018
5F2FF7,earnings-positive,100,69,10/11/2018
5F3E74,public-offering,100,43,10/11/2018
61E975,dividend,100,50,10/11/2018
63F892,index-listing,100,76,10/11/2018
6.52E+64,earnings-guidance,100,50,10/11/2018
68BA15,conference-call,100,50,10/11/2018
6ABCB8,earnings,100,50,10/11/2018
6BD606,acquisition-acquirer,100,49,10/11/2018
6CC55E,earnings,100,50,10/11/2018
6DC1D7,conference-call,100,50,10/11/2018
6E8864,executive-appointment,100,54,10/11/2018
6ED519,conference-call,100,50,10/11/2018
6F6559,dividend,100,50,10/11/2018
704B78,public-offering,100,43,10/11/2018
713810,investment-investor,100,55,10/11/2018
713810,partnership,100,61,10/11/2018
728737,earnings,100,50,10/11/2018
728737,dividend,100,50,10/11/2018
72C2CE,conference-call,100,50,10/11/2018
72CB93,earnings,100,50,10/11/2018
73A71F,conference-call,100,50,10/11/2018
756BB4,partnership,100,61,10/11/2018
762A3E,executive-appointment,100,54,10/11/2018
76CEFB,earnings,100,50,10/11/2018
76D79A,earnings-guidance,100,50,10/11/2018
773A17,earnings,100,50,10/11/2018
7740DE,same-store-sales-down,100,49,10/11/2018
791D59,earnings,100,50,10/11/2018
791EC1,conference-call,100,50,10/11/2018
7AC86E,earnings-guidance,100,50,10/11/2018
7B9212,revenues,100,50,10/11/2018
7BAAE7,earnings,100,50,10/11/2018
7D97DE,conference-call,100,50,10/11/2018
837C04,conference-call,100,50,10/11/2018
838ADD,earnings,100,50,10/11/2018
85DA04,acquisition-acquirer,100,49,10/11/2018
85DE00,conference-call,100,50,10/11/2018
86A1B9,earnings,100,50,10/11/2018
88193E,conference-call,100,50,10/11/2018
8C6C1B,facility-open,100,65,10/11/2018
8DBE73,conference-call,100,50,10/11/2018
8DE74B,conference-call,100,50,10/11/2018
8E10BF,conference-participant,100,50,10/11/2018
8E8E6E,executive-appointment,100,54,10/11/2018
94637C,partnership,100,61,10/11/2018
94637C,partnership,100,61,10/11/2018
94756D,earnings,100,50,10/11/2018
971F7B,earnings,100,50,10/11/2018
9.74E+08,earnings,100,50,10/11/2018
9CA4C6,executive-appointment,100,54,10/11/2018
9CDA4F,earnings,100,50,10/11/2018
9CF9B1,earnings,100,50,10/11/2018
9E575E,executive-appointment,100,54,10/11/2018
A15C71,executive-appointment,100,54,10/11/2018
A1E3B3,product-release,100,64,10/11/2018
A1EAC8,conference-call,100,50,10/11/2018
A1EAC8,executive-appointment,100,54,10/11/2018
A48593,conference-call,100,50,10/11/2018
A5A4F5,acquisition-acquirer,100,49,10/11/2018
A6213D,dividend,100,50,10/11/2018
A6FB29,buybacks,100,74,10/11/2018
A6FC89,partnership,100,61,10/11/2018
A746F6,conference-call,100,50,10/11/2018
A74F6F,conference-call,100,50,10/11/2018
AA5C8E,earnings,100,50,10/11/2018
ADD9DC,facility-open,100,65,10/11/2018
B05118,earnings,100,50,10/11/2018
B1B10C,dividend-up,100,81,10/11/2018
B2DAF6,earnings,100,50,10/11/2018
B4C673,conference-call,100,50,10/11/2018
B840EF,product-release,100,64,10/11/2018
BB0587,conference-call,100,50,10/11/2018
BB88B6,partnership,100,61,10/11/2018
BBF349,earnings,100,50,10/11/2018
BD682F,earnings,100,50,10/11/2018
BD8517,earnings,100,50,10/11/2018
BE379D,clinical-trials,100,56,10/11/2018
BF79F5,conference-call,100,50,10/11/2018
C4C77F,dividend-up,100,81,10/11/2018
C66B44,conference-call,100,50,10/11/2018
C7AE14,acquisition-acquirer,100,49,10/11/2018
C8257F,conference-call,100,50,10/11/2018
C8A248,dividend,100,50,10/11/2018
C8A248,dividend,100,50,10/11/2018
C98CDB,earnings,100,50,10/11/2018
C9F39B,executive-appointment,100,54,10/11/2018
CA1620,conference-call,100,50,10/11/2018
CB6A9C,executive-appointment,100,54,10/11/2018
CD4DA8,earnings,100,50,10/11/2018
CE4FD9,conference-call,100,50,10/11/2018
CEC5B9,dividend,100,50,10/11/2018
D08D2C,dividend,100,50,10/11/2018
D2E553,dividend-up,100,81,10/11/2018
D42DBA,hirings,100,65,10/11/2018
D5938F,partnership,100,61,10/11/2018
D5AF19,partnership,100,61,10/11/2018
D65A13,conference-call,100,50,10/11/2018
D8442A,business-contract,100,69,10/11/2018
D8442A,partnership,100,61,10/11/2018
D8442A,business-contract,100,69,10/11/2018
D8442A,partnership,100,61,10/11/2018
D8442A,business-contract,100,69,10/11/2018
DB396B,conference-call,100,50,10/11/2018
DB9829,award,100,58,10/11/2018
DD1BA1,acquisition-completed-acquirer,100,49,10/11/2018
DD9E41,earnings,100,50,10/11/2018
E05DC8,earnings,100,50,10/11/2018
E49AA3,partnership,100,61,10/11/2018
E67C2C,earnings,100,50,10/11/2018
E93A40,earnings,100,50,10/11/2018
ED7F13,earnings,100,50,10/11/2018
EE967B,earnings,100,50,10/11/2018
EEEA9F,earnings,100,50,10/11/2018
EFD406,conference-call,100,50,10/11/2018
F179ED,earnings,100,50,10/11/2018
F3EDB4,dividend,100,50,10/11/2018
F46EC9,earnings,100,50,10/11/2018
F46EC9,dividend,100,50,10/11/2018
F47871,note-sale,100,52,10/11/2018
F5D499,merger,100,66,10/11/2018
F6E248,earnings,100,50,10/11/2018
F6FF0D,ipo,100,71,10/11/2018
F702CA,product-price-raise,100,57,10/11/2018
F85CC0,earnings,100,50,10/11/2018
F88A04,earnings,100,50,10/11/2018
FA918D,earnings-guidance,100,50,10/11/2018
FACF19,earnings,100,50,10/11/2018
FB7724,earnings,100,50,10/11/2018
FC80E6,conference-call,100,50,10/11/2018
FD4BBE,earnings,100,50,10/11/2018
FFE543,earnings,100,50,10/11/2018
48590,partnership,100,61,10/12/2018
71860,earnings,100,50,10/12/2018
099C88,business-contract,100,69,10/12/2018
0C6861,board-meeting,100,51,10/12/2018
0F91FC,conference-call,100,50,10/12/2018
0FDE97,partnership,100,61,10/12/2018
147C38,earnings,100,50,10/12/2018
152FA5,orphan-drug-designation,100,76,10/12/2018
1866B2,executive-appointment,100,54,10/12/2018
1AF7E2,earnings,100,50,10/12/2018
1F19C8,conference-call,100,50,10/12/2018
28DCF3,earnings,100,50,10/12/2018
2950FF,earnings,100,50,10/12/2018
2B9DBB,conference-call,100,50,10/12/2018
2CB4C9,dividend,100,50,10/12/2018
2CB4C9,executive-appointment,100,54,10/12/2018
2EBA55,dividend,100,50,10/12/2018
2EBC0B,award,100,58,10/12/2018
339F20,unit-acquisition-acquirer,100,49,10/12/2018
34B97A,donation,100,54,10/12/2018
3.50E+27,earnings,100,50,10/12/2018
366A08,conference-call,100,50,10/12/2018
3696BF,conference-call,100,50,10/12/2018
36C09B,legal-issues-defendant,100,22,10/12/2018
370C50,product-price-raise,100,57,10/12/2018
3B318A,legal-issues-defendant,100,22,10/12/2018
3B318A,legal-issues-defendant,100,22,10/12/2018
3E39A5,earnings-guidance,100,50,10/12/2018
425BDC,conference-call,100,50,10/12/2018
4A6F00,legal-issues-defendant,100,22,10/12/2018
4A6F00,legal-issues-defendant,100,22,10/12/2018
4A6F00,legal-issues-defendant,100,22,10/12/2018
4A6F00,legal-issues-defendant,100,22,10/12/2018
4C7DB5,union-pact,100,61,10/12/2018
51E682,business-contract,100,69,10/12/2018
51E682,acquisition-acquirer,100,49,10/12/2018
52D936,executive-resignation,100,44,10/12/2018
53A226,earnings,100,50,10/12/2018
55438C,product-release,100,64,10/12/2018
562853,conference-call,100,50,10/12/2018
56632F,dividend,100,50,10/12/2018
57B174,dividend,100,50,10/12/2018
58CA9A,earnings,100,50,10/12/2018
5FF95F,earnings,100,50,10/12/2018
619882,earnings,100,50,10/12/2018
61B81B,earnings-positive,100,69,10/12/2018
61B81B,earnings-positive,100,69,10/12/2018
61B81B,earnings-positive,100,69,10/12/2018
61B81B,earnings-positive,100,69,10/12/2018
61B81B,earnings-positive,100,69,10/12/2018
61B81B,earnings-positive,100,69,10/12/2018
61B81B,earnings-positive,100,69,10/12/2018
629F0F,dividend,100,50,10/12/2018
62B1C6,earnings,100,50,10/12/2018
633043,earnings,100,50,10/12/2018
665D7D,legal-issues-defendant,100,22,10/12/2018
66749D,earnings-guidance,100,50,10/12/2018
66E04A,award,100,58,10/12/2018
69C99E,conference-participant,100,50,10/12/2018
6CDFC6,conference-call,100,50,10/12/2018
6D3B7B,earnings,100,50,10/12/2018
722D55,earnings,100,50,10/12/2018
752A70,earnings,100,50,10/12/2018
762B8D,dividend,100,50,10/12/2018
7712CB,conference-call,100,50,10/12/2018
7823A3,facility-open,100,65,10/12/2018
789A7D,dividend-up,100,81,10/12/2018
7D5384,conference-call,100,50,10/12/2018
859281,earnings,100,50,10/12/2018
85DA04,partnership,100,61,10/12/2018
85DE00,business-contract,100,69,10/12/2018
862941,earnings,100,50,10/12/2018
86A1B9,donation,100,54,10/12/2018
8C6C1B,facility-open,100,65,10/12/2018
8DE56F,earnings,100,50,10/12/2018
93965C,earnings,100,50,10/12/2018
93F143,earnings,100,50,10/12/2018
950CDB,earnings,100,50,10/12/2018
97AF94,dividend,100,50,10/12/2018
99ACAD,earnings,100,50,10/12/2018
9C8664,conference-call,100,50,10/12/2018
9C8BC3,dividend,100,50,10/12/2018
9D4EC7,conference-call,100,50,10/12/2018
A52B6B,acquisition-completed-acquirer,100,49,10/12/2018
A58224,board-meeting,100,51,10/12/2018
A5A4F5,acquisition-acquirer,100,49,10/12/2018
A7CCF0,conference-call,100,50,10/12/2018
A8B137,executive-appointment,100,54,10/12/2018
AA1EAA,earnings,100,50,10/12/2018
AEEB76,product-release,100,64,10/12/2018
B642E8,executive-appointment,100,54,10/12/2018
B642E8,executive-appointment,100,54,10/12/2018
B803B1,board-meeting,100,51,10/12/2018
BC948D,board-meeting,100,51,10/12/2018
BCC55F,conference-call,100,50,10/12/2018
BE7BA4,conference-call,100,50,10/12/2018
BEB756,credit-extension-provider,100,57,10/12/2018
C3DE7D,government-contract,100,69,10/12/2018
C5C137,business-contract,100,69,10/12/2018
C7859D,earnings-up,100,68,10/12/2018
C7859D,earnings,100,50,10/12/2018
C7859D,earnings,100,50,10/12/2018
C7859D,earnings,100,50,10/12/2018
C7859D,earnings,100,50,10/12/2018
C7859D,earnings,100,50,10/12/2018
C8257F,executive-resignation,100,44,10/12/2018
C8257F,executive-resignation,100,44,10/12/2018
CC35BE,executive-resignation,100,44,10/12/2018
CF6A5A,earnings,100,50,10/12/2018
D2C0B6,buybacks,100,74,10/12/2018
D2E553,executive-appointment,100,54,10/12/2018
D3FA2C,conference-call,100,50,10/12/2018
D58A11,earnings,100,50,10/12/2018
E0339F,executive-appointment,100,54,10/12/2018
E393B0,merger-completed,100,66,10/12/2018
E592F0,earnings,100,50,10/12/2018
E6BC2C,executive-appointment,100,54,10/12/2018
E829E8,earnings,100,50,10/12/2018
E87676,conference-call,100,50,10/12/2018
E8846E,earnings-positive,100,69,10/12/2018
EC4E82,trading-halt,100,43,10/12/2018
ECDEB2,earnings,100,50,10/12/2018
ED0402,unit-acquisition-acquirer,100,49,10/12/2018
ED0402,unit-acquisition-acquirer,100,49,10/12/2018
F2E253,executive-appointment,100,54,10/12/2018
F5D499,trading-halt,100,43,10/12/2018
F8084B,earnings,100,50,10/12/2018
F8BDCE,earnings,100,50,10/12/2018
F8BDCE,earnings,100,50,10/12/2018
FACCF6,earnings,100,50,10/12/2018
FEC475,conference-call,100,50,10/12/2018
FF4343,conference-call,100,50,10/12/2018
3B318A,legal-issues-defendant,100,22,10/13/2018
48F795,legal-issues-defendant,100,22,10/13/2018
4A6F00,legal-issues-defendant,100,22,10/13/2018
EE6F1C,business-combination,100,54,10/14/2018
EE6F1C,business-combination,100,54,10/14/2018
EE6F1C,earnings-up,100,68,10/14/2018
EE6F1C,earnings,100,50,10/14/2018
EE6F1C,earnings,100,50,10/14/2018
00326E,conference-call,100,50,10/15/2018
0142B5,conference-call,100,50,10/15/2018
0157B1,donation,100,54,10/15/2018
01D03F,partnership,100,61,10/15/2018
03B431,conference-call,100,50,10/15/2018
03D5F9,earnings,100,50,10/15/2018
03FB17,earnings,100,50,10/15/2018
095A04,ipo-completed,100,76,10/15/2018
0C2A0D,earnings,100,50,10/15/2018
0CC01F,executive-appointment,100,54,10/15/2018
0DBB81,executive-appointment,100,54,10/15/2018
0ED415,conference-call,100,50,10/15/2018
0F0440,donation,100,54,10/15/2018
0FDE97,conference-call,100,50,10/15/2018
1096C6,partnership,100,61,10/15/2018
147C38,dividend,100,50,10/15/2018
1834C0,earnings-guidance,100,50,10/15/2018
1A3E1B,donation,100,54,10/15/2018
1D943E,earnings,100,50,10/15/2018
1D9E55,earnings,100,50,10/15/2018
21022F,earnings,100,50,10/15/2018
222BF9,conference-call,100,50,10/15/2018
238302,conference-call,100,50,10/15/2018
251988,business-contract,100,69,10/15/2018
26F31D,earnings,100,50,10/15/2018
2A1009,acquisition-completed-acquirer,100,49,10/15/2018
2BBE62,earnings,100,50,10/15/2018
2D2D43,earnings,100,50,10/15/2018
2EB88B,acquisition-completed-acquirer,100,49,10/15/2018
2EBA55,conference-call,100,50,10/15/2018
2F94A5,executive-appointment,100,54,10/15/2018
31643A,award,100,58,10/15/2018
32F943,business-contract,100,69,10/15/2018
32F943,business-contract,100,69,10/15/2018
33FD66,product-release,100,64,10/15/2018
349DA4,earnings,100,50,10/15/2018
34E9F9,dividend,100,50,10/15/2018
3587B4,executive-appointment,100,54,10/15/2018
35AE32,executive-appointment,100,54,10/15/2018
36529A,clinical-trials-positive,100,87,10/15/2018
367E1C,earnings,100,50,10/15/2018
37020C,earnings-guidance,100,50,10/15/2018
3798B9,earnings,100,50,10/15/2018
387541,dividend,100,50,10/15/2018
3B318A,legal-issues-defendant,100,22,10/15/2018
3B318A,legal-issues-defendant,100,22,10/15/2018
3B318A,legal-issues-defendant,100,22,10/15/2018
3BB616,unit-acquisition-acquirer,100,49,10/15/2018
3BCF24,earnings,100,50,10/15/2018
3DB18B,earnings,100,50,10/15/2018
3DD5E2,loan-recipient,100,59,10/15/2018
4.03E+05,earnings-guidance,100,50,10/15/2018
416C55,product-release,100,64,10/15/2018
416C55,partnership,100,61,10/15/2018
429BFB,conference-call,100,50,10/15/2018
4595EF,conference-call,100,50,10/15/2018
485445,earnings,100,50,10/15/2018
49A344,business-contract,100,69,10/15/2018
4A2457,partnership,100,61,10/15/2018
4A6F00,product-release,100,64,10/15/2018
4A6F00,legal-issues-defendant,100,22,10/15/2018
4D8E5E,acquisition-completed-acquirer,100,49,10/15/2018
4EEE7E,business-contract,100,69,10/15/2018
4F0A80,acquisition-completed-acquirer,100,49,10/15/2018
504FE2,business-contract,100,69,10/15/2018
51F541,conference-call,100,50,10/15/2018
520632,executive-appointment,100,54,10/15/2018
5225A4,conference-organizer,100,57,10/15/2018
525A1C,earnings,100,50,10/15/2018
55438C,partnership,100,61,10/15/2018
55ACCB,partnership,100,61,10/15/2018
56277A,partnership,100,61,10/15/2018
5A64D5,conference-call,100,50,10/15/2018
5CEE02,earnings,100,50,10/15/2018
5EC388,earnings,100,50,10/15/2018
5F3E74,public-offering,100,43,10/15/2018
5FE4B6,conference-call,100,50,10/15/2018
619882,dividend,100,50,10/15/2018
61A586,earnings,100,50,10/15/2018
6284B5,executive-appointment,100,54,10/15/2018
62B1C6,earnings,100,50,10/15/2018
665440,executive-appointment,100,54,10/15/2018
66667F,revenue-up,100,91,10/15/2018
68E3E0,conference-call,100,50,10/15/2018
6B236C,conference-call,100,50,10/15/2018
6D1ADF,conference-call,100,50,10/15/2018
709AED,conference-participant,100,50,10/15/2018
70FCEF,executive-appointment,100,54,10/15/2018
726EEA,executive-appointment,100,54,10/15/2018
72DF04,earnings,100,50,10/15/2018
7448A3,conference-call,100,50,10/15/2018
7.83E+79,earnings,100,50,10/15/2018
7B6C88,conference-call,100,50,10/15/2018
7BEA98,patient-enrollment-complete,100,64,10/15/2018
7C790D,conference-call,100,50,10/15/2018
7CBC40,earnings,100,50,10/15/2018
7DC1C4,earnings,100,50,10/15/2018
7E3F8F,earnings,100,50,10/15/2018
82C202,earnings,100,50,10/15/2018
8303CD,conference-call,100,50,10/15/2018
859281,acquisition-completed-acquirer,100,49,10/15/2018
85DA04,award,100,58,10/15/2018
8AC65D,conference-call,100,50,10/15/2018
8C6C1B,facility-open,100,65,10/15/2018
8D4AE6,earnings,100,50,10/15/2018
901327,earnings,100,50,10/15/2018
91E5EE,earnings,100,50,10/15/2018
92D757,executive-appointment,100,54,10/15/2018
934CC3,executive-appointment,100,54,10/15/2018
96F126,business-contract,100,69,10/15/2018
99028D,acquisition-completed-acquirer,100,49,10/15/2018
990AD0,earnings,100,50,10/15/2018
990AD0,earnings,100,50,10/15/2018
9934AD,conference-call,100,50,10/15/2018
9AF3DC,product-release,100,64,10/15/2018
9AF3DC,product-release,100,64,10/15/2018
9C25FF,earnings-guidance,100,50,10/15/2018
9FF5F1,earnings,100,50,10/15/2018
A21649,conference-call,100,50,10/15/2018
A29DBD,conference-call,100,50,10/15/2018
A52533,facility-open,100,65,10/15/2018
A52B6B,executive-appointment,100,54,10/15/2018
A5A4F5,acquisition-acquirer,100,49,10/15/2018
A6213D,earnings,100,50,10/15/2018
A6828A,partnership,100,61,10/15/2018
A6828A,partnership,100,61,10/15/2018
AADE0B,conference-call,100,50,10/15/2018
AD23DE,partnership,100,61,10/15/2018
AD3008,earnings,100,50,10/15/2018
ADD9DC,executive-appointment,100,54,10/15/2018
AFF7B4,dividend,100,50,10/15/2018
B2206F,award,100,58,10/15/2018
BC5680,earnings,100,50,10/15/2018
BCE9DA,acquisition-acquirer,100,49,10/15/2018
BCE9DA,acquisition-acquirer,100,49,10/15/2018
BD15E8,acquisition-completed-acquirer,100,49,10/15/2018
BDD12C,dividend,100,50,10/15/2018
BE645B,executive-appointment,100,54,10/15/2018
C3BAE7,earnings,100,50,10/15/2018
C83B88,product-release,100,64,10/15/2018
C93C44,conference-participant,100,50,10/15/2018
C941DC,conference-call,100,50,10/15/2018
C9881C,product-release,100,64,10/15/2018
C9881C,product-release,100,64,10/15/2018
CA212F,business-contract,100,69,10/15/2018
CA3CB9,earnings,100,50,10/15/2018
CE2791,conference-call,100,50,10/15/2018
CFF97C,acquisition-completed-acquirer,100,49,10/15/2018
D06996,earnings,100,50,10/15/2018
D29B44,earnings,100,50,10/15/2018
D33D8C,earnings-up,100,68,10/15/2018
D33D8C,earnings-up,100,68,10/15/2018
D33D8C,earnings-up,100,68,10/15/2018
D33D8C,earnings-up,100,68,10/15/2018
D33D8C,earnings-up,100,68,10/15/2018
D33D8C,earnings-up,100,68,10/15/2018
D3C794,earnings,100,50,10/15/2018
D57D99,earnings,100,50,10/15/2018
D6489C,partnership,100,61,10/15/2018
D64EDF,earnings,100,50,10/15/2018
D8442A,partnership,100,61,10/15/2018
D8DA3D,revenues,100,50,10/15/2018
DB5CA5,facility-open,100,65,10/15/2018
DF01B1,earnings,100,50,10/15/2018
DF01B1,earnings,100,50,10/15/2018
E09556,earnings,100,50,10/15/2018
E21871,executive-appointment,100,54,10/15/2018
E30B34,award,100,58,10/15/2018
E90C84,conference-call,100,50,10/15/2018
E96E0B,earnings,100,50,10/15/2018
EA62FC,conference-call,100,50,10/15/2018
EB6965,conference-call,100,50,10/15/2018
EE6F1C,partnership,100,61,10/15/2018
EF25A5,executive-appointment,100,54,10/15/2018
F179ED,acquisition-acquirer,100,49,10/15/2018
F179ED,acquisition-acquirer,100,49,10/15/2018
F30508,dividend,100,50,10/15/2018
F30508,dividend,100,50,10/15/2018
F5349B,executive-appointment,100,54,10/15/2018
F5D499,trading-resumed,100,58,10/15/2018
F5D499,conference-call,100,50,10/15/2018
F702CA,dividend,100,50,10/15/2018
F8BA6C,executive-appointment,100,54,10/15/2018
F93C8A,dividend,100,50,10/15/2018
F9AA02,merger-completed,100,66,10/15/2018
F9CAF8,earnings-guidance,100,50,10/15/2018
003B70,executive-appointment,100,54,10/16/2018
0157B1,investment-investor,100,55,10/16/2018
0157B1,product-release,100,64,10/16/2018
04996E,earnings,100,50,10/16/2018
04EB2F,earnings,100,50,10/16/2018
06A456,market-entry,100,57,10/16/2018
07C907,earnings,100,50,10/16/2018
07C907,earnings,100,50,10/16/2018
07CA6A,dividend-up,100,81,10/16/2018
09062E,conference-call,100,50,10/16/2018
0919B1,conference-call,100,50,10/16/2018
0A7650,earnings,100,50,10/16/2018
0B57D7,earnings,100,50,10/16/2018
0C4131,conference-call,100,50,10/16/2018
0C466B,earnings,100,50,10/16/2018
0C466B,earnings,100,50,10/16/2018
0F65C9,conference-call,100,50,10/16/2018
1065BC,conference-call,100,50,10/16/2018
108A2B,conference-call,100,50,10/16/2018
168A5D,facility-open,100,65,10/16/2018
1921DD,partnership,100,61,10/16/2018
1CD09C,partnership,100,61,10/16/2018
1E9A6D,dividend,100,50,10/16/2018
1EBF8D,partnership,100,61,10/16/2018
205AD5,earnings,100,50,10/16/2018
205AD5,earnings,100,50,10/16/2018
205AD5,earnings,100,50,10/16/2018
205AD5,earnings,100,50,10/16/2018
205AD5,donation,100,54,10/16/2018
21153F,partnership,100,61,10/16/2018
2158DF,earnings,100,50,10/16/2018
21F9CA,earnings,100,50,10/16/2018
221783,acquisition-completed-acquirer,100,49,10/16/2018
228D42,partnership,100,61,10/16/2018
24D81E,earnings,100,50,10/16/2018
2571FA,business-contract,100,69,10/16/2018
26D8ED,conference-call,100,50,10/16/2018
282C18,facility-sale,100,52,10/16/2018
2B7A40,earnings,100,50,10/16/2018
2C19A4,conference-call,100,50,10/16/2018
2F960F,conference-call,100,50,10/16/2018
3.14E+47,earnings-positive,100,69,10/16/2018
3.14E+47,earnings,100,50,10/16/2018
3.14E+47,earnings,100,50,10/16/2018
3.14E+47,earnings,100,50,10/16/2018
3.14E+47,earnings,100,50,10/16/2018
3.14E+47,earnings,100,50,10/16/2018
3.14E+47,earnings,100,50,10/16/2018
3.14E+47,earnings,100,50,10/16/2018
3.20E+263,clinical-trials,100,56,10/16/2018
3471C0,partnership,100,61,10/16/2018
373B06,earnings,100,50,10/16/2018
3A3948,product-release,100,64,10/16/2018
3A3948,product-release,100,64,10/16/2018
3A3948,earnings,100,50,10/16/2018
3B318A,legal-issues-defendant,100,22,10/16/2018
3BB616,earnings,100,50,10/16/2018
3BC360,conference-call,100,50,10/16/2018
3C7F5F,legal-issues-defendant,100,22,10/16/2018
3CCC90,executive-appointment,100,54,10/16/2018
3CCC90,dividend,100,50,10/16/2018
3DCECC,acquisition-completed-acquirer,100,49,10/16/2018
408380,earnings,100,50,10/16/2018
41B53E,earnings,100,50,10/16/2018
41EC04,conference-call,100,50,10/16/2018
422CE3,facility-upgrade,100,65,10/16/2018
43E8F5,conference-call,100,50,10/16/2018
448215,earnings,100,50,10/16/2018
448BF3,executive-appointment,100,54,10/16/2018
44ED36,earnings,100,50,10/16/2018
46A16E,conference-call,100,50,10/16/2018
490D4B,conference-call,100,50,10/16/2018
49BBBC,executive-appointment,100,54,10/16/2018
4A3438,conference-call,100,50,10/16/2018
4A6F00,partnership,100,61,10/16/2018
4EE14A,earnings,100,50,10/16/2018
4EE14A,earnings,100,50,10/16/2018
4F9487,merger,100,66,10/16/2018
514067,conference-call,100,50,10/16/2018
51527B,conference-call,100,50,10/16/2018
545272,conference-call,100,50,10/16/2018
553949,hirings,100,65,10/16/2018
55438C,partnership,100,61,10/16/2018
56765E,earnings,100,50,10/16/2018
5704AC,earnings,100,50,10/16/2018
57B174,conference-call,100,50,10/16/2018
57CAAB,earnings,100,50,10/16/2018
57F3DA,earnings,100,50,10/16/2018
586FFD,conference-call,100,50,10/16/2018
589F5A,dividend,100,50,10/16/2018
594402,business-contract,100,69,10/16/2018
594402,business-contract,100,69,10/16/2018
59C539,dividend-up,100,81,10/16/2018
5B3415,earnings,100,50,10/16/2018
5B7739,conference-call,100,50,10/16/2018
5CCDAD,earnings,100,50,10/16/2018
5FF95F,earnings,100,50,10/16/2018
5FF95F,earnings,100,50,10/16/2018
5FF95F,earnings,100,50,10/16/2018
5FF95F,earnings,100,50,10/16/2018
5FF95F,earnings,100,50,10/16/2018
60FE03,executive-appointment,100,54,10/16/2018
60FE03,executive-appointment,100,54,10/16/2018
636BBF,partnership,100,61,10/16/2018
67B923,conference-call,100,50,10/16/2018
6A01DF,earnings,100,50,10/16/2018
6BC6F9,earnings,100,50,10/16/2018
6D3B7B,earnings,100,50,10/16/2018
6E8864,conference-call,100,50,10/16/2018
6EB9DA,earnings,100,50,10/16/2018
6EB9DA,earnings,100,50,10/16/2018
6EB9DA,earnings,100,50,10/16/2018
6EB9DA,legal-issues-defendant,100,22,10/16/2018
70FCEF,executive-appointment,100,54,10/16/2018
7255D2,revenue-guidance-up,100,83,10/16/2018
726EEA,dividend,100,50,10/16/2018
72FCA3,award,100,58,10/16/2018
747219,conference-participant,100,50,10/16/2018
771985,unit-acquisition-acquirer,100,49,10/16/2018
7D35D8,earnings-guidance,100,50,10/16/2018
7F3669,partnership,100,61,10/16/2018
82F088,note-sale,100,52,10/16/2018
850779,earnings-per-share-positive,100,69,10/16/2018
850779,earnings-per-share,100,50,10/16/2018
850779,earnings-per-share,100,50,10/16/2018
850779,earnings-per-share,100,50,10/16/2018
860AB6,conference-call,100,50,10/16/2018
8C5519,earnings,100,50,10/16/2018
8C5519,earnings,100,50,10/16/2018
8C5519,earnings,100,50,10/16/2018
8C5519,earnings,100,50,10/16/2018
8C5519,earnings,100,50,10/16/2018
8C5519,earnings,100,50,10/16/2018
8CF6DD,earnings,100,50,10/16/2018
8D4486,earnings,100,50,10/16/2018
8D4486,earnings,100,50,10/16/2018
8D4486,earnings,100,50,10/16/2018
8D4486,earnings,100,50,10/16/2018
8D9993,conference-call,100,50,10/16/2018
8DDA23,dividend,100,50,10/16/2018
8FF2EF,earnings,100,50,10/16/2018
92B625,business-contract,100,69,10/16/2018
92B625,business-contract,100,69,10/16/2018
92D6A5,dividend,100,50,10/16/2018
92D9C9,earnings-guidance,100,50,10/16/2018
945DE6,dividend,100,50,10/16/2018
94983E,stake-acquirer,100,48,10/16/2018
95DC1F,revenue-up,100,69,10/16/2018
968B00,earnings,100,50,10/16/2018
96F126,earnings,100,50,10/16/2018
97AAF6,earnings,100,50,10/16/2018
9810C0,product-release,100,64,10/16/2018
9.92E+94,earnings,100,50,10/16/2018
9CA4C6,dividend,100,50,10/16/2018
9CA4C6,earnings-up,100,68,10/16/2018
9D2790,donation,100,54,10/16/2018
9E0811,earnings,100,50,10/16/2018
A2CA3F,earnings,100,50,10/16/2018
A2CA3F,buybacks,100,74,10/16/2018
A4D173,conference-call,100,50,10/16/2018
A4D173,conference-call,100,50,10/16/2018
A5A4F5,acquisition-acquirer,100,49,10/16/2018
A6828A,earnings,100,50,10/16/2018
A6828A,partnership,100,61,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
A746F6,earnings-per-share-positive,100,69,10/16/2018
AA09AD,earnings,100,50,10/16/2018
AA98ED,legal-issues-defendant,100,22,10/16/2018
ACC7D3,earnings,100,50,10/16/2018
AEF2C3,conference-call,100,50,10/16/2018
AFD1CA,conference-call,100,50,10/16/2018
AFF43F,earnings,100,50,10/16/2018
AFF43F,dividend,100,50,10/16/2018
AFF7B4,board-meeting,100,51,10/16/2018
B0FE08,conference-call,100,50,10/16/2018
B13B68,business-contract,100,69,10/16/2018
B2206F,product-release,100,64,10/16/2018
B80AD1,regulatory-product-application,100,69,10/16/2018
B80AD1,regulatory-product-application,100,69,10/16/2018
B96DF5,earnings,100,50,10/16/2018
B9764A,earnings,100,50,10/16/2018
BDEC1E,executive-appointment,100,54,10/16/2018
BFCACF,conference-call,100,50,10/16/2018
BFD0A7,facility-open,100,65,10/16/2018
C0BA36,conference-call,100,50,10/16/2018
C15F8F,conference-participant,100,50,10/16/2018
C188F8,legal-issues-defendant,100,22,10/16/2018
C356AC,executive-appointment,100,54,10/16/2018
C3BAE7,acquisition-completed-acquirer,100,49,10/16/2018
C45CE7,earnings,100,50,10/16/2018
C4706C,dividend,100,50,10/16/2018
C5C137,executive-appointment,100,54,10/16/2018
C7FC95,partnership,100,61,10/16/2018
C8257F,earnings,100,50,10/16/2018
C8A059,earnings,100,50,10/16/2018
C8A248,product-release,100,64,10/16/2018
C97B2D,acquisition-completed-acquirer,100,49,10/16/2018
C99CC8,award,100,58,10/16/2018
CBFFDD,partnership,100,61,10/16/2018
CBFFDD,partnership,100,61,10/16/2018
CD06A2,earnings,100,50,10/16/2018
CD06A2,earnings,100,50,10/16/2018
CD2A4D,conference-participant,100,50,10/16/2018
CF351E,earnings,100,50,10/16/2018
D1AE3B,dividend,100,50,10/16/2018
D29F43,conference-call,100,50,10/16/2018
D3DE34,executive-appointment,100,54,10/16/2018
D5AF19,earnings,100,50,10/16/2018
D6EAA3,product-release,100,64,10/16/2018
D8442A,executive-appointment,100,54,10/16/2018
DBB28E,partnership,100,61,10/16/2018
DC1405,earnings,100,50,10/16/2018
DC6AA0,earnings,100,50,10/16/2018
DDB002,conference-call,100,50,10/16/2018
DF46C5,partnership,100,61,10/16/2018
DF532D,earnings,100,50,10/16/2018
DF532D,earnings,100,50,10/16/2018
E06265,executive-appointment,100,54,10/16/2018
E074A0,earnings,100,50,10/16/2018
E26FC3,donation,100,54,10/16/2018
E26FC3,earnings-up,100,68,10/16/2018
E6A53A,earnings,100,50,10/16/2018
EB36DE,conference-call,100,50,10/16/2018
ECD263,earnings,100,50,10/16/2018
ED0D7C,dividend,100,50,10/16/2018
EEA734,clinical-trials,100,56,10/16/2018
EEA734,clinical-trials,100,56,10/16/2018
F0EEFB,operating-earnings,100,50,10/16/2018
F3016C,earnings,100,50,10/16/2018
F30508,executive-appointment,100,54,10/16/2018
F3EDB4,business-contract,100,69,10/16/2018
F51DB0,conference-call,100,50,10/16/2018
F7935D,clinical-trials,100,56,10/16/2018
FC1A6E,legal-issues-defendant,100,22,10/16/2018
FD39EB,reorganization,100,53,10/16/2018
FD6926,business-contract,100,69,10/16/2018
FEC475,facility-open,100,65,10/16/2018
FF6644,partnership,100,61,10/16/2018
01D03F,partnership,100,61,10/17/2018
20751,fast-track-designation,100,81,10/17/2018
20751,orphan-drug-designation,100,76,10/17/2018
03F5A4,earnings-positive,100,69,10/17/2018
0B4D10,earnings,100,50,10/17/2018
0BD4E8,conference-call,100,50,10/17/2018
0CC01F,earnings,100,50,10/17/2018
0CC62B,award,100,58,10/17/2018
10100E,ipo-pricing,100,50,10/17/2018
1220D2,earnings,100,50,10/17/2018
12E454,stock-gain,100,63,10/17/2018
149301,earnings,100,50,10/17/2018
14BA06,conference-participant,100,50,10/17/2018
1748B3,earnings,100,50,10/17/2018
1748B3,earnings,100,50,10/17/2018
1748B3,earnings,100,50,10/17/2018
1748B3,earnings,100,50,10/17/2018
1748B3,earnings,100,50,10/17/2018
1748B3,earnings,100,50,10/17/2018
1.79E+10,conference-call,100,50,10/17/2018
19CAC7,earnings,100,50,10/17/2018
19CAC7,earnings,100,50,10/17/2018
1A2D9F,earnings,100,50,10/17/2018
1A9DE1,earnings-up,100,68,10/17/2018
1A9DE1,earnings-up,100,68,10/17/2018
1A9DE1,earnings-up,100,68,10/17/2018
1AB808,earnings,100,50,10/17/2018
1D1B07,executive-appointment,100,54,10/17/2018
1D1B07,executive-appointment,100,54,10/17/2018
1D5C51,conference-call,100,50,10/17/2018
1DA44F,dividend-up,100,81,10/17/2018
1DE526,conference-call,100,50,10/17/2018
1DEBBE,earnings,100,50,10/17/2018
1EBF8D,executive-appointment,100,54,10/17/2018
1FA8F7,earnings-positive,100,69,10/17/2018
20BEEA,executive-appointment,100,54,10/17/2018
20BEEA,earnings-up,100,68,10/17/2018
20BEEA,earnings,100,50,10/17/2018
20BEEA,earnings,100,50,10/17/2018
221445,conference-call,100,50,10/17/2018
22C58E,product-release,100,64,10/17/2018
239106,conference-call,100,50,10/17/2018
2.45E+15,earnings,100,50,10/17/2018
25AB8E,partnership,100,61,10/17/2018
25AB8E,partnership,100,61,10/17/2018
26F99F,ipo-pricing,100,50,10/17/2018
272704,earnings-up,100,68,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
272704,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
275300,earnings,100,50,10/17/2018
28AF37,earnings,100,50,10/17/2018
292A70,earnings-up,100,68,10/17/2018
2C3348,legal-issues-defendant,100,22,10/17/2018
2C3348,legal-issues-defendant,100,22,10/17/2018
2CA60F,earnings,100,50,10/17/2018
2DB344,earnings,100,50,10/17/2018
2F6782,note-sale,100,52,10/17/2018
31A7CC,earnings-up,100,68,10/17/2018
31AA84,earnings,100,50,10/17/2018
32CB22,earnings,100,50,10/17/2018
3.30E+34,earnings-up,100,68,10/17/2018
3.30E+34,earnings-up,100,68,10/17/2018
3.30E+34,earnings-up,100,68,10/17/2018
3461CF,executive-appointment,100,54,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
34B411,earnings,100,50,10/17/2018
370C50,dividend,100,50,10/17/2018
387541,earnings,100,50,10/17/2018
3A3447,earnings,100,50,10/17/2018
3BE00F,earnings,100,50,10/17/2018
3CBA2A,conference-call,100,50,10/17/2018
3CCC90,earnings,100,50,10/17/2018
3DCECC,conference-call,100,50,10/17/2018
3F96D5,acquisition-completed-acquirer,100,49,10/17/2018
3F96D5,acquisition-completed-acquirer,100,49,10/17/2018
408089,dividend,100,50,10/17/2018
416291,dividend,100,50,10/17/2018
41A93D,earnings,100,50,10/17/2018
435ACE,earnings,100,50,10/17/2018
4455C4,earnings-guidance-up,100,83,10/17/2018
447FC6,conference-call,100,50,10/17/2018
467F2C,conference-participant,100,50,10/17/2018
494EB9,dividend,100,50,10/17/2018
49CC59,executive-resignation,100,44,10/17/2018
4A6F00,stock-gain,100,63,10/17/2018
4B3676,earnings,100,50,10/17/2018
4BBA23,conference-call,100,50,10/17/2018
4D72C8,conference-call,100,50,10/17/2018
4DD09F,executive-appointment,100,54,10/17/2018
4E913D,product-release,100,64,10/17/2018
4EE14A,business-contract,100,69,10/17/2018
4EE14A,business-contract,100,69,10/17/2018
4EEB00,merger,100,66,10/17/2018
4F9926,product-release,100,64,10/17/2018
51888A,dividend,100,50,10/17/2018
51888A,revenues,100,50,10/17/2018
51B442,earnings,100,50,10/17/2018
520632,earnings,100,50,10/17/2018
520632,earnings,100,50,10/17/2018
520632,earnings,100,50,10/17/2018
520632,earnings,100,50,10/17/2018
520632,earnings,100,50,10/17/2018
520632,earnings,100,50,10/17/2018
53F491,earnings-per-share-positive,100,69,10/17/2018
5480A7,earnings-up,100,68,10/17/2018
5480A7,earnings-up,100,68,10/17/2018
5480A7,earnings-up,100,68,10/17/2018
5480A7,earnings-up,100,68,10/17/2018
56AFF4,operating-earnings,100,50,10/17/2018
5BE42C,dividend,100,50,10/17/2018
5F60CE,earnings,100,50,10/17/2018
5F6D73,earnings,100,50,10/17/2018
5F6D73,earnings,100,50,10/17/2018
5F6D73,earnings,100,50,10/17/2018
5F6D73,earnings,100,50,10/17/2018
5F6D73,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
6166D1,earnings,100,50,10/17/2018
619882,conference-organizer,100,57,10/17/2018
61BCA7,partnership,100,61,10/17/2018
622DBE,conference-call,100,50,10/17/2018
639BD6,conference-participant,100,50,10/17/2018
68E3E0,asset-sale,100,62,10/17/2018
693ECD,earnings,100,50,10/17/2018
69C99E,orphan-drug-designation,100,76,10/17/2018
6A961B,conference-call,100,50,10/17/2018
6BC6F9,executive-appointment,100,54,10/17/2018
6D3F35,partnership,100,61,10/17/2018
70FCEF,executive-appointment,100,54,10/17/2018
7273FF,acquisition-acquirer,100,49,10/17/2018
762B8D,earnings,100,50,10/17/2018
775439,earnings,100,50,10/17/2018
7A5D58,dividend,100,50,10/17/2018
7A975D,earnings,100,50,10/17/2018
7A975D,earnings,100,50,10/17/2018
7A975D,earnings,100,50,10/17/2018
7BC92D,executive-appointment,100,54,10/17/2018
7C62A3,conference-call,100,50,10/17/2018
7DD8CC,conference-call,100,50,10/17/2018
7E1D5D,business-contract,100,69,10/17/2018
8275FE,earnings,100,50,10/17/2018
84A6B9,earnings-up,100,77,10/17/2018
8D4486,earnings,100,50,10/17/2018
8D4486,partnership,100,61,10/17/2018
8D4486,partnership,100,61,10/17/2018
905356,conference-call,100,50,10/17/2018
92B047,earnings,100,50,10/17/2018
93633B,earnings,100,50,10/17/2018
93633B,earnings,100,50,10/17/2018
93633B,earnings,100,50,10/17/2018
93633B,earnings,100,50,10/17/2018
93D207,partnership,100,61,10/17/2018
93D207,dividend-up,100,81,10/17/2018
942165,earnings,100,50,10/17/2018
950CDB,dividend,100,50,10/17/2018
957A07,business-contract,100,69,10/17/2018
95F59E,earnings,100,50,10/17/2018
9.62E+76,earnings,100,50,10/17/2018
9.62E+76,earnings,100,50,10/17/2018
9.62E+76,earnings,100,50,10/17/2018
9.65E+09,conference-call,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
965360,earnings,100,50,10/17/2018
966DBE,earnings,100,50,10/17/2018
97644E,earnings,100,50,10/17/2018
986AF6,conference-call,100,50,10/17/2018
990AD0,dividend,100,50,10/17/2018
990AD0,conference-organizer,100,57,10/17/2018
9A2760,acquisition-acquirer,100,49,10/17/2018
9E98F2,earnings,100,50,10/17/2018
9E98F2,earnings,100,50,10/17/2018
9E98F2,earnings,100,50,10/17/2018
9F03CF,unit-acquisition-completed-acquirer,100,49,10/17/2018
9F048E,product-release,100,64,10/17/2018
A398F8,earnings,100,50,10/17/2018
A41450,earnings,100,50,10/17/2018
A5A4F5,acquisition-acquirer,100,49,10/17/2018
A631A3,product-release,100,64,10/17/2018
A666C8,earnings,100,50,10/17/2018
A79F7D,conference-participant,100,50,10/17/2018
A8AC4C,earnings,100,50,10/17/2018
A9ED24,dividend,100,50,10/17/2018
AA5C8E,dividend,100,50,10/17/2018
AA5C8E,dividend,100,50,10/17/2018
AA5C8E,dividend,100,50,10/17/2018
AA5C8E,dividend,100,50,10/17/2018
AA5C8E,dividend,100,50,10/17/2018
AA5C8E,dividend,100,50,10/17/2018
AA5C8E,dividend,100,50,10/17/2018
AABEA0,dividend,100,50,10/17/2018
AAEE21,conference-call,100,50,10/17/2018
AD3C93,earnings,100,50,10/17/2018
ADF1B0,conference-call,100,50,10/17/2018
AE3113,earnings,100,50,10/17/2018
AE4125,conference-call,100,50,10/17/2018
B09B1F,conference-call,100,50,10/17/2018
B3ED62,conference-call,100,50,10/17/2018
B53C12,conference-call,100,50,10/17/2018
B7202A,conference-call,100,50,10/17/2018
B7FA9B,conference-call,100,50,10/17/2018
B840EF,partnership,100,61,10/17/2018
B8DD94,executive-appointment,100,54,10/17/2018
BB88B6,investment-investor,100,55,10/17/2018
BD682F,dividend,100,50,10/17/2018
BDD12C,earnings,100,50,10/17/2018
BDEC1E,clinical-trials,100,56,10/17/2018
BE5935,earnings-revision,100,29,10/17/2018
C037A8,conference-call,100,50,10/17/2018
C32A39,dividend,100,50,10/17/2018
C62AA4,conference-call,100,50,10/17/2018
C9F39B,earnings,100,50,10/17/2018
C9F39B,earnings,100,50,10/17/2018
C9F39B,earnings,100,50,10/17/2018
C9F39B,earnings,100,50,10/17/2018
C9F39B,earnings,100,50,10/17/2018
C9F39B,earnings,100,50,10/17/2018
C9F39B,earnings,100,50,10/17/2018
CB7AB2,partnership,100,61,10/17/2018
CBBFBF,earnings,100,50,10/17/2018
CBFFDD,partnership,100,61,10/17/2018
CBFFDD,partnership,100,61,10/17/2018
CFD4B6,conference-call,100,50,10/17/2018
D139BC,conference-call,100,50,10/17/2018
D17F7E,dividend,100,50,10/17/2018
D1AE3B,earnings,100,50,10/17/2018
D1C26F,conference-participant,100,50,10/17/2018
D27FAB,conference-call,100,50,10/17/2018
D56D6D,acquisition-acquirer,100,49,10/17/2018
D93A25,earnings,100,50,10/17/2018
DA90E1,dividend,100,50,10/17/2018
DC0D18,earnings,100,50,10/17/2018
DF18E6,executive-appointment,100,54,10/17/2018
E114F4,conference-call,100,50,10/17/2018
E19A99,earnings,100,50,10/17/2018
E28D9C,conference-call,100,50,10/17/2018
E802CE,conference-call,100,50,10/17/2018
E8846E,donation,100,54,10/17/2018
E9C7C0,earnings,100,50,10/17/2018
E9E6FD,executive-appointment,100,54,10/17/2018
EAEBF3,dividend,100,50,10/17/2018
EBD89A,conference-call,100,50,10/17/2018
F1C04C,conference-call,100,50,10/17/2018
F32F88,conference-call,100,50,10/17/2018
F48947,earnings,100,50,10/17/2018
F51DB0,legal-issues-defendant,100,22,10/17/2018
F5349B,partnership,100,61,10/17/2018
FAEABE,earnings-up,100,68,10/17/2018
FAEABE,earnings-up,100,68,10/17/2018
FAEABE,earnings-up,100,68,10/17/2018
FD39EB,dividend,100,50,10/17/2018
FD39EB,earnings,100,50,10/17/2018
FDF799,earnings,100,50,10/17/2018
FFAB4A,earnings,100,50,10/17/2018
FFE543,legal-issues-defendant,100,22,10/17/2018
FFE543,legal-issues-defendant,100,22,10/17/2018
03CF95,partnership,100,61,10/18/2018
03CF95,earnings,100,50,10/18/2018
03CF95,earnings,100,50,10/18/2018
03CF95,earnings,100,50,10/18/2018
03CF95,earnings,100,50,10/18/2018
03CF95,earnings,100,50,10/18/2018
03CF95,earnings,100,50,10/18/2018
43862,conference-call,100,50,10/18/2018
083F72,dividend-up,100,81,10/18/2018
95294,earnings,100,50,10/18/2018
099A02,earnings,100,50,10/18/2018
099A02,earnings,100,50,10/18/2018
099C88,business-contract,100,69,10/18/2018
099C88,conference-call,100,50,10/18/2018
0BC17A,dividend,100,50,10/18/2018
0BC17A,earnings,100,50,10/18/2018
0C355F,conference-call,100,50,10/18/2018
0C6861,legal-issues-defendant,100,22,10/18/2018
0C8D82,earnings,100,50,10/18/2018
105D00,earnings,100,50,10/18/2018
105D00,earnings,100,50,10/18/2018
105D00,earnings,100,50,10/18/2018
105D00,earnings,100,50,10/18/2018
105D00,earnings,100,50,10/18/2018
105D00,earnings,100,50,10/18/2018
105D00,earnings,100,50,10/18/2018
10C19B,earnings,100,50,10/18/2018
10C19B,earnings,100,50,10/18/2018
10C19B,earnings,100,50,10/18/2018
10C19B,earnings,100,50,10/18/2018
10C19B,earnings,100,50,10/18/2018
10C19B,earnings,100,50,10/18/2018
10C19B,earnings,100,50,10/18/2018
1748F6,merger-regulatory-approval,100,81,10/18/2018
184866,earnings,100,50,10/18/2018
18EC17,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A3E1B,earnings,100,50,10/18/2018
1A6A94,dividend,100,50,10/18/2018
1AC649,clinical-trials,100,56,10/18/2018
1CD09C,conference-call,100,50,10/18/2018
1DB6A6,earnings,100,50,10/18/2018
1E04A5,earnings,100,50,10/18/2018
1EC3E8,executive-appointment,100,54,10/18/2018
1F3CFB,earnings,100,50,10/18/2018
1F3CFB,executive-appointment,100,54,10/18/2018
2096DE,earnings,100,50,10/18/2018
20BEEA,conference-call,100,50,10/18/2018
214051,earnings,100,50,10/18/2018
219B21,conference-call,100,50,10/18/2018
225CA2,dividend,100,50,10/18/2018
228D42,partnership,100,61,10/18/2018
24A89A,executive-appointment,100,54,10/18/2018
24A89A,executive-appointment,100,54,10/18/2018
24CB56,earnings-positive,100,69,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
24CB56,earnings,100,50,10/18/2018
26CC63,dividend,100,50,10/18/2018
275300,dividend,100,50,10/18/2018
295F9F,conference-call,100,50,10/18/2018
2C35B5,conference-participant,100,50,10/18/2018
2DC88B,earnings,100,50,10/18/2018
2EB88B,earnings,100,50,10/18/2018
2F1299,partnership,100,61,10/18/2018
2F6782,conference-call,100,50,10/18/2018
2F7474,earnings,100,50,10/18/2018
301493,legal-issues-defendant,100,22,10/18/2018
31553A,earnings,100,50,10/18/2018
31666F,earnings,100,50,10/18/2018
31AA84,award,100,58,10/18/2018
31DB20,earnings,100,50,10/18/2018
32F943,earnings,100,50,10/18/2018
339F20,earnings,100,50,10/18/2018
3.30E+34,dividend,100,50,10/18/2018
342218,dividend-up,100,81,10/18/2018
343996,dividend,100,50,10/18/2018
343996,dividend,100,50,10/18/2018
35AE32,earnings,100,50,10/18/2018
370C50,supply-guidance-increase,100,74,10/18/2018
370C50,earnings,100,50,10/18/2018
372037,conference-call,100,50,10/18/2018
384CD3,credit-extension-recipient,100,69,10/18/2018
39BFF6,dividend,100,50,10/18/2018
39FB23,earnings,100,50,10/18/2018
39FB23,earnings,100,50,10/18/2018
39FB23,earnings,100,50,10/18/2018
39FB23,acquisition-acquirer,100,49,10/18/2018
39FB23,dividend,100,50,10/18/2018
3B318A,executive-appointment,100,54,10/18/2018
3C3B6B,earnings,100,50,10/18/2018
3C6CCC,earnings,100,50,10/18/2018
3C7F5F,executive-appointment,100,54,10/18/2018
3C8A04,earnings,100,50,10/18/2018
3ED92D,conference-call,100,50,10/18/2018
425BDC,force-majeure,100,25,10/18/2018
442769,conference-call,100,50,10/18/2018
4455C4,conference-call,100,50,10/18/2018
44740A,conference-call,100,50,10/18/2018
449A26,earnings-positive,100,69,10/18/2018
449A26,dividend,100,50,10/18/2018
451D61,conference-call,100,50,10/18/2018
453282,earnings-per-share-positive,100,69,10/18/2018
45BC35,acquisition-acquirer,100,49,10/18/2018
47FCF2,earnings,100,50,10/18/2018
487B7A,dividend,100,50,10/18/2018
49BBBC,acquisition-interest-acquirer,100,46,10/18/2018
4A6F00,partnership,100,61,10/18/2018
4C37C5,partnership,100,61,10/18/2018
4C37C5,earnings-per-share-positive,100,69,10/18/2018
4C37C5,earnings-per-share,100,50,10/18/2018
4C37C5,earnings-per-share,100,50,10/18/2018
4C5CC9,conference-call,100,50,10/18/2018
4D203E,earnings-up,100,68,10/18/2018
4EEE7E,earnings,100,50,10/18/2018
510EA1,earnings,100,50,10/18/2018
51888A,executive-appointment,100,54,10/18/2018
5225A4,earnings,100,50,10/18/2018
5225A4,earnings,100,50,10/18/2018
5225A4,earnings,100,50,10/18/2018
5225A4,earnings,100,50,10/18/2018
5225A4,earnings,100,50,10/18/2018
539F49,ipo-pricing,100,50,10/18/2018
548AC0,revenues,100,50,10/18/2018
56632F,earnings,100,50,10/18/2018
57DDB9,partnership,100,61,10/18/2018
5876DC,dividend,100,50,10/18/2018
58CA9A,dividend,100,50,10/18/2018
59C539,earnings,100,50,10/18/2018
5BC2F4,dividend,100,50,10/18/2018
5BFE94,dividend-up,100,81,10/18/2018
5DE5A5,earnings-up,100,68,10/18/2018
5DE5A5,earnings,100,50,10/18/2018
5DE5A5,earnings,100,50,10/18/2018
5EAA43,conference-call,100,50,10/18/2018
601785,dividend,100,50,10/18/2018
6.18E+08,earnings,100,50,10/18/2018
619882,conference-organizer,100,57,10/18/2018
622037,earnings,100,50,10/18/2018
62B1C6,dividend,100,50,10/18/2018
62B20A,earnings,100,50,10/18/2018
636639,earnings,100,50,10/18/2018
636639,earnings,100,50,10/18/2018
636639,earnings,100,50,10/18/2018
636931,earnings,100,50,10/18/2018
641F17,merger,100,66,10/18/2018
6474BA,earnings-positive,100,69,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
6474BA,earnings,100,50,10/18/2018
665D7D,partnership,100,61,10/18/2018
665D7D,legal-issues-defendant,100,22,10/18/2018
6844D2,acquisition-acquirer,100,49,10/18/2018
68B03F,executive-appointment,100,54,10/18/2018
68B03F,executive-appointment,100,54,10/18/2018
68B03F,executive-appointment,100,54,10/18/2018
6C987C,earnings-up,100,79,10/18/2018
6.00E+19,conference-call,100,50,10/18/2018
6E8349,earnings,100,50,10/18/2018
701531,earnings,100,50,10/18/2018
70CA28,public-offering,100,43,10/18/2018
713810,partnership,100,61,10/18/2018
7273FF,earnings,100,50,10/18/2018
73BCBA,conference-call,100,50,10/18/2018
73C521,dividend,100,50,10/18/2018
7.40E+289,dividend-up,100,59,10/18/2018
7520CC,earnings,100,50,10/18/2018
762A3E,conference-call,100,50,10/18/2018
766047,dividend,100,50,10/18/2018
76F067,stake-acquirer,100,48,10/18/2018
7710F3,earnings,100,50,10/18/2018
7AB859,drilling,100,68,10/18/2018
7AB859,drilling,100,68,10/18/2018
7AB859,drilling,100,68,10/18/2018
7BAAE7,dividend,100,50,10/18/2018
7F0372,earnings,100,50,10/18/2018
8.10E+32,executive-appointment,100,54,10/18/2018
82F088,note-sale,100,52,10/18/2018
83A065,conference-call,100,50,10/18/2018
845655,conference-call,100,50,10/18/2018
855DF7,dividend,100,50,10/18/2018
85CDC9,earnings,100,50,10/18/2018
87B81A,earnings,100,50,10/18/2018
893904,earnings,100,50,10/18/2018
89B2E7,earnings,100,50,10/18/2018
8A0368,conference-call,100,50,10/18/2018
8D4486,partnership,100,61,10/18/2018
8D4486,business-contract,100,69,10/18/2018
8DDA23,earnings-positive,100,69,10/18/2018
8FF2EF,note-sale,100,52,10/18/2018
915E7B,credit-extension-provider,100,57,10/18/2018
92D6A5,earnings,100,50,10/18/2018
93D207,partnership,100,61,10/18/2018
94563D,earnings,100,50,10/18/2018
9470CC,earnings,100,50,10/18/2018
954A47,earnings-positive,100,69,10/18/2018
95C392,executive-appointment,100,54,10/18/2018
979451,earnings,100,50,10/18/2018
97AAF6,dividend,100,50,10/18/2018
986AF6,earnings,100,50,10/18/2018
986AF6,earnings,100,50,10/18/2018
986AF6,earnings,100,50,10/18/2018
989E2F,earnings,100,50,10/18/2018
989E2F,earnings,100,50,10/18/2018
989E2F,earnings,100,50,10/18/2018
98CEBB,earnings,100,50,10/18/2018
9AF3DC,partnership,100,61,10/18/2018
9B4066,unit-acquisition-acquirer,100,49,10/18/2018
9C5BA5,dividend,100,50,10/18/2018
9D5D35,conference-participant,100,50,10/18/2018
9E575E,earnings,100,50,10/18/2018
9F5CBB,conference-call,100,50,10/18/2018
9F6B1A,partnership,100,61,10/18/2018
9F6B1A,partnership,100,61,10/18/2018
A29A46,conference-call,100,50,10/18/2018
A4CD53,earnings,100,50,10/18/2018
A52533,earnings,100,50,10/18/2018
A5A4F5,acquisition-acquirer,100,49,10/18/2018
A60354,conference-call,100,50,10/18/2018
A6213D,partnership,100,61,10/18/2018
A63820,earnings,100,50,10/18/2018
A65325,index-listing,100,76,10/18/2018
A6828A,dividend,100,50,10/18/2018
A7F0A5,earnings,100,50,10/18/2018
A8CBDA,dividend,100,50,10/18/2018
AA247D,earnings,100,50,10/18/2018
AC7C4F,business-contract,100,69,10/18/2018
AD1ACF,market-entry,100,57,10/18/2018
AD22F2,acquisition-acquirer,100,49,10/18/2018
AD23DE,conference-call,100,50,10/18/2018
AD9F1D,award,100,58,10/18/2018
AFD7DD,conference-call,100,50,10/18/2018
B0998E,earnings,100,50,10/18/2018
B4F5F4,conference-call,100,50,10/18/2018
B5766D,earnings,100,50,10/18/2018
B5766D,earnings,100,50,10/18/2018
B5766D,earnings,100,50,10/18/2018
B5766D,earnings,100,50,10/18/2018
B5766D,earnings,100,50,10/18/2018
B5766D,earnings,100,50,10/18/2018
B5766D,earnings,100,50,10/18/2018
B5BA39,earnings,100,50,10/18/2018
B642E8,stake-acquirer,100,48,10/18/2018
B642E8,acquisition-acquiree,100,76,10/18/2018
B642E8,acquisition-acquiree,100,76,10/18/2018
B642E8,unit-acquisition-acquiree,100,76,10/18/2018
B8DD94,conference-call,100,50,10/18/2018
B8F71F,executive-appointment,100,54,10/18/2018
BB127B,award,100,58,10/18/2018
BB88B6,partnership,100,61,10/18/2018
BFEA04,conference-call,100,50,10/18/2018
C29715,earnings,100,50,10/18/2018
C29715,earnings,100,50,10/18/2018
C2F597,earnings,100,50,10/18/2018
C3EE99,index-listing,100,76,10/18/2018
C407A0,patent-awarded,100,72,10/18/2018
C407A0,patent-awarded,100,72,10/18/2018
C41C25,earnings,100,50,10/18/2018
C4A912,conference-call,100,50,10/18/2018
C72B8F,conference-call,100,50,10/18/2018
C9B932,earnings,100,50,10/18/2018
C9E107,dividend,100,50,10/18/2018
CA1620,earnings,100,50,10/18/2018
CA212F,dividend,100,50,10/18/2018
CBDB4D,clinical-trials,100,56,10/18/2018
CBDB4D,clinical-trials,100,56,10/18/2018
CE1002,dividend,100,50,10/18/2018
CEDFD5,clinical-trials,100,56,10/18/2018
CEDFD5,clinical-trials,100,56,10/18/2018
D0DE27,earnings,100,50,10/18/2018
D1C0B9,earnings,100,50,10/18/2018
D296C6,earnings,100,50,10/18/2018
D45285,conference-call,100,50,10/18/2018
D4AC65,conference-call,100,50,10/18/2018
D5A350,executive-appointment,100,54,10/18/2018
D650A7,earnings,100,50,10/18/2018
D721C6,earnings-up,100,68,10/18/2018
D75910,executive-resignation,100,44,10/18/2018
D78BF1,revenues,100,50,10/18/2018
D7AC6E,earnings,100,50,10/18/2018
D8C09D,earnings-guidance,100,50,10/18/2018
DA0A9E,dividend,100,50,10/18/2018
DD9E41,executive-appointment,100,54,10/18/2018
DDCB34,conference-call,100,50,10/18/2018
DE5611,conference-participant,100,50,10/18/2018
E0339F,earnings,100,50,10/18/2018
E0339F,earnings,100,50,10/18/2018
E0339F,earnings,100,50,10/18/2018
E0339F,earnings,100,50,10/18/2018
E0339F,earnings,100,50,10/18/2018
E124EB,earnings,100,50,10/18/2018
E124EB,earnings,100,50,10/18/2018
E124EB,earnings,100,50,10/18/2018
E15736,conference-call,100,50,10/18/2018
E15736,conference-call,100,50,10/18/2018
E2CFD2,conference-call,100,50,10/18/2018
E2F130,earnings,100,50,10/18/2018
E2F66E,earnings-guidance,100,50,10/18/2018
E393B0,earnings-up,100,81,10/18/2018
E49AA3,earnings,100,50,10/18/2018
E4CE73,partnership,100,61,10/18/2018
E6EDED,earnings,100,50,10/18/2018
E84500,dividend,100,50,10/18/2018
E8B315,earnings-positive,100,69,10/18/2018
E94704,earnings,100,50,10/18/2018
E94704,earnings,100,50,10/18/2018
E94704,earnings,100,50,10/18/2018
E94704,earnings,100,50,10/18/2018
E94704,earnings,100,50,10/18/2018
E94704,earnings,100,50,10/18/2018
EAA0A7,earnings,100,50,10/18/2018
EAEBF3,earnings,100,50,10/18/2018
EB2F14,earnings,100,50,10/18/2018
EB5E78,conference-call,100,50,10/18/2018
ECD263,partnership,100,61,10/18/2018
ED9C04,partnership,100,61,10/18/2018
EEA6B3,executive-appointment,100,54,10/18/2018
EEA6B3,dividend,100,50,10/18/2018
EF1AD9,dividend,100,50,10/18/2018
EF1AD9,earnings,100,50,10/18/2018
EF1AD9,earnings,100,50,10/18/2018
EF1AD9,earnings,100,50,10/18/2018
EF25A5,partnership,100,61,10/18/2018
EF5BED,dividend,100,50,10/18/2018
EF5BED,earnings-positive,100,69,10/18/2018
EF5BED,earnings,100,50,10/18/2018
EF5BED,earnings,100,50,10/18/2018
EF5BED,earnings,100,50,10/18/2018
EF5BED,earnings,100,50,10/18/2018
F179ED,partnership,100,61,10/18/2018
F1CD47,earnings,100,50,10/18/2018
F24FF0,conference-call,100,50,10/18/2018
F2E253,legal-issues-defendant,100,22,10/18/2018
F40EE2,partnership,100,61,10/18/2018
F4F46F,conference-call,100,50,10/18/2018
F57F6F,earnings,100,50,10/18/2018
F702CA,earnings,100,50,10/18/2018
F702CA,earnings,100,50,10/18/2018
F702CA,earnings,100,50,10/18/2018
F702CA,earnings,100,50,10/18/2018
F702CA,earnings,100,50,10/18/2018
F702CA,earnings,100,50,10/18/2018
F7FCA4,conference-call,100,50,10/18/2018
FA36A4,dividend,100,50,10/18/2018
FB728F,dividend,100,50,10/18/2018
FBD92D,earnings,100,50,10/18/2018
FD6926,conference-call,100,50,10/18/2018
FD9A97,earnings,100,50,10/18/2018
00FC70,conference-call,100,50,10/19/2018
02870F,conference-call,100,50,10/19/2018
48590,product-release,100,64,10/19/2018
0BB9E5,earnings,100,50,10/19/2018
0CE7F6,earnings,100,50,10/19/2018
0D26E0,earnings-up,100,78,10/19/2018
0D26E0,earnings-up,100,78,10/19/2018
0D26E0,earnings-up,100,78,10/19/2018
0D26E0,earnings-up,100,78,10/19/2018
0E5223,conference-call,100,50,10/19/2018
10100E,ipo-completed,100,76,10/19/2018
10673F,earnings-up,100,68,10/19/2018
10673F,earnings,100,50,10/19/2018
108BD2,earnings-up,100,68,10/19/2018
126F95,earnings,100,50,10/19/2018
126F95,earnings,100,50,10/19/2018
126F95,earnings,100,50,10/19/2018
126F95,earnings,100,50,10/19/2018
139303,conference-call,100,50,10/19/2018
1.79E+10,executive-resignation,100,44,10/19/2018
1F43A1,earnings,100,50,10/19/2018
200D8B,product-release,100,64,10/19/2018
225CA2,conference-call,100,50,10/19/2018
249674,conference-call,100,50,10/19/2018
27A791,earnings,100,50,10/19/2018
2CB4C9,donation,100,54,10/19/2018
2E61CC,earnings,100,50,10/19/2018
301493,legal-issues-defendant,100,22,10/19/2018
319BE2,conference-call,100,50,10/19/2018
355B19,dividend,100,50,10/19/2018
370C50,product-price-raise,100,57,10/19/2018
39FB23,executive-appointment,100,54,10/19/2018
3D9999,earnings-positive,100,69,10/19/2018
3F4668,earnings,100,50,10/19/2018
46CF27,acquisition-completed-acquirer,100,49,10/19/2018
48F795,legal-issues-defendant,100,22,10/19/2018
48F795,fraud-defendant,100,20,10/19/2018
4C7DB5,earnings,100,50,10/19/2018
4EC4C1,conference-call,100,50,10/19/2018
539F49,ipo-pricing,100,50,10/19/2018
539F49,ipo-pricing,100,50,10/19/2018
539F49,ipo-pricing,100,50,10/19/2018
539F49,ipo-pricing,100,50,10/19/2018
53E575,conference-call,100,50,10/19/2018
5BC2F4,earnings-per-share-up,100,63,10/19/2018
5BC2F4,earnings-per-share,100,50,10/19/2018
5BC2F4,earnings-per-share,100,50,10/19/2018
5BC2F4,earnings-per-share,100,50,10/19/2018
5BC2F4,earnings-per-share,100,50,10/19/2018
5BFE94,earnings,100,50,10/19/2018
5C7601,conference-organizer,100,57,10/19/2018
61E975,conference-call,100,50,10/19/2018
62B1C6,dividend,100,50,10/19/2018
62CDDE,conference-call,100,50,10/19/2018
647143,dividend,100,50,10/19/2018
66667F,partnership,100,61,10/19/2018
66CB62,earnings,100,50,10/19/2018
68BA15,acquisition-acquirer,100,49,10/19/2018
6B5379,executive-resignation,100,44,10/19/2018
6CD55A,earnings,100,50,10/19/2018
6DDA15,earnings,100,50,10/19/2018
7032D0,earnings,100,50,10/19/2018
726EEA,earnings,100,50,10/19/2018
72F0FC,dividend-up,100,81,10/19/2018
72F0FC,earnings,100,50,10/19/2018
731675,conference-call,100,50,10/19/2018
7A5097,conference-call,100,50,10/19/2018
7ACD98,earnings-guidance,100,50,10/19/2018
82FD6D,conference-call,100,50,10/19/2018
85DA04,earnings,100,50,10/19/2018
868808,executive-appointment,100,54,10/19/2018
88193E,executive-appointment,100,54,10/19/2018
8A8E41,partnership,100,61,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8B2C4A,earnings-up,100,68,10/19/2018
8C6C1B,donation,100,54,10/19/2018
8E8E6E,award,100,58,10/19/2018
911ACB,earnings,100,50,10/19/2018
931AE7,clinical-trials,100,56,10/19/2018
94756D,conference-participant,100,50,10/19/2018
9592FB,regulatory-product-approval-granted,100,81,10/19/2018
997348,earnings,100,50,10/19/2018
997348,earnings,100,50,10/19/2018
9AF3DC,dividend,100,50,10/19/2018
9F62D1,earnings,100,50,10/19/2018
A5A4F5,acquisition-acquirer,100,49,10/19/2018
AE7D16,earnings,100,50,10/19/2018
BFE02C,earnings-positive,100,69,10/19/2018
C0200F,earnings,100,50,10/19/2018
C0200F,earnings,100,50,10/19/2018
C0200F,earnings,100,50,10/19/2018
C65004,earnings,100,50,10/19/2018
CBFFDD,product-release,100,64,10/19/2018
CBFFDD,product-release,100,64,10/19/2018
CC339B,earnings,100,50,10/19/2018
CD2A4D,conference-call,100,50,10/19/2018
CDFCC9,legal-issues-defendant,100,22,10/19/2018
D25249,conference-call,100,50,10/19/2018
D697DE,earnings,100,50,10/19/2018
D78CCD,earnings,100,50,10/19/2018
D78CCD,earnings,100,50,10/19/2018
D78CCD,earnings,100,50,10/19/2018
D78CCD,earnings,100,50,10/19/2018
D78CCD,earnings,100,50,10/19/2018
D78CCD,earnings,100,50,10/19/2018
D8ECA1,executive-appointment,100,54,10/19/2018
DF204B,conference-call,100,50,10/19/2018
E00373,earnings,100,50,10/19/2018
E1E36F,dividend,100,50,10/19/2018
E2F130,dividend,100,50,10/19/2018
E30B34,earnings,100,50,10/19/2018
E68E62,clinical-trials,100,56,10/19/2018
E68E62,clinical-trials,100,56,10/19/2018
E6E012,dividend-up,100,59,10/19/2018
E8D221,dividend,100,50,10/19/2018
ECF709,executive-resignation,100,44,10/19/2018
EE04F0,legal-issues-defendant,100,22,10/19/2018
EF25A5,earnings,100,50,10/19/2018
F31B13,earnings-positive,100,69,10/19/2018
F80FF9,conference-call,100,50,10/19/2018
F82D37,earnings-up,100,68,10/19/2018
F82D37,earnings,100,50,10/19/2018
F82D37,earnings,100,50,10/19/2018
FDD3FC,clinical-trials,100,56,10/19/2018
FF6644,earnings,100,50,10/19/2018
FF6644,earnings,100,50,10/19/2018
FF6644,earnings,100,50,10/19/2018
FF6644,earnings,100,50,10/19/2018
FF6644,earnings,100,50,10/19/2018
FF6644,earnings,100,50,10/19/2018
FF6644,earnings,100,50,10/19/2018
FFE543,legal-issues-defendant,100,22,10/19/2018
48F795,legal-issues-defendant,100,22,10/20/2018
4C92B9,legal-issues-defendant,100,22,10/20/2018
4C92B9,legal-issues-defendant,100,22,10/20/2018
4E7C1F,product-release,100,64,10/20/2018
3C7F5F,executive-resignation,100,44,10/21/2018
4C92B9,legal-issues-defendant,100,22,10/21/2018
4E7C1F,product-release,100,64,10/21/2018
6CC55E,clinical-trials-positive,100,87,10/21/2018
9978F1,clinical-trials,100,56,10/21/2018
C45C1F,clinical-trials,100,56,10/21/2018
00067A,partnership,100,61,10/22/2018
0157B1,partnership,100,61,10/22/2018
054E7E,executive-appointment,100,54,10/22/2018
0560D8,earnings,100,50,10/22/2018
08A40F,earnings-per-share-positive,100,69,10/22/2018
08A40F,earnings-per-share-positive,100,69,10/22/2018
08A40F,earnings-per-share-positive,100,69,10/22/2018
08A40F,earnings-per-share-positive,100,69,10/22/2018
08A40F,earnings-per-share-positive,100,69,10/22/2018
08A40F,earnings-per-share-positive,100,69,10/22/2018
08A40F,earnings-per-share-positive,100,69,10/22/2018
98977,earnings,100,50,10/22/2018
0A748B,earnings,100,50,10/22/2018
0A748B,earnings,100,50,10/22/2018
0A7650,earnings-positive,100,69,10/22/2018
0A7650,earnings-positive,100,69,10/22/2018
0A7650,earnings-positive,100,69,10/22/2018
0A7650,earnings-positive,100,69,10/22/2018
0C6861,legal-issues-defendant,100,22,10/22/2018
0CCCB7,conference-call,100,50,10/22/2018
1080C0,clinical-trials,100,56,10/22/2018
152AB9,executive-appointment,100,54,10/22/2018
15789A,revenue-volume-up,100,57,10/22/2018
1748F6,acquisition-completed-acquirer,100,49,10/22/2018
17EDA5,partnership,100,61,10/22/2018
182BE7,earnings,100,50,10/22/2018
1A3E1B,dividend,100,50,10/22/2018
1D1B07,note-sale,100,52,10/22/2018
1D1B07,note-sale,100,52,10/22/2018
1E1125,conference-organizer,100,57,10/22/2018
1E1125,executive-appointment,100,54,10/22/2018
1EBF8D,regulatory-product-review-positive,100,73,10/22/2018
1FE3CB,earnings,100,50,10/22/2018
206852,earnings,100,50,10/22/2018
21D903,executive-appointment,100,54,10/22/2018
228D42,partnership,100,61,10/22/2018
249674,executive-appointment,100,54,10/22/2018
25AB8E,conference-call,100,50,10/22/2018
297DA8,earnings,100,50,10/22/2018
2A9C0A,earnings-positive,100,69,10/22/2018
2A9C0A,earnings,100,50,10/22/2018
2A9C0A,earnings,100,50,10/22/2018
2A9C0A,earnings,100,50,10/22/2018
2A9C0A,earnings,100,50,10/22/2018
2A9C0A,earnings,100,50,10/22/2018
2B49F4,earnings,100,50,10/22/2018
2B49F4,earnings,100,50,10/22/2018
2B49F4,earnings,100,50,10/22/2018
2B8179,clinical-trials,100,56,10/22/2018
2BF36E,conference-call,100,50,10/22/2018
2C3348,legal-issues-defendant,100,22,10/22/2018
2C35B5,public-offering,100,43,10/22/2018
2CC71C,executive-appointment,100,54,10/22/2018
2D981A,legal-issues-defendant,100,22,10/22/2018
2DC88B,executive-appointment,100,54,10/22/2018
2DDB22,earnings-guidance,100,50,10/22/2018
2DDB22,earnings-guidance,100,50,10/22/2018
2E89AE,legal-issues-defendant,100,22,10/22/2018
2E902B,earnings,100,50,10/22/2018
2E902B,earnings,100,50,10/22/2018
301493,executive-appointment,100,54,10/22/2018
309922,earnings,100,50,10/22/2018
30E01D,earnings,100,50,10/22/2018
31F25C,earnings,100,50,10/22/2018
32C8CD,earnings,100,50,10/22/2018
32CB22,market-entry,100,57,10/22/2018
32CB22,unit-acquisition-acquirer,100,49,10/22/2018
34B97A,conference-participant,100,50,10/22/2018
34E9F9,conference-call,100,50,10/22/2018
370C50,product-price-raise,100,57,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
38FB49,earnings,100,50,10/22/2018
396D7C,clinical-trials,100,56,10/22/2018
396D7C,clinical-trials,100,56,10/22/2018
39FB23,award,100,58,10/22/2018
3A4BDB,earnings-up,100,68,10/22/2018
3A4BDB,earnings-up,100,68,10/22/2018
3A4BDB,earnings-up,100,68,10/22/2018
3A4BDB,earnings-up,100,68,10/22/2018
3A4BDB,earnings-up,100,68,10/22/2018
3ACF46,business-contract,100,69,10/22/2018
3B318A,legal-issues-defendant,100,22,10/22/2018
3C7F5F,legal-issues-defendant,100,22,10/22/2018
3DE4D1,earnings,100,50,10/22/2018
3DE4D1,executive-appointment,100,54,10/22/2018
434F38,legal-verdict-favored,100,78,10/22/2018
44740A,executive-appointment,100,54,10/22/2018
450ECB,earnings,100,50,10/22/2018
46017C,award,100,58,10/22/2018
4649D5,conference-call,100,50,10/22/2018
49914B,earnings,100,50,10/22/2018
4A6F00,partnership,100,61,10/22/2018
4A6F00,legal-verdict-disfavored,100,22,10/22/2018
4A6F00,legal-verdict-disfavored,100,22,10/22/2018
4A6F00,legal-verdict-disfavored,100,22,10/22/2018
4C92B9,legal-issues-defendant,100,22,10/22/2018
4C92B9,legal-issues-defendant,100,22,10/22/2018
4C92B9,legal-issues-defendant,100,22,10/22/2018
4D371E,earnings,100,50,10/22/2018
4F9926,partnership,100,61,10/22/2018
54A646,earnings-up,100,72,10/22/2018
54A646,earnings-up,100,72,10/22/2018
54A646,earnings-up,100,72,10/22/2018
55438C,dividend,100,50,10/22/2018
57634F,earnings,100,50,10/22/2018
583223,earnings,100,50,10/22/2018
5876DC,acquisition-acquirer,100,49,10/22/2018
594402,business-contract,100,69,10/22/2018
594402,business-contract,100,69,10/22/2018
59A832,conference-call,100,50,10/22/2018
5B15E1,earnings,100,50,10/22/2018
5C8D61,earnings,100,50,10/22/2018
5D0337,executive-appointment,100,54,10/22/2018
5DA8B3,earnings,100,50,10/22/2018
5F1B7B,earnings,100,50,10/22/2018
5F9CE3,unit-acquisition-acquirer,100,49,10/22/2018
61B81B,product-release,100,64,10/22/2018
647143,earnings,100,50,10/22/2018
647143,earnings,100,50,10/22/2018
647143,earnings,100,50,10/22/2018
647143,earnings,100,50,10/22/2018
66667F,partnership,100,61,10/22/2018
66667F,partnership,100,61,10/22/2018
6B5379,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6C4D2F,earnings,100,50,10/22/2018
6DD6BA,earnings,100,50,10/22/2018
6DD6BA,earnings,100,50,10/22/2018
6DD6BA,earnings,100,50,10/22/2018
6F3FA8,conference-call,100,50,10/22/2018
717DB4,earnings,100,50,10/22/2018
756BB4,award,100,58,10/22/2018
75F665,earnings,100,50,10/22/2018
7A2A49,conference-call,100,50,10/22/2018
7A975D,dividend,100,50,10/22/2018
7B1156,earnings-guidance,100,50,10/22/2018
7B4B91,conference-call,100,50,10/22/2018
7BC92D,award,100,58,10/22/2018
7C75FD,conference-call,100,50,10/22/2018
7E3F8F,earnings,100,50,10/22/2018
7E3F8F,earnings,100,50,10/22/2018
7E3F8F,earnings,100,50,10/22/2018
7E3F8F,earnings,100,50,10/22/2018
7F2922,earnings,100,50,10/22/2018
7F9E16,conference-call,100,50,10/22/2018
83066C,conference-call,100,50,10/22/2018
83598E,earnings,100,50,10/22/2018
859281,earnings,100,50,10/22/2018
859281,earnings,100,50,10/22/2018
859281,earnings,100,50,10/22/2018
859281,earnings,100,50,10/22/2018
859281,earnings,100,50,10/22/2018
859281,earnings,100,50,10/22/2018
85AD00,earnings,100,50,10/22/2018
881190,earnings,100,50,10/22/2018
881190,earnings,100,50,10/22/2018
881190,earnings,100,50,10/22/2018
881190,earnings,100,50,10/22/2018
893904,hirings,100,65,10/22/2018
895D56,conference-participant,100,50,10/22/2018
89F693,earnings,100,50,10/22/2018
8A8E41,earnings,100,50,10/22/2018
8D4486,partnership,100,61,10/22/2018
8D4486,partnership,100,61,10/22/2018
8D4486,partnership,100,61,10/22/2018
8D9993,dividend,100,50,10/22/2018
8E4F9A,partnership,100,61,10/22/2018
8E93A4,earnings,100,50,10/22/2018
903AB4,earnings,100,50,10/22/2018
903AB4,earnings,100,50,10/22/2018
903AB4,earnings,100,50,10/22/2018
903AB4,earnings,100,50,10/22/2018
903AB4,earnings,100,50,10/22/2018
907ED2,earnings,100,50,10/22/2018
944B2E,note-sale,100,52,10/22/2018
94756D,facility-open,100,65,10/22/2018
94C0B5,earnings,100,50,10/22/2018
95DE39,executive-appointment,100,54,10/22/2018
972356,product-release,100,64,10/22/2018
99028D,conference-call,100,50,10/22/2018
990AD0,acquisition-completed-acquiree,100,76,10/22/2018
990AD0,product-release,100,64,10/22/2018
990AD0,conference-organizer,100,57,10/22/2018
9ABD30,earnings,100,50,10/22/2018
9B4066,credit-extension-recipient,100,69,10/22/2018
9BB35A,conference-call,100,50,10/22/2018
9C5BA5,conference-call,100,50,10/22/2018
9CE4C7,earnings,100,50,10/22/2018
9D2790,earnings,100,50,10/22/2018
9F5997,executive-appointment,100,54,10/22/2018
9F6B1A,partnership,100,61,10/22/2018
A247F5,award,100,58,10/22/2018
A3800A,earnings,100,50,10/22/2018
A4A612,earnings,100,50,10/22/2018
A5628C,executive-appointment,100,54,10/22/2018
A5A4F5,acquisition-acquirer,100,49,10/22/2018
A8B137,earnings,100,50,10/22/2018
A8B137,earnings,100,50,10/22/2018
A8B137,earnings,100,50,10/22/2018
A8B137,earnings,100,50,10/22/2018
A8B137,earnings,100,50,10/22/2018
AA98ED,earnings,100,50,10/22/2018
AAC8B6,conference-organizer,100,57,10/22/2018
ADF1B0,earnings,100,50,10/22/2018
ADF1B0,earnings,100,50,10/22/2018
ADF1B0,earnings,100,50,10/22/2018
ADF1B0,earnings,100,50,10/22/2018
ADFB3A,conference-call,100,50,10/22/2018
B2F431,earnings,100,50,10/22/2018
B2F431,earnings,100,50,10/22/2018
B2F431,earnings,100,50,10/22/2018
B2F431,earnings,100,50,10/22/2018
B2F431,earnings,100,50,10/22/2018
B604DF,earnings,100,50,10/22/2018
B604DF,earnings,100,50,10/22/2018
B604DF,earnings,100,50,10/22/2018
B604DF,earnings,100,50,10/22/2018
B604DF,dividend,100,50,10/22/2018
B604DF,earnings,100,50,10/22/2018
B604DF,dividend,100,50,10/22/2018
B9CD50,award,100,58,10/22/2018
BB58FF,conference-organizer,100,57,10/22/2018
BDE867,operating-earnings,100,50,10/22/2018
BDF2BD,conference-call,100,50,10/22/2018
C0BA36,conference-participant,100,50,10/22/2018
C11C46,earnings,100,50,10/22/2018
C188F8,legal-issues-defendant,100,22,10/22/2018
C2F597,executive-appointment,100,54,10/22/2018
C3DE7D,executive-appointment,100,54,10/22/2018
C4F9C6,clinical-trials,100,56,10/22/2018
C50B26,note-sale,100,52,10/22/2018
C598D7,acquisition-acquirer,100,49,10/22/2018
C598D7,revenue-up,100,62,10/22/2018
C598D7,revenues,100,50,10/22/2018
C598D7,revenues,100,50,10/22/2018
C598D7,revenues,100,50,10/22/2018
C5F463,partnership,100,61,10/22/2018
C83B88,conference-call,100,50,10/22/2018
C9F39B,unit-acquisition-acquiree,100,76,10/22/2018
CAB222,conference-call,100,50,10/22/2018
CC6FF5,earnings,100,50,10/22/2018
CCB623,revenues,100,50,10/22/2018
CCB623,public-offering,100,43,10/22/2018
CE96E7,executive-appointment,100,54,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
CFE5BE,earnings-up,100,68,10/22/2018
D0DFE5,earnings,100,50,10/22/2018
D1C0B9,partnership,100,61,10/22/2018
D20C8F,earnings,100,50,10/22/2018
D6489C,business-combination,100,54,10/22/2018
D6489C,product-release,100,64,10/22/2018
D6EAA3,conference-participant,100,50,10/22/2018
D854DD,conference-participant,100,50,10/22/2018
D8760C,earnings-up,100,68,10/22/2018
D8760C,earnings,100,50,10/22/2018
D8760C,earnings,100,50,10/22/2018
D8760C,earnings,100,50,10/22/2018
D8760C,earnings,100,50,10/22/2018
D8760C,earnings,100,50,10/22/2018
DAC66A,earnings,100,50,10/22/2018
DB5CA5,partnership,100,61,10/22/2018
DC2F77,dividend,100,50,10/22/2018
DE5611,acquisition-completed-acquirer,100,49,10/22/2018
DF46C5,dividend,100,50,10/22/2018
DF46C5,earnings-guidance-up,100,83,10/22/2018
DF46C5,earnings,100,50,10/22/2018
DF46C5,earnings,100,50,10/22/2018
DF46C5,earnings,100,50,10/22/2018
E0647D,earnings,100,50,10/22/2018
E0647D,earnings,100,50,10/22/2018
E30B34,award,100,58,10/22/2018
E4158B,earnings-positive,100,69,10/22/2018
E4158B,earnings,100,50,10/22/2018
E4158B,earnings,100,50,10/22/2018
E4158B,earnings,100,50,10/22/2018
E4158B,earnings,100,50,10/22/2018
E4158B,earnings,100,50,10/22/2018
E4CE73,product-release,100,64,10/22/2018
E68733,executive-death,100,31,10/22/2018
E68C3D,earnings,100,50,10/22/2018
E74B55,partnership,100,61,10/22/2018
E754F0,fundraising,100,64,10/22/2018
E87676,dividend,100,50,10/22/2018
E8846E,conference-participant,100,50,10/22/2018
E90C84,conference-call,100,50,10/22/2018
EA4E68,earnings,100,50,10/22/2018
ECDEB2,earnings,100,50,10/22/2018
ED9C04,award,100,58,10/22/2018
F02170,executive-appointment,100,54,10/22/2018
F2E253,legal-issues-defendant,100,22,10/22/2018
F44EA2,earnings,100,50,10/22/2018
F4E992,dividend,100,50,10/22/2018
F5C78B,dividend-up,100,74,10/22/2018
F5C78B,earnings,100,50,10/22/2018
F6A945,earnings,100,50,10/22/2018
F7935D,clinical-trials-start,100,64,10/22/2018
F95726,earnings,100,50,10/22/2018
FACF19,partnership,100,61,10/22/2018
FAEABE,dividend,100,50,10/22/2018
FF6644,legal-issues-defendant,100,22,10/22/2018
0157B1,product-release,100,64,10/23/2018
02870F,facility-open,100,65,10/23/2018
31025,earnings,100,50,10/23/2018
03B8CF,earnings,100,50,10/23/2018
03B8CF,earnings,100,50,10/23/2018
03B8CF,earnings,100,50,10/23/2018
03B8CF,earnings,100,50,10/23/2018
03B8CF,earnings,100,50,10/23/2018
48590,executive-appointment,100,54,10/23/2018
053EFF,conference-call,100,50,10/23/2018
55018,earnings-positive,100,69,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
55018,earnings,100,50,10/23/2018
68396,earnings,100,50,10/23/2018
070B45,earnings,100,50,10/23/2018
09062E,conference-participant,100,50,10/23/2018
099A92,earnings,100,50,10/23/2018
0B400D,earnings-guidance,100,50,10/23/2018
0BF198,conference-call,100,50,10/23/2018
0C4131,earnings,100,50,10/23/2018
0C4131,earnings-up,100,68,10/23/2018
0C4131,earnings-up,100,68,10/23/2018
0C4131,earnings-up,100,68,10/23/2018
0C6861,legal-issues-defendant,100,22,10/23/2018
0FC848,earnings,100,50,10/23/2018
102727,earnings,100,50,10/23/2018
102727,earnings,100,50,10/23/2018
102727,earnings,100,50,10/23/2018
102727,earnings,100,50,10/23/2018
10AE08,stock-splits,100,49,10/23/2018
125212,earnings,100,50,10/23/2018
12DE76,partnership,100,61,10/23/2018
12DE76,partnership,100,61,10/23/2018
1348C9,earnings,100,50,10/23/2018
1348C9,earnings,100,50,10/23/2018
1348C9,earnings,100,50,10/23/2018
1348C9,earnings,100,50,10/23/2018
14BA33,conference-participant,100,50,10/23/2018
165B3A,earnings-positive,100,69,10/23/2018
165B3A,earnings-positive,100,69,10/23/2018
165B3A,earnings-positive,100,69,10/23/2018
165B3A,earnings-positive,100,69,10/23/2018
16FC89,earnings,100,50,10/23/2018
1782D5,earnings,100,50,10/23/2018
182B8C,partnership,100,61,10/23/2018
1BDB2A,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1E9A6D,earnings,100,50,10/23/2018
1F9D90,earnings,100,50,10/23/2018
1FA8F7,acquisition-acquirer,100,49,10/23/2018
202E5A,conference-call,100,50,10/23/2018
221783,partnership,100,61,10/23/2018
241AF7,conference-call,100,50,10/23/2018
2667B6,earnings,100,50,10/23/2018
270B78,earnings,100,50,10/23/2018
2720AB,earnings,100,50,10/23/2018
27C10F,earnings,100,50,10/23/2018
282C18,earnings,100,50,10/23/2018
28B730,earnings,100,50,10/23/2018
28DCF3,earnings-up,100,59,10/23/2018
2ABF77,clinical-trials-positive,100,87,10/23/2018
2AE625,conference-participant,100,50,10/23/2018
2C35B5,public-offering,100,43,10/23/2018
2C7505,legal-issues-defendant,100,22,10/23/2018
2CB4C9,earnings,100,50,10/23/2018
2CBB58,operating-earnings-up,100,80,10/23/2018
2CBB58,operating-earnings-up,100,80,10/23/2018
2CBB58,operating-earnings-up,100,80,10/23/2018
2CBB58,operating-earnings-up,100,80,10/23/2018
2D485F,acquisition-acquirer,100,49,10/23/2018
2D643C,dividend,100,50,10/23/2018
2E2E6E,earnings-up,100,68,10/23/2018
2F5256,earnings,100,50,10/23/2018
31803E,earnings,100,50,10/23/2018
3461CF,dividend,100,50,10/23/2018
36529A,public-offering,100,43,10/23/2018
39BFF6,earnings,100,50,10/23/2018
39BFF6,earnings,100,50,10/23/2018
39BFF6,earnings,100,50,10/23/2018
3B318A,legal-issues-defendant,100,22,10/23/2018
3DC887,product-release,100,64,10/23/2018
3F1C69,executive-appointment,100,54,10/23/2018
3F4668,executive-appointment,100,54,10/23/2018
3F6A9C,dividend,100,50,10/23/2018
401072,earnings,100,50,10/23/2018
41785E,earnings,100,50,10/23/2018
417BF9,conference-participant,100,50,10/23/2018
420168,conference-participant,100,50,10/23/2018
427F32,conference-call,100,50,10/23/2018
44DDBD,conference-call,100,50,10/23/2018
453282,dividend-up,100,81,10/23/2018
48F795,legal-issues-defendant,100,22,10/23/2018
492117,earnings,100,50,10/23/2018
4A6F00,legal-issues-defendant,100,22,10/23/2018
4B3DC9,earnings-positive,100,69,10/23/2018
4C37C5,dividend,100,50,10/23/2018
4C92B9,legal-issues-defendant,100,22,10/23/2018
4C92B9,earnings,100,50,10/23/2018
4DD09F,earnings,100,50,10/23/2018
4E7C1F,earnings,100,50,10/23/2018
4E7C1F,earnings,100,50,10/23/2018
4E7C1F,earnings,100,50,10/23/2018
4E7C1F,partnership,100,61,10/23/2018
507AE7,investment-investor,100,55,10/23/2018
52FB2F,earnings,100,50,10/23/2018
539F49,ipo-completed,100,76,10/23/2018
543900,legal-issues-defendant,100,22,10/23/2018
54DF47,earnings-guidance,100,50,10/23/2018
553949,conference-call,100,50,10/23/2018
556F08,executive-appointment,100,54,10/23/2018
55ACCB,partnership,100,61,10/23/2018
55C9B5,partnership,100,61,10/23/2018
55D0F3,earnings,100,50,10/23/2018
5675EB,dividend,100,50,10/23/2018
5675EB,earnings,100,50,10/23/2018
57A854,earnings,100,50,10/23/2018
583A75,earnings,100,50,10/23/2018
58B46F,dividend,100,50,10/23/2018
5F9CE3,earnings,100,50,10/23/2018
5FE4B6,conference-participant,100,50,10/23/2018
6137BF,earnings,100,50,10/23/2018
6137BF,earnings,100,50,10/23/2018
6559D8,patient-enrollment-complete,100,64,10/23/2018
662682,earnings,100,50,10/23/2018
665D7D,legal-issues-defendant,100,22,10/23/2018
66667F,conference-participant,100,50,10/23/2018
69345C,partnership,100,61,10/23/2018
69345C,partnership,100,61,10/23/2018
69FDFC,executive-appointment,100,54,10/23/2018
6B0E45,dividend,100,50,10/23/2018
6BD606,conference-call,100,50,10/23/2018
6CB7F9,earnings,100,50,10/23/2018
6CF43C,earnings,100,50,10/23/2018
6D4636,conference-call,100,50,10/23/2018
6F0096,earnings,100,50,10/23/2018
6F0096,earnings,100,50,10/23/2018
6F0096,earnings,100,50,10/23/2018
6F0096,earnings,100,50,10/23/2018
6F3FA8,conference-participant,100,50,10/23/2018
704B78,earnings,100,50,10/23/2018
713810,product-release,100,64,10/23/2018
71553E,earnings,100,50,10/23/2018
72609A,conference-call,100,50,10/23/2018
72DF04,conference-participant,100,50,10/23/2018
72EF75,earnings,100,50,10/23/2018
732A9B,conference-participant,100,50,10/23/2018
73C521,earnings,100,50,10/23/2018
73C521,earnings,100,50,10/23/2018
73C521,earnings,100,50,10/23/2018
73C521,earnings,100,50,10/23/2018
73C521,earnings,100,50,10/23/2018
73C521,earnings,100,50,10/23/2018
73C521,business-contract,100,69,10/23/2018
7410C3,earnings,100,50,10/23/2018
752A70,earnings,100,50,10/23/2018
75F665,earnings,100,50,10/23/2018
75F665,earnings,100,50,10/23/2018
75F665,dividend,100,50,10/23/2018
765913,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
767F86,earnings,100,50,10/23/2018
76F067,dividend,100,50,10/23/2018
7B492C,conference-call,100,50,10/23/2018
7D35D8,earnings,100,50,10/23/2018
7D35D8,earnings,100,50,10/23/2018
7D5FD6,earnings,100,50,10/23/2018
7F3665,earnings,100,50,10/23/2018
7F3A5F,partnership,100,61,10/23/2018
803FED,conference-call,100,50,10/23/2018
803FED,dividend,100,50,10/23/2018
805CD8,conference-call,100,50,10/23/2018
8.10E+32,dividend,100,50,10/23/2018
81222C,earnings,100,50,10/23/2018
81F4BE,earnings,100,50,10/23/2018
81F4BE,earnings,100,50,10/23/2018
81F4BE,earnings,100,50,10/23/2018
81F4BE,earnings,100,50,10/23/2018
81F4BE,earnings,100,50,10/23/2018
82F088,conference-call,100,50,10/23/2018
835C86,dividend,100,50,10/23/2018
8377DB,earnings,100,50,10/23/2018
8377DB,earnings,100,50,10/23/2018
8377DB,earnings,100,50,10/23/2018
8377DB,earnings,100,50,10/23/2018
8377DB,earnings,100,50,10/23/2018
845533,earnings,100,50,10/23/2018
877734,conference-call,100,50,10/23/2018
890FF4,conference-call,100,50,10/23/2018
895D56,conference-call,100,50,10/23/2018
89FBB1,dividend,100,50,10/23/2018
8A8E41,partnership,100,61,10/23/2018
8AB37F,conference-call,100,50,10/23/2018
8B3B0E,executive-appointment,100,54,10/23/2018
8C311A,product-release,100,64,10/23/2018
8DAAB9,earnings-up,100,68,10/23/2018
8E3F58,earnings,100,50,10/23/2018
93F143,earnings,100,50,10/23/2018
93F143,earnings,100,50,10/23/2018
93F143,earnings,100,50,10/23/2018
93F143,earnings,100,50,10/23/2018
949D62,earnings,100,50,10/23/2018
9548BB,earnings,100,50,10/23/2018
9.54E+32,earnings,100,50,10/23/2018
9.54E+32,earnings,100,50,10/23/2018
96F126,earnings,100,50,10/23/2018
96F126,earnings,100,50,10/23/2018
97B027,conference-call,100,50,10/23/2018
990AD0,conference-organizer,100,57,10/23/2018
990AD0,conference-organizer,100,57,10/23/2018
990AD0,conference-organizer,100,57,10/23/2018
990AD0,conference-organizer,100,57,10/23/2018
9.92E+94,earnings,100,50,10/23/2018
9.92E+94,earnings,100,50,10/23/2018
9.92E+94,earnings,100,50,10/23/2018
99ACAD,dividend,100,50,10/23/2018
9A02C4,earnings,100,50,10/23/2018
9A02C4,dividend,100,50,10/23/2018
9E4A5F,earnings,100,50,10/23/2018
9E98F2,partnership,100,61,10/23/2018
9F048E,earnings,100,50,10/23/2018
9F048E,earnings,100,50,10/23/2018
9F048E,earnings,100,50,10/23/2018
9F048E,earnings,100,50,10/23/2018
9F048E,earnings,100,50,10/23/2018
A0F146,conference-call,100,50,10/23/2018
A350C1,partnership,100,61,10/23/2018
A403CF,earnings,100,50,10/23/2018
A4B899,conference-call,100,50,10/23/2018
A4D173,earnings,100,50,10/23/2018
A4D173,earnings,100,50,10/23/2018
A5195E,earnings,100,50,10/23/2018
A5A4F5,acquisition-acquirer,100,49,10/23/2018
A5E715,earnings-per-share-positive,100,69,10/23/2018
A6213D,partnership,100,61,10/23/2018
A65325,earnings-positive,100,69,10/23/2018
A65325,earnings,100,50,10/23/2018
A65325,earnings,100,50,10/23/2018
A65325,earnings,100,50,10/23/2018
A65325,earnings,100,50,10/23/2018
A65325,earnings,100,50,10/23/2018
A65325,earnings,100,50,10/23/2018
A6828A,acquisition-interest-acquirer,100,46,10/23/2018
A7102F,conference-call,100,50,10/23/2018
A868C9,conference-call,100,50,10/23/2018
AA98ED,legal-issues-defendant,100,22,10/23/2018
AC3584,facility-open,100,65,10/23/2018
ACD9A4,earnings,100,50,10/23/2018
AE4EEB,earnings,100,50,10/23/2018
AEBB80,earnings,100,50,10/23/2018
B05000,acquisition-acquirer,100,49,10/23/2018
B0B969,conference-call,100,50,10/23/2018
B37FB4,earnings-up,100,68,10/23/2018
B5766D,dividend,100,50,10/23/2018
B8F71F,earnings,100,50,10/23/2018
B96637,conference-call,100,50,10/23/2018
BB5142,earnings,100,50,10/23/2018
BB5271,business-contract,100,69,10/23/2018
BBC05B,operating-earnings,100,50,10/23/2018
BC3AD2,earnings,100,50,10/23/2018
BC3AD2,earnings,100,50,10/23/2018
BCC13E,earnings,100,50,10/23/2018
BD15E8,earnings,100,50,10/23/2018
BD9668,earnings,100,50,10/23/2018
BE379D,earnings,100,50,10/23/2018
C07E05,earnings,100,50,10/23/2018
C0BA36,award,100,58,10/23/2018
C0BA36,award,100,58,10/23/2018
C188F8,legal-issues-defendant,100,22,10/23/2018
C1CBA4,earnings-positive,100,69,10/23/2018
C32A39,earnings-per-share-positive,100,69,10/23/2018
C41C25,dividend,100,50,10/23/2018
C45CE7,earnings,100,50,10/23/2018
C624A1,earnings,100,50,10/23/2018
C624A1,earnings,100,50,10/23/2018
C7859D,conference-participant,100,50,10/23/2018
C81E00,acquisition-completed-acquirer,100,49,10/23/2018
C85A72,acquisition-acquirer,100,49,10/23/2018
C8923A,earnings,100,50,10/23/2018
C9E107,earnings-per-share-positive,100,69,10/23/2018
CA1620,product-release,100,64,10/23/2018
CA1620,legal-issues-defendant,100,22,10/23/2018
CB89EA,earnings,100,50,10/23/2018
CBA33B,stock-splits,100,49,10/23/2018
CD06A2,dividend,100,50,10/23/2018
CDAA0E,earnings,100,50,10/23/2018
CDFCC9,legal-issues-defendant,100,22,10/23/2018
CEDFD5,clinical-trials,100,56,10/23/2018
CEDFD5,clinical-trials,100,56,10/23/2018
CF9054,earnings,100,50,10/23/2018
CFF15D,partnership,100,61,10/23/2018
CFF15D,dividend,100,50,10/23/2018
D06755,conference-participant,100,50,10/23/2018
D1173F,earnings,100,50,10/23/2018
D1173F,earnings,100,50,10/23/2018
D1173F,earnings,100,50,10/23/2018
D1173F,earnings,100,50,10/23/2018
D1173F,earnings,100,50,10/23/2018
D139BC,earnings,100,50,10/23/2018
D17C1B,earnings,100,50,10/23/2018
D17C1B,earnings,100,50,10/23/2018
D17C1B,earnings,100,50,10/23/2018
D296C6,earnings,100,50,10/23/2018
D3FD6D,conference-call,100,50,10/23/2018
D501DC,earnings,100,50,10/23/2018
D6489C,partnership,100,61,10/23/2018
D6534D,conference-call,100,50,10/23/2018
D7918D,dividend,100,50,10/23/2018
D8760C,executive-appointment,100,54,10/23/2018
D9B1C9,dividend-up,100,58,10/23/2018
DBFB51,conference-call,100,50,10/23/2018
DC486E,earnings,100,50,10/23/2018
DC486E,earnings,100,50,10/23/2018
DC486E,earnings,100,50,10/23/2018
DC486E,earnings,100,50,10/23/2018
DD3BB1,earnings,100,50,10/23/2018
DD3BB1,earnings,100,50,10/23/2018
DDB002,earnings,100,50,10/23/2018
DDC415,earnings,100,50,10/23/2018
DDC415,earnings,100,50,10/23/2018
DE20DF,dividend,100,50,10/23/2018
DF11D9,earnings,100,50,10/23/2018
E06265,conference-call,100,50,10/23/2018
E0F4E5,executive-appointment,100,54,10/23/2018
E22FDE,partnership,100,61,10/23/2018
E3656D,earnings,100,50,10/23/2018
E49AA3,product-release,100,64,10/23/2018
E68733,regulatory-product-approval-granted,100,81,10/23/2018
E69BA5,conference-call,100,50,10/23/2018
E6D89E,earnings,100,50,10/23/2018
E6D89E,earnings,100,50,10/23/2018
E6D89E,earnings,100,50,10/23/2018
E6D89E,earnings,100,50,10/23/2018
E6E012,revenues,100,50,10/23/2018
E70531,partnership,100,61,10/23/2018
E754F0,earnings,100,50,10/23/2018
E8846E,dividend,100,50,10/23/2018
E8B21D,revenue-up,100,69,10/23/2018
E8B21D,earnings-up,100,68,10/23/2018
E8B21D,earnings-up,100,68,10/23/2018
E8B21D,earnings-up,100,68,10/23/2018
E8B21D,earnings-up,100,68,10/23/2018
E94704,conference-participant,100,50,10/23/2018
E9E6FD,earnings,100,50,10/23/2018
E9FF33,earnings,100,50,10/23/2018
EB43F4,orphan-drug-designation,100,76,10/23/2018
EB7FBF,dividend,100,50,10/23/2018
EC1AF3,award,100,58,10/23/2018
EC1AF3,conference-call,100,50,10/23/2018
EC99D0,earnings,100,50,10/23/2018
ECD263,note-sale,100,52,10/23/2018
ECDEB2,earnings,100,50,10/23/2018
ED0402,revenue-up,100,71,10/23/2018
ED0402,revenue-up,100,71,10/23/2018
ED0402,revenue-up,100,71,10/23/2018
ED0402,revenue-up,100,71,10/23/2018
EEA734,business-contract,100,69,10/23/2018
EF5BED,product-release,100,64,10/23/2018
F04E05,dividend,100,50,10/23/2018
F0A9DE,earnings,100,50,10/23/2018
F18844,award,100,58,10/23/2018
F24FF0,earnings,100,50,10/23/2018
F2526D,earnings,100,50,10/23/2018
F294DD,earnings,100,50,10/23/2018
F294DD,earnings,100,50,10/23/2018
F294DD,earnings,100,50,10/23/2018
F294DD,earnings,100,50,10/23/2018
F2E253,legal-issues-defendant,100,22,10/23/2018
F2E253,conference-call,100,50,10/23/2018
F3816D,clinical-trials,100,56,10/23/2018
F40EE2,earnings,100,50,10/23/2018
F5A214,earnings,100,50,10/23/2018
F5C78B,earnings,100,50,10/23/2018
F5D410,earnings-guidance-up,100,83,10/23/2018
F6DE54,earnings,100,50,10/23/2018
F72E4B,earnings,100,50,10/23/2018
F72E4B,earnings,100,50,10/23/2018
F72E4B,earnings,100,50,10/23/2018
F72E4B,earnings,100,50,10/23/2018
F85CC0,earnings-per-share,100,50,10/23/2018
FA044A,earnings,100,50,10/23/2018
FA35C6,earnings,100,50,10/23/2018
FAEABE,executive-appointment,100,54,10/23/2018
FC1A6E,legal-issues-defendant,100,22,10/23/2018
FD0CA4,earnings,100,50,10/23/2018
FDD3FC,clinical-trials-start,100,64,10/23/2018
FE7A63,earnings,100,50,10/23/2018
FE7A63,earnings,100,50,10/23/2018
FE7A63,earnings,100,50,10/23/2018
FE7A63,earnings,100,50,10/23/2018
FE7A63,earnings,100,50,10/23/2018
FE7A63,earnings,100,50,10/23/2018
FE7A63,earnings,100,50,10/23/2018
00698D,donation,100,54,10/24/2018
00698D,conference-participant,100,50,10/24/2018
0142B5,dividend,100,50,10/24/2018
01478A,executive-appointment,100,54,10/24/2018
0157B1,unit-acquisition-acquiree,100,76,10/24/2018
0358AF,earnings-up,100,68,10/24/2018
03596A,earnings,100,50,10/24/2018
03FB17,legal-issues-defendant,100,22,10/24/2018
58828,operating-earnings,100,50,10/24/2018
71860,dividend,100,50,10/24/2018
71860,earnings,100,50,10/24/2018
07C69F,earnings,100,50,10/24/2018
081AB9,dividend,100,50,10/24/2018
081AB9,earnings,100,50,10/24/2018
0986B5,earnings,100,50,10/24/2018
09F623,dividend-up,100,81,10/24/2018
0A77DB,partnership,100,61,10/24/2018
0AB700,earnings,100,50,10/24/2018
0C136E,earnings,100,50,10/24/2018
0C2A0D,dividend-guidance,100,50,10/24/2018
0C6861,legal-issues-defendant,100,22,10/24/2018
0CBC4D,revenues,100,50,10/24/2018
0CE204,earnings,100,50,10/24/2018
0DC050,earnings,100,50,10/24/2018
0DC050,earnings,100,50,10/24/2018
0DC050,earnings,100,50,10/24/2018
0DC050,earnings,100,50,10/24/2018
0E2992,earnings,100,50,10/24/2018
0E439E,earnings,100,50,10/24/2018
0E439E,earnings,100,50,10/24/2018
0E439E,earnings,100,50,10/24/2018
0E6027,earnings-positive,100,69,10/24/2018
0F91FC,earnings,100,50,10/24/2018
102F04,earnings,100,50,10/24/2018
10943B,earnings,100,50,10/24/2018
10C19B,legal-issues-defendant,100,22,10/24/2018
12DE76,partnership,100,61,10/24/2018
152AB9,conference-call,100,50,10/24/2018
152B9E,earnings,100,50,10/24/2018
152E1D,credit-extension-recipient,100,69,10/24/2018
15901B,product-release,100,64,10/24/2018
159739,earnings,100,50,10/24/2018
168A5D,investment-investor,100,55,10/24/2018
16F4D8,earnings,100,50,10/24/2018
16F4D8,earnings,100,50,10/24/2018
16F4D8,earnings,100,50,10/24/2018
16F4D8,earnings,100,50,10/24/2018
16F4D8,earnings,100,50,10/24/2018
197019,earnings,100,50,10/24/2018
1B5FEA,earnings,100,50,10/24/2018
1CD708,earnings,100,50,10/24/2018
1E4FB9,partnership,100,61,10/24/2018
1E5786,dividend,100,50,10/24/2018
1E7785,conference-participant,100,50,10/24/2018
1E8A99,earnings,100,50,10/24/2018
1F3CFB,legal-issues-defendant,100,22,10/24/2018
1F3CFB,legal-issues-defendant,100,22,10/24/2018
1F716B,donation,100,54,10/24/2018
2031CE,earnings-up,100,68,10/24/2018
2031CE,earnings-up,100,68,10/24/2018
2031CE,earnings-up,100,68,10/24/2018
2031CE,earnings-up,100,68,10/24/2018
2031CE,earnings-up,100,68,10/24/2018
221AD7,earnings,100,50,10/24/2018
24C48B,conference-call,100,50,10/24/2018
25102A,earnings,100,50,10/24/2018
25102A,earnings,100,50,10/24/2018
25102A,earnings,100,50,10/24/2018
25102A,earnings,100,50,10/24/2018
25102A,earnings,100,50,10/24/2018
25102A,dividend,100,50,10/24/2018
251988,earnings,100,50,10/24/2018
251988,earnings,100,50,10/24/2018
251988,earnings,100,50,10/24/2018
251988,earnings,100,50,10/24/2018
251988,earnings,100,50,10/24/2018
251988,earnings,100,50,10/24/2018
25DD05,earnings,100,50,10/24/2018
264EB3,earnings,100,50,10/24/2018
26FA41,revenues,100,50,10/24/2018
270305,earnings,100,50,10/24/2018
270305,earnings,100,50,10/24/2018
270305,earnings,100,50,10/24/2018
29A4CC,earnings,100,50,10/24/2018
29A4CC,earnings,100,50,10/24/2018
29A4CC,earnings,100,50,10/24/2018
29A4CC,earnings,100,50,10/24/2018
29A4CC,earnings,100,50,10/24/2018
29A4CC,earnings,100,50,10/24/2018
29A4CC,earnings,100,50,10/24/2018
2.90E+62,earnings,100,50,10/24/2018
2.90E+62,earnings,100,50,10/24/2018
2.90E+62,earnings,100,50,10/24/2018
2.90E+62,earnings,100,50,10/24/2018
2.90E+62,earnings,100,50,10/24/2018
2.90E+62,earnings,100,50,10/24/2018
2.90E+62,dividend,100,50,10/24/2018
2B0AF4,earnings,100,50,10/24/2018
2C3348,legal-issues-defendant,100,22,10/24/2018
2C7505,legal-issues-defendant,100,22,10/24/2018
2D643C,earnings,100,50,10/24/2018
2F94A5,dividend,100,50,10/24/2018
301493,legal-issues-defendant,100,22,10/24/2018
30DFD3,earnings,100,50,10/24/2018
31A7CC,dividend,100,50,10/24/2018
326EDD,earnings,100,50,10/24/2018
32CB22,note-sale,100,52,10/24/2018
32CB22,note-sale,100,52,10/24/2018
32F943,earnings,100,50,10/24/2018
33E8C7,earnings,100,50,10/24/2018
33E8C7,earnings,100,50,10/24/2018
33E8C7,earnings,100,50,10/24/2018
343996,earnings,100,50,10/24/2018
3471C0,executive-appointment,100,54,10/24/2018
34B411,dividend,100,50,10/24/2018
366A08,executive-appointment,100,54,10/24/2018
366A08,spin-off,100,58,10/24/2018
36A1CB,conference-call,100,50,10/24/2018
3.73E+87,revenues,100,50,10/24/2018
3.73E+87,revenues,100,50,10/24/2018
3.73E+87,revenues,100,50,10/24/2018
389CFB,conference-call,100,50,10/24/2018
3B2311,earnings,100,50,10/24/2018
3D9999,dividend,100,50,10/24/2018
3F6A9C,conference-call,100,50,10/24/2018
3F868D,conference-call,100,50,10/24/2018
408089,partnership,100,61,10/24/2018
416C55,earnings,100,50,10/24/2018
41B0E2,earnings,100,50,10/24/2018
425BDC,earnings,100,50,10/24/2018
4290EF,earnings,100,50,10/24/2018
42DC93,unit-acquisition-completed-acquirer,100,49,10/24/2018
458D2C,earnings,100,50,10/24/2018
4649D5,conference-participant,100,50,10/24/2018
468DD4,earnings,100,50,10/24/2018
47752F,earnings,100,50,10/24/2018
47752F,earnings,100,50,10/24/2018
47752F,earnings,100,50,10/24/2018
47752F,earnings,100,50,10/24/2018
49CC59,asset-sale,100,62,10/24/2018
4B3555,earnings,100,50,10/24/2018
4B5054,dividend,100,50,10/24/2018
4B6EF9,dividend,100,50,10/24/2018
4B6EF9,executive-appointment,100,54,10/24/2018
4B6EF9,earnings,100,50,10/24/2018
4C1FA1,earnings,100,50,10/24/2018
4C1FA1,earnings,100,50,10/24/2018
4C1FA1,earnings,100,50,10/24/2018
4C1FA1,earnings,100,50,10/24/2018
4C1FA1,earnings,100,50,10/24/2018
4C1FA1,earnings,100,50,10/24/2018
4C37C5,partnership,100,61,10/24/2018
4C6C63,earnings,100,50,10/24/2018
4C6C63,earnings,100,50,10/24/2018
4C6C63,earnings,100,50,10/24/2018
4C6C63,earnings,100,50,10/24/2018
4C6C63,earnings,100,50,10/24/2018
4C92B9,legal-issues-defendant,100,22,10/24/2018
4C92B9,legal-issues-defendant,100,22,10/24/2018
4C92B9,legal-issues-defendant,100,22,10/24/2018
4D8313,revenues,100,50,10/24/2018
4D8313,revenues,100,50,10/24/2018
4D8313,revenues,100,50,10/24/2018
4D971D,earnings,100,50,10/24/2018
4D971D,earnings,100,50,10/24/2018
4D971D,earnings,100,50,10/24/2018
4D971D,earnings,100,50,10/24/2018
4D971D,earnings,100,50,10/24/2018
4D971D,earnings,100,50,10/24/2018
4EEE7E,business-contract,100,69,10/24/2018
4F9487,earnings-positive,100,69,10/24/2018
510EA1,earnings,100,50,10/24/2018
525A1C,award,100,58,10/24/2018
532D47,earnings,100,50,10/24/2018
539F49,ipo-completed,100,76,10/24/2018
539F49,ipo-completed,100,76,10/24/2018
539F49,ipo-completed,100,76,10/24/2018
539F49,ipo-completed,100,76,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
55438C,earnings,100,50,10/24/2018
5546DA,earnings-per-share-positive,100,69,10/24/2018
5546DA,earnings-per-share-positive,100,69,10/24/2018
5546DA,earnings-per-share-positive,100,69,10/24/2018
5546DA,earnings-per-share-positive,100,69,10/24/2018
5546DA,earnings-per-share-positive,100,69,10/24/2018
556F08,earnings,100,50,10/24/2018
55C289,earnings,100,50,10/24/2018
56AFF4,dividend,100,50,10/24/2018
57CAAB,earnings,100,50,10/24/2018
58C2D4,conference-participant,100,50,10/24/2018
58EA22,conference-participant,100,50,10/24/2018
594402,earnings,100,50,10/24/2018
59872F,partnership,100,61,10/24/2018
59872F,reorganization-unit,100,53,10/24/2018
59872F,partnership,100,61,10/24/2018
59DB8C,executive-appointment,100,54,10/24/2018
59F0B0,operating-earnings,100,50,10/24/2018
5A64D5,acquisition-acquirer,100,49,10/24/2018
5A64D5,acquisition-acquirer,100,49,10/24/2018
5A64D5,earnings,100,50,10/24/2018
5A9F54,earnings-up,100,68,10/24/2018
5A9F54,earnings-up,100,68,10/24/2018
5A9F54,earnings-up,100,68,10/24/2018
5A9F54,earnings-up,100,68,10/24/2018
5AAE17,conference-call,100,50,10/24/2018
5AF08A,earnings,100,50,10/24/2018
5B3FA2,earnings,100,50,10/24/2018
5B97B2,earnings,100,50,10/24/2018
5DD48B,earnings,100,50,10/24/2018
5DD48B,earnings,100,50,10/24/2018
5F2FF7,dividend,100,50,10/24/2018
60DD84,revenues,100,50,10/24/2018
60DD84,revenues,100,50,10/24/2018
60DD84,revenues,100,50,10/24/2018
65CF8E,earnings,100,50,10/24/2018
6634D9,earnings,100,50,10/24/2018
66E04A,earnings,100,50,10/24/2018
66E04A,earnings,100,50,10/24/2018
66E04A,earnings,100,50,10/24/2018
66E04A,earnings,100,50,10/24/2018
66E04A,earnings,100,50,10/24/2018
66E04A,earnings,100,50,10/24/2018
66E04A,earnings,100,50,10/24/2018
67529E,earnings,100,50,10/24/2018
67529E,earnings,100,50,10/24/2018
67529E,earnings,100,50,10/24/2018
67529E,earnings,100,50,10/24/2018
67529E,earnings,100,50,10/24/2018
67529E,earnings,100,50,10/24/2018
67529E,earnings,100,50,10/24/2018
69345C,earnings,100,50,10/24/2018
69345C,earnings,100,50,10/24/2018
69345C,earnings,100,50,10/24/2018
69345C,earnings,100,50,10/24/2018
694749,earnings,100,50,10/24/2018
6ACFBF,earnings,100,50,10/24/2018
6B5379,dividend,100,50,10/24/2018
6BDA0C,conference-call,100,50,10/24/2018
6C4D2F,dividend-up,100,81,10/24/2018
6E1E61,earnings,100,50,10/24/2018
6E705B,product-release,100,64,10/24/2018
6E7060,conference-call,100,50,10/24/2018
728737,earnings,100,50,10/24/2018
73C9E2,executive-death,100,31,10/24/2018
746373,earnings,100,50,10/24/2018
746373,earnings,100,50,10/24/2018
763724,conference-call,100,50,10/24/2018
76B926,earnings,100,50,10/24/2018
76B926,earnings,100,50,10/24/2018
7AC86E,earnings-up,100,68,10/24/2018
7AC86E,earnings,100,50,10/24/2018
7AC86E,earnings,100,50,10/24/2018
7B6C88,earnings,100,50,10/24/2018
7B9AFA,unit-acquisition-acquirer,100,49,10/24/2018
7C75FD,dividend,100,50,10/24/2018
7E2DE6,earnings,100,50,10/24/2018
7E62B5,earnings,100,50,10/24/2018
7F3669,partnership,100,61,10/24/2018
7FD8B9,conference-call,100,50,10/24/2018
80C400,conference-call,100,50,10/24/2018
818A2F,dividend,100,50,10/24/2018
834152,executive-appointment,100,54,10/24/2018
838ADD,earnings-up,100,68,10/24/2018
838ADD,earnings-up,100,68,10/24/2018
838ADD,earnings-up,100,68,10/24/2018
838ADD,earnings-up,100,68,10/24/2018
838ADD,earnings-up,100,68,10/24/2018
838ADD,earnings-up,100,68,10/24/2018
838ADD,earnings-up,100,68,10/24/2018
83B1C8,partnership,100,61,10/24/2018
83B1C8,earnings,100,50,10/24/2018
85DA04,acquisition-completed-acquirer,100,49,10/24/2018
8665BA,earnings,100,50,10/24/2018
8C1238,conference-call,100,50,10/24/2018
8E93A4,dividend,100,50,10/24/2018
8EEA28,dividend,100,50,10/24/2018
8FF2EF,conference-call,100,50,10/24/2018
901327,partnership,100,61,10/24/2018
911AB8,dividend,100,50,10/24/2018
922F0C,earnings-per-share-up,100,84,10/24/2018
9.31E+77,conference-call,100,50,10/24/2018
93F143,product-release,100,64,10/24/2018
942165,dividend,100,50,10/24/2018
9546A5,conference-call,100,50,10/24/2018
9592FB,earnings,100,50,10/24/2018
9673BD,conference-call,100,50,10/24/2018
979451,earnings,100,50,10/24/2018
97AF94,earnings,100,50,10/24/2018
98CAED,earnings,100,50,10/24/2018
98CAED,earnings,100,50,10/24/2018
98CAED,earnings,100,50,10/24/2018
98CAED,dividend-up,100,81,10/24/2018
98CEBB,conference-participant,100,50,10/24/2018
990AD0,executive-appointment,100,54,10/24/2018
990AD0,dividend,100,50,10/24/2018
9B0C9C,conference-participant,100,50,10/24/2018
9BB35A,earnings-per-share-positive,100,69,10/24/2018
9BB35A,earnings-per-share,100,50,10/24/2018
9BB35A,earnings-per-share,100,50,10/24/2018
9BB35A,earnings-per-share,100,50,10/24/2018
9BB35A,dividend,100,50,10/24/2018
9BF177,executive-appointment,100,54,10/24/2018
9C8664,earnings,100,50,10/24/2018
9D30A8,earnings,100,50,10/24/2018
9DDE1B,earnings,100,50,10/24/2018
9EA947,conference-participant,100,50,10/24/2018
9F37C5,dividend,100,50,10/24/2018
9F37C5,earnings,100,50,10/24/2018
9F6B1A,earnings,100,50,10/24/2018
9F6B1A,earnings,100,50,10/24/2018
9F6B1A,earnings,100,50,10/24/2018
9F6B1A,earnings,100,50,10/24/2018
9F6B1A,earnings,100,50,10/24/2018
9FA83B,conference-call,100,50,10/24/2018
A2CAF7,earnings,100,50,10/24/2018
A37D68,partnership,100,61,10/24/2018
A398F8,conference-participant,100,50,10/24/2018
A403CF,earnings,100,50,10/24/2018
A433A5,earnings,100,50,10/24/2018
A5A4F5,acquisition-acquirer,100,49,10/24/2018
A63387,acquisition-acquirer,100,49,10/24/2018
A63387,award,100,58,10/24/2018
A63387,award,100,58,10/24/2018
A8B137,dividend,100,50,10/24/2018
A99576,earnings,100,50,10/24/2018
AA847A,earnings,100,50,10/24/2018
AA98ED,legal-issues-defendant,100,22,10/24/2018
AABEA0,earnings-up,100,72,10/24/2018
AADE0B,dividend,100,50,10/24/2018
AB7F05,earnings,100,50,10/24/2018
AB7F05,earnings,100,50,10/24/2018
AB7F05,earnings,100,50,10/24/2018
AB7F05,earnings,100,50,10/24/2018
AD23DE,earnings,100,50,10/24/2018
AD23DE,earnings,100,50,10/24/2018
AD23DE,earnings,100,50,10/24/2018
AD23DE,earnings,100,50,10/24/2018
AD23DE,earnings,100,50,10/24/2018
AD3C93,earnings,100,50,10/24/2018
AFF7B4,earnings,100,50,10/24/2018
AFF7B4,earnings,100,50,10/24/2018
AFF7B4,earnings,100,50,10/24/2018
AFF7B4,earnings,100,50,10/24/2018
B1B10C,earnings,100,50,10/24/2018
B1B10C,earnings,100,50,10/24/2018
B1B10C,earnings,100,50,10/24/2018
B33E77,earnings,100,50,10/24/2018
B48FC9,earnings,100,50,10/24/2018
B5766D,executive-appointment,100,54,10/24/2018
B6082A,earnings,100,50,10/24/2018
B642E8,earnings,100,50,10/24/2018
B66928,earnings,100,50,10/24/2018
B8EF97,dividend,100,50,10/24/2018
BAAA60,earnings,100,50,10/24/2018
BB0587,legal-issues-defendant,100,22,10/24/2018
BB07E4,award,100,58,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BB88B6,earnings,100,50,10/24/2018
BBAE2A,earnings,100,50,10/24/2018
BC4876,dividend,100,50,10/24/2018
BDCC11,conference-call,100,50,10/24/2018
BDD12C,earnings,100,50,10/24/2018
BFCACF,earnings,100,50,10/24/2018
C01737,conference-participant,100,50,10/24/2018
C05839,earnings,100,50,10/24/2018
C05839,earnings,100,50,10/24/2018
C05839,earnings,100,50,10/24/2018
C05839,earnings,100,50,10/24/2018
C05839,earnings,100,50,10/24/2018
C062D4,dividend,100,50,10/24/2018
C1114B,conference-call,100,50,10/24/2018
C188F8,legal-issues-defendant,100,22,10/24/2018
C27E19,operating-earnings,100,50,10/24/2018
C38440,earnings,100,50,10/24/2018
C38440,earnings,100,50,10/24/2018
C5E100,conference-call,100,50,10/24/2018
C66A8C,ipo-pricing,100,50,10/24/2018
C97B2D,earnings,100,50,10/24/2018
C9B932,earnings,100,50,10/24/2018
C9B932,earnings,100,50,10/24/2018
CA99D7,conference-call,100,50,10/24/2018
CBA33B,earnings,100,50,10/24/2018
CBBFBF,dividend,100,50,10/24/2018
CC35BE,earnings,100,50,10/24/2018
CC8F6E,earnings,100,50,10/24/2018
CD4DA8,earnings,100,50,10/24/2018
CDFCC9,legal-issues-defendant,100,22,10/24/2018
CFE5BE,dividend,100,50,10/24/2018
CFF97C,partnership,100,61,10/24/2018
CFF97C,partnership,100,61,10/24/2018
D04D9F,conference-call,100,50,10/24/2018
D17C1B,executive-appointment,100,54,10/24/2018
D21D8A,earnings,100,50,10/24/2018
D21D8A,earnings,100,50,10/24/2018
D21D8A,earnings,100,50,10/24/2018
D21D8A,earnings,100,50,10/24/2018
D21D8A,earnings,100,50,10/24/2018
D21D8A,earnings,100,50,10/24/2018
D21D8A,earnings,100,50,10/24/2018
D437C3,earnings,100,50,10/24/2018
D4463B,earnings,100,50,10/24/2018
D58A11,earnings,100,50,10/24/2018
D58A11,earnings,100,50,10/24/2018
D58A11,earnings,100,50,10/24/2018
D5A350,earnings,100,50,10/24/2018
D7A953,earnings,100,50,10/24/2018
DB396B,earnings,100,50,10/24/2018
DB396B,earnings,100,50,10/24/2018
DB396B,earnings,100,50,10/24/2018
DB396B,dividend,100,50,10/24/2018
DCD97F,earnings,100,50,10/24/2018
DD3BB1,earnings,100,50,10/24/2018
DEF058,acquisition-acquirer,100,49,10/24/2018
DEF058,earnings,100,50,10/24/2018
DFADDB,partnership,100,61,10/24/2018
DFADDB,partnership,100,61,10/24/2018
E0339F,dividend,100,50,10/24/2018
E05DC8,stake-acquirer,100,48,10/24/2018
E07573,dividend,100,50,10/24/2018
E09997,facility-close,100,47,10/24/2018
E259C7,revenue-up,100,69,10/24/2018
E259C7,revenue-up,100,69,10/24/2018
E259C7,revenue-up,100,69,10/24/2018
E259C7,revenue-up,100,69,10/24/2018
E38906,earnings,100,50,10/24/2018
E4CE73,product-release,100,64,10/24/2018
E5752F,earnings,100,50,10/24/2018
E5F0A8,earnings-positive,100,69,10/24/2018
E5F0A8,earnings,100,50,10/24/2018
E5F0A8,earnings,100,50,10/24/2018
E5F0A8,earnings,100,50,10/24/2018
E70531,legal-issues-defendant,100,22,10/24/2018
E829E8,earnings-per-share-positive,100,69,10/24/2018
E90C84,earnings,100,50,10/24/2018
E959F3,earnings,100,50,10/24/2018
ED2A5E,conference-call,100,50,10/24/2018
ED2EFD,dividend-up,100,81,10/24/2018
ED79D9,conference-call,100,50,10/24/2018
ED9576,earnings,100,50,10/24/2018
EDF5CA,dividend,100,50,10/24/2018
F0B2B5,conference-call,100,50,10/24/2018
F0B877,earnings,100,50,10/24/2018
F179ED,executive-appointment,100,54,10/24/2018
F50BAB,earnings,100,50,10/24/2018
F50BAB,earnings,100,50,10/24/2018
F50BAB,earnings,100,50,10/24/2018
F50BAB,earnings,100,50,10/24/2018
F7902B,earnings,100,50,10/24/2018
F7902B,earnings,100,50,10/24/2018
F8084B,earnings-positive,100,69,10/24/2018
F92DBC,partnership,100,61,10/24/2018
F93C8A,conference-call,100,50,10/24/2018
FA918D,dividend,100,50,10/24/2018
FACF19,dividend,100,50,10/24/2018
FAE021,earnings-per-share-up,100,70,10/24/2018
FAE021,earnings-per-share-up,100,70,10/24/2018
FAE021,earnings-per-share-up,100,70,10/24/2018
FAE021,earnings-per-share-up,100,70,10/24/2018
FAE021,earnings-per-share-up,100,70,10/24/2018
FAE021,earnings-per-share-up,100,70,10/24/2018
FC1A6E,earnings,100,50,10/24/2018
FC1B7B,earnings,100,50,10/24/2018
FC4550,earnings,100,50,10/24/2018
FC9A88,earnings-up,100,68,10/24/2018
FD4E8D,revenue-up,100,69,10/24/2018
FD4E8D,revenues,100,50,10/24/2018
FD4E8D,revenues,100,50,10/24/2018
FDC7E6,dividend,100,50,10/24/2018
FDC7E6,earnings,100,50,10/24/2018
FE1A1D,operating-earnings,100,50,10/24/2018
FEE4B0,dividend,100,50,10/24/2018
FFCD0E,revenue-up,100,54,10/24/2018
FFE543,legal-issues-defendant,100,22,10/24/2018
9397,earnings,100,50,10/25/2018
9397,earnings,100,50,10/25/2018
01478A,earnings,100,50,10/25/2018
0157B1,facility-open,100,65,10/25/2018
0157B1,facility-open,100,65,10/25/2018
0157B1,revenue-up,100,73,10/25/2018
0157B1,revenue-up,100,73,10/25/2018
0157B1,revenue-up,100,73,10/25/2018
0157B1,revenue-up,100,73,10/25/2018
0157B1,revenue-up,100,73,10/25/2018
0157B1,revenue-up,100,73,10/25/2018
034B61,revenue-up,100,71,10/25/2018
048B70,conference-call,100,50,10/25/2018
0560D8,dividend,100,50,10/25/2018
61366,earnings,100,50,10/25/2018
061A3B,earnings,100,50,10/25/2018
061A3B,earnings,100,50,10/25/2018
061A3B,earnings,100,50,10/25/2018
75172,conference-call,100,50,10/25/2018
07CA6A,earnings,100,50,10/25/2018
07CA6A,executive-appointment,100,54,10/25/2018
083F72,executive-resignation,100,44,10/25/2018
0A0D9E,partnership,100,61,10/25/2018
0A1D77,earnings-positive,100,69,10/25/2018
0A1D77,earnings,100,50,10/25/2018
0A1D77,earnings,100,50,10/25/2018
0A1D77,earnings,100,50,10/25/2018
0A1D77,earnings,100,50,10/25/2018
0A1D77,earnings,100,50,10/25/2018
0A9D0A,earnings,100,50,10/25/2018
0B2071,earnings,100,50,10/25/2018
0B2071,earnings,100,50,10/25/2018
0BC17A,conference-participant,100,50,10/25/2018
0E499E,earnings,100,50,10/25/2018
0ED415,earnings,100,50,10/25/2018
0ED415,earnings,100,50,10/25/2018
0ED415,earnings,100,50,10/25/2018
0F04E5,earnings,100,50,10/25/2018
0F04E5,earnings,100,50,10/25/2018
0F04E5,earnings,100,50,10/25/2018
108FDA,earnings,100,50,10/25/2018
1096C6,executive-appointment,100,54,10/25/2018
1151F4,earnings,100,50,10/25/2018
1151F4,earnings,100,50,10/25/2018
1151F4,earnings,100,50,10/25/2018
1151F4,earnings,100,50,10/25/2018
1151F4,earnings,100,50,10/25/2018
1151F4,earnings,100,50,10/25/2018
1151F4,earnings,100,50,10/25/2018
119CB6,revenue-up,100,69,10/25/2018
1220D2,regulatory-product-approval-granted,100,81,10/25/2018
129DC8,earnings,100,50,10/25/2018
129DC8,earnings,100,50,10/25/2018
129DC8,earnings,100,50,10/25/2018
129DC8,earnings,100,50,10/25/2018
13C3E0,earnings-positive,100,69,10/25/2018
1490F3,credit-extension-recipient,100,69,10/25/2018
1490F3,earnings,100,50,10/25/2018
1490F3,earnings,100,50,10/25/2018
1490F3,earnings,100,50,10/25/2018
1490F3,earnings,100,50,10/25/2018
1490F3,earnings,100,50,10/25/2018
1490F3,earnings,100,50,10/25/2018
156A99,earnings,100,50,10/25/2018
15789A,earnings,100,50,10/25/2018
159AE4,earnings,100,50,10/25/2018
159AE4,earnings,100,50,10/25/2018
159AE4,earnings,100,50,10/25/2018
159AE4,earnings,100,50,10/25/2018
15B10D,conference-call,100,50,10/25/2018
1.79E+10,earnings,100,50,10/25/2018
196D18,executive-appointment,100,54,10/25/2018
1A6A94,executive-appointment,100,54,10/25/2018
1AF7E2,earnings-up,100,68,10/25/2018
1AF7E2,earnings,100,50,10/25/2018
1AF7E2,earnings,100,50,10/25/2018
1AF7E2,earnings,100,50,10/25/2018
1AF7E2,earnings,100,50,10/25/2018
1AF7E2,earnings,100,50,10/25/2018
1BC12C,business-contract,100,69,10/25/2018
1C599A,earnings,100,50,10/25/2018
1DA44F,earnings-up,100,68,10/25/2018
1DA44F,earnings,100,50,10/25/2018
1DA44F,earnings,100,50,10/25/2018
1DA44F,earnings,100,50,10/25/2018
1DA44F,earnings,100,50,10/25/2018
1E68B3,earnings,100,50,10/25/2018
1EBF8D,earnings,100,50,10/25/2018
1EBF8D,dividend-up,100,81,10/25/2018
1F3CFB,legal-issues-defendant,100,22,10/25/2018
1F3CFB,legal-issues-defendant,100,22,10/25/2018
1F9258,executive-appointment,100,54,10/25/2018
20DC4E,earnings,100,50,10/25/2018
21022F,debt-renegotiation,100,59,10/25/2018
21268E,conference-participant,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
21DED4,revenues,100,50,10/25/2018
223216,revenue-up,100,59,10/25/2018
228D42,partnership,100,61,10/25/2018
228D42,partnership,100,61,10/25/2018
2491BC,earnings,100,50,10/25/2018
2491BC,earnings,100,50,10/25/2018
251988,partnership,100,61,10/25/2018
25529C,earnings,100,50,10/25/2018
25A6CC,earnings,100,50,10/25/2018
25A6CC,earnings,100,50,10/25/2018
25A6CC,earnings,100,50,10/25/2018
25A6CC,earnings,100,50,10/25/2018
270305,dividend,100,50,10/25/2018
270B78,executive-appointment,100,54,10/25/2018
272472,earnings,100,50,10/25/2018
272704,dividend,100,50,10/25/2018
279916,product-release,100,64,10/25/2018
284289,earnings,100,50,10/25/2018
28DCA8,earnings,100,50,10/25/2018
28DCF3,earnings,100,50,10/25/2018
29B702,earnings,100,50,10/25/2018
2A17B1,earnings-up,100,68,10/25/2018
2A17B1,earnings-up,100,68,10/25/2018
2A17B1,earnings-up,100,68,10/25/2018
2B5483,earnings,100,50,10/25/2018
2B9DBB,earnings,100,50,10/25/2018
2BA977,earnings,100,50,10/25/2018
2DA92D,earnings,100,50,10/25/2018
2E6514,earnings,100,50,10/25/2018
2E6514,earnings,100,50,10/25/2018
2E6514,earnings,100,50,10/25/2018
2E6514,earnings,100,50,10/25/2018
2EB88B,business-contract,100,69,10/25/2018
2F94A5,earnings,100,50,10/25/2018
301493,conference-call,100,50,10/25/2018
306623,conference-call,100,50,10/25/2018
319BE2,executive-appointment,100,54,10/25/2018
319BE2,dividend-up,100,81,10/25/2018
319BE2,earnings,100,50,10/25/2018
328250,earnings,100,50,10/25/2018
3390DE,earnings,100,50,10/25/2018
3471C0,conference-call,100,50,10/25/2018
34A959,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
366A08,earnings,100,50,10/25/2018
371C01,earnings,100,50,10/25/2018
371C01,earnings,100,50,10/25/2018
373B06,dividend,100,50,10/25/2018
39692D,acquisition-acquirer,100,49,10/25/2018
39692D,earnings,100,50,10/25/2018
3A94DF,earnings,100,50,10/25/2018
3B20AB,earnings,100,50,10/25/2018
3B8484,earnings,100,50,10/25/2018
3BB616,earnings,100,50,10/25/2018
3BB616,earnings,100,50,10/25/2018
3BB616,earnings,100,50,10/25/2018
3E15F6,earnings,100,50,10/25/2018
3E15F6,earnings,100,50,10/25/2018
3E15F6,earnings,100,50,10/25/2018
3E15F6,earnings,100,50,10/25/2018
3F4668,executive-appointment,100,54,10/25/2018
4017AD,earnings,100,50,10/25/2018
408089,earnings,100,50,10/25/2018
416C55,board-meeting,100,51,10/25/2018
4290EF,dividend,100,50,10/25/2018
434F38,earnings,100,50,10/25/2018
444CC8,conference-call,100,50,10/25/2018
44740A,earnings,100,50,10/25/2018
449217,earnings-positive,100,69,10/25/2018
449217,earnings,100,50,10/25/2018
449217,earnings,100,50,10/25/2018
449217,earnings,100,50,10/25/2018
449217,earnings,100,50,10/25/2018
4595EF,earnings,100,50,10/25/2018
45ABCC,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
46CF27,earnings,100,50,10/25/2018
47752F,product-release,100,64,10/25/2018
479930,earnings,100,50,10/25/2018
49CC59,conference-call,100,50,10/25/2018
4A5C8D,revenue-up,100,69,10/25/2018
4A5C8D,earnings,100,50,10/25/2018
4BD6DB,earnings,100,50,10/25/2018
4C92B9,legal-issues-defendant,100,22,10/25/2018
4C92B9,legal-issues-defendant,100,22,10/25/2018
4C92B9,legal-issues-defendant,100,22,10/25/2018
4C92B9,legal-issues-defendant,100,22,10/25/2018
4D371E,conference-participant,100,50,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4D7BD8,earnings-up,100,68,10/25/2018
4E913D,earnings-up,100,61,10/25/2018
4E913D,earnings-up,100,61,10/25/2018
4EE167,earnings,100,50,10/25/2018
4EE167,earnings,100,50,10/25/2018
50070E,conference-call,100,50,10/25/2018
504FE2,earnings,100,50,10/25/2018
513A86,earnings,100,50,10/25/2018
519FE0,earnings,100,50,10/25/2018
51B442,earnings,100,50,10/25/2018
51E682,earnings,100,50,10/25/2018
52015A,earnings,100,50,10/25/2018
53A226,earnings,100,50,10/25/2018
543900,legal-issues-defendant,100,22,10/25/2018
567F3D,earnings,100,50,10/25/2018
567F3D,earnings,100,50,10/25/2018
567F3D,earnings,100,50,10/25/2018
567F3D,earnings,100,50,10/25/2018
567F3D,earnings,100,50,10/25/2018
57356F,earnings,100,50,10/25/2018
57356F,earnings,100,50,10/25/2018
57356F,earnings,100,50,10/25/2018
586BD7,conference-call,100,50,10/25/2018
586FFD,revenues,100,50,10/25/2018
586FFD,revenues,100,50,10/25/2018
589F5A,earnings,100,50,10/25/2018
59B229,earnings,100,50,10/25/2018
59B229,earnings,100,50,10/25/2018
59B229,earnings,100,50,10/25/2018
59B229,earnings,100,50,10/25/2018
59B229,earnings,100,50,10/25/2018
5B6C11,acquisition-acquirer,100,49,10/25/2018
5D02B7,earnings,100,50,10/25/2018
5D0337,earnings,100,50,10/25/2018
5D16CF,earnings,100,50,10/25/2018
5D1956,earnings,100,50,10/25/2018
5D63F1,facility-open,100,65,10/25/2018
5DD486,earnings,100,50,10/25/2018
5FE4B6,earnings,100,50,10/25/2018
5FE4B6,earnings,100,50,10/25/2018
616E3B,earnings,100,50,10/25/2018
616E3B,earnings,100,50,10/25/2018
616E3B,earnings,100,50,10/25/2018
616E3B,earnings,100,50,10/25/2018
616E3B,earnings,100,50,10/25/2018
619882,conference-organizer,100,57,10/25/2018
622037,dividend,100,50,10/25/2018
6284B5,dividend-up,100,81,10/25/2018
6284B5,earnings,100,50,10/25/2018
6284B5,earnings,100,50,10/25/2018
62EFEE,earnings,100,50,10/25/2018
63E8D5,earnings,100,50,10/25/2018
63E8D5,earnings,100,50,10/25/2018
641F17,earnings,100,50,10/25/2018
641F17,earnings,100,50,10/25/2018
641F17,earnings,100,50,10/25/2018
641F17,earnings,100,50,10/25/2018
641F17,earnings,100,50,10/25/2018
641F17,earnings,100,50,10/25/2018
64FF65,executive-appointment,100,54,10/25/2018
662682,dividend,100,50,10/25/2018
6634D9,partnership,100,61,10/25/2018
665618,dividend-up,100,60,10/25/2018
665618,earnings-up,100,68,10/25/2018
665618,earnings-up,100,68,10/25/2018
66E04A,stake-acquiree,100,62,10/25/2018
68586A,conference-call,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69E8E1,earnings,100,50,10/25/2018
69FDFC,executive-appointment,100,54,10/25/2018
69FDFC,executive-appointment,100,54,10/25/2018
6ABCB8,earnings,100,50,10/25/2018
6CDFC6,earnings,100,50,10/25/2018
6D3F35,earnings,100,50,10/25/2018
6D3F35,earnings,100,50,10/25/2018
6D3F35,earnings,100,50,10/25/2018
6D3F35,earnings,100,50,10/25/2018
6DC1D7,earnings,100,50,10/25/2018
6E8349,earnings,100,50,10/25/2018
724F84,earnings,100,50,10/25/2018
72CB93,earnings,100,50,10/25/2018
73529F,earnings,100,50,10/25/2018
73C9E2,earnings,100,50,10/25/2018
7448A3,earnings,100,50,10/25/2018
762A3E,dividend,100,50,10/25/2018
762A3E,earnings,100,50,10/25/2018
76CEFB,earnings,100,50,10/25/2018
76E80F,partnership,100,61,10/25/2018
773A17,revenue-up,100,64,10/25/2018
773A17,revenue-up,100,69,10/25/2018
773A17,revenue-up,100,69,10/25/2018
7771D7,earnings,100,50,10/25/2018
782B46,dividend,100,50,10/25/2018
78A1BB,earnings-up,100,68,10/25/2018
791D59,revenues,100,50,10/25/2018
791D59,revenues,100,50,10/25/2018
791D59,revenues,100,50,10/25/2018
791D59,revenues,100,50,10/25/2018
791D59,revenues,100,50,10/25/2018
791D59,revenues,100,50,10/25/2018
791D59,revenues,100,50,10/25/2018
7A0EC4,conference-participant,100,50,10/25/2018
7A5D58,earnings,100,50,10/25/2018
7B0BA6,dividend,100,50,10/25/2018
7B1E50,earnings,100,50,10/25/2018
7BAAE7,earnings-per-share-positive,100,69,10/25/2018
7BAAE7,earnings,100,50,10/25/2018
7C4F43,earnings,100,50,10/25/2018
7D5384,earnings,100,50,10/25/2018
7D5384,earnings,100,50,10/25/2018
7D5384,earnings,100,50,10/25/2018
7D5384,earnings,100,50,10/25/2018
7DC1C4,earnings,100,50,10/25/2018
7E0EB0,earnings,100,50,10/25/2018
80D744,earnings,100,50,10/25/2018
81A88D,earnings,100,50,10/25/2018
8.22E+27,earnings,100,50,10/25/2018
8303CD,earnings,100,50,10/25/2018
830BDB,earnings,100,50,10/25/2018
830BDB,earnings,100,50,10/25/2018
830BDB,earnings,100,50,10/25/2018
830BDB,earnings,100,50,10/25/2018
834152,clinical-trials-start,100,64,10/25/2018
83598E,dividend-up,100,81,10/25/2018
837C04,dividend,100,50,10/25/2018
837C04,earnings,100,50,10/25/2018
855DF7,executive-appointment,100,54,10/25/2018
860AB6,dividend,100,50,10/25/2018
860AB6,dividend,100,50,10/25/2018
8665BA,acquisition-completed-acquirer,100,49,10/25/2018
8.79E+06,earnings,100,50,10/25/2018
8817D5,earnings-up,100,68,10/25/2018
8B2C4A,buybacks,100,74,10/25/2018
8B3B0E,earnings,100,50,10/25/2018
8B6E7E,conference-call,100,50,10/25/2018
8D4486,partnership,100,61,10/25/2018
8D4486,business-contract,100,69,10/25/2018
8D5145,earnings,100,50,10/25/2018
8DE74B,earnings,100,50,10/25/2018
8E0E32,earnings,100,50,10/25/2018
8E4250,earnings,100,50,10/25/2018
8E4F9A,conference-call,100,50,10/25/2018
8F3231,acquisition-acquirer,100,49,10/25/2018
8F3231,earnings-up,100,68,10/25/2018
900356,earnings-up,100,68,10/25/2018
900356,earnings,100,50,10/25/2018
900356,earnings,100,50,10/25/2018
900356,earnings,100,50,10/25/2018
902255,earnings,100,50,10/25/2018
9043FE,earnings,100,50,10/25/2018
9043FE,earnings,100,50,10/25/2018
911AB8,executive-appointment,100,54,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
911AB8,earnings,100,50,10/25/2018
9196A2,conference-organizer,100,57,10/25/2018
92B625,conference-call,100,50,10/25/2018
92D9C9,earnings,100,50,10/25/2018
934029,earnings,100,50,10/25/2018
93C130,earnings,100,50,10/25/2018
93C130,dividend,100,50,10/25/2018
943239,earnings,100,50,10/25/2018
94563D,revenue-up,100,69,10/25/2018
94637C,earnings,100,50,10/25/2018
94756D,earnings,100,50,10/25/2018
965360,dividend,100,50,10/25/2018
9.74E+08,earnings,100,50,10/25/2018
9.74E+08,earnings,100,50,10/25/2018
9.74E+08,earnings,100,50,10/25/2018
9.74E+08,earnings,100,50,10/25/2018
9810C0,earnings,100,50,10/25/2018
990AD0,earnings,100,50,10/25/2018
990AD0,conference-organizer,100,57,10/25/2018
990AD0,conference-organizer,100,57,10/25/2018
9.92E+94,executive-appointment,100,54,10/25/2018
9.97E+09,earnings,100,50,10/25/2018
9B4066,unit-acquisition-acquirer,100,49,10/25/2018
9B5968,earnings,100,50,10/25/2018
9B5968,earnings,100,50,10/25/2018
9CDA4F,earnings,100,50,10/25/2018
9CE4C7,conference-participant,100,50,10/25/2018
9CF9B1,earnings,100,50,10/25/2018
9D307D,earnings,100,50,10/25/2018
9D4EC7,revenue-up,100,58,10/25/2018
9D4EC7,revenue-up,100,58,10/25/2018
9D4EC7,revenue-up,100,58,10/25/2018
9EA947,dividend,100,50,10/25/2018
9EBAFA,conference-call,100,50,10/25/2018
9EED50,earnings-up,100,68,10/25/2018
9F03CF,earnings,100,50,10/25/2018
9F03CF,dividend,100,50,10/25/2018
9FD2D9,earnings,100,50,10/25/2018
9FD2D9,earnings,100,50,10/25/2018
9FD2D9,earnings,100,50,10/25/2018
A02FB1,earnings,100,50,10/25/2018
A1A317,earnings,100,50,10/25/2018
A1A317,earnings,100,50,10/25/2018
A1A317,earnings,100,50,10/25/2018
A1A317,earnings,100,50,10/25/2018
A247F5,earnings,100,50,10/25/2018
A28675,earnings,100,50,10/25/2018
A398B9,earnings,100,50,10/25/2018
A398B9,earnings,100,50,10/25/2018
A398B9,earnings,100,50,10/25/2018
A4386C,dividend,100,50,10/25/2018
A5151E,buybacks,100,74,10/25/2018
A5151E,earnings,100,50,10/25/2018
A5A4F5,acquisition-acquirer,100,49,10/25/2018
A5B913,earnings,100,50,10/25/2018
A5B913,earnings,100,50,10/25/2018
A5B913,earnings,100,50,10/25/2018
A5B913,unit-acquisition-acquiree,100,76,10/25/2018
A5B913,unit-acquisition-acquiree,100,76,10/25/2018
A63387,executive-appointment,100,54,10/25/2018
A63820,earnings,100,50,10/25/2018
A63820,earnings,100,50,10/25/2018
A63820,earnings,100,50,10/25/2018
A63820,earnings,100,50,10/25/2018
A7CCF0,earnings-up,100,68,10/25/2018
A7CCF0,earnings,100,50,10/25/2018
A7CCF0,earnings,100,50,10/25/2018
A806FA,dividend-up,100,81,10/25/2018
A871B0,earnings,100,50,10/25/2018
A8CBDA,earnings-positive,100,69,10/25/2018
A94637,revenues,100,50,10/25/2018
AADE0B,earnings,100,50,10/25/2018
ABBAD1,earnings,100,50,10/25/2018
ABEE43,earnings,100,50,10/25/2018
AC1952,earnings,100,50,10/25/2018
AC1952,earnings,100,50,10/25/2018
AC1952,earnings,100,50,10/25/2018
AC1952,earnings,100,50,10/25/2018
AC1952,earnings,100,50,10/25/2018
AC1952,earnings,100,50,10/25/2018
AC775C,conference-call,100,50,10/25/2018
AC7AAE,conference-call,100,50,10/25/2018
AC7AAE,conference-call,100,50,10/25/2018
AD375D,earnings,100,50,10/25/2018
ADD9DC,facility-open,100,65,10/25/2018
B076A1,conference-call,100,50,10/25/2018
B08954,earnings,100,50,10/25/2018
B106FA,earnings,100,50,10/25/2018
B13B68,partnership,100,61,10/25/2018
B2206F,executive-appointment,100,54,10/25/2018
B381D8,earnings,100,50,10/25/2018
B5DE80,earnings,100,50,10/25/2018
B5DE80,earnings,100,50,10/25/2018
B619CB,earnings-positive,100,69,10/25/2018
B6CD92,earnings,100,50,10/25/2018
B80AD1,executive-appointment,100,54,10/25/2018
B8A51F,earnings,100,50,10/25/2018
B8F71F,executive-appointment,100,54,10/25/2018
BAAA60,dividend,100,50,10/25/2018
BB58FF,conference-participant,100,50,10/25/2018
BBBB41,dividend,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC3AD2,earnings,100,50,10/25/2018
BC5680,earnings-up,100,68,10/25/2018
BC5680,earnings-up,100,68,10/25/2018
BD682F,earnings,100,50,10/25/2018
BDD12C,earnings,100,50,10/25/2018
BDD12C,partnership,100,61,10/25/2018
BEB756,earnings,100,50,10/25/2018
BF79F5,earnings,100,50,10/25/2018
BF79F5,earnings,100,50,10/25/2018
BF79F5,earnings,100,50,10/25/2018
C16A8F,dividend,100,50,10/25/2018
C188F8,legal-issues-defendant,100,22,10/25/2018
C2609A,dividend,100,50,10/25/2018
C4F567,revenue-up,100,69,10/25/2018
C4F567,revenue-up,100,69,10/25/2018
C4F567,revenue-up,100,69,10/25/2018
C4F567,revenue-up,100,69,10/25/2018
C4F567,executive-appointment,100,54,10/25/2018
C5C137,partnership,100,61,10/25/2018
C5D2AE,earnings,100,50,10/25/2018
C5D2AE,executive-appointment,100,54,10/25/2018
C66B44,partnership,100,61,10/25/2018
C72B8F,earnings,100,50,10/25/2018
C7859D,conference-participant,100,50,10/25/2018
C81E00,operating-earnings,100,50,10/25/2018
C83B88,earnings,100,50,10/25/2018
C83B88,earnings,100,50,10/25/2018
C83B88,earnings,100,50,10/25/2018
C83B88,earnings,100,50,10/25/2018
C83B88,earnings,100,50,10/25/2018
C83B88,earnings,100,50,10/25/2018
C83B88,dividend,100,50,10/25/2018
C8FAC7,earnings,100,50,10/25/2018
C99CC8,earnings,100,50,10/25/2018
CA1620,fraud-defendant,100,20,10/25/2018
CB22CD,revenue-up,100,69,10/25/2018
CB22CD,revenue-up,100,69,10/25/2018
CB89EA,facility-open,100,65,10/25/2018
CC35BE,unit-acquisition-acquirer,100,49,10/25/2018
CC6F6E,conference-participant,100,50,10/25/2018
CDAB24,earnings,100,50,10/25/2018
CDEDFE,earnings,100,50,10/25/2018
CE1002,earnings,100,50,10/25/2018
CE1002,earnings,100,50,10/25/2018
CE1002,earnings,100,50,10/25/2018
CE1002,earnings,100,50,10/25/2018
CE1002,earnings,100,50,10/25/2018
CE96E7,earnings,100,50,10/25/2018
CE96E7,earnings,100,50,10/25/2018
CE96E7,earnings,100,50,10/25/2018
CEDFD5,clinical-trials,100,56,10/25/2018
CEDFD5,clinical-trials,100,56,10/25/2018
CF6A5A,earnings,100,50,10/25/2018
CFF15D,conference-call,100,50,10/25/2018
CFF97C,earnings,100,50,10/25/2018
CFF97C,earnings,100,50,10/25/2018
CFF97C,earnings,100,50,10/25/2018
CFF97C,earnings,100,50,10/25/2018
CFF97C,earnings,100,50,10/25/2018
CFF97C,credit-rating-set-rater,20,50,10/25/2018
D0DFE5,earnings,100,50,10/25/2018
D13F1C,conference-call,100,50,10/25/2018
D29B44,partnership,100,61,10/25/2018
D33D8C,buybacks,100,74,10/25/2018
D3F64D,earnings,100,50,10/25/2018
D3F64D,earnings,100,50,10/25/2018
D3F64D,earnings,100,50,10/25/2018
D3F64D,earnings,100,50,10/25/2018
D3F64D,earnings,100,50,10/25/2018
D3F64D,earnings,100,50,10/25/2018
D3F64D,earnings,100,50,10/25/2018
D4070C,earnings,100,50,10/25/2018
D518D8,revenues,100,50,10/25/2018
D518D8,earnings,100,50,10/25/2018
D518D8,earnings,100,50,10/25/2018
D518D8,earnings,100,50,10/25/2018
D518D8,earnings,100,50,10/25/2018
D56D6D,conference-participant,100,50,10/25/2018
D56E4C,conference-call,100,50,10/25/2018
D6EAA3,reorganization-unit,100,53,10/25/2018
D6EAA3,dividend,100,50,10/25/2018
D76AEF,conference-call,100,50,10/25/2018
D82EF3,executive-appointment,100,54,10/25/2018
D8760C,dividend,100,50,10/25/2018
D8F347,earnings-up,100,68,10/25/2018
D8F347,earnings-up,100,68,10/25/2018
D8F347,earnings,100,50,10/25/2018
D9164D,dividend,100,50,10/25/2018
D9164D,earnings,100,50,10/25/2018
D96202,earnings,100,50,10/25/2018
D9B1C9,earnings,100,50,10/25/2018
D9B1C9,earnings,100,50,10/25/2018
D9B1C9,earnings,100,50,10/25/2018
DA199F,earnings,100,50,10/25/2018
DA90E1,earnings,100,50,10/25/2018
DA91AE,conference-participant,100,50,10/25/2018
DAFED3,earnings,100,50,10/25/2018
DAFED3,earnings,100,50,10/25/2018
DAFED3,earnings,100,50,10/25/2018
DAFED3,earnings,100,50,10/25/2018
DBCA3F,earnings,100,50,10/25/2018
DC0998,earnings,100,50,10/25/2018
DC0998,earnings,100,50,10/25/2018
DC0998,earnings,100,50,10/25/2018
DC0998,earnings,100,50,10/25/2018
DC0998,earnings,100,50,10/25/2018
DC1405,conference-participant,100,50,10/25/2018
DC5299,operating-earnings,100,50,10/25/2018
DD0099,earnings-up,100,68,10/25/2018
DD0F15,earnings,100,50,10/25/2018
DF6FDD,earnings,100,50,10/25/2018
E05DC8,earnings,100,50,10/25/2018
E074A0,executive-appointment,100,54,10/25/2018
E10D31,dividend,100,50,10/25/2018
E1BD05,earnings,100,50,10/25/2018
E1E093,partnership,100,61,10/25/2018
E1E093,partnership,100,61,10/25/2018
E1E093,product-release,100,64,10/25/2018
E2CB7B,earnings,100,50,10/25/2018
E30B34,executive-appointment,100,54,10/25/2018
E40FB6,earnings,100,50,10/25/2018
E40FB6,earnings,100,50,10/25/2018
E40FB6,earnings,100,50,10/25/2018
E40FB6,earnings,100,50,10/25/2018
E40FB6,earnings,100,50,10/25/2018
E74FED,earnings,100,50,10/25/2018
E82A2D,conference-participant,100,50,10/25/2018
E866D2,earnings-positive,100,69,10/25/2018
E866D2,earnings-positive,100,69,10/25/2018
E866D2,earnings-positive,100,69,10/25/2018
E866D2,earnings-positive,100,69,10/25/2018
E866D2,earnings-positive,100,69,10/25/2018
E866D2,earnings-positive,100,69,10/25/2018
E93A40,earnings,100,50,10/25/2018
E99180,earnings,100,50,10/25/2018
E9FF33,executive-appointment,100,54,10/25/2018
EA62FC,dividend,100,50,10/25/2018
EB61C4,earnings,100,50,10/25/2018
EB7FBF,earnings,100,50,10/25/2018
EBD89A,earnings,100,50,10/25/2018
ED0D7C,earnings,100,50,10/25/2018
ED0D7C,earnings,100,50,10/25/2018
ED0D7C,earnings,100,50,10/25/2018
ED0D7C,earnings,100,50,10/25/2018
ED8676,earnings-up,100,68,10/25/2018
ED8676,earnings-up,100,68,10/25/2018
ED8676,earnings-up,100,68,10/25/2018
ED8676,earnings-up,100,68,10/25/2018
ED8676,earnings-up,100,68,10/25/2018
ED8676,earnings-up,100,68,10/25/2018
ED8676,earnings-up,100,68,10/25/2018
ED8676,dividend,100,50,10/25/2018
EE1E44,earnings,100,50,10/25/2018
EE1E44,earnings,100,50,10/25/2018
EE1E44,earnings,100,50,10/25/2018
EE1E44,earnings,100,50,10/25/2018
EE1E44,earnings,100,50,10/25/2018
EE1E44,earnings,100,50,10/25/2018
EEEA9F,earnings-up,100,68,10/25/2018
EEEA9F,earnings,100,50,10/25/2018
EEEA9F,earnings,100,50,10/25/2018
EEEA9F,earnings,100,50,10/25/2018
EFA7B2,earnings,100,50,10/25/2018
F0027C,earnings,100,50,10/25/2018
F02D0A,dividend,100,50,10/25/2018
F04E05,earnings,100,50,10/25/2018
F1C04C,operating-earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F294DD,earnings,100,50,10/25/2018
F3FCC3,conference-call,100,50,10/25/2018
F4E882,earnings,100,50,10/25/2018
F6E248,earnings,100,50,10/25/2018
F6E248,dividend,100,50,10/25/2018
F721A7,earnings,100,50,10/25/2018
F721A7,earnings,100,50,10/25/2018
F721A7,note-sale,100,52,10/25/2018
F721A7,note-sale,100,52,10/25/2018
F793FA,earnings,100,50,10/25/2018
F7FCA4,dividend,100,50,10/25/2018
F88A04,earnings,100,50,10/25/2018
FA36A4,executive-appointment,100,54,10/25/2018
FA918D,earnings,100,50,10/25/2018
FA918D,earnings,100,50,10/25/2018
FAE021,product-release,100,64,10/25/2018
FC1F9D,earnings,100,50,10/25/2018
FC80E6,earnings,100,50,10/25/2018
FD4BBE,earnings,100,50,10/25/2018
FD4BBE,earnings,100,50,10/25/2018
FD4BBE,earnings,100,50,10/25/2018
FD9526,earnings-guidance-up,100,83,10/25/2018
FDF28E,conference-participant,100,50,10/25/2018
FE89E0,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
FF4343,earnings,100,50,10/25/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
03B8CF,earnings,100,50,10/26/2018
0490C6,earnings,100,50,10/26/2018
51332,dividend,100,50,10/26/2018
0BD4E8,earnings,100,50,10/26/2018
0BD4E8,earnings,100,50,10/26/2018
0BD4E8,earnings,100,50,10/26/2018
0BD4E8,earnings,100,50,10/26/2018
0BD4E8,earnings,100,50,10/26/2018
0D03C8,earnings,100,50,10/26/2018
0FDE97,earnings,100,50,10/26/2018
0FDE97,earnings,100,50,10/26/2018
0FDE97,earnings,100,50,10/26/2018
0FDE97,earnings,100,50,10/26/2018
0FDE97,earnings,100,50,10/26/2018
0FDE97,earnings,100,50,10/26/2018
0FDE97,earnings,100,50,10/26/2018
10C19B,legal-issues-defendant,100,22,10/26/2018
139303,earnings,100,50,10/26/2018
152E1D,conference-call,100,50,10/26/2018
1.79E+10,product-release,100,64,10/26/2018
184988,clinical-trials,100,56,10/26/2018
1866B2,conference-call,100,50,10/26/2018
19C105,earnings,100,50,10/26/2018
1EC3E8,earnings,100,50,10/26/2018
1F3CFB,legal-issues-defendant,100,22,10/26/2018
253B2F,conference-call,100,50,10/26/2018
270305,earnings,100,50,10/26/2018
272472,dividend,100,50,10/26/2018
2DB344,buybacks,100,74,10/26/2018
2F98A5,dividend,100,50,10/26/2018
338544,earnings,100,50,10/26/2018
3461CF,earnings,100,50,10/26/2018
383ADA,earnings,100,50,10/26/2018
3.88E+02,earnings,100,50,10/26/2018
3E39A5,dividend,100,50,10/26/2018
3FACA7,earnings-positive,100,69,10/26/2018
3FACA7,earnings,100,50,10/26/2018
3FACA7,earnings,100,50,10/26/2018
408089,partnership,100,61,10/26/2018
423279,dividend,100,50,10/26/2018
460C93,earnings,100,50,10/26/2018
4A2457,conference-call,100,50,10/26/2018
4A2457,conference-participant,100,50,10/26/2018
4A5C8D,legal-issues-defendant,100,22,10/26/2018
4B5054,earnings,100,50,10/26/2018
4D371E,dividend,100,50,10/26/2018
4E6F5A,clinical-trials,100,56,10/26/2018
4EC4C1,business-contract,100,69,10/26/2018
4EC4C1,earnings,100,50,10/26/2018
4EC4C1,business-contract,100,69,10/26/2018
56277A,earnings,100,50,10/26/2018
562853,earnings,100,50,10/26/2018
57DDB9,conference-call,100,50,10/26/2018
586FFD,executive-appointment,100,54,10/26/2018
58CA9A,regulatory-stress-test,100,50,10/26/2018
596116,earnings,100,50,10/26/2018
5E6959,earnings-up,100,68,10/26/2018
6166D1,partnership,100,61,10/26/2018
619882,regulatory-stress-test,100,50,10/26/2018
665D7D,legal-issues-defendant,100,22,10/26/2018
69CE71,conference-call,100,50,10/26/2018
6E7060,dividend,100,50,10/26/2018
6F39FC,conference-call,100,50,10/26/2018
7032D0,earnings,100,50,10/26/2018
72EF75,dividend,100,50,10/26/2018
76BD96,conference-call,100,50,10/26/2018
76BECC,conference-call,100,50,10/26/2018
76F067,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7999F3,earnings,100,50,10/26/2018
7B4B91,earnings,100,50,10/26/2018
7FC386,earnings,100,50,10/26/2018
80C400,earnings,100,50,10/26/2018
81EAD4,conference-call,100,50,10/26/2018
82B57E,earnings,100,50,10/26/2018
863350,facility-open,100,65,10/26/2018
863350,facility-open,100,65,10/26/2018
86AA9C,earnings,100,50,10/26/2018
8AC740,conference-call,100,50,10/26/2018
8EDACA,legal-issues-defendant,100,22,10/26/2018
8EDACA,legal-issues-defendant,100,22,10/26/2018
902255,conference-participant,100,50,10/26/2018
931AE7,clinical-trials,100,56,10/26/2018
97B027,dividend,100,50,10/26/2018
9B730A,clinical-trials-positive,100,87,10/26/2018
9D6A24,dividend-up,100,56,10/26/2018
A2CA3F,dividend,100,50,10/26/2018
A5A4F5,acquisition-acquirer,100,49,10/26/2018
A6213D,conference-call,100,50,10/26/2018
A666C8,earnings,100,50,10/26/2018
A666C8,earnings,100,50,10/26/2018
A666C8,earnings,100,50,10/26/2018
A666C8,earnings,100,50,10/26/2018
AAC8B6,conference-call,100,50,10/26/2018
AC642C,earnings,100,50,10/26/2018
AC642C,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
AD9F1D,earnings,100,50,10/26/2018
B09B1F,earnings-up,100,68,10/26/2018
B09B1F,earnings,100,50,10/26/2018
B09B1F,earnings,100,50,10/26/2018
B77F14,conference-call,100,50,10/26/2018
BBBB41,executive-appointment,100,54,10/26/2018
BD8517,conference-participant,100,50,10/26/2018
BDD12C,earnings,100,50,10/26/2018
BE14CF,dividend,100,50,10/26/2018
C01737,earnings,100,50,10/26/2018
C037A8,executive-appointment,100,54,10/26/2018
C03C8B,conference-participant,100,50,10/26/2018
C564E4,clinical-trials,100,56,10/26/2018
C5C137,dividend,100,50,10/26/2018
C72B8F,award,100,58,10/26/2018
CB9E13,conference-call,100,50,10/26/2018
CBCC6A,earnings,100,50,10/26/2018
CBCC6A,earnings,100,50,10/26/2018
CC0C78,earnings,100,50,10/26/2018
D57D99,executive-appointment,100,54,10/26/2018
D57D99,dividend,100,50,10/26/2018
D7F569,dividend,100,50,10/26/2018
D7F569,earnings,100,50,10/26/2018
D88EF3,earnings,100,50,10/26/2018
D88EF3,earnings,100,50,10/26/2018
D88EF3,earnings,100,50,10/26/2018
D88EF3,earnings,100,50,10/26/2018
D88EF3,earnings,100,50,10/26/2018
D88EF3,earnings,100,50,10/26/2018
DA0A9E,earnings,100,50,10/26/2018
DB5CA5,dividend,100,50,10/26/2018
DB5CA5,dividend,100,50,10/26/2018
E30B34,award,100,58,10/26/2018
E5D914,conference-call,100,50,10/26/2018
E82A2D,dividend,100,50,10/26/2018
E87676,revenue-up,100,69,10/26/2018
E87676,earnings,100,50,10/26/2018
E87676,earnings,100,50,10/26/2018
E8846E,conference-participant,100,50,10/26/2018
EB36DE,merger,100,66,10/26/2018
EB6965,earnings,100,50,10/26/2018
EB6965,earnings,100,50,10/26/2018
EB6965,earnings,100,50,10/26/2018
EB6965,earnings,100,50,10/26/2018
EB6965,earnings,100,50,10/26/2018
EB6965,earnings,100,50,10/26/2018
EB6965,earnings,100,50,10/26/2018
EE1E44,executive-appointment,100,54,10/26/2018
EE6F1C,dividend,100,50,10/26/2018
EEBCEF,dividend,100,50,10/26/2018
F47871,executive-appointment,100,54,10/26/2018
F4CDA3,conference-call,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F6FA6A,earnings,100,50,10/26/2018
F748C7,executive-appointment,100,54,10/26/2018
FA36A4,earnings,100,50,10/26/2018
FA40E2,acquisition-completed-acquirer,100,49,10/26/2018
FBDA0F,earnings,100,50,10/26/2018
FC1A6E,legal-issues-defendant,100,22,10/26/2018
FC1A6E,legal-issues-defendant,100,22,10/26/2018
FD0CA4,dividend,100,50,10/26/2018
FF4BA4,earnings,100,50,10/26/2018
FF4BA4,earnings,100,50,10/26/2018
FF4BA4,earnings,100,50,10/26/2018
FF4BA4,earnings,100,50,10/26/2018
FF4BA4,earnings,100,50,10/26/2018
FF4BA4,earnings,100,50,10/26/2018
FFCD0E,conference-call,100,50,10/26/2018
36C09B,legal-issues-defendant,100,22,10/27/2018
3B318A,legal-issues-defendant,100,22,10/27/2018
3B318A,legal-issues-defendant,100,22,10/27/2018
48F795,legal-issues-defendant,100,22,10/27/2018
4A6F00,legal-verdict-disfavored,100,22,10/27/2018
543900,legal-issues-defendant,100,22,10/27/2018
835C86,earnings,100,50,10/27/2018
96A6CD,clinical-trials,100,56,10/27/2018
790C34,earnings,100,50,10/28/2018
8D4486,acquisition-acquirer,100,49,10/28/2018
8D4486,acquisition-acquirer,100,49,10/28/2018
8D4486,acquisition-acquirer,100,49,10/28/2018
8D4486,acquisition-acquirer,100,49,10/28/2018
8D4486,acquisition-acquirer,100,49,10/28/2018
8D4486,acquisition-acquirer,100,49,10/28/2018
F0B335,clinical-trials-positive,100,87,10/28/2018
0157B1,donation,100,54,10/29/2018
034B61,partnership,100,61,10/29/2018
75172,executive-appointment,100,54,10/29/2018
0B2071,dividend,100,50,10/29/2018
0BC29E,executive-appointment,100,54,10/29/2018
0C2A0D,revenues,100,50,10/29/2018
0C2A0D,revenues,100,50,10/29/2018
0C2A0D,revenues,100,50,10/29/2018
0C2A0D,revenues,100,50,10/29/2018
0C6861,legal-issues-defendant,100,22,10/29/2018
1080C0,earnings,100,50,10/29/2018
1151F4,product-release,100,64,10/29/2018
1216D1,earnings,100,50,10/29/2018
1216D1,merger,100,66,10/29/2018
125212,earnings,100,50,10/29/2018
12DE76,acquisition-completed-acquiree,100,76,10/29/2018
152E1D,executive-appointment,100,54,10/29/2018
1748B3,buybacks,100,74,10/29/2018
17EDA5,partnership,100,61,10/29/2018
197612,earnings,100,50,10/29/2018
1A5957,earnings,100,50,10/29/2018
1D943E,earnings,100,50,10/29/2018
1E9A6D,executive-appointment,100,54,10/29/2018
1F43A1,merger-regulatory-approval,100,81,10/29/2018
20DC4E,dividend,100,50,10/29/2018
21022F,earnings,100,50,10/29/2018
221445,earnings,100,50,10/29/2018
222BF9,earnings,100,50,10/29/2018
253B2F,conference-participant,100,50,10/29/2018
26F31D,earnings,100,50,10/29/2018
26F31D,earnings,100,50,10/29/2018
26F31D,earnings,100,50,10/29/2018
26F31D,earnings,100,50,10/29/2018
270305,executive-appointment,100,54,10/29/2018
270305,merger-regulatory-approval,100,81,10/29/2018
27A791,earnings,100,50,10/29/2018
2ABF77,conference-call,100,50,10/29/2018
2C3348,legal-issues-defendant,100,22,10/29/2018
2C7505,legal-issues-defendant,100,22,10/29/2018
2C7505,legal-issues-defendant,100,22,10/29/2018
2F1299,conference-call,100,50,10/29/2018
2F5256,award,100,58,10/29/2018
2FEA66,operating-earnings,100,50,10/29/2018
30AB63,earnings,100,50,10/29/2018
3.30E+34,acquisition-completed-acquirer,100,49,10/29/2018
33E9D5,public-offering,100,43,10/29/2018
36C09B,legal-issues-defendant,100,22,10/29/2018
37020C,conference-participant,100,50,10/29/2018
37727A,earnings-guidance-up,100,83,10/29/2018
37727A,earnings,100,50,10/29/2018
37727A,earnings,100,50,10/29/2018
37727A,earnings,100,50,10/29/2018
37727A,earnings,100,50,10/29/2018
37727A,earnings,100,50,10/29/2018
3B318A,legal-issues-defendant,100,22,10/29/2018
3B37F7,conference-call,100,50,10/29/2018
3C11C4,executive-appointment,100,54,10/29/2018
3DB18B,earnings,100,50,10/29/2018
3DD5E2,partnership,100,61,10/29/2018
3DED49,conference-call,100,50,10/29/2018
3E39A5,conference-participant,100,50,10/29/2018
401072,executive-appointment,100,54,10/29/2018
408380,product-release,100,64,10/29/2018
41C528,conference-call,100,50,10/29/2018
429BFB,earnings,100,50,10/29/2018
435ACE,dividend,100,50,10/29/2018
4455C4,earnings,100,50,10/29/2018
4455C4,earnings,100,50,10/29/2018
4455C4,earnings,100,50,10/29/2018
4455C4,earnings,100,50,10/29/2018
453282,conference-participant,100,50,10/29/2018
47FCF2,partnership,100,61,10/29/2018
48F795,legal-issues-defendant,100,22,10/29/2018
494EB9,earnings,100,50,10/29/2018
4A2457,award,100,58,10/29/2018
4A5C8D,legal-issues-defendant,100,22,10/29/2018
4A6F00,partnership,100,61,10/29/2018
4A6F00,product-release,100,64,10/29/2018
4A6F00,legal-issues-defendant,100,22,10/29/2018
4BDCA7,conference-call,100,50,10/29/2018
4C31F3,conference-call,100,50,10/29/2018
4C92B9,legal-issues-defendant,100,22,10/29/2018
4C92B9,legal-issues-defendant,100,22,10/29/2018
4D8E5E,earnings,100,50,10/29/2018
50070E,business-contract,100,69,10/29/2018
50070E,business-contract,100,69,10/29/2018
504FE2,buybacks,100,74,10/29/2018
507AE7,earnings,100,50,10/29/2018
5088A5,earnings,100,50,10/29/2018
514067,earnings,100,50,10/29/2018
51F541,earnings,100,50,10/29/2018
5.43E+08,partnership,100,61,10/29/2018
543900,legal-issues-defendant,100,22,10/29/2018
57634F,earnings,100,50,10/29/2018
57A854,executive-appointment,100,54,10/29/2018
5A9A82,legal-issues-defendant,100,22,10/29/2018
5BE42C,earnings,100,50,10/29/2018
5C8D61,earnings,100,50,10/29/2018
5C8D61,earnings,100,50,10/29/2018
5C8D61,earnings,100,50,10/29/2018
5D1329,executive-appointment,100,54,10/29/2018
5EF130,conference-call,100,50,10/29/2018
62A48D,acquisition-acquirer,100,49,10/29/2018
63F892,patent-infringement-defendant,100,26,10/29/2018
665D7D,legal-issues-defendant,100,22,10/29/2018
66749D,earnings-up,100,68,10/29/2018
66749D,earnings-up,100,68,10/29/2018
66749D,earnings-up,100,68,10/29/2018
66749D,earnings-up,100,68,10/29/2018
66749D,earnings-up,100,68,10/29/2018
66A667,conference-participant,100,50,10/29/2018
68B03F,earnings,100,50,10/29/2018
68B03F,earnings,100,50,10/29/2018
68B03F,earnings,100,50,10/29/2018
68B03F,earnings,100,50,10/29/2018
693ECD,earnings,100,50,10/29/2018
693ECD,earnings,100,50,10/29/2018
6D3F35,executive-appointment,100,54,10/29/2018
6D4636,earnings,100,50,10/29/2018
6D6B40,earnings,100,50,10/29/2018
6DDA15,conference-call,100,50,10/29/2018
6F0096,conference-participant,100,50,10/29/2018
6F3936,executive-appointment,100,54,10/29/2018
709AED,dividend-up,100,81,10/29/2018
709AED,buybacks,100,74,10/29/2018
709AED,earnings,100,50,10/29/2018
709AED,earnings,100,50,10/29/2018
709AED,earnings,100,50,10/29/2018
709AED,earnings,100,50,10/29/2018
713810,partnership,100,61,10/29/2018
735388,earnings,100,50,10/29/2018
75F665,merger,100,66,10/29/2018
769F40,earnings,100,50,10/29/2018
7710F3,business-contract,100,69,10/29/2018
782B46,earnings,100,50,10/29/2018
787D14,executive-appointment,100,54,10/29/2018
79340A,earnings,100,50,10/29/2018
797C20,conference-call,100,50,10/29/2018
7A10FF,earnings,100,50,10/29/2018
7CBC40,earnings,100,50,10/29/2018
7CBC40,earnings,100,50,10/29/2018
7CBC40,earnings,100,50,10/29/2018
7CBC40,earnings,100,50,10/29/2018
7F3669,executive-appointment,100,54,10/29/2018
7F3669,earnings,100,50,10/29/2018
7F3A5F,conference-participant,100,50,10/29/2018
803FED,executive-appointment,100,54,10/29/2018
82E58A,earnings-guidance,100,50,10/29/2018
83598E,earnings,100,50,10/29/2018
850779,dividend,100,50,10/29/2018
860AB6,earnings,100,50,10/29/2018
8665BA,conference-participant,100,50,10/29/2018
8665BA,partnership,100,61,10/29/2018
8665BA,facility-open,100,65,10/29/2018
8802B4,earnings,100,50,10/29/2018
885758,earnings,100,50,10/29/2018
8876D6,business-contract,100,69,10/29/2018
8AB85C,clinical-trials,100,56,10/29/2018
8BE916,earnings,100,50,10/29/2018
8C1238,earnings,100,50,10/29/2018
8C1238,earnings,100,50,10/29/2018
8C1238,earnings,100,50,10/29/2018
8C1238,earnings,100,50,10/29/2018
8C311A,product-release,100,64,10/29/2018
8FE7A5,earnings,100,50,10/29/2018
9043FE,acquisition-acquirer,100,49,10/29/2018
9043FE,acquisition-acquirer,100,49,10/29/2018
954004,facility-open,100,65,10/29/2018
968103,earnings,100,50,10/29/2018
9.86E+03,earnings,100,50,10/29/2018
990AD0,conference-organizer,100,57,10/29/2018
990AD0,conference-organizer,100,57,10/29/2018
990AD0,conference-organizer,100,57,10/29/2018
990AD0,conference-organizer,100,57,10/29/2018
9.92E+94,partnership,100,61,10/29/2018
9A2760,earnings,100,50,10/29/2018
9BB35A,earnings,100,50,10/29/2018
9BB35A,earnings,100,50,10/29/2018
9BB35A,earnings,100,50,10/29/2018
9BB35A,earnings,100,50,10/29/2018
9BB35A,earnings,100,50,10/29/2018
9D65C1,earnings,100,50,10/29/2018
9EA947,earnings,100,50,10/29/2018
9F18FA,earnings,100,50,10/29/2018
9F18FA,earnings,100,50,10/29/2018
A204A7,earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A350C1,operating-earnings,100,50,10/29/2018
A47F2E,earnings,100,50,10/29/2018
A5A4F5,acquisition-acquirer,100,49,10/29/2018
A9ED24,earnings,100,50,10/29/2018
A9ED24,earnings,100,50,10/29/2018
A9ED24,earnings,100,50,10/29/2018
A9ED24,earnings,100,50,10/29/2018
A9ED24,earnings,100,50,10/29/2018
AA98ED,legal-issues-defendant,100,22,10/29/2018
AC7AAE,earnings,100,50,10/29/2018
AD1ACF,conference-call,100,50,10/29/2018
AD23DE,executive-appointment,100,54,10/29/2018
AD3C93,note-sale,100,52,10/29/2018
AE4125,earnings,100,50,10/29/2018
AE4125,earnings,100,50,10/29/2018
AEF2C3,revenues,100,50,10/29/2018
B05000,conference-participant,100,50,10/29/2018
B076A1,earnings,100,50,10/29/2018
B076A1,earnings,100,50,10/29/2018
B076A1,earnings,100,50,10/29/2018
B076A1,earnings,100,50,10/29/2018
B0D41A,earnings,100,50,10/29/2018
B2206F,earnings,100,50,10/29/2018
B614F8,product-release,100,64,10/29/2018
B8DD94,facility-close,100,47,10/29/2018
BB02FB,earnings-per-share-positive,100,69,10/29/2018
BB02FB,earnings-per-share,100,50,10/29/2018
BB02FB,earnings-per-share,100,50,10/29/2018
BB02FB,earnings-per-share,100,50,10/29/2018
BB02FB,earnings-per-share,100,50,10/29/2018
BB127B,partnership,100,61,10/29/2018
BB5271,earnings,100,50,10/29/2018
BC4876,earnings,100,50,10/29/2018
BDEF34,earnings,100,50,10/29/2018
BDEF34,earnings,100,50,10/29/2018
BDEF34,earnings,100,50,10/29/2018
BDEF34,earnings,100,50,10/29/2018
BDEF34,earnings,100,50,10/29/2018
BDEF34,earnings,100,50,10/29/2018
BDEF34,earnings,100,50,10/29/2018
BE14CF,earnings,100,50,10/29/2018
BEB756,merger-regulatory-approval,100,81,10/29/2018
C0BA36,partnership,100,61,10/29/2018
C0F70B,earnings,100,50,10/29/2018
C16A8F,earnings,100,50,10/29/2018
C16A8F,earnings,100,50,10/29/2018
C16A8F,earnings,100,50,10/29/2018
C16A8F,earnings,100,50,10/29/2018
C3CF29,earnings,100,50,10/29/2018
C3F99F,business-contract,100,69,10/29/2018
C4A432,conference-call,100,50,10/29/2018
C5C0E9,acquisition-acquirer,100,49,10/29/2018
C5F463,partnership,100,61,10/29/2018
C941DC,earnings,100,50,10/29/2018
C9A96E,sponsorship,100,57,10/29/2018
C9E107,conference-participant,100,50,10/29/2018
C9F39B,executive-appointment,100,54,10/29/2018
CA1620,legal-issues-defendant,100,22,10/29/2018
CC339B,product-release,100,64,10/29/2018
CD051C,conference-call,100,50,10/29/2018
CDD75E,conference-call,100,50,10/29/2018
CDFCC9,legal-issues-defendant,100,22,10/29/2018
CE5664,dividend,100,50,10/29/2018
CFF97C,dividend,100,50,10/29/2018
D06996,earnings,100,50,10/29/2018
D11C1C,market-entry,100,57,10/29/2018
D15833,conference-call,100,50,10/29/2018
D3C794,earnings,100,50,10/29/2018
D57D99,earnings,100,50,10/29/2018
D598E7,earnings,100,50,10/29/2018
D6489C,award,100,58,10/29/2018
D78BF1,award,100,58,10/29/2018
D9164D,executive-appointment,100,54,10/29/2018
D9B1C9,business-contract,100,69,10/29/2018
DB88A1,partnership,100,61,10/29/2018
DD1BA1,earnings,100,50,10/29/2018
DD9E41,earnings,100,50,10/29/2018
DD9E41,earnings,100,50,10/29/2018
DD9E41,earnings,100,50,10/29/2018
DD9E41,earnings,100,50,10/29/2018
DD9E41,earnings,100,50,10/29/2018
DD9E41,earnings,100,50,10/29/2018
DDB002,executive-appointment,100,54,10/29/2018
DF204B,business-contract,100,69,10/29/2018
E09997,conference-call,100,50,10/29/2018
E0F4E5,acquisition-interest-acquiree,100,82,10/29/2018
E15736,earnings,100,50,10/29/2018
E41190,acquisition-acquiree,100,76,10/29/2018
E61888,conference-call,100,50,10/29/2018
E70531,earnings,100,50,10/29/2018
E7BF32,earnings,100,50,10/29/2018
E7BF32,earnings,100,50,10/29/2018
EBC84C,earnings,100,50,10/29/2018
EBC84C,earnings,100,50,10/29/2018
EBC84C,earnings,100,50,10/29/2018
EBC84C,earnings,100,50,10/29/2018
EBC84C,earnings,100,50,10/29/2018
EBC84C,earnings,100,50,10/29/2018
EBC84C,earnings,100,50,10/29/2018
F2E253,legal-issues-defendant,100,22,10/29/2018
F2E253,legal-issues-defendant,100,22,10/29/2018
F4D241,earnings,100,50,10/29/2018
F7935D,regulatory-product-approval-granted,100,81,10/29/2018
FACF19,executive-appointment,100,54,10/29/2018
FC1B7B,buybacks,100,74,10/29/2018
FD2565,conference-call,100,50,10/29/2018
FD4588,acquisition-acquirer,100,49,10/29/2018
FD6926,award,100,58,10/29/2018
FE7A63,conference-participant,100,50,10/29/2018
FF6644,spin-off,100,58,10/29/2018
00067A,partnership,100,61,10/30/2018
0157B1,product-release,100,64,10/30/2018
0157B1,partnership,100,61,10/30/2018
018C11,earnings,100,50,10/30/2018
034B61,product-release,100,64,10/30/2018
034B61,conference-participant,100,50,10/30/2018
03596A,government-contract,100,69,10/30/2018
03D5F9,earnings,100,50,10/30/2018
053EFF,earnings,100,50,10/30/2018
0560D8,conference-participant,100,50,10/30/2018
0560D8,product-release,100,64,10/30/2018
06A456,award,100,58,10/30/2018
075CF7,dividend,100,50,10/30/2018
07EC43,earnings,100,50,10/30/2018
07EC43,earnings,100,50,10/30/2018
07EC43,earnings,100,50,10/30/2018
07EC43,earnings,100,50,10/30/2018
099C88,earnings,100,50,10/30/2018
099C88,earnings,100,50,10/30/2018
0B13E8,conference-call,100,50,10/30/2018
0B9E6F,earnings,100,50,10/30/2018
0BA8CE,earnings,100,50,10/30/2018
0BF198,earnings,100,50,10/30/2018
0CC62B,earnings,100,50,10/30/2018
0CC62B,earnings,100,50,10/30/2018
0CC62B,earnings,100,50,10/30/2018
0CC62B,earnings,100,50,10/30/2018
0F04E5,conference-participant,100,50,10/30/2018
0F65C9,earnings,100,50,10/30/2018
0F65C9,dividend-up,100,60,10/30/2018
1096C6,earnings,100,50,10/30/2018
10C19B,legal-issues-defendant,100,22,10/30/2018
11074E,earnings,100,50,10/30/2018
1272B3,earnings,100,50,10/30/2018
12E454,earnings,100,50,10/30/2018
12E454,earnings,100,50,10/30/2018
131443,earnings,100,50,10/30/2018
131443,earnings,100,50,10/30/2018
131443,earnings,100,50,10/30/2018
131443,earnings,100,50,10/30/2018
131443,earnings,100,50,10/30/2018
131443,earnings,100,50,10/30/2018
138DDE,earnings,100,50,10/30/2018
149301,dividend,100,50,10/30/2018
14BA33,earnings,100,50,10/30/2018
165B86,conference-call,100,50,10/30/2018
168A5D,product-release,100,64,10/30/2018
16B882,earnings,100,50,10/30/2018
180DA0,earnings,100,50,10/30/2018
180DA0,earnings,100,50,10/30/2018
180DA0,earnings,100,50,10/30/2018
1834C0,dividend,100,50,10/30/2018
184988,earnings,100,50,10/30/2018
18D9FA,conference-call,100,50,10/30/2018
19BF16,conference-participant,100,50,10/30/2018
1AB023,conference-call,100,50,10/30/2018
1AB023,conference-call,100,50,10/30/2018
1AB023,conference-call,100,50,10/30/2018
1BC12C,dividend,100,50,10/30/2018
1BDB2A,acquisition-acquirer,100,49,10/30/2018
1BDB2A,conference-participant,100,50,10/30/2018
1BDB2A,dividend,100,50,10/30/2018
1CB9D3,conference-call,100,50,10/30/2018
1D9E55,earnings,100,50,10/30/2018
1DEBBE,executive-appointment,100,54,10/30/2018
1DF15D,earnings,100,50,10/30/2018
1DF15D,earnings,100,50,10/30/2018
1E1125,conference-organizer,100,57,10/30/2018
1E1125,conference-organizer,100,57,10/30/2018
1FC422,earnings,100,50,10/30/2018
1FCC00,fundraising,100,64,10/30/2018
206852,conference-participant,100,50,10/30/2018
2082EA,conference-call,100,50,10/30/2018
2093B1,earnings,100,50,10/30/2018
214051,earnings,100,50,10/30/2018
214051,earnings,100,50,10/30/2018
214051,earnings,100,50,10/30/2018
214051,earnings,100,50,10/30/2018
214051,earnings,100,50,10/30/2018
214051,earnings,100,50,10/30/2018
21F9CA,revenues,100,50,10/30/2018
2262BD,earnings,100,50,10/30/2018
228D42,partnership,100,61,10/30/2018
22C58E,earnings,100,50,10/30/2018
267718,earnings,100,50,10/30/2018
267718,earnings,100,50,10/30/2018
267718,earnings,100,50,10/30/2018
267718,earnings,100,50,10/30/2018
267718,earnings,100,50,10/30/2018
267718,earnings,100,50,10/30/2018
267718,earnings,100,50,10/30/2018
26D8ED,earnings,100,50,10/30/2018
2950FF,earnings,100,50,10/30/2018
2C7505,legal-issues-defendant,100,22,10/30/2018
2CA60F,partnership,100,61,10/30/2018
2DC88B,conference-participant,100,50,10/30/2018
2DDB22,earnings,100,50,10/30/2018
2E0496,earnings,100,50,10/30/2018
2EC172,earnings,100,50,10/30/2018
2EC172,earnings,100,50,10/30/2018
2EC172,earnings,100,50,10/30/2018
2EC172,earnings,100,50,10/30/2018
2EC172,earnings,100,50,10/30/2018
2EC172,earnings,100,50,10/30/2018
2F24A5,earnings,100,50,10/30/2018
30CBF9,product-release,100,64,10/30/2018
314D88,earnings,100,50,10/30/2018
3159AA,facility-open,100,65,10/30/2018
33FD66,earnings,100,50,10/30/2018
33FD66,earnings,100,50,10/30/2018
33FD66,earnings,100,50,10/30/2018
33FD66,earnings,100,50,10/30/2018
3461CF,partnership,100,61,10/30/2018
34B97A,earnings,100,50,10/30/2018
34B97A,earnings,100,50,10/30/2018
34B97A,earnings,100,50,10/30/2018
34B97A,earnings,100,50,10/30/2018
34B97A,earnings,100,50,10/30/2018
3.50E+27,earnings,100,50,10/30/2018
37020C,earnings,100,50,10/30/2018
37020C,earnings,100,50,10/30/2018
37020C,earnings,100,50,10/30/2018
37020C,earnings,100,50,10/30/2018
37020C,earnings,100,50,10/30/2018
37020C,earnings,100,50,10/30/2018
373B06,earnings,100,50,10/30/2018
3798B9,earnings,100,50,10/30/2018
3798B9,executive-resignation,100,44,10/30/2018
384CD3,earnings,100,50,10/30/2018
38FB49,dividend,100,50,10/30/2018
396D7C,earnings,100,50,10/30/2018
39BFF6,product-release,100,64,10/30/2018
3B37F7,buybacks,100,74,10/30/2018
3BA1BF,conference-call,100,50,10/30/2018
3BCF24,earnings-up,100,71,10/30/2018
3CBA2A,unit-acquisition-acquiree,100,76,10/30/2018
3F1C69,earnings,100,50,10/30/2018
3F4497,earnings,100,50,10/30/2018
401072,earnings,100,50,10/30/2018
41D61C,earnings,100,50,10/30/2018
41EC04,earnings,100,50,10/30/2018
41EC04,earnings,100,50,10/30/2018
41EC04,earnings,100,50,10/30/2018
41EC04,earnings,100,50,10/30/2018
41ED98,conference-call,100,50,10/30/2018
420168,earnings,100,50,10/30/2018
42AABD,earnings,100,50,10/30/2018
435ACE,conference-participant,100,50,10/30/2018
43E8F5,earnings,100,50,10/30/2018
44209A,earnings,100,50,10/30/2018
442587,earnings,100,50,10/30/2018
442587,earnings,100,50,10/30/2018
447FC6,earnings,100,50,10/30/2018
447FC6,earnings,100,50,10/30/2018
447FC6,earnings,100,50,10/30/2018
44DDBD,earnings,100,50,10/30/2018
467F2C,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
47FCF2,earnings,100,50,10/30/2018
49A344,government-contract,100,69,10/30/2018
4A2457,business-contract,100,69,10/30/2018
4B49CF,conference-participant,100,50,10/30/2018
4BEB48,product-release,100,64,10/30/2018
4C5CC9,dividend,100,50,10/30/2018
4C92B9,legal-issues-defendant,100,22,10/30/2018
4F0A80,earnings-up,100,78,10/30/2018
4FB770,earnings,100,50,10/30/2018
5065B1,unit-acquisition-acquirer,100,49,10/30/2018
53E575,earnings,100,50,10/30/2018
53EF9E,earnings,100,50,10/30/2018
53EF9E,earnings,100,50,10/30/2018
54512F,earnings,100,50,10/30/2018
54A713,earnings,100,50,10/30/2018
54F1D2,executive-appointment,100,54,10/30/2018
553949,earnings,100,50,10/30/2018
55C9B5,earnings,100,50,10/30/2018
564F3E,earnings,100,50,10/30/2018
567F3D,conference-participant,100,50,10/30/2018
57B174,earnings,100,50,10/30/2018
57B174,earnings,100,50,10/30/2018
57B174,earnings,100,50,10/30/2018
57B174,earnings,100,50,10/30/2018
57B174,earnings,100,50,10/30/2018
596116,earnings,100,50,10/30/2018
5968F9,earnings,100,50,10/30/2018
5CCDAD,earnings,100,50,10/30/2018
5D1329,conference-call,100,50,10/30/2018
5D41E4,conference-call,100,50,10/30/2018
5D63F1,facility-open,100,65,10/30/2018
5D63F1,business-contract,100,69,10/30/2018
5F60CE,earnings,100,50,10/30/2018
605F40,earnings,100,50,10/30/2018
6.18E+08,product-release,100,64,10/30/2018
619882,conference-organizer,100,57,10/30/2018
61BCA7,earnings,100,50,10/30/2018
64854A,conference-call,100,50,10/30/2018
649CBD,earnings,100,50,10/30/2018
649CBD,legal-issues-defendant,100,22,10/30/2018
64FF65,conference-call,100,50,10/30/2018
665618,conference-participant,100,50,10/30/2018
66CB62,acquisition-acquirer,100,49,10/30/2018
66CB62,operating-earnings,100,50,10/30/2018
67B923,earnings,100,50,10/30/2018
68E3E0,earnings,100,50,10/30/2018
68E3E0,earnings,100,50,10/30/2018
68E3E0,earnings,100,50,10/30/2018
68E3E0,earnings,100,50,10/30/2018
68E3E0,earnings,100,50,10/30/2018
68E3E0,earnings,100,50,10/30/2018
6B494E,earnings,100,50,10/30/2018
6CC55E,earnings,100,50,10/30/2018
6CF43C,earnings,100,50,10/30/2018
6D156D,earnings,100,50,10/30/2018
6D9B53,executive-appointment,100,54,10/30/2018
6.00E+19,business-contract,100,69,10/30/2018
6E705B,product-release,100,64,10/30/2018
6E8864,operating-earnings,100,50,10/30/2018
70CA28,conference-call,100,50,10/30/2018
71B0CF,earnings,100,50,10/30/2018
72609A,earnings,100,50,10/30/2018
72609A,earnings,100,50,10/30/2018
72609A,earnings,100,50,10/30/2018
732449,earnings,100,50,10/30/2018
73A71F,dividend,100,50,10/30/2018
7410C3,earnings,100,50,10/30/2018
742AAB,conference-call,100,50,10/30/2018
7.44E+09,dividend-up,100,56,10/30/2018
7.40E+289,earnings,100,50,10/30/2018
766047,public-offering,100,43,10/30/2018
76F067,earnings,100,50,10/30/2018
76F067,earnings,100,50,10/30/2018
7734AC,dividend-up,100,81,10/30/2018
7823A3,earnings,100,50,10/30/2018
7823A3,earnings,100,50,10/30/2018
7823A3,earnings,100,50,10/30/2018
7823A3,earnings,100,50,10/30/2018
7823A3,earnings,100,50,10/30/2018
78F776,trading-halt,100,43,10/30/2018
79167B,earnings,100,50,10/30/2018
79167B,earnings,100,50,10/30/2018
79167B,earnings,100,50,10/30/2018
791D59,partnership,100,61,10/30/2018
7A10FF,facility-open,100,65,10/30/2018
7B0BA6,earnings,100,50,10/30/2018
7B0BA6,earnings,100,50,10/30/2018
7B0BA6,earnings,100,50,10/30/2018
7B0BA6,earnings,100,50,10/30/2018
7B0BA6,earnings,100,50,10/30/2018
7B0BA6,earnings,100,50,10/30/2018
7C790D,conference-participant,100,50,10/30/2018
7EA323,earnings,100,50,10/30/2018
7F9984,earnings,100,50,10/30/2018
7F9BE2,dividend,100,50,10/30/2018
81222C,conference-participant,100,50,10/30/2018
81222C,conference-participant,100,50,10/30/2018
824CCA,earnings,100,50,10/30/2018
82FD6D,executive-appointment,100,54,10/30/2018
83598E,conference-participant,100,50,10/30/2018
84AB66,earnings-positive,100,69,10/30/2018
85DE00,earnings,100,50,10/30/2018
85DE00,dividend,100,50,10/30/2018
860AB6,ownership-increase-owner,100,56,10/30/2018
863350,facility-open,100,65,10/30/2018
86BAC7,earnings,100,50,10/30/2018
88193E,earnings,100,50,10/30/2018
88350F,earnings-per-share-up,100,68,10/30/2018
88350F,earnings-per-share-up,100,68,10/30/2018
88350F,earnings-per-share-up,100,68,10/30/2018
88350F,investment-investor,100,55,10/30/2018
8A0368,earnings,100,50,10/30/2018
8A0368,earnings,100,50,10/30/2018
8A0368,earnings,100,50,10/30/2018
8AC65D,earnings,100,50,10/30/2018
8D4486,dividend,100,50,10/30/2018
8D4486,dividend,100,50,10/30/2018
8D9993,earnings-up,100,72,10/30/2018
8D9993,earnings-up,100,68,10/30/2018
8D9993,earnings-up,100,68,10/30/2018
8D9993,earnings-up,100,68,10/30/2018
8E82A6,dividend,100,50,10/30/2018
8E8E6E,earnings,100,50,10/30/2018
8E9CD8,earnings-up,100,68,10/30/2018
8E9CD8,earnings,100,50,10/30/2018
8E9CD8,earnings,100,50,10/30/2018
8E9CD8,earnings,100,50,10/30/2018
8E9CD8,earnings,100,50,10/30/2018
8EDACA,legal-issues-defendant,100,22,10/30/2018
8EDACA,legal-issues-defendant,100,22,10/30/2018
8EDACA,legal-issues-defendant,100,22,10/30/2018
8EEA28,earnings,100,50,10/30/2018
8FCA78,earnings,100,50,10/30/2018
8FCA78,earnings,100,50,10/30/2018
8FCA78,earnings,100,50,10/30/2018
8FCA78,earnings,100,50,10/30/2018
8FCA78,earnings,100,50,10/30/2018
902670,dividend,100,50,10/30/2018
911AB8,earnings-guidance,100,50,10/30/2018
91E5EE,business-contract,100,69,10/30/2018
93F143,product-release,100,64,10/30/2018
940C3D,earnings,100,50,10/30/2018
945DE6,revenue-up,100,69,10/30/2018
945DE6,revenue-up,100,69,10/30/2018
945DE6,revenue-up,100,69,10/30/2018
95DC1F,business-contract,100,69,10/30/2018
972356,earnings,100,50,10/30/2018
972356,earnings,100,50,10/30/2018
972356,earnings,100,50,10/30/2018
972356,earnings,100,50,10/30/2018
972356,earnings,100,50,10/30/2018
98D33E,dividend,100,50,10/30/2018
990AD0,earnings,100,50,10/30/2018
990AD0,conference-organizer,100,57,10/30/2018
990AD0,partnership,100,61,10/30/2018
990AD0,conference-organizer,100,57,10/30/2018
9978F1,clinical-trials-filed,100,60,10/30/2018
9A602D,earnings-per-share-positive,100,69,10/30/2018
9A602D,earnings-per-share-positive,100,69,10/30/2018
9A602D,earnings-per-share-positive,100,69,10/30/2018
9A602D,earnings-per-share-positive,100,69,10/30/2018
9A602D,earnings-per-share-positive,100,69,10/30/2018
9A602D,earnings-per-share-positive,100,69,10/30/2018
9A602D,earnings-per-share-positive,100,69,10/30/2018
9B0C9C,earnings,100,50,10/30/2018
9B0C9C,earnings,100,50,10/30/2018
9B0C9C,earnings,100,50,10/30/2018
9B5968,partnership,100,61,10/30/2018
9D6A24,acquisition-regulatory-approval-acquirer,100,54,10/30/2018
9D6A24,acquisition-regulatory-approval-acquirer,100,54,10/30/2018
9F5CBB,dividend,100,50,10/30/2018
A05C43,earnings,100,50,10/30/2018
A23747,earnings,100,50,10/30/2018
A38F30,earnings,100,50,10/30/2018
A41450,earnings,100,50,10/30/2018
A429A5,earnings-up,100,68,10/30/2018
A429A5,earnings,100,50,10/30/2018
A429A5,earnings,100,50,10/30/2018
A429A5,earnings,100,50,10/30/2018
A429A5,earnings,100,50,10/30/2018
A429A5,earnings,100,50,10/30/2018
A47A7D,earnings,100,50,10/30/2018
A47A7D,executive-appointment,100,54,10/30/2018
A4D173,dividend,100,50,10/30/2018
A4D173,dividend,100,50,10/30/2018
A4F67C,earnings,100,50,10/30/2018
A5A4F5,acquisition-acquirer,100,49,10/30/2018
A7102F,conference-participant,100,50,10/30/2018
A7CCF0,award,100,58,10/30/2018
A80FE0,earnings,100,50,10/30/2018
A87CD6,earnings,100,50,10/30/2018
A87CD6,dividend,100,50,10/30/2018
AB7726,earnings,100,50,10/30/2018
AC3584,earnings,100,50,10/30/2018
ACDF88,conference-call,100,50,10/30/2018
AEEB76,conference-participant,100,50,10/30/2018
AFD1CA,earnings,100,50,10/30/2018
B05118,dividend,100,50,10/30/2018
B2DAF6,earnings,100,50,10/30/2018
B446B8,earnings,100,50,10/30/2018
B446B8,earnings,100,50,10/30/2018
B446B8,earnings,100,50,10/30/2018
B4703C,earnings-per-share-positive,100,69,10/30/2018
B4703C,earnings,100,50,10/30/2018
B4C673,partnership,100,61,10/30/2018
B560AF,earnings,100,50,10/30/2018
B560AF,earnings,100,50,10/30/2018
B560AF,earnings,100,50,10/30/2018
B614F8,business-contract,100,69,10/30/2018
B72BE9,conference-call,100,50,10/30/2018
B73395,conference-call,100,50,10/30/2018
B83BCE,earnings,100,50,10/30/2018
B8A51F,conference-participant,100,50,10/30/2018
B9764A,conference-participant,100,50,10/30/2018
BB0787,earnings,100,50,10/30/2018
BB0787,earnings,100,50,10/30/2018
BBBB41,earnings,100,50,10/30/2018
BBBB41,earnings,100,50,10/30/2018
BBBB41,earnings,100,50,10/30/2018
BBBB41,earnings,100,50,10/30/2018
BBBB41,earnings,100,50,10/30/2018
BBBB41,earnings,100,50,10/30/2018
BDCC11,partnership,100,61,10/30/2018
BDD12C,facility-upgrade,100,65,10/30/2018
BE379D,conference-call,100,50,10/30/2018
BE86A1,earnings-up,100,64,10/30/2018
BFAEB4,dividend-up,100,81,10/30/2018
BFAEB4,dividend,100,50,10/30/2018
BFD0A7,conference-call,100,50,10/30/2018
C2609A,earnings,100,50,10/30/2018
C3F99F,earnings,100,50,10/30/2018
C50B26,note-sale,100,52,10/30/2018
C564E4,conference-call,100,50,10/30/2018
C5C0E9,earnings,100,50,10/30/2018
C659EB,earnings,100,50,10/30/2018
C659EB,earnings,100,50,10/30/2018
C659EB,earnings,100,50,10/30/2018
C659EB,earnings,100,50,10/30/2018
C7AE14,earnings,100,50,10/30/2018
C85A72,revenue-up,100,67,10/30/2018
C85A72,revenue-up,100,67,10/30/2018
C85A72,revenue-up,100,67,10/30/2018
C85A72,revenue-up,100,67,10/30/2018
C9A96E,sponsorship,100,57,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
C9D866,earnings,100,50,10/30/2018
CB89EA,product-release,100,64,10/30/2018
CC176E,earnings,100,50,10/30/2018
CC8F6E,conference-participant,100,50,10/30/2018
CDC817,earnings,100,50,10/30/2018
CDE51C,earnings,100,50,10/30/2018
CE1002,note-sale,100,52,10/30/2018
CE4E6D,conference-call,100,50,10/30/2018
CE4FD9,earnings,100,50,10/30/2018
CE4FD9,earnings,100,50,10/30/2018
CE4FD9,earnings,100,50,10/30/2018
CE4FD9,earnings,100,50,10/30/2018
CE5664,earnings,100,50,10/30/2018
CE5664,earnings,100,50,10/30/2018
CE5664,earnings,100,50,10/30/2018
CF3FF9,earnings,100,50,10/30/2018
D04D9F,earnings,100,50,10/30/2018
D15833,earnings,100,50,10/30/2018
D17F7E,earnings,100,50,10/30/2018
D17F7E,earnings,100,50,10/30/2018
D17F7E,earnings,100,50,10/30/2018
D17F7E,earnings,100,50,10/30/2018
D17F7E,earnings,100,50,10/30/2018
D17F7E,earnings,100,50,10/30/2018
D17F7E,earnings,100,50,10/30/2018
D29B44,earnings,100,50,10/30/2018
D2B9E5,earnings,100,50,10/30/2018
D2B9E5,earnings,100,50,10/30/2018
D2B9E5,earnings,100,50,10/30/2018
D2B9E5,earnings,100,50,10/30/2018
D3DE34,earnings,100,50,10/30/2018
D4070C,note-sale,100,52,10/30/2018
D7918D,operating-earnings,100,50,10/30/2018
D854F3,conference-participant,100,50,10/30/2018
D8DBA3,operating-earnings,100,50,10/30/2018
D9164D,conference-participant,100,50,10/30/2018
DB06B0,earnings,100,50,10/30/2018
DB06B0,earnings,100,50,10/30/2018
DB06B0,earnings,100,50,10/30/2018
DB06B0,earnings,100,50,10/30/2018
DB06B0,earnings,100,50,10/30/2018
DB9829,conference-participant,100,50,10/30/2018
DDEA6A,earnings,100,50,10/30/2018
DF01B1,conference-participant,100,50,10/30/2018
DF11D9,buybacks,100,74,10/30/2018
DFADDB,conference-call,100,50,10/30/2018
E06265,earnings,100,50,10/30/2018
E10D31,earnings,100,50,10/30/2018
E114F4,earnings,100,50,10/30/2018
E114F4,earnings,100,50,10/30/2018
E114F4,earnings,100,50,10/30/2018
E114F4,buybacks,100,74,10/30/2018
E124EB,conference-participant,100,50,10/30/2018
E22FDE,earnings,100,50,10/30/2018
E30A8F,earnings,100,50,10/30/2018
E30A8F,earnings,100,50,10/30/2018
E30A8F,earnings,100,50,10/30/2018
E30A8F,earnings,100,50,10/30/2018
E30A8F,earnings,100,50,10/30/2018
E4CE73,conference-call,100,50,10/30/2018
E4CE73,index-listing,100,76,10/30/2018
E69BA5,earnings,100,50,10/30/2018
E74B55,partnership,100,61,10/30/2018
E74B55,earnings,100,50,10/30/2018
E82A2D,earnings,100,50,10/30/2018
E84500,earnings,100,50,10/30/2018
E8A49A,earnings,100,50,10/30/2018
EA62FC,conference-participant,100,50,10/30/2018
EB36DE,earnings,100,50,10/30/2018
EC70EC,earnings,100,50,10/30/2018
EC70EC,earnings,100,50,10/30/2018
EC70EC,earnings,100,50,10/30/2018
EC70EC,earnings,100,50,10/30/2018
EC70EC,earnings,100,50,10/30/2018
EC70EC,earnings,100,50,10/30/2018
EE74E1,partnership,100,61,10/30/2018
EE967B,earnings,100,50,10/30/2018
EE967B,earnings,100,50,10/30/2018
EEA6B3,operating-earnings,100,50,10/30/2018
EEBCEF,earnings,100,50,10/30/2018
F0B2B5,earnings,100,50,10/30/2018
F1529C,dividend,100,50,10/30/2018
F40EE2,award,100,58,10/30/2018
F46EC9,earnings,100,50,10/30/2018
F46EC9,earnings,100,50,10/30/2018
F46EC9,earnings,100,50,10/30/2018
F46EC9,earnings,100,50,10/30/2018
F46EC9,earnings,100,50,10/30/2018
F46EC9,earnings,100,50,10/30/2018
F6E248,clinical-trials,100,56,10/30/2018
F6E248,earnings,100,50,10/30/2018
F9CAF8,earnings-per-share-up,100,67,10/30/2018
F9CAF8,earnings-per-share-up,100,67,10/30/2018
F9CAF8,earnings-per-share-up,100,67,10/30/2018
FBD92D,partnership,100,61,10/30/2018
FBD92D,partnership,100,61,10/30/2018
FC4550,partnership,100,61,10/30/2018
FF5413,earnings-positive,100,69,10/30/2018
FF5413,earnings-positive,100,69,10/30/2018
FF5413,earnings-positive,100,69,10/30/2018
FFAB4A,earnings,100,50,10/30/2018
00067A,conference-participant,100,50,10/31/2018
003B70,operating-earnings,100,50,10/31/2018
00E601,operating-earnings,100,50,10/31/2018
13528,acquisition-acquirer,100,49,10/31/2018
0325B7,conference-call,100,50,10/31/2018
078D52,revenues,100,50,10/31/2018
078D52,revenues,100,50,10/31/2018
07CA6A,executive-appointment,100,54,10/31/2018
099A92,earnings,100,50,10/31/2018
0A9D0A,dividend,100,50,10/31/2018
0B4D10,earnings,100,50,10/31/2018
0BC29E,earnings,100,50,10/31/2018
0BC29E,earnings,100,50,10/31/2018
0BC29E,earnings,100,50,10/31/2018
0BC29E,earnings,100,50,10/31/2018
0BC29E,earnings,100,50,10/31/2018
0BC29E,earnings,100,50,10/31/2018
0BC29E,earnings,100,50,10/31/2018
0BF528,conference-call,100,50,10/31/2018
0EC508,earnings,100,50,10/31/2018
1065BC,earnings,100,50,10/31/2018
10C19B,legal-issues-defendant,100,22,10/31/2018
10C19B,legal-issues-defendant,100,22,10/31/2018
10C19B,legal-issues-defendant,100,22,10/31/2018
1201B5,earnings,100,50,10/31/2018
1220D2,earnings,100,50,10/31/2018
12731D,conference-call,100,50,10/31/2018
12DE76,conference-call,100,50,10/31/2018
12DE76,conference-call,100,50,10/31/2018
135B09,earnings-up,100,68,10/31/2018
147C38,executive-resignation,100,44,10/31/2018
149301,earnings,100,50,10/31/2018
14ED2B,dividend-up,100,63,10/31/2018
15901B,fundraising,100,64,10/31/2018
16B183,operating-earnings,100,50,10/31/2018
17EDA5,partnership,100,61,10/31/2018
17EDA5,award,100,58,10/31/2018
1880C5,conference-organizer,100,57,10/31/2018
190B91,acquisition-completed-acquirer,100,49,10/31/2018
190B91,earnings,100,50,10/31/2018
190B91,earnings,100,50,10/31/2018
190B91,earnings,100,50,10/31/2018
190B91,earnings,100,50,10/31/2018
1921DD,product-release,100,64,10/31/2018
197612,conference-participant,100,50,10/31/2018
1A5957,earnings,100,50,10/31/2018
1A5957,earnings,100,50,10/31/2018
1A5957,earnings,100,50,10/31/2018
1A5957,earnings,100,50,10/31/2018
1A5957,earnings,100,50,10/31/2018
1A5D5D,acquisition-acquirer,100,49,10/31/2018
1A5D5D,acquisition-acquirer,100,49,10/31/2018
1A5D5D,earnings,100,50,10/31/2018
1A5D5D,earnings,100,50,10/31/2018
1AB808,revenue-up,100,79,10/31/2018
1AB808,revenue-up,100,79,10/31/2018
1AB808,revenue-up,100,79,10/31/2018
1AB808,revenue-up,100,79,10/31/2018
1B16C1,earnings-guidance,100,50,10/31/2018
1B637E,earnings,100,50,10/31/2018
1CD4B5,conference-participant,100,50,10/31/2018
1D5C51,earnings,100,50,10/31/2018
1DEBBE,earnings,100,50,10/31/2018
1E1125,conference-organizer,100,57,10/31/2018
1E1125,conference-organizer,100,57,10/31/2018
1F19C8,earnings-up,100,60,10/31/2018
1F43A1,merger-completed,100,66,10/31/2018
1F716B,earnings-guidance-up,100,83,10/31/2018
1FA886,earnings,100,50,10/31/2018
1FAF22,earnings-guidance,100,50,10/31/2018
1FAF22,earnings,100,50,10/31/2018
1FAF22,earnings,100,50,10/31/2018
1FAF22,earnings,100,50,10/31/2018
1FAF22,earnings,100,50,10/31/2018
1FAF22,earnings,100,50,10/31/2018
20D00A,operating-earnings,100,50,10/31/2018
21D903,conference-participant,100,50,10/31/2018
227F04,earnings,100,50,10/31/2018
24FA23,earnings,100,50,10/31/2018
250BEE,dividend,100,50,10/31/2018
25102A,conference-participant,100,50,10/31/2018
263216,earnings,100,50,10/31/2018
263216,earnings,100,50,10/31/2018
263216,earnings,100,50,10/31/2018
263216,earnings,100,50,10/31/2018
263216,earnings,100,50,10/31/2018
2920D5,asset-sale,100,62,10/31/2018
295F9F,earnings,100,50,10/31/2018
2.90E+62,conference-participant,100,50,10/31/2018
2AA6A8,conference-call,100,50,10/31/2018
2C3348,legal-issues-defendant,100,22,10/31/2018
2D2D43,dividend,100,50,10/31/2018
2D643C,conference-participant,100,50,10/31/2018
2E1322,executive-appointment,100,54,10/31/2018
2F6782,dividend,100,50,10/31/2018
2F6782,earnings,100,50,10/31/2018
2FDEE3,earnings,100,50,10/31/2018
3224CC,earnings,100,50,10/31/2018
32CB22,acquisition-completed-acquirer,100,49,10/31/2018
32CB22,acquisition-completed-acquirer,100,49,10/31/2018
339F20,earnings,100,50,10/31/2018
343996,earnings,100,50,10/31/2018
343996,earnings,100,50,10/31/2018
349DA4,earnings,100,50,10/31/2018
349DA4,earnings,100,50,10/31/2018
349DA4,earnings,100,50,10/31/2018
35AE32,executive-appointment,100,54,10/31/2018
35AE32,earnings,100,50,10/31/2018
35AE32,earnings,100,50,10/31/2018
35AE32,earnings,100,50,10/31/2018
35AE32,earnings,100,50,10/31/2018
37426C,ipo-pricing,100,50,10/31/2018
384CD3,conference-participant,100,50,10/31/2018
385DD4,executive-resignation,100,44,10/31/2018
385DD4,executive-resignation,100,44,10/31/2018
3A113F,earnings,100,50,10/31/2018
3A3447,acquisition-completed-acquirer,100,49,10/31/2018
3A3447,acquisition-completed-acquirer,100,49,10/31/2018
3B8484,acquisition-acquirer,100,49,10/31/2018
3B9886,conference-call,100,50,10/31/2018
3BC360,earnings,100,50,10/31/2018
3BC360,earnings,100,50,10/31/2018
3BC360,earnings,100,50,10/31/2018
3BC360,earnings,100,50,10/31/2018
3BE00F,asset-sale,100,62,10/31/2018
3BE00F,unit-acquisition-acquiree,100,76,10/31/2018
3CCC90,executive-appointment,100,54,10/31/2018
3DDE54,earnings,100,50,10/31/2018
3DDE54,earnings,100,50,10/31/2018
3DDE54,earnings,100,50,10/31/2018
3DDE54,earnings,100,50,10/31/2018
3DDE54,earnings,100,50,10/31/2018
3DDE54,earnings,100,50,10/31/2018
442769,earnings,100,50,10/31/2018
442769,earnings,100,50,10/31/2018
442769,earnings,100,50,10/31/2018
442769,earnings,100,50,10/31/2018
447FC6,buybacks,100,74,10/31/2018
448BF3,earnings,100,50,10/31/2018
44A4FC,conference-participant,100,50,10/31/2018
45ABCC,conference-participant,100,50,10/31/2018
4885C8,dividend,100,50,10/31/2018
48F795,legal-issues-defendant,100,22,10/31/2018
4A6F00,partnership,100,61,10/31/2018
4A6F00,partnership,100,61,10/31/2018
4C3FE9,earnings,100,50,10/31/2018
4D8124,dividend,100,50,10/31/2018
4DD203,conference-call,100,50,10/31/2018
52BF94,earnings,100,50,10/31/2018
52BF94,earnings,100,50,10/31/2018
52BF94,earnings,100,50,10/31/2018
52BF94,earnings,100,50,10/31/2018
5.43E+08,earnings,100,50,10/31/2018
54A646,dividend,100,50,10/31/2018
550D01,market-entry,100,57,10/31/2018
56B7C1,earnings,100,50,10/31/2018
57EF50,dividend,100,50,10/31/2018
57EF50,conference-call,100,50,10/31/2018
57F3DA,earnings,100,50,10/31/2018
594402,earnings,100,50,10/31/2018
59DB8C,ipo-pricing,100,50,10/31/2018
59DB8C,ipo-pricing,100,50,10/31/2018
5D1329,earnings,100,50,10/31/2018
5D41E4,executive-appointment,100,54,10/31/2018
5DE5A5,conference-participant,100,50,10/31/2018
5EAA43,business-contract,100,69,10/31/2018
5EF130,earnings,100,50,10/31/2018
5F60CE,earnings-positive,100,69,10/31/2018
5FDBD0,operating-earnings,100,50,10/31/2018
619882,conference-organizer,100,57,10/31/2018
61E975,earnings-positive,100,69,10/31/2018
639BD6,revenues,100,50,10/31/2018
639BD6,revenues,100,50,10/31/2018
639BD6,revenues,100,50,10/31/2018
641F17,dividend,100,50,10/31/2018
649CBD,legal-issues-defendant,100,22,10/31/2018
649CBD,legal-issues-defendant,100,22,10/31/2018
649CBD,legal-issues-defendant,100,22,10/31/2018
649CBD,legal-issues-defendant,100,22,10/31/2018
649CBD,legal-issues-defendant,100,22,10/31/2018
665D7D,legal-issues-defendant,100,22,10/31/2018
665D7D,clinical-trials-positive,100,87,10/31/2018
66E3C0,revenue-up,100,63,10/31/2018
66E3C0,revenue-up,100,63,10/31/2018
66ECFD,earnings,100,50,10/31/2018
673C9A,conference-call,100,50,10/31/2018
6810DE,earnings,100,50,10/31/2018
68BA15,trading-halt,100,43,10/31/2018
68E6E9,earnings,100,50,10/31/2018
6B0E45,earnings,100,50,10/31/2018
6B67BD,earnings,100,50,10/31/2018
6C6D73,facility-open,100,65,10/31/2018
6CB7F9,buybacks,100,74,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6E7060,earnings,100,50,10/31/2018
6EB9DA,dividend,100,50,10/31/2018
6F0096,buybacks,100,74,10/31/2018
6F39FC,dividend,100,50,10/31/2018
6FCEF9,earnings,100,50,10/31/2018
719477,earnings,100,50,10/31/2018
719477,earnings,100,50,10/31/2018
719477,earnings,100,50,10/31/2018
7273FF,earnings,100,50,10/31/2018
72FCA3,executive-appointment,100,54,10/31/2018
73A213,earnings,100,50,10/31/2018
747219,dividend,100,50,10/31/2018
763724,earnings-up,100,68,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
771985,earnings,100,50,10/31/2018
787D14,earnings-guidance,100,50,10/31/2018
789A7D,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
78F9ED,earnings,100,50,10/31/2018
790D0D,earnings,100,50,10/31/2018
791D59,conference-participant,100,50,10/31/2018
7A10FF,facility-open,100,65,10/31/2018
7AB859,earnings,100,50,10/31/2018
7AB859,earnings,100,50,10/31/2018
7AB859,earnings,100,50,10/31/2018
7AB859,earnings,100,50,10/31/2018
7AB859,earnings,100,50,10/31/2018
7AB859,earnings,100,50,10/31/2018
7B8CB5,dividend,100,50,10/31/2018
7BC92D,earnings,100,50,10/31/2018
7BEA98,patient-enrollment-complete,100,64,10/31/2018
7BEA98,patient-enrollment-complete,100,64,10/31/2018
7C62A3,earnings,100,50,10/31/2018
7C75FD,earnings,100,50,10/31/2018
7D35D8,partnership,100,61,10/31/2018
7DA412,earnings,100,50,10/31/2018
7DD584,earnings,100,50,10/31/2018
7FDE1C,conference-call,100,50,10/31/2018
805CD8,acquisition-acquirer,100,49,10/31/2018
805CD8,earnings,100,50,10/31/2018
82B57E,earnings,100,50,10/31/2018
82B57E,earnings,100,50,10/31/2018
82B57E,earnings,100,50,10/31/2018
82B57E,earnings,100,50,10/31/2018
82B57E,dividend,100,50,10/31/2018
83B1C8,earnings,100,50,10/31/2018
86478F,earnings,100,50,10/31/2018
8665BA,conference-participant,100,50,10/31/2018
86F123,conference-call,100,50,10/31/2018
87B81A,revenues,100,50,10/31/2018
87B81A,revenues,100,50,10/31/2018
87B81A,revenues,100,50,10/31/2018
87B81A,revenues,100,50,10/31/2018
87B81A,revenues,100,50,10/31/2018
87B81A,dividend,100,50,10/31/2018
880C0C,earnings,100,50,10/31/2018
890FF4,conference-participant,100,50,10/31/2018
896771,dividend-up,100,81,10/31/2018
896771,earnings,100,50,10/31/2018
8B1E11,earnings,100,50,10/31/2018
8DBBE6,earnings,100,50,10/31/2018
8DBE73,revenues,100,50,10/31/2018
8DBE73,revenues,100,50,10/31/2018
8DBE73,revenues,100,50,10/31/2018
8DBE73,buybacks,100,74,10/31/2018
8DCBBB,earnings,100,50,10/31/2018
8DCBBB,earnings,100,50,10/31/2018
8E8E6E,partnership,100,61,10/31/2018
8EDACA,legal-issues-defendant,100,22,10/31/2018
8EDACA,legal-issues-defendant,100,22,10/31/2018
8EDACA,legal-issues-defendant,100,22,10/31/2018
8EDACA,legal-issues-defendant,100,22,10/31/2018
8EF425,earnings,100,50,10/31/2018
8EF425,earnings,100,50,10/31/2018
8EF425,earnings,100,50,10/31/2018
8EF425,earnings,100,50,10/31/2018
8EF425,earnings,100,50,10/31/2018
8EF425,earnings,100,50,10/31/2018
8F8F2F,earnings,100,50,10/31/2018
8F8F2F,earnings,100,50,10/31/2018
9004C4,conference-call,100,50,10/31/2018
901327,earnings,100,50,10/31/2018
901327,earnings,100,50,10/31/2018
901327,earnings,100,50,10/31/2018
901327,earnings,100,50,10/31/2018
901327,earnings,100,50,10/31/2018
913437,partnership,100,61,10/31/2018
9196A2,conference-organizer,100,57,10/31/2018
9196A2,conference-organizer,100,57,10/31/2018
92005C,earnings,100,50,10/31/2018
92D9C9,public-offering,100,43,10/31/2018
94C0B5,dividend,100,50,10/31/2018
957A07,conference-participant,100,50,10/31/2018
9592FB,earnings,100,50,10/31/2018
9.65E+09,earnings,100,50,10/31/2018
977A1E,dividend,100,50,10/31/2018
980C14,earnings,100,50,10/31/2018
990AD0,conference-organizer,100,57,10/31/2018
990AD0,conference-organizer,100,57,10/31/2018
990AD0,conference-organizer,100,57,10/31/2018
990AD0,conference-organizer,100,57,10/31/2018
99DC8D,executive-appointment,100,54,10/31/2018
9AF3DC,earnings,100,50,10/31/2018
9B4066,unit-acquisition-acquirer,100,49,10/31/2018
9B5968,executive-appointment,100,54,10/31/2018
9B730A,conference-call,100,50,10/31/2018
9E3224,earnings,100,50,10/31/2018
9F5997,earnings,100,50,10/31/2018
A1BB98,conference-call,100,50,10/31/2018
A1EAC8,business-contract,100,69,10/31/2018
A398F8,earnings,100,50,10/31/2018
A3AAA5,earnings,100,50,10/31/2018
A4386C,earnings,100,50,10/31/2018
A4386C,earnings,100,50,10/31/2018
A4386C,earnings,100,50,10/31/2018
A4386C,earnings,100,50,10/31/2018
A4386C,credit-rating-upgrade,100,77,10/31/2018
A4D173,executive-appointment,100,54,10/31/2018
A4D173,executive-appointment,100,54,10/31/2018
A5A4F5,acquisition-acquirer,100,49,10/31/2018
A6828A,business-contract,100,69,10/31/2018
A6ABE9,earnings-positive,100,69,10/31/2018
A70BF5,earnings,100,50,10/31/2018
A70BF5,earnings,100,50,10/31/2018
A70BF5,earnings,100,50,10/31/2018
A70BF5,earnings,100,50,10/31/2018
A70BF5,earnings,100,50,10/31/2018
A70BF5,earnings,100,50,10/31/2018
A806FA,earnings,100,50,10/31/2018
A806FA,earnings,100,50,10/31/2018
A806FA,earnings,100,50,10/31/2018
A806FA,earnings,100,50,10/31/2018
A8FDE8,earnings,100,50,10/31/2018
A8FDE8,dividend,100,50,10/31/2018
AA09AD,earnings,100,50,10/31/2018
AAEE21,earnings,100,50,10/31/2018
AD23DE,conference-participant,100,50,10/31/2018
AE4EEB,executive-appointment,100,54,10/31/2018
AE79CD,earnings,100,50,10/31/2018
AEFC90,business-contract,100,69,10/31/2018
B106FA,acquisition-completed-acquirer,100,49,10/31/2018
B1A85D,earnings,100,50,10/31/2018
B77F14,earnings,100,50,10/31/2018
B77F14,earnings,100,50,10/31/2018
B77F14,earnings,100,50,10/31/2018
B77F14,earnings,100,50,10/31/2018
B7BBFF,conference-call,100,50,10/31/2018
B98EFA,operating-earnings,100,50,10/31/2018
BB0587,earnings,100,50,10/31/2018
BB127B,conference-call,100,50,10/31/2018
BBC05B,conference-participant,100,50,10/31/2018
C062D4,earnings,100,50,10/31/2018
C062D4,earnings,100,50,10/31/2018
C062D4,earnings,100,50,10/31/2018
C062D4,earnings,100,50,10/31/2018
C062D4,earnings,100,50,10/31/2018
C062D4,earnings,100,50,10/31/2018
C062D4,earnings,100,50,10/31/2018
C062D4,unit-acquisition-acquiree,100,76,10/31/2018
C230FE,earnings-per-share-up,100,68,10/31/2018
C230FE,earnings,100,50,10/31/2018
C2DD02,conference-call,100,50,10/31/2018
C2E426,earnings,100,50,10/31/2018
C4F9C6,earnings,100,50,10/31/2018
C54140,acquisition-completed-acquirer,100,49,10/31/2018
C584BE,earnings,100,50,10/31/2018
C5C137,earnings,100,50,10/31/2018
C9881C,acquisition-completed-acquirer,100,49,10/31/2018
C9E04B,conference-call,100,50,10/31/2018
CA14CC,earnings,100,50,10/31/2018
CA14CC,earnings,100,50,10/31/2018
CA14CC,earnings,100,50,10/31/2018
CA212F,acquisition-acquiree,100,76,10/31/2018
CB88B3,earnings,100,50,10/31/2018
CBBFBF,earnings,100,50,10/31/2018
CBFFDD,earnings,100,50,10/31/2018
CBFFDD,earnings,100,50,10/31/2018
CBFFDD,trading-halt,100,43,10/31/2018
CBFFDD,trading-resumed,100,58,10/31/2018
CC35BE,acquisition-acquirer,100,49,10/31/2018
CCB623,earnings,100,50,10/31/2018
CCB623,public-offering,100,43,10/31/2018
CCBBAD,earnings,100,50,10/31/2018
CD4DA8,conference-participant,100,50,10/31/2018
CDC217,conference-call,100,50,10/31/2018
CE1002,conference-participant,100,50,10/31/2018
CE5C6E,earnings,100,50,10/31/2018
CEC08B,earnings-positive,100,69,10/31/2018
CEC5B9,conference-call,100,50,10/31/2018
CFD4B6,earnings,100,50,10/31/2018
CFD4B6,earnings,100,50,10/31/2018
CFD4B6,earnings,100,50,10/31/2018
CFF97C,credit-rating-upgrade-rater,20,50,10/31/2018
D06755,earnings,100,50,10/31/2018
D06755,earnings,100,50,10/31/2018
D06755,earnings,100,50,10/31/2018
D06755,earnings,100,50,10/31/2018
D09938,earnings,100,50,10/31/2018
D0DE27,conference-participant,100,50,10/31/2018
D0DFE5,executive-appointment,100,54,10/31/2018
D11C1C,conference-call,100,50,10/31/2018
D20C8F,earnings,100,50,10/31/2018
D33270,partnership,100,61,10/31/2018
D54E62,dividend,100,50,10/31/2018
D57D99,partnership,100,61,10/31/2018
D650A7,revenue-up,100,71,10/31/2018
D650A7,revenue-up,100,71,10/31/2018
D650A7,revenue-up,100,71,10/31/2018
D650A7,dividend,100,50,10/31/2018
D6853F,conference-participant,100,50,10/31/2018
D6853F,business-contract,100,69,10/31/2018
D6853F,dividend,100,50,10/31/2018
D81463,earnings,100,50,10/31/2018
D81463,dividend,100,50,10/31/2018
D8442A,product-release,100,64,10/31/2018
D8442A,business-contract,100,69,10/31/2018
D8442A,business-contract,100,69,10/31/2018
D9FC89,earnings,100,50,10/31/2018
D9FC89,earnings,100,50,10/31/2018
D9FC89,earnings,100,50,10/31/2018
D9FC89,earnings,100,50,10/31/2018
DA0A9E,acquisition-completed-acquirer,100,49,10/31/2018
DB7014,operating-earnings,100,50,10/31/2018
DC437D,earnings,100,50,10/31/2018
DD7A96,earnings,100,50,10/31/2018
DF42A0,conference-call,100,50,10/31/2018
E0207A,earnings,100,50,10/31/2018
E0207A,earnings,100,50,10/31/2018
E0207A,earnings,100,50,10/31/2018
E0207A,earnings,100,50,10/31/2018
E07573,earnings,100,50,10/31/2018
E07573,earnings,100,50,10/31/2018
E07573,earnings,100,50,10/31/2018
E13782,earnings,100,50,10/31/2018
E1BD05,acquisition-interest-acquiree,100,82,10/31/2018
E1E093,product-release,100,64,10/31/2018
E1E36F,earnings,100,50,10/31/2018
E1E36F,earnings,100,50,10/31/2018
E1E36F,earnings,100,50,10/31/2018
E1E36F,earnings,100,50,10/31/2018
E1E36F,earnings,100,50,10/31/2018
E1E36F,earnings,100,50,10/31/2018
E21871,earnings,100,50,10/31/2018
E28D9C,earnings,100,50,10/31/2018
E3E68E,earnings,100,50,10/31/2018
E3E68E,executive-appointment,100,54,10/31/2018
E5D914,earnings,100,50,10/31/2018
E5D914,earnings,100,50,10/31/2018
E5D914,earnings,100,50,10/31/2018
E70531,dividend,100,50,10/31/2018
E802CE,earnings,100,50,10/31/2018
E802CE,earnings,100,50,10/31/2018
E8C557,earnings,100,50,10/31/2018
ECF4F8,earnings,100,50,10/31/2018
ED4560,dividend-up,100,81,10/31/2018
EEA734,conference-call,100,50,10/31/2018
EEEA9F,public-offering,100,43,10/31/2018
F0B877,investment-investor,100,55,10/31/2018
F0EEFB,earnings,100,50,10/31/2018
F0EEFB,earnings,100,50,10/31/2018
F0EEFB,earnings,100,50,10/31/2018
F0EEFB,earnings,100,50,10/31/2018
F11638,earnings,100,50,10/31/2018
F1529C,conference-participant,100,50,10/31/2018
F15E41,earnings,100,50,10/31/2018
F15E41,earnings,100,50,10/31/2018
F15E41,earnings,100,50,10/31/2018
F15E41,earnings,100,50,10/31/2018
F31B13,dividend-up,100,72,10/31/2018
F39E1E,earnings,100,50,10/31/2018
F4CDA3,earnings,100,50,10/31/2018
F6E1B5,earnings,100,50,10/31/2018
F6E248,partnership,100,61,10/31/2018
F7FCA4,earnings,100,50,10/31/2018
F7FCA4,earnings,100,50,10/31/2018
F7FCA4,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F8C5D7,earnings,100,50,10/31/2018
F90EE5,earnings,100,50,10/31/2018
FA35C6,earnings,100,50,10/31/2018
FAB97A,executive-appointment,100,54,10/31/2018
FC1A6E,legal-issues-defendant,100,22,10/31/2018
FD6926,conference-participant,100,50,10/31/2018
FE609F,conference-call,100,50,10/31/2018
FE89E0,executive-resignation,100,44,10/31/2018
FEE4B0,conference-participant,100,50,10/31/2018
FF6644,legal-issues-defendant,100,22,10/31/2018
FF6644,conference-participant,100,50,10/31/2018
FF6644,legal-issues-defendant,100,22,10/31/2018
0142B5,earnings-per-share-positive,100,69,11/1/2018
02870F,earnings-up,100,68,11/1/2018
02870F,earnings-up,100,68,11/1/2018
02870F,earnings-up,100,68,11/1/2018
02870F,earnings-up,100,68,11/1/2018
02870F,earnings-up,100,68,11/1/2018
03542C,earnings,100,50,11/1/2018
03B431,earnings,100,50,11/1/2018
03FAA6,earnings,100,50,11/1/2018
03FAA6,earnings,100,50,11/1/2018
03FAA6,earnings,100,50,11/1/2018
03FAA6,earnings,100,50,11/1/2018
03FAA6,earnings,100,50,11/1/2018
55018,dividend,100,50,11/1/2018
0560D8,conference-participant,100,50,11/1/2018
05AF14,executive-appointment,100,54,11/1/2018
0624BE,partnership,100,61,11/1/2018
68396,earnings,100,50,11/1/2018
06C826,conference-call,100,50,11/1/2018
06C826,conference-call,100,50,11/1/2018
06EF42,conference-call,100,50,11/1/2018
070B45,conference-participant,100,50,11/1/2018
0A77DB,earnings,100,50,11/1/2018
0AD2E3,earnings-up,100,68,11/1/2018
0B7375,conference-call,100,50,11/1/2018
0BC853,earnings,100,50,11/1/2018
0C355F,partnership,100,61,11/1/2018
0C4131,acquisition-completed-acquirer,100,49,11/1/2018
0C6293,conference-call,100,50,11/1/2018
0C6861,legal-issues-defendant,100,22,11/1/2018
0E499E,earnings,100,50,11/1/2018
0EF1AF,executive-appointment,100,54,11/1/2018
0F2BC9,business-contract,100,69,11/1/2018
105D00,dividend,100,50,11/1/2018
106394,earnings,100,50,11/1/2018
1096C6,executive-appointment,100,54,11/1/2018
10C19B,legal-issues-defendant,100,22,11/1/2018
10C19B,legal-issues-defendant,100,22,11/1/2018
119CB6,dividend,100,50,11/1/2018
152E1D,conference-participant,100,50,11/1/2018
15789A,award,100,58,11/1/2018
15B10D,partnership,100,61,11/1/2018
16C544,earnings,100,50,11/1/2018
16F4D8,executive-appointment,100,54,11/1/2018
1782D5,executive-appointment,100,54,11/1/2018
184866,earnings,100,50,11/1/2018
1A3E1B,executive-appointment,100,54,11/1/2018
1A6A94,earnings,100,50,11/1/2018
1B4F31,earnings,100,50,11/1/2018
1B4F31,earnings,100,50,11/1/2018
1B4F31,earnings,100,50,11/1/2018
1B4F31,earnings,100,50,11/1/2018
1B4F31,earnings,100,50,11/1/2018
1B9535,earnings,100,50,11/1/2018
1C2593,executive-appointment,100,54,11/1/2018
1CD09C,earnings,100,50,11/1/2018
1CD708,spin-off,100,58,11/1/2018
1CD708,spin-off,100,58,11/1/2018
1E04A5,earnings-up,100,68,11/1/2018
1E04A5,earnings,100,50,11/1/2018
1E04A5,earnings,100,50,11/1/2018
1E04A5,earnings,100,50,11/1/2018
1E1125,earnings,100,50,11/1/2018
1E1125,conference-organizer,100,57,11/1/2018
1E68B3,business-contract,100,69,11/1/2018
1E83DE,conference-participant,100,50,11/1/2018
1F08A6,earnings,100,50,11/1/2018
1F19C8,acquisition-acquirer,100,49,11/1/2018
1F9258,earnings,100,50,11/1/2018
1FE7F0,earnings,100,50,11/1/2018
1FE7F0,earnings,100,50,11/1/2018
1FE7F0,earnings,100,50,11/1/2018
1FE7F0,earnings,100,50,11/1/2018
219B21,earnings,100,50,11/1/2018
219B21,earnings,100,50,11/1/2018
219B21,earnings,100,50,11/1/2018
219B21,earnings,100,50,11/1/2018
21D903,earnings,100,50,11/1/2018
221AD7,executive-resignation,100,44,11/1/2018
239106,unit-acquisition-acquirer,100,49,11/1/2018
239106,earnings-per-share-positive,100,69,11/1/2018
239106,earnings-per-share-positive,100,69,11/1/2018
239106,earnings-per-share-positive,100,69,11/1/2018
24CB56,earnings,100,50,11/1/2018
24CB56,conference-participant,100,50,11/1/2018
250BEE,earnings,100,50,11/1/2018
250BEE,earnings,100,50,11/1/2018
250BEE,earnings,100,50,11/1/2018
250BEE,earnings,100,50,11/1/2018
250BEE,earnings,100,50,11/1/2018
251988,partnership,100,61,11/1/2018
251988,business-contract,100,69,11/1/2018
253B2F,earnings,100,50,11/1/2018
253B2F,earnings,100,50,11/1/2018
253B2F,business-contract,100,69,11/1/2018
2571FA,earnings,100,50,11/1/2018
2571FA,earnings,100,50,11/1/2018
2571FA,earnings,100,50,11/1/2018
25A6CC,conference-participant,100,50,11/1/2018
26CC63,conference-participant,100,50,11/1/2018
270305,merger-completed,100,66,11/1/2018
270B78,earnings,100,50,11/1/2018
27BFA1,dividend,100,50,11/1/2018
28DCF3,acquisition-completed-acquirer,100,49,11/1/2018
29CEBF,earnings,100,50,11/1/2018
29CEBF,earnings,100,50,11/1/2018
29CEBF,earnings,100,50,11/1/2018
29CEBF,earnings,100,50,11/1/2018
2A1009,earnings,100,50,11/1/2018
2A1009,earnings,100,50,11/1/2018
2A1009,earnings,100,50,11/1/2018
2A1009,earnings,100,50,11/1/2018
2A1009,earnings,100,50,11/1/2018
2B0AF4,dividend,100,50,11/1/2018
2B7A40,executive-appointment,100,54,11/1/2018
2BAE5F,earnings,100,50,11/1/2018
2BAE5F,earnings,100,50,11/1/2018
2BAE5F,earnings,100,50,11/1/2018
2C19A4,earnings-guidance,100,50,11/1/2018
2C19A4,earnings,100,50,11/1/2018
2C19A4,earnings,100,50,11/1/2018
2C19A4,earnings,100,50,11/1/2018
2C681C,executive-appointment,100,54,11/1/2018
2C681C,executive-appointment,100,54,11/1/2018
2C681C,conference-call,100,50,11/1/2018
2C681C,conference-call,100,50,11/1/2018
2D2D43,earnings,100,50,11/1/2018
2DC88B,earnings,100,50,11/1/2018
2F6782,conference-participant,100,50,11/1/2018
2F7A7E,earnings,100,50,11/1/2018
2F9304,partnership,100,61,11/1/2018
301493,legal-issues-defendant,100,22,11/1/2018
3159AA,conference-call,100,50,11/1/2018
315EB0,earnings,100,50,11/1/2018
315EB0,earnings,100,50,11/1/2018
315EB0,earnings,100,50,11/1/2018
315EB0,earnings,100,50,11/1/2018
315EB0,earnings,100,50,11/1/2018
315EB0,earnings,100,50,11/1/2018
315EB0,dividend,100,50,11/1/2018
3224CC,conference-participant,100,50,11/1/2018
332F87,earnings-up,100,68,11/1/2018
332F87,earnings-positive,100,69,11/1/2018
332F87,earnings-positive,100,69,11/1/2018
332F87,earnings-positive,100,69,11/1/2018
332F87,earnings-positive,100,69,11/1/2018
332F87,earnings-positive,100,69,11/1/2018
353DBB,dividend,100,50,11/1/2018
3587B4,product-release,100,64,11/1/2018
35F4B5,earnings-guidance-up,100,83,11/1/2018
35F4B5,earnings,100,50,11/1/2018
35F4B5,acquisition-completed-acquirer,100,49,11/1/2018
371B0A,earnings,100,50,11/1/2018
372037,dividend,100,50,11/1/2018
372037,earnings,100,50,11/1/2018
372037,earnings,100,50,11/1/2018
37B618,unit-acquisition-acquirer,100,49,11/1/2018
382EAE,note-sale,100,52,11/1/2018
383ADA,earnings,100,50,11/1/2018
387375,earnings,100,50,11/1/2018
387541,conference-participant,100,50,11/1/2018
3ACF46,earnings,100,50,11/1/2018
3ACF46,earnings,100,50,11/1/2018
3ACF46,earnings,100,50,11/1/2018
3ACF46,earnings,100,50,11/1/2018
3ACF46,earnings,100,50,11/1/2018
3ACF46,earnings,100,50,11/1/2018
3B2311,earnings,100,50,11/1/2018
3B8484,revenue-up,100,69,11/1/2018
3C7F5F,earnings,100,50,11/1/2018
3C7F5F,earnings,100,50,11/1/2018
3CBA2A,earnings,100,50,11/1/2018
3D7971,earnings,100,50,11/1/2018
3D7971,earnings,100,50,11/1/2018
3D7971,earnings,100,50,11/1/2018
3D7971,earnings,100,50,11/1/2018
3D7971,earnings,100,50,11/1/2018
3D7971,earnings,100,50,11/1/2018
3D7971,earnings,100,50,11/1/2018
3DC887,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3ED92D,earnings,100,50,11/1/2018
3F6A9C,earnings,100,50,11/1/2018
3F868D,earnings,100,50,11/1/2018
3FBC9B,operating-earnings,100,50,11/1/2018
415188,dividend,100,50,11/1/2018
415188,earnings,100,50,11/1/2018
416C55,dividend-up,100,55,11/1/2018
417BF9,conference-call,100,50,11/1/2018
43E8F5,conference-participant,100,50,11/1/2018
44A4FC,partnership,100,61,11/1/2018
451D61,earnings,100,50,11/1/2018
451D61,earnings,100,50,11/1/2018
46017C,earnings,100,50,11/1/2018
4.60E+06,earnings,100,50,11/1/2018
4806CE,earnings,100,50,11/1/2018
4806CE,earnings,100,50,11/1/2018
4885C8,earnings,100,50,11/1/2018
499C75,earnings,100,50,11/1/2018
49A344,earnings,100,50,11/1/2018
49A344,earnings,100,50,11/1/2018
49A344,earnings,100,50,11/1/2018
49F4D0,earnings,100,50,11/1/2018
4A5C8D,executive-appointment,100,54,11/1/2018
4BDCA7,clinical-trials,100,56,11/1/2018
4C350A,earnings,100,50,11/1/2018
4C350A,earnings,100,50,11/1/2018
4D229C,earnings,100,50,11/1/2018
4D8124,earnings,100,50,11/1/2018
4D8124,earnings,100,50,11/1/2018
4DD09F,business-contract,100,69,11/1/2018
4E2D94,earnings,100,50,11/1/2018
4E2D94,buybacks,100,74,11/1/2018
4E2D94,dividend,100,50,11/1/2018
4E5784,earnings,100,50,11/1/2018
4EEE7E,earnings,100,50,11/1/2018
4F9487,acquisition-completed-acquirer,100,49,11/1/2018
4F9487,acquisition-completed-acquirer,100,49,11/1/2018
4FCC78,earnings,100,50,11/1/2018
50070E,conference-organizer,100,57,11/1/2018
50070E,earnings,100,50,11/1/2018
51D876,revenue-up,100,69,11/1/2018
524CE4,earnings,100,50,11/1/2018
525A1C,earnings,100,50,11/1/2018
525A1C,earnings,100,50,11/1/2018
525A1C,earnings,100,50,11/1/2018
525A1C,earnings,100,50,11/1/2018
525A1C,earnings,100,50,11/1/2018
525A1C,earnings,100,50,11/1/2018
525A1C,earnings,100,50,11/1/2018
546A27,earnings,100,50,11/1/2018
55ACCB,earnings,100,50,11/1/2018
55ACCB,earnings,100,50,11/1/2018
55ACCB,earnings,100,50,11/1/2018
55C9B5,partnership,100,61,11/1/2018
56632F,earnings,100,50,11/1/2018
56632F,earnings,100,50,11/1/2018
56632F,earnings,100,50,11/1/2018
56EFC7,dividend,100,50,11/1/2018
56FB7C,dividend-up,100,81,11/1/2018
5704AC,operating-earnings,100,50,11/1/2018
583223,earnings,100,50,11/1/2018
586BD7,earnings,100,50,11/1/2018
5876DC,earnings,100,50,11/1/2018
58CA9A,facility-open,100,65,11/1/2018
5A423F,earnings,100,50,11/1/2018
5A9A82,earnings,100,50,11/1/2018
5A9A82,earnings,100,50,11/1/2018
5A9A82,earnings,100,50,11/1/2018
5A9A82,earnings,100,50,11/1/2018
5AF08A,buybacks,100,74,11/1/2018
5B3415,earnings,100,50,11/1/2018
5B3415,earnings,100,50,11/1/2018
5B3FA2,revenue-up,100,69,11/1/2018
5B3FA2,revenue-up,100,69,11/1/2018
5C7601,earnings,100,50,11/1/2018
5EAA43,executive-appointment,100,54,11/1/2018
5F3E74,earnings,100,50,11/1/2018
5F3E74,earnings,100,50,11/1/2018
6.18E+08,earnings,100,50,11/1/2018
6.18E+08,earnings,100,50,11/1/2018
6.18E+08,earnings,100,50,11/1/2018
619882,earnings,100,50,11/1/2018
619882,conference-organizer,100,57,11/1/2018
62A48D,earnings,100,50,11/1/2018
636639,dividend,100,50,11/1/2018
63F892,earnings,100,50,11/1/2018
64854A,executive-appointment,100,54,11/1/2018
649CBD,legal-issues-defendant,100,22,11/1/2018
64E615,earnings,100,50,11/1/2018
64E615,earnings,100,50,11/1/2018
64E615,earnings,100,50,11/1/2018
64E615,earnings,100,50,11/1/2018
651C85,earnings,100,50,11/1/2018
6559D8,conference-call,100,50,11/1/2018
65CF8E,executive-appointment,100,54,11/1/2018
66ECFD,partnership,100,61,11/1/2018
67303E,earnings,100,50,11/1/2018
67B052,earnings,100,50,11/1/2018
68BA15,trading-resumed,100,58,11/1/2018
68E3E0,dividend,100,50,11/1/2018
69C99E,earnings,100,50,11/1/2018
6A01DF,acquisition-acquiree,100,76,11/1/2018
6A01DF,earnings,100,50,11/1/2018
6A3C35,earnings,100,50,11/1/2018
6A3C35,earnings,100,50,11/1/2018
6A3C35,earnings,100,50,11/1/2018
6A3C35,earnings,100,50,11/1/2018
6A3C35,earnings,100,50,11/1/2018
6B0784,conference-call,100,50,11/1/2018
6B5379,earnings,100,50,11/1/2018
6B5379,earnings,100,50,11/1/2018
6B5379,earnings,100,50,11/1/2018
6BC6F9,unit-acquisition-acquirer,100,49,11/1/2018
6BF593,earnings,100,50,11/1/2018
6BF593,earnings,100,50,11/1/2018
6D1ADF,earnings,100,50,11/1/2018
6D3B7B,dividend,100,50,11/1/2018
6.00E+19,earnings,100,50,11/1/2018
6EA292,earnings,100,50,11/1/2018
6ED519,earnings,100,50,11/1/2018
6F0A63,earnings,100,50,11/1/2018
6F92A9,earnings,100,50,11/1/2018
701531,earnings,100,50,11/1/2018
705636,dividend,100,50,11/1/2018
713810,product-release,100,64,11/1/2018
719477,conference-call,100,50,11/1/2018
71E2EF,dividend,100,50,11/1/2018
7239BB,executive-appointment,100,54,11/1/2018
72C2CE,earnings,100,50,11/1/2018
735388,dividend,100,50,11/1/2018
73A71F,earnings,100,50,11/1/2018
73BCBA,earnings,100,50,11/1/2018
73BCBA,earnings,100,50,11/1/2018
73BCBA,earnings,100,50,11/1/2018
73BCBA,earnings,100,50,11/1/2018
7.45E+28,earnings,100,50,11/1/2018
747219,earnings,100,50,11/1/2018
752A70,unit-acquisition-acquiree,100,76,11/1/2018
763DBE,earnings,100,50,11/1/2018
789ADD,earnings,100,50,11/1/2018
789ADD,earnings,100,50,11/1/2018
789ADD,earnings,100,50,11/1/2018
789ADD,earnings,100,50,11/1/2018
793C11,earnings,100,50,11/1/2018
793C11,earnings,100,50,11/1/2018
793C11,earnings,100,50,11/1/2018
793C11,earnings,100,50,11/1/2018
7ADE57,acquisition-completed-acquirer,100,49,11/1/2018
7AF5B8,partnership,100,61,11/1/2018
7B0BA6,conference-participant,100,50,11/1/2018
7B492C,earnings,100,50,11/1/2018
7B6EB1,earnings,100,50,11/1/2018
7B8CB5,earnings,100,50,11/1/2018
7BEA98,conference-call,100,50,11/1/2018
7C4F43,earnings,100,50,11/1/2018
7CD98F,earnings,100,50,11/1/2018
7D7716,earnings,100,50,11/1/2018
7D7716,earnings,100,50,11/1/2018
7D7716,earnings,100,50,11/1/2018
7D7716,earnings,100,50,11/1/2018
7D7716,earnings,100,50,11/1/2018
7D7716,earnings,100,50,11/1/2018
7F9BE2,earnings,100,50,11/1/2018
8.10E+32,buybacks,100,74,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
8.10E+32,earnings,100,50,11/1/2018
810FAD,conference-participant,100,50,11/1/2018
835C86,earnings,100,50,11/1/2018
835C86,earnings,100,50,11/1/2018
83E0AC,conference-call,100,50,11/1/2018
85CDC9,earnings,100,50,11/1/2018
862941,earnings-guidance,100,50,11/1/2018
86A1B9,earnings-up,100,68,11/1/2018
86A1B9,earnings-up,100,68,11/1/2018
86A1B9,earnings-up,100,68,11/1/2018
86A1B9,earnings-up,100,68,11/1/2018
86A1B9,earnings-up,100,68,11/1/2018
8802B4,note-sale,100,52,11/1/2018
88923D,acquisition-acquirer,100,49,11/1/2018
88923D,acquisition-acquirer,100,49,11/1/2018
88923D,earnings,100,50,11/1/2018
88923D,earnings,100,50,11/1/2018
88923D,earnings,100,50,11/1/2018
88923D,earnings,100,50,11/1/2018
88923D,earnings,100,50,11/1/2018
88923D,earnings,100,50,11/1/2018
89F693,earnings,100,50,11/1/2018
8AB85C,patient-enrollment-complete,100,64,11/1/2018
8B1F37,earnings,100,50,11/1/2018
8B3B0E,conference-participant,100,50,11/1/2018
8B9B3B,earnings,100,50,11/1/2018
8BAA15,earnings,100,50,11/1/2018
8BAA15,earnings,100,50,11/1/2018
8BAA15,earnings,100,50,11/1/2018
8E4F9A,operating-earnings,100,50,11/1/2018
8EDACA,legal-issues-defendant,100,22,11/1/2018
8EDACA,legal-issues-defendant,100,22,11/1/2018
902255,dividend,100,50,11/1/2018
9196A2,conference-organizer,100,57,11/1/2018
92B625,earnings,100,50,11/1/2018
92B73F,dividend,100,50,11/1/2018
92D757,asset-sale,100,62,11/1/2018
92D9C9,public-offering,100,43,11/1/2018
93965C,executive-appointment,100,54,11/1/2018
93965C,earnings,100,50,11/1/2018
93965C,earnings,100,50,11/1/2018
93AD2E,earnings,100,50,11/1/2018
9470CC,earnings,100,50,11/1/2018
947B0B,earnings,100,50,11/1/2018
94983E,earnings,100,50,11/1/2018
958938,conference-call,100,50,11/1/2018
95C392,business-contract,100,69,11/1/2018
95C392,earnings,100,50,11/1/2018
9673BD,dividend,100,50,11/1/2018
968966,earnings,100,50,11/1/2018
96A6CD,earnings,100,50,11/1/2018
971F7B,conference-participant,100,50,11/1/2018
971F7B,earnings,100,50,11/1/2018
971F7B,earnings,100,50,11/1/2018
971F7B,earnings,100,50,11/1/2018
971F7B,earnings,100,50,11/1/2018
971F7B,earnings,100,50,11/1/2018
977A1E,earnings,100,50,11/1/2018
97AAF6,earnings,100,50,11/1/2018
97AAF6,earnings,100,50,11/1/2018
97AAF6,earnings,100,50,11/1/2018
97AAF6,earnings,100,50,11/1/2018
97AAF6,earnings,100,50,11/1/2018
9.97E+09,earnings,100,50,11/1/2018
9B4066,dividend,100,50,11/1/2018
9C25FF,earnings,100,50,11/1/2018
9C5174,revenue-up,100,71,11/1/2018
9C5174,revenues,100,50,11/1/2018
9D5D35,earnings,100,50,11/1/2018
9D5FA4,earnings,100,50,11/1/2018
9E298A,earnings,100,50,11/1/2018
9E575E,earnings,100,50,11/1/2018
9E575E,earnings,100,50,11/1/2018
9E575E,earnings,100,50,11/1/2018
9E98F2,conference-participant,100,50,11/1/2018
9EA947,executive-appointment,100,54,11/1/2018
9EBAFA,acquisition-acquirer,100,49,11/1/2018
9F5997,conference-participant,100,50,11/1/2018
9F71E5,product-release,100,64,11/1/2018
9FB4B7,conference-call,100,50,11/1/2018
9FD2D9,conference-participant,100,50,11/1/2018
A072C4,conference-call,100,50,11/1/2018
A15C71,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A16DEA,earnings,100,50,11/1/2018
A247F5,earnings-per-share-positive,100,69,11/1/2018
A247F5,earnings-per-share-positive,100,69,11/1/2018
A247F5,earnings-per-share-positive,100,69,11/1/2018
A28675,earnings,100,50,11/1/2018
A3800A,dividend,100,50,11/1/2018
A43906,earnings,100,50,11/1/2018
A47F2E,conference-participant,100,50,11/1/2018
A4BCDE,earnings,100,50,11/1/2018
A52533,earnings,100,50,11/1/2018
A5A4F5,acquisition-acquirer,100,49,11/1/2018
A5A4F5,product-release,100,64,11/1/2018
A5A4F5,product-release,100,64,11/1/2018
A5E715,conference-participant,100,50,11/1/2018
A60354,earnings,100,50,11/1/2018
A60354,earnings,100,50,11/1/2018
A60354,earnings,100,50,11/1/2018
A6213D,partnership,100,61,11/1/2018
A6213D,partnership,100,61,11/1/2018
A6FC89,earnings,100,50,11/1/2018
A7F0A5,executive-resignation,100,44,11/1/2018
A7F0A5,earnings,100,50,11/1/2018
A868C9,conference-participant,100,50,11/1/2018
A8B137,stake-acquirer,100,48,11/1/2018
A94637,revenues,100,50,11/1/2018
A94637,revenues,100,50,11/1/2018
AA1EAA,earnings,100,50,11/1/2018
AD23DE,executive-appointment,100,54,11/1/2018
AD3008,earnings,100,50,11/1/2018
AD3C93,conference-call,100,50,11/1/2018
ADD9DC,facility-open,100,65,11/1/2018
AEFC90,conference-participant,100,50,11/1/2018
AF210D,executive-appointment,100,54,11/1/2018
AF93DE,conference-call,100,50,11/1/2018
B01111,earnings,100,50,11/1/2018
B01215,conference-call,100,50,11/1/2018
B05118,earnings,100,50,11/1/2018
B0998E,earnings,100,50,11/1/2018
B0998E,earnings,100,50,11/1/2018
B0998E,earnings,100,50,11/1/2018
B0998E,earnings,100,50,11/1/2018
B0998E,earnings,100,50,11/1/2018
B0998E,earnings,100,50,11/1/2018
B0B969,earnings,100,50,11/1/2018
B0D41A,earnings,100,50,11/1/2018
B1A85D,acquisition-completed-acquirer,100,49,11/1/2018
B1FC3B,business-contract,100,69,11/1/2018
B2256A,earnings,100,50,11/1/2018
B2E6B5,executive-appointment,100,54,11/1/2018
B2E6B5,executive-appointment,100,54,11/1/2018
B303A6,earnings,100,50,11/1/2018
B303A6,earnings,100,50,11/1/2018
B303A6,earnings,100,50,11/1/2018
B303A6,earnings,100,50,11/1/2018
B303A6,earnings,100,50,11/1/2018
B303A6,earnings,100,50,11/1/2018
B381D8,earnings,100,50,11/1/2018
B3A166,conference-call,100,50,11/1/2018
B3ED62,earnings,100,50,11/1/2018
B5734D,business-contract,100,69,11/1/2018
B5734D,business-contract,100,69,11/1/2018
B642E8,executive-appointment,100,54,11/1/2018
B642E8,executive-appointment,100,54,11/1/2018
B642E8,executive-appointment,100,54,11/1/2018
B7EB38,earnings,100,50,11/1/2018
B7EB38,earnings,100,50,11/1/2018
B934BF,earnings,100,50,11/1/2018
BB07E4,dividend,100,50,11/1/2018
BBC05B,operating-earnings,100,50,11/1/2018
BCC13E,conference-participant,100,50,11/1/2018
BD8517,earnings,100,50,11/1/2018
BDD12C,partnership,100,61,11/1/2018
BDEC1E,conference-call,100,50,11/1/2018
BE7BA4,unit-acquisition-acquirer,100,49,11/1/2018
BE7BA4,earnings-guidance-up,100,83,11/1/2018
BFEA04,earnings,100,50,11/1/2018
BFEA04,earnings,100,50,11/1/2018
BFEA04,earnings,100,50,11/1/2018
BFEA04,earnings,100,50,11/1/2018
C0030A,earnings,100,50,11/1/2018
C0030A,earnings,100,50,11/1/2018
C0030A,earnings,100,50,11/1/2018
C0030A,earnings,100,50,11/1/2018
C0030A,earnings,100,50,11/1/2018
C03C8B,earnings,100,50,11/1/2018
C03C8B,earnings,100,50,11/1/2018
C03C8B,earnings,100,50,11/1/2018
C03C8B,earnings,100,50,11/1/2018
C03C8B,earnings,100,50,11/1/2018
C03C8B,earnings,100,50,11/1/2018
C03C8B,earnings,100,50,11/1/2018
C062D4,partnership,100,61,11/1/2018
C0BA36,earnings,100,50,11/1/2018
C0BA36,earnings,100,50,11/1/2018
C0BA36,earnings,100,50,11/1/2018
C0F70B,conference-participant,100,50,11/1/2018
C188F8,earnings,100,50,11/1/2018
C188F8,business-contract,100,69,11/1/2018
C2F597,earnings,100,50,11/1/2018
C356AC,dividend,100,50,11/1/2018
C356AC,earnings,100,50,11/1/2018
C356AC,earnings,100,50,11/1/2018
C356AC,earnings,100,50,11/1/2018
C356AC,earnings,100,50,11/1/2018
C356AC,earnings,100,50,11/1/2018
C4706C,conference-call,100,50,11/1/2018
C4C77F,buybacks,100,74,11/1/2018
C54140,acquisition-completed-acquirer,100,49,11/1/2018
C54140,earnings,100,50,11/1/2018
C5D2AE,conference-participant,100,50,11/1/2018
C6C702,earnings,100,50,11/1/2018
C8923A,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C8A248,earnings,100,50,11/1/2018
C98CDB,earnings,100,50,11/1/2018
C9A96E,earnings,100,50,11/1/2018
C9E4EC,earnings,100,50,11/1/2018
CA1620,legal-issues-defendant,100,22,11/1/2018
CB22CD,dividend,100,50,11/1/2018
CB7AB2,executive-appointment,100,54,11/1/2018
CBDB4D,conference-call,100,50,11/1/2018
CC6FF5,product-release,100,64,11/1/2018
CCB623,public-offering,100,43,11/1/2018
CD2A4D,earnings,100,50,11/1/2018
CD4DA8,executive-appointment,100,54,11/1/2018
CD4DA8,executive-appointment,100,54,11/1/2018
CDD75E,executive-appointment,100,54,11/1/2018
CDE118,earnings,100,50,11/1/2018
CED4D0,earnings,100,50,11/1/2018
CF6A5A,dividend,100,50,11/1/2018
CFD4B6,dividend,100,50,11/1/2018
CFF97C,product-release,100,64,11/1/2018
D03C7A,earnings,100,50,11/1/2018
D08D2C,earnings,100,50,11/1/2018
D08D2C,earnings,100,50,11/1/2018
D08D2C,earnings,100,50,11/1/2018
D08D2C,earnings,100,50,11/1/2018
D08D2C,earnings,100,50,11/1/2018
D0DE27,earnings,100,50,11/1/2018
D1C26F,earnings,100,50,11/1/2018
D21D8A,buybacks,100,74,11/1/2018
D29F43,earnings,100,50,11/1/2018
D33270,partnership,100,61,11/1/2018
D45285,earnings,100,50,11/1/2018
D45285,earnings,100,50,11/1/2018
D4AC65,partnership,100,61,11/1/2018
D4AC65,earnings,100,50,11/1/2018
D4AC65,earnings,100,50,11/1/2018
D4AC65,earnings,100,50,11/1/2018
D4AC65,earnings,100,50,11/1/2018
D4AC65,earnings,100,50,11/1/2018
D4AC65,earnings,100,50,11/1/2018
D5938F,clinical-trials,100,56,11/1/2018
D65A13,revenue-up,100,76,11/1/2018
D65A13,revenue-up,100,76,11/1/2018
D65A13,revenue-up,100,69,11/1/2018
D6853F,earnings,100,50,11/1/2018
D6853F,earnings,100,50,11/1/2018
D6853F,earnings,100,50,11/1/2018
D78BF1,facility-open,100,65,11/1/2018
D82EF3,conference-participant,100,50,11/1/2018
D8442A,earnings,100,50,11/1/2018
D8442A,earnings,100,50,11/1/2018
D8442A,earnings,100,50,11/1/2018
D8DA3D,earnings,100,50,11/1/2018
D8DA3D,earnings,100,50,11/1/2018
D8DA3D,earnings,100,50,11/1/2018
D8DA3D,earnings,100,50,11/1/2018
D8DA3D,earnings,100,50,11/1/2018
D8DA3D,earnings,100,50,11/1/2018
D8DA3D,earnings,100,50,11/1/2018
D8ECA1,business-contract,100,69,11/1/2018
DA0CB8,earnings,100,50,11/1/2018
DA91AE,conference-participant,100,50,11/1/2018
DA9443,earnings,100,50,11/1/2018
DB7EC3,earnings,100,50,11/1/2018
DB88A1,executive-appointment,100,54,11/1/2018
DC0D18,earnings,100,50,11/1/2018
DC0D18,earnings,100,50,11/1/2018
DC0D18,earnings,100,50,11/1/2018
DC0D18,earnings,100,50,11/1/2018
DC2F77,earnings,100,50,11/1/2018
DC437D,dividend,100,50,11/1/2018
DD0F15,earnings,100,50,11/1/2018
DDCB34,dividend-up,100,68,11/1/2018
DDCB34,earnings,100,50,11/1/2018
DE20DF,operating-earnings,100,50,11/1/2018
DF1F7A,earnings,100,50,11/1/2018
DF5F14,conference-call,100,50,11/1/2018
DF6FDD,conference-participant,100,50,11/1/2018
E09E2B,conference-call,100,50,11/1/2018
E0D3BA,earnings,100,50,11/1/2018
E12A6E,earnings,100,50,11/1/2018
E16133,conference-call,100,50,11/1/2018
E1BD05,revenues,100,50,11/1/2018
E1BD05,revenues,100,50,11/1/2018
E2F66E,revenue-up,100,69,11/1/2018
E30B34,executive-appointment,100,54,11/1/2018
E35610,earnings,100,50,11/1/2018
E35610,earnings,100,50,11/1/2018
E35610,earnings,100,50,11/1/2018
E35610,earnings,100,50,11/1/2018
E49AA3,earnings,100,50,11/1/2018
E49AA3,earnings,100,50,11/1/2018
E592F0,earnings,100,50,11/1/2018
E592F0,earnings,100,50,11/1/2018
E592F0,earnings,100,50,11/1/2018
E592F0,earnings,100,50,11/1/2018
E67C2C,earnings,100,50,11/1/2018
E6BC2C,campaign-ad-release,100,59,11/1/2018
E6D89E,acquisition-acquirer,100,49,11/1/2018
ED3CA8,earnings,100,50,11/1/2018
EE6F1C,product-release,100,64,11/1/2018
EE74E1,earnings-per-share-positive,100,69,11/1/2018
EE74E1,earnings-per-share-positive,100,69,11/1/2018
EE74E1,earnings-per-share-positive,100,69,11/1/2018
EEA6B3,conference-participant,100,50,11/1/2018
EEB5F9,fast-track-designation,100,81,11/1/2018
EEEA9F,public-offering,100,43,11/1/2018
EF5914,earnings,100,50,11/1/2018
EF7163,earnings,100,50,11/1/2018
F0027C,earnings,100,50,11/1/2018
F02D0A,earnings,100,50,11/1/2018
F02D0A,earnings,100,50,11/1/2018
F0B335,earnings,100,50,11/1/2018
F1CD47,earnings,100,50,11/1/2018
F2E253,dividend,100,50,11/1/2018
F3816D,earnings,100,50,11/1/2018
F47871,earnings,100,50,11/1/2018
F47871,clinical-trials,100,56,11/1/2018
F47871,clinical-trials,100,56,11/1/2018
F4CDA3,unit-acquisition-acquirer,100,49,11/1/2018
F4F46F,earnings,100,50,11/1/2018
F51DB0,earnings,100,50,11/1/2018
F57F6F,earnings,100,50,11/1/2018
F58C23,conference-organizer,100,57,11/1/2018
F748C7,partnership,100,61,11/1/2018
F7935D,earnings,100,50,11/1/2018
F80389,earnings,100,50,11/1/2018
F85CC0,earnings,100,50,11/1/2018
FAB97A,earnings,100,50,11/1/2018
FD4588,earnings,100,50,11/1/2018
FD4588,earnings,100,50,11/1/2018
FD4588,earnings,100,50,11/1/2018
FD4588,earnings,100,50,11/1/2018
FD4BBE,conference-participant,100,50,11/1/2018
FD554E,conference-call,100,50,11/1/2018
FD6926,earnings,100,50,11/1/2018
FD6926,earnings,100,50,11/1/2018
FD6926,earnings,100,50,11/1/2018
FD6926,earnings,100,50,11/1/2018
FD6926,earnings,100,50,11/1/2018
FD6926,earnings,100,50,11/1/2018
FD6926,dividend,100,50,11/1/2018
FE89E0,asset-sale,100,62,11/1/2018
FEE4B0,earnings-up,100,68,11/1/2018
FEE4B0,earnings-up,100,68,11/1/2018
FEE4B0,earnings-up,100,68,11/1/2018
FEE4B0,earnings-up,100,68,11/1/2018
FEE4B0,earnings-up,100,68,11/1/2018
FF6644,legal-issues-defendant,100,22,11/1/2018
FF6644,legal-issues-defendant,100,22,11/1/2018
FF6644,legal-issues-defendant,100,22,11/1/2018
FFE543,legal-issues-defendant,100,22,11/1/2018
002A99,earnings,100,50,11/2/2018
13528,conference-call,100,50,11/2/2018
034B61,executive-appointment,100,54,11/2/2018
034B61,executive-appointment,100,54,11/2/2018
034B61,executive-appointment,100,54,11/2/2018
036C6F,acquisition-acquirer,100,49,11/2/2018
0919B1,earnings,100,50,11/2/2018
0C2A0D,executive-appointment,100,54,11/2/2018
0C6861,legal-issues-defendant,100,22,11/2/2018
0E5619,conference-call,100,50,11/2/2018
157D9F,conference-call,100,50,11/2/2018
17EDA5,award,100,58,11/2/2018
19C105,earnings,100,50,11/2/2018
19C105,earnings,100,50,11/2/2018
19C105,earnings,100,50,11/2/2018
19C105,dividend,100,50,11/2/2018
1E1125,conference-organizer,100,57,11/2/2018
1F43A1,earnings,100,50,11/2/2018
275300,conference-participant,100,50,11/2/2018
2A4131,earnings,100,50,11/2/2018
2AE625,earnings,100,50,11/2/2018
2D485F,dividend,100,50,11/2/2018
2DC88B,executive-appointment,100,54,11/2/2018
32F943,conference-participant,100,50,11/2/2018
35F4B5,conference-participant,100,50,11/2/2018
37B120,earnings,100,50,11/2/2018
37E18B,conference-call,100,50,11/2/2018
389CFB,earnings,100,50,11/2/2018
38C46F,dividend,100,50,11/2/2018
39692D,conference-participant,100,50,11/2/2018
3B318A,legal-issues-defendant,100,22,11/2/2018
3C11C4,earnings,100,50,11/2/2018
3C11C4,conference-participant,100,50,11/2/2018
4290EF,product-release,100,64,11/2/2018
4C92B9,legal-issues-defendant,100,22,11/2/2018
4DD09F,legal-issues-defendant,100,22,11/2/2018
4F783B,dividend,100,50,11/2/2018
5340D0,conference-participant,100,50,11/2/2018
54F271,executive-appointment,100,54,11/2/2018
5A53BF,earnings,100,50,11/2/2018
5DD486,acquisition-completed-acquirer,100,49,11/2/2018
5DE5A5,dividend,100,50,11/2/2018
60FE03,earnings,100,50,11/2/2018
649CBD,legal-issues-defendant,100,22,11/2/2018
665D7D,earnings,100,50,11/2/2018
6A6BDC,earnings,100,50,11/2/2018
6B236C,dividend,100,50,11/2/2018
6BD606,dividend,100,50,11/2/2018
6D2BF6,earnings,100,50,11/2/2018
6ED519,legal-issues-defendant,100,22,11/2/2018
6ED519,legal-issues-defendant,100,22,11/2/2018
6F30F9,earnings,100,50,11/2/2018
705636,earnings-positive,100,69,11/2/2018
7255D2,earnings,100,50,11/2/2018
726EEA,earnings-up,100,68,11/2/2018
726EEA,earnings-up,100,68,11/2/2018
726EEA,earnings-up,100,68,11/2/2018
726EEA,earnings-up,100,68,11/2/2018
726EEA,earnings-up,100,68,11/2/2018
726EEA,conference-participant,100,50,11/2/2018
73529F,debt-extension-recipient,100,73,11/2/2018
76BD96,dividend,100,50,11/2/2018
76E80F,executive-appointment,100,54,11/2/2018
7A0EC4,product-release,100,64,11/2/2018
7D7716,award,100,58,11/2/2018
7F2922,earnings,100,50,11/2/2018
81EAD4,earnings-up,100,68,11/2/2018
81EAD4,earnings,100,50,11/2/2018
81EAD4,earnings,100,50,11/2/2018
81EAD4,earnings,100,50,11/2/2018
82FD6D,earnings,100,50,11/2/2018
848C0B,earnings,100,50,11/2/2018
87486A,earnings,100,50,11/2/2018
87486A,earnings,100,50,11/2/2018
87486A,earnings,100,50,11/2/2018
87486A,earnings,100,50,11/2/2018
8E10BF,conference-call,100,50,11/2/2018
8EDACA,legal-issues-defendant,100,22,11/2/2018
913437,executive-appointment,100,54,11/2/2018
9196A2,conference-organizer,100,57,11/2/2018
9548BB,conference-participant,100,50,11/2/2018
95C575,earnings,100,50,11/2/2018
95F59E,earnings,100,50,11/2/2018
9.65E+07,conference-call,100,50,11/2/2018
96BFF4,earnings,100,50,11/2/2018
971334,earnings-up,100,68,11/2/2018
971334,earnings-up,100,68,11/2/2018
971334,earnings-up,100,68,11/2/2018
971334,earnings-up,100,68,11/2/2018
971334,earnings-up,100,68,11/2/2018
979451,conference-participant,100,50,11/2/2018
98D33E,earnings-up,100,68,11/2/2018
990AD0,conference-organizer,100,57,11/2/2018
9D30A8,conference-participant,100,50,11/2/2018
9D6A24,acquisition-completed-acquirer,100,49,11/2/2018
A52B6B,earnings,100,50,11/2/2018
A5A4F5,acquisition-acquirer,100,49,11/2/2018
A6828A,product-recall,100,29,11/2/2018
A94637,executive-appointment,100,54,11/2/2018
A94718,conference-call,100,50,11/2/2018
AA3AB8,earnings,100,50,11/2/2018
B2AA0A,earnings,100,50,11/2/2018
B2AA0A,regulatory-stress-test,100,50,11/2/2018
B2D492,earnings,100,50,11/2/2018
B4B281,conference-call,100,50,11/2/2018
B5BA39,earnings,100,50,11/2/2018
B5BA39,earnings,100,50,11/2/2018
B5BA39,earnings,100,50,11/2/2018
B5BA39,earnings,100,50,11/2/2018
B5BA39,earnings,100,50,11/2/2018
B5BA39,earnings,100,50,11/2/2018
B5BA39,earnings,100,50,11/2/2018
B5BA39,dividend,100,50,11/2/2018
B5BA39,executive-resignation,100,44,11/2/2018
B83BCE,conference-participant,100,50,11/2/2018
BCC55F,earnings-up,100,68,11/2/2018
BD8517,facility-open,100,65,11/2/2018
BFE02C,conference-participant,100,50,11/2/2018
C01737,earnings,100,50,11/2/2018
C01737,earnings,100,50,11/2/2018
C3BCD5,earnings,100,50,11/2/2018
C3BCD5,earnings,100,50,11/2/2018
C5C137,business-contract,100,69,11/2/2018
C62AA4,executive-appointment,100,54,11/2/2018
C66B44,buybacks,100,74,11/2/2018
C66B44,earnings,100,50,11/2/2018
CA1620,legal-issues-defendant,100,22,11/2/2018
CA1620,legal-issues-defendant,100,22,11/2/2018
D54E62,earnings-positive,100,69,11/2/2018
D54E62,earnings-positive,100,69,11/2/2018
D54E62,earnings-positive,100,69,11/2/2018
D6144F,conference-call,100,50,11/2/2018
D65A13,conference-participant,100,50,11/2/2018
D854F3,earnings-positive,100,69,11/2/2018
D854F3,earnings,100,50,11/2/2018
D854F3,earnings,100,50,11/2/2018
DB23C8,earnings,100,50,11/2/2018
DB23C8,earnings,100,50,11/2/2018
DB23C8,earnings,100,50,11/2/2018
DB23C8,earnings,100,50,11/2/2018
DB5CA5,earnings,100,50,11/2/2018
DBEF02,earnings,100,50,11/2/2018
DDB002,conference-participant,100,50,11/2/2018
E05DC8,acquisition-completed-acquirer,100,49,11/2/2018
E70531,earnings-up,100,82,11/2/2018
E70531,earnings-up,100,82,11/2/2018
E70531,earnings-up,100,82,11/2/2018
E70531,earnings-up,100,82,11/2/2018
E70531,earnings-up,100,82,11/2/2018
E959F3,dividend,100,50,11/2/2018
EBC84C,dividend,100,50,11/2/2018
ED2EFD,earnings,100,50,11/2/2018
ED79D9,product-release,100,64,11/2/2018
EE04F0,conference-call,100,50,11/2/2018
EEB5F9,conference-participant,100,50,11/2/2018
EEEA9F,conference-participant,100,50,11/2/2018
EF77A3,conference-participant,100,50,11/2/2018
F1529C,earnings,100,50,11/2/2018
F1529C,earnings,100,50,11/2/2018
F32F88,dividend,100,50,11/2/2018
F32F88,earnings-up,100,68,11/2/2018
F6581D,earnings,100,50,11/2/2018
F6A987,earnings-up,100,68,11/2/2018
F6E248,acquisition-acquiree,100,76,11/2/2018
F721A7,note-sale,100,52,11/2/2018
F721A7,note-sale,100,52,11/2/2018
F73DD1,dividend,100,50,11/2/2018
F80FF9,earnings,100,50,11/2/2018
FAE021,facility-open,100,65,11/2/2018
FDE409,conference-participant,100,50,11/2/2018
FF6644,legal-issues-defendant,100,22,11/2/2018
FFE543,legal-issues-defendant,100,22,11/2/2018
10C19B,legal-issues-defendant,100,22,11/3/2018
3D9999,legal-issues-defendant,100,22,11/3/2018
CA1620,legal-issues-defendant,100,22,11/3/2018
00D6B5,earnings,100,50,11/5/2018
0325B7,earnings,100,50,11/5/2018
03542C,acquisition-acquirer,100,49,11/5/2018
03542C,buybacks,100,74,11/5/2018
03542C,earnings,100,50,11/5/2018
48781,asset-sale,100,62,11/5/2018
04996E,earnings,100,50,11/5/2018
04996E,earnings,100,50,11/5/2018
0560D8,earnings,100,50,11/5/2018
0560D8,earnings,100,50,11/5/2018
0560D8,earnings,100,50,11/5/2018
0560D8,earnings,100,50,11/5/2018
083F72,conference-call,100,50,11/5/2018
95294,acquisition-acquirer,100,49,11/5/2018
099C88,conference-participant,100,50,11/5/2018
09DE1F,acquisition-completed-acquirer,100,49,11/5/2018
09DE1F,earnings,100,50,11/5/2018
0C6861,legal-issues-defendant,100,22,11/5/2018
0DE3D5,operating-earnings,100,50,11/5/2018
0E5223,operating-earnings,100,50,11/5/2018
0F65C9,conference-participant,100,50,11/5/2018
1080C0,earnings,100,50,11/5/2018
108A2B,operating-earnings,100,50,11/5/2018
1201B5,market-entry,100,57,11/5/2018
12731D,conference-call,100,50,11/5/2018
13A782,earnings,100,50,11/5/2018
13C3E0,business-contract,100,69,11/5/2018
152E1D,operating-earnings,100,50,11/5/2018
152E1D,operating-earnings,100,50,11/5/2018
152E1D,operating-earnings,100,50,11/5/2018
152E1D,operating-earnings,100,50,11/5/2018
152E1D,operating-earnings,100,50,11/5/2018
152E1D,operating-earnings,100,50,11/5/2018
1834C0,acquisition-acquirer,100,49,11/5/2018
1834C0,earnings,100,50,11/5/2018
188394,earnings,100,50,11/5/2018
1921DD,unit-acquisition-acquiree,100,76,11/5/2018
19BF16,earnings,100,50,11/5/2018
19BF16,earnings,100,50,11/5/2018
19BF16,earnings,100,50,11/5/2018
1A2D9F,executive-appointment,100,54,11/5/2018
1B4F31,conference-participant,100,50,11/5/2018
1D1B07,conference-participant,100,50,11/5/2018
1D1B07,conference-participant,100,50,11/5/2018
1DB6A6,dividend,100,50,11/5/2018
1E1125,conference-organizer,100,57,11/5/2018
1E7785,earnings,100,50,11/5/2018
1E7785,earnings,100,50,11/5/2018
1E7785,earnings,100,50,11/5/2018
1E7785,earnings,100,50,11/5/2018
1E7785,earnings,100,50,11/5/2018
1E7785,earnings,100,50,11/5/2018
1E7785,earnings,100,50,11/5/2018
1F43A1,acquisition-completed-acquirer,100,49,11/5/2018
202E5A,executive-appointment,100,54,11/5/2018
23207A,conference-call,100,50,11/5/2018
238302,earnings,100,50,11/5/2018
241AF7,earnings,100,50,11/5/2018
249674,earnings,100,50,11/5/2018
249674,earnings,100,50,11/5/2018
249674,earnings,100,50,11/5/2018
249674,earnings,100,50,11/5/2018
25102A,conference-participant,100,50,11/5/2018
270B78,executive-appointment,100,54,11/5/2018
284289,conference-participant,100,50,11/5/2018
2920D5,conference-participant,100,50,11/5/2018
297DA8,earnings,100,50,11/5/2018
2B0AF4,executive-appointment,100,54,11/5/2018
2C7505,legal-issues-defendant,100,22,11/5/2018
2CA60F,earnings,100,50,11/5/2018
2CC71C,conference-call,100,50,11/5/2018
2D485F,earnings,100,50,11/5/2018
2D485F,earnings,100,50,11/5/2018
2D485F,earnings,100,50,11/5/2018
2E89AE,earnings,100,50,11/5/2018
2E902B,conference-participant,100,50,11/5/2018
2EB88B,business-contract,100,69,11/5/2018
2EBA55,earnings,100,50,11/5/2018
2F9304,earnings,100,50,11/5/2018
2F960F,earnings,100,50,11/5/2018
31DB20,earnings,100,50,11/5/2018
337024,earnings,100,50,11/5/2018
337024,earnings,100,50,11/5/2018
33AD83,partnership,100,61,11/5/2018
367E1C,earnings,100,50,11/5/2018
36C09B,legal-issues-defendant,100,22,11/5/2018
370C50,note-sale,100,52,11/5/2018
385DD4,earnings,100,50,11/5/2018
3A3447,earnings,100,50,11/5/2018
3AF7FD,dividend,100,50,11/5/2018
3B318A,legal-issues-defendant,100,22,11/5/2018
3B37F7,earnings,100,50,11/5/2018
3B37F7,earnings,100,50,11/5/2018
3B37F7,earnings,100,50,11/5/2018
3B37F7,earnings,100,50,11/5/2018
3C7F5F,dividend,100,50,11/5/2018
3CCC90,product-release,100,64,11/5/2018
3D6933,pretax-earnings-positive,100,69,11/5/2018
3D6933,pretax-earnings-positive,100,69,11/5/2018
3D6933,pretax-earnings-positive,100,69,11/5/2018
3DD5E2,conference-participant,100,50,11/5/2018
3E15F6,trading-halt,100,43,11/5/2018
3F96D5,earnings,100,50,11/5/2018
41B53E,earnings,100,50,11/5/2018
41B53E,earnings,100,50,11/5/2018
41B53E,earnings,100,50,11/5/2018
41C528,earnings,100,50,11/5/2018
41C528,earnings,100,50,11/5/2018
427F32,dividend,100,50,11/5/2018
427F32,conference-participant,100,50,11/5/2018
434F38,unit-acquisition-acquirer,100,49,11/5/2018
435ACE,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
43A74A,earnings,100,50,11/5/2018
44209A,partnership,100,61,11/5/2018
448215,earnings,100,50,11/5/2018
44ED36,earnings,100,50,11/5/2018
4649D5,earnings,100,50,11/5/2018
485445,earnings,100,50,11/5/2018
485445,earnings,100,50,11/5/2018
485445,earnings,100,50,11/5/2018
485445,earnings,100,50,11/5/2018
485445,earnings,100,50,11/5/2018
485445,earnings,100,50,11/5/2018
48F795,legal-issues-defendant,100,22,11/5/2018
490D4B,earnings,100,50,11/5/2018
490D4B,earnings,100,50,11/5/2018
4A6F00,legal-issues-defendant,100,22,11/5/2018
4AE584,earnings,100,50,11/5/2018
4BDCA7,earnings,100,50,11/5/2018
4C31F3,earnings,100,50,11/5/2018
4C31F3,earnings,100,50,11/5/2018
4C31F3,earnings,100,50,11/5/2018
4C92B9,legal-issues-defendant,100,22,11/5/2018
4E3D15,operating-earnings,100,50,11/5/2018
4EE14A,operating-earnings,100,50,11/5/2018
4EE14A,operating-earnings,100,50,11/5/2018
4EE167,conference-participant,100,50,11/5/2018
5340D0,earnings,100,50,11/5/2018
5403F8,earnings,100,50,11/5/2018
543900,legal-issues-defendant,100,22,11/5/2018
543900,legal-issues-defendant,100,22,11/5/2018
57EF50,earnings-up,100,68,11/5/2018
58CA9A,executive-resignation,100,44,11/5/2018
5A0FF1,conference-participant,100,50,11/5/2018
5DD486,conference-organizer,100,57,11/5/2018
5E1DF3,earnings-up,100,68,11/5/2018
619882,investment-investor,100,55,11/5/2018
619882,investment-investor,100,55,11/5/2018
619882,conference-organizer,100,57,11/5/2018
619882,conference-organizer,100,57,11/5/2018
61A586,earnings,100,50,11/5/2018
62B1C6,earnings,100,50,11/5/2018
62F41C,dividend,100,50,11/5/2018
62F41C,earnings,100,50,11/5/2018
649CBD,legal-issues-defendant,100,22,11/5/2018
64FF65,earnings,100,50,11/5/2018
6.52E+64,earnings,100,50,11/5/2018
6559D8,partnership,100,61,11/5/2018
665440,conference-call,100,50,11/5/2018
665D7D,legal-issues-defendant,100,22,11/5/2018
69FDFC,executive-appointment,100,54,11/5/2018
6A171E,earnings,100,50,11/5/2018
6B236C,earnings,100,50,11/5/2018
6BDA0C,dividend,100,50,11/5/2018
6D0CAB,earnings-per-share-positive,100,69,11/5/2018
6D0CAB,earnings-per-share,100,50,11/5/2018
6D0CAB,earnings-per-share,100,50,11/5/2018
6D0CAB,earnings-per-share,100,50,11/5/2018
6D0CAB,earnings-per-share,100,50,11/5/2018
6D0CAB,earnings-per-share,100,50,11/5/2018
6D0CAB,earnings-per-share,100,50,11/5/2018
6E7060,business-contract,100,69,11/5/2018
6ED519,legal-issues-defendant,100,22,11/5/2018
6F3FA8,earnings,100,50,11/5/2018
6F3FA8,earnings,100,50,11/5/2018
6F3FA8,earnings,100,50,11/5/2018
6F3FA8,earnings,100,50,11/5/2018
6F3FA8,earnings,100,50,11/5/2018
717DB4,earnings,100,50,11/5/2018
717DB4,earnings,100,50,11/5/2018
717DB4,earnings,100,50,11/5/2018
717DB4,earnings,100,50,11/5/2018
7262F2,earnings,100,50,11/5/2018
7262F2,earnings,100,50,11/5/2018
72FCA3,executive-appointment,100,54,11/5/2018
72FCA3,executive-appointment,100,54,11/5/2018
73A213,earnings,100,50,11/5/2018
73A213,earnings,100,50,11/5/2018
741937,executive-appointment,100,54,11/5/2018
7.44E+09,earnings,100,50,11/5/2018
762A3E,partnership,100,61,11/5/2018
76D79A,earnings,100,50,11/5/2018
76DD0C,earnings,100,50,11/5/2018
76E80F,facility-close,100,47,11/5/2018
76F067,partnership,100,61,11/5/2018
7712CB,earnings,100,50,11/5/2018
7712CB,earnings,100,50,11/5/2018
7712CB,earnings,100,50,11/5/2018
7712CB,earnings,100,50,11/5/2018
7712CB,earnings,100,50,11/5/2018
7712CB,earnings,100,50,11/5/2018
7712CB,earnings,100,50,11/5/2018
790C34,partnership,100,61,11/5/2018
790C34,partnership,100,61,11/5/2018
791EC1,earnings,100,50,11/5/2018
797C20,earnings,100,50,11/5/2018
7A2A49,earnings,100,50,11/5/2018
7A51FE,earnings,100,50,11/5/2018
7B1156,earnings,100,50,11/5/2018
7C4168,earnings,100,50,11/5/2018
7C790D,earnings,100,50,11/5/2018
7F3A5F,earnings,100,50,11/5/2018
83066C,earnings,100,50,11/5/2018
83A065,earnings,100,50,11/5/2018
858942,earnings,100,50,11/5/2018
85DA04,earnings,100,50,11/5/2018
85DA04,earnings,100,50,11/5/2018
85DA04,earnings,100,50,11/5/2018
85DA04,earnings,100,50,11/5/2018
877734,earnings,100,50,11/5/2018
877734,earnings,100,50,11/5/2018
877734,earnings,100,50,11/5/2018
877734,earnings,100,50,11/5/2018
883D82,earnings,100,50,11/5/2018
885758,earnings,100,50,11/5/2018
890FF4,earnings,100,50,11/5/2018
890FF4,earnings,100,50,11/5/2018
890FF4,earnings,100,50,11/5/2018
890FF4,earnings,100,50,11/5/2018
890FF4,earnings,100,50,11/5/2018
890FF4,earnings,100,50,11/5/2018
893904,earnings,100,50,11/5/2018
895D56,executive-appointment,100,54,11/5/2018
895D56,conference-call,100,50,11/5/2018
89F693,acquisition-acquirer,100,49,11/5/2018
8AB37F,revenue-up,100,86,11/5/2018
8AB37F,earnings,100,50,11/5/2018
8AC740,earnings,100,50,11/5/2018
8B1F37,executive-appointment,100,54,11/5/2018
8B3B0E,partnership,100,61,11/5/2018
8C311A,earnings,100,50,11/5/2018
8E10BF,regulatory-product-approval-granted,100,81,11/5/2018
8EDACA,legal-issues-defendant,100,22,11/5/2018
8EDACA,legal-issues-defendant,100,22,11/5/2018
915E7B,earnings,100,50,11/5/2018
9196A2,conference-organizer,100,57,11/5/2018
9196A2,conference-organizer,100,57,11/5/2018
91E5EE,earnings,100,50,11/5/2018
92D230,conference-call,100,50,11/5/2018
92D757,earnings,100,50,11/5/2018
9368BE,earnings,100,50,11/5/2018
93D207,partnership,100,61,11/5/2018
940C3D,dividend,100,50,11/5/2018
94637C,partnership,100,61,11/5/2018
94637C,partnership,100,61,11/5/2018
9548BB,dividend,100,50,11/5/2018
957A07,earnings,100,50,11/5/2018
967D92,earnings,100,50,11/5/2018
968B00,earnings-positive,100,69,11/5/2018
968B00,earnings-positive,100,69,11/5/2018
97B027,earnings-up,100,68,11/5/2018
97B027,earnings-up,100,68,11/5/2018
97B027,earnings-up,100,68,11/5/2018
98CEBB,earnings,100,50,11/5/2018
98CEBB,business-contract,100,69,11/5/2018
990AD0,conference-organizer,100,57,11/5/2018
9978F1,clinical-trials,100,56,11/5/2018
99ACAD,earnings,100,50,11/5/2018
99ACAD,earnings,100,50,11/5/2018
99ACAD,earnings,100,50,11/5/2018
99ACAD,earnings,100,50,11/5/2018
99ACAD,earnings,100,50,11/5/2018
99DC8D,dividend,100,50,11/5/2018
9C5BA5,earnings,100,50,11/5/2018
9CA619,executive-appointment,100,54,11/5/2018
9D2790,earnings,100,50,11/5/2018
9D2790,earnings,100,50,11/5/2018
9D2790,earnings,100,50,11/5/2018
9D2790,earnings,100,50,11/5/2018
9D2790,earnings,100,50,11/5/2018
9D2790,earnings,100,50,11/5/2018
9D5D35,earnings,100,50,11/5/2018
9D5D35,earnings,100,50,11/5/2018
9D6A24,earnings-up,100,68,11/5/2018
9D6A24,earnings,100,50,11/5/2018
9D6A24,earnings,100,50,11/5/2018
9D6A24,earnings,100,50,11/5/2018
9D6A24,earnings,100,50,11/5/2018
9FF5F1,conference-participant,100,50,11/5/2018
A204A7,earnings,100,50,11/5/2018
A29DBD,award,100,58,11/5/2018
A5DD24,conference-participant,100,50,11/5/2018
A631A3,partnership,100,61,11/5/2018
A63387,earnings,100,50,11/5/2018
A63387,partnership,100,61,11/5/2018
A871B0,earnings,100,50,11/5/2018
AA3AB8,earnings,100,50,11/5/2018
AA98ED,legal-issues-defendant,100,22,11/5/2018
AAEE21,partnership,100,61,11/5/2018
AC7AAE,earnings,100,50,11/5/2018
ACF0B4,earnings,100,50,11/5/2018
AECCA9,executive-appointment,100,54,11/5/2018
B106FA,earnings,100,50,11/5/2018
B1FC3B,credit-extension-recipient,100,69,11/5/2018
B37FB4,unit-acquisition-acquiree,100,76,11/5/2018
B37FB4,conference-participant,100,50,11/5/2018
B3A166,earnings,100,50,11/5/2018
B5734D,unit-acquisition-acquirer,100,49,11/5/2018
B642E8,business-contract,100,69,11/5/2018
B642E8,business-contract,100,69,11/5/2018
B642E8,business-contract,100,69,11/5/2018
B73395,earnings,100,50,11/5/2018
B73395,earnings,100,50,11/5/2018
B73395,earnings,100,50,11/5/2018
B73395,earnings,100,50,11/5/2018
B73395,earnings,100,50,11/5/2018
B73395,earnings,100,50,11/5/2018
B9CD50,earnings,100,50,11/5/2018
BB58FF,earnings-up,100,68,11/5/2018
BCE9DA,earnings,100,50,11/5/2018
BCE9DA,earnings,100,50,11/5/2018
BCE9DA,earnings,100,50,11/5/2018
BCE9DA,earnings,100,50,11/5/2018
BCE9DA,earnings,100,50,11/5/2018
BFD0A7,credit-extension-recipient,100,69,11/5/2018
C15F8F,earnings,100,50,11/5/2018
C356AC,going-private,100,74,11/5/2018
C3CF29,earnings,100,50,11/5/2018
C3CF29,earnings,100,50,11/5/2018
C3CF29,earnings,100,50,11/5/2018
C3DE7D,earnings,100,50,11/5/2018
C48574,credit-extension-provider,100,57,11/5/2018
C4FBDC,earnings,100,50,11/5/2018
C564E4,earnings,100,50,11/5/2018
C598D7,partnership,100,61,11/5/2018
C62AA4,earnings,100,50,11/5/2018
C7AE14,dividend,100,50,11/5/2018
CA1620,legal-issues-defendant,100,22,11/5/2018
CA1620,legal-issues-defendant,100,22,11/5/2018
CA212F,earnings,100,50,11/5/2018
CAB222,earnings,100,50,11/5/2018
CBFFDD,conference-participant,100,50,11/5/2018
CBFFDD,conference-participant,100,50,11/5/2018
CC8F6E,award,100,58,11/5/2018
CDFCC9,legal-issues-defendant,100,22,11/5/2018
CFD4B6,conference-participant,100,50,11/5/2018
CFF97C,operating-earnings,100,50,11/5/2018
D0909F,conference-participant,100,50,11/5/2018
D11C1C,operating-earnings,100,50,11/5/2018
D17C1B,product-release,100,64,11/5/2018
D4AC65,product-release,100,64,11/5/2018
D5938F,business-contract,100,69,11/5/2018
D6534D,executive-appointment,100,54,11/5/2018
D854DD,conference-call,100,50,11/5/2018
D90F43,award,100,58,11/5/2018
D9E036,conference-participant,100,50,11/5/2018
DA48E4,unit-acquisition-acquirer,100,49,11/5/2018
DAFED3,conference-participant,100,50,11/5/2018
DB23C8,executive-appointment,100,54,11/5/2018
DB88A1,earnings-up,100,68,11/5/2018
DBFB51,earnings,100,50,11/5/2018
DC0D18,executive-appointment,100,54,11/5/2018
DE5611,product-release,100,64,11/5/2018
DFADDB,earnings,100,50,11/5/2018
E074A0,earnings,100,50,11/5/2018
E114F4,conference-participant,100,50,11/5/2018
E11C41,earnings,100,50,11/5/2018
E1E093,product-release,100,64,11/5/2018
E2CB7B,acquisition-acquirer,100,49,11/5/2018
E2CB7B,acquisition-acquirer,100,49,11/5/2018
E610CD,earnings,100,50,11/5/2018
E610CD,earnings,100,50,11/5/2018
E610CD,earnings,100,50,11/5/2018
E71AE6,earnings,100,50,11/5/2018
E7BF32,earnings,100,50,11/5/2018
E7BF32,earnings,100,50,11/5/2018
E96E0B,earnings,100,50,11/5/2018
EA62FC,earnings,100,50,11/5/2018
EB43F4,earnings,100,50,11/5/2018
EB7FBF,unit-acquisition-completed-acquirer,100,49,11/5/2018
EC4E82,credit-extension-recipient,100,69,11/5/2018
ED7F13,earnings,100,50,11/5/2018
EF77A3,legal-issues-defendant,100,22,11/5/2018
EF77A3,legal-issues-defendant,100,22,11/5/2018
EFA7B2,earnings,100,50,11/5/2018
F0027C,clinical-trials,100,56,11/5/2018
F02170,earnings,100,50,11/5/2018
F1C04C,dividend,100,50,11/5/2018
F1C04C,executive-appointment,100,54,11/5/2018
F1CD47,conference-participant,100,50,11/5/2018
F30508,partnership,100,61,11/5/2018
F44EA2,earnings,100,50,11/5/2018
F48947,earnings,100,50,11/5/2018
F4CDA3,conference-participant,100,50,11/5/2018
F4D241,earnings,100,50,11/5/2018
F6FF0D,earnings-above-expectations,100,88,11/5/2018
FC1A6E,earnings-per-share-positive,100,69,11/5/2018
FC1A6E,earnings-per-share,100,50,11/5/2018
FC1A6E,earnings-per-share,100,50,11/5/2018
FC1A6E,earnings-per-share,100,50,11/5/2018
FC4550,dividend,100,50,11/5/2018
FD0CA4,conference-participant,100,50,11/5/2018
FD2565,earnings,100,50,11/5/2018
FF6644,legal-issues-defendant,100,22,11/5/2018
FF6644,legal-issues-defendant,100,22,11/5/2018
FF6644,legal-issues-defendant,100,22,11/5/2018
FFCD0E,earnings,100,50,11/5/2018
FFE543,legal-issues-defendant,100,22,11/5/2018
0157B1,product-release,100,64,11/6/2018
018C11,conference-participant,100,50,11/6/2018
20751,earnings,100,50,11/6/2018
036C6F,acquisition-acquirer,100,49,11/6/2018
04EB2F,earnings-up,100,68,11/6/2018
04EB2F,earnings,100,50,11/6/2018
04EB2F,earnings,100,50,11/6/2018
04EB2F,earnings,100,50,11/6/2018
04EB2F,earnings,100,50,11/6/2018
55018,unit-acquisition-acquiree,100,76,11/6/2018
0624BE,earnings,100,50,11/6/2018
06C826,executive-appointment,100,54,11/6/2018
06C826,earnings,100,50,11/6/2018
06C826,earnings,100,50,11/6/2018
070B45,earnings,100,50,11/6/2018
09062E,earnings,100,50,11/6/2018
09062E,earnings,100,50,11/6/2018
09062E,earnings,100,50,11/6/2018
099C88,business-contract,100,69,11/6/2018
0A0D9E,earnings,100,50,11/6/2018
0A0D9E,earnings,100,50,11/6/2018
0A0D9E,earnings,100,50,11/6/2018
0B400D,earnings,100,50,11/6/2018
0B400D,earnings,100,50,11/6/2018
0BC29E,acquisition-completed-acquirer,100,49,11/6/2018
0BF198,conference-participant,100,50,11/6/2018
0E2992,public-offering,100,43,11/6/2018
0E5619,conference-call,100,50,11/6/2018
10C19B,legal-issues-defendant,100,22,11/6/2018
10C19B,legal-issues-defendant,100,22,11/6/2018
10C19B,legal-issues-defendant,100,22,11/6/2018
1151F4,unit-acquisition-acquirer,100,49,11/6/2018
147C38,partnership,100,61,11/6/2018
14833D,earnings-up,100,68,11/6/2018
14833D,earnings,100,50,11/6/2018
14833D,earnings,100,50,11/6/2018
14833D,earnings,100,50,11/6/2018
14BA06,earnings,100,50,11/6/2018
14BA06,earnings,100,50,11/6/2018
14BA06,earnings,100,50,11/6/2018
14BA06,earnings,100,50,11/6/2018
14BA06,earnings,100,50,11/6/2018
14BA06,earnings,100,50,11/6/2018
152AB9,earnings,100,50,11/6/2018
165B86,earnings,100,50,11/6/2018
190B91,partnership,100,61,11/6/2018
1C2593,conference-call,100,50,11/6/2018
1CB9D3,earnings,100,50,11/6/2018
1CDD1C,earnings,100,50,11/6/2018
1E1125,conference-organizer,100,57,11/6/2018
1E1125,conference-organizer,100,57,11/6/2018
1E1125,conference-organizer,100,57,11/6/2018
1FAF22,conference-participant,100,50,11/6/2018
202E5A,earnings,100,50,11/6/2018
2082EA,earnings,100,50,11/6/2018
221AD7,legal-issues-defendant,100,22,11/6/2018
221AD7,legal-issues-defendant,100,22,11/6/2018
221AD7,legal-issues-defendant,100,22,11/6/2018
221AD7,legal-issues-defendant,100,22,11/6/2018
222BF9,dividend,100,50,11/6/2018
228D42,executive-appointment,100,54,11/6/2018
228D42,partnership,100,61,11/6/2018
239106,conference-participant,100,50,11/6/2018
24C48B,earnings,100,50,11/6/2018
24C48B,earnings,100,50,11/6/2018
24C48B,earnings,100,50,11/6/2018
24C48B,earnings,100,50,11/6/2018
25102A,award,100,58,11/6/2018
251988,product-release,100,64,11/6/2018
28B730,earnings,100,50,11/6/2018
28DCA8,executive-appointment,100,54,11/6/2018
2920D5,earnings,100,50,11/6/2018
2B7A40,earnings-per-share-positive,100,69,11/6/2018
2B7A40,earnings-positive,100,69,11/6/2018
2B7A40,earnings-positive,100,69,11/6/2018
2B7A40,earnings-positive,100,69,11/6/2018
2B7A40,earnings-positive,100,69,11/6/2018
2B8179,clinical-trials-complete,100,56,11/6/2018
2B8179,earnings,100,50,11/6/2018
2C3348,legal-issues-defendant,100,22,11/6/2018
2D643C,executive-appointment,100,54,11/6/2018
31803E,earnings,100,50,11/6/2018
355B19,earnings,100,50,11/6/2018
36A1CB,earnings-up,100,68,11/6/2018
36A1CB,earnings-up,100,68,11/6/2018
370C50,product-price-raise,100,57,11/6/2018
382EAE,operating-earnings,100,50,11/6/2018
396D7C,earnings,100,50,11/6/2018
3A3447,facility-open,100,65,11/6/2018
3AF7FD,earnings,100,50,11/6/2018
3B318A,conference-participant,100,50,11/6/2018
3BE00F,earnings,100,50,11/6/2018
3BE00F,earnings,100,50,11/6/2018
3BE00F,earnings,100,50,11/6/2018
3BE00F,acquisition-completed-acquiree,100,76,11/6/2018
3C6CCC,earnings,100,50,11/6/2018
3C6CCC,earnings,100,50,11/6/2018
3C6CCC,earnings,100,50,11/6/2018
3C6CCC,earnings,100,50,11/6/2018
3C6CCC,earnings,100,50,11/6/2018
3DCECC,earnings,100,50,11/6/2018
3F1C69,earnings,100,50,11/6/2018
3F4668,revenue-up,100,69,11/6/2018
4.03E+05,earnings,100,50,11/6/2018
4.03E+05,earnings,100,50,11/6/2018
4.03E+05,earnings,100,50,11/6/2018
4.03E+05,earnings,100,50,11/6/2018
4.03E+05,dividend-up,100,81,11/6/2018
40B903,earnings,100,50,11/6/2018
4.00E+163,legal-issues-defendant,100,22,11/6/2018
40F7DE,conference-call,100,50,11/6/2018
416291,earnings,100,50,11/6/2018
41C36B,earnings,100,50,11/6/2018
427F32,earnings,100,50,11/6/2018
44A4FC,earnings,100,50,11/6/2018
45444E,earnings,100,50,11/6/2018
48F795,legal-issues-defendant,100,22,11/6/2018
4.91E+58,earnings-up,100,68,11/6/2018
4.91E+58,earnings-up,100,68,11/6/2018
4.91E+58,earnings-up,100,68,11/6/2018
4.91E+58,earnings-up,100,68,11/6/2018
4.91E+58,earnings-up,100,68,11/6/2018
4.91E+58,earnings-up,100,68,11/6/2018
4.91E+58,earnings-up,100,68,11/6/2018
492117,executive-appointment,100,54,11/6/2018
4A2457,earnings,100,50,11/6/2018
4A6F00,legal-issues-defendant,100,22,11/6/2018
4B49CF,conference-participant,100,50,11/6/2018
4C5CC9,earnings-guidance-up,100,83,11/6/2018
4C5CC9,earnings-guidance-up,100,83,11/6/2018
4C5CC9,earnings-guidance-up,100,83,11/6/2018
4C5CC9,earnings-guidance-up,100,83,11/6/2018
4C92B9,earnings,100,50,11/6/2018
4DD09F,earnings,100,50,11/6/2018
4DD09F,earnings,100,50,11/6/2018
4DD09F,earnings,100,50,11/6/2018
4E5784,conference-participant,100,50,11/6/2018
4F9487,executive-appointment,100,54,11/6/2018
50070E,acquisition-acquiree,100,76,11/6/2018
504FE2,partnership,100,61,11/6/2018
504FE2,executive-appointment,100,54,11/6/2018
543900,legal-issues-defendant,100,22,11/6/2018
54512F,earnings,100,50,11/6/2018
545272,earnings,100,50,11/6/2018
5487B1,earnings,100,50,11/6/2018
5487B1,earnings,100,50,11/6/2018
5487B1,earnings,100,50,11/6/2018
5487B1,earnings,100,50,11/6/2018
5487B1,earnings,100,50,11/6/2018
54F1D2,earnings,100,50,11/6/2018
550D01,earnings,100,50,11/6/2018
56765E,earnings,100,50,11/6/2018
56FB7C,earnings,100,50,11/6/2018
583223,conference-participant,100,50,11/6/2018
586BD7,conference-participant,100,50,11/6/2018
589803,earnings,100,50,11/6/2018
58C2D4,earnings,100,50,11/6/2018
58CA9A,partnership,100,61,11/6/2018
59A832,earnings,100,50,11/6/2018
5B15E1,earnings,100,50,11/6/2018
5B3415,business-contract,100,69,11/6/2018
5EAA43,business-contract,100,69,11/6/2018
5F9CE3,unit-acquisition-completed-acquirer,100,49,11/6/2018
622DBE,earnings,100,50,11/6/2018
62B1C6,earnings,100,50,11/6/2018
62B1C6,executive-resignation,100,44,11/6/2018
62CDDE,earnings,100,50,11/6/2018
641F17,executive-resignation,100,44,11/6/2018
649CBD,conference-call,100,50,11/6/2018
649CBD,legal-issues-defendant,100,22,11/6/2018
649CBD,legal-issues-defendant,100,22,11/6/2018
6634D9,earnings,100,50,11/6/2018
66ECFD,dividend-up,100,81,11/6/2018
6810DE,earnings,100,50,11/6/2018
68AB62,earnings,100,50,11/6/2018
69CE71,earnings,100,50,11/6/2018
69CE71,earnings,100,50,11/6/2018
69CE71,earnings,100,50,11/6/2018
69CE71,earnings,100,50,11/6/2018
69CE71,earnings,100,50,11/6/2018
69CE71,earnings,100,50,11/6/2018
69CE71,earnings,100,50,11/6/2018
6B6375,earnings,100,50,11/6/2018
6BC6F9,executive-appointment,100,54,11/6/2018
6BC6F9,revenue-up,100,71,11/6/2018
6BC6F9,revenue-up,100,69,11/6/2018
6BC6F9,revenue-up,100,69,11/6/2018
6BD606,supply-decrease,100,28,11/6/2018
6BD606,earnings-positive,100,69,11/6/2018
6ED519,legal-issues-defendant,100,22,11/6/2018
704B78,earnings,100,50,11/6/2018
71553E,earnings,100,50,11/6/2018
717DB4,partnership,100,61,11/6/2018
71E2EF,earnings,100,50,11/6/2018
729368,earnings,100,50,11/6/2018
72CB93,conference-participant,100,50,11/6/2018
7448A3,conference-participant,100,50,11/6/2018
762B8D,earnings,100,50,11/6/2018
790C34,product-release,100,64,11/6/2018
790D0D,dividend,100,50,11/6/2018
7AB859,capital-increase,100,43,11/6/2018
7ACD98,award,100,58,11/6/2018
7B0BA6,partnership,100,61,11/6/2018
7D85A9,earnings,100,50,11/6/2018
7DD8CC,earnings,100,50,11/6/2018
7E3F8F,conference-participant,100,50,11/6/2018
7F3665,earnings,100,50,11/6/2018
80D744,dividend,100,50,11/6/2018
81222C,earnings,100,50,11/6/2018
82F088,earnings,100,50,11/6/2018
834152,clinical-trials,100,56,11/6/2018
83E0AC,earnings,100,50,11/6/2018
845533,earnings,100,50,11/6/2018
855DF7,earnings,100,50,11/6/2018
85CDC9,conference-participant,100,50,11/6/2018
863350,facility-open,100,65,11/6/2018
895D56,operating-earnings,100,50,11/6/2018
89E771,earnings,100,50,11/6/2018
89FBB1,earnings,100,50,11/6/2018
89FBB1,earnings,100,50,11/6/2018
89FBB1,earnings,100,50,11/6/2018
8C6C1B,conference-call,100,50,11/6/2018
8CF6DD,dividend,100,50,11/6/2018
8CF6DD,conference-call,100,50,11/6/2018
8D4486,partnership,100,61,11/6/2018
8D4486,partnership,100,61,11/6/2018
8DCF18,executive-appointment,100,54,11/6/2018
8DCF18,earnings,100,50,11/6/2018
8E3F58,earnings,100,50,11/6/2018
8EDACA,legal-issues-defendant,100,22,11/6/2018
902255,earnings,100,50,11/6/2018
902255,earnings,100,50,11/6/2018
902255,earnings,100,50,11/6/2018
9087B9,earnings,100,50,11/6/2018
90D6A5,earnings,100,50,11/6/2018
90D6A5,earnings,100,50,11/6/2018
90D6A5,earnings,100,50,11/6/2018
90D6A5,earnings,100,50,11/6/2018
911CA9,earnings,100,50,11/6/2018
911CA9,earnings,100,50,11/6/2018
9196A2,conference-organizer,100,57,11/6/2018
9196A2,conference-organizer,100,57,11/6/2018
9196A2,conference-organizer,100,57,11/6/2018
925759,earnings,100,50,11/6/2018
925759,earnings,100,50,11/6/2018
9.31E+77,earnings,100,50,11/6/2018
934029,conference-participant,100,50,11/6/2018
9470CC,business-contract,100,69,11/6/2018
9470CC,conference-participant,100,50,11/6/2018
9546A5,earnings,100,50,11/6/2018
95A92E,earnings,100,50,11/6/2018
98CEBB,partnership,100,61,11/6/2018
99028D,earnings,100,50,11/6/2018
9978F1,earnings,100,50,11/6/2018
9B730A,conference-participant,100,50,11/6/2018
9C009A,earnings,100,50,11/6/2018
9C8BC3,earnings-up,100,68,11/6/2018
9C8BC3,earnings-up,100,68,11/6/2018
9C8BC3,earnings-up,100,68,11/6/2018
9C8BC3,earnings-up,100,68,11/6/2018
9C8BC3,earnings-up,100,68,11/6/2018
9CA432,earnings,100,50,11/6/2018
9CA619,dividend,100,50,11/6/2018
9D4EC7,dividend,100,50,11/6/2018
9E0811,earnings,100,50,11/6/2018
9F18FA,earnings,100,50,11/6/2018
9F18FA,earnings,100,50,11/6/2018
A05C43,earnings,100,50,11/6/2018
A05C43,earnings,100,50,11/6/2018
A05C43,earnings,100,50,11/6/2018
A05C43,earnings,100,50,11/6/2018
A1E3B3,earnings,100,50,11/6/2018
A1EAC8,conference-call,100,50,11/6/2018
A1EAC8,business-contract,100,69,11/6/2018
A21649,earnings,100,50,11/6/2018
A29DBD,earnings,100,50,11/6/2018
A4B899,earnings-up,100,68,11/6/2018
A5195E,earnings,100,50,11/6/2018
A5DD24,earnings,100,50,11/6/2018
A631A3,acquisition-acquirer,100,49,11/6/2018
A631A3,product-release,100,64,11/6/2018
A6828A,regulatory-product-approval-granted,100,81,11/6/2018
A6828A,conference-participant,100,50,11/6/2018
A7102F,earnings-up,100,68,11/6/2018
A7102F,earnings,100,50,11/6/2018
A7102F,earnings,100,50,11/6/2018
A7102F,earnings,100,50,11/6/2018
A74F6F,revenues,100,50,11/6/2018
A74F6F,revenues,100,50,11/6/2018
A79F7D,earnings,100,50,11/6/2018
A868C9,revenues,100,50,11/6/2018
A868C9,revenues,100,50,11/6/2018
A868C9,revenues,100,50,11/6/2018
AC775C,earnings,100,50,11/6/2018
AC775C,earnings,100,50,11/6/2018
AC775C,earnings,100,50,11/6/2018
AC7C4F,business-contract,100,69,11/6/2018
AD9F1D,facility-open,100,65,11/6/2018
AEBB80,earnings,100,50,11/6/2018
B04426,conference-call,100,50,11/6/2018
B05000,revenues,100,50,11/6/2018
B1DF3C,earnings,100,50,11/6/2018
B53C12,operating-earnings,100,50,11/6/2018
B54A74,earnings,100,50,11/6/2018
B7FA9B,earnings,100,50,11/6/2018
B840EF,earnings,100,50,11/6/2018
B8A51F,earnings,100,50,11/6/2018
B8DD94,operating-earnings,100,50,11/6/2018
B9764A,acquisition-acquirer,100,49,11/6/2018
B9764A,earnings,100,50,11/6/2018
B98EFA,earnings,100,50,11/6/2018
BAD655,earnings,100,50,11/6/2018
BB0787,executive-resignation,100,44,11/6/2018
BB0787,business-contract,100,69,11/6/2018
BCC13E,revenue-up,100,69,11/6/2018
BCC13E,revenues,100,50,11/6/2018
BD44C9,earnings,100,50,11/6/2018
BDA775,earnings,100,50,11/6/2018
BE5935,earnings,100,50,11/6/2018
C07E05,earnings,100,50,11/6/2018
C188F8,business-contract,100,69,11/6/2018
C2E39B,earnings,100,50,11/6/2018
C356AC,acquisition-interest-acquiree,100,82,11/6/2018
C3BAE7,earnings,100,50,11/6/2018
C3BAE7,earnings,100,50,11/6/2018
C3BAE7,earnings,100,50,11/6/2018
C3BAE7,earnings,100,50,11/6/2018
C3BAE7,earnings,100,50,11/6/2018
C3BAE7,earnings,100,50,11/6/2018
C3F99F,earnings,100,50,11/6/2018
C407A0,earnings,100,50,11/6/2018
C45C1F,conference-participant,100,50,11/6/2018
C4A241,buybacks,100,74,11/6/2018
C4A241,earnings,100,50,11/6/2018
C74887,conference-participant,100,50,11/6/2018
C8A059,earnings,100,50,11/6/2018
C97B2D,conference-participant,100,50,11/6/2018
C97B2D,conference-participant,100,50,11/6/2018
CB7AB2,award,100,58,11/6/2018
CB89EA,earnings,100,50,11/6/2018
CB9E13,earnings,100,50,11/6/2018
CBCC6A,investment-investor,100,55,11/6/2018
CBFFDD,business-contract,100,69,11/6/2018
CBFFDD,business-contract,100,69,11/6/2018
CC0C78,earnings,100,50,11/6/2018
CC3EC4,earnings,100,50,11/6/2018
CC8F6E,earnings,100,50,11/6/2018
CDAB24,earnings,100,50,11/6/2018
CF351E,earnings,100,50,11/6/2018
CF351E,earnings,100,50,11/6/2018
CF351E,earnings,100,50,11/6/2018
CF3FF9,earnings,100,50,11/6/2018
D13F1C,earnings-up,100,68,11/6/2018
D13F1C,earnings-up,100,68,11/6/2018
D13F1C,earnings-up,100,68,11/6/2018
D13F1C,earnings-up,100,68,11/6/2018
D13F1C,earnings-up,100,68,11/6/2018
D3CEDF,earnings,100,50,11/6/2018
D3CEDF,earnings,100,50,11/6/2018
D3CEDF,earnings,100,50,11/6/2018
D3CEDF,earnings,100,50,11/6/2018
D3FA2C,earnings,100,50,11/6/2018
D3FD6D,revenues,100,50,11/6/2018
D3FD6D,revenues,100,50,11/6/2018
D3FD6D,revenues,100,50,11/6/2018
D3FD6D,revenues,100,50,11/6/2018
D54E62,executive-appointment,100,54,11/6/2018
D5938F,conference-participant,100,50,11/6/2018
D60BB2,earnings,100,50,11/6/2018
D63B0F,earnings,100,50,11/6/2018
D63B0F,earnings,100,50,11/6/2018
D63B0F,earnings,100,50,11/6/2018
D64C6D,executive-appointment,100,54,11/6/2018
D6534D,earnings,100,50,11/6/2018
D6534D,earnings,100,50,11/6/2018
D69D42,earnings,100,50,11/6/2018
D77F7E,earnings,100,50,11/6/2018
D8C09D,earnings,100,50,11/6/2018
D8ECA1,earnings,100,50,11/6/2018
D9E036,earnings,100,50,11/6/2018
DA0A9E,conference-call,100,50,11/6/2018
DA48E4,earnings-per-share-positive,100,69,11/6/2018
DC1405,earnings,100,50,11/6/2018
DC2F77,conference-organizer,100,57,11/6/2018
DD682D,earnings,100,50,11/6/2018
DDEA6A,operating-earnings,100,50,11/6/2018
DF01B1,earnings,100,50,11/6/2018
DF01B1,earnings,100,50,11/6/2018
DF01B1,earnings,100,50,11/6/2018
DF01B1,earnings,100,50,11/6/2018
E06265,dividend,100,50,11/6/2018
E0647D,earnings,100,50,11/6/2018
E0647D,earnings,100,50,11/6/2018
E0647D,earnings,100,50,11/6/2018
E0647D,earnings,100,50,11/6/2018
E0647D,earnings,100,50,11/6/2018
E09997,earnings,100,50,11/6/2018
E15736,earnings,100,50,11/6/2018
E1BD05,executive-appointment,100,54,11/6/2018
E49AA3,product-release,100,64,11/6/2018
E49AA3,product-release,100,64,11/6/2018
E4CE73,partnership,100,61,11/6/2018
E6A53A,earnings,100,50,11/6/2018
E71AE6,conference-participant,100,50,11/6/2018
E8C557,earnings,100,50,11/6/2018
EC1AF3,earnings,100,50,11/6/2018
EC8116,operating-earnings,100,50,11/6/2018
ED4560,earnings,100,50,11/6/2018
EE6F1C,regulatory-product-approval-granted,100,81,11/6/2018
F0EEFB,executive-appointment,100,54,11/6/2018
F179ED,earnings,100,50,11/6/2018
F179ED,earnings,100,50,11/6/2018
F179ED,earnings,100,50,11/6/2018
F179ED,earnings,100,50,11/6/2018
F179ED,earnings,100,50,11/6/2018
F1C04C,conference-participant,100,50,11/6/2018
F1EB39,conference-participant,100,50,11/6/2018
F1EB39,business-contract,100,69,11/6/2018
F2E253,earnings,100,50,11/6/2018
F2E253,earnings,100,50,11/6/2018
F2E253,earnings,100,50,11/6/2018
F2E253,earnings,100,50,11/6/2018
F2E253,earnings,100,50,11/6/2018
F2E253,earnings,100,50,11/6/2018
F3016C,earnings,100,50,11/6/2018
F3016C,earnings,100,50,11/6/2018
F3016C,earnings,100,50,11/6/2018
F3016C,earnings,100,50,11/6/2018
F3816D,conference-participant,100,50,11/6/2018
F5C8AB,earnings-per-share-positive,100,69,11/6/2018
F5C8AB,earnings-per-share-positive,100,69,11/6/2018
F5C8AB,earnings-per-share,100,50,11/6/2018
F5C8AB,earnings-per-share,100,50,11/6/2018
F5C8AB,dividend,100,50,11/6/2018
F5D410,conference-participant,100,50,11/6/2018
F6E1B5,executive-appointment,100,54,11/6/2018
F721A7,note-sale,100,52,11/6/2018
F721A7,note-sale,100,52,11/6/2018
F88147,earnings,100,50,11/6/2018
F88A04,executive-appointment,100,54,11/6/2018
F90EE5,executive-appointment,100,54,11/6/2018
F93C8A,earnings,100,50,11/6/2018
F9AA02,earnings,100,50,11/6/2018
FB728F,earnings,100,50,11/6/2018
FB7724,earnings,100,50,11/6/2018
FBD92D,earnings-up,100,68,11/6/2018
FBD92D,earnings,100,50,11/6/2018
FBD92D,earnings,100,50,11/6/2018
FDF28E,earnings,100,50,11/6/2018
FEBFE1,executive-appointment,100,54,11/6/2018
FF227B,earnings,100,50,11/6/2018
FF6644,legal-issues-defendant,100,22,11/6/2018
FF6644,facility-open,100,65,11/6/2018
FF6644,legal-issues-defendant,100,22,11/6/2018
FF6644,legal-issues-defendant,100,22,11/6/2018
FFAB4A,dividend,100,50,11/6/2018
00067A,earnings,100,50,11/7/2018
001F1B,revenues,100,50,11/7/2018
0157B1,product-release,100,64,11/7/2018
0157B1,partnership,100,61,11/7/2018
0157B1,partnership,100,61,11/7/2018
0157B1,partnership,100,61,11/7/2018
02ACBD,conference-call,100,50,11/7/2018
02FC1A,earnings,100,50,11/7/2018
02FC1A,earnings,100,50,11/7/2018
03FB17,earnings,100,50,11/7/2018
03FB17,executive-appointment,100,54,11/7/2018
04996E,conference-participant,100,50,11/7/2018
053EFF,dividend,100,50,11/7/2018
05D148,earnings,100,50,11/7/2018
06A456,conference-call,100,50,11/7/2018
06C826,acquisition-acquirer,100,49,11/7/2018
06C826,acquisition-acquirer,100,49,11/7/2018
98977,earnings,100,50,11/7/2018
0CADBC,earnings,100,50,11/7/2018
0CE204,earnings,100,50,11/7/2018
0DBB81,conference-participant,100,50,11/7/2018
0E64D4,earnings,100,50,11/7/2018
0E64D4,earnings,100,50,11/7/2018
0F2BC9,earnings-up,100,68,11/7/2018
0F2BC9,earnings-up,100,68,11/7/2018
0F2BC9,earnings-up,100,68,11/7/2018
0FC848,earnings,100,50,11/7/2018
0FE3A6,earnings,100,50,11/7/2018
10100E,earnings,100,50,11/7/2018
102F04,earnings,100,50,11/7/2018
1096C6,earnings,100,50,11/7/2018
1201B5,revenue-up,100,82,11/7/2018
1220D2,conference-participant,100,50,11/7/2018
12731D,earnings,100,50,11/7/2018
129DC8,executive-appointment,100,54,11/7/2018
12E454,product-release,100,64,11/7/2018
138DDE,earnings,100,50,11/7/2018
139303,conference-organizer,100,57,11/7/2018
13C3E0,partnership,100,61,11/7/2018
147C38,earnings,100,50,11/7/2018
14833D,legal-issues-defendant,100,22,11/7/2018
154272,earnings,100,50,11/7/2018
157D9F,acquisition-acquirer,100,49,11/7/2018
157D9F,acquisition-acquirer,100,49,11/7/2018
157D9F,acquisition-acquirer,100,49,11/7/2018
157D9F,acquisition-acquirer,100,49,11/7/2018
157D9F,earnings,100,50,11/7/2018
157D9F,earnings,100,50,11/7/2018
157D9F,earnings,100,50,11/7/2018
157D9F,earnings,100,50,11/7/2018
157D9F,earnings,100,50,11/7/2018
157D9F,acquisition-acquirer,100,49,11/7/2018
159739,stake-acquirer,100,48,11/7/2018
159739,stake-acquirer,100,48,11/7/2018
15B10D,earnings,100,50,11/7/2018
15B10D,earnings,100,50,11/7/2018
15B10D,earnings,100,50,11/7/2018
168A5D,executive-appointment,100,54,11/7/2018
1834C0,conference-participant,100,50,11/7/2018
1866B2,earnings,100,50,11/7/2018
1880C5,earnings,100,50,11/7/2018
18D9FA,earnings,100,50,11/7/2018
1921DD,business-contract,100,69,11/7/2018
1921DD,partnership,100,61,11/7/2018
196D18,earnings,100,50,11/7/2018
1AB023,earnings,100,50,11/7/2018
1AB023,earnings,100,50,11/7/2018
1AB023,earnings,100,50,11/7/2018
1AD9CC,revenues,100,50,11/7/2018
1B5FEA,earnings,100,50,11/7/2018
1C599A,earnings,100,50,11/7/2018
1CD09C,conference-participant,100,50,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E1125,conference-organizer,100,57,11/7/2018
1E4FB9,earnings,100,50,11/7/2018
1F3CFB,earnings,100,50,11/7/2018
1F464F,earnings,100,50,11/7/2018
2003A5,earnings,100,50,11/7/2018
200D8B,earnings,100,50,11/7/2018
2082EA,conference-participant,100,50,11/7/2018
2158DF,earnings,100,50,11/7/2018
2158DF,earnings,100,50,11/7/2018
2158DF,earnings,100,50,11/7/2018
2158DF,earnings,100,50,11/7/2018
2158DF,earnings,100,50,11/7/2018
221783,earnings,100,50,11/7/2018
221783,earnings,100,50,11/7/2018
221783,earnings,100,50,11/7/2018
221783,earnings,100,50,11/7/2018
221783,earnings,100,50,11/7/2018
221AD7,legal-issues-defendant,100,22,11/7/2018
221AD7,legal-issues-defendant,100,22,11/7/2018
2262BD,earnings,100,50,11/7/2018
232053,earnings,100,50,11/7/2018
23207A,product-release,100,64,11/7/2018
239106,note-sale,100,52,11/7/2018
2.45E+15,dividend,100,50,11/7/2018
24FA23,earnings,100,50,11/7/2018
25AB8E,earnings,100,50,11/7/2018
2667B6,business-contract,100,69,11/7/2018
26F99F,conference-participant,100,50,11/7/2018
27B191,earnings,100,50,11/7/2018
27B191,earnings,100,50,11/7/2018
27B191,dividend,100,50,11/7/2018
2AA6A8,earnings,100,50,11/7/2018
2B49F4,dividend,100,50,11/7/2018
2B8179,conference-participant,100,50,11/7/2018
2BDC1C,partnership,100,61,11/7/2018
2BDC1C,partnership,100,61,11/7/2018
2BDC1C,earnings,100,50,11/7/2018
2C3348,legal-issues-defendant,100,22,11/7/2018
2C681C,earnings,100,50,11/7/2018
2C681C,earnings,100,50,11/7/2018
2C7505,earnings,100,50,11/7/2018
2D981A,earnings,100,50,11/7/2018
2E0496,conference-participant,100,50,11/7/2018
2F98A5,earnings,100,50,11/7/2018
306623,earnings,100,50,11/7/2018
30DE64,earnings,100,50,11/7/2018
314D88,earnings,100,50,11/7/2018
31643A,earnings,100,50,11/7/2018
31803E,conference-participant,100,50,11/7/2018
3461CF,stake-acquirer,100,48,11/7/2018
3461CF,credit-rating-upgrade-rater,20,50,11/7/2018
34E9F9,earnings,100,50,11/7/2018
34E9F9,earnings,100,50,11/7/2018
34E9F9,earnings,100,50,11/7/2018
34E9F9,earnings,100,50,11/7/2018
34E9F9,earnings,100,50,11/7/2018
367E1C,conference-participant,100,50,11/7/2018
36C09B,conference-call,100,50,11/7/2018
371B0A,conference-participant,100,50,11/7/2018
37B120,conference-participant,100,50,11/7/2018
396D7C,conference-participant,100,50,11/7/2018
3A3447,facility-open,100,65,11/7/2018
3CCC90,executive-appointment,100,54,11/7/2018
3D9999,legal-issues-defendant,100,22,11/7/2018
3D9999,legal-issues-defendant,100,22,11/7/2018
3D9999,legal-issues-defendant,100,22,11/7/2018
3EE65E,earnings,100,50,11/7/2018
4017AD,earnings,100,50,11/7/2018
4.00E+163,legal-issues-defendant,100,22,11/7/2018
4.00E+163,legal-issues-defendant,100,22,11/7/2018
416C55,earnings,100,50,11/7/2018
41A93D,earnings,100,50,11/7/2018
41ED98,earnings,100,50,11/7/2018
422A82,earnings,100,50,11/7/2018
422A82,earnings,100,50,11/7/2018
422A82,earnings,100,50,11/7/2018
429BFB,conference-participant,100,50,11/7/2018
448BF3,conference-participant,100,50,11/7/2018
450ECB,earnings,100,50,11/7/2018
468DD4,earnings,100,50,11/7/2018
46A16E,earnings,100,50,11/7/2018
48F795,earnings,100,50,11/7/2018
4.91E+58,award,100,58,11/7/2018
4A2457,business-contract,100,69,11/7/2018
4A6F00,partnership,100,61,11/7/2018
4A6F00,partnership,100,61,11/7/2018
4AC91D,earnings,100,50,11/7/2018
4BEB48,earnings,100,50,11/7/2018
4BEB48,earnings,100,50,11/7/2018
4BEB48,earnings,100,50,11/7/2018
4BEB48,earnings,100,50,11/7/2018
4C350A,executive-death,100,31,11/7/2018
4C3FE9,earnings,100,50,11/7/2018
4D229C,earnings,100,50,11/7/2018
4D8124,executive-resignation,100,44,11/7/2018
4DD203,earnings,100,50,11/7/2018
4E6F5A,earnings,100,50,11/7/2018
4F783B,earnings,100,50,11/7/2018
4F783B,earnings,100,50,11/7/2018
4F783B,earnings,100,50,11/7/2018
4F783B,earnings,100,50,11/7/2018
4F783B,earnings,100,50,11/7/2018
507AE7,dividend,100,50,11/7/2018
50D1EC,earnings,100,50,11/7/2018
54512F,product-release,100,64,11/7/2018
54A713,dividend,100,50,11/7/2018
556F08,earnings,100,50,11/7/2018
583A75,revenue-volume,100,50,11/7/2018
5968F9,earnings,100,50,11/7/2018
59872F,conference-call,100,50,11/7/2018
5A0FF1,earnings,100,50,11/7/2018
5A0FF1,earnings,100,50,11/7/2018
5A9A82,executive-appointment,100,54,11/7/2018
5B3FA2,product-release,100,64,11/7/2018
5B3FA2,conference-participant,100,50,11/7/2018
5B7739,earnings,100,50,11/7/2018
5C2A47,earnings,100,50,11/7/2018
5CEE02,earnings,100,50,11/7/2018
5D02B7,buybacks,100,74,11/7/2018
5DD486,dividend,100,50,11/7/2018
60EA12,dividend,100,50,11/7/2018
60EA12,earnings-up,100,68,11/7/2018
60EA12,earnings,100,50,11/7/2018
60EA12,earnings,100,50,11/7/2018
619882,conference-organizer,100,57,11/7/2018
62B1C6,executive-resignation,100,44,11/7/2018
633043,earnings,100,50,11/7/2018
64636E,earnings,100,50,11/7/2018
649CBD,earnings,100,50,11/7/2018
649CBD,earnings,100,50,11/7/2018
649CBD,earnings,100,50,11/7/2018
657097,earnings,100,50,11/7/2018
67B052,conference-participant,100,50,11/7/2018
68586A,executive-appointment,100,54,11/7/2018
68E6E9,dividend,100,50,11/7/2018
693ECD,conference-participant,100,50,11/7/2018
694749,earnings,100,50,11/7/2018
694749,earnings,100,50,11/7/2018
694749,earnings,100,50,11/7/2018
694749,earnings,100,50,11/7/2018
6A961B,earnings,100,50,11/7/2018
6B67BD,earnings,100,50,11/7/2018
6BDA0C,earnings,100,50,11/7/2018
6BDA0C,earnings,100,50,11/7/2018
6BDA0C,earnings,100,50,11/7/2018
6BDA0C,earnings,100,50,11/7/2018
6CC55E,conference-participant,100,50,11/7/2018
6DDA15,earnings,100,50,11/7/2018
6DDA15,earnings,100,50,11/7/2018
6DDA15,earnings,100,50,11/7/2018
6DDA15,earnings,100,50,11/7/2018
6DDA15,earnings,100,50,11/7/2018
6DDA15,earnings,100,50,11/7/2018
6DDA15,earnings,100,50,11/7/2018
6-Dec-05,earnings,100,50,11/7/2018
6E8864,conference-participant,100,50,11/7/2018
6F39FC,earnings,100,50,11/7/2018
701531,conference-participant,100,50,11/7/2018
722DE3,earnings,100,50,11/7/2018
723548,operating-earnings,100,50,11/7/2018
726DDF,executive-appointment,100,54,11/7/2018
726DDF,earnings,100,50,11/7/2018
73F70F,conference-call,100,50,11/7/2018
756045,earnings,100,50,11/7/2018
76959C,earnings,100,50,11/7/2018
769F40,earnings,100,50,11/7/2018
76BECC,earnings,100,50,11/7/2018
76BECC,earnings,100,50,11/7/2018
76BECC,earnings,100,50,11/7/2018
7823A3,conference-participant,100,50,11/7/2018
787D14,executive-resignation,100,44,11/7/2018
787D14,earnings,100,50,11/7/2018
7A3633,earnings,100,50,11/7/2018
7ACD98,earnings,100,50,11/7/2018
7BEA98,earnings,100,50,11/7/2018
7C790D,conference-participant,100,50,11/7/2018
7F3A5F,partnership,100,61,11/7/2018
7FD8B9,earnings,100,50,11/7/2018
7FDE1C,earnings,100,50,11/7/2018
810FAD,earnings,100,50,11/7/2018
818A2F,earnings,100,50,11/7/2018
824CCA,earnings,100,50,11/7/2018
834152,conference-participant,100,50,11/7/2018
83A065,public-offering,100,43,11/7/2018
8665BA,executive-appointment,100,54,11/7/2018
86BAC7,dividend,100,50,11/7/2018
877C0C,earnings,100,50,11/7/2018
881190,dividend,100,50,11/7/2018
881190,executive-appointment,100,54,11/7/2018
88350F,partnership,100,61,11/7/2018
88611B,earnings,100,50,11/7/2018
8876D6,earnings-guidance-up,100,83,11/7/2018
8B9B3B,conference-participant,100,50,11/7/2018
8BAA15,partnership,100,61,11/7/2018
8BFAA4,earnings,100,50,11/7/2018
8BFAA4,earnings,100,50,11/7/2018
8BFAA4,earnings,100,50,11/7/2018
8DAAB9,dividend-up,100,70,11/7/2018
8E4F9A,business-contract,100,69,11/7/2018
8E82A6,revenue-up,100,69,11/7/2018
8E82A6,revenue-up,100,69,11/7/2018
8E82A6,revenue-up,100,69,11/7/2018
8E82A6,revenue-up,100,69,11/7/2018
8E82A6,revenue-up,100,69,11/7/2018
8E82A6,revenue-up,100,69,11/7/2018
8E8E6E,partnership,100,61,11/7/2018
8EDACA,legal-issues-defendant,100,22,11/7/2018
8FCA78,dividend,100,50,11/7/2018
902670,earnings,100,50,11/7/2018
902670,earnings,100,50,11/7/2018
902670,earnings,100,50,11/7/2018
902670,earnings,100,50,11/7/2018
913437,earnings,100,50,11/7/2018
9196A2,conference-organizer,100,57,11/7/2018
9196A2,conference-organizer,100,57,11/7/2018
9196A2,conference-organizer,100,57,11/7/2018
92005C,earnings,100,50,11/7/2018
922F0C,dividend,100,50,11/7/2018
925759,conference-participant,100,50,11/7/2018
92D757,earnings,100,50,11/7/2018
92D757,earnings,100,50,11/7/2018
9.31E+77,conference-participant,100,50,11/7/2018
944B2E,earnings,100,50,11/7/2018
944B2E,earnings,100,50,11/7/2018
944B2E,earnings,100,50,11/7/2018
944B2E,earnings,100,50,11/7/2018
944B2E,earnings,100,50,11/7/2018
944B2E,earnings,100,50,11/7/2018
944B2E,earnings,100,50,11/7/2018
94637C,conference-participant,100,50,11/7/2018
949625,earnings,100,50,11/7/2018
966DBE,earnings,100,50,11/7/2018
966DBE,earnings,100,50,11/7/2018
966DBE,earnings,100,50,11/7/2018
966DBE,earnings,100,50,11/7/2018
966DBE,earnings,100,50,11/7/2018
9673BD,earnings,100,50,11/7/2018
96A6CD,conference-participant,100,50,11/7/2018
97644E,earnings,100,50,11/7/2018
97644E,earnings,100,50,11/7/2018
97644E,earnings,100,50,11/7/2018
97644E,earnings,100,50,11/7/2018
97644E,earnings,100,50,11/7/2018
97AF94,earnings,100,50,11/7/2018
9934AD,earnings,100,50,11/7/2018
9978F1,conference-participant,100,50,11/7/2018
9B730A,earnings,100,50,11/7/2018
9C5174,partnership,100,61,11/7/2018
9D307D,executive-appointment,100,54,11/7/2018
9D30A8,partnership,100,61,11/7/2018
9D4EC7,acquisition-acquirer,100,49,11/7/2018
9D4EC7,executive-appointment,100,54,11/7/2018
9DDE1B,earnings,100,50,11/7/2018
9DDE1B,earnings,100,50,11/7/2018
9DDE1B,dividend,100,50,11/7/2018
9E575E,conference-participant,100,50,11/7/2018
9E91C6,earnings,100,50,11/7/2018
9F03CF,stake-acquirer,100,48,11/7/2018
9FA83B,earnings,100,50,11/7/2018
9FB4B7,earnings,100,50,11/7/2018
9FF5F1,earnings,100,50,11/7/2018
A01664,earnings,100,50,11/7/2018
A072C4,conference-participant,100,50,11/7/2018
A16DEA,executive-appointment,100,54,11/7/2018
A1EAC8,dividend-up,100,81,11/7/2018
A26EF7,earnings,100,50,11/7/2018
A26EF7,earnings,100,50,11/7/2018
A26EF7,rights-issue,100,43,11/7/2018
A3F598,earnings,100,50,11/7/2018
A3F598,earnings,100,50,11/7/2018
A3F598,earnings,100,50,11/7/2018
A3F598,earnings,100,50,11/7/2018
A43906,conference-participant,100,50,11/7/2018
A4CD53,earnings,100,50,11/7/2018
A4CD53,earnings,100,50,11/7/2018
A4CD53,earnings,100,50,11/7/2018
A5A4F5,acquisition-acquirer,100,49,11/7/2018
A6828A,product-release,100,64,11/7/2018
A6828A,product-release,100,64,11/7/2018
A94718,earnings,100,50,11/7/2018
AC642C,conference-participant,100,50,11/7/2018
ACF0B4,earnings,100,50,11/7/2018
AD23DE,partnership,100,61,11/7/2018
AE3113,earnings,100,50,11/7/2018
AEF2C3,conference-participant,100,50,11/7/2018
AF93DE,earnings,100,50,11/7/2018
AFD7DD,earnings,100,50,11/7/2018
B08C51,earnings,100,50,11/7/2018
B13B68,earnings,100,50,11/7/2018
B290A2,conference-participant,100,50,11/7/2018
B2E6B5,executive-appointment,100,54,11/7/2018
B2E6B5,dividend-up,100,58,11/7/2018
B2E6B5,earnings,100,50,11/7/2018
B2E6B5,earnings,100,50,11/7/2018
B2E6B5,earnings,100,50,11/7/2018
B37FB4,dividend,100,50,11/7/2018
B3CB74,conference-organizer,100,57,11/7/2018
B4528F,earnings,100,50,11/7/2018
B4528F,earnings,100,50,11/7/2018
B48FC9,revenue-up,100,69,11/7/2018
B48FC9,revenue-up,100,69,11/7/2018
B642E8,business-contract,100,69,11/7/2018
B642E8,earnings-up,100,68,11/7/2018
B66928,earnings,100,50,11/7/2018
B66928,earnings,100,50,11/7/2018
B66928,earnings,100,50,11/7/2018
B66928,earnings,100,50,11/7/2018
B66928,earnings,100,50,11/7/2018
B66928,earnings,100,50,11/7/2018
B66928,dividend,100,50,11/7/2018
B7BBFF,earnings,100,50,11/7/2018
B7BBFF,buybacks,100,74,11/7/2018
B80AD1,conference-participant,100,50,11/7/2018
B8EF97,legal-issues-defendant,100,22,11/7/2018
B8EF97,revenues,100,50,11/7/2018
B8EF97,legal-issues-defendant,100,22,11/7/2018
BB127B,executive-appointment,100,54,11/7/2018
BC5680,acquisition-completed-acquirer,100,49,11/7/2018
BCC55F,conference-participant,100,50,11/7/2018
BDE867,dividend,100,50,11/7/2018
BDEC1E,earnings,100,50,11/7/2018
C1114B,earnings,100,50,11/7/2018
C1114B,earnings,100,50,11/7/2018
C1114B,earnings,100,50,11/7/2018
C188F8,earnings,100,50,11/7/2018
C2DD02,earnings,100,50,11/7/2018
C2E120,earnings,100,50,11/7/2018
C3BCD5,unit-acquisition-acquiree,100,76,11/7/2018
C3EE99,conference-call,100,50,11/7/2018
C425AE,earnings,100,50,11/7/2018
C45C1F,earnings,100,50,11/7/2018
C4F9C6,earnings,100,50,11/7/2018
C584BE,earnings,100,50,11/7/2018
C81E00,acquisition-acquirer,100,49,11/7/2018
C951A2,earnings,100,50,11/7/2018
C951A2,earnings,100,50,11/7/2018
C951A2,earnings,100,50,11/7/2018
C951A2,earnings,100,50,11/7/2018
C951A2,earnings,100,50,11/7/2018
C951A2,earnings,100,50,11/7/2018
C97B2D,conference-participant,100,50,11/7/2018
C9E04B,earnings,100,50,11/7/2018
CA99D7,earnings,100,50,11/7/2018
CB6A9C,earnings,100,50,11/7/2018
CB7AB2,earnings,100,50,11/7/2018
CBCC6A,investment-investor,100,55,11/7/2018
CC35BE,earnings,100,50,11/7/2018
CC35BE,earnings,100,50,11/7/2018
CC35BE,earnings,100,50,11/7/2018
CC35BE,earnings,100,50,11/7/2018
CC35BE,earnings,100,50,11/7/2018
CC6FF5,product-release,100,64,11/7/2018
CDE118,dividend,100,50,11/7/2018
CDFCC9,dividend,100,50,11/7/2018
CDFCC9,earnings,100,50,11/7/2018
CDFCC9,earnings,100,50,11/7/2018
CDFCC9,earnings,100,50,11/7/2018
CDFCC9,earnings,100,50,11/7/2018
CDFCC9,earnings,100,50,11/7/2018
CE5C6E,earnings,100,50,11/7/2018
CFF15D,earnings,100,50,11/7/2018
CFF15D,earnings,100,50,11/7/2018
D06755,dividend,100,50,11/7/2018
D09938,earnings,100,50,11/7/2018
D139BC,earnings,100,50,11/7/2018
D25249,earnings,100,50,11/7/2018
D29B44,conference-participant,100,50,11/7/2018
D29F43,dividend,100,50,11/7/2018
D2B9E5,award,100,58,11/7/2018
D518D8,dividend-up,100,67,11/7/2018
D5A350,dividend-up,100,58,11/7/2018
D60BB2,index-listing,100,76,11/7/2018
D6144F,earnings,100,50,11/7/2018
D6489C,award,100,58,11/7/2018
D76AEF,earnings,100,50,11/7/2018
D854F3,dividend,100,50,11/7/2018
D90441,earnings,100,50,11/7/2018
DA48E4,conference-participant,100,50,11/7/2018
DB2E4E,earnings,100,50,11/7/2018
DB9F70,earnings,100,50,11/7/2018
DBB28E,partnership,100,61,11/7/2018
DD0F15,conference-participant,100,50,11/7/2018
DD1BA1,earnings,100,50,11/7/2018
DD1BA1,earnings,100,50,11/7/2018
DD1BA1,earnings,100,50,11/7/2018
DD1BA1,earnings,100,50,11/7/2018
DD1BA1,earnings,100,50,11/7/2018
DD1BA1,earnings,100,50,11/7/2018
DD1BA1,earnings,100,50,11/7/2018
DE4924,conference-call,100,50,11/7/2018
DF5F14,earnings,100,50,11/7/2018
E19A99,earnings,100,50,11/7/2018
E1E093,partnership,100,61,11/7/2018
E20392,earnings,100,50,11/7/2018
E259C7,dividend,100,50,11/7/2018
E30B34,award,100,58,11/7/2018
E38906,earnings,100,50,11/7/2018
E41190,legal-issues-defendant,100,22,11/7/2018
E61888,earnings,100,50,11/7/2018
E68E62,regulatory-product-approval-granted,100,81,11/7/2018
E68E62,earnings,100,50,11/7/2018
E7BF32,product-release,100,64,11/7/2018
E866D2,revenue-volume,100,50,11/7/2018
EA79C7,earnings,100,50,11/7/2018
EAA0A7,earnings,100,50,11/7/2018
EAA0A7,earnings,100,50,11/7/2018
EAA0A7,earnings,100,50,11/7/2018
EAA0A7,earnings,100,50,11/7/2018
EBC84C,executive-appointment,100,54,11/7/2018
EBC84C,conference-participant,100,50,11/7/2018
EC4E82,merger-completed,100,66,11/7/2018
ED2A5E,earnings,100,50,11/7/2018
ED2A5E,earnings,100,50,11/7/2018
ED2A5E,earnings,100,50,11/7/2018
ED2A5E,earnings,100,50,11/7/2018
ED2A5E,earnings,100,50,11/7/2018
ED2A5E,earnings,100,50,11/7/2018
ED2A5E,earnings,100,50,11/7/2018
EDD234,conference-call,100,50,11/7/2018
EEA734,earnings,100,50,11/7/2018
EF77A3,legal-issues-defendant,100,22,11/7/2018
EF77A3,legal-issues-defendant,100,22,11/7/2018
EFD406,earnings,100,50,11/7/2018
EFD406,earnings,100,50,11/7/2018
EFD406,earnings,100,50,11/7/2018
EFD406,earnings,100,50,11/7/2018
EFD406,earnings,100,50,11/7/2018
EFD406,earnings,100,50,11/7/2018
EFD406,earnings,100,50,11/7/2018
F00285,earnings,100,50,11/7/2018
F11638,product-release,100,64,11/7/2018
F18844,dividend,100,50,11/7/2018
F18844,earnings,100,50,11/7/2018
F3FCC3,earnings,100,50,11/7/2018
F3FCC3,dividend,100,50,11/7/2018
F47871,conference-participant,100,50,11/7/2018
F47871,fast-track-designation,100,81,11/7/2018
F48947,conference-participant,100,50,11/7/2018
F4E992,earnings,100,50,11/7/2018
F5349B,earnings,100,50,11/7/2018
F5349B,dividend-up,100,81,11/7/2018
F569FD,conference-participant,100,50,11/7/2018
F6581D,earnings,100,50,11/7/2018
F6DCE4,executive-appointment,100,54,11/7/2018
F6E1B5,earnings,100,50,11/7/2018
F769E9,conference-call,100,50,11/7/2018
F9CAF8,dividend,100,50,11/7/2018
FC01C0,earnings,100,50,11/7/2018
FC1736,conference-participant,100,50,11/7/2018
FC80E6,dividend,100,50,11/7/2018
FC9869,earnings,100,50,11/7/2018
FD0CA4,conference-participant,100,50,11/7/2018
FD554E,earnings,100,50,11/7/2018
FD554E,conference-participant,100,50,11/7/2018
FD9A97,dividend,100,50,11/7/2018
FE609F,earnings,100,50,11/7/2018
FEC475,earnings,100,50,11/7/2018
FF6644,legal-issues-defendant,100,22,11/7/2018
FFE543,conference-participant,100,50,11/7/2018
002A99,earnings,100,50,11/8/2018
0157B1,product-release,100,64,11/8/2018
20751,conference-participant,100,50,11/8/2018
48590,earnings,100,50,11/8/2018
054E7E,earnings,100,50,11/8/2018
75172,earnings,100,50,11/8/2018
95294,buybacks,100,74,11/8/2018
0A9D0A,earnings,100,50,11/8/2018
0AD2E3,conference-participant,100,50,11/8/2018
0B4D10,dividend,100,50,11/8/2018
0B7375,earnings,100,50,11/8/2018
0BF198,executive-appointment,100,54,11/8/2018
0BF198,executive-appointment,100,54,11/8/2018
0C355F,earnings,100,50,11/8/2018
0C355F,earnings,100,50,11/8/2018
0C355F,earnings,100,50,11/8/2018
0C355F,earnings,100,50,11/8/2018
0C6293,earnings,100,50,11/8/2018
0C6293,earnings,100,50,11/8/2018
0CCCB7,dividend,100,50,11/8/2018
0CCCB7,earnings,100,50,11/8/2018
0D03C8,earnings,100,50,11/8/2018
0E439E,dividend,100,50,11/8/2018
0E499E,conference-participant,100,50,11/8/2018
0E5619,earnings,100,50,11/8/2018
0F0693,earnings,100,50,11/8/2018
1080C0,executive-appointment,100,54,11/8/2018
10C19B,legal-issues-defendant,100,22,11/8/2018
1151F4,public-offering,100,43,11/8/2018
11A49E,earnings,100,50,11/8/2018
1279ED,earnings,100,50,11/8/2018
139303,conference-organizer,100,57,11/8/2018
14391F,earnings,100,50,11/8/2018
14391F,earnings,100,50,11/8/2018
14391F,earnings,100,50,11/8/2018
14391F,earnings,100,50,11/8/2018
147098,partnership,100,61,11/8/2018
14833D,legal-issues-defendant,100,22,11/8/2018
152FA5,executive-appointment,100,54,11/8/2018
1.79E+10,dividend,100,50,11/8/2018
1.79E+10,campaign-ad-release,100,59,11/8/2018
182B8C,earnings,100,50,11/8/2018
182BE7,earnings,100,50,11/8/2018
190B91,award,100,58,11/8/2018
1921DD,acquisition-completed-acquirer,100,49,11/8/2018
196D18,conference-participant,100,50,11/8/2018
1AC649,earnings,100,50,11/8/2018
1AE482,earnings,100,50,11/8/2018
1AE482,earnings,100,50,11/8/2018
1AE482,earnings,100,50,11/8/2018
1B16C1,earnings,100,50,11/8/2018
1DDEDA,earnings,100,50,11/8/2018
1E1125,conference-organizer,100,57,11/8/2018
1E1125,conference-organizer,100,57,11/8/2018
1E1125,conference-organizer,100,57,11/8/2018
1E1125,conference-organizer,100,57,11/8/2018
1F352C,earnings,100,50,11/8/2018
1F9258,revenues,100,50,11/8/2018
1F9258,earnings,100,50,11/8/2018
1F9258,earnings,100,50,11/8/2018
21268E,earnings,100,50,11/8/2018
221783,conference-participant,100,50,11/8/2018
221AD7,buybacks,100,74,11/8/2018
221AD7,legal-issues-defendant,100,22,11/8/2018
221AD7,legal-issues-defendant,100,22,11/8/2018
228D42,business-contract,100,69,11/8/2018
22C58E,conference-participant,100,50,11/8/2018
23207A,earnings,100,50,11/8/2018
239106,note-sale,100,52,11/8/2018
24C48B,dividend,100,50,11/8/2018
251988,legal-issues-defendant,100,22,11/8/2018
27C10F,earnings,100,50,11/8/2018
27C10F,earnings,100,50,11/8/2018
27C10F,earnings,100,50,11/8/2018
27C10F,earnings,100,50,11/8/2018
27C10F,earnings,100,50,11/8/2018
2B5483,earnings,100,50,11/8/2018
2B7A40,dividend,100,50,11/8/2018
2BBE62,earnings,100,50,11/8/2018
2BBE62,earnings,100,50,11/8/2018
2BBE62,earnings,100,50,11/8/2018
2BF36E,earnings,100,50,11/8/2018
2C3348,earnings,100,50,11/8/2018
2CC71C,earnings,100,50,11/8/2018
2DC88B,legal-issues-defendant,100,22,11/8/2018
2E1322,earnings,100,50,11/8/2018
2E1322,earnings,100,50,11/8/2018
2EB04E,partnership,100,61,11/8/2018
301493,legal-issues-defendant,100,22,11/8/2018
301493,earnings,100,50,11/8/2018
314D88,conference-participant,100,50,11/8/2018
3159AA,facility-open,100,65,11/8/2018
3159AA,market-entry,100,57,11/8/2018
31DB20,buybacks,100,74,11/8/2018
32C8CD,earnings,100,50,11/8/2018
3.20E+263,earnings,100,50,11/8/2018
32F24A,earnings,100,50,11/8/2018
342218,earnings,100,50,11/8/2018
342218,earnings,100,50,11/8/2018
3461CF,executive-appointment,100,54,11/8/2018
3461CF,executive-appointment,100,54,11/8/2018
3461CF,executive-appointment,100,54,11/8/2018
3471C0,earnings,100,50,11/8/2018
34A959,revenues,100,50,11/8/2018
34A959,buybacks,100,74,11/8/2018
35557B,earnings,100,50,11/8/2018
3587B4,earnings,100,50,11/8/2018
3587B4,earnings,100,50,11/8/2018
3587B4,earnings,100,50,11/8/2018
3587B4,earnings,100,50,11/8/2018
37B618,earnings,100,50,11/8/2018
37E18B,operating-earnings,100,50,11/8/2018
385DD4,dividend,100,50,11/8/2018
3B318A,legal-issues-defendant,100,22,11/8/2018
3B37F7,joint-venture,100,62,11/8/2018
3C3B6B,earnings,100,50,11/8/2018
3C3B6B,earnings,100,50,11/8/2018
3C3B6B,earnings,100,50,11/8/2018
3C75D6,earnings-up,100,68,11/8/2018
3C75D6,earnings,100,50,11/8/2018
3C75D6,earnings,100,50,11/8/2018
3CCC90,award,100,58,11/8/2018
3D9999,legal-issues-defendant,100,22,11/8/2018
3DD5E2,product-release,100,64,11/8/2018
3DD5E2,operating-earnings,100,50,11/8/2018
3E39A5,revenues,100,50,11/8/2018
3ED92D,executive-appointment,100,54,11/8/2018
3F1C69,conference-participant,100,50,11/8/2018
3F96D5,earnings,100,50,11/8/2018
407878,earnings,100,50,11/8/2018
4.00E+163,legal-issues-defendant,100,22,11/8/2018
4.00E+163,legal-issues-defendant,100,22,11/8/2018
4135F7,earnings,100,50,11/8/2018
416C55,executive-appointment,100,54,11/8/2018
43A060,earnings,100,50,11/8/2018
43A060,earnings,100,50,11/8/2018
43A060,earnings,100,50,11/8/2018
43A060,earnings,100,50,11/8/2018
448BF3,earnings,100,50,11/8/2018
449217,earnings-positive,100,69,11/8/2018
45ABCC,revenue-up,100,73,11/8/2018
45ABCC,revenue-up,100,73,11/8/2018
45ABCC,revenue-up,100,73,11/8/2018
45ABCC,revenue-up,100,73,11/8/2018
4.60E+06,earnings,100,50,11/8/2018
48F795,legal-issues-defendant,100,22,11/8/2018
49CC59,earnings,100,50,11/8/2018
4A2457,business-contract,100,69,11/8/2018
4A3438,earnings,100,50,11/8/2018
4A3438,earnings,100,50,11/8/2018
4A3438,earnings,100,50,11/8/2018
4A3438,earnings,100,50,11/8/2018
4B7006,earnings,100,50,11/8/2018
4BBA23,earnings,100,50,11/8/2018
4BDCA7,executive-appointment,100,54,11/8/2018
4D72C8,earnings,100,50,11/8/2018
4D72C8,earnings,100,50,11/8/2018
50D1EC,conference-participant,100,50,11/8/2018
513A86,earnings,100,50,11/8/2018
52FB2F,earnings,100,50,11/8/2018
52FB2F,earnings,100,50,11/8/2018
52FB2F,earnings,100,50,11/8/2018
52FB2F,earnings,100,50,11/8/2018
52FB2F,earnings,100,50,11/8/2018
546A27,earnings,100,50,11/8/2018
5.47E+28,earnings,100,50,11/8/2018
55CD6F,operating-earnings,100,50,11/8/2018
55D0F3,earnings,100,50,11/8/2018
562853,dividend,100,50,11/8/2018
567F3D,dividend,100,50,11/8/2018
57A854,earnings,100,50,11/8/2018
57A854,earnings,100,50,11/8/2018
586BD7,conference-participant,100,50,11/8/2018
58B46F,earnings-per-share-positive,100,69,11/8/2018
58EA22,partnership,100,61,11/8/2018
5A423F,conference-participant,100,50,11/8/2018
5B226B,earnings-up,100,68,11/8/2018
5B226B,earnings-up,100,68,11/8/2018
5B226B,earnings-up,100,68,11/8/2018
5B3FA2,earnings,100,50,11/8/2018
5C2A47,earnings,100,50,11/8/2018
5D1329,conference-participant,100,50,11/8/2018
5D41E4,conference-participant,100,50,11/8/2018
5D63F1,earnings,100,50,11/8/2018
5D63F1,executive-appointment,100,54,11/8/2018
5EAA43,earnings,100,50,11/8/2018
5FE4B6,dividend,100,50,11/8/2018
620381,earnings,100,50,11/8/2018
629F0F,earnings,100,50,11/8/2018
6559D8,earnings,100,50,11/8/2018
65D0AA,fundraising,100,64,11/8/2018
676FFD,earnings,100,50,11/8/2018
68586A,conference-participant,100,50,11/8/2018
68586A,earnings,100,50,11/8/2018
6925EB,earnings,100,50,11/8/2018
69345C,award,100,58,11/8/2018
6B0784,earnings,100,50,11/8/2018
6E8349,product-release,100,64,11/8/2018
6ED519,legal-issues-defendant,100,22,11/8/2018
6F22E7,conference-call,100,50,11/8/2018
6FCEF9,facility-open,100,65,11/8/2018
6FCEF9,facility-open,100,65,11/8/2018
713810,facility-open,100,65,11/8/2018
7255D2,earnings,100,50,11/8/2018
741937,revenue-up,100,69,11/8/2018
741937,earnings,100,50,11/8/2018
741937,earnings,100,50,11/8/2018
742AAB,earnings,100,50,11/8/2018
7.45E+28,earnings,100,50,11/8/2018
769F40,partnership,100,61,11/8/2018
7710F3,earnings,100,50,11/8/2018
7710F3,earnings,100,50,11/8/2018
7740DE,same-store-sales-down,100,49,11/8/2018
7771D7,earnings,100,50,11/8/2018
7771D7,earnings,100,50,11/8/2018
7771D7,earnings,100,50,11/8/2018
7771D7,earnings,100,50,11/8/2018
7ACBA4,earnings,100,50,11/8/2018
7AF5B8,earnings,100,50,11/8/2018
7B492C,buybacks,100,74,11/8/2018
7B6C88,award,100,58,11/8/2018
7B9212,revenues,100,50,11/8/2018
7E1D5D,award,100,58,11/8/2018
7E1D5D,earnings,100,50,11/8/2018
7F3A5F,partnership,100,61,11/8/2018
7F3A5F,partnership,100,61,11/8/2018
7F3A5F,partnership,100,61,11/8/2018
7F9984,product-release,100,64,11/8/2018
803FED,earnings,100,50,11/8/2018
81EAD4,business-contract,100,69,11/8/2018
82B57E,executive-appointment,100,54,11/8/2018
82C202,earnings,100,50,11/8/2018
838ADD,partnership,100,61,11/8/2018
838ADD,partnership,100,61,11/8/2018
83A065,public-offering,100,43,11/8/2018
83E0AC,conference-call,100,50,11/8/2018
8665BA,dividend,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86AA9C,earnings,100,50,11/8/2018
86F123,earnings-up,100,68,11/8/2018
88923D,partnership,100,61,11/8/2018
89F693,product-release,100,64,11/8/2018
89F693,legal-issues-defendant,100,22,11/8/2018
8B1E11,facility-open,100,65,11/8/2018
8B9B3B,earnings,100,50,11/8/2018
8D0EEA,earnings,100,50,11/8/2018
8D4486,partnership,100,61,11/8/2018
8D5145,executive-appointment,100,54,11/8/2018
8D5145,dividend,100,50,11/8/2018
8DE56F,earnings,100,50,11/8/2018
9196A2,conference-organizer,100,57,11/8/2018
9196A2,conference-organizer,100,57,11/8/2018
931AE7,earnings,100,50,11/8/2018
943239,earnings,100,50,11/8/2018
943239,earnings,100,50,11/8/2018
947B0B,earnings,100,50,11/8/2018
958938,earnings,100,50,11/8/2018
9.65E+07,earnings,100,50,11/8/2018
9.65E+07,earnings,100,50,11/8/2018
96A6CD,earnings,100,50,11/8/2018
96F126,award,100,58,11/8/2018
9.86E+03,earnings,100,50,11/8/2018
9978F1,clinical-trials-start,100,64,11/8/2018
9ABD30,earnings,100,50,11/8/2018
9B4066,unit-acquisition-acquirer,100,49,11/8/2018
9D307D,earnings,100,50,11/8/2018
9E4A5F,earnings,100,50,11/8/2018
9E5C2C,earnings,100,50,11/8/2018
9EBAFA,earnings,100,50,11/8/2018
9F5CBB,earnings,100,50,11/8/2018
A017F4,conference-participant,100,50,11/8/2018
A072C4,clinical-trials,100,56,11/8/2018
A072C4,earnings,100,50,11/8/2018
A0F146,earnings,100,50,11/8/2018
A16DEA,executive-appointment,100,54,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1BB98,earnings,100,50,11/8/2018
A1EAC8,earnings,100,50,11/8/2018
A29A46,earnings,100,50,11/8/2018
A350C1,dividend,100,50,11/8/2018
A350C1,dividend,100,50,11/8/2018
A350C1,dividend,100,50,11/8/2018
A3800A,earnings,100,50,11/8/2018
A403CF,earnings,100,50,11/8/2018
A403CF,dividend,100,50,11/8/2018
A495F7,earnings,100,50,11/8/2018
A5195E,conference-participant,100,50,11/8/2018
A52B6B,award,100,58,11/8/2018
A6213D,acquisition-acquirer,100,49,11/8/2018
A753BB,earnings,100,50,11/8/2018
A94637,dividend,100,50,11/8/2018
AAC8B6,earnings,100,50,11/8/2018
AB4A7E,earnings,100,50,11/8/2018
AC3584,revenue-up,100,86,11/8/2018
AC3584,revenue-up,100,86,11/8/2018
AC642C,earnings,100,50,11/8/2018
AC642C,earnings,100,50,11/8/2018
ACC7D3,earnings,100,50,11/8/2018
ADD9DC,facility-open,100,65,11/8/2018
ADF092,earnings,100,50,11/8/2018
ADF092,earnings,100,50,11/8/2018
ADF1B0,executive-appointment,100,54,11/8/2018
ADFB3A,earnings,100,50,11/8/2018
AE3113,conference-participant,100,50,11/8/2018
AE7D16,government-contract,100,69,11/8/2018
AE7D16,settlement,100,56,11/8/2018
B01215,earnings,100,50,11/8/2018
B0D41A,conference-participant,100,50,11/8/2018
B1A85D,earnings,100,50,11/8/2018
B1DF3C,conference-participant,100,50,11/8/2018
B2D799,earnings,100,50,11/8/2018
B33E77,earnings,100,50,11/8/2018
B4528F,executive-appointment,100,54,11/8/2018
B4703C,product-recall,100,29,11/8/2018
B54A74,conference-participant,100,50,11/8/2018
B7202A,earnings,100,50,11/8/2018
B7202A,earnings,100,50,11/8/2018
B7BDA3,earnings,100,50,11/8/2018
B7BDA3,earnings,100,50,11/8/2018
B803B1,earnings,100,50,11/8/2018
B80AD1,earnings,100,50,11/8/2018
B83D67,conference-participant,100,50,11/8/2018
B8EF97,legal-issues-defendant,100,22,11/8/2018
BAD9EA,earnings,100,50,11/8/2018
BB0587,dividend,100,50,11/8/2018
BB88B6,conference-participant,100,50,11/8/2018
BBF349,earnings,100,50,11/8/2018
BBF349,earnings,100,50,11/8/2018
BBF349,earnings,100,50,11/8/2018
BD9668,dividend-up,100,81,11/8/2018
BDF2BD,conference-participant,100,50,11/8/2018
BFD0A7,earnings,100,50,11/8/2018
BFD0A7,earnings,100,50,11/8/2018
BFD0A7,earnings,100,50,11/8/2018
C05839,asset-sale,100,62,11/8/2018
C05839,asset-sale,100,62,11/8/2018
C2E426,settlement,100,56,11/8/2018
C36189,earnings,100,50,11/8/2018
C45CE7,dividend,100,50,11/8/2018
C4A912,earnings,100,50,11/8/2018
C4A912,earnings,100,50,11/8/2018
C4A912,earnings,100,50,11/8/2018
C4A912,earnings,100,50,11/8/2018
C58D71,earnings,100,50,11/8/2018
C58D71,earnings,100,50,11/8/2018
C5E100,earnings,100,50,11/8/2018
C65004,revenue-up,100,73,11/8/2018
C65004,revenue-up,100,69,11/8/2018
C66A8C,earnings,100,50,11/8/2018
C7FC95,product-release,100,64,11/8/2018
C8A248,unit-acquisition-acquiree,100,76,11/8/2018
C9732E,earnings,100,50,11/8/2018
C99CC8,revenue-up,100,69,11/8/2018
C99CC8,revenue-up,100,69,11/8/2018
C99CC8,revenue-up,100,69,11/8/2018
C99CC8,revenue-up,100,69,11/8/2018
C99CC8,revenue-up,100,69,11/8/2018
C9E04B,product-release,100,64,11/8/2018
CBDB4D,earnings,100,50,11/8/2018
CCB623,earnings,100,50,11/8/2018
CD051C,earnings,100,50,11/8/2018
CD051C,earnings,100,50,11/8/2018
CD051C,earnings,100,50,11/8/2018
CD051C,earnings,100,50,11/8/2018
CD051C,earnings,100,50,11/8/2018
CD4DA8,conference-organizer,100,57,11/8/2018
CDAA0E,executive-appointment,100,54,11/8/2018
CDAB24,executive-resignation,100,44,11/8/2018
CDFCC9,legal-issues-defendant,100,22,11/8/2018
CE96E7,dividend,100,50,11/8/2018
CEC5B9,partnership,100,61,11/8/2018
D07B07,earnings,100,50,11/8/2018
D5938F,earnings,100,50,11/8/2018
D697DE,earnings,100,50,11/8/2018
D6EAA3,earnings,100,50,11/8/2018
D6EAA3,earnings,100,50,11/8/2018
D6EAA3,earnings,100,50,11/8/2018
D6EAA3,earnings,100,50,11/8/2018
D6EAA3,earnings,100,50,11/8/2018
D8442A,market-entry,100,57,11/8/2018
D8ECA1,earnings,100,50,11/8/2018
D8ECA1,earnings,100,50,11/8/2018
D8ECA1,earnings,100,50,11/8/2018
D8ECA1,earnings,100,50,11/8/2018
D90F43,partnership,100,61,11/8/2018
DC6AA0,earnings,100,50,11/8/2018
DDCB34,conference-participant,100,50,11/8/2018
DDEA6A,conference-participant,100,50,11/8/2018
DF18E6,earnings,100,50,11/8/2018
DF42A0,dividend,100,50,11/8/2018
DF42A0,earnings-up,100,68,11/8/2018
DF5F14,merger,100,66,11/8/2018
DF5F14,merger,100,66,11/8/2018
DF5F14,merger,100,66,11/8/2018
DF5F14,merger,100,66,11/8/2018
E16133,earnings,100,50,11/8/2018
E20392,conference-participant,100,50,11/8/2018
E21871,dividend,100,50,11/8/2018
E2CB7B,earnings,100,50,11/8/2018
E2CFD2,earnings,100,50,11/8/2018
E30B34,partnership,100,61,11/8/2018
E38906,clinical-trials-complete,100,56,11/8/2018
E3E68E,product-release,100,64,11/8/2018
E41190,earnings,100,50,11/8/2018
E41190,earnings,100,50,11/8/2018
E41190,earnings,100,50,11/8/2018
E41190,earnings,100,50,11/8/2018
E41190,earnings,100,50,11/8/2018
E6BC2C,public-offering,100,43,11/8/2018
E6D89E,partnership,100,61,11/8/2018
E71AE6,earnings,100,50,11/8/2018
E94704,dividend-up,100,66,11/8/2018
EA79C7,conference-participant,100,50,11/8/2018
EAEBF3,earnings,100,50,11/8/2018
EB43F4,earnings,100,50,11/8/2018
EB5E78,earnings-above-expectations,100,88,11/8/2018
EB5E78,earnings-above-expectations,100,88,11/8/2018
EB5E78,earnings-above-expectations,100,88,11/8/2018
EB5E78,earnings-above-expectations,100,88,11/8/2018
EB5E78,earnings-above-expectations,100,88,11/8/2018
ED9C04,acquisition-acquirer,100,49,11/8/2018
ED9C04,acquisition-acquirer,100,49,11/8/2018
ED9C04,acquisition-acquirer,100,49,11/8/2018
ED9C04,earnings,100,50,11/8/2018
ED9C04,earnings,100,50,11/8/2018
ED9C04,earnings,100,50,11/8/2018
ED9C04,earnings,100,50,11/8/2018
ED9C04,earnings,100,50,11/8/2018
EE04F0,earnings,100,50,11/8/2018
EE04F0,earnings,100,50,11/8/2018
EE04F0,earnings,100,50,11/8/2018
EE04F0,earnings,100,50,11/8/2018
EEB5F9,earnings,100,50,11/8/2018
EF25A5,earnings,100,50,11/8/2018
EF25A5,earnings,100,50,11/8/2018
EF25A5,earnings,100,50,11/8/2018
EF25A5,earnings,100,50,11/8/2018
EF5914,earnings,100,50,11/8/2018
EF77A3,legal-issues-defendant,100,22,11/8/2018
EF77A3,legal-issues-defendant,100,22,11/8/2018
F1CD47,dividend,100,50,11/8/2018
F30508,conference-participant,100,50,11/8/2018
F3816D,earnings,100,50,11/8/2018
F3EDB4,business-contract,100,69,11/8/2018
F47871,earnings,100,50,11/8/2018
F569FD,earnings,100,50,11/8/2018
F58C23,earnings,100,50,11/8/2018
F58C23,earnings,100,50,11/8/2018
F73DD1,earnings,100,50,11/8/2018
F73DD1,earnings,100,50,11/8/2018
F73DD1,earnings,100,50,11/8/2018
F73DD1,earnings,100,50,11/8/2018
F73DD1,earnings,100,50,11/8/2018
F73DD1,earnings,100,50,11/8/2018
F73DD1,earnings,100,50,11/8/2018
F769E9,earnings,100,50,11/8/2018
F83279,earnings,100,50,11/8/2018
F83279,earnings,100,50,11/8/2018
F8BA6C,conference-participant,100,50,11/8/2018
FAE021,dividend,100,50,11/8/2018
FC1A6E,conference-participant,100,50,11/8/2018
FC1F9D,dividend,100,50,11/8/2018
FD39EB,earnings,100,50,11/8/2018
FD9A97,earnings,100,50,11/8/2018
FDD3FC,earnings,100,50,11/8/2018
FDF799,earnings,100,50,11/8/2018
FDF799,earnings,100,50,11/8/2018
FF227B,conference-participant,100,50,11/8/2018
FF6644,legal-issues-defendant,100,22,11/8/2018
03D5F9,legal-issues-defendant,100,22,11/9/2018
0490C6,earnings,100,50,11/9/2018
0490C6,earnings,100,50,11/9/2018
0490C6,earnings,100,50,11/9/2018
0490C6,earnings,100,50,11/9/2018
84625,earnings,100,50,11/9/2018
84625,earnings,100,50,11/9/2018
84625,dividend,100,50,11/9/2018
0C2A0D,conference-participant,100,50,11/9/2018
0C6861,earnings,100,50,11/9/2018
0DBB81,earnings,100,50,11/9/2018
0E5619,conference-participant,100,50,11/9/2018
147098,earnings,100,50,11/9/2018
14833D,legal-issues-defendant,100,22,11/9/2018
14833D,legal-issues-defendant,100,22,11/9/2018
15789A,earnings,100,50,11/9/2018
16B882,earnings,100,50,11/9/2018
184988,clinical-trials,100,56,11/9/2018
18EC17,executive-appointment,100,54,11/9/2018
19CAC7,dividend,100,50,11/9/2018
1D3A00,dividend,100,50,11/9/2018
1E1125,conference-organizer,100,57,11/9/2018
1E1125,conference-organizer,100,57,11/9/2018
21153F,buybacks,100,74,11/9/2018
21153F,buybacks,100,74,11/9/2018
24A89A,earnings,100,50,11/9/2018
24A89A,earnings,100,50,11/9/2018
25D3CE,earnings,100,50,11/9/2018
27C10F,executive-appointment,100,54,11/9/2018
2A6DBE,earnings,100,50,11/9/2018
2C3348,legal-issues-defendant,100,22,11/9/2018
2C3348,earnings,100,50,11/9/2018
2C35B5,earnings,100,50,11/9/2018
2CB4C9,partnership,100,61,11/9/2018
2CC71C,conference-participant,100,50,11/9/2018
2DC88B,legal-issues-defendant,100,22,11/9/2018
341759,conference-participant,100,50,11/9/2018
367434,earnings,100,50,11/9/2018
367434,earnings,100,50,11/9/2018
36A1CB,dividend,100,50,11/9/2018
36C09B,earnings,100,50,11/9/2018
37B120,public-offering,100,43,11/9/2018
37B120,public-offering,100,43,11/9/2018
385DD4,executive-appointment,100,54,11/9/2018
3ACF46,conference-participant,100,50,11/9/2018
3ACF46,acquisition-completed-acquirer,100,49,11/9/2018
3D9999,legal-issues-defendant,100,22,11/9/2018
4.00E+163,legal-issues-defendant,100,22,11/9/2018
4.00E+163,legal-issues-defendant,100,22,11/9/2018
4.00E+163,legal-issues-defendant,100,22,11/9/2018
416291,executive-appointment,100,54,11/9/2018
41785E,dividend,100,50,11/9/2018
43A74A,conference-participant,100,50,11/9/2018
458D2C,revenue-volume,100,50,11/9/2018
45BC35,conference-participant,100,50,11/9/2018
4A2457,business-contract,100,69,11/9/2018
4AE584,revenues,100,50,11/9/2018
4AE584,revenues,100,50,11/9/2018
4AE584,revenues,100,50,11/9/2018
4E4E75,conference-call,100,50,11/9/2018
543900,legal-issues-defendant,100,22,11/9/2018
550D01,buybacks,100,74,11/9/2018
57DDB9,conference-participant,100,50,11/9/2018
5B35C7,earnings-up,100,68,11/9/2018
5B35C7,earnings-up,100,68,11/9/2018
5C7601,award,100,58,11/9/2018
5D63F1,partnership,100,61,11/9/2018
5F3D91,earnings,100,50,11/9/2018
5F3D91,earnings,100,50,11/9/2018
5F3D91,earnings,100,50,11/9/2018
60EA12,conference-participant,100,50,11/9/2018
619882,product-release,100,64,11/9/2018
64854A,earnings,100,50,11/9/2018
649CBD,legal-issues-defendant,100,22,11/9/2018
649CBD,legal-issues-defendant,100,22,11/9/2018
66749D,dividend,100,50,11/9/2018
69C99E,earnings,100,50,11/9/2018
6D0CAB,dividend,100,50,11/9/2018
6DDA15,conference-participant,100,50,11/9/2018
728737,dividend,100,50,11/9/2018
76E80F,dividend,100,50,11/9/2018
7AC86E,dividend-up,100,57,11/9/2018
7B1E50,dividend,100,50,11/9/2018
7B1E50,dividend,100,50,11/9/2018
7B9AFA,conference-participant,100,50,11/9/2018
7BAAE7,dividend,100,50,11/9/2018
7FD8B9,conference-participant,100,50,11/9/2018
817ED9,earnings,100,50,11/9/2018
834152,earnings,100,50,11/9/2018
868808,executive-resignation,100,44,11/9/2018
883D82,earnings,100,50,11/9/2018
89F693,conference-participant,100,50,11/9/2018
8E10BF,earnings,100,50,11/9/2018
8EDACA,legal-issues-defendant,100,22,11/9/2018
9196A2,conference-organizer,100,57,11/9/2018
9196A2,conference-organizer,100,57,11/9/2018
92D230,earnings,100,50,11/9/2018
92D230,earnings,100,50,11/9/2018
92D230,earnings,100,50,11/9/2018
92D230,earnings,100,50,11/9/2018
92D230,earnings,100,50,11/9/2018
92D230,earnings,100,50,11/9/2018
92D230,earnings,100,50,11/9/2018
92D757,asset-sale,100,62,11/9/2018
94983E,dividend,100,50,11/9/2018
968966,dividend,100,50,11/9/2018
96BFF4,earnings-positive,100,69,11/9/2018
96BFF4,earnings-positive,100,69,11/9/2018
96BFF4,earnings-positive,100,69,11/9/2018
97644E,executive-appointment,100,54,11/9/2018
980C14,dividend,100,50,11/9/2018
990AD0,conference-organizer,100,57,11/9/2018
990AD0,conference-organizer,100,57,11/9/2018
9978F1,clinical-trials,100,56,11/9/2018
9978F1,clinical-trials-start,100,64,11/9/2018
9BB35A,public-offering,100,43,11/9/2018
A6213D,award,100,58,11/9/2018
A8FDE8,conference-participant,100,50,11/9/2018
ACD9A4,dividend,100,50,11/9/2018
AD23DE,dividend,100,50,11/9/2018
AE79CD,product-release,100,64,11/9/2018
AE7D16,earnings,100,50,11/9/2018
AE7D16,legal-issues-defendant,100,22,11/9/2018
B05000,executive-appointment,100,54,11/9/2018
B4F5F4,conference-call,100,50,11/9/2018
B8EF97,legal-issues-defendant,100,22,11/9/2018
B8F71F,dividend,100,50,11/9/2018
BDE867,earnings,100,50,11/9/2018
BDE867,earnings,100,50,11/9/2018
BDE867,earnings,100,50,11/9/2018
C0200F,dividend,100,50,11/9/2018
C0BA36,acquisition-acquirer,100,49,11/9/2018
C0BA36,acquisition-acquirer,100,49,11/9/2018
C0BA36,acquisition-acquirer,100,49,11/9/2018
C188F8,legal-issues-defendant,100,22,11/9/2018
C2E39B,executive-resignation,100,44,11/9/2018
C3BCD5,dividend,100,50,11/9/2018
C564E4,conference-participant,100,50,11/9/2018
C81E00,acquisition-completed-acquirer,100,49,11/9/2018
C81E00,acquisition-completed-acquirer,100,49,11/9/2018
C8923A,conference-participant,100,50,11/9/2018
C941DC,conference-participant,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C99CC8,earnings,100,50,11/9/2018
C9E04B,partnership,100,61,11/9/2018
CDD75E,earnings,100,50,11/9/2018
CDFCC9,legal-issues-defendant,100,22,11/9/2018
CE2791,earnings,100,50,11/9/2018
D0909F,conference-participant,100,50,11/9/2018
D27FAB,earnings,100,50,11/9/2018
DB23C8,conference-participant,100,50,11/9/2018
DDEA6A,legal-issues-defendant,100,22,11/9/2018
DF1F7A,dividend,100,50,11/9/2018
E124EB,award,100,58,11/9/2018
E26FC3,product-release,100,64,11/9/2018
E26FC3,product-release,100,64,11/9/2018
E30B34,conference-participant,100,50,11/9/2018
E30B34,conference-participant,100,50,11/9/2018
E68733,earnings,100,50,11/9/2018
E6BC2C,public-offering,100,43,11/9/2018
EC4E82,earnings-up,100,68,11/9/2018
ED9576,dividend,100,50,11/9/2018
EF77A3,legal-issues-defendant,100,22,11/9/2018
F4F46F,business-contract,100,69,11/9/2018
F5D410,board-meeting,100,51,11/9/2018
F6E248,clinical-trials-positive,100,87,11/9/2018
F82D37,dividend,100,50,11/9/2018
FC80E6,executive-appointment,100,54,11/9/2018
FCA54E,earnings,100,50,11/9/2018
FF4BA4,dividend,100,50,11/9/2018
FF5413,revenue-volume,100,50,11/9/2018
FF6644,acquisition-completed-acquirer,100,49,11/9/2018
10C19B,legal-issues-defendant,100,22,11/10/2018
1151F4,index-listing,100,76,11/10/2018
14833D,legal-issues-defendant,100,22,11/10/2018
1748B3,conference-participant,100,50,11/10/2018
221AD7,legal-issues-defendant,100,22,11/10/2018
619882,product-release,100,64,11/10/2018
8EDACA,legal-issues-defendant,100,22,11/10/2018
8EDACA,legal-issues-defendant,100,22,11/10/2018
AA98ED,legal-issues-defendant,100,22,11/10/2018
AE7D16,legal-issues-defendant,100,22,11/10/2018
AE7D16,legal-issues-defendant,100,22,11/10/2018
AE7D16,legal-issues-defendant,100,22,11/10/2018
C45C1F,clinical-trials,100,56,11/10/2018
D5AF19,settlement,100,56,11/10/2018
DBB28E,partnership,100,61,11/10/2018
E8846E,settlement,100,56,11/10/2018
FF6644,legal-issues-defendant,100,22,11/10/2018
152E1D,legal-issues-defendant,100,22,11/11/2018
E8846E,donation,100,54,11/11/2018
9397,partnership,100,61,11/12/2018
03596A,earnings,100,50,11/12/2018
06CB5B,revenue-up,100,51,11/12/2018
099C88,note-sale,100,52,11/12/2018
0A6824,dividend,100,50,11/12/2018
0A6824,executive-appointment,100,54,11/12/2018
0C136E,executive-appointment,100,54,11/12/2018
0D03C8,conference-participant,100,50,11/12/2018
11A49E,clinical-trials,100,56,11/12/2018
125212,appeal-plaintiff,100,22,11/12/2018
1348C9,executive-appointment,100,54,11/12/2018
139303,conference-organizer,100,57,11/12/2018
147098,dividend,100,50,11/12/2018
157CC1,ipo-pricing,100,50,11/12/2018
16B183,business-contract,100,69,11/12/2018
1921DD,partnership,100,61,11/12/2018
197019,award,100,58,11/12/2018
1D3A00,conference-call,100,50,11/12/2018
1D9E55,conference-participant,100,50,11/12/2018
1E1125,conference-organizer,100,57,11/12/2018
1E1125,conference-organizer,100,57,11/12/2018
1E1125,conference-organizer,100,57,11/12/2018
1E1125,conference-organizer,100,57,11/12/2018
1E9A6D,executive-appointment,100,54,11/12/2018
228D42,business-contract,100,69,11/12/2018
24FA23,clinical-trials,100,56,11/12/2018
2B49F4,executive-appointment,100,54,11/12/2018
2C3348,legal-issues-defendant,100,22,11/12/2018
2C7505,legal-issues-defendant,100,22,11/12/2018
2CC60C,conference-call,100,50,11/12/2018
2DC88B,legal-issues-defendant,100,22,11/12/2018
2F1299,business-contract,100,69,11/12/2018
30DE64,clinical-trials,100,56,11/12/2018
35F4B5,dividend,100,50,11/12/2018
36C09B,legal-issues-defendant,100,22,11/12/2018
39FB23,partnership,100,61,11/12/2018
3A113F,executive-appointment,100,54,11/12/2018
3B318A,legal-issues-defendant,100,22,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3BA1BF,earnings,100,50,11/12/2018
3E39A5,executive-appointment,100,54,11/12/2018
4.00E+163,legal-issues-defendant,100,22,11/12/2018
4.00E+163,legal-issues-defendant,100,22,11/12/2018
442769,conference-participant,100,50,11/12/2018
448BF3,private-placement,100,56,11/12/2018
448BF3,business-contract,100,69,11/12/2018
448BF3,conference-call,100,50,11/12/2018
48F795,legal-issues-defendant,100,22,11/12/2018
49BBBC,partnership,100,61,11/12/2018
4A6F00,legal-issues-defendant,100,22,11/12/2018
4C92B9,legal-issues-defendant,100,22,11/12/2018
5065B1,unit-acquisition-acquiree,100,76,11/12/2018
543900,legal-issues-defendant,100,22,11/12/2018
55C9B5,product-release,100,64,11/12/2018
55C9B5,product-release,100,64,11/12/2018
5B6C11,dividend,100,50,11/12/2018
5D63F1,facility-open,100,65,11/12/2018
5E6959,dividend-up,100,62,11/12/2018
616E3B,dividend,100,50,11/12/2018
649CBD,legal-issues-defendant,100,22,11/12/2018
649CBD,legal-issues-defendant,100,22,11/12/2018
665D7D,legal-issues-defendant,100,22,11/12/2018
69FDFC,product-release,100,64,11/12/2018
6BDA0C,acquisition-acquirer,100,49,11/12/2018
6D2BF6,earnings,100,50,11/12/2018
701531,regulatory-product-approval-granted,100,81,11/12/2018
75F982,partnership,100,61,11/12/2018
762A3E,executive-appointment,100,54,11/12/2018
803FED,conference-participant,100,50,11/12/2018
84920B,earnings,100,50,11/12/2018
86A1B9,executive-appointment,100,54,11/12/2018
877C0C,business-contract,100,69,11/12/2018
877C0C,business-contract,100,69,11/12/2018
87B81A,executive-resignation,100,44,11/12/2018
8A8E41,conference-participant,100,50,11/12/2018
8BAA15,award,100,58,11/12/2018
8D0EEA,executive-appointment,100,54,11/12/2018
8D4486,partnership,100,61,11/12/2018
9196A2,conference-organizer,100,57,11/12/2018
9196A2,conference-organizer,100,57,11/12/2018
9196A2,conference-organizer,100,57,11/12/2018
91C82E,partnership,100,61,11/12/2018
92D757,executive-appointment,100,54,11/12/2018
944B2E,note-sale,100,52,11/12/2018
96BFF4,business-contract,100,69,11/12/2018
972356,product-release,100,64,11/12/2018
990AD0,conference-organizer,100,57,11/12/2018
990AD0,conference-organizer,100,57,11/12/2018
994468,dividend,100,50,11/12/2018
A4BCDE,partnership,100,61,11/12/2018
A6828A,conference-participant,100,50,11/12/2018
AA98ED,legal-issues-defendant,100,22,11/12/2018
ABBAD1,acquisition-acquirer,100,49,11/12/2018
AD3C93,product-release,100,64,11/12/2018
AD6141,earnings,100,50,11/12/2018
AD6141,buybacks,100,74,11/12/2018
AD6141,dividend,100,50,11/12/2018
AD9F1D,facility-open,100,65,11/12/2018
AE7D16,legal-issues-defendant,100,22,11/12/2018
AE7D16,legal-issues-defendant,100,22,11/12/2018
B0FE08,earnings-up,100,68,11/12/2018
B0FE08,earnings-up,100,68,11/12/2018
B0FE08,earnings-up,100,68,11/12/2018
B0FE08,earnings-up,100,68,11/12/2018
B1B10C,executive-appointment,100,54,11/12/2018
B642E8,product-release,100,64,11/12/2018
B7202A,conference-participant,100,50,11/12/2018
B98EFA,conference-participant,100,50,11/12/2018
BDCC11,earnings,100,50,11/12/2018
BFD0A7,conference-participant,100,50,11/12/2018
C11C46,earnings,100,50,11/12/2018
C188F8,business-contract,100,69,11/12/2018
C188F8,business-contract,100,69,11/12/2018
C83B88,conference-organizer,100,57,11/12/2018
C99CC8,partnership,100,61,11/12/2018
C9E4EC,earnings,100,50,11/12/2018
CD4DA8,conference-organizer,100,57,11/12/2018
CDAB24,conference-participant,100,50,11/12/2018
CDFCC9,legal-issues-defendant,100,22,11/12/2018
CFF97C,credit-rating-upgrade-rater,20,50,11/12/2018
CFF97C,credit-rating-upgrade-rater,20,50,11/12/2018
D8ECA1,dividend,100,50,11/12/2018
E261E9,earnings,100,50,11/12/2018
E2CB7B,conference-participant,100,50,11/12/2018
E49AA3,business-contract,100,69,11/12/2018
E5752F,unit-acquisition-acquiree,100,76,11/12/2018
E5752F,acquisition-acquiree,100,76,11/12/2018
E6BC2C,conference-call,100,50,11/12/2018
E74B55,executive-appointment,100,54,11/12/2018
EAA0A7,conference-participant,100,50,11/12/2018
EAEBF3,conference-participant,100,50,11/12/2018
F0027C,clinical-trials-positive,100,87,11/12/2018
F179ED,conference-participant,100,50,11/12/2018
F18844,executive-appointment,100,54,11/12/2018
F4D241,conference-participant,100,50,11/12/2018
F6E248,conference-participant,100,50,11/12/2018
F6FA6A,executive-appointment,100,54,11/12/2018
F72E4B,earnings,100,50,11/12/2018
F72E4B,earnings,100,50,11/12/2018
F7ADEB,earnings,100,50,11/12/2018
F7ADEB,earnings,100,50,11/12/2018
F7ADEB,earnings,100,50,11/12/2018
F7ADEB,earnings,100,50,11/12/2018
FAB97A,conference-participant,100,50,11/12/2018
FACF19,conference-participant,100,50,11/12/2018
FAE021,award,100,58,11/12/2018
FC1A6E,legal-issues-defendant,100,22,11/12/2018
FD0CA4,acquisition-acquirer,100,49,11/12/2018
FDF28E,conference-participant,100,50,11/12/2018
FEC475,dividend,100,50,11/12/2018
FF5413,dividend,100,50,11/12/2018
FFCD0E,earnings-guidance,100,50,11/12/2018
0157B1,business-contract,100,69,11/13/2018
0157B1,facility-open,100,65,11/13/2018
0157B1,facility-open,100,65,11/13/2018
20751,earnings,100,50,11/13/2018
03B8CF,dividend,100,50,11/13/2018
03D5F9,legal-issues-defendant,100,22,11/13/2018
03D5F9,note-sale,100,52,11/13/2018
03FB17,dividend,100,50,11/13/2018
68396,public-offering,100,43,11/13/2018
06EF42,unit-acquisition-acquirer,100,49,11/13/2018
0A1D77,executive-appointment,100,54,11/13/2018
0A77DB,partnership,100,61,11/13/2018
0B13E8,earnings,100,50,11/13/2018
0B400D,unit-acquisition-acquirer,100,49,11/13/2018
0B57D7,dividend,100,50,11/13/2018
0EF1AF,conference-call,100,50,11/13/2018
10C19B,legal-issues-defendant,100,22,11/13/2018
1151F4,public-offering,100,43,11/13/2018
1279ED,executive-appointment,100,54,11/13/2018
12A3A3,dividend,100,50,11/13/2018
139303,conference-organizer,100,57,11/13/2018
139303,conference-organizer,100,57,11/13/2018
139303,conference-organizer,100,57,11/13/2018
14391F,public-offering,100,43,11/13/2018
1490F3,dividend,100,50,11/13/2018
152E1D,legal-issues-defendant,100,22,11/13/2018
152FA5,clinical-trials-filed,100,60,11/13/2018
15901B,executive-appointment,100,54,11/13/2018
17EDA5,partnership,100,61,11/13/2018
1921DD,business-contract,100,69,11/13/2018
1B4F31,business-contract,100,69,11/13/2018
1CB9D3,executive-appointment,100,54,11/13/2018
1DDEDA,legal-issues-defendant,100,22,11/13/2018
1DEBBE,executive-appointment,100,54,11/13/2018
1E1125,conference-organizer,100,57,11/13/2018
1FAF22,dividend,100,50,11/13/2018
1FC422,earnings,100,50,11/13/2018
21D903,executive-resignation,100,44,11/13/2018
221AD7,legal-issues-defendant,100,22,11/13/2018
228D42,partnership,100,61,11/13/2018
228D42,partnership,100,61,11/13/2018
2920D5,unit-acquisition-acquiree,100,76,11/13/2018
2D76CE,earnings,100,50,11/13/2018
2D76CE,earnings,100,50,11/13/2018
2D76CE,earnings,100,50,11/13/2018
2DC88B,legal-issues-defendant,100,22,11/13/2018
2EB04E,partnership,100,61,11/13/2018
2F1299,earnings,100,50,11/13/2018
2F1299,earnings,100,50,11/13/2018
2F1299,earnings,100,50,11/13/2018
2F1299,earnings,100,50,11/13/2018
2F1299,earnings,100,50,11/13/2018
2F1299,earnings,100,50,11/13/2018
2F1299,earnings,100,50,11/13/2018
2F7474,dividend,100,50,11/13/2018
33AD83,partnership,100,61,11/13/2018
341759,earnings,100,50,11/13/2018
35F4B5,product-release,100,64,11/13/2018
36C09B,clinical-trials,100,56,11/13/2018
3A3447,facility-open,100,65,11/13/2018
3B318A,conference-call,100,50,11/13/2018
3B50FE,conference-call,100,50,11/13/2018
3D7971,dividend,100,50,11/13/2018
3E70FC,earnings,100,50,11/13/2018
4.00E+163,legal-issues-defendant,100,22,11/13/2018
4.00E+163,legal-issues-defendant,100,22,11/13/2018
416C55,partnership,100,61,11/13/2018
420168,note-sale,100,52,11/13/2018
42EFC7,earnings,100,50,11/13/2018
4398A2,earnings,100,50,11/13/2018
444CC8,partnership,100,61,11/13/2018
44A4FC,facility-open,100,65,11/13/2018
4.60E+06,conference-participant,100,50,11/13/2018
49BBBC,product-release,100,64,11/13/2018
4A6F00,partnership,100,61,11/13/2018
4A7C1F,earnings,100,50,11/13/2018
4A7C1F,earnings,100,50,11/13/2018
4A7C1F,earnings,100,50,11/13/2018
4AC91D,dividend,100,50,11/13/2018
4AE584,partnership,100,61,11/13/2018
4C6C63,conference-participant,100,50,11/13/2018
4FB770,dividend,100,50,11/13/2018
539F49,conference-participant,100,50,11/13/2018
543900,legal-issues-defendant,100,22,11/13/2018
54DF47,earnings-guidance-up,100,83,11/13/2018
55438C,partnership,100,61,11/13/2018
587EDF,earnings,100,50,11/13/2018
5D02B7,dividend,100,50,11/13/2018
5D41E4,earnings,100,50,11/13/2018
5F1B7B,earnings,100,50,11/13/2018
619882,facility-open,100,65,11/13/2018
61B81B,acquisition-acquiree,100,76,11/13/2018
6.52E+64,legal-issues-defendant,100,22,11/13/2018
665440,earnings,100,50,11/13/2018
665440,earnings,100,50,11/13/2018
665440,earnings,100,50,11/13/2018
665D7D,conference-participant,100,50,11/13/2018
673C9A,earnings,100,50,11/13/2018
6810DE,executive-appointment,100,54,11/13/2018
69494C,conference-call,100,50,11/13/2018
69E8E1,executive-appointment,100,54,11/13/2018
69E8E1,executive-appointment,100,54,11/13/2018
69E8E1,executive-appointment,100,54,11/13/2018
6C6D73,product-release,100,64,11/13/2018
6E1E61,buybacks,100,74,11/13/2018
6ED519,legal-issues-defendant,100,22,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
713810,product-release,100,64,11/13/2018
713810,partnership,100,61,11/13/2018
713810,partnership,100,61,11/13/2018
71694D,business-contract,100,69,11/13/2018
71B0CF,partnership,100,61,11/13/2018
71B0CF,earnings,100,50,11/13/2018
747219,conference-participant,100,50,11/13/2018
7.49E+07,acquisition-acquiree,100,76,11/13/2018
766047,partnership,100,61,11/13/2018
76D79A,reverse-stock-splits,100,51,11/13/2018
76DD0C,earnings,100,50,11/13/2018
76E80F,conference-call,100,50,11/13/2018
7823A3,partnership,100,61,11/13/2018
7823A3,product-release,100,64,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7AB859,partnership,100,61,11/13/2018
7B1E50,product-release,100,64,11/13/2018
7BAAE7,executive-appointment,100,54,11/13/2018
7BC92D,earnings,100,50,11/13/2018
7E2DE6,buybacks,100,74,11/13/2018
82E58A,dividend,100,50,11/13/2018
85DA04,product-release,100,64,11/13/2018
86A1B9,donation,100,54,11/13/2018
86BAC7,executive-appointment,100,54,11/13/2018
8AB85C,earnings,100,50,11/13/2018
8D4486,partnership,100,61,11/13/2018
8E4F9A,conference-participant,100,50,11/13/2018
8EDACA,conference-call,100,50,11/13/2018
9043FE,spin-off,100,58,11/13/2018
9043FE,spin-off,100,58,11/13/2018
9196A2,conference-organizer,100,57,11/13/2018
925759,conference-participant,100,50,11/13/2018
9.39E+69,earnings,100,50,11/13/2018
93F143,dividend,100,50,11/13/2018
940C3D,business-contract,100,69,11/13/2018
940C3D,public-offering,100,43,11/13/2018
947B0B,executive-appointment,100,54,11/13/2018
95C575,dividend,100,50,11/13/2018
95DC1F,partnership,100,61,11/13/2018
968B00,dividend,100,50,11/13/2018
97AAF6,public-offering,100,43,11/13/2018
990AD0,conference-organizer,100,57,11/13/2018
9A2760,earnings,100,50,11/13/2018
9AF3DC,conference-organizer,100,57,11/13/2018
9B5968,partnership,100,61,11/13/2018
9BB35A,public-offering,100,43,11/13/2018
9C5BA5,conference-participant,100,50,11/13/2018
9D5FA4,government-contract,100,69,11/13/2018
9F62D1,dividend,100,50,11/13/2018
A017F4,earnings,100,50,11/13/2018
A47A7D,product-release,100,64,11/13/2018
A47A7D,product-release,100,64,11/13/2018
A48593,earnings-up,100,68,11/13/2018
A48593,earnings,100,50,11/13/2018
A48593,earnings,100,50,11/13/2018
A6213D,earnings,100,50,11/13/2018
A746F6,buybacks,100,74,11/13/2018
A79F7D,earnings,100,50,11/13/2018
AA98ED,partnership,100,61,11/13/2018
AC7C4F,executive-appointment,100,54,11/13/2018
ACDF88,earnings,100,50,11/13/2018
ACDF88,earnings,100,50,11/13/2018
ACDF88,earnings,100,50,11/13/2018
ACDF88,earnings,100,50,11/13/2018
AD22F2,conference-call,100,50,11/13/2018
AD6141,public-offering,100,43,11/13/2018
AE7D16,legal-issues-defendant,100,22,11/13/2018
AEEB76,conference-participant,100,50,11/13/2018
B04426,earnings,100,50,11/13/2018
B05000,earnings-up,100,68,11/13/2018
B05000,earnings,100,50,11/13/2018
B08C51,earnings,100,50,11/13/2018
B290A2,earnings,100,50,11/13/2018
B5734D,executive-appointment,100,54,11/13/2018
B73395,conference-participant,100,50,11/13/2018
BA218A,index-listing,100,76,11/13/2018
BE645B,earnings,100,50,11/13/2018
C2E39B,earnings,100,50,11/13/2018
C2E39B,earnings,100,50,11/13/2018
C2E39B,earnings,100,50,11/13/2018
C2E39B,earnings,100,50,11/13/2018
C3BAE7,conference-participant,100,50,11/13/2018
C8A248,note-sale,100,52,11/13/2018
C8A248,public-offering,100,43,11/13/2018
C8A248,award,100,58,11/13/2018
C93C44,earnings,100,50,11/13/2018
CA1620,conference-participant,100,50,11/13/2018
CA212F,business-contract,100,69,11/13/2018
CC3EC4,earnings,100,50,11/13/2018
CD4DA8,conference-organizer,100,57,11/13/2018
CDAA0E,earnings,100,50,11/13/2018
CDC817,earnings,100,50,11/13/2018
CDFCC9,legal-issues-defendant,100,22,11/13/2018
CE5C6E,clinical-trials,100,56,11/13/2018
CE8A7B,earnings,100,50,11/13/2018
CF3FF9,clinical-trials-positive,100,87,11/13/2018
CFE5BE,acquisition-acquirer,100,49,11/13/2018
D17C1B,revenue-volume,100,50,11/13/2018
D17C1B,executive-appointment,100,54,11/13/2018
D5B13D,earnings,100,50,11/13/2018
D6144F,product-release,100,64,11/13/2018
D64C6D,executive-appointment,100,54,11/13/2018
D70365,earnings,100,50,11/13/2018
D75910,conference-call,100,50,11/13/2018
D77F7E,product-release,100,64,11/13/2018
D77F7E,product-release,100,64,11/13/2018
D854DD,earnings,100,50,11/13/2018
D9FC89,conference-call,100,50,11/13/2018
DA91AE,dividend,100,50,11/13/2018
DBB28E,partnership,100,61,11/13/2018
DBCA3F,buybacks,100,74,11/13/2018
DC0066,earnings,100,50,11/13/2018
DC6EF3,earnings,100,50,11/13/2018
DD1BA1,partnership,100,61,11/13/2018
DF18E6,conference-participant,100,50,11/13/2018
E13782,earnings,100,50,11/13/2018
E21871,note-sale,100,52,11/13/2018
E22FDE,earnings,100,50,11/13/2018
E30B34,dividend,100,50,11/13/2018
E30B34,dividend,100,50,11/13/2018
E68733,regulatory-product-approval-granted,100,81,11/13/2018
E6BC2C,executive-appointment,100,54,11/13/2018
E829E8,dividend,100,50,11/13/2018
E8846E,product-release,100,64,11/13/2018
ECF709,earnings,100,50,11/13/2018
F05B1B,earnings,100,50,11/13/2018
F05B1B,earnings,100,50,11/13/2018
F05B1B,earnings,100,50,11/13/2018
F39E1E,earnings,100,50,11/13/2018
F3D2EB,buybacks,100,74,11/13/2018
F6A392,earnings,100,50,11/13/2018
F6A987,dividend,100,50,11/13/2018
F6DE54,dividend,100,50,11/13/2018
F9AA02,clinical-trials,100,56,11/13/2018
FA35C6,award,100,58,11/13/2018
FC9A88,executive-appointment,100,54,11/13/2018
FD9526,dividend,100,50,11/13/2018
FDF799,public-offering,100,43,11/13/2018
FF227B,earnings,100,50,11/13/2018
00067A,partnership,100,61,11/14/2018
00326E,earnings,100,50,11/14/2018
0157B1,business-contract,100,69,11/14/2018
03D5F9,legal-issues-defendant,100,22,11/14/2018
03D5F9,legal-issues-defendant,100,22,11/14/2018
03D5F9,legal-issues-defendant,100,22,11/14/2018
03D5F9,legal-issues-defendant,100,22,11/14/2018
048B70,executive-appointment,100,54,11/14/2018
048B70,executive-appointment,100,54,11/14/2018
048B70,executive-appointment,100,54,11/14/2018
55018,partnership,100,61,11/14/2018
55018,partnership,100,61,11/14/2018
55018,partnership,100,61,11/14/2018
68396,public-offering,100,43,11/14/2018
0A77DB,earnings,100,50,11/14/2018
0A77DB,executive-resignation,100,44,11/14/2018
0B13E8,public-offering,100,43,11/14/2018
0BD970,earnings,100,50,11/14/2018
0EF1AF,earnings,100,50,11/14/2018
0F65C9,public-offering,100,43,11/14/2018
0F65C9,public-offering,100,43,11/14/2018
106394,unit-acquisition-acquirer,100,49,11/14/2018
106394,public-offering,100,43,11/14/2018
1065BC,dividend,100,50,11/14/2018
12DE76,earnings,100,50,11/14/2018
12DE76,earnings,100,50,11/14/2018
12DE76,earnings,100,50,11/14/2018
12DE76,earnings,100,50,11/14/2018
139303,conference-organizer,100,57,11/14/2018
139303,conference-organizer,100,57,11/14/2018
139303,conference-organizer,100,57,11/14/2018
139303,conference-organizer,100,57,11/14/2018
13A782,conference-participant,100,50,11/14/2018
13D576,acquisition-acquirer,100,49,11/14/2018
1490F3,facility-open,100,65,11/14/2018
1490F3,facility-open,100,65,11/14/2018
152E1D,legal-issues-defendant,100,22,11/14/2018
152E1D,legal-issues-defendant,100,22,11/14/2018
152E1D,legal-issues-defendant,100,22,11/14/2018
152FA5,earnings,100,50,11/14/2018
15B10D,earnings-guidance,100,50,11/14/2018
19BF16,conference-participant,100,50,11/14/2018
1E1125,conference-organizer,100,57,11/14/2018
1FAF22,product-release,100,64,11/14/2018
202E5A,clinical-trials-start,100,64,11/14/2018
2093B1,dividend,100,50,11/14/2018
21022F,dividend,100,50,11/14/2018
21153F,product-release,100,64,11/14/2018
222BF9,public-offering,100,43,11/14/2018
228D42,partnership,100,61,11/14/2018
263216,dividend-up,100,81,11/14/2018
26DC29,conference-call,100,50,11/14/2018
26E3BA,earnings,100,50,11/14/2018
2720AB,acquisition-completed-acquirer,100,49,11/14/2018
297DA8,revenue-guidance,100,50,11/14/2018
297DA8,revenue-guidance,100,50,11/14/2018
2B49F4,conference-call,100,50,11/14/2018
2EB88B,unit-acquisition-acquirer,100,49,11/14/2018
2FEA66,dividend,100,50,11/14/2018
306623,dividend,100,50,11/14/2018
34B411,acquisition-acquirer,100,49,11/14/2018
3.50E+27,dividend-up,100,57,11/14/2018
3.50E+27,executive-appointment,100,54,11/14/2018
385DD4,executive-appointment,100,54,11/14/2018
3A1C46,ipo-pricing,100,50,11/14/2018
3A3447,facility-open,100,65,11/14/2018
3B37F7,acquisition-completed-acquirer,100,49,11/14/2018
3C8A04,dividend,100,50,11/14/2018
3D9999,legal-issues-defendant,100,22,11/14/2018
4.03E+05,regulatory-product-approval-granted,100,81,11/14/2018
422A82,earnings,100,50,11/14/2018
422CE3,partnership,100,61,11/14/2018
422CE3,dividend,100,50,11/14/2018
434F38,acquisition-completed-acquirer,100,49,11/14/2018
449447,revenue-up,100,85,11/14/2018
45ABCC,partnership,100,61,11/14/2018
46017C,conference-participant,100,50,11/14/2018
47FCF2,business-contract,100,69,11/14/2018
4A7C1F,earnings,100,50,11/14/2018
4C350A,conference-call,100,50,11/14/2018
4ECD1A,earnings,100,50,11/14/2018
50070E,conference-organizer,100,57,11/14/2018
51F541,dividend,100,50,11/14/2018
53E575,conference-participant,100,50,11/14/2018
53EF9E,dividend,100,50,11/14/2018
5403F8,executive-appointment,100,54,11/14/2018
55438C,legal-issues-defendant,100,22,11/14/2018
586FFD,dividend-up,100,81,11/14/2018
587EDF,earnings,100,50,11/14/2018
5D0337,donation,100,54,11/14/2018
62A48D,earnings,100,50,11/14/2018
649CBD,executive-appointment,100,54,11/14/2018
65CF8E,dividend,100,50,11/14/2018
69C99E,patient-enrollment-complete,100,64,11/14/2018
6D0CAB,business-contract,100,69,11/14/2018
6F3936,conference-call,100,50,11/14/2018
70CA28,executive-appointment,100,54,11/14/2018
719477,dividend,100,50,11/14/2018
719B43,fundraising,100,64,11/14/2018
7239BB,conference-call,100,50,11/14/2018
728737,public-offering,100,43,11/14/2018
7410C3,executive-appointment,100,54,11/14/2018
7448A3,dividend,100,50,11/14/2018
7.49E+07,earnings,100,50,11/14/2018
7CD98F,dividend,100,50,11/14/2018
7FEEE1,earnings,100,50,11/14/2018
838ADD,partnership,100,61,11/14/2018
83E0AC,dividend,100,50,11/14/2018
85DA04,partnership,100,61,11/14/2018
88D80A,earnings,100,50,11/14/2018
8D4486,award,100,58,11/14/2018
8FF2EF,earnings,100,50,11/14/2018
92D757,dividend,100,50,11/14/2018
934029,clinical-trials-start,100,64,11/14/2018
934CC3,earnings,100,50,11/14/2018
93F143,trading-listing,100,61,11/14/2018
940C3D,public-offering,100,43,11/14/2018
940C3D,ownership-decrease-owner,100,46,11/14/2018
94563D,conference-participant,100,50,11/14/2018
96B4FF,earnings,100,50,11/14/2018
96B4FF,earnings,100,50,11/14/2018
972356,product-release,100,64,11/14/2018
9.92E+94,executive-appointment,100,54,11/14/2018
99ACAD,product-release,100,64,11/14/2018
9AF3DC,product-release,100,64,11/14/2018
9C009A,donation,100,54,11/14/2018
9F5997,business-contract,100,69,11/14/2018
9FA83B,buybacks,100,74,11/14/2018
A2A9BA,earnings,100,50,11/14/2018
A5628C,executive-appointment,100,54,11/14/2018
A5A4F5,award,100,58,11/14/2018
A5A4F5,award,100,58,11/14/2018
A63387,executive-appointment,100,54,11/14/2018
A790A5,conference-call,100,50,11/14/2018
A806FA,award,100,58,11/14/2018
A871B0,conference-participant,100,50,11/14/2018
ADFB3A,conference-participant,100,50,11/14/2018
AE7D16,legal-issues-defendant,100,22,11/14/2018
AE7D16,legal-issues-defendant,100,22,11/14/2018
AE7D16,legal-issues-defendant,100,22,11/14/2018
AE7D16,legal-issues-defendant,100,22,11/14/2018
B446B8,award,100,58,11/14/2018
B8EF97,legal-issues-defendant,100,22,11/14/2018
B8EF97,legal-issues-defendant,100,22,11/14/2018
BD682F,dividend,100,50,11/14/2018
BDA775,note-sale,100,52,11/14/2018
BFE02C,partnership,100,61,11/14/2018
C2F597,debt-restructuring,100,59,11/14/2018
C4452A,partnership,100,61,11/14/2018
C5C137,partnership,100,61,11/14/2018
C5C137,earnings,100,50,11/14/2018
C5C137,earnings,100,50,11/14/2018
C5C137,earnings,100,50,11/14/2018
C5C137,earnings,100,50,11/14/2018
C83B88,partnership,100,61,11/14/2018
C8A248,note-sale,100,52,11/14/2018
C8A248,note-sale,100,52,11/14/2018
CD051C,conference-participant,100,50,11/14/2018
CD4DA8,conference-organizer,100,57,11/14/2018
CD4DA8,executive-appointment,100,54,11/14/2018
CDAF5B,dividend,100,50,11/14/2018
CDC217,earnings,100,50,11/14/2018
CE5664,product-release,100,64,11/14/2018
D0DE27,dividend,100,50,11/14/2018
D17C1B,product-release,100,64,11/14/2018
D1C26F,earnings-up,100,68,11/14/2018
D54E62,business-contract,100,69,11/14/2018
D64C6D,facility-open,100,65,11/14/2018
D64C6D,facility-open,100,65,11/14/2018
D721C6,dividend,100,50,11/14/2018
D8DBA3,dividend-up,100,81,11/14/2018
D90F43,partnership,100,61,11/14/2018
D9E036,legal-issues-defendant,100,22,11/14/2018
DC1405,conference-participant,100,50,11/14/2018
DE4924,dividend,100,50,11/14/2018
DE4924,earnings,100,50,11/14/2018
E1C16B,conference-participant,100,50,11/14/2018
E35610,note-sale,100,52,11/14/2018
E4CE73,conference-participant,100,50,11/14/2018
E69BA5,dividend,100,50,11/14/2018
E6BC2C,earnings,100,50,11/14/2018
E866D2,dividend,100,50,11/14/2018
E8846E,conference-organizer,100,57,11/14/2018
ED79D9,dividend-up,100,81,11/14/2018
ED79D9,acquisition-completed-acquirer,100,49,11/14/2018
ED7F13,public-offering,100,43,11/14/2018
EDD234,earnings,100,50,11/14/2018
EF45B6,earnings,100,50,11/14/2018
EF77A3,legal-issues-defendant,100,22,11/14/2018
F0B2B5,acquisition-completed-acquirer,100,49,11/14/2018
F0B2B5,acquisition-completed-acquirer,100,49,11/14/2018
F0B2B5,acquisition-completed-acquirer,100,49,11/14/2018
F30508,regulatory-product-application,100,69,11/14/2018
F30508,regulatory-product-application,100,69,11/14/2018
F4E992,earnings,100,50,11/14/2018
F7935D,earnings,100,50,11/14/2018
F82D37,executive-resignation,100,44,11/14/2018
F88147,earnings,100,50,11/14/2018
FC1B7B,dividend,100,50,11/14/2018
FC4550,dividend,100,50,11/14/2018
FCA54E,earnings,100,50,11/14/2018
FDF1C0,dividend,100,50,11/14/2018
FDF799,public-offering,100,43,11/14/2018
00D6B5,dividend,100,50,11/15/2018
13528,dividend,100,50,11/15/2018
0157B1,product-release,100,64,11/15/2018
0157B1,product-release,100,64,11/15/2018
02ACBD,earnings,100,50,11/15/2018
0358AF,acquisition-completed-acquirer,100,49,11/15/2018
036C6F,dividend,100,50,11/15/2018
03CF95,acquisition-completed-acquirer,100,49,11/15/2018
03D5F9,legal-issues-defendant,100,22,11/15/2018
71860,conference-participant,100,50,11/15/2018
0968A5,conference-call,100,50,11/15/2018
0C8D82,acquisition-completed-acquirer,100,49,11/15/2018
0FDE97,executive-appointment,100,54,11/15/2018
106394,public-offering,100,43,11/15/2018
135B09,dividend-up,100,81,11/15/2018
135B09,executive-appointment,100,54,11/15/2018
139303,conference-organizer,100,57,11/15/2018
139303,conference-organizer,100,57,11/15/2018
139303,conference-organizer,100,57,11/15/2018
14833D,legal-issues-defendant,100,22,11/15/2018
14BA33,conference-participant,100,50,11/15/2018
15901B,executive-appointment,100,54,11/15/2018
17EDA5,executive-appointment,100,54,11/15/2018
17EDA5,buybacks,100,74,11/15/2018
190B91,award,100,58,11/15/2018
1DE526,earnings,100,50,11/15/2018
1DEBBE,executive-appointment,100,54,11/15/2018
1E1125,conference-organizer,100,57,11/15/2018
1E1125,conference-organizer,100,57,11/15/2018
227F04,conference-participant,100,50,11/15/2018
228D42,product-release,100,64,11/15/2018
228D42,partnership,100,61,11/15/2018
228D42,partnership,100,61,11/15/2018
24CB56,dividend,100,50,11/15/2018
251988,partnership,100,61,11/15/2018
25529C,buybacks,100,74,11/15/2018
284289,dividend,100,50,11/15/2018
2.89E+11,dividend,100,50,11/15/2018
2B9DBB,dividend,100,50,11/15/2018
2F5256,dividend,100,50,11/15/2018
306623,unit-acquisition-completed-acquiree,100,67,11/15/2018
30CBF9,executive-resignation,100,44,11/15/2018
3159AA,earnings,100,50,11/15/2018
339F20,dividend-up,100,81,11/15/2018
36C09B,legal-issues-defendant,100,22,11/15/2018
384CD3,dividend,100,50,11/15/2018
3A3447,facility-open,100,65,11/15/2018
3BA1BF,executive-appointment,100,54,11/15/2018
3BC360,executive-appointment,100,54,11/15/2018
3DE4D1,dividend,100,50,11/15/2018
414FFF,conference-call,100,50,11/15/2018
422CE3,earnings,100,50,11/15/2018
422CE3,earnings,100,50,11/15/2018
422CE3,earnings,100,50,11/15/2018
422CE3,earnings,100,50,11/15/2018
422CE3,earnings,100,50,11/15/2018
42978B,conference-call,100,50,11/15/2018
4A7C1F,executive-appointment,100,54,11/15/2018
4A7C1F,executive-appointment,100,54,11/15/2018
4BD6DB,acquisition-completed-acquirer,100,49,11/15/2018
4C92B9,legal-issues-defendant,100,22,11/15/2018
4ECD1A,dividend,100,50,11/15/2018
50070E,legal-issues-defendant,100,22,11/15/2018
539F49,partnership,100,61,11/15/2018
5EAA43,dividend,100,50,11/15/2018
619882,dividend,100,50,11/15/2018
6.52E+64,legal-issues-defendant,100,22,11/15/2018
6634D9,note-sale,100,52,11/15/2018
67303E,conference-participant,100,50,11/15/2018
6830FE,earnings,100,50,11/15/2018
69494C,earnings,100,50,11/15/2018
6B236C,executive-appointment,100,54,11/15/2018
6E8349,dividend,100,50,11/15/2018
6FCEF9,earnings,100,50,11/15/2018
728737,public-offering,100,43,11/15/2018
72DF04,facility-open,100,65,11/15/2018
73F70F,dividend,100,50,11/15/2018
790C34,buybacks,100,74,11/15/2018
791EC1,unit-acquisition-acquirer,100,49,11/15/2018
7A0EC4,earnings,100,50,11/15/2018
7AF907,earnings,100,50,11/15/2018
7AF907,earnings-negative,100,33,11/15/2018
7B0BA6,executive-appointment,100,54,11/15/2018
7B8CB5,dividend,100,50,11/15/2018
7C4F43,clinical-trials,100,56,11/15/2018
8.10E+32,dividend,100,50,11/15/2018
817ED9,dividend,100,50,11/15/2018
8.10E+205,earnings-guidance,100,50,11/15/2018
8377DB,partnership,100,61,11/15/2018
859D62,dividend-up,100,55,11/15/2018
8A8E41,donation,100,54,11/15/2018
8A8E41,product-release,100,64,11/15/2018
8A8E41,partnership,100,61,11/15/2018
8B4A45,facility-open,100,65,11/15/2018
8BE916,dividend,100,50,11/15/2018
8EDACA,legal-issues-defendant,100,22,11/15/2018
8EEA28,earnings,100,50,11/15/2018
8F6995,earnings-up,100,68,11/15/2018
8FE7A5,conference-participant,100,50,11/15/2018
905356,earnings-per-share-positive,100,69,11/15/2018
905356,earnings,100,50,11/15/2018
905356,earnings,100,50,11/15/2018
913437,earnings,100,50,11/15/2018
954A47,dividend,100,50,11/15/2018
97AAF6,public-offering,100,43,11/15/2018
9.97E+09,dividend,100,50,11/15/2018
9B4066,unit-acquisition-acquirer,100,49,11/15/2018
9C25FF,business-contract,100,69,11/15/2018
9D2790,dividend,100,50,11/15/2018
9E298A,dividend-up,100,81,11/15/2018
9E298A,earnings,100,50,11/15/2018
A403CF,executive-appointment,100,54,11/15/2018
A4BCDE,earnings,100,50,11/15/2018
A52B6B,conference-participant,100,50,11/15/2018
A60354,dividend,100,50,11/15/2018
A631A3,earnings,100,50,11/15/2018
A63387,earnings,100,50,11/15/2018
A75D43,earnings,100,50,11/15/2018
ACDF88,dividend,100,50,11/15/2018
ADD9DC,facility-open,100,65,11/15/2018
AE7D16,legal-issues-defendant,100,22,11/15/2018
AE7D16,legal-issues-defendant,100,22,11/15/2018
AE7D16,legal-issues-defendant,100,22,11/15/2018
AECCA9,conference-call,100,50,11/15/2018
AED61E,partnership,100,61,11/15/2018
B1A85D,donation,100,54,11/15/2018
B1DF3C,partnership,100,61,11/15/2018
B76C82,earnings,100,50,11/15/2018
B934BF,dividend-up,100,81,11/15/2018
BB127B,award,100,58,11/15/2018
BB127B,partnership,100,61,11/15/2018
BCC55F,award,100,58,11/15/2018
BDA775,public-offering,100,43,11/15/2018
C062D4,conference-participant,100,50,11/15/2018
C27E19,dividend-up,100,81,11/15/2018
C48574,earnings,100,50,11/15/2018
C83B88,business-contract,100,69,11/15/2018
C8A248,dividend,100,50,11/15/2018
C9F39B,executive-appointment,100,54,11/15/2018
CA3CB9,earnings,100,50,11/15/2018
CAC8D0,donation,100,54,11/15/2018
CD051C,conference-participant,100,50,11/15/2018
CD4DA8,conference-organizer,100,57,11/15/2018
CD4DA8,conference-organizer,100,57,11/15/2018
CEC5B9,earnings,100,50,11/15/2018
CEC5B9,earnings,100,50,11/15/2018
CEC5B9,earnings,100,50,11/15/2018
D03C7A,dividend,100,50,11/15/2018
D57D99,executive-appointment,100,54,11/15/2018
D60BB2,dividend,100,50,11/15/2018
D64C6D,dividend-up,100,60,11/15/2018
D6534D,dividend,100,50,11/15/2018
D6853F,award,100,58,11/15/2018
D78BF1,dividend,100,50,11/15/2018
D8F347,dividend,100,50,11/15/2018
D9E036,legal-issues-defendant,100,22,11/15/2018
DAFED3,dividend,100,50,11/15/2018
DF204B,product-release,100,64,11/15/2018
DF204B,dividend,100,50,11/15/2018
E05026,merger-regulatory-approval,100,81,11/15/2018
E09997,unit-acquisition-acquirer,100,49,11/15/2018
E09E2B,earnings,100,50,11/15/2018
E09E2B,earnings,100,50,11/15/2018
E09E2B,earnings,100,50,11/15/2018
E16133,public-offering,100,43,11/15/2018
E49AA3,dividend-up,100,60,11/15/2018
E6A53A,business-contract,100,69,11/15/2018
E6A53A,business-contract,100,69,11/15/2018
E6A53A,dividend,100,50,11/15/2018
E6BC2C,public-offering,100,43,11/15/2018
EC4E82,acquisition-completed-acquirer,100,49,11/15/2018
EF5BED,partnership,100,61,11/15/2018
EF5BED,executive-appointment,100,54,11/15/2018
F1EB39,earnings-guidance,100,50,11/15/2018
F509E2,conference-call,100,50,11/15/2018
F6581D,public-offering,100,43,11/15/2018
F6FA6A,acquisition-acquirer,100,49,11/15/2018
F748C7,partnership,100,61,11/15/2018
F90EE5,dividend,100,50,11/15/2018
F93C8A,dividend,100,50,11/15/2018
FC01C0,acquisition-completed-acquirer,100,49,11/15/2018
FDD3FC,patient-enrollment-complete,100,64,11/15/2018
FF4343,dividend,100,50,11/15/2018
FF6644,legal-issues-defendant,100,22,11/15/2018
13528,product-recall,100,29,11/16/2018
03D5F9,legal-issues-defendant,100,22,11/16/2018
0A0D9E,conference-participant,100,50,11/16/2018
0B13E8,public-offering,100,43,11/16/2018
1065BC,partnership,100,61,11/16/2018
15789A,partnership,100,61,11/16/2018
197019,merger-regulatory-approval,100,81,11/16/2018
1CD708,buybacks,100,74,11/16/2018
1E1125,reverse-stock-splits,100,51,11/16/2018
205AD5,donation,100,54,11/16/2018
221445,dividend,100,50,11/16/2018
26DC29,product-release,100,64,11/16/2018
2D981A,conference-participant,100,50,11/16/2018
2DB344,dividend,100,50,11/16/2018
2EB04E,partnership,100,61,11/16/2018
3461CF,conference-participant,100,50,11/16/2018
382EAE,note-sale,100,52,11/16/2018
3A1C46,ipo-completed,100,76,11/16/2018
42312F,earnings,100,50,11/16/2018
449217,merger-completed,100,66,11/16/2018
450ECB,acquisition-completed-acquiree,100,76,11/16/2018
467F2C,buybacks,100,74,11/16/2018
4A5C8D,legal-issues-defendant,100,22,11/16/2018
4A5C8D,legal-issues-defendant,100,22,11/16/2018
4A5C8D,legal-issues-defendant,100,22,11/16/2018
519FE0,legal-issues-defendant,100,22,11/16/2018
51E682,dividend,100,50,11/16/2018
564F3E,dividend,100,50,11/16/2018
58CA9A,product-release,100,64,11/16/2018
5A9A82,dividend-guidance,100,50,11/16/2018
619882,business-contract,100,69,11/16/2018
662682,business-contract,100,69,11/16/2018
6634D9,note-sale,100,52,11/16/2018
665D7D,donation,100,54,11/16/2018
665D7D,donation,100,54,11/16/2018
67529E,executive-appointment,100,54,11/16/2018
6844D2,dividend,100,50,11/16/2018
766047,merger-regulatory-approval,100,81,11/16/2018
766047,merger-regulatory-approval,100,81,11/16/2018
78F9ED,dividend,100,50,11/16/2018
7A51FE,executive-appointment,100,54,11/16/2018
7BEA98,conference-participant,100,50,11/16/2018
8614A2,conference-call,100,50,11/16/2018
88611B,dividend,100,50,11/16/2018
89E771,shareholder-rights-plan,100,43,11/16/2018
8A8E41,unit-acquisition-acquirer,100,49,11/16/2018
8BFAA4,dividend,100,50,11/16/2018
8D4486,partnership,100,61,11/16/2018
8D4486,product-release,100,64,11/16/2018
91E5EE,fundraising,100,64,11/16/2018
971334,dividend,100,50,11/16/2018
97FE80,acquisition-completed-acquirer,100,49,11/16/2018
A4B899,dividend,100,50,11/16/2018
A5A4F5,acquisition-acquirer,100,49,11/16/2018
A5DD24,clinical-trials,100,56,11/16/2018
A60354,executive-resignation,100,44,11/16/2018
A8E72A,earnings,100,50,11/16/2018
A9ED24,dividend,100,50,11/16/2018
AD6141,public-offering,100,43,11/16/2018
B0FE08,dividend,100,50,11/16/2018
B4C673,dividend,100,50,11/16/2018
B762D3,dividend,100,50,11/16/2018
B8EF97,legal-issues-defendant,100,22,11/16/2018
BB88B6,partnership,100,61,11/16/2018
C598D7,acquisition-completed-acquirer,100,49,11/16/2018
C5C0E9,acquisition-completed-acquirer,100,49,11/16/2018
C5D2AE,award,100,58,11/16/2018
C99CC8,partnership,100,61,11/16/2018
CA99D7,dividend,100,50,11/16/2018
CD4DA8,conference-organizer,100,57,11/16/2018
CF6A5A,earnings,100,50,11/16/2018
D20C8F,note-sale,100,52,11/16/2018
D57D99,facility-open,100,65,11/16/2018
D76AEF,dividend,100,50,11/16/2018
DBB28E,conference-call,100,50,11/16/2018
DF6FDD,executive-appointment,100,54,11/16/2018
E0207A,acquisition-completed-acquirer,100,49,11/16/2018
E05026,merger-completed,100,66,11/16/2018
E09997,buybacks,100,74,11/16/2018
E10D31,legal-issues-defendant,100,22,11/16/2018
E1E093,partnership,100,61,11/16/2018
E259C7,business-contract,100,69,11/16/2018
E30B34,award,100,58,11/16/2018
E49AA3,legal-verdict-favored,100,78,11/16/2018
E8846E,dividend,100,50,11/16/2018
E8B315,acquisition-completed-acquirer,100,49,11/16/2018
E90C84,dividend,100,50,11/16/2018
EC4E82,acquisition-completed-acquirer,100,49,11/16/2018
EC8116,legal-issues-defendant,100,22,11/16/2018
ECF709,executive-appointment,100,54,11/16/2018
ED9576,legal-issues-defendant,100,22,11/16/2018
F6581D,public-offering,100,43,11/16/2018
FDF799,public-offering,100,43,11/16/2018
3B318A,legal-issues-defendant,100,22,11/17/2018
4C92B9,legal-issues-defendant,100,22,11/17/2018
AE7D16,legal-issues-defendant,100,22,11/17/2018
E10D31,legal-issues-defendant,100,22,11/17/2018
251988,business-contract,100,69,11/18/2018
4A6F00,legal-issues-defendant,100,22,11/18/2018
00067A,partnership,100,61,11/19/2018
00067A,donation,100,54,11/19/2018
13528,partnership,100,61,11/19/2018
03D5F9,antitrust-suit-defendant,100,21,11/19/2018
09F623,loan-recipient,100,59,11/19/2018
0C28D1,executive-appointment,100,54,11/19/2018
0CC62B,conference-participant,100,50,11/19/2018
0CE7F6,dividend,100,50,11/19/2018
106394,public-offering,100,43,11/19/2018
10C19B,legal-issues-defendant,100,22,11/19/2018
10C19B,legal-issues-defendant,100,22,11/19/2018
126F95,dividend-up,100,81,11/19/2018
12E454,business-contract,100,69,11/19/2018
12E454,business-contract,100,69,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
139303,conference-organizer,100,57,11/19/2018
14833D,legal-issues-defendant,100,22,11/19/2018
1834C0,acquisition-completed-acquirer,100,49,11/19/2018
1DEBBE,executive-appointment,100,54,11/19/2018
1E1125,conference-organizer,100,57,11/19/2018
1E1125,conference-organizer,100,57,11/19/2018
20BEEA,dividend,100,50,11/19/2018
221AD7,legal-issues-defendant,100,22,11/19/2018
25D3CE,acquisition-acquiree,100,76,11/19/2018
25D3CE,ownership-decrease-owner,100,46,11/19/2018
2C35B5,conference-participant,100,50,11/19/2018
2C7505,legal-issues-defendant,100,22,11/19/2018
2C7505,legal-issues-defendant,100,22,11/19/2018
2E2E6E,buybacks,100,74,11/19/2018
2EBC0B,dividend,100,50,11/19/2018
3.14E+47,dividend,100,50,11/19/2018
315EB0,facility-open,100,65,11/19/2018
3.20E+263,conference-participant,100,50,11/19/2018
33AD83,conference-call,100,50,11/19/2018
3461CF,award,100,58,11/19/2018
36C09B,legal-issues-defendant,100,22,11/19/2018
3A3447,dividend-up,100,81,11/19/2018
3B318A,legal-issues-defendant,100,22,11/19/2018
3B37F7,acquisition-acquirer,100,49,11/19/2018
3C11C4,earnings,100,50,11/19/2018
3C3B6B,partnership,100,61,11/19/2018
3D9999,legal-issues-defendant,100,22,11/19/2018
4.00E+163,legal-issues-defendant,100,22,11/19/2018
42AABD,stake-acquirer,100,48,11/19/2018
45ABCC,product-release,100,64,11/19/2018
48F795,legal-issues-defendant,100,22,11/19/2018
4.91E+58,executive-appointment,100,54,11/19/2018
49BBBC,earnings,100,50,11/19/2018
49F4D0,dividend,100,50,11/19/2018
4A5C8D,legal-issues-defendant,100,22,11/19/2018
4A6F00,partnership,100,61,11/19/2018
4A6F00,partnership,100,61,11/19/2018
4A6F00,legal-issues-defendant,100,22,11/19/2018
4C92B9,legal-issues-defendant,100,22,11/19/2018
4E7C1F,conference-participant,100,50,11/19/2018
4F9926,business-contract,100,69,11/19/2018
4F9926,business-contract,100,69,11/19/2018
50070E,conference-organizer,100,57,11/19/2018
51D876,executive-appointment,100,54,11/19/2018
543900,legal-issues-defendant,100,22,11/19/2018
54512F,business-contract,100,69,11/19/2018
548AC0,conference-call,100,50,11/19/2018
54F271,earnings,100,50,11/19/2018
56EFC7,earnings,100,50,11/19/2018
586FFD,unit-acquisition-acquirer,100,49,11/19/2018
589846,conference-call,100,50,11/19/2018
5D87DF,dividend,100,50,11/19/2018
5E7E82,partnership,100,61,11/19/2018
620381,executive-appointment,100,54,11/19/2018
649CBD,legal-issues-defendant,100,22,11/19/2018
665D7D,legal-issues-defendant,100,22,11/19/2018
69345C,conference-participant,100,50,11/19/2018
693ECD,clinical-trials-filed,100,60,11/19/2018
69C99E,conference-participant,100,50,11/19/2018
6B6375,clinical-trials,100,56,11/19/2018
6F22E7,earnings-guidance,100,50,11/19/2018
731675,facility-close,100,47,11/19/2018
756BB4,earnings,100,50,11/19/2018
75F665,dividend,100,50,11/19/2018
763DBE,conference-participant,100,50,11/19/2018
76BECC,business-contract,100,69,11/19/2018
76DD0C,conference-participant,100,50,11/19/2018
7AF5B8,clinical-trials-positive,100,87,11/19/2018
7CBC40,executive-appointment,100,54,11/19/2018
7D7716,award,100,58,11/19/2018
7EA323,earnings,100,50,11/19/2018
7FDE1C,executive-appointment,100,54,11/19/2018
810FAD,dividend,100,50,11/19/2018
81EAD4,business-contract,100,69,11/19/2018
863350,facility-open,100,65,11/19/2018
863350,facility-open,100,65,11/19/2018
863350,facility-open,100,65,11/19/2018
88193E,conference-participant,100,50,11/19/2018
885758,partnership,100,61,11/19/2018
89F693,award,100,58,11/19/2018
8A8E41,donation,100,54,11/19/2018
8A8E41,donation,100,54,11/19/2018
8B1F37,executive-appointment,100,54,11/19/2018
8BE916,executive-resignation,100,44,11/19/2018
8C6C1B,donation,100,54,11/19/2018
8C6C1B,dividend,100,50,11/19/2018
8D0EEA,conference-participant,100,50,11/19/2018
90D6A5,acquisition-acquirer,100,49,11/19/2018
90D6A5,acquisition-acquirer,100,49,11/19/2018
957A07,conference-participant,100,50,11/19/2018
966ACE,clinical-trials,100,56,11/19/2018
967D92,dividend,100,50,11/19/2018
98A286,earnings,100,50,11/19/2018
9AF3DC,analyst-ratings-change-neutral-rater,20,50,11/19/2018
9B5968,acquisition-completed-acquirer,100,49,11/19/2018
9C25FF,partnership,100,61,11/19/2018
9C5174,conference-participant,100,50,11/19/2018
9FD2D9,acquisition-acquirer,100,49,11/19/2018
9FD2D9,acquisition-acquirer,100,49,11/19/2018
A26EF7,rights-issue,100,43,11/19/2018
A4CD53,conference-participant,100,50,11/19/2018
A52533,facility-open,100,65,11/19/2018
A5A4F5,acquisition-acquirer,100,49,11/19/2018
A6213D,acquisition-acquiree,100,76,11/19/2018
A6828A,clinical-trials-start,100,64,11/19/2018
A6828A,clinical-trials-start,100,64,11/19/2018
A79F7D,conference-participant,100,50,11/19/2018
A7CCF0,award,100,58,11/19/2018
A8CBDA,conference-participant,100,50,11/19/2018
AA98ED,legal-issues-defendant,100,22,11/19/2018
AAC8B6,dividend-up,100,53,11/19/2018
AAC8B6,dividend-up,100,53,11/19/2018
ACC7D3,conference-participant,100,50,11/19/2018
ADD9DC,earnings,100,50,11/19/2018
AE7D16,legal-issues-defendant,100,22,11/19/2018
B2DAF6,executive-appointment,100,54,11/19/2018
B381D8,clinical-trials-start,100,64,11/19/2018
B3CB74,sanctions-target,100,19,11/19/2018
B4C673,partnership,100,61,11/19/2018
B4C673,executive-appointment,100,54,11/19/2018
B85DCE,stake-acquiree,100,62,11/19/2018
B8EF97,legal-issues-defendant,100,22,11/19/2018
BB0587,executive-appointment,100,54,11/19/2018
BE379D,rights-issue,100,43,11/19/2018
BF5959,conference-call,100,50,11/19/2018
C15DB3,dividend,100,50,11/19/2018
C1CBA4,dividend,100,50,11/19/2018
C3DE7D,product-release,100,64,11/19/2018
C3DE7D,product-release,100,64,11/19/2018
C3DE7D,earnings,100,50,11/19/2018
C4A432,executive-appointment,100,54,11/19/2018
C5C0E9,conference-participant,100,50,11/19/2018
C7AE14,executive-appointment,100,54,11/19/2018
C8A248,award,100,58,11/19/2018
C951A2,executive-appointment,100,54,11/19/2018
CC339B,executive-appointment,100,54,11/19/2018
CC35BE,award,100,58,11/19/2018
CC8F6E,buybacks,100,74,11/19/2018
CD4DA8,conference-organizer,100,57,11/19/2018
CD4DA8,conference-organizer,100,57,11/19/2018
CD4DA8,conference-organizer,100,57,11/19/2018
CD4DA8,conference-organizer,100,57,11/19/2018
CD4DA8,conference-organizer,100,57,11/19/2018
CDAA0E,conference-participant,100,50,11/19/2018
CEC5B9,public-offering,100,43,11/19/2018
CFF57D,conference-call,100,50,11/19/2018
D0DFE5,executive-appointment,100,54,11/19/2018
D1AE3B,executive-appointment,100,54,11/19/2018
D2E553,executive-appointment,100,54,11/19/2018
D4AC65,partnership,100,61,11/19/2018
D64C6D,executive-appointment,100,54,11/19/2018
D6853F,conference-participant,100,50,11/19/2018
D6EAA3,conference-call,100,50,11/19/2018
D8442A,business-contract,100,69,11/19/2018
D8C09D,buybacks,100,74,11/19/2018
DDB002,executive-appointment,100,54,11/19/2018
DF6FDD,dividend,100,50,11/19/2018
E20BFE,revenues,100,50,11/19/2018
E20BFE,revenues,100,50,11/19/2018
E49AA3,business-contract,100,69,11/19/2018
E4CE73,business-contract,100,69,11/19/2018
E5752F,earnings,100,50,11/19/2018
E5752F,spin-off,100,58,11/19/2018
E68733,merger-regulatory-approval,100,81,11/19/2018
E8C557,conference-participant,100,50,11/19/2018
ED79D9,earnings,100,50,11/19/2018
EEA734,conference-participant,100,50,11/19/2018
EF77A3,legal-issues-defendant,100,22,11/19/2018
F11638,revenue-up,100,77,11/19/2018
F11638,revenue-up,100,69,11/19/2018
F11638,revenue-up,100,69,11/19/2018
F11638,revenue-up,100,69,11/19/2018
F11638,revenue-up,100,69,11/19/2018
F46EC9,government-contract,100,69,11/19/2018
F6DCE4,product-release,100,64,11/19/2018
F6DCE4,conference-call,100,50,11/19/2018
F7902B,conference-participant,100,50,11/19/2018
F80389,dividend,100,50,11/19/2018
F92DBC,partnership,100,61,11/19/2018
FACF19,product-release,100,64,11/19/2018
FC01C0,earnings,100,50,11/19/2018
FC01C0,earnings,100,50,11/19/2018
FC01C0,earnings,100,50,11/19/2018
FC01C0,earnings,100,50,11/19/2018
FC1A6E,legal-issues-defendant,100,22,11/19/2018
00E601,dividend,100,50,11/20/2018
01478A,dividend,100,50,11/20/2018
018C11,facility-open,100,65,11/20/2018
02FC1A,conference-participant,100,50,11/20/2018
036C6F,conference-participant,100,50,11/20/2018
07EC43,legal-issues-defendant,100,22,11/20/2018
07EC43,conference-participant,100,50,11/20/2018
0A77DB,conference-participant,100,50,11/20/2018
0B7375,conference-participant,100,50,11/20/2018
0C4131,buybacks,100,74,11/20/2018
0CE7F6,partnership,100,61,11/20/2018
0CE7F6,earnings,100,50,11/20/2018
0D03C8,conference-participant,100,50,11/20/2018
0E5619,conference-participant,100,50,11/20/2018
0F0440,earnings,100,50,11/20/2018
0F0440,earnings,100,50,11/20/2018
10673F,dividend,100,50,11/20/2018
12A3A3,earnings-guidance,100,50,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
139303,conference-organizer,100,57,11/20/2018
152AB9,conference-participant,100,50,11/20/2018
157D9F,conference-participant,100,50,11/20/2018
188394,award,100,58,11/20/2018
1921DD,partnership,100,61,11/20/2018
1BC12C,executive-appointment,100,54,11/20/2018
1C2593,earnings,100,50,11/20/2018
1C2593,market-entry,100,57,11/20/2018
1CDD1C,product-release,100,64,11/20/2018
1DE526,conference-participant,100,50,11/20/2018
1E1125,conference-organizer,100,57,11/20/2018
1E1125,conference-organizer,100,57,11/20/2018
1E1125,conference-organizer,100,57,11/20/2018
1E1125,conference-organizer,100,57,11/20/2018
1E1125,conference-organizer,100,57,11/20/2018
1E1125,conference-organizer,100,57,11/20/2018
1E8A99,dividend-up,100,81,11/20/2018
202E5A,conference-participant,100,50,11/20/2018
205AD5,conference-organizer,100,57,11/20/2018
21153F,partnership,100,61,11/20/2018
21153F,partnership,100,61,11/20/2018
21153F,partnership,100,61,11/20/2018
21153F,partnership,100,61,11/20/2018
221AD7,legal-issues-defendant,100,22,11/20/2018
25AB8E,partnership,100,61,11/20/2018
26DC29,conference-participant,100,50,11/20/2018
279916,earnings,100,50,11/20/2018
292A70,partnership,100,61,11/20/2018
301493,partnership,100,61,11/20/2018
30AB63,earnings-guidance,100,50,11/20/2018
3.14E+47,buybacks,100,74,11/20/2018
370C50,product-price-raise,100,57,11/20/2018
385DD4,regulatory-investigation,100,22,11/20/2018
3A3447,executive-appointment,100,54,11/20/2018
3B20AB,conference-participant,100,50,11/20/2018
3B37F7,executive-appointment,100,54,11/20/2018
3BE00F,conference-participant,100,50,11/20/2018
3C3B6B,partnership,100,61,11/20/2018
3DD5E2,conference-participant,100,50,11/20/2018
40B903,earnings,100,50,11/20/2018
40B903,earnings,100,50,11/20/2018
40B903,earnings,100,50,11/20/2018
40B903,earnings,100,50,11/20/2018
41A93D,conference-participant,100,50,11/20/2018
42EFC7,conference-participant,100,50,11/20/2018
434F38,executive-appointment,100,54,11/20/2018
4A6F00,product-release,100,64,11/20/2018
4A7C1F,executive-appointment,100,54,11/20/2018
4A7C1F,executive-appointment,100,54,11/20/2018
4BDCA7,conference-participant,100,50,11/20/2018
4E7C1F,executive-appointment,100,54,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
50070E,conference-organizer,100,57,11/20/2018
543900,earnings,100,50,11/20/2018
543900,earnings,100,50,11/20/2018
543900,earnings,100,50,11/20/2018
543900,earnings,100,50,11/20/2018
543900,earnings,100,50,11/20/2018
543900,earnings,100,50,11/20/2018
567F3D,conference-participant,100,50,11/20/2018
583223,conference-participant,100,50,11/20/2018
58CA9A,conference-organizer,100,57,11/20/2018
58CA9A,conference-organizer,100,57,11/20/2018
58CA9A,conference-organizer,100,57,11/20/2018
58CA9A,conference-participant,100,50,11/20/2018
58CA9A,conference-organizer,100,57,11/20/2018
5E7E82,earnings-above-expectations,100,88,11/20/2018
5F3D91,conference-participant,100,50,11/20/2018
61B81B,conference-participant,100,50,11/20/2018
62A48D,conference-participant,100,50,11/20/2018
64E346,acquisition-acquirer,100,49,11/20/2018
64E346,earnings,100,50,11/20/2018
6634D9,legal-issues-defendant,100,22,11/20/2018
665D7D,legal-issues-defendant,100,22,11/20/2018
69CE71,conference-participant,100,50,11/20/2018
6D7F1D,business-contract,100,69,11/20/2018
6D7F1D,business-contract,100,69,11/20/2018
6E705B,conference-participant,100,50,11/20/2018
732A9B,conference-participant,100,50,11/20/2018
73F7F9,conference-call,100,50,11/20/2018
741937,conference-participant,100,50,11/20/2018
762A3E,acquisition-acquiree,100,76,11/20/2018
762A3E,acquisition-acquiree,100,76,11/20/2018
762A3E,acquisition-acquirer,100,49,11/20/2018
76E80F,revenues,100,50,11/20/2018
76E80F,revenues,100,50,11/20/2018
76E80F,revenues,100,50,11/20/2018
76E80F,revenues,100,50,11/20/2018
771985,conference-participant,100,50,11/20/2018
7740DE,earnings-per-share-positive,100,69,11/20/2018
7A5097,earnings,100,50,11/20/2018
7C4F43,conference-participant,100,50,11/20/2018
7E3F8F,business-contract,100,69,11/20/2018
7F3669,conference-participant,100,50,11/20/2018
7F9984,buybacks,100,74,11/20/2018
817ED9,earnings,100,50,11/20/2018
817ED9,earnings,100,50,11/20/2018
817ED9,earnings,100,50,11/20/2018
817ED9,earnings,100,50,11/20/2018
81EAD4,business-contract,100,69,11/20/2018
81EAD4,business-contract,100,69,11/20/2018
81EAD4,business-contract,100,69,11/20/2018
82E58A,earnings,100,50,11/20/2018
859D62,earnings,100,50,11/20/2018
85DE00,conference-participant,100,50,11/20/2018
863350,earnings,100,50,11/20/2018
87486A,conference-participant,100,50,11/20/2018
8B4A45,earnings,100,50,11/20/2018
8C311A,partnership,100,61,11/20/2018
8C6C1B,earnings,100,50,11/20/2018
8C6C1B,earnings,100,50,11/20/2018
8CF6DD,donation,100,54,11/20/2018
8DE56F,award,100,58,11/20/2018
8E8E6E,award,100,58,11/20/2018
8EDACA,earnings-guidance,100,50,11/20/2018
8EDACA,executive-appointment,100,54,11/20/2018
8EDACA,legal-issues-defendant,100,22,11/20/2018
8F3BCC,conference-call,100,50,11/20/2018
90B678,dividend,100,50,11/20/2018
92B73F,unit-acquisition-acquiree,100,76,11/20/2018
931AE7,conference-participant,100,50,11/20/2018
94637C,conference-participant,100,50,11/20/2018
972356,partnership,100,61,11/20/2018
977A1E,executive-appointment,100,54,11/20/2018
990AD0,conference-organizer,100,57,11/20/2018
990AD0,conference-organizer,100,57,11/20/2018
9934AD,conference-call,100,50,11/20/2018
9978F1,conference-participant,100,50,11/20/2018
9A602D,fundraising,100,64,11/20/2018
9B5968,executive-appointment,100,54,11/20/2018
9BB35A,conference-participant,100,50,11/20/2018
A05C43,executive-appointment,100,54,11/20/2018
A3F598,acquisition-acquiree,100,76,11/20/2018
A3F598,acquisition-acquiree,100,76,11/20/2018
A495F7,award,100,58,11/20/2018
A5195E,executive-appointment,100,54,11/20/2018
A5A4F5,acquisition-acquirer,100,49,11/20/2018
A5E715,dividend,100,50,11/20/2018
A7102F,conference-participant,100,50,11/20/2018
ACC7D3,conference-participant,100,50,11/20/2018
AD22F2,earnings,100,50,11/20/2018
AD22F2,earnings,100,50,11/20/2018
AD22F2,earnings,100,50,11/20/2018
AD22F2,earnings,100,50,11/20/2018
AD22F2,earnings,100,50,11/20/2018
AD3008,conference-participant,100,50,11/20/2018
AE7D16,legal-issues-defendant,100,22,11/20/2018
AFD1CA,facility-open,100,65,11/20/2018
B3CB74,conference-organizer,100,57,11/20/2018
B560AF,dividend,100,50,11/20/2018
B66928,buybacks,100,74,11/20/2018
B66928,product-release,100,64,11/20/2018
BCC55F,conference-participant,100,50,11/20/2018
BFE02C,conference-participant,100,50,11/20/2018
C0F70B,conference-participant,100,50,11/20/2018
C4706C,earnings,100,50,11/20/2018
C4A432,earnings,100,50,11/20/2018
C4A432,earnings,100,50,11/20/2018
C4A432,earnings,100,50,11/20/2018
C4C77F,conference-call,100,50,11/20/2018
C5D2AE,conference-participant,100,50,11/20/2018
C66B44,executive-appointment,100,54,11/20/2018
C7859D,conference-participant,100,50,11/20/2018
C81E00,conference-participant,100,50,11/20/2018
C81E00,conference-participant,100,50,11/20/2018
C83B88,conference-participant,100,50,11/20/2018
C97B2D,acquisition-interest-acquirer,100,46,11/20/2018
C9A96E,conference-participant,100,50,11/20/2018
CB7AB2,conference-participant,100,50,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CD4DA8,conference-organizer,100,57,11/20/2018
CE4E6D,product-release,100,64,11/20/2018
CF7292,conference-call,100,50,11/20/2018
D1AE3B,dividend,100,50,11/20/2018
D56D6D,earnings,100,50,11/20/2018
D5AF19,dividend,100,50,11/20/2018
D64C6D,conference-call,100,50,11/20/2018
D64EDF,buybacks,100,74,11/20/2018
D7918D,conference-participant,100,50,11/20/2018
DA48E4,dividend,100,50,11/20/2018
DC2B00,conference-call,100,50,11/20/2018
E0207A,dividend,100,50,11/20/2018
E10D31,legal-issues-defendant,100,22,11/20/2018
E10D31,legal-issues-defendant,100,22,11/20/2018
E16133,public-offering,100,43,11/20/2018
E4158B,dividend,100,50,11/20/2018
E49AA3,patent-awarded,100,72,11/20/2018
E4CE73,earnings,100,50,11/20/2018
E68733,earnings,100,50,11/20/2018
E68C3D,earnings-up,100,68,11/20/2018
E68C3D,earnings,100,50,11/20/2018
E68C3D,earnings,100,50,11/20/2018
E68C3D,earnings,100,50,11/20/2018
E68C3D,earnings,100,50,11/20/2018
E8846E,conference-participant,100,50,11/20/2018
EBD89A,business-contract,100,69,11/20/2018
ED2A5E,conference-participant,100,50,11/20/2018
EF25A5,conference-participant,100,50,11/20/2018
F0A9DE,dividend,100,50,11/20/2018
F4E992,conference-participant,100,50,11/20/2018
F4F46F,conference-participant,100,50,11/20/2018
F6DCE4,earnings,100,50,11/20/2018
F6DCE4,earnings,100,50,11/20/2018
F6DCE4,earnings,100,50,11/20/2018
F6DCE4,earnings,100,50,11/20/2018
F8BA6C,conference-participant,100,50,11/20/2018
FC1A6E,legal-issues-defendant,100,22,11/20/2018
FC1B7B,conference-participant,100,50,11/20/2018
FDD3FC,conference-participant,100,50,11/20/2018
FEC475,executive-appointment,100,54,11/20/2018
FF6644,legal-issues-defendant,100,22,11/20/2018
03D5F9,legal-issues-defendant,100,22,11/21/2018
0624BE,dividend,100,50,11/21/2018
0C28D1,business-contract,100,69,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
139303,conference-organizer,100,57,11/21/2018
197612,dividend,100,50,11/21/2018
1E1125,conference-organizer,100,57,11/21/2018
1E1125,conference-organizer,100,57,11/21/2018
1E1125,conference-organizer,100,57,11/21/2018
1E1125,conference-organizer,100,57,11/21/2018
1FA886,executive-appointment,100,54,11/21/2018
1FA886,executive-appointment,100,54,11/21/2018
2031CE,dividend,100,50,11/21/2018
238302,buybacks,100,74,11/21/2018
26F99F,earnings,100,50,11/21/2018
2D643C,conference-participant,100,50,11/21/2018
2DA92D,dividend,100,50,11/21/2018
31803E,conference-participant,100,50,11/21/2018
37020C,conference-participant,100,50,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings-positive,100,69,11/21/2018
431B74,earnings,100,50,11/21/2018
431B74,earnings,100,50,11/21/2018
431B74,earnings,100,50,11/21/2018
431B74,earnings,100,50,11/21/2018
431B74,earnings,100,50,11/21/2018
431B74,earnings,100,50,11/21/2018
4A2457,business-contract,100,69,11/21/2018
4A6F00,partnership,100,61,11/21/2018
50070E,conference-organizer,100,57,11/21/2018
5480A7,dividend,100,50,11/21/2018
55C9B5,partnership,100,61,11/21/2018
5B35C7,dividend-up,100,81,11/21/2018
5E7E82,dividend,100,50,11/21/2018
636BBF,partnership,100,61,11/21/2018
64E346,conference-participant,100,50,11/21/2018
66667F,partnership,100,61,11/21/2018
704B78,conference-participant,100,50,11/21/2018
728737,public-offering,100,43,11/21/2018
72FCA3,market-entry,100,57,11/21/2018
76F067,conference-participant,100,50,11/21/2018
7710F3,executive-appointment,100,54,11/21/2018
7740DE,dividend,100,50,11/21/2018
848C0B,dividend-up,100,81,11/21/2018
85AD00,dividend,100,50,11/21/2018
860AB6,award,100,58,11/21/2018
877C0C,conference-participant,100,50,11/21/2018
87B81A,conference-participant,100,50,11/21/2018
89E771,earnings,100,50,11/21/2018
8E82A6,business-contract,100,69,11/21/2018
8F6995,earnings-guidance,100,50,11/21/2018
954004,conference-call,100,50,11/21/2018
95DC1F,conference-call,100,50,11/21/2018
967D92,unit-acquisition-acquirer,100,49,11/21/2018
97693A,conference-call,100,50,11/21/2018
990AD0,conference-organizer,100,57,11/21/2018
A247F5,product-release,100,64,11/21/2018
A3BFAA,merger-completed,100,66,11/21/2018
A5A4F5,acquisition-acquirer,100,49,11/21/2018
A631A3,conference-participant,100,50,11/21/2018
A8CBDA,product-release,100,64,11/21/2018
B3CB74,conference-organizer,100,57,11/21/2018
B3CB74,conference-organizer,100,57,11/21/2018
C062D4,conference-participant,100,50,11/21/2018
C97B2D,conference-participant,100,50,11/21/2018
CBBFBF,executive-resignation,100,44,11/21/2018
CBFFDD,conference-participant,100,50,11/21/2018
CBFFDD,conference-participant,100,50,11/21/2018
CCBBAD,dividend-up,100,54,11/21/2018
CD4DA8,conference-organizer,100,57,11/21/2018
CD4DA8,conference-organizer,100,57,11/21/2018
CD4DA8,conference-organizer,100,57,11/21/2018
CD4DA8,conference-organizer,100,57,11/21/2018
CD4DA8,conference-organizer,100,57,11/21/2018
CD4DA8,conference-organizer,100,57,11/21/2018
D42DBA,asset-sale,100,62,11/21/2018
D5AF19,conference-participant,100,50,11/21/2018
E09E2B,partnership,100,61,11/21/2018
E10D31,legal-issues-defendant,100,22,11/21/2018
E20392,conference-participant,100,50,11/21/2018
E4CE73,conference-participant,100,50,11/21/2018
E68733,acquisition-acquirer,100,49,11/21/2018
E7BF32,conference-participant,100,50,11/21/2018
E7BF32,conference-participant,100,50,11/21/2018
E8846E,conference-organizer,100,57,11/21/2018
EB2F14,dividend,100,50,11/21/2018
ECA300,conference-call,100,50,11/21/2018
F57F6F,conference-organizer,100,57,11/21/2018
F57F6F,conference-organizer,100,57,11/21/2018
FD39EB,earnings,100,50,11/21/2018
33AD83,business-contract,100,69,11/22/2018
A5A4F5,acquisition-acquirer,100,49,11/22/2018
D8442A,business-contract,100,69,11/22/2018
0A7650,dividend,100,50,11/23/2018
139303,conference-organizer,100,57,11/23/2018
2667B6,acquisition-regulatory-approval-acquirer,100,54,11/23/2018
2C7505,legal-issues-defendant,100,22,11/23/2018
48F795,legal-issues-defendant,100,22,11/23/2018
4A6F00,business-contract,100,69,11/23/2018
5B226B,dividend,100,50,11/23/2018
81EAD4,business-contract,100,69,11/23/2018
9DDE1B,business-contract,100,69,11/23/2018
A5A4F5,acquisition-acquirer,100,49,11/23/2018
AA98ED,legal-issues-defendant,100,22,11/23/2018
D8442A,business-contract,100,69,11/23/2018
E10D31,legal-issues-defendant,100,22,11/23/2018
EF45B6,dividend,100,50,11/23/2018
1921DD,product-release,100,64,11/24/2018
228D42,business-contract,100,69,11/25/2018
2C7505,legal-issues-defendant,100,22,11/25/2018
2C7505,legal-issues-defendant,100,22,11/25/2018
4A6F00,business-contract,100,69,11/25/2018
4F9926,business-contract,100,69,11/25/2018
543900,legal-issues-defendant,100,22,11/25/2018
D8442A,business-contract,100,69,11/25/2018
D8442A,business-contract,100,69,11/25/2018
D8442A,business-contract,100,69,11/25/2018
D8442A,business-contract,100,69,11/25/2018
D8442A,business-contract,100,69,11/25/2018
D8442A,business-contract,100,69,11/25/2018
D8442A,business-contract,100,69,11/25/2018
E5752F,product-release,100,64,11/25/2018
E68E62,conference-call,100,50,11/25/2018
00D6B5,business-contract,100,69,11/26/2018
0157B1,partnership,100,61,11/26/2018
0157B1,partnership,100,61,11/26/2018
0157B1,partnership,100,61,11/26/2018
43862,executive-resignation,100,44,11/26/2018
07CA6A,note-sale,100,52,11/26/2018
07CA6A,note-sale,100,52,11/26/2018
081AB9,conference-participant,100,50,11/26/2018
10C19B,legal-issues-defendant,100,22,11/26/2018
10C19B,legal-issues-defendant,100,22,11/26/2018
139303,conference-organizer,100,57,11/26/2018
139303,conference-organizer,100,57,11/26/2018
139303,conference-organizer,100,57,11/26/2018
139303,conference-organizer,100,57,11/26/2018
139303,conference-organizer,100,57,11/26/2018
14833D,conference-participant,100,50,11/26/2018
14833D,legal-issues-defendant,100,22,11/26/2018
1490F3,executive-appointment,100,54,11/26/2018
152E1D,legal-issues-defendant,100,22,11/26/2018
152E1D,legal-issues-defendant,100,22,11/26/2018
152FA5,conference-participant,100,50,11/26/2018
1748F6,earnings,100,50,11/26/2018
197019,public-offering,100,43,11/26/2018
1A3E1B,conference-call,100,50,11/26/2018
1BC12C,facility-close,100,47,11/26/2018
1E1125,conference-organizer,100,57,11/26/2018
1E1125,conference-organizer,100,57,11/26/2018
1E1125,conference-organizer,100,57,11/26/2018
1E1125,conference-organizer,100,57,11/26/2018
1E1125,conference-organizer,100,57,11/26/2018
1E1125,conference-organizer,100,57,11/26/2018
1E1125,conference-organizer,100,57,11/26/2018
227F04,conference-participant,100,50,11/26/2018
22C58E,index-listing,100,76,11/26/2018
249674,credit-extension-recipient,100,69,11/26/2018
24A89A,executive-appointment,100,54,11/26/2018
25102A,conference-participant,100,50,11/26/2018
26008A,conference-call,100,50,11/26/2018
26DC29,conference-participant,100,50,11/26/2018
28AF37,conference-participant,100,50,11/26/2018
2ABF77,earnings,100,50,11/26/2018
2ABF77,earnings,100,50,11/26/2018
2C7505,legal-issues-defendant,100,22,11/26/2018
31553A,executive-appointment,100,54,11/26/2018
3461CF,credit-rating-upgrade-rater,20,50,11/26/2018
34A959,partnership,100,61,11/26/2018
34A959,business-contract,100,69,11/26/2018
34A959,business-contract,100,69,11/26/2018
36C09B,legal-issues-defendant,100,22,11/26/2018
3B318A,legal-issues-defendant,100,22,11/26/2018
3D9999,legal-issues-defendant,100,22,11/26/2018
444CC8,business-contract,100,69,11/26/2018
4.91E+58,executive-appointment,100,54,11/26/2018
4A5C8D,legal-issues-defendant,100,22,11/26/2018
4A6F00,business-contract,100,69,11/26/2018
4A6F00,business-contract,100,69,11/26/2018
4A6F00,business-contract,100,69,11/26/2018
4A6F00,legal-issues-defendant,100,22,11/26/2018
4C7DB5,buybacks,100,74,11/26/2018
4C92B9,legal-issues-defendant,100,22,11/26/2018
50070E,conference-organizer,100,57,11/26/2018
50070E,conference-organizer,100,57,11/26/2018
50070E,conference-organizer,100,57,11/26/2018
50070E,conference-organizer,100,57,11/26/2018
50070E,conference-organizer,100,57,11/26/2018
504FE2,conference-participant,100,50,11/26/2018
5225A4,partnership,100,61,11/26/2018
543900,legal-issues-defendant,100,22,11/26/2018
543900,business-contract,100,69,11/26/2018
543900,business-contract,100,69,11/26/2018
59DB8C,executive-appointment,100,54,11/26/2018
5D41E4,buybacks,100,74,11/26/2018
620381,conference-call,100,50,11/26/2018
62B1C6,buybacks,100,74,11/26/2018
633054,partnership,100,61,11/26/2018
633054,partnership,100,61,11/26/2018
649CBD,legal-issues-defendant,100,22,11/26/2018
6.52E+64,legal-issues-defendant,100,22,11/26/2018
722D55,conference-participant,100,50,11/26/2018
7448A3,conference-participant,100,50,11/26/2018
7712CB,public-offering,100,43,11/26/2018
790D0D,earnings,100,50,11/26/2018
7B9212,earnings,100,50,11/26/2018
7B9212,earnings,100,50,11/26/2018
83E0AC,public-offering,100,43,11/26/2018
84A6B9,executive-appointment,100,54,11/26/2018
87486A,dividend,100,50,11/26/2018
88D80A,facility-open,100,65,11/26/2018
8E4F9A,conference-participant,100,50,11/26/2018
8EDACA,legal-issues-defendant,100,22,11/26/2018
8F6995,dividend-up,100,56,11/26/2018
9004C4,earnings-up,100,68,11/26/2018
93D207,business-contract,100,69,11/26/2018
94983E,business-contract,100,69,11/26/2018
96F126,business-contract,100,69,11/26/2018
971F7B,conference-participant,100,50,11/26/2018
977A1E,merger,100,66,11/26/2018
9B4066,facility-sale,100,52,11/26/2018
9B730A,business-contract,100,69,11/26/2018
9B730A,business-contract,100,69,11/26/2018
9EBAFA,acquisition-acquirer,100,49,11/26/2018
9F37C5,dividend,100,50,11/26/2018
9F71E5,conference-participant,100,50,11/26/2018
9FF5F1,executive-appointment,100,54,11/26/2018
A21649,dividend,100,50,11/26/2018
A43906,executive-appointment,100,54,11/26/2018
A5151E,credit-extension-recipient,100,69,11/26/2018
A5A4F5,acquisition-acquirer,100,49,11/26/2018
A63387,public-offering,100,43,11/26/2018
A72FD9,earnings,100,50,11/26/2018
AA98ED,legal-issues-defendant,100,22,11/26/2018
B3CB74,conference-organizer,100,57,11/26/2018
B3CB74,conference-organizer,100,57,11/26/2018
B3CB74,conference-organizer,100,57,11/26/2018
B3CB74,conference-organizer,100,57,11/26/2018
B840EF,note-sale,100,52,11/26/2018
B98EFA,conference-participant,100,50,11/26/2018
B9CD50,conference-participant,100,50,11/26/2018
BBC05B,product-release,100,64,11/26/2018
C3BCD5,executive-appointment,100,54,11/26/2018
C9E4EC,conference-participant,100,50,11/26/2018
CC176E,partnership,100,61,11/26/2018
CD4DA8,conference-organizer,100,57,11/26/2018
CD4DA8,conference-organizer,100,57,11/26/2018
CDFCC9,conference-participant,100,50,11/26/2018
CF351E,product-release,100,64,11/26/2018
D0DFE5,market-entry,100,57,11/26/2018
D1173F,business-contract,100,69,11/26/2018
D15833,dividend,100,50,11/26/2018
D1C26F,conference-participant,100,50,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,business-contract,100,69,11/26/2018
D8442A,product-release,100,64,11/26/2018
D93A25,credit-extension-recipient,100,69,11/26/2018
DA91AE,earnings,100,50,11/26/2018
DA91AE,acquisition-completed-acquirer,100,49,11/26/2018
DAFED3,conference-participant,100,50,11/26/2018
DB23C8,executive-appointment,100,54,11/26/2018
DC0066,conference-participant,100,50,11/26/2018
DD7A96,partnership,100,61,11/26/2018
DDEA6A,conference-participant,100,50,11/26/2018
E15736,index-listing,100,76,11/26/2018
E68E62,business-contract,100,69,11/26/2018
E68E62,clinical-trials,100,56,11/26/2018
E68E62,clinical-trials,100,56,11/26/2018
E68E62,business-contract,100,69,11/26/2018
E68E62,public-offering,100,43,11/26/2018
E8846E,conference-organizer,100,57,11/26/2018
E9C7C0,conference-participant,100,50,11/26/2018
ECDEB2,dividend,100,50,11/26/2018
F46EC9,conference-participant,100,50,11/26/2018
F7935D,clinical-trials-start,100,64,11/26/2018
F8BA6C,conference-participant,100,50,11/26/2018
FC1A6E,legal-issues-defendant,100,22,11/26/2018
FE7A63,executive-appointment,100,54,11/26/2018
FF4343,executive-appointment,100,54,11/26/2018
FF4343,executive-appointment,100,54,11/26/2018
FF4343,executive-resignation,100,44,11/26/2018
00698D,executive-resignation,100,44,11/27/2018
0157B1,facility-open,100,65,11/27/2018
0157B1,partnership,100,61,11/27/2018
0325B7,acquisition-completed-acquirer,100,49,11/27/2018
03D5F9,legal-issues-defendant,100,22,11/27/2018
03D5F9,legal-issues-defendant,100,22,11/27/2018
48781,credit-extension-recipient,100,69,11/27/2018
48781,credit-extension-recipient,100,69,11/27/2018
61366,earnings-guidance,100,50,11/27/2018
070B45,conference-participant,100,50,11/27/2018
71860,award,100,58,11/27/2018
07EC43,conference-participant,100,50,11/27/2018
0986B5,dividend,100,50,11/27/2018
099A92,conference-participant,100,50,11/27/2018
099C88,conference-participant,100,50,11/27/2018
0E2992,dividend,100,50,11/27/2018
1096C6,partnership,100,61,11/27/2018
1201B5,conference-participant,100,50,11/27/2018
12DE76,partnership,100,61,11/27/2018
139303,conference-organizer,100,57,11/27/2018
139303,conference-organizer,100,57,11/27/2018
13C3E0,donation,100,54,11/27/2018
152E1D,legal-issues-defendant,100,22,11/27/2018
159739,dividend,100,50,11/27/2018
159739,dividend,100,50,11/27/2018
159AE4,conference-call,100,50,11/27/2018
184866,patient-enrollment-complete,100,64,11/27/2018
184866,patient-enrollment-complete,100,64,11/27/2018
18D9FA,business-contract,100,69,11/27/2018
1921DD,partnership,100,61,11/27/2018
1BDB2A,conference-participant,100,50,11/27/2018
1DEBBE,executive-appointment,100,54,11/27/2018
1E1125,conference-organizer,100,57,11/27/2018
1E1125,conference-organizer,100,57,11/27/2018
1E1125,conference-organizer,100,57,11/27/2018
1E1125,conference-organizer,100,57,11/27/2018
1E1125,conference-organizer,100,57,11/27/2018
1E83DE,conference-participant,100,50,11/27/2018
1EBF8D,clinical-trials,100,56,11/27/2018
21153F,executive-appointment,100,54,11/27/2018
221AD7,legal-issues-defendant,100,22,11/27/2018
228D42,partnership,100,61,11/27/2018
228D42,partnership,100,61,11/27/2018
228D42,executive-appointment,100,54,11/27/2018
23207A,conference-participant,100,50,11/27/2018
267718,partnership,100,61,11/27/2018
26F99F,clinical-trials-start,100,64,11/27/2018
2D643C,executive-appointment,100,54,11/27/2018
2E0496,award,100,58,11/27/2018
2E2E6E,dividend-up,100,77,11/27/2018
2E902B,conference-participant,100,50,11/27/2018
314D88,conference-participant,100,50,11/27/2018
3461CF,award,100,58,11/27/2018
367434,merger,100,66,11/27/2018
367434,merger,100,66,11/27/2018
367434,merger,100,66,11/27/2018
385DD4,conference-participant,100,50,11/27/2018
39FB23,partnership,100,61,11/27/2018
3B50FE,earnings,100,50,11/27/2018
3B9886,earnings,100,50,11/27/2018
3B9886,earnings,100,50,11/27/2018
3B9886,earnings,100,50,11/27/2018
3C3B6B,conference-participant,100,50,11/27/2018
3D9999,legal-issues-defendant,100,22,11/27/2018
3EE65E,earnings,100,50,11/27/2018
4.00E+163,earnings,100,50,11/27/2018
4.00E+163,legal-issues-defendant,100,22,11/27/2018
4.00E+163,legal-issues-defendant,100,22,11/27/2018
449A26,acquisition-acquirer,100,49,11/27/2018
449A26,acquisition-acquirer,100,49,11/27/2018
49CC59,executive-resignation,100,44,11/27/2018
4A3438,conference-participant,100,50,11/27/2018
4A6F00,regulatory-investigation,100,22,11/27/2018
4C37C5,dividend,100,50,11/27/2018
4EEB00,executive-appointment,100,54,11/27/2018
4F0A80,dividend,100,50,11/27/2018
50070E,conference-organizer,100,57,11/27/2018
50070E,conference-organizer,100,57,11/27/2018
50070E,conference-organizer,100,57,11/27/2018
50070E,conference-organizer,100,57,11/27/2018
50070E,conference-organizer,100,57,11/27/2018
5340D0,public-offering,100,43,11/27/2018
543900,legal-issues-defendant,100,22,11/27/2018
54DF47,acquisition-acquirer,100,49,11/27/2018
54F271,earnings,100,50,11/27/2018
59872F,earnings,100,50,11/27/2018
59B229,buybacks,100,74,11/27/2018
59DB8C,conference-participant,100,50,11/27/2018
5D0337,executive-appointment,100,54,11/27/2018
5D0337,executive-appointment,100,54,11/27/2018
5DE5A5,conference-participant,100,50,11/27/2018
5F9CE3,unit-acquisition-acquirer,100,49,11/27/2018
619882,credit-extension-provider,100,57,11/27/2018
619882,credit-extension-provider,100,57,11/27/2018
62B1C6,buybacks,100,74,11/27/2018
67303E,patient-enrollment-complete,100,64,11/27/2018
67B052,clinical-trials,100,56,11/27/2018
69C99E,debt-extension-recipient,100,73,11/27/2018
69E8E1,executive-resignation,100,44,11/27/2018
69E8E1,executive-resignation,100,44,11/27/2018
69E8E1,executive-resignation,100,44,11/27/2018
6C6D73,government-contract,100,69,11/27/2018
6CC55E,executive-appointment,100,54,11/27/2018
6CD55A,dividend,100,50,11/27/2018
70CA28,conference-participant,100,50,11/27/2018
70FCEF,earnings,100,50,11/27/2018
71B0CF,clinical-trials,100,56,11/27/2018
723548,public-offering,100,43,11/27/2018
72DF04,partnership,100,61,11/27/2018
72FCA3,executive-appointment,100,54,11/27/2018
73A71F,product-price-raise,100,57,11/27/2018
763DBE,conference-participant,100,50,11/27/2018
763DBE,clinical-trials-positive,100,87,11/27/2018
767F86,conference-participant,100,50,11/27/2018
7712CB,public-offering,100,43,11/27/2018
7712CB,public-offering,100,43,11/27/2018
7AB859,drilling,100,68,11/27/2018
7AB859,drilling,100,68,11/27/2018
7AB859,drilling,100,68,11/27/2018
7AC86E,donation,100,54,11/27/2018
7BC92D,conference-participant,100,50,11/27/2018
7C62A3,business-contract,100,69,11/27/2018
7C62A3,business-contract,100,69,11/27/2018
7DA412,product-release,100,64,11/27/2018
7F3669,conference-participant,100,50,11/27/2018
817ED9,donation,100,54,11/27/2018
8614A2,earnings,100,50,11/27/2018
8A8E41,business-contract,100,69,11/27/2018
8B8656,donation,100,54,11/27/2018
8E3F58,conference-participant,100,50,11/27/2018
8F8F2F,executive-appointment,100,54,11/27/2018
92B625,executive-appointment,100,54,11/27/2018
92D757,conference-participant,100,50,11/27/2018
96F126,partnership,100,61,11/27/2018
97644E,conference-participant,100,50,11/27/2018
977A1E,partnership,100,61,11/27/2018
98CAED,revenue-guidance,100,50,11/27/2018
990AD0,conference-organizer,100,57,11/27/2018
990AD0,conference-organizer,100,57,11/27/2018
9A602D,product-release,100,64,11/27/2018
9BBFA5,conference-call,100,50,11/27/2018
9D56F2,dividend-up,100,81,11/27/2018
9D6A24,note-sale,100,52,11/27/2018
A37D68,earnings,100,50,11/27/2018
A398F8,conference-participant,100,50,11/27/2018
A41450,business-contract,100,69,11/27/2018
A52533,executive-appointment,100,54,11/27/2018
A5A4F5,acquisition-acquirer,100,49,11/27/2018
A6213D,conference-call,100,50,11/27/2018
A631A3,conference-participant,100,50,11/27/2018
A6FB29,earnings,100,50,11/27/2018
A761FE,conference-call,100,50,11/27/2018
A80FE0,conference-participant,100,50,11/27/2018
AA98ED,legal-issues-defendant,100,22,11/27/2018
AC7C4F,product-release,100,64,11/27/2018
AD3C93,conference-participant,100,50,11/27/2018
AE7D16,legal-issues-defendant,100,22,11/27/2018
AE7D16,legal-issues-defendant,100,22,11/27/2018
AE7D16,legal-issues-defendant,100,22,11/27/2018
AED6CF,conference-call,100,50,11/27/2018
AEF2C3,conference-participant,100,50,11/27/2018
B13B68,conference-participant,100,50,11/27/2018
B1DF3C,conference-participant,100,50,11/27/2018
B2206F,conference-participant,100,50,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B3CB74,conference-organizer,100,57,11/27/2018
B4C673,partnership,100,61,11/27/2018
B619CB,executive-appointment,100,54,11/27/2018
B7FA9B,commodity-buy,100,55,11/27/2018
B8EF97,legal-issues-defendant,100,22,11/27/2018
BB127B,earnings-up,100,68,11/27/2018
BDF85E,earnings,100,50,11/27/2018
C3DE7D,partnership,100,61,11/27/2018
C97B2D,conference-participant,100,50,11/27/2018
CC0C78,clinical-trials-start,100,64,11/27/2018
CD4DA8,conference-organizer,100,57,11/27/2018
CD4DA8,conference-organizer,100,57,11/27/2018
CDC817,conference-participant,100,50,11/27/2018
CE5664,executive-appointment,100,54,11/27/2018
CE96E7,executive-appointment,100,54,11/27/2018
D33270,business-contract,100,69,11/27/2018
D58A11,conference-participant,100,50,11/27/2018
D5AF19,partnership,100,61,11/27/2018
D650A7,conference-participant,100,50,11/27/2018
D854F3,executive-appointment,100,54,11/27/2018
D8F347,executive-appointment,100,54,11/27/2018
D9E036,legal-issues-defendant,100,22,11/27/2018
DB88A1,earnings,100,50,11/27/2018
DBB28E,partnership,100,61,11/27/2018
DBB28E,product-release,100,64,11/27/2018
DBCA3F,debt-extension-provider,100,52,11/27/2018
DC486E,dividend,100,50,11/27/2018
DD1BA1,conference-participant,100,50,11/27/2018
E1E093,award,100,58,11/27/2018
E8846E,conference-organizer,100,57,11/27/2018
EAA0A7,conference-participant,100,50,11/27/2018
EC8116,legal-issues-defendant,100,22,11/27/2018
EF5BED,conference-participant,100,50,11/27/2018
EF5BED,business-contract,100,69,11/27/2018
EF77A3,legal-issues-defendant,100,22,11/27/2018
F1529C,conference-participant,100,50,11/27/2018
F30508,earnings-guidance,100,50,11/27/2018
F43A11,conference-call,100,50,11/27/2018
F66B58,conference-call,100,50,11/27/2018
F80389,merger-regulatory-approval,100,81,11/27/2018
FC1A6E,legal-issues-defendant,100,22,11/27/2018
FDE409,earnings,100,50,11/27/2018
FF227B,executive-appointment,100,54,11/27/2018
FF6644,legal-issues-defendant,100,22,11/27/2018
00067A,buybacks,100,74,11/28/2018
9397,conference-participant,100,50,11/28/2018
0157B1,partnership,100,61,11/28/2018
0157B1,product-release,100,64,11/28/2018
0157B1,product-release,100,64,11/28/2018
03D5F9,legal-issues-defendant,100,22,11/28/2018
0919B1,dividend,100,50,11/28/2018
0968A5,executive-appointment,100,54,11/28/2018
099C88,government-contract,100,69,11/28/2018
0A9D0A,settlement,100,56,11/28/2018
0BC29E,conference-participant,100,50,11/28/2018
1279ED,conference-participant,100,50,11/28/2018
14833D,legal-issues-defendant,100,22,11/28/2018
14833D,legal-issues-defendant,100,22,11/28/2018
14833D,legal-issues-defendant,100,22,11/28/2018
14833D,legal-issues-defendant,100,22,11/28/2018
14BA06,dividend,100,50,11/28/2018
14BA06,executive-resignation,100,44,11/28/2018
152E1D,legal-issues-defendant,100,22,11/28/2018
15901B,award,100,58,11/28/2018
190BE6,earnings,100,50,11/28/2018
1921DD,regulatory-investigation,100,22,11/28/2018
1CF3A8,earnings,100,50,11/28/2018
1D3A00,earnings,100,50,11/28/2018
1D3A00,earnings,100,50,11/28/2018
1D3A00,earnings,100,50,11/28/2018
1D3A00,earnings,100,50,11/28/2018
1DEBBE,credit-extension-recipient,100,69,11/28/2018
1DEBBE,buybacks,100,74,11/28/2018
1E1125,conference-organizer,100,57,11/28/2018
1F716B,donation,100,54,11/28/2018
1FE3CB,merger-regulatory-approval,100,81,11/28/2018
225CA2,award,100,58,11/28/2018
228D42,dividend-up,100,81,11/28/2018
239106,conference-participant,100,50,11/28/2018
28B730,acquisition-acquirer,100,49,11/28/2018
28B730,acquisition-acquirer,100,49,11/28/2018
29A4CC,dividend,100,50,11/28/2018
2E1322,conference-participant,100,50,11/28/2018
2F9304,conference-participant,100,50,11/28/2018
2F98A5,earnings,100,50,11/28/2018
306623,unit-acquisition-acquiree,100,76,11/28/2018
31AA84,award,100,58,11/28/2018
36C09B,legal-issues-defendant,100,22,11/28/2018
3EE65E,conference-participant,100,50,11/28/2018
43E8F5,conference-participant,100,50,11/28/2018
48F795,legal-issues-defendant,100,22,11/28/2018
49A344,business-contract,100,69,11/28/2018
4A6F00,partnership,100,61,11/28/2018
4B3676,conference-participant,100,50,11/28/2018
4E4E75,conference-call,100,50,11/28/2018
4E7C1F,business-contract,100,69,11/28/2018
4ECD1A,partnership,100,61,11/28/2018
50070E,conference-organizer,100,57,11/28/2018
50070E,conference-organizer,100,57,11/28/2018
50070E,conference-organizer,100,57,11/28/2018
50070E,conference-organizer,100,57,11/28/2018
50070E,conference-organizer,100,57,11/28/2018
50070E,conference-organizer,100,57,11/28/2018
50070E,conference-organizer,100,57,11/28/2018
55438C,legal-issues-defendant,100,22,11/28/2018
589846,earnings,100,50,11/28/2018
59872F,product-release,100,64,11/28/2018
59B229,executive-appointment,100,54,11/28/2018
5B226B,business-contract,100,69,11/28/2018
5C2A47,partnership,100,61,11/28/2018
63F892,product-release,100,64,11/28/2018
68BA15,earnings,100,50,11/28/2018
69CE71,acquisition-completed-acquirer,100,49,11/28/2018
69CE71,acquisition-completed-acquirer,100,49,11/28/2018
69CE71,acquisition-completed-acquirer,100,49,11/28/2018
69CE71,acquisition-completed-acquirer,100,49,11/28/2018
6F3936,earnings,100,50,11/28/2018
6F3936,earnings,100,50,11/28/2018
6F3936,earnings,100,50,11/28/2018
6F3936,earnings,100,50,11/28/2018
6F3936,earnings,100,50,11/28/2018
6F3936,earnings,100,50,11/28/2018
6F3936,earnings,100,50,11/28/2018
701531,conference-participant,100,50,11/28/2018
7239BB,earnings,100,50,11/28/2018
7239BB,facility-open,100,65,11/28/2018
762A3E,executive-appointment,100,54,11/28/2018
78A1BB,dividend-up,100,81,11/28/2018
7ADE57,conference-call,100,50,11/28/2018
7D35D8,conference-participant,100,50,11/28/2018
7FDE1C,executive-appointment,100,54,11/28/2018
80D744,product-release,100,64,11/28/2018
81A88D,credit-extension-recipient,100,69,11/28/2018
83E0AC,public-offering,100,43,11/28/2018
877734,executive-appointment,100,54,11/28/2018
8AB37F,conference-participant,100,50,11/28/2018
8CF6DD,conference-participant,100,50,11/28/2018
8EDACA,legal-issues-defendant,100,22,11/28/2018
943239,buybacks,100,74,11/28/2018
98A286,earnings-per-share-positive,100,69,11/28/2018
990AD0,conference-organizer,100,57,11/28/2018
990AD0,conference-organizer,100,57,11/28/2018
990AD0,conference-organizer,100,57,11/28/2018
9981C6,earnings,100,50,11/28/2018
9CA619,conference-call,100,50,11/28/2018
9CDA4F,conference-participant,100,50,11/28/2018
A1E3B3,earnings,100,50,11/28/2018
A1E3B3,earnings,100,50,11/28/2018
A1E3B3,earnings,100,50,11/28/2018
A1E3B3,earnings,100,50,11/28/2018
A1E3B3,earnings,100,50,11/28/2018
A247F5,conference-participant,100,50,11/28/2018
A5A4F5,acquisition-acquirer,100,49,11/28/2018
A631A3,conference-participant,100,50,11/28/2018
A63387,award,100,58,11/28/2018
A72AB6,earnings-above-expectations,100,88,11/28/2018
A790A5,revenue-up,100,62,11/28/2018
A790A5,revenue-up,100,62,11/28/2018
A790A5,revenue-up,100,62,11/28/2018
A790A5,revenue-up,100,62,11/28/2018
AA3AB8,earnings,100,50,11/28/2018
AE4125,executive-appointment,100,54,11/28/2018
B01111,earnings,100,50,11/28/2018
B2E6B5,public-offering,100,43,11/28/2018
B303A6,business-contract,100,69,11/28/2018
B3CB74,conference-organizer,100,57,11/28/2018
B3CB74,conference-organizer,100,57,11/28/2018
B54A74,conference-participant,100,50,11/28/2018
B840EF,note-sale,100,52,11/28/2018
B840EF,public-offering,100,43,11/28/2018
B8EF97,facility-upgrade,100,65,11/28/2018
BC3AD2,dividend,100,50,11/28/2018
BCC55F,executive-appointment,100,54,11/28/2018
C01737,executive-appointment,100,54,11/28/2018
C15F8F,earnings,100,50,11/28/2018
C22BE8,earnings-up,100,68,11/28/2018
C22BE8,earnings,100,50,11/28/2018
C22BE8,earnings,100,50,11/28/2018
C22BE8,earnings,100,50,11/28/2018
C3BCD5,trading-listing,100,61,11/28/2018
C4C77F,executive-appointment,100,54,11/28/2018
C5C137,note-sale,100,52,11/28/2018
C5C137,note-sale,100,52,11/28/2018
C6C702,conference-participant,100,50,11/28/2018
C9E04B,executive-appointment,100,54,11/28/2018
CAC8D0,settlement,100,56,11/28/2018
CD4DA8,conference-participant,100,50,11/28/2018
D2C0B6,earnings,100,50,11/28/2018
D82EF3,partnership,100,61,11/28/2018
D8442A,legal-issues-defendant,100,22,11/28/2018
DBCA3F,credit-extension-provider,100,57,11/28/2018
DD0F15,sponsorship,100,57,11/28/2018
DF532D,conference-participant,100,50,11/28/2018
E35610,revenue-up,100,83,11/28/2018
E68E62,public-offering,100,43,11/28/2018
E7BF32,patent-filing,100,64,11/28/2018
E7BF32,patent-filing,100,64,11/28/2018
E8846E,conference-organizer,100,57,11/28/2018
EB5E78,conference-participant,100,50,11/28/2018
F02170,revenue-up,100,70,11/28/2018
F02170,revenue-up,100,69,11/28/2018
F02170,revenue-up,100,69,11/28/2018
F02170,revenue-up,100,69,11/28/2018
F02170,revenue-up,100,69,11/28/2018
F0B2B5,executive-appointment,100,54,11/28/2018
F15E41,legal-issues-defendant,100,22,11/28/2018
F15E41,legal-issues-defendant,100,22,11/28/2018
F57F6F,conference-organizer,100,57,11/28/2018
FA35C6,conference-participant,100,50,11/28/2018
FACF19,market-entry,100,57,11/28/2018
FC1A6E,conference-participant,100,50,11/28/2018
FD554E,dividend,100,50,11/28/2018
0157B1,partnership,100,61,11/29/2018
0157B1,partnership,100,61,11/29/2018
0157B1,partnership,100,61,11/29/2018
55018,conference-organizer,100,57,11/29/2018
0624BE,earnings,100,50,11/29/2018
0624BE,executive-appointment,100,54,11/29/2018
06A456,earnings,100,50,11/29/2018
06A456,earnings,100,50,11/29/2018
06A456,earnings,100,50,11/29/2018
06A456,earnings,100,50,11/29/2018
078D52,unit-acquisition-acquirer,100,49,11/29/2018
08A40F,donation,100,54,11/29/2018
0968A5,earnings,100,50,11/29/2018
0C28D1,executive-appointment,100,54,11/29/2018
0C28D1,executive-appointment,100,54,11/29/2018
10100E,earnings,100,50,11/29/2018
143C52,earnings,100,50,11/29/2018
14833D,legal-issues-defendant,100,22,11/29/2018
152E1D,legal-issues-defendant,100,22,11/29/2018
1F9258,conference-participant,100,50,11/29/2018
1FCC00,conference-call,100,50,11/29/2018
202E5A,executive-appointment,100,54,11/29/2018
225CA2,executive-appointment,100,54,11/29/2018
26F99F,earnings,100,50,11/29/2018
2CB4C9,award,100,58,11/29/2018
2D643C,executive-appointment,100,54,11/29/2018
2F9304,earnings,100,50,11/29/2018
315EB0,facility-open,100,65,11/29/2018
33AD83,earnings,100,50,11/29/2018
36C09B,legal-issues-defendant,100,22,11/29/2018
37B618,unit-acquisition-acquirer,100,49,11/29/2018
3CBA2A,facility-open,100,65,11/29/2018
414FFF,earnings-per-share-above-expectations,100,83,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share,100,50,11/29/2018
414FFF,earnings-per-share-up,100,68,11/29/2018
422A82,award,100,58,11/29/2018
4A6F00,campaign-ad-release,100,59,11/29/2018
4AC91D,earnings,100,50,11/29/2018
4B7006,earnings,100,50,11/29/2018
4D971D,dividend,100,50,11/29/2018
50070E,conference-organizer,100,57,11/29/2018
504FE2,business-contract,100,69,11/29/2018
53A226,dividend,100,50,11/29/2018
5.43E+08,partnership,100,61,11/29/2018
543900,executive-appointment,100,54,11/29/2018
55438C,legal-issues-defendant,100,22,11/29/2018
55438C,legal-issues-defendant,100,22,11/29/2018
55438C,legal-issues-defendant,100,22,11/29/2018
5BC2F4,partnership,100,61,11/29/2018
601785,executive-appointment,100,54,11/29/2018
6284B5,partnership,100,61,11/29/2018
662682,note-sale,100,52,11/29/2018
6830FE,earnings,100,50,11/29/2018
68586A,conference-participant,100,50,11/29/2018
6C987C,dividend,100,50,11/29/2018
6E705B,product-release,100,64,11/29/2018
6F3FA8,dividend,100,50,11/29/2018
73BCBA,partnership,100,61,11/29/2018
73F70F,earnings,100,50,11/29/2018
76BD96,public-offering,100,43,11/29/2018
7E3F8F,public-offering,100,43,11/29/2018
8.10E+205,earnings,100,50,11/29/2018
8377DB,conference-participant,100,50,11/29/2018
859281,note-sale,100,52,11/29/2018
87B81A,executive-appointment,100,54,11/29/2018
8802B4,conference-participant,100,50,11/29/2018
8DCF18,legal-issues-defendant,100,22,11/29/2018
901327,buybacks,100,74,11/29/2018
902255,dividend-up,100,60,11/29/2018
905356,partnership,100,61,11/29/2018
94637C,conference-participant,100,50,11/29/2018
96F126,business-contract,100,69,11/29/2018
97AAF6,award,100,58,11/29/2018
986AF6,acquisition-acquirer,100,49,11/29/2018
990AD0,conference-organizer,100,57,11/29/2018
990AD0,conference-organizer,100,57,11/29/2018
997348,dividend,100,50,11/29/2018
9978F1,regulatory-product-approval-granted,100,81,11/29/2018
9F048E,earnings,100,50,11/29/2018
A495F7,partnership,100,61,11/29/2018
A52B6B,earnings,100,50,11/29/2018
A5A4F5,acquisition-acquirer,100,49,11/29/2018
A631A3,earnings,100,50,11/29/2018
A631A3,earnings,100,50,11/29/2018
A631A3,earnings,100,50,11/29/2018
A631A3,earnings,100,50,11/29/2018
A631A3,earnings,100,50,11/29/2018
A631A3,earnings,100,50,11/29/2018
A631A3,earnings,100,50,11/29/2018
A63387,public-offering,100,43,11/29/2018
A6FC89,earnings-up,100,68,11/29/2018
A6FC89,earnings,100,50,11/29/2018
A6FC89,earnings,100,50,11/29/2018
A6FC89,earnings,100,50,11/29/2018
B2E6B5,public-offering,100,43,11/29/2018
B3CB74,conference-organizer,100,57,11/29/2018
B3CB74,conference-organizer,100,57,11/29/2018
B642E8,award,100,58,11/29/2018
B8F71F,executive-appointment,100,54,11/29/2018
C0BA36,conference-participant,100,50,11/29/2018
C356AC,acquisition-acquirer,100,49,11/29/2018
C4C77F,executive-resignation,100,44,11/29/2018
C5C137,fundraising,100,64,11/29/2018
C66A8C,earnings,100,50,11/29/2018
C66A8C,earnings,100,50,11/29/2018
C66A8C,earnings,100,50,11/29/2018
C66A8C,earnings,100,50,11/29/2018
C66A8C,earnings,100,50,11/29/2018
C99CC8,conference-participant,100,50,11/29/2018
CC339B,dividend,100,50,11/29/2018
CC6F6E,earnings,100,50,11/29/2018
CC6F6E,earnings,100,50,11/29/2018
CC6F6E,earnings,100,50,11/29/2018
CC6F6E,earnings,100,50,11/29/2018
CDAF5B,assets,100,50,11/29/2018
CDAF5B,assets,100,50,11/29/2018
CDAF5B,buybacks,100,74,11/29/2018
CDFCC9,conference-participant,100,50,11/29/2018
CDFCC9,conference-participant,100,50,11/29/2018
D1CFC8,conference-call,100,50,11/29/2018
D296C6,dividend,100,50,11/29/2018
D3CEDF,legal-issues-defendant,100,22,11/29/2018
D3F64D,dividend,100,50,11/29/2018
D42DBA,earnings,100,50,11/29/2018
DB9829,earnings,100,50,11/29/2018
DC0998,dividend,100,50,11/29/2018
DFADDB,conference-participant,100,50,11/29/2018
E15736,acquisition-completed-acquirer,100,49,11/29/2018
E8846E,conference-organizer,100,57,11/29/2018
E96E0B,conference-participant,100,50,11/29/2018
EC99D0,acquisition-interest-acquirer,100,46,11/29/2018
ED9576,legal-issues-defendant,100,22,11/29/2018
EEB5F9,executive-appointment,100,54,11/29/2018
EEB5F9,conference-participant,100,50,11/29/2018
EF1AD9,product-release,100,64,11/29/2018
F15E41,legal-issues-defendant,100,22,11/29/2018
F15E41,legal-issues-defendant,100,22,11/29/2018
F1EB39,earnings,100,50,11/29/2018
F46EC9,conference-participant,100,50,11/29/2018
F57F6F,conference-organizer,100,57,11/29/2018
F7935D,business-contract,100,69,11/29/2018
F80389,credit-extension-recipient,100,69,11/29/2018
F90EE5,product-release,100,64,11/29/2018
FA40E2,earnings,100,50,11/29/2018
FC1A6E,legal-issues-defendant,100,22,11/29/2018
02870F,dividend,100,50,11/30/2018
034B61,conference-participant,100,50,11/30/2018
06C826,conference-participant,100,50,11/30/2018
09062E,unit-acquisition-acquirer,100,49,11/30/2018
1272B3,acquisition-acquirer,100,49,11/30/2018
14833D,legal-issues-defendant,100,22,11/30/2018
159739,conference-call,100,50,11/30/2018
159739,conference-call,100,50,11/30/2018
1748F6,unit-acquisition-acquiree,100,76,11/30/2018
1D943E,conference-participant,100,50,11/30/2018
1DE526,conference-participant,100,50,11/30/2018
2158DF,conference-participant,100,50,11/30/2018
267718,business-contract,100,69,11/30/2018
295F9F,executive-appointment,100,54,11/30/2018
2AA6A8,regulatory-product-approval-granted,100,81,11/30/2018
2E61CC,unit-acquisition-completed-acquirer,100,49,11/30/2018
314D88,executive-appointment,100,54,11/30/2018
32CB22,acquisition-completed-acquirer,100,49,11/30/2018
366A08,spin-off,100,58,11/30/2018
36C09B,legal-issues-defendant,100,22,11/30/2018
385DD4,legal-issues-defendant,100,22,11/30/2018
385DD4,legal-issues-defendant,100,22,11/30/2018
385DD4,legal-issues-defendant,100,22,11/30/2018
385DD4,legal-issues-defendant,100,22,11/30/2018
385DD4,legal-issues-defendant,100,22,11/30/2018
385DD4,legal-issues-defendant,100,22,11/30/2018
39FB23,investment-investor,100,55,11/30/2018
3A6D90,dividend,100,50,11/30/2018
3A94DF,dividend-up,100,58,11/30/2018
435ACE,conference-participant,100,50,11/30/2018
4A5C8D,facility-open,100,65,11/30/2018
4C3FE9,conference-participant,100,50,11/30/2018
50070E,conference-organizer,100,57,11/30/2018
50070E,conference-organizer,100,57,11/30/2018
53F491,buybacks,100,74,11/30/2018
54DF47,dividend,100,50,11/30/2018
55438C,legal-issues-defendant,100,22,11/30/2018
55438C,product-release,100,64,11/30/2018
55438C,legal-issues-defendant,100,22,11/30/2018
55438C,product-release,100,64,11/30/2018
55C9B5,business-contract,100,69,11/30/2018
55CD6F,dividend,100,50,11/30/2018
57DDB9,conference-participant,100,50,11/30/2018
59872F,conference-participant,100,50,11/30/2018
5D87DF,earnings,100,50,11/30/2018
665D7D,business-contract,100,69,11/30/2018
66E3C0,award,100,58,11/30/2018
68BA15,acquisition-acquirer,100,49,11/30/2018
6D3F35,conference-participant,100,50,11/30/2018
6DC1D7,dividend,100,50,11/30/2018
6E705B,partnership,100,61,11/30/2018
6E705B,partnership,100,61,11/30/2018
6E705B,partnership,100,61,11/30/2018
7273FF,acquisition-completed-acquirer,100,49,11/30/2018
75F982,dividend,100,50,11/30/2018
76BD96,public-offering,100,43,11/30/2018
7E3F8F,public-offering,100,43,11/30/2018
8665BA,facility-open,100,65,11/30/2018
89E771,dividend,100,50,11/30/2018
8AB37F,index-listing,100,76,11/30/2018
8B4A45,facility-open,100,65,11/30/2018
9043FE,spin-off,100,58,11/30/2018
9043FE,spin-off,100,58,11/30/2018
9043FE,spin-off,100,58,11/30/2018
9043FE,spin-off,100,58,11/30/2018
93C130,dividend,100,50,11/30/2018
986AF6,dividend-up,100,81,11/30/2018
990AD0,conference-organizer,100,57,11/30/2018
990AD0,conference-organizer,100,57,11/30/2018
990AD0,conference-organizer,100,57,11/30/2018
990AD0,conference-organizer,100,57,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9A602D,acquisition-interest-acquirer,100,46,11/30/2018
9F6B1A,earnings-guidance-up,100,83,11/30/2018
A5151E,conference-participant,100,50,11/30/2018
A5A4F5,acquisition-acquirer,100,49,11/30/2018
A60354,unit-acquisition-acquirer,100,49,11/30/2018
A79F7D,conference-participant,100,50,11/30/2018
A96867,dividend,100,50,11/30/2018
AD1ACF,acquisition-completed-acquirer,100,49,11/30/2018
B05000,acquisition-completed-acquirer,100,49,11/30/2018
B0D41A,regulatory-product-approval-granted,100,81,11/30/2018
B4B281,earnings,100,50,11/30/2018
B4B281,earnings,100,50,11/30/2018
B4B281,earnings,100,50,11/30/2018
B604DF,acquisition-acquirer,100,49,11/30/2018
BDEF34,dividend-up,100,62,11/30/2018
C7859D,dividend,100,50,11/30/2018
C85A72,partnership,100,61,11/30/2018
C85A72,partnership,100,61,11/30/2018
C9C62A,earnings,100,50,11/30/2018
CFF97C,conference-participant,100,50,11/30/2018
D11C1C,executive-resignation,100,44,11/30/2018
D2B9E5,acquisition-completed-acquirer,100,49,11/30/2018
DB23C8,conference-participant,100,50,11/30/2018
DE5611,dividend,100,50,11/30/2018
E10D31,legal-issues-defendant,100,22,11/30/2018
E10D31,legal-issues-defendant,100,22,11/30/2018
E1E093,unit-acquisition-completed-acquiree,100,67,11/30/2018
E22FDE,partnership,100,61,11/30/2018
E259C7,acquisition-acquirer,100,49,11/30/2018
E68C3D,conference-participant,100,50,11/30/2018
E68E62,public-offering,100,43,11/30/2018
F11638,conference-participant,100,50,11/30/2018
F15E41,legal-issues-defendant,100,22,11/30/2018
F57F6F,executive-appointment,100,54,11/30/2018
F57F6F,executive-appointment,100,54,11/30/2018
F721A7,spin-off,100,58,11/30/2018
F721A7,spin-off,100,58,11/30/2018
F748C7,partnership,100,61,11/30/2018
F80389,acquisition-completed-acquirer,100,49,11/30/2018
F80389,merger-completed,100,66,11/30/2018
FC1A6E,legal-issues-defendant,100,22,11/30/2018
385DD4,legal-issues-defendant,100,22,12/1/2018
55438C,legal-issues-defendant,100,22,12/1/2018
620381,clinical-trials,100,56,12/1/2018
67303E,clinical-trials,100,56,12/1/2018
D5938F,clinical-trials,100,56,12/1/2018
DA9443,clinical-trials,100,56,12/1/2018
401072,clinical-trials,100,56,12/2/2018
55438C,product-release,100,64,12/2/2018
55438C,product-release,100,64,12/2/2018
55438C,product-release,100,64,12/2/2018
B290A2,clinical-trials,100,56,12/2/2018
D5938F,clinical-trials,100,56,12/2/2018
D5938F,clinical-trials,100,56,12/2/2018
9397,acquisition-acquirer,100,49,12/3/2018
0142B5,product-price-raise,100,57,12/3/2018
034B61,acquisition-completed-acquirer,100,49,12/3/2018
55018,conference-organizer,100,57,12/3/2018
55018,conference-organizer,100,57,12/3/2018
070B45,executive-appointment,100,54,12/3/2018
083F72,earnings,100,50,12/3/2018
98977,clinical-trials-positive,100,87,12/3/2018
98977,clinical-trials-positive,100,87,12/3/2018
0C355F,buybacks,100,74,12/3/2018
0C355F,buybacks,100,74,12/3/2018
0F2BC9,executive-appointment,100,54,12/3/2018
10C19B,legal-issues-defendant,100,22,12/3/2018
1151F4,business-contract,100,69,12/3/2018
1201B5,executive-appointment,100,54,12/3/2018
1348C9,dividend,100,50,12/3/2018
14833D,legal-issues-defendant,100,22,12/3/2018
14833D,legal-issues-defendant,100,22,12/3/2018
14833D,legal-issues-defendant,100,22,12/3/2018
1782D5,dividend,100,50,12/3/2018
17EDA5,partnership,100,61,12/3/2018
1880C5,conference-call,100,50,12/3/2018
1B4F31,executive-appointment,100,54,12/3/2018
1E9A6D,fundraising,100,64,12/3/2018
1EBF8D,conference-participant,100,50,12/3/2018
1FA886,business-contract,100,69,12/3/2018
228D42,partnership,100,61,12/3/2018
24D81E,facility-open,100,65,12/3/2018
25AB8E,partnership,100,61,12/3/2018
25AB8E,partnership,100,61,12/3/2018
26DC29,legal-issues-defendant,100,22,12/3/2018
2C35B5,regulatory-product-approval-granted,100,81,12/3/2018
2C35B5,executive-appointment,100,54,12/3/2018
2E0496,acquisition-acquirer,100,49,12/3/2018
2EC172,conference-participant,100,50,12/3/2018
3461CF,credit-rating-upgrade-rater,20,50,12/3/2018
34E9F9,business-contract,100,69,12/3/2018
36C09B,legal-issues-defendant,100,22,12/3/2018
37727A,public-offering,100,43,12/3/2018
385DD4,legal-issues-defendant,100,22,12/3/2018
385DD4,legal-issues-defendant,100,22,12/3/2018
385DD4,legal-issues-defendant,100,22,12/3/2018
385DD4,legal-issues-defendant,100,22,12/3/2018
385DD4,conference-participant,100,50,12/3/2018
39FB23,acquisition-completed-acquirer,100,49,12/3/2018
3B318A,legal-issues-defendant,100,22,12/3/2018
3DCECC,acquisition-acquirer,100,49,12/3/2018
435ACE,acquisition-completed-acquirer,100,49,12/3/2018
44A4FC,investment-investor,100,55,12/3/2018
451D61,clinical-trials,100,56,12/3/2018
451D61,clinical-trials,100,56,12/3/2018
451D61,clinical-trials,100,56,12/3/2018
46A16E,conference-participant,100,50,12/3/2018
4806CE,executive-appointment,100,54,12/3/2018
49A344,executive-appointment,100,54,12/3/2018
4A5C8D,legal-issues-defendant,100,22,12/3/2018
4A6F00,legal-issues-defendant,100,22,12/3/2018
4AC91D,executive-appointment,100,54,12/3/2018
4BDCA7,clinical-trials,100,56,12/3/2018
4C92B9,legal-issues-defendant,100,22,12/3/2018
4E4E75,executive-appointment,100,54,12/3/2018
4FCC78,acquisition-completed-acquirer,100,49,12/3/2018
539F49,earnings,100,50,12/3/2018
5487B1,executive-appointment,100,54,12/3/2018
55438C,legal-issues-defendant,100,22,12/3/2018
55C289,dividend,100,50,12/3/2018
55C9B5,partnership,100,61,12/3/2018
55C9B5,executive-appointment,100,54,12/3/2018
56EA2B,dividend,100,50,12/3/2018
59872F,partnership,100,61,12/3/2018
59B229,earnings-guidance,100,50,12/3/2018
59B229,earnings-guidance,100,50,12/3/2018
5BE42C,executive-appointment,100,54,12/3/2018
5D02B7,conference-call,100,50,12/3/2018
5D16CF,acquisition-completed-acquirer,100,49,12/3/2018
5DA8B3,acquisition-completed-acquirer,100,49,12/3/2018
5FDBD0,public-offering,100,43,12/3/2018
609208,conference-call,100,50,12/3/2018
6166D1,conference-call,100,50,12/3/2018
620381,clinical-trials,100,56,12/3/2018
620381,clinical-trials,100,56,12/3/2018
620381,clinical-trials,100,56,12/3/2018
633043,executive-appointment,100,54,12/3/2018
649CBD,legal-issues-defendant,100,22,12/3/2018
649CBD,legal-issues-defendant,100,22,12/3/2018
64E346,acquisition-acquirer,100,49,12/3/2018
65CF8E,executive-appointment,100,54,12/3/2018
665D7D,donation,100,54,12/3/2018
6F0096,dividend,100,50,12/3/2018
70CA28,product-release,100,64,12/3/2018
70CA28,product-release,100,64,12/3/2018
728737,executive-appointment,100,54,12/3/2018
756BB4,conference-call,100,50,12/3/2018
76F067,conference-participant,100,50,12/3/2018
7B8CB5,conference-participant,100,50,12/3/2018
803FED,conference-participant,100,50,12/3/2018
804708,dividend,100,50,12/3/2018
810FAD,partnership,100,61,12/3/2018
817ED9,partnership,100,61,12/3/2018
830BDB,conference-participant,100,50,12/3/2018
830BDB,executive-appointment,100,54,12/3/2018
834152,clinical-trials,100,56,12/3/2018
863350,conference-call,100,50,12/3/2018
8A8E41,product-release,100,64,12/3/2018
8B9B3B,clinical-trials-positive,100,87,12/3/2018
8B9B3B,clinical-trials-positive,100,87,12/3/2018
8DAAB9,executive-appointment,100,54,12/3/2018
8E10BF,conference-participant,100,50,12/3/2018
8EDACA,legal-issues-defendant,100,22,12/3/2018
8EF425,dividend,100,50,12/3/2018
8F3231,executive-appointment,100,54,12/3/2018
91C82E,asset-sale,100,62,12/3/2018
94637C,partnership,100,61,12/3/2018
947B0B,clinical-trials-positive,100,87,12/3/2018
949625,joint-venture,100,62,12/3/2018
954004,conference-call,100,50,12/3/2018
958938,acquisition-completed-acquirer,100,49,12/3/2018
958938,acquisition-completed-acquirer,100,49,12/3/2018
97644E,acquisition-completed-acquirer,100,49,12/3/2018
97693A,conference-call,100,50,12/3/2018
990AD0,conference-organizer,100,57,12/3/2018
9B4066,facility-sale,100,52,12/3/2018
A47A7D,executive-appointment,100,54,12/3/2018
A5A4F5,acquisition-acquirer,100,49,12/3/2018
A6213D,revenue-up,100,58,12/3/2018
A63387,public-offering,100,43,12/3/2018
A63820,donation,100,54,12/3/2018
A65325,acquisition-completed-acquirer,100,49,12/3/2018
A6828A,business-contract,100,69,12/3/2018
A6828A,partnership,100,61,12/3/2018
A6FB29,earnings-up,100,68,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
A6FB29,earnings,100,50,12/3/2018
AAC8B6,asset-sale,100,62,12/3/2018
AAC8B6,asset-sale,100,62,12/3/2018
AADE0B,stake-acquirer,100,48,12/3/2018
AADE0B,stake-acquirer,100,48,12/3/2018
AB7726,buybacks,100,74,12/3/2018
AD375D,market-entry,100,57,12/3/2018
B05000,executive-appointment,100,54,12/3/2018
B1FC3B,business-contract,100,69,12/3/2018
B604DF,executive-appointment,100,54,12/3/2018
B803B1,note-sale,100,52,12/3/2018
B85DCE,executive-appointment,100,54,12/3/2018
BDE867,acquisition-completed-acquirer,100,49,12/3/2018
BE7BA4,settlement,100,56,12/3/2018
BFE02C,executive-appointment,100,54,12/3/2018
C0200F,executive-appointment,100,54,12/3/2018
C07E05,partnership,100,61,12/3/2018
C29715,executive-appointment,100,54,12/3/2018
C36189,executive-appointment,100,54,12/3/2018
C4A432,asset-sale,100,62,12/3/2018
C83B88,partnership,100,61,12/3/2018
C97B2D,conference-participant,100,50,12/3/2018
CAD7D9,conference-call,100,50,12/3/2018
CBB77B,earnings,100,50,12/3/2018
CC0C78,patent-filing,100,64,12/3/2018
CC0C78,patent-filing,100,64,12/3/2018
CDD75E,executive-appointment,100,54,12/3/2018
CDE51C,patent-infringement-defendant,100,26,12/3/2018
CFF57D,executive-appointment,100,54,12/3/2018
CFF97C,credit-rating-confirmation-rater,20,50,12/3/2018
D17F7E,acquisition-completed-acquirer,100,49,12/3/2018
D622D5,unit-acquisition-acquirer,100,49,12/3/2018
D75910,earnings,100,50,12/3/2018
DC437D,credit-extension-recipient,100,69,12/3/2018
DC5299,dividend,100,50,12/3/2018
DC6AA0,asset-sale,100,62,12/3/2018
DC6AA0,conference-participant,100,50,12/3/2018
DD0099,acquisition-completed-acquiree,100,76,12/3/2018
DE5611,product-release,100,64,12/3/2018
DF18E6,executive-appointment,100,54,12/3/2018
E0207A,public-offering,100,43,12/3/2018
E0207A,public-offering,100,43,12/3/2018
E124EB,dividend,100,50,12/3/2018
E4CE73,product-release,100,64,12/3/2018
E5752F,conference-participant,100,50,12/3/2018
E5F0A8,acquisition-completed-acquirer,100,49,12/3/2018
E6BC2C,merger,100,66,12/3/2018
E6BC2C,merger,100,66,12/3/2018
EB61C4,acquisition-acquirer,100,49,12/3/2018
EE6F1C,executive-appointment,100,54,12/3/2018
F02170,conference-participant,100,50,12/3/2018
F0EEFB,conference-participant,100,50,12/3/2018
F15E41,legal-issues-defendant,100,22,12/3/2018
F509E2,earnings,100,50,12/3/2018
F57F6F,conference-organizer,100,57,12/3/2018
F57F6F,conference-organizer,100,57,12/3/2018
F57F6F,conference-organizer,100,57,12/3/2018
F6DCE4,partnership,100,61,12/3/2018
FC1A6E,legal-issues-defendant,100,22,12/3/2018
FE7A63,dividend,100,50,12/3/2018
FFE543,legal-issues-defendant,100,22,12/3/2018
00326D,asset-sale,100,62,12/4/2018
018C11,facility-open,100,65,12/4/2018
034B61,partnership,100,61,12/4/2018
03D5F9,legal-issues-defendant,100,22,12/4/2018
03FAA6,conference-participant,100,50,12/4/2018
06EF42,unit-acquisition-acquirer,100,49,12/4/2018
0BC29E,executive-appointment,100,54,12/4/2018
0C8D82,business-contract,100,69,12/4/2018
0CE7F6,product-release,100,64,12/4/2018
10C19B,legal-issues-defendant,100,22,12/4/2018
147C38,unit-acquisition-completed-acquiree,100,67,12/4/2018
152E1D,legal-issues-defendant,100,22,12/4/2018
168A5D,partnership,100,61,12/4/2018
17EDA5,partnership,100,61,12/4/2018
1866B2,executive-appointment,100,54,12/4/2018
1CD09C,partnership,100,61,12/4/2018
1E9A6D,executive-appointment,100,54,12/4/2018
1F3CFB,executive-appointment,100,54,12/4/2018
1FA886,business-contract,100,69,12/4/2018
1FAF22,conference-participant,100,50,12/4/2018
221AD7,legal-issues-defendant,100,22,12/4/2018
221AD7,legal-issues-defendant,100,22,12/4/2018
228D42,partnership,100,61,12/4/2018
228D42,partnership,100,61,12/4/2018
26CC63,earnings,100,50,12/4/2018
26DC29,award,100,58,12/4/2018
279916,earnings,100,50,12/4/2018
2CB4C9,unit-acquisition-completed-acquirer,100,49,12/4/2018
31AA84,conference-participant,100,50,12/4/2018
32CB22,executive-appointment,100,54,12/4/2018
33E9D5,earnings,100,50,12/4/2018
3461CF,award,100,58,12/4/2018
37426C,earnings,100,50,12/4/2018
37727A,public-offering,100,43,12/4/2018
385DD4,legal-issues-defendant,100,22,12/4/2018
385DD4,legal-issues-defendant,100,22,12/4/2018
385DD4,facility-open,100,65,12/4/2018
385DD4,legal-issues-defendant,100,22,12/4/2018
385DD4,legal-issues-defendant,100,22,12/4/2018
38C46F,dividend,100,50,12/4/2018
3A6D90,executive-resignation,100,44,12/4/2018
3D9999,legal-issues-defendant,100,22,12/4/2018
40B903,dividend,100,50,12/4/2018
4.00E+163,legal-issues-defendant,100,22,12/4/2018
415188,index-listing,100,76,12/4/2018
57F3DA,unit-acquisition-acquirer,100,49,12/4/2018
5D02B7,business-contract,100,69,12/4/2018
5D63F1,facility-open,100,65,12/4/2018
5E6959,product-release,100,64,12/4/2018
5F3D91,debt-extension-recipient,100,73,12/4/2018
5FDBD0,public-offering,100,43,12/4/2018
619882,conference-organizer,100,57,12/4/2018
649CBD,legal-issues-defendant,100,22,12/4/2018
68B03F,executive-appointment,100,54,12/4/2018
68B03F,executive-appointment,100,54,12/4/2018
68B03F,executive-appointment,100,54,12/4/2018
69FDFC,earnings,100,50,12/4/2018
6B5379,unit-acquisition-acquiree,100,76,12/4/2018
713810,product-release,100,64,12/4/2018
731675,product-release,100,64,12/4/2018
7FD8B9,conference-participant,100,50,12/4/2018
8.10E+32,executive-appointment,100,54,12/4/2018
83A065,dividend,100,50,12/4/2018
85DE00,product-release,100,64,12/4/2018
873DB9,business-contract,100,69,12/4/2018
88D80A,dividend,100,50,12/4/2018
89FBB1,buybacks,100,74,12/4/2018
8D4AE6,dividend,100,50,12/4/2018
8EF425,dividend,100,50,12/4/2018
903AB4,dividend-up,100,81,12/4/2018
92005C,executive-appointment,100,54,12/4/2018
96F126,business-contract,100,69,12/4/2018
98CEBB,award,100,58,12/4/2018
99DC8D,conference-call,100,50,12/4/2018
9B5968,acquisition-completed-acquirer,100,49,12/4/2018
9E575E,business-contract,100,69,12/4/2018
9E575E,business-contract,100,69,12/4/2018
A16DEA,headquarters-change,100,50,12/4/2018
A247F5,executive-appointment,100,54,12/4/2018
A37D68,earnings,100,50,12/4/2018
A5A4F5,acquisition-acquirer,100,49,12/4/2018
A63820,earnings,100,50,12/4/2018
A761FE,earnings,100,50,12/4/2018
A761FE,earnings,100,50,12/4/2018
A790A5,executive-appointment,100,54,12/4/2018
A96867,executive-appointment,100,54,12/4/2018
AA3AB8,earnings,100,50,12/4/2018
AB4A7E,conference-participant,100,50,12/4/2018
ACF77B,dividend-up,100,81,12/4/2018
ADF1B0,partnership,100,61,12/4/2018
AECCA9,dividend,100,50,12/4/2018
AED61E,earnings,100,50,12/4/2018
B076A1,dividend,100,50,12/4/2018
B1FC3B,award,100,58,12/4/2018
B1FC3B,earnings,100,50,12/4/2018
B33E77,clinical-trials-start,100,64,12/4/2018
B3CB74,conference-organizer,100,57,12/4/2018
B3CB74,conference-organizer,100,57,12/4/2018
B8EF97,legal-issues-defendant,100,22,12/4/2018
B9CD50,conference-participant,100,50,12/4/2018
C3BCD5,note-sale,100,52,12/4/2018
C3DE7D,executive-appointment,100,54,12/4/2018
C50B26,earnings,100,50,12/4/2018
C50B26,legal-issues-defendant,100,22,12/4/2018
C81E00,dividend-up,100,61,12/4/2018
C81E00,dividend-up,100,61,12/4/2018
CDAF5B,dividend,100,50,12/4/2018
CFF57D,earnings,100,50,12/4/2018
CFF57D,earnings,100,50,12/4/2018
CFF57D,earnings,100,50,12/4/2018
CFF57D,earnings,100,50,12/4/2018
D64C6D,executive-appointment,100,54,12/4/2018
D75910,earnings,100,50,12/4/2018
D76AEF,conference-participant,100,50,12/4/2018
D8760C,executive-resignation,100,44,12/4/2018
D8DA3D,executive-appointment,100,54,12/4/2018
DBB28E,earnings,100,50,12/4/2018
DC1405,public-offering,100,43,12/4/2018
DC2B00,earnings,100,50,12/4/2018
DD9E41,patent-awarded,100,72,12/4/2018
DE5611,earnings,100,50,12/4/2018
E10D31,legal-issues-defendant,100,22,12/4/2018
E5AAA3,partnership,100,61,12/4/2018
E8846E,conference-organizer,100,57,12/4/2018
EAA0A7,business-contract,100,69,12/4/2018
EAA0A7,business-contract,100,69,12/4/2018
ECF709,same-store-sales-up,100,53,12/4/2018
ECF709,same-store-sales-up,100,62,12/4/2018
EF77A3,legal-issues-defendant,100,22,12/4/2018
F1EB39,conference-participant,100,50,12/4/2018
F43A11,earnings,100,50,12/4/2018
FADF1A,conference-call,100,50,12/4/2018
FC1B7B,buybacks,100,74,12/4/2018
FC4550,dividend,100,50,12/4/2018
FC9A88,buybacks,100,74,12/4/2018
FD554E,dividend,100,50,12/4/2018
FF6644,legal-issues-defendant,100,22,12/4/2018
FF6644,legal-issues-defendant,100,22,12/4/2018
FF6644,legal-issues-defendant,100,22,12/4/2018
13528,acquisition-completed-acquirer,100,49,12/5/2018
13528,acquisition-completed-acquirer,100,49,12/5/2018
034B61,business-contract,100,69,12/5/2018
034B61,business-contract,100,69,12/5/2018
0B57D7,executive-resignation,100,44,12/5/2018
0BC29E,executive-appointment,100,54,12/5/2018
0BF528,earnings-up,100,68,12/5/2018
12DE76,dividend,100,50,12/5/2018
14833D,legal-issues-defendant,100,22,12/5/2018
14BA33,dividend,100,50,12/5/2018
184866,clinical-trials-start,100,64,12/5/2018
1D1B07,earnings,100,50,12/5/2018
1D1B07,earnings,100,50,12/5/2018
1F19C8,credit-extension-provider,100,57,12/5/2018
1F43A1,dividend-up,100,81,12/5/2018
28F905,conference-participant,100,50,12/5/2018
292A70,earnings,100,50,12/5/2018
2B8179,conference-participant,100,50,12/5/2018
3461CF,credit-rating-upgrade-rater,20,50,12/5/2018
3461CF,award,100,58,12/5/2018
34B411,buybacks,100,74,12/5/2018
4.00E+163,legal-issues-defendant,100,22,12/5/2018
4.00E+163,legal-issues-defendant,100,22,12/5/2018
41B53E,bankruptcy,100,7,12/5/2018
431B74,dividend-up,100,81,12/5/2018
431B74,dividend-up,100,81,12/5/2018
43A060,product-release,100,64,12/5/2018
43A74A,executive-appointment,100,54,12/5/2018
5065B1,dividend,100,50,12/5/2018
54512F,credit-extension-recipient,100,69,12/5/2018
583A75,revenue-volume,100,50,12/5/2018
59DB8C,earnings,100,50,12/5/2018
5DD486,dividend,100,50,12/5/2018
605F40,conference-participant,100,50,12/5/2018
619882,conference-organizer,100,57,12/5/2018
636BBF,product-release,100,64,12/5/2018
636BBF,partnership,100,61,12/5/2018
636BBF,earnings,100,50,12/5/2018
6.52E+64,legal-issues-defendant,100,22,12/5/2018
6634D9,legal-issues-defendant,100,22,12/5/2018
67303E,legal-issues-defendant,100,22,12/5/2018
67B052,conference-participant,100,50,12/5/2018
69CE71,product-release,100,64,12/5/2018
6F6559,earnings,100,50,12/5/2018
73BCBA,executive-appointment,100,54,12/5/2018
76D79A,dividend,100,50,12/5/2018
7ADE57,earnings,100,50,12/5/2018
7ADE57,earnings,100,50,12/5/2018
7E1D5D,earnings,100,50,12/5/2018
7E1D5D,earnings,100,50,12/5/2018
7E1D5D,earnings,100,50,12/5/2018
7E1D5D,earnings,100,50,12/5/2018
8.10E+32,executive-appointment,100,54,12/5/2018
859D62,earnings,100,50,12/5/2018
859D62,earnings-positive,100,69,12/5/2018
859D62,earnings-positive,100,69,12/5/2018
859D62,earnings-positive,100,69,12/5/2018
859D62,earnings-positive,100,69,12/5/2018
859D62,earnings-positive,100,69,12/5/2018
85CDC9,clinical-trials-start,100,64,12/5/2018
85CDC9,clinical-trials-start,100,64,12/5/2018
85CDC9,clinical-trials-start,100,64,12/5/2018
85CDC9,clinical-trials-start,100,64,12/5/2018
85CDC9,clinical-trials-start,100,64,12/5/2018
85CDC9,clinical-trials-start,100,64,12/5/2018
85DA04,executive-appointment,100,54,12/5/2018
89F693,product-release,100,64,12/5/2018
8AB85C,conference-participant,100,50,12/5/2018
8B1F37,dividend,100,50,12/5/2018
8DBBE6,executive-appointment,100,54,12/5/2018
8E4250,earnings,100,50,12/5/2018
901327,legal-issues-defendant,100,22,12/5/2018
9.31E+77,conference-call,100,50,12/5/2018
94563D,business-contract,100,69,12/5/2018
94637C,earnings,100,50,12/5/2018
968966,award,100,58,12/5/2018
96B4FF,conference-participant,100,50,12/5/2018
979451,legal-issues-defendant,100,22,12/5/2018
98CEBB,business-contract,100,69,12/5/2018
9981C6,executive-appointment,100,54,12/5/2018
9A602D,acquisition-acquirer,100,49,12/5/2018
9A602D,dividend-up,100,62,12/5/2018
A3800A,legal-issues-defendant,100,22,12/5/2018
A5A4F5,acquisition-acquirer,100,49,12/5/2018
AD23DE,executive-appointment,100,54,12/5/2018
AE4EEB,note-sale,100,52,12/5/2018
AECCA9,earnings,100,50,12/5/2018
B1A85D,business-contract,100,69,12/5/2018
B6082A,dividend,100,50,12/5/2018
C1114B,partnership,100,61,12/5/2018
C188F8,conference-participant,100,50,12/5/2018
C3F99F,conference-participant,100,50,12/5/2018
C5C137,executive-appointment,100,54,12/5/2018
C83B88,product-release,100,64,12/5/2018
CBB77B,dividend,100,50,12/5/2018
CFF15D,product-release,100,64,12/5/2018
CFF97C,partnership,100,61,12/5/2018
D0909F,dividend,100,50,12/5/2018
D0909F,dividend,100,50,12/5/2018
D54E62,executive-appointment,100,54,12/5/2018
D854F3,conference-participant,100,50,12/5/2018
DA0A9E,business-contract,100,69,12/5/2018
E10D31,legal-issues-defendant,100,22,12/5/2018
E13782,conference-participant,100,50,12/5/2018
E70531,donation,100,54,12/5/2018
EB5E78,product-release,100,64,12/5/2018
EF5BED,partnership,100,61,12/5/2018
F30508,partnership,100,61,12/5/2018
F3EDB4,earnings,100,50,12/5/2018
F3EDB4,partnership,100,61,12/5/2018
F5349B,executive-appointment,100,54,12/5/2018
F569FD,conference-participant,100,50,12/5/2018
F5D059,conference-call,100,50,12/5/2018
F6DE54,product-price-raise,100,57,12/5/2018
F92DBC,executive-appointment,100,54,12/5/2018
002A99,executive-appointment,100,54,12/6/2018
00326E,business-contract,100,69,12/6/2018
00698D,conference-call,100,50,12/6/2018
01D03F,regulatory-product-approval-granted,100,81,12/6/2018
01D03F,regulatory-product-approval-granted,100,81,12/6/2018
01D03F,regulatory-product-approval-granted,100,81,12/6/2018
03596A,partnership,100,61,12/6/2018
07C907,dividend,100,50,12/6/2018
08A40F,merger-regulatory-approval,100,81,12/6/2018
095A04,business-contract,100,69,12/6/2018
09DE1F,earnings,100,50,12/6/2018
0BA2EF,earnings,100,50,12/6/2018
0BA2EF,earnings,100,50,12/6/2018
0CE7F6,partnership,100,61,12/6/2018
0CE7F6,partnership,100,61,12/6/2018
1201B5,campaign-ad-release,100,59,12/6/2018
125212,clinical-trials-start,100,64,12/6/2018
1748F6,earnings,100,50,12/6/2018
1921DD,legal-issues-defendant,100,22,12/6/2018
1AD9CC,earnings,100,50,12/6/2018
1AE482,award,100,58,12/6/2018
1CD708,dividend,100,50,12/6/2018
1D1B07,stake-acquirer,100,48,12/6/2018
1D1B07,stake-acquirer,100,48,12/6/2018
1FAF22,executive-appointment,100,54,12/6/2018
2093B1,unit-acquisition-acquirer,100,49,12/6/2018
227D48,acquisition-completed-acquirer,100,49,12/6/2018
26DC29,earnings,100,50,12/6/2018
274B8A,conference-call,100,50,12/6/2018
2920D5,earnings,100,50,12/6/2018
2CC60C,dividend,100,50,12/6/2018
2EC172,acquisition-completed-acquirer,100,49,12/6/2018
2F9304,award,100,58,12/6/2018
2FF046,earnings,100,50,12/6/2018
2FF046,earnings,100,50,12/6/2018
2FF046,earnings,100,50,12/6/2018
2FF046,earnings,100,50,12/6/2018
31643A,dividend,100,50,12/6/2018
343996,dividend-guidance-up,100,83,12/6/2018
37B618,dividend,100,50,12/6/2018
385DD4,legal-issues-defendant,100,22,12/6/2018
385DD4,legal-issues-defendant,100,22,12/6/2018
385DD4,legal-issues-defendant,100,22,12/6/2018
397A8F,earnings,100,50,12/6/2018
3B318A,legal-issues-defendant,100,22,12/6/2018
3D9999,legal-issues-defendant,100,22,12/6/2018
42978B,revenues,100,50,12/6/2018
42978B,revenues,100,50,12/6/2018
42978B,revenues,100,50,12/6/2018
42978B,revenues,100,50,12/6/2018
442587,executive-appointment,100,54,12/6/2018
47752F,dividend,100,50,12/6/2018
4A2457,award,100,58,12/6/2018
4D371E,donation,100,54,12/6/2018
4D8124,executive-appointment,100,54,12/6/2018
4E4E75,earnings,100,50,12/6/2018
4EEB00,conference-participant,100,50,12/6/2018
539F49,executive-appointment,100,54,12/6/2018
5.43E+08,business-contract,100,69,12/6/2018
548AC0,earnings,100,50,12/6/2018
55438C,business-contract,100,69,12/6/2018
56B7C1,award,100,58,12/6/2018
56EFC7,earnings,100,50,12/6/2018
58C2D4,executive-appointment,100,54,12/6/2018
5D1329,partnership,100,61,12/6/2018
619882,executive-appointment,100,54,12/6/2018
6634D9,note-sale,100,52,12/6/2018
69FDFC,executive-appointment,100,54,12/6/2018
6EA292,dividend,100,50,12/6/2018
7032D0,dividend,100,50,12/6/2018
70FCEF,earnings,100,50,12/6/2018
73F7F9,earnings,100,50,12/6/2018
7448A3,executive-resignation,100,44,12/6/2018
756BB4,earnings-up,100,68,12/6/2018
756BB4,earnings,100,50,12/6/2018
756BB4,earnings,100,50,12/6/2018
756BB4,earnings,100,50,12/6/2018
7740DE,same-store-sales-down,100,44,12/6/2018
7A0EC4,earnings,100,50,12/6/2018
7A0EC4,executive-appointment,100,54,12/6/2018
7A10FF,dividend,100,50,12/6/2018
7B9212,revenues,100,50,12/6/2018
7D5FD6,dividend-up,100,71,12/6/2018
7F3A5F,partnership,100,61,12/6/2018
7FC386,dividend-up,100,81,12/6/2018
826FD6,earnings,100,50,12/6/2018
863350,earnings,100,50,12/6/2018
880C0C,dividend,100,50,12/6/2018
8876D6,partnership,100,61,12/6/2018
8876D6,partnership,100,61,12/6/2018
8A8E41,dividend,100,50,12/6/2018
8B3B0E,dividend,100,50,12/6/2018
8C311A,product-release,100,64,12/6/2018
8C5519,dividend,100,50,12/6/2018
8D4486,partnership,100,61,12/6/2018
8D4486,partnership,100,61,12/6/2018
8D4486,acquisition-acquiree,100,76,12/6/2018
8D4486,acquisition-acquiree,100,76,12/6/2018
8D4486,acquisition-acquiree,100,76,12/6/2018
8F8F2F,dividend,100,50,12/6/2018
901327,legal-issues-defendant,100,22,12/6/2018
901327,legal-issues-defendant,100,22,12/6/2018
901327,legal-issues-defendant,100,22,12/6/2018
903AB4,executive-resignation,100,44,12/6/2018
9087B9,buybacks,100,74,12/6/2018
90D6A5,dividend,100,50,12/6/2018
9196A2,partnership,100,61,12/6/2018
931AE7,conference-participant,100,50,12/6/2018
93633B,dividend-up,100,81,12/6/2018
94637C,dividend-up,100,81,12/6/2018
947B0B,clinical-trials,100,56,12/6/2018
954004,earnings,100,50,12/6/2018
9592FB,public-offering,100,43,12/6/2018
95DC1F,earnings,100,50,12/6/2018
95DC1F,earnings,100,50,12/6/2018
95DC1F,earnings,100,50,12/6/2018
95DC1F,earnings,100,50,12/6/2018
97693A,earnings,100,50,12/6/2018
979451,legal-issues-defendant,100,22,12/6/2018
979451,legal-issues-defendant,100,22,12/6/2018
979451,legal-issues-defendant,100,22,12/6/2018
9810C0,dividend,100,50,12/6/2018
9.82E+06,earnings,100,50,12/6/2018
9981C6,dividend,100,50,12/6/2018
9B5968,executive-appointment,100,54,12/6/2018
9C8664,note-sale,100,52,12/6/2018
A16DEA,dividend,100,50,12/6/2018
A1EAC8,executive-appointment,100,54,12/6/2018
A5A4F5,acquisition-acquirer,100,49,12/6/2018
AA847A,executive-appointment,100,54,12/6/2018
AA98ED,dividend,100,50,12/6/2018
ADD9DC,earnings,100,50,12/6/2018
ADF1B0,business-contract,100,69,12/6/2018
AE7D16,legal-issues-defendant,100,22,12/6/2018
B05000,executive-appointment,100,54,12/6/2018
B1FC3B,business-contract,100,69,12/6/2018
B1FC3B,earnings,100,50,12/6/2018
B1FC3B,dividend,100,50,12/6/2018
B66928,partnership,100,61,12/6/2018
B72BE9,dividend-up,100,81,12/6/2018
B8EF97,revenues,100,50,12/6/2018
BB127B,award,100,58,12/6/2018
BC5680,product-release,100,64,12/6/2018
BC5680,product-release,100,64,12/6/2018
C06EB6,earnings,100,50,12/6/2018
C5D2AE,award,100,58,12/6/2018
C5E100,partnership,100,61,12/6/2018
C659EB,dividend-up,100,59,12/6/2018
C83B88,partnership,100,61,12/6/2018
C8A248,executive-appointment,100,54,12/6/2018
C9D866,market-entry,100,57,12/6/2018
CA1620,dividend,100,50,12/6/2018
CD2DA4,earnings,100,50,12/6/2018
CD4DA8,business-contract,100,69,12/6/2018
CF211D,earnings,100,50,12/6/2018
CF7292,earnings,100,50,12/6/2018
D17C1B,executive-appointment,100,54,12/6/2018
D17C1B,product-release,100,64,12/6/2018
D1AE3B,executive-appointment,100,54,12/6/2018
D2E553,earnings,100,50,12/6/2018
D2E553,earnings,100,50,12/6/2018
D4070C,dividend-up,100,81,12/6/2018
D437C3,business-contract,100,69,12/6/2018
D48275,dividend-up,100,56,12/6/2018
D5AF19,executive-appointment,100,54,12/6/2018
D6144F,executive-appointment,100,54,12/6/2018
D650A7,acquisition-acquirer,100,49,12/6/2018
D854DD,dividend,100,50,12/6/2018
DA0CB8,dividend-up,100,81,12/6/2018
DB2E4E,business-contract,100,69,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB88A1,earnings,100,50,12/6/2018
DB9829,earnings-up,100,68,12/6/2018
DB9829,earnings,100,50,12/6/2018
DB9829,earnings,100,50,12/6/2018
DB9829,earnings,100,50,12/6/2018
DCD97F,dividend,100,50,12/6/2018
E09556,conference-call,100,50,12/6/2018
E10D31,legal-issues-defendant,100,22,12/6/2018
E10D31,dividend,100,50,12/6/2018
E261E9,buybacks,100,74,12/6/2018
E8846E,legal-issues-defendant,100,22,12/6/2018
E8B21D,dividend,100,50,12/6/2018
ECA300,earnings,100,50,12/6/2018
EEA6B3,executive-appointment,100,54,12/6/2018
F509E2,executive-appointment,100,54,12/6/2018
F5349B,award,100,58,12/6/2018
F66B58,dividend,100,50,12/6/2018
F83279,dividend,100,50,12/6/2018
FA40E2,dividend,100,50,12/6/2018
FA40E2,executive-appointment,100,54,12/6/2018
FDE409,revenues,100,50,12/6/2018
FEBFE1,conference-participant,100,50,12/6/2018
FEBFE1,earnings,100,50,12/6/2018
FEC475,earnings-guidance,100,50,12/6/2018
FEC475,earnings,100,50,12/6/2018
FF9FF6,credit-extension-provider,100,57,12/6/2018
FF9FF6,credit-extension-provider,100,57,12/6/2018
FFE543,award,100,58,12/6/2018
001F1B,revenues,100,50,12/7/2018
01D03F,regulatory-product-approval-granted,100,81,12/7/2018
01D03F,regulatory-product-approval-granted,100,81,12/7/2018
0358AF,dividend,100,50,12/7/2018
03D5F9,legal-issues-defendant,100,22,12/7/2018
03D5F9,legal-issues-defendant,100,22,12/7/2018
04CCCD,revenue-up,100,69,12/7/2018
04CCCD,revenue-up,100,69,12/7/2018
07CA6A,executive-appointment,100,54,12/7/2018
07CA6A,executive-appointment,100,54,12/7/2018
0A7650,executive-appointment,100,54,12/7/2018
0B73A7,earnings,100,50,12/7/2018
0B73A7,earnings,100,50,12/7/2018
0E499E,conference-participant,100,50,12/7/2018
0E64D4,acquisition-completed-acquirer,100,49,12/7/2018
152E1D,legal-issues-defendant,100,22,12/7/2018
165B86,business-contract,100,69,12/7/2018
1921DD,dividend,100,50,12/7/2018
1E83DE,earnings,100,50,12/7/2018
1F08A6,dividend,100,50,12/7/2018
1FA886,business-contract,100,69,12/7/2018
1FCC00,dividend,100,50,12/7/2018
1FCC00,earnings,100,50,12/7/2018
1FCC00,earnings,100,50,12/7/2018
1FCC00,earnings,100,50,12/7/2018
253B2F,dividend,100,50,12/7/2018
2BA977,stake-acquirer,100,48,12/7/2018
2BA977,stake-acquirer,100,48,12/7/2018
2E61CC,partnership,100,61,12/7/2018
2E902B,dividend,100,50,12/7/2018
2EBA55,dividend,100,50,12/7/2018
2F98A5,product-recall,100,29,12/7/2018
31F25C,merger-regulatory-approval,100,81,12/7/2018
3587B4,executive-appointment,100,54,12/7/2018
366A08,conference-call,100,50,12/7/2018
385DD4,legal-issues-defendant,100,22,12/7/2018
3B318A,legal-issues-defendant,100,22,12/7/2018
3BB616,dividend,100,50,12/7/2018
422CE3,donation,100,54,12/7/2018
4A6F00,legal-issues-defendant,100,22,12/7/2018
4A7C1F,executive-appointment,100,54,12/7/2018
4D8313,buybacks,100,74,12/7/2018
4E3D15,dividend,100,50,12/7/2018
504FE2,dividend,100,50,12/7/2018
5088A5,dividend,100,50,12/7/2018
543900,executive-appointment,100,54,12/7/2018
5DD48B,executive-appointment,100,54,12/7/2018
665618,credit-extension-recipient,100,69,12/7/2018
69FDFC,award,100,58,12/7/2018
6A01DF,legal-issues-defendant,100,22,12/7/2018
76F067,dividend-up,100,60,12/7/2018
7B6C88,partnership,100,61,12/7/2018
7C4F43,clinical-trials,100,56,12/7/2018
8.73E+09,executive-appointment,100,54,12/7/2018
8D4486,acquisition-acquiree,100,76,12/7/2018
8DBE73,partnership,100,61,12/7/2018
901327,legal-issues-defendant,100,22,12/7/2018
901327,legal-issues-defendant,100,22,12/7/2018
907ED2,acquisition-completed-acquirer,100,49,12/7/2018
950CDB,earnings,100,50,12/7/2018
979451,legal-issues-defendant,100,22,12/7/2018
979451,legal-issues-defendant,100,22,12/7/2018
979451,legal-issues-defendant,100,22,12/7/2018
9934AD,earnings-guidance,100,50,12/7/2018
9934AD,earnings-guidance,100,50,12/7/2018
9BF177,earnings,100,50,12/7/2018
9CA432,dividend,100,50,12/7/2018
9E98F2,conference-participant,100,50,12/7/2018
A495F7,product-release,100,64,12/7/2018
A4BCDE,dividend,100,50,12/7/2018
A5A4F5,acquisition-acquirer,100,49,12/7/2018
A70BF5,dividend-up,100,81,12/7/2018
AA7FE0,conference-call,100,50,12/7/2018
B8A51F,conference-participant,100,50,12/7/2018
BD15E8,unit-acquisition-acquirer,100,49,12/7/2018
BFE02C,dividend,100,50,12/7/2018
C9C62A,earnings,100,50,12/7/2018
CF351E,dividend,100,50,12/7/2018
CF351E,dividend-up,100,59,12/7/2018
D25249,dividend,100,50,12/7/2018
D854DD,buybacks,100,74,12/7/2018
DA48E4,executive-appointment,100,54,12/7/2018
DD7A96,dividend,100,50,12/7/2018
E68733,dividend,100,50,12/7/2018
E6EDED,dividend,100,50,12/7/2018
E866D2,revenue-volume,100,50,12/7/2018
E8846E,donation,100,54,12/7/2018
EB7FBF,conference-call,100,50,12/7/2018
EF77A3,legal-issues-defendant,100,22,12/7/2018
F0B2B5,legal-issues-defendant,100,22,12/7/2018
FE7A63,merger-regulatory-approval,100,81,12/7/2018
732A9B,clinical-trials,100,56,12/8/2018
979451,legal-issues-defendant,100,22,12/8/2018
C83B88,partnership,100,61,12/8/2018
01D03F,partnership,100,61,12/10/2018
03542C,dividend,100,50,12/10/2018
03FAA6,ownership-decrease-owner,100,46,12/10/2018
0CE204,business-contract,100,69,12/10/2018
10C19B,legal-issues-defendant,100,22,12/10/2018
12F98C,earnings-per-share-up,100,77,12/10/2018
168A5D,partnership,100,61,12/10/2018
1834C0,unit-acquisition-acquirer,100,49,12/10/2018
1921DD,dividend,100,50,12/10/2018
1921DD,dividend,100,50,12/10/2018
1921DD,dividend,100,50,12/10/2018
1921DD,executive-appointment,100,54,12/10/2018
19BF16,acquisition-acquirer,100,49,12/10/2018
19BF16,acquisition-acquirer,100,49,12/10/2018
19BF16,acquisition-acquirer,100,49,12/10/2018
1D9E55,award,100,58,12/10/2018
1EBF8D,executive-resignation,100,44,12/10/2018
1F716B,donation,100,54,12/10/2018
1FA886,partnership,100,61,12/10/2018
20D00A,executive-appointment,100,54,12/10/2018
241AF7,dividend,100,50,12/10/2018
250BEE,dividend,100,50,12/10/2018
267718,product-release,100,64,12/10/2018
27B191,acquisition-completed-acquirer,100,49,12/10/2018
2AA6A8,executive-appointment,100,54,12/10/2018
2C7505,settlement,100,56,12/10/2018
2CA60F,executive-appointment,100,54,12/10/2018
314D88,executive-appointment,100,54,12/10/2018
36E479,earnings,100,50,12/10/2018
37B618,unit-acquisition-acquirer,100,49,12/10/2018
3B318A,legal-issues-defendant,100,22,12/10/2018
3B318A,earnings,100,50,12/10/2018
3B8484,acquisition-acquirer,100,49,12/10/2018
3C7F5F,partnership,100,61,12/10/2018
4.00E+163,award,100,58,12/10/2018
42AABD,award,100,58,12/10/2018
4398A2,regulatory-product-approval-granted,100,81,12/10/2018
444CC8,executive-appointment,100,54,12/10/2018
448215,dividend,100,50,12/10/2018
458D2C,product-release,100,64,12/10/2018
458D2C,revenue-volume,100,50,12/10/2018
4A5C8D,legal-issues-defendant,100,22,12/10/2018
4A6F00,legal-issues-defendant,100,22,12/10/2018
4C92B9,legal-issues-defendant,100,22,12/10/2018
4F9926,campaign-ad-release,100,59,12/10/2018
4FB770,debt-increase,100,26,12/10/2018
50070E,business-contract,100,69,12/10/2018
5065B1,earnings,100,50,12/10/2018
57DDB9,partnership,100,61,12/10/2018
596116,dividend,100,50,12/10/2018
59A832,dividend,100,50,12/10/2018
5AF08A,unit-acquisition-acquirer,100,49,12/10/2018
5B226B,business-contract,100,69,12/10/2018
5BC2F4,executive-appointment,100,54,12/10/2018
5C7601,business-contract,100,69,12/10/2018
5C7601,business-contract,100,69,12/10/2018
6137BF,partnership,100,61,12/10/2018
619882,conference-organizer,100,57,12/10/2018
61B81B,conference-call,100,50,12/10/2018
627186,earnings,100,50,12/10/2018
649CBD,legal-issues-defendant,100,22,12/10/2018
69C99E,clinical-trials-positive,100,87,12/10/2018
69FDFC,product-release,100,64,12/10/2018
731675,conference-organizer,100,57,12/10/2018
76F067,partnership,100,61,12/10/2018
76F067,partnership,100,61,12/10/2018
787D14,award,100,58,12/10/2018
7999F3,dividend,100,50,12/10/2018
7AF5B8,clinical-trials-start,100,64,12/10/2018
82B57E,executive-appointment,100,54,12/10/2018
85DA04,award,100,58,12/10/2018
8BAA15,revenue-guidance,100,50,12/10/2018
8EDACA,legal-issues-defendant,100,22,12/10/2018
94637C,partnership,100,61,12/10/2018
94637C,partnership,100,61,12/10/2018
9548BB,acquisition-acquirer,100,49,12/10/2018
967D92,acquisition-completed-acquirer,100,49,12/10/2018
96F126,executive-appointment,100,54,12/10/2018
972356,partnership,100,61,12/10/2018
979451,legal-issues-defendant,100,22,12/10/2018
980C14,dividend,100,50,12/10/2018
9B0C9C,conference-participant,100,50,12/10/2018
9B5968,partnership,100,61,12/10/2018
9C8BC3,dividend-up,100,55,12/10/2018
9D3360,unit-acquisition-acquirer,100,49,12/10/2018
9EBAFA,acquisition-acquirer,100,49,12/10/2018
A4386C,public-offering,100,43,12/10/2018
A5A4F5,acquisition-acquirer,100,49,12/10/2018
A6213D,executive-appointment,100,54,12/10/2018
A65325,conference-call,100,50,12/10/2018
A72FD9,earnings,100,50,12/10/2018
AADE0B,acquisition-acquirer,100,49,12/10/2018
AB7726,executive-appointment,100,54,12/10/2018
AB7726,executive-appointment,100,54,12/10/2018
AE7D16,product-release,100,64,12/10/2018
AE7D16,product-release,100,64,12/10/2018
AED6CF,earnings,100,50,12/10/2018
AED6CF,earnings,100,50,12/10/2018
B076A1,executive-appointment,100,54,12/10/2018
B614F8,revenue-guidance,100,50,12/10/2018
B73395,buybacks,100,74,12/10/2018
BCC55F,award,100,58,12/10/2018
BD682F,dividend,100,50,12/10/2018
C062D4,executive-appointment,100,54,12/10/2018
C48574,revenue-up,100,84,12/10/2018
C48574,revenue-up,100,84,12/10/2018
C48574,revenue-up,100,84,12/10/2018
C83B88,executive-appointment,100,54,12/10/2018
C83B88,facility-open,100,65,12/10/2018
C85A72,acquisition-completed-acquirer,100,49,12/10/2018
C9881C,conference-call,100,50,12/10/2018
CBB77B,earnings,100,50,12/10/2018
CBB77B,earnings,100,50,12/10/2018
CBBFBF,executive-appointment,100,54,12/10/2018
CDC217,executive-appointment,100,54,12/10/2018
CDD75E,executive-appointment,100,54,12/10/2018
CFF97C,credit-rating-set-rater,20,50,12/10/2018
CFF97C,executive-resignation,100,44,12/10/2018
CFF97C,executive-appointment,100,54,12/10/2018
D06755,executive-appointment,100,54,12/10/2018
D2B9E5,unit-acquisition-acquiree,100,76,12/10/2018
DF8855,business-contract,100,69,12/10/2018
E05026,conference-call,100,50,12/10/2018
E09556,earnings,100,50,12/10/2018
E13782,patient-enrollment-start,100,58,12/10/2018
E1E093,partnership,100,61,12/10/2018
E28D9C,partnership,100,61,12/10/2018
E30B34,executive-appointment,100,54,12/10/2018
E3656D,earnings,100,50,12/10/2018
E5F0A8,merger,100,66,12/10/2018
E6E012,executive-appointment,100,54,12/10/2018
E6E012,executive-appointment,100,54,12/10/2018
E8E899,earnings-guidance-up,100,83,12/10/2018
E8E899,buybacks,100,74,12/10/2018
EEA734,clinical-trials,100,56,12/10/2018
EEB5F9,clinical-trials-start,100,64,12/10/2018
EF77A3,earnings,100,50,12/10/2018
F179ED,executive-appointment,100,54,12/10/2018
F3EDB4,award,100,58,12/10/2018
F5349B,executive-appointment,100,54,12/10/2018
F66B58,earnings,100,50,12/10/2018
F6E248,executive-appointment,100,54,12/10/2018
F7902B,award,100,58,12/10/2018
F7ADEB,acquisition-interest-acquiree,100,82,12/10/2018
FC1736,earnings,100,50,12/10/2018
FD9526,credit-extension-recipient,100,69,12/10/2018
FEBFE1,earnings,100,50,12/10/2018
FF4343,buybacks,100,74,12/10/2018
0157B1,partnership,100,61,12/11/2018
03D5F9,legal-issues-defendant,100,22,12/11/2018
61366,earnings-guidance,100,50,12/11/2018
06EF42,unit-acquisition-acquirer,100,49,12/11/2018
71860,executive-appointment,100,54,12/11/2018
0A6824,business-contract,100,69,12/11/2018
0E3436,earnings,100,50,12/11/2018
0F0693,merger-regulatory-approval,100,81,12/11/2018
0F0693,merger-regulatory-approval,100,81,12/11/2018
12DE76,business-contract,100,69,12/11/2018
12DE76,business-contract,100,69,12/11/2018
143C52,executive-appointment,100,54,12/11/2018
152E1D,legal-issues-defendant,100,22,12/11/2018
156A99,executive-appointment,100,54,12/11/2018
1921DD,fundraising,100,64,12/11/2018
21245F,facility-open,100,65,12/11/2018
21DED4,dividend-up,100,60,12/11/2018
221AD7,legal-issues-defendant,100,22,12/11/2018
228D42,partnership,100,61,12/11/2018
2CC60C,revenue-up,100,69,12/11/2018
2CC60C,revenue-up,100,69,12/11/2018
2CC60C,revenue-up,100,69,12/11/2018
2EB04E,partnership,100,61,12/11/2018
2FDEE3,dividend,100,50,12/11/2018
32F943,executive-appointment,100,54,12/11/2018
3471C0,partnership,100,61,12/11/2018
366A08,conference-call,100,50,12/11/2018
37426C,earnings,100,50,12/11/2018
382EAE,facility-open,100,65,12/11/2018
385DD4,legal-issues-defendant,100,22,12/11/2018
3B37F7,executive-appointment,100,54,12/11/2018
3D9999,legal-issues-defendant,100,22,12/11/2018
3D9999,legal-issues-defendant,100,22,12/11/2018
3DC887,product-release,100,64,12/11/2018
3DCECC,conference-organizer,100,57,12/11/2018
3DE4D1,product-recall,100,29,12/11/2018
3DE4D1,product-recall,100,29,12/11/2018
4.00E+163,legal-issues-defendant,100,22,12/11/2018
427F32,executive-appointment,100,54,12/11/2018
4398A2,executive-appointment,100,54,12/11/2018
44209A,product-release,100,64,12/11/2018
453282,unit-acquisition-acquirer,100,49,12/11/2018
4C7DB5,executive-appointment,100,54,12/11/2018
4E4E75,dividend,100,50,12/11/2018
5065B1,earnings,100,50,12/11/2018
520632,conference-participant,100,50,12/11/2018
520632,conference-participant,100,50,12/11/2018
553949,award,100,58,12/11/2018
56EA2B,conference-call,100,50,12/11/2018
59F0B0,dividend,100,50,12/11/2018
5B6C11,dividend,100,50,12/11/2018
5BE42C,dividend,100,50,12/11/2018
5E6959,business-contract,100,69,12/11/2018
619882,conference-organizer,100,57,12/11/2018
619882,conference-organizer,100,57,12/11/2018
619882,conference-organizer,100,57,12/11/2018
619882,dividend,100,50,12/11/2018
633054,product-release,100,64,12/11/2018
633054,product-release,100,64,12/11/2018
63F892,partnership,100,61,12/11/2018
66A667,earnings,100,50,12/11/2018
66A667,earnings,100,50,12/11/2018
6830FE,partnership,100,61,12/11/2018
6830FE,business-contract,100,69,12/11/2018
69FDFC,product-release,100,64,12/11/2018
6C4D2F,executive-appointment,100,54,12/11/2018
7255D2,award,100,58,12/11/2018
728737,dividend,100,50,12/11/2018
728737,dividend,100,50,12/11/2018
76F067,partnership,100,61,12/11/2018
76F067,partnership,100,61,12/11/2018
76F067,partnership,100,61,12/11/2018
817ED9,partnership,100,61,12/11/2018
8303CD,executive-appointment,100,54,12/11/2018
838ADD,buybacks,100,74,12/11/2018
838ADD,acquisition-regulatory-approval-acquirer,100,54,12/11/2018
84A6B9,acquisition-acquirer,100,49,12/11/2018
84A6B9,acquisition-acquirer,100,49,12/11/2018
859D62,conference-call,100,50,12/11/2018
890FF4,fundraising,100,64,12/11/2018
89F693,partnership,100,61,12/11/2018
8AB85C,clinical-trials,100,56,12/11/2018
8AC740,dividend,100,50,12/11/2018
8D4486,executive-appointment,100,54,12/11/2018
8D4486,executive-appointment,100,54,12/11/2018
9196A2,partnership,100,61,12/11/2018
9196A2,business-contract,100,69,12/11/2018
91E5EE,dividend,100,50,12/11/2018
950CDB,dividend,100,50,12/11/2018
9592FB,public-offering,100,43,12/11/2018
966ACE,public-offering,100,43,12/11/2018
9.92E+94,dividend,100,50,12/11/2018
99DC8D,earnings,100,50,12/11/2018
9CA619,executive-appointment,100,54,12/11/2018
9EBAFA,public-offering,100,43,12/11/2018
A29DBD,partnership,100,61,12/11/2018
A3AAA5,dividend,100,50,12/11/2018
A3AAA5,dividend,100,50,12/11/2018
A47A7D,business-contract,100,69,12/11/2018
A47A7D,business-contract,100,69,12/11/2018
A5A4F5,acquisition-acquirer,100,49,12/11/2018
A6213D,executive-resignation,100,44,12/11/2018
A6828A,business-contract,100,69,12/11/2018
A6828A,business-contract,100,69,12/11/2018
AD23DE,patent-awarded,100,72,12/11/2018
AE7D16,legal-issues-defendant,100,22,12/11/2018
AEBB80,dividend-up,100,82,12/11/2018
AEFC90,earnings,100,50,12/11/2018
B37FB4,earnings,100,50,12/11/2018
B840EF,donation,100,54,12/11/2018
B8EF97,legal-issues-defendant,100,22,12/11/2018
B8EF97,legal-issues-defendant,100,22,12/11/2018
B9764A,partnership,100,61,12/11/2018
BDEC1E,regulatory-product-approval-granted,100,81,12/11/2018
C188F8,credit-extension-recipient,100,69,12/11/2018
C22BE8,acquisition-acquirer,100,49,12/11/2018
C50B26,earnings,100,50,12/11/2018
C8257F,dividend,100,50,12/11/2018
C85A72,public-offering,100,43,12/11/2018
C8FAC7,donation,100,54,12/11/2018
CAC8D0,earnings,100,50,12/11/2018
CBFFDD,executive-resignation,100,44,12/11/2018
CBFFDD,executive-resignation,100,44,12/11/2018
CE4FD9,executive-appointment,100,54,12/11/2018
D0909F,acquisition-acquiree,100,76,12/11/2018
D56D6D,dividend,100,50,12/11/2018
D65A13,partnership,100,61,12/11/2018
D6EAA3,board-meeting,100,51,12/11/2018
D7AC6E,dividend-up,100,81,12/11/2018
DC6AA0,equity-shelf-registration,100,43,12/11/2018
DF6FDD,product-release,100,64,12/11/2018
E10D31,legal-issues-defendant,100,22,12/11/2018
E13782,business-contract-terminated,100,31,12/11/2018
E16133,executive-appointment,100,54,12/11/2018
E9FF33,executive-appointment,100,54,12/11/2018
EB43F4,partnership,100,61,12/11/2018
EB61C4,acquisition-acquirer,100,49,12/11/2018
EC4E82,dividend-up,100,58,12/11/2018
ECF709,board-meeting,100,51,12/11/2018
EDD234,executive-appointment,100,54,12/11/2018
EF77A3,legal-issues-defendant,100,22,12/11/2018
F1529C,executive-appointment,100,54,12/11/2018
F48947,conference-participant,100,50,12/11/2018
F4F46F,executive-appointment,100,54,12/11/2018
F7935D,clinical-trials-positive,100,87,12/11/2018
F7935D,clinical-trials-positive,100,87,12/11/2018
F7ADEB,acquisition-interest-acquiree,100,82,12/11/2018
F9AA02,clinical-trials-start,100,64,12/11/2018
FAB97A,public-offering,100,43,12/11/2018
FACF19,earnings-guidance,100,50,12/11/2018
FACF19,product-release,100,64,12/11/2018
FC9A88,fundraising,100,64,12/11/2018
FF6644,earnings,100,50,12/11/2018
FF6644,legal-issues-defendant,100,22,12/11/2018
00326D,dividend,100,50,12/12/2018
03D5F9,legal-issues-defendant,100,22,12/12/2018
0A0CF0,dividend,100,50,12/12/2018
0BD4E8,government-contract,100,69,12/12/2018
0C2A0D,award,100,58,12/12/2018
1151F4,dividend,100,50,12/12/2018
129DC8,executive-appointment,100,54,12/12/2018
12DE76,conference-participant,100,50,12/12/2018
12DE76,conference-participant,100,50,12/12/2018
13A782,conference-participant,100,50,12/12/2018
14833D,legal-issues-defendant,100,22,12/12/2018
157D9F,executive-appointment,100,54,12/12/2018
16B183,business-contract,100,69,12/12/2018
16C544,dividend,100,50,12/12/2018
16C544,public-offering,100,43,12/12/2018
1BC12C,partnership,100,61,12/12/2018
1BC12C,partnership,100,61,12/12/2018
1BC12C,partnership,100,61,12/12/2018
1D943E,partnership,100,61,12/12/2018
1EBF8D,partnership,100,61,12/12/2018
1F716B,business-contract,100,69,12/12/2018
1FA886,business-contract,100,69,12/12/2018
202E5A,conference-participant,100,50,12/12/2018
21D903,name-change,100,49,12/12/2018
221445,buybacks,100,74,12/12/2018
25DD05,dividend,100,50,12/12/2018
25DD05,dividend,100,50,12/12/2018
275300,dividend,100,50,12/12/2018
292A70,dividend,100,50,12/12/2018
2BA977,dividend,100,50,12/12/2018
2E6514,executive-appointment,100,54,12/12/2018
2E902B,earnings-guidance,100,50,12/12/2018
2F7A7E,dividend,100,50,12/12/2018
2F960F,public-offering,100,43,12/12/2018
31553A,earnings-guidance,100,50,12/12/2018
319BE2,executive-appointment,100,54,12/12/2018
326EDD,dividend,100,50,12/12/2018
35557B,executive-appointment,100,54,12/12/2018
36E479,earnings,100,50,12/12/2018
384CD3,buybacks,100,74,12/12/2018
385DD4,legal-issues-defendant,100,22,12/12/2018
3BB616,buybacks,100,74,12/12/2018
3C7F5F,acquisition-acquiree,100,76,12/12/2018
3E15F6,trading-resumed,100,58,12/12/2018
3E15F6,trading-halt,100,43,12/12/2018
420168,business-contract,100,69,12/12/2018
449A26,business-contract,100,69,12/12/2018
485445,dividend,100,50,12/12/2018
4C92B9,legal-issues-defendant,100,22,12/12/2018
4F9926,facility-open,100,65,12/12/2018
55438C,legal-issues-defendant,100,22,12/12/2018
56277A,dividend,100,50,12/12/2018
589846,award,100,58,12/12/2018
58B46F,dividend,100,50,12/12/2018
5C2A47,award,100,58,12/12/2018
5CC29D,conference-call,100,50,12/12/2018
5D0337,executive-appointment,100,54,12/12/2018
5F3D91,partnership,100,61,12/12/2018
5FDBD0,earnings-guidance-up,100,83,12/12/2018
619882,conference-organizer,100,57,12/12/2018
619882,conference-organizer,100,57,12/12/2018
619882,conference-organizer,100,57,12/12/2018
6.52E+64,legal-issues-defendant,100,22,12/12/2018
66667F,partnership,100,61,12/12/2018
6D9B53,product-release,100,64,12/12/2018
713810,business-contract,100,69,12/12/2018
72FCA3,earnings,100,50,12/12/2018
73C521,executive-appointment,100,54,12/12/2018
7.44E+09,stake-acquirer,100,48,12/12/2018
767F86,dividend,100,50,12/12/2018
76D79A,reverse-stock-splits,100,51,12/12/2018
77B8E9,conference-participant,100,50,12/12/2018
7A5097,dividend,100,50,12/12/2018
7A975D,earnings,100,50,12/12/2018
7B0BA6,business-contract,100,69,12/12/2018
8.10E+205,product-release,100,64,12/12/2018
82B57E,executive-appointment,100,54,12/12/2018
838ADD,executive-appointment,100,54,12/12/2018
8B8656,earnings,100,50,12/12/2018
8E10BF,regulatory-product-approval-granted,100,81,12/12/2018
8EDACA,legal-issues-defendant,100,22,12/12/2018
8F3BCC,conference-call,100,50,12/12/2018
8FF2EF,earnings,100,50,12/12/2018
940C3D,partnership,100,61,12/12/2018
971F7B,unit-acquisition-acquirer,100,49,12/12/2018
979451,legal-issues-defendant,100,22,12/12/2018
9EBAFA,public-offering,100,43,12/12/2018
A21649,dividend,100,50,12/12/2018
A43906,executive-appointment,100,54,12/12/2018
A43906,dividend,100,50,12/12/2018
A5A4F5,acquisition-acquirer,100,49,12/12/2018
AEF2C3,executive-appointment,100,54,12/12/2018
B5DE80,conference-call,100,50,12/12/2018
B7FA9B,executive-appointment,100,54,12/12/2018
BCC55F,sanctions-target,100,19,12/12/2018
BDE867,asset-sale,100,62,12/12/2018
BE14CF,conference-participant,100,50,12/12/2018
C03C8B,buybacks,100,74,12/12/2018
C05839,dividend,100,50,12/12/2018
C22BE8,dividend,100,50,12/12/2018
C29715,buybacks,100,74,12/12/2018
C4452A,executive-appointment,100,54,12/12/2018
C50B26,unit-acquisition-acquirer,100,49,12/12/2018
C50B26,acquisition-acquirer,100,49,12/12/2018
C5C137,note-sale,100,52,12/12/2018
C5C137,note-sale,100,52,12/12/2018
C5F463,partnership,100,61,12/12/2018
C83B88,conference-call,100,50,12/12/2018
CE1002,partnership,100,61,12/12/2018
CE5664,award,100,58,12/12/2018
CFF15D,partnership,100,61,12/12/2018
CFF97C,credit-rating-outlook-stable-rater,20,50,12/12/2018
D17C1B,revenue-volume,100,50,12/12/2018
D1AE3B,conference-call,100,50,12/12/2018
D27FAB,fundraising,100,64,12/12/2018
D2C0B6,earnings,100,50,12/12/2018
D4AC65,product-release,100,64,12/12/2018
D75910,dividend,100,50,12/12/2018
DA0A9E,conference-call,100,50,12/12/2018
DD1BA1,market-entry,100,57,12/12/2018
DF46C5,partnership,100,61,12/12/2018
DF5F14,dividend,100,50,12/12/2018
E10D31,legal-issues-defendant,100,22,12/12/2018
E70531,donation,100,54,12/12/2018
E8846E,earnings,100,50,12/12/2018
E8D221,earnings,100,50,12/12/2018
EC99D0,conference-call,100,50,12/12/2018
ED9C04,partnership,100,61,12/12/2018
EE967B,executive-appointment,100,54,12/12/2018
F15E41,legal-issues-defendant,100,22,12/12/2018
F30508,partnership,100,61,12/12/2018
F30508,partnership,100,61,12/12/2018
F30508,partnership,100,61,12/12/2018
F43A11,partnership,100,61,12/12/2018
F4F46F,buybacks,100,74,12/12/2018
F6DA75,earnings,100,50,12/12/2018
FAB97A,public-offering,100,43,12/12/2018
FE7A63,executive-appointment,100,54,12/12/2018
FF5413,revenue-volume,100,50,12/12/2018
0142B5,product-price-raise,100,57,12/13/2018
0142B5,product-price-raise,100,57,12/13/2018
0157B1,legal-issues-defendant,100,22,12/13/2018
03B8CF,product-release,100,64,12/13/2018
03B8CF,product-release,100,64,12/13/2018
95294,business-contract,100,69,12/13/2018
0A0CF0,earnings,100,50,12/13/2018
0B4D10,dividend,100,50,12/13/2018
0BA2EF,dividend,100,50,12/13/2018
0BD4E8,dividend,100,50,12/13/2018
0BD4E8,executive-appointment,100,54,12/13/2018
0BF528,executive-appointment,100,54,12/13/2018
0F0693,merger-completed,100,66,12/13/2018
105D00,buybacks,100,74,12/13/2018
106394,dividend,100,50,12/13/2018
106394,dividend,100,50,12/13/2018
11B8A4,executive-appointment,100,54,12/13/2018
13C3E0,product-release,100,64,12/13/2018
14833D,legal-issues-defendant,100,22,12/13/2018
16B183,dividend,100,50,12/13/2018
16FC89,dividend,100,50,12/13/2018
1921DD,stake-acquiree,100,62,12/13/2018
1A6A94,credit-extension-recipient,100,69,12/13/2018
1DA44F,executive-appointment,100,54,12/13/2018
1E9A6D,fundraising,100,64,12/13/2018
228D42,acquisition-acquiree,100,76,12/13/2018
228D42,acquisition-acquiree,100,76,12/13/2018
228D42,acquisition-acquiree,100,76,12/13/2018
251988,executive-appointment,100,54,12/13/2018
27C10F,partnership,100,61,12/13/2018
282C18,dividend,100,50,12/13/2018
2920D5,buybacks,100,74,12/13/2018
295F9F,reorganization,100,53,12/13/2018
2B8179,clinical-trials-start,100,64,12/13/2018
2D643C,executive-appointment,100,54,12/13/2018
2D981A,legal-issues-defendant,100,22,12/13/2018
2F960F,dividend,100,50,12/13/2018
37727A,dividend,100,50,12/13/2018
37B618,unit-acquisition-acquirer,100,49,12/13/2018
3E15F6,trading-resumed,100,58,12/13/2018
3E15F6,dividend-up,100,57,12/13/2018
40B903,product-recall,100,29,12/13/2018
4398A2,conference-participant,100,50,12/13/2018
448BF3,executive-appointment,100,54,12/13/2018
467F2C,facility-open,100,65,12/13/2018
4A6F00,partnership,100,61,12/13/2018
4A6F00,partnership,100,61,12/13/2018
4A6F00,partnership,100,61,12/13/2018
4AC91D,partnership,100,61,12/13/2018
4C31F3,acquisition-acquirer,100,49,12/13/2018
4C31F3,acquisition-acquirer,100,49,12/13/2018
55438C,product-release,100,64,12/13/2018
55C289,name-change,100,49,12/13/2018
58CA9A,earnings,100,50,12/13/2018
5A423F,conference-participant,100,50,12/13/2018
5BC2F4,dividend,100,50,12/13/2018
616E3B,dividend-guidance-up,100,83,12/13/2018
619882,conference-organizer,100,57,12/13/2018
619882,facility-open,100,65,12/13/2018
619882,facility-open,100,65,12/13/2018
619882,conference-organizer,100,57,12/13/2018
665D7D,buybacks,100,74,12/13/2018
6CC55E,conference-participant,100,50,12/13/2018
743C70,earnings,100,50,12/13/2018
7.49E+07,legal-issues-defendant,100,22,12/13/2018
7520CC,executive-appointment,100,54,12/13/2018
766047,dividend,100,50,12/13/2018
767F86,executive-appointment,100,54,12/13/2018
76F067,partnership,100,61,12/13/2018
79167B,executive-appointment,100,54,12/13/2018
7A10FF,unit-acquisition-acquiree,100,76,12/13/2018
7ACBA4,dividend,100,50,12/13/2018
7B1E50,drilling,100,68,12/13/2018
7F9E16,buybacks,100,74,12/13/2018
8.10E+32,board-meeting,100,51,12/13/2018
89B2E7,dividend,100,50,12/13/2018
94983E,partnership,100,61,12/13/2018
966ACE,public-offering,100,43,12/13/2018
9A02C4,conference-call,100,50,12/13/2018
9D4EC7,expenses-guidance,100,50,12/13/2018
9F71E5,product-release,100,64,12/13/2018
A21649,executive-appointment,100,54,12/13/2018
A5A4F5,acquisition-acquirer,100,49,12/13/2018
A666C8,executive-appointment,100,54,12/13/2018
A6828A,business-contract,100,69,12/13/2018
A6828A,business-contract,100,69,12/13/2018
A7102F,buybacks,100,74,12/13/2018
A75D43,executive-appointment,100,54,12/13/2018
AA1EAA,dividend,100,50,12/13/2018
ADF092,business-contract,100,69,12/13/2018
ADF092,business-contract,100,69,12/13/2018
AE4EEB,dividend,100,50,12/13/2018
AE7D16,partnership,100,61,12/13/2018
B1A85D,settlement,100,56,12/13/2018
B1B10C,executive-appointment,100,54,12/13/2018
B1FC3B,business-contract,100,69,12/13/2018
B642E8,asset-sale,100,62,12/13/2018
B642E8,asset-sale,100,62,12/13/2018
B8EF97,operating-earnings,100,50,12/13/2018
BFAEB4,conference-call,100,50,12/13/2018
C06EB6,revenue-up,100,69,12/13/2018
C06EB6,revenue-up,100,69,12/13/2018
C15DB3,executive-appointment,100,54,12/13/2018
C2DD02,dividend,100,50,12/13/2018
C62AA4,dividend,100,50,12/13/2018
C85A72,executive-appointment,100,54,12/13/2018
C9881C,revenue-up,100,69,12/13/2018
C9881C,revenue-up,100,69,12/13/2018
C9881C,revenue-up,100,69,12/13/2018
C9881C,revenue-up,100,69,12/13/2018
C99CC8,award,100,58,12/13/2018
CAD7D9,conference-call,100,50,12/13/2018
CBFFDD,executive-appointment,100,54,12/13/2018
CBFFDD,executive-appointment,100,54,12/13/2018
CD2A4D,conference-participant,100,50,12/13/2018
D139BC,dividend,100,50,12/13/2018
D296C6,dividend,100,50,12/13/2018
D2E553,dividend,100,50,12/13/2018
D33D8C,dividend,100,50,12/13/2018
D3FD6D,dividend,100,50,12/13/2018
D622D5,dividend-up,100,81,12/13/2018
DB5CA5,executive-appointment,100,54,12/13/2018
DC6AA0,buybacks,100,74,12/13/2018
DEF058,business-contract,100,69,12/13/2018
DF204B,facility-open,100,65,12/13/2018
E09997,acquisition-completed-acquirer,100,49,12/13/2018
E2CB7B,acquisition-completed-acquirer,100,49,12/13/2018
E3E68E,legal-issues-defendant,100,22,12/13/2018
E40FB6,merger,100,66,12/13/2018
E4CE73,partnership,100,61,12/13/2018
E6A53A,executive-appointment,100,54,12/13/2018
E8B315,dividend,100,50,12/13/2018
EB7FBF,note-sale,100,52,12/13/2018
EEA6B3,business-contract,100,69,12/13/2018
F15E41,legal-issues-defendant,100,22,12/13/2018
F15E41,legal-issues-defendant,100,22,12/13/2018
F30508,partnership,100,61,12/13/2018
F5D410,earnings-guidance,100,50,12/13/2018
F5D410,earnings-guidance,100,50,12/13/2018
F85CC0,investment-investor,100,55,12/13/2018
F93C8A,public-offering,100,43,12/13/2018
FADF1A,earnings,100,50,12/13/2018
03D5F9,legal-issues-defendant,100,22,12/14/2018
0C136E,dividend-up,100,62,12/14/2018
0DE3D5,executive-appointment,100,54,12/14/2018
0E64D4,acquisition-acquirer,100,49,12/14/2018
138DDE,dividend,100,50,12/14/2018
152E1D,legal-issues-defendant,100,22,12/14/2018
17EDA5,partnership,100,61,12/14/2018
221AD7,legal-issues-defendant,100,22,12/14/2018
251988,dividend-up,100,52,12/14/2018
267718,dividend,100,50,12/14/2018
2BF36E,dividend,100,50,12/14/2018
39FB23,acquisition-acquirer,100,49,12/14/2018
4A6F00,partnership,100,61,12/14/2018
4C92B9,legal-issues-defendant,100,22,12/14/2018
520632,dividend-up,100,64,12/14/2018
520632,dividend-up,100,64,12/14/2018
54DF47,dividend,100,50,12/14/2018
54DF47,dividend,100,50,12/14/2018
5876DC,executive-appointment,100,54,12/14/2018
5C7601,executive-appointment,100,54,12/14/2018
5D63F1,dividend,100,50,12/14/2018
5DA8B3,buybacks,100,74,12/14/2018
619882,dividend,100,50,12/14/2018
629F0F,equity-shelf-registration,100,43,12/14/2018
64E346,executive-appointment,100,54,12/14/2018
657097,dividend,100,50,12/14/2018
6ABCB8,dividend,100,50,12/14/2018
6BF593,dividend,100,50,12/14/2018
6D3B7B,dividend-up,100,81,12/14/2018
75F982,business-contract,100,69,12/14/2018
75F982,business-contract,100,69,12/14/2018
765913,executive-appointment,100,54,12/14/2018
7F7C87,ipo-pricing,100,50,12/14/2018
863350,facility-open,100,65,12/14/2018
8E82A6,business-contract,100,69,12/14/2018
977A1E,dividend-up,100,81,12/14/2018
986AF6,earnings-guidance,100,50,12/14/2018
A1EAC8,executive-appointment,100,54,12/14/2018
A5A4F5,conference-call,100,50,12/14/2018
A5A4F5,conference-call,100,50,12/14/2018
A5A4F5,acquisition-acquirer,100,49,12/14/2018
A6828A,clinical-trials-filed,100,60,12/14/2018
A6828A,clinical-trials-filed,100,60,12/14/2018
AD22F2,buybacks,100,74,12/14/2018
BDF85E,dividend,100,50,12/14/2018
BE379D,rights-issue,100,43,12/14/2018
C74887,earnings,100,50,12/14/2018
C9F39B,dividend,100,50,12/14/2018
CA99D7,acquisition-completed-acquirer,100,49,12/14/2018
CF6A5A,earnings,100,50,12/14/2018
CFD4B6,donation,100,54,12/14/2018
CFF97C,credit-rating-outlook-positive-rater,20,50,12/14/2018
D3FA2C,dividend,100,50,12/14/2018
D622D5,earnings,100,50,12/14/2018
D69D42,dividend,100,50,12/14/2018
D8442A,product-release,100,64,12/14/2018
D96202,conference-call,100,50,12/14/2018
E3E68E,buybacks,100,74,12/14/2018
E3E68E,legal-issues-defendant,100,22,12/14/2018
E3E68E,legal-issues-defendant,100,22,12/14/2018
E8B315,facility-open,100,65,12/14/2018
EA4E68,dividend-up,100,81,12/14/2018
EE967B,dividend,100,50,12/14/2018
EF5BED,earnings,100,50,12/14/2018
F15E41,legal-issues-defendant,100,22,12/14/2018
F294DD,dividend,100,50,12/14/2018
F30508,partnership,100,61,12/14/2018
F31B13,executive-appointment,100,54,12/14/2018
F4CDA3,dividend-up,100,81,12/14/2018
F6DCE4,product-release,100,64,12/14/2018
F80389,dividend,100,50,12/14/2018
F85CC0,dividend,100,50,12/14/2018
F93C8A,public-offering,100,43,12/14/2018
FAB97A,public-offering,100,43,12/14/2018
FD39EB,reorganization-complete,100,74,12/14/2018
FD39EB,reorganization-complete,100,74,12/14/2018
55438C,product-release,100,64,12/15/2018
9E91C6,executive-appointment,100,54,12/15/2018
6CC55E,partnership,100,61,12/16/2018
6CC55E,partnership,100,61,12/16/2018
0157B1,revenue-up,100,73,12/17/2018
0157B1,facility-open,100,65,12/17/2018
06C826,facility-open,100,65,12/17/2018
0CC01F,dividend-up,100,75,12/17/2018
10C19B,legal-issues-defendant,100,22,12/17/2018
143C9C,unit-acquisition-acquiree,100,76,12/17/2018
15901B,executive-appointment,100,54,12/17/2018
168A5D,executive-appointment,100,54,12/17/2018
16C544,credit-extension-recipient,100,69,12/17/2018
1AF7E2,dividend,100,50,12/17/2018
1CD708,executive-appointment,100,54,12/17/2018
1E04A5,executive-appointment,100,54,12/17/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/17/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/17/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/17/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/17/2018
21D903,executive-appointment,100,54,12/17/2018
221AD7,legal-issues-defendant,100,22,12/17/2018
25A6CC,unit-acquisition-acquirer,100,49,12/17/2018
25A6CC,unit-acquisition-acquirer,100,49,12/17/2018
26008A,revenue-up,100,69,12/17/2018
26008A,revenue-up,100,69,12/17/2018
26008A,revenue-up,100,69,12/17/2018
26008A,revenue-up,100,69,12/17/2018
26F99F,executive-appointment,100,54,12/17/2018
272472,buybacks,100,74,12/17/2018
27C10F,acquisition-acquirer,100,49,12/17/2018
27C10F,business-contract,100,69,12/17/2018
27C10F,business-contract,100,69,12/17/2018
27C10F,business-contract,100,69,12/17/2018
314D88,executive-appointment,100,54,12/17/2018
31AA84,dividend,100,50,12/17/2018
33AD83,conference-call,100,50,12/17/2018
35F4B5,private-placement,100,56,12/17/2018
39FB23,executive-appointment,100,54,12/17/2018
3A3447,facility-open,100,65,12/17/2018
3C8A04,conference-call,100,50,12/17/2018
3D9999,legal-issues-defendant,100,22,12/17/2018
416291,dividend,100,50,12/17/2018
416291,credit-extension-recipient,100,69,12/17/2018
420168,dividend,100,50,12/17/2018
449A26,conference-call,100,50,12/17/2018
450ECB,executive-appointment,100,54,12/17/2018
453282,earnings,100,50,12/17/2018
490D4B,award,100,58,12/17/2018
49914B,earnings-guidance,100,50,12/17/2018
4A2457,award,100,58,12/17/2018
4A5C8D,legal-issues-defendant,100,22,12/17/2018
4A6F00,congressional-testimony-summoned,100,50,12/17/2018
4C31F3,acquisition-acquirer,100,49,12/17/2018
4C92B9,legal-issues-defendant,100,22,12/17/2018
520632,conference-call,100,50,12/17/2018
5340D0,facility-open,100,65,12/17/2018
53E575,product-release,100,64,12/17/2018
5403F8,executive-appointment,100,54,12/17/2018
54DF47,acquisition-completed-acquirer,100,49,12/17/2018
54DF47,buybacks,100,74,12/17/2018
55438C,dividend-up,100,70,12/17/2018
56277A,conference-call,100,50,12/17/2018
5675EB,dividend,100,50,12/17/2018
5704AC,dividend,100,50,12/17/2018
59F0B0,conference-call,100,50,12/17/2018
5BE42C,executive-appointment,100,54,12/17/2018
5E1DF3,earnings-guidance,100,50,12/17/2018
619882,conference-organizer,100,57,12/17/2018
619882,conference-organizer,100,57,12/17/2018
619882,conference-organizer,100,57,12/17/2018
619882,conference-organizer,100,57,12/17/2018
619882,partnership,100,61,12/17/2018
619882,conference-organizer,100,57,12/17/2018
649CBD,legal-issues-defendant,100,22,12/17/2018
665440,patent-awarded,100,72,12/17/2018
6844D2,reorganization-unit,100,53,12/17/2018
693ECD,regulatory-product-approval-granted,100,81,12/17/2018
6CF43C,dividend,100,50,12/17/2018
6E705B,executive-appointment,100,54,12/17/2018
6FCEF9,buybacks,100,74,12/17/2018
70FCEF,executive-appointment,100,54,12/17/2018
7448A3,buybacks,100,74,12/17/2018
767F86,executive-resignation,100,44,12/17/2018
76BD96,dividend,100,50,12/17/2018
76DD0C,index-listing,100,76,12/17/2018
7DD8CC,dividend,100,50,12/17/2018
826FD6,dividend,100,50,12/17/2018
88350F,executive-appointment,100,54,12/17/2018
8AB37F,public-offering,100,43,12/17/2018
8B2C4A,merger,100,66,12/17/2018
8E93A4,merger,100,66,12/17/2018
8EDACA,legal-issues-defendant,100,22,12/17/2018
8EDACA,legal-issues-defendant,100,22,12/17/2018
9196A2,dividend,100,50,12/17/2018
91E5EE,private-placement,100,56,12/17/2018
94637C,partnership,100,61,12/17/2018
94637C,partnership,100,61,12/17/2018
9BF177,executive-appointment,100,54,12/17/2018
9FB4B7,executive-resignation,100,44,12/17/2018
9FD2D9,fundraising,100,64,12/17/2018
A1EAC8,product-release,100,64,12/17/2018
A5A4F5,acquisition-acquirer,100,49,12/17/2018
A5DD24,executive-appointment,100,54,12/17/2018
A6828A,buybacks,100,74,12/17/2018
A8FDE8,credit-extension-recipient,100,69,12/17/2018
A9ED24,dividend,100,50,12/17/2018
AC3584,investment-investor,100,55,12/17/2018
AD375D,dividend,100,50,12/17/2018
AED6CF,reverse-stock-splits,100,51,12/17/2018
B0998E,dividend,100,50,12/17/2018
B1A85D,executive-appointment,100,54,12/17/2018
B3CB74,sanctions-target,100,19,12/17/2018
B85DCE,executive-appointment,100,54,12/17/2018
BDD12C,executive-resignation,100,44,12/17/2018
C4C77F,merger-completed,100,66,12/17/2018
C4F9C6,clinical-trials-filed,100,60,12/17/2018
CA1620,partnership,100,61,12/17/2018
CC339B,executive-appointment,100,54,12/17/2018
CE5C6E,executive-appointment,100,54,12/17/2018
CEDFD5,clinical-trials-filed,100,60,12/17/2018
CEDFD5,clinical-trials-filed,100,60,12/17/2018
CEDFD5,clinical-trials-filed,100,60,12/17/2018
CEDFD5,clinical-trials-filed,100,60,12/17/2018
CF211D,earnings,100,50,12/17/2018
CFF15D,product-release,100,64,12/17/2018
D11C1C,dividend,100,50,12/17/2018
D33270,business-contract,100,69,12/17/2018
D598E7,conference-call,100,50,12/17/2018
D622D5,executive-appointment,100,54,12/17/2018
D63B0F,dividend,100,50,12/17/2018
D6EAA3,executive-appointment,100,54,12/17/2018
D7AC6E,conference-call,100,50,12/17/2018
E07573,executive-appointment,100,54,12/17/2018
E1E093,business-contract,100,69,12/17/2018
E26FC3,earnings,100,50,12/17/2018
E2F130,conference-call,100,50,12/17/2018
E38906,clinical-trials-positive,100,87,12/17/2018
E3E68E,legal-issues-defendant,100,22,12/17/2018
E3E68E,legal-issues-defendant,100,22,12/17/2018
E4CE73,partnership,100,61,12/17/2018
E71AE6,clinical-trials-start,100,64,12/17/2018
EBD89A,business-contract,100,69,12/17/2018
ED7F13,dividend,100,50,12/17/2018
EF77A3,legal-issues-defendant,100,22,12/17/2018
F0027C,clinical-trials-start,100,64,12/17/2018
F1529C,conference-call,100,50,12/17/2018
F4E882,executive-appointment,100,54,12/17/2018
FC1736,revenues,100,50,12/17/2018
FC1A6E,executive-appointment,100,54,12/17/2018
FDF799,executive-resignation,100,44,12/17/2018
FF6644,legal-issues-defendant,100,22,12/17/2018
0157B1,product-release,100,64,12/18/2018
20751,orphan-drug-designation,100,76,12/18/2018
03D5F9,executive-appointment,100,54,12/18/2018
03D5F9,legal-issues-defendant,100,22,12/18/2018
55018,conference-call,100,50,12/18/2018
05AF14,earnings,100,50,12/18/2018
05AF14,dividend,100,50,12/18/2018
07CA6A,executive-appointment,100,54,12/18/2018
07CA6A,executive-appointment,100,54,12/18/2018
0A7650,dividend,100,50,12/18/2018
0C2A0D,award,100,58,12/18/2018
0E64D4,executive-appointment,100,54,12/18/2018
108A2B,dividend,100,50,12/18/2018
10AE08,ipo-pricing,100,50,12/18/2018
12A3A3,revenue-up,100,69,12/18/2018
12A3A3,revenue-up,100,69,12/18/2018
12A3A3,revenue-up,100,69,12/18/2018
12A3A3,revenue-up,100,69,12/18/2018
12DE76,acquisition-interest-acquirer,100,46,12/18/2018
12DE76,partnership,100,61,12/18/2018
12E454,executive-appointment,100,54,12/18/2018
1490F3,executive-appointment,100,54,12/18/2018
152E1D,legal-issues-defendant,100,22,12/18/2018
15B10D,partnership,100,61,12/18/2018
184988,partnership,100,61,12/18/2018
184988,partnership,100,61,12/18/2018
1880C5,business-contract,100,69,12/18/2018
20BEEA,earnings-guidance,100,50,12/18/2018
26CC63,earnings-up,100,68,12/18/2018
26CC63,earnings-up,100,68,12/18/2018
26CC63,earnings-up,100,68,12/18/2018
26CC63,earnings-up,100,68,12/18/2018
292A70,trading-delisting,100,36,12/18/2018
2E6514,index-listing,100,76,12/18/2018
2EBA55,capital-increase,100,43,12/18/2018
2EBA55,capital-increase,100,43,12/18/2018
3.14E+47,dividend,100,50,12/18/2018
32DCB3,award,100,58,12/18/2018
33E9D5,earnings,100,50,12/18/2018
3461CF,credit-rating-affirmation-rater,20,50,12/18/2018
370C50,product-price-raise,100,57,12/18/2018
37B120,index-listing,100,76,12/18/2018
3A113F,conference-participant,100,50,12/18/2018
3A3447,facility-open,100,65,12/18/2018
3A3447,facility-open,100,65,12/18/2018
3BCF24,dividend,100,50,12/18/2018
3F4497,dividend,100,50,12/18/2018
4.00E+163,legal-issues-defendant,100,22,12/18/2018
431B74,product-release,100,64,12/18/2018
431B74,product-release,100,64,12/18/2018
43A060,partnership,100,61,12/18/2018
44209A,product-release,100,64,12/18/2018
49BBBC,earnings,100,50,12/18/2018
4A2457,business-contract,100,69,12/18/2018
4C5CC9,executive-appointment,100,54,12/18/2018
4D203E,acquisition-acquirer,100,49,12/18/2018
4D203E,business-contract,100,69,12/18/2018
4F783B,dividend,100,50,12/18/2018
4F9487,dividend,100,50,12/18/2018
545272,dividend,100,50,12/18/2018
56277A,conference-participant,100,50,12/18/2018
56EA2B,conference-participant,100,50,12/18/2018
58CA9A,award,100,58,12/18/2018
5B97B2,dividend-guidance,100,50,12/18/2018
5D41E4,business-contract,100,69,12/18/2018
5DA8B3,private-placement,100,56,12/18/2018
6166D1,dividend,100,50,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
619882,conference-organizer,100,57,12/18/2018
62F41C,dividend,100,50,12/18/2018
66667F,partnership,100,61,12/18/2018
676FFD,acquisition-acquirer,100,49,12/18/2018
6844D2,earnings,100,50,12/18/2018
6844D2,earnings,100,50,12/18/2018
6844D2,earnings,100,50,12/18/2018
6D3F35,legal-issues-defendant,100,22,12/18/2018
70FCEF,executive-appointment,100,54,12/18/2018
73BCBA,product-release,100,64,12/18/2018
73C521,earnings,100,50,12/18/2018
7.40E+289,dividend,100,50,12/18/2018
789A7D,executive-appointment,100,54,12/18/2018
78A1BB,executive-appointment,100,54,12/18/2018
82C202,earnings-guidance,100,50,12/18/2018
830BDB,conference-participant,100,50,12/18/2018
8377DB,dividend-up,100,81,12/18/2018
8AB37F,public-offering,100,43,12/18/2018
8C5519,earnings,100,50,12/18/2018
915E7B,dividend,100,50,12/18/2018
94983E,acquisition-completed-acquirer,100,49,12/18/2018
95DC1F,product-release,100,64,12/18/2018
95DC1F,partnership,100,61,12/18/2018
990AD0,dividend,100,50,12/18/2018
9BBFA5,earnings,100,50,12/18/2018
9BF177,earnings,100,50,12/18/2018
9C5174,conference-participant,100,50,12/18/2018
9D6A24,conference-call,100,50,12/18/2018
9E3224,dividend,100,50,12/18/2018
9E98F2,product-release,100,64,12/18/2018
A247F5,business-contract,100,69,12/18/2018
A26EF7,rights-issue,100,43,12/18/2018
A5151E,facility-open,100,65,12/18/2018
A5A4F5,acquisition-acquirer,100,49,12/18/2018
AA5C8E,legal-issues-defendant,100,22,12/18/2018
AE7D16,legal-issues-defendant,100,22,12/18/2018
B1FC3B,business-contract,100,69,12/18/2018
B642E8,dividend,100,50,12/18/2018
B76C82,executive-resignation,100,44,12/18/2018
B8A51F,conference-call,100,50,12/18/2018
BAD655,executive-appointment,100,54,12/18/2018
BDE867,partnership,100,61,12/18/2018
BDEC1E,clinical-trials,100,56,12/18/2018
BDEC1E,legal-issues-defendant,100,22,12/18/2018
BF79F5,dividend,100,50,12/18/2018
C03C8B,conference-participant,100,50,12/18/2018
C3BCD5,partnership,100,61,12/18/2018
C4FBDC,merger-failed,100,21,12/18/2018
C7859D,facility-open,100,65,12/18/2018
CAC8D0,executive-appointment,100,54,12/18/2018
D1C26F,product-release,100,64,12/18/2018
D1CFC8,earnings,100,50,12/18/2018
D4070C,executive-resignation,100,44,12/18/2018
D6489C,business-contract,100,69,12/18/2018
D9E036,joint-venture,100,62,12/18/2018
DBCA3F,executive-appointment,100,54,12/18/2018
DC0998,dividend,100,50,12/18/2018
E10D31,legal-issues-defendant,100,22,12/18/2018
E10D31,legal-issues-defendant,100,22,12/18/2018
E3E68E,legal-issues-defendant,100,22,12/18/2018
E3E68E,legal-issues-defendant,100,22,12/18/2018
E4158B,executive-appointment,100,54,12/18/2018
EBC84C,business-contract,100,69,12/18/2018
F04E05,buybacks,100,74,12/18/2018
F15E41,legal-issues-defendant,100,22,12/18/2018
F30508,partnership,100,61,12/18/2018
F30508,partnership,100,61,12/18/2018
F3EDB4,earnings,100,50,12/18/2018
F6A945,earnings,100,50,12/18/2018
F748C7,dividend,100,50,12/18/2018
FA40E2,business-contract,100,69,12/18/2018
FC9A88,dividend-up,100,81,12/18/2018
FE89E0,facility-sale,100,52,12/18/2018
03F5A4,dividend-up,100,81,12/19/2018
095A04,conference-participant,100,50,12/19/2018
0AB700,dividend,100,50,12/19/2018
14833D,legal-issues-defendant,100,22,12/19/2018
17EDA5,executive-appointment,100,54,12/19/2018
19BF16,conference-participant,100,50,12/19/2018
1BC12C,executive-appointment,100,54,12/19/2018
1CD4B5,partnership,100,61,12/19/2018
1E83DE,earnings,100,50,12/19/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/19/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/19/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/19/2018
1EBF8D,regulatory-product-approval-granted,100,81,12/19/2018
2031CE,acquisition-acquirer,100,49,12/19/2018
21153F,executive-appointment,100,54,12/19/2018
238302,dividend,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
251988,earnings,100,50,12/19/2018
267718,joint-venture,100,62,12/19/2018
26CC63,conference-participant,100,50,12/19/2018
292A70,earnings-up,100,68,12/19/2018
295F9F,credit-extension-recipient,100,69,12/19/2018
297DA8,executive-appointment,100,54,12/19/2018
29A4CC,business-contract,100,69,12/19/2018
342218,dividend,100,50,12/19/2018
3461CF,credit-rating-set-rater,20,50,12/19/2018
34B97A,executive-appointment,100,54,12/19/2018
36529A,clinical-trials-complete,100,56,12/19/2018
370C50,index-listing,100,76,12/19/2018
385DD4,legal-issues-defendant,100,22,12/19/2018
385DD4,legal-issues-defendant,100,22,12/19/2018
3A3447,facility-open,100,65,12/19/2018
3B37F7,business-contract,100,69,12/19/2018
3CCC90,conference-call,100,50,12/19/2018
3DDE54,earnings,100,50,12/19/2018
3FBC9B,executive-appointment,100,54,12/19/2018
429BFB,conference-participant,100,50,12/19/2018
442587,partnership,100,61,12/19/2018
44A4FC,conference-participant,100,50,12/19/2018
4649D5,executive-appointment,100,54,12/19/2018
4A2457,government-contract,100,69,12/19/2018
4A5C8D,acquisition-acquirer,100,49,12/19/2018
4C37C5,conference-call,100,50,12/19/2018
4C92B9,legal-issues-defendant,100,22,12/19/2018
4D8124,executive-appointment,100,54,12/19/2018
4E7C1F,conference-participant,100,50,12/19/2018
4FCC78,acquisition-completed-acquirer,100,49,12/19/2018
50070E,conference-organizer,100,57,12/19/2018
53E575,conference-participant,100,50,12/19/2018
55438C,legal-issues-defendant,100,22,12/19/2018
55438C,earnings,100,50,12/19/2018
55438C,conference-call,100,50,12/19/2018
57DDB9,partnership,100,61,12/19/2018
58CA9A,partnership,100,61,12/19/2018
59DB8C,earnings,100,50,12/19/2018
5B97B2,buybacks,100,74,12/19/2018
5E6959,unit-acquisition-acquiree,100,76,12/19/2018
5E7E82,executive-appointment,100,54,12/19/2018
609208,earnings,100,50,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
619882,conference-organizer,100,57,12/19/2018
633043,dividend,100,50,12/19/2018
63E8D5,dividend,100,50,12/19/2018
641F17,earnings,100,50,12/19/2018
6474BA,earnings,100,50,12/19/2018
6D156D,conference-participant,100,50,12/19/2018
6F6559,earnings,100,50,12/19/2018
6F6559,earnings,100,50,12/19/2018
6F6559,earnings,100,50,12/19/2018
6F6559,earnings,100,50,12/19/2018
717DB4,executive-appointment,100,54,12/19/2018
722D55,executive-appointment,100,54,12/19/2018
763724,dividend-up,100,81,12/19/2018
767F86,executive-appointment,100,54,12/19/2018
76F067,partnership,100,61,12/19/2018
76F067,partnership,100,61,12/19/2018
775439,dividend,100,50,12/19/2018
7A5097,executive-appointment,100,54,12/19/2018
7AB859,drilling,100,68,12/19/2018
7AB859,drilling,100,68,12/19/2018
7AF907,private-placement,100,56,12/19/2018
7BEA98,clinical-trials,100,56,12/19/2018
7D5FD6,earnings,100,50,12/19/2018
7E1D5D,partnership,100,61,12/19/2018
7E2DE6,earnings,100,50,12/19/2018
8377DB,business-contract,100,69,12/19/2018
8377DB,conference-call,100,50,12/19/2018
877C0C,conference-participant,100,50,12/19/2018
893904,index-listing,100,76,12/19/2018
895D56,executive-appointment,100,54,12/19/2018
911ACB,dividend,100,50,12/19/2018
913437,buybacks,100,74,12/19/2018
92B625,public-offering,100,43,12/19/2018
92D757,discrimination-defendant,100,36,12/19/2018
934029,conference-participant,100,50,12/19/2018
9.39E+69,orphan-drug-designation,100,76,12/19/2018
9470CC,note-sale,100,52,12/19/2018
979451,legal-issues-defendant,100,22,12/19/2018
9B5968,award,100,58,12/19/2018
9CA619,earnings,100,50,12/19/2018
9D30A8,unit-acquisition-acquirer,100,49,12/19/2018
9D65C1,executive-appointment,100,54,12/19/2018
9F03CF,executive-appointment,100,54,12/19/2018
A5A4F5,acquisition-acquirer,100,49,12/19/2018
A6828A,conference-call,100,50,12/19/2018
A7102F,conference-participant,100,50,12/19/2018
AD3C93,conference-call,100,50,12/19/2018
B1B10C,product-release,100,64,12/19/2018
B1B10C,product-release,100,64,12/19/2018
B1FC3B,business-contract,100,69,12/19/2018
B642E8,business-contract,100,69,12/19/2018
B7FA9B,business-contract,100,69,12/19/2018
B8EF97,legal-issues-defendant,100,22,12/19/2018
BB5142,executive-appointment,100,54,12/19/2018
BFE02C,executive-appointment,100,54,12/19/2018
C2E120,dividend,100,50,12/19/2018
C45C1F,clinical-trials-positive,100,87,12/19/2018
C4FBDC,business-contract,100,69,12/19/2018
C8FAC7,partnership,100,61,12/19/2018
C99CC8,executive-appointment,100,54,12/19/2018
CAC8D0,earnings,100,50,12/19/2018
CAC8D0,earnings,100,50,12/19/2018
CCBBAD,executive-resignation,100,44,12/19/2018
CDEDFE,buybacks,100,74,12/19/2018
CE4E6D,business-contract,100,69,12/19/2018
CE5C6E,conference-participant,100,50,12/19/2018
D4463B,dividend,100,50,12/19/2018
D854F3,conference-call,100,50,12/19/2018
D88EF3,partnership,100,61,12/19/2018
DC1405,conference-participant,100,50,12/19/2018
DFADDB,partnership,100,61,12/19/2018
E05026,earnings,100,50,12/19/2018
E3E68E,legal-issues-defendant,100,22,12/19/2018
E68733,acquisition-completed-acquirer,100,49,12/19/2018
E6EDED,conference-call,100,50,12/19/2018
E8A49A,executive-appointment,100,54,12/19/2018
E99180,dividend,100,50,12/19/2018
ED79D9,conference-participant,100,50,12/19/2018
F15E41,legal-issues-defendant,100,22,12/19/2018
F30508,dividend-up,100,65,12/19/2018
F30508,earnings-guidance,100,50,12/19/2018
F30508,earnings-guidance,100,50,12/19/2018
F30508,dividend-up,100,65,12/19/2018
F30508,partnership,100,61,12/19/2018
F5D410,conference-participant,100,50,12/19/2018
F6E248,partnership,100,61,12/19/2018
F80389,earnings-guidance,100,50,12/19/2018
F80389,earnings-guidance,100,50,12/19/2018
F80389,earnings-guidance,100,50,12/19/2018
FACF19,partnership,100,61,12/19/2018
002A99,clinical-trials-positive,100,87,12/20/2018
00698D,earnings,100,50,12/20/2018
13528,conference-participant,100,50,12/20/2018
01D03F,partnership,100,61,12/20/2018
09DE1F,partnership,100,61,12/20/2018
0A0CF0,earnings,100,50,12/20/2018
0A9D0A,conference-participant,100,50,12/20/2018
0C8D82,asset-sale,100,62,12/20/2018
0CCCB7,executive-appointment,100,54,12/20/2018
10100E,conference-participant,100,50,12/20/2018
1216D1,executive-appointment,100,54,12/20/2018
1490F3,acquisition-completed-acquirer,100,49,12/20/2018
152E1D,legal-issues-defendant,100,22,12/20/2018
157CC1,earnings,100,50,12/20/2018
168A5D,executive-appointment,100,54,12/20/2018
16FC89,buybacks,100,74,12/20/2018
1A2D9F,executive-appointment,100,54,12/20/2018
1A2D9F,executive-appointment,100,54,12/20/2018
1A9DE1,dividend,100,50,12/20/2018
1C2593,executive-appointment,100,54,12/20/2018
1FA8F7,note-sale,100,52,12/20/2018
1FC422,product-release,100,64,12/20/2018
221AD7,legal-issues-defendant,100,22,12/20/2018
227F04,acquisition-acquirer,100,49,12/20/2018
227F04,acquisition-acquirer,100,49,12/20/2018
22C58E,conference-participant,100,50,12/20/2018
24C48B,partnership,100,61,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
251988,earnings,100,50,12/20/2018
2.89E+11,executive-resignation,100,44,12/20/2018
2ABF77,conference-participant,100,50,12/20/2018
2BA977,stake-acquirer,100,48,12/20/2018
2BDC1C,index-listing,100,76,12/20/2018
2BF36E,legal-issues-defendant,100,22,12/20/2018
2BF36E,legal-issues-defendant,100,22,12/20/2018
2C7505,legal-issues-defendant,100,22,12/20/2018
2E89AE,conference-participant,100,50,12/20/2018
32F943,clinical-trials-filed,100,60,12/20/2018
342218,executive-appointment,100,54,12/20/2018
34B97A,executive-appointment,100,54,12/20/2018
396D7C,executive-appointment,100,54,12/20/2018
4017AD,dividend,100,50,12/20/2018
45BC35,conference-participant,100,50,12/20/2018
510EA6,earnings,100,50,12/20/2018
510EA6,earnings,100,50,12/20/2018
514067,legal-issues-defendant,100,22,12/20/2018
514067,legal-issues-defendant,100,22,12/20/2018
51B442,business-contract,100,69,12/20/2018
52FB2F,facility-open,100,65,12/20/2018
543900,executive-appointment,100,54,12/20/2018
54DF47,asset-sale,100,62,12/20/2018
55438C,product-release,100,64,12/20/2018
55438C,legal-issues-defendant,100,22,12/20/2018
55C9B5,conference-call,100,50,12/20/2018
586BD7,clinical-trials,100,56,12/20/2018
5C7601,earnings,100,50,12/20/2018
5CC29D,dividend-up,100,81,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
619882,conference-organizer,100,57,12/20/2018
627186,conference-participant,100,50,12/20/2018
62F41C,dividend,100,50,12/20/2018
64E346,acquisition-completed-acquirer,100,49,12/20/2018
665D7D,conference-participant,100,50,12/20/2018
665D7D,regulatory-product-application,100,69,12/20/2018
66ECFD,earnings,100,50,12/20/2018
67303E,legal-issues-defendant,100,22,12/20/2018
6810DE,partnership,100,61,12/20/2018
6810DE,partnership,100,61,12/20/2018
68E6E9,earnings,100,50,12/20/2018
69345C,index-listing,100,76,12/20/2018
6B67BD,index-listing,100,76,12/20/2018
6CC55E,clinical-trials-start,100,64,12/20/2018
6D3F35,index-listing,100,76,12/20/2018
6ED519,executive-appointment,100,54,12/20/2018
6F5DD2,earnings,100,50,12/20/2018
6F5DD2,earnings,100,50,12/20/2018
701531,patient-enrollment-complete,100,64,12/20/2018
7448A3,conference-participant,100,50,12/20/2018
75768D,earnings,100,50,12/20/2018
75768D,earnings,100,50,12/20/2018
75768D,earnings,100,50,12/20/2018
75768D,earnings,100,50,12/20/2018
76BD96,executive-appointment,100,54,12/20/2018
7771D7,earnings,100,50,12/20/2018
7ADE57,dividend,100,50,12/20/2018
7F3669,product-release,100,64,12/20/2018
7FEEE1,fast-track-designation,100,81,12/20/2018
82BB33,executive-resignation,100,44,12/20/2018
84AB66,dividend,100,50,12/20/2018
850779,earnings,100,50,12/20/2018
85AD00,acquisition-regulatory-approval-acquiree,100,81,12/20/2018
85DE00,conference-participant,100,50,12/20/2018
868808,dividend-up,100,72,12/20/2018
8D4486,partnership,100,61,12/20/2018
8E8E6E,business-contract,100,69,12/20/2018
8EDACA,legal-issues-defendant,100,22,12/20/2018
8FE7A5,government-contract,100,69,12/20/2018
8FE7A5,award,100,58,12/20/2018
911ACB,acquisition-regulatory-approval-acquirer,100,54,12/20/2018
91C82E,conference-call,100,50,12/20/2018
92D9C9,dividend,100,50,12/20/2018
9.31E+77,clinical-trials-positive,100,87,12/20/2018
95A92E,executive-appointment,100,54,12/20/2018
95DC1F,executive-resignation,100,44,12/20/2018
967D92,facility-sale,100,52,12/20/2018
96B4FF,conference-participant,100,50,12/20/2018
979451,legal-issues-defendant,100,22,12/20/2018
9978F1,index-listing,100,76,12/20/2018
9C25FF,executive-appointment,100,54,12/20/2018
9C5BA5,dividend,100,50,12/20/2018
A5151E,executive-appointment,100,54,12/20/2018
A5A4F5,acquisition-acquirer,100,49,12/20/2018
A6213D,conference-call,100,50,12/20/2018
A63387,partnership,100,61,12/20/2018
A6828A,regulatory-product-application,100,69,12/20/2018
AA98ED,business-contract,100,69,12/20/2018
AC7C4F,business-contract,100,69,12/20/2018
AECCA9,acquisition-acquirer,100,49,12/20/2018
AECCA9,acquisition-acquirer,100,49,12/20/2018
B290A2,orphan-drug-designation,100,76,12/20/2018
B48FC9,conference-participant,100,50,12/20/2018
B560AF,executive-appointment,100,54,12/20/2018
B5734D,business-contract,100,69,12/20/2018
B642E8,unit-acquisition-acquirer,100,49,12/20/2018
B8F71F,earnings,100,50,12/20/2018
BCE9DA,dividend,100,50,12/20/2018
BCE9DA,dividend,100,50,12/20/2018
BE645B,orphan-drug-designation,100,76,12/20/2018
BFAEB4,earnings,100,50,12/20/2018
BFE02C,conference-call,100,50,12/20/2018
C2E39B,note-sale,100,52,12/20/2018
C83B88,investment-investor,100,55,12/20/2018
C83B88,investment-investor,100,55,12/20/2018
C8FAC7,partnership,100,61,12/20/2018
CB7AB2,partnership,100,61,12/20/2018
CD2DA4,conference-participant,100,50,12/20/2018
CDAF5B,unit-acquisition-acquirer,100,49,12/20/2018
D064D5,earnings,100,50,12/20/2018
D07B07,conference-call,100,50,12/20/2018
D08D2C,fundraising,100,64,12/20/2018
D21D8A,dividend,100,50,12/20/2018
D4AC65,partnership,100,61,12/20/2018
D57D99,award,100,58,12/20/2018
D64C6D,earnings,100,50,12/20/2018
D697DE,conference-participant,100,50,12/20/2018
D7918D,settlement,100,56,12/20/2018
DBEF02,buybacks,100,74,12/20/2018
DC486E,earnings,100,50,12/20/2018
DF18E6,conference-participant,100,50,12/20/2018
DFADDB,index-listing,100,76,12/20/2018
E114F4,patent-awarded,100,72,12/20/2018
E11C41,dividend,100,50,12/20/2018
E3E68E,legal-issues-defendant,100,22,12/20/2018
E3E68E,legal-issues-defendant,100,22,12/20/2018
E61888,dividend,100,50,12/20/2018
E84500,dividend,100,50,12/20/2018
E8E899,earnings,100,50,12/20/2018
E959F3,earnings,100,50,12/20/2018
E96E0B,conference-participant,100,50,12/20/2018
ECD263,earnings,100,50,12/20/2018
ECDEB2,dividend,100,50,12/20/2018
ED79D9,award,100,58,12/20/2018
EEB5F9,conference-participant,100,50,12/20/2018
EF77A3,earnings,100,50,12/20/2018
F1CD47,conference-participant,100,50,12/20/2018
F30508,business-contract,100,69,12/20/2018
F6DE54,settlement,100,56,12/20/2018
F6E248,partnership,100,61,12/20/2018
F6E248,partnership,100,61,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FA40E2,earnings,100,50,12/20/2018
FACF19,partnership,100,61,12/20/2018
FACF19,earnings,100,50,12/20/2018
FDD3FC,clinical-trials-start,100,64,12/20/2018
FE7A63,earnings,100,50,12/20/2018
FF6644,legal-issues-defendant,100,22,12/20/2018
0157B1,business-contract,100,69,12/21/2018
03D5F9,legal-issues-defendant,100,22,12/21/2018
06EF42,earnings,100,50,12/21/2018
0A6824,business-contract,100,69,12/21/2018
10AE08,ipo-completed,100,76,12/21/2018
1151F4,conference-call,100,50,12/21/2018
152E1D,legal-issues-defendant,100,22,12/21/2018
1921DD,business-contract,100,69,12/21/2018
1E68B3,unit-acquisition-acquirer,100,49,12/21/2018
1EA923,conference-participant,100,50,12/21/2018
1FAF22,conference-call,100,50,12/21/2018
205AD5,conference-call,100,50,12/21/2018
221AD7,award,100,58,12/21/2018
2BF36E,legal-issues-defendant,100,22,12/21/2018
2BF36E,conference-participant,100,50,12/21/2018
2BF36E,legal-issues-defendant,100,22,12/21/2018
2F24A5,earnings,100,50,12/21/2018
339F20,dividend-up,100,57,12/21/2018
33FD66,earnings,100,50,12/21/2018
3461CF,award,100,58,12/21/2018
3798B9,executive-appointment,100,54,12/21/2018
3BE00F,dividend,100,50,12/21/2018
3DD5E2,conference-participant,100,50,12/21/2018
425BDC,force-majeure-lifted,100,75,12/21/2018
448BF3,conference-participant,100,50,12/21/2018
49F4D0,dividend,100,50,12/21/2018
4A5C8D,legal-issues-defendant,100,22,12/21/2018
4B3555,dividend,100,50,12/21/2018
4D371E,earnings,100,50,12/21/2018
50070E,conference-organizer,100,57,12/21/2018
5546DA,buybacks,100,74,12/21/2018
586BD7,conference-participant,100,50,12/21/2018
589846,legal-issues-plaintiff,100,44,12/21/2018
5F9CE3,asset-sale,100,62,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
619882,conference-organizer,100,57,12/21/2018
63F892,award,100,58,12/21/2018
649CBD,legal-issues-defendant,100,22,12/21/2018
657097,unit-acquisition-acquirer,100,49,12/21/2018
6F30F9,earnings,100,50,12/21/2018
6F6559,acquisition-completed-acquirer,100,49,12/21/2018
723548,dividend,100,50,12/21/2018
75F665,conference-call,100,50,12/21/2018
76DD0C,credit-extension-recipient,100,69,12/21/2018
7C4F43,index-listing,100,76,12/21/2018
8817D5,conference-call,100,50,12/21/2018
8EDACA,legal-issues-defendant,100,22,12/21/2018
92D757,asset-sale,100,62,12/21/2018
9.31E+77,conference-participant,100,50,12/21/2018
9.39E+69,index-listing,100,76,12/21/2018
9470CC,note-sale,100,52,12/21/2018
95F59E,conference-participant,100,50,12/21/2018
96F126,partnership,100,61,12/21/2018
96F126,business-contract,100,69,12/21/2018
9CA432,facility-open,100,65,12/21/2018
A47A7D,business-contract,100,69,12/21/2018
A47F2E,index-listing,100,76,12/21/2018
A4CD53,conference-participant,100,50,12/21/2018
A5A4F5,acquisition-acquirer,100,49,12/21/2018
A70BF5,earnings,100,50,12/21/2018
AA7FE0,earnings,100,50,12/21/2018
AA7FE0,earnings,100,50,12/21/2018
AA7FE0,earnings,100,50,12/21/2018
AA7FE0,earnings,100,50,12/21/2018
AA7FE0,earnings,100,50,12/21/2018
AFDF2E,earnings-revision,100,29,12/21/2018
B4F5F4,asset-sale,100,62,12/21/2018
B6CD92,dividend-up,100,81,12/21/2018
BE86A1,dividend,100,50,12/21/2018
C062D4,conference-participant,100,50,12/21/2018
C83B88,partnership,100,61,12/21/2018
C97B2D,conference-participant,100,50,12/21/2018
CD4DA8,partnership,100,61,12/21/2018
CE4E6D,business-contract,100,69,12/21/2018
CE4FD9,earnings,100,50,12/21/2018
D598E7,executive-appointment,100,54,12/21/2018
D63B0F,loan-provider,100,57,12/21/2018
D64C6D,executive-appointment,100,54,12/21/2018
DF11D9,executive-appointment,100,54,12/21/2018
E0339F,earnings,100,50,12/21/2018
E09E2B,legal-issues-defendant,100,22,12/21/2018
E10D31,legal-issues-defendant,100,22,12/21/2018
E2F66E,buybacks,100,74,12/21/2018
E3E68E,legal-issues-defendant,100,22,12/21/2018
E68E62,index-listing,100,76,12/21/2018
EAEA91,dividend,100,50,12/21/2018
EF7163,dividend,100,50,12/21/2018
F3D2EB,dividend,100,50,12/21/2018
F4F46F,conference-participant,100,50,12/21/2018
F5D410,executive-appointment,100,54,12/21/2018
F5D410,executive-appointment,100,54,12/21/2018
F82D37,conference-call,100,50,12/21/2018
168A5D,executive-appointment,100,54,12/22/2018
55438C,product-release,100,64,12/22/2018
E3E68E,legal-issues-defendant,100,22,12/22/2018
03D5F9,legal-issues-defendant,100,22,12/24/2018
10C19B,legal-issues-defendant,100,22,12/24/2018
16B882,credit-extension-recipient,100,69,12/24/2018
221AD7,legal-issues-defendant,100,22,12/24/2018
275300,conference-participant,100,50,12/24/2018
2BF36E,legal-issues-defendant,100,22,12/24/2018
301493,donation,100,54,12/24/2018
3D9999,legal-issues-defendant,100,22,12/24/2018
4.00E+163,legal-issues-defendant,100,22,12/24/2018
4A5C8D,legal-issues-defendant,100,22,12/24/2018
4A5C8D,legal-issues-defendant,100,22,12/24/2018
4F9926,business-contract,100,69,12/24/2018
514067,legal-issues-defendant,100,22,12/24/2018
514067,legal-issues-defendant,100,22,12/24/2018
619882,conference-organizer,100,57,12/24/2018
649CBD,legal-issues-defendant,100,22,12/24/2018
665D7D,partnership,100,61,12/24/2018
67303E,legal-issues-defendant,100,22,12/24/2018
67303E,legal-issues-defendant,100,22,12/24/2018
71B0CF,reverse-stock-splits,100,51,12/24/2018
8BAA15,business-contract,100,69,12/24/2018
8EDACA,legal-issues-defendant,100,22,12/24/2018
A5A4F5,acquisition-acquirer,100,49,12/24/2018
A6828A,conference-participant,100,50,12/24/2018
A8E72A,index-listing,100,76,12/24/2018
B8EF97,legal-issues-defendant,100,22,12/24/2018
CFF97C,credit-rating-set-rater,20,50,12/24/2018
DBEF02,executive-resignation,100,44,12/24/2018
E09E2B,legal-issues-defendant,100,22,12/24/2018
E09E2B,legal-issues-defendant,100,22,12/24/2018
E09E2B,legal-issues-defendant,100,22,12/24/2018
E3E68E,legal-issues-defendant,100,22,12/24/2018
E6BC2C,merger-completed,100,66,12/24/2018
EF77A3,legal-issues-defendant,100,22,12/24/2018
FF6644,legal-issues-defendant,100,22,12/24/2018
106394,unit-acquisition-completed-acquirer,100,49,12/26/2018
10C19B,legal-issues-defendant,100,22,12/26/2018
14833D,legal-issues-defendant,100,22,12/26/2018
152E1D,legal-issues-defendant,100,22,12/26/2018
1EBF8D,business-contract,100,69,12/26/2018
2BF36E,legal-issues-defendant,100,22,12/26/2018
2EBA55,buybacks,100,74,12/26/2018
385DD4,legal-issues-defendant,100,22,12/26/2018
385DD4,legal-issues-defendant,100,22,12/26/2018
3F96D5,product-release,100,64,12/26/2018
46017C,conference-participant,100,50,12/26/2018
4A5C8D,legal-issues-defendant,100,22,12/26/2018
514067,legal-issues-defendant,100,22,12/26/2018
55438C,legal-issues-defendant,100,22,12/26/2018
619882,conference-organizer,100,57,12/26/2018
619882,conference-organizer,100,57,12/26/2018
67303E,legal-issues-defendant,100,22,12/26/2018
8DCF18,conference-participant,100,50,12/26/2018
979451,legal-issues-defendant,100,22,12/26/2018
979451,legal-issues-defendant,100,22,12/26/2018
980C14,executive-appointment,100,54,12/26/2018
9B4066,unit-acquisition-acquirer,100,49,12/26/2018
9F37C5,dividend,100,50,12/26/2018
A0F146,executive-appointment,100,54,12/26/2018
AE7D16,legal-issues-defendant,100,22,12/26/2018
B5734D,loan-recipient,100,59,12/26/2018
B80AD1,product-release,100,64,12/26/2018
B80AD1,product-release,100,64,12/26/2018
C7859D,conference-call,100,50,12/26/2018
D15833,dividend,100,50,12/26/2018
D88EF3,conference-call,100,50,12/26/2018
E09E2B,legal-issues-defendant,100,22,12/26/2018
E10D31,legal-issues-defendant,100,22,12/26/2018
E10D31,legal-issues-defendant,100,22,12/26/2018
E3E68E,legal-issues-defendant,100,22,12/26/2018
EDF5CA,conference-call,100,50,12/26/2018
F15E41,legal-issues-defendant,100,22,12/26/2018
F7935D,product-release,100,64,12/26/2018
FD6926,conference-participant,100,50,12/26/2018
00067A,conference-participant,100,50,12/27/2018
00326D,conference-call,100,50,12/27/2018
95294,legal-issues-defendant,100,22,12/27/2018
0E2992,conference-call,100,50,12/27/2018
182BE7,conference-participant,100,50,12/27/2018
27A791,conference-participant,100,50,12/27/2018
27BFA1,conference-call,100,50,12/27/2018
2F7474,dividend,100,50,12/27/2018
31803E,conference-participant,100,50,12/27/2018
31F25C,conference-call,100,50,12/27/2018
4.00E+163,legal-issues-defendant,100,22,12/27/2018
4E4E75,conference-participant,100,50,12/27/2018
514067,legal-issues-defendant,100,22,12/27/2018
514067,legal-issues-defendant,100,22,12/27/2018
546A9C,conference-call,100,50,12/27/2018
55438C,business-contract,100,69,12/27/2018
55438C,legal-issues-defendant,100,22,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
619882,conference-organizer,100,57,12/27/2018
649CBD,legal-issues-defendant,100,22,12/27/2018
67303E,legal-issues-defendant,100,22,12/27/2018
76DD0C,conference-participant,100,50,12/27/2018
791D59,conference-participant,100,50,12/27/2018
834152,executive-resignation,100,44,12/27/2018
88193E,conference-participant,100,50,12/27/2018
8E10BF,fast-track-designation,100,81,12/27/2018
8E93A4,merger,100,66,12/27/2018
92B625,conference-call,100,50,12/27/2018
94563D,conference-participant,100,50,12/27/2018
A5A4F5,acquisition-acquirer,100,49,12/27/2018
A8B137,conference-call,100,50,12/27/2018
C2E39B,executive-appointment,100,54,12/27/2018
C45C1F,conference-participant,100,50,12/27/2018
C7859D,index-listing,100,76,12/27/2018
CB6A9C,acquisition-completed-acquirer,100,49,12/27/2018
CBBFBF,business-contract,100,69,12/27/2018
CC8F6E,conference-participant,100,50,12/27/2018
CE8A7B,partnership,100,61,12/27/2018
D2B9E5,executive-appointment,100,54,12/27/2018
D56E4C,acquisition-completed-acquiree,100,76,12/27/2018
D56E4C,asset-sale,100,62,12/27/2018
D650A7,equity-shelf-registration,100,43,12/27/2018
D93A25,conference-call,100,50,12/27/2018
E09E2B,legal-issues-defendant,100,22,12/27/2018
E124EB,conference-call,100,50,12/27/2018
E9FF33,earnings,100,50,12/27/2018
EAA0A7,campaign-ad-release,100,59,12/27/2018
95294,legal-issues-defendant,100,22,12/28/2018
95294,legal-issues-defendant,100,22,12/28/2018
0CC01F,earnings,100,50,12/28/2018
10C19B,earnings,100,50,12/28/2018
19CAC7,executive-resignation,100,44,12/28/2018
1F716B,conference-participant,100,50,12/28/2018
20403D,dividend,100,50,12/28/2018
21245F,fundraising,100,64,12/28/2018
25102A,conference-call,100,50,12/28/2018
251988,earnings,100,50,12/28/2018
272704,earnings,100,50,12/28/2018
451D61,conference-participant,100,50,12/28/2018
619882,conference-organizer,100,57,12/28/2018
619882,conference-organizer,100,57,12/28/2018
619882,conference-organizer,100,57,12/28/2018
67303E,legal-issues-defendant,100,22,12/28/2018
9004C4,dividend,100,50,12/28/2018
9F5CBB,dividend,100,50,12/28/2018
A5A4F5,acquisition-acquirer,100,49,12/28/2018
A631A3,dividend,100,50,12/28/2018
B5734D,conference-call,100,50,12/28/2018
C03C8B,conference-call,100,50,12/28/2018
C27E19,executive-resignation,100,44,12/28/2018
C9F39B,conference-call,100,50,12/28/2018
D65A13,conference-participant,100,50,12/28/2018
E09E2B,legal-issues-defendant,100,22,12/28/2018
E09E2B,legal-issues-defendant,100,22,12/28/2018
E8846E,business-contract,100,69,12/28/2018
FEE4B0,earnings,100,50,12/28/2018
14833D,legal-issues-defendant,100,22,12/29/2018
55438C,legal-issues-defendant,100,22,12/29/2018
B8EF97,legal-issues-defendant,100,22,12/29/2018
E10D31,legal-issues-defendant,100,22,12/29/2018
02FC1A,conference-participant,100,50,12/31/2018
036C6F,conference-call,100,50,12/31/2018
036C6F,earnings,100,50,12/31/2018
036C6F,earnings,100,50,12/31/2018
036C6F,earnings,100,50,12/31/2018
036C6F,earnings,100,50,12/31/2018
04CCCD,dividend,100,50,12/31/2018
95294,legal-issues-defendant,100,22,12/31/2018
0BC29E,acquisition-completed-acquirer,100,49,12/31/2018
0C6861,dividend,100,50,12/31/2018
1F19C8,credit-extension-provider,100,57,12/31/2018
1F9D90,conference-participant,100,50,12/31/2018
3D9999,legal-issues-defendant,100,22,12/31/2018
40F7DE,legal-issues-defendant,100,22,12/31/2018
40F7DE,legal-issues-defendant,100,22,12/31/2018
4A2457,business-contract,100,69,12/31/2018
594402,conference-participant,100,50,12/31/2018
619882,conference-organizer,100,57,12/31/2018
619882,conference-organizer,100,57,12/31/2018
619882,conference-organizer,100,57,12/31/2018
619882,conference-organizer,100,57,12/31/2018
619882,conference-organizer,100,57,12/31/2018
619882,conference-organizer,100,57,12/31/2018
649CBD,legal-issues-defendant,100,22,12/31/2018
69CE71,conference-participant,100,50,12/31/2018
6D3F35,spin-off,100,58,12/31/2018
913437,unit-acquisition-acquirer,100,49,12/31/2018
A5A4F5,acquisition-acquirer,100,49,12/31/2018
AD3C93,business-contract,100,69,12/31/2018
AED6CF,reverse-stock-splits,100,51,12/31/2018
B803B1,dividend,100,50,12/31/2018
B9764A,conference-participant,100,50,12/31/2018
BDA775,dividend,100,50,12/31/2018
DC0998,spin-off,100,58,12/31/2018
DC0998,spin-off,100,58,12/31/2018
FD554E,stake-acquirer,100,48,12/31/2018
FF6644,legal-issues-defendant,100,22,12/31/2018
